PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Asakura, H; Hashii, N; Uema, M; Kawasaki, N; Sugita-Konishi, Y; Igimi, S; Yamamoto, S				Asakura, Hiroshi; Hashii, Noritaka; Uema, Masashi; Kawasaki, Nana; Sugita-Konishi, Yoshiko; Igimi, Shizunobu; Yamamoto, Shigeki			Campylobacter jejuni pdxA Affects Flagellum-Mediated Motility to Alter Host Colonization	PLOS ONE			English	Article							ESCHERICHIA-COLI; PYRIDOXAL 5'-PHOSPHATE; GLYCOSYLATION; ACONITASE; BIOSYNTHESIS; GENES; VITAMIN-B-6; SEQUENCE; ENZYMES; ACNB	Vitamin B6 (pyridoxal-5'-phosphate, PLP) is linked to a variety of biological functions in prokaryotes. Here, we report that the pdxA (putative 4-hydroxy-L-threonine phosphate dehydrogenase) gene plays a pivotal role in the PLP-dependent regulation of flagellar motility, thereby altering host colonization in a leading foodborne pathogen, Campylobacter jejuni. A C. jejuni pdxA mutant failed to produce PLP and exhibited a coincident loss of flagellar motility. Mass spectrometric analyses showed a 3-fold reduction in the main flagellar glycan pseudaminic acid (Pse) associated with the disruption of pdxA. The pdxA mutant also exhibited reduced growth rates compared with the WT strain. Comparative metabolomic analyses revealed differences in respiratory/energy metabolism between WT C. jejuni and the pdxA mutant, providing a possible explanation for the differential growth fitness between the two strains. Consistent with the lack of flagellar motility, the pdxA mutant showed impaired motility-mediated responses (bacterial adhesion, ERK1/2 activation, and IL-8 production) in INT407 cells and reduced colonization of chickens compared with the WT strain. Overall, this study demonstrated that the pdxA gene affects the PLP-mediated flagellar motility function, mainly through alteration of Pse modification, and the disruption of this gene also alters the respiratory/energy metabolisms to potentially affect host colonization. Our data therefore present novel implications regarding the utility of PLP and its dependent enzymes as potent target(s) for the control of this pathogen in the poultry host.	[Asakura, Hiroshi; Uema, Masashi; Igimi, Shizunobu; Yamamoto, Shigeki] Natl Inst Hlth Sci, Div Biomed Food Res, Setagaya Ku, Tokyo 1588501, Japan; [Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo, Japan; [Sugita-Konishi, Yoshiko] Azabu Univ, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Azabu University	Asakura, H (corresponding author), Natl Inst Hlth Sci, Div Biomed Food Res, Setagaya Ku, Tokyo 1588501, Japan.	hasakura@nihs.go.jp	Asakura, Hiroshi/AAK-6592-2021	Asakura, Hiroshi/0000-0002-4890-037X	Japan Society for the Promotion of Science (JSPS) [22780275]; Ministry of Health, Labour, and Welfare, Japan [H24-shokuhin-ippan-009]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part through funding from a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (22780275), and a grant from Ministry of Health, Labour, and Welfare, Japan (H24-shokuhin-ippan-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura H, 2007, FEMS MICROBIOL LETT, V275, P278, DOI 10.1111/j.1574-6968.2007.00893.x; Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Bradbury AJ, 1996, MICROBIOL-SGM, V142, P389, DOI 10.1099/13500872-142-2-389; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Cunningham L, 1997, MICROBIOL-UK, V143, P3795, DOI 10.1099/00221287-143-12-3795; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Dick T, 2010, MOL MICROBIOL, V78, P980, DOI 10.1111/j.1365-2958.2010.07381.x; Drewke C, 2001, VITAM HORM, V61, P121; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Forouhar F, 2010, ACTA CRYSTALLOGR F, V66, P1562, DOI 10.1107/S1744309110040649; Friedman C.R., 2000, CAMPYLOBACTER, P121; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; Grubman A, 2010, MBIO, V1, DOI 10.1128/mBio.00112-10; Guccione E, 2010, ENVIRON MICROBIOL, V12, P576, DOI 10.1111/j.1462-2920.2009.02096.x; GUERRY P, 1991, J BACTERIOL, V173, P4757, DOI 10.1128/jb.173.15.4757-4764.1991; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; GUERRY P, 1994, METHOD ENZYMOL, V235, P474; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Hobb RI, 2009, MICROBIOL-SGM, V155, P979, DOI 10.1099/mic.0.024539-0; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Kappes B, 2011, BBA-PROTEINS PROTEOM, V1814, P1567, DOI 10.1016/j.bbapap.2011.07.018; Keeney KM, 2011, CURR OPIN MICROBIOL, V14, P92, DOI 10.1016/j.mib.2010.12.012; Kelly DJ, 2001, HELICOBACTER PYLORI; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Line JE, 2010, J MICROBIOL METH, V80, P198, DOI 10.1016/j.mimet.2009.12.011; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Malerba F, 2007, BIOCHEM J, V404, P477, DOI 10.1042/BJ20061681; McNally DJ, 2006, J BIOL CHEM, V281, P18489, DOI 10.1074/jbc.M603777200; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Mozzarelli A, 2006, CHEM REC, V6, P275, DOI 10.1002/tcr.20094; Muller IB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004406; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; NACHAMKIN I, 1993, APPL ENVIRON MICROB, V59, P1269, DOI 10.1128/AEM.59.5.1269-1273.1993; Obhi RK, 2005, J BIOL CHEM, V280, P20902, DOI 10.1074/jbc.M413832200; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; REYES AA, 1994, AM J PHYSIOL, V267, pF331, DOI 10.1152/ajprenal.1994.267.3.F331; Safo MK, 2005, ACTA CRYSTALLOGR D, V61, P599, DOI 10.1107/S0907444905005512; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Stahl M, 2011, FUNCT INTEGR GENOMIC, V11, P241, DOI 10.1007/s10142-011-0214-7; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Velayudhan J, 2004, INFECT IMMUN, V72, P260, DOI 10.1128/IAI.72.1.260-268.2004; Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033; Watson RO, 2005, CELL MICROBIOL, V7, P655, DOI 10.1111/j.1462-5822.2004.00498.x; Weerakoon DR, 2009, MICROB PATHOGENESIS, V47, P8, DOI 10.1016/j.micpath.2009.04.009; WU WH, 1973, J BIOL CHEM, V248, P1696; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Yuki N, 2010, METHODS MOL BIOL, V600, P51, DOI 10.1007/978-1-60761-454-8_4	59	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70418	10.1371/journal.pone.0070418	http://dx.doi.org/10.1371/journal.pone.0070418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936426	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500033
J	Hernandez-Avila, JE; Rodriguez, MH; Santos-Luna, R; Sanchez-Castaneda, V; Roman-Perez, S; Rios-Salgado, VH; Salas-Sarmiento, JA				Eugenio Hernandez-Avila, Juan; Rodriguez, Mario-Henry; Santos-Luna, Rene; Sanchez-Castaneda, Veronica; Roman-Perez, Susana; Hugo Rios-Salgado, Victor; Alberto Salas-Sarmiento, Jesus			Nation-Wide, Web-Based, Geographic Information System for the Integrated Surveillance and Control of Dengue Fever in Mexico	PLOS ONE			English	Article							IMPLEMENTATION; TECHNOLOGIES; IMPACT	Dengue fever incidence and its geographical distribution are increasing throughout the world. Quality and timely information is essential for its prevention and control. A web based, geographically enabled, dengue integral surveillance system (Dengue-GIS) was developed for the nation-wide collection, integration, analysis and reporting of geo-referenced epidemiologic, entomologic, and control interventions data. Consensus in the design and practical operation of the system was a key factor for its acceptance. Working with information systems already implemented as a starting point facilitated its acceptance by officials and operative personnel. Dengue-GIS provides the geographical detail needed to plan, asses and evaluate the impact of control activities. The system is beginning to be adopted as a knowledge base by vector control programs. It is used to generate evidence on impact and cost-effectiveness of control activities, promoting the use of information for decision making at all levels of the vector control program. Dengue-GIS has also been used as a hypothesis generator for the academic community. This GIS-based model system for dengue surveillance and the experience gathered during its development and implementation could be useful in other dengue endemic countries and extended to other infectious or chronic diseases.	[Eugenio Hernandez-Avila, Juan; Rodriguez, Mario-Henry; Santos-Luna, Rene; Sanchez-Castaneda, Veronica; Roman-Perez, Susana; Hugo Rios-Salgado, Victor] Natl Inst Publ Hlth Mexico, Cuernavaca, Morelos, Mexico; [Alberto Salas-Sarmiento, Jesus] Publ Hlth Sch Mexico, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica	Santos-Luna, R (corresponding author), Natl Inst Publ Hlth Mexico, Cuernavaca, Morelos, Mexico.	rsantos@insp.mx	Santos Luna, Rene/C-8724-2014	Santos Luna, Rene/0000-0002-4730-5317; Hernandez-Avila, Juan Eugenio/0000-0001-9638-6718	National Council for Science and Technology "CONACyT"	National Council for Science and Technology "CONACyT"(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by the National Council for Science and Technology "CONACyT" (http://www.conacyt.gob.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; Bivand R, 2008, APPL SPATIAL DATA AN, Vxiv; Center for Disease Control, 2012, DENGUENET; Chalermkittichai S, 2006, APPL WEB BASED GEOGR; Chang AY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-49; Chao DL, 2012, PLOS NEGLECT TROP D, V6, P1; Cuellar-Luna LC-RM, 2009, GEOGRAPHICAL INFORM, P166; Duncombe J, 2012, AM J TROP MED HYG, V86, P753, DOI 10.4269/ajtmh.2012.11-0650; ESRI, 2011, ARCGIS DESKT REL 10; Fong J., 1999, J BRAZILIAN COMPUTER, V6, P50; Halstead SB, 2002, LANCET, V360, P1243, DOI 10.1016/S0140-6736(02)11276-1; Health Metrics Network WHO, 2005, REV HLTH INF SYST HI; Instituto Nacional de Estadistica y Geografia, 2010, MARC GEOEST NAC; Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042; Kusnanto H FA, WEB BASED INTEGRATED; Letson GW, 2009, J CLIN VIROL, V46, pS10, DOI 10.1016/S1386-6532(09)70288-4; Levine N, 2010, HOT SPOT ANALISIS 1; Mihalas GI, 2008, STUD HEALTH TECHNOL, V134, P21; Minnesota Uo, 2011, MAPSERVER 6 2 0 DOC; Neteler M, 2004, OPEN SOURCE GIS GRAS, Vxxvi; OCDE, 2005, EST OCDE SIST SAL; Roman-Vinas R, 2010, MED CLIN-BARCELONA, V134, P39, DOI 10.1016/S0025-7753(10)70008-7; San-Martin J, 2007, REV PANAM SALUD PUBL, V21; [Secretaria de Salud Centro Nacional para la Prevencion y Control de Enfermedades (CENAVECE)], 2007, PROGR ACC ESP DENG 2; Secretaria de Salud, 2011, DIARIO OFICIAL FEDER; Secretaria de Salud, 2010, PAN NAC DENG; [Secretaria de Salud Centro Nacional para la Prevencion y Control de Enfermedades (CENAVECE)], 2008, LIN VIG EP FIEBR DEN; Secretaria de Salud, 1994, DIARIO OFICIAL FEDER; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Sithiprasasna Ratana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P918; WHO, 2009, DENGUE DENGUE HAEMOR; World Health Organization, 2012, GLOB HLTH ATL	32	45	50	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70231	10.1371/journal.pone.0070231	http://dx.doi.org/10.1371/journal.pone.0070231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936394	gold, Green Submitted, Green Published			2022-12-27	WOS:000324401500025
J	Kalra, RS; Bapat, SA				Kalra, Rajkumar S.; Bapat, Sharmila A.			Expression Proteomics Predicts Loss of RXR-gamma during Progression of Epithelial Ovarian Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; GENETIC PROGRESSION; PROTEIN EXPRESSION; STEM; APOPTOSIS; MODEL; TRANSFORMATION; HALLMARKS	The process of cellular transformation involves cascades of molecular changes that are modulated through altered epigenetic, transcription, post-translational and protein regulatory networks. Thus, identification of transformation-associated protein alterations can provide an insight into major regulatory pathways activated during disease progression. In the present protein expression profiling approach, we identified differential sets of proteins in a two-dimensional gel electrophoresis screen of a serous ovarian adenocarcinoma progression model. Function-based categorization of the proteins exclusively associated with pre-transformed cells identified four cellular processes of which RXR-gamma is known to modulate cellular differentiation and apoptosis. We thus probed the functional relevance of RXR-gamma expression and signaling in these two pathways during tumor progression. RXR-gamma expression was observed to modulate cellular differentiation and apoptosis in steady-state pre-transformed cells. Interestingly, retinoid treatment was found to enhance RXR-gamma expression in transformed cells and sensitize them towards apoptosis in vitro, and also reduce growth of xenografts derived from transformed cells. Our findings emphasize that loss of RXR-gamma levels appears to provide mechanistic benefits to transformed cells towards the acquisition of resistance to apoptosis hallmark of cancer, while effective retinoid treatment may present a viable approach towards sensitization of tumor cells to apoptosis through induction of RXR-gamma expression.	[Kalra, Rajkumar S.; Bapat, Sharmila A.] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Bapat, SA (corresponding author), Natl Ctr Cell Sci, NCCS Complex,Pune Univ Campus, Pune, Maharashtra, India.	sabapat@nccs.res.in	Bapat, Sharmila/AGU-4130-2022; Kalra, RAJKUMAR S/L-6944-2018	Bapat, Sharmila/0000-0002-9557-2233; Kalra, RAJKUMAR S/0000-0002-8181-457X	Department of Biotechnology, Government of India, New Delhi [BT/PR7186/MED/14/965/2006]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India, New Delhi to SAB [Grant no. BT/PR7186/MED/14/965/2006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Am Can So Inc., 2012, CANC FACTS FIG 2012; Auersperg N, 1997, J CELL PHYSIOL, V173, P261, DOI 10.1002/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO;2-G; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Brabender J, 2005, CARCINOGENESIS, V26, P525, DOI 10.1093/carcin/bgi006; Califano J, 1996, CANCER RES, V56, P2488; Cvetkovic D, 2003, CLIN CANCER RES, V9, P1013; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Dumont N, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2457; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Garnis C, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-9; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Konopleva M, 2004, MOL CANCER THER, V3, P1249; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Kuppumbatti YS, 2000, J NATL CANCER I, V92, P475, DOI 10.1093/jnci/92.6.475; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lee SM, 2010, CANCER GENET CYTOGEN, V197, P39, DOI 10.1016/j.cancergencyto.2009.10.008; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Roberts D, 2002, DNA CELL BIOL, V21, P11, DOI 10.1089/10445490252810276; Sharma N, 2010, DIFFERENTIATION, V79, P218, DOI 10.1016/j.diff.2010.02.001; SIMONEAU AR, 1994, WORLD J UROL, V12, P89; Wani AA, 2006, ONCOGENE, V25, P6336, DOI 10.1038/sj.onc.1209649; Xie BX, 2011, J ANDROL, V32, P170, DOI 10.2164/jandrol.109.008748	32	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70398	10.1371/journal.pone.0070398	http://dx.doi.org/10.1371/journal.pone.0070398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936423	Green Submitted, gold, Green Published			2022-12-27	WOS:000324401500032
J	Borchers, S; Freund, S; Rath, A; Streif, S; Reichl, U; Findeisen, R				Borchers, Steffen; Freund, Susann; Rath, Alexander; Streif, Stefan; Reichl, Udo; Findeisen, Rolf			Identification of Growth Phases and Influencing Factors in Cultivations with AGE1.HN Cells Using Set-Based Methods	PLOS ONE			English	Article							PARAMETER-ESTIMATION; OPTIMIZATION METHOD; MODEL INVALIDATION; HYBRIDOMA GROWTH; METABOLISM; MEDIA; PH; CONSUMPTION; IMPROVEMENT; SUBSTRATE	Production of bio-pharmaceuticals in cell culture, such as mammalian cells, is challenging. Mathematical models can provide support to the analysis, optimization, and the operation of production processes. In particular, unstructured models are suited for these purposes, since they can be tailored to particular process conditions. To this end, growth phases and the most relevant factors influencing cell growth and product formation have to be identified. Due to noisy and erroneous experimental data, unknown kinetic parameters, and the large number of combinations of influencing factors, currently there are only limited structured approaches to tackle these issues. We outline a structured set-based approach to identify different growth phases and the factors influencing cell growth and metabolism. To this end, measurement uncertainties are taken explicitly into account to bound the time-dependent specific growth rate based on the observed increase of the cell concentration. Based on the bounds on the specific growth rate, we can identify qualitatively different growth phases and (in-)validate hypotheses on the factors influencing cell growth and metabolism. We apply the approach to a mammalian suspension cell line (AGE1.HN). We show that growth in batch culture can be divided into two main growth phases. The initial phase is characterized by exponential growth dynamics, which can be described consistently by a relatively simple unstructured and segregated model. The subsequent phase is characterized by a decrease in the specific growth rate, which, as shown, results from substrate limitation and the pH of the medium. An extended model is provided which describes the observed dynamics of cell growth and main metabolites, and the corresponding kinetic parameters as well as their confidence intervals are estimated. The study is complemented by an uncertainty and outlier analysis. Overall, we demonstrate utility of set-based methods for analyzing cell growth and metabolism under conditions of uncertainty.	[Borchers, Steffen; Streif, Stefan; Findeisen, Rolf] Otto Von Guericke Univ, Inst Syst Theory & Automat Control, Magdeburg, Germany; [Borchers, Steffen; Freund, Susann] Int Max Planck Res Sch, Magdeburg, Germany; [Freund, Susann; Rath, Alexander; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Freund, Susann; Reichl, Udo] Otto Von Guericke Univ, Inst Proc Engn, Magdeburg, Germany	Otto von Guericke University; Max Planck Society; Max Planck Society; Otto von Guericke University	Findeisen, R (corresponding author), Otto Von Guericke Univ, Inst Syst Theory & Automat Control, Magdeburg, Germany.	rolf.findeisen@ovgu.de	Findeisen, Rolf/E-9630-2013	Findeisen, Rolf/0000-0002-9112-5946; Streif, Stefan/0000-0002-3398-1226	German Federal Ministry of Education & Research (BMBF) [0315506B]	German Federal Ministry of Education & Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by the German Federal Ministry of Education & Research (BMBF) grant number 0315506B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey J.E., 1986, BIOCH ENG FUNDAMENTA; Bailey JE, 1996, BIOTECHNOL BIOENG, V52, P109, DOI 10.1002/(SICI)1097-0290(19961005)52:1<109::AID-BIT11>3.3.CO;2-1; Balsa-Canto E, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-26; Banga JR, 2002, IND ENG CHEM RES, V41, P2425, DOI 10.1021/ie010183d; BATT BC, 1989, BIOTECHNOL BIOENG, V34, P515, DOI 10.1002/bit.260340412; Ben-Gal I, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P131, DOI 10.1007/0-387-25465-X_7; Borchers S, 2009, IEEE DECIS CONTR P, P6786, DOI 10.1109/CDC.2009.5400403; Boyd S., 2004, CONVEX OPTIMIZATION; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chmiel H, 2006, BIOPROZESSTECHNIK; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Cruz HJ, 1999, BIOTECHNOL BIOENG, V66, P104, DOI 10.1002/(SICI)1097-0290(1999)66:2<104::AID-BIT3>3.0.CO;2-#; De Alwis DM, 2007, BIOPROC BIOSYST ENG, V30, P107, DOI 10.1007/s00449-006-0107-7; Doyle A, 1998, CELLS TISSUE CULT; Dunn I. J., 2003, BIOL REACTION ENG; EAGLE H, 1973, J CELL PHYSIOL, V82, P1, DOI 10.1002/jcp.1040820102; Ederer M, 2007, BIOPHYS J, V92, P1846, DOI 10.1529/biophysj.106.094094; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Frahm B, 2003, BIOPROC BIOSYST ENG, V26, P1, DOI 10.1007/s00449-003-0335-z; Funk W., 2007, QUALITY ASSURANCE AN; GOERGEN JL, 1993, CYTOTECHNOLOGY, V11, P189, DOI 10.1007/BF00749869; Haag JE, 2005, BIOPROC BIOSYST ENG, V27, P303, DOI 10.1007/s00449-005-0408-2; Haggstrom L, 2000, CELL METABOLISM ANIM; Hodge VJ, 2004, ARTIF INTELL REV, V22, P85, DOI 10.1023/B:AIRE.0000045502.10941.a9; Jaqaman K, 2006, NAT REV MOL CELL BIO, V7, P813, DOI 10.1038/nrm2030; Johnson R. A., 2002, APPL MULTIVARIATE ST, V4; Joshi M, 2006, METAB ENG, V8, P447, DOI 10.1016/j.ymben.2006.04.003; Kikuchi S, 2003, BIOINFORMATICS, V19, P643, DOI 10.1093/bioinformatics/btg027; Kim SY, 2003, COMPUT OPTIM APPL, V26, P143, DOI 10.1023/A:1025794313696; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kojima M, 2003, J OPER RES SOC JPN, V46, P125, DOI 10.15807/jorsj.46.125; Kremling A, 2004, GENOME RES, V14, P1773, DOI 10.1101/gr.1226004; Kuepfer L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-12; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Ljung L., 1998, SYSTEM IDENTIFICATIO; Lohr V, 2009, VACCINE, V27, P4975, DOI 10.1016/j.vaccine.2009.05.083; Looby M, 2011, BIOTECHNOL PROGR, V27, P1718, DOI 10.1002/btpr.672; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; MCQUEEN A, 1990, BIOTECHNOL BIOENG, V35, P1067, DOI 10.1002/bit.260351102; Meier SJ, 1999, BIOTECHNOL BIOENG, V62, P468, DOI 10.1002/(SICI)1097-0290(19990220)62:4<468::AID-BIT10>3.0.CO;2-N; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Neermann J, 1996, J CELL PHYSIOL, V166, P152; Nesterov Y, 1994, SIAM J APPL MATH, V13; Niklas J, 2011, BIOPROC BIOSYST ENG, V34, P533, DOI 10.1007/s00449-010-0502-y; O'Sullivan F., 1986, STAT SCI, V1, P502, DOI DOI 10.1214/ss/1177013525; Oliveira O, 2004, COMPUT PHYS COMMUN, V158, P73, DOI 10.1016/j.cpc.2003.12.001; Orman Mehmet A., 2011, Critical Reviews in Biomedical Engineering, V39, P511; OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P121, DOI 10.1021/bp00002a005; OZTURK SS, 1992, BIOTECHNOL BIOENG, V39, P418, DOI 10.1002/bit.260390408; Portner R, 1996, J BIOTECHNOL, V49, P119, DOI 10.1016/0168-1656(96)01535-0; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Rumschinski P, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-69; Sandig V, 2007, [No title captured], Patent No. [Wo 2007/054516a1, 2007054516]; Stephanopoulos G. N., 1998, METAB ENG, P115, DOI [10.1016/b978-012666260-3/50005-4, DOI 10.1016/B978-012666260-3/50005-4]; Streif S, 2012, BIOINFORMATICS, V28, P1290, DOI 10.1093/bioinformatics/bts137; TZIAMPAZIS E, 1994, CYTOTECHNOLOGY, V14, P191, DOI 10.1007/BF00749616; Wahl A, 2008, BIOTECHNOL BIOENG, V101, P135, DOI 10.1002/bit.21873; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; Yu M, 2011, BIOTECHNOL BIOENG, V108, P1078, DOI 10.1002/bit.23031; ZENG AP, 1995, BIOTECHNOL PROGR, V11, P71, DOI 10.1021/bp00031a010	60	9	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e68124	10.1371/journal.pone.0068124	http://dx.doi.org/10.1371/journal.pone.0068124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936299	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800003
J	Lehmann, M; Nguemo, F; Wagh, V; Pfannkuche, K; Hescheler, J; Reppel, M				Lehmann, Martin; Nguemo, Filomain; Wagh, Vilas; Pfannkuche, Kurt; Hescheler, Juergen; Reppel, Michael			Evidence for a Critical Role of Catecholamines for Cardiomyocyte Lineage Commitment in Murine Embryonic Stem Cells	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE GENE; MOUSE FETAL-DEVELOPMENT; TARGETED DISRUPTION; RESERPINE RIGIDITY; PARKINSONS-DISEASE; DIFFERENTIATION; EPINEPHRINE; RECEPTORS; PROTEIN; TISSUE	Catecholamine release is known to modulate cardiac output by increasing heart rate. Although much is known about catecholamine function and regulation in adults, little is known about the presence and role of catecholamines during heart development. The present study aimed therefore to evaluate the effects of different catecholamines on early heart development in an in vitro setting using embryonic stem (ES) cell-derived cardiomyocytes. Effects of catecholamine depletion induced by reserpine were examined in murine ES cells (line D3, alpha PIG44) during differentiation. Cardiac differentiation was assessed by immunocytochemistry, qRT-PCR, quantification of beating clusters, flow cytometry and pharmacological approaches. Proliferation was analyzed by EB cross-section measurements, while functionality of cardiomyocytes was studied by extracellular field potential (FP) measurements using microelectrode arrays (MEAs). To further differentiate between substance-specific effects of reserpine and catecholamine action via alpha- and beta-receptors we proved the involvement of adrenergic receptors by application of unspecific alpha- and beta-receptor antagonists. Reserpine treatment led to remarkable down-regulation of cardiac-specific genes, proteins and mesodermal marker genes. In more detail, the average ratio of similar to 40% spontaneously beating control clusters was significantly reduced by 100%, 91.1% and 20.0% on days 10, 12, and 14, respectively. Flow cytometry revealed a significant reduction (by 71.6%, n = 11) of eGFP positive CMs after reserpine treatment. By contrast, reserpine did not reduce EB growth while number of neuronal cells in reserpine-treated EBs was significantly increased. MEA measurements of reserpine-treated EBs showed lower FP frequencies and weak responsiveness to adrenergic and muscarinic stimulation. Interestingly we found that developmental inhibition after alpha- and beta-adrenergic blocker application mimicked developmental changes with reserpine. Using several methodological approaches our data suggest that reserpine inhibits cardiac differentiation. Thus catecholamines play a critical role during development.	[Lehmann, Martin; Nguemo, Filomain; Pfannkuche, Kurt; Hescheler, Juergen; Reppel, Michael] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany; [Wagh, Vilas] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Reppel, Michael] Med Univ Lubeck, Dept Cardiol, D-23538 Lubeck, Germany	University of Cologne; University of California System; University of California San Francisco; University of Lubeck	Lehmann, M (corresponding author), Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany.	lehmannm@uni-koeln.de	Wagh, Vilas/B-3267-2009	Nguemo, Filomain/0000-0002-2236-6797; Pfannkuche, Kurt Paul/0000-0002-4284-774X	BMBF [FKZ 0313926B]; Koln Fortune	BMBF(Federal Ministry of Education & Research (BMBF)); Koln Fortune	The project was funded by the "BMBF" (FKZ 0313926B; www.bmbf.de) and the "Koln Fortune" (http://www.medfak.uni-koeln.de/index.php?id=195) Program. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CAT; Banach K, 2003, AM J PHYSIOL-HEART C, V284, pH2114, DOI 10.1152/ajpheart.01106.2001; Bezard E, 1998, REV NEUROSCIENCE, V9, P71; Bezard E, 2011, MOVEMENT DISORD, V26, P993, DOI 10.1002/mds.23696; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; CARON MG, 1993, RECENT PROG HORM RES, V48, P277; Ebert SN, 2004, DEV DYNAM, V231, P849, DOI 10.1002/dvdy.20188; Ebert SN, 2001, CIRC RES, V88, P117, DOI 10.1161/01.RES.88.1.117; Ebert SN, 2006, CARDIOVASC RES, V72, P364, DOI 10.1016/j.cardiores.2006.08.013; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; FLACH FF, 1955, ANN NY ACAD SCI, V61, P161, DOI 10.1111/j.1749-6632.1955.tb42462.x; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Frenzel LP, 2009, STEM CELLS, V27, P307, DOI 10.1634/stemcells.2008-0528; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; HODACH RJ, 1974, TERATOLOGY, V9, P203, DOI 10.1002/tera.1420090211; HSU FONG-YEN, 1933, CHINESE JOUR PHYSIOL, V7, P243; Huang MH, 1996, J CLIN INVEST, V98, P1298, DOI 10.1172/JCI118916; IGNARRO LJ, 1968, J PHARMACOL EXP THER, V159, P38; JURNA I, 1969, N-S ARCH PHARMAKOL, V262, P309, DOI 10.1007/BF00538433; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Keys JR, 2004, RECENT PROG HORM RES, V59, P13, DOI 10.1210/rp.59.1.13; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kobayashi K, 2000, J NEUROSCI, V20, P2418; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Markowitz C, 1931, AM J PHYSIOL, V97, P271, DOI 10.1152/ajplegacy.1931.97.2.271; MORRISON AB, 1973, NEUROPHARMACOLOGY, V12, P725, DOI 10.1016/0028-3908(73)90012-9; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Petersen KM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001185; Reuss B, 2003, J NEUROSCI, V23, P6404; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; SCHLUMPF M, 1979, ANAT EMBRYOL, V156, P177, DOI 10.1007/BF00300013; Stett A, 2003, ANAL BIOANAL CHEM, V377, P486, DOI 10.1007/s00216-003-2149-x; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; WAGNER BH, 1982, PHARMACOL BIOCHEM BE, V16, P731, DOI 10.1016/0091-3057(82)90226-X; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x; Zheng Ming, 2004, Shengli Xuebao, V56, P1; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	44	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70913	10.1371/journal.pone.0070913	http://dx.doi.org/10.1371/journal.pone.0070913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936474	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800054
J	Zhou, YB; Lu, LY; Liu, WP; Zhang, JL				Zhou, Yanbo; Lu, Linyuan; Liu, Weiping; Zhang, Jianlin			The Power of Ground User in Recommender Systems	PLOS ONE			English	Article								Accuracy and diversity are two important aspects to evaluate the performance of recommender systems. Two diffusion-based methods were proposed respectively inspired by the mass diffusion (MD) and heat conduction (HC) processes on networks. It has been pointed out that MD has high recommendation accuracy yet low diversity, while HC succeeds in seeking out novel or niche items but with relatively low accuracy. The accuracy-diversity dilemma is a long-term challenge in recommender systems. To solve this problem, we introduced a background temperature by adding a ground user who connects to all the items in the user-item bipartite network. Performing the HC algorithm on the network with ground user (GHC), it showed that the accuracy can be largely improved while keeping the diversity. Furthermore, we proposed a weighted form of the ground user (WGHC) by assigning some weights to the newly added links between the ground user and the items. By turning the weight as a free parameter, an optimal value subject to the highest accuracy is obtained. Experimental results on three benchmark data sets showed that the WGHC outperforms the state-of-the-art method MD for both accuracy and diversity.	[Zhou, Yanbo; Lu, Linyuan; Zhang, Jianlin] Hangzhou Normal Univ, Alibaba Business Coll, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Zhou, Yanbo; Lu, Linyuan; Liu, Weiping; Zhang, Jianlin] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland	Hangzhou Normal University; University of Fribourg	Lu, LY (corresponding author), Hangzhou Normal Univ, Alibaba Business Coll, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China.	linyuan.lue@unifr.ch			EU FET-Open project QLectives [231200]; National Natural Science Foundation of China [11205042]; Hangzhou Normal University	EU FET-Open project QLectives; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University	This work was supported by EU FET-Open project QLectives (No. 231200), the National Natural Science Foundation of China (No. 11205042) and the research start-up fund of Hangzhou Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gantner Zeno, 2011, P 5 ACM C REC SYST, P305, DOI [DOI 10.1145/2043932.2043989, 10.1145/2043932.2043989]; Goldberg K, 2001, INFORM RETRIEVAL, V4, P133, DOI 10.1023/A:1011419012209; Jarvelin K, 2002, ACM T INFORM SYST, V20, P422, DOI 10.1145/582415.582418; Konstan JA, 1997, COMMUN ACM, V40, P77, DOI 10.1145/245108.245126; Laureti P, 2006, EUROPHYS LETT, V75, P1006, DOI 10.1209/epl/i2006-10204-8; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Maslov S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248701; McNee S. M., 2006, P 2006 C HUM FACT CO, P1097; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Ren J, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/58007; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Zhang FG, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/58005; Zhang YC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154301; Zhou T, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/58004; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123008	23	14	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70094	10.1371/journal.pone.0070094	http://dx.doi.org/10.1371/journal.pone.0070094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936380	Green Published, gold			2022-12-27	WOS:000324545800035
J	Armbruster, B; Roy, S; Kapur, A; Schneider, JA				Armbruster, Benjamin; Roy, Sourya; Kapur, Abhinav; Schneider, John A.			Sex Role Segregation and Mixing among Men Who Have Sex with Men: Implications for Biomedical HIV Prevention Interventions	PLOS ONE			English	Article							HOMOSEXUAL ROLE SEPARATION; ANTIRETROVIRAL THERAPY; CIRCUMCISION STATUS; RISK; TRANSMISSION; INDIA; AIDS; INFECTION; TIME	Objective: Men who have sex with men (MSM) practice role segregation - insertive or receptive only sex positions instead of a versatile role - in several international settings where candidate biomedical HIV prevention interventions (e.g., circumcision, anal microbicide) will be tested. The effects of these position-specific interventions on HIV incidence are modeled. Materials and Methods: We developed a deterministic compartmental model to predict HIV incidence among Indian MSM using data from 2003-2010. The model's sex mixing matrix was derived from network data of Indian MSM (n = 4604). Our model captures changing distribution of sex roles over time. We modeled microbicide and circumcision efficacy on trials with heterosexuals. Results: Increasing numbers of versatile MSM resulted in little change in HIV incidence over 20 years. Anal microbicides and circumcision would decrease the HIV prevalence at 10 years from 15.6% to 12.9% and 12.7% respectively. Anal microbicides would provide similar protection to circumcision at the population level despite lower modeled efficacy (54% and 60% risk reduction, respectively). Combination of the interventions were additive: in 5 years, the reduction in HIV prevalence of the combination (-3.2%) is almost the sum of their individual reductions in HIV prevalence (-1.8% and -1.7%). Conclusions: MSM sex role segregation and mixing, unlike changes in the sex role distribution, may be important for evaluating HIV prevention interventions in international settings. Synergies between some position-specific prevention interventions such as circumcision and anal microbicides warrant further study.	[Armbruster, Benjamin] Northwestern Univ, Dept Ind Engn & Management Sci, Evanston, IL 60208 USA; [Roy, Sourya] Northwestern Univ, Dept Elect Engn & Comp Sci, Evanston, IL USA; [Kapur, Abhinav] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Schneider, John A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Schneider, John A.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	Northwestern University; Northwestern University; University of Chicago; University of Chicago; University of Chicago	Schneider, JA (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jschnei1@medicine.bsd.uchicago.edu	Armbruster, Benjamin/B-7455-2009		National Institutes of Health [R21 HD068352, R21AI098599, U01 GM087729-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD068352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R21 HD068352, R21AI098599, and U01 GM087729-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; DeGruttola V, 2011, CLIN INFECT DIS, V52, P1050, DOI 10.1093/cid/cir094; Enns EA, 2011, INT J STD A IN PRESS; Gini Index, 2011, WORLD BANK DEV INDIC; Goodreau SM, 2005, J INFECT DIS, V191, pS147, DOI 10.1086/425268; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hallett TB, 2008, PLOS MED, V5, P403, DOI 10.1371/journal.pmed.0050053; Hemmige V, 2011, AIDS PATIENT CARE ST; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Jozkowski K, 2010, AIDS PATIENT CARE ST, V24, P465, DOI 10.1089/apc.2010.0082; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; LAUMANN EO, 2001, SEX LOVE HLTH AM; Lorway R, 2010, SEX TRANSM INFECT, V86, P70, DOI 10.1136/sti.2010.044909; McGowan I, 2011, AIDS BEHAV, V15, pS66, DOI 10.1007/s10461-011-9899-9; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; NFHS-3, 2005, NFHS 3; Schneider JA, 2011, AIDS BEHAV; Schneider JA, 2011, NOVEL HYBRID EGOCENT; Schneider JA, 2011, NOVEL MEN WHO HAVE S; Schneider JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011922; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; UNAIDS, 2010, IND 2010 COUNTR PROG; Vadivoo S, 2008, AIDS, V22, pS137, DOI 10.1097/01.aids.0000343772.82647.2d; van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819; VANDRUTEN H, 1992, J SEX RES, V29, P477, DOI 10.1080/00224499209551663; Weller S, 2002, UGESKRIFT LAEGER, V164, P5497; WHO, 2010, UN ACC REP, P116; WHO Global Health Observatory Data Repository, 2009, WHO GLOB HLTH OBS DA; WILEY JA, 1989, J SEX RES, V26, P434, DOI 10.1080/00224498909551526; Wiysonge CS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007496.pub2	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70043	10.1371/journal.pone.0070043	http://dx.doi.org/10.1371/journal.pone.0070043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219PB	23936374	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400034
J	Wang, JZ; Chen, JX; Enns, CA; Mayinger, P				Wang, Jinzhi; Chen, Juxing; Enns, Caroline A.; Mayinger, Peter			The First Transmembrane Domain of Lipid Phosphatase SAC1 Promotes Golgi Localization	PLOS ONE			English	Article							MEMBRANE-SPANNING DOMAIN; ENDOPLASMIC-RETICULUM; RETENTION; PROTEIN; YEAST; ALPHA-2,6-SIALYLTRANSFERASE; MECHANISM; APPARATUS; RESIDUES; CYSTEINE	The lipid phosphatase Sac1 cycles between endoplasmic reticulum and cisternal Golgi compartments. In proliferating mammalian cells, a canonical dilysine motif at the C-terminus of Sac1 is required for coatomer complex-I ( COP-I)-binding and continuous retrieval to the ER. Starvation triggers accumulation of Sac1 at the Golgi. The mechanism responsible for Golgi retention of Sac1 is unknown. Here we show that the first of the two transmembrane regions in human SAC1 (TM1) functions in Golgi localization. A minimal construct containing only TM1 and the adjacent flanking sequences is concentrated at the Golgi. Transplanting TM1 into transferrin receptor 2 ( TfR2) induces Golgi accumulation of this normally plasma membrane and endosomal protein, indicating that TM1 is sufficient for Golgi localization. In addition, we determined that the N-terminal cytoplasmic domain of SAC1 also promotes Golgi localization, even when TM1 is mutated or absent. We conclude that the distribution of SAC1 within the Golgi is controlled via both passive membrane thickness-dependent partitioning of TM1 and a retention mechanism that requires the N-terminal cytoplasmic region.	[Wang, Jinzhi; Mayinger, Peter] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97201 USA; [Chen, Juxing; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Mayinger, P (corresponding author), Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97201 USA.	mayinger@ohsu.edu			National Institutes of Health [RO1 GM084088, RO1 DK05488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166, R37DK054488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants RO1 GM084088 (to P.M.) and RO1 DK05488 (to C.A.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Cheong FY, 2010, TRAFFIC, V11, P1180, DOI 10.1111/j.1600-0854.2010.01092.x; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; de Graffenried CL, 2004, J BIOL CHEM, V279, P40035, DOI 10.1074/jbc.M405709200; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Konrad G, 2002, J BIOL CHEM, V277, P10547, DOI 10.1074/jbc.M200090200; Liu Y, 2008, MOL BIOL CELL, V19, P3080, DOI 10.1091/mbc.E07-12-1290; Machamer C E, 1991, Trends Cell Biol, V1, P141, DOI 10.1016/0962-8924(91)90001-P; MACHAMER CE, 1987, J CELL BIOL, V105, P1205, DOI 10.1083/jcb.105.3.1205; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Qian R, 2001, J BIOL CHEM, V276, P28641, DOI 10.1074/jbc.M103664200; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; Szul T, 2011, PHYSIOLOGY, V26, P348, DOI 10.1152/physiol.00017.2011; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; WHITTERS EA, 1993, J CELL BIOL, V122, P79, DOI 10.1083/jcb.122.1.79; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; Wood CM, 2012, FISH PHYSIOL, V31B, P1, DOI 10.1016/S1546-5098(11)31023-0; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170	29	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71112	10.1371/journal.pone.0071112	http://dx.doi.org/10.1371/journal.pone.0071112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936490	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400096
J	Barbour, AG; Hirsch, CM; Langeroudi, AG; Meinardi, S; Lewis, ERG; Estabragh, AS; Blake, DR				Barbour, Alan G.; Hirsch, Charlotte M.; Langeroudi, Arash Ghalyanchi; Meinardi, Simone; Lewis, Eric R. G.; Estabragh, Azadeh Shojaee; Blake, Donald R.			Elevated Carbon Monoxide in the Exhaled Breath of Mice during a Systemic Bacterial Infection	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; BORRELIA-BURGDORFERI; HEME OXYGENASE-1; HERMSII; SEPSIS; NO; CO	Blood is the specimen of choice for most laboratory tests for diagnosis and disease monitoring. Sampling exhaled breath is a noninvasive alternative to phlebotomy and has the potential for real-time monitoring at the bedside. Improved instrumentation has advanced breath analysis for several gaseous compounds from humans. However, application to small animal models of diseases and physiology has been limited. To extend breath analysis to mice, we crafted a means for collecting nose-only breath samples from groups and individual animals who were awake. Samples were subjected to gas chromatography and mass spectrometry procedures developed for highly sensitive analysis of trace volatile organic compounds (VOCs) in the atmosphere. We evaluated the system with experimental systemic infections of severe combined immunodeficiency Mus musculus with the bacterium Borrelia hermsii. Infected mice developed bacterial densities of,10 7 per ml of blood by day 4 or 5 and in comparison to uninfected controls had hepatosplenomegaly and elevations of both inflammatory and anti-inflammatory cytokines. While 12 samples from individual infected mice on days 4 and 5 and 6 samples from uninfected mice did not significantly differ for 72 different VOCs, carbon monoxide (CO) was elevated in samples from infected mice, with a mean (95% confidence limits) effect size of 4.2 (2.8-5.6), when differences in CO2 in the breath were taken into account. Normalized CO values declined to the uninfected range after one day of treatment with the antibiotic ceftriaxone. Strongly correlated with CO in the breath were levels of heme oxygenase-1 protein in serum and HMOX1 transcripts in whole blood. These results (i) provide further evidence of the informativeness of CO concentration in the exhaled breath during systemic infection and inflammation, and (ii) encourage evaluation of this noninvasive analytic approach in other various other rodent models of infection and for utility in clinical management.	[Barbour, Alan G.; Langeroudi, Arash Ghalyanchi; Lewis, Eric R. G.; Estabragh, Azadeh Shojaee] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Barbour, Alan G.; Langeroudi, Arash Ghalyanchi; Lewis, Eric R. G.; Estabragh, Azadeh Shojaee] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Hirsch, Charlotte M.; Meinardi, Simone; Blake, Donald R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Hirsch, Charlotte M.; Meinardi, Simone; Blake, Donald R.] Univ Calif Irvine, Environm Mol Sci Inst, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Barbour, AG (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA.	abarbour@uci.edu		Barbour, Alan/0000-0002-0719-5248; Blake, Donald/0000-0002-8283-5014	National Institutes of Health [U54 AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant U54 AI065359 to the Pacific-Southwest Regional Center of Excellence for Biodefense and Emerging Infections. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AG, 2005, TICK-BORNE DISEASES OF HUMANS, P268; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Buszewski B, 2007, BIOMED CHROMATOGR, V21, P553, DOI 10.1002/bmc.835; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Colman JJ, 2001, ANAL CHEM, V73, P3723, DOI 10.1021/ac010027g; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Dercho Ryan A., 2006, Journal of Pharmacological and Toxicological Methods, V54, P288, DOI 10.1016/j.vascn.2006.01.004; Epiphanio S, 2008, CELL HOST MICROBE, V3, P331, DOI 10.1016/j.chom.2008.04.003; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Guaman AV, 2012, J CHROMATOGR B, V881-82, P76, DOI 10.1016/j.jchromb.2011.12.001; Kamboures MA, 2005, P NATL ACAD SCI USA, V102, P15762, DOI 10.1073/pnas.0507263102; Kazragis RJ, 1996, ANTIMICROB AGENTS CH, V40, P2632, DOI 10.1128/AAC.40.11.2632; KITTEN T, 1992, GENETICS, V132, P311; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Ligor M, 2009, CLIN CHEM LAB MED, V47, P550, DOI 10.1515/CCLM.2009.133; Meinardi S, 2012, BIOCH BIOPHYS ACTA; MILLEVILLE GS, 1985, PEDIATR RES, V19, P94, DOI 10.1203/00006450-198501000-00025; Morimatsu H, 2006, AM J PHYSIOL-LUNG C, V290, pL114, DOI 10.1152/ajplung.00031.2005; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Novak BJ, 2007, P NATL ACAD SCI USA, V104, P15613, DOI 10.1073/pnas.0706533104; Risby TH, 2006, APPL PHYS B-LASERS O, V85, P421, DOI 10.1007/s00340-006-2280-4; Rochette L, 2013, PHARMACOL THERAPEUT, V137, P133, DOI 10.1016/j.pharmthera.2012.09.007; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schulz S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00068; Sethi JM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-45; Simpson IJ, 2010, ATMOS CHEM PHYS, V10, P11931, DOI 10.5194/acp-10-11931-2010; Vautz W, 2010, J APPL PHYSIOL, V108, P697, DOI 10.1152/japplphysiol.00658.2009; Vreman H.J., 2000, CARBON MONOXIDE TOXI, P19; Walther M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002579; Wegiel B, 2013, TRENDS MOL MED, V19, P3, DOI 10.1016/j.molmed.2012.10.001; Yachie A, 2003, EXP BIOL MED, V228, P550, DOI 10.1177/15353702-0322805-26; Zegdi R, 2002, INTENS CARE MED, V28, P793, DOI 10.1007/s00134-002-1269-7; Zhong JM, 2004, MOL MICROBIOL, V51, P729, DOI 10.1046/j.1365-2958.2003.03849.x	34	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69802	10.1371/journal.pone.0069802	http://dx.doi.org/10.1371/journal.pone.0069802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936104	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700044
J	Sakimoto, Y; Okada, K; Takeda, K; Sakata, S				Sakimoto, Yuya; Okada, Kana; Takeda, Kozue; Sakata, Shogo			Transient Decline in Hippocampal Theta Activity during the Acquisition Process of the Negative Patterning Task	PLOS ONE			English	Article							CONFIGURAL TASKS; RHYTHM; MOVEMENT; BEHAVIOR; MEMORY; RATS; ELICITATION; INHIBITION; FREQUENCY; AMPLITUDE	Hippocampal function is important in the acquisition of negative patterning but not of simple discrimination. This study examined rat hippocampal theta activity during the acquisition stages (early, middle, and late) of the negative patterning task (A+, B+, AB-). The results showed that hippocampal theta activity began to decline transiently (for 500 ms after non-reinforced stimulus presentation) during the late stage of learning in the negative patterning task. In addition, this transient decline in hippocampal theta activity in the late stage was lower in the negative patterning task than in the simple discrimination task. This transient decline during the late stage of task acquisition may be related to a learning process distinctive of the negative patterning task but not the simple discrimination task. We propose that the transient decline of hippocampal theta activity reflects inhibitory learning and/or response inhibition after the presentation of a compound stimulus specific to the negative patterning task.	[Sakimoto, Yuya] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Okada, Kana; Takeda, Kozue; Sakata, Shogo] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima, Hiroshima 724, Japan	Yamaguchi University; Hiroshima University	Sakimoto, Y (corresponding author), Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan.	yuyasakimoto@gmail.com	Okada, Kana/ABD-2149-2020; Skimoto, Yuya/GLU-9872-2022; Sakata, Shogo/A-6700-2018	Okada, Kana/0000-0002-7702-0603; Sakata, Shogo/0000-0003-4895-8245	Ministry of Education, Culture, Sports, Science and Technology of Japan [21300125]; Graduate School of Integrated Arts and Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Graduate School of Integrated Arts and Sciences	Financial support for this study was provided by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 21300125) and Grantsin-Aid for Propulsion Project of the Graduate School of Integrated Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN CN, 1984, BRAIN RES, V322, P261, DOI 10.1016/0006-8993(84)90116-1; Alvarado MC, 1995, BEHAV NEUROSCI, V109, P1052, DOI 10.1037/0735-7044.109.6.1052; Chan KH, 2003, COGN AFFECT BEHAV NE, V3, P111, DOI 10.3758/CABN.3.2.111; Chan KH, 2001, BEHAV BRAIN RES, V119, P111, DOI 10.1016/S0166-4328(00)00363-6; Davidson TL, 2004, NEUROSCI BIOBEHAV R, V28, P261, DOI 10.1016/j.neubiorev.2004.02.001; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Olvera-Cortes ME, 2012, BEHAV BRAIN RES, V226, P555, DOI 10.1016/j.bbr.2011.10.019; GRASTYAN E, 1959, ELECTROEN CLIN NEURO, V11, P409, DOI 10.1016/0013-4694(59)90040-9; GRAY JA, 1971, ELECTROEN CLIN NEURO, V30, P189, DOI 10.1016/0013-4694(71)90053-8; Griffin AL, 2004, BEHAV NEUROSCI, V118, P403, DOI 10.1037/0735-7044.118.2.403; MAREN S, 1994, BEHAV NEUROSCI, V108, P44, DOI 10.1037/0735-7044.108.1.44; Masuoka T, 2006, BRAIN RES, V1103, P159, DOI 10.1016/j.brainres.2006.04.003; MONMAUR P, 1991, BRAIN RES, V544, P150, DOI 10.1016/0006-8993(91)90898-6; Olvera-Cortes E, 2004, BRAIN RES BULL, V62, P379, DOI 10.1016/j.brainresbull.2003.10.003; Olvera-Cortes E, 2002, BRAIN RES BULL, V58, P261, DOI 10.1016/S0361-9230(02)00769-4; SADOWSKI B, 1962, ELECTROEN CLIN NEURO, V14, P465, DOI 10.1016/0013-4694(62)90052-4; Sakimoto Y, 2013, BEHAV BRAIN RES, V246, P132, DOI 10.1016/j.bbr.2013.02.012; Sakimoto Y, 2013, EXP BRAIN RES, V225, P177, DOI 10.1007/s00221-012-3359-2; Sakimoto Y, 2013, BEHAV BRAIN RES, V237, P1, DOI 10.1016/j.bbr.2012.09.013; Sinnamon HM, 2006, NEUROSCIENCE, V140, P779, DOI 10.1016/j.neuroscience.2006.02.058; Sinnamon HM, 2005, BEHAV BRAIN RES, V160, P236, DOI 10.1016/j.bbr.2004.12.006; SUTHERLAND RJ, 1989, PSYCHOBIOLOGY, V17, P129; SUTHERLAND RJ, 1990, BEHAV BRAIN RES, V37, P57, DOI 10.1016/0166-4328(90)90072-M; Takano Y, 2010, BRAIN RES, V1342, P94, DOI 10.1016/j.brainres.2010.04.050; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; WHISHAW IQ, 1973, BEHAV BIOL, V8, P461, DOI 10.1016/S0091-6773(73)80041-0; Wyble BP, 2004, HIPPOCAMPUS, V14, P662, DOI 10.1002/hipo.20012; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70756	10.1371/journal.pone.0070756	http://dx.doi.org/10.1371/journal.pone.0070756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936249	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700082
J	Sommer, W; Sturmer, B; Shmuilovich, O; Martin-Loeches, M; Schacht, A				Sommer, Werner; Stuermer, Birgit; Shmuilovich, Olga; Martin-Loeches, Manuel; Schacht, Annekathrin			How about Lunch? Consequences of the Meal Context on Cognition and Emotion	PLOS ONE			English	Article							POSITIVE AFFECT; ERP COMPONENTS; MOOD; FOOD; ATTENTION; LOCATION; BENEFITS; CHOICE; MODULE; STATES	Although research addresses the effects of a meal's context on food preference, the psychological consequences of meal situations are largely unexplored. We compared the cognitive and emotional effects of a restaurant meal eaten in the company of others to a solitary meal consumed in a plain office using pre- and post-tests analysis and controlling for the kind and amount of food consumed. Three tasks were conducted, measuring: (1) semantic memory (2) cognitive control and error monitoring, and (3) processing of emotional facial expressions. Covert processes in these tasks were assessed with event-related brain potentials. A mood rating questionnaire indicated a relaxation effect of the restaurant as compared to the plain meal situation. The restaurant meal increased sensitivity to threatening facial expressions and diminished cognitive control and error monitoring. No effects were observed for semantic memory. These findings provide the first experimental evidence that a restaurant meal with a social component may be more relaxing than a meal eaten alone in a plain setting and may reduce cognitive control.	[Sommer, Werner; Shmuilovich, Olga] Univ Berlin, Dept Psychol, Berlin, Germany; [Stuermer, Birgit] Int Psychoanalyt Univ, Berlin, Germany; [Martin-Loeches, Manuel] UCM ISCIII, Ctr Human Evolut & Behav, Madrid, Spain; [Martin-Loeches, Manuel] Univ Complutense Madrid, Dept Psychobiol, Madrid, Spain; [Schacht, Annekathrin] Univ Gottingen, Courant Res Ctr Text Struct, D-37073 Gottingen, Germany	Complutense University of Madrid; University of Gottingen	Sommer, W (corresponding author), Univ Berlin, Dept Psychol, Berlin, Germany.	werner.sommer@cms.hu-berlin.de	Schacht, Annekathrin/B-2521-2014; Sommer, Werner/N-1945-2019; Martin-Loeches, Manuel/G-4288-2017; Sommer, Werner/H-4672-2011	Sommer, Werner/0000-0001-5266-3445; Martin-Loeches, Manuel/0000-0002-3487-8423; Sommer, Werner/0000-0001-5266-3445	Wolfgang-Kohler-Zentrum zur Erforschung von Konflikten in Intelligenten Systemen	Wolfgang-Kohler-Zentrum zur Erforschung von Konflikten in Intelligenten Systemen	This research was supported by the Wolfgang-Kohler-Zentrum zur Erforschung von Konflikten in Intelligenten Systemen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Baas M, 2008, PSYCHOL BULL, V134, P779, DOI 10.1037/a0012815; BLESS H, 1995, PERS SOC PSYCHOL B, V21, P766, DOI 10.1177/0146167295217010; Boutrolle I, 2007, FOOD QUAL PREFER, V18, P490, DOI 10.1016/j.foodqual.2006.06.003; Cardello AV, 1996, FOOD QUAL PREFER, V7, P7, DOI 10.1016/0950-3293(95)00028-3; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; Dimigen O, 2012, NEUROIMAGE, V62, P381, DOI 10.1016/j.neuroimage.2012.04.006; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Edwards JSA, 2003, FOOD QUAL PREFER, V14, P647, DOI 10.1016/S0950-3293(02)00189-1; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Federmeier KD, 2001, NEUROSCI LETT, V305, P149, DOI 10.1016/S0304-3940(01)01843-2; Flammang J. A., 2009, TASTE CIVILIZATION F; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Jimenez-Ortega L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033718; Jones Martin, 2007, FEAST WHY HUMANS SHA; Junghofer M, 2006, NEUROREPORT, V17, P225, DOI 10.1097/01.wnr.0000198437.59883.bb; King SC, 2004, FOOD QUAL PREFER, V15, P645, DOI 10.1016/j.foodqual.2004.04.010; Kniffin KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040445; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Larson MJ, 2009, NEUROPSYCHOLOGY, V23, P433, DOI 10.1037/a0015723; Leuthold H, 1999, CLIN NEUROPHYSIOL, V110, P342, DOI 10.1016/S1388-2457(98)00058-3; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Meiselman H.L., 2008, PRODUCT EXPERIENCE, P559, DOI [10.1016/B978-008045089-6.50027-7, DOI 10.1016/B978-008045089-6.50027-7]; Meiselman HL, 2000, PHYSIOL BEHAV, V70, P119, DOI 10.1016/S0031-9384(00)00268-7; Mitchell RLC, 2007, NEUROPSYCHOLOGIA, V45, P617, DOI 10.1016/j.neuropsychologia.2006.06.030; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; RELLECKE J, 2012, THESIS HUMBOLDT U BE, P37; Rellecke J, 2013, BRAIN TOPOGR, V26, P62, DOI 10.1007/s10548-012-0261-y; Rellecke J, 2012, BIOL PSYCHOL, V90, P23, DOI 10.1016/j.biopsycho.2012.02.002; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; Rozin P, 1996, CURR DIR PSYCHOL SCI, V5, P18, DOI 10.1111/1467-8721.ep10772690; Rozin P, 2005, J NUTR EDUC BEHAV, V37, pS107, DOI 10.1016/S1499-4046(06)60209-1; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Sobal J, 2003, APPETITE, V41, P181, DOI 10.1016/S0195-6663(03)00078-3; Steyer, 1997, MEHRDIMENSIONALE BEF; Sturmer B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00335; van Steenbergen H, 2010, PSYCHOL SCI, V21, P1629, DOI 10.1177/0956797610385951; van Steenbergen H, 2009, PSYCHOL SCI, V20, P1473, DOI 10.1111/j.1467-9280.2009.02470.x; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; West R, 2008, CEREB CORTEX, V18, P1112, DOI 10.1093/cercor/bhm142	46	18	18	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70314	10.1371/journal.pone.0070314	http://dx.doi.org/10.1371/journal.pone.0070314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936184	Green Published, gold			2022-12-27	WOS:000322633700065
J	Donitz, J; Grossmann, D; Schild, I; Schmitt-Engel, C; Bradler, S; Prpic, NM; Bucher, G				Doenitz, Juergen; Grossmann, Daniela; Schild, Inga; Schmitt-Engel, Christian; Bradler, Sven; Prpic, Nikola-Michael; Bucher, Gregor			TrOn: An Anatomical Ontology for the Beetle Tribolium castaneum	PLOS ONE			English	Article							RED FLOUR BEETLE; GENE ONTOLOGY; TOOL	In a morphological ontology the expert's knowledge is represented in terms, which describe morphological structures and how these structures relate to each other. With the assistance of ontologies this expert knowledge is made processable by machines, through a formal and standardized representation of terms and their relations to each other. The red flour beetle Tribolium castaneum, a representative of the most species rich animal taxon on earth (the Coleoptera), is an emerging model organism for development, evolution, physiology, and pest control. In order to foster Tribolium research, we have initiated the Tribolium Ontology (TrOn), which describes the morphology of the red flour beetle. The content of this ontology comprises so far most external morphological structures as well as some internal ones. All modeled structures are consistently annotated for the developmental stages larva, pupa and adult. In TrOn all terms are grouped into three categories: Generic terms represent morphological structures, which are independent of a developmental stage. In contrast, downstream of such terms are concrete terms which stand for a dissectible structure of a beetle at a specific life stage. Finally, there are mixed terms describing structures that are only found at one developmental stage. These terms combine the characteristics of generic and concrete terms with features of both. These annotation principles take into account the changing morphology of the beetle during development and provide generic terms to be used in applications or for cross linking with other ontologies and data resources. We use the ontology for implementing an intuitive search function at the electronic iBeetle-Base, which stores morphological defects found in a genome wide RNA interference (RNAi) screen. The ontology is available for download at http://ibeetle-base.uni-goettingen.de.	[Doenitz, Juergen; Grossmann, Daniela; Schild, Inga; Schmitt-Engel, Christian; Bradler, Sven; Prpic, Nikola-Michael; Bucher, Gregor] Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Doenitz, Juergen] Univ Med Ctr Gottingen, Dept Bioinformat, Gottingen, Germany	University of Gottingen	Donitz, J (corresponding author), Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany.	juergen.doenitz@bioinf.med.uni-goettingen.de	Bucher, Gregor/B-9004-2015; Bradler, Sven/D-8655-2015	Bucher, Gregor/0000-0002-4615-6401; Bradler, Sven/0000-0001-9307-1032; Donitz, Jurgen/0000-0002-8401-8851; Schmitt-Engel, Christian/0000-0002-8731-1519	DFG research unit FOR1234 iBeetle; German Research Foundation; Gottingen University	DFG research unit FOR1234 iBeetle(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Gottingen University	The authors acknowledge funding by the DFG research unit FOR1234 iBeetle (http://www.dfg.de/) and the support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2008, INSECT BIOCHEM MOLEC, V38, P959, DOI 10.1016/j.ibmb.2008.07.006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bertone MA, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas057; Brown SJ, 2009, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.EM0126; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Doenitz Juergen, 2012, Frontiers in Genetics, V3, P197, DOI 10.3389/fgene.2012.00197; Dreyer D, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/neuro.06.003.2010; Fu JP, 2012, P NATL ACAD SCI USA, V109, P7782, DOI 10.1073/pnas.1116641109; Grossmann D, 2009, DEV GENES EVOL, V219, P469, DOI 10.1007/s00427-009-0310-z; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; Knowles-Barley S, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq005; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Mabee P, 2012, J APPL ICHTHYOL, V28, P300, DOI 10.1111/j.1439-0426.2012.01985.x; Mitten EK, 2012, INSECT BIOCHEM MOLEC, V42, P854, DOI 10.1016/j.ibmb.2012.08.001; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Osumi-Sutherland D, 2012, BIOINFORMATICS, V28, P1262, DOI 10.1093/bioinformatics/bts113; Posnien N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002416; Posnien N, 2010, ARTHROPOD STRUCT DEV, V39, P399, DOI 10.1016/j.asd.2010.08.002; Schinko JB, 2008, DEV BIOL, V317, P600, DOI 10.1016/j.ydbio.2008.03.005; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Sokoloff A, 1974, BIOL TRIBOLIUM; Steinmann H, 1999, HDB ZOOLOGY NATUR 34, V4; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; WINSTON ME, 1987, COGNITIVE SCI, V11, P417, DOI 10.1207/s15516709cog1104_2; Wohfrom H, 2006, MECH DEVELOP, V123, P430, DOI 10.1016/j.mod.2006.04.003; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	30	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70695	10.1371/journal.pone.0070695	http://dx.doi.org/10.1371/journal.pone.0070695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936240	Green Submitted, gold, Green Published			2022-12-27	WOS:000323114200101
J	Iwasa, M; Kobayashi, Y; Mifuji-Moroka, R; Hara, N; Miyachi, H; Sugimoto, R; Tanaka, H; Fujita, N; Gabazza, EC; Takei, Y				Iwasa, Motoh; Kobayashi, Yoshinao; Mifuji-Moroka, Rumi; Hara, Nagisa; Miyachi, Hirohide; Sugimoto, Ryosuke; Tanaka, Hideaki; Fujita, Naoki; Gabazza, Esteban C.; Takei, Yoshiyuki			Branched-Chain Amino Acid Supplementation Reduces Oxidative Stress and Prolongs Survival in Rats with Advanced Liver Cirrhosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TRANSCRIPTION FACTOR FOXO1; VIRUS-INFECTION; PATHWAY; RISK; MICE; GRANULES; DISEASE; ALBUMIN; IRON	Long-term supplementation with branched-chain amino acids (BCAA) is associated with prolonged survival and decreased frequency of development of hepatocellular carcinoma (HCC) in patients with liver cirrhosis. However, the pharmaceutical mechanism underlying this association is still unclear. We investigated whether continuous BCAA supplementation increases survival rate of rats exposed to a fibrogenic agent and influences the iron accumulation, oxidative stress, fibrosis, and gluconeogenesis in the liver. Further, the effects of BCAA on gluconeogenesis in cultured cells were also investigated. A significant improvement in cumulative survival was observed in BCAA-supplemented rats with advanced cirrhosis compared to untreated rats with cirrhosis (P<0.05). The prolonged survival due to BCAA supplementation was associated with reduction of iron contents, reactive oxygen species production and attenuated fibrosis in the liver. In addition, BCAA ameliorated glucose metabolism by forkhead box protein O1 pathway in the liver. BCAA prolongs survival in cirrhotic rats and this was likely the consequences of reduced iron accumulation, oxidative stress and fibrosis and improved glucose metabolism in the liver.	[Iwasa, Motoh; Kobayashi, Yoshinao; Mifuji-Moroka, Rumi; Miyachi, Hirohide; Sugimoto, Ryosuke; Tanaka, Hideaki; Fujita, Naoki; Takei, Yoshiyuki] Mie Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie 514, Japan; [Kobayashi, Yoshinao] Mie Univ, Grad Sch Med, Ctr Phys & Mental Hlth, Tsu, Mie 514, Japan; [Hara, Nagisa] Mie Univ, Sch Hosp, Div Dietary Serv, Tsu, Mie 514, Japan; [Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Iwasa, M (corresponding author), Mie Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie 514, Japan.	motoh@clin.medic.mie-u.ac.jp		Gabazza, Esteban/0000-0001-5748-1499				Alla V, 2005, SEMIN LIVER DIS, V25, P461, DOI 10.1055/s-2005-923317; AMMENDOLA R, 1995, FEBS LETT, V371, P209, DOI 10.1016/0014-5793(95)00871-6; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Comporti MM, 1998, FREE RADICAL RES, V28, P623, DOI 10.3109/10715769809065818; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Fujita N, 2008, J HEPATOL, V49, P702, DOI 10.1016/j.jhep.2008.05.014; Fukushima H, 2007, HEPATOL RES, V37, P765, DOI 10.1111/j.1872-034X.2007.00123.x; Hagiwara A, 2012, J CELL PHYSIOL, V227, P2097, DOI 10.1002/jcp.22941; Holecek M, 2010, NUTRITION, V26, P482, DOI 10.1016/j.nut.2009.06.027; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kobayashi Y, 2013, INT J CLIN MED, V4, P10; Kuwahata M, 2012, J CLIN BIOCHEM NUTR, V50, P67, DOI 10.3164/jcbn.11-37; Lecube A, 2004, DIABETES CARE, V27, P2669, DOI 10.2337/diacare.27.11.2669; Marchesini G, 2003, GASTROENTEROLOGY, V124, P1792, DOI 10.1016/S0016-5085(03)00323-8; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1016/S1542-3565(05)00017-0; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Muzzi A, 2005, J HEPATOL, V42, P41, DOI 10.1016/j.jhep.2004.09.022; Pictrangelo A, 2004, NAT CLIN PRACT GASTR, V1, P39, DOI 10.1038/ncpgasthep0019; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Takeo M, 2005, J GASTROEN HEPATOL, V20, P562, DOI 10.1111/j.1440-1746.2005.03770.x; Tanaka H, 2008, BRIT J CANCER, V98, P580, DOI 10.1038/sj.bjc.6604204; Yoshiji H, 2009, J GASTROENTEROL, V44, P483, DOI 10.1007/s00535-009-0031-0	27	45	54	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70309	10.1371/journal.pone.0070309	http://dx.doi.org/10.1371/journal.pone.0070309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936183	gold, Green Published			2022-12-27	WOS:000322433300099
J	Larsen, SC; Angquist, L; Sorensen, TIA; Heitmann, BL				Larsen, Sofus C.; Angquist, Lars; Sorensen, Thorkild I. A.; Heitmann, Berit L.			24h Urinary Sodium Excretion and Subsequent Change in Weight, Waist Circumference and Body Composition	PLOS ONE			English	Article							SALT INTAKE; ELECTROLYTE; CONSUMPTION; MORTALITY; CHILDREN; WATER; MEN; FAT	Background: In the same period as the increasing obesity epidemic, there has been an increased consumption of highly processed foods with a high salt content, and a few studies have suggested that a diet with a high salt content may be associated with obesity. Objective: To investigate the association between 24 h urinary sodium excretion and subsequent change in body weight (BW), waist circumference (WC), body fat (BF) and fat free mass (FFM) among adults. Design: A longitudinal population study based on the Danish part of the MONICA project, with examinations in 1987-1988 and 1993-1994. Complete information on 24 h urinary sodium excretion along with repeated measures of obesity, as well as on potential confounders, was obtained from 215 subjects. Linear regression was used to examine the association between sodium excretion, as a measure of salt consumption, and subsequent changes in BW, WC, BF and FFM, and further evaluated by restricted cubic splines. Stepwise adjustments were made for selected covariates. Results: Neither the crude nor the adjusted models showed any statistically significant associations between sodium excretion and change in BW or WC. Likewise, we found no significant association between sodium excretion and change in BF and FFM in the unadjusted models. However, after adjusting for potential baseline confounders and the concurrent BW change, we found a significant increase in BF of 0.24 kg (P = 0.015, CI: 0.05 to 0.43) per 100 mmol increase in 24 h urinary sodium excretion (equivalent to 6 g of salt), during the 6-year study period. Moreover, during the same period, we found a significant association with FFM of -0.21 kg (P = 0.041, CI: -0.40 to -0.01). Conclusions: These results suggest that a diet with a high salt content may have a negative influence on development in body composition by expanding BF and reducing FFM.	[Larsen, Sofus C.; Angquist, Lars; Sorensen, Thorkild I. A.; Heitmann, Berit L.] Inst Prevent Med, Bispebjerg, Denmark; [Larsen, Sofus C.; Angquist, Lars; Sorensen, Thorkild I. A.; Heitmann, Berit L.] Frederiksberg Univ Hosp, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Heitmann, Berit L.] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Heitmann, Berit L.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Southern Denmark	Larsen, SC (corresponding author), Inst Prevent Med, Bispebjerg, Denmark.	sofus.christian.larsen@regionh.dk	Larsen, Sofus Christian/AAO-5894-2020	Larsen, Sofus Christian/0000-0002-0838-9378; Angquist, Lars/0000-0002-9516-4424; Heitmann, Berit Lilienthal/0000-0002-6809-4504	Danish Council for Strategic Research [09-067111]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work is carried out as a part of the research program of Gene-diet interactions in obesity (GENDINOB). GENDINOB is supported by the Danish Council for Strategic Research (Grant 09-067111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DYER AR, 1994, AM J EPIDEMIOL, V139, P940, DOI 10.1093/oxfordjournals.aje.a117100; Fonseca-Alaniz MH, 2007, OBESITY, V15, P2200, DOI 10.1038/oby.2007.261; Harrell FE, 2001, REGRESSION MODELING; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; Heer M, 2009, BRIT J NUTR, V101, P1286, DOI 10.1017/S0007114508088041; Heitmann BL, 2009, OBESITY, V17, P136, DOI 10.1038/oby.2008.479; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Heitmann BL, 2000, INT J OBESITY, V24, P435, DOI 10.1038/sj.ijo.0801176; HEITMANN BL, 1995, BRIT MED J, V311, P986; HEITMANN BL, 1990, INT J OBESITY, V14, P789; Hoffmann IS, 2009, NUTR METAB CARDIOVAS, V19, P123, DOI 10.1016/j.numecd.2008.02.011; Hulthen L, 2010, PUBLIC HEALTH NUTR, V13, P601, DOI 10.1017/S1368980009991431; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Libuda L, 2012, PUBLIC HEALTH NUTR, V15, P433, DOI 10.1017/S1368980011002138; Osler M, 2010, INT J EPIDEMIOL; Walker Jay, 2007, Interact Cardiovasc Thorac Surg, V6, P793, DOI 10.1510/icvts.2007.165415	17	59	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69689	10.1371/journal.pone.0069689	http://dx.doi.org/10.1371/journal.pone.0069689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936079	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300059
J	Wang, WC; Hsu, YH; Lin, NS; Wu, CY; Lai, YC; Hu, CC				Wang, Wei-Chen; Hsu, Yau-Heiu; Lin, Na-Sheng; Wu, Chia-Ying; Lai, Yi-Chin; Hu, Chung-Chi			A Novel Prokaryotic Promoter Identified in the Genome of Some Monopartite Begomoviruses	PLOS ONE			English	Article							ABUTILON MOSAIC-VIRUS; DNA-REPLICATION; NUCLEOTIDE-SEQUENCE; GENE-REGULATION; RNA-POLYMERASE; MESSENGER-RNA; EVOLUTION; PROTEIN; GEMINIVIRUSES; TRANSCRIPTION	Geminiviruses are known to exhibit both prokaryotic and eukaryotic features in their genomes, with the ability to express their genes and even replicate in bacterial cells. We have demonstrated previously the existence of unit-length single-stranded circular DNAs of Ageratum yellow vein virus (AYVV, a species in the genus Begomovirus, family Geminiviridae) in Escherichia coli cells, which prompted our search for unknown prokaryotic functions in the begomovirus genomes. By using a promoter trapping strategy, we identified a novel prokaryotic promoter, designated AV3 promoter, in nts 762-831 of the AYVV genome. Activity assays revealed that the AV3 promoter is strong, unidirectional, and constitutive, with an endogenous downstream ribosome binding site and a translatable short open reading frame of eight amino acids. Sequence analyses suggested that the AV3 promoter might be a remnant of prokaryotic ancestors that could be related to certain promoters of bacteria from marine or freshwater environments. The discovery of the prokaryotic AV3 promoter provided further evidence for the prokaryotic origin in the evolutionary history of geminiviruses.	[Wang, Wei-Chen; Hsu, Yau-Heiu; Wu, Chia-Ying; Lai, Yi-Chin; Hu, Chung-Chi] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lin, Na-Sheng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan	National Chung Hsing University; Academia Sinica - Taiwan	Hu, CC (corresponding author), Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan.	cchu@dragon.nchu.edu.tw			National Science Council, Executive Yuan, ROC [NSC 97-2313-B-005-038-MY3, NSC 99-2321-B-005-011-MY3]	National Science Council, Executive Yuan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grants NSC 97-2313-B-005-038-MY3 and NSC 99-2321-B-005-011-MY3 to CCH from National Science Council, Executive Yuan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BONEN L, 1975, P NATL ACAD SCI USA, V72, P2310, DOI 10.1073/pnas.72.6.2310; Brown JK, 2011, VIRUS TAXONOMY, P351; Brown SD, 2011, J BACTERIOL, V193, P3682, DOI 10.1128/JB.05209-11; CHANNARAYAPPA, 1992, CAN J BOT, V70, P1747, DOI 10.1139/b92-216; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; CSORDASTOTH E, 1979, NUCLEIC ACIDS RES, V7, P2189, DOI 10.1093/nar/7.8.2189; Daligault H, 2011, STAND GENOMIC SCI, V4, P352, DOI 10.4056/sigs.1964579; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Frey PM, 2001, VIRUS GENES, V22, P231, DOI 10.1023/A:1008183827072; FRISCHMUTH T, 1990, VIROLOGY, V178, P461, DOI 10.1016/0042-6822(90)90343-P; Goff LJ, 1996, J PHYCOL, V32, P297, DOI 10.1111/j.0022-3646.1996.00297.x; GRONING BR, 1990, MOL GEN GENET, V220, P485, DOI 10.1007/BF00391759; GRONING BR, 1987, P NATL ACAD SCI USA, V84, P8996, DOI 10.1073/pnas.84.24.8996; GUARENTE L, 1980, CELL, V20, P543, DOI 10.1016/0092-8674(80)90640-6; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; HOWARTH AJ, 1986, J MOL EVOL, V23, P313, DOI 10.1007/BF02100640; INOUYE T, 1980, Annals of the Phytopathological Society of Japan, V46, P49, DOI 10.3186/jjphytopath.46.49; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; KOONIN EV, 1992, J GEN VIROL, V73, P2763, DOI 10.1099/0022-1317-73-10-2763; Krupovic M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-112; Lefeuvre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019193; Liao JyeYann, 2007, Plant Pathology Bulletin, V16, P11; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; Morita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023184; MORRISKRSINICH BAM, 1985, NUCLEIC ACIDS RES, V13, P7237, DOI 10.1093/nar/13.20.7237; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; NAGAR S, 1995, PLANT CELL, V7, P705, DOI 10.1105/tpc.7.6.705; Nakagawa S, 2005, INT J SYST EVOL MICR, V55, P925, DOI 10.1099/ijs.0.63480-0; Nawaz-Ul-Rehman MS, 2009, FEBS LETT, V583, P1825, DOI 10.1016/j.febslet.2009.05.045; Novick RP, 1998, TRENDS BIOCHEM SCI, V23, P434, DOI 10.1016/S0968-0004(98)01302-4; PETTY ITD, 1986, NUCLEIC ACIDS RES, V14, P5113, DOI 10.1093/nar/14.12.5113; Preiss W, 2003, J VIROL, V77, P2972, DOI 10.1128/JVI.77.5.2972-2980.2003; PRIBNOW D, 1975, P NATL ACAD SCI USA, V72, P784, DOI 10.1073/pnas.72.3.784; Rana VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042168; Rigden JE, 1996, P NATL ACAD SCI USA, V93, P10280, DOI 10.1073/pnas.93.19.10280; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Saccardo F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-185; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Saunders K, 2003, NATURE, V422, P831, DOI 10.1038/422831a; Selth LA, 2002, FEBS LETT, V516, P179, DOI 10.1016/S0014-5793(02)02539-5; Shiina T, 2005, INT REV CYTOL, V244, P1, DOI 10.1016/S0074-7696(05)44001-2; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Shivaprasad PV, 2005, J VIROL, V79, P8149, DOI 10.1128/JVI.79.13.8149-8163.2005; SMITH TF, 1981, J MOL EVOL, V18, P38, DOI 10.1007/BF01733210; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STENGER DC, 1991, P NATL ACAD SCI USA, V88, P8029, DOI 10.1073/pnas.88.18.8029; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; TOWNSEND R, 1985, EMBO J, V4, P33, DOI 10.1002/j.1460-2075.1985.tb02313.x; Wu CY, 2007, VIRUS RES, V125, P14, DOI 10.1016/j.virusres.2006.12.001	62	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70037	10.1371/journal.pone.0070037	http://dx.doi.org/10.1371/journal.pone.0070037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936138	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300085
J	Zhang, JQ; Xia, CJ; Duan, CX; Sun, SL; Wang, XM; Wu, XF; Zhu, ZD				Zhang, Jiqing; Xia, Changjian; Duan, Canxing; Sun, Suli; Wang, Xiaoming; Wu, Xiaofei; Zhu, Zhendong			Identification and Candidate Gene Analysis of a Novel Phytophthora Resistance Gene Rps10 in a Chinese Soybean Cultivar	PLOS ONE			English	Article							DISEASE-RESISTANCE; CONFERRING RESISTANCE; STEM ROT; SOJAE; KINASE; PTO; SEQUENCE; ENCODES; RACES; RICE	Resistance to Phytophthora sojae isolate PsMC1 was evaluated in 102 F-2:3 families derived from a cross between the resistant soybean cultivar Wandou 15 and the susceptible cultivar Williams and genotyped using simple sequence repeat (SSR) markers. The segregation ratio of resistant, segregating, and susceptible phenotypes in the population suggested that the resistance in Wandou 15 was dominant and monogenic. Twenty-six polymorphic SSR markers were identified on soybean chromosome 17 (Molecular linkage group D2; MLG D2), which were linked to the resistance gene based on bulked segregation analysis (BSA). Markers Sattwd15-24/25 and Sattwd15-47 flanked the resistance gene at a distance of 0.5 cM and 0.8 cM, respectively. Two cosegregating markers, Sattwd15-28 and Sattwd15-32, were also screened in this region. This is the first Rps resistance gene mapped on chromosome 17, which is designated as Rps10. Eight putative genes were found in the mapped region between markers Sattwd15-24/25 and Sattwd15-47. Among them, two candidate genes encoding serine/threonine (Ser/Thr) protein kinases in Wandou 15 and Williams were identified and sequenced. And the differences in genomic sequence and the putative amino acid sequence, respectively, were identified within each candidate gene between Wandou 15 and Williams. This novel gene Rps10 and the linked markers should be useful in developing soybean cultivars with durable resistance to P. sojae.	[Zhang, Jiqing; Xia, Changjian; Duan, Canxing; Sun, Suli; Wang, Xiaoming; Wu, Xiaofei; Zhu, Zhendong] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhu, ZD (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China.	zhuzhendong@caas.cn			Special Fund for Agro-scientific Research in the Public Interest [201303018]; Program of Protection of Crop Germplasm Resources from the Ministry of Agriculture of the People's Republic of China [NB2010-2130135-25-14]	Special Fund for Agro-scientific Research in the Public Interest; Program of Protection of Crop Germplasm Resources from the Ministry of Agriculture of the People's Republic of China	This work was mainly supported by the Special Fund for Agro-scientific Research in the Public Interest (201303018) and the Program of Protection of Crop Germplasm Resources (NB2010-2130135-25-14) from the Ministry of Agriculture of the People's Republic of China. The funders had no role in this study design, data collection and analysis, decision publish, or preparation of the manuscript.	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Anderson TR, 2003, DIS FIELD CROPS CANA; [Anonymous], 1991, ACTA PHYTOPATHOL SIN, DOI DOI 10.13926/J.CNKI.APPS.1991.04.018; Arahana VS, 2001, CROP SCI, V41, P180, DOI 10.2135/cropsci2001.411180x; Chen XiaoLing, 2008, Scientia Agricultura Sinica, V41, P1227; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Cui LK, 2010, PLANT DIS, V94, P881, DOI 10.1094/PDIS-94-7-0881; Dorrance AE, 2000, PLANT DIS, V84, P1303, DOI 10.1094/PDIS.2000.84.12.1303; Dorrance AE, 2003, PLANT DIS, V87, P308, DOI 10.1094/PDIS.2003.87.3.308; [范爱颖 FAN Ai-Ying], 2009, [作物学报, Acta Agronomica Sinica], V35, P1844; FARIASNETO AF, 2007, MOL BREEDING, V20, P53, DOI DOI 10.1007/S11032-006-9072-8; Gao H, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-29; Gordon SG, 2006, CROP SCI, V46, P168, DOI 10.2135/cropsci2004.04-0024; Graham MA, 2002, GENETICS, V162, P1961; Grau CR, 2004, AGRONOMY MONOGR, P679; HAAS JH, 1976, PHYTOPATHOLOGY, V66, P1361, DOI 10.1094/Phyto-66-1361; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; KAUFMANN MJ, 1958, PHYTOPATHOLOGY, V48, P201; Kim DH, 2010, THEOR APPL GENET, V120, P1443, DOI 10.1007/s00122-010-1266-0; Kim YT, 2010, MOL BIOL REP, V37, P717, DOI 10.1007/s11033-009-9570-y; Li BY, 1999, CHIN J OIL CROP SCI, V21, P47; Li JS, 2007, ANHUI AGR SCI B, V13, P108; Maroof MAS, 2010, PLANT GENOME-US, V3, P14, DOI 10.3835/plantgenome2009.07.0020; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Nelson BD, 2008, PLANT DIS, V92, P1062, DOI 10.1094/PDIS-92-7-1062; Ryley MJ, 1998, PLANT DIS, V82, P1048, DOI 10.1094/PDIS.1998.82.9.1048; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Sandhu D, 2004, GENETICS, V168, P2157, DOI 10.1534/genetics.104.032037; Satterlee JS, 1998, J MEMBRANE BIOL, V164, P205, DOI 10.1007/s002329900406; Schmitthenner A.F., 1999, COMPENDIUM SOYBEAN D, V4th edn, P39; SCHMITTHENNER AF, 1985, PLANT DIS, V69, P362, DOI 10.1094/PD-69-362; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sugimoto T, 2011, EUPHYTICA, V182, P133, DOI 10.1007/s10681-011-0525-8; Sugimoto T, 2011, BREEDING SCI, V61, P511, DOI 10.1270/jsbbs.61.511; Sun S, 2011, PLANT BREEDING, V130, P139, DOI 10.1111/j.1439-0523.2010.01794.x; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Wu XL, 2011, AGR SCI CHINA, V10, P1506, DOI 10.1016/S1671-2927(11)60145-4; Xia ChangJian, 2011, Chinese Journal of Oil Crop Sciences, V33, P396; [姚海燕 YAO Hai-yan], 2010, [植物遗传资源学报, Journal of Plant Genetic Resources], V11, P213; Yu AnLiang, 2010, Chinese Journal of Oil Crop Sciences, V32, P462; Yuan JZ, 2012, J PLANT GENOME SCI, V1, P10, DOI DOI 10.5147/pggb.v1i1.147; Zhang SZ, 2010, PLANT DIS, V94, P87, DOI 10.1094/PDIS-94-1-0087; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2; Zhu ZhenDong, 2001, Acta Phytopathologica Sinica, V31, P236; Zhu ZhenDong, 2007, Acta Agronomica Sinica, V33, P154; Zhu ZhenDong, 2003, Scientia Agricultura Sinica, V36, P793; Zou HW, 2011, PLANT OMICS, V4, P53	53	28	34	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69799	10.1371/journal.pone.0069799	http://dx.doi.org/10.1371/journal.pone.0069799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936102	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300067
J	Guo, LY; Xing, YY; Pan, R; Jiang, ML; Gong, Z; Lin, LQ; Wang, JB; Xiong, GY; Dong, J				Guo, Luyan; Xing, Yanyan; Pan, Rui; Jiang, Mingliang; Gong, Zheng; Lin, Liqing; Wang, Junbing; Xiong, Guoyin; Dong, Jun			Curcumin Protects Microglia and Primary Rat Cortical Neurons against HIV-1 gp120-Mediated Inflammation and Apoptosis	PLOS ONE			English	Article							ANTIINFLAMMATORY AGENT; 4-AMINOPYRIDINE; MEMORY	Curcumin is a molecule found in turmeric root that has anti-inflammatory, antioxidant, and anti-tumor properties and has been widely used as both an herbal drug and a food additive to treat or prevent neurodegenerative diseases. To explore whether curcumin is able to ameliorate HIV-1-associated neurotoxicity, we treated a murine microglial cell line (N9) and primary rat cortical neurons with curcumin in the presence or absence of neurotoxic HIV-1 gp120 (V3 loop) protein. We found that HIV-1 gp120 profoundly induced N9 cells to produce reactive oxygen species (ROS), tumor necrosis factor-alpha (TNF-alpha) and monocyte chemoattractant protein-1 (MCP-1). HIV-1 gp120 also induced apoptosis of primary rat cortical neurons. Curcumin exerted a powerful inhibitory effect against HIV-1 gp120-induced neuronal damage, reducing the production of ROS, TNF-alpha and MCP-1 by N9 cells and inhibiting apoptosis of primary rat cortical neurons. Curcumin may exert its biological activities through inhibition of the delayed rectification and transient outward potassium (K+) current, as curcumin effectively reduced HIV-1 gp120-mediated elevation of the delayed rectification and transient outward K+ channel current in neurons. We conclude that HIV-1 gp120 increases ROS, TNF-alpha and MCP-1 production in microglia, and induces cortical neuron apoptosis by affecting the delayed rectification and transient outward K+ channel current. Curcumin reduces production of ROS and inflammatory mediators in HIV-1-gp120-stimulated microglia, and protects cortical neurons against HIV-1-mediated apoptosis, most likely through inhibition of HIV-1 gp120-induced elevation of the delayed rectification and transient outward K+ current.	[Guo, Luyan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynaecol, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Luyan; Xing, Yanyan; Jiang, Mingliang; Gong, Zheng; Lin, Liqing; Wang, Junbing; Xiong, Guoyin; Dong, Jun] Jinan Univ, Coll Med, Key Lab State Adm Tradit Chinese Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Guo, Luyan; Xing, Yanyan; Jiang, Mingliang; Gong, Zheng; Lin, Liqing; Wang, Junbing; Xiong, Guoyin; Dong, Jun] Jinan Univ, Coll Med, Inst Brain Res, Guangzhou, Guangdong, Peoples R China; [Guo, Luyan; Xing, Yanyan; Jiang, Mingliang; Gong, Zheng; Lin, Liqing; Wang, Junbing; Xiong, Guoyin; Dong, Jun] Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China; [Pan, Rui] Jinan Univ, Coll Med, Affiliated Hosp 1, Dept Orthoped, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University; Jinan University; Jinan University; Jinan University	Dong, J (corresponding author), Jinan Univ, Coll Med, Key Lab State Adm Tradit Chinese Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	dongjunbox@163.com	Xing, Yanyan/ABH-6983-2020		National Natural Science Foundation of China [81171134]; National Basic Research Program of China C973 program [2011CB707500]; Science and Technology Foundation of Guangzhou [2010Y1-C291]; Science and Technology Foundation of Guangdong [2010B030700017]; Key laboratory's Open Fund of Jinan University [2011ZD003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China C973 program(National Basic Research Program of China); Science and Technology Foundation of Guangzhou; Science and Technology Foundation of Guangdong; Key laboratory's Open Fund of Jinan University	This work was supported by National Natural Science Foundation of China, number 81171134; National Basic Research Program of China C973 program, number 2011CB707500; Science and Technology Foundation of Guangzhou, number 2010Y1-C291; Science and Technology Foundation of Guangdong, number 2010B030700017; The Key laboratory's Open Fund of Jinan University, number 2011ZD003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; CHEN L, 2011, PLOS ONE, V6; Chi XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024412; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Desai M, 2013, APOPTOSIS NEURONAL A, P29; Gong Z, 2012, NEURAL REGEN RES, V7, P171, DOI 10.3969/j.issn.1673-5374.2012.03.002; Hu CL, 2006, NEUROPHARMACOLOGY, V51, P737, DOI 10.1016/j.neuropharm.2006.05.013; Hu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.110; Jiao S, 2007, J NEUROCHEM, V100, P979, DOI 10.1111/j.1471-4159.2006.04261.x; Keblesh JP, 2009, J NEUROIMMUNE PHARM, V4, P317, DOI 10.1007/s11481-009-9161-7; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; Lugo JN, 2012, LEARN MEMORY, V19, P182, DOI 10.1101/lm.023614.111; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Piper JT, 1998, INT J BIOCHEM CELL B, V30, P445, DOI 10.1016/S1357-2725(98)00015-6; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Rezai-Zadeh K, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-41; Shafer TJ, 2010, TOXICOL IN VITRO, V24, P2053, DOI 10.1016/j.tiv.2010.08.016; Szabo I, 2010, FEBS LETT, V584, P2049, DOI 10.1016/j.febslet.2010.01.038; Tang HM, 2009, LIFE SCI, V85, P1, DOI 10.1016/j.lfs.2009.03.013; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Wei L, 2003, STROKE, V34, P1281, DOI 10.1161/01.STR.0000065828.18661.FE; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186; Zhou X, 2011, CELL DEATH DIFFER, V18, P493, DOI 10.1038/cdd.2010.120	27	68	69	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70565	10.1371/journal.pone.0070565	http://dx.doi.org/10.1371/journal.pone.0070565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936448	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500044
J	Ludford, KT; Vagenas, P; Lama, JR; Peinado, J; Gonzales, P; Leiva, R; Pun, M; Sanchez, J; Altice, FL				Ludford, Kaysia T.; Vagenas, Panagiotis; Lama, Javier R.; Peinado, Jesus; Gonzales, Pedro; Leiva, Rene; Pun, Monica; Sanchez, Jorge; Altice, Frederick L.		Peruvian HIV Sentinel Surveillance	Screening for Drug and Alcohol Use Disorders and Their Association with HIV-Related Sexual Risk Behaviors among Men Who Have Sex with Men in Peru	PLOS ONE			English	Article							SUBSTANCE-USE; TRANSMITTED INFECTIONS; UNITED-STATES; WOMEN; SEROCONVERSION; INTERVENTIONS; METAANALYSIS; ADVENTURISM; PREVENTION; ADHERENCE	Background: Peru's HIV epidemic is concentrated among men who have sex with men (MSM). The contribution of alcohol use disorders (AUDs) to known high-risk behaviors associated with HIV transmission in this context has not been well characterized. Methods: Between June and October 2011, 5,148 sexually active MSM were recruited using convenience sampling in five cities to participate in a cross-sectional bio-behavioral survey. Five high-risk sexual criteria previously associated with incident HIV infection in this setting were selected a priori as the dependent outcomes. Screening for AUDs used the validated Alcohol Use Disorders Identification Test (AUDIT) and AUDS were stratified by severity. Unadjusted and adjusted odds ratios (AOR) were computed to establish the independent correlates of the five dependent outcomes. Results: The majority (62.8%) of participants met screening criteria for having an AUD, which were independently correlated with each of the following high-risk sexual risk behaviors in the previous 6 months: 1) >5 sexual partners [AOR = 1.76; (1.54-2.02)]; 2) sex with an HIV-infected partner [AOR = 1.29; (1.03-1.62)]; 3) having a sexually transmitted infection [AOR = 1.38; (1.13-1.68)]; 4) being a sex worker [AOR = 1.61; (1.40-1.87)]; and 5) unprotected sex during last encounter [AOR = 1.22; (1.09-1.38)]. Recent drug use was also correlated with having >5 sexual partners [AOR = 1.42 (1.19-1.71)], sex work [AOR = 1.97 (1.63-2.39)] and unprotected sex during last encounter [AOR = 1.31 (1.11-1.54)]. For each dependent variable, the association with AUDs significantly increased with increasing AUD severity. Conclusions: AUDs are highly prevalent among MSM in Peru and are associated with increased HIV risk-taking behaviors that are associated with HIV transmission. Strategies that target problematic drinking such as medication-assisted therapy, behavioral counseling and structural interventions could potentially reduce risky behaviors and ultimately reduce HIV transmission among MSM in Peru.	[Ludford, Kaysia T.; Vagenas, Panagiotis; Altice, Frederick L.] Yale Univ, Sch Med, Infect Dis Sect, AIDS Program, New Haven, CT 06520 USA; [Lama, Javier R.; Peinado, Jesus; Gonzales, Pedro; Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Leiva, Rene; Pun, Monica] Minist Hlth, Gen Directorate Epidemiol, Lima, Peru; [Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	Yale University; Yale University	Altice, FL (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, AIDS Program, New Haven, CT 06520 USA.	frederick.altice@yale.edu	Peinado, Jesus/AFN-6160-2022; Vagenas, Panagiotis/H-7850-2013	Peinado, Jesus/0000-0003-2015-3170; Vagenas, Panagiotis/0000-0003-2107-0377; Altice, Frederick/0000-0002-7860-693X; Pun, Monica/0000-0001-8299-355X	Asociacion Civil Impacta Educacion y Salud, Peru; National Institute on Drug Abuse [K24 DA017072, R01 DA032106]; Downs International Health Student Travel Fellowship (Yale University); Infectious Diseases Society of America Education and Research Foundation Medical Scholars Program; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, R01DA032106] Funding Source: NIH RePORTER	Asociacion Civil Impacta Educacion y Salud, Peru; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Downs International Health Student Travel Fellowship (Yale University); Infectious Diseases Society of America Education and Research Foundation Medical Scholars Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Asociacion Civil Impacta Educacion y Salud, Peru; career development grants from the National Institute on Drug Abuse (K24 DA017072, FLA); research grants from the National Institute on Drug Abuse (R01 DA032106, FLA and PV); the Downs International Health Student Travel Fellowship (Yale University, KTL); the Infectious Diseases Society of America Education and Research Foundation Medical Scholars Program (KTL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2005, J URBAN HEALTH, V82, P312, DOI 10.1093/jurban/jti055; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Azar MM, 2010, DRUG ALCOHOL DEPEN, V112, P178, DOI 10.1016/j.drugalcdep.2010.06.014; Babor TF., 2001, AUDIT ALCOHOL USE DI; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; Carcamo CP, 2012, LANCET INFECT DIS, V12, P765, DOI 10.1016/S1473-3099(12)70144-5; Celentano DD, 2006, SEX TRANSM DIS, V33, P265, DOI 10.1097/01.olq.0000187207.10992.4e; Deiss R.G., 2013, DRUG ALCOHOL DEPEND; DEVIDA, 2006, ENC NAC CONS DROG PO; DiFranceisco W, 1996, SEX TRANSM DIS, V23, P453, DOI 10.1097/00007435-199611000-00003; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; George W H, 2000, Annu Rev Sex Res, V11, P92; Heath J, 2012, AIDS BEHAV, V16, P578, DOI 10.1007/s10461-011-9921-2; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Hirshfield S, 2004, AIDS CARE, V16, P1036, DOI 10.1080/09540120412331292525; Jacob ST, 2011, AIDS BEHAV, V15, P897, DOI 10.1007/s10461-010-9853-2; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kippax S, 1998, AIDS CARE, V10, P677, DOI 10.1080/09540129848307; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Leobon A, 2011, AIDS CARE, V23, P25, DOI 10.1080/09540121.2010.498866; Luchters S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-384; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mimiaga MJ, 2013, AIDS CARE; Pappas MK, 2011, AIDS CARE, V23, P1410, DOI 10.1080/09540121.2011.565027; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Simbayi LC, 2004, J STUD ALCOHOL, V65, P434, DOI 10.15288/jsa.2004.65.434; Stall R., 2000, AIDS BEHAV, V4, P181, DOI [10.1023/A:1009516608672, DOI 10.1023/A:1009516608672]; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Weinhardt L S, 2000, Annu Rev Sex Res, V11, P125; Woolf SE, 2009, AIDS BEHAV, V13, P757, DOI 10.1007/s10461-007-9354-0; World Health Organization, 2001, ALCOHOL USE DISORDER	37	36	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69966	10.1371/journal.pone.0069966	http://dx.doi.org/10.1371/journal.pone.0069966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217ZG	23936364	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500020
J	Elgharably, H; Mann, E; Awad, H; Ganesh, K; Das Ghatak, P; Gordillo, G; Sai-Sudhakar, CB; Roy, S; Wozniak, DJ; Sen, CK				Elgharably, Haytham; Mann, Ethan; Awad, Hamdy; Ganesh, Kasturi; Das Ghatak, Piya; Gordillo, Gayle; Sai-Sudhakar, Chittoor B.; Roy, Sashwati; Wozniak, Daniel J.; Sen, Chandan K.			First Evidence of Sternal Wound Biofilm following Cardiac Surgery	PLOS ONE			English	Article							SURGICAL-SITE INFECTION; ARTERY-BYPASS GRAFT; BACTERIAL BIOFILMS; POSTOPERATIVE MEDIASTINITIS; STAPHYLOCOCCUS-EPIDERMIDIS; MICROBIOLOGY; PATHOGENESIS; CLOSURE; COMPLICATIONS; MECHANISMS	Management of deep sternal wound infection (SWI), a serious complication after cardiac surgery with high morbidity and mortality incidence, requires invasive procedures such as, debridement with primary closure or myocutaneous flap reconstruction along with use of broad spectrum antibiotics. The purpose of this clinical series is to investigate the presence of biofilm in patients with deep SWI. A biofilm is a complex microbial community in which bacteria attach to a biological or non-biological surface and are embedded in a self-produced extracellular polymeric substance. Biofilm related infections represent a major clinical challenge due to their resistance to both host immune defenses and standard antimicrobial therapies. Candidates for this clinical series were patients scheduled for a debridement procedure of an infected sternal wound after a cardiac surgery. Six patients with SWI were recruited in the study. All cases had marked dehiscence of all layers of the wound down to the sternum with no signs of healing after receiving broad spectrum antibiotics post-surgery. After consenting patients, tissue and/or extracted stainless steel wires were collected during the debridement procedure. Debrided tissues examined by Gram stain showed large aggregations of Gram positive cocci. Immuno-fluorescent staining of the debrided tissues using a specific antibody against staphylococci demonstrated the presence of thick clumps of staphylococci colonizing the wound bed. Evaluation of tissue samples with scanning electron microscope (SEM) imaging showed three-dimensional aggregates of these cocci attached to the wound surface. More interestingly, SEM imaging of the extracted wires showed attachment of cocci aggregations to the wire metal surface. These observations along with the clinical presentation of the patients provide the first evidence that supports the presence of biofilm in such cases. Clinical introduction of the biofilm infection concept in deep SWI may advance the current management strategies from standard antimicrobial therapy to anti-biofilm strategy.	[Elgharably, Haytham; Ganesh, Kasturi; Das Ghatak, Piya; Sai-Sudhakar, Chittoor B.; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Elgharably, Haytham; Ganesh, Kasturi; Das Ghatak, Piya; Gordillo, Gayle; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Elgharably, Haytham; Ganesh, Kasturi; Das Ghatak, Piya; Gordillo, Gayle; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Ctr Regenerat Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Elgharably, Haytham; Ganesh, Kasturi; Das Ghatak, Piya; Gordillo, Gayle; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Ctr Cell Based Therapies, Wexner Med Ctr, Columbus, OH 43210 USA; [Elgharably, Haytham; Ganesh, Kasturi; Das Ghatak, Piya; Gordillo, Gayle; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Comprehens Wound Ctr, Wexner Med Ctr, Columbus, OH 43210 USA; [Awad, Hamdy; Wozniak, Daniel J.] Ohio State Univ, Dept Anesthesiol, Wexner Med Ctr, Columbus, OH 43210 USA; [Mann, Ethan] Ohio State Univ, Dept Microbial Infect & Immun & Microbiol, Wexner Med Ctr, Columbus, OH 43210 USA; [Gordillo, Gayle] Ohio State Univ, Dept Plast Surg, Wexner Med Ctr, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University; Ohio State University; Ohio State University; Ohio State University; Ohio State University	Sen, CK (corresponding author), Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA.	chandan.sen@osumc.edu			National Institutes of Health awards [GM069589, GM 077185, NR013898, DK076566]; NCRR [UL1RR025755]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK076566, R01DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069589, R01GM077185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013898] Funding Source: NIH RePORTER	National Institutes of Health awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by National Institutes of Health awards GM069589 & GM 077185 to CKS, NR013898 to CKS and DJW, DK076566 to SR and a pilot fund from NCRR UL1RR025755 to HA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDYK DF, 1991, J VASC SURG, V13, P575; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; ElOakley RM, 1996, ANN THORAC SURG, V61, P1030, DOI 10.1016/0003-4975(95)01035-1; Engelman R, 2007, ANN THORAC SURG, V83, P1569, DOI 10.1016/j.athoracsur.2006.09.046; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Gardlund B, 2002, EUR J CARDIO-THORAC, V21, P825, DOI 10.1016/S1010-7940(02)00084-2; Gummert JF, 2002, THORAC CARDIOV SURG, V50, P87, DOI 10.1055/s-2002-26691; Han A, 2011, WOUND REPAIR REGEN, V19, P532, DOI 10.1111/j.1524-475X.2011.00720.x; Hidron AI, 2009, LANCET INFECT DIS, V9, P384, DOI 10.1016/S1473-3099(09)70133-1; Hollenbeak CS, 2000, CHEST, V118, P397, DOI 10.1378/chest.118.2.397; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Kathju S, 2009, SURG INFECT, V10, P457, DOI 10.1089/sur.2008.062; Kjaergard HK, 1999, J HEART VALVE DIS, V8, P140; Lopez-Leban F, 2010, INT J ARTIF ORGANS, V33, P582, DOI 10.1177/039139881003300904; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339; MARRIE TJ, 1984, J CLIN MICROBIOL, V19, P687, DOI 10.1128/JCM.19.5.687-693.1984; Matros E, 2010, J THORAC CARDIOV SUR, V139, P680, DOI 10.1016/j.jtcvs.2009.10.006; Mauermann WJ, 2008, BEST PRACT RES-CLIN, V22, P423, DOI 10.1016/j.bpa.2008.04.003; McCann MT, 2008, J PHARM PHARMACOL, V60, P1551, DOI 10.1211/jpp/60.12.0001; Negri A, 2002, EUR J CARDIO-THORAC, V22, P571, DOI 10.1016/S1010-7940(02)00411-6; Olsson E, 2007, APMIS, V115, P142, DOI 10.1111/j.1600-0463.2007.apm_559.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Owen S, 2010, JNP-J NURSE PRACT, V6, P371; Panuncialman J, 2007, CLIN PLAST SURG, V34, P621, DOI 10.1016/j.cps.2007.07.003; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Poncelet AJ, 2008, EUR J CARDIO-THORAC, V33, P232, DOI 10.1016/j.ejcts.2007.11.016; Raad I, 2007, ANTIMICROB AGENTS CH, V51, P1656, DOI 10.1128/AAC.00350-06; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Rhoads D D, 2008, J Wound Care, V17, P502; Schols RM, 2011, EUR J PLAST SURG, V34, P487, DOI 10.1007/s00238-011-0573-2; Sharma M, 2004, INFECT CONT HOSP EP, V25, P468, DOI 10.1086/502423; Singh Kimberly, 2011, Semin Plast Surg, V25, P25, DOI 10.1055/s-0031-1275168; Stahle E, 1997, EUR J CARDIO-THORAC, V11, P1146, DOI 10.1016/S1010-7940(97)01210-4; Stoodley P, 2008, J BONE JOINT SURG AM, V90A, P1751, DOI 10.2106/JBJS.G.00838; Stoodley P, 2010, PEDIATR NEUROSURG, V46, P127, DOI 10.1159/000319396; TAVILLA G, 1991, ANN THORAC SURG, V52, P1179, DOI 10.1016/0003-4975(91)91310-R; Wolcott, 2008, WOUNDS UK, V4, P108; Wolcott R D, 2008, J Wound Care, V17, P145; Wolcott R D, 2009, J Wound Care, V18, P317; Wolcott RD, 2010, J WOUND CARE, V19, P320, DOI 10.12968/jowc.2010.19.8.77709; Wolcott RD, 2010, J WOUND CARE, V19, P272; Wolcott R D, 2009, J Wound Care, V18, P54; Wolcott R D, 2008, J Wound Care, V17, P513	49	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70360	10.1371/journal.pone.0070360	http://dx.doi.org/10.1371/journal.pone.0070360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936415	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400059
J	Mittal, AK; Chaturvedi, NK; Rohlfsen, RA; Gupta, P; Joshi, AD; Hegde, GV; Bociek, RG; Joshi, SS				Mittal, Amit K.; Chaturvedi, Nagendra K.; Rohlfsen, Rae A.; Gupta, Payal; Joshi, Avadhut D.; Hegde, Ganapati V.; Bociek, R. Gregory; Joshi, Shantaram S.			Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							B-CELLS; CD38 EXPRESSION; APOPTOSIS RESISTANCE; AGGRESSIVE DISEASE; GENE-EXPRESSION; T-LYMPHOCYTES; CD152 CTLA-4; CLL PATIENTS; ACTIVATION; MICROENVIRONMENT	Earlier, we reported that CTLA4 expression is inversely correlated with CD38 expression in chronic lymphocytic leukemia (CLL) cells. However, the specific role of CTLA4 in CLL pathogenesis remains unknown. Therefore, to elucidate the possible role of CTLA4 in CLL pathogenesis, CTLA4 was down-regulated in primary CLL cells. We then evaluated proliferation/survival in these cells using MTT, H-3-thymidine uptake and Annexin-V apoptosis assays. We also measured expression levels of downstream molecules involved in B-cell proliferation/survival signaling including STAT1, NFATC2, c-Fos, c-Myc, and Bcl-2 using microarray, PCR, western blotting analyses, and a stromal cell culture system. CLL cells with CTLA4 down-regulation demonstrated a significant increase in proliferation and survival along with an increased expression of STAT1, STAT1 phosphorylation, NFATC2, c-Fos phosphorylation, c-Myc, Ki-67 and Bcl-2 molecules. In addition, compared to controls, the CTLA4-downregulated CLL cells showed a decreased frequency of apoptosis, which also correlated with increased expression of Bcl-2. Interestingly, CLL cells from lymph node and CLL cells co-cultured on stroma expressed lower levels of CTLA4 and higher levels of c-Fos, c-Myc, and Bcl-2 compared to CLL control cells. These results indicate that microenvironment-controlled-CTLA4 expression mediates proliferation/survival of CLL cells by regulating the expression/ activation of STAT1, NFATC2, c-Fos, c-Myc, and/or Bcl-2.	[Mittal, Amit K.; Chaturvedi, Nagendra K.; Rohlfsen, Rae A.; Gupta, Payal; Joshi, Avadhut D.; Hegde, Ganapati V.; Joshi, Shantaram S.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Bociek, R. Gregory] Univ Nebraska Med Ctr, Sect Oncol Hematol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Joshi, SS (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA.	ssjoshi@unmc.edu	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001	CLL Foundation, Houston, TX; Lymphoma Research Foundation, New York, NY; UNMC, College of Medicine Dean's Research Funds	CLL Foundation, Houston, TX; Lymphoma Research Foundation, New York, NY; UNMC, College of Medicine Dean's Research Funds	This work was supported by the CLL Foundation, Houston, TX; Lymphoma Research Foundation, New York, NY; and partially supported from the UNMC, College of Medicine Dean's Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malak NA, 2008, BLOOD, V111, P4145, DOI 10.1182/blood-2007-08-110338; Brunner MC, 1999, J IMMUNOL, V162, P5813; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Cols M, 2012, J IMMUNOL, V188, P6071, DOI 10.4049/jimmunol.1102066; Cross AH, 1999, EUR J IMMUNOL, V29, P3140, DOI 10.1002/(SICI)1521-4141(199910)29:10<3140::AID-IMMU3140>3.3.CO;2-N; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Dickinson JD, 2006, INT J MOL MED, V17, P769; Dighiero G, 2008, LANCET, V371, P1017, DOI 10.1016/S0140-6736(08)60456-0; Doyle AM, 2001, J EXP MED, V194, P893, DOI 10.1084/jem.194.7.893; Durig J, 2002, LEUKEMIA, V16, P30, DOI 10.1038/sj.leu.2402339; Gibson HM, 2007, J IMMUNOL, V179, P3831, DOI 10.4049/jimmunol.179.6.3831; Gilling CE, 2012, BRIT J HAEMATOL, V158, P216, DOI 10.1111/j.1365-2141.2012.09148.x; Greenfield EA, 1997, J IMMUNOL, V158, P2025; Greenwald RJ, 2002, EUR J IMMUNOL, V32, P366, DOI 10.1002/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5; HARPER K, 1991, J IMMUNOL, V147, P1037; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Hurwitz AA, 1998, P NATL ACAD SCI USA, V95, P10067, DOI 10.1073/pnas.95.17.10067; Joshi AD, 2007, CLIN CANCER RES, V13, P5295, DOI 10.1158/1078-0432.CCR-07-0283; Kay NE, 2005, LEUKEMIA RES, V29, P1009, DOI 10.1016/j.leukres.2004.11.025; Kienle D, 2006, BLOOD, V107, P2090, DOI 10.1182/blood-2005-04-1483; Kosmaczewska A, 2005, LEUKEMIA, V19, P301, DOI 10.1038/sj.leu.2403588; Lee YK, 2005, LEUKEMIA, V19, P513, DOI 10.1038/sj.leu.2403667; Lima MAP, 2008, DIAGN MOL PATHOL, V17, P82, DOI 10.1097/PDM.0b013e31814e5d8f; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Martinez-Lostao L, 2005, LEUKEMIA LYMPHOMA, V46, P435, DOI 10.1080/10428190400018398; McCarthy BA, 2008, MOL MED, V14, P618, DOI 10.2119/2008.00061.McCarthy; Mittal AK, 2007, INT J MOL MED, V20, P461; Motta M, 2005, LEUKEMIA, V19, P1788, DOI 10.1038/sj.leu.2403907; Muzio M, 2008, BLOOD, V112, P188, DOI 10.1182/blood-2007-09-111344; Oracki SA, 2010, J IMMUNOL, V184, P757, DOI 10.4049/jimmunol.0804349; Palacios F, 2010, BLOOD, V115, P4488, DOI 10.1182/blood-2009-12-257758; Pandiyan P, 2004, J EXP MED, V199, P831, DOI 10.1084/jem.20031058; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Quandt D, 2007, J IMMUNOL, V179, P7316, DOI 10.4049/jimmunol.179.11.7316; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Salvi S, 2012, CANCER IMMUNOL IMMUN, V61, P1463, DOI 10.1007/s00262-012-1211-y; Scheipers P, 1998, P NATL ACAD SCI USA, V95, P10083, DOI 10.1073/pnas.95.17.10083; Schuh K, 1996, LEUKEMIA LYMPHOMA, V23, P583, DOI 10.3109/10428199609054868; Seldeen KL, 2008, ARCH BIOCHEM BIOPHYS, V473, P48, DOI 10.1016/j.abb.2008.02.024; Shen Yulei, 2004, BMC Immunology, V5; Sun H, 1997, TRANSPLANTATION, V64, P1838, DOI 10.1097/00007890-199712270-00035; Suwalska K, 2008, HUM IMMUNOL, V69, P193, DOI 10.1016/j.humimm.2008.01.014; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tomic J, 2006, J IMMUNOL, V176, P3830, DOI 10.4049/jimmunol.176.6.3830; Vogt B, 2009, AUTOIMMUNITY, V42, P380, DOI 10.1080/08916930902832470; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Zhang LZ, 2011, INT J CANCER, V129, P1162, DOI 10.1002/ijc.25785	53	28	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70352	10.1371/journal.pone.0070352	http://dx.doi.org/10.1371/journal.pone.0070352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936412	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400057
J	Zhao, B; Zhang, KY; Bhuripanyo, K; Choi, CHJ; Villhauer, EB; Li, H; Zheng, N; Kiyokawa, H; Schindelin, H; Yin, J				Zhao, Bo; Zhang, Keya; Bhuripanyo, Karan; Choi, Chan Hee J.; Villhauer, Eric B.; Li, Heng; Zheng, Ning; Kiyokawa, Hiroaki; Schindelin, Hermann; Yin, Jun			Profiling the Cross Reactivity of Ubiquitin with the Nedd8 Activating Enzyme by Phage Display	PLOS ONE			English	Article							PROTEIN NEDD8; E1; SYSTEM; CONJUGATION; PATHWAY; COMPLEX; LIGASES; PURIFICATION; NEDDYLATION; EXPRESSION	The C-terminal peptides of ubiquitin (UB) and UB-like proteins (UBLs) play a key role in their recognition by the specific activating enzymes (E1s) to launch their transfer through the respective enzymatic cascades thus modifying cellular proteins. UB and Nedd8, a UBL regulating the activity of cullin-RING UB ligases, only differ by one residue at their C-termini; yet each has its specific E1 for the activation reaction. It has been reported recently that UAE can cross react with Nedd8 to enable its passage through the UB transfer cascade for protein neddylation. To elucidate differences in UB recognition by UAE and NAE, we carried out phage selection of a UB library with randomized C-terminal sequences based on the catalytic formation of UB similar to NAE thioester conjugates. Our results confirmed the previous finding that residue 72 of UB plays a "gate-keeping" role in E1 selectivity. We also found that diverse sequences flanking residue 72 at the UB C-terminus can be accommodated by NAE for activation. Furthermore heptameric peptides derived from the C-terminal sequences of UB variants selected for NAE activation can function as mimics of Nedd8 to form thioester conjugates with NAE and the downstream E2 enzyme Ubc12 in the Nedd8 transfer cascade. Once the peptides are charged onto the cascade enzymes, the full-length Nedd8 protein is effectively blocked from passing through the cascade for the critical modification of cullin. We have thus identified a new class of inhibitors of protein neddylation based on the profiles of the UB C-terminal sequences recognized by NAE.	[Zhao, Bo; Zhang, Keya; Bhuripanyo, Karan; Choi, Chan Hee J.; Villhauer, Eric B.; Yin, Jun] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Li, Heng; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Kiyokawa, Hiroaki] Northwestern Univ, Dept Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Schindelin, Hermann] Univ Wurzburg, Inst Biol Struct, D-97070 Wurzburg, Germany	University of Chicago; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Northwestern University; Feinberg School of Medicine; University of Wurzburg; University of Wurzburg	Yin, J (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	junyin@uchicago.edu	Li, Heng/J-2081-2015; Schindelin, Hermann/Q-2697-2019	Choi, Chan Hee/0000-0002-9892-9330; Kiyokawa, Hiroaki/0000-0002-7942-6455	University of Chicago; National Science Foundation [1057092]; National Institute of Health [1R01GM104498]; Deutsche Forschungsgemeinschaft [SCHI 425/6-1, FZ 82]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE [R01CA112282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104498] Funding Source: NIH RePORTER	University of Chicago(University of Chicago); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a lab startup grant from the University of Chicago, a National Science Foundation CAREER award (1057092) to J.Y., a National Institute of Health grant 1R01GM104498 to J.Y. and H. K., and by the Deutsche Forschungsgemeinschaft (SCHI 425/6-1 and FZ 82) to H. S. This work was also funded in part by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust (to J.Y. and H. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbas III CF, 2000, PHAGE DISPLAY LAB MA; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; CRAMERI R, 1993, GENE, V137, P69, DOI 10.1016/0378-1119(93)90253-Y; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, METHOD ENZYMOL, V398, P9, DOI 10.1016/S0076-6879(05)98002-6; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Leidecker O, 2012, CELL CYCLE, V11, P1142, DOI 10.4161/cc.11.6.19559; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Overington J.P., 1992, CURR OPIN STRUC BIOL, V2, P394, DOI 10.1016/0959-440X(92)90231-U; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Souphron J, 2008, BIOCHEMISTRY-US, V47, P8961, DOI 10.1021/bi800604c; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zhao B, 2012, ACS CHEM BIOL, V7, P2027, DOI 10.1021/cb300339p; Zhao B, 2012, ORG LETT, V14, P5760, DOI 10.1021/ol3027736; Zhao B, 2012, CHEM BIOL, V19, P1265, DOI 10.1016/j.chembiol.2012.07.023	34	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70312	10.1371/journal.pone.0070312	http://dx.doi.org/10.1371/journal.pone.0070312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936405	gold, Green Submitted, Green Published			2022-12-27	WOS:000324518400053
J	Amaral, MM; Sacerdoti, F; Jancic, C; Repetto, HA; Paton, AW; Paton, JC; Ibarra, C				Amaral, Maria M.; Sacerdoti, Flavia; Jancic, Carolina; Repetto, Horacio A.; Paton, Adrienne W.; Paton, James C.; Ibarra, Cristina			Action of Shiga Toxin Type-2 and Subtilase Cytotoxin on Human Microvascular Endothelial Cells	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI; LEUKOCYTE ADHESION; UP-REGULATION; AB(5) TOXIN; HELA-CELLS; APOPTOSIS; PATHOGENESIS; INFECTION; POTENT	The hemolytic uremic syndrome (HUS) associated with diarrhea is a complication of Shiga toxin (Stx)-producing Escherichia coli (STEC) infection. In Argentina, HUS is endemic and responsible for acute and chronic renal failure in children younger than 5 years old. The human kidney is the most affected organ due to the presence of very Stx-sensitive cells, such as microvascular endothelial cells. Recently, Subtilase cytotoxin (SubAB) was proposed as a new toxin that may contribute to HUS pathogenesis, although its action on human glomerular endothelial cells (HGEC) has not been described yet. In this study, we compared the effects of SubAB with those caused by Stx2 on primary cultures of HGEC isolated from fragments of human pediatric renal cortex. HGEC were characterized as endothelial since they expressed von Willebrand factor (VWF) and platelet/endothelial cell adhesion molecule 1 (PECAM-1). HGEC also expressed the globotriaosylceramide (Gb3) receptor for Stx2. Both, Stx2 and SubAB induced swelling and detachment of HGEC and the consequent decrease in cell viability in a time-dependent manner. Preincubation of HGEC with C-9 -a competitive inhibitor of Gb3 synthesis-protected HGEC from Stx2 but not from SubAB cytotoxic effects. Stx2 increased apoptosis in a time-dependent manner while SubAB increased apoptosis at 4 and 6 h but decreased at 24 h. The apoptosis induced by SubAB relative to Stx2 was higher at 4 and 6 h, but lower at 24 h. Furthermore, necrosis caused by Stx2 was significantly higher than that induced by SubAB at all the time points evaluated. Our data provide evidence for the first time how SubAB could cooperate with the development of endothelial damage characteristic of HUS pathogenesis.	[Amaral, Maria M.; Sacerdoti, Flavia; Ibarra, Cristina] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina; [Jancic, Carolina] Acad Nacl Med Buenos Aires, Lab Inmunidad Innata, Inst Med Expt IMEX CONICET, Buenos Aires, DF, Argentina; [Repetto, Horacio A.] Hosp Nacl Profesor Alejandro Posadas, Serv Pediat, Buenos Aires, DF, Argentina; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Buenos Aires; Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; University of Adelaide	Amaral, MM (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina.	mamaral@fmed.uba.ar	Ibarra, Cristina/D-6242-2016	Amaral, Maria Marta/0000-0002-3902-2464; Sacerdoti, Flavia/0000-0002-8480-756X	CONICET; Universidad de Buenos Aires; ANPCYT	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); ANPCYT(ANPCyT)	This work was supported by grants to Maria Marta Amaral from CONICET and Cristina Ibarra from Universidad de Buenos Aires, CONICET and ANPCYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli SP, 1999, CURR OPIN NEPHROL HY, V8, P459, DOI 10.1097/00041552-199907000-00010; BITZAN M, 1994, INFECT IMMUN, V62, P3337, DOI 10.1128/IAI.62.8.3337-3347.1994; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonomini M, 2002, KIDNEY INT, V62, P1358, DOI 10.1046/j.1523-1755.2002.00560.x; BOYD B, 1989, NEPHRON, V51, P207, DOI 10.1159/000185286; Brigotti M, 2011, PEDIATR INFECT DIS J, V30, P486, DOI 10.1097/INF.0b013e3182074d22; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; CAPRIOLI A, 1992, J INFECT DIS, V166, P154, DOI 10.1093/infdis/166.1.154; Cooling LLW, 1998, INFECT IMMUN, V66, P4355; Creydt VP, 2006, MICROBES INFECT, V8, P410, DOI 10.1016/j.micinf.2005.07.005; Foller M, 2008, IUBMB LIFE, V60, P661, DOI 10.1002/iub.106; FURUKAWA K, 1988, J BIOL CHEM, V263, P18507; Galli L, 2010, VET MICROBIOL, V143, P307, DOI 10.1016/j.vetmic.2009.11.028; GRANT DS, 1990, ANN NY ACAD SCI, V588, P61, DOI 10.1111/j.1749-6632.1990.tb13197.x; HABBIB, 1992, THROMBOTIC THROMBOCY, P315; HAREPETTO, 2009, NEFROLOGIA CLIN, P286; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; KARPMAN D, 2002, CURR PAEDIAT, V12; LOO T, 2001, J AM SOC NEPHROL, V12, P800; Matsuura G, 2009, INFECT IMMUN, V77, P2919, DOI 10.1128/IAI.01510-08; Matussek A, 2003, BLOOD, V102, P1323, DOI 10.1182/blood-2002-10-3301; May KL, 2010, INFECT IMMUN, V78, P4691, DOI 10.1128/IAI.00801-10; Mcginn S, 2004, NEPHROLOGY, V9, P229, DOI 10.1111/j.1440-1797.2004.00254.x; MORIGI M, 1995, BLOOD, V86, P4553, DOI 10.1182/blood.V86.12.4553.bloodjournal86124553; Morigi M, 2001, BLOOD, V98, P1828, DOI 10.1182/blood.V98.6.1828; OBRIG TG, 1993, J BIOL CHEM, V268, P15484; Obrig TG, 2012, CURR TOP MICROBIOL, V357, P105, DOI 10.1007/82_2011_172; Obrig TG, 2010, TOXINS, V2, P2769, DOI 10.3390/toxins2122769; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Pijpers AHJM, 2001, J AM SOC NEPHROL, V12, P767, DOI 10.1681/ASN.V124767; Repetto HA, 1997, KIDNEY INT, V52, P1708, DOI 10.1038/ki.1997.508; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; Rozenfeld PA, 2009, CLIN CHIM ACTA, V403, P194, DOI 10.1016/j.cca.2009.02.016; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Saydam G, 2003, LEUKEMIA RES, V27, P709, DOI 10.1016/S0145-2126(02)00347-8; TURI S, 1994, PEDIATR NEPHROL, V8, P26, DOI 10.1007/BF00868253; vanSetten PA, 1996, BLOOD, V88, P174, DOI 10.1182/blood.V88.1.174.bloodjournal881174; vanSetten PA, 1997, KIDNEY INT, V51, P1245, DOI 10.1038/ki.1997.170; Wang H, 2007, J INFECT DIS, V196, P1093, DOI 10.1086/521364; Wang H, 2010, J INFECT DIS, V202, P1415, DOI 10.1086/656534; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Yahiro K, 2006, MOL MICROBIOL, V62, P480, DOI 10.1111/j.1365-2958.2006.05379.x; Yahiro K, 2010, MICROB PATHOGENESIS, V49, P153, DOI 10.1016/j.micpath.2010.05.007; Zanchi C, 2008, J IMMUNOL, V181, P1460, DOI 10.4049/jimmunol.181.2.1460; Zappulla Donatella, 2008, J Cardiometab Syndr, V3, P30, DOI 10.1111/j.1559-4572.2008.07263.x; Zoja C, 2001, J NEPHROL, V14, pS58; Zoja C, 2002, KIDNEY INT, V62, P846, DOI 10.1046/j.1523-1755.2002.00503.x; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	53	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70431	10.1371/journal.pone.0070431	http://dx.doi.org/10.1371/journal.pone.0070431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936204	Green Published, gold			2022-12-27	WOS:000323114200082
J	Mijele, D; Obanda, V; Omondi, P; Soriguer, RC; Gakuya, F; Otiende, M; Hongo, P; Alasaad, S				Mijele, Domnic; Obanda, Vincent; Omondi, Patrick; Soriguer, Ramon C.; Gakuya, Francis; Otiende, Moses; Hongo, Peter; Alasaad, Samer			Spatio-Temporal Distribution of Injured Elephants in Masai Mara and the Putative Negative and Positive Roles of the Local Community	PLOS ONE			English	Article							AFRICAN ELEPHANTS; RISK; SEGREGATION; PATTERNS	Background: Very few studies have ever focused on the elephants that are wounded or killed as local communities attempt to scare these animals away from their settlements and farms, or on the cases in which local people take revenge after elephants have killed or injured humans. On the other hand, local communities live in close proximity to elephants and hence can play a positive role in elephant conservation by informing the authorities of the presence of injured elephants. Methodology/Principal Findings: Between 2007 and 2011, 129 elephants were monitored in Masai Mara (Kenya), of which 54 had various types of active (intentionally caused) or passive (non-intentionally caused) injuries. Also studied were 75 random control samples of apparently unaffected animals. The observed active injuries were as expected biased by age, with adults suffering more harm; on the other hand, no such bias was observed in the case of passive injuries. Bias was also observed in elephant sex since more males than females were passively and actively injured. Cases of passive and active injuries in elephants were negatively related to the proximity to roads and farms; the distribution of injured elephants was not affected by the presence of either human settlements or water sources. Overall more elephants were actively injured during the dry season than the wet season as expected. Local communities play a positive role by informing KWS authorities of the presence of injured elephants and reported 43% of all cases of injured elephants. Conclusions: Our results suggest that the negative effect of local communities on elephants could be predicted by elephant proximity to farms and roads. In addition, local communities may be able to play a more positive role in elephant conservation given that they are key informants in the early detection of injured elephants.	[Mijele, Domnic; Obanda, Vincent; Omondi, Patrick; Gakuya, Francis; Otiende, Moses; Hongo, Peter] Kenya Wildlife Serv, Nairobi, Kenya; [Soriguer, Ramon C.; Alasaad, Samer] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Alasaad, Samer] Univ Zurich, Inst Evolutionary Biol & Environm Studies IEU, Zurich, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Zurich	Mijele, D (corresponding author), Kenya Wildlife Serv, Nairobi, Kenya.	dmijele@kws.go.ke; sameralasaad@hotmail.com	Angelone, Samer/G-4727-2013; Soriguer, Ramon/J-1494-2014	Angelone, Samer/0000-0003-0868-7276; Soriguer, Ramon/0000-0002-9165-7766				Ahlering MA, 2011, ANIM CONSERV, V14, P124, DOI 10.1111/j.1469-1795.2010.00400.x; Archie EA, 2012, MOL ECOL, V21, P765, DOI 10.1111/j.1365-294X.2011.05237.x; Barnes RFW, 1996, MAMMAL REV, V26, P67, DOI 10.1111/j.1365-2907.1996.tb00147.x; Barnes RFW, 1995, PACHYDERM, V19, P33; Burke T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002417; Chiyo PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031382; Chiyo PI, 2011, J APPL ECOL, V48, P788, DOI 10.1111/j.1365-2664.2011.01967.x; Chiyo PI, 2011, BEHAV ECOL, V22, P552, DOI 10.1093/beheco/arr016; Corti P, 2002, CAN J ZOOL, V80, P2108, DOI [10.1139/z02-207, 10.1139/Z02-207]; Dublin H.T., 1983, P291; Dublin HT, 1997, CONSERVING AFRICAS E; Ekanayaka Sampath K.K., 2011, Gajah, V34, P20; Estes R. D., 1999, SAFARI COMPANION GUI; Gakuya F, 2012, PARASITOLOGY; Gakuya F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043342; Gakuya Francis, 2003, Pachyderm, V35, P77; Hoare RE, 1999, CONSERV BIOL, V13, P633, DOI 10.1046/j.1523-1739.1999.98035.x; Irigia BK, 1990, ELEPHANT CROP RAIDIN; Jackson TR, 2008, ORYX, V42, P83, DOI 10.1017/S0030605308001117; Kabunge SK, 1991, WATER DEV PLAN LAIKI; KIIRU W., 1995, PACHYDERM, V19, P15; Kiring J.W., 2007, APPL ECOL ENV RES, V5, P49, DOI DOI 10.15666/AEER/0502_; Kock RA, 1993, ZOO WILD ANIMAL MED; Kyale DM, 2011, PACHYDERM, P48; Mijele D, 2011, MOVING ELEPHANTS NAR; Ngene SM, 2009, AFR J ECOL, V47, P234, DOI 10.1111/j.1365-2028.2008.01018.x; Ngure N, 1992, SWARA, V15, P25; NORTON-GRIFFITHS M, 1975, East African Wildlife Journal, V13, P347, DOI 10.1111/j.1365-2028.1975.tb00144.x; Norton-Griffiths M, 1978, HDB AFRICAN WILDLIFE, V1; Noss AJ, 1998, CONSERV BIOL, V12, P390, DOI 10.1046/j.1523-1739.1998.96027.x; O'Connell-Rodwell CE, 2000, BIOL CONSERV, V93, P381, DOI 10.1016/S0006-3207(99)00108-1; Obanda V, 2008, PACHYDERM, P54; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ogutu OJ, 2007, AFR J ECOL, V46, P132; Osborn FV, 2004, AFR J ECOL, V42, P322, DOI 10.1111/j.1365-2028.2004.00531.x; OTTICHILO WK, 1987, BIOL CONSERV, V41, P279, DOI 10.1016/0006-3207(87)90091-7; Parker G. E., 2007, HUMAN ELEPHANT CONFL; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; SUKUMAR R, 1988, ANIM BEHAV, V36, P1233, DOI 10.1016/S0003-3472(88)80084-8; Thouless Chris R., 1994, Oryx, V28, P119; THOULESS CR, 1995, BIOL CONSERV, V72, P99, DOI 10.1016/0006-3207(94)00071-W; Turchin Peter, 1998; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0	44	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71179	10.1371/journal.pone.0071179	http://dx.doi.org/10.1371/journal.pone.0071179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936262	Green Published, gold			2022-12-27	WOS:000323114200115
J	Pagliardini, S; Gosgnach, S; Dickson, CT				Pagliardini, Silvia; Gosgnach, Simon; Dickson, Clayton T.			Spontaneous Sleep-Like Brain State Alternations and Breathing Characteristics in Urethane Anesthetized Mice	PLOS ONE			English	Article							CORTICAL ACTIVATION STATES; VENTILATORY BEHAVIOR; ELECTROMYOGRAPHIC ACTIVITY; AUGMENTED BREATHS; PATTERNS; C57BL/6J; MUSCLES; SIGHS; GENIOGLOSSUS; MODULATION	Brain state alternations resembling those of sleep spontaneously occur in rats under urethane anesthesia and they are closely linked with sleep-like respiratory changes. Although rats are a common model for both sleep and respiratory physiology, we sought to determine if similar brain state and respiratory changes occur in mice under urethane. We made local field potential recordings from the hippocampus and measured respiratory activity by means of EMG recordings in intercostal, genioglossus, and abdominal muscles. Similar to results in adult rats, urethane anesthetized mice displayed quasi-periodic spontaneous forebrain state alternations between deactivated patterns resembling slow wave sleep (SWS) and activated patterns resembling rapid eye movement (REM) sleep. These alternations were associated with an increase in breathing rate, respiratory variability, a depression of inspiratory related activity in genioglossus muscle and an increase in expiratory-related abdominal muscle activity when comparing deactivated (SWS-like) to activated (REM-like) states. These results demonstrate that urethane anesthesia consistently induces sleep-like brain state alternations and correlated changes in respiratory activity across different rodent species. They open up the powerful possibility of utilizing transgenic mouse technology for the advancement and translation of knowledge regarding sleep cycle alternations and their impact on respiration.	[Pagliardini, Silvia; Gosgnach, Simon; Dickson, Clayton T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Pagliardini, Silvia; Gosgnach, Simon; Dickson, Clayton T.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Pagliardini, Silvia; Gosgnach, Simon] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Dickson, Clayton T.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Pagliardini, S (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	silviap@ualberta.ca		Pagliardini, Silvia/0000-0002-1482-9173	Women and Children Health. Research Institute; Canada Foundation for Innovation; Natural Science and Engineering Research Council of Canada; Parker B Francis Foundation; Alberta Innovates Health Solutions;  [DT In funding which 1st org punctuation is separation or part of org not clear];  [w18]	Women and Children Health. Research Institute; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parker B Francis Foundation; Alberta Innovates Health Solutions; ; 	Research funded by Women and Children Health. Research Institute (SP, SG), Canada Foundation for Innovation (SG), Natural Science and Engineering Research Council of Canada (CTD) and Parker B Francis Foundation (SP). SG and CTD are Alberta Innovates Health Solutions funded investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antkowiak B, 2001, NATURWISSENSCHAFTEN, V88, P201, DOI 10.1007/s001140100230; ASERINSK.E, 1965, SCIENCE, V150, P763, DOI 10.1126/science.150.3697.763-a; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Barone MTU, 2011, DIABETES RES CLIN PR, V91, P129, DOI 10.1016/j.diabres.2010.07.011; BARTLETT D, 1971, RESP PHYSIOL, V12, P230, DOI 10.1016/0034-5687(71)90055-7; Brooks PL, 2011, J NEUROSCI, V31, P7111, DOI 10.1523/JNEUROSCI.0347-11.2011; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Chen XJ, 2006, NEUROIMAGE, V29, P99, DOI 10.1016/j.neuroimage.2005.07.008; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Douglas CL, 2005, J APPL PHYSIOL, V98, P918, DOI 10.1152/japplphysiol.00900.2004; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Ennaceur A, 2006, BEHAV BRAIN RES, V174, P9, DOI 10.1016/j.bbr.2006.07.001; Fraigne JJ, 2011, SLEEP, V34, P425, DOI 10.1093/sleep/34.4.425; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Friedman L, 2004, J APPL PHYSIOL, V97, P1787, DOI 10.1152/japplphysiol.01394.2003; Fukumizu M, 2004, PHYSIOL BEHAV, V82, P721, DOI 10.1016/j.physbeh.2004.06.011; Gonsenhauser I, 2004, J APPL PHYSIOL, V97, P888, DOI 10.1152/japplphysiol.01346.2003; GRAHN DA, 1989, AM J PHYSIOL, V257, pR1496, DOI 10.1152/ajpregu.1989.257.6.R1496; Han F, 2002, J APPL PHYSIOL, V92, P1133, DOI 10.1152/japplphysiol.00785.2001; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Havekes R, 2012, CELL SIGNAL, V24, P1251, DOI 10.1016/j.cellsig.2012.02.010; Hoch B, 1998, BIOL NEONATE, V74, P16, DOI 10.1159/000014006; Horner RL, 2008, RESP PHYSIOL NEUROBI, V164, P179, DOI 10.1016/j.resp.2008.06.012; Hunter JD, 1998, RESP PHYSIOL, V112, P71, DOI 10.1016/S0034-5687(98)00018-8; Hunter JD, 1998, RESP PHYSIOL, V112, P83, DOI 10.1016/S0034-5687(98)00020-6; Kato T, 2011, ARCH ITAL BIOL, V149, P478, DOI 10.4449/aib.v149i4.1317; Kiss T, 2013, NEUROSCIENCE, V237, P255, DOI 10.1016/j.neuroscience.2013.01.058; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Krieger J, 2005, RESP PHYSL BREATHING, P232; Lu JW, 2009, RESP PHYSIOL NEUROBI, V167, P307, DOI 10.1016/j.resp.2009.06.004; MARSHALL JM, 1988, J PHYSIOL-LONDON, V400, P15, DOI 10.1113/jphysiol.1988.sp017107; McNamara F, 2002, J PHYSIOL-LONDON, V538, P263, DOI 10.1113/jphysiol.2001.012507; MEGIRIAN D, 1985, EXP NEUROL, V90, P118, DOI 10.1016/0014-4886(85)90045-7; MEGIRIAN D, 1987, J PHYSIOL-LONDON, V389, P99, DOI 10.1113/jphysiol.1987.sp016648; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nakamura A, 2003, J APPL PHYSIOL, V94, P525, DOI 10.1152/japplphysiol.00226.2002; NAVARRO M, 1991, GEN PHARMACOL, V22, P713, DOI 10.1016/0306-3623(91)90084-J; OREM J, 1993, J APPL PHYSIOL, V74, P761, DOI 10.1152/jappl.1993.74.2.761; Pagliardini S, 2012, J NEUROSCI, V32, P11259, DOI 10.1523/JNEUROSCI.0948-12.2012; Qureshi M, 2009, NEONATOLOGY, V96, P43, DOI 10.1159/000201738; Real C, 2009, RESP PHYSIOL NEUROBI, V168, P230, DOI 10.1016/j.resp.2009.07.003; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931, DOI 10.1152/jappl.1978.44.6.931; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; SAUERLAND EK, 1976, EXP NEUROL, V51, P160, DOI 10.1016/0014-4886(76)90061-3; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; Song Z, 2009, J APPL PHYSIOL, V106, P1223, DOI 10.1152/japplphysiol.91192.2008; SUAUDEAU C, 1992, NEUROPHARMACOLOGY, V31, P1115, DOI 10.1016/0028-3908(92)90007-C; Thompson S A, 2001, Curr Opin Pharmacol, V1, P78, DOI 10.1016/S1471-4892(01)00013-3; Trinder J, 2011, SLEEP, V34, P983, DOI 10.5665/SLEEP.1144; TSUBONE H, 1979, JPN J VET SCI, V41, P495; VANTWYVER H, 1969, PHYSIOL BEHAV, V4, P901, DOI 10.1016/0031-9384(69)90038-9; WEISS T, 1964, EXPERIENTIA, V20, P280, DOI 10.1007/BF02151809; Whitten TA, 2009, J NEUROPHYSIOL, V102, P1647, DOI 10.1152/jn.00374.2009; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Yamauchi M, 2008, J APPL PHYSIOL, V105, P518, DOI 10.1152/japplphysiol.00069.2008	57	59	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70411	10.1371/journal.pone.0070411	http://dx.doi.org/10.1371/journal.pone.0070411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936201	gold, Green Submitted, Green Published			2022-12-27	WOS:000323114200081
J	Palm-Espling, ME; Andersson, CD; Bjorn, E; Linusson, A; Wittung-Stafshede, P				Palm-Espling, Maria E.; Andersson, C. David; Bjorn, Erik; Linusson, Anna; Wittung-Stafshede, Pernilla			Determinants for Simultaneous Binding of Copper and Platinum to Human Chaperone Atox1: Hitchhiking not Hijacking	PLOS ONE			English	Article							METAL-METAL BONDS; CELLULAR PHARMACOLOGY; CISPLATIN RESISTANCE; TRANSPORTER ATP7B; BASIS-SETS; COMPLEXES; PROTEIN; METALLOCHAPERONE; ABSORPTION; CHEMISTRY	Cisplatin (CisPt) is an anticancer agent that has been used for decades to treat a variety of cancers. CisPt treatment causes many side effects due to interactions with proteins that detoxify the drug before reaching the DNA. One key player in CisPt resistance is the cellular copper-transport system involving the uptake protein Ctr1, the cytoplasmic chaperone Atox1 and the secretory path ATP7A/B proteins. CisPt has been shown to bind to ATP7B, resulting in vesicle sequestering of the drug. In addition, we and others showed that the apo-form of Atox1 could interact with CisPt in vitro and in vivo. Since the function of Atox1 is to transport copper (Cu) ions, it is important to assess how CisPt binding depends on Cu-loading of Atox1. Surprisingly, we recently found that CisPt interacted with Cu-loaded Atox1 in vitro at a position near the Cu site such that unique spectroscopic features appeared. Here, we identify the binding site for CisPt in the Cu-loaded form of Atox1 using strategic variants and a combination of spectroscopic and chromatographic methods. We directly prove that both metals can bind simultaneously and that the unique spectroscopic signals originate from an Atox1 monomer species. Both Cys in the Cu-site (Cys12, Cys15) are needed to form the di-metal complex, but not Cys41. Removing Met10 in the conserved metal-binding motif makes the loop more floppy and, despite metal binding, there are no metal-metal electronic transitions. In silico geometry minimizations provide an energetically favorable model of a tentative ternary Cu-Pt-Atox1 complex. Finally, we demonstrate that Atox1 can deliver CisPt to the fourth metal binding domain 4 of ATP7B (WD4), indicative of a possible drug detoxification mechanism.	[Palm-Espling, Maria E.; Andersson, C. David; Bjorn, Erik; Linusson, Anna; Wittung-Stafshede, Pernilla] Umea Univ, Dept Chem, Umea, Sweden	Umea University	Wittung-Stafshede, P (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	pernilla.wittung@chem.umu.se	wittung-stafshede, pernilla/AAV-4392-2021	wittung-stafshede, pernilla/0000-0003-1058-1964	Swedish Natural Research Council; Knut and Alice Wallenberg Foundation; Goran Gustafsson Foundation; Umea University	Swedish Natural Research Council(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Goran Gustafsson Foundation; Umea University	The Swedish Natural Research Council (PWS, AL), the Knut and Alice Wallenberg Foundation (PWS), Goran Gustafsson Foundation (PWS), and Umea University (PWS) provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Alvarez HM, 2009, SCIENCE; Anastassopoulou I, 2004, BIOCHEMISTRY-US, V43, P13046, DOI 10.1021/bi0487591; [Anonymous], 2007, TURBOMOLE V6 3 1 201; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Arnesano F, 2007, ANGEW CHEM INT EDIT, V46, P9062, DOI 10.1002/anie.200703271; Arnesano F, 2011, J AM CHEM SOC, V133, P18361, DOI 10.1021/ja207346p; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; BANKS CV, 1958, J AM CHEM SOC, V80, P4767, DOI 10.1021/ja01551a004; Boal AK, 2009, J AM CHEM SOC, V131, P14196, DOI 10.1021/ja906363t; Calderone V, 2006, ANGEW CHEM INT EDIT, V45, P1267, DOI 10.1002/anie.200502599; Casini A, 2007, CHEM COMMUN, P156, DOI 10.1039/b611122j; Dolgova NV, 2009, BIOCHEM J, V419, P51, DOI 10.1042/BJ20081359; Figgen D, 2005, CHEM PHYS, V311, P227, DOI 10.1016/j.chemphys.2004.10.005; Fusch G, 1996, INORG CHIM ACTA, V252, P167, DOI 10.1016/S0020-1693(96)05311-X; Gabbiani C, 2012, CHEM COMMUN, V48, P11623, DOI 10.1039/c2cc36610j; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Guo Z, 2009, THESIS U MAINE; Hermann G, 2013, METALLOMICS, V5, P636, DOI 10.1039/c3mt20251h; Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710; Howell SB, 2010, MOL PHARMACOL, V77, P887, DOI 10.1124/mol.109.063172; Hua HQ, 2011, BIOMETALS, V24, P445, DOI 10.1007/s10534-011-9438-1; Hussain F, 2007, BBA-PROTEINS PROTEOM, V1774, P1316, DOI 10.1016/j.bbapap.2007.07.020; Hussain F, 2009, J AM CHEM SOC, V131, P16371, DOI 10.1021/ja9058266; Katano K, 2004, CLIN CANCER RES, V10, P4578, DOI 10.1158/1078-0432.CCR-03-0689; Katano K, 2002, CANCER RES, V62, P6559; Kihlken MA, 2002, BIOCHEM J, V368, P729, DOI 10.1042/BJ20021036; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Komatsu M, 2000, CANCER RES, V60, P1312; Lewis J., 1965, PURE APPL CHEM, V10, P11, DOI 10.1351/pac196510010011; Liang ZD, 2012, MOL CANCER THER, V11, P2483, DOI 10.1158/1535-7163.MCT-12-0580; Lindahl PA, 2012, J INORG BIOCHEM, V106, P172, DOI 10.1016/j.jinorgbio.2011.08.012; Moret ME, 2008, ORGANOMETALLICS, V27, P4903, DOI 10.1021/om800403y; Moret ME, 2010, ANGEW CHEM INT EDIT, V49, P2873, DOI 10.1002/anie.200906480; Niemiec MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036102; Palm ME, 2011, P NATL ACAD SCI USA, V108, P6951, DOI 10.1073/pnas.1012899108; Palm-Espling ME, 2012, BIOCHEM PHARMACOL, V83, P874, DOI 10.1016/j.bcp.2012.01.018; Rodriguez-Granillo A, 2009, BIOCHEMISTRY-US, V48, P960, DOI 10.1021/bi8018652; Safaei R, 2012, J INORG BIOCHEM, V110, P8, DOI 10.1016/j.jinorgbio.2012.02.016; Safaei R, 2009, J INORG BIOCHEM, V103, P333, DOI 10.1016/j.jinorgbio.2008.11.012; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Sreerama N, 2000, CIRCULAR DICHROISM P; Tippayamontri T, 2011, INVEST NEW DRUG, V29, P1321, DOI 10.1007/s10637-010-9494-3; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Wu ZY, 2009, J BIOL INORG CHEM, V14, P1313, DOI 10.1007/s00775-009-0576-7; Xia BH, 2003, J AM CHEM SOC, V125, P10362, DOI 10.1021/ja0355325; Yam VWW, 1999, J CHEM SOC DALTON, P2913	52	40	43	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70473	10.1371/journal.pone.0070473	http://dx.doi.org/10.1371/journal.pone.0070473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936210	gold, Green Submitted, Green Published			2022-12-27	WOS:000323114200087
J	Koch, K; Norgaard, M; Schonheyder, HC; Thomsen, RW; Sogaard, M				Koch, Kristoffer; Norgaard, Mette; Schonheyder, Henrik Carl; Thomsen, Reimar Wernich; Sogaard, Mette		Danish Collaborative Bacteremia	Effect of Socioeconomic Status on Mortality after Bacteremia in Working-Age Patients. A Danish Population-Based Cohort Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HOSPITALIZED-PATIENTS; COMPUTER ALGORITHMS; CRITICALLY-ILL; MARITAL-STATUS; SEVERE SEPSIS; EPIDEMIOLOGY; COMORBIDITY; REGISTERS; SURVEILLANCE	Objectives: To examine the effect of socioeconomic status (SES) on mortality in patients with bacteremia and the underlying factors that may mediate differences in mortality. Methods: We conducted a population-based cohort study in two Danish regions. All patients 30 to 65 years of age with first time bacteremia from 2000 through 2008 were identified in a population-based microbiological bacteremia database (n = 8,653). Individual-level data on patients' SES (educational level and personal income) and comorbid conditions were obtained from public and medical registries. We used Cox regression to examine mortality within 30 days after bacteremia with and without cumulative adjustment for potential mediators. Results: Bacteremia patients of low SES were more likely to live alone and be unmarried than patients of high SES. They also had more pre-existing comorbidity, more substance abuse, more Staphylococcus aureus and nosocomial infections, and more admissions to small nonteaching hospitals. Overall, 1,374 patients (15.9%) died within 30 days of follow-up. Patients of low SES had consistently higher mortality after bacteremia than those of high SES crude hazard ratio for low vs. high education, 1.38 [95% confidence interval (CI), 1.18-1.61]; crude hazard ratio for low-income vs. high-income tertile, 1.58 [CI, 1.39-1.80]. Adjustment for differences in social support, pre-existing comorbidity, substance abuse, place of acquisition of the infection, and microbial agent substantially attenuated the effect of SES on mortality (adjusted hazard ratio for low vs. high education, 1.15 [95% CI, 0.98-1.36]; adjusted hazard ratio for low-income vs. high-income tertile, 1.29 [CI, 1.12-1.49]). Further adjustment for characteristics of the admitting hospital had minimal effect on observed mortality differences. Conclusions: Low SES was strongly associated with increased 30-day mortality after bacteremia. Less social support, more pre-existing comorbidity, more substance abuse, and differences in place of acquisition and agent of infection appeared to mediate much of the observed disparities in mortality.	[Koch, Kristoffer; Schonheyder, Henrik Carl; Sogaard, Mette] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Koch, Kristoffer; Norgaard, Mette; Thomsen, Reimar Wernich; Sogaard, Mette] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University	Koch, K (corresponding author), Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark.	k.koch@rn.dk		Sogaard, Mette/0000-0002-2830-4968; Thomsen, Reimar/0000-0001-9135-3474; Norgaard, Mette/0000-0001-6110-5891	Institute of Clinical Medicine, Aarhus University Hospital, Denmark	Institute of Clinical Medicine, Aarhus University Hospital, Denmark	This study received financial support from the Institute of Clinical Medicine, Aarhus University Hospital, Denmark. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Bates DW, 1997, J INFECT DIS, V176, P1538, DOI 10.1086/514153; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Burton DC, 2010, AM J PUBLIC HEALTH, V100, P1904, DOI 10.2105/AJPH.2009.181313; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen JS, 2012, EUR J CLIN MICROBIOL; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; GORDON HS, 1995, ARCH INTERN MED, V155, P2465, DOI 10.1001/archinte.155.22.2465; Gradel KO, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-139; Huggan PJ, 2010, INTERN MED J, V40, P117, DOI 10.1111/j.1445-5994.2009.01910.x; Iwashyna TJ, 2003, SOC SCI MED, V57, P2137, DOI 10.1016/S0277-9536(02)00546-4; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; Madsen KM, 1998, INFECT CONT HOSP EP, V19, P175; McLoone P, 1999, BRIT MED J, V319, P1003, DOI 10.1136/bmj.319.7215.1003; Mendu ML, 2012, CRIT CARE MED, V40, P1427, DOI 10.1097/CCM.0b013e318241e51e; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Peelen L, 2007, CRIT CARE, V11, DOI 10.1186/cc5727; Petersson F, 2011, SCAND J PUBLIC HEALT, V39, P95, DOI 10.1177/1403494811408483; PITTET D, 1993, INTENS CARE MED, V19, P265, DOI 10.1007/BF01690546; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Seymour CW, 2010, CHEST, V137, P1289, DOI 10.1378/chest.09-2661; Shahin J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3394; Sogaard M, 2008, J AM GERIATR SOC, V56, P1593, DOI 10.1111/j.1532-5415.2008.01855.x; Sogaard M, 2011, CLIN INFECT DIS, V52, P61, DOI 10.1093/cid/ciq069; Stelianides S, 1999, EUR J CLIN MICROBIOL, V18, P704, DOI 10.1007/s100960050382; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Trick WE, 2004, EMERG INFECT DIS, V10, P1612, DOI 10.3201/eid1009.030978; UNESCO, 2006, INT STANDARD CLASSIF; Uslan DZ, 2007, ARCH INTERN MED, V167, P834, DOI 10.1001/archinte.167.8.834; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307	34	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70082	10.1371/journal.pone.0070082	http://dx.doi.org/10.1371/journal.pone.0070082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191SQ	23936145	gold, Green Submitted, Green Published			2022-12-27	WOS:000322433300087
J	Franciosi, M; Lucisano, G; Lapice, E; Strippoli, GFM; Pellegrini, F; Nicolucci, A				Franciosi, Monica; Lucisano, Giuseppe; Lapice, Emanuela; Strippoli, Giovanni F. M.; Pellegrini, Fabio; Nicolucci, Antonio			Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review	PLOS ONE			English	Article							GLUCOSE-LOWERING AGENTS; BREAST-CANCER; COLORECTAL-CANCER; PANCREATIC-CANCER; PROSTATE-CANCER; REDUCED RISK; HEPATOCELLULAR-CARCINOMA; RETROSPECTIVE COHORT; INCIDENT CANCER; DECREASED RISK	Aims/Hypothesis: Diabetes treatments were related with either an increased or reduced risk of cancer. There is ongoing debate about a potential protective action of metformin. To summarize evidence on the association between metformin and risk of cancer and cancer mortality in patients with diabetes. Methods: Data source: MEDLINE and EMBASE (January 1966-April 2012). We selected randomized studies comparing metformin and other hypoglycaemic agents and observational studies exploring the association between exposure to metformin and cancer. Outcomes were cancer mortality, all malignancies and site-specific cancers. Results: Of 25307 citations identified, 12 randomized controlled trials (21,595 patients) and 41 observational studies (1,029,389 patients) met the inclusion criteria. In observational studies there was a significant association of exposure to metformin with the risk of cancer death [6 studies, 24,410 patients, OR:0.65, 95%CI: 0.53-0.80], all malignancies [18 studies, 561,836 patients, OR:0.73, 95%CI: 0.61-0.88], liver [8 studies, 312,742 patients, OR:0.34; 95%CI: 0.19-0.60] colorectal [12 studies, 871,365 patients, OR:0.83, 95%CI: 0.74-0.92], pancreas [9 studies, 847,248 patients, OR:0.56, 95%CI: 0.36-0.86], stomach [2 studies, 100701 patients, OR: 0.83, 95%CI: 0.76-0.91], and esophagus cancer [2 studies, 100694 patients, OR:0.90, 95%CI: 0.83-0.98]. No significant difference of risk was observed in randomized trials. Metformin was not associated with the risk of: breast cancer, lung cancer, ovarian cancer, uterus cancer, prostate cancer, bladder cancer, kidney cancer, and melanoma. Conclusions/Interpretation: Results suggest that Metformin might be associated with a significant reduction in the risk of cancer and cancer-related mortality. Randomized trials specifically designed to evaluate the efficacy of metformin as an anticancer agent are warranted.	[Franciosi, Monica; Lucisano, Giuseppe; Strippoli, Giovanni F. M.; Pellegrini, Fabio; Nicolucci, Antonio] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Chieti, Italy; [Lapice, Emanuela] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Strippoli, Giovanni F. M.] Diaverum Med Sci Off, Lund, Sweden; [Strippoli, Giovanni F. M.] Univ Sydney, Sch Publ Hlth, Darlington, Australia; [Strippoli, Giovanni F. M.] Univ Bari, Bari, Italy	Consorzio Mario Negri Sud; University of Naples Federico II; Diaverum; University of Sydney; Universita degli Studi di Bari Aldo Moro	Franciosi, M (corresponding author), Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Chieti, Italy.	franciosi@negrisud.it						Adami HO, 1996, J NATL CANCER I, V88, P1472, DOI 10.1093/jnci/88.20.1472; Aschner P, 2010, DIABETES OBES METAB, V12, P252, DOI 10.1111/j.1463-1326.2009.01187.x; Azoulay L, 2011, CANCER EPIDEM BIOMAR, V20, P337, DOI 10.1158/1055-9965.EPI-10-0940; Baur DM, 2011, METABOLISM, V60, P1363, DOI 10.1016/j.metabol.2010.09.012; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bo S, 2012, DIABETES OBES METAB, V14, P23, DOI 10.1111/j.1463-1326.2011.01480.x; Bodmer M, 2012, AM J GASTROENTEROL, V107, P620, DOI 10.1038/ajg.2011.483; Bodmer M, 2012, CANCER EPIDEM BIOMAR, V21, P280, DOI 10.1158/1055-9965.EPI-11-0992-T; Bodmer M, 2011, GYNECOL ONCOL, V123, P200, DOI 10.1016/j.ygyno.2011.06.038; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Bosco JLF, 2011, CANCER EPIDEM BIOMAR, V20, P101, DOI 10.1158/1055-9965.EPI-10-0817; Bowker SL, 2010, DIABETOLOGIA, V53, P1631, DOI 10.1007/s00125-010-1750-8; Buchs AE, 2011, METABOLISM, V60, P1379, DOI 10.1016/j.metabol.2011.05.002; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Chlebowski RT, 2012, J CLIN ONCOL, V30, P2844, DOI 10.1200/JCO.2011.39.7505; CHOW WH, 1995, J NATL CANCER I, V87, P930, DOI 10.1093/jnci/87.12.930; Chung YW, 2008, DIS COLON RECTUM, V51, P593, DOI 10.1007/s10350-007-9184-1; Col NF, 2012, BREAST CANCER RES TR, V135, P639, DOI 10.1007/s10549-012-2170-x; Cryer DR, 2005, DIABETES CARE, V28, P539, DOI 10.2337/diacare.28.3.539; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Donadon V, 2010, LIVER INT, V30, P750, DOI 10.1111/j.1478-3231.2010.02223.x; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Ferrara A, 2011, DIABETES CARE, V34, P923, DOI 10.2337/dc10-1067; Goke B, 2008, HORM METAB RES, V40, P892, DOI 10.1055/s-0028-1082334; Gregorio F, 1999, DIABETIC MED, V16, P1016, DOI 10.1046/j.1464-5491.1999.00201.x; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Hanefeld M, 2004, DIABETES CARE, V27, P141, DOI 10.2337/diacare.27.1.141; Hassan MM, 2010, CANCER-AM CANCER SOC, V116, P1938, DOI 10.1002/cncr.24982; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hense HW, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-15; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Home PD, 2010, DIABETOLOGIA, V53, P1838, DOI 10.1007/s00125-010-1804-y; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kawaguchi T, 2010, LIVER INT, V30, P479, DOI 10.1111/j.1478-3231.2009.02191.x; Keating NL, 2007, MED CARE, V45, P869, DOI 10.1097/MLR.0b013e31806728e9; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Lewis JD, 2008, GASTROENTEROLOGY, V135, P1914, DOI 10.1053/j.gastro.2008.09.004; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lund SS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4324; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Mellbin LG, 2011, DIABETOLOGIA, V54, P1308, DOI 10.1007/s00125-011-2084-x; Monami M, 2008, EXP CLIN ENDOCR DIAB, V116, P184, DOI 10.1055/s-2007-992157; Monami M, 2011, DIABETES CARE, V34, P129, DOI 10.2337/dc10-1287; Monami M, 2009, ACTA DIABETOL, V46, P279, DOI 10.1007/s00592-008-0083-2; Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699; Murtola TJ, 2008, AM J EPIDEMIOL, V168, P925, DOI 10.1093/aje/kwn190; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nestler JE, 2008, NEW ENGL J MED, V358, P47, DOI 10.1056/NEJMct0707092; Nicolucci A, 2010, ACTA DIABETOL, V47, P87, DOI 10.1007/s00592-010-0187-3; Nkontchou G, 2011, J CLIN ENDOCR METAB, V96, P2601, DOI 10.1210/jc.2010-2415; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Oliveria SA, 2008, DIABETES METAB SYND, V2, P47, DOI 10.1016/j.dsx.2007.11.002; Papanas N, 2009, EXPERT OPIN PHARMACO, V10, P2395, DOI 10.1517/14656560903176453; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Ramos-Nino ME, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-17; Ruiter R, 2012, DIABETES CARE, V35, P119, DOI 10.2337/dc11-0857; Schernthaner G, 2004, J CLIN ENDOCR METAB, V89, P6068, DOI 10.1210/jc.2003-030861; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES, P368; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Stevens RJ, 2012, DIABETOLOGIA, V55, P2593, DOI 10.1007/s00125-012-2653-7; Tan BX, 2011, CANCER-AM CANCER SOC, V117, P5103, DOI 10.1002/cncr.26151; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Will JC, 1999, EPIDEMIOLOGY, V10, P313, DOI 10.1097/00001648-199905000-00021; Williams-Herman D, 2010, DIABETES OBES METAB, V12, P442, DOI 10.1111/j.1463-1326.2010.01204.x; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Yang XL, 2011, DIABETES CARE, V34, P375, DOI 10.2337/dc10-1509; Yang XL, 2010, DIABETES RES CLIN PR, V90, P343, DOI 10.1016/j.diabres.2010.08.022; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhang ZJ, 2012, J CLIN ENDOCR METAB, V97, P2347, DOI 10.1210/jc.2012-1267; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	82	301	317	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71583	10.1371/journal.pone.0071583	http://dx.doi.org/10.1371/journal.pone.0071583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936520	gold, Green Published, Green Submitted			2022-12-27	WOS:000324545800065
J	Marley, A; Choy, RWY; von Zastrow, M				Marley, Aaron; Choy, Regina Wai-Yan; von Zastrow, Mark			GPR88 Reveals a Discrete Function of Primary Cilia as Selective Insulators of GPCR Cross-Talk	PLOS ONE			English	Article							PLASMA-MEMBRANE; RECEPTORS; LOCALIZATION; ENDOCYTOSIS; EXPRESSION; DESENSITIZATION; IDENTIFICATION	A number of G protein-coupled receptors (GPCRs) localize to primary cilia but the functional significance of cilia to GPCR signaling remains incompletely understood. We investigated this question by focusing on the D1 dopamine receptor (D1R) and beta-2 adrenergic receptor (B2AR), closely related catecholamine receptors that signal by stimulating production of the diffusible second messenger cyclic AMP (cAMP) but differ in localization relative to cilia. D1Rs robustly concentrate on cilia of IMCD3 cells, as shown previously in other ciliated cell types, but disrupting cilia did not affect D1R surface expression or ability to mediate a concentration-dependent cAMP response. By developing a FRET-based biosensor suitable for resolving intra-from extra-ciliary cAMP changes, we found that the D1R-mediated cAMP response is not restricted to cilia and extends into the extra-ciliary cytoplasm. Conversely the B2AR, which we show here is effectively excluded from cilia, also generated a cAMP response in both ciliary and extra-ciliary compartments. We identified a distinct signaling effect of primary cilia through investigating GPR88, an orphan GPCR that is co-expressed with the D1R in brain, and which we show here is targeted to cilia similarly to the D1R. In ciliated cells, mutational activation of GPR88 strongly reduced the D1R-mediated cAMP response but did not affect the B2AR-mediated response. In marked contrast, in non-ciliated cells, GPR88 was distributed throughout the plasma membrane and inhibited the B2AR response. These results identify a discrete 'insulating' function of primary cilia in conferring selectivity on integrated catecholamine signaling through lateral segregation of receptors, and suggest a cellular activity of GPR88 that might underlie its effects on dopamine-dependent behaviors.	[von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	mark.vonzastrow@ucsf.edu			National Institutes of Health (NIH) [DA012864, DA010711, DA010154]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R29DA010711, R01DA010711, R01DA012864, R37DA010711] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were supported by the National Institutes of Health (NIH) (DA012864, DA010711 and DA010154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Chen CH, 1999, BIOPHYS J, V76, P2861, DOI 10.1016/S0006-3495(99)77440-0; Choi YH, 2011, P NATL ACAD SCI USA, V108, P10679, DOI 10.1073/pnas.1016214108; Gao XX, 2010, CHEMBIOCHEM, V11, P147, DOI 10.1002/cbic.200900594; Ghate A, 2007, NEUROSCIENCE, V146, P1182, DOI 10.1016/j.neuroscience.2007.02.040; Goldstein DS, 2006, CELL MOL NEUROBIOL, V26, P695, DOI 10.1007/s10571-006-9041-0; Green JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046304; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hamon M, 1999, NEUROPSYCHOPHARMACOL, V21, pS68, DOI 10.1038/sj.npp.1395368; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Logue SF, 2009, MOL CELL NEUROSCI, V42, P438, DOI 10.1016/j.mcn.2009.09.007; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Marley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046647; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Massart R, 2009, EUR J NEUROSCI, V30, P397, DOI 10.1111/j.1460-9568.2009.06842.x; Mizushima K, 2000, GENOMICS, V69, P314, DOI 10.1006/geno.2000.6340; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Quintana A, 2012, NAT NEUROSCI, V15, P1547, DOI 10.1038/nn.3239; Schafer J, 1996, ANN NY ACAD SCI, V805, P601; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Thirstrup K, 2010, CONSTITUTIVELY ACTIV; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Yoder BK, 1995, P ASSOC AM PHYSICIAN, V107, P314; Yu YJ, 2009, J NEUROSCI, V29, P222, DOI 10.1523/JNEUROSCI.4315-08.2009	35	47	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70857	10.1371/journal.pone.0070857	http://dx.doi.org/10.1371/journal.pone.0070857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936473	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800053
J	Nowicki, D; Verga, P; Siegelmann, H				Nowicki, Dimitri; Verga, Patrick; Siegelmann, Hava			Modeling Reconsolidation in Kernel Associative Memory	PLOS ONE			English	Article							COLLECTIVE COMPUTATIONAL PROPERTIES; DYNAMICS; CONSOLIDATION; EXTINCTION; MECHANISMS; RETRIEVAL; NETWORKS	Memory reconsolidation is a central process enabling adaptive memory and the perception of a constantly changing reality. It causes memories to be strengthened, weakened or changed following their recall. A computational model of memory reconsolidation is presented. Unlike Hopfield-type memory models, our model introduces an unbounded number of attractors that are updatable and can process real-valued, large, realistic stimuli. Our model replicates three characteristic effects of the reconsolidation process on human memory: increased association, extinction of fear memories, and the ability to track and follow gradually changing objects. In addition to this behavioral validation, a continuous time version of the reconsolidation model is introduced. This version extends average rate dynamic models of brain circuits exhibiting persistent activity to include adaptivity and an unbounded number of attractors.	[Nowicki, Dimitri; Verga, Patrick; Siegelmann, Hava] Univ Massachusetts, Dept Comp Sci, Biol Inspired Neural & Dynam Syst BINDS Lab, Amherst, MA 01003 USA; [Nowicki, Dimitri] Ctr Cybernet, Inst Math Machines & Syst Problems NASU, Kiev, Ukraine; [Siegelmann, Hava] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; National Academy of Sciences Ukraine; V. M. Glushkov Institute of Cybernetics, National Academy of Sciences of Ukraine; University of Massachusetts System; University of Massachusetts Amherst	Nowicki, D (corresponding author), Univ Massachusetts, Dept Comp Sci, Biol Inspired Neural & Dynam Syst BINDS Lab, Amherst, MA 01003 USA.	nowicki@cs.umass.edu; hava@cs.umass.edu		Nowicki, Dmitry/0000-0001-8188-3957	Office of Naval Research (ONR) [N00014-09-1-0069]	Office of Naval Research (ONR)(Office of Naval Research)	This research was supported by Office of Naval Research (ONR) grant AWARD # N00014-09-1-0069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absil PA, 2004, ACTA APPL MATH, V80, P199, DOI 10.1023/B:ACAP.0000013855.14971.91; Agren T, 2012, SCIENCE, V337, P1550, DOI 10.1126/science.1223006; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Albert A., 1972, REGRESSION MOORE PEN; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Antoine B, 2012, PROGR NEUROBIOLOGY; Barlow DH, 2004, ANXIETY ITS DISORDER; Ben-Hur A., 2002, Journal of Machine Learning Research, V2, P125, DOI 10.1162/15324430260185565; Besnard A, 2012, J NEUROSCI, V32, P3281, DOI 10.1523/JNEUROSCI.6368-11.2012; Besnard S, 2012, HIPPOCAMPUS, V22, P814, DOI 10.1002/hipo.20942; Blumenfeld B, 2006, NEURON, V52, P383, DOI 10.1016/j.neuron.2006.08.016; Buice M, 2009, ARXIV09023925V2; do Carmo M. P., 1992, RIEMANNIAN GEOMETRY; Dudai Y, 1997, NEURON, V18, P179, DOI 10.1016/S0896-6273(00)80257-3; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Eichenbaum H, 2006, NEURON, V50, P350, DOI 10.1016/j.neuron.2006.04.017; Golkar A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00080; Golub GH., 2013, MATRIX COMPUTATIONS; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Maass W, 2007, PLOS COMPUTATIONAL B, V3; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Medina JH, 2008, BEHAV BRAIN RES, V192, P61, DOI 10.1016/j.bbr.2008.02.006; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Nowicki D, 2009, FRONTIERS SYSTEMS NE, DOI [10.3389/conf.neuro.06.2009.03.271, DOI 10.3389/C0N-F.NEUR0.06.2009.03.271]; Nowicki D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010955; Osan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023113; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; PERSONNAZ L, 1986, PHYS REV A, V34, P4217, DOI 10.1103/PhysRevA.34.4217; Preminger S, 2009, P NATL ACAD SCI USA, V106, P5371, DOI 10.1073/pnas.0802111106; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; Siegelmann HT, 2008, PHYSICA D, V237, P1207, DOI 10.1016/j.physd.2008.03.038; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Vapnik V., 1998, STAT LEARNING THEORY; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786	46	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e68189	10.1371/journal.pone.0068189	http://dx.doi.org/10.1371/journal.pone.0068189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XU	23936300	gold, Green Published, Green Submitted			2022-12-27	WOS:000324545800004
J	Shayegan, M; Forde, NR				Shayegan, Marjan; Forde, Nancy R.			Microrheological Characterization of Collagen Systems: From Molecular Solutions to Fibrillar Gels	PLOS ONE			English	Article							VISCOELASTIC PROPERTIES; FLEXIBILITY; RHEOLOGY; DRIVEN; DEPENDENCE; MORPHOLOGY; MECHANISM; STIFFNESS; BEHAVIOR; PH	Collagen is the most abundant protein in the extracellular matrix (ECM), where its structural organization conveys mechanical information to cells. Using optical-tweezers-based microrheology, we investigated mechanical properties both of collagen molecules at a range of concentrations in acidic solution where fibrils cannot form and of gels of collagen fibrils formed at neutral pH, as well as the development of microscale mechanical heterogeneity during the self-assembly process. The frequency scaling of the complex shear modulus even at frequencies of similar to 10 kHz was not able to resolve the flexibility of collagen molecules in acidic solution. In these solutions, molecular interactions cause significant transient elasticity, as we observed for 5 mg/ml solutions at frequencies above similar to 200 Hz. We found the viscoelasticity of solutions of collagen molecules to be spatially homogeneous, in sharp contrast to the heterogeneity of self-assembled fibrillar collagen systems, whose elasticity varied by more than an order of magnitude and in power-law behavior at different locations within the sample. By probing changes in the complex shear modulus over 100-minute timescales as collagen self-assembled into fibrils, we conclude that microscale heterogeneity appears during early phases of fibrillar growth and continues to develop further during this growth phase. Experiments in which growing fibrils dislodge microspheres from an optical trap suggest that fibril growth is a force-generating process. These data contribute to understanding how heterogeneities develop during self-assembly, which in turn can help synthesis of new materials for cellular engineering.	[Shayegan, Marjan] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Forde, Nancy R.] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Forde, NR (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	nforde@sfu.ca	Forde, Nancy R/D-8865-2015	Forde, Nancy R/0000-0002-5479-7073	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) [http://www.nserc-crsng.gc.ca/index_eng.asp]. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addas KM, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021503; AMIS EJ, 1985, INT J BIOL MACROMOL, V7, P130, DOI 10.1016/0141-8130(85)90014-5; Arevalo RC, 2010, BIOPHYS J, V99, pL65, DOI 10.1016/j.bpj.2010.08.008; Atakhorrami M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061501; Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Chae BS, 2005, LANGMUIR, V21, P3084, DOI 10.1021/la0480890; Dasgupta BR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051505; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Doi M., 1988, THEORY POLYM DYNAMIC; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Everaers R, 1999, PHYS REV LETT, V82, P3717, DOI 10.1103/PhysRevLett.82.3717; FERTALA A, 1994, J BIOL CHEM, V269, P11584; Forgacs G, 2003, BIOPHYS J, V84, P1272, DOI 10.1016/S0006-3495(03)74942-X; Fratzl P., 2008, P1, DOI 10.1007/978-0-387-73906-9_1; Fusco S, 2007, BIORHEOLOGY, V44, P403; Gautieri A, 2012, MATRIX BIOL, V31, P141, DOI 10.1016/j.matbio.2011.11.005; Gautieri A, 2009, PROTEIN SCI, V18, P161, DOI 10.1002/pro.21; GELMAN RA, 1979, J BIOL CHEM, V254, P1741; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; Gobeaux F, 2010, SOFT MATTER, V6, P3769, DOI 10.1039/b922151d; Graham JS, 2004, EXP CELL RES, V299, P335, DOI 10.1016/j.yexcr.2004.05.022; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Helary C, 2010, BIOMATERIALS, V31, P481, DOI 10.1016/j.biomaterials.2009.09.073; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hough LA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031802; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Huh JY, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031802; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Kadler KE, 1996, BIOCHEM J, V316, P1; Kar K, 2008, PROTEIN SCI, V17, P1086, DOI 10.1110/ps.083441308; Lai GL, 2008, INT J BIOL MACROMOL, V42, P285, DOI 10.1016/j.ijbiomac.2007.12.010; Larsen TH, 2009, MACROMOLECULES, V42, P8443, DOI 10.1021/ma901423n; Latinovic O, 2010, J BIOMECH, V43, P500, DOI 10.1016/j.jbiomech.2009.09.041; Li YP, 2009, MAT SCI ENG C-BIO S, V29, P1643, DOI 10.1016/j.msec.2009.01.001; Lindstrom SB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051905; Mizuno D, 2008, MACROMOLECULES, V41, P7194, DOI 10.1021/ma801218z; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; NESTLER FHM, 1983, BIOPOLYMERS, V22, P1747, DOI 10.1002/bip.360220710; Newman S, 1997, BIOPOLYMERS, V41, P337, DOI 10.1002/(SICI)1097-0282(199703)41:3<337::AID-BIP9>3.0.CO;2-T; Obermayer B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.040801; Parekh A, 2007, ANN BIOMED ENG, V35, P1231, DOI 10.1007/s10439-007-9273-2; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Pesce G, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/3/034016; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; Rezaei N, 2011, P SPIE; Savin T, 2007, SOFT MATTER, V3, P1194, DOI 10.1039/b700434f; Shankar V, 2002, J RHEOL, V46, P1111, DOI 10.1122/1.1501927; Shayegan M, 2012, MATER RES SOC S P; Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052; Sun YL, 2002, BIOCHEM BIOPH RES CO, V295, P382, DOI 10.1016/S0006-291X(02)00685-X; Tseng Y, 2002, J BIOL CHEM, V277, P18143, DOI 10.1074/jbc.M110868200; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; van der Horst A, 2008, OPT EXPRESS, V16, P20987, DOI 10.1364/OE.16.020987; Velegol D, 2001, BIOPHYS J, V81, P1786, DOI 10.1016/S0006-3495(01)75829-8; Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588; WOOD GC, 1960, BIOCHEM J, V75, P598, DOI 10.1042/bj0750598; Xu JY, 1998, MACROMOLECULES, V31, P6486, DOI 10.1021/ma9717754; Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039; Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]	68	69	73	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70590	10.1371/journal.pone.0070590	http://dx.doi.org/10.1371/journal.pone.0070590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936454	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800047
J	Takahashi, K; Kurokawa, K; Moyo, P; Jung, DJ; An, JH; Chigweshe, L; Paul, E; Lee, BL				Takahashi, Kazue; Kurokawa, Kenji; Moyo, Patience; Jung, Dong-Jun; An, Jang-Hyun; Chigweshe, Lorencia; Paul, Elahna; Lee, Bok Luel			Intradermal Immunization with Wall Teichoic Acid (WTA) Elicits and Augments an Anti-WTA IgG Response that Protects Mice from Methicillin-Resistant Staphylococcus aureus Infection Independent of Mannose-Binding Lectin Status	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; IMMUNE-RESPONSE; DEFICIENT MICE; RECOGNITION; SUSCEPTIBILITY; LIPOPROTEINS; VACCINATION; MECHANISMS; INCREASES; VIRULENCE	The objectives of this study were to investigate the immune response to intradermal immunization with wall teichoic acid (WTA) and the effect of MBL deficiency in a murine model of infection with methicillin-resistant Staphylococcus aureus (MRSA). WTA is a bacterial cell wall component that is implicated in invasive infection. We tested susceptibility to MRSA infection in wild type (WT) and MBL deficient mice using two strains of MRSA: MW2, a community-associated MRSA (CA-MRSA); and COL, a healthcare-associated MRSA (HA-MRSA). We also performed in vitro assays to investigate the effects of anti-WTA IgG containing murine serum on complement activation and bacterial growth in whole blood. We found that MBL knockout (KO) mice are relatively resistant to a specific MRSA strain, MW2 CA-MRSA, compared to WT mice, while both strains of mice had similar susceptibility to a different strain, COL HA-MRSA. Intradermal immunization with WTA elicited and augmented an anti-WTA IgG response in both WT and MBL KO mice. WTA immunization significantly reduced susceptibility to both MW2 CA-MRSA and COL HA-MRSA, independent of the presence of MBL. The protective mechanisms of anti-WTA IgG are mediated at least in part by complement activation and clearance of bacteria from blood. The significance of these findings is that 1) Intradermal immunization with WTA induces production of anti-WTA IgG; and 2) This anti-WTA IgG response protects from infection with both MW2 CA-MRSA and COL HA-MRSA even in the absence of MBL, the deficiency of which is common in humans.	[Takahashi, Kazue; Moyo, Patience; Chigweshe, Lorencia; Paul, Elahna] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Paul, Elahna] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Pediat Nephrol, Boston, MA USA; [Kurokawa, Kenji; Jung, Dong-Jun; An, Jang-Hyun; Lee, Bok Luel] Pusan Natl Univ, Natl Res Lab Def Prot, Coll Pharm, Pusan, South Korea	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Pusan National University	Takahashi, K (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA.	ktakahashi1@partners.org		Chigweshe, Lorencia/0000-0001-6535-6663	National Institutes of Health [U01-074503]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported in part by a National Institutes of Health grant U01-074503. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Chang WC, 2011, BIOCHEM PHARMACOL, V81, P388, DOI 10.1016/j.bcp.2010.10.012; Combadiere B, 2011, HUM VACCINES, V7, P811, DOI 10.4161/hv.7.8.16274; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Creech CB, 2005, PEDIATR INFECT DIS J, V24, P617, DOI 10.1097/01.inf.0000168746.62226.a4; Ding YP, 2008, J BACTERIOL, V190, P7123, DOI 10.1128/JB.00655-08; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Ehlert K, 1999, CURR PHARM DESIGN, V5, P45; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Firbas C, 2010, VACCINE, V28, P2397, DOI 10.1016/j.vaccine.2009.12.072; Gaikwad S, 1984, J Postgrad Med, V30, P229; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Guttormsen HK, 2009, CLIN IMMUNOL, V130, P264, DOI 10.1016/j.clim.2008.09.012; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Jung DJ, 2012, J IMMUNOL; Kohler T, 2009, J BACTERIOL, V191, P4482, DOI 10.1128/JB.00221-09; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012; Moller-Kristensen M, 2007, J INVEST DERMATOL, V127, P1524, DOI 10.1038/sj.jid.5700748; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Romani N, 2010, IMMUNOL CELL BIOL, V88, P424, DOI 10.1038/icb.2010.39; Ruseva M, 2009, IMMUNOLOGY, V127, P279, DOI 10.1111/j.1365-2567.2008.03016.x; Santos IKFD, 2001, INFECT IMMUN, V69, P5212, DOI 10.1128/IAI.69.8.5212-5215.2001; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Smithson A, 2008, CLIN INFECT DIS, V47, P1492, DOI 10.1086/593106; STEIN KE, 1992, J INFECT DIS, V165, pS49, DOI 10.1093/infdis/165-Supplement_1-S49; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Takahashi K, 2005, CLIN INFECT DIS, V41, pS440, DOI 10.1086/431987; Teunissen MBM, 2012, CURR TOP MICROBIOL, V351, P25, DOI 10.1007/82_2011_169; Trotonda MP, 2009, J INFECT DIS, V199, P209, DOI 10.1086/595740; Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Weidenmaier C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013227	46	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69739	10.1371/journal.pone.0069739	http://dx.doi.org/10.1371/journal.pone.0069739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936347	gold, Green Published, Green Submitted			2022-12-27	WOS:000324545800022
J	El-Menyar, A; Ahmed, E; Albinali, H; Al-Thani, H; Gehani, A; Singh, R; Al Suwaidi, J				El-Menyar, Ayman; Ahmed, Emad; Albinali, Hajar; Al-Thani, Hassan; Gehani, Abdurrazak; Singh, Rajvir; Al Suwaidi, Jassim			Mortality Trends in Women and Men Presenting with Acute Coronary Syndrome: Insights from a 20-Year Registry	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; EURO HEART SURVEY; GENDER-DIFFERENCES; SEX-DIFFERENCES; CARDIAC-CATHETERIZATION; CLINICAL PRESENTATION; MEDITERRANEAN BASIN; RISK-FACTORS; MANAGEMENT; OUTCOMES	Background: Coronary artery disease (CAD) is the leading cause of mortality worldwide. The present study evaluated the impact of gender in patients hospitalized with acute coronary syndromes (ACS) over a 20-year period in Qatar. Methods: Data were collected retrospectively from the registry of the department of cardiology for all patients admitted with ACS during the study period (1991-2010) and were analyzed according to gender. Results: Among 16,736 patients who were admitted with ACS, 14262 (85%) were men and 2474 (15%) were women. Cardiovascular risk factors were more prevalent among women in comparison to men. On admission, women presented mainly with non-ST-elevation ACS and were more likely to be undertreated with beta-blockers (BB), antiplatelet agents and reperfusion therapy in comparison to men. However, from 1999 through 2010, the use of aspirin, angiotensin-converting enzyme inhibitors and BB increased from 66% to 79%, 27% to 41% and 17% to 49%, respectively in women. In the same period, relative risk reduction for mortality was 64% in women and 51% in men. Across the 20-year period, the mortality rate decreased from 27% to 7% among the Middle Eastern Arab women. Multivariate logistic regression analysis showed that female gender was independent predictor of in-hospital mortality (odd ratio 1.51, 95% CI 1.27-1.79). Conclusions: Women presenting with ACS are high-risk population and their in-hospital mortality remains higher for all age groups in comparison to men. Although, substantial improvement in the hospital outcome has been observed, guidelines adherence and improvement in the hospital care have not yet been optimized.	[El-Menyar, Ayman; Gehani, Abdurrazak] Weill Cornell Med Sch, Dept Clin Med, Doha, Qatar; [El-Menyar, Ayman] Hamad Med Corp, Dept Trauma Surg, Clin Res, Doha, Qatar; [El-Menyar, Ayman] Ahmed Maher Teaching Hosp, Cardiol Unit, Dept Med, Cairo, Egypt; [Ahmed, Emad; Albinali, Hajar; Gehani, Abdurrazak; Singh, Rajvir; Al Suwaidi, Jassim] Hamad Med Corp, Dept Cardiol, Heart Hosp, Doha, Qatar; [Al-Thani, Hassan] Hamad Med Corp, Dept Vasc Surg, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Hamad Medical Corporation; Hamad Medical Corporation	Al Suwaidi, J (corresponding author), Hamad Med Corp, Dept Cardiol, Heart Hosp, Doha, Qatar.	jalsuwaidi@hotmail.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; al suwaidi, MB, ChB, FACC, FESC, FSCAI, jassim/0000-0002-5299-9106				Al Suwaidi Jassim, 2012, Acute Card Care, V14, P81, DOI 10.3109/17482941.2012.655298; Al Suwaidi J, 2012, AM J CARDIOL, V109, P395, DOI 10.1016/j.amjcard.2011.09.026; American Heart Association, 2003, HEART DIS STROK STAT; Anand SS, 2005, J AM COLL CARDIOL, V46, P1845, DOI 10.1016/j.jacc.2005.05.091; Anderson RD, 2007, CIRCULATION, V115, P823, DOI 10.1161/CIRCULATIONAHA.106.685859; [Anonymous], LANCET, V354, P701; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; Cucuianu M., 1993, Revue Roumaine de Medecine Interne, V31, P183; Daly C, 2006, CIRCULATION, V113, P490, DOI 10.1161/CIRCULATIONAHA.105.561647; Donnelly TT, 2012, HEALTH CARE WOMEN IN, V33, P1114, DOI 10.1080/07399332.2012.712172; El-Menyar A, 2011, J CARDIOL, V57, P165, DOI 10.1016/j.jjcc.2010.11.008; El-Menyar A, 2009, AM J CARDIOL, V104, P1018, DOI 10.1016/j.amjcard.2009.06.003; El-Menyar Ayman A, 2009, Expert Rev Cardiovasc Ther, V7, P411, DOI 10.1586/erc.09.10; Elsaesser A, 2004, CIRCULATION, V109, P565, DOI 10.1161/01.CIR.0000116022.77781.26; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Heer T, 2002, AM J CARDIOL, V89, P511, DOI 10.1016/S0002-9149(01)02289-5; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; Lundblad Dan, 2008, BMC Cardiovasc Disord, V8, P17, DOI 10.1186/1471-2261-8-17; Mandelzweig L, 2006, EUR HEART J, V27, P2285, DOI 10.1093/eurheartj/ehl196; Novack V, 2008, AM J MED, V121, P597, DOI 10.1016/j.amjmed.2008.01.041; Panduranga P, 2010, ANGIOLOGY, V61, P744, DOI 10.1177/0003319710369794; Poon S, 2012, AM HEART J, V163, P66, DOI 10.1016/j.ahj.2011.09.025; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Rathore SS, 2001, JAMA-J AM MED ASSOC, V286, P2849, DOI 10.1001/jama.286.22.2849; Rathore Sudhir, 2006, J Interv Cardiol, V19, P245, DOI 10.1111/j.1540-8183.2006.00138.x; Rosengren A, 2004, EUR HEART J, V25, P663, DOI 10.1016/j.ehj.2004.02.023; Setoguchi S, 2008, AM J CARDIOL, V101, P1531, DOI 10.1016/j.amjcard.2008.02.033; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; STEGNAR M, 1993, THROMB RES, V69, P81, DOI 10.1016/0049-3848(93)90005-9; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Xhyheri B, 2010, PROG CARDIOVASC DIS, V53, P227, DOI 10.1016/j.pcad.2010.07.004; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	49	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70066	10.1371/journal.pone.0070066	http://dx.doi.org/10.1371/journal.pone.0070066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936143	Green Submitted, gold, Green Published			2022-12-27	WOS:000322633700053
J	Bao, W; Qiu, HF; Yang, TT; Luo, X; Zhang, HJ; Wan, XP				Bao, Wei; Qiu, Haifeng; Yang, Tingting; Luo, Xin; Zhang, Huijuan; Wan, Xiaoping			Upregulation of TrkB Promotes Epithelial-Mesenchymal Transition and Anoikis Resistance in Endometrial Carcinoma	PLOS ONE			English	Article							NEUROTROPHIC RECEPTOR TRKB; PANCREATIC-CANCER CELLS; KINASE-B; NEUROBLASTOMA-CELLS; TUMOR PROGRESSION; FACTOR ACTIVATION; COLON-CANCER; METASTASIS; EXPRESSION; BDNF	Mechanisms governing the metastasis of endometrial carcinoma (EC) are poorly defined. Recent data support a role for the cell surface receptor tyrosine kinase TrkB in the progression of several human tumors. Here we present evidence for a direct role of TrkB in human EC. Immunohistochemical analysis revealed that TrkB and its secreted ligand, brain-derived neurotrophic factor (BDNF), are more highly expressed in EC than in normal endometrium. High TrkB levels correlated with lymph node metastasis (p<0.05) and lymphovascular space involvement (p<0.05) in EC. Depletion of TrkB by stable shRNA-mediated knockdown decreased the migratory and invasive capacity of cancer cell lines in vitro and resulted in anoikis in suspended cells. Conversely, exogenous expression of TrkB increased cell migration and invasion and promoted anoikis resistance in suspension culture. Furthermore, over-expression of TrkB or stimulation by BDNF resulted in altered the expression of molecular mediators of the epithelial-to-mesenchymal transition (EMT). RNA interference (RNAi)-mediated depletion of the downstream regulator, Twist, blocked TrkB-induced EMT-like transformation. The use of in vivo models revealed decreased peritoneal dissemination in TrkB-depleted EC cells. Additionally, TrkB-depleted EC cells underwent mesenchymal-to-epithelial transition and anoikis in vivo. Our data support a novel function for TrkB in promoting EMT and resistance to anoikis. Thus, TrkB may constitute a potential therapeutic target in human EC.	[Bao, Wei] Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai 200030, Peoples R China; [Qiu, Haifeng; Yang, Tingting; Wan, Xiaoping] Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Luo, Xin] Shanghai Jiao Tong Univ, Dept Ctr Res Lab, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Huijuan] Shanghai Jiao Tong Univ, Dept Pathol, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wan, XP (corresponding author), Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	wanxp@sjtu.edu.cn	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022		National Natural Science Foundation of China [81072139, 81172476]; Science and Technology Commission of Shanghai Municipality [12ZR1451400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by the National Natural Science Foundation of China (no. 81072139, no. 81172476) and the Project of Science and Technology Commission of Shanghai Municipality (no. 12ZR1451400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger DL, 2007, ENDOCRINE, V31, P167, DOI 10.1007/s12020-007-0025-8; Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025; Bahng AY, 2012, J GYNECOL ONCOL, V23, P257, DOI 10.3802/jgo.2012.23.4.257; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Bronzetti E, 2008, ONCOL REP, V19, P969; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Creasman W, 2009, INT J GYNECOL OBSTET, V105, P109, DOI 10.1016/j.ijgo.2009.02.010; de Farias CB, 2012, BIOCHEM BIOPH RES CO, V425, P328, DOI 10.1016/j.bbrc.2012.07.091; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Geiger TR, 2005, CANCER RES, V65, P7033, DOI 10.1158/0008-5472.CAN-05-0709; Harada T, 2011, CLIN CANCER RES, V17, P2638, DOI 10.1158/1078-0432.CCR-10-3034; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jaboin J, 2002, CANCER RES, V62, P6756; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030246; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Makino K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041049; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Odate S, 2013, LUNG CANCER, V79, P205, DOI 10.1016/j.lungcan.2012.12.004; Okamura K, 2012, LUNG CANCER, V78, P100, DOI 10.1016/j.lungcan.2012.07.011; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Roesler R, 2011, EXPERT REV ANTICANC, V11, P1473, DOI [10.1586/ERA.11.150, 10.1586/era.11.150]; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Sasahira T, 2013, HUM PATHOL; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Sclabas GM, 2005, CLIN CANCER RES, V11, P440; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Sorosky JI, 2012, OBSTET GYNECOL, V120, P383, DOI 10.1097/AOG.0b013e3182605bf1; Tanaka K, 2009, J SURG ONCOL, V99, P307, DOI 10.1002/jso.21232; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson CC, 2007, GUT, V56, P95, DOI 10.1136/gut.2005.083691; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Vale CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003915.pub4; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yu XH, 2008, CANCER SCI, V99, P543, DOI 10.1111/j.1349-7006.2007.00722.x; Yu YJ, 2010, APMIS, V118, P188, DOI 10.1111/j.1600-0463.2009.02577.x; Zhang Y, 2008, ONCOLOGY-BASEL, V75, P17, DOI 10.1159/000151615	47	59	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70616	10.1371/journal.pone.0070616	http://dx.doi.org/10.1371/journal.pone.0070616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936232	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200095
J	Romorini, L; Riva, DA; Bluguermann, C; Richardson, GAV; Scassa, ME; Sevlever, GE; Miriuka, SG				Romorini, Leonardo; Ariel Riva, Diego; Blueguermann, Carolina; Videla Richardson, Guillermo Agustin; Elida Scassa, Maria; Emilio Sevlever, Gustavo; Gabriel Miriuka, Santiago			Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth	PLOS ONE			English	Article							HUMAN BLASTOCYSTS; LINES; CULTURES; CONTAMINATION; CIPROFLOXACIN; ELIMINATION; INFECTION; PREVENTION; INVITRO; PCR	Human embryonic stem cells (hESCs) are self-renewing pluripotent cells that can differentiate into specialized cells and hold great promise as models for human development and disease studies, cell-replacement therapies, drug discovery and in vitro cytotoxicity tests. The culture and differentiation of these cells are both complex and expensive, so it is essential to extreme aseptic conditions. hESCs are susceptible to Mycoplasma sp. infection, which is hard to detect and alters stem cell-associated properties. The purpose of this work was to evaluate the efficacy and cytotoxic effect of Plasmocin (TM) and ciprofloxacin (specific antibiotics used for Mycoplasma sp. eradication) on hESCs. Mycoplasma sp. infected HUES-5 884 (H5 884, stable hESCs H5-brachyury promoter-GFP line) cells were effectively cured with a 14 days Plasmocin (TM) 25 mu g/ml treatment (curative treatment) while maintaining stemness characteristic features. Furthermore, cured H5 884 cells exhibit the same karyotype as the parental H5 line and expressed GFP, through up-regulation of brachyury promoter, at day 4 of differentiation onset. Moreover, H5 cells treated with ciprofloxacin 10 mu g/ml for 14 days (mimic of curative treatment) and H5 and WA09 (H9) hESCs treated with Plasmocin (TM) 5 mu g/ml (prophylactic treatment) for 5 passages retained hESCs features, as judged by the expression of stemness-related genes (TRA1-60, TRA1-81, SSEA-4, Oct-4, Nanog) at mRNA and protein levels. In addition, the presence of specific markers of the three germ layers (brachyury, Nkx2.5 and cTnT: mesoderm; AFP: endoderm; nestin and Pax-6: ectoderm) was verified in in vitro differentiated antibiotic-treated hESCs. In conclusion, we found that Plasmocin (TM) and ciprofloxacin do not affect hESCs stemness and pluripotency nor cell viability. However, curative treatments slightly diminished cell growth rate. This cytotoxic effect was reversible as cells regained normal growth rate upon antibiotic withdrawal.	[Romorini, Leonardo; Ariel Riva, Diego; Blueguermann, Carolina; Videla Richardson, Guillermo Agustin; Elida Scassa, Maria; Emilio Sevlever, Gustavo; Gabriel Miriuka, Santiago] Fdn Lucha Enfermedades Neurol Infancia, Lab Invest Aplicada Nuerociencias, Lab Biol Desarrollo Celular, Buenos Aires, DF, Argentina		Miriuka, SG (corresponding author), Fdn Lucha Enfermedades Neurol Infancia, Lab Invest Aplicada Nuerociencias, Lab Biol Desarrollo Celular, Buenos Aires, DF, Argentina.	smiriuka@fleni.org.ar	Romorini, Leonardo/AGK-7429-2022; Miriuka, Santiago/AAM-4051-2020; Miriuka, Santiago/ABE-9614-2020; Sevlever, Gustavo/Q-2219-2015	Romorini, Leonardo/0000-0002-3972-0991; Miriuka, Santiago/0000-0003-2402-3920; Sevlever, Gustavo/0000-0002-9567-7553; Bluguermann, Carolina/0000-0003-3761-2951	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PID2007-00112, PID2007-00111]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) PID2007-00112 and PID2007-00111. CB and GVR are Graduate fellows. LR and DAR are post-doctoral fellows. MES is a Researcher Member of FLENI. SGM is a Research Member of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronckaers A, 2008, BIOCHEM PHARMACOL, V76, P188, DOI 10.1016/j.bcp.2008.04.019; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Cobo F, 2007, CELL BIOL INT, V31, P991, DOI 10.1016/j.cellbi.2007.03.010; Colletti GA, 2012, J BIOL CHEM, V287, P8082, DOI 10.1074/jbc.M111.285536; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; HAHN T, 1991, EXP HEMATOL, V19, P157; HAY RJ, 1989, NATURE, V339, P487, DOI 10.1038/339487a0; Kazemiha VM, 2011, CYTOTECHNOLOGY, V63, P609, DOI 10.1007/s10616-011-9378-1; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; KOTANI H, 1991, IN VITRO CELL DEV B, V27, P509; LEVINE EM, 1968, P NATL ACAD SCI USA, V60, P583, DOI 10.1073/pnas.60.2.583; Markoullis K, 2009, TRANSGENIC RES, V18, P71, DOI 10.1007/s11248-008-9218-z; MCGARRITY GJ, 1976, IN VITRO CELL DEV B, V12, P643; Mowles J M, 1988, Cytotechnology, V1, P355, DOI 10.1007/BF00365081; Nikfarjam L, 2012, CELL J, V13, P203; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; RIDGWAY GL, 1984, EUR J CLIN MICROBIOL, V3, P344, DOI 10.1007/BF01977491; Singh S, 2008, PARASITOL RES, V104, P181, DOI 10.1007/s00436-008-1181-3; SOMEKH E, 1989, J PHARMACOL EXP THER, V248, P415; STANBRIDGE E, 1971, BACTERIOL REV, V35, P206, DOI 10.1128/MMBR.35.2.206-227.1971; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; UPHOFF CC, 1992, J IMMUNOL METHODS, V149, P43, DOI 10.1016/S0022-1759(12)80047-0; Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P86; Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79; Uphoff CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/267678; Uphoff CC, 2011, METHODS MOL BIOL, V731, P105, DOI 10.1007/978-1-61779-080-5_9; VANKUPPEVELD FJM, 1994, APPL ENVIRON MICROB, V60, P149, DOI 10.1128/AEM.60.1.149-152.1994; Wobus AM, 2011, ARCH TOXICOL, V85, P79, DOI 10.1007/s00204-010-0641-6; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43	33	15	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70267	10.1371/journal.pone.0070267	http://dx.doi.org/10.1371/journal.pone.0070267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936178	Green Submitted, gold, Green Published			2022-12-27	WOS:000323114200072
J	Rydwik, E; Welmer, AK; Angleman, S; Fratiglioni, L; Wang, HX				Rydwik, Elisabeth; Welmer, Anna-Karin; Angleman, Sara; Fratiglioni, Laura; Wang, Hui-Xin			Is Midlife Occupational Physical Activity Related to Disability in Old Age? The SNAC-Kungsholmen Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; ITALIAN RURAL-AREAS; LEISURE-TIME; FOLLOW-UP; RISK-FACTORS; WORK-ENVIRONMENT; SITTING TIME; SPORTS; HEALTH; COHORT	Objectives: Leisure-time physical activity (PA) has been established to be related to more years lived without disability. However, less is known about the relationship between occupational PA and disability in old age. The aim of the study was 1) to investigate whether midlife occupational PA is related to late-life disability, and 2) to test the hypothesis that the association differs according to the occupational categories of blue and white collar work. Methods: The study population was derived from the Swedish National Study on Aging and Care, and consisted of a random sample of 1804 subjects aged 72 and above. The association of occupational PA during the longest held occupation with disability in old age was determined using logistic regression. Results: There was no significant relationship between occupational PA and disability in personal or instrumental activities of daily living (ADL) after controlling for demographic and health-related factors. However, in stratified analyses moderate levels of occupational PA was associated with a lower odds ratio of dependency in personal ADL amongst white collar workers, compared to low level of occupational PA (OR = 0.34 95% C1 0.12-0.98). Conclusions: Moderate levels of midlife occupational PA were associated with a decreased risk of personal ADL disability in old age among white collar workers, but not among blue collar workers. Our results highlight the importance of encouraging white collar workers to engage in physical activity during or outside work hours.	[Rydwik, Elisabeth; Welmer, Anna-Karin; Angleman, Sara; Fratiglioni, Laura; Wang, Hui-Xin] Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Rydwik, Elisabeth; Welmer, Anna-Karin; Angleman, Sara; Fratiglioni, Laura; Wang, Hui-Xin] Stockholm Univ, S-10691 Stockholm, Sweden; [Rydwik, Elisabeth] Jakobsbergs Hosp, Res & Dev Unit, Stockholm Cty Council, Jarfalla, Sweden; [Welmer, Anna-Karin] Karolinska Univ Hosp, Stockholm, Sweden; [Fratiglioni, Laura] Stockholm Gerontol Res Ctr, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Stockholm County Council; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Rydwik, E (corresponding author), Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	elisabeth.rydwik@ki.se	Welmer, Anna-Karin/AAL-3446-2021	Welmer, Anna-Karin/0000-0001-5819-8724; Rydwik, Elisabeth/0000-0003-0550-1675; Wang, Hui-Xin/0000-0002-5051-4929; Angleman, Sara/0000-0002-9520-5716	Swedish Ministry of Health and Social Affairs; Swedish Research Council; Swedish Council for Working Life and Social Research; American Alzheimer foundation; Alzheimer foundation, Sweden; Swedish Brain Power program; Fredrik and Ingrid Thurings foundation; Gun and Bertil Stohnes foundation; Gamla Tjanarinnor foundation; Stockholm County Council; Soderstrom-Konigska foundation; Handlanden Hjalmar Svenssons Forskningsfond; Konung Gustaf V:s och Drottning Victorias Frimurare foundation; Board of Research at Karolinska Institutet; Centre for Health Care Science at Karolinska Institutet	Swedish Ministry of Health and Social Affairs; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); American Alzheimer foundation; Alzheimer foundation, Sweden; Swedish Brain Power program; Fredrik and Ingrid Thurings foundation; Gun and Bertil Stohnes foundation; Gamla Tjanarinnor foundation; Stockholm County Council(Stockholm County Council); Soderstrom-Konigska foundation; Handlanden Hjalmar Svenssons Forskningsfond; Konung Gustaf V:s och Drottning Victorias Frimurare foundation; Board of Research at Karolinska Institutet(Karolinska Institutet); Centre for Health Care Science at Karolinska Institutet	This work was supported by the Swedish Ministry of Health and Social Affairs; the Swedish Research Council; Swedish Council for Working Life and Social Research; the American Alzheimer foundation; the Alzheimer foundation, Sweden; the Swedish Brain Power program; the Fredrik and Ingrid Thurings foundation; Gun and Bertil Stohnes foundation; Gamla Tjanarinnor foundation; Stockholm County Council; Soderstrom-Konigska foundation; Handlanden Hjalmar Svenssons Forskningsfond; the Konung Gustaf V:s och Drottning Victorias Frimurare foundation, the Board of Research at Karolinska Institutet; the Centre for Health Care Science at Karolinska Institutet. The authors are not employed by the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Arndt V, 2005, OCCUP ENVIRON MED, V62, P559, DOI 10.1136/oem.2004.018135; Atlantis E, 2006, J OCCUP HEALTH PSYCH, V11, P291, DOI 10.1037/1076-8998.11.4.291; Caban-Martinez AJ, 2011, AM J PUBLIC HEALTH, V101, P1729, DOI 10.2105/AJPH.2011.300173; Feinglass J, 2005, ARTHRIT RHEUM-ARTHR, V53, P879, DOI 10.1002/art.21579; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANDIN K, 1995, GERONTOLOGY, V41, P109; Graff-Iversen S, 2007, RES Q EXERCISE SPORT, V78, P151; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Holtermann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054548; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P357, DOI 10.5271/sjweh.2913; Jaglal Susan B., 1995, Annals of Epidemiology, V5, P321, DOI 10.1016/1047-2797(94)00100-8; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Lagergren M, 2004, AGING CLIN EXP RES, V16, P158; Leino-Arjas P, 2004, OCCUP ENVIRON MED, V61, P1032, DOI 10.1136/oem.2003.012054; Li CY, 2000, OCCUP ENVIRON MED, V57, P550, DOI 10.1136/oem.57.8.550; Lund T, 2006, BMJ-BRIT MED J, V332, P449, DOI 10.1136/bmj.38731.622975.3A; Menotti A, 2005, ACTA CARDIOL, V60, P521, DOI 10.2143/AC.60.5.2004974; Menotti A, 2006, AGING CLIN EXP RES, V18, P394; Mummery WK, 2005, AM J PREV MED, V29, P91, DOI 10.1016/j.amepre.2005.04.003; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Nusselder WJ, 2008, J EPIDEMIOL COMMUN H, V62, P823, DOI 10.1136/jech.2007.067165; Pohjonen T, 2001, PREV MED, V32, P465, DOI 10.1006/pmed.2001.0837; Raghunathan TE, 2001, SURV METHODOL, V27, P86; Ramsay SE, 2008, ANN EPIDEMIOL, V18, P896, DOI 10.1016/j.annepidem.2008.09.006; Ratzlaff CR, 2012, BRIT J SPORT MED, V46, P699, DOI 10.1136/bjsports-2011-090800; Reinhardt JD, 2013, OCCUP ENVIRON MED, V70, P156, DOI 10.1136/oemed-2012-100924; Rossignol M, 2003, OCCUP ENVIRON MED, V60, P882, DOI 10.1136/oem.60.11.882; Russo A, 2006, OCCUP ENVIRON MED, V63, P438, DOI 10.1136/oem.2005.023549; Rydwik E, 2012, EUR J PUBLIC HLTH; SALONEN JT, 1988, AM J EPIDEMIOL, V127, P87, DOI 10.1093/oxfordjournals.aje.a114794; Singh MAF, 2002, CLIN GERIATR MED, V18, P431; Statistics Sweden (SCB), 1982, SWED SOC CLASS; Torgen M, 2000, SCAND J WORK ENV HEA, V26, P161, DOI 10.5271/sjweh.526; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; von Bonsdorff Mikaela B, 2011, CMAJ, V183, pE235, DOI 10.1503/cmaj.100713; Vuillemin A, 2011, OBESITY FACTS, V4, P479, DOI 10.1159/000335255; Wang YJ, 2010, J AM COLL CARDIOL, V56, P1140, DOI 10.1016/j.jacc.2010.05.035; WARD MM, 1995, J GERONTOL A-BIOL, V50, pM70, DOI 10.1093/gerona/50A.2.M70; Wennberg P, 2006, EUR J CARDIOV PREV R, V13, P924, DOI 10.1097/01.hjr.0000239470.49003.c3; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	42	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70471	10.1371/journal.pone.0070471	http://dx.doi.org/10.1371/journal.pone.0070471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936209	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200086
J	Das, AJ; Stephenson, NL; Flint, A; Das, T; van Mantgem, PJ				Das, Adrian J.; Stephenson, Nathan L.; Flint, Alan; Das, Tapash; van Mantgem, Phillip J.			Climatic Correlates of Tree Mortality in Water- and Energy-Limited Forests	PLOS ONE			English	Article							DIE-OFF; VEGETATION DISTRIBUTION; SEVERE DROUGHT; GROWTH; TEMPERATURE; MODELS; RATES; RESPONSES; DYNAMICS; INCREASE	Recent increases in tree mortality rates across the western USA are correlated with increasing temperatures, but mechanisms remain unresolved. Specifically, increasing mortality could predominantly be a consequence of temperature-induced increases in either (1) drought stress, or (2) the effectiveness of tree-killing insects and pathogens. Using long-term data from California's Sierra Nevada mountain range, we found that in water-limited (low-elevation) forests mortality was unambiguously best modeled by climatic water deficit, consistent with the first mechanism. In energy-limited (high-elevation) forests deficit models were only equivocally better than temperature models, suggesting that the second mechanism is increasingly important in these forests. We could not distinguish between models predicting mortality using absolute versus relative changes in water deficit, and these two model types led to different forecasts of mortality vulnerability under future climate scenarios. Our results provide evidence for differing climatic controls of tree mortality in water- and energy-limited forests, while highlighting the need for an improved understanding of tree mortality processes.	[Das, Adrian J.; Stephenson, Nathan L.] US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA USA; [Flint, Alan] US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA; [Das, Tapash] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [van Mantgem, Phillip J.] US Geol Survey, Western Ecol Res Ctr, Arcata, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of California System; University of California San Diego; Scripps Institution of Oceanography; United States Department of the Interior; United States Geological Survey	Das, AJ (corresponding author), US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA USA.	adas@usgs.gov			U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	Funding provided by the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams H. D., 2010, EOS T AM GEOPHYS UN, V91, P153, DOI DOI 10.1029/2010EO170003; Adams HD, 2004, OECOLOGIA, V140, P217, DOI 10.1007/s00442-004-1585-4; Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; ayan D., 2009, CEC5002009014D; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Bigler C, 2004, ECOL MODEL, V174, P225, DOI 10.1016/j.ecolmodel.2003.09.025; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bouwer L. M., 2004, Climate change in contrasting river basins: adaptation strategies for water, food and environment, P25, DOI 10.1079/9780851998350.0025; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 1998, MODEL SELECTION INFE; CAPRIO AC, 1995, INTGTR320 USDA FOR S; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Daly C, 2004, UP TO DATE MONTHLY C, P13; Davis F., 1998, CALIFORNIA GAP ANAL; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Fites-Kaufman JA, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P456; Flint A. L., 2007, APPL BASIN CHARACTER; Flint L.E., 2007, GROUND WATER RECHARG, P29; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Flint LE, 2012, SIMULATION CLIMATE C; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Gitlin AR, 2006, CONSERV BIOL, V20, P1477, DOI 10.1111/j.1523-1739.2006.00424.x; GRAUMLICH LJ, 1991, ECOLOGY, V72, P1, DOI 10.2307/1938895; GRAUMLICH LJ, 1993, QUATERNARY RES, V39, P249, DOI 10.1006/qres.1993.1029; Hawkes C, 2000, ECOL MODEL, V126, P225, DOI 10.1016/S0304-3800(00)00267-2; Hicke JA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000101; Hickman J. C., 1993, JEPSON MANUAL HIGHER; Hidalgo H.G., 2008, CEC5002007123 PIER; Joslin JD, 2000, NEW PHYTOL, V147, P117, DOI 10.1046/j.1469-8137.2000.00692.x; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Landhausser SM, 1996, CAN J BOT, V74, P686, DOI 10.1139/b96-087; Littell JS, 2008, ECOL MONOGR, V78, P349, DOI 10.1890/07-0712.1; Lloyd AH, 1997, ECOLOGY, V78, P1199, DOI 10.1890/0012-9658(1997)078[1199:HDOTFI]2.0.CO;2; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2008, ECOHYDROLOGY, V1, P193, DOI 10.1002/eco.20; McDowell NG, 2010, GLOBAL CHANGE BIOL, V16, P399, DOI 10.1111/j.1365-2486.2009.01994.x; Meehl GA, 2003, J CLIMATE, V16, P426, DOI [10.1175/1520-0442(2003)016<0426:SAGGFA>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0426:SAGGFA&gt;2.0.CO;2]; Metcalfe DB, 2008, PLANT SOIL, V311, P189, DOI 10.1007/s11104-008-9670-9; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Nalder IA, 1998, AGR FOREST METEOROL, V92, P211, DOI 10.1016/S0168-1923(98)00102-6; Natural Resources Conservation Service, 2019, WEB SOIL SURV; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Stephenson N.L., 1988, CLIMATIC CONTROL VEG; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Stouffer RJ, 2006, J CLIMATE, V19, P723, DOI 10.1175/JCLI3632.1; Tague C, 2009, ECOHYDROLOGY, V2, P541, DOI 10.1002/eco.88; Trujillo E, 2012, NAT GEOSCI, V5, P705, DOI [10.1038/NGEO1571, 10.1038/ngeo1571]; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Williams AP, 2012, NATURE CLIMATE CHANG	65	68	68	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69917	10.1371/journal.pone.0069917	http://dx.doi.org/10.1371/journal.pone.0069917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936118	Green Published, gold			2022-12-27	WOS:000322433300074
J	Date, P; Dweck, HKM; Stensmyr, MC; Shann, J; Hansson, BS; Rollmann, SM				Date, Priya; Dweck, Hany K. M.; Stensmyr, Marcus C.; Shann, Jodi; Hansson, Bill S.; Rollmann, Stephanie M.			Divergence in Olfactory Host Plant Preference in D-mojavensis in Response to Cactus Host Use	PLOS ONE			English	Article							DROSOPHILA-MOJAVENSIS; REPRODUCTIVE ISOLATION; CHEMOSENSORY BASIS; RACE FORMATION; RECEPTOR; SHIFTS; EVOLUTION; FRUIT; POPULATIONS; SELECTION	Divergence in host adaptive traits has been well studied from an ecological and evolutionary perspective, but identification of the proximate mechanisms underlying such divergence is less well understood. Behavioral preferences for host plants are often mediated by olfaction and shifts in preference may be accompanied by changes in the olfactory system. In this study, we examine the evolution of host plant preferences in cactophilic Drosophila mojavensis that feeds and breeds on different cacti throughout its range. We show divergence in electrophysiological responses and olfactory behavior among populations with host plant shifts. Specifically, significant divergence was observed in the Mojave Desert population that specializes on barrel cactus. Differences were observed in electrophysiological responses of the olfactory organs and in behavioral responses to barrel cactus volatiles. Together our results suggest that the peripheral nervous system has changed in response to different ecological environments and that these changes likely contribute to divergence among D. mojavensis populations.	[Date, Priya; Shann, Jodi; Rollmann, Stephanie M.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Dweck, Hany K. M.; Stensmyr, Marcus C.; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	University System of Ohio; University of Cincinnati; Max Planck Society	Stensmyr, MC (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	mstensmyr@ice.mpg.de; stephanie.rollmann@uc.edu	Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223; Stensmyr, Marcus/0000-0003-4009-9212	National Institute of Health [GM080592]; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080592] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from the National Institute of Health to SMR (GM080592) and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2007, J BIOL CHEM, V282, P1216, DOI 10.1074/jbc.M609355200; ALCORN SM, 1991, INT J SYST BACTERIOL, V41, P197, DOI 10.1099/00207713-41-2-197; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Downing RJ, 1985, THESIS U DENVER DENV; Etges WJ, 2010, EVOLUTION, V64, P3549, DOI 10.1111/j.1558-5646.2010.01096.x; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; FELLOWS DP, 1972, ECOLOGY, V53, P850, DOI 10.2307/1934300; Fogleman J.C., 1982, P191; Fogleman J.C., 1990, P121; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Heed W.G., 1986, P311; Heed W.B., 1982, P65; Heed W. B., 1978, ECOLOGICAL GENETICS, P109, DOI DOI 10.1007/978-1-4612-6330-2; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kliman RM, 2000, GENETICS, V156, P1913; Knowles LL, 2001, P NATL ACAD SCI USA, V98, P8692, DOI 10.1073/pnas.151123998; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lachaise D, 2004, GENETICA, V120, P17, DOI 10.1023/B:GENE.0000017627.27537.ef; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Matzkin LM, 2003, GENETICS, V163, P181; Newby BD, 1998, J INSECT BEHAV, V11, P691, DOI 10.1023/A:1022398809881; Nosil P, 2005, EVOLUTION, V59, P705; Olsson S, 2006, J COMP PHYSIOL A, V192, P279, DOI 10.1007/s00359-005-0069-2; Pinero JC, 2007, ENTOMOL EXP APPL, V125, P185, DOI 10.1111/j.1570-7458.2007.00614.x; Reed LK, 2007, MOL ECOL, V16, P1007, DOI 10.1111/j.1365-294X.2006.02941.x; REED MELIA R., 1938, PHYSIOL ZOOL, V11, P317; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; RUIZ A, 1990, J HERED, V81, P30, DOI 10.1093/oxfordjournals.jhered.a110922; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Smith G, 2012, MOL ECOL, V21, P3293, DOI 10.1111/j.1365-294X.2012.05604.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; STARMER WT, 1977, P NATL ACAD SCI USA, V74, P387, DOI 10.1073/pnas.74.1.387; STARMER WT, 1982, MICROBIAL ECOL, V8, P71, DOI 10.1007/BF02011463; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Stensmyr MC, 2003, P ROY SOC B-BIOL SCI, V270, P2333, DOI 10.1098/rspb.2003.2512; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Tasin M, 2006, NATURWISSENSCHAFTEN, V93, P141, DOI 10.1007/s00114-005-0077-7; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; ZOUROS E, 1980, EVOLUTION, V34, P421, DOI 10.1111/j.1558-5646.1980.tb04830.x	40	33	33	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70027	10.1371/journal.pone.0070027	http://dx.doi.org/10.1371/journal.pone.0070027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936137	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300084
J	Huik, K; Avi, R; Carrillo, A; Harper, N; Pauskar, M; Sadam, M; Karki, T; Krispin, T; Kongo, UK; Jermilova, T; Ruutel, K; Talu, A; Abel-Ollo, K; Uuskula, A; Ahuja, SK; He, WJ; Lutsar, I				Huik, Kristi; Avi, Radko; Carrillo, Andrew; Harper, Nathan; Pauskar, Merit; Sadam, Maarja; Karki, Tonis; Krispin, Tonu; Kongo, Ulvi-Kaire; Jermilova, Tatiana; Rueuetel, Kristi; Talu, Ave; Abel-Ollo, Katri; Uuskuela, Anneli; Ahuja, Sunil K.; He, Weijing; Lutsar, Irja			CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HUMAN-IMMUNODEFICIENCY-VIRUS; DISEASE PROGRESSION; HIV-1 INFECTION; CHEMOKINE; EXPRESSION; CCR5-DELTA-32; ASSOCIATION; FREQUENCY; IMPACT	Background: Up to 90% HIV-1 positive intravenous drug users (IDUs) are co-infected with HCV. Although best recognized for its function as a major co-receptor for cell entry of HIV, CC chemokine receptor 5 (CCR5) has also been implicated in the pathogenesis of HCV infection. Here, we investigated whether CCR5 haplotypes influence HIV-1 and HCV seropositivity among 373 Caucasian IDUs from Estonia. Methods: Of these IDUs, 56% and 44% were HIV and HCV seropositive, respectively, and 47% were coinfected. 500 blood donors seronegative for HIV and HCV were also evaluated. CCR5 haplotypes (HHA to HHG*2) were derived after genotyping nine CCR2-CCR5 polymorphisms. The association between CCR5 haplotypes with HIV and/or HCV seropositivity was determined using logistic regression analysis. Co-variates included in the models were length of intravenous drug use, HBV serostatus and copy number of CCL3L1, the gene encoding the most potent HIV-suppressive chemokine and ligand for CCR5. Results: Compared to IDUs seronegative for both HCV and HIV (HCV2/HIV-), IDUs who were HCV+/HIV- and HCV+/HIV+ were 92% and 82%, respectively, less likely to possess the CCR5-HHG*1 haplotype, after controlling for co-variates (P-adjusted = 1.89x10(-4) and 0.003, respectively). This association was mostly due to subjects bearing the CCR5 HHE and HHG*1 haplotype pairs. Approximately 25% and < 10% of HCV-/HIV- IDUs and HCV2/HIV- blood donors, respectively, possessed the HHE/HHG*1 genotype. Conclusions: Our findings suggest that HHG*1-bearing CCR5 genotypes influence HCV seropositivity in a group of Caucasian IDUs.	[Huik, Kristi; Avi, Radko; Pauskar, Merit; Sadam, Maarja; Karki, Tonis; Krispin, Tonu; Lutsar, Irja] Univ Tartu, Fac Med, Dept Microbiol, EE-50090 Tartu, Estonia; [Carrillo, Andrew; Harper, Nathan; Ahuja, Sunil K.; He, Weijing] South Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX USA; [Carrillo, Andrew; Harper, Nathan; Ahuja, Sunil K.; He, Weijing] South Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX USA; [Carrillo, Andrew; Harper, Nathan; Ahuja, Sunil K.; He, Weijing] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Kongo, Ulvi-Kaire] North Estonia Med Ctr Fdn, Immunoheamatol Reference Lab, Tallinn, Estonia; [Jermilova, Tatiana] Blood Ctr Kohtla Jarve, Kohtla Jarve, Estonia; [Rueuetel, Kristi; Talu, Ave; Abel-Ollo, Katri] Natl Inst Hlth Dev, Tallinn, Estonia; [Uuskuela, Anneli] Univ Tartu, Fac Med, Dept Publ Hlth, EE-50090 Tartu, Estonia	University of Tartu; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; National Institute for Health Development - Estonia; University of Tartu	He, WJ (corresponding author), South Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX USA.	hew@uthscsa.edu; Irja.Lutsar@ut.ee	Huik, Kristi/AGY-9109-2022; Uusküla, Anneli/H-3303-2015; Talu, Ave/D-7677-2014; lutsar, irja/H-3177-2015	Uusküla, Anneli/0000-0002-4036-3856; Talu, Ave/0000-0003-3543-483X; Huik, Kristi/0000-0002-1569-8830; Avi, Radko/0000-0002-9640-8427	Veterans Affairs (VA) Center for AIDS and HIV Infection; VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health (NIH) [R37AI046326]; Doris Duke Distinguished Clinical Scientist Award; VA MERIT award; Elizabeth Glaser Pediatric AIDS Foundation; Max and Minnie Tomerlin Voelcker Fund; European Union through the European Regional Development Fund; Estonian Science Foundation [8004, 8415, 8856]; Basic Financing and the Target Financing of Estonian Ministry of Education and Research [SF0180004s12]; European Commission funded project Expanding Network for Comprehensive; Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population [2005305]; Global Fund; National HIV/AIDS Strategy; US Civilian Research Development Foundation [ESX0-2722-TA06]; US National Institutes of Health, National Institute on Drug Abuse [R01DA03574]; Archimedes Foundation and Norwegian Financial Mechanism/ EEA [EE0016]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003574] Funding Source: NIH RePORTER	Veterans Affairs (VA) Center for AIDS and HIV Infection(US Department of Veterans Affairs); VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); VA MERIT award(US Department of Veterans Affairs); Elizabeth Glaser Pediatric AIDS Foundation; Max and Minnie Tomerlin Voelcker Fund; European Union through the European Regional Development Fund(European Commission); Estonian Science Foundation; Basic Financing and the Target Financing of Estonian Ministry of Education and Research; European Commission funded project Expanding Network for Comprehensive; Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population; Global Fund; National HIV/AIDS Strategy; US Civilian Research Development Foundation; US National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Archimedes Foundation and Norwegian Financial Mechanism/ EEA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work at San Antonio was supported by the Veterans Affairs (VA) Center for AIDS and HIV Infection and VA Center for Personalized Medicine of the South Texas Veterans Health Care System, a National Institutes of Health (NIH) MERIT grant (R37AI046326), and the Doris Duke Distinguished Clinical Scientist Award to S.K.A. S.K.A. is also supported by a VA MERIT award, the Elizabeth Glaser Pediatric AIDS Foundation, the Burroughs Welcome Clinical Scientist Award in Translational Research and the Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund. The work at Estonia was supported by European Union through the European Regional Development Fund; Estonian Science Foundation (grants 8004, 8415 and 8856); Basic Financing and the Target Financing of Estonian Ministry of Education and Research (SF0180004s12); European Commission funded project Expanding Network for Comprehensive and Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population Nr. 2005305 (ENCAP); Global Fund to Fight HIV, Tuberculosis and Malaria Program "Scaling up the response to HIV in Estonia'' for 2003-2007; National HIV/AIDS Strategy for 2006-2015; US Civilian Research Development Foundation (grant ESX0-2722-TA06); US National Institutes of Health, National Institute on Drug Abuse (grant R01DA03574); the Archimedes Foundation and Norwegian Financial Mechanism/EEA(grant EE0016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel-Ollo K, 2009, AIDS CARE, V21, P851, DOI 10.1080/09540120802657522; Adojaan M, 2005, JAIDS-J ACQ IMM DEF, V39, P598; An P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002328; Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x; Broadhead RS, 1999, PUBLIC HEALTH REP, V114, P439, DOI 10.1093/phr/114.5.439; Catano G, 2011, J INFECT DIS, V203, P263, DOI 10.1093/infdis/jiq023; Dorak MT, 2002, IMMUNOL RES, V26, P167, DOI 10.1385/IR:26:1-3:167; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Goulding C, 2005, GUT, V54, P1157, DOI 10.1136/gut.2004.055699; Grebely J, 2011, CURR OPIN HIV AIDS, V6, P501, DOI 10.1097/COH.0b013e32834bcb36; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Huik K, 2010, J INFECT DIS, V201, P730, DOI 10.1086/650491; Husman AD, 1999, J IMMUNOL, V163, P4597; Hyde CL, 2010, CIRC-CARDIOVASC GENE, V3, P162, DOI 10.1161/CIRCGENETICS.109.897793; Katsounas A, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-9; Konishi I, 2004, INTERVIROLOGY, V47, P114, DOI 10.1159/000077835; Ksiaa Cheikh Rouhou Leila, 2011, Arab J Nephrol Transplant, V4, P117; Kusano F, 2000, LAB INVEST, V80, P415, DOI 10.1038/labinvest.3780046; Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062; Li M, 2005, AIDS RES HUM RETROV, V21, P111, DOI 10.1089/aid.2005.21.111; Macias J, 2011, CURR OPIN HIV AIDS, V6, P491, DOI 10.1097/COH.0b013e32834bca2d; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Malhotra R, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-22; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nguyen GT, 1999, J ACQ IMMUN DEF SYND, V22, P75, DOI 10.1097/00042560-199909010-00010; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Promrat K, 2003, GASTROENTEROLOGY, V124, P352, DOI 10.1053/gast.2003.50061; Ruiz-Ferrer M, 2004, J VIRAL HEPATITIS, V11, P319, DOI 10.1111/j.1365-2893.2004.00510.x; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Shields PL, 1999, J IMMUNOL, V163, P6236; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Solari R, 1997, J BIOL CHEM, V272, P9617; Soo HM, 2002, VIROLOGY, V303, P253, DOI 10.1006/viro.2002.1617; Thoelen I, 2005, VIRAL IMMUNOL, V18, P232, DOI 10.1089/vim.2005.18.232; Walsh N, 2012, CURR OPIN HIV AIDS, V7, P339, DOI 10.1097/COH.0b013e328354131e; Woitas RP, 2002, GASTROENTEROLOGY, V122, P1721, DOI 10.1053/gast.2002.33660; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zetterberg V, 2004, AIDS RES HUM RETROV, V20, P1148, DOI 10.1089/aid.2004.20.1148; Zhang MD, 2003, GASTROENTEROLOGY, V124, P867, DOI 10.1053/gast.2003.50132	42	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70561	10.1371/journal.pone.0070561	http://dx.doi.org/10.1371/journal.pone.0070561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936229	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300109
J	Michaud, V; Randriamparany, T; Albina, E				Michaud, Vincent; Randriamparany, Tantely; Albina, Emmanuel			Comprehensive Phylogenetic Reconstructions of African Swine Fever Virus: Proposal for a New Classification and Molecular Dating of the Virus	PLOS ONE			English	Article							DNA-SEQUENCES; RATES; GENE; RECOMBINATION; TRANSMISSION; PROTEIN; P72; MITOCHONDRIAL; EPIDEMIOLOGY; DIVERSITY	African swine fever (ASF) is a highly lethal disease of domestic pigs caused by the only known DNA arbovirus. It was first described in Kenya in 1921 and since then many isolates have been collected worldwide. However, although several phylogenetic studies have been carried out to understand the relationships between the isolates, no molecular dating analyses have been achieved so far. In this paper, comprehensive phylogenetic reconstructions were made using newly generated, publicly available sequences of hundreds of ASFV isolates from the past 70 years. Analyses focused on B646L, CP204L, and E183L genes from 356, 251, and 123 isolates, respectively. Phylogenetic analyses were achieved using maximum likelihood and Bayesian coalescence methods. A new lineage-based nomenclature is proposed to designate 35 different clusters. In addition, dating of ASFV origin was carried out from the molecular data sets. To avoid bias, diversity due to positive selection or recombination events was neutralized. The molecular clock analyses revealed that ASFV strains currently circulating have evolved over 300 years, with a time to the most recent common ancestor (TMRCA) in the early 18th century.	[Michaud, Vincent; Albina, Emmanuel] CIRAD, UMR CMAEE, Montpellier, France; [Albina, Emmanuel] CIRAD, UMR CMAEE, Petit Bourg, Guadeloupe, France; [Michaud, Vincent] INRA, CMAEE UMR1309, F-34060 Montpellier, France; [Randriamparany, Tantely] Lab Natl Diagnost Vet, Antananarivo, Madagascar	CIRAD; CIRAD; INRAE	Michaud, V (corresponding author), CIRAD, UMR CMAEE, Montpellier, France.	vincent.michaud@cirad.fr		Albina, Emmanuel/0000-0002-6613-3047; RANDRIAMPARANY, Tantely/0000-0002-4829-4146	Wellcome Trust [210183. 183, AHDW/03/04]; European Community's Seventh Framework Programme [KBBE- 211691- ASFRISK, KBBE - 311931 - ASForce]; European Union through the Network of Excellence EPIZONE [FOOD-CT-2006-016236]	Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme(European Commission); European Union through the Network of Excellence EPIZONE	This work was financially supported by the Wellcome Trust (No210183. 183, AHDW/03/04)(http://www.wellcome.ac.uk/) and the European Community's Seventh Framework Programme (FP7/2007-2013) (http://cordis.europa.eu/fp7/home_en.html) under grant agreement KBBE- 211691- ASFRISK, partially funded by the European Community's Seventh Framework Programme (FP7/2012-2015) (http://cordis.europa.eu/projects/rcn/105070_en.html) under grant agreement KBBE - 311931 - ASForce, and also partially funded by the European Union through the Network of Excellence EPIZONE (number FOOD-CT-2006-016236)(http://www.epizone-eu.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bastos ADS, 2003, ARCH VIROL, V148, P693, DOI 10.1007/s00705-002-0946-8; BLASCO R, 1989, VIROLOGY, V168, P330, DOI 10.1016/0042-6822(89)90273-0; BLASCO R, 1989, VIROLOGY, V173, P251, DOI 10.1016/0042-6822(89)90241-9; Blench RM, 1999, ORIGINS DEV AFRICAN, P335; Boshoff CI, 2007, VET MICROBIOL, V121, P45, DOI 10.1016/j.vetmic.2006.11.007; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Delaroque N, 2000, VIROLOGY, V269, P148, DOI 10.1006/viro.2000.0225; Dixon L.K., 2005, VIRUS TAXONOMY, P135, DOI DOI 10.1186/1743-422X-2-64; DIXON LK, 1988, J GEN VIROL, V69, P2981, DOI 10.1099/0022-1317-69-12-2981; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Gallardo C, 2009, VIRUS GENES, V38, P85, DOI 10.1007/s11262-008-0293-2; Garcel A, 2007, J GEN VIROL, V88, P1906, DOI 10.1099/vir.0.82708-0; Giammarioli M, 2011, VIRUS GENES, V42, P377, DOI 10.1007/s11262-011-0587-7; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Gonzague M, 2001, EPIDEMIOL INFECT, V126, P453, DOI 10.1017/S0950268801005465; Gulenkin VM, 2011, PREV VET MED, V102, P167, DOI 10.1016/j.prevetmed.2011.07.004; Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Hernaez B, 2008, FEBS LETT, V582, P3275, DOI 10.1016/j.febslet.2008.08.031; HESS WR, 1989, J MED ENTOMOL, V26, P314, DOI 10.1093/jmedent/26.4.314; Holmes EC, 2007, CURR TOP MICROBIOL, V315, P51; Holmes EC, 2004, MOL ECOL, V13, P745, DOI 10.1046/j.1365-294X.2003.02051.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2010, INFECT GENET EVOL, V10, P50, DOI 10.1016/j.meegid.2009.10.001; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kusimba CM, 2000, HINTERLANDS CITIES A, V606005, P13; Levathes LE, 1994, CHINA RULED SEAS TRE, P1405; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lubisi BA, 2005, ARCH VIROL, V150, P2439, DOI 10.1007/s00705-005-0602-1; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Misinzo G, 2011, TRANSBOUND EMERG DIS, V58, P86, DOI 10.1111/j.1865-1682.2010.01177.x; MONTGOMERY R. Eustace, 1921, Journal of Comparative Pathology and Therapeutics, V34, P159; Neilan JG, 2004, VIROLOGY, V319, P337, DOI 10.1016/j.virol.2003.11.011; Nix RJ, 2006, ARCH VIROL, V151, P2475, DOI 10.1007/s00705-006-0794-z; Ogata H, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-178; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Penrith M. L., 2004, Infectious diseases of livestock. Volume Two, P1088; Penrith ML, 2009, J S AFR VET ASSOC, V80, P58; PLOWRIGH.W, 1974, RES VET SCI, V17, P106, DOI 10.1016/S0034-5288(18)33716-0; Plowright W., 1977, Agricultural research seminar on hog cholera/classical swine fever and African swine fever, held at the Tierarztliche Hochschule, Hannover, September 6-11, 1976., P575; Plug I, 2001, TRANSVAAL MUSEUM MON, V13; Rambaut A., 2003, TRACER COMPUTER PROG; Ramirez O, 2009, MOL BIOL EVOL, V26, P2061, DOI 10.1093/molbev/msp118; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowlands RJ, 2008, EMERG INFECT DIS, V14, P1870, DOI 10.3201/eid1412.080591; SCHNITZLER P, 1991, VIROLOGY, V182, P835, DOI 10.1016/0042-6822(91)90625-L; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SMITH JM, 1992, J MOL EVOL, V34, P126; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; SUN HC, 1995, J GEN VIROL, V76, P1117, DOI 10.1099/0022-1317-76-5-1117; Swart H, 2010, S AFR J ANIM SCI, V40, P121; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tidona CA, 1998, VIRUS GENES, V16, P59, DOI 10.1023/A:1007949710031; WESLEY RD, 1984, PREV VET MED, V2, P53, DOI 10.1016/0167-5877(84)90048-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zsak L, 2005, J CLIN MICROBIOL, V43, P112, DOI 10.1128/JCM.43.1.112-119.2005; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	70	41	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69662	10.1371/journal.pone.0069662	http://dx.doi.org/10.1371/journal.pone.0069662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936068	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300058
J	Do, JL; Bonni, A; Tuszynski, MH				Do, Jiun L.; Bonni, Azad; Tuszynski, Mark H.			SnoN Facilitates Axonal Regeneration after Spinal Cord Injury	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; IN-VIVO; GROWTH; MORPHOGENESIS; NEURONS; PATHWAY; CELLS; GENE; SKI; DEGRADATION	Adult CNS neurons exhibit a reduced capacity for growth compared to developing neurons, due in part to downregulation of growth-associated genes as development is completed. We tested the hypothesis that SnoN, an embryonically regulated transcription factor that specifies growth of the axonal compartment, can enhance growth in injured adult neurons. In vitro, SnoN overexpression in dissociated adult DRG neuronal cultures significantly enhanced neurite outgrowth. Moreover, TGF-beta 1, a negative regulator of SnoN, inhibited neurite outgrowth, and SnoN over-expression overcame this inhibition. We then examined whether SnoN influenced axonal regeneration in vivo: indeed, expression of a mutant form of SnoN resistant to degradation significantly enhanced axonal regeneration following cervical spinal cord injury, despite peri-lesional upregulation of TGF-beta 1. Thus, a developmental mechanism that specifies extension of the axonal compartment also promotes axonal regeneration after adult CNS injury.	[Do, Jiun L.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tuszynski, Mark H.] Vet Affairs Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	mtuszynski@ucsd.edu		Do, Jiun/0000-0003-4768-0624	Veterans Administration; NIH [NS42291]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042291, R01NS041021] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Veterans Administration, NIH (NS42291), and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bonni S, 2012, FEBS LETT, V586, P1977, DOI 10.1016/j.febslet.2012.02.048; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hollis ER, 2010, MOL THER, V18, P1496, DOI 10.1038/mt.2010.97; Ikeuchi Y, 2009, J NEUROSCI, V29, P4312, DOI 10.1523/JNEUROSCI.0126-09.2009; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Low K, 2010, GENE THER, V17, P577, DOI 10.1038/gt.2010.14; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Moore DL, 2011, DEV NEUROBIOL, V71, P1186, DOI 10.1002/dneu.20934; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Tessier-Lavigne Marc, 2002, Harvey Lect, V98, P103; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Yu PP, 2011, EXP NEUROL, V231, P38, DOI 10.1016/j.expneurol.2011.05.013; Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71906	10.1371/journal.pone.0071906	http://dx.doi.org/10.1371/journal.pone.0071906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936531	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800070
J	Hu, XL; Yang, R; Zhang, X; Chen, L; Xiang, XW; Gong, CL; Wu, XF				Hu, Xiaolong; Yang, Rui; Zhang, Xing; Chen, Lin; Xiang, Xingwei; Gong, Chengliang; Wu, Xiaofeng			Molecular Cloning and Functional Characterization of the Dual Oxidase (BmDuox) Gene from the Silkworm Bombyx mori	PLOS ONE			English	Article							NADPH OXIDASE; SWISS-MODEL; NOX/DUOX FAMILY; INNATE IMMUNITY; NOX ENZYMES; PROTEIN; EXPRESSION; HOMOLOGY; HYPERTENSION; ENVIRONMENT	Reactive oxygen species (ROS) from nicotinamide adenine dinucleotide phosphate (NADPH) oxidases and their related dual oxidases are known to have significant roles in innate immunity and cell proliferation. In this study, the 5,545 bp cDNA of the silkworm Bombyx mori dual oxidase (BmDuox) gene containing a full-length open reading frame was cloned. It was shown to include an N-terminal signal peptide consisting of 28 amino acid residues, a 240 bp 5'-terminal untranslated region (5'-UTR), an 802 bp 3'-terminal region (3'-UTR), which contains nine ATTTA motifs, and a 4,503 bp open reading frame encoding a polypeptide of 1,500 amino acid residues. Structural analysis indicated that BmDuox contains a typical peroxidase domain at the N-terminus followed by a calcium-binding domain, a ferric-reducing domain, six transmembrane regions and binding domains for flavin adenine dinucleotide (FAD) and nicotinamide adenine dinucleotide (NAD). Transcriptional analysis revealed that BmDuox mRNA was expressed more highly in the head, testis and trachea compared to the midgut, hemocyte, Malpighian tube, ovary, fat bodies and silk glands. BmDuox mRNA was expressed during all the developmental stages of the silkworm. Subcellular localization revealed that BmDoux was present mainly in the periphery of the cells. Some cytoplasmic staining was detected, with rare signals in the nucleus. Expression of BmDuox was induced significantly in the larval midgut upon challenge by Escherichia coli and Bombyx mori nucleopolyhedrovirus (BmNPV). BmDuox-deleted larvae showed a marked increase in microbial proliferation in the midgut after ingestion of fluorescence-labeled bacteria compared to the control. We conclude that reducing BmDuox expression greatly increased the bacterial load, suggesting BmDuox has an important role in inhibiting microbial proliferation and the maintenance of homeostasis in the silkworm midgut.	[Hu, Xiaolong; Yang, Rui; Chen, Lin; Xiang, Xingwei; Wu, Xiaofeng] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xing] Zhejiang Univ, Inst Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Gong, Chengliang] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou, Peoples R China	Zhejiang University; Zhejiang University; Soochow University - China	Wu, XF (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	wuxiaofeng@zju.edu.cn			National Basic Research Program of China [2012CB114600]; Natural Scientific Foundation of China [31272506]	National Basic Research Program of China(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (Grant No. 2012CB114600) and Natural Scientific Foundation of China (31272506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Boots AW, 2009, J BIOL CHEM, V284, P17858, DOI 10.1074/jbc.M809761200; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chiu HJ, 2001, STRUCTURE, V9, P311, DOI 10.1016/S0969-2126(01)00589-5; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Flores MV, 2010, BIOCHEM BIOPH RES CO, V400, P164, DOI 10.1016/j.bbrc.2010.08.037; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Inada M, 2012, MOL CELL PROBE, V26, P29, DOI 10.1016/j.mcp.2011.11.002; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Keller A, 2004, FREE RADICAL RES, V38, P1257, DOI 10.1080/10715760400022145; Kiss PJ, 2006, CURR BIOL, V16, P208, DOI 10.1016/j.cub.2005.12.025; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li YM, 2010, BIOCHEM BIOPH RES CO, V391, P1427, DOI 10.1016/j.bbrc.2009.12.082; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; NEWBURGER PE, 1991, J BIOL CHEM, V266, P16171; Nguyen TTA, 2011, J BIOL CHEM, V286, P33244, DOI 10.1074/jbc.M111.263178; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Rigutto S, 2009, J BIOL CHEM, V284, P6725, DOI 10.1074/jbc.M806893200; Ritsick DR, 2007, FREE RADICAL BIO MED, V43, P31, DOI 10.1016/j.freeradbiomed.2007.03.006; Ritsick DR, 2004, BIOCHEM SOC SYMP, V71, P85; Rokutan K, 2008, SEMIN IMMUNOPATHOL, V30, P315, DOI 10.1007/s00281-008-0124-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Zhao Y, 2009, SCI CHINA SER C, V52, P1131, DOI 10.1007/s11427-009-0148-7	44	11	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70118	10.1371/journal.pone.0070118	http://dx.doi.org/10.1371/journal.pone.0070118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936382	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800036
J	Slater, BJ; McLoughlin, S; Hilton, J				Slater, Ben J.; McLoughlin, Stephen; Hilton, Jason			Peronosporomycetes (Oomycota) from a Middle Permian Permineralised Peat within the Bainmedart Coal Measures, Prince Charles Mountains, Antarctica	PLOS ONE			English	Article							REVISED STRATIGRAPHY; FOSSIL RECORD; SP NOV.; EXTINCTION; RECOVERY; PLANT; GEN.; SAPROLEGNIACEAE; LEPIDODENDRON; VEGETATION	The fossil record of Peronosporomycetes (water moulds) is rather sparse, though their distinctive ornamentation means they are probably better reported than some true fungal groups. Here we describe a rare Palaeozoic occurrence of this group from a Guadalupian (Middle Permian) silicified peat deposit in the Bainmedart Coal Measures, Prince Charles Mountains, Antarctica. Specimens are numerous and comprise two morphologically distinct kinds of ornamented oogonia, of which some are attached to hyphae by a septum. Combresomyces caespitosus sp. nov. consists of spherical oogonia bearing densely spaced, long, hollow, slender, conical papillae with multiple sharply pointed, strongly divergent, apical branches that commonly form a pseudoreticulate pattern under optical microscopy. The oogonia are attached to a parental hypha by a short truncated stalk with a single septum. Combresomyces rarus sp. nov. consists of spherical oogonia bearing widely spaced, hollow, broad, conical papillae that terminate in a single bifurcation producing a pair of acutely divergent sharply pointed branches. The oogonium bears a short truncate extension where it attaches to the parental hypha. We propose that similarities in oogonium shape, size, spine morphology and hyphal attachment between the Permian forms from the Prince Charles Mountains and other reported Peronosporomycetes from Devonian to Triassic strata at widely separated localities elsewhere in the world delimit an extinct but once cosmopolitan Palaeozoic to early Mesozoic branch of the peronosporomycete clade. We name this order Combresomycetales and note that it played an important role in late Palaeozoic and early Mesozoic peatland ecosystems worldwide.	[Slater, Ben J.; Hilton, Jason] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [McLoughlin, Stephen] Swedish Museum Nat Hist, Dept Paleobiol, S-10405 Stockholm, Sweden	University of Birmingham; Swedish Museum of Natural History	Slater, BJ (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	bxs574@bham.ac.uk	Hilton, Jason/F-5830-2012	Hilton, Jason/0000-0003-0286-8236; Slater, Ben/0000-0002-5774-9114	Australian Antarctic Division via Antarctic Science Advisory Council [509]; Natural Environment Research Council [NE/H5250381/1]; EU [SE-TAF-4827]; Swedish Research Council (VR); Australian Research Council	Australian Antarctic Division via Antarctic Science Advisory Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); Swedish Research Council (VR)(Swedish Research Council); Australian Research Council(Australian Research Council)	The Australian Antarctic Division provided financial and logistical support for collection of the specimens via Antarctic Science Advisory Council Project 509. This research forms part of a doctoral investigation by BJS supported by the Natural Environment Research Council (NE/H5250381/1 to BJS) and the Synthesys program of the EU to support research on museum collections (SE-TAF-4827 to BJS). SM acknowledges funding support from the Swedish Research Council (VR) and the Australian Research Council (Linkage) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www.nerc.ac.uk/; http://www.synthesys.info/; http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; http://www.arc.gov.au/)	Adl S, 2011, SOIL BIOL BIOCHEM, V43, P726, DOI 10.1016/j.soilbio.2010.12.003; Baptista Filipe R., 2004, Braz. J. Bot., V27, P281, DOI 10.1590/S0100-84042004000200008; Bary De, 1863, ANN SCI NAT BOT BIOL, V20, P5; BEAKES GW, 1995, CAN J BOT, V73, pS701, DOI 10.1139/b95-313; BHATTACHARYA D, 1991, J MOL EVOL, V33, P525, DOI 10.1007/BF02102805; Bhattacharya Debashish, 2009, P116; Blakey R, 2012, RECONSTRUCTING ANCIE; BRIGGS DEG, 1990, PALEOBIOLOGY, V16, P204, DOI 10.1017/S009483730000988X; Brozova Jana, 2002, Plant Protection Science, V38, P29; Cavalier-Smith T., 1986, Progress phycol. Res., V4, P309; Christensen CM, 1951, MOLDS MAN INTRO FUNG; COOK KL, 2001, NOVA HEDWIGIA, V122, P231; David JC, 2002, CONSTANCEA, V83; de Bary HA., 1860, JB WISS BOT, V2, P169; Dell B, 2005, FOREST CONSCIOUSNESS, P391; DICK MW, 1995, CAN J BOT, V73, pS712, DOI 10.1139/b95-314; Dick MW, 2001, MYCOTA, V7, P39; Dick MW, 1999, MYCOL RES, V103, P1119, DOI 10.1017/S0953756299008643; Dick MW, 2001, STRAMINIPILOUS FUNGI; Dieguez-Uribeondo J, 2009, FUNGAL GENET BIOL, V46, P365, DOI 10.1016/j.fgb.2009.02.004; Dotzler N, 2008, MYCOL RES, V112, P1107, DOI 10.1016/j.mycres.2008.03.003; Drechsler C, 1946, PHYTOPATHOLOGY, V33, P285; Erwin D. H., 2006, EXTINCTION LIFE EART; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Fedorov L.V., 1982, ANTARCTIC GEOSCI, P73; Fielding CR, 1996, SEDIMENTOLOGY, V43, P295, DOI 10.1046/j.1365-3091.1996.d01-6.x; Massini JG, 2012, PALAIOS, V27, P55, DOI 10.2110/palo.2011.p11-076r; Grunwald NJ, 2008, MOL PLANT PATHOL, V9, P729, DOI [10.1111/j.1364-3703.2008.00500.x, 10.1111/J.1364-3703.2008.00500.X]; Grunwald NJ, 2012, CAN J PLANT PATHOL, V34, P13, DOI 10.1080/07060661.2012.664568; HALLETT IC, 1986, T BRIT MYCOL SOC, V86, P457, DOI 10.1016/S0007-1536(86)80189-9; Harrowfield M, 2005, GEOLOGY, V33, P197, DOI 10.1130/G21081.1; Hemsley AR, 2004, REV PALAEOBOT PALYNO, V130, P105, DOI 10.1016/j.revpalbo.2003.12.004; Heungens K, 2000, APPL ENVIRON MICROB, V66, P5192, DOI 10.1128/AEM.66.12.5192-5200.2000; Holdgate GR, 2005, INT J COAL GEOL, V63, P156, DOI 10.1016/j.coal.2005.02.011; Jobard M, 2010, AQUAT SCI, V72, P255, DOI 10.1007/s00027-010-0133-z; Krings M, 2007, CR PALEVOL, V6, P431, DOI 10.1016/j.crpv.2007.09.008; Krings M, 2012, J PALEONTOL, V86, P358, DOI 10.1666/11-087.1; Krings M, 2011, REV PALAEOBOT PALYNO, V168, P1, DOI 10.1016/j.revpalbo.2011.09.001; Krings M, 2011, MYCOLOGIA, V103, P445, DOI 10.3852/10-278; Krings M, 2010, FUNGAL BIOL-UK, V114, P446, DOI 10.1016/j.funbio.2010.03.006; Krings M, 2010, CR PALEVOL, V9, P5, DOI 10.1016/j.crpv.2009.10.002; Krings Michael, 2009, Zitteliana Reihe A, V48-49, P171; Lindstrom S, 2007, REV PALAEOBOT PALYNO, V145, P89, DOI 10.1016/j.revpalbo.2006.09.002; McLoughlin S, 1997, GEOL MAG, V134, P781, DOI 10.1017/S0016756897007528; McLoughlin S, 1997, ANTARCT SCI, V9, P281, DOI 10.1017/S0954102097000370; McLoughlin S, 1996, REV PALAEOBOT PALYNO, V92, P207, DOI 10.1016/0034-6667(96)00134-0; McLoughlin S, 1997, GEOL MAG, V134, P335, DOI 10.1017/S0016756897006870; Mostowfizadeh-Ghalamfarsa R, 2010, FUNGAL BIOL-UK, V114, P325, DOI 10.1016/j.funbio.2010.02.001; Paul B, 1999, FEMS MICROBIOL LETT, V173, P69, DOI 10.1111/j.1574-6968.1999.tb13486.x; Petersen AB, 2000, MYCOL RES, V104, P1295, DOI 10.1017/S0953756200003075; Phillips AJ, 2008, TRENDS MICROBIOL, V16, P13, DOI 10.1016/j.tim.2007.10.013; PIROZYNSKI KA, 1976, ANNU REV PHYTOPATHOL, V14, P237, DOI 10.1146/annurev.py.14.090176.001321; PIROZYNSKI KA, 1976, BIOL MEMOIRS, V11, P104; Poinar GO., 1992, LIFE AMBER; Porter Susannah M., 2006, V27, P1; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; Schmidt AR, 2008, AM J BOT, V95, P1328, DOI 10.3732/ajb.0800143; Schmidt AR, 2004, PALAEONTOLOGY, V47, P185, DOI 10.1111/j.0031-0239.2004.00368.x; SCHOPF JM, 1970, SCIENCE, V169, P274, DOI 10.1126/science.169.3942.274; Schwendemann AB, 2009, REV PALAEOBOT PALYNO, V154, P1, DOI 10.1016/j.revpalbo.2008.11.003; SCOTESE CR, 1997, 900497 U TEX DEP GEO; Slater BJ, 2012, PALAEOGEOGR PALAEOCL, V363, P109, DOI 10.1016/j.palaeo.2012.08.018; Slater BJ, 2011, REV PALAEOBOT PALYNO, V167, P140, DOI 10.1016/j.revpalbo.2011.07.007; Spring O, 2004, PLANTA, V219, P910, DOI 10.1007/s00425-004-1341-3; STAGG HMJ, 1985, TECTONOPHYSICS, V114, P315, DOI 10.1016/0040-1951(85)90019-8; Strullu-Derrien C, 2011, P ROY SOC B-BIOL SCI, V278, P675, DOI 10.1098/rspb.2010.1603; Taylor TN, 2006, MYCOL RES, V110, P628, DOI 10.1016/j.mycres.2006.02.009; Taylor TN, 2011, PALAIOS, V26, P239, DOI 10.2110/palo.2010.p10-131r; Vajda V, 2007, REV PALAEOBOT PALYNO, V144, P99, DOI 10.1016/j.revpalbo.2005.09.007; Veevers JJ, 2004, EARTH-SCI REV, V68, P1, DOI 10.1016/j.earscirev.2004.05.002; VONBROEMBSEN SL, 1985, PLANT DIS, V69, P715, DOI 10.1094/PD-69-715; Willamson W.C., 1878, PHILOS T ROY SOC LON, V169, P319, DOI DOI 10.1098/RSTL.1878.0010; Williamson W. C., 1883, PHIL T ROY SOC LON B, V174, P459; Williamson WC., 1980, PHILOS T ROYAL SOC L, V171, P493, DOI DOI 10.1098/RSTL.1880.0014; Womack T, 2012, PALAEOGEOGR PALAEOCL, V344, P39, DOI 10.1016/j.palaeo.2012.05.012	75	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70707	10.1371/journal.pone.0070707	http://dx.doi.org/10.1371/journal.pone.0070707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936465	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800049
J	Behr, B; Longaker, MT; Quarto, N				Behr, Bjoern; Longaker, Michael T.; Quarto, Natalina			Absence of Endochondral Ossification and Craniosynostosis in Posterior Frontal Cranial Sutures of Axin2(-/-) Mice	PLOS ONE			English	Article							NEGATIVE REGULATOR; SIGNALING PATHWAY; NEURAL CREST; SOX9; GROWTH; WNT; CHONDROCYTES; CARTILAGE; CELLS; FATE	During the first month of life, the murine posterior-frontal suture (PF) of the cranial vault closes through endochondral ossification, while other sutures remain patent. These processes are tightly regulated by canonical Wnt signaling. Low levels of active canonical Wnt signaling enable endochondral ossification and therefore PF-suture closure, whereas constitutive activation of canonical Wnt causes PF-suture patency. We therefore sought to test this concept with a knockout mouse model. PF-sutures of Axin2(-/-) mice, which resemble a state of constantly activated canonical Wnt signaling, were investigated during the physiological time course of PF-suture closure and compared in detail with wild type littermates. Histological analysis revealed that the architecture in Axin2(-/-) PF-sutures was significantly altered in comparison to wild type. The distance between the endocranial layers was dramatically increased and suture closure was significantly delayed. Moreover, physiological endochondral ossification did not occur, rather an ectopic cartilage appeared between the endocranial and ectocranial bone layers at P7 which eventually involutes at P13. Quantitative PCR analysis showed the lack of Col10 alpha 1 upregulation in Axin2(-/-) PF-suture. Immunohistochemistry and gene expression analysis also revealed high levels of type II collagen as compared to type I collagen and absence of Mmp-9 in the cartilage of Axin2(-/-) PF-suture. Moreover, TUNEL staining showed a high percentage of apoptotic chondrocytes in Axin2(-/-) PF-sutures at P9 and P11 as compared to wild type. These data indicated that Axin2(-/-) PF-sutures lack physiological endochondral ossification, contain ectopic cartilage and display delayed suture closure.	[Behr, Bjoern; Longaker, Michael T.; Quarto, Natalina] Stanford Univ, Sch Med, Dept Surg, Hagey Lab, Stanford, CA 94305 USA; [Behr, Bjoern] Ruhr Univ Bochum, Bergmannsheil, BG Univ Hosp, Dept Plast & Hand Surg,Burn Ctr, Bochum, Germany; [Quarto, Natalina] Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy	Stanford University; Ruhr University Bochum; University of Naples Federico II	Quarto, N (corresponding author), Stanford Univ, Sch Med, Dept Surg, Hagey Lab, Stanford, CA 94305 USA.	quarto@unina.it	Behr, Björn/AAS-1877-2021		Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIH [R21DE019274]; German Research Foundation [DFG BE 4169-1]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019274] Funding Source: NIH RePORTER	Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Oak Foundation, the Hagey Laboratory for Pediatric Regenerative Medicine, NIH R21DE019274 to MTL and the German Research Foundation (DFG BE 4169-1) to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Behr B, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00037; Behr B, 2010, DEV BIOL, V344, P922, DOI 10.1016/j.ydbio.2010.06.009; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Jepsen KJ, 2001, J BONE MINER RES, V16, P1854, DOI 10.1359/jbmr.2001.16.10.1854; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; MOSS ML, 1958, AM J ANAT, V102, P141, DOI 10.1002/aja.1001020107; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Sahar DE, 2005, DEV BIOL, V280, P344, DOI 10.1016/j.ydbio.2005.01.022; Slater BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003914; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786	24	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70240	10.1371/journal.pone.0070240	http://dx.doi.org/10.1371/journal.pone.0070240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936395	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400045
J	Benjamin, R; Banerjee, A; Sunder, SR; Gaddam, S; Valluri, VL; Banerjee, S				Benjamin, Ronald; Banerjee, Atoshi; Sunder, Sharada Ramaseri; Gaddam, Sumanlatha; Valluri, Vijaya Lakshmi; Banerjee, Sharmistha			Discordance in CD4+T-Cell Levels and Viral Loads with Co-Occurrence of Elevated Peripheral TNF-alpha and IL-4 in Newly Diagnosed HIV-TB Co-Infected Cases	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RECONSTITUTION INFLAMMATORY SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; CD4(+) LYMPHOCYTES; VIRUS-INFECTION; INTERFERON; CYTOKINE; DISEASE	Background: Cytokines are the hallmark of immune response to different pathogens and often dictate the disease outcome. HIV infection and tuberculosis (TB) are more destructive when confronted together than either alone. Clinical data related to the immune status of HIV-TB patients before the initiation of any drug therapy is not well documented. This study aimed to collect the baseline information pertaining to the immune status of HIV-TB co-infected patients and correlate the same with CD4+T cell levels and viral loads at the time of diagnosis prior to any drug therapy. Methodology/Principal Findings: We analyzed the cytokines, CD4+T cell levels and viral loads to determine the immune environment in HIV-TB co-infection. The study involved four categories namely, Healthy controls (n = 57), TB infected (n = 57), HIV infected (n = 59) and HIV-TB co-infected (n = 57) patients. The multi-partite comparison and correlation between cytokines, CD4+T-cell levels and viral loads prior to drug therapy, showed an altered TH1 and TH2 response, as indicated by the cytokine profiles and skewed IFN-gamma/IL-10 ratio. Inadequate CD4+T cell counts in HIV-TB patients did not correlate with high viral loads and vice-versa. When compared to HIV category, 34% of HIV-TB patients had concurrent high plasma levels of IL-4 and TNF-alpha at the time of diagnosis. TB relapse was observed in 5 of these HIV-TB co-infected patients who also displayed high IFN-gamma/IL-10 ratio. Conclusion/Significance: With these studies, we infer (i) CD4+T-cell levels as baseline criteria to report the disease progression in terms of viral load in HIV-TB co-infected patients can be misleading and (ii) co-occurrence of high TNF-alpha and IL-4 levels along with a high ratio of IFN-gamma/IL-10, prior to drug therapy, may increase the susceptibility of HIV-TB co-infected patients to hyper-inflammation and TB relapse.	[Benjamin, Ronald; Banerjee, Atoshi; Banerjee, Sharmistha] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Sunder, Sharada Ramaseri; Valluri, Vijaya Lakshmi] Blue Peter Publ Hlth & Res Ctr, LEPRA India, Immunol Mol Biol & Biochem Div, Hyderabad, Andhra Pradesh, India; [Gaddam, Sumanlatha] Bhagawan Mahavir Med Res Ctr, Dept Immunol, Hyderabad, Andhra Pradesh, India	University of Hyderabad	Banerjee, S (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	sbanerjee.uohyd@gmail.com	Banerjee, Atoshi/AAU-9256-2020; Valluri, Vijaya Lakshmi/S-9219-2019; Babu, Ronald/AAT-6101-2020; Banerjee, Atoshi/M-6404-2018	Banerjee, Atoshi/0000-0002-3134-1268; Babu, Ronald/0000-0003-2622-9359; Banerjee, Atoshi/0000-0002-3134-1268	Department of Biotechnology [DBT-RGYI: BT/PR10303/GBD/27/74/2007, DBT-CoE: BT/01/COE/07/02]; Council of Scientific and Industrial Research; United Grants Commission	Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); United Grants Commission	This study was supported by grants from Department of Biotechnology (http://dbtindia.nic.in/index.asp) (DBT-RGYI: BT/PR10303/GBD/27/74/2007; DBT-CoE: BT/01/COE/07/02) to SB. AB and RB are funded by research fellowship from Council of Scientific and Industrial Research and United Grants Commission, respectively. Infrastructure support by DBT-CREB and DST-PURSE to the Department of Biochemistry and School of Life Sciences, University of Hyderabad is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aska AI, 2011, EUR J MED RES, V16, P285, DOI 10.1186/2047-783X-16-6-285; BARNES PF, 1990, J IMMUNOL, V145, P149; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bordon J, 2011, CYTOKINE, V56, P325, DOI 10.1016/j.cyto.2011.08.018; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Elser B, 2002, IMMUNITY, V17, P703, DOI 10.1016/S1074-7613(02)00471-5; Fenhalls G, 2000, INFECT IMMUN, V68, P2827, DOI 10.1128/IAI.68.5.2827-2836.2000; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Herbein G, 2010, RETROVIROLOGY, V7, P33; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; Hulgan T, 2007, J INFECT DIS, V195, P425, DOI 10.1086/510536; Jung AC, 1998, J GEN INTERN MED, V13, P131, DOI 10.1046/j.1525-1497.1998.00031.x; Lin PL, 2007, J INVEST DERM SYMP P, V12, P22, DOI 10.1038/sj.jidsymp.5650027; Louis S, 2010, J LEUKOCYTE BIOL, V87, P645, DOI 10.1189/jlb.1009684; Mariani F., 2001, Current Molecular Medicine (Hilversum), V1, P209, DOI 10.2174/1566524013363933; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mojtahedi Z, 2012, MED HYPOTHESES, V78, P776, DOI 10.1016/j.mehy.2012.03.003; Nakata K, 1997, AM J RESP CRIT CARE, V155, P996, DOI 10.1164/ajrccm.155.3.9117038; OSWALD IP, 1992, J IMMUNOL, V148, P3578; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Rook GAW, 2007, CURR MOL MED, V7, P327; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Schluger NW, 1998, AM J RESP CRIT CARE, V157, P679, DOI 10.1164/ajrccm.157.3.9708002; Sharma SK, 2011, INDIAN J MED RES, V134, P866, DOI 10.4103/0971-5916.92632; Sharma SK, 2010, INDIAN J MED RES, V131, P804; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Skolimowska KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046481; Subramanyam S, 2004, J INTERF CYTOK RES, V24, P101, DOI 10.1089/107999004322813345; TAKASHIMA T, 1990, INFECT IMMUN, V58, P3286, DOI 10.1128/IAI.58.10.3286-3292.1990; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; van den Broek M, 2000, J IMMUNOL, V164, P371, DOI 10.4049/jimmunol.164.1.371; WEISSMAN D, 1994, AIDS RES HUM RETROV, V10, P1199, DOI 10.1089/aid.1994.10.1199; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542	35	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70250	10.1371/journal.pone.0070250	http://dx.doi.org/10.1371/journal.pone.0070250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936398	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400048
J	Hanauer, DA; Ramakrishnan, N; Seyfried, LS				Hanauer, David A.; Ramakrishnan, Naren; Seyfried, Lisa S.			Describing the Relationship between Cat Bites and Human Depression Using Data from an Electronic Health Record	PLOS ONE			English	Article							TOXOPLASMA-GONDII INFECTION; HUMAN SOCIAL SUPPORT; PET OWNERSHIP; RISK-FACTORS; UNITED-STATES; PRIMARY-CARE; EMERGENCY-DEPARTMENTS; PSYCHOLOGICAL HEALTH; COMPANION ANIMALS; DRUG-INTERACTIONS	Data mining approaches have been increasingly applied to the electronic health record and have led to the discovery of numerous clinical associations. Recent data mining studies have suggested a potential association between cat bites and human depression. To explore this possible association in more detail we first used administrative diagnosis codes to identify patients with either depression or bites, drawn from a population of 1.3 million patients. We then conducted a manual chart review in the electronic health record of all patients with a code for a bite to accurately determine which were from cats or dogs. Overall there were 750 patients with cat bites, 1,108 with dog bites, and approximately 117,000 patients with depression. Depression was found in 41.3% of patients with cat bites and 28.7% of those with dog bites. Furthermore, 85.5% of those with both cat bites and depression were women, compared to 64.5% of those with dog bites and depression. The probability of a woman being diagnosed with depression at some point in her life if she presented to our health system with a cat bite was 47.0%, compared to 24.2% of men presenting with a similar bite. The high proportion of depression in patients who had cat bites, especially among women, suggests that screening for depression could be appropriate in patients who present to a clinical provider with a cat bite. Additionally, while no causative link is known to explain this association, there is growing evidence to suggest that the relationship between cats and human mental illness, such as depression, warrants further investigation.	[Hanauer, David A.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Ramakrishnan, Naren] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Seyfried, Lisa S.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Virginia Polytechnic Institute & State University; University of Michigan System; University of Michigan	Hanauer, DA (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	hanauer@med.umich.edu			National Center for Advancing Translational Sciences of the National Institutes of Health [2UL1TR000433-06]; University of Michigan Cancer Center's (UMCC) Biomedical Informatics Core; National Institutes of Health through the UMCC Support Grant [CA46592]; US NSF Grant [CCF-0937133]; Direct For Computer & Info Scie & Enginr [0937133] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Michigan Cancer Center's (UMCC) Biomedical Informatics Core; National Institutes of Health through the UMCC Support Grant; US NSF Grant(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number 2UL1TR000433-06. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support for the EMERSE tool was provided by the University of Michigan Cancer Center's (UMCC) Biomedical Informatics Core with partial support from the National Institutes of Health through the UMCC Support Grant (CA46592). This research was also supported in part by US NSF Grant CCF-0937133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2001, HYPERTENSION, V38, P815, DOI 10.1161/hyp.38.4.815; Am. Vet. Med. Assoc, 2012, US PET OWN DEM SOURC; ANDERSON WP, 1992, MED J AUSTRALIA, V157, P298, DOI 10.5694/j.1326-5377.1992.tb137178.x; [Anonymous], 2004, PET ACC HEALTHC UK M; [Anonymous], 2012, FRONT PSYCHOL, DOI DOI 10.3389/FPSYG.2012.00234; [Anonymous], 2004, ITS OFF PURR PUSS CA; Antonacopoulos NMD, 2010, ANTHROZOOS, V23, P37, DOI 10.2752/175303710X12627079939143; Arhant-Sudhir K, 2011, CLIN EXP PHARMACOL P, V38, P734, DOI 10.1111/j.1440-1681.2011.05583.x; Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; Arroll B, 2005, ANN FAM MED, V3, P449, DOI 10.1370/afm.349; Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Barker SB, 2008, J VET MED EDUC, V35, P487, DOI 10.3138/jvme.35.4.487; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Blakeley K, 2009, FORBES; Botsis Taxiarchis, 2010, Summit Transl Bioinform, V2010, P1; Boyer K, 2011, CLIN INFECT DIS, V53, P1081, DOI 10.1093/cid/cir667; Bregman B, 2012, PUBLIC HEALTH REP, V127, P195, DOI 10.1177/003335491212700208; Carlsen KCL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043214; Chur-Hansen A, 2010, INT J EVID-BASED HEA, V8, P140, DOI 10.1111/j.1744-1609.2010.00176.x; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; Coyne JC, 2003, ANN INTERN MED, V138, P767, DOI 10.7326/0003-4819-138-9-200305060-00017; Culpepper L, 2012, CURR PSYCHIAT REP, V14, P345, DOI 10.1007/s11920-012-0275-x; Dahl Eilif, 1998, Tidsskrift for den Norske Laegeforening, V118, P2614; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Das AK, 2003, ANN INTERN MED, V138, P767, DOI 10.7326/0003-4819-138-9-200305060-00018; Dendle C, 2008, EMERG MED AUSTRALAS, V20, P458, DOI 10.1111/j.1742-6723.2008.01130.x; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Desai MM, 2006, MED CARE, V44, P175, DOI 10.1097/01.mlr.0000196962.97345.21; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Enmarker I, 2012, SCAND J PUBLIC HEALT, V40, P718, DOI 10.1177/1403494812465031; Esch KJ, 2013, CLIN MICROBIOL REV, V26, P58, DOI 10.1128/CMR.00067-12; Farmer A, 2002, BRIT J PSYCHIAT, V181, P118; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Foldes-Busque G, 2011, AM J EMERG MED, V29, P743, DOI 10.1016/j.ajem.2010.02.021; Fond G, 2013, ENCEPHALE, V39, P38, DOI 10.1016/j.encep.2012.06.014; Friedman C, 2012, INT J MED INFORM; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; FRIEDMANN E, 1995, AM J CARDIOL, V76, P1213, DOI 10.1016/S0002-9149(99)80343-9; Friedmann E, 2011, ANTHROZOOS, V24, P273, DOI 10.2752/175303711X13045914865268; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Goodwin D, 1997, GAZE MUTUAL GAZE ITS, P20; Gosling SD, 2010, ANTHROZOOS, V23, P213, DOI 10.2752/175303710X12750451258850; GRIEGO RD, 1995, J AM ACAD DERMATOL, V33, P1019, DOI 10.1016/0190-9622(95)90296-1; Groer MW, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.004; Hall P L, 2000, Br J Nurs, V9, P2220; Hanauer David A, 2006, AMIA Annu Symp Proc, P941; Hanauer DA, 2013, J AM MED INFORM ASSN, V20, P332, DOI 10.1136/amiajnl-2012-001117; Hanauer DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005203; Heath TJ, 2007, AUST VET J, V85, P290, DOI 10.1111/j.1751-0813.2007.00180.x; HEMSWORTH PH, 1986, APPL ANIM BEHAV SCI, V15, P45, DOI 10.1016/0168-1591(86)90021-3; Hickie IB, 2002, MED J AUSTRALIA, V177, pS111; Hills PJ, 2011, BRIT J PSYCHOL, V102, P260, DOI 10.1348/000712610X519314; HIRSCH AR, 1994, HEADACHE, V34, P542, DOI 10.1111/j.1526-4610.1994.hed3409542.x; Holmes AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021132; Hripcsak G, 2011, J BIOMED DISCOV COLL, V6, DOI 10.5210/disco.v6i0.3581; Huffman JC, 2003, PSYCHOSOMATICS, V44, P222, DOI 10.1176/appi.psy.44.3.222; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Jones JM, 2007, COMPANIONSHIP LOVE A; Kar N, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-1; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; KIDD AH, 1980, PSYCHOL REP, V46, P939, DOI 10.2466/pr0.1980.46.3.939; KIZER KW, 1979, JACEP-J AM COLL EMER, V8, P134, DOI 10.1016/S0361-1124(79)80339-1; Koivusilta LK, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000109; Koshgarian L, 2008, VET MED NEW ENGLAND; Kost Rhonda, 2012, AMIA Annu Symp Proc, V2012, P1284; Krause-Parello CA, 2012, GERIATR NURS, V33, P194, DOI 10.1016/j.gerinurse.2011.12.005; Lindsay DS, 1997, VET PARASITOL, V73, P27, DOI 10.1016/S0304-4017(97)00048-4; Ling VJ, 2011, J NERV MENT DIS, V199, P440, DOI 10.1097/NMD.0b013e318221416e; Lofstedt J, 2003, CAN VET J, V44, P533; MacBean CE, 2007, MED J AUSTRALIA, V186, P38, DOI 10.5694/j.1326-5377.2007.tb00787.x; Mack KA, 2004, J WOMENS HEALTH, V13, P754, DOI 10.1089/jwh.2004.13.754; Maradiegue AH, 2013, J PSYCHOSOC NURS MEN, V51, P27, DOI 10.3928/02793695-20130109-04; Marlin B. M., 2012, UNSUPERVISED PATTERN, P389; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matter HC, 1998, EUR J EPIDEMIOL, V14, P483, DOI 10.1023/A:1007460213308; Mayon-White R, 2005, BRIT MED J, V331, P1254, DOI 10.1136/bmj.331.7527.1254; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; McWilliams L, 2003, BRIT J PSYCHIAT, V182, P80, DOI 10.1192/bjp.182.1.80; Mertens C., 1989, Anthrozoos, V2, P83, DOI 10.2752/089279389787058109; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miman O, 2010, PSYCHIAT RES, V177, P263, DOI 10.1016/j.psychres.2009.12.013; Mullins IM, 2006, COMPUT BIOL MED, V36, P1351, DOI 10.1016/j.compbiomed.2005.08.003; Mulrow CD, 2000, AM J MED, V108, P54, DOI 10.1016/S0002-9343(99)00316-2; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; O'Neil ME, 2007, PUBLIC HEALTH REP, V122, P764, DOI 10.1177/003335490712200608; Oka K, 2009, J PHYS ACT HEALTH, V6, P412, DOI 10.1123/jpah.6.4.412; Ostanello F, 2005, EMERG MED J, V22, P260, DOI 10.1136/emj.2004.014886; Palacio J, 2007, J FELINE MED SURG, V9, P188, DOI 10.1016/j.jfms.2006.11.001; Parslow RA, 2005, GERONTOLOGY, V51, P40, DOI 10.1159/000081433; Parslow RA, 2003, MED J AUSTRALIA, V179, P466, DOI 10.5694/j.1326-5377.2003.tb05649.x; Patnaik D, 2011, EXPERIENCES MINING T, P360; Patrick GR, 1998, PUBLIC HEALTH REP, V113, P252; Peacock J, 2012, J CLIN PSYCHOL, V68, P292, DOI 10.1002/jclp.20866; Pedersen MG, 2012, ARCH GEN PSYCHIAT, V69, P1123, DOI 10.1001/archgenpsychiatry.2012.668; Philipsen TEJ, 2006, ACTA CHIR BELG, V106, P692; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Porter SC, 1997, ANN EMERG MED, V29, P141, DOI 10.1016/S0196-0644(97)70320-2; Proops L, 2010, ANIM COGN, V13, P197, DOI 10.1007/s10071-009-0257-5; Raina P, 1999, J AM GERIATR SOC, V47, P323, DOI 10.1111/j.1532-5415.1999.tb02996.x; Rawson NSB, 1997, SOC PSYCH PSYCH EPID, V32, P191, DOI 10.1007/BF00788238; Reid PJ, 2009, BEHAV PROCESS, V80, P325, DOI 10.1016/j.beproc.2008.11.002; Rhodes ET, 2007, DIABETES CARE, V30, P141, DOI 10.2337/dc06-1142; Rieger G, 1999, ANTHROZOOS, V12, P224, DOI 10.2752/089279399787000066; Roque FS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002141; Scott EG, 2006, ACAD EMERG MED, V13, P537, DOI 10.1111/j.1553-2712.2006.tb01005.x; Segrin C, 2000, CLIN PSYCHOL REV, V20, P379, DOI 10.1016/S0272-7358(98)00104-4; SERPELL J, 1991, J ROY SOC MED, V84, P717, DOI 10.1177/014107689108401208; Seyfried L, 2009, INT J MED INFORM, V78, pE13, DOI 10.1016/j.ijmedinf.2009.05.002; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; Stromberg R, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-34; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; Terra VC, 2012, SEIZURE-EUR J EPILEP, V21, P649, DOI 10.1016/j.seizure.2012.06.012; Thomas F, 2012, BIOL LETTERS, V8, P101, DOI 10.1098/rsbl.2011.0588; Turner DC, 2003, ANTHROZOOS, V16, P213, DOI 10.2752/089279303786992143; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012; Vittecoq M, 2012, BIOL LETTERS, V8, P1042, DOI 10.1098/rsbl.2012.0625; Vittecoq M, 2012, INFECT GENET EVOL, V12, P496, DOI 10.1016/j.meegid.2012.01.013; Wang XY, 2009, J AM MED INFORM ASSN, V16, P328, DOI 10.1197/jamia.M3028; WATSON NL, 1993, ANTHROZOOS, V6, P135, DOI 10.2752/089279393787002295; Wells DL, 2009, J ALTERN COMPLEM MED, V15, P407, DOI 10.1089/acm.2008.0496; Westgarth C, 2010, VET REC, V166, P354, DOI 10.1136/vr.c1606; Wisdom JP, 2009, AM J ORTHOPSYCHIAT, V79, P430, DOI 10.1037/a0016812; Wood L, 2005, SOC SCI MED, V61, P1159, DOI 10.1016/j.socscimed.2005.01.017; Wright A, 2010, J BIOMED INFORM, V43, P891, DOI 10.1016/j.jbi.2010.09.009; WRIGHT JC, 1990, PUBLIC HEALTH REP, V105, P420; Yang Lei, 2011, AMIA Annu Symp Proc, V2011, P915; ZASLOFF RL, 1994, PSYCHOL REP, V75, P747, DOI 10.2466/pr0.1994.75.2.747; Zhang YF, 2012, J CLIN PSYCHIAT, V73, P1069, DOI 10.4088/JCP.11m07532; Zheng Kai, 2011, AMIA Annu Symp Proc, V2011, P1630; Zheng K, 2011, J AM MED INFORM ASSN, V18, P282, DOI 10.1136/amiajnl-2011-000009	139	24	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70585	10.1371/journal.pone.0070585	http://dx.doi.org/10.1371/journal.pone.0070585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219PB	23936453	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400075
J	Hoffmann, EM; Lamparter, J; Mirshahi, A; Elflein, H; Hoehn, R; Wolfram, C; Lorenz, K; Adler, M; Wild, PS; Schulz, A; Mathes, B; Blettner, M; Pfeiffer, N				Hoffmann, Esther M.; Lamparter, Julia; Mirshahi, Alireza; Elflein, Heike; Hoehn, Rene; Wolfram, Christian; Lorenz, Katrin; Adler, Max; Wild, Philipp S.; Schulz, Andreas; Mathes, Barbara; Blettner, Maria; Pfeiffer, Norbert			Distribution of Central Corneal Thickness and its Association with Ocular Parameters in a Large Central European Cohort: The Gutenberg Health Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GOLDMANN APPLANATION TONOMETRY; DYNAMIC CONTOUR TONOMETRY; IN-SITU KERATOMILEUSIS; BLUE MOUNTAINS EYE; INTRAOCULAR-PRESSURE; HYPERTENSION TREATMENT; ULTRASOUND PACHYMETRY; VISUAL IMPAIRMENT; BARBADOS EYE	Main objective: To evaluate the distribution of central corneal thickness (CCT) in a large German cohort and to analyse its relationship with intraocular pressure and further ocular factors. Design: Population-based, prospective, cohort study. Methods: The Gutenberg Health Study (GHS) cohort included 4,698 eligible enrollees of 5,000 subjects (age range 35-74 years) who participated in the survey from 2007 to 2008. All participants underwent an ophthalmological examination including slitlamp biomicroscopy, intraocular pressure measurement, central corneal thickness measurement, fundus examination, and were given a questionnaire regarding glaucoma history. Furthermore, all subjects underwent fundus photography and visual field testing using frequency doubling perimetry. Results: Mean CCT was 557.3 +/- 34.3 mu m (male) and 551.6 +/- 35.2 mu m in female subjects (Mean CCT from right and left eyes). Younger male participants (35-44 years) presented slightly thicker CCT than those older. We noted a significant CCT difference of 4 mu m between right and left eyes, but a high correlation between eyes (Wilcoxon test for related samples: p<0.0001). Univariable linear regression stratified by gender showed that IOP was correlated with CCT (p<0.0001). A 10 mu m increase in CCT led to an increase in IOP between 0.35-0.38 mm Hg, depending on the eye and gender. Multivariable linear regression analysis revealed correlations between gender, spherical equivalent (right eyes), and CCT (p<.0001 and p = 0.03, respectively). Conclusions: We observed positive correlations between CCT and IOP and gender. CCT was not correlated with age, contact lens wear, positive family history for glaucoma, lens status, or iris colour.	[Hoffmann, Esther M.; Lamparter, Julia; Mirshahi, Alireza; Elflein, Heike; Hoehn, Rene; Wolfram, Christian; Lorenz, Katrin; Adler, Max; Pfeiffer, Norbert] Univ Med Ctr, Dept Ophthalmol, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr, Dept Internal Med 2, Mainz, Germany; [Blettner, Maria] Univ Med Ctr, Dept Internal Med 2, Gutenberg Hlth Study, Mainz, Germany; [Blettner, Maria] Univ Med Ctr, Dept Biostat & Epidemiol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Hoffmann, EM (corresponding author), Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.	ehoffman@uni-mainz.de	Hoffmann, Esther/AAY-3575-2020; Hoffmann, Esther/AAO-5968-2021; Pfeiffer, Norbert/AAO-7586-2020; Wild, Philipp S./M-2106-2019	Hoffmann, Esther/0000-0002-0949-4268; Wild, Philipp/0000-0003-4413-9752; Hohn, Rene/0000-0003-2870-1469	regional council of Rhineland-Palatine ("Stiftung Rheinland-Pfalz fur Innovation") [AZ 961-386261/733]; University Medical Centre Mainz, Germany; Boehringer Ingelheim, Germany; PHILIPS Medical Systems	regional council of Rhineland-Palatine ("Stiftung Rheinland-Pfalz fur Innovation"); University Medical Centre Mainz, Germany; Boehringer Ingelheim, Germany(Boehringer Ingelheim); PHILIPS Medical Systems	The Gutenberg Health Study is financed by the regional council of Rhineland-Palatine ("Stiftung Rheinland-Pfalz fur Innovation", contract number AZ 961-386261/733), the research programmes "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the University Medical Centre Mainz, Germany and its contract with Boehringer Ingelheim, Germany, and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaian E, 2004, OPHTHALMOLOGY, V111, P2211, DOI 10.1016/j.ophtha.2004.06.013; Annette H, 2008, J GLAUCOMA, V17, P361, DOI 10.1097/IJG.0b013e31815c3ad3; Barkana Y, 2005, J CATARACT REFR SURG, V31, P1729, DOI 10.1016/j.jcrs.2005.03.058; Barleon L, 2006, AM J OPHTHALMOL, V142, P583, DOI 10.1016/j.ajo.2006.05.030; Bayer A, 2010, J GLAUCOMA; Boehm AG, 2008, INVEST OPHTH VIS SCI, V49, P2472, DOI 10.1167/iovs.07-1366; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x; Francis BA, 2007, OPHTHALMOLOGY, V114, P20, DOI 10.1016/j.ophtha.2006.06.047; Friedman DS, 2006, ARCH OPHTHALMOL-CHIC, V124, P1625, DOI 10.1001/archopht.124.11.1625; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Gordon MO, 2007, OPHTHALMOLOGY, V114, P10, DOI 10.1016/j.ophtha.2006.08.031; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Grewal DS, 2010, J CATARACT REFR SURG, V36, P954, DOI 10.1016/j.jcrs.2009.12.033; Hashemi H, 2009, CORNEA, V28, P395, DOI 10.1097/ICO.0b013e31818c4d62; HJORTDAL JO, 1995, ACTA OPHTHALMOL SCAN, V73, P5; Hyman L, 2001, OPHTHALMOLOGY, V108, P1751, DOI 10.1016/S0161-6420(01)00590-5; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Kaufmann C, 2003, INVEST OPHTH VIS SCI, V44, P3790, DOI 10.1167/iovs.02-0946; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Kotecha A, 2010, OPHTHALMOLOGY, V117, P730, DOI 10.1016/j.ophtha.2009.09.020; Landers JA, 2007, AM J OPHTHALMOL, V143, P360, DOI 10.1016/j.ajo.2006.09.047; Leite MT, 2010, AM J OPHTHALMOL, V150, P163, DOI 10.1016/j.ajo.2010.02.024; Leske M Cristina, 2004, Curr Opin Ophthalmol, V15, P102; Medeiros FA, 2006, J GLAUCOMA, V15, P364, DOI 10.1097/01.ijg.0000212268.42606.97; Miglior S, 2007, AM J OPHTHALMOL, V144, P266, DOI 10.1016/j.ajo.2007.04.040; Miglior S, 2007, OPHTHALMOLOGY, V114, P3, DOI 10.1016/j.ophtha.2006.05.075; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Nemesure B, 2003, ARCH OPHTHALMOL-CHIC, V121, P240; Pache M, 2005, GRAEF ARCH CLIN EXP, V243, P763, DOI 10.1007/s00417-005-1124-y; Pfeiffer N, 2007, OPHTHALMOLOGY, V114, P454, DOI 10.1016/j.ophtha.2006.07.039; Renier C, 2009, INT OPHTHALMOL; Rochtchina E, 2002, CLIN EXP OPHTHALMOL, V30, P173, DOI 10.1046/j.1442-9071.2002.00519.x; Siganos DS, 2004, J CATARACT REFR SURG, V30, P746, DOI 10.1016/j.jcrs.2003.12.033; TIELSCH JM, 1991, AM J EPIDEMIOL, V134, P1102, DOI 10.1093/oxfordjournals.aje.a116013; Tomidokoro A, 2007, AM J OPHTHALMOL, V144, P152, DOI 10.1016/j.ajo.2007.02.031; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Varma R, 2004, OPHTHALMOLOGY, V111, P1439, DOI 10.1016/j.ophtha.2004.01.025; Vijaya L, 2010, OPHTHALMOLOGY, V117, P700, DOI 10.1016/j.ophtha.2009.09.025; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; Wolfs RC, 1997, AM J OPHTHALMOL, V123, P767, DOI 10.1016/S0002-9394(14)71125-0; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; Wong TT, 2009, INVEST OPHTH VIS SCI, V50, P4097, DOI 10.1167/iovs.08-2822; Zhang HT, 2008, GRAEF ARCH CLIN EXP, V246, P587, DOI 10.1007/s00417-007-0760-9	49	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e66158	10.1371/journal.pone.0066158	http://dx.doi.org/10.1371/journal.pone.0066158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936291	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400002
J	Lei, FY; Song, JY; Haque, R; Haque, M; Xiong, XF; Fang, DY; Croft, M; Song, JX				Lei, Fengyang; Song, Jianyong; Haque, Rizwanul; Haque, Mohammad; Xiong, Xiaofang; Fang, Deyu; Croft, Michael; Song, Jianxun			Regulation of A1 by OX40 Contributes to CD8(+) T Cell Survival and Anti-Tumor Activity	PLOS ONE			English	Article							BCL-2 HOMOLOG A1; IN-VIVO; LEUKOCYTE DEVELOPMENT; B-CELLS; X-L; TUMOR; COSTIMULATION; ACTIVATION; EXPRESSION; RESPONSES	The TNFR family member OX40 (CD134) is critical for optimal clonal expansion and survival of T cells. However, the intracellular targets of OX40 in CD8 T cells are not fully understood. Here we show that A1, a Bcl-2 family protein, is regulated by OX40 in effector CD8 T cells. In contrast to wild-type T cells, OX40-deficient CD8 T cells failed to maintain A1 expression driven by antigen. Conversely, enforced OX40 stimulation promoted A1 expression. In both situations, the expression of A1 directly correlated with CD8 T cell survival. In addition, exogenous expression of A1 in OX40-deficient CD8 T cells reversed their survival defect in vitro and in vivo. Moreover, forced expression of A1 in CD8 T cells from OX40-deficient mice restored the ability of these T cells to suppress tumor growth in a murine model. These results indicate that OX40 signals regulate CD8 T cell survival at least in part through maintaining expression of the anti-apoptotic molecule A1, and provide new insight into the mechanism by which OX40 may impact anti-tumor immunity.	[Lei, Fengyang; Haque, Rizwanul; Haque, Mohammad; Xiong, Xiaofang; Song, Jianxun] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA USA; [Song, Jianyong] Third Mil Med Univ, Ctr Irradiat, Chongqing, Peoples R China; [Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Army Medical University; Northwestern University; Feinberg School of Medicine; La Jolla Institute for Immunology	Song, JX (corresponding author), Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA USA.	jus35@psu.edu	Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [K18CA151798, R01AI079056]; American Cancer Society Institutional Research Grant; NATIONAL CANCER INSTITUTE [K18CA151798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Institutional Research Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded, in part, under grants with the National Institutes of Health Grant K18CA151798 and the American Cancer Society Institutional Research Grant to J.S., and the National Institutes of Health Grant R01AI079056 to D.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal-Pakala P, 2004, J IMMUNOL, V172, P4821, DOI 10.4049/jimmunol.172.8.4821; Bekiaris V, 2009, EUR J IMMUNOL, V39, P2120; Boettler T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002913; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Chuang PI, 2002, BLOOD, V99, P3350, DOI 10.1182/blood.V99.9.3350; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Fan GF, 2010, BLOOD, V115, P3559, DOI 10.1182/blood-2009-08-236760; Gonzalez J, 2003, BLOOD, V101, P2679, DOI 10.1182/blood-2002-04-1229; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Hendriks J, J IMMUNOL, V175, P1665; Herold MJ, 2006, J BIOL CHEM, V281, P13663, DOI 10.1074/jbc.M600266200; Humphreys IR, 2007, J IMMUNOL, V179, P2195, DOI 10.4049/jimmunol.179.4.2195; Kucharczak JF, 2005, CELL DEATH DIFFER, V12, P1225, DOI 10.1038/sj.cdd.4401684; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Lee SW, 2006, J IMMUNOL, V177, P4464, DOI 10.4049/jimmunol.177.7.4464; Mandal M, 2005, J EXP MED, V201, P603, DOI 10.1084/jem.20041924; Mousavi SF, 2008, J IMMUNOL, V181, P5990, DOI 10.4049/jimmunol.181.9.5990; Murata S, 2006, J IMMUNOL, V176, P974; Orlofsky A, 2002, J IMMUNOL, V168, P1840, DOI 10.4049/jimmunol.168.4.1840; Ottina E, 2012, BLOOD, V119, P6032, DOI 10.1182/blood-2011-12-399089; Ottina E, 2012, EXP CELL RES, V318, P1291, DOI 10.1016/j.yexcr.2012.01.021; Redmond WL, 2007, J IMMUNOL, V179, P7244, DOI 10.4049/jimmunol.179.11.7244; Redmond WL, 2009, EUR J IMMUNOL, V39, P2184, DOI 10.1002/eji.200939348; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Ruby CE, 2007, EUR J IMMUNOL, V37, P157, DOI 10.1002/eji.200636428; Salek-Ardakani S, 2011, J VIROL, V85, P9051, DOI 10.1128/JVI.00619-11; Salek-Ardakani S, 2011, J CLIN INVEST, V121, P296, DOI 10.1172/JCI42056; Salek-Ardakani S, 2008, J IMMUNOL, V181, P7969, DOI 10.4049/jimmunol.181.11.7969; Sanchez PJ, 2012, VACCINE, V30, P1154, DOI 10.1016/j.vaccine.2011.12.017; So T, 2011, P NATL ACAD SCI USA, V108, P2903, DOI 10.1073/pnas.1008765108; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Song AH, 2005, J IMMUNOL, V175, P3534, DOI 10.4049/jimmunol.175.6.3534; Song JX, 2008, J IMMUNOL, V180, P7240, DOI 10.4049/jimmunol.180.11.7240; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Song JX, 2004, NAT IMMUNOL, V5, P150, DOI 10.1038/ni1030; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Whitecross KF, 2009, BLOOD, V113, P1982, DOI 10.1182/blood-2008-05-156851; Xiang Z, 2001, J EXP MED, V194, P1561, DOI 10.1084/jem.194.11.1561; Yang Y, 2012, BLOOD, V120, P4533, DOI 10.1182/blood-2012-02-407163; Zhao BH, 2009, J IMMUNOL, V182, P6744, DOI 10.4049/jimmunol.0804387	41	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70635	10.1371/journal.pone.0070635	http://dx.doi.org/10.1371/journal.pone.0070635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936461	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400080
J	Ringshausen, FC; de Roux, A; Pletz, MW; Hamalainen, N; Welte, T; Rademacher, J				Ringshausen, Felix C.; de Roux, Andres; Pletz, Mathias W.; Haemaelaeinen, Nina; Welte, Tobias; Rademacher, Jessica			Bronchiectasis-Associated Hospitalizations in Germany, 2005-2011: A Population-Based Study of Disease Burden and Trends	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ORPHAN DISEASE; AZITHROMYCIN; COPD; EXACERBATIONS; PREVENTION	Background: Representative population-based data on the epidemiology of bronchiectasis in Europe are limited. The aim of the present study was to investigate the current burden and the trends of bronchiectasis-associated hospitalizations and associated conditions in Germany in order to inform focused patient care and to facilitate the allocation of healthcare resources. Methods: The nationwide diagnosis-related groups hospital statistics for the years 2005-2011 were used in order to identify hospitalizations with bronchiectasis as any hospital discharge diagnosis according to the International Classification of Diseases, 10th revision, code J47, (acquired) bronchiectasis. Poisson log-linear regression analysis was used to assess the significance of trends. In addition, the overall length of hospital stay (LOS) and the in-hospital mortality in comparison to the nationwide overall mortality due to bronchiectasis as the primary diagnosis was assessed. Results: Overall, 61,838 records with bronchiectasis were extracted from more than 125 million hospitalizations. The average annual age-adjusted rate for bronchiectasis as any diagnosis was 9.4 hospitalizations per 100,000 population. Hospitalization rates increased significantly during the study period, with the highest rate of 39.4 hospitalizations per 100,000 population among men aged 75-84 years and the most pronounced average annual increases among females. Besides numerous bronchiectasis-associated conditions, chronic obstructive pulmonary disease (COPD) was most frequently found in up to 39.2% of hospitalizations with bronchiectasis as the primary diagnosis. The mean LOS was comparable to that for COPD. Overall, only 40% of bronchiectasis-associated deaths occurred inside the hospital. Conclusions: The present study provides evidence of a changing epidemiology and a steadily increasing prevalence of bronchiectasis-associated hospitalizations. Moreover, it confirms the diversity of bronchiectasis-associated conditions and the possible association between bronchiectasis and COPD. As the major burden of disease may be managed out-of-hospital, prospective patient registries are needed to establish the exact prevalence of bronchiectasis according to the specific underlying condition.	[Ringshausen, Felix C.; Welte, Tobias; Rademacher, Jessica] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [de Roux, Andres] Ctr Resp Med Charlottenburg Castle, Berlin, Germany; [Pletz, Mathias W.] Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany; [Haemaelaeinen, Nina] Inst Lung Res, Berlin, Germany	Hannover Medical School; Friedrich Schiller University of Jena	Ringshausen, FC (corresponding author), Hannover Med Sch, Dept Resp Med, Hannover, Germany.	Ringshausen.Felix@mh-hannover.de	Ringshausen, Felix C./AAA-9154-2021; Rademacher, Jessica/ABG-1898-2020; Pletz, Mathias Wilhelm/H-9782-2019	Ringshausen, Felix C./0000-0001-9084-4968; Pletz, Mathias Wilhelm/0000-0001-8157-2753	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG); German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The authors acknowledge financial support for open access publishing by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). MWP was supported by a grant from the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung), grant number 01KI1204. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Andres J, 2011, VERSORGUNGSBERICHT 2; Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; Bilton D, 2011, EUR RESPIR MONOGR, P1, DOI 10.1183/1025448x.10003110; European Centre for Disease Prevention and Control (ECDC)/WHO Regional Office for Europe, 2012, TUB SURV MON EUR 201; FIELD CE, 1969, ARCH DIS CHILD, V44, P551, DOI 10.1136/adc.44.237.551; Floto RA, 2011, EUROPEAN RESP MONOGR, V52; German Federal Statistical Office, 2013, FACTS FIG STAT SOC; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; King Paul T, 2009, Int J Chron Obstruct Pulmon Dis, V4, P411; Kwak HJ, 2010, TOHOKU J EXP MED, V222, P237, DOI 10.1620/tjem.222.237; Landry JS, 2012, CHRON DIS INJ CAN, V33, P47; Martinez-Garcia MA, 2013, AM J RESP CRIT CARE, V187, P823, DOI 10.1164/rccm.201208-1518OC; Miravitiles M, 2013, EUR RESPIR J, V41, P1252, DOI 10.1183/09031936.00118912; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Patel IS, 2004, AM J RESP CRIT CARE, V170, P400, DOI 10.1164/rccm.200305-648OC; Rademacher J, 2011, DTSCH ARZTEBL INT, V108, P809, DOI 10.3238/arztebl.2011.0809; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Robert Koch Institute and Federal Statistical Office, 2013, GERM FED HLTH MON SY; Saynajakangas O, 1997, RESP MED, V91, P395, DOI 10.1016/S0954-6111(97)90251-1; Seitz AE, 2012, CHEST, DOI 10.1378/chest.11-2209; Seitz AE, 2010, CHEST, V138, P944, DOI 10.1378/chest.10-0099; Shoemark A, 2007, RESP MED, V101, P1163, DOI 10.1016/j.rmed.2006.11.008; Tsang KW, 2004, INT J TUBERC LUNG D, V8, P691; Twiss J, 2005, ARCH DIS CHILD, V90, P737, DOI 10.1136/adc.2004.066472; Viviani L, 2012, EUROPEAN CYSTIC FIBR; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed; Wilson R, 2012, LANCET, V380, P627, DOI 10.1016/S0140-6736(12)61261-6; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2	30	97	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71109	10.1371/journal.pone.0071109	http://dx.doi.org/10.1371/journal.pone.0071109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936489	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400095
J	Castillo, AG; Pidoux, AL; Catania, S; Durand-Dubief, M; Choi, ES; Hamilton, G; Ekwall, K; Allshire, RC				Castillo, Araceli G.; Pidoux, Alison L.; Catania, Sandra; Durand-Dubief, Mickel; Choi, Eun Shik; Hamilton, Georgina; Ekwall, Karl; Allshire, Robin C.			Telomeric Repeats Facilitate CENP-A(Cnp1) Incorporation via Telomere Binding Proteins	PLOS ONE			English	Article							CENP-A CHROMATIN; E3 UBIQUITIN LIGASE; HISTONE H3 VARIANT; FISSION YEAST; DOMAIN PROTEIN; HETEROCHROMATIN; CENTROMERE; DROSOPHILA; TAZ1; RNAI	The histone H3 variant, CENP-A, is normally assembled upon canonical centromeric sequences, but there is no apparent obligate coupling of sequence and assembly, suggesting that centromere location can be epigenetically determined. To explore the tolerances and constraints on CENP-A deposition we investigated whether certain locations are favoured when additional CENP-A(Cnp1) is present in fission yeast cells. Our analyses show that additional CENP-A(Cnp1) accumulates within and close to heterochromatic centromeric outer repeats, and over regions adjacent to rDNA and telomeres. The use of minichromosome derivatives with unique DNA sequences internal to chromosome ends shows that telomeres are sufficient to direct CENP-A(Cnp1) deposition. However, chromosome ends are not required as CENP-A(Cnp1) deposition also occurs at telomere repeats inserted at an internal locus and correlates with the presence of H3K9 methylation near these repeats. The Ccq1 protein, which is known to bind telomere repeats and recruit telomerase, was found to be required to induce H3K9 methylation and thus promote the incorporation of CENP-A(Cnp1) near telomere repeats. These analyses demonstrate that at non-centromeric chromosomal locations the presence of heterochromatin influences the sites at which CENP-A is incorporated into chromatin and, thus, potentially the location of centromeres.	[Castillo, Araceli G.; Pidoux, Alison L.; Catania, Sandra; Choi, Eun Shik; Hamilton, Georgina; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Castillo, Araceli G.; Pidoux, Alison L.; Catania, Sandra; Choi, Eun Shik; Hamilton, Georgina; Allshire, Robin C.] Univ Edinburgh, Sch Biol, Inst Cell Biol, Edinburgh, Midlothian, Scotland; [Durand-Dubief, Mickel; Ekwall, Karl] Karolinska Inst, Novum, Dept Biosci & Nutr, Huddinge, Sweden	University of Edinburgh; University of Edinburgh; Karolinska Institutet	Allshire, RC (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Durand-Dubief, Mickael/O-2315-2019; Castillo, Araceli G/C-5158-2013	Durand-Dubief, Mickael/0000-0002-8556-4459; Castillo, Araceli G/0000-0003-3990-5475; Choi, Eun Shik/0000-0002-2306-2103; Ekwall, Karl/0000-0002-3029-4041; Allshire, Robin/0000-0002-8005-3625	Wellcome Trust [095021, 065061, 092076]; Swedish Cancer Society; Swedish Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Wellcome Trust supported the work of RCA [095021], [065061]. Work in the Wellcome Trust Centre for Cell Biology is supported by the Wellcome Trust core funding [092076]. RCA is a Wellcome Trust Principal Fellow. Work in the KE laboratory is supported by grants from the Swedish Cancer Society and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Choi ES, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002985; Choi ES, 2011, J BIOL CHEM, V286, P23600, DOI 10.1074/jbc.M111.228510; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Dehe PM, 2012, MOL CELL, V46, P797, DOI 10.1016/j.molcel.2012.04.022; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; Lefrancois P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003209; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Maggert KA, 2001, GENETICS, V158, P1615; Mandell JG, 2005, J BIOL CHEM, V280, P5249, DOI 10.1074/jbc.M412756200; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Mendiburo MJ, 2011, SCIENCE, V334, P686, DOI 10.1126/science.1206880; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nasuda S, 2005, P NATL ACAD SCI USA, V102, P9842, DOI 10.1073/pnas.0504235102; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; Olszak AM, 2011, NAT CELL BIOL, V13, P799, DOI 10.1038/ncb2272; Pidoux AL, 2000, J CELL SCI, V113, P4177; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Shang WH, 2010, GENOME RES, V20, P1219, DOI 10.1101/gr.106245.110; SHANG WH, 2013, DEV CELL, V24, P1, DOI DOI 10.1016/J.DEVCEL.2012.11.020.PUBMED:23328396; Steglich B, 2012, NUCLEUS-PHILA, V3, P77, DOI 10.4161/nucl.18825; Sugawara N., 1988, THESIS HARVARD U CAM; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Tomita K, 2008, GENE DEV, V22, P3461, DOI 10.1101/gad.498608; Topp CN, 2009, CYTOGENET GENOME RES, V124, P228, DOI 10.1159/000218128; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083	50	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69673	10.1371/journal.pone.0069673	http://dx.doi.org/10.1371/journal.pone.0069673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936074	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700038
J	See, L; Comber, A; Salk, C; Fritz, S; van der Velde, M; Perger, C; Schill, C; McCallum, I; Kraxner, F; Obersteiner, M				See, Linda; Comber, Alexis; Salk, Carl; Fritz, Steffen; van der Velde, Marijn; Perger, Christoph; Schill, Christian; McCallum, Ian; Kraxner, Florian; Obersteiner, Michael			Comparing the Quality of Crowdsourced Data Contributed by Expert and Non-Experts	PLOS ONE			English	Article							LAND; VOLUNTEERS	There is currently a lack of in-situ environmental data for the calibration and validation of remotely sensed products and for the development and verification of models. Crowdsourcing is increasingly being seen as one potentially powerful way of increasing the supply of in-situ data but there are a number of concerns over the subsequent use of the data, in particular over data quality. This paper examined crowdsourced data from the Geo-Wiki crowdsourcing tool for land cover validation to determine whether there were significant differences in quality between the answers provided by experts and non-experts in the domain of remote sensing and therefore the extent to which crowdsourced data describing human impact and land cover can be used in further scientific research. The results showed that there was little difference between experts and non-experts in identifying human impact although results varied by land cover while experts were better than non-experts in identifying the land cover type. This suggests the need to create training materials with more examples in those areas where difficulties in identification were encountered, and to offer some method for contributors to reflect on the information they contribute, perhaps by feeding back the evaluations of their contributed data or by making additional training materials available. Accuracies were also found to be higher when the volunteers were more consistent in their responses at a given location and when they indicated higher confidence, which suggests that these additional pieces of information could be used in the development of robust measures of quality in the future.	[See, Linda; Salk, Carl; Fritz, Steffen; van der Velde, Marijn; Perger, Christoph; McCallum, Ian; Kraxner, Florian; Obersteiner, Michael] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria; [Comber, Alexis] Univ Leicester, Dept Geog, Leicester LE1 7RH, Leics, England; [Salk, Carl] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Perger, Christoph] Univ Appl Sci, Wiener Neustadt, Austria; [Schill, Christian] Univ Freiburg, D-79106 Freiburg, Germany	International Institute for Applied Systems Analysis (IIASA); University of Leicester; University of Colorado System; University of Colorado Boulder; University of Freiburg	See, L (corresponding author), Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria.	see@iiasa.ac.at	van der Velde, Marijn/B-3305-2009; Comber, Alexis/O-4170-2014	van der Velde, Marijn/0000-0002-9103-7081; Kraxner, Florian/0000-0003-3832-6236; Comber, Alexis/0000-0002-3652-7846; , Steffen/0000-0003-0420-8549; Salk, Carl/0000-0003-2833-8292	Austrian Agency for the Promotion of Science [828332]	Austrian Agency for the Promotion of Science	Funding from the Austrian Agency for the Promotion of Science via the project LandSpotting (No. 828332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonney R, 2009, PUBLIC PARTICIPATION; Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Clery D, 2011, SCIENCE, V333, P173, DOI 10.1126/science.333.6039.173; Comber A, 2013, INT J APPL EARTH OBS, V23, P37, DOI 10.1016/j.jag.2012.11.002; Foody GM, 2012, USING VOLUNTEERED DA, P2368; Fritz S, 2005, INT J GEOGR INF SCI, V19, P787, DOI 10.1080/13658810500072020; Fritz S, 2013, ENVIRON SCI TECHNOL, V47, P1688, DOI 10.1021/es303141h; Fritz S, 2012, ENVIRON MODELL SOFTW, V31, P110, DOI 10.1016/j.envsoft.2011.11.015; Fritz S, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044005; Fritz S, 2009, REMOTE SENS-BASEL, V1, P345, DOI 10.3390/rs1030345; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goodchild MF, 2012, SPAT STAT-NETH, V1, P110, DOI 10.1016/j.spasta.2012.03.002; Haklay M, 2010, CARTOGR J, V47, P315, DOI 10.1179/000870410X12911304958827; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; Lopresti D, 2002, LECT NOTES COMPUT SC, V2390, P46; Milcinski G, 2011, RISE CROWD SOURCING; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; Nayar A, 2009, NATURE NEWS; Perger C., 2012, GI FORUM 2012 GEOVIZ, P83; Preis T., 2012, SCI REPORTS, V2; Schuurman N, 2009, ENVIRON PLANN D, V27, P571, DOI 10.1068/d3809; See LM, 2006, IEEE T GEOSCI REMOTE, V44, P1740, DOI 10.1109/TGRS.2006.874750; Theobald DM, 2004, FRONT ECOL ENVIRON, V2, P139, DOI 10.1890/1540-9295(2004)002[0139:PELCIA]2.0.CO;2; van der Velde M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024022	24	102	104	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69958	10.1371/journal.pone.0069958	http://dx.doi.org/10.1371/journal.pone.0069958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936126	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700048
J	Abian, O; Vega, S; Sancho, J; Velazquez-Campoy, A				Abian, Olga; Vega, Sonia; Sancho, Javier; Velazquez-Campoy, Adrian			Allosteric Inhibitors of the NS3 Protease from the Hepatitis C Virus	PLOS ONE			English	Article							ZINC-BINDING; NS4A PROTEIN; IDENTIFICATION; DOMAIN; SITE; TELAPREVIR; MUTATIONS; SEQUENCE; ZNTA	The nonstructural protein 3 (NS3) from the hepatitis C virus processes the non-structural region of the viral precursor polyprotein in infected hepatic cells. The NS3 protease activity has been considered a target for drug development since its identification two decades ago. Although specific inhibitors have been approved for clinical therapy very recently, resistance-associated mutations have already been reported for those drugs, compromising their long-term efficacy. Therefore, there is an urgent need for new anti-HCV agents with low susceptibility to resistance-associated mutations. Regarding NS3 protease, two strategies have been followed: competitive inhibitors blocking the active site and allosteric inhibitors blocking the binding of the accessory viral protein NS4A. In this work we exploit the intrinsic Zn+2-regulated plasticity of the protease to identify a new type of allosteric inhibitors. In the absence of Zn+2, the NS3 protease adopts a partially-folded inactive conformation. We found ligands binding to the Zn+2-free NS3 protease, trap the inactive protein, and block the viral life cycle. The efficacy of these compounds has been confirmed in replicon cell assays. Importantly, direct calorimetric assays reveal a low impact of known resistance-associated mutations, and enzymatic assays provide a direct evidence of their inhibitory activity. They constitute new low molecular-weight scaffolds for further optimization and provide several advantages: 1) new inhibition mechanism simultaneously blocking substrate and cofactor interactions in a non-competitive fashion, appropriate for combination therapy; 2) low impact of known resistance-associated mutations; 3) inhibition of NS4A binding, thus blocking its several effects on NS3 protease.	[Abian, Olga; Vega, Sonia; Sancho, Javier; Velazquez-Campoy, Adrian] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit IQFR CSIC BIFI, Zaragoza, Spain; [Abian, Olga] Inst Aragones Ciencias Salud, IIS Aragon, Zaragoza, Spain; [Abian, Olga] Ctr Invest Biomed Red Area Temat Enfermedades Hep, Barcelona, Spain; [Sancho, Javier; Velazquez-Campoy, Adrian] Univ Zaragoza, Dept Biochem & Mol & Cell Biol, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Govt Aragon, Fdn ARAID, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Zaragoza	Abian, O (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit IQFR CSIC BIFI, Zaragoza, Spain.	oabifra@unizar.es; adrianvc@unizar.es	Velazquez-Campoy, Adrian/E-7946-2012; Sancho, javier/AAA-1225-2019; ABIAN, OLGA/K-8935-2014; Vega, Sonia/G-5658-2016	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Sancho, javier/0000-0002-2879-9200; ABIAN, OLGA/0000-0001-5664-1729; Vega, Sonia/0000-0002-1232-6310	Spanish Ministerio de Ciencia e Innovacion [BFU2010-19451, PTA2009-2341-I, BFU2010-16297]; Miguel Servet Program from Instituto de Salud Carlos III [CP07/00289]; Fondo de Investigaciones Sanitarias [PI10/00186]; Diputacion General de Aragon [PI044/09, B89-2011/2012, B01-2011/2012]; Universidad de Zaragoza - Spain [UZ2009-BIO-05]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Miguel Servet Program from Instituto de Salud Carlos III; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Diputacion General de Aragon(Gobierno de Aragon); Universidad de Zaragoza - Spain	This work was supported by Spanish Ministerio de Ciencia e Innovacion (BFU2010-19451 to AVC, PTA2009-2341-I to SV, and BFU2010-16297 to JS), Miguel Servet Program from Instituto de Salud Carlos III (CP07/00289 to OA), Fondo de Investigaciones Sanitarias (PI10/00186 to OA), Diputacion General de Aragon (PI044/09 to AVC, Protein Targets Group B89-2011/2012 to JS, and Digestive Pathology Group B01-2011/2012 to OA), and Universidad de Zaragoza - Spain (UZ2009-BIO-05 to AVC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abian O, 2010, BIOPHYS J, V99, P3811, DOI 10.1016/j.bpj.2010.10.037; Abian O, 2009, PROTEINS, V77, P624, DOI 10.1002/prot.22475; Binet MRB, 2000, FEBS LETT, V473, P67, DOI 10.1016/S0014-5793(00)01509-X; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; Butkiewicz NJ, 1996, VIROLOGY, V225, P328, DOI 10.1006/viro.1996.0607; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Courcambeck J, 2006, ANTIVIR THER, V11, P847; Cremades N, 2009, ACS CHEM BIOL, V4, P928, DOI 10.1021/cb900166q; DeFrancesco R, 1996, BIOCHEMISTRY-US, V35, P13282, DOI 10.1021/bi9616458; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pey AL, 2008, J CLIN INVEST, V118, P2858, DOI 10.1172/JCI34355; Rizza SA, 2011, DRUG TODAY, V47, P743, DOI 10.1358/dot.2011.47.10.1656503; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; Taliani M, 1996, ANAL BIOCHEM, V240, P60, DOI 10.1006/abio.1996.0331; TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995; Thibeault D, 2009, BIOCHEMISTRY-US, V48, P744, DOI 10.1021/bi801931e; Tomei L, 1996, J GEN VIROL, V77, P1065, DOI 10.1099/0022-1317-77-5-1065; Urbani A, 1998, J BIOL CHEM, V273, P18760, DOI 10.1074/jbc.273.30.18760; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Walker MA, 1999, DRUG DISCOV TODAY, V4, P518, DOI 10.1016/S1359-6446(99)01414-2	31	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69773	10.1371/journal.pone.0069773	http://dx.doi.org/10.1371/journal.pone.0069773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936097	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200045
J	Ma, YY; Liang, DM; Liu, J; Wen, JG; Servoll, E; Waaler, G; Saeter, T; Axcrona, K; Vlatkovic, L; Axcrona, U; Paus, E; Yang, Y; Zhang, ZQ; Kvalheim, G; Nesland, JM; Suo, ZH				Ma, Yuanyuan; Liang, Dongming; Liu, Jian; Wen, Jian-Guo; Servoll, Einar; Waaler, Gudmund; Saeter, Thorstein; Axcrona, Karol; Vlatkovic, Ljiljana; Axcrona, Ulrika; Paus, Elisabeth; Yang, Yue; Zhang, Zhiqian; Kvalheim, Gunnar; Nesland, Jahn M.; Suo, Zhenhe			SHBG Is an Important Factor in Stemness Induction of Cells by DHT In Vitro and Associated with Poor Clinical Features of Prostate Carcinomas	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; SKELETAL-MUSCLE FIBERS; ANDROGEN RECEPTOR; MCF-7 CELLS; STEROID-HORMONES; CANCER CELLS; NONGENOMIC ACTIONS; GENE-EXPRESSION; BREAST-CANCER; MARKER THY-1	Androgen plays a vital role in prostate cancer development. However, it is not clear whether androgens influence stem-like properties of prostate cancer, a feature important for prostate cancer progression. In this study, we show that upon DHT treatment in vitro, prostate cancer cell lines LNCaP and PC-3 were revealed with higher clonogenic potential and higher expression levels of stemness related factors CD44, CD90, Oct3/4 and Nanog. Moreover, sex hormone binding globulin (SHBG) was also simultaneously upregulated in these cells. When the SHBG gene was blocked by SHBG siRNA knock-down, the induction of Oct3/4, Nanog, CD44 and CD90 by DHT was also correspondingly blocked in these cells. Immunohistochemical evaluation of clinical samples disclosed weakly positive, and areas negative for SHBG expression in the benign prostate tissues, while most of the prostate carcinomas were strongly positive for SHBG. In addition, higher levels of SHBG expression were significantly associated with higher Gleason score, more seminal vesicle invasions and lymph node metastases. Collectively, our results show a role of SHBG in upregulating stemness of prostate cancer cells upon DHT exposure in vitro, and SHBG expression in prostate cancer samples is significantly associated with poor clinicopathological features, indicating a role of SHBG in prostate cancer progression.	[Ma, Yuanyuan; Liang, Dongming; Liu, Jian; Vlatkovic, Ljiljana; Axcrona, Ulrika; Nesland, Jahn M.; Suo, Zhenhe] Univ Oslo, Dept Pathol, Norwegian Radium Hosp, Inst Clin Med,Oslo Univ Hosp,Fac Med, Oslo, Norway; [Ma, Yuanyuan; Yang, Yue] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Canc Hosp & Inst,Dept Thorac Surg 2, Beijing 100871, Peoples R China; [Wen, Jian-Guo] Zhengzhou Univ, Dept Surg, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Servoll, Einar; Waaler, Gudmund; Saeter, Thorstein] Soerlandet Hosp, Dept Surg, Arendal, Norway; [Axcrona, Karol] Univ Oslo, Dept Urol, Norwegian Radium Hosp, Oslo Univ Hosp, Oslo, Norway; [Paus, Elisabeth] Univ Oslo, Dept Med Biochem, Oslo Univ Hosp, Oslo, Norway; [Zhang, Zhiqian] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Dept Cell Biol,Canc Hosp & Inst, Beijing 100871, Peoples R China; [Kvalheim, Gunnar] Univ Oslo, Dept Cell Therapy, Norwegian Radium Hosp, Oslo Univ Hosp, Oslo, Norway; [Suo, Zhenhe] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China	University of Oslo; Peking University; Zhengzhou University; University of Oslo; University of Oslo; Peking University; University of Oslo; Zhengzhou University	Suo, ZH (corresponding author), Univ Oslo, Dept Pathol, Norwegian Radium Hosp, Inst Clin Med,Oslo Univ Hosp,Fac Med, Oslo, Norway.	zhenhes@medisin.uio.no	Paus, Elisabeth/F-9678-2014; Wen, Jian Guo/P-3185-2014	Wen, Jian Guo/0000-0003-0952-118X; , Karol/0000-0002-5011-0107	Norwegian Radium Hospital Research Foundation; National Natural Science Foundation of China [81272824]	Norwegian Radium Hospital Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the The Norwegian Radium Hospital Research Foundation and National Natural Science Foundation of China, grant no 81272824. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bonaccorsi L, 2000, ENDOCRINOLOGY, V141, P3172, DOI 10.1210/en.141.9.3172; Chokkalingam AP, 2007, FRONT BIOSCI-LANDMRK, V12, P3436, DOI 10.2741/2325; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Farnsworth WE, 2004, MED HYPOTHESES, V62, P954, DOI 10.1016/j.mehy.2004.01.024; FISSORE F, 1994, STEROIDS, V59, P661, DOI 10.1016/0039-128X(94)90023-X; Fortunati N, 2010, MOL CELL ENDOCRINOL, V316, P86, DOI 10.1016/j.mce.2009.09.012; Fortunati N, 1996, ENDOCRINOLOGY, V137, P686, DOI 10.1210/en.137.2.686; Fortunati N, 1999, J STEROID BIOCHEM, V70, P73, DOI 10.1016/S0960-0760(99)00092-8; FORTUNATI N, 1993, J STEROID BIOCHEM, V45, P435, DOI 10.1016/0960-0760(93)90012-L; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Hamdi MM, 2011, J PHYSIOL-LONDON, V589, P3623, DOI 10.1113/jphysiol.2011.207175; Hamdi MM, 2010, J PHYSIOL-LONDON, V588, P511, DOI 10.1113/jphysiol.2009.182162; He J, 2011, MOL CELL PROTEOMICS; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Houghton J, 2007, SEMIN CANCER BIOL, V17, P191, DOI 10.1016/j.semcancer.2006.04.003; Hryb DJ, 2002, J BIOL CHEM, V277, P26618, DOI 10.1074/jbc.M202495200; Huggins C, 2002, J UROLOGY, V167, P948, DOI 10.1016/S0022-5347(02)80307-X; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Ishiguro H, 2011, CANCER SCI, V102, P1576, DOI 10.1111/j.1349-7006.2011.01972.x; Janne M, 1999, ENDOCRINOLOGY, V140, P4166, DOI 10.1210/en.140.9.4166; JOSEPH DR, 1994, VITAM HORM, V49, P197; Kahn SM, 2008, ADV EXP MED BIOL, V617, P557, DOI 10.1007/978-0-387-69080-3_57; Kahn SM, 2002, J ENDOCRINOL, V175, P113, DOI 10.1677/joe.0.1750113; Kobayashi S, 2011, P NATL ACAD SCI USA, V108, P14479, DOI 10.1073/pnas.1109767108; Kong DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033729; Kristiansen G, 2010, LAB INVEST, V90, P1102, DOI 10.1038/labinvest.2010.70; LABRIE F, 1982, CLIN INVEST MED, V5, P267; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; LOUKOVAARA M, 1995, J CLIN ENDOCR METAB, V80, P160, DOI 10.1210/jc.80.1.160; Ma YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029170; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Masson NM, 2006, AM J PHYSIOL-GASTR L, V291, pG45, DOI 10.1152/ajpgi.00465.2005; Nakhla AM, 1997, J BIOL CHEM, V272, P6838, DOI 10.1074/jbc.272.11.6838; Nakhla AM, 1996, ENDOCRINOLOGY, V137, P4126, DOI 10.1210/en.137.10.4126; NAKHLA AM, 1990, J CLIN ENDOCR METAB, V71, P398, DOI 10.1210/jcem-71-2-398; NOBLE RL, 1977, CANCER RES, V37, P1929; Perusquia M, 1999, EUR J PHARMACOL, V371, P169, DOI 10.1016/S0014-2999(99)00161-2; Petersen BE, 1998, HEPATOLOGY, V27, P433, DOI 10.1002/hep.510270218; POLLARD M, 1982, PROSTATE, V3, P563, DOI 10.1002/pros.2990030605; Revelli A, 1998, ENDOCR REV, V19, P3, DOI 10.1210/er.19.1.3; Rodriguez-Berriguete Gonzalo, 2012, J Signal Transduct, V2012, P169170, DOI 10.1155/2012/169170; ROSNER W, 1992, J ANDROL, V13, P101; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; Salonia A, 2009, UROLOGY, V73, P850, DOI 10.1016/j.urology.2008.09.026; Sirab N, 2011, INT J CANC; Tysnes BB, 2010, NEOPLASIA, V12, P506, DOI 10.1593/neo.10290; VOIGT KD, 1986, J STEROID BIOCHEM, V25, P749, DOI 10.1016/0022-4731(86)90304-3; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365	51	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70558	10.1371/journal.pone.0070558	http://dx.doi.org/10.1371/journal.pone.0070558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936228	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200094
J	Timmes, AG; Moore, RA; Fischer, ER; Priola, SA				Timmes, Andrew G.; Moore, Roger A.; Fischer, Elizabeth R.; Priola, Suzette A.			Recombinant Prion Protein Refolded with Lipid and RNA Has the Biochemical Hallmarks of a Prion but Lacks In Vivo Infectivity	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE INFECTION; METHIONINE OXIDATION; MAMMALIAN PRIONS; MASS-SPECTROMETRY; VITRO GENERATION; TRANSGENIC MICE; WILD-TYPE; RESISTANT; CONVERSION	During prion infection, the normal, protease-sensitive conformation of prion protein (PrPC) is converted via seeded polymerization to an abnormal, infectious conformation with greatly increased protease-resistance (PrPSc). In vitro, protein misfolding cyclic amplification (PMCA) uses PrPSc in prion-infected brain homogenates as an initiating seed to convert PrPC and trigger the self-propagation of PrPSc over many cycles of amplification. While PMCA reactions produce high levels of protease-resistant PrP, the infectious titer is often lower than that of brain-derived PrPSc. More recently, PMCA techniques using bacterially derived recombinant PrP (rPrP) in the presence of lipid and RNA but in the absence of any starting PrPSc seed have been used to generate infectious prions that cause disease in wild-type mice with relatively short incubation times. These data suggest that lipid and/or RNA act as cofactors to facilitate the de novo formation of high levels of prion infectivity. Using rPrP purified by two different techniques, we generated a self-propagating protease-resistant rPrP molecule that, regardless of the amount of RNA and lipid used, had a molecular mass, protease resistance and insolubility similar to that of PrPSc. However, we were unable to detect prion infectivity in any of our reactions using either cell-culture or animal bioassays. These results demonstrate that the ability to self-propagate into a protease-resistant insoluble conformer is not unique to infectious PrP molecules. They suggest that the presence of RNA and lipid cofactors may facilitate the spontaneous refolding of PrP into an infectious form while also allowing the de novo formation of self-propagating, but non-infectious, rPrP-res.	[Timmes, Andrew G.; Moore, Roger A.; Priola, Suzette A.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Fischer, Elizabeth R.] NIAID, Electron Microscopy Unit, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Priola, SA (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	spriola@niaid.nih.gov			National Institute of Allergy and Infectious Disease, National Institutes of Health [AI000752-17]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI001105] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health (AI000752-17). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Prior to submission, approval had to be obtained to publish from NIH.	APFFEL A, 1995, J CHROMATOGR A, V712, P177, DOI 10.1016/0021-9673(95)00175-M; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baral PK, 2012, ACTA CRYSTALLOGR D, V68, P1501, DOI 10.1107/S0907444912037328; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; CALDER PC, 1991, INT J BIOCHEM, V23, P1335, DOI 10.1016/0020-711X(91)90274-Q; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; Chen ML, 2007, ANAL CHEM, V79, P2031, DOI 10.1021/ac061743r; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DROCHMANS P, 1962, J ULTRA MOL STRUCT R, V6, P141, DOI 10.1016/S0022-5320(62)90050-3; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Greil CS, 2008, VIROLOGY, V379, P284, DOI 10.1016/j.virol.2008.07.006; HAMMOND DN, 1990, BRAIN RES, V512, P190, DOI 10.1016/0006-8993(90)90626-M; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; Leblanc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030872; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Levine RL, 2006, RAPID COMMUN MASS SP, V20, P1828, DOI 10.1002/rcm.2519; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; McNally KL, 2009, J VIROL, V83, P4469, DOI 10.1128/JVI.02412-08; MERZ PA, 1981, ACTA NEUROPATHOL, V54, P63, DOI 10.1007/BF00691333; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; MORAND K, 1993, RAPID COMMUN MASS SP, V7, P738, DOI 10.1002/rcm.1290070811; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Panza G, 2008, REJUV RES, V11, P365, DOI 10.1089/rej.2008.0698; Piro JR, 2011, BIOCHEMISTRY-US, V50, P7111, DOI 10.1021/bi200786p; Priola SA, 2006, MOL BIOTECHNOL, V33, P71; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; RACE RE, 1992, J GEN VIROL, V73, P3319, DOI 10.1099/0022-1317-73-12-3319; Raymond GJ, 2012, J VIROL, V86, P11763, DOI 10.1128/JVI.01353-12; Satoh K, 2003, J GEN VIROL, V84, P2885, DOI 10.1099/vir.0.19236-0; Shikiya RA, 2011, J VIROL, V85, P13439, DOI 10.1128/JVI.06134-11; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sim VL, 2009, NEUROBIOL AGING, V30, P2031, DOI 10.1016/j.neurobiolaging.2008.02.016; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Stevens LA, 2009, P NATL ACAD SCI USA, V106, P19796, DOI 10.1073/pnas.0910633106; Taggart C, 2000, J BIOL CHEM, V275, P27258; Vorberg I, 2004, J BIOL CHEM, V279, P29218, DOI 10.1074/jbc.M402576200; Vorberg I, 2002, J BIOL CHEM, V277, P36775, DOI 10.1074/jbc.M206865200; Wang F, 2012, J VIROL, V86, P1874, DOI 10.1128/JVI.06216-11; Wang F, 2011, METHODS, V53, P208, DOI 10.1016/j.ymeth.2010.12.013; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weber P, 2006, P NATL ACAD SCI USA, V103, P15818, DOI 10.1073/pnas.0605608103; Wolschner C, 2009, P NATL ACAD SCI USA, V106, P7756, DOI 10.1073/pnas.0902688106; Younan ND, 2012, J BIOL CHEM, V287, P28263, DOI 10.1074/jbc.M112.354779; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	68	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71081	10.1371/journal.pone.0071081	http://dx.doi.org/10.1371/journal.pone.0071081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936256	Green Submitted, gold, Green Published			2022-12-27	WOS:000323114200110
J	Wang, YH; Xiang, LM; Wang, CH; Tang, C; He, XJ				Wang, Yihai; Xiang, Limin; Wang, Chunhua; Tang, Chao; He, Xiangjiu			Antidiabetic and Antioxidant Effects and Phytochemicals of Mulberry Fruit (Morus alba L.) Polyphenol Enhanced Extract	PLOS ONE			English	Article							ALPHA-GLUCOSIDASE; FLAVONOID GLYCOSIDES; IN-VITRO; PHENOLICS; DEPSIDES; ANTHOCYANINS; INHIBITION; ALKALOIDS; AMYLASE; PARTS	The antidiabetic and antioxidant activities of the ethyl acetate-soluble extract (MFE) of mulberry fruit (Morus alba L.) were investigated. In vitro, MFE showed potent a-glucosidase inhibitory activity and radical-scavenging activities against DPPH and superoxide anion radicals. In vivo, MFE could significantly decrease fasting blood glucose (FBG) and glycosylated serum protein (GSP), and increase antioxidant enzymatic activities (SOD, CAT, GSH-Px) in streptozotocin (STZ)-induced diabetic mice. Bioactivity-guided fractionation of the MFE led to the isolation of 25 phenolic compounds, and their structures were identified on the basis of MS and NMR data. All the 25 compounds were isolated from mulberry fruit for the first time. Also, the a-glucosidase inhibitory activity and antioxidant activity of the phenolics were evaluated. Potent a-glucosidase inhibitory and radical-scavenging activities of these phenolics suggested that they may be partially responsible for the antidiabetic and antioxidant activities of mulberry fruit.	[Wang, Yihai; Xiang, Limin; Wang, Chunhua; Tang, Chao; He, Xiangjiu] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430072, Peoples R China	Wuhan University	He, XJ (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430072, Peoples R China.	hexiangjiu@whu.edu.cn	Wang, Yihai/L-7462-2019; He, Xiangjiu/M-4008-2016	He, Xiangjiu/0000-0002-1631-7657				ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; Asano N, 2001, J AGR FOOD CHEM, V49, P4208, DOI 10.1021/jf010567e; BENNINI B, 1992, PHYTOCHEMISTRY, V31, P2483, DOI 10.1016/0031-9422(92)83305-I; Bettaieb I, 2010, J AGR FOOD CHEM, V58, P10410, DOI 10.1021/jf102248j; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CC, 2005, FOOD CHEM, V91, P601, DOI 10.1016/j.foodchem.2004.06.039; DELLEMONACHE G, 1995, PHYTOCHEMISTRY, V39, P575, DOI 10.1016/0031-9422(94)00971-U; El Mousallami AMD, 2002, PHYTOCHEMISTRY, V60, P807, DOI 10.1016/S0031-9422(02)00177-2; Ranilla LG, 2010, BIORESOURCE TECHNOL, V101, P4676, DOI 10.1016/j.biortech.2010.01.093; Granica S, 2013, J AGR FOOD CHEM, V61, P801, DOI 10.1021/jf304002h; Hillenbrand M, 2004, PLANTA MED, V70, P380, DOI 10.1055/s-2004-818956; Hong JungHee, 2004, Nutritional Sciences, V7, P127; Huang HP, 2008, J AGR FOOD CHEM, V56, P9286, DOI 10.1021/jf8013102; Jeong JC, 2010, NUTR CANCER, V62, P402, DOI 10.1080/01635580903441287; Kang MH, 2012, J AGR FOOD CHEM, V60, P2517, DOI 10.1021/jf205086b; Kang TH, 2006, NEUROSCI LETT, V391, P122, DOI 10.1016/j.neulet.2005.08.053; Kerem Z, 2006, J AGR FOOD CHEM, V54, P1243, DOI 10.1021/jf052436+; Kim HG, 2010, BRIT J NUTR, V104, P8, DOI 10.1017/S0007114510000218; KIM MN, 1992, PLANTA MED, V58, P285, DOI 10.1055/s-2006-961460; Kim SB, 2013, J ETHNOPHARMACOL, V145, P393, DOI 10.1016/j.jep.2012.11.007; Kishore PH, 2003, CHEM PHARM BULL, V51, P194, DOI 10.1248/cpb.51.194; LARSON RA, 1988, PHYTOCHEMISTRY, V27, P969, DOI 10.1016/0031-9422(88)80254-1; Li T., 2005, CHINESE J CLIN PHARM, V10, P1129; Liu LK, 2009, J AGR FOOD CHEM, V57, P7605, DOI 10.1021/jf9014697; Lv PC, 2010, J ENZYM INHIB MED CH, V25, P590, DOI 10.3109/14756360903357551; Mai TT, 2007, J NUTR SCI VITAMINOL, V53, P267, DOI 10.3177/jnsv.53.267; MARKHAM KR, 1984, PHYTOCHEMISTRY, V23, P2049, DOI 10.1016/S0031-9422(00)84968-7; MERFORT I, 1987, PLANTA MED, P434, DOI 10.1055/s-2006-962766; Orhan DD, 2003, PHARM BIOL, V41, P475, DOI 10.1080/13880200308951337; Orhan N, 2006, J ETHNOPHARMACOL, V108, P280, DOI 10.1016/j.jep.2006.05.010; OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290; Pehluvan M, 2012, J ANIM PLANT SCI, V22, P665; Pistelli L, 1996, PHYTOCHEMISTRY, V42, P1455, DOI 10.1016/0031-9422(96)00128-8; Rao RJ, 2003, BIOORG MED CHEM LETT, V13, P2777, DOI 10.1016/S0960-894X(03)00494-3; Reis B, 2010, J AGR FOOD CHEM, V58, P6986, DOI 10.1021/jf100569j; Reynertson KA, 2006, J NAT PROD, V69, P1228, DOI 10.1021/np0600999; Ryu HW, 2010, J AGR FOOD CHEM, V58, P202, DOI 10.1021/jf903068k; SATO Y, 1979, BIOCHEM MED METAB B, V21, P104, DOI 10.1016/0006-2944(79)90061-9; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Seyoum A, 2006, PHYTOCHEMISTRY, V67, P2058, DOI 10.1016/j.phytochem.2006.07.002; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013463; SHEN Z, 1985, PHYTOCHEMISTRY, V24, P155, DOI 10.1016/S0031-9422(00)80826-2; Sroka Z, 2003, FOOD CHEM TOXICOL, V41, P753, DOI 10.1016/S0278-6915(02)00329-0; Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149; Turner A, 2007, J NAT PROD, V70, P253, DOI 10.1021/np060260f; Valentao P, 2001, J AGR FOOD CHEM, V49, P3476, DOI 10.1021/jf001145s; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Wang H, 2010, FOOD CHEM, V123, P6, DOI 10.1016/j.foodchem.2010.03.088; Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a; Wu T, 2008, CHEM NAT COMPD+, V44, P370, DOI 10.1007/s10600-008-9067-2; Wurms K. V., 2006, Asian Journal of Biochemistry, V1, P325; Yang XL, 2010, FOOD CHEM TOXICOL, V48, P2374, DOI 10.1016/j.fct.2010.05.074; Yao Sheng, 2005, Chinese Journal of Natural Medicines, V3, P219; Zhang W, 2008, J FOOD SCI, V73, pC512, DOI 10.1111/j.1750-3841.2008.00854.x	54	156	171	5	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71144	10.1371/journal.pone.0071144	http://dx.doi.org/10.1371/journal.pone.0071144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936259	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200112
J	Yuan, XT; Zhang, T; Wan, XF				Yuan, Xiao-Tong; Zhang, Tong; Wan, Xiu-Feng			A Joint Matrix Completion and Filtering Model for Influenza Serological Data Integration	PLOS ONE			English	Article								Antigenic characterization based on serological data, such as Hemagglutination Inhibition (HI) assay, is one of the routine procedures for influenza vaccine strain selection. In many cases, it would be impossible to measure all pairwise antigenic correlations between testing antigens and reference antisera in each individual experiment. Thus, we have to combine and integrate the HI tables from a number of individual experiments. Measurements from different experiments may be inconsistent due to different experimental conditions. Consequently we will observe a matrix with missing data and possibly inconsistent measurements. In this paper, we develop a new mathematical model, which we refer to as Joint Matrix Completion and Filtering, for HI data integration. In this approach, we simultaneously handle the incompleteness and uncertainty of observations by assuming that the underlying merged HI data matrix has low rank, as well as carefully modeling different levels of noises in each individual table. An efficient blockwise coordinate descent procedure is developed for optimization. The performance of our approach is validated on synthetic and real influenza datasets. The proposed joint matrix completion and filtering model can be adapted as a general model for biological data integration, targeting data noises and missing values within and across experiments.	[Yuan, Xiao-Tong] Nanjing Univ Informat Sci & Technol, Sch Informat & Control, Nanjing, Jiangsu, Peoples R China; [Yuan, Xiao-Tong; Zhang, Tong] Rutgers State Univ, Dept Stat, Piscataway, NJ USA; [Wan, Xiu-Feng] Mississippi State Univ, Dept Basic Sci, Mississippi State, MS 39762 USA	Nanjing University of Information Science & Technology; Rutgers State University New Brunswick; Mississippi State University	Zhang, T (corresponding author), Rutgers State Univ, Dept Stat, Piscataway, NJ USA.	tzhang@stat.rutgers.edu; wan@cvm.msstate.edu	Zhang, Tong/HGC-1090-2022		National Institutes of Health National Institute of Allergy and Infectious Diseases [RC1AI086830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086830] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by National Institutes of Health National Institute of Allergy and Infectious Diseases RC1AI086830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo WK, 2012, INFLUENZA OTHER RESP, V6, P142, DOI 10.1111/j.1750-2659.2011.00277.x; Balzano L, 2010, ABS10064046 CORR; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Cai ZP, 2011, INFLUENZA OTHER RESP, V5, P204; Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Jain P., 2010, ADV NEURAL INFORM PR; Ma SQ, 2011, MATH PROGRAM, V128, P321, DOI 10.1007/s10107-009-0306-5; Papedes A, 2001, J THEOR BIOL, V21, P57; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Wen W, 2010, 1007 TR RIC U	15	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69842	10.1371/journal.pone.0069842	http://dx.doi.org/10.1371/journal.pone.0069842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936111	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300069
J	Barbarese, E; Ifrim, MF; Hsieh, L; Guo, CY; Tatavarty, V; Maggipinto, MJ; Korza, G; Tutolo, JW; Giampetruzzi, A; Le, H; Ma, XM; Levine, E; Bishop, B; Kim, DO; Kuwada, S; Carson, JH				Barbarese, Elisa; Ifrim, Marius F.; Hsieh, Lawrence; Guo, Caiying; Tatavarty, Vedakumar; Maggipinto, Michael J.; Korza, George; Tutolo, Jessica W.; Giampetruzzi, Anthony; Le, Hien; Ma, Xin-Ming; Levine, Eric; Bishop, Brian; Kim, Duck O.; Kuwada, Shigeyuki; Carson, John H.			Conditional Knockout of Tumor Overexpressed Gene in Mouse Neurons Affects RNA Granule Assembly, Granule Translation, LTP and Short Term Habituation	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; BEHAVIORAL CHARACTERIZATION; ULTRASONIC VOCALIZATIONS; PASSIVE-AVOIDANCE; TOG DOMAINS; ARC/ARG3.1; MICE; CONSOLIDATION; POTENTIATION; TRAFFICKING	In neurons, specific RNAs are assembled into granules, which are translated in dendrites, however the functional consequences of granule assembly are not known. Tumor overexpressed gene (TOG) is a granule-associated protein containing multiple binding sites for heterogeneous nuclear ribonucleoprotein (hnRNP) A2, another granule component that recognizes cis-acting sequences called hnRNP A2 response elements (A2REs) present in several granule RNAs. Translation in granules is sporadic, which is believed to reflect monosomal translation, with occasional bursts, which are believed to reflect polysomal translation. In this study, TOG expression was conditionally knocked out (TOG cKO) in mouse hippocampal neurons using cre/lox technology. In TOG cKO cultured neurons granule assembly and bursty translation of activity-regulated cytoskeletal associated (ARC) mRNA, an A2RE RNA, are disrupted. In TOG cKO brain slices synaptic sensitivity and long term potentiation (LTP) are reduced. TOG cKO mice exhibit hyperactivity, perseveration and impaired short term habituation. These results suggest that in hippocampal neurons TOG is required for granule assembly, granule translation and synaptic plasticity, and affects behavior.	[Barbarese, Elisa; Hsieh, Lawrence; Maggipinto, Michael J.; Tutolo, Jessica W.; Giampetruzzi, Anthony; Le, Hien; Ma, Xin-Ming; Levine, Eric; Bishop, Brian; Kim, Duck O.; Kuwada, Shigeyuki] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Ifrim, Marius F.; Tatavarty, Vedakumar; Korza, George; Carson, John H.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT USA; [Guo, Caiying] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Barbarese, E (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA.	barbarese@nso2.uchc.edu	Kim, Duck/AAO-4554-2021	Kim, Duck/0000-0002-1778-3887; Hsieh, Lawrence/0000-0002-5425-9785; levine, eric/0000-0002-2535-9509	National Institutes of Health (NIH) [NS19943, NS15190]; Robert Leet and Clara Guthrie Patterson Trust; University of Connecticut Health Center	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Leet and Clara Guthrie Patterson Trust; University of Connecticut Health Center	This work was supported by grants from the National Institutes of Health (NIH) #NS19943 to EB and #NS15190 to JHC, by a grant from The Robert Leet and Clara Guthrie Patterson Trust to EB, and by grants from the University of Connecticut Health Center to EB and JHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; ANDERSEN P, 1969, ACTA PHYSIOL SCAND, V76, pA4; Baarendse PJJ, 2008, HIPPOCAMPUS, V18, P11, DOI 10.1002/hipo.20356; Bainbridge NK, 2008, BEHAV BRAIN RES, V190, P50, DOI 10.1016/j.bbr.2008.02.001; Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; BARBARESE E, 1995, J CELL SCI, V108, P2781; Bortolotto Zuner A, 2011, Curr Protoc Neurosci, VChapter 6, DOI 10.1002/0471142301.ns0613s54; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brenes JC, 2009, BEHAV BRAIN RES, V197, P125, DOI 10.1016/j.bbr.2008.08.014; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Charrasse S, 1998, J CELL SCI, V111, P1371; Chou T, 2003, BIOPHYS J, V85, P755, DOI 10.1016/S0006-3495(03)74518-4; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cook MN, 2001, BEHAV NEUROSCI, V115, P468, DOI 10.1037/0735-7044.115.2.468; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; D'Hooge R, 1999, NEUROSCI LETT, V273, P93, DOI 10.1016/S0304-3940(99)00647-3; Deacon RMJ, 2005, BEHAV BRAIN RES, V156, P241, DOI 10.1016/j.bbr.2004.05.027; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Deshmukh SS, 2003, J NEUROSCI, V23, P1903; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gould TD, 2008, BEHAV BRAIN RES, V189, P117, DOI 10.1016/j.bbr.2007.12.028; Grossman AW, 2006, BRAIN RES, V1084, P158, DOI 10.1016/j.brainres.2006.02.044; Grutzendler J, 2003, METHODS, V30, P79, DOI 10.1016/S1046-2023(03)00009-4; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Han SP, 2010, TRAFFIC, V11, P886, DOI 10.1111/j.1600-0854.2010.01072.x; Higashida H, 2011, BIOL PHARM BULL, V34, P1369, DOI 10.1248/bpb.34.1369; Hirokawa N, 2006, J NEUROSCI, V26, P7139, DOI 10.1523/JNEUROSCI.1821-06.2006; Hu XD, 2011, J NEUROSCI, V31, P15597, DOI 10.1523/JNEUROSCI.2445-11.2011; Jiang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012278; Khan MA, 2005, BIOCHEMISTRY-US, V44, P4510, DOI 10.1021/bi047298g; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kiraly DD, 2010, BIOL PSYCHIAT, V68, P249, DOI 10.1016/j.biopsych.2010.03.024; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Kosturko LD, 2005, MOL BIOL CELL, V16, P1938, DOI 10.1091/mbc.E04-08-0709; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; RIEKKINEN P, 1993, J PHARMACOL EXP THER, V267, P1484; Sanderson DJ, 2010, NEUROPSYCHOLOGIA, V48, P2303, DOI 10.1016/j.neuropsychologia.2010.03.018; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tatavarty V, 2012, MOL BIOL CELL, V23, P918, DOI 10.1091/mbc.E11-07-0622; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; WYSOCKI CJ, 1982, PHYSIOL BEHAV, V29, P315, DOI 10.1016/0031-9384(82)90021-X; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Zhang GA, 2012, J NEUROSCI, V32, P599, DOI 10.1523/JNEUROSCI.2463-11.2012	65	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69989	10.1371/journal.pone.0069989	http://dx.doi.org/10.1371/journal.pone.0069989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936366	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500021
J	Ihara, M; Kawano, Y; Urano, M; Okabe, A				Ihara, Masaki; Kawano, Yusuke; Urano, Miho; Okabe, Ayako			Light Driven CO2 Fixation by Using Cyanobacterial Photosystem I and NADPH-Dependent Formate Dehydrogenase	PLOS ONE			English	Article							STRAIN PCC 7120; FORMIC-ACID; METABOLISM; GROWTH	The ultimate goal of this research is to construct a new direct CO2 fixation system using photosystems in living algae. Here, we report light-driven formate production from CO2 by using cyanobacterial photosystem I (PS I). Formate, a chemical hydrogen carrier and important industrial material, can be produced from CO2 by using the reducing power and the catalytic function of formate dehydrogenase (FDH). We created a bacterial FDH mutant that experimentally switched the cofactor specificity from NADH to NADPH, and combined it with an in vitro-reconstituted cyanobacterial light-driven NADPH production system consisting of PS I, ferredoxin (Fd), and ferredoxin-NADP(+)-reductase (FNR). Consequently, light-dependent formate production under a CO2 atmosphere was successfully achieved. In addition, we introduced the NADPH-dependent FDH mutant into heterocysts of the cyanobacterium Anabaena sp. PCC 7120 and demonstrated an increased formate concentration in the cells. These results provide a new possibility for photobiological CO2 fixation.	[Ihara, Masaki; Kawano, Yusuke; Urano, Miho; Okabe, Ayako] Shinshu Univ, Fac Agr, Minamiminowa, Nagano, Japan; [Ihara, Masaki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan	Shinshu University; Japan Science & Technology Agency (JST)	Ihara, M (corresponding author), Shinshu Univ, Fac Agr, Minamiminowa, Nagano, Japan.	m_ihara@shinshu-u.ac.jp		Kawano, Yusuke/0000-0002-6845-8902	PRESTO (Precursory Research for Embryonic Science and Technology) in JST (Japan Science and Technology Agency) program	PRESTO (Precursory Research for Embryonic Science and Technology) in JST (Japan Science and Technology Agency) program	This research was supported by PRESTO (Precursory Research for Embryonic Science and Technology) in JST (Japan Science and Technology Agency) program. The URL of any funder's website is "http://www.jst.go.jp/kisoken/presto/en/index.html". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGIS C, 1975, J BIOL CHEM, V250, P2783; Bothe H, 2010, MICROBIOL MOL BIOL R, V74, P529, DOI 10.1128/MMBR.00033-10; Crable Bryan R, 2011, Enzyme Res, V2011, P532536, DOI 10.4061/2011/532536; Ehira S, 2012, MICROBIOL-SGM, V158, P1437, DOI 10.1099/mic.0.057729-0; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; FERRY JG, 1990, FEMS MICROBIOL LETT, V87, P377, DOI 10.1111/j.1574-6968.1990.tb04940.x; HORNSEY DJ, 1971, INT J APPL RADIAT IS, V22, P381, DOI 10.1016/0020-708X(71)90066-4; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Kurayama F, 2004, ADV POWDER TECHNOL, V15, P51, DOI 10.1163/15685520460740061; Leonhartsberger S, 2002, J MOL MICROB BIOTECH, V4, P269; Miyatani R, 2004, J MOL CATAL B-ENZYM, V27, P121, DOI 10.1016/j.molcatb.2003.11.003; Moal G, 2012, BBA-BIOENERGETICS, V1817, P1635, DOI 10.1016/j.bbabio.2012.05.015; Nakamoto H, 1999, PLANT CELL PHYSIOL, V40, P9, DOI 10.1093/oxfordjournals.pcp.a029479; THOMAS CM, 1987, ANNU REV MICROBIOL, V41, P77, DOI 10.1146/annurev.mi.41.100187.000453; Tsujisho I, 2006, CATAL COMMUN, V7, P173, DOI 10.1016/j.catcom.2005.10.005; Wang Y, 2005, J BACTERIOL, V187, P8489, DOI 10.1128/JB.187.24.8489-8493.2005; WEI TF, 1994, J BACTERIOL, V176, P4473, DOI 10.1128/JB.176.15.4473-4482.1994; Wu WH, 2009, J MOL CATAL B-ENZYM, V61, P157, DOI 10.1016/j.molcatb.2009.06.005; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935	20	20	20	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71581	10.1371/journal.pone.0071581	http://dx.doi.org/10.1371/journal.pone.0071581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936519	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500078
J	Morozov, VY; Ioshikhes, IP				Morozov, Vyacheslav Y.; Ioshikhes, Ilya P.			Optimized Position Weight Matrices in Prediction of Novel Putative Binding Sites for Transcription Factors in the Drosophila melanogaster Genome	PLOS ONE			English	Article							PROTEIN; IDENTIFICATION; SPECIFICITIES; HOMEODOMAIN; DISCOVERY; WORDS	Position weight matrices (PWMs) have become a tool of choice for the identification of transcription factor binding sites in DNA sequences. DNA-binding proteins often show degeneracy in their binding requirement and thus the overall binding specificity of many proteins is unknown and remains an active area of research. Although existing PWMs are more reliable predictors than consensus string matching, they generally result in a high number of false positive hits. Our previous study introduced a promising approach to PWM refinement in which known motifs are used to computationally mine putative binding sites directly from aligned promoter regions using composition of similar sites. In the present study, we extended this technique originally tested on single examples of transcription factors (TFs) and showed its capability to optimize PWM performance to predict new binding sites in the fruit fly genome. We propose refined PWMs in mono-and dinucleotide versions similarly computed for a large variety of transcription factors of Drosophila melanogaster. Along with the addition of many auxiliary sites the optimization includes variation of the PWM motif length, the binding sites location on the promoters and the PWM score threshold. To assess the predictive performance of the refined PWMs we compared them to conventional TRANSFAC and JASPAR sources. The results have been verified using performed tests and literature review. Overall, the refined PWMs containing putative sites derived from real promoter content processed using optimized parameters had better general accuracy than conventional PWMs.	[Morozov, Vyacheslav Y.; Ioshikhes, Ilya P.] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Ioshikhes, Ilya P.] Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Ioshikhes, Ilya P.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Ioshikhes, IP (corresponding author), Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada.	iioschik@uottawa.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN/372240-2009]; Canada Foundation for Innovation [22880]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported by a Natural Sciences and Engineering Research Council of Canada http://www.nserc-crsng.gc.ca/index_eng.asp (grant number RGPIN/372240-2009) and Canada Foundation for Innovation Leaders Opportunity Fund/Ontario Research Fund http://www.innovation.ca/(grant number 22880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berger Michael F., 2006, V338, P245; BIGGIN MD, 1988, CELL, V53, P713, DOI 10.1016/0092-8674(88)90089-X; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Burden Heather E, 2005, Genome Inform, V16, P49; Carey M.F., 2008, TRANSCRIPTIONAL REGU; Chen KB, 2010, BIOINFORMATICS, V26, pi504, DOI 10.1093/bioinformatics/btq379; CHERBAS L, 1993, INSECT BIOCHEM MOLEC, V23, P81, DOI 10.1016/0965-1748(93)90085-7; DORN A, 1992, EMBO J, V11, P279, DOI 10.1002/j.1460-2075.1992.tb05050.x; EKKER SC, 1991, EMBO J, V10, P1179, DOI 10.1002/j.1460-2075.1991.tb08058.x; EKKER SC, 1992, EMBO J, V11, P4059, DOI 10.1002/j.1460-2075.1992.tb05499.x; Gershenzon NI, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-161; Gershenzon NI, 2005, NUCLEIC ACIDS RES, V33, P2290, DOI 10.1093/nar/gki519; Hertzberg L, 2007, BIOINFORMATICS, V23, P1737, DOI 10.1093/bioinformatics/btm249; JOHNSON FB, 1990, GENE DEV, V4, P1044, DOI 10.1101/gad.4.6.1044; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Leung MY, 1996, J COMPUT BIOL, V3, P345, DOI 10.1089/cmb.1996.3.345; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mitchell T.M, 2003, MACH LEARN; Mohrmann L, 2002, J BIOL CHEM, V277, P47385, DOI 10.1074/jbc.M202341200; Moses AM, 2006, PLOS COMPUT BIOL, V13, P3551; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Orihara M, 1999, GENES CELLS, V4, P205, DOI 10.1046/j.1365-2443.1999.00254.x; Pickert L, 1998, BIOINFORMATICS, V14, P244, DOI 10.1093/bioinformatics/14.3.244; PRUM B, 1995, J ROY STAT SOC B MET, V57, P205; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sinha S, 2002, NUCLEIC ACIDS RES, V30, P5549, DOI 10.1093/nar/gkf669; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x	35	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e68712	10.1371/journal.pone.0068712	http://dx.doi.org/10.1371/journal.pone.0068712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936309	gold, Green Published			2022-12-27	WOS:000324401500006
J	Zhang, XJ; Yao, Q; Cai, ZP; Xie, XL; Zhu, HH				Zhang, Xianjiao; Yao, Qing; Cai, Zhuoping; Xie, Xiaolin; Zhu, Honghui			Isolation and Identification of Myxobacteria from Saline-Alkaline Soils in Xinjiang, China	PLOS ONE			English	Article							GEN. NOV.; MARINE MYXOBACTERIUM; PATTERNS	Fifty-eight terrestrial and salt-tolerant myxobacteria were isolated from the saline-alkaline soils collected from Xinjiang, China. Based on the morphologies and the 16S rRNA gene sequences, these isolates were assigned into 6 genera, Myxococcus, Cystobacter, Corallococcus, Sorangium, Nannocystis and Polyangium. All the strains grew better with 1% NaCl than without NaCl. Some Myxococcus strains were able to grow at 2% NaCl concentration, suggesting that these strains may be particular type of terrestrial myxobacteria.	[Zhang, Xianjiao; Zhu, Honghui] Tarim Univ, Coll Life Sci, Xinjiang Prod & Struct Corps Key Lab Protect & Ut, Alar, Xinjiang, Peoples R China; [Zhang, Xianjiao; Cai, Zhuoping; Xie, Xiaolin; Zhu, Honghui] Guangdong Inst Microbiol, Guangdong Prov Microbial Culture Collect & Applic, Guangdong Open Lab Appl Microbiol, State Key Lab Appl Microbiol Minist Guangdong Pro, Guangzhou, Guangdong, Peoples R China; [Yao, Qing] South China Agr Univ, Guangzhou, Guangdong, Peoples R China	Tarim University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; South China Agricultural University	Zhu, HH (corresponding author), Tarim Univ, Coll Life Sci, Xinjiang Prod & Struct Corps Key Lab Protect & Ut, Alar, Xinjiang, Peoples R China.	zhuhonghui66@yahoo.com.cn	YAO, Qing/B-3206-2009; Zhu, Honghui/N-2251-2015	YAO, Qing/0000-0003-3449-6166; ZHU, Honghui/0000-0001-6854-8417	Natural Science Foundation of China [31170009]; Natural Science Foundation of Guangdong [10151007002000008]; Opening Project by Xinjiang Production & Struction Corps Key Laboratory of Protection & Utilization of Biological Resources in Tarim Basin [BRZD1004]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Opening Project by Xinjiang Production & Struction Corps Key Laboratory of Protection & Utilization of Biological Resources in Tarim Basin	This work was supported by Natural Science Foundation of China (Project no. 31170009), Natural Science Foundation of Guangdong (Project no. 10151007002000008), and the Opening Project by Xinjiang Production & Struction Corps Key Laboratory of Protection & Utilization of Biological Resources in Tarim Basin (Project no. BRZD1004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fang XM, 2001, BIODIV SCI, V9, P207; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Fudou R, 2002, J GEN APPL MICROBIOL, V48, P109, DOI 10.2323/jgam.48.109; Iizuka T, 1998, FEMS MICROBIOL LETT, V169, P317, DOI 10.1111/j.1574-6968.1998.tb13335.x; Iizuka T, 2003, SYST APPL MICROBIOL, V26, P189, DOI 10.1078/072320203322346038; Iizuka T, 2003, INT J SYST EVOL MICR, V53, P189, DOI 10.1099/ijs.0.02418-0; Kampfer P, 1996, CAN J MICROBIOL, V42, P989; Li WJ, 2007, INT J SYST EVOL MICR, V57, P1424, DOI 10.1099/ijs.0.64749-0; Li YZ, 2002, J MICROBIOL METH, V50, P205, DOI 10.1016/S0167-7012(02)00029-5; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; NELLIS LF, 1964, J BACTERIOL, V87, P230, DOI 10.1128/JB.87.1.230-231.1964; REICHENBACH H, 1983, Journal of Microbiological Methods, V1, P77, DOI 10.1016/0167-7012(83)90017-9; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Reichenbach H, 2001, J IND MICROBIOL BIOT, V27, P149, DOI 10.1038/sj.jim.7000025; Reichenbach H., 2005, BERGEYS MANUAL SYSTE, V2, P1059; Reichenbach H., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_26; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Sasser M, 1990, IDENTIFICATION BACTE; SHIMKETS L, 1992, P NATL ACAD SCI USA, V89, P9459, DOI 10.1073/pnas.89.20.9459; Singh BN, 1971, INDIAN J MICROBIOL, V11, P47; Sproer C, 1999, INT J SYST BACTERIOL, V49, P1255, DOI 10.1099/00207713-49-3-1255; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wenzel SC, 2009, MOL BIOSYST, V5, P567, DOI 10.1039/b901287g; Wu ZH, 2005, ENVIRON MICROBIOL, V7, P1602, DOI 10.1111/j.1462-2920.2005.00852.x; Zhang J, 2002, APPL MICROBIOL BIOT, V59, P517, DOI 10.1007/s00253-002-1023-7; Zhang YQ, 2005, APPL ENVIRON MICROB, V71, P3331, DOI 10.1128/AEM.71.6.3331-3336.2005	31	15	20	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70466	10.1371/journal.pone.0070466	http://dx.doi.org/10.1371/journal.pone.0070466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936436	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500038
J	Portero-Tresserra, M; Cristobal-Narvaez, P; Marti-Nicolovius, M; Guillazo-Blanch, G; Vale-Martinez, A				Portero-Tresserra, Marta; Cristobal-Narvaez, Paula; Marti-Nicolovius, Margarita; Guillazo-Blanch, Gemma; Vale-Martinez, Anna			D-cycloserine in Prelimbic Cortex Reverses Scopolamine-Induced Deficits in Olfactory Memory in Rats	PLOS ONE			English	Article							METHYL-D-ASPARTATE; MUSCARINIC RECEPTOR BLOCKADE; MEDIAL PREFRONTAL CORTEX; GLYCINE SITE AGONIST; NMDA RECEPTOR; FEAR EXTINCTION; WORKING-MEMORY; SOCIAL TRANSMISSION; CONTEXTUAL FEAR; SPATIAL MEMORY	A significant interaction between N-methyl-D-aspartate (NMDA) and muscarinic receptors has been suggested in the modulation of learning and memory processes. The present study further investigates this issue and explores whether d-cycloserine (DCS), a partial agonist at the glycine binding site of the NMDA receptors that has been regarded as a cognitive enhancer, would reverse scopolamine (SCOP)-induced amnesia in two olfactory learning tasks when administered into the prelimbic cortex (PLC). Thus, in experiment 1, DCS (10 mg/site) was infused prior to acquisition of odor discrimination (ODT) and social transmission of food preference (STFP), which have been previously characterized as paradigms sensitive to PLC muscarinic blockade. Immediately after learning such tasks, SCOP was injected (20 mg/site) and the effects of both drugs (alone and combined) were tested in 24-h retention tests. To assess whether DCS effects may depend on the difficulty of the task, in the STFP the rats expressed their food preference either in a standard two-choice test (experiment 1) or a more challenging three-choice test (experiment 2). The results showed that bilateral intra-PLC infusions of SCOP markedly disrupted the ODT and STFP memory tests. Additionally, infusions of DCS alone into the PLC enhanced ODT but not STFP retention. However, the DCS treatment reversed SCOP-induced memory deficits in both tasks, and this effect seemed more apparent in ODT and 3-choice STFP. Such results support the interaction between the glutamatergic and the cholinergic systems in the PLC in such a way that positive modulation of the NMDA receptor/channel, through activation of the glycine binding site, may compensate dysfunction of muscarinic neurotransmission involved in stimulus-reward and relational learning tasks.	[Portero-Tresserra, Marta; Cristobal-Narvaez, Paula; Marti-Nicolovius, Margarita; Guillazo-Blanch, Gemma; Vale-Martinez, Anna] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, Inst Neurociencies, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Vale-Martinez, A (corresponding author), Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, Inst Neurociencies, E-08193 Barcelona, Spain.	anna.vale@uab.cat	Guillazo-Blanch, Gemma/E-9765-2011; Guillazo-Blanch, Gemma/N-8060-2019; Marti-Nicolovius, Margarita/C-9244-2011; Cristóbal-Narváez, Paula/K-3265-2017; Vale-Martinez, Anna/C-9690-2011; Cristóbal-Narváez, Paula/AFU-7048-2022; PORTERO-TRESSERRA, MARTA/F-3350-2016	Guillazo-Blanch, Gemma/0000-0002-8297-7100; Guillazo-Blanch, Gemma/0000-0002-8297-7100; Marti-Nicolovius, Margarita/0000-0002-8669-6285; Cristóbal-Narváez, Paula/0000-0001-8184-6347; Vale-Martinez, Anna/0000-0001-7369-7134; Cristóbal-Narváez, Paula/0000-0001-8184-6347; PORTERO-TRESSERRA, MARTA/0000-0003-4149-1339	Ministerio de Ciencia e Innovacion [PSI2011-26862]; Ministerio de Ciencia e Innovacion (FPI) [BES-2009-015395]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Ciencia e Innovacion (FPI)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by funds from the Ministerio de Ciencia e Innovacion (PSI2011-26862; FPI grant to MP-T: BES-2009-015395) http://www.idi.mineco.gob.es/portal/site/MICINN/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2001, NEUROREPORT, V12, P3375, DOI 10.1097/00001756-200110290-00045; Akirav I, 2009, LEARN MEMORY, V16, P682, DOI 10.1101/lm.1565109; Alvarez P, 2002, NEUROBIOL LEARN MEM, V78, P470, DOI 10.1006/nlme.2002.4068; Andersen JM, 2002, BEHAV BRAIN RES, V129, P211, DOI 10.1016/S0166-4328(01)00318-7; [Anonymous], PSYCHOPHARMACOLOGY, V215, P549; Assini FL, 2009, BEHAV BRAIN RES, V204, P206, DOI 10.1016/j.bbr.2009.06.005; Aura J, 1998, EUR J PHARMACOL, V342, P15, DOI 10.1016/S0014-2999(97)01512-4; Aura J, 2000, EUR J PHARMACOL, V390, P313, DOI 10.1016/S0014-2999(00)00054-6; BAXTER MG, 1994, NEUROBIOL AGING, V15, P207, DOI 10.1016/0197-4580(94)90114-7; Billard JM, 2007, EUR J NEUROSCI, V25, P2260, DOI 10.1111/j.1460-9568.2007.05488.x; Boix-Trelis N, 2007, NEUROBIOL LEARN MEM, V87, P659, DOI 10.1016/j.nlm.2006.12.003; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; Burne THJ, 2010, NEUROBIOL LEARN MEM, V93, P268, DOI 10.1016/j.nlm.2009.10.007; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; Carballo-Marquez A, 2007, LEARN MEMORY, V14, P616, DOI 10.1101/lm.597507; Carballo-Marquez A, 2009, NEUROBIOL LEARN MEM, V91, P98, DOI 10.1016/j.nlm.2008.09.014; Carballo-Marquez A, 2009, HIPPOCAMPUS, V19, P446, DOI 10.1002/hipo.20530; Chang CH, 2011, LEARN MEMORY, V18, P221, DOI 10.1101/lm.2070111; CHESSELL IP, 1995, NEUROPHARMACOLOGY, V34, P1289, DOI 10.1016/0028-3908(95)00096-O; Collingridge GL, 2003, NEUROSCI RES, V47, P3, DOI 10.1016/S0168-0102(03)00160-3; Delatour B, 2000, BEHAV BRAIN RES, V109, P113, DOI 10.1016/S0166-4328(99)00168-0; DIJK SN, 1995, BRIT J PHARMACOL, V115, P1169, DOI 10.1111/j.1476-5381.1995.tb15020.x; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Drever BD, 2007, J ALZHEIMERS DIS, V12, P319; Dubiela FP, 2005, BRAIN RES, V1037, P157, DOI 10.1016/j.brainres.2005.01.005; Eichenbaum H, 1999, BEHAV BRAIN RES, V103, P123, DOI 10.1016/S0166-4328(99)00044-3; FISHKIN RJ, 1993, BEHAV NEURAL BIOL, V59, P150, DOI 10.1016/0163-1047(93)90886-M; Golden GJ, 2007, PHARMACOL BIOCHEM BE, V86, P587, DOI 10.1016/j.pbb.2007.02.004; GREUEL JM, 1988, SCIENCE, V242, P74, DOI 10.1126/science.2902687; Hlinak Z, 1998, BEHAV BRAIN RES, V91, P83, DOI 10.1016/S0166-4328(97)00107-1; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kawabe K, 1998, BRAIN RES, V814, P226, DOI 10.1016/S0006-8993(98)01043-9; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Khakpai F, 2012, BEHAV BRAIN RES, V231, P1, DOI 10.1016/j.bbr.2012.02.049; Kishi A, 1998, NEUROSCI LETT, V257, P131, DOI 10.1016/S0304-3940(98)00824-6; Klinkenberg I, 2011, COMP SCOPOLAMINE BIP; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Kochlamazashvili G, 2012, J NEUROSCI, V32, P2263, DOI 10.1523/JNEUROSCI.5103-11.2012; Kuriyama K, 2011, PSYCHOPHARMACOLOGY, V218, P589, DOI 10.1007/s00213-011-2353-x; Kuriyama K, 2011, NEUROBIOL LEARN MEM, V95, P505, DOI 10.1016/j.nlm.2011.02.017; Land C, 1999, NEUROBIOL LEARN MEM, V72, P158, DOI 10.1006/nlme.1998.3897; Lelong V, 2001, NEUROPHARMACOLOGY, V41, P517, DOI 10.1016/S0028-3908(01)00085-5; Li HB, 1997, BEHAV BRAIN RES, V83, P225, DOI 10.1016/S0166-4328(97)86075-5; Lovibond PF, 2011, BIOL PSYCHOL, V87, P393, DOI 10.1016/j.biopsycho.2011.05.002; Mahmoodi G, 2010, NEUROBIOL LEARN MEM, V94, P83, DOI 10.1016/j.nlm.2010.04.004; MARKRAM H, 1990, NEUROSCI LETT, V113, P62, DOI 10.1016/0304-3940(90)90495-U; Matsuoka N, 1996, J PHARMACOL EXP THER, V278, P891; Matsuoka N, 1996, NEUROREPORT, V7, P565, DOI 10.1097/00001756-199601310-00045; Mattinson CE, 2011, J NEUROSCI METH, V202, P199, DOI 10.1016/j.jneumeth.2011.08.020; Miranda MI, 2007, NEUROBIOL LEARN MEM, V87, P343, DOI 10.1016/j.nlm.2006.09.010; Navakkode S, 2012, HIPPOCAMPUS, V22, P335, DOI 10.1002/hipo.20902; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; Nunnink M, 2007, PHARMACOL BIOCHEM BE, V87, P321, DOI 10.1016/j.pbb.2007.05.006; Ohno M, 1996, EUR J PHARMACOL, V318, P267, DOI 10.1016/S0014-2999(96)00907-7; Onur OA, 2010, BIOL PSYCHIAT, V67, P1205, DOI 10.1016/j.biopsych.2010.01.022; Otani S, 2003, J PHYSIOL-PARIS, V97, P423, DOI 10.1016/j.jphysparis.2004.01.002; Oualian Catherine, 2010, Learn Mem, V17, P654, DOI 10.1101/lm.1858010; Ozawa T, 2012, NEUROSCI LETT, V509, P13, DOI 10.1016/j.neulet.2011.12.031; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Figueredo LZP, 2008, BRAIN RES BULL, V77, P71, DOI 10.1016/j.brainresbull.2008.05.008; Peters J, 2013, NEUROSCIENCE, V230, P24, DOI 10.1016/j.neuroscience.2012.11.004; PITKANEN M, 1995, J NEURAL TRANSM-PARK, V9, P133, DOI 10.1007/BF02259655; Pitkanen M, 1995, EUR NEUROPSYCHOPHARM, V5, P457; Portero-Tresserra M, 2013, NEUROBIOL LEARN MEM, V100, P1, DOI 10.1016/j.nlm.2012.11.003; Pussinen R, 1999, J PSYCHOPHARMACOL, V13, P171, DOI 10.1177/026988119901300210; Puumala T, 1998, EUR NEUROPSYCHOPHARM, V8, P17, DOI 10.1016/S0924-977X(97)00040-0; QUARTERMAIN D, 1994, EUR J PHARMACOL, V257, P7, DOI 10.1016/0014-2999(94)90687-4; Quiroz-Padilla MF, 2007, NEUROBIOL LEARN MEM, V88, P198, DOI 10.1016/j.nlm.2007.06.002; Quiroz-Padilla MF, 2006, NEUROBIOL LEARN MEM, V86, P256, DOI 10.1016/j.nlm.2006.03.007; Ren JT, 2013, PROG NEURO-PSYCHOPH, V44, P257, DOI 10.1016/j.pnpbp.2013.02.017; Riedel G, 2009, BEHAV BRAIN RES, V204, P217, DOI 10.1016/j.bbr.2009.06.012; RIEKKINEN P, 1995, BRAIN RES, V685, P46, DOI 10.1016/0006-8993(95)00422-M; Riekkinen P, 1998, NEUROREPORT, V9, P1633, DOI 10.1097/00001756-199805110-00068; Roberts M, 2002, BEHAV NEUROSCI, V116, P1059, DOI 10.1037//0735-7044.116.6.1059; Rodgers RJ, 2011, BEHAV NEUROSCI, V125, P106, DOI 10.1037/a0022343; Ross RS, 2006, J NEUROSCI, V26, P4852, DOI 10.1523/JNEUROSCI.0659-06.2006; Ross RS, 2005, LEARN MEMORY, V12, P302, DOI 10.1101/lm.91605; Rouaud E, 2003, BRIT J PHARMACOL, V140, P1051, DOI 10.1038/sj.bjp.0705541; Saito Y, 2013, SYNAPSE, V67, P161, DOI 10.1002/syn.21621; SCHUSTER GM, 1992, EUR J PHARMACOL, V224, P97, DOI 10.1016/0014-2999(92)94825-G; SIRVIO J, 1992, NEUROSCI LETT, V146, P215, DOI 10.1016/0304-3940(92)90081-H; Sunyer B, 2008, AMINO ACIDS, V34, P485, DOI 10.1007/s00726-007-0511-6; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; THOMPSON LT, 1992, NATURE, V359, P638, DOI 10.1038/359638a0; Tronel S, 2003, J NEUROSCI, V23, P5472; Tronel S, 2002, LEARN MEMORY, V9, P105, DOI 10.1101/lm.47802; Vale-Martinez A, 2002, EUR J NEUROSCI, V16, P983, DOI 10.1046/j.1460-9568.2002.02153.x; van Kerkhof LWM, 2013, NEUROPSYCHOPHARMACOL, V38, P1899, DOI 10.1038/npp.2013.83; VIDAL C, 1993, NEUROSCIENCE, V56, P23, DOI 10.1016/0306-4522(93)90558-W; Villarejo-Rodriguez I, 2013, BEHAV BRAIN RES, V238, P289, DOI 10.1016/j.bbr.2012.10.041; Villarejo-Rodriguez I, 2010, BEHAV BRAIN RES, V213, P113, DOI 10.1016/j.bbr.2010.04.016; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Wallenstein GV, 2001, NEUROBIOL LEARN MEM, V75, P245, DOI 10.1006/nlme.2001.4005; WINOCUR G, 1990, BEHAV NEUROSCI, V104, P544, DOI 10.1037/0735-7044.104.4.544; Winocur G, 1998, BEHAV NEUROSCI, V112, P89, DOI 10.1037/0735-7044.112.1.89; Winocur G, 1999, J NEUROSCI, V19, P9611; Winocur G, 2001, HIPPOCAMPUS, V11, P18, DOI 10.1002/1098-1063(2001)11:1<18::AID-HIPO1016>3.0.CO;2-5; Wrenn CC, 2003, BEHAV NEUROSCI, V117, P21, DOI 10.1037/0735-7044.117.1.21; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Yamamoto S, 2008, NEUROPSYCHOPHARMACOL, V33, P2108, DOI 10.1038/sj.npp.1301605; Zhang XL, 2008, NEUROPHARMACOLOGY, V55, P1238, DOI 10.1016/j.neuropharm.2008.08.018; Zlomuzica A, 2007, PSYCHOPHARMACOLOGY, V193, P503, DOI 10.1007/s00213-007-0816-x	103	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70584	10.1371/journal.pone.0070584	http://dx.doi.org/10.1371/journal.pone.0070584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936452	gold, Green Published, Green Submitted			2022-12-27	WOS:000324545800046
J	Wang, ZL; Zou, L; Zhong, R; Zhu, BB; Chen, W; Shen, N; Ke, JT; Lou, J; Song, RR; Miao, XP				Wang, Zhenling; Zou, Li; Zhong, Rong; Zhu, Beibei; Chen, Wei; Shen, Na; Ke, Juntao; Lou, Jiao; Song, Ranran; Miao, Xiao-Ping			Associations between Two Genetic Variants in NKX2-5 and Risk of Congenital Heart Disease in Chinese Population: A Meta-Analysis	PLOS ONE			English	Article							VENTRICULAR SEPTAL-DEFECTS; MOLECULAR-CLONING; MUTATIONS; GATA4; EXPRESSION; PATHWAYS; PROMOTER; PROTEIN	Background: NKX2-5 is a transcriptional factor, which plays an important role in heart formation and development. Two genetic variants in the coding region of NKX2-5, 63A>G (rs2277923) and 606G>C (rs3729753), have been investigated in the risk of congenital heart disease (CHD), although with inconsistent results. Thus, a meta-analysis was performed to clarify the associations between the two variants and CHD risk in the Chinese population. Methods and Results: Relevant studies were identified by searching PubMed, ISI Web of Science and CNKI databases and by reviewing the reference lists of retrieved articles. Then, the data from eligible studies were combined in an allelic model. A total of 7 and 4 studies were ultimately included for 63A>G and 606G>C, respectively. The results of overall meta-analyses showed that significant association was detected for 63A>G (OR = 1.26, 95% CI = 1.02-1.56, P-heterogeneity = 0.009, I-2 = 65.1%), but not for 606G>C (OR = 1.22, 95% CI = 0.75-1.96, P-heterogeneity = 0.412, I-2 = 0.0%). Regarding 63A>G variant, positive results were also obtained in the subgroups of atrial septal defect and large-sample-size study. Besides, the sensitivity analysis indicated that significant association was still detected after deletion of the individual studies with positive result and striking heterogeneity. Conclusion: Our results revealed that the 63A>G variant in NKX2-5, but not the 606G>C, may contribute to CHD risk for Chinese.	[Wang, Zhenling; Zou, Li; Zhong, Rong; Zhu, Beibei; Chen, Wei; Shen, Na; Ke, Juntao; Lou, Jiao; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Wang, Zhenling; Zou, Li; Zhong, Rong; Zhu, Beibei; Chen, Wei; Shen, Na; Ke, Juntao; Lou, Jiao; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat,Tongji Med Co, Minist Educ,Key Lab Environm & Hlth,Sch Publ Hlth, Minist Environm Protect,Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Song, Ranran] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Song, RR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430074, Peoples R China.	ranransong@gmail.com; miaoxp@mail.hust.edu.cn	Song, Ranran/Z-3997-2019; miao, xiaoping/C-4336-2011; Zhong, Rong/Q-1813-2019	Song, Ranran/0000-0002-8354-7698; miao, xiaoping/0000-0002-6818-9722; 				Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Beffagna G, 2012, J CARDIOVASC MED HAG; Benson DW, 2010, PEDIATR CARDIOL, V31, P422, DOI 10.1007/s00246-009-9607-y; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dinesh SM, 2010, NY SCI J, V3, P43; Ding Jian-Dong, 2009, Zhonghua Yi Xue Za Zhi, V89, P1114; Draus JM, 2009, J MED GENET, V46, P115, DOI 10.1136/jmg.2008.060277; Dunwoodie SL, 2007, SEMIN CELL DEV BIOL, V18, P54, DOI 10.1016/j.semcdb.2006.12.003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Granados-Riveron JT, 2012, CONGENIT HEART DIS, V7, P151, DOI 10.1111/j.1747-0803.2011.00573.x; Hamanoue H, 2009, CARDIOL YOUNG, V19, P482, DOI 10.1017/S1047951109990813; Kasahara H, 2003, J MOL CELL CARDIOL, V35, P243, DOI 10.1016/S0022-2828(03)00002-6; Khetyar M, 2008, GENET TEST, V12, P467, DOI 10.1089/gte.2007.0122; Kiewitz R, 2000, BBA-MOL CELL RES, V1498, P207, DOI 10.1016/S0167-4889(00)00097-5; Liu Xing-yuan, 2009, Zhonghua Yi Xue Za Zhi, V89, P2395; Liu Xing-yuan, 2009, Zhonghua Er Ke Za Zhi, V47, P696; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MANTEL N, 1959, J NATL CANCER I, V22, P719; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; Pang SC, 2012, PEDIATR CARDIOL, V33, P1355, DOI 10.1007/s00246-012-0346-0; Peng T, 2010, GENETICA, V138, P1231, DOI 10.1007/s10709-010-9522-4; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Ping OY, 2011, CLIN CHIM ACTA, V412, P170, DOI 10.1016/j.cca.2010.09.035; Reamon-Buettner SM, 2004, J MED GENET, V41, P684, DOI 10.1136/jmg.2003.017483; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Scholl AM, 2009, WIRES SYST BIOL MED, V1, P220, DOI 10.1002/wsbm.8; Shi L, 2005, J CAPITAL U MED SCI, V26; Shieh JTC, 2012, AM J MED GENET A, V158A, P1236, DOI 10.1002/ajmg.a.35272; Shiojima I, 1996, CIRC RES, V79, P920, DOI 10.1161/01.RES.79.5.920; Song RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025603; Stallmeyer B, 2010, CLIN GENET, V78, P533, DOI 10.1111/j.1399-0004.2010.01422.x; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Terada R, 2011, CARDIOVASC RES, V91, P289, DOI 10.1093/cvr/cvr037; Torrado Mario, 2005, J Mol Cell Cardiol, V38, P353, DOI 10.1016/j.yjmcc.2004.11.034; Turbay D, 1996, MOL MED, V2, P86, DOI 10.1007/BF03402205; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Verheugt CL, 2010, EUR HEART J, V31, P1220, DOI 10.1093/eurheartj/ehq032; Watanabe Y, 2012, P NATL ACAD SCI; Willingham-Rocky LA, 2007, GENE EXPR PATTERNS, V7, P66, DOI 10.1016/j.modgep.2006.05.010; Wu GH, 2012, TRANSL RES, V159, P376, DOI 10.1016/j.trsl.2011.10.012; Xiong F, 2012, CARDIOVASC PATHOL; Zhang WM, 2009, GENET TEST MOL BIOMA, V13, P159, DOI 10.1089/gtmb.2008.0044; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536; Zou L, 2012, AM J MED GENET B, V159B, P970, DOI 10.1002/ajmg.b.32102; Zou YM, 1997, DEVELOPMENT, V124, P793	49	11	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70979	10.1371/journal.pone.0070979	http://dx.doi.org/10.1371/journal.pone.0070979			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936479	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800058
J	Li, LN; Dimitriadis, EK; Yang, Y; Li, J; Yuan, ZH; Qiao, CP; Beley, C; Smith, RH; Garcia, L; Kotin, RM				Li, Lina; Dimitriadis, Emilios K.; Yang, Yu; Li, Juan; Yuan, Zhenhua; Qiao, Chunping; Beley, Cyriaque; Smith, Richard H.; Garcia, Luis; Kotin, Robert M.			Production and Characterization of Novel Recombinant Adeno-Associated Virus Replicative-Form Genomes: A Eukaryotic Source of DNA for Gene Transfer	PLOS ONE			English	Article							PLASMID DNA; ESCHERICHIA-COLI; IMMUNE-RESPONSES; IN-VITRO; EFFICIENT TRANSDUCTION; VIRAL VECTORS; INSECT CELLS; REP PROTEIN; THERAPY; TOLL-LIKE-RECEPTOR-9	Conventional non-viral gene transfer uses bacterial plasmid DNA containing antibiotic resistance genes, cis-acting bacterial sequence elements, and prokaryotic methylation patterns that may adversely affect transgene expression and vector stability in vivo. Here, we describe novel replicative forms of a eukaryotic vector DNA that consist solely of an expression cassette flanked by adeno-associated virus (AAV) inverted terminal repeats. Extensive structural analyses revealed that this AAV-derived vector DNA consists of linear, duplex molecules with covalently closed ends (termed closed-ended, linear duplex, or "CELiD'', DNA). CELiD vectors, produced in Sf9 insect cells, require AAV rep gene expression for amplification. Amounts of CELiD DNA produced from insect cell lines stably transfected with an ITR-flanked transgene exceeded 60 mg per 5x10(9) Sf9 cells, and 1-15 mg from a comparable number of parental Sf9 cells in which the transgene was introduced via recombinant baculovirus infection. In mice, systemically delivered CELiD DNA resulted in long-term, stable transgene expression in the liver. CELiD vectors represent a novel eukaryotic alternative to bacterial plasmid DNA.	[Li, Lina; Yang, Yu; Smith, Richard H.; Kotin, Robert M.] NHLBI, Lab Mol Virol & Gene Therapy, NIH, Bethesda, MD 20892 USA; [Dimitriadis, Emilios K.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA; [Li, Juan; Yuan, Zhenhua; Qiao, Chunping] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA; [Beley, Cyriaque; Garcia, Luis] Univ Versailles, Fac Hlth Sci, St Quentin En Yvelines, France	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); University of North Carolina; University of North Carolina Chapel Hill; UDICE-French Research Universities; Universite Paris Saclay	Kotin, RM (corresponding author), NHLBI, Lab Mol Virol & Gene Therapy, NIH, Bldg 10, Bethesda, MD 20892 USA.	kotinr@nhlbi.nih.gov	García, Luis V/GQA-9712-2022		National Heart, Lung, and Blood Institute (RMK); National Institute of Biomedical Engineering Imaging and Bioengineering; National Institutes of Health; International Collaborative Effort (ICE) for Duchenne Muscular Dystrophy; Duchenne Parent 1 Project France; Association Monegasquecontre les Myopathies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000085] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (RMK); National Institute of Biomedical Engineering Imaging and Bioengineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Collaborative Effort (ICE) for Duchenne Muscular Dystrophy; Duchenne Parent 1 Project France; Association Monegasquecontre les Myopathies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by Intramural Research Programs of the National Heart, Lung, and Blood Institute (RMK) and National Institute of Biomedical Engineering Imaging and Bioengineering (EKD) of the National Institutes of Health. The International Collaborative Effort (ICE) for Duchenne Muscular Dystrophy, the Duchenne Parent 1 Project France, and the Association Monegasquecontre les Myopathies (RMK and LG) provided additional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Busam RD, 2008, ACTA CRYSTALLOGR D, V64, P206, DOI 10.1107/S090744490706012X; Carrillo-Carrasco N, 2012, J INHERIT METAB DIS, V35, P91, DOI 10.1007/s10545-011-9364-y; Cecchini S, 2011, HUM GENE THER, V22, P1021, DOI 10.1089/hum.2010.250; Chaconas G, 2010, ANNU REV MICROBIOL, V64, P185, DOI 10.1146/annurev.micro.112408.134037; Chen ZH, 2011, VIRAL IMMUNOL, V24, P199, DOI 10.1089/vim.2010.0116; Chiorini JA, 1999, J VIROL, V73, P4293, DOI 10.1128/JVI.73.5.4293-4298.1999; CHIORINI JA, 1994, J VIROL, V68, P7448, DOI 10.1128/JVI.68.11.7448-7457.1994; Dalpke A, 2006, INFECT IMMUN, V74, P940, DOI 10.1128/IAI.74.2.940-946.2006; Dane AP, 2013, GENE THER, V20, P460, DOI 10.1038/gt.2012.67; Darquet AM, 1997, GENE THER, V4, P1341, DOI 10.1038/sj.gt.3300540; Hickman AB, 2004, MOL CELL, V13, P403, DOI 10.1016/S1097-2765(04)00023-1; Huang WM, 2004, J MOL BIOL, V337, P77, DOI 10.1016/j.jmb.2004.01.012; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Jooss K, 2003, GENE THER, V10, P955, DOI 10.1038/sj.gt.3302037; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kitajima K, 2006, ATHEROSCLEROSIS, V186, P65, DOI 10.1016/j.atherosclerosis.2005.07.009; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mann CJ, 2012, GENE THER, V19, P1177, DOI 10.1038/gt.2011.198; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Nafissi N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-154; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; Ravin NV, 2003, FEMS MICROBIOL LETT, V221, P1, DOI 10.1016/S0378-1097(03)00125-3; RICHARDSON CC, 1964, J BIOL CHEM, V239, P251; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sawamura D, 2005, J GENE MED, V7, P664, DOI 10.1002/jgm.709; Smith RH, 2000, J VIROL, V74, P3122, DOI 10.1128/JVI.74.7.3122-3129.2000; Smith RH, 1997, J VIROL, V71, P4461, DOI 10.1128/JVI.71.6.4461-4471.1997; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; Thaci B, 2011, ONCOTARGET, V2, P113; Traktman Paula, 2004, Methods Mol Biol, V269, P169; Urabe M, 2006, J VIROL, V80, P1874, DOI 10.1128/JVI.80.4.1874-1885.2006; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; URCELAY E, 1995, J VIROL, V69, P2038, DOI 10.1128/JVI.69.4.2038-2046.1995; VALERA A, 1994, HUM GENE THER, V5, P449, DOI 10.1089/hum.1994.5.4-449; Vandermeulen G, 2011, MOL THER, V19, P1942, DOI 10.1038/mt.2011.182; Wang L, 2005, GENE THER, V12, P1453, DOI 10.1038/sj.gt.3302539; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; WEISS B, 1976, J BIOL CHEM, V251, P1896; WICKS IP, 1995, HUM GENE THER, V6, P317, DOI 10.1089/hum.1995.6.3-317; Wooddell CI, 2011, HUM GENE THER, V22, P225, DOI 10.1089/hum.2010.113; Yan ZH, 2012, GENE, V506, P289, DOI 10.1016/j.gene.2012.07.009	44	8	26	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69879	10.1371/journal.pone.0069879	http://dx.doi.org/10.1371/journal.pone.0069879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936358	gold, Green Submitted, Green Published			2022-12-27	WOS:000324518400026
J	Pearce, SC; Mani, V; Boddicker, RL; Johnson, JS; Weber, TE; Ross, JW; Rhoads, RP; Baumgard, LH; Gabler, NK				Pearce, Sarah C.; Mani, Venkatesh; Boddicker, Rebecca L.; Johnson, Jay S.; Weber, Thomas E.; Ross, Jason W.; Rhoads, Robert P.; Baumgard, Lance H.; Gabler, Nicholas K.			Heat Stress Reduces Intestinal Barrier Integrity and Favors Intestinal Glucose Transport in Growing Pigs	PLOS ONE			English	Article							EPITHELIAL-CELLS; TIGHT JUNCTIONS; DYSFUNCTION; MECHANISMS; EXPRESSION; INCREASE; OCCLUDIN; PHOSPHORYLATION; PERMEABILITY; TEMPERATURE	Excessive heat exposure reduces intestinal integrity and post-absorptive energetics that can inhibit wellbeing and be fatal. Therefore, our objectives were to examine how acute heat stress (HS) alters intestinal integrity and metabolism in growing pigs. Animals were exposed to either thermal neutral (TN, 21 degrees C; 35-50% humidity; n = 8) or HS conditions (35 degrees C; 24-43% humidity; n = 8) for 24 h. Compared to TN, rectal temperatures in HS pigs increased by 1.6 degrees C and respiration rates by 2-fold (P<0.05). As expected, HS decreased feed intake by 53% (P<0.05) and body weight (P, 0.05) compared to TN pigs. Ileum heat shock protein 70 expression increased (P, 0.05), while intestinal integrity was compromised in the HS pigs (ileum and colon TER decreased; P<0.05). Furthermore, HS increased serum endotoxin concentrations (P=0.05). Intestinal permeability was accompanied by an increase in protein expression of myosin light chain kinase (P<0.05) and casein kinase II-alpha (P = 0.06). Protein expression of tight junction (TJ) proteins in the ileum revealed claudin 3 and occludin expression to be increased overall due to HS (P<0.05), while there were no differences in claudin 1 expression. Intestinal glucose transport and blood glucose were elevated due to HS (P<0.05). This was supported by increased ileum Na+/K+ ATPase activity in HS pigs. SGLT-1 protein expression was unaltered; however, HS increased ileal GLUT-2 protein expression (P=0.06). Altogether, these data indicate that HS reduce intestinal integrity and increase intestinal stress and glucose transport.	[Pearce, Sarah C.; Mani, Venkatesh; Boddicker, Rebecca L.; Johnson, Jay S.; Weber, Thomas E.; Ross, Jason W.; Baumgard, Lance H.; Gabler, Nicholas K.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Rhoads, Robert P.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Iowa State University; Virginia Polytechnic Institute & State University	Gabler, NK (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	ngabler@iastate.edu	Baumgard, Lance Hall/AAZ-7090-2021; Rhoads, Robert P/F-2861-2016	Rhoads, Robert P/0000-0002-5205-5834; Luchtel, Rebecca/0000-0002-7523-5010	Iowa Pork Producers Association; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-67003-30007]	Iowa Pork Producers Association; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This research was partially supported by the Iowa Pork Producers Association and the Agriculture and Food Research Initiative Competitive Grant 2011-67003-30007 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrazi A, 2012, J IMMUNOL, V188, P4543, DOI 10.4049/jimmunol.1103114; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Baumgard LH, 2011, ENV PHYSL; Berglund JJ, 2001, AM J PHYSIOL-GASTR L, V281, pG1487; BOUCHAMA A, 1991, J APPL PHYSIOL, V70, P2640, DOI 10.1152/jappl.1991.70.6.2640; Cant JP, 1996, J ANIM SCI, V74, P2541; Collin A, 2001, ANIM SCI, V72, P519, DOI 10.1017/S1357729800052048; DAHLQVIST A, 1984, SCAND J CLIN LAB INV, V44, P169, DOI 10.3109/00365518409161400; DAllaire S, 1996, CAN VET J, V37, P237; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Dokladny K, 2008, AM J PATHOL, V172, P659, DOI 10.2353/ajpath.2008.070522; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Ferraris RP, 2000, ANNU REV NUTR, V20, P195, DOI 10.1146/annurev.nutr.20.1.195; Fuller W, 2003, CARDIOVASC RES, V57, P1044, DOI 10.1016/S0008-6363(02)00810-6; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Gabler NK, 2007, J NUTR, V137, P2351; Gaffin SL, 1996, WILD ENVIRON MED, V7, P312, DOI 10.1580/1080-6032(1996)007[0312:EATTAP]2.3.CO;2; Garriga C, 2006, AM J PHYSIOL-REG I, V290, pR195, DOI 10.1152/ajpregu.00393.2005; HALES JRS, 1979, AM J PHYSIOL, V237, pH705, DOI 10.1152/ajpheart.1979.237.6.H705; Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Kansagra K, 2003, AM J PHYSIOL-GASTR L, V285, pG1162, DOI 10.1152/ajpgi.00243.2003; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Kosatsky Tom, 2005, Euro Surveill, V10, P148; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Leon LR, 2007, PROG BRAIN RES, V162, P481, DOI 10.1016/S0079-6123(06)62024-4; LoVecchio F, 2007, AM J EMERG MED, V25, P442, DOI 10.1016/j.ajem.2006.11.026; MILLIGAN LP, 1985, J NUTR, V115, P1374, DOI 10.1093/jn/115.10.1374; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Musch MW, 2006, AM J PHYSIOL-GASTR L, V290, pG222, DOI 10.1152/ajpgi.00301.2005; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; O'Neill Luke A J, 2011, Biochem J, V438, pe5, DOI 10.1042/BJ20111386; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Prosser C, 2004, J APPL PHYSIOL, V96, P650, DOI 10.1152/japplphysiol.00295.2003; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; RONCARI G, 1969, INT J PROT RES, V1, P45; Singleton KD, 2006, SHOCK, V25, P295, DOI 10.1097/01.shk.0000196548.10634.02; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Song XZ, 2009, ASIAN AUSTRAL J ANIM, V22, P246, DOI 10.5713/ajas.2009.80358; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; Tomita Mikio, 2004, Drug Metab Pharmacokinet, V19, P33, DOI 10.2133/dmpk.19.33; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; UEDA I, 1970, ANAL BIOCHEM, V37, P169, DOI 10.1016/0003-2697(70)90273-3; Webel DM, 1997, J ANIM SCI, V75, P1514; Wright EM, 2000, ANN NY ACAD SCI, V915, P54; Yamagata K, 2004, NEUROBIOL DIS, V17, P491, DOI 10.1016/j.nbd.2004.08.001; Yan YE, 2006, MED HYPOTHESES, V67, P609, DOI 10.1016/j.mehy.2005.12.048; Yang PC, 2007, J GASTROEN HEPATOL, V22, P1823, DOI 10.1111/j.1440-1746.2006.04710.x; Yu LCH, 2005, FASEB J, V19, P1822, DOI 10.1096/fj.05-4226com; Yu LCH, 2008, INT J PARASITOL, V38, P923, DOI 10.1016/j.ijpara.2007.12.004; Yu LCH, 2006, EXP CELL RES, V312, P3276, DOI 10.1016/j.yexcr.2006.06.023; Zhang Q, 2012, INFLAMMATION, V35, P23, DOI 10.1007/s10753-010-9285-1	61	190	203	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70215	10.1371/journal.pone.0070215	http://dx.doi.org/10.1371/journal.pone.0070215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936392	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400043
J	Liu, T; Li, M; Zhang, Y; Pang, ZY; Xiao, W; Yang, Y; Luo, KJ				Liu, Tian; Li, Ming; Zhang, Yan; Pang, Zunyu; Xiao, Wei; Yang, Yang; Luo, Kaijun			A Role for Innexin2 and Innexin3 Proteins from Spodoptera litura in Apoptosis	PLOS ONE			English	Article							GAP-JUNCTION; ATP RELEASE; CELL-LINE; POLYDNAVIRUS; HEMICHANNEL; NUCLEOPOLYHEDROVIRUS; ASTROCYTES; ACTIVATION; CONNEXINS; HEMOCYTES	Gap junctions formed by two hemichannels from two neighboring cells are cell-to-cell communication channels; hemichannels are communication channels between intracellular and extracellular environments. Hemichannels are hexameric proteins formed by connexins, pannexins, innexins and vinnexins. Innexin-hemichannels (innexons) exist in the lepidopteran cell surface, but their component innexins and functions have not been reported. Recent studies by others have demonstrated that hemichannels, connexons and pannexons from vertebrates serve as regulators of apoptosis via inactivating the PI3K/Akt signaling pathway. Here, the apoptogenic properties of innexons are demonstrated using two innexin cDNAs, Spli-inx2 and Spli-inx3, which were isolated from hemocytes of lepidopteran Spodoptera litura. Alignment analysis revealed that these two genes belong to a conserved innexin family, as they contain the insect signature YYQWV motif at the beginning of the second transmembrane domain. Immunofluorescence showed that two fusion proteins, Inx2-V5 and Inx3-V5, were localized predominantly in the cell membrane, cytoplasm and also nuclei. Ectopic expression in Sf9 cells and over-expression of Inx2 and Inx3 in Spli221 cells promoted apoptosis. In the Spli221 cells, apoptotic cells presented remarkable membrane blebbing. This study also showed that Sf9 and Spli221 cells undergo low level apoptosis under normal culture conditions, but not Hi5 cells. In Hi5 stable cell lines, biotinylation was used to isolate surface proteins and confirm Inx2 and Inx3 localization in the cell membrane and also further data showed that Hi5 cells may activate the PI3K signaling pathway via phosphorylating molecular Akt downstream. This result suggests that innexon-promoted apoptosis may be involving the PI3K/Akt signaling pathway. These findings will facilitate further examinations of the apoptotic regulation by the PI3K/Akt signaling pathway and comparative studies of innexons, connexons, pannexons, and vinnexons.	[Liu, Tian; Li, Ming; Zhang, Yan; Pang, Zunyu; Xiao, Wei; Yang, Yang; Luo, Kaijun] Yunnan Univ, Sch Life Sci, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Kunming, Yunnan, Peoples R China	Yunnan University	Luo, KJ (corresponding author), Yunnan Univ, Sch Life Sci, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Kunming, Yunnan, Peoples R China.	kaijun_luo@ynu.edu.cn	Luo, Kaijun/AGL-3479-2022		NSFC [31060251, 31260448]; 973 program [2013CB127600]; SRF for ROCS, SEM; YN-NSF [2011FZ003, 2012FB120]; Foundation for key teacher of Yunnan University	NSFC(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); YN-NSF; Foundation for key teacher of Yunnan University	This study was supported by NSFC projects (31060251; 31260448), 973 program (2013CB127600) and The Project-sponsored by SRF for ROCS, SEM to KL, and YN-NSF (2011FZ003, 2012FB120), and Foundation for key teacher of Yunnan University to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2007, FEBS LETT, V581, P5703, DOI 10.1016/j.febslet.2007.11.030; Baroja-Mazo A, 2012, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbamem.2012,01.002, DOI 10.1016/J.BBAMEM.2012]; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chi JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032531; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Dobrowolski R, 2007, J MEMBRANE BIOL, V219, P9, DOI 10.1007/s00232-007-9055-7; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; GRANADOS RR, 1994, J INVERTEBR PATHOL, V64, P260, DOI 10.1016/S0022-2011(94)90400-6; Gupta Ayodhya P., 1991, P133; Hechler B, 2011, PURINERG SIGNAL, V7, P293, DOI 10.1007/s11302-011-9247-6; Huang J, 2008, ACTA PHARMACOL SIN, V29, P951, DOI 10.1111/j.1745-7254.2008.00826.x; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Jackson SP, 2004, BIOCHEM SOC T, V32, P387, DOI 10.1042/BST0320387; Khurad AM, 2009, IN VITRO CELL DEV-AN, V45, P414, DOI 10.1007/s11626-009-9197-2; Koval M, 1997, J CELL BIOL, V137, P847, DOI 10.1083/jcb.137.4.847; LanzMendoza H, 1996, CELL IMMUNOL, V169, P47, DOI 10.1006/cimm.1996.0089; Lavine MD, 2003, INSECT MOL BIOL, V12, P441, DOI 10.1046/j.1365-2583.2003.00428.x; Li Guanghong, 1998, Acta Scientiarum Naturalium Universitatis Sunyatseni, V37, P1; Liu JJ, 2010, ANN HEMATOL, V89, P1089, DOI 10.1007/s00277-010-0996-z; Luo KJ, 2006, J INSECT PHYSIOL, V52, P795, DOI 10.1016/j.jinsphys.2006.04.007; Luo KJ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0106; Marziano NK, 2011, J VIROL, V85, P10222, DOI 10.1128/JVI.00691-11; Meyer-Fernandes JR, 2000, ARCH BIOCHEM BIOPHYS, V382, P152, DOI 10.1006/abbi.2000.1980; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Pech LL, 2000, J INSECT PHYSIOL, V46, P1565, DOI 10.1016/S0022-1910(00)00083-4; Peter C, 2010, CURR BIOL, V20, pR940, DOI 10.1016/j.cub.2010.09.066; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; STRAND MR, 1994, J GEN VIROL, V75, P3007, DOI 10.1099/0022-1317-75-11-3007; Su V, 2012, ARCH BIOCHEM BIOPHYS, V524, P16, DOI 10.1016/j.abb.2011.12.027; Turnbull MW, 2005, CURR BIOL, V15, pR491, DOI 10.1016/j.cub.2005.06.052; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Vinken M, 2012, TOXICOL SCI, V125, P175, DOI 10.1093/toxsci/kfr277; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Xiao W, 2009, VIROLOGY, V391, P83, DOI 10.1016/j.virol.2009.06.007; Yanase T, 1998, ACTA VIROL, V42, P293; Yeager M, 2007, CURR OPIN CELL BIOL, V19, P521, DOI 10.1016/j.ceb.2007.09.001; Yen MR, 2007, PROG BIOPHYS MOL BIO, V94, P5, DOI 10.1016/j.pbiomolbio.2007.03.006; Zhang J, 1996, J BIOL CHEM, V271, P6265, DOI 10.1074/jbc.271.11.6265; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102; Zhuang SF, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700341200	48	16	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70456	10.1371/journal.pone.0070456	http://dx.doi.org/10.1371/journal.pone.0070456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936205	gold, Green Submitted, Green Published			2022-12-27	WOS:000323114200083
J	Sanchez-Romero, I; Ariza, A; Wilson, KS; Skjot, M; Vind, J; De Maria, L; Skov, LK; Sanchez-Ruiz, JM				Sanchez-Romero, Inmaculada; Ariza, Antonio; Wilson, Keith S.; Skjot, Michael; Vind, Jesper; De Maria, Leonardo; Skov, Lars K.; Sanchez-Ruiz, Jose M.			Mechanism of Protein Kinetic Stabilization by Engineered Disulfide Crosslinks	PLOS ONE			English	Article							AGGREGATION RATES; CRYSTAL-STRUCTURE; BONDS; STABILITY; LYSOZYME; PHYTASE; RIBONUCLEASE; PRINCIPLES; PATHWAYS; COMPLEX	The impact of disulfide bonds on protein stability goes beyond simple equilibrium thermodynamics effects associated with the conformational entropy of the unfolded state. Indeed, disulfide crosslinks may play a role in the prevention of dysfunctional association and strongly affect the rates of irreversible enzyme inactivation, highly relevant in biotechnological applications. While these kinetic-stability effects remain poorly understood, by analogy with proposed mechanisms for processes of protein aggregation and fibrillogenesis, we propose that they may be determined by the properties of sparsely-populated, partially-unfolded intermediates. Here we report the successful design, on the basis of high temperature molecular-dynamics simulations, of six thermodynamically and kinetically stabilized variants of phytase from Citrobacter braakii (a biotechnologically important enzyme) with one, two or three engineered disulfides. Activity measurements and 3D crystal structure determination demonstrate that the engineered crosslinks do not cause dramatic alterations in the native structure. The inactivation kinetics for all the variants displays a strongly non-Arrhenius temperature dependence, with the time-scale for the irreversible denaturation process reaching a minimum at a given temperature within the range of the denaturation transition. We show this striking feature to be a signature of a key role played by a partially unfolded, intermediate state/ensemble. Energetic and mutational analyses confirm that the intermediate is highly unfolded (akin to a proposed critical intermediate in the misfolding of the prion protein), a result that explains the observed kinetic stabilization. Our results provide a rationale for the kinetic-stability consequences of disulfide-crosslink engineering and an experimental methodology to arrive at energetic/structural descriptions of the sparsely populated and elusive intermediates that play key roles in irreversible protein denaturation.	[Sanchez-Romero, Inmaculada; Sanchez-Ruiz, Jose M.] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain; [Ariza, Antonio; Wilson, Keith S.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Skjot, Michael; Vind, Jesper; De Maria, Leonardo; Skov, Lars K.] Novozymes AS, Bagsvaerd, Denmark	University of Granada; University of York - UK; Novozymes	Sanchez-Ruiz, JM (corresponding author), Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain.	sanchezr@ugr.es	Sanchez-Ruiz, Jose/H-2849-2015; Ariza, Antonio/H-7830-2019; De Maria, Leonardo/AAH-1026-2021	Sanchez-Ruiz, Jose/0000-0002-9056-3928; Ariza, Antonio/0000-0003-4364-823X; De Maria, Leonardo/0000-0002-8061-4242; Sanchez Romero, Inmaculada/0000-0001-7088-2000; Wilson, Keith/0000-0002-3581-2194	Spanish Ministry of Science and Innovation [BIO2009-09562, CSD2009-00088]; FEDER Funds	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER Funds(European Commission)	This work was supported by grants BIO2009-09562, CSD2009-00088 from the Spanish Ministry of Science and Innovation, and FEDER Funds (JMS-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Ariza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065062; Bemporad F, 2012, BIOPHYS J, V102, P2595, DOI 10.1016/j.bpj.2012.03.057; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Bohm K, 2010, FEBS J, V277, P1284, DOI 10.1111/j.1742-4658.2010.07559.x; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Buell AK, 2011, J AM CHEM SOC, V133, P7737, DOI 10.1021/ja109620d; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Compton JR, 2011, PROTEINS, V79, P1048, DOI 10.1002/prot.22933; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Day R, 2003, ADV PROTEIN CHEM, V66, P373; Dhulesia A, 2010, J AM CHEM SOC, V132, P15580, DOI 10.1021/ja103524m; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Grana-Montes R, 2012, ANTIOXID REDOX SIGN, V16, P1, DOI 10.1089/ars.2011.3936; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kostrewa D, 1997, NAT STRUCT BIOL, V4, P185, DOI 10.1038/nsb0397-185; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lim D, 2000, NAT STRUCT BIOL, V7, P108; Martensson LG, 2002, BIOCHEMISTRY-US, V41, P15867, DOI 10.1021/bi020433+; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; MITCHINSON C, 1989, BIOCHEMISTRY-US, V28, P4807, DOI 10.1021/bi00437a043; Oakley AJ, 2010, BIOCHEM BIOPH RES CO, V397, P745, DOI 10.1016/j.bbrc.2010.06.024; PACE CN, 1988, J BIOL CHEM, V263, P11820; Pecher P, 2009, BIOPHYS CHEM, V141, P21, DOI 10.1016/j.bpc.2008.12.005; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Ragon M, 2009, ACTA CRYSTALLOGR F, V65, P321, DOI 10.1107/S1744309109008653; Ramakrishnan V, 2012, PROTEINS, V80, P920, DOI 10.1002/prot.23249; Remmele RL, 2005, J AM CHEM SOC, V127, P8328, DOI 10.1021/ja043466g; Roberts CJ, 2011, INT J PHARMACEUT, V418, P318, DOI 10.1016/j.ijpharm.2011.03.064; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Siadat Omid Ranaei, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-12; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; VILLAFRANCA JE, 1983, SCIENCE, V222, P782, DOI 10.1126/science.6356360; Weiss WF, 2009, J PHARM SCI-US, V98, P1246, DOI 10.1002/jps.21521; WELLS JA, 1986, J BIOL CHEM, V261, P6564; WETZEL R, 1987, TRENDS BIOCHEM SCI, V12, P478, DOI 10.1016/0968-0004(87)90234-9; Wozniak-Knopp G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030083; Xiang T, 2004, J MOL BIOL, V339, P437, DOI 10.1016/j.jmb.2004.03.057; Yu H, 2012, P NATL ACAD SCI USA, V109, P5283, DOI 10.1073/pnas.1107736109; ZHANG T, 1994, NAT STRUCT BIOL, V1, P434, DOI 10.1038/nsb0794-434	45	26	29	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70013	10.1371/journal.pone.0070013	http://dx.doi.org/10.1371/journal.pone.0070013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936134	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200054
J	Taube, D; Xu, J; Yang, XP; Undrovinas, A; Peterson, E; Harding, P				Taube, David; Xu, Jiang; Yang, Xiao-Ping; Undrovinas, Albertas; Peterson, Edward; Harding, Pamela			Fractalkine Depresses Cardiomyocyte Contractility	PLOS ONE			English	Article							CARDIAC MYOCYTES; HEART-FAILURE; DILATED CARDIOMYOPATHY; TROPONIN-I; AUTOIMMUNE MYOCARDITIS; TARGETED DELETION; GENE-EXPRESSION; EP4 RECEPTORS; INFLAMMATION; CELLS	Background: Our laboratory reported that male mice with cardiomyocyte-selective knockout of the prostaglandin E-2 EP4 receptor sub-type (EP4 KO) exhibit reduced cardiac function. Gene array on left ventricles (LV) showed increased fractalkine, a chemokine implicated in heart failure. We therefore hypothesized that fractalkine is regulated by PGE(2) and contributes to depressed contractility via alterations in intracellular calcium. Methods: Fractalkine was measured in LV of 28-32 week old male EP4 KO and wild type controls (WT) by ELISA and the effect of PGE(2) on fractalkine secretion was measured in cultured neonatal cardiomyocytes and fibroblasts. The effect of fractalkine on contractility and intracellular calcium was determined in Fura-2 AM-loaded, electrical field-paced cardiomyocytes. Cardiomyocytes (AVM) from male C57Bl/6 mice were treated with fractalkine and responses measured under basal conditions and after isoproterenol (Iso) stimulation. Results: LV fractalkine was increased in EP4 KO mice but surprisingly, PGE(2) regulated fractalkine secretion only in fibroblasts. Fractalkine treatment of AVM decreased both the speed of contraction and relaxation under basal conditions and after Iso stimulation. Despite reducing contractility after Iso stimulation, fractalkine increased the Ca2+ transient amplitude but decreased phosphorylation of cardiac troponin I, suggesting direct effects on the contractile machinery. Conclusions: Fractalkine depresses myocyte contractility by mechanisms downstream of intracellular calcium.	[Taube, David; Xu, Jiang; Yang, Xiao-Ping; Harding, Pamela] Henry Ford Hosp, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Undrovinas, Albertas] Henry Ford Hosp, Cardiovasc Res Div, Detroit, MI 48202 USA; [Peterson, Edward] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA; [Peterson, Edward] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Harding, P (corresponding author), Henry Ford Hosp, Hypertens & Vasc Res Div, Detroit, MI 48202 USA.	phardin1@hfhs.org			NIH [5P01HL028982]; Rita Lorraine Koncewicz Estate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Lorraine Koncewicz Estate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH grant 5P01HL028982 sub project 2 (PH). The work was also supported in part by funds from the Rita Lorraine Koncewicz Estate to support heart failure research at Henry Ford Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cawley SM, 2011, AM J PHYSIOL-HEART C, V301, pH157, DOI 10.1152/ajpheart.01273.2010; Comerford I, 2011, IMMUNOL CELL BIOL, V89, P183, DOI 10.1038/icb.2010.164; Date T, 2009, CIRC J, V73, P932, DOI 10.1253/circj.CJ-08-0856; Escher F, 2011, HEART, V97, P733, DOI 10.1136/hrt.2010.205716; HARDING P, 1995, HYPERTENSION, V25, P421, DOI 10.1161/01.HYP.25.3.421; Harding P, 2011, AM J PHYSIOL-HEART C, V300, pH1053, DOI 10.1152/ajpheart.00772.2010; Harding P, 2010, AM J PHYSIOL-HEART C, V298, pH623, DOI 10.1152/ajpheart.00746.2009; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; HOLZINGER C, 1995, CIRCULATION, V92, P2876, DOI 10.1161/01.CIR.92.10.2876; Husberg C, 2008, J MOL CELL CARDIOL, V45, P261, DOI 10.1016/j.yjmcc.2008.05.009; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; LaRocca TJ, 2010, J CARDIOVASC PHARM, V56, P548, DOI 10.1097/FJC.0b013e3181f713fe; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Ludwig A, 2007, THROMB HAEMOSTASIS, V97, P694; Matsumoto Y, 2004, J IMMUNOL, V173, P3535, DOI 10.4049/jimmunol.173.5.3535; Minami M, 2008, J BIOL CHEM, V283, P9692, DOI 10.1074/jbc.M709663200; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Ogawa M, 2009, TRANSPLANTATION, V87, P1645, DOI 10.1097/TP.0b013e3181a5c84c; Park J, 2012, TRANSPL P, V44, P1026, DOI 10.1016/j.transproceed.2012.03.045; Pyo RT, 2006, J MOL CELL CARDIOL, V41, P834, DOI 10.1016/j.yjmcc.2006.08.008; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Richter B, 2012, THROMB HAEMOSTASIS, V108, P1220, DOI 10.1160/TH12-03-0195; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Shi J, 2010, J IMMUNOL, V184, P7207, DOI 10.4049/jimmunol.0903487; Sozzani S, 1998, J CHEMOTHERAPY, V10, P142, DOI 10.1179/joc.1998.10.2.142; Sung MJ, 2010, CELL PHYSIOL BIOCHEM, V26, P431, DOI 10.1159/000320566; Suzuki JI, 2006, J MOL CELL CARDIOL, V40, P688, DOI 10.1016/j.yjmcc.2006.01.006; Tang EHC, 2011, CARDIOVASC RES, V89, P234, DOI 10.1093/cvr/cvq262; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xuan WL, 2011, CARDIOVASC RES, V92, P385, DOI 10.1093/cvr/cvr221; Yoshida T, 2005, CARDIOVASC RES, V68, P278, DOI 10.1016/j.cardiores.2005.06.006; Zahner G, 2009, BIOCHEM J, V422, P563, DOI 10.1042/BJ20090420; Zhang J, 2011, J PROTEOME RES, V10, P4054, DOI 10.1021/pr200258m; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388	35	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69832	10.1371/journal.pone.0069832	http://dx.doi.org/10.1371/journal.pone.0069832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936109	gold, Green Submitted, Green Published			2022-12-27	WOS:000323114200047
J	Vissing, NH; Sevelsted, A; Bisgaard, H				Vissing, Nadja Hawwa; Sevelsted, Astrid; Bisgaard, Hans			Public Hygiene Campaign in Denmark during the 2009 H1N1 Pandemic Had No Effect on Hospitalization Rate of Communicable Diseases in Children	PLOS ONE			English	Article							CONTROLLED-TRIAL; CARE	Background: During the 2009 H1N1 pandemic the Danish National board of Health carried out massive public hygiene campaigns to limit spread of disease. We aimed to investigate whether this resulted in lower incidences of communicable diseases in the paediatric population. Methods: The study compared annual hospitalization rates for childhood infections from 2005 to 2011. Results: Admission rates for infections were higher during the year of the pandemic compared to the rest of the period. Conclusion: There were no indications of a preventive effect by the hygiene campaign on incidence of severe common childhood infections.	[Vissing, Nadja Hawwa; Sevelsted, Astrid; Bisgaard, Hans] Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Gentofte, Denmark	University of Copenhagen	Bisgaard, H (corresponding author), Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Gentofte, Denmark.	bisgaard@copsac.com	Bisgaard, Hans/N-4761-2016	Bisgaard, Hans/0000-0003-4131-7592; sevelsted, astrid/0000-0001-7117-2334				Aiello AE, 2002, LANCET INFECT DIS, V2, P103, DOI 10.1016/S1473-3099(02)00184-6; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Danish Association of Communications (Dansk Kommunikationsforening), INFL A KUNST INF UD; Ejemot RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub2; Gubbels S, 2010, EURO SURVEILL, V15; KOTCH JB, 1994, PEDIATRICS, V94, P991; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Molbak K, 2011, VACCINE, V29, pB63, DOI 10.1016/j.vaccine.2011.03.064; *NAT BOARD HLTH, 2006, PAND PLAN 2006; National Board of Health, INF REG INFL; Roberts L, 2000, PEDIATRICS, V105, P738, DOI 10.1542/peds.105.4.738; Rostgaard Klaus, 2008, Epidemiol Perspect Innov, V5, P7, DOI 10.1186/1742-5573-5-7; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Widgren K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013939; World Health Organization, INT CLASS DIS	16	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70946	10.1371/journal.pone.0070946	http://dx.doi.org/10.1371/journal.pone.0070946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936255	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200109
J	Gao, LB; Xu, HS; Bi, HX; Xi, WM; Bao, B; Wang, XY; Bi, C; Chang, YF				Gao, Lubo; Xu, Huasen; Bi, Huaxing; Xi, Weimin; Bao, Biao; Wang, Xiaoyan; Bi, Chao; Chang, Yifang			Intercropping Competition between Apple Trees and Crops in Agroforestry Systems on the Loess Plateau of China	PLOS ONE			English	Article							ALLEY CROPPING SYSTEM; GROUND INTERACTIONS; SOIL-WATER; MAIZE; PRODUCTIVITY; GROWTH; YIELD; USA; PHOTOSYNTHESIS; PERFORMANCE	Agroforestry has been widely practiced in the Loess Plateau region of China because of its prominent effects in reducing soil and water losses, improving land-use efficiency and increasing economic returns. However, the agroforestry practices may lead to competition between crops and trees for underground soil moisture and nutrients, and the trees on the canopy layer may also lead to shortage of light for crops. In order to minimize interspecific competition and maximize the benefits of tree-based intercropping systems, we studied photosynthesis, growth and yield of soybean (Glycine max L. Merr.) and peanut (Arachis hypogaea L.) by measuring photosynthetically active radiation, net photosynthetic rate, soil moisture and soil nutrients in a plantation of apple (Malus pumila M.) at a spacing of 4 m x 5 m on the Loess Plateau of China. The results showed that for both intercropping systems in the study region, soil moisture was the primary factor affecting the crop yields followed by light. Deficiency of the soil nutrients also had a significant impact on crop yields. Compared with soybean, peanut was more suitable for intercropping with apple trees to obtain economic benefits in the region. We concluded that apple-soybean and apple-peanut intercropping systems can be practical and beneficial in the region. However, the distance between crops and tree rows should be adjusted to minimize interspecies competition. Agronomic measures such as regular canopy pruning, root barriers, additional irrigation and fertilization also should be applied in the intercropping systems.	[Gao, Lubo; Xu, Huasen; Bi, Huaxing; Bao, Biao; Wang, Xiaoyan; Bi, Chao; Chang, Yifang] Beijing Forestry Univ, Coll Water & Soil Conservat, Beijing, Peoples R China; [Bi, Huaxing] Minist Educ, Key Lab Soil & Water Conservat, Beijing, Peoples R China; [Xi, Weimin] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX USA	Beijing Forestry University; Texas A&M University System; Texas A&M University Kingsville	Bi, HX (corresponding author), Beijing Forestry Univ, Coll Water & Soil Conservat, Beijing, Peoples R China.	bhx@bjfu.edu.cn		Xi, Weimin/0000-0002-2827-8851	National Scientific and Technology Program of China [2011BAD38B02]; CFERN & GENE Award Funds on Ecological paper	National Scientific and Technology Program of China; CFERN & GENE Award Funds on Ecological paper	This paper was supported by National Scientific and Technology Program of China (No. 2011BAD38B02) and CFERN & GENE Award Funds on Ecological paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burel F, 1996, CRIT REV PLANT SCI, V15, P169, DOI 10.1080/713608130; Cheng D, 1994, RESOURCE MICROBIOLOG, P32; Friday JB, 2002, AGROFOREST SYST, V55, P125, DOI 10.1023/A:1020598110484; Garrett HEG, 1997, FOREST ECOL MANAG, V91, P5, DOI 10.1016/S0378-1127(96)03884-4; Hall DJM, 2002, AUST J EXP AGR, V42, P729, DOI 10.1071/EA02009; Hirota I, 2004, AGROFOREST SYST, V60, P181, DOI 10.1023/B:AGFO.0000013293.77907.64; Hou QJ, 2003, AGROFOREST SYST, V57, P137, DOI 10.1023/A:1023977316170; Jose S, 2000, AGROFOREST SYST, V48, P41, DOI 10.1023/A:1006289322392; Kowalchuk TE, 1995, CAN J SOIL SCI, V75, P543, DOI 10.4141/cjss95-077; Lehmann J, 1998, FOREST ECOL MANAG, V111, P157, DOI 10.1016/S0378-1127(98)00322-3; Li W., 1994, AGROFORESTRY CHINA, P14; Lott JE, 2000, FOREST ECOL MANAG, V139, P187, DOI 10.1016/S0378-1127(00)00267-X; Meng P, 2003, RES AGROFORESTRY CHI, P235; Meng Ping, 2004, Forest Research, V17, P167; Miller AW, 2001, AGROFOREST SYST, V53, P247, DOI 10.1023/A:1013327510748; Namirembe S., 1999, THESIS UK U WALES, P206; Newman SM, 1997, AGROFOREST SYST, V39, P23, DOI 10.1023/A:1005938310106; Ong CK, 1996, TREE CROP INTERACTIO, P386; Peng Xiao-bang, 2008, Yingyong Shengtai Xuebao, V19, P2414; Peng XB, 2009, AGROFOREST SYST, V76, P569, DOI 10.1007/s10457-009-9227-9; Reynolds PE, 2007, ECOL ENG, V29, P362, DOI 10.1016/j.ecoleng.2006.09.024; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; SINGH RP, 1989, AGROFOREST SYST, V9, P259, DOI 10.1007/BF00141088; Thevathasan N. V., 2004, Journal of Crop Improvement, V12, P339, DOI 10.1300/J411v12n01_04; Thomas J, 1998, AGROFOREST SYST, V41, P293, DOI 10.1023/A:1006018020318; Unkovich M, 2003, AUST J AGR RES, V54, P751, DOI 10.1071/AR03049; WANI SP, 1995, PLANT SOIL, V174, P29, DOI 10.1007/BF00032240; Yun L, 2012, ARID LAND RES MANAG, V26, P285, DOI 10.1080/15324982.2012.694394; Yun Lei, 2011, Yingyong Shengtai Xuebao, V22, P1225; Yun Lei, 2009, Journal of Northeast Forestry University, V37, P70; [张继春 Zhang Jichun], 2004, [石油学报, Acta Petrolei Sinica], V25, P52; Zhang Jin-Song, 2004, Forest Research, V17, P284; Zhang JinSong, 2003, World Forestry Research, V16, P10; Zhang JinSong, 2002, Scientia Silvae Sinicae, V38, P30; Zhu Q., 2003, SUSTAINABLE MANAGEME, P160	35	72	85	10	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70739	10.1371/journal.pone.0070739	http://dx.doi.org/10.1371/journal.pone.0070739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936246	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300114
J	Kuepper, R; Ceccarini, J; Lataster, J; van Os, J; van Kroonenburgh, M; van Gerven, JMA; Marcelis, M; Van Laere, K; Henquet, C				Kuepper, Rebecca; Ceccarini, Jenny; Lataster, Johan; van Os, Jim; van Kroonenburgh, Marinus; van Gerven, Joop M. A.; Marcelis, Machteld; Van Laere, Koen; Henquet, Cecile			Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: F-18-Fallypride Positron Emission Tomography Study	PLOS ONE			English	Article							IN-VIVO DETECTION; CANNABIS USE; PREFRONTAL CORTEX; RECEPTOR-BINDING; HUMAN STRIATUM; BRAIN; PET; SCHIZOPHRENIA; MARIJUANA; COGNITION	Cannabis use is associated with psychosis, particularly in those with expression of, or vulnerability for, psychotic illness. The biological underpinnings of these differential associations, however, remain largely unknown. We used Positron Emission Tomography and F-18-fallypride to test the hypothesis that genetic risk for psychosis is expressed by differential induction of dopamine release by Delta(9)-THC (delta-9-tetrahydrocannabinol, the main psychoactive ingredient of cannabis). In a single dynamic PET scanning session, striatal dopamine release after pulmonary administration of Delta(9)-THC was measured in 9 healthy cannabis users (average risk psychotic disorder), 8 patients with psychotic disorder (high risk psychotic disorder) and 7 un-related first-degree relatives (intermediate risk psychotic disorder). PET data were analyzed applying the linear extension of the simplified reference region model (LSRRM), which accounts for time-dependent changes in F-18-fallypride displacement. Voxel-based statistical maps, representing specific D-2/3 binding changes, were computed to localize areas with increased ligand displacement after Delta(9)-THC administration, reflecting dopamine release. While Delta(9)-THC was not associated with dopamine release in the control group, significant ligand displacement induced by Delta(9)-THC in striatal subregions, indicative of dopamine release, was detected in both patients and relatives. This was most pronounced in caudate nucleus. This is the first study to demonstrate differential sensitivity to Delta(9)-THC in terms of increased endogenous dopamine release in individuals at risk for psychosis.	[Kuepper, Rebecca; Lataster, Johan; van Os, Jim; Marcelis, Machteld; Henquet, Cecile] Maastricht Univ, Dept Psychiat & Psychol, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands; [Henquet, Cecile] PsyQ Heerlen, Mondriaan, South Limburg, Netherlands; [Ceccarini, Jenny; Van Laere, Koen] Univ Hosp, Div Nucl Med, Louvain, Belgium; [Ceccarini, Jenny; Van Laere, Koen] Catholic Univ, Louvain, Belgium; [Lataster, Johan] Open Univ Netherlands, Fac Psychol, Heerlen, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London, England; [van Kroonenburgh, Marinus] Maastricht Univ, Med Ctr, Div Nucl Med, Maastricht, Netherlands; [van Gerven, Joop M. A.] Ctr Human Drug Res, Leiden, Netherlands	Maastricht University; Open University Netherlands; University of London; King's College London; Maastricht University	Kuepper, R (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands.	r.kuepper@maastrichtuniversity.nl	van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Ceccarini, Jenny/AAY-9271-2020; Lataster, Johan/S-9462-2017; Ceccarini, Jenny/AAE-5084-2019	van Os, Jim/0000-0002-7245-1586; Ceccarini, Jenny/0000-0003-2774-9516; Lataster, Johan/0000-0003-3889-8154; Marcelis, Machteld/0000-0003-0045-9244	NWO, the Dutch council for scientific research (ZonMW VENI grant)	NWO, the Dutch council for scientific research (ZonMW VENI grant)	The work was supported by a grant of NWO, the Dutch council for scientific research (ZonMW VENI grant to C. Henquet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnone D, 2008, NEUROIMAGE, V41, P1067, DOI 10.1016/j.neuroimage.2008.02.064; Barkus E, 2008, PSYCHOL MED, V38, P1267, DOI 10.1017/S0033291707002619; Barkus EJ, 2006, PSYCHOPATHOLOGY, V39, P175, DOI 10.1159/000092678; Barkus E, 2011, J PSYCHOPHARMACOL, V25, P1462, DOI 10.1177/0269881110382465; Bossong MG, 2009, NEUROPSYCHOPHARMACOL, V34, P759, DOI 10.1038/npp.2008.138; Bowdle TA, 1998, ANESTHESIOLOGY, V88, P82, DOI 10.1097/00000542-199801000-00015; Ceccarini J, 2012, J NUCL MED, V53, P1565, DOI 10.2967/jnumed.111.099416; Christian BT, 2006, NEUROIMAGE, V31, P139, DOI 10.1016/j.neuroimage.2005.11.052; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; Genetic Risk and Outcome in Psychosis (GROUP) Investigators, 2011, ARCH GEN PSYCHIAT, V68, P138; Giuffrida A, 2004, NEUROPSYCHOPHARMACOL, V29, P2108, DOI 10.1038/sj.npp.1300558; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Hazekamp A, 2006, J PHARM SCI-US, V95, P1308, DOI 10.1002/jps.20574; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; Henquet C, 2010, BRIT J PSYCHIAT, V196, P447, DOI 10.1192/bjp.bp.109.072249; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; KAY S R, 1989, British Journal of Psychiatry, V155, P59; Koethe D, 2009, BRIT J PSYCHIAT, V194, P371, DOI 10.1192/bjp.bp.108.053843; Kuepper R, 2012, HANDB EXP PHARMACOL, V212, P1, DOI 10.1007/978-3-642-25761-2_1; Kuepper R, 2010, SCHIZOPHR RES, V121, P107, DOI 10.1016/j.schres.2010.05.031; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lataster J, 2011, NEUROIMAGE, V58, P1081, DOI 10.1016/j.neuroimage.2011.07.030; MATHEW RJ, 1992, J CEREBR BLOOD F MET, V12, P750, DOI 10.1038/jcbfm.1992.106; Mathew RJ, 1997, LIFE SCI, V60, P2075, DOI 10.1016/S0024-3205(97)00195-1; Matochik JA, 2005, DRUG ALCOHOL DEPEN, V77, P23, DOI 10.1016/j.drugalcdep.2004.06.011; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Morrison PD, 2009, SCHIZOPHRENIA BULL, V35, P668, DOI 10.1093/schbul/sbp049; Mukherjee J, 2002, SYNAPSE, V46, P170, DOI 10.1002/syn.10128; Mukherjee J, 1999, NUCL MED BIOL, V26, P519, DOI 10.1016/S0969-8051(99)00012-8; O'Leary DS, 2002, NEUROPSYCHOPHARMACOL, V26, P802, DOI 10.1016/S0893-133X(01)00425-0; OVERALL JE, 1988, PSYCHOPHARMACOL BULL, V24, P97; Pappata S, 2002, NEUROIMAGE, V16, P1015, DOI 10.1006/nimg.2002.1121; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pistis M, 2002, BRAIN RES, V948, P155, DOI 10.1016/S0006-8993(02)03055-X; Ramaekers JG, 2006, DRUG ALCOHOL DEPEN, V85, P114, DOI 10.1016/j.drugalcdep.2006.03.015; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stokes PRA, 2009, NEUROIMAGE, V48, P186, DOI 10.1016/j.neuroimage.2009.06.029; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; Voruganti LNP, 2001, PSYCHIAT RES-NEUROIM, V107, P173, DOI 10.1016/S0925-4927(01)00104-4; Vrieze E, 2013, HUM BRAIN MAPP, V34, P575, DOI 10.1002/hbm.21456; Wechsler D., 2000, WAIS 3 NEDERLANDSTAL; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wong DF, 2010, NEUROIMAGE, V52, P1505, DOI 10.1016/j.neuroimage.2010.04.034; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694; Zammit S, 2008, BRIT J PSYCHIAT, V193, P357, DOI 10.1192/bjp.bp.107.046375; Zuurman L, 2008, J PSYCHOPHARMACOL, V22, P707, DOI 10.1177/0269881108089581	51	65	65	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70378	10.1371/journal.pone.0070378	http://dx.doi.org/10.1371/journal.pone.0070378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936196	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300101
J	van Ooijen, G; Hindle, M; Martin, SF; Barrios-Llerena, M; Sanchez, F; Bouget, FY; O'Neill, JS; Le Bihan, T; Millar, AJ				van Ooijen, Gerben; Hindle, Matthew; Martin, Sarah F.; Barrios-Llerena, Martin; Sanchez, Frederic; Bouget, Francois-Yves; O'Neill, John S.; Le Bihan, Thierry; Millar, Andrew J.			Functional Analysis of Casein Kinase 1 in a Minimal Circadian System	PLOS ONE			English	Article							DROSOPHILA CLOCK GENE; PERIOD PROTEIN; CKI-EPSILON; DOUBLE-TIME; PHOSPHORYLATION; TRANSCRIPTION; EVOLUTION; HYPERPHOSPHORYLATION; DEGRADATION; INHIBITOR	The Earth's rotation has driven the evolution of cellular circadian clocks to facilitate anticipation of the solar cycle. Some evidence for timekeeping mechanism conserved from early unicellular life through to modern organisms was recently identified, but the components of this oscillator are currently unknown. Although very few clock components appear to be shared across higher species, Casein Kinase 1 (CK1) is known to affect timekeeping across metazoans and fungi, but has not previously been implicated in the circadian clock in the plant kingdom. We now show that modulation of CK1 function lengthens circadian rhythms in Ostreococcus tauri, a unicellular marine algal species at the base of the green lineage, separated from humans by similar to 1.5 billion years of evolution. CK1 contributes to timekeeping in a phase-dependent manner, indicating clock-mediated gating of CK1 activity. Label-free proteomic analyses upon overexpression as well as inhibition revealed CK1-responsive phosphorylation events on a set of target proteins, including highly conserved potentially clock-relevant cellular regulator proteins. These results have major implications for our understanding of cellular timekeeping and can inform future studies in any circadian organism.	[van Ooijen, Gerben; Hindle, Matthew; Martin, Sarah F.; Barrios-Llerena, Martin; Le Bihan, Thierry; Millar, Andrew J.] Univ Edinburgh, SynthSys, Edinburgh, Midlothian, Scotland; [van Ooijen, Gerben] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [van Ooijen, Gerben; Le Bihan, Thierry; Millar, Andrew J.] Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh, Midlothian, Scotland; [Sanchez, Frederic; Bouget, Francois-Yves] Univ Paris 06, CNRS, Paris, France; [Sanchez, Frederic; Bouget, Francois-Yves] Observ Oceanol, Lab Oceanog Microbienne, Banyuls Sur Mer, France; [O'Neill, John S.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Edinburgh; University of Edinburgh; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; MRC Laboratory Molecular Biology	van Ooijen, G (corresponding author), Univ Edinburgh, SynthSys, Edinburgh, Midlothian, Scotland.	Gerben.vanOoijen@ed.ac.uk; Andrew.Millar@ed.ac.uk	Le Bihan, Thierry/AAN-2534-2020; Barrios-LLerena, Martin/AAM-8152-2020; van Ooijen, Gerben/E-9371-2013; Millar, Andrew J/G-2423-2012	van Ooijen, Gerben/0000-0001-7967-0637; Millar, Andrew J/0000-0003-1756-3654; Hindle, Matthew/0000-0002-6870-4069; Le Bihan, Thierry/0000-0003-0498-8063; O'Neill, John Stuart/0000-0003-2204-6096; Barrios-LLerena, Martin/0000-0002-1416-8686	BBSRC [BB/J009423]; SynthSys; a Centre for Integrative Systems Biology; BBSRC; EPSRC [BB/D019621]; Royal Society [UF110173, RG120372]; Wellcome Trust [093734/Z/10/Z]; BBSRC [BB/J009423/1, BB/D019621/1] Funding Source: UKRI; MRC [MC_UP_1201/4] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009423/1, BB/D019621/1] Funding Source: researchfish; Medical Research Council [MC_UP_1201/4] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SynthSys; a Centre for Integrative Systems Biology; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by BBSRC award BB/J009423 and SynthSys; a Centre for Integrative Systems Biology supported by BBSRC and EPSRC award BB/D019621. GvO is supported by the Royal Society by a University Research Fellowship (UF110173) and a Research Grant (RG120372). JSO is supported by the Wellcome Trust (093734/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arey R, 2012, BEHAV PHARMACOL, V23, P392, DOI 10.1097/FBP.0b013e32835651fd; Badura L, 2007, J PHARMACOL EXP THER, V322, P730, DOI 10.1124/jpet.107.122846; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Chiu JC, 2011, CELL, V145, P357, DOI 10.1016/j.cell.2011.04.002; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Cote RG, 2012, MOL CELL PROTEOMICS, V11, P1682, DOI 10.1074/mcp.O112.021543; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Edwards KD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.81; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gerard C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00413; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Heijde M, 2010, PLANT CELL ENVIRON, V33, P1614, DOI 10.1111/j.1365-3040.2010.02168.x; HENDERSON GP, 2007, PLOS ONE, V2, DOI DOI 10.1371/J0URNAL.P0NE.0000749.PUBMED:17710148; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kusakina J, 2012, TRENDS PLANT SCI, V17, P575, DOI 10.1016/j.tplants.2012.06.008; Le Bihan T, 2011, J PROTEOMICS, V74, P2060, DOI 10.1016/j.jprot.2011.05.028; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Matsunaga S, 2012, NEUROSCI LETT, V529, P66, DOI 10.1016/j.neulet.2012.08.070; McCarthy MJ, 2012, J BIOL RHYTHM, V27, P339, DOI 10.1177/0748730412456367; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Novak B, 1998, PHILOS T ROY SOC B, V353, P2063, DOI 10.1098/rstb.1998.0352; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Olmedo M, 2012, P NATL ACAD SCI USA, V109, P20479, DOI 10.1073/pnas.1211705109; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Shanware NP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.224014; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Syed S, 2011, J BIOL CHEM, V286, P27654, DOI 10.1074/jbc.M111.243618; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; van Ooijen G, 2012, TRENDS BIOCHEM SCI, V37, P484, DOI 10.1016/j.tibs.2012.07.006; van Ooijen G, 2012, JOVE-J VIS EXP, DOI 10.3791/4074; van Ooijen G, 2011, CURR BIOL, V21, P869, DOI 10.1016/j.cub.2011.03.060; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	61	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70021	10.1371/journal.pone.0070021	http://dx.doi.org/10.1371/journal.pone.0070021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936135	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300083
J	Mata, M; Martinez, I; Melero, JA; Tenor, H; Cortijo, J				Mata, Manuel; Martinez, Isidoro; Melero, Jose A.; Tenor, Herman; Cortijo, Julio			Roflumilast Inhibits Respiratory Syncytial Virus Infection in Human Differentiated Bronchial Epithelial Cells	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; PDE4 INHIBITOR; INFLAMMATORY MEDIATORS; CILIA MOTILITY; PROTEIN-KINASE; KAPPA-B; EXPRESSION; EXACERBATIONS; REPLICATION; ACTIVATION	Respiratory syncytial virus (RSV) causes acute exacerbations in COPD and asthma. RSV infects bronchial epithelial cells (HBE) that trigger RSV associated lung pathology. This study explores whether the phosphodiesterase 4 (PDE4) inhibitor Roflumilast N-oxide (RNO), alters RSV infection of well-differentiated HBE (WD-HBE) in vitro. WD-HBE were RSV infected in the presence or absence of RNO (0.1-100 nM). Viral infection (staining of F and G proteins, nucleoprotein RNA level), mRNA of ICAM-1, ciliated cell markers (digital high speed videomicroscopy, beta-tubulin immunofluorescence, Foxj1 and Dnai2 mRNA), Goblet cells (PAS), mRNA of MUC5AC and CLCA1, mRNA and protein level of IL-13, IL-6, IL-8, TNF alpha, formation of H2O2 and the anti-oxidative armamentarium (mRNA of Nrf2, HO-1, GPx; total antioxidant capacity (TAC) were measured at day 10 or 15 post infection. RNO inhibited RSV infection of WD-HBE, prevented the loss of ciliated cells and markers, reduced the increase of MUC5AC and CLCA1 and inhibited the increase of IL-13, IL-6, IL-8, TNF alpha and ICAM-1. Additionally RNO reversed the reduction of Nrf2, HO-1 and GPx mRNA levels and consequently restored the TAC and reduced the H2O2 formation. RNO inhibits RSV infection of WD-HBE cultures and mitigates the cytopathological changes associated to this virus.	[Mata, Manuel; Cortijo, Julio] Univ Gen Hosp Valencia, Res Fdn, Valencia, Spain; [Mata, Manuel; Cortijo, Julio] Ctr Invest Biomed Red CIBER Enfermedades Resp, Valencia, Spain; [Mata, Manuel; Cortijo, Julio] Univ Valencia, Valencia, Spain; [Martinez, Isidoro] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Interacc Virus Celula, Madrid, Spain; [Melero, Jose A.] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Biol Viral, Madrid, Spain; [Martinez, Isidoro; Melero, Jose A.] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain; [Tenor, Herman] Takeda Pharmaceut Int, Zurich, Switzerland	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Valencia; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Mata, M (corresponding author), Univ Gen Hosp Valencia, Res Fdn, Valencia, Spain.	mata_manroi@gva.es	Morcillo, Esteban/I-1552-2015; Martínez, Isidoro/J-3032-2012; Roig, Manuel Mata/G-4338-2015	Morcillo, Esteban/0000-0003-4373-9457; Martínez, Isidoro/0000-0002-9949-9264; Roig, Manuel Mata/0000-0002-1506-7983; Melero, Jose A./0000-0001-8148-6521	Ministry of Economy and Competitiveness; Health Institute 'Carlos III' of the Spanish Government; Regional Government from GeneralitatValenciana [GV2007/287, AP073/10];  [SAF2008-03113/SAF2011-26443];  [PI10/02294];  [CB06/06/0027]	Ministry of Economy and Competitiveness; Health Institute 'Carlos III' of the Spanish Government; Regional Government from GeneralitatValenciana; ; ; 	This work was supported by grants SAF2008-03113/SAF2011-26443 (JC), PI10/02294 (MM), and CIBERES (CB06/06/0027) from the Ministry of Economy and Competitiveness and the Health Institute 'Carlos III' of the Spanish Government and research grants from Regional Government (GV2007/287 and AP073/10, from GeneralitatValenciana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengot M, 2010, AM J RHINOL ALLERGY, V24, P175, DOI 10.2500/ajra.2010.24.3448; Arnold R, 2006, VIROLOGY, V350, P335, DOI 10.1016/j.virol.2006.03.008; Asada M, 2012, RESP PHYSIOL NEUROBI, V180, P112, DOI 10.1016/j.resp.2011.10.017; Asada M, 2009, ANTIVIR RES, V83, P191, DOI 10.1016/j.antiviral.2009.05.003; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Bateman ED, 2011, EUR RESPIR J, V38, P553, DOI 10.1183/09031936.00178710; Bethke TD, 2007, J CLIN PHARMACOL, V47, P26, DOI 10.1177/0091270006294529; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Cho HY, 2009, AM J RESP CRIT CARE, V179, P138, DOI 10.1164/rccm.200804-535OC; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cortijo J, 2009, BRIT J PHARMACOL, V156, P534, DOI 10.1111/j.1476-5381.2008.00041.x; Dent G, 1998, PULM PHARMACOL THER, V11, P47, DOI 10.1006/pupt.1998.0115; Dimopoulos G, 2012, PULM PHARMACOL THER, V25, P12, DOI 10.1016/j.pupt.2011.08.004; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Falsey AR, 2005, DRUG AGING, V22, P577, DOI 10.2165/00002512-200522070-00004; Fink K, 2008, J IMMUNOL, V180, P6911, DOI 10.4049/jimmunol.180.10.6911; Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]; Fuhrmann M, 1999, AM J RESP CELL MOL, V20, P292, DOI 10.1165/ajrcmb.20.2.3140; Garofalo RP, 2013, ANTIOXID REDOX SIGN, V18, P186, DOI 10.1089/ars.2011.4307; Gower TL, 2001, ANTIMICROB AGENTS CH, V45, P1231, DOI 10.1128/AAC.45.4.1231-1237.2001; Growcott EJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-9; Hansbro NG, 2008, PHARMACOL THERAPEUT, V117, P313, DOI 10.1016/j.pharmthera.2007.11.002; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Hohne K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038369; Hosakote YM, 2011, AM J RESP CRIT CARE, V183, P1550, DOI 10.1164/rccm.201010-1755OC; Hosakote YM, 2009, AM J RESP CELL MOL, V41, P348, DOI 10.1165/rcmb.2008-0330OC; Iesato K, 2008, RESPIRATION, V76, P434, DOI 10.1159/000151729; Kokot A, 2009, ENDOCRINOLOGY, V150, P3197, DOI 10.1210/en.2008-1315; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Kwak HJ, 2005, J PHARMACOL EXP THER, V315, P1188, DOI 10.1124/jpet.105.092056; Kwak HJ, 2008, CELL SIGNAL, V20, P803, DOI 10.1016/j.cellsig.2007.12.011; Lay MK, 2013, MICROBES INFECT; Leverence JT, 2011, CHEM-BIOL INTERACT, V189, P72, DOI 10.1016/j.cbi.2010.09.026; Look DC, 2001, AM J PATHOL, V159, P2055, DOI 10.1016/S0002-9440(10)63057-X; Lopez-Campos JL, 2012, ARCH BRONCONEUMOL, V48, P426, DOI 10.1016/j.arbres.2012.03.002; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; Mata M, 2005, THORAX, V60, P144, DOI 10.1136/thx.2004.025692; Mata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048037; Mata M, 2011, BIOCHEM PHARMACOL, V82, P548, DOI 10.1016/j.bcp.2011.05.014; MBIGUINO A, 1991, J VIROL METHODS, V31, P161, DOI 10.1016/0166-0934(91)90154-R; Meja KK, 2004, J PHARMACOL EXP THER, V309, P833, DOI 10.1124/jpet.103.060020; Milara J, 2012, BRIT J PHARMACOL, V166, P2243, DOI 10.1111/j.1476-5381.2012.01929.x; Mukherjee S, 2010, EXPERT REV ANTI-INFE, V8, P617, DOI 10.1586/ERI.10.39; Murphy DM, 2006, J HEART LUNG TRANSPL, V25, P1436, DOI 10.1016/j.healun.2006.09.005; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Okada SF, 2011, AM J RESP CELL MOL, V45, P253, DOI 10.1165/rcmb.2010-0253OC; Pace E, 2011, CELL IMMUNOL, V268, P47, DOI 10.1016/j.cellimm.2011.02.004; Rabe KF, 2011, BRIT J PHARMACOL, V163, P53, DOI 10.1111/j.1476-5381.2011.01218.x; Ramaswamy M, 2009, COPD, V6, P64, DOI 10.1080/15412550902724024; Reddy PJ, 2008, COPD, V5, P5, DOI 10.1080/15412550701817573; Rennard SI, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-18; Schudt C, 2011, HANDB EXP PHARMACOL, V204, P1, DOI 10.1007/978-3-642-17969-3_1; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Wright LC, 1998, AM J PHYSIOL-LUNG C, V275, pL694, DOI 10.1152/ajplung.1998.275.4.L694	54	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69670	10.1371/journal.pone.0069670	http://dx.doi.org/10.1371/journal.pone.0069670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936072	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000145
J	Wang, H; Sridhar, B; Leinwand, LA; Anseth, KS				Wang, Huan; Sridhar, Balaji; Leinwand, Leslie A.; Anseth, Kristi S.			Characterization of Cell Subpopulations Expressing Progenitor Cell Markers in Porcine Cardiac Valves	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INTERSTITIAL-CELLS; MYOFIBROBLAST ACTIVATION; NG2 PROTEOGLYCAN; OB-CADHERIN; STEM-CELLS; ADULT; DIFFERENTIATION; CALCIFICATION; TRANSPORTER	Valvular interstitial cells (VICs) are the main population of cells found in cardiac valves. These resident fibroblastic cells play important roles in maintaining proper valve function, and their dysregulation has been linked to disease progression in humans. Despite the critical functions of VICs, their cellular composition is still not well defined for humans and other mammals. Given the limited availability of healthy human valves and the similarity in valve structure and function between humans and pigs, we characterized porcine VICs (pVICs) based on expression of cell surface proteins and sorted a specific subpopulation of pVICs to study its functions. We found that small percentages of pVICs express the progenitor cell markers ABCG2 (similar to 5%), NG2 (similar to 5%) or SEA-4 (similar to 7%), whereas another subpopulation (similar to 5%) expresses OB-CDH, a type of cadherin expressed by myofibroblasts or osteo-progenitors. pVICs isolated from either aortic or pulmonary valves express most of these protein markers at similar levels. Interestingly, OB-CDH, NG2 and SSEA-4 all label distinct valvular subpopulations relative to each other; however, NG2 and ABCG2 are co-expressed in the same cells. ABCG2(+) cells were further characterized and found to deposit more calcified matrix than ABCG2(-) cells upon osteogenic induction, suggesting that they may be involved in the development of osteogenic VICs during valve pathology. Cell profiling based on flow cytometry and functional studies with sorted primary cells provide not only new and quantitative information about the cellular composition of porcine cardiac valves, but also contribute to our understanding of how a subpopulation of valvular cells (ABCG2(+) cells) may participate in tissue repair and disease progression.	[Wang, Huan; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wang, Huan; Sridhar, Balaji; Leinwand, Leslie A.; Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Sridhar, Balaji; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Anseth, KS (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.	kristi.anseth@colorado.edu		WANG, HUAN/0000-0002-3857-5737; Sridhar, Balaji/0000-0003-3427-1047; Wang, Huan/0000-0001-9048-2733; LEINWAND, LESLIE/0000-0003-1470-4810	National Institutes of Health [R01 HL089260]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090, T32GM008497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported by National Institutes of Health (R01 HL089260) and Howard Hughes Medical Institute grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031; Bischoff J, 2011, J CARDIOVASC TRANSL, V4, P710, DOI 10.1007/s12265-011-9312-0; Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237; Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061; Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Deb A, 2005, J HEART VALVE DIS, V14, P674; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Doyle MJ, 2011, J CELL BIOL, V195, P147, DOI 10.1083/jcb.201103159; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gilbert PM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt44; Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009; Hajdu Z, 2011, J MOL CELL CARDIOL, V51, P955, DOI 10.1016/j.yjmcc.2011.08.006; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; *IN TISC, 2007, NAT BIOTECHNOL, V25, P803; JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1; Kii I, 2004, J BONE MINER RES, V19, P1840, DOI 10.1359/JBMR.040812; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Latif N, 2007, J HEART VALVE DIS, V16, P56; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Mohler ER, 2004, AM J CARDIOL, V94, P1396, DOI 10.1016/j.amjcard.2004.08.013; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; OKAZAKI M, 1994, J BIOL CHEM, V269, P12092; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Pho M, 2008, AM J PHYSIOL-HEART C, V294, pH1767, DOI 10.1152/ajpheart.01305.2007; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pittet P, 2008, J CELL SCI, V121, P877, DOI 10.1242/jcs.024877; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Rattazzi M, 2008, ARTERIOSCL THROM VAS, V28, P2165, DOI 10.1161/ATVBAHA.108.174342; Sereti KI, 2013, CIRC RES, V112, P27, DOI 10.1161/CIRCRESAHA.111.300010; SIMONNEAU L, 1995, CELL ADHES COMMUN, V3, P115, DOI 10.3109/15419069509081281; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Veinot JP, 2006, CARDIOVASC PATHOL, V15, P36, DOI 10.1016/j.carpath.2005.08.005; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969; Wylie-Sears J, 2011, ARTERIOSCL THROM VAS, V31, P598, DOI 10.1161/ATVBAHA.110.216184; Zapata AG, 2012, ADV EXP MED BIOL, V741, P135, DOI 10.1007/978-1-4614-2098-9_10; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	51	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69667	10.1371/journal.pone.0069667	http://dx.doi.org/10.1371/journal.pone.0069667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936071	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000144
J	Steinacher, R; Osman, F; Lorenz, A; Bryer, C; Whitby, MC				Steinacher, Roland; Osman, Fekret; Lorenz, Alexander; Bryer, Claire; Whitby, Matthew C.			Slx8 Removes Pli1-Dependent Protein-SUMO Conjugates Including SUMOylated Topoisomerase I to Promote Genome Stability	PLOS ONE			English	Article							THYMINE-DNA GLYCOSYLASE; REPLICATION FORKS; UBIQUITIN LIGASE; RECOMBINATION; REPAIR; COMPLEX; TERMINATION; PATHWAY; PCNA; REARRANGEMENTS	The SUMO-dependent ubiquitin ligase Slx8 plays key roles in promoting genome stability, including the processing of trapped Topoisomerase I (Top1) cleavage complexes and removal of toxic SUMO conjugates. We show that it is the latter function that constitutes Slx8's primary role in fission yeast. The SUMO conjugates in question are formed by the SUMO ligase Pli1, which is necessary for limiting spontaneous homologous recombination when Top1 is present. Surprisingly there is no requirement for Pli1 to limit recombination in the vicinity of a replication fork blocked at the programmed barrier RTS1. Notably, once committed to Pli1-mediated SUMOylation Slx8 becomes essential for genotoxin resistance, limiting both spontaneous and RTS1 induced recombination, and promoting normal chromosome segregation. We show that Slx8 removes Pli1-dependent Top1-SUMO conjugates and in doing so helps to constrain recombination at RTS1. Overall our data highlight how SUMOylation and SUMO-dependent ubiquitylation by the Pli1-Slx8 axis contribute in different ways to maintain genome stability.	[Steinacher, Roland; Osman, Fekret; Lorenz, Alexander; Bryer, Claire; Whitby, Matthew C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Whitby, MC (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	matthew.whitby@bioch.ox.ac.uk	Lorenz, Alexander/B-4735-2008	Lorenz, Alexander/0000-0003-1925-3713; Whitby, Matthew/0000-0003-0951-3374; Bryer, Claire/0000-0002-7900-3460	Wellcome Trust [090767/Z/09/Z]; DFG	Wellcome Trust(Wellcome Trust); DFG(German Research Foundation (DFG))	This work was funded by grant 090767/Z/09/Z from the Wellcome Trust (http://www.wellcome.ac.uk/). Roland Steinacher was supported in part by a Research Fellowship from the DFG (http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2005, EMBO J, V24, P2011, DOI 10.1038/sj.emboj.7600670; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012636; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Chen XL, 2007, GENETICS, V177, P17, DOI 10.1534/genetics.107.074708; Codlin S, 2003, EMBO J, V22, P3431, DOI 10.1093/emboj/cdg330; DARPA P, 1990, CANCER RES, V50, P6919; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Heideker J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001320; Horie K, 2002, ONCOGENE, V21, P7913, DOI 10.1038/sj.onc.1205917; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Ii T, 2007, CELL CYCLE, V6, P2800, DOI 10.4161/cc.6.22.4882; Inagawa T, 2009, P NATL ACAD SCI USA, V106, P7927, DOI 10.1073/pnas.0812323106; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jentsch S, 2010, SUBCELL BIOCHEM, V54, P184, DOI 10.1007/978-1-4419-6676-6_15; Kai M, 2007, NAT CELL BIOL, V9, P691, DOI 10.1038/ncb1600; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Lorenz A, 2009, MOL CELL BIOL, V29, P4742, DOI 10.1128/MCB.00471-09; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mullen JR, 2008, J BIOL CHEM, V283, P19912, DOI 10.1074/jbc.M802690200; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Osman Fekret, 2009, V521, P535, DOI [10.1007/978-1-60327-817-5_31, 10.1007/978-1-60327-815-7_31]; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Burkovics P, 2013, EMBO J, V32, P742, DOI 10.1038/emboj.2013.9; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Schleker T, 2009, DNA REPAIR, V8, P1089, DOI 10.1016/j.dnarep.2009.04.010; SQUIRES S, 1993, CANCER RES, V53, P2012; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Ulrich HD, 2005, CELL CYCLE, V4, P1699, DOI 10.4161/cc.4.12.2194; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Watts FZ, 2007, BIOCHEM SOC T, V35, P1379, DOI 10.1042/BST0351379; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Xhemalce B, 2004, EMBO J, V23, P3844, DOI 10.1038/sj.emboj.7600394; Xhemalce B, 2007, P NATL ACAD SCI USA, V104, P893, DOI 10.1073/pnas.0605442104; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200	66	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71960	10.1371/journal.pone.0071960	http://dx.doi.org/10.1371/journal.pone.0071960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936535	Green Submitted, Green Published, gold			2022-12-27	WOS:000324401500085
J	Romano, CM; Lauck, M; Salvador, FS; Lima, CR; Villas-Boas, LS; Araujo, ESA; Levi, JE; Pannuti, CS; O'Connor, D; Kallas, EG				Romano, Camila Malta; Lauck, Michael; Salvador, Felipe S.; Lima, Celia Rodrigues; Villas-Boas, Lucy S.; Araujo, Evaldo Stanislau A.; Levi, Jose Eduardo; Pannuti, Claudio Sergio; O'Connor, David; Kallas, Esper Georges			Inter- and Intra-Host Viral Diversity in a Large Seasonal DENV2 Outbreak	PLOS ONE			English	Article							DENGUE VIRUS; EVOLUTIONARY DYNAMICS; ARBOVIRUS; SELECTION; PRESSURE; PATTERNS; MUTATION; TYPE-2; TIME	Background: High genetic diversity at both inter-and intra-host level are hallmarks of RNA viruses due to the error-prone nature of their genome replication. Several groups have evaluated the extent of viral variability using different RNA virus deep sequencing methods. Although much of this effort has been dedicated to pathogens that cause chronic infections in humans, few studies investigated arthropod-borne, acute viral infections. Methods and Principal Findings: We deep sequenced the complete genome of ten DENV2 isolates from representative classical and severe cases sampled in a large outbreak in Brazil using two different approaches. Analysis of the consensus genomes confirmed the larger extent of the 2010 epidemic in comparison to a previous epidemic caused by the same viruses in another city two years before (genetic distance = 0.002 and 0.0008 respectively). Analysis of viral populations within the host revealed a high level of conservation. After excluding homopolymer regions of 454/Roche generated sequences, we found 10 to 44 variable sites per genome population at a frequency of >1%, resulting in very low intra-host genetic diversity. While up to 60% of all variable sites at intra-host level were non-synonymous changes, only 10% of inter-host variability resulted from non-synonymous mutations, indicative of purifying selection at the population level. Conclusions and Significance: Despite the error-prone nature of RNA-dependent RNA-polymerase, dengue viruses maintain low levels of intra-host variability.	[Romano, Camila Malta; Salvador, Felipe S.; Lima, Celia Rodrigues; Villas-Boas, Lucy S.; Levi, Jose Eduardo; Pannuti, Claudio Sergio] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, Brazil; [Romano, Camila Malta; Salvador, Felipe S.; Lima, Celia Rodrigues; Villas-Boas, Lucy S.; Levi, Jose Eduardo; Pannuti, Claudio Sergio] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias LIMHC, Sao Paulo, Brazil; [Lauck, Michael; O'Connor, David] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Araujo, Evaldo Stanislau A.] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil; [Kallas, Esper Georges] Univ Sao Paulo, Fac Med, Disciplina Imunol Clin & Alergia LIM 60, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Wisconsin System; University of Wisconsin Madison; Universidade de Sao Paulo; Universidade de Sao Paulo	Romano, CM (corresponding author), Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.	cmromano@usp.br	Romano, Camila M/C-8185-2013; Romano, Camila/ABC-2883-2020; Salvador, Felipe Scassi/AAU-8431-2021	Romano, Camila/0000-0003-4550-1987; Kallas, Esper/0000-0003-2026-6925; o'connor, david/0000-0003-2139-470X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/12313-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazilian Ministry of Science and Technology (CNPq) [476088/2009-7]; National Institutes of Health [R01 AI077376-04A1]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015459, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077376] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazilian Ministry of Science and Technology (CNPq)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant #10/12313-5 to CMR) and by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazilian Ministry of Science and Technology (CNPq, grant #476088/2009-7 to EGK). URL of FAPESP: www.fapesp.br; URL of CNPq: www.cnpq.br; URL of Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also made possible in part by National Institutes of Health grant R01 AI077376-04A1. The research was conducted, in part, at a facility constructed with support from Research Facilities Improvement Program grants RR15459-01 and RR020141-01.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Becker EA, 2012, GENOME BIOL EVOL, V4, P457, DOI 10.1093/gbe/evs029; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; CVE DdZ, 2010, DAD PROV CVE DENG; de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004; Descloux E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000493; Santos Cecília Luiza Simões dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P11; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hoper D, 2012, J VIROL, V86, P1394, DOI 10.1128/JVI.00797-11; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Kanesa-thasan N, 1998, EMERG INFECT DIS, V4, P299, DOI 10.3201/eid0402.980220; Kumar SRP, 2010, J GEN VIROL, V91, P707, DOI 10.1099/vir.0.017954-0; Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06; Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11; Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019447; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; Murcia PR, 2010, J VIROL, V84, P6943, DOI 10.1128/JVI.00112-10; Ninomiya M, 2012, J CLIN MICROBIOL, V50, P857, DOI 10.1128/JCM.05715-11; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; PAHO, 2008, NUMB REP CAS DENG DE; Parameswaran P, 2012, J VIROL; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rogozin IB, 2003, MUTAT RES-REV MUTAT, V544, P65, DOI 10.1016/S1383-5742(03)00032-2; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; SABINO E, 1993, AIDS RES HUM RETROV, V9, P1265, DOI 10.1089/aid.1993.9.1265; Strauss BS, 1999, MUTAT RES-REV MUTAT, V437, P195, DOI 10.1016/S1383-5742(99)00066-6; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681; Thai KTD, 2012, J VIROL, V86, P835, DOI 10.1128/JVI.05985-11; VARTANIAN JP, 1992, AIDS, V6, P1095, DOI 10.1097/00002030-199210000-00005; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; Wang WK, 2002, VIROLOGY, V303, P181, DOI 10.1006/viro.2002.1635; Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; World Health Organization, 2009, DENG GUID DIAGN TREA, P147, DOI DOI 10.7705/BIOMEDICA.V37I4.3370	48	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70318	10.1371/journal.pone.0070318	http://dx.doi.org/10.1371/journal.pone.0070318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936406	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800039
J	Critchfield, AS; Yao, G; Jaishankar, A; Friedlander, RS; Lieleg, O; Doyle, PS; McKinley, G; House, M; Ribbeck, K				Critchfield, Agatha S.; Yao, Grace; Jaishankar, Aditya; Friedlander, Ronn S.; Lieleg, Oliver; Doyle, Patrick S.; McKinley, Gareth; House, Michael; Ribbeck, Katharina			Cervical Mucus Properties Stratify Risk for Preterm Birth	PLOS ONE			English	Article							MICROBIAL INVASION; WOMEN; PREDICTION; PLUG; PROGESTERONE; INFECTION; HYDROGELS; CERCLAGE; LABOR; TERM	Background: Ascending infection from the colonized vagina to the normally sterile intrauterine cavity is a well-documented cause of preterm birth. The primary physical barrier to microbial ascension is the cervical canal, which is filled with a dense and protective mucus plug. Despite its central role in separating the vaginal from the intrauterine tract, the barrier properties of cervical mucus have not been studied in preterm birth. Methods and Findings: To study the protective function of the cervical mucus in preterm birth we performed a pilot case-control study to measure the viscoelasticity and permeability properties of mucus obtained from pregnant women at high-risk and low-risk for preterm birth. Using extensional and shear rheology we found that cervical mucus from women at high-risk for preterm birth was more extensible and forms significantly weaker gels compared to cervical mucus from women at low-risk of preterm birth. Moreover, permeability measurements using fluorescent microbeads show that high-risk mucus was more permeable compared with low-risk mucus. Conclusions: Our findings suggest that critical biophysical barrier properties of cervical mucus in women at high-risk for preterm birth are compromised compared to women with healthy pregnancy. We hypothesize that impaired barrier properties of cervical mucus could contribute to increased rates of intrauterine infection seen in women with preterm birth. We furthermore suggest that a robust association of spinnbarkeit and preterm birth could be an effectively exploited biomarker for preterm birth prediction.	[Critchfield, Agatha S.; House, Michael] Tufts Med Ctr, Div Maternal Fetal Med, Dept Obstet & Gynecol, Boston, MA USA; [Yao, Grace; Lieleg, Oliver; Ribbeck, Katharina] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Friedlander, Ronn S.] MIT Harvard Div Hlth Sci & Technol, Cambridge, MA USA; [Jaishankar, Aditya; McKinley, Gareth] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Doyle, Patrick S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Tufts Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ribbeck, K (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ribbeck@mit.edu	Doyle, Patrick S/H-7031-2013; Jaishankar, Aditya/J-7908-2015; McKinley, Gareth/G-4872-2011	Doyle, Patrick S/0000-0003-2147-9172; Jaishankar, Aditya/0000-0003-4738-8439; Lieleg, Oliver/0000-0002-6874-7456; Critchfield, Agatha/0000-0003-1411-1150; McKinley, Gareth/0000-0001-8323-2779	MIT startup; Charles E. Reed Faculty Initiative Funds; Burroughs Wellcome Fund Preterm Birth Research Grant; Reproductive Scientist Development Program (NIH) [2K12HD000849-25]; March of Dimes Birth Defects Foundation; National Science Foundation; German Academic Exchange Service (DAAD); NASA Microgravity Fluid Sciences (Code UG) [NNX09AV99G]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER	MIT startup; Charles E. Reed Faculty Initiative Funds; Burroughs Wellcome Fund Preterm Birth Research Grant; Reproductive Scientist Development Program (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); National Science Foundation(National Science Foundation (NSF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NASA Microgravity Fluid Sciences (Code UG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was funded in part by MIT startup, the Charles E. Reed Faculty Initiative Funds, and the Burroughs Wellcome Fund Preterm Birth Research Grant to KR. Additional support came from the Reproductive Scientist Development Program (NIH grant #2K12HD000849-25) and the March of Dimes Birth Defects Foundation to MH. RSF is supported through the National Science Foundation Graduate Research Fellowship Program. OL was supported through a postdoc fellowship from the German Academic Exchange Service (DAAD). AJ is funded by NASA Microgravity Fluid Sciences (Code UG, grant no. NNX09AV99G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher N, 2004, AM J OBSTET GYNECOL, V191, P1232, DOI 10.1016/j.ajog.2004.03.023; Becher N, 2009, ACTA OBSTET GYN SCAN, V88, P502, DOI 10.1080/00016340902852898; Behrman R.E, 2006, PRETERM BIRTH CAUSES; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; CHANTLER E, 1986, SEMIN REPROD ENDOCR, V4, P333, DOI 10.1055/s-2007-1022513; CHRETIEN FC, 1978, ACTA OBSTET GYN SCAN, V57, P337, DOI 10.3109/00016347809154028; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; Conde-Agudelo A, 2011, BJOG-INT J OBSTET GY, V118, P1042, DOI 10.1111/j.1471-0528.2011.02923.x; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; da Fonseca EB, 2009, SEMIN PERINATOL, V33, P334, DOI 10.1053/j.semperi.2009.06.006; DAUNTER B, 1980, EUR J OBSTET GYN R B, V10, P141, DOI 10.1016/0028-2243(80)90056-8; DAUNTER B, 1976, BRIT J OBSTET GYNAEC, V83, P738, DOI 10.1111/j.1471-0528.1976.tb00925.x; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Goldenberg RL, 2000, AM J OBSTET GYNECOL, V182, P625, DOI 10.1067/mob.2000.104210; Goldenherg RL, 2000, AM J OBSTET GYNECOL, V182, P631, DOI 10.1067/mob.2000.104211; Gomez R, 2005, AM J OBSTET GYNECOL, V192, P678, DOI 10.1016/j.ajog.2004.10.624; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Hein M, 2005, ACTA OBSTET GYN SCAN, V84, P734, DOI 10.1111/j.0001-6349.2005.00525.x; Hein M, 2002, AM J OBSTET GYNECOL, V187, P137, DOI 10.1067/mob.2002.123034; Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lieleg O, 2012, BIOMACROMOLECULES, V13, P1724, DOI 10.1021/bm3001292; Lieleg O, 2011, TRENDS CELL BIOL, V21, P543, DOI 10.1016/j.tcb.2011.06.002; Lieleg O, 2010, BIOPHYS J, V98, P1782, DOI 10.1016/j.bpj.2010.01.012; Limvarapuss C, 1992, Asia Oceania J Obstet Gynaecol, V18, P147; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Mathews T J, 2011, Natl Vital Stat Rep, V59, P1; Mathews T J, 2008, Natl Vital Stat Rep, V57, P1; McKinley GH, 2005, RHEOL REV, P1; Navath RS, 2011, MOL PHARMACEUT, V8, P1209, DOI 10.1021/mp200027z; Owen J, 2001, JAMA-J AM MED ASSOC, V286, P1340, DOI 10.1001/jama.286.11.1340; ROMERO R, 1992, AM J OBSTET GYNECOL, V167, P1086, DOI 10.1016/S0002-9378(12)80043-3; Romero R, 2006, AM J OBSTET GYNECOL, V194, P1, DOI 10.1016/j.ajog.2005.12.002; Romero R, 2008, AM J OBSTET GYNECOL, V198, P1, DOI 10.1016/j.ajog.2007.11.031; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Sakai M, 2006, AM J OBSTET GYNECOL, V194, P14, DOI 10.1016/j.ajog.2005.06.014; Stout MJ, 2013, AM J OBSTET GYNECOLO, V208, pe221; Vaisbuch E, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.007; von Elm E, 2008, GAC SANIT, V22, P144, DOI 10.1157/13119325; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]; ZAHM JM, 1986, B EUR PHYSIOPATH RES, V22, P609	46	48	51	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69528	10.1371/journal.pone.0069528	http://dx.doi.org/10.1371/journal.pone.0069528			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936335	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400016
J	Moodley, Y; Vaghjiani, V; Chan, J; Baltic, S; Ryan, M; Tchongue, J; Samuel, CS; Murthi, P; Parolini, O; Manuelpillai, U				Moodley, Yuben; Vaghjiani, Vijesh; Chan, James; Baltic, Svetlana; Ryan, Marisa; Tchongue, Jorge; Samuel, Chrishan S.; Murthi, Padma; Parolini, Ornella; Manuelpillai, Ursula			Anti-Inflammatory Effects of Adult Stem Cells in Sustained Lung Injury: A Comparative Study	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; MULTIPOTENT STROMAL CELLS; MATRIX METALLOPROTEINASES; PULMONARY FIBROSIS; TRANSPLANTATION; RAT; EXPRESSION; GROWTH; TSG-6	Lung diseases are a major cause of global morbidity and mortality that are treated with limited efficacy. Recently stem cell therapies have been shown to effectively treat animal models of lung disease. However, there are limitations to the translation of these cell therapies to clinical disease. Studies have shown that delayed treatment of animal models does not improve outcomes and that the models do not reflect the repeated injury that is present in most lung diseases. We tested the efficacy of amnion mesenchymal stem cells (AM-MSC), bone marrow MSC (BM-MSC) and human amniotic epithelial cells (hAEC) in C57BL/6 mice using a repeat dose bleomycin-induced model of lung injury that better reflects the repeat injury seen in lung diseases. The dual bleomycin dose led to significantly higher levels of inflammation and fibrosis in the mouse lung compared to a single bleomycin dose. Intravenously infused stem cells were present in the lung in similar numbers at days 7 and 21 post cell injection. In addition, stem cell injection resulted in a significant decrease in inflammatory cell infiltrate and a reduction in IL-1 (AM-MSC), IL-6 (AM-MSC, BM-MSC, hAEC) and TNF-alpha (AM-MSC). The only trophic factor tested that increased following stem cell injection was IL-1RA (AM-MSC). IL-1RA levels may be modulated by GM-CSF produced by AM-MSC. Furthermore, only AM-MSC reduced collagen deposition and increased MMP-9 activity in the lung although there was a reduction of the pro-fibrogenic cytokine TGF-beta following BM-MSC, AM-MSC and hAEC treatment. Therefore, AM-MSC may be more effective in reducing injury following delayed injection in the setting of repeated lung injury.	[Moodley, Yuben; Baltic, Svetlana; Ryan, Marisa] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Moodley, Yuben; Baltic, Svetlana; Ryan, Marisa] Royal Perth Hosp, Perth, WA, Australia; [Moodley, Yuben] Royal Perth Hosp, Dept Resp & Sleep Med, Perth, WA, Australia; [Moodley, Yuben; Baltic, Svetlana; Ryan, Marisa] Lung Inst Western Australia, Perth, WA, Australia; [Vaghjiani, Vijesh; Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Chan, James; Tchongue, Jorge] Monash Univ, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia; [Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Samuel, Chrishan S.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Murthi, Padma] Univ Melbourne, Dept Obstet & Gynecol, Parkville, Vic 3052, Australia; [Murthi, Padma] Royal Womens Hosp, Dept Perinatal Med, Pregnancy Res Ctr, Parkville, Vic, Australia; [Parolini, Ornella] Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy	University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; Monash University; Monash University; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne	Manuelpillai, U (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia.	ursula.manuelpillai@monash.edu	PAROLINI, ORNELLA/ABI-7862-2020; Baltic, Svetlana/C-2313-2014; Murthi, Padma/AAY-5395-2021; PAROLINI, ORNELLA/C-7946-2013	PAROLINI, ORNELLA/0000-0002-5211-6430; PAROLINI, ORNELLA/0000-0002-5211-6430; Baltic, Svetlana/0000-0002-3428-940X; Vaghjiani, Vijesh/0000-0001-8004-3876	Monash University Collaborative Grant; Australian National Health and Medical Research Council (NHMRC) [606473, 436634, 509140]; NHMRC; National Ministry of Health and Education and Fondazione Cariplo, Italy; Victorian Government's Operational Infrastructure Support Program	Monash University Collaborative Grant; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Ministry of Health and Education and Fondazione Cariplo, Italy; Victorian Government's Operational Infrastructure Support Program	This work was funded by a Monash University Collaborative Grant to YM and UM. UM is supported by Australian National Health and Medical Research Council (NHMRC) Project Grant #606473; JC by #436634; PM by #509140; CS by a NHMRC Senior Research Fellowship, and OP by the National Ministry of Health and Education and Fondazione Cariplo, Italy. VV and UM supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; BROWN RFR, 1988, TOXICOLOGY, V51, P101, DOI 10.1016/0300-483X(88)90084-4; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Chimenti L, 2012, EUR RESP J; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Gabazza EC, 2002, AM J RESP CRIT CARE, V165, P845, DOI 10.1164/ajrccm.165.6.correspondence_c; Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770; Gomperts BN, 2007, ANNU REV MED, V58, P285, DOI 10.1146/annurev.med.58.081905.134954; Hodges RJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.038; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496; Marongiu Fabio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e05s12; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Pierro M, 2010, AM J PHYSIOL-LUNG C, V298, pL732, DOI 10.1152/ajplung.00099.2010; Pinart M, 2009, RESP PHYSIOL NEUROBI, V166, P41, DOI 10.1016/j.resp.2009.01.002; Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Samuel CS, 1996, ENDOCRINOLOGY, V137, P3884, DOI 10.1210/en.137.9.3884; Vandooren J, 2013, CRIT REV BIOCH MOL B; Weiskirchen R, 2009, FRONT BIOSCI, V14, P4992, DOI 10.2741/3583; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Xu YL, 2012, CHINESE MED J-PEKING, V125, P2012, DOI 10.3760/cma.j.issn.0366-6999.2012.11.031; Zapata-Tarres M, 2013, PEDIAT INFECT DIS J; Zhang H, 2013, MOL CELL BIOCHEM, V375, P11, DOI 10.1007/s11010-012-1512-7; Zheng YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041392	39	79	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69299	10.1371/journal.pone.0069299	http://dx.doi.org/10.1371/journal.pone.0069299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936322	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400012
J	Moxnes, JF; de Blasio, BF; Leegaard, TM; Moen, AEF				Moxnes, John F.; de Blasio, Birgitte Freiesleben; Leegaard, Truls Michael; Moen, Aina E. Fossum			Methicillin-Resistant Staphylococcus aureus (MRSA) Is Increasing in Norway: A Time Series Analysis of Reported MRSA and Methicillin-Sensitive S. aureus Cases, 1997-2010	PLOS ONE			English	Article							INFECTION-CONTROL PRACTICES; CLOSTRIDIUM-DIFFICILE; CLINICAL INCIDENCE; ANTIMICROBIAL USE; ANTIBIOTIC USE; HEALTH-CARE; COLONIZATION; PREVALENCE; REDUCTION; HOSPITALS	Background: Accurate estimates of the incidence and prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections are needed to inform public health policies. In Norway, where both MRSA infection and carriage are notifiable conditions, the reported incidence of MRSA is slowly increasing. However, the proportion of MRSA in relation to all S. aureus isolates is unknown, making it difficult to determine if the rising incidence is real or an artifact of an increasing number of tests performed. Aim: To characterize recent trends in MRSA infections and obtain a more complete understanding of the MRSA level in Norway. Methods: All reported cases of MRSA and methicillin-sensitive S. aureus (MSSA) from Oslo County (1997-2010) and Health Region East (2008-2008), representing approximately 11% and 36% of the Norwegian population, respectively, were analyzed using a stochastic time series analysis to characterize trends. Results: In Oslo County, the proportion of methicillin-resistant cases increased from 0.73% to 3.78% during the study period and was well modeled by an exponential growth with a doubling constant of 5.7 years (95% CI 4.5-7.4 years). In Health Region East, the proportion of MRSA cases increased from 0.4% to 2.1% from 2002 to 2008, with a best-fitting linear increase of 0.26% (95% CI 0.21-0.30%) per year. In both cases, the choice of a linear or exponential model for the time trend produced only marginally different model fits. We found no significant changes due to revised national MRSA guidelines published in June 2009. Significant variations in the increasing time trend were observed in the five hospitals within the region. The yearly reported incidence of MSSA was relatively stable in both study areas although we found seasonal patterns with peaks in August. Conclusion: The level of MRSA is increasing in Norway, and the proportion of methicillin resistance in all S. aureus isolates are higher than the reported proportion of MRSA in invasive infections.	[Moxnes, John F.] Norwegian Def Res Estab, Dept Protect, N-2007 Kjeller, Norway; [de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway; [de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Leegaard, Truls Michael] Univ Oslo, Dept Microbiol & Infect Control, Div Diagnost & Technol, Akershus Univ Hosp, Lorenskog, Norway; [Leegaard, Truls Michael; Moen, Aina E. Fossum] Univ Oslo, Inst Clin Med, Lorenskog, Norway; [Moen, Aina E. Fossum] Univ Oslo, Sect Clin Mol Biol & Lab Sci EpiGen, Div Med, Akershus Univ Hosp, Lorenskog, Norway	Norwegian Defence Research Establishment; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; University of Oslo; University of Oslo	Moxnes, JF (corresponding author), Norwegian Def Res Estab, Dept Protect, N-2007 Kjeller, Norway.	John-F.Moxnes@ffi.no	Moen, Aina/M-5209-2019	Moen, Aina/0000-0002-1892-846X	South-Eastern Norway Regional Health Authority [2005162]	South-Eastern Norway Regional Health Authority	This work was supported by a grant from the South-Eastern Norway Regional Health Authority, http://www.helse-sorost.no, (Grant number 2005162) to AEFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldeyab MA, 2008, J ANTIMICROB CHEMOTH, V62, P593, DOI 10.1093/jac/dkn198; Andersen BM, 2007, J INFECTION, V55, P531, DOI 10.1016/j.jinf.2007.09.008; Bertrand X, 2012, J HOSP INFECT, V82, P164, DOI 10.1016/j.jhin.2012.07.013; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; Ellingson K, 2011, INFECT CONT HOSP EP, V32, P1, DOI 10.1086/657665; Elstrom P, 2012, J HOSP INFECT, V80, P36, DOI 10.1016/j.jhin.2011.10.004; European Centre for Disease Prevention and Control, 2010, ANN EP REP COMM DIS; European Centre for Disease Prevention and Control, 2010, ANT RES SURV EUR 200; Feng PJI, 2011, INFECT CONT HOSP EP, V32, P20, DOI 10.1086/657668; Fossum AE, 2006, CLIN MICROBIOL INFEC, V12, P627, DOI 10.1111/j.1469-0691.2006.01467.x; Gebski V, 2012, EPIDEMIOL INFECT, V140, P2131, DOI 10.1017/S0950268812000179; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Jarvis WR, 2012, AM J INFECT CONTROL, V40, P194, DOI 10.1016/j.ajic.2012.02.001; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Lafaurie M, 2012, J ANTIMICROB CHEMOTH, V67, P1010, DOI 10.1093/jac/dkr555; Leekha S, 2012, CLIN MICROBIOL INFEC, V18, P927, DOI 10.1111/j.1469-0691.2012.03955.x; Leendert van der Werff HF, 2008, TIDSSKR NOR LAEGEFOR, V128, P2734; Lopez-Lozano JM, 2000, INT J ANTIMICROB AG, V14, P21, DOI 10.1016/S0924-8579(99)00135-1; Moen AEF, 2010, FEMS IMMUNOL MED MIC, V58, P374, DOI 10.1111/j.1574-695X.2009.00649.x; Mostofsky E, 2011, J ANTIMICROB CHEMOTH, V66, P2199, DOI 10.1093/jac/dkr278; Moxnes JF, 2010, ADV MATH PHYS, V2010, DOI 10.1155/2010/509326; Muller AA, 2003, CLIN INFECT DIS, V36, P971, DOI 10.1086/374221; National Institute of Public Health The Norwegian Directorate of Health, 2009, INF CONTR 16 MRSA GU; National Institute of Public Health The Norwegian Directorate of Health, 2004, INF CONTR 10 MRSA GU; Parienti JJ, 2011, J HOSP INFECT, V78, P118, DOI 10.1016/j.jhin.2011.03.008; Shanson D C, 1981, J Hosp Infect, V2, P11, DOI 10.1016/0195-6701(81)90003-7; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Vernaz N, 2008, J ANTIMICROB CHEMOTH, V62, P601, DOI 10.1093/jac/dkn199	29	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70499	10.1371/journal.pone.0070499	http://dx.doi.org/10.1371/journal.pone.0070499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936442	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400071
J	Xiong, WH; Duvoisin, RM; Adamus, G; Jeffrey, BG; Gellman, C; Morgans, CW				Xiong, Wei-Hong; Duvoisin, Robert M.; Adamus, Grazyna; Jeffrey, Brett G.; Gellman, Celia; Morgans, Catherine W.			Serum TRPM1 Autoantibodies from Melanoma Associated Retinopathy Patients Enter Retinal ON-Bipolar Cells and Attenuate the Electroretinogram in Mice	PLOS ONE			English	Article							PARANEOPLASTIC RETINOPATHY; ANTIBODIES; CHANNELS; ROD	Melanoma-associated retinopathy (MAR) is a paraneoplastic syndrome associated with cutaneous malignant melanoma and the presence of autoantibodies that label neurons in the inner retina. The visual symptoms and electroretinogram (ERG) phenotype characteristic of MAR resemble the congenital visual disease caused by mutations in TRPM1, a cation channel expressed by both melanocytes and retinal bipolar cells. Four serum samples from MAR patients were identified as TRPM1 immunoreactive by 1. Labeling of ON-bipolar cells in TRPM1+/+ but not TRPM1-/- mouse retina, 2. Labeling of TRPM1-transfected CHO cells; and 3. Attenuation of the ERG b-wave following intravitreal injection of TRPM1-positive MAR IgG into wild-type mouse eyes, and the appearance of the IgG in the retinal bipolar cells at the conclusion of the experiment. Furthermore, the epitope targeted by the MAR autoantibodies was localized within the amino-terminal cytoplasmic domain of TRPM1. Incubation of live retinal neurons with TRPM1-positive MAR serum resulted in the selective accumulation of IgG in ON-bipolar cells from TRPM1+/+ mice, but not TRPM1-/- mice, suggesting that the visual deficits in MAR are caused by the uptake of TRPM1 autoantibodies into ON-bipolar cells, where they bind to an intracellular epitope of the channel and reduce the ON-bipolar cell response to light.	[Xiong, Wei-Hong; Adamus, Grazyna; Gellman, Celia; Morgans, Catherine W.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Duvoisin, Robert M.; Morgans, Catherine W.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Jeffrey, Brett G.] NEI, NIH, Bethesda, MD 20892 USA	Oregon Health & Science University; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Morgans, CW (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	morgansc@ohsu.edu		Morgans, Catherine/0000-0002-7287-3447	OCTRI, Medical Research Foundation of Oregon [NIHR01EY018625, NIHR01EY022369, NIH5P30EY010572]; NATIONAL EYE INSTITUTE [R01EY022369, R01EY018625, P30EY010572] Funding Source: NIH RePORTER	OCTRI, Medical Research Foundation of Oregon; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the following grants: NIHR01EY018625 (CWM), NIHR01EY022369 (CWM), OCTRI, Medical Research Foundation of Oregon, NIH5P30EY010572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P477; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bazhin AV, 2009, INT J CANCER, V124, P140, DOI 10.1002/ijc.23909; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Boeck K, 1997, BRIT J DERMATOL, V137, P457, DOI 10.1111/j.1365-2133.1997.tb03759.x; Dhingra A, 2011, J NEUROSCI, V31, P3962, DOI 10.1523/JNEUROSCI.6007-10.2011; Gittinger JW, 1999, AM J OPHTHALMOL, V127, P612, DOI 10.1016/S0002-9394(98)00431-0; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Haus AH, 2002, NEURO-OPHTHALMOLOGY, V27, P121, DOI 10.1076/noph.27.1.121.14294; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Keltner JL, 2001, J NEURO-OPHTHALMOL, V21, P173, DOI 10.1097/00041327-200109000-00004; Koh A. H. C., 2001, Documenta Ophthalmologica, V102, P19, DOI 10.1023/A:1017586118749; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Kondo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019911; Ladewig G, 2005, BRIT J DERMATOL, V152, P931, DOI 10.1111/j.1365-2133.2005.06480.x; Lei B, 2000, INVEST OPHTH VIS SCI, V41, P262; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Lu Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P1572, DOI 10.1001/archophthalmol.2009.311; Mannermaa E, 2006, ADV DRUG DELIVER REV, V58, P1136, DOI 10.1016/j.addr.2006.07.024; MILAM AH, 1993, INVEST OPHTH VIS SCI, V34, P91; Morgans CW, 2010, BIOESSAYS, V32, P609, DOI 10.1002/bies.200900198; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Myers DA, 2004, J CLIN ONCOL, V22, P746, DOI 10.1200/JCO.2004.05.036; Nakamura M, 2010, MOL VIS, V16, P425; Oancea E, 2011, ADV EXP MED BIOL, V704, P135, DOI 10.1007/978-94-007-0265-3_7; Pfohler C, 2003, BRIT J DERMATOL, V149, P74, DOI 10.1046/j.1365-2133.2003.05377.x; Raz-Prag D, 2010, P NATL ACAD SCI USA, V107, P12710, DOI 10.1073/pnas.0913472107; Shen Y, 2009, J NEUROSCI, V31, P10060; Shiraga S, 2002, J NEUROIMMUNOL, V132, P72, DOI 10.1016/S0165-5728(02)00314-4; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; WEINSTEIN JM, 1994, OPHTHALMOLOGY, V101, P1236; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Zacks DN, 2001, AM J OPHTHALMOL, V132, P578, DOI 10.1016/S0002-9394(01)01086-8; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163	35	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69506	10.1371/journal.pone.0069506	http://dx.doi.org/10.1371/journal.pone.0069506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936334	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400015
J	Zhang, SJ; Guo, JT; Wu, JZ; Yang, G				Zhang, Shijian; Guo, Ju-Tao; Wu, Jim Z.; Yang, Guang			Identification and Characterization of Multiple TRIM Proteins That Inhibit Hepatitis B Virus Transcription	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; CYTOTOXIC T-LYMPHOCYTES; NUCLEOCAPSID PROMOTER; GENE-EXPRESSION; CIRCULAR DNA; BINDING-SITE; KINASE-C; INFECTION; CELLS; REPLICATION	Tripartite motif (TRIM) proteins constitute a family of over 100 members that share conserved tripartite motifs and exhibit diverse biological functions. Several TRIM proteins have been shown to restrict viral infections and regulate host cellular innate immune responses. In order to identify TRIM proteins that modulate the infection of hepatitis B virus (HBV), we tested 38 human TRIMs for their effects on HBV gene expression, capsid assembly and DNA synthesis in human hepatoma cells (HepG2). The study revealed that ectopic expression of 8 TRIM proteins in HepG2 cells potently reduced the amounts of secreted HBV surface and e antigens as well as intracellular capsid and capsid DNA. Mechanistic analyses further demonstrated that the 8 TRIMs not only reduced the expression of HBV mRNAs, but also inhibited HBV enhancer I and enhancer II activities. Studies focused on TRIM41 revealed that a HBV DNA segment spanning nucleotide 1638 to nucleotide 1763 was essential for TRIM41-mediated inhibition of HBV enhancer II activity and the inhibitory effect depended on the E3 ubiquitin ligase activity of TRIM41 as well as the integrity of TRIM41 C-terminal domain. Moreover, knockdown of endogenous TRIM41 in a HepG2-derived stable cell line significantly increased the level of HBV preC/C RNA, leading to an increase in viral core protein, capsid and capsid DNA. Our studies have thus identified eight TRIM proteins that are able to inhibit HBV transcription and provided strong evidences suggesting the endogenous role of TRIM41 in regulating HBV transcription in human hepatoma cells.	[Zhang, Shijian; Wu, Jim Z.; Yang, Guang] Roche R&D Ctr China LTD, Shanghai, Peoples R China; [Zhang, Shijian] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Guo, Ju-Tao] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Inst Biotechnol & Virol Res, Doylestown, PA USA	Roche Holding; Fudan University; Drexel University	Yang, G (corresponding author), Roche R&D Ctr China LTD, Shanghai, Peoples R China.	guang.yang@roche.com	Zhang, Shijian/P-9353-2015	Zhang, Shijian/0000-0002-2017-6754	Roche Pharma Research and Early development	Roche Pharma Research and Early development	The authors have the following interests: Co-authors Shijian Zhang, Jim Z. Wu and Guang Yang are employed by Roche R&D Center China LTD. Roche Pharma Research and Early development, as the funder of this study, gave a general strategy about this study and approved the submission of this manuscript for publication. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ACS G, 1987, P NATL ACAD SCI USA, V84, P4641, DOI 10.1073/pnas.84.13.4641; ALMOG Y, 1992, ANTIVIR RES, V19, P285, DOI 10.1016/0166-3542(92)90010-3; Banks KE, 2002, J VIROL, V76, P12974, DOI 10.1128/JVI.76.24.12974-12980.2002; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; GUIDOTTI LG, 1994, P NATL ACAD SCI USA, V91, P3764, DOI 10.1073/pnas.91.9.3764; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Guo H, 2009, J VIROL, V83, P847, DOI 10.1128/JVI.02008-08; Guo JT, 2000, J VIROL, V74, P1495, DOI 10.1128/JVI.74.3.1495-1505.2000; Guo JT, 2003, J VIROL, V77, P1885, DOI 10.1128/JVI.77.3.1885-1893.2003; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; JILBERT AR, 1992, J VIROL, V66, P1377, DOI 10.1128/JVI.66.3.1377-1388.1992; JOHNSON JL, 1995, VIROLOGY, V208, P147, DOI 10.1006/viro.1995.1138; Kajaste-Rudnitski A, 2011, J VIROL, V85, P5183, DOI 10.1128/JVI.02302-10; KAJINO K, 1994, J VIROL, V68, P5792, DOI 10.1128/JVI.68.9.5792-5803.1994; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Li M, 1995, VIROLOGY, V214, P371, DOI 10.1006/viro.1995.0046; Mao RC, 2011, J VIROL, V85, P1048, DOI 10.1128/JVI.01998-10; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Munir M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc2; Nawa T, 2012, VIROLOGY, V432, P452, DOI 10.1016/j.virol.2012.07.002; Oke V, 2012, J AUTOIMMUN, V39, P77, DOI 10.1016/j.jaut.2012.01.014; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Perrillo R, 2009, HEPATOLOGY, V49, pS103, DOI 10.1002/hep.22956; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Raney AK, 1997, J VIROL, V71, P1058, DOI 10.1128/JVI.71.2.1058-1071.1997; Robek MD, 2002, J VIROL, V76, P3570, DOI 10.1128/JVI.76.7.3570-3574.2002; Rowe HM, 2013, GENOME RES; Ruby T, 2005, IMMUNOGENETICS, V57, P116, DOI 10.1007/s00251-005-0770-x; Shen Y, 2012, J BIOL CHEM, V287, P36404, DOI 10.1074/jbc.M112.397075; Shi LP, 2012, J VIROL, V86, P10059, DOI 10.1128/JVI.00535-12; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Summers J, 2003, P NATL ACAD SCI USA, V100, P11652, DOI 10.1073/pnas.1635109100; Tanaka M, 2005, MOL BIOL REP, V32, P87, DOI 10.1007/s11033-004-6613-2; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Wang J, 2011, J VIROL, V85, P3733, DOI 10.1128/JVI.02546-10; Wang SH, 2012, GASTROENTEROLOGY, V142, P989, DOI 10.1053/j.gastro.2011.12.045; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Xu CX, 2010, J VIROL, V84, P9332, DOI 10.1128/JVI.00918-10; Zhao KW, 2011, BIOCHEM J, V437, P323, DOI 10.1042/BJ20101388; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	57	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70001	10.1371/journal.pone.0070001	http://dx.doi.org/10.1371/journal.pone.0070001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936368	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400029
J	Silveira, GF; Wowk, PF; Machado, AMB; dos Santos, CND; Bordignon, J				Silveira, Guilherme Ferreira; Wowk, Pryscilla Fanini; Breckenfeld Machado, Analia Maria; Duarte dos Santos, Claudia Nunes; Bordignon, Juliano			Immature Dendritic Cells Generated from Cryopreserved Human Monocytes Show Impaired Ability to Respond to LPS and to Induce Allogeneic Lymphocyte Proliferation	PLOS ONE			English	Article							VIRUS; MATURATION; TOLERANCE; APOPTOSIS; MATURE	Dendritic cells play a key role in the immune system, in the sensing of foreign antigens and triggering of an adaptive immune response. Cryopreservation of human monocytes was investigated to understand its effect on differentiation into immature monocyte-derived dendritic cells (imdDCs), the response to inflammatory stimuli and the ability to induce allogeneic lymphocyte proliferation. Cryopreserved (crp)-monocytes were able to differentiate into imdDCs, albeit to a lesser extent than freshly (frh)-obtained monocytes. Furthermore, crp-imdDCs had lower rates of maturation and cytokine/chemokine secretion in response to LPS than frh-imdDCs. Lower expression of Toll-like receptor 4 (at 24 and 48 h) and higher susceptibility to apoptosis in crp-imdDCs than in fresh cells would account for the impaired maturation and cytokine/chemokine secretion observed. A mixed leukocyte reaction showed that lymphocyte proliferation was lower with crp-imdDCs than with frh-imdDCs. These findings suggested that the source of monocytes used to generate human imdDCs could influence the accuracy of results observed in studies of the immune response to pathogens, lymphocyte activation, vaccination and antigen sensing. It is not always possible to work with freshly isolated monocytes but the possible effects of freezing/thawing on the biology and responsiveness of imdDCs should be taken into account.	[Silveira, Guilherme Ferreira; Wowk, Pryscilla Fanini; Duarte dos Santos, Claudia Nunes; Bordignon, Juliano] Fiocruz MS, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil; [Wowk, Pryscilla Fanini] Fiocruz MS, Inst Carlos Chagas, Lab Regulacao Expressa Genica, Curitiba, Parana, Brazil; [Breckenfeld Machado, Analia Maria] Ctr Hematol & Hemoterapia Parana, Prod Div, Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	dos Santos, CND (corresponding author), Fiocruz MS, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.	clsantos@tecpar.br	Wowk, Pryscilla Fanini/AAR-7230-2020; Silveira, Guilherme/Z-6230-2019; Wowk, Pryscilla/AAA-3281-2019; Bordignon, Juliano/Z-6268-2019; dos Santos, Claudia Duarte/P-4868-2019; dos Santos, Claudia Nunes Duarte/E-1857-2018	Silveira, Guilherme/0000-0002-1866-0563; Bordignon, Juliano/0000-0002-1965-6152; dos Santos, Claudia Duarte/0000-0001-8707-6638; dos Santos, Claudia Nunes Duarte/0000-0001-8707-6638; Wowk, Pryscilla/0000-0002-8976-2647	Fiocruz; CNPq National Counsel of Technological and Scientific Development [477203/2009-4, 552258/2011-3]; Fundacao, Araucaria [18707/2010]	Fiocruz; CNPq National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao, Araucaria	Financial support was obtained from Fiocruz, CNPq National Counsel of Technological and Scientific Development(477203/2009-4 and 552258/2011-3) and Fundacao, Araucaria (18707/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Blazquez AB, 2011, CURR OPIN ALLERGY CL, V11, P279, DOI 10.1097/ACI.0b013e3283489bab; Campbell DE, 2009, CLIN VACCINE IMMUNOL, V16, P1648, DOI 10.1128/CVI.00259-09; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Ghanekar Smita A, 2007, J Immune Based Ther Vaccines, V5, P7, DOI 10.1186/1476-8518-5-7; HARRIS LW, 1977, CRYOBIOLOGY, V14, P662, DOI 10.1016/0011-2240(77)90021-9; Hayden H, 2009, J IMMUNOTHER, V32, P638, DOI 10.1097/CJI.0b013e3181a5bc13; Hori S, 2004, J IMMUNOTHER, V27, P27, DOI 10.1097/00002371-200401000-00003; Huerta S, 2007, J SURG RES, V139, P143, DOI 10.1016/j.jss.2006.07.034; INGALLS RR, 1995, J EXP MED, V181, P1473, DOI 10.1084/jem.181.4.1473; Klagge IM, 1999, J GEN VIROL, V80, P823, DOI 10.1099/0022-1317-80-4-823; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Lewalle P, 2000, J IMMUNOL METHODS, V240, P69, DOI 10.1016/S0022-1759(00)00173-3; Li CY, 2011, J CELL PHYSIOL, V226, P2338, DOI 10.1002/jcp.22576; Maier M, 2009, HUM IMMUNOL, V70, P803, DOI 10.1016/j.humimm.2009.07.007; Makino M, 1997, SCAND J IMMUNOL, V45, P618, DOI 10.1046/j.1365-3083.1997.d01-441.x; Meijerink M, 2011, J IMMUNOL METHODS, V373, P136, DOI 10.1016/j.jim.2011.08.010; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Nestle FO, 2007, J CLIN INVEST, V117, P2382, DOI 10.1172/JCI33349; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Patenaude J, 2011, CELL IMMUNOL, V271, P184, DOI 10.1016/j.cellimm.2011.06.020; Rescigno M, 1999, IMMUNOL TODAY, V20, P200, DOI 10.1016/S0167-5699(98)01427-3; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Silveira GF, 2011, J VIROL, V85, P5374, DOI 10.1128/JVI.01915-10; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; van Kooten C, 2011, TRANSPLANTATION, V91, P2, DOI 10.1097/TP.0b013e31820263b3; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Willmann K, 2000, J LEUKOCYTE BIOL, V67, P536, DOI 10.1002/jlb.67.4.536	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e71291	10.1371/journal.pone.0071291	http://dx.doi.org/10.1371/journal.pone.0071291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936267	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700084
J	Fenne, IS; Helland, T; Flageng, MH; Dankel, SN; Mellgren, G; Sagen, JV				Fenne, Ingvild S.; Helland, Thomas; Flageng, Marianne H.; Dankel, Simon N.; Mellgren, Gunnar; Sagen, Jorn V.			Downregulation of Steroid Receptor Coactivator-2 Modulates Estrogen-Responsive Genes and Stimulates Proliferation of MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; TRANSCRIPTIONAL COACTIVATOR; BINDING PROTEIN; SRC FAMILY; AIB1; EXPRESSION; ACTIVATION; TIF2; COREGULATORS; DISTINCT	The p160/Steroid Receptor Coactivators SRC-1, SRC-2/GRIP1, and SRC-3/AIB1 are important regulators of Estrogen Receptor alpha (ER alpha) activity. However, whereas the functions of SRC-1 and SRC-3 in breast tumourigenesis have been extensively studied, little is known about the role of SRC-2. Previously, we reported that activation of the cAMP-dependent protein kinase, PKA, facilitates ubiquitination and proteasomal degradation of SRC-2 which in turn leads to inhibition of SRC-2-coactivation of ER alpha and changed expression of the ER alpha target gene, pS2. Here we have characterized the global program of transcription in SRC-2-depleted MCF-7 breast cancer cells using short-hairpin RNA technology, and in MCF-7 cells exposed to PKA activating agents. In order to identify genes that may be regulated through PKA-induced downregulation of SRC-2, overlapping transcriptional targets in response to the respective treatments were characterized. Interestingly, we observed decreased expression of several breast cancer tumour suppressor genes (e. g., TAGLN, EGR1, BCL11b, CAV1) in response to both SRC-2 knockdown and PKA activation, whereas the expression of a number of other genes implicated in cancer progression (e. g., RET, BCAS1, TFF3, CXCR4, ADM) was increased. In line with this, knockdown of SRC-2 also stimulated proliferation of MCF-7 cells. Together, these results suggest that SRC-2 may have an antiproliferative function in breast cancer cells.	[Fenne, Ingvild S.; Helland, Thomas; Flageng, Marianne H.; Dankel, Simon N.; Mellgren, Gunnar; Sagen, Jorn V.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Fenne, Ingvild S.; Helland, Thomas; Flageng, Marianne H.; Dankel, Simon N.; Mellgren, Gunnar; Sagen, Jorn V.] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Sagen, JV (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	jorn.sagen@med.uib.no	Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986; Dankel, Simon/0000-0001-6972-1824	Norwegian Cancer Society; Western Norway Regional Health Authority; KG Jebsen Center for Diabetes Research; Connie Gulborg Jansens legat; Meltzerfondet, University of Bergen	Norwegian Cancer Society(Norwegian Cancer Society); Western Norway Regional Health Authority; KG Jebsen Center for Diabetes Research; Connie Gulborg Jansens legat; Meltzerfondet, University of Bergen	Funding for this project was provided by the Norwegian Cancer Society (https://kreftforeningen.no), The Western Norway Regional Health Authority (http://www.helse-bergen.no/forskning/sam arbeidsorganet), KG Jebsen Center for Diabetes Research (http://www.uib.no/diabetes), Connie Gulborg Jansens legat (http://www.uib.no/mofa/forskning/fond-og-legater), and Meltzerfondet, University of Bergen (http://meltzerfondet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDHAHERI MH, 2006, MOL ENDOCRINOL; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borud B, 2002, MOL ENDOCRINOL, V16, P757, DOI 10.1210/me.16.4.757; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Dudek P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001859; Eng C, 1999, J CLIN ONCOL, V17, P380, DOI 10.1200/JCO.1999.17.1.380; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Fenne IS, 2008, ENDOCRINOLOGY, V149, P4336, DOI 10.1210/en.2008-0037; Flageng MH, 2009, BRIT J CANCER, V101, P1253, DOI 10.1038/sj.bjc.6605324; Fleming FJ, 2004, J CLIN PATHOL, V57, P1069, DOI 10.1136/jcp.2004.016733; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gregory CW, 2001, CANCER RES, V61, P4315; Grivas PD, 2009, INT J COLORECTAL DIS, V24, P613, DOI 10.1007/s00384-009-0647-9; Han SJ, 2006, MOL ENDOCRINOL, V20, P45, DOI 10.1210/me.2005-0310; Hino M, 2003, SURG TODAY, V33, P486, DOI 10.1007/s10595-002-2538-4; Hoang T, 2004, J BIOL CHEM, V279, P49120, DOI 10.1074/jbc.M409746200; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Jennings CJ, 2012, J THORAC ONCOL, V7, P243, DOI 10.1097/JTO.0b013e31822f6544; Jeong JW, 2007, ENDOCRINOLOGY, V148, P4238, DOI 10.1210/en.2007-0122; Jeong JW, 2006, MOL ENDOCRINOL, V20, P1138, DOI 10.1210/me.2005-0407; Jeong KW, 2012, MOL ENDOCRINOL, V26, P955, DOI 10.1210/me.2012-1066; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; Kefalopoulou Z, 2012, J NEURO-ONCOL, V106, P23, DOI 10.1007/s11060-011-0637-y; Kershah SM, 2004, GYNECOL ONCOL, V92, P304, DOI 10.1016/j.ygyno.2003.10.007; KUNG W, 1983, CELL BIOL INT REP, V7, P345, DOI 10.1016/0309-1651(83)90074-7; Lamb D, 2002, J CELL PHYSIOL, V192, P216, DOI 10.1002/jcp.10131; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li SS, 2007, CELL SIGNAL, V19, P1101, DOI 10.1016/j.cellsig.2007.02.002; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; Liang ZX, 2005, CANCER RES, V65, P967; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Ma G, 2011, INT J BIOL SCI, V7, P664, DOI 10.7150/ijbs.7.664; Martinez A, 2002, J NATL CANCER I, V94, P1226; Modder UI, 2009, J BIOL CHEM, V284, P18767, DOI 10.1074/jbc.M109.000836; Moi LLH, 2010, CLIN CANCER RES, V16, P2176, DOI 10.1158/1078-0432.CCR-09-1859; Morandi A, 2011, TRENDS MOL MED, V17, P149, DOI 10.1016/j.molmed.2010.12.007; MUCIGNATCARETTA.AC, 2011, CANCERS, P913; Mukherjee A, 2007, Ernst Schering Found Symp Proc, P55; Murphy LC, 2000, CANCER RES, V60, P6266; Myers E, 2004, BRIT J CANCER, V91, P1687, DOI 10.1038/sj.bjc.6602156; O'Donnell KA, 2012, P NATL ACAD SCI USA, V109, pE1377, DOI 10.1073/pnas.1115433109; ONATE SA, 1995, SCIENCE, V270, P1354; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Planas-Silva MD, 2001, CANCER RES, V61, P3858; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Tien JCY, 2009, INT J BIOL SCI, V5, P256; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Hoang T, 2013, ENDOCRINOLOGY, V154, P1513, DOI 10.1210/en.2012-2049; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Walsh CA, 2012, INT J BIOL SCI, V8, P470, DOI 10.7150/ijbs.4125; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; York B, 2013, MOL ENDOCRINOL, V27, P366, DOI 10.1210/me.2012-1324; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhao C, 2003, CANCER, V98, P18, DOI 10.1002/cncr.11482; Zou JX, 2006, PROSTATE, V66, P1474, DOI 10.1002/pros.20477; Zwart W, 2011, EMBO J, V30, P4764, DOI 10.1038/emboj.2011.368	70	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70096	10.1371/journal.pone.0070096	http://dx.doi.org/10.1371/journal.pone.0070096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936147	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200058
J	Mitchell, JC; Bach, PA; Cassisi, JE				Mitchell, Jonathan C.; Bach, Patricia A.; Cassisi, Jeffrey E.			The Use of Structured Imagery and Dispositional Measurement to Assess Situational Use of Mindfulness Skills	PLOS ONE			English	Article							EMOTIONAL AVOIDANCE; SELF-REPORT; ATTENTION; SUPPRESSION; ACCEPTANCE; SCALE	The recent proliferation of studies on mindfulness produced varying theoretical models, each based in part on how mindfulness is assessed. These models agree, however, that mindfulness encompasses moment-to-moment or situational experiences. Incongruence between dispositional and situational assessment would be problematic for theory and empirical research. In particular, it remains to be established whether situational measurement is an accurate method for mindfulness assessment and whether dispositional measures are able to accurately detect mindfulness skills in various situations. The association between dispositional and situational mindfulness processes (i.e., situational attention awareness and emotion acceptance) was examined in two studies. In Study 1 (N = 148), independent groups who reported high and low levels of dispositional mindfulness skills were compared on a continuous measure of situational mindfulness skills. In Study 2 (N = 317), dispositional mindfulness questionnaires were used to predict situational use of mindfulness skills. Results suggest not only that situational measures accurately detect use of mindfulness skills, but also that dispositional measures can predict one's use of situational mindfulness skills. Findings from both studies were consistent across both positive and negative situations. Moreover, neither neuroticism nor extraversion was shown to have a moderating effect on the relationship between dispositional and situational use of mindfulness skills. The implications of these findings for clinical practice and future investigations pertaining to measurement validity in this area are discussed.	[Mitchell, Jonathan C.; Bach, Patricia A.; Cassisi, Jeffrey E.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Mitchell, JC (corresponding author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.	jonathanm@knights.ucf.edu; Jeffrey.Cassisi@ucf.edu	Cassisi, Jeffrey/S-2974-2018	Cassisi, Jeffrey/0000-0003-2288-5690				Bach P, MINDFULNESS IN PRESS; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; BALL SA, 1990, PERS INDIV DIFFER, V11, P343, DOI 10.1016/0191-8869(90)90216-E; Barlow D. H., 2018, UNIFIED PROTOCOL TRA, V2nd; Bergomi C, 2013, MINDFULNESS, V4, P18, DOI 10.1007/s12671-012-0102-9; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Brown KW, 2007, PSYCHOL INQ, V18, P211, DOI 10.1080/10478400701598298; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Buchheld N., 2001, J MEDITATION MEDITAT, V1, P11, DOI DOI 10.1016/J.PAID.2005.11.025; Chiesa A, 2011, J CLIN PSYCHOL, V67, P404, DOI 10.1002/jclp.20776; DERRYBERRY D, 1994, J PERS SOC PSYCHOL, V66, P1128, DOI 10.1037/0022-3514.66.6.1128; Ekman P., 1982, EMOT HUM FACE, P39; Erisman SM, 2010, EMOTION, V10, P72, DOI 10.1037/a0017162; Eysenck HJ, 1994, MANUAL EYSENCK PERSO; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; Feldner MT, 2003, BEHAV RES THER, V41, P403, DOI 10.1016/S0005-7967(02)00020-7; FOA EB, 1980, BEHAV RES THER, V18, P449, DOI 10.1016/0005-7967(80)90010-8; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Grigorenko EL, 2010, PSYCHOL ASSESSMENT, V22, P893, DOI 10.1037/a0020703; Grossman P, 2011, PSYCHOL ASSESSMENT, V23, P1034, DOI 10.1037/a0022713; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hayes SC, 2003, CLIN PSYCHOL-SCI PR, V10, P161, DOI 10.1093/clipsy/bpg018; Hayes SC, 1999, PSYCHOL REC, V49, P33, DOI 10.1007/BF03395305; Heeren A, 2009, BEHAV RES THER, V47, P403, DOI 10.1016/j.brat.2009.01.017; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Karekla M, 2004, BEHAV THER, V35, P725, DOI 10.1016/S0005-7894(04)80017-0; Lau MA, 2006, J CLIN PSYCHOL, V62, P1445, DOI 10.1002/jclp.20326; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Marcks BA, 2005, BEHAV RES THER, V43, P433, DOI 10.1016/j.brat.2004.03.005; Millon T., 1997, MILLON CLIN MULTIAXI; Moore R. G., 1996, MEASURE AWAREN UNPUB; Pleva J, 2002, BEHAV COGN PSYCHOTH, V30, P399, DOI 10.1017/S1352465802004022; Robinson MD, 2003, PSYCHOLOGY OF EVALUATION, P275; Sauer S, 2013, MINDFULNESS, V4, P3, DOI 10.1007/s12671-012-0122-5; Tabachnick B. G., 2013, USING MULTIVARIATE S; Thompson RJ, 2009, J RES PERS, V43, P875, DOI 10.1016/j.jrp.2009.07.006; Wallace JF, 1998, PERS INDIV DIFFER, V24, P253, DOI 10.1016/S0191-8869(97)00153-0; Whitehead LC, 2007, SOC SCI MED, V65, P782, DOI 10.1016/j.socscimed.2007.03.005	39	2	2	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70253	10.1371/journal.pone.0070253	http://dx.doi.org/10.1371/journal.pone.0070253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201AX	23936175	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200070
J	Regan, RE; Duffin, J; Fisher, JA				Regan, Rosemary E.; Duffin, James; Fisher, Joseph A.			Instability of the Middle Cerebral Artery Blood Flow in Response to CO2	PLOS ONE			English	Article							CEREBROVASCULAR REACTIVITY; WHITE-MATTER; STEP CHANGES; HYPERCAPNIA; AUTOREGULATION; VELOCITY; MRI; MECHANISMS; PERFUSION; DIAMETER	Background: The middle cerebral artery supplies long end-artery branches to perfuse the deep white matter and shorter peripheral branches to perfuse cortical and subcortical tissues. A generalized vasodilatory stimulus such as carbon dioxide not only results in an increase in flow to these various tissue beds but also redistribution among them. We employed a fast step increase in carbon dioxide to detect the dynamics of the cerebral blood flow response. Methodology/Principal Findings: The study was approved by the Research Ethics Board of the University Health Network at the University of Toronto. We used transcranial ultrasound to measure the time course of middle cerebral artery blood flow velocity in 28 healthy adults. Normoxic, isoxic step increases in arterial carbon dioxide tension of 10 mmHg from both hypocapnic and normocapnic baselines were produced using a new prospective targeting system that enabled a more rapid step change than has been previously achievable. In most of the 28 subjects the responses at both carbon dioxide ranges were characterised by more complex responses than a single exponential rise. Most responses were characterised by a fast initial response which then declined rapidly to a nadir, followed by a slower secondary response, with some showing oscillations before stabilising. Conclusions/Significance: A rapid step increase in carbon dioxide tension is capable of inducing instability in the cerebral blood flow control system. These dynamic aspects of the cerebral blood flow responses to rapid changes in carbon dioxide must be taken into account when using transcranial blood flow velocity in a single artery segment to measure cerebrovascular reactivity.	[Regan, Rosemary E.; Duffin, James; Fisher, Joseph A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Duffin, James; Fisher, Joseph A.] Univ Toronto, Dept Anaesthesia, Toronto, ON, Canada; [Duffin, James; Fisher, Joseph A.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Duffin, J (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	j.duffin@utoronto.ca		Duffin, James/0000-0003-2270-7392	University of Toronto; Thornhill Research Inc.	University of Toronto(University of Toronto); Thornhill Research Inc.	Please note that this research was supported by University of Toronto Merit award to JAF and a non-directed grant from Thornhill Research Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This funding does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Ainslie PN, 2010, J APPL PHYSIOL, V108, P1447, DOI 10.1152/japplphysiol.00257.2010; Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Alexandrov AV, 2002, J NEUROIMAGING, V12, P236, DOI 10.1177/10528402012003005; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Battisti-Charbonney A, 2011, J PHYSIOL-LONDON, V589, P3039, DOI 10.1113/jphysiol.2011.206052; Belfort MA, 1996, AM J OBSTET GYNECOL, V174, P246, DOI 10.1016/S0002-9378(96)70402-7; Binks AP, 2008, J APPL PHYSIOL, V104, P212, DOI 10.1152/japplphysiol.00069.2007; Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Conklin J, 2010, STROKE, V41, P1610, DOI 10.1161/STROKEAHA.110.579540; Cui Z, 2012, RESP PHYSIOL NEUROBI, V180, P126, DOI 10.1016/j.resp.2011.11.002; Dineen NE, 2010, J APPL PHYSIOL, V108, P604, DOI 10.1152/japplphysiol.01157.2009; Diomedi M, 2001, J NEUROL SCI, V185, P49, DOI 10.1016/S0022-510X(01)00462-2; Duffin J, 2011, RESP PHYSIOL NEUROBI, V177, P71, DOI 10.1016/j.resp.2011.04.009; ELLINGSEN I, 1987, ACTA PHYSIOL SCAND, V129, P157, DOI 10.1111/j.1748-1716.1987.tb08054.x; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Fierstra J, 2011, INTENS CARE MED, V37, P1543, DOI 10.1007/s00134-011-2260-y; Fierstra J, 2010, J NEUROL NEUROSUR PS, V81, P290, DOI 10.1136/jnnp.2009.188078; Giller CA, 2003, J NEUROIMAGING, V13, P97, DOI 10.1177/1051228403251633; Han J, 2010, THESIS TORONTO; Hill MA, 2006, CLIN HEMORHEOL MICRO, V34, P67; Hsu YY, 2009, J MAGN RESON IMAGING, V30, P1078, DOI 10.1002/jmri.21960; Ito S, 2008, J PHYSIOL-LONDON, V586, P3675, DOI 10.1113/jphysiol.2008.154716; Kastrup A, 1997, STROKE, V28, P2353, DOI 10.1161/01.STR.28.12.2353; Khoo M. C. K., 1999, IEEE PRESS SERIES BI; LINDEGAARD KF, 1987, STROKE, V18, P1025, DOI 10.1161/01.STR.18.6.1025; Lucas SJE, 2010, HYPERTENSION, V55, P698, DOI 10.1161/HYPERTENSIONAHA.109.146290; LUPETIN AR, 1995, RADIOGRAPHICS, V15, P179, DOI 10.1148/radiographics.15.1.7899596; Mandell DM, 2008, STROKE, V39, P2021, DOI 10.1161/STROKEAHA.107.506709; Mandell DM, 2008, STROKE, V39, P1993, DOI 10.1161/STROKEAHA.107.501692; Matteis M, 1998, STROKE, V29, P963, DOI 10.1161/01.STR.29.5.963; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Noth U, 2008, NMR BIOMED, V21, P464, DOI 10.1002/nbm.1210; Panerai RB, 2010, J APPL PHYSIOL, V109, P1860, DOI 10.1152/japplphysiol.00857.2010; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Perregaux D, 1999, METABOLISM, V48, P227, DOI 10.1016/S0026-0495(99)90039-2; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; Prisman E, 2008, J MAGN RESON IMAGING, V27, P185, DOI 10.1002/jmri.21102; Rostrup E, 2000, NEUROIMAGE, V11, P87, DOI 10.1006/nimg.1999.0526; Sato K, 2012, J PHYSIOL-LONDON, V590, P3277, DOI 10.1113/jphysiol.2012.230425; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Slessarev M, 2007, J PHYSIOL-LONDON, V581, P1207, DOI 10.1113/jphysiol.2007.129395; Valdueza JM, 1999, STROKE, V30, P81, DOI 10.1161/01.STR.30.1.81; van der Zande FHR, 2005, NEURORADIOLOGY, V47, P114, DOI 10.1007/s00234-004-1274-3; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551	46	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70751	10.1371/journal.pone.0070751	http://dx.doi.org/10.1371/journal.pone.0070751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936248	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200104
J	Sun, QZ; Lan, RT; Wang, JP; Xia, SL; Wang, YT; Wang, Y; Jin, D; Yu, B; Knirel, YA; Xu, JG				Sun, Qiangzheng; Lan, Ruiting; Wang, Jianping; Xia, Shengli; Wang, Yiting; Wang, Yan; Jin, Dong; Yu, Bo; Knirel, Yuriy A.; Xu, Jianguo			Identification and Characterization of a Novel Shigella flexneri Serotype Yv in China	PLOS ONE			English	Article							O-ANTIGEN MODIFICATION; MOLECULAR CHARACTERIZATION; CONVERTING BACTERIOPHAGES; MODIFICATION GENES; EMERGENCE; SEQUENCE; CONVERSION; GENOME	Shigella flexneri is the major cause of bacterial shigellosis in developing countries. S. flexneri is divided into at least 19 serotypes, the majority of which are modifications of the same basic O-antigen by glucosylation and/or O-acetylation of its sugar residues by phage encoded serotype-converting genes. Recently, a plasmid encoded phosphoethanolamine (PEtN) modification of the O-antigen has been reported, which is responsible for the presence of the MASF IV-1 determinant and results in conversion of traditional serotypes X, 4a and Y to novel serotypes Xv, 4av and Yv, respectively. In this study, we characterized 19 serotype Yv strains isolated in China. A variant of the O-antigen phosphoethanolamine transferase gene opt (formerly called lpt-O) carried by a pSFxv_2-like plasmid was found in serotype Yv strains, which specifies the phosphorylation pattern on the O-antigen of this serotype. For the majority of the O-antigen units, the PEtN modification occurs on Rha(III), while for a minority, modifications occur on both Rha(II) and Rha(III). Serotype-specific gene detection and PFGE analysis suggested that these serotype Yv isolates were originated from serotypes Y, Xv and 2a by acquisition of an opt-carrying plasmid and/or inactivation of serotype-specific gene gtrII or gtrX. These data, combined with those of serotypes Xv and 4av reported earlier, demonstrate that the plasmid-encoded PEtN modification is an important serotype conversion mechanism in S. flexneri, in addition to glucosylation and O-acetylation.	[Sun, Qiangzheng; Wang, Jianping; Wang, Yiting; Wang, Yan; Jin, Dong; Yu, Bo; Xu, Jianguo] China CDC, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Xia, Shengli] Inst Infect Dis Control & Prevent, Henan Ctr Dis Control Prevent, Branch Enter Dis Control & Prevent, Zhengzhou, Peoples R China; [Knirel, Yuriy A.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of New South Wales Sydney; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry	Xu, JG (corresponding author), China CDC, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xujianguo@icdc.cn	wang, yiting/GYU-5306-2022; Knirel, Yuriy A/E-2058-2014	Lan, Ruiting/0000-0001-9834-5258	National Natural Science Foundation of China [81271788]; National Basic Research Priorities Program [2011CB504901]; Project of State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID203, 2008SKLID106]; National Key Program for Infectious Diseases of China [2013ZX10004221, 2013ZX10004216-001-002]; Russian Foundation for Basic Research [12-04-00172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program(National Basic Research Program of China); Project of State Key Laboratory for Infectious Disease Prevention and Control; National Key Program for Infectious Diseases of China; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grants from the National Natural Science Foundation of China (No. 81271788), the National Basic Research Priorities Program (2011CB504901), the Project of State Key Laboratory for Infectious Disease Prevention and Control (2011SKLID203, 2008SKLID106), the National Key Program for Infectious Diseases of China (2013ZX10004221, 2013ZX10004216-001-002), and the Russian Foundation for Basic Research (12-04-00172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2001, MICROBIOL-UK, V147, P851, DOI 10.1099/00221287-147-4-851; Adhikari P, 1999, J BACTERIOL, V181, P4711, DOI 10.1128/JB.181.15.4711-4718.1999; Allison GE, 2002, J BACTERIOL, V184, P1974, DOI 10.1128/JB.184.7.1974-1987.2002; Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; CARLIN NIA, 1989, J CLIN MICROBIOL, V27, P1163, DOI 10.1128/JCM.27.6.1163-1166.1989; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Chen JH, 2003, FEMS MICROBIOL LETT, V224, P277, DOI 10.1016/S0378-1097(03)00470-1; CLARK CA, 1991, GENE, V107, P43, DOI 10.1016/0378-1119(91)90295-M; Foster RA, 2011, CARBOHYD RES, V346, P872, DOI 10.1016/j.carres.2011.02.013; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; Institute CaLS, 2009, M100S19 I CALS CLIN; Knirel YA, 2013, GLYCOBIOLOGY, V23, P475, DOI 10.1093/glycob/cws222; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lacher DW, 2007, J BACTERIOL, V189, P342, DOI 10.1128/JB.01472-06; Luo X, 2012, DIAGN MICR INFEC DIS, V74, P316, DOI 10.1016/j.diagmicrobio.2012.06.022; Mavris M, 1997, MOL MICROBIOL, V26, P939, DOI 10.1046/j.1365-2958.1997.6301997.x; Perepelov AV, 2012, FEMS IMMUNOL MED MIC, V66, P201, DOI 10.1111/j.1574-695X.2012.01000.x; Perepelov AV, 2009, CARBOHYD RES, V344, P1588, DOI 10.1016/j.carres.2009.03.022; Qiu SF, 2011, J CLIN MICROBIOL, V49, P1148, DOI 10.1128/JCM.01946-10; Roberts F, 2005, FEMS IMMUNOL MED MIC, V45, P285, DOI 10.1016/j.femsim.2005.05.002; SIMMONS DAR, 1987, J MED MICROBIOL, V23, P289, DOI 10.1099/00222615-23-4-289; Stagg RM, 2009, J BACTERIOL, V191, P6612, DOI 10.1128/JB.00628-09; Sun QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046095; Sun QZ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-269; Sun QZ, 2011, J CLIN MICROBIOL, V49, P3766, DOI 10.1128/JCM.01259-11; Talukder KA, 2001, J CLIN MICROBIOL, V39, P3757, DOI 10.1128/JCM.39.10.3757-3759.2001; VERMA NK, 1991, MOL MICROBIOL, V5, P71, DOI 10.1111/j.1365-2958.1991.tb01827.x; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09	29	34	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70238	10.1371/journal.pone.0070238	http://dx.doi.org/10.1371/journal.pone.0070238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936172	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200067
J	da Silva, KR; Costa, R; Crevelari, ES; Lacerda, MS; Albertini, CMD; Martinelli, M; Santana, JE; Vissoci, JRN; Pietrobon, R; Barros, JV				da Silva, Katia Regina; Costa, Roberto; Crevelari, Elizabeth Sartori; Lacerda, Marianna Sobral; de Moraes Albertini, Caio Marcos; Martinelli Filho, Martino; Santana, Jose Eduardo; Nickenig Vissoci, Joao Ricardo; Pietrobon, Ricardo; Barros, Jacson V.			Glocal Clinical Registries: Pacemaker Registry Design and Implementation for Global and Local Integration - Methodology and Case Study	PLOS ONE			English	Article							ASSOCIATION TASK-FORCE; KEY DATA ELEMENTS; CARDIAC-RESYNCHRONIZATION THERAPY; STANDARDS WRITING COMMITTEE; ELECTRONIC DATA CAPTURE; DEVELOP DATA STANDARDS; AMERICAN-COLLEGE; DEFINITIONS; HEALTH; DEFIBRILLATOR	Background: The ability to apply standard and interoperable solutions for implementing and managing medical registries as well as aggregate, reproduce, and access data sets from legacy formats and platforms to advanced standard formats and operating systems are crucial for both clinical healthcare and biomedical research settings. Purpose: Our study describes a reproducible, highly scalable, standard framework for a device registry implementation addressing both local data quality components and global linking problems. Methods and Results: We developed a device registry framework involving the following steps: (1) Data standards definition and representation of the research workflow, (2) Development of electronic case report forms using REDCap (Research Electronic Data Capture), (3) Data collection according to the clinical research workflow and, (4) Data augmentation by enriching the registry database with local electronic health records, governmental database and linked open data collections, (5) Data quality control and (6) Data dissemination through the registry Web site. Our registry adopted all applicable standardized data elements proposed by American College Cardiology/American Heart Association Clinical Data Standards, as well as variables derived from cardiac devices randomized trials and Clinical Data Interchange Standards Consortium. Local interoperability was performed between REDCap and data derived from Electronic Health Record system. The original data set was also augmented by incorporating the reimbursed values paid by the Brazilian government during a hospitalization for pacemaker implantation. By linking our registry to the open data collection repository Linked Clinical Trials (LinkedCT) we found 130 clinical trials which are potentially correlated with our pacemaker registry. Conclusion: This study demonstrates how standard and reproducible solutions can be applied in the implementation of medical registries to constitute a re-usable framework. Such approach has the potential to facilitate data integration between healthcare and research settings, also being a useful framework to be used in other biomedical registries.	[da Silva, Katia Regina; Crevelari, Elizabeth Sartori; Lacerda, Marianna Sobral; de Moraes Albertini, Caio Marcos] Univ Sao Paulo, Sch Med, Clin Hosp, Heart Inst InCor, Sao Paulo, Brazil; [da Silva, Katia Regina; Pietrobon, Ricardo] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Costa, Roberto] Univ Sao Paulo, Sch Med, Clin Hosp, Heart Inst InCor,Dept Cardiovasc Surg, Sao Paulo, Brazil; [Martinelli Filho, Martino] Univ Sao Paulo, Sch Med, Clin Hosp, Heart Inst InCor,Dept Cardiol, Sao Paulo, Brazil; [Nickenig Vissoci, Joao Ricardo] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Nickenig Vissoci, Joao Ricardo] Pontific Catholic Univ Sao Paulo, Sao Paulo, Brazil; [Nickenig Vissoci, Joao Ricardo] Fac Inga, Dept Med, Maringa, Parana, Brazil; [Barros, Jacson V.] Univ Sao Paulo, Sch Med, Clin Hosp, Sao Paulo, Brazil	Universidade de Sao Paulo; Duke University; Universidade de Sao Paulo; Universidade de Sao Paulo; Duke University; Pontificia Universidade Catolica de Sao Paulo; Centro Universitario Inga (UNINGA); Universidade de Sao Paulo	da Silva, KR (corresponding author), Univ Sao Paulo, Sch Med, Clin Hosp, Heart Inst InCor, Sao Paulo, Brazil.	katia.regina@incor.usp.br	Martinelli, Martino/D-9785-2012; Lacerda, Marianna Sobral/I-4553-2013; Silva, Katia/D-1261-2013; Costa, Roberto/F-2682-2012; Barros, Jacson V/J-5539-2014	Martinelli, Martino/0000-0003-4440-8078; Silva, Katia/0000-0002-5723-8285; Costa, Roberto/0000-0001-6104-9113; Barros, Jacson V/0000-0003-0169-9776; Santana, Jose Eduardo/0000-0003-3433-0481	CAPES Foundation, Ministry of Education of Brazil [3928/11-0]	CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by CAPES Foundation, Ministry of Education of Brazil [Postdoctoral Fellowship Program 3928/11-0]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Carvalho ECA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039671; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Bax JJ, 2009, J AM COLL CARDIOL, V53, P1933, DOI 10.1016/j.jacc.2008.11.061; Bradley CJ, 2010, HEALTH SERV RES, V45, P1468, DOI 10.1111/j.1475-6773.2010.01142.x; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Buxton AE, 2006, CIRCULATION, V114, P2534, DOI 10.1161/CIRCULATIONAHA.106.180199; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Center for Devices and Radiological Health, POST STUD; Chan Kitty S, 2010, Med Care Res Rev, V67, P503, DOI 10.1177/1077558709359007; Connolly SJ, 2000, NEW ENGL J MED, V342, P1385, DOI 10.1056/NEJM200005113421902; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Carvalho ECA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013893; Dreyer NA, 2009, JAMA-J AM MED ASSOC, V302, P790, DOI 10.1001/jama.2009.1092; Fowler M, 2003, UML DISTILLED BRIEF; Fragoso G, 2004, COMP FUNCT GENOM, V5, P648, DOI 10.1002/cfg.445; Gliklich RE, 2020, REGISTRIES EVALUATIN, V4th, DOI 10.23970/AHRQEPCREGISTRIES4; Hammond WE, 2008, STUD HEALTH TECHNOL, V134, P245; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haux R, 2006, INT J MED INFORM, V75, P795, DOI 10.1016/j.ijmedinf.2006.05.045; Hendel RC, 2009, CIRCULATION, V119, P154, DOI 10.1161/CIRCULATIONAHA.108.191393; Hicks KA, 2010, STANDARDIZED DEFINIT; Jacobs JP, 2010, ANN THORAC SURG, V90, P1150, DOI 10.1016/j.athoracsur.2010.05.042; Lamas GA, 2002, NEW ENGL J MED, V346, P1854, DOI 10.1056/NEJMoa013040; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Lopez MH, 2012, MED CARE, V50, pS38, DOI 10.1097/MLR.0b013e318259becd; Lyratzopoulos G, 2008, LANCET, V371, P1734, DOI 10.1016/S0140-6736(08)60742-4; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1929, DOI 10.1001/jama.295.16.1929; McCourt B, 2007, DRUG INF J, V41, P393, DOI 10.1177/009286150704100313; McNamara RL, 2004, CIRCULATION, V109, P3223, DOI 10.1161/01.CIR.0000131893.41821.D1; Paxton Elizabeth W, 2012, Perm J, V16, P36; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Prokosch HU, 2009, METHOD INFORM MED, V48, P38, DOI 10.3414/ME9132; R Development Core Team, 2012, R LANG ENV STAT COMP; Radford MJ, 2007, CIRCULATION, V115, P936, DOI 10.1161/CIRCULATIONAHA.107.182215; Radford Martha J, 2005, Circulation, V112, P1888, DOI 10.1161/CIRCULATIONAHA.105.170073; Rector TS, 1987, HEART FAIL, V3, P198; Richesson RL, 2007, J AM MED INFORM ASSN, V14, P687, DOI 10.1197/jamia.M2470; Rumsfeld J, 2009, US CARDIOLOGY, V6, P11; Sedrakyan A, 2010, MED CARE, V48, pS121, DOI 10.1097/MLR.0b013e3181d991c4; Shah J, 2010, CLIN ORTHOP RELAT R, V468, P2664, DOI 10.1007/s11999-010-1469-3; Stodden V., 2009, INT J COMMUN LAW POL, P55; Stofmeel MAM, 2001, PACE, V24, P288, DOI 10.1046/j.1460-9592.2001.00288.x; Tracy CM, 2012, CIRCULATION, V126, P1784, DOI 10.1161/CIR.0b013e3182618569; Uslan DZ, 2012, PACE, V35, P81, DOI 10.1111/j.1540-8159.2011.03257.x; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Weintraub WS, 2011, J AM COLL CARDIOL, V58, P202, DOI 10.1016/j.jacc.2011.05.001; Zerhouni EA, 2004, SCIENCE, V306, P1895, DOI 10.1126/science.1106929	47	17	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e71090	10.1371/journal.pone.0071090	http://dx.doi.org/10.1371/journal.pone.0071090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936257	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300117
J	Herrera, CM; Medrano, M; Bazaga, P				Herrera, Carlos M.; Medrano, Monica; Bazaga, Pilar			Epigenetic Differentiation Persists after Male Gametogenesis in Natural Populations of the Perennial Herb Helleborus foetidus (Ranunculaceae)	PLOS ONE			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; DISCRETE POPULATIONS; STATISTICAL-ANALYSIS; TRANSCRIPTION FACTOR; CPG METHYLATION; INHERITANCE; POLYMORPHISM; PLANTS; POLLEN	Despite the importance of assessing the stability of epigenetic variation in non-model organisms living in real-world scenarios, no studies have been conducted on the transgenerational persistence of epigenetic structure in wild plant populations. This gap in knowledge is hindering progress in the interpretation of natural epigenetic variation. By applying the methylation-sensitive amplified fragment length polymorphism (MSAP) technique to paired plant-pollen (i.e., sporophyte-male gametophyte) DNA samples, and then comparing methylation patterns and epigenetic population differentiation in sporophytes and their descendant gametophytes, we investigated transgenerational constancy of epigenetic structure in three populations of the perennial herb Helleborus foetidus (Ranunculaceae). Single-locus and multilocus analyses revealed extensive epigenetic differentiation between sporophyte populations. Locus-by-locus comparisons of methylation status in individual sporophytes and descendant gametophytes showed that similar to 75% of epigenetic markers persisted unchanged through gametogenesis. In spite of some epigenetic reorganization taking place during gametogenesis, multilocus epigenetic differentiation between sporophyte populations was preserved in the subsequent gametophyte stage. In addition to illustrating the efficacy of applying the MSAP technique to paired plant-pollen DNA samples to investigate epigenetic gametic inheritance in wild plants, this paper suggests that epigenetic differentiation between adult plant populations of H. foetidus is likely to persist across generations.	[Herrera, Carlos M.; Medrano, Monica; Bazaga, Pilar] CSIC, Estn Biol Donana, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Herrera, CM (corresponding author), CSIC, Estn Biol Donana, Seville, Spain.	herrera@cica.es	Herrera, Carlos/AAS-3831-2020; Herrera, Carlos M/A-4088-2008; Medrano, Mónica/A-2326-2010; Bazaga, Pilar/Z-4637-2019	Herrera, Carlos/0000-0003-2452-3888; Herrera, Carlos M/0000-0003-2452-3888; Medrano, Mónica/0000-0002-2816-4192; 	Ministerio de Ciencia e Innovacion [CGL2010-15964]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Ministerio de Ciencia e Innovacion Grant CGL2010-15964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Becker C, 2012, CURR OPIN PLANT BIOL, V15, P562, DOI 10.1016/j.pbi.2012.08.004; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Berger F, 2011, ANNU REV PLANT BIOL, V62, P461, DOI 10.1146/annurev-arplant-042110-103824; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Castiglioni P, 1999, THEOR APPL GENET, V99, P425, DOI 10.1007/s001220051253; Chagne D, 2002, ANN FOREST SCI, V59, P627, DOI 10.1051/forest:2002048; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Crawford R.M.M., 2008, ECOLOGICAL LIMITS CL; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Dickinson HG, 2009, BIOL REV, V84, P589, DOI 10.1111/j.1469-185X.2009.00088.x; ECHLIN P, 1972, J CELL SCI, V11, P111; EXCOFFIER L, 1992, GENETICS, V131, P479; Fang J, 2008, J HORTIC SCI BIOTECH, V83, P833, DOI 10.1080/14620316.2008.11512469; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Finnegan EJ, 1998, P NATL ACAD SCI USA, V95, P5824, DOI 10.1073/pnas.95.10.5824; Flatscher R, 2012, GENET RES INT, V2012, DOI 10.1155/2012/698421; Fraley C, 2012, 597 U WASH DEP STAT; Gao LX, 2010, PLANT CELL ENVIRON, V33, P1820, DOI 10.1111/j.1365-3040.2010.02186.x; Guitian J, 2003, PLANT SYST EVOL, V241, P139, DOI 10.1007/s00606-003-0046-6; Gutierrez-Marcos JF, 2012, PLANT CELL PHYSIOL, V53, P817, DOI 10.1093/pcp/pcs052; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2008, MOL ECOL, V17, P5378, DOI 10.1111/j.1365-294X.2008.04004.x; Herrera C.M., 2009, MULTIPLICITY UNITY P; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Jablonka E., 1995, EPIGENETIC INHERITAN; Jablonka E, 2013, PROG BIOPHYS MOL BIO, V111, P99, DOI 10.1016/j.pbiomolbio.2012.08.014; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Janousek B, 2002, GENOME, V45, P930, DOI [10.1139/g02-052, 10.1139/G02-052]; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Klekowski E, 1988, MUTATION DEV SELECTI; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Legendre P., 2012, NUMERICAL ECOLOGY; Li YD, 2008, ECOL RES, V23, P927, DOI 10.1007/s11284-007-0459-8; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Mathew B., 1989, HELLEBORES; Migicovsky Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00020; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Novero AU, 2012, PLANT OMICS, V5, P559; Noyer JL, 2005, GENETICA, V124, P61, DOI 10.1007/s10709-004-7319-z; Oakeley EJ, 1996, PLANT MOL BIOL, V31, P927, DOI 10.1007/BF00019481; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; R Core Team, 2021, R LANGUAGE ENV STAT; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Richards CL, 2010, BIOSCIENCE, V60, P232, DOI 10.1525/bio.2010.60.3.9; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; SAS Institute, 2006, GLIMMIX PROC; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Scoville AG, 2011, NEW PHYTOL, V191, P251, DOI 10.1111/j.1469-8137.2011.03656.x; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takeda S, 2006, CHROMOSOMA, V115, P27, DOI 10.1007/s00412-005-0031-7; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Venables WN., 2002, MODERN APPL STAT S, V4; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; WERNER K, 1994, FLORA, V189, P97; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010	71	24	24	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70730	10.1371/journal.pone.0070730	http://dx.doi.org/10.1371/journal.pone.0070730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936245	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300113
J	Suzuki, T; Igarashi, K; Dohra, H; Someya, T; Takano, T; Harada, K; Omae, S; Hirai, H; Yano, K; Kawagishi, H				Suzuki, Tomohiro; Igarashi, Kaori; Dohra, Hideo; Someya, Takumi; Takano, Tomoyuki; Harada, Kiyonori; Omae, Saori; Hirai, Hirofumi; Yano, Kentaro; Kawagishi, Hirokazu			A New Omics Data Resource of Pleurocybella porrigens for Gene Discovery	PLOS ONE			English	Article							GENOME ANNOTATION; EXPRESSION; IDENTIFICATION; ALIGNMENT; SEQUENCE; ACID	Background: Pleurocybella porrigens is a mushroom-forming fungus, which has been consumed as a traditional food in Japan. In 2004, 55 people were poisoned by eating the mushroom and 17 people among them died of acute encephalopathy. Since then, the Japanese government has been alerting Japanese people to take precautions against eating the P. porrigens mushroom. Unfortunately, despite efforts, the molecular mechanism of the encephalopathy remains elusive. The genome and transcriptome sequence data of P. porrigens and the related species, however, are not stored in the public database. To gain the omics data in P. porrigens, we sequenced genome and transcriptome of its fruiting bodies and mycelia by next generation sequencing. Methodology/Principal Findings: Short read sequences of genomic DNAs and mRNAs in P. porrigens were generated by Illumina Genome Analyzer. Genome short reads were de novo assembled into scaffolds using Velvet. Comparisons of genome signatures among Agaricales showed that P. porrigens has a unique genome signature. Transcriptome sequences were assembled into contigs (unigenes). Biological functions of unigenes were predicted by Gene Ontology and KEGG pathway analyses. The majority of unigenes would be novel genes without significant counterparts in the public omics databases. Conclusions: Functional analyses of unigenes present the existence of numerous novel genes in the basidiomycetes division. The results mean that the omics information such as genome, transcriptome and metabolome in basidiomycetes is short in the current databases. The large-scale omics information on P. porrigens, provided from this research, will give a new data resource for gene discovery in basidiomycetes.	[Suzuki, Tomohiro; Kawagishi, Hirokazu] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan; [Igarashi, Kaori; Someya, Takumi; Takano, Tomoyuki; Harada, Kiyonori; Yano, Kentaro] Meiji Univ, Sch Agr, Bioinformat Lab, Kawasaki, Kanagawa, Japan; [Dohra, Hideo] Shizuoka Univ, Inst Genet Res & Biotechnol, Suruga Ku, Shizuoka, Japan; [Omae, Saori; Hirai, Hirofumi; Kawagishi, Hirokazu] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Suruga Ku, Shizuoka, Japan	Shizuoka University; Meiji University; Shizuoka University; Shizuoka University	Yano, K (corresponding author), Meiji Univ, Sch Agr, Bioinformat Lab, Kawasaki, Kanagawa, Japan.	kyano@isc.meiji.ac.jp; achkawa@ipc.shizuoka.ac.jp	Hirai, Hirofumi/N-6158-2019	Dohra, Hideo/0000-0002-3919-3538	MAFF; MEXT [24102513, 24113518]; JSPS [24248021, 23248005, 20380023]; A-STEP [AS232Z02832E]; CREST from JST; Meiji University; Grants-in-Aid for Scientific Research [24102513] Funding Source: KAKEN	MAFF(Ministry of Agriculture Forestry & Fisheries - Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); A-STEP(National Aeronautics & Space Administration (NASA)); CREST from JST(Core Research for Evolutional Science and Technology (CREST)); Meiji University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Research and Development Projects for Application in Promoting New Policy of Agriculture Forestry and Fisheries from MAFF, a Grant-in-Aid for Scientific Research on Innovative Areas "Chemical Biology of Natural Products" from MEXT (Grant Number 24102513), and a Grant-in-Aid for Scientific Research (A) from JSPS (Grant Number 24248021) to H. K. This work was also supported in part by a Grant in-Aid for Scientific Research on Innovative Areas (No. 24113518) from MEXT, A-STEP (AS232Z02832E) and CREST from JST, Research Funding for Computational Software Supporting Program from Meiji University, and a Grant-in-Aid for Scientific Research (A) (23248005) and Scientific Research (B) (20380023) from JSPS to K.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth GC, 2001, AINSWORTH BISBYS DIC; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bianchi ME, 2000, EMBO REP, V1, P109, DOI 10.1093/embo-reports/kvd030; Corcoran D, 2006, REPRODUCTION, V131, P651, DOI 10.1530/rep.1.01015; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; Curtin CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033840; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Fungal Genome Initiative, 2002, WHIT PAP DEV FUNG RE; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Green KA, 2004, CELL MOL LIFE SCI, V61, P1867, DOI 10.1007/s00018-004-3366-y; Greenacre M., 2007, CORRES ANAL PRACTICE; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hamada K, 2011, PLANT CELL PHYSIOL, V52, P220, DOI 10.1093/pcp/pcq195; Hasegawa T, 2007, CHEM PHARM BULL, V55, P1748, DOI 10.1248/cpb.55.1748; Hawksworth D. L., 2001, International Journal of Medicinal Mushrooms, V3, P333, DOI 10.1615/IntJMedMushr.v3.i4.50; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Horibe M, 2009, PHYTOCHEMISTRY, V71, P648, DOI [10.1016/j.phytochem, DOI 10.1016/J.PHYT0CHEM.2009.12.003.PUBMED:20096904]; Kawaguchi T, 2010, TETRAHEDRON, V66, P504, DOI 10.1016/j.tet.2009.11.041; Knoll A, 2011, J EXP BOT, V62, P1565, DOI 10.1093/jxb/erq357; Kothe E, 2001, APPL MICROBIOL BIOT, V56, P602, DOI 10.1007/s002530100763; Kues U, 2000, APPL MICROBIOL BIOT, V54, P141, DOI 10.1007/s002530000396; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Lomascolo A, 1999, TRENDS BIOTECHNOL, V17, P282, DOI 10.1016/S0167-7799(99)01313-X; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Matsuura M, 2009, NAT CHEM BIOL, V5, P465, DOI 10.1038/nchembio.179; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishida Hiromi, 2012, Int J Evol Biol, V2012, P205274, DOI 10.1155/2012/205274; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Sasaki H, 2006, BIOL PHARM BULL, V29, P2514, DOI 10.1248/bpb.29.2514; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Suzuki T, 2009, BIOSCI BIOTECH BIOCH, V73, P702, DOI 10.1271/bbb.80774; Takata T, 2009, J HEALTH SCI, V55, P373, DOI 10.1248/jhs.55.373; Wakimoto T, 2011, ANGEW CHEM INT EDIT, V50, P1168, DOI 10.1002/anie.201004646; Yano K, 2006, NUCLEIC ACIDS RES, V34, P1532, DOI 10.1093/nar/gkl058; Yano K, 2005, JPN Kokai Tokkyo Koho JP, Patent No. [2005-073569, 2005073569]; Yano K, 2010, World Patent, Patent No. [WO/2010/106794, 2010106794]; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	44	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69681	10.1371/journal.pone.0069681	http://dx.doi.org/10.1371/journal.pone.0069681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936076	Green Submitted, gold, Green Published			2022-12-27	WOS:000325211000147
J	Tsukamoto, K; Buck, L; Inman, W; Griffith, L; Kocher, O; Krieger, M				Tsukamoto, Kosuke; Buck, Lorenna; Inman, Walker; Griffith, Linda; Kocher, Olivier; Krieger, Monty			Challenges in Using Cultured Primary Rodent Hepatocytes or Cell Lines to Study Hepatic HDL Receptor SR-BI Regulation by Its Cytoplasmic Adaptor PDZK1	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; APOPROTEIN-A-I; SCAVENGER RECEPTOR; PROTEIN PDZK1; RAT HEPATOCYTES; CHYLOMICRON METABOLISM; SURFACE LOCALIZATION; CHOLESTEROL LEVELS; C-TERMINUS	Background: PDZK1 is a four PDZ-domain containing cytoplasmic protein that binds to a variety of membrane proteins via their C-termini and can influence the abundance, localization and/or function of its target proteins. One of these targets in hepatocytes in vivo is the HDL receptor SR-BI. Normal hepatic expression of SR-BI protein requires PDZK1 - <5% of normal hepatic SR-BI is seen in the livers of PDZK1 knockout mice. Progress has been made in identifying features of PDZK1 required to control hepatic SR-BI in vivo using hepatic expression of wild-type and mutant forms of PDZK1 in wild-type and PDZK1 KO transgenic mice. Such in vivo studies are time consuming and expensive, and cannot readily be used to explore many features of the underlying molecular and cellular mechanisms. Methodology/Principal Findings: Here we have explored the potential to use either primary rodent hepatocytes in culture using 2D collagen gels with newly developed optimized conditions or PDZK1/SR-BI co-transfected cultured cell lines (COS, HEK293) for such studies. SR-BI and PDZK1 protein and mRNA expression levels fell rapidly in primary hepatocyte cultures, indicating this system does not adequately mimic hepatocytes in vivo for analysis of the PDZK1 dependence of SR-BI. Although PDZK1 did alter SR-BI protein expression in the cell lines, its influence was independent of SR-BI's C-terminus, and thus is not likely to occur via the same mechanism as that which occurs in hepatocytes in vivo. Conclusions/Significance: Caution must be exercised in using primary hepatocytes or cultured cell lines when studying the mechanism underlying the regulation of hepatic SR-BI by PDZK1. It may be possible to use SR-BI and PDZK1 expression as sensitive markers for the in vivo-like state of hepatocytes to further improve primary hepatocyte cell culture conditions.	[Tsukamoto, Kosuke; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA; [Buck, Lorenna; Inman, Walker; Griffith, Linda] MIT, Cambridge, MA 02139 USA; [Kocher, Olivier] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Sch Med, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Krieger, M (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	krieger@mit.edu		Griffith, Linda/0000-0002-1801-5548	National Institutes of Health [HL052212, HL066105, HL077780, ES015241, GM068762]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105, R01HL077780, R01HL052212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants to MK (HL052212 and HL066105), OK (HL077780) and LG (ES015241 and GM068762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.nih.gov/	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; BISSELL DM, 1990, MOL BIOL MED, V7, P187; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Brill A, 2012, ARTERIOSCL THROM VAS, V32, P1841, DOI 10.1161/ATVBAHA.112.252130; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Eyre NS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001130; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Fu T, 2003, J BIOL CHEM, V278, P52559, DOI 10.1074/jbc.M310892200; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GLASS C, 1985, J BIOL CHEM, V260, P744; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Hwa AJ, 2007, FASEB J, V21, P2564, DOI 10.1096/fj.06-7473com; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Kannel BW, 1971, ANN INTERN MED, V74, P1; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2011, J BIOL CHEM, V286, P25171, DOI 10.1074/jbc.M111.242362; Kocher O, 2010, J BIOL CHEM, V285, P34999, DOI 10.1074/jbc.M110.164418; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Korporaal SJA, 2011, ARTERIOSCL THROM VAS, V31, P34, DOI 10.1161/ATVBAHA.110.210252; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Lecluyse E, 1999, DRUG METAB DISPOS, V27, P909; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martinez SM, 2010, TOXICOL APPL PHARM, V249, P208, DOI 10.1016/j.taap.2010.09.012; MASLANSKY CJ, 1982, IN VITRO CELL DEV B, V18, P683; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; MICHALOPOULOS G, 1975, EXP CELL RES, V94, P70, DOI 10.1016/0014-4827(75)90532-7; Miettinen HE, 2001, J CLIN INVEST, V108, P1717, DOI 10.1172/JCI13288; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; Nieland TJF, 2011, BIOCHEMISTRY-US, V50, P1818, DOI 10.1021/bi101657j; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Out R, 2005, J LIPID RES, V46, P1172, DOI 10.1194/jlr.M400361-JLR200; Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200; Richert L, 2002, TOXICOL IN VITRO, V16, P89, DOI 10.1016/S0887-2333(01)00099-6; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Saddar S, 2010, ARTERIOSCL THROM VAS, V30, P144, DOI 10.1161/ATVBAHA.109.196170; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shih SC, 2005, EXP MOL PATHOL, V79, P14, DOI 10.1016/j.yexmp.2005.03.004; Shih SC, 2009, CANCER RES, V69, P3272, DOI 10.1158/0008-5472.CAN-08-4886; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; Stylianou IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006521; Teslovich TM, 2011, NEW ENGL J MED, V364, P136; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Tsukamoto K, 2013, J BIOL CHEM IN PRESS; Wada Y, 2011, CYTOTECHNOLOGY, V63, P25, DOI 10.1007/s10616-010-9315-8; Webb NR, 1997, J LIPID RES, V38, P1490; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Yesilaltay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008103; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zahid MN, 2012, HEPATOLOGY, DOI [10.1002/hep.26097, DOI 10.1002/HEP.26097.[]	64	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69725	10.1371/journal.pone.0069725	http://dx.doi.org/10.1371/journal.pone.0069725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936087	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000149
J	Thirunavukkarasu, N; Hossain, F; Mohan, S; Shiriga, K; Mittal, S; Sharma, R; Singh, RK; Gupta, HS				Thirunavukkarasu, Nepolean; Hossain, Firoz; Mohan, Sweta; Shiriga, Kaliyugam; Mittal, Swati; Sharma, Rinku; Singh, Rita Kumari; Gupta, Hari Shankar			Genome-Wide Expression of Transcriptomes and Their Co-Expression Pattern in Subtropical Maize (Zea mays L.) under Waterlogging Stress	PLOS ONE			English	Article							LOW-OXYGEN; ANOXIA TOLERANCE; ARABIDOPSIS; RICE; ETHYLENE; PLANTS; GENES; PROTEINS; HYPOXIA; NETWORK	Waterlogging causes extensive damage to maize crops in tropical and subtropical regions. The identification of tolerance genes and their interactions at the molecular level will be helpful to engineer tolerant genotypes. A whole-genome transcriptome assay revealed the specific role of genes in response to waterlogging stress in susceptible and tolerant genotypes. Genes involved in the synthesis of ethylene and auxin, cell wall metabolism, activation of G-proteins and formation of aerenchyma and adventitious roots, were upregulated in the tolerant genotype. Many transcription factors, particularly ERFs, MYB, HSPs, MAPK, and LOB-domain protein were involved in regulation of these traits. Genes responsible for scavenging of ROS generated under stress were expressed along with those involved in carbohydrate metabolism. The physical locations of 21 genes expressed in the tolerant genotype were found to correspond with the marker intervals of known QTLs responsible for development of adaptive traits. Among the candidate genes, most showed synteny with genes of sorghum and foxtail millet. Co-expression analysis of 528 microarray samples including 16 samples from the present study generated seven functional modules each in the two genotypes, with differing characteristics. In the tolerant genotype, stress genes were co-expressed along with peroxidase and fermentation pathway genes.	[Thirunavukkarasu, Nepolean; Hossain, Firoz; Mohan, Sweta; Shiriga, Kaliyugam; Mittal, Swati; Sharma, Rinku; Singh, Rita Kumari; Gupta, Hari Shankar] Indian Agr Res Inst, Div Genet, Maize Genet & Breeding Unit, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Thirunavukkarasu, N (corresponding author), Indian Agr Res Inst, Div Genet, Maize Genet & Breeding Unit, New Delhi 110012, India.	tnepolean@gmail.com			National Agricultural Innovation Project (NAIP)-Component (IV), India	National Agricultural Innovation Project (NAIP)-Component (IV), India	The study was funded by the National Agricultural Innovation Project (NAIP)-Component (IV), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bailey-Serres J, 2005, ANN BOT-LONDON, V96, P507, DOI 10.1093/aob/mci206; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Banti V, 2010, PLANT PHYSIOL, V152, P1471, DOI 10.1104/pp.109.149815; Baxter-Burrell A, 2002, SCIENCE, V296, P2026, DOI 10.1126/science.1071505; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Choi WG, 2007, J BIOL CHEM, V282, P24209, DOI 10.1074/jbc.M700982200; Conesa A, 2008, INT J PLANT GENOMICS, V2008; DEVETTEN NC, 1995, PLANT J, V7, P589, DOI 10.1046/j.1365-313X.1995.7040589.x; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Fukushima A, 2012, PLANT PHYSIOL, V158, P1487, DOI 10.1104/pp.111.188367; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Gibbs J, 2003, FUNCT PLANT BIOL, V30, P1, DOI [10.1071/PP98095_ER, 10.1071/PP98095]; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hoeren FU, 1998, GENETICS, V149, P479; Hong SH, 2002, J EXP BOT, V53, P2271, DOI 10.1093/jxb/erf075; Hsu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028888; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jackson M. B., 1984, Flooding and plant growth, P47; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Mangeon A, 2011, J EXP BOT, V62, P221, DOI 10.1093/jxb/erq259; Mano Y, 2006, PLANT SOIL, V281, P269, DOI 10.1007/s11104-005-4268-y; Marino R, 2009, MOL GENET GENOMICS, V281, P163, DOI 10.1007/s00438-008-0401-y; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Mergemann H, 2000, PLANT PHYSIOL, V124, P609, DOI 10.1104/pp.124.2.609; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P785, DOI 10.1093/pcp/pcr035; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Negi S, 2010, PLANT J, V61, P3, DOI 10.1111/j.1365-313X.2009.04027.x; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Ookawara R, 2005, ANN BOT-LONDON, V96, P693, DOI 10.1093/aob/mci221; Parent C., 2008, PLANT STRESS, P20, DOI DOI 10.1038/S41598-020-73072-6; Ponnamperuma F. N., 1984, Flooding and plant growth, P9; Ricoult C, 2005, PHYSIOL PLANTARUM, V123, P30, DOI 10.1111/j.1399-3054.2005.00449.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Saab IN, 1996, PLANT PHYSIOL, V112, P385, DOI 10.1104/pp.112.1.385; SACHS MM, 1980, CELL, V20, P761, DOI 10.1016/0092-8674(80)90322-0; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sauter M, 2002, J EXP BOT, V53, P2325, DOI 10.1093/jxb/erf096; SETTER TL, 1987, PLANT CELL ENVIRON, V10, P767; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subbaiah CC, 2000, J EXP BOT, V51, P721, DOI 10.1093/jexbot/51.345.721; Subbaiah CC, 2003, ANN BOT-LONDON, V91, P119, DOI 10.1093/aob/mcf210; Tang WH, 2005, SCI CHINA SER C, V48, P337, DOI 10.1360/062004-27; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; Tufekci M.A., 2005, J CELL MOL BIOL, V4, P9; Wang J, 2008, J PLANT PHYSIOL, V165, P1519, DOI 10.1016/j.jplph.2007.08.008; Warsi MZ., 2009, BOT RES INT, V2, P211; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103; Zaidi PH, 2007, FIELD CROP RES, V101, P117, DOI 10.1016/j.fcr.2006.10.002; Zaidi PH, 2010, MAYDICA, V55, P17; Zaidi PH, 2008, AUST J CROP SCI, V1, P78; Zhang ZX, 2005, RUSS J PLANT PHYSL+, V52, P43, DOI 10.1007/s11183-005-0007-8; Zhou Jian, 2012, Australian Journal of Crop Science, V6, P756; Zou XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-189	61	47	55	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70433	10.1371/journal.pone.0070433	http://dx.doi.org/10.1371/journal.pone.0070433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936429	Green Submitted, Green Published, gold			2022-12-27	WOS:000324401500034
J	Vendra, VPR; Agarwal, G; Chandani, S; Talla, V; Srinivasan, N; Balasubramanian, D				Vendra, Venkata Pulla Rao; Agarwal, Garima; Chandani, Sushil; Talla, Venu; Srinivasan, Narayanaswamy; Balasubramanian, Dorairajan			Structural Integrity of the Greek Key Motif in beta gamma-Crystallins Is Vital for Central Eye Lens Transparency	PLOS ONE			English	Article							P23T MUTANT; FLUORESCENT DYE; IN-VITRO; CATARACT; AGGREGATION; MUTATION; SOLUBILITY; CHILDHOOD; PROTEINS; HYDROPHOBICITY	Background: We highlight an unrecognized physiological role for the Greek key motif, an evolutionarily conserved super-secondary structural topology of the beta gamma-crystallins. These proteins constitute the bulk of the human eye lens, packed at very high concentrations in a compact, globular, short-range order, generating transparency. Congenital cataract (affecting 400,000 newborns yearly worldwide), associated with 54 mutations in beta gamma-crystallins, occurs in two major phenotypes nuclear cataract, which blocks the central visual axis, hampering the development of the growing eye and demanding earliest intervention, and the milder peripheral progressive cataract where surgery can wait. In order to understand this phenotypic dichotomy at the molecular level, we have studied the structural and aggregation features of representative mutations. Methods: Wild type and several representative mutant proteins were cloned, expressed and purified and their secondary and tertiary structural details, as well as structural stability, were compared in solution, using spectroscopy. Their tendencies to aggregate in vitro and in cellulo were also compared. In addition, we analyzed their structural differences by molecular modeling in silico. Results: Based on their properties, mutants are seen to fall into two classes. Mutants A36P, L45PL54P, R140X, and G165fs display lowered solubility and structural stability, expose several buried residues to the surface, aggregate in vitro and in cellulo, and disturb/distort the Greek key motif. And they are associated with nuclear cataract. In contrast, mutants P24T and R77S, associated with peripheral cataract, behave quite similar to the wild type molecule, and do not affect the Greek key topology. Conclusion: When a mutation distorts even one of the four Greek key motifs, the protein readily self-aggregates and precipitates, consistent with the phenotype of nuclear cataract, while mutations not affecting the motif display 'native state aggregation', leading to peripheral cataract, thus offering a protein structural rationale for the cataract phenotypic dichotomy "distort motif, lose central vision".	[Vendra, Venkata Pulla Rao; Balasubramanian, Dorairajan] LV Prasad Eye Inst, Hyderabad Eye Res Fdn, Hyderabad, Andhra Pradesh, India; [Agarwal, Garima; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Chandani, Sushil] Novarus Discoveries Pvt Ltd, Hyderabad, Andhra Pradesh, India; [Talla, Venu] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	L. V. Prasad Eye Institute; Indian Institute of Science (IISC) - Bangalore; University of Miami	Balasubramanian, D (corresponding author), LV Prasad Eye Inst, Hyderabad Eye Res Fdn, Hyderabad, Andhra Pradesh, India.	dbala@lvpei.org		Talla, Venu/0000-0002-5695-7536	Department of Biotechnology, India; Hyderabad Eye Research Foundation	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Hyderabad Eye Research Foundation	This work was supported by grants from the Department of Biotechnology, India, and the Hyderabad Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya L, 2003, SURV OPHTHALMOL, V48, P125, DOI 10.1016/S0039-6257(02)00462-9; ANDLEY UP, 1994, INVEST OPHTH VIS SCI, V35, P3094; AUGUSTEYN RC, 1994, BBA-PROTEIN STRUCT M, V1205, P89, DOI 10.1016/0167-4838(94)90096-5; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Augusteyn RC, 2010, EXP EYE RES, V90, P643, DOI 10.1016/j.exer.2010.01.013; Banerjee PR, 2010, P NATL ACAD SCI USA, V108, P574; Banerjee PR, 2011, J MOL BIOL, V412, P647, DOI 10.1016/j.jmb.2011.07.058; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Benedek GB, 1997, INVEST OPHTH VIS SCI, V38, P1911; Birch EE, 2009, J AAPOS, V13, P67, DOI 10.1016/j.jaapos.2008.07.010; Brubaker WD, 2011, BIOPHYS J, V100, P498, DOI 10.1016/j.bpj.2010.12.3691; CLARK AC, 1993, J BIOL CHEM, V268, P10773; Das P, 2010, PROTEIN SCI, V19, P131, DOI 10.1002/pro.296; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Evans P, 2004, J MOL BIOL, V343, P435, DOI 10.1016/j.jmb.2004.08.050; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Gunton JD, 2007, PROTEIN CONDENSATION: KINETIC PATHWAYS TO CRYSTALLIZATION AND DISEASE, P1, DOI 10.1017/CBO9780511535321; Hubbard S. J., 1993, NACCESS; HUTCHINSON EG, 1993, PROTEIN ENG, V6, P233, DOI 10.1093/protein/6.3.233; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Ji FL, 2013, J BIOL CHEM, V288, P99, DOI 10.1074/jbc.M112.416354; Ji FL, 2012, BIOCHEMISTRY-US, V51, P2588, DOI 10.1021/bi300199d; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Kong FR, 2011, PROTEIN SCI, V20, P513, DOI 10.1002/pro.583; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Krishnamurthy Rupa, 2008, Int Ophthalmol Clin, V48, P175, DOI 10.1097/IIO.0b013e3181694b31; Kuhli-Hattenbach C, 2008, AM J OPHTHALMOL, V146, P1, DOI 10.1016/j.ajo.2008.02.014; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; LAPATTO R, 1991, J MOL BIOL, V222, P1067, DOI 10.1016/0022-2836(91)90594-V; Ma ZW, 2009, BIOCHEMISTRY-US, V48, P7334, DOI 10.1021/bi900467a; MCAVOY JW, 1978, J EMBRYOL EXP MORPH, V44, P149; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Pande A, 2005, BIOCHEMISTRY-US, V44, P2491, DOI 10.1021/bi0479611; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Pande A, 2010, BIOCHEMISTRY-US, V49, P6122, DOI 10.1021/bi100664s; Pande A, 2009, BIOCHEMISTRY-US, V48, P4937, DOI 10.1021/bi9004182; Pande A, 2009, BIOCHEM BIOPH RES CO, V382, P196, DOI 10.1016/j.bbrc.2009.03.007; Pande J, 2011, LECT ANN M ASS RES V; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Putzar L, 2010, RESTOR NEUROL NEUROS, V28, P251, DOI 10.3233/RNN-2010-0526; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Sahin E, 2011, BIOCHEMISTRY-US, V50, P628, DOI 10.1021/bi100978r; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Shiels A, 2010, MOL VIS, V16, P2007; Singh D, 2006, MOL VIS, V12, P1372; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; Sutter M, 2007, J FLUORESC, V17, P181, DOI 10.1007/s10895-007-0156-6; Talla V, 2008, INVEST OPHTH VIS SCI, V49, P3483, DOI 10.1167/iovs.07-1114; Vendra VPR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051401; Vendra VPR, 2010, MOL VIS, V16, P2822; Wang XH, 2004, INVEST OPHTH VIS SCI, V45, P3608, DOI 10.1167/iovs.04-0423; Wistow G, 2005, FEBS J, V272, P2276, DOI 10.1111/j.1742-4658.2005.04655.x	61	30	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70336	10.1371/journal.pone.0070336	http://dx.doi.org/10.1371/journal.pone.0070336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936409	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000324401500027
J	Abdoul-Azize, S; Atek-Mebarki, F; Bitam, A; Sadou, H; Koceir, EA; Khan, NA				Abdoul-Azize, Souleymane; Atek-Mebarki, Feriel; Bitam, Arezki; Sadou, Hassimi; Koceir, Elhadj Ahmed; Khan, Naim Akhtar			Oro-Gustatory Perception of Dietary Lipids and Calcium Signaling in Taste Bud Cells Are Altered in Nutritionally Obesity-Prone Psammomys obesus	PLOS ONE			English	Article							FATTY-ACIDS; ORAL-SENSITIVITY; PREFERENCE; CD36; WILD; MASS	Since the increasing prevalence of obesity is one of the major health problems of the modern era, understanding the mechanisms of oro-gustatory detection of dietary fat is critical for the prevention and treatment of obesity. We have conducted the present study on Psammomys obesus, the rodent desert gerbil which is a unique polygenic natural animal model of obesity. Our results show that obese animals exhibit a strong preference for lipid solutions in a two-bottle test. Interestingly, the expression of CD36, a lipido-receptor, in taste buds cells (TBC), isolated from circumvallate papillae, was decreased at mRNA level, but remained unaltered at protein level, in obese animals. We further studied the effects of linoleic acid (LA), a long-chain fatty acid, on the increases in free intracellular calcium (Ca2+) concentrations, [Ca2+]i, in the TBC of P. obesus. LA induced increases in [Ca2+]i, largely via CD36, from intracellular pool, followed by the opening of store-operated Ca2+ (SOC) channels in the TBC of these animals. The action of this fatty acid on the increases in [Ca2+]i was higher in obese animals than that in controls. However, the release of Ca2+ from intracellular stores, studied also by employing thapsigargin, was lower in TBC of obese animals than control rodents. In this study, we show, for the first time, that increased lipid intake and altered Ca2+ signaling in TBC are associated with obesity in Psammomys obesus.	[Abdoul-Azize, Souleymane; Khan, Naim Akhtar] Univ Bourgogne, Agrosup, UMR U866 INSERM, Dijon, France; [Atek-Mebarki, Feriel; Bitam, Arezki; Koceir, Elhadj Ahmed] USTHB, FSB, Bioenerget & Intermediary Metab Lab, Algiers, Algeria; [Sadou, Hassimi] Univ Abdou Moumouni, Lab Nutr, Niamey, Niger	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University Science & Technology Houari Boumediene	Khan, NA (corresponding author), Univ Bourgogne, Agrosup, UMR U866 INSERM, Dijon, France.	Naim.Khan@u-bourgogne.fr	Abdoul-Azize, Souleymane/AAB-2181-2021; ENSA - NHSA, Algiers/AAF-1768-2019	KOCEIR, Elhadj-Ahmed/0000-0003-1345-2535; Abdoul-Azize, Souleymane/0000-0003-2065-9091	bilateral Franco-Algerian collaborative project "Tassili" [12MDU855]	bilateral Franco-Algerian collaborative project "Tassili"	The study was a part of a bilateral Franco-Algerian collaborative project "Tassili" (grant number 12MDU855). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumrad NA, 2005, J CLIN INVEST, V115, P2965, DOI 10.1172/JCI26955; Andrews SP, 2007, CHEM-EUR J, V13, P5688, DOI 10.1002/chem.200700302; BARNETT M, 1994, DIABETOLOGIA, V37, P671, DOI 10.1007/s001250050162; Blundell JE, 1997, J AM DIET ASSOC, V97, pS63, DOI 10.1016/S0002-8223(97)00733-5; Bouderba S, 2012, EXP DIABETES RES, DOI 10.1155/2012/430176; Bray GA, 2004, PHYSIOL BEHAV, V83, P549, DOI 10.1016/j.physbeh.2004.08.039; CARLES J, 1956, B SOC CHIM BIOL, V38, P255; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Ferriere F, 1997, BIOCHEM J, V323, P251, DOI 10.1042/bj3230251; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRENKEL G, 1972, LAB ANIM SCI, V22, P40; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Gilbertson TA, 1998, ANN NY ACAD SCI, V855, P165, DOI 10.1111/j.1749-6632.1998.tb10560.x; Kaiser N, 2005, DIABETES, V54, P138, DOI 10.2337/diabetes.54.1.138; Kaiser Nurit, 2012, Methods Mol Biol, V933, P89, DOI 10.1007/978-1-62703-068-7_7; KALDERON B, 1986, DIABETES, V35, P717, DOI 10.2337/diabetes.35.6.717; Khan NA, 2009, BBA-MOL CELL BIOL L, V1791, P149, DOI 10.1016/j.bbalip.2009.01.001; Koceir EA, 2003, DIABETES METAB, V29, P363, DOI 10.1016/S1262-3636(07)70047-2; Kuda O, 2013, J BIOL CHEM; Lahfa FB, 1995, CELL MOL BIOL RES, V41, P387; Lanfer A, 2012, INT J OBESITY, V36, P27, DOI 10.1038/ijo.2011.164; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Levy E, 2010, ENDOCRINOLOGY, V151, P958, DOI 10.1210/en.2009-0866; MARQUIE G, 1984, DIABETES, V33, P438, DOI 10.2337/diabetes.33.5.438; Mela DJ, 2001, OBES RES, V9, p249S, DOI 10.1038/oby.2001.127; Palgi N, 2008, COMP BIOCHEM PHYS A, V149, P197, DOI 10.1016/j.cbpa.2007.11.010; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Stewart JE, 2012, INT J OBESITY, V36, P834, DOI 10.1038/ijo.2011.155; Stewart JE, 2011, CLIN NUTR, V30, P838, DOI 10.1016/j.clnu.2011.06.007; Stewart JE, 2010, BRIT J NUTR, V104, P145, DOI 10.1017/S0007114510000267; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; Triboulot C, 2001, J NUTR, V131, P2364, DOI 10.1093/jn/131.9.2364; World Health Organization, 2000, WHO TECHN REP SER, P894; Xiao JZ, 2012, J OBES, V2012, DOI 10.1155/2012/369097; Ziv E, 1995, LESSONS ANIMAL DIABE, P285	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e68532	10.1371/journal.pone.0068532	http://dx.doi.org/10.1371/journal.pone.0068532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936306	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400009
J	Alwan, FM; Baharum, A; Hassan, GS				Alwan, Faris M.; Baharum, Adam; Hassan, Geehan S.			Reliability Measurement for Mixed Mode Failures of 33/11 Kilovolt Electric Power Distribution Stations	PLOS ONE			English	Article							P-VALUE; MTBF; DEFINE; SYSTEM; INCOME; MTTR	The reliability of the electrical distribution system is a contemporary research field due to diverse applications of electricity in everyday life and diverse industries. However a few research papers exist in literature. This paper proposes a methodology for assessing the reliability of 33/11 Kilovolt high-power stations based on average time between failures. The objective of this paper is to find the optimal fit for the failure data via time between failures. We determine the parameter estimation for all components of the station. We also estimate the reliability value of each component and the reliability value of the system as a whole. The best fitting distribution for the time between failures is a three parameter Dagum distribution with a scale parameter beta = 90.001 and shape parameters k = 0.33998 and alpha = 2.4011. Our analysis reveals that the reliability value decreased by 38.2% in each 30 days. We believe that the current paper is the first to address this issue and its analysis. Thus, the results obtained in this research reflect its originality. We also suggest the practicality of using these results for power systems for both the maintenance of power systems models and preventive maintenance models.	[Alwan, Faris M.; Baharum, Adam] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Hassan, Geehan S.] Univ Sains Malaysia, Sch Comp Sci, George Town, Malaysia; [Alwan, Faris M.] Univ Baghdad, Coll Adm & Econ, Dept Stat, Baghdad, Iraq; [Hassan, Geehan S.] Univ Baghdad, Ibn Rushud Coll Educ, Baghdad, Iraq	Universiti Sains Malaysia; Universiti Sains Malaysia; University of Baghdad; University of Baghdad	Alwan, FM (corresponding author), Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia.	faris.or@gmail.com	Sabah, Geehan/AAB-6657-2019; Alwan, Faris M./AAJ-5851-2021	Sabah, Geehan/0000-0002-7260-3279; Alwan, Faris M./0000-0003-1082-8314; BAHARUM, ADAM/0000-0002-1541-982X	USM Incentive Grant [1001/PMATHS/823005]	USM Incentive Grant	This research was supported by the USM Incentive Grant: 1001/PMATHS/823005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan F M, 2012, APPL MATH SCI, V6, P6327; Alwan F. M., 2013, RES J APPL SCI ENG T, V5, P3489; Alwan FM, 2012, INT C STAT SCI BUS E, P370; [Anonymous], SYSTEMS RELIABILITY; Audin G, 2002, BUS COMMUN REV, V32, P22; Billinton R, 1996, RELIABILITY EVALUATI; BRYANT CM, 1979, TECHNOMETRICS, V21, P33, DOI 10.2307/1268578; Carter A.D.S., 1997, MECH RELIABILITY DES; Carter ADS, 1986, MECH RELIABILITY; Chaubey Y. P., 1993, TECHNOMETRICS, V35, P450, DOI DOI 10.2307/1270279; DAGUM C, 1980, ECON APPL, V33, P327; Dagum C, 2008, ECON STUD INEQUAL SO, V5, P3, DOI 10.1007/978-0-387-72796-7_1; DAVISON A, 1982, READ RES QUART, V17, P187, DOI 10.2307/747483; Dhillon B.S., 2006, MAINTAINABILITY MAIN; Domma F, 2002, QUADERNI STAT, V4, P1; Domma F, 2009, TECHNICAL REPORT; Domma F, 2011, J APPL STAT, V38, P2971, DOI 10.1080/02664763.2011.578613; EASY-FIT, 2013, SOFTW PAR EST; Fakhraei Roudsari F, 2011, THESIS KTH SWEDEN; Gaj F, 2008, E-GOVERNMENT: ICT PROFESSIONALISM AND COMPETENCES - SERVICE SCIENCE, P235; Garvin D.A., 1996, IEEE ENG MANAGEMENT, V24, P15; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Hamada MS, 2008, SPRINGER SER STAT, P1; HEDGES SB, 1992, MOL BIOL EVOL, V9, P366; HOLTZ J, 1990, IEEE T IND ELECTRON, V37, P506, DOI 10.1109/41.103455; Ibe O, 2008, MARKOV PROCESSES STO; Jha SK, 2011, INT J COMPUTER SCI T, V2, P135; KULLSTAM PA, 1981, IEEE T RELIAB, V30, P393, DOI 10.1109/TR.1981.5221134; Kumar UD, 1999, RELIAB ENG SYST SAFE, V64, P127, DOI 10.1016/S0951-8320(98)00048-9; Martz H.F., 1982, BAYESIAN RELIABILITY; MEYER J, 1983, J ECON THEORY, V31, P153, DOI 10.1016/0022-0531(83)90026-1; Paul Barringer P, 2004, 18 INT FOR PROC AN C, P2; Purcell IF, 1999, EUR J HEART FAIL, V1, P7, DOI 10.1016/S1388-9842(98)00009-9; SCHNEEWEISS WG, 1981, IEEE T RELIAB, V30, P362, DOI 10.1109/TR.1981.5221115; Zio E, 2007, SER QUAL RELIAB ENG, V13, P1	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69716	10.1371/journal.pone.0069716	http://dx.doi.org/10.1371/journal.pone.0069716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936346	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400021
J	Bossong, MG; Jansma, JM; van Hell, HH; Jager, G; Kahn, RS; Ramsey, NF				Bossong, Matthijs G.; Jansma, J. Martijn; van Hell, Hendrika H.; Jager, Gerry; Kahn, Rene S.; Ramsey, Nick F.			Default Mode Network in the Effects of Delta 9-Tetrahydrocannabinol (THC) on Human Executive Function	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; WORKING-MEMORY; ENDOCANNABINOID SYSTEM; HEALTHY-VOLUNTEERS; PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; ERROR AWARENESS; BRAIN-FUNCTION; NEURAL BASIS; FMRI	Evidence is increasing for involvement of the endocannabinoid system in cognitive functions including attention and executive function, as well as in psychiatric disorders characterized by cognitive deficits, such as schizophrenia. Executive function appears to be associated with both modulation of active networks and inhibition of activity in the default mode network. In the present study, we examined the role of the endocannabinoid system in executive function, focusing on both the associated brain network and the default mode network. A pharmacological functional magnetic resonance imaging (fMRI) study was conducted with a placebo-controlled, cross-over design, investigating effects of the endocannabinoid agonist Delta 9-tetrahydrocannabinol (THC) on executive function in 20 healthy volunteers, using a continuous performance task with identical pairs. Task performance was impaired after THC administration, reflected in both an increase in false alarms and a reduction in detected targets. This was associated with reduced deactivation in a set of brain regions linked to the default mode network, including posterior cingulate cortex and angular gyrus. Less deactivation was significantly correlated with lower performance after THC. Regions that were activated by the continuous performance task, notably bilateral prefrontal and parietal cortex, did not show effects of THC. These findings suggest an important role for the endocannabinoid system in both default mode modulation and executive function. This may be relevant for psychiatric disorders associated with executive function deficits, such as schizophrenia and ADHD.	[Bossong, Matthijs G.; Jansma, J. Martijn; van Hell, Hendrika H.; Jager, Gerry; Ramsey, Nick F.] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Bossong, Matthijs G.] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London, England; [Jager, Gerry] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Kahn, Rene S.] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of London; King's College London; Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Bossong, MG (corresponding author), Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	matthijs.bossong@kcl.ac.uk		ramsey, nick/0000-0002-7136-259X	Top Institute Pharma [T5-107]	Top Institute Pharma	This study is performed within the framework of Top Institute Pharma (www.tipharma.com), project number T5-107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; Baddeley A. D, 1986, WORKING MEMORY; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Bossong MG, 2012, BIOL PSYCHIAT, V71, P693, DOI 10.1016/j.biopsych.2012.01.008; Bossong MG, 2012, J COGNITIVE NEUROSCI, V24, P588, DOI 10.1162/jocn_a_00156; Bossong MG, 2009, NEUROPSYCHOPHARMACOL, V34, P759, DOI 10.1038/npp.2008.138; Bowdle TA, 1998, ANESTHESIOLOGY, V88, P82, DOI 10.1097/00000542-199801000-00015; Brett M, 2002, NEUROIMAGE, V16; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cole DM, 2010, NEUROIMAGE, V52, P590, DOI 10.1016/j.neuroimage.2010.04.251; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Drummond SPA, 2005, SLEEP, V28, P1059; Fassbender C, 2009, BRAIN RES, V1273, P114, DOI 10.1016/j.brainres.2009.02.070; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Gur RE, 2007, AM J PSYCHIAT, V164, P442, DOI 10.1176/appi.ajp.164.3.442; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hahn B, 2007, J NEUROSCI, V27, P3477, DOI 10.1523/JNEUROSCI.5129-06.2007; Hart CL, 2005, PSYCHOPHARMACOLOGY, V181, P237, DOI 10.1007/s00213-005-2234-2; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Henquet C, 2006, NEUROPSYCHOPHARMACOL, V31, P2748, DOI 10.1038/sj.npp.1301197; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Iannetti GD, 2007, MAGN RESON IMAGING, V25, P978, DOI 10.1016/j.mri.2007.03.018; Jansma JM, 2007, HUM BRAIN MAPP, V28, P431, DOI 10.1002/hbm.20297; Jansma JM, 2004, SCHIZOPHR RES, V68, P159, DOI 10.1016/S0920-9964(03)00127-0; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; KLONOFF H, 1974, SCIENCE, V186, P317, DOI 10.1126/science.186.4161.317; Klumpers LE, 2012, NEUROIMAGE, V63, P1701, DOI 10.1016/j.neuroimage.2012.07.051; Leweke FM, 2008, ADDICT BIOL, V13, P264, DOI 10.1111/j.1369-1600.2008.00106.x; Liddle EB, 2011, J CHILD PSYCHOL PSYC, V52, P761, DOI 10.1111/j.1469-7610.2010.02333.x; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Minzenberg MJ, 2011, PSYCHOPHARMACOLOGY, V215, P23, DOI 10.1007/s00213-010-2111-5; Morrison PD, 2009, PSYCHOL MED, V39, P1607, DOI 10.1017/S0033291709005522; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Peterson BS, 2009, AM J PSYCHIAT, V166, P1286, DOI 10.1176/appi.ajp.2009.08050724; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Pomarol-Clotet E, 2010, NEUROIMAGE, V53, P899, DOI 10.1016/j.neuroimage.2010.04.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramaekers JG, 2006, NEUROPSYCHOPHARMACOL, V31, P2296, DOI 10.1038/sj.npp.1301068; Ramsey NF, 2002, BRAIN, V125, P1793, DOI 10.1093/brain/awf188; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Salgado-Pineda P, 2004, NEUROIMAGE, V21, P840, DOI 10.1016/j.neuroimage.2003.10.027; Sambataro F, 2013, SCHIZOPHRENIA BULL, V39, P206, DOI 10.1093/schbul/sbr128; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Stevens MC, 2007, AM J PSYCHIAT, V164, P1737, DOI 10.1176/appi.ajp.2007.06050876; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Strakowski SM, 2004, NEUROPSYCHOPHARMACOL, V29, P1734, DOI 10.1038/sj.npp.1300492; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tamm L, 2006, AM J PSYCHIAT, V163, P1033, DOI 10.1176/appi.ajp.163.6.1033; Tanabe J, 2011, PSYCHOPHARMACOLOGY, V216, P287, DOI 10.1007/s00213-011-2221-8; Uddin LQ, 2009, NEUROSCI BIOBEHAV R, V33, P1198, DOI 10.1016/j.neubiorev.2009.06.002; van Buuren M, 2009, HUM BRAIN MAPP, V30, P3031, DOI 10.1002/hbm.20729; van Hedel H, 2011, 2011 INT C VIRT REH, P1, DOI [10.1109/icvr.2011.5971872, DOI 10.1109/ICVR.2011.5971872]; van Hell HH, 2012, PSYCHOPHARMACOLOGY, V219, P981, DOI 10.1007/s00213-011-2428-8; van Hell HH, 2011, INT J METH PSYCH RES, V20, P10, DOI 10.1002/mpr.327; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Zandbelt BB, 2008, NEUROIMAGE, V42, P196, DOI 10.1016/j.neuroimage.2008.04.183; Zuurman L, 2008, J PSYCHOPHARMACOL, V22, P707, DOI 10.1177/0269881108089581; Zuurman L, 2009, BRIT J CLIN PHARMACO, V67, P5, DOI 10.1111/j.1365-2125.2008.03329.x	72	42	42	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70074	10.1371/journal.pone.0070074	http://dx.doi.org/10.1371/journal.pone.0070074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936144	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700054
J	Contreras, JM; Banaji, MR; Mitchell, JP				Contreras, Juan Manuel; Banaji, Mahzarin R.; Mitchell, Jason P.			Multivoxel Patterns in Fusiform Face Area Differentiate Faces by Sex and Race	PLOS ONE			English	Article							REPRESENTATIONS; PERCEPTION; IDENTITY; FMRI	Although prior research suggests that fusiform gyrus represents the sex and race of faces, it remains unclear whether fusiform face area (FFA)-the portion of fusiform gyrus that is functionally-defined by its preferential response to faces-contains such representations. Here, we used functional magnetic resonance imaging to evaluate whether FFA represents faces by sex and race. Participants were scanned while they categorized the sex and race of unfamiliar Black men, Black women, White men, and White women. Multivariate pattern analysis revealed that multivoxel patterns in FFA-but not other face-selective brain regions, other category-selective brain regions, or early visual cortex-differentiated faces by sex and race. Specifically, patterns of voxel-based responses were more similar between individuals of the same sex than between men and women, and between individuals of the same race than between Black and White individuals. By showing that FFA represents the sex and race of faces, this research contributes to our emerging understanding of how the human brain perceives individuals from two fundamental social categories.	[Contreras, Juan Manuel; Banaji, Mahzarin R.; Mitchell, Jason P.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Contreras, JM (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	jmcontr@fas.harvard.edu			Department of Education; National Science Foundation of the United States	Department of Education(US Department of Education); National Science Foundation of the United States(National Science Foundation (NSF))	JMC was supported by graduate fellowships from the Department of Education and the National Science Foundation of the United States. These organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 2004, NEUROIMAGE, V23, P905, DOI 10.1016/j.neuroimage.2004.07.060; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Brosch T, 2012, PSYCHOL SCI; Cohen J.E., 1988, STAT POWER ANAL BEHA; Contreras JM, 2012, SOC COGN AFFECT NEUR, V7, P764, DOI 10.1093/scan/nsr053; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Davies-Thompson J, 2012, CEREB CORTEX; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farkas LG, 2005, J CRANIOFAC SURG, V16, P615, DOI 10.1097/01.scs.0000171847.58031.9e; FERRARIO VF, 1993, J ANAT, V183, P593; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grinband J, 2008, NEUROIMAGE, V43, P509, DOI 10.1016/j.neuroimage.2008.07.065; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Henson R, 2001, NEUROIMAGE, V13, pS149; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kaul C, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00238; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Natu V, 2011, NEUROIMAGE, V54, P2547, DOI 10.1016/j.neuroimage.2010.10.006; Op de Beeck HP, 2010, NEUROIMAGE, V49, P3414, DOI 10.1016/j.neuroimage.2009.11.022; Puce A, 1998, J NEUROSCI, V18, P2188; Quadflieg S, 2011, NEUROIMAGE, V57, P549, DOI 10.1016/j.neuroimage.2011.05.004; Ratner KG, 2012, SOC COGN AFFECT NEUR; Rhodes G, 2011, SCI SOCIAL VISION, P347; Rhodes G., 2011, OXFORD HDB FACE PERC, P263, DOI DOI 10.1093/OXFORDHB/9780199559053.001.0001; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; van den Hurk J, 2011, CEREB CORTEX, V21, P2893, DOI 10.1093/cercor/bhr093; Weil RS, 2010, CURR OPIN NEUROL, V23, P649, DOI 10.1097/WCO.0b013e32834028c7; Wong C, 2012, BRAIN RES, V1449, P94, DOI 10.1016/j.brainres.2012.02.017; Xu XK, 2009, VISION RES, V49, P2800, DOI 10.1016/j.visres.2009.08.021	39	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69684	10.1371/journal.pone.0069684	http://dx.doi.org/10.1371/journal.pone.0069684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936077	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700039
J	Kong, Q; Wang, L; Liu, ZR; Kwon, NJ; Kim, SC; Yu, JH				Kong, Qing; Wang, Long; Liu, Zengran; Kwon, Nak-Jung; Kim, Sun Chang; Yu, Jae-Hyuk			G beta-Like CpcB Plays a Crucial Role for Growth and Development of Aspergillus nidulans and Aspergillus fumigatus	PLOS ONE			English	Article							CROSS-PATHWAY REGULATION; G-PROTEIN; ASEXUAL SPORULATION; SEXUAL DEVELOPMENT; GENE-CLUSTER; REGULATOR; SUBUNIT; KINASE; FLBA; BIOSYNTHESIS	Growth, development, virulence and secondary metabolism in fungi are governed by heterotrimeric G proteins (G proteins). A G beta-like protein called Gib2 has been shown to function as an atypical G beta in Gpa1-cAMP signaling in Cryptococcus neoformans. We found that the previously reported CpcB (cross pathway control B) protein is the ortholog of Gib2 in Aspergillus nidulans and Aspergillus fumigatus. In this report, we further characterize the roles of CpcB in governing growth, development and toxigenesis in the two aspergilli. The deletion of cpcB results in severely impaired cellular growth, delayed spore germination, and defective asexual sporulation (conidiation) in both aspergilli. Moreover, CpcB is necessary for proper expression of the key developmental activator brlA during initiation and progression of conidiation in A. nidulans and A. fumigatus. Somewhat in accordance with the previous study, the absence of cpcB results in the formation of fewer, but not micro-, cleistothecia in A. nidulans in the presence of wild type veA, an essential activator of sexual development. However, the cpcB deletion mutant cleistothecia contain no ascospores, validating that CpcB is required for progression and completion of sexual fruiting including ascosporogenesis. Furthermore, unlike the canonical G beta SfaD, CpcB is not needed for the biosynthesis of the mycotoxin sterigmatocystin (ST) as the cpcB null mutant produced reduced amount of ST with unaltered STC gene expression. However, in A. fumigatus, the deletion of cpcB results in the blockage of gliotoxin (GT) production. Further genetic analyses in A. nidulans indicate that CpcB may play a central role in vegetative growth, which might be independent of FadA- and GanB-mediated signaling. A speculative model summarizing the roles of CpcB in conjunction with SfaD in A. nidulans is presented.	[Kong, Qing] Ocean Univ China, Sch Food Sci & Engn, Qingdao, Shandong, Peoples R China; [Kong, Qing; Kwon, Nak-Jung; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Kong, Qing; Kwon, Nak-Jung; Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Wang, Long] Chinese Acad Sci, Systemat Mycol & Lichenol Lab, Inst Microbiol, Beijing, Peoples R China; [Liu, Zengran] Hebei Univ Econ & Business, Coll Biosci & Bioengn, Shijiazhuang, Hebei, Peoples R China; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Dae Jon, South Korea	Ocean University of China; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Chinese Academy of Sciences; Institute of Microbiology, CAS; Hebei University of Economics & Business; Korea Advanced Institute of Science & Technology (KAIST)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jyu1@wisc.edu	Yu, Jae-Hyuk/A-2343-2008; Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011		National Natural Science Foundation of China [31000823]; Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology [2011-0031955]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); China Scholarship Council(China Scholarship Council)	This work was supported by National Natural Science Foundation of China (31000823) to QK, and the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031955) to SCK and JHY. LW, ZL and QK were supported by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Brodskii L I, 1995, Biokhimiia, V60, P1221; Brookman JL, 2000, CURR OPIN MICROBIOL, V3, P468, DOI 10.1016/S1369-5274(00)00124-7; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; CARSIOTIS M, 1974, J BACTERIOL, V119, P889, DOI 10.1128/JB.119.3.889-892.1974; Chang MH, 2004, GENETICS, V167, P1305, DOI 10.1534/genetics.103.025379; CHANG YC, 1993, GENETICS, V133, P29; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; Hoffmann B, 2000, MOL MICROBIOL, V37, P28, DOI 10.1046/j.1365-2958.2000.01954.x; Jun SC, 2011, J MICROBIOL, V49, P418, DOI 10.1007/s12275-011-0193-3; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kwon NJ, 2012, EUKARYOT CELL, V11, P1399, DOI 10.1128/EC.00255-12; Kwon NJ, 2010, FUNGAL GENET BIOL, V47, P981, DOI 10.1016/j.fgb.2010.08.009; Lafon A, 2005, GENETICS, V171, P71, DOI 10.1534/genetics.105.040584; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LEE BN, 1994, MOL MICROBIOL, V14, P323, DOI 10.1111/j.1365-2958.1994.tb01293.x; Liebmann B, 2003, MOL GENET GENOMICS, V269, P420, DOI 10.1007/s00438-003-0852-0; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55, DOI 10.1128/MCB.11.1.55; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Palmer DA, 2006, J BIOL CHEM, V281, P32596, DOI 10.1074/jbc.M602768200; PALUH JL, 1988, P NATL ACAD SCI USA, V85, P3728, DOI 10.1073/pnas.85.11.3728; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Park Hee Soo, 2012, Methods Mol Biol, V944, P183, DOI 10.1007/978-1-62703-122-6_13; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; PIOTROWSKA M, 1980, J GEN MICROBIOL, V116, P335; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; Rosen S, 1999, EMBO J, V18, P5592, DOI 10.1093/emboj/18.20.5592; Seo JA, 2006, EUKARYOT CELL, V5, P400, DOI 10.1128/EC.5.2.400-410.2006; Seo JA, 2003, GENETICS, V165, P1083; Seo JA, 2005, GENETICS, V171, P81, DOI 10.1534/genetics.105.042796; SEWALL TC, 1990, DEV BIOL, V138, P499, DOI 10.1016/0012-1606(90)90215-5; Shaaban MI, 2010, EUKARYOT CELL, V9, P1816, DOI 10.1128/EC.00189-10; Shimizu K, 2001, GENETICS, V157, P591; Shin KS, 2013, J PROTEOMICS, V87, P40, DOI 10.1016/j.jprot.2013.05.009; Shin KS, 2009, CURR GENET, V55, P631, DOI 10.1007/s00294-009-0276-4; STACK M, 1971, J ASSOC OFF ANA CHEM, V54, P86; Suen YK, 2001, FREE RADICAL RES, V35, P1, DOI 10.1080/10715760100300541; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tao L, 2011, MICROBIOL-SGM, V157, P313, DOI 10.1099/mic.0.044271-0; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; Xue T, 2004, ARCH MICROBIOL, V182, P346, DOI 10.1007/s00203-004-0707-z; Yu JH, 2006, EUKARYOT CELL, V5, P1577, DOI 10.1128/EC.00193-06; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Yu JH, 2006, J MICROBIOL, V44, P145; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; YU JH, 1995, J BACTERIOL, V177, P4792, DOI 10.1128/jb.177.16.4792-4800.1995; Yu JH, 1996, EMBO J, V15, P5184, DOI 10.1002/j.1460-2075.1996.tb00903.x; Yu JH, 1999, GENETICS, V151, P97	63	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70355	10.1371/journal.pone.0070355	http://dx.doi.org/10.1371/journal.pone.0070355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936193	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200078
J	Tan, HL; Gozal, D; Samiei, A; Bhattacharjee, R; Wang, Y; Ramirez, HM; Bandla, HPR; Kulkarni, R; Kheirandish-Gozal, L				Tan, Hui-Leng; Gozal, David; Samiei, Arash; Bhattacharjee, Rakesh; Wang, Yang; Ramirez, Helena Molero; Bandla, Hari P. R.; Kulkarni, Richa; Kheirandish-Gozal, Leila			T Regulatory Lymphocytes and Endothelial Function in Pediatric Obstructive Sleep Apnea	PLOS ONE			English	Article							METABOLIC SYNDROME; GENE-EXPRESSION; ADIPOSE-TISSUE; CELLS CONTROL; CHILDREN; OBESE; DYSFUNCTION; LEPTIN; ATHEROSCLEROSIS; INFLAMMATION	Background: Obstructive sleep apnea (OSA) is a low-grade inflammatory disease affecting the cardiovascular and metabolic systems. Increasing OSA severity reduces T-regulatory lymphocytes (Tregs) in OSA children. Since Tregs modulate endothelial activation, and attenuate insulin resistance, we hypothesized that Tregs are associated with endothelial and metabolic dysfunction in pediatric OSA. Methods: 50 consecutively recruited children (ages 4.8-12 years) underwent overnight polysomnography and fasting homeostatic model (HOMA) of insulin resistance was assessed. Percentage of Tregs using flow cytometry, and endothelial function, expressed as the time to peak occlusive hyperemia (Tmax), were examined. In a subgroup of children (n = 21), in vitro Treg suppression tests were performed. Results: Circulating Tregs were not significantly associated with either BMI z score or HOMA. However, a significant inverse correlation between percentage of Tregs and Tmax emerged (p<0.0001, r = -0.56). A significant negative correlation between Tregs suppression and the sleep pressure score (SPS), a surrogate measure of sleep fragmentation emerged (p = 0.02, r = -0.51) emerged, but was not present with AHI. Conclusions: Endothelial function, but not insulin resistance, in OSA children is strongly associated with circulating Tregs and their suppressive function, and appears to correlate with sleep fragmentation. Thus, alterations in T cell lymphocytes may contribute to cardiovascular morbidity in pediatric OSA.	[Tan, Hui-Leng; Gozal, David; Samiei, Arash; Bhattacharjee, Rakesh; Wang, Yang; Ramirez, Helena Molero; Bandla, Hari P. R.; Kulkarni, Richa; Kheirandish-Gozal, Leila] Univ Chicago, Pritzker Sch Med, Dept Pediat, Sect Pediat Sleep Med,Biol Sci Div, Chicago, IL 60637 USA	University of Chicago	Kheirandish-Gozal, L (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Pediat, Sect Pediat Sleep Med,Biol Sci Div, Chicago, IL 60637 USA.	lgozal@peds.bsd.uchicago.edu	Gozal, David/M-9492-2017; Bhattacharjee, Rakesh/ABC-8810-2021; Gozal, David/ABH-3805-2020	Gozal, Leila/0000-0003-3332-1057	National Institutes of Health (NIH) [K12 HL-090003]; NIH [HL-065270, HL-086662]; European Respiratory Society Fellowship (STRTF fellowship) [125-2011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086662, K12HL090003, R01HL065270] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Respiratory Society Fellowship (STRTF fellowship); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	LKG is supported by National Institutes of Health (NIH) grant K12 HL-090003; DG is supported by NIH grants HL-065270 and HL-086662; HLT is supported by a European Respiratory Society Fellowship (STRTF fellowship no. 125-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; [Anonymous], 2011, Adv Cardiol, V46, P139, DOI 10.1159/000325108; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Bhattacharjee R, 2012, CHEST, V141, P682, DOI 10.1378/chest.11-1777; Bhattacharjee R, 2009, PROG CARDIOVASC DIS, V51, P416, DOI 10.1016/j.pcad.2008.03.002; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Dubern B, 2010, INT J PEDIATR OBES, V5, P230, DOI 10.3109/17477160903473705; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Gozal D, 2001, Sleep Breath, V5, P35; Gozal D, 2008, AM J RESP CRIT CARE, V177, P369, DOI 10.1164/rccm.200608-1190PP; Gozal D, 2007, CIRCULATION, V116, P2307, DOI 10.1161/CIRCULATIONAHA.107.696823; Gozal D, 2010, PEDIATRICS, V126, pE1161, DOI 10.1542/peds.2010-0688; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Iber C., 2007, AASM MANUAL SCORING; Kasal DA, 2012, HYPERTENSION, V59, P324, DOI 10.1161/HYPERTENSIONAHA.111.181123; Kassan M, 2011, ARTERIOSCL THROM VAS, V31, P2534, DOI 10.1161/ATVBAHA.111.233262; Khalyfa A, 2011, SLEEP, V34, P153, DOI 10.1093/sleep/34.2.153; Kheirandish-Gozal L, 2010, SLEEP MED, V11, P714, DOI 10.1016/j.sleep.2009.12.013; Kheirandish-Gozal L, 2010, AM J RESP CRIT CARE, V182, P92, DOI 10.1164/rccm.200912-1845OC; Kim J, 2012, AM J RESP CRIT CARE, V185, P330, DOI 10.1164/rccm.201106-1026OC; Kim J, 2011, CHEST, V140, P408, DOI 10.1378/chest.10-2161; Kim J, 2010, CHEST, V138, P91, DOI 10.1378/chest.09-2832; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Luczynski W, 2010, SCAND J IMMUNOL, V71, P115, DOI 10.1111/j.1365-3083.2009.02354.x; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Matarese G, 2010, TRENDS MOL MED, V16, P247, DOI 10.1016/j.molmed.2010.04.002; Matrougui K, 2011, AM J PATHOL, V178, P434, DOI 10.1016/j.ajpath.2010.11.034; Montgomery-Downs HE, 2006, PEDIATRICS, V117, P741, DOI 10.1542/peds.2005-1067; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; O'Brien LM, 2006, CHEST, V129, P947, DOI 10.1378/chest.129.4.947; O'Brien LM, 2004, SLEEP, V27, P279, DOI 10.1093/sleep/27.2.279; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Redline S, 2007, AM J RESP CRIT CARE, V176, P401, DOI 10.1164/rccm.200703-375OC; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Svec P, 2007, EXP CLIN ENDOCR DIAB, V115, P439, DOI 10.1055/s-2007-960494; Taleb S, 2008, J INTERN MED, V263, P489, DOI 10.1111/j.1365-2796.2008.01944.x; Tan HL, 2013, SLEEP, V36, P913, DOI 10.5665/sleep.2724; Tauman R, 2004, SLEEP, V27, P274, DOI 10.1093/sleep/27.2.274; Tauman R, 2006, SLEEP MED, V7, P229, DOI 10.1016/j.sleep.2005.09.009; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Verhulst SL, 2007, J PEDIATR-US, V150, P608, DOI 10.1016/j.jpeds.2007.01.051; Young T, 2008, SLEEP, V31, P1071; Zeyda M., 2011, OBESITY, V19, P743, DOI [DOI 10.1038/oby.2010.123, 10.1038/oby.2010.123]; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0	50	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69710	10.1371/journal.pone.0069710	http://dx.doi.org/10.1371/journal.pone.0069710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936084	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200044
J	Drobniak, SM; Wiejaczka, D; Arct, A; Dubiec, A; Gustafsson, L; Cichon, M				Drobniak, Szymon M.; Wiejaczka, Dariusz; Arct, Aneta; Dubiec, Anna; Gustafsson, Lars; Cichon, Mariusz			Low Cross-Sex Genetic Correlation in Carotenoid-Based Plumage Traits in the Blue Tit Nestlings (Cyanistes caeruleus)	PLOS ONE			English	Article							COLOR; SELECTION; HERITABILITY; DIMORPHISM	In some bird species, both adult and juvenile individuals are often brightly coloured. It has been commonly assumed that identical plumage colouration present in both sexes results from strong intersexual genetic correlations in colour-related traits. Here, we aimed at testing this hypothesis in juvenile individuals and looked at genetic parameters describing carotenoid-based colouration of blue tit nestlings in a wild population. To separate genetic and environmental sources of phenotypic variation we performed a cross-fostering experiment. Our analyses confirmed the existence of sexual dichromatism in blue tit nestlings and revealed a significant, although low, genetic component of carotenoid-based colouration. However, genetic effects are expressed differently across sexes as indicated by low cross-sex genetic correlations (r(mf)). Thus our results do not support the prediction of generally high rmf and suggest that intersexual constraints on the evolution of colouration traits may be weaker than expected. We hypothesise that observed patterns of genetic correlations result from sex-specific selective pressures acting on nestling plumage colouration.	[Drobniak, Szymon M.; Wiejaczka, Dariusz; Arct, Aneta; Cichon, Mariusz] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Dubiec, Anna] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Gustafsson, Lars] Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, Uppsala, Sweden	Jagiellonian University; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Uppsala University	Drobniak, SM (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	szymek.drobniak@uj.edu.pl	Gustafsson, Lars/O-8056-2019; Drobniak, Szymon Marian/K-4954-2015; Dubiec, Anna/H-2941-2012; Gustafsson, Lars/A-7634-2012	Gustafsson, Lars/0000-0001-6566-2863; Drobniak, Szymon Marian/0000-0001-8101-6247; Dubiec, Anna/0000-0003-4007-5915; Gustafsson, Lars/0000-0001-6566-2863; Arct, Aneta/0000-0001-6324-6938; Cichon, Mariusz/0000-0002-6164-6951	National Science Center [N N304 061140]; Foundation for Polish Science	National Science Center(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	Research was funded by the National Science Center (grant number N N304 061140) and by the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; [Anonymous], 2010, R LANG ENV STAT COMP; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Bonduriansky R, 2007, SEX SIZE GENDER ROLE; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Butcher GS, 1989, CURRENT ORNITHOLOGY, V6; Butler MW, 2011, BEHAV ECOL SOCIOBIOL, V65, P401, DOI 10.1007/s00265-010-1074-1; Charmantier A, 2005, MOL ECOL, V14, P2839, DOI 10.1111/j.1365-294X.2005.02619.x; Conner JK, 2012, EVOLUTION, V66, P3313, DOI 10.1111/j.1558-5646.2012.01794.x; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Drobniak SM, 2010, J EVOLUTION BIOL, V23, P1286, DOI 10.1111/j.1420-9101.2010.01993.x; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Fitze PS, 2002, BEHAV ECOL, V13, P401, DOI 10.1093/beheco/13.3.401; Fitze PS, 2003, OECOLOGIA, V137, P148, DOI 10.1007/s00442-003-1323-3; Fitze PS, 2003, EVOLUTION, V57, P144; Foley J.D., 1984, FUNDAMENTALS INTERAC; Hadfield JD, 2006, J EVOLUTION BIOL, V19, P1104, DOI 10.1111/j.1420-9101.2006.01095.x; Hadfield JD, 2006, P ROY SOC B-BIOL SCI, V273, P1347, DOI 10.1098/rspb.2005.3459; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Hunt S, 1998, P ROY SOC B-BIOL SCI, V265, P451, DOI 10.1098/rspb.1998.0316; Johnsen A, 2003, P ROY SOC B-BIOL SCI, V270, P1263, DOI 10.1098/rspb.2003.2375; Lynch M., 1998, GENETICS ANAL QUANTI; Mainwaring MC, 2011, IBIS, V153, P175, DOI 10.1111/j.1474-919X.2010.01071.x; McDaniel SF, 2007, EVOLUTION, V11, P2353; PART T, 1989, J ANIM ECOL, V58, P305, DOI 10.2307/5002; PARTALI V, 1987, COMP BIOCHEM PHYS B, V87, P885, DOI 10.1016/0305-0491(87)90408-1; Poissant J, 2009, J EVOLUTION BIOL, V22, P2558, DOI 10.1111/j.1420-9101.2009.01862.x; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; Roff D.A., 1997, EVOLUTIONARY QUANTIT; ROHWER S, 1975, EVOLUTION, V29, P593, DOI 10.1111/j.1558-5646.1975.tb00853.x; Senar JC, 2002, P ROY SOC B-BIOL SCI, V269, P257, DOI 10.1098/rspb.2001.1882; SLAGSVOLD T, 1985, J ZOOL, V206, P321; Svensson L., 1992, IDENTIFICATION GUIDE; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Tschirren B, 2005, OECOLOGIA, V143, P477, DOI 10.1007/s00442-004-1812-z	37	9	9	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69786	10.1371/journal.pone.0069786	http://dx.doi.org/10.1371/journal.pone.0069786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936101	Green Published, gold			2022-12-27	WOS:000322433300066
J	Baer, G; Baumann, P; Buettcher, M; Heininger, U; Berthet, G; Schafer, J; Bucher, HC; Trachsel, D; Schneider, J; Gambon, M; Reppucci, D; Bonhoeffer, JM; Stahelin-Massik, J; Schuetz, P; Mueller, B; Szinnai, G; Schaad, UB; Bonhoeffer, J				Baer, Gurli; Baumann, Philipp; Buettcher, Michael; Heininger, Ulrich; Berthet, Gerald; Schaefer, Juliane; Bucher, Heiner C.; Trachsel, Daniel; Schneider, Jacques; Gambon, Muriel; Reppucci, Diana; Bonhoeffer, Jessica M.; Staehelin-Massik, Jody; Schuetz, Philipp; Mueller, Beat; Szinnai, Gabor; Schaad, Urs B.; Bonhoeffer, Jan			Procalcitonin Guidance to Reduce Antibiotic Treatment of Lower Respiratory Tract Infection in Children and Adolescents (ProPAED): A Randomized Controlled Trial	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CALCITONIN-I GENE; VIRAL PNEUMONIA; DIFFERENTIATION; INTERVENTION; PRESCRIPTION; EXPRESSION; RESISTANCE; BACTERIAL; THERAPY	Background: Antibiotics are overused in children and adolescents with lower respiratory tract infection (LRTI). Serum-procalcitonin (PCT) can be used to guide treatment when bacterial infection is suspected. Its role in pediatric LRTI is unclear. Methods: Between 01/2009 and 02/2010 we randomized previously healthy patients 1 month to 18 years old presenting with LRTI to the emergency departments of two pediatric hospitals in Switzerland to receive antibiotics either according to a PCT guidance algorithm established for adult LRTI or standard care clinical guidelines. In intention-to-treat analyses, antibiotic prescribing rate, duration of antibiotic treatment, and number of days with impairment of daily activities within 14 days of randomization were compared between the two groups. Results: In total 337 children, mean age 3.8 years (range 0.1-18), were included. Antibiotic prescribing rates were not significantly different in PCT guided patients compared to controls (OR 1.26; 95% CI 0.81, 1.95). Mean duration of antibiotic exposure was reduced from 6.3 to 4.5 days under PCT guidance (-1.8 days; 95% CI -3.1, 20.5; P = 0.039) for all LRTI and from 9.1 to 5.7 days for pneumonia (-3.4 days 95% CI -4.9, -1.7; P < 0.001). There was no apparent difference in impairment of daily activities between PCT guided and control patients. Conclusion: PCT guidance reduced antibiotic exposure by reducing the duration of antibiotic treatment, while not affecting the antibiotic prescribing rate. The latter may be explained by the low baseline prescribing rate in Switzerland for pediatric LRTI and the choice of an inappropriately low PCT cut-off level for this population.	[Baer, Gurli; Heininger, Ulrich; Trachsel, Daniel; Schneider, Jacques; Szinnai, Gabor; Schaad, Urs B.; Bonhoeffer, Jan] Univ Basel, Dept Pediat, Basel, Switzerland; [Baumann, Philipp; Heininger, Ulrich; Trachsel, Daniel; Schneider, Jacques; Gambon, Muriel; Reppucci, Diana; Bonhoeffer, Jessica M.; Szinnai, Gabor; Schaad, Urs B.; Bonhoeffer, Jan] Univ Childrens Hosp Basel, Basel, Switzerland; [Buettcher, Michael; Berthet, Gerald; Staehelin-Massik, Jody] Kantonsspital Aarau, Dept Pediat, Aarau, Switzerland; [Schaefer, Juliane; Bucher, Heiner C.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Schuetz, Philipp] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Mueller, Beat] Kantonsspital Aarau, Dept Internal Med, Basel, Switzerland	University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); University of Basel; University of Basel; Kantonsspital Aarau AG (KSA)	Bonhoeffer, J (corresponding author), Univ Basel, Dept Pediat, Basel, Switzerland.	jan.bonhoeffer@ukbb.ch	Mueller, Beat/G-2662-2012; Bonhoeffer, Jan/E-5903-2014; schuetz, philipp/C-8475-2013	schuetz, philipp/0000-0001-6400-4949; Buettcher, Michael/0000-0001-6086-6162; Bonhoeffer, Jan/0000-0001-9704-8315; Szinnai, Gabor/0000-0003-0559-2597	Division of Infectious Diseases and Vaccines, University Children's Hospital, Basel, Switzerland	Division of Infectious Diseases and Vaccines, University Children's Hospital, Basel, Switzerland	The Division of Infectious Diseases and Vaccines, University Children's Hospital, Basel, Switzerland supported this work as an investigator-initiated trial. Procalcitonin test kits and platform were provided by B.R.A.H.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth M, 2006, J CLIN PHARM THER, V31, P461, DOI 10.1111/j.1365-2710.2006.00765.x; Awasthi S, 2004, BMJ-BRIT MED J, V328, P791; Baer G, 2008, EUR J PEDIATR, V167, P63, DOI 10.1007/s00431-007-0427-x; Briel Matthias, 2005, BMC Fam Pract, V6, P34, DOI 10.1186/1471-2296-6-34; British Thoracic Society, 2002, THORAX, V57, pi1; Christ-Crain M, 2007, EUR RESPIR J, V30, P556, DOI 10.1183/09031936.00166106; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; Davison AC, 1997, BOOTSTRAP METHODS TH; Domenech VS, 2001, J INVEST MED, V49, P514, DOI 10.2310/6650.2001.33628; Don M, 2009, PEDIATR INT, V51, P91, DOI 10.1111/j.1442-200X.2008.02678.x; Esposito S, 2011, RESP MED, V105, P1939, DOI 10.1016/j.rmed.2011.09.003; Finkelstein JA, 2000, ARCH PEDIAT ADOL MED, V154, P395, DOI 10.1001/archpedi.154.4.395; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hazir T, 2002, LANCET, V360, P835; Korppi M, 2004, PEDIATR INT, V46, P545, DOI 10.1111/j.1442-200x.2004.01947.x; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Meropol SB, 2009, BRIT J GEN PRACT, V59, P735, DOI 10.3399/bjgp09X472610; Meury S, 2004, EUR J PEDIATR, V163, P359, DOI 10.1007/s00431-004-1445-6; Muller B, 2004, CLIN INFECT DIS, V39, P1867, DOI 10.1086/426148; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; Newcombe R. G., 2000, STAT CONFIDENCE, V2, P45; Regev-Yochay G, 2011, CLIN INFECT DIS, V53, P33, DOI 10.1093/cid/cir272; Schuetz P, 2012, CLIN INFECT DIS, V55, P651, DOI 10.1093/cid/cis464; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Sharland M, 2007, J ANTIMICROB CHEMOTH, V60, pI15, DOI 10.1093/jac/dkm153; Stocker M, 2010, NEONATOLOGY, V97, P165, DOI 10.1159/000241296; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Thrane N, 2003, J ANTIMICROB CHEMOTH, V51, P683, DOI 10.1093/jac/dkg118; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; van Woensel JBM, 2003, BMJ-BRIT MED J, V327, P36, DOI 10.1136/bmj.327.7405.36; Virkki R, 2002, THORAX, V57, P438, DOI 10.1136/thorax.57.5.438; Watson L, 2001, FAM PRACT, V18, P553, DOI 10.1093/fampra/18.5.553; Winchester CC, 2009, CHEST, V135, P1163, DOI 10.1378/chest.07-2940	37	74	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e68419	10.1371/journal.pone.0068419	http://dx.doi.org/10.1371/journal.pone.0068419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936304	Green Submitted, Green Published, gold			2022-12-27	WOS:000324401500002
J	Guo, WW; Zheng, BX; Cai, ZM; Xu, LZ; Guo, D; Cao, LL; Wang, YP				Guo, Wenwen; Zheng, Bixia; Cai, Zhenming; Xu, Lizhi; Guo, Dong; Cao, Lili; Wang, Yaping			The Polymorphic AluYb8 Insertion in the MUTYH Gene is Associated with Reduced Type 1 Protein Expression and Reduced Mitochondrial DNA Content	PLOS ONE			English	Article							MISMATCH REPAIR PROTEIN; HOMOLOG HMYH; COPY NUMBER; SUBCELLULAR-LOCALIZATION; MAMMALIAN HOMOLOG; MUTATIONS; MYH; POLYPOSIS; DISEASE; ENZYME	The human mutY homolog (MUTYH) participates in base excision repair (BER), which is critical for repairing oxidized DNA bases and maintaining DNA replication fidelity. The polymorphic AluYb8 insertion in the 15th intron of the MUTYH gene (AluYb8MUTYH) has been shown to associate with an aggregated 8-hydroxy-2'-deoxyguanosine (8-OH-dG) lesion in genomic DNA and to serve as a risk factor for age-related diseases. In this work, we demonstrate that this variant is associated with a significant reduction of the type 1 MUTYH protein that localizes to mitochondria. Notably, this variant affects mitochondrial DNA (mtDNA) maintenance and functional mitochondrial mass in individuals homozygous for the AluYb8MUTYH variant. These findings provide evidence for an association between the AluYb8MUTYH variant and decreased mitochondrial homeostasis and, consequently, contribute to elucidating the roles of the AluYb8MUTYH variant in impairing the mitochondrial base excision repair (mtBER) system and increasing the risk of acquiring an age-related disease.	[Guo, Wenwen; Zheng, Bixia; Cai, Zhenming; Xu, Lizhi; Guo, Dong; Cao, Lili; Wang, Yaping] Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210008, Jiangsu, Peoples R China; [Guo, Wenwen; Zheng, Bixia; Cai, Zhenming; Xu, Lizhi; Guo, Dong; Cao, Lili; Wang, Yaping] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Guo, Wenwen; Wang, Yaping] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Wang, YP (corresponding author), Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210008, Jiangsu, Peoples R China.	wangyap@nju.edu.cn		Guo, Wenwen/0000-0001-8563-0359	National Natural Science Foundation of China [81270152, 81070273, 81070579]; Open Foundation of the State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-201201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of the State Key Laboratory of Pharmaceutical Biotechnology	This work was partly supported by the National Natural Science Foundation of China (grant number: 81270152, 81070273, 81070579) and the Open Foundation of the State Key Laboratory of Pharmaceutical Biotechnology (grant number: KF-GN-201201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Arai T, 2006, ACTA NEUROPATHOL, V112, P139, DOI 10.1007/s00401-006-0081-9; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802; Capshew CR, 2012, NUCLEIC ACIDS RES, V40, P8637, DOI 10.1093/nar/gks590; Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004; Chen HM, 2011, MOL CELL ENDOCRINOL, V332, P301, DOI 10.1016/j.mce.2010.11.021; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Eng L, 2004, HUM MUTAT, V23, P67, DOI 10.1002/humu.10295; Gu TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-563; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P2374, DOI 10.1093/nar/gkl246; Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x; Kim CJ, 2004, ONCOGENE, V23, P6820, DOI 10.1038/sj.onc.1207574; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lin L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000225; Makalowski W, 2000, GENE, V259, P61, DOI 10.1016/S0378-1119(00)00436-4; MCGOLDRICK JP, 1995, MOL CELL BIOL, V15, P989; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; Out AA, 2010, HUM MUTAT, V31, P1205, DOI 10.1002/humu.21343; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; Parker A, 2000, NUCLEIC ACIDS RES, V28, P3206, DOI 10.1093/nar/28.17.3206; Plotz G, 2012, HUM MUTAT, V33, P1067, DOI 10.1002/humu.22059; PONTI M, 1991, NUCLEIC ACIDS RES, V19, P2929, DOI 10.1093/nar/19.11.2929; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Shinmura A, 2000, NUCLEIC ACIDS RES, V28, P4912, DOI 10.1093/nar/28.24.4912; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Sun CX, 2010, FREE RADICAL BIO MED, V48, P430, DOI 10.1016/j.freeradbiomed.2009.11.015; Szmulewicz MN, 1998, ELECTROPHORESIS, V19, P1260, DOI 10.1002/elps.1150190806; Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638; Tsai-Wu JJ, 2000, J CELL BIOCHEM, V77, P666, DOI 10.1002/(SICI)1097-4644(20000615)77:4<666::AID-JCB14>3.0.CO;2-X; Yarygin KN, 2006, B EXP BIOL MED+, V141, P161, DOI 10.1007/s10517-006-0117-0	35	60	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70718	10.1371/journal.pone.0070718	http://dx.doi.org/10.1371/journal.pone.0070718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936466	Green Submitted, gold, Green Published			2022-12-27	WOS:000324401500048
J	Liang, X; Xu, HJ; Li, CY; Yin, SK; Xu, TT; Liu, JS; Li, ZY				Liang, Xin; Xu, Huijuan; Li, Caiyue; Yin, Shikui; Xu, Tingting; Liu, Jinsong; Li, Zhiyuan			Functional Identification of Close Proximity Amino Acid Side Chains within the Transmembrane-Spanning Helixes of the P2X2 Receptor	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; AGONIST BINDING; ATP BINDING; DOMAIN; PERMEABILITY; ACCESS; PORE; ACTIVATION; TRANSITION; IVERMECTIN	The transition from the closed to open state greatly alters the intra-and inter-subunit interactions of the P2X receptor (P2XR). The interactions that occur in the transmembrane domain of the P2X2R remain unclear. We used substituted cysteine mutagenesis disulfide mapping to identify pairs of residues that are in close proximity within the transmembrane domain of rP2X2R and compared our results to the predicted positions of these amino acids obtained from a rat P2X2R homology model of the available open and closed zebrafish P2X4R structures. Alternations in channel function were measured as a change in the ATP-gated current before and after exposure to dithiothreitol. Thirty-six pairs of double mutants of rP2X2R expressed in HEK293 cells produced normal functioning channels. Thirty-five pairs of these mutants did not exhibit a functionally detectable disulfide bond. The double mutant H33C/S345C formed redox-dependent cross-links in the absence of ATP. Dithiothreitol ruptured the disulfide bond of H33C/S345C and induced a 2 to 3-fold increase in current. The EC50 for H33C/S345C before dithiothreitol treatment was similar to 2-fold higher than that after dithiothreitol treatment. Dithiothreitol reduced the EC50 to wild-type levels. Furthermore, expression of trimeric concatamer receptors with Cys mutations at some but not all six positions showed that the more disulfide bond formation sites within the concatamer, the greater current potentiation after dithiothreitol incubation. Immunoblot analysis of H33C/S345C revealed one monomer band under nonreducing conditions strongly suggesting that disulfide bonds are formed within single subunits (intra-subunit) and not between two subunits (inter-subunit). Taken together, these data indicate that His33 and Ser345 are proximal to each other across an intra-subunit interface. The relative movement between the first transmembrane and the second transmembrane in the intra-subunit is likely important for transmitting the action of ATP binding to the opening of the channel.	[Liang, Xin; Xu, Huijuan; Li, Caiyue; Li, Zhiyuan] Univ Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Yin, Shikui] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Xu, Tingting; Liu, Jinsong] Univ Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Chinese Academy of Sciences, CAS; State Key Laboratory of Respiratory Disease	Li, ZY (corresponding author), Univ Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou, Guangdong, Peoples R China.	li_zhiyuan@gibh.ac.cn	li, zhiyuan/HGD-9581-2022		National Natural Science Foundation of China [81171037/H0903]; 973 programme [2012CB966400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 programme(National Basic Research Program of China)	This work was financially supported by the National Natural Science Foundation of China (81171037/H0903)(http://www.nsfc.gov.cn/Portal0/default152.htm) and 973 programme (2012CB966400)(http://www.973.gov.cn/Default_3.aspx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando RD, 2010, BRIT J PHARMACOL, V159, P1106, DOI 10.1111/j.1476-5381.2009.00596.x; Bhattacharya A, 2013, J NEUROSCI, V33, P8035, DOI 10.1523/JNEUROSCI.4682-12.2013; Burnstock G, 2012, BRIT J PHARMACOL, V167, P238, DOI 10.1111/j.1476-5381.2012.02008.x; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Eddy MC, 2009, CHEM SENSES, V34, P789, DOI 10.1093/chemse/bjp068; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Enescu M, 2003, PHYS CHEM CHEM PHYS, V5, P3762, DOI 10.1039/b306790d; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; Faiman GA, 1996, PROTEIN ENG, V9, P315, DOI 10.1093/protein/9.3.315; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hausmann R, 2013, MOL PHARMACOL, V83, P73, DOI 10.1124/mol.112.081489; Horn JR, 2003, J MOL BIOL, V331, P497, DOI 10.1016/S0022-2836(03)00783-6; Huang TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050581; Illes P, 2012, NEUROSCIENTIST, V18, P422, DOI 10.1177/1073858411418524; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Jelinkova I, 2006, BIOCHEM BIOPH RES CO, V349, P619, DOI 10.1016/j.bbrc.2006.08.084; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Jiang RT, 2010, J BIOL CHEM, V285, P15805, DOI 10.1074/jbc.M110.101980; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; King BF, 1996, BRIT J PHARMACOL, V117, P1371, DOI 10.1111/j.1476-5381.1996.tb15293.x; Klein K, 2012, PLOS ONE, V7; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Lammer AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019983; Lee WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039952; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Marquez-Klaka B, 2009, EUR BIOPHYS J BIOPHY, V38, P329, DOI 10.1007/s00249-008-0325-9; Michel AD, 2009, BRIT J PHARMACOL, V156, P1312, DOI 10.1111/j.1476-5381.2009.00135.x; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Norenberg W, 2012, BRIT J PHARMACOL, V167, P48, DOI 10.1111/j.1476-5381.2012.01987.x; Reyes Juan P, 2011, Front Biosci (Schol Ed), V3, P1101; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Spelta V, 2003, BRIT J PHARMACOL, V138, P131, DOI 10.1038/sj.bjp.0705018; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Torres GE, 1999, J BIOL CHEM, V274, P22359, DOI 10.1074/jbc.274.32.22359; Woods LT, 2012, AM J PHYSIOL-CELL PH, V303, pC790, DOI 10.1152/ajpcell.00072.2012	50	4	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70629	10.1371/journal.pone.0070629	http://dx.doi.org/10.1371/journal.pone.0070629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936459	gold, Green Published, Green Submitted			2022-12-27	WOS:000324401500045
J	Zhang, J; Lazarenko, OP; Kang, J; Blackburn, ML; Ronis, MJJ; Badger, TM; Chen, JR				Zhang, Jian; Lazarenko, Oxana P.; Kang, Jie; Blackburn, Michael L.; Ronis, Martin J. J.; Badger, Thomas M.; Chen, Jin-Ran			Feeding Blueberry Diets to Young Rats Dose-Dependently Inhibits Bone Resorption through Suppression of RANKL in Stromal Cells	PLOS ONE			English	Article							PPAR-GAMMA; OSTEOBLAST DIFFERENTIATION; PHENOLIC-ACIDS; OSTEOPOROSIS; OBESITY; OSTEOCLASTOGENESIS; ADIPOGENESIS; PPAR-GAMMA-2; PROGENITORS; EXPRESSION	Previous studies have demonstrated that weanling rats fed AIN-93G semi-purified diets supplemented with 10% whole blueberry (BB) powder for two weeks beginning on postnatal day 21 (PND21) significantly increased bone formation at PND35. However, the minimal level of dietary BB needed to produce these effects is, as yet, unknown. The current study examined the effects of three different levels of BB diet supplementation (1, 3, and 5%) for 35 days beginning on PND25 on bone quality, and osteoclastic bone resorption in female rats. Peripheral quantitative CT scan (pQCT) of tibia, demonstrated that bone mineral density (BMD) and content (BMC) were dose-dependently increased in BB-fed rats compared to controls (P<0.05). Significantly increased bone mass after feeding 5% BB extracts was also observed in a TEN (total enteral nutrition) rat model in which daily caloric and food intake was precisely controlled. Expression of RANKL (receptor activator of nuclear factor-kappa B ligand) a protein essential for osteoclast formation was dose-dependently decreased in the femur of BB animals. In addition, expression of PPAR gamma (peroxisome proliferator-activated receptor gamma) which regulates bone marrow adipogenesis was suppressed in BB diet rats compared to non-BB diet controls. Finally, a set of in vitro cell cultures revealed that the inhibitory effect of BB diet rat serum on RANKL expression was more profound in mesenchymal stromal cells compared to its effect on mature osteoblasts, pre-adipocytes and osteocytes. These results suggest that inhibition of bone resorption may contribute to increased bone mass during early development after BB consumption.	[Zhang, Jian; Lazarenko, Oxana P.; Kang, Jie; Blackburn, Michael L.; Ronis, Martin J. J.; Badger, Thomas M.; Chen, Jin-Ran] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Zhang, Jian; Lazarenko, Oxana P.; Kang, Jie; Blackburn, Michael L.; Ronis, Martin J. J.; Badger, Thomas M.; Chen, Jin-Ran] Arkansas Childrens Nutr Ctr, Little Rock, AR USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.	chenjinran@uams.edu			United States Department of Agriculture (USDA)/Agriculture Research Service [CRIS 6251-51000-006-03s]	United States Department of Agriculture (USDA)/Agriculture Research Service(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture (USDA)/Agriculture Research Service CRIS 6251-51000-006-03s to the Arkansas Children's Nutrition Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Chen JR, 2006, J PHARMACOL EXP THER, V319, P1182, DOI 10.1124/jpet.106.109454; Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704; Chen JR, 2010, J BONE MINER RES, V25, P2399, DOI 10.1002/jbmr.137; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Cho SW, 2011, J BONE MINER RES, V26, P1939, DOI 10.1002/jbmr.366; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Khateeb J, 2010, ATHEROSCLEROSIS, V208, P119, DOI 10.1016/j.atherosclerosis.2009.08.051; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lanham-New SA, 2006, AM J CLIN NUTR, V83, P1254, DOI 10.1093/ajcn/83.6.1254; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Li Y, 2008, DIABETES OBES METAB, V10, P10, DOI 10.1111/j.1463-1326.2007.00708.x; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Marecki JC, 2011, J NUTR BIOCHEM, V22, P142, DOI 10.1016/j.jnutbio.2010.01.001; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Siegel S., 1988, NONPARAMETRIC STAT B; Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tylavsky FA, 2004, AM J CLIN NUTR, V79, P311; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wedge David E., 2001, J Med Food, V4, P49, DOI 10.1089/10966200152053703; Wei W, 2011, MOL CELL BIOL, V31, P4692, DOI 10.1128/MCB.05979-11; Weivoda MM, 2012, BONE, V50, P467, DOI 10.1016/j.bone.2011.09.056; Wu XL, 2009, MOL NUTR FOOD RES, V53, pS76, DOI 10.1002/mnfr.200800231; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w; Zhang J, 2013, AGE, V35, P807, DOI 10.1007/s11357-012-9412-z; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024486; Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI 10.1359/JBMR.070813	36	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70438	10.1371/journal.pone.0070438	http://dx.doi.org/10.1371/journal.pone.0070438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936431	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500035
J	Chen, Z; Pittman, EF; Romaguera, J; Fayad, L; Wang, M; Neelapu, SS; Mclaughlin, P; Kwak, L; McCarty, N				Chen, Zheng; Pittman, Eric F.; Romaguera, Jorge; Fayad, Luis; Wang, Michael; Neelapu, Sattva S.; Mclaughlin, Peter; Kwak, Larry; McCarty, Nami			Nuclear Translocation of B-Cell-Specific Transcription Factor, BACH2, Modulates ROS Mediated Cytotoxic Responses in Mantle Cell Lymphoma	PLOS ONE			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; OXIDATIVE STRESS; PHASE-II; ACTIVATION; EXPRESSION; GENERATION; RESISTANCE; INDUCTION; APOPTOSIS; PROTEINS	BACH2, a B-cell specific transcription factor, plays a critical role in oxidative stress-mediated apoptosis. Bortezomib (Velcade (TM)) is widely used to treat relapsed mantle cell lymphoma (MCL) patients despite varying clinical outcomes. As one of the potential mechanisms of action, bortezomib was reported to elicit endoplasmic reticulum (ER) stress which triggers reactive oxygen species (ROS). In the present study, we investigated the redox-sensitive intracellular mechanism that might play a critical role in bortezomib response in MCL cells. We demonstrated that in MCL cells that are sensitive to bortezomib treatments, BACH2 was translocated to the nucleus in response to bortezomib and induced apoptotic responses through the modulation of anti-oxidative and anti-apoptotic genes. On the other hand, in bortezomib resistant cells, BACH2 expression was confined in the cytoplasm and no suppression of antiapoptotic or antioxidative genes, Nrf2, Gss, CAT, HO-1 and MCL1, was detected. Importantly, levels of BACH2 were significantly higher in bortezomib sensitive MCL patient cells, indicating that BACH2 levels could be an indicator for clinical bortezomib responses. BACH2 translocation to the cytoplasm after phosphorylation was inhibited by PI3K inhibitors and combinatory regimens of bortezomib and PI3K inhibitors sensitized MCL cells to bortezomib. These data suggest that cellular distribution of BACH2 in response to ROS determines the threshold for the induction of apoptosis. Therapies that inhibit BACH2 phosphorylation could be the key for increasing bortezomib cytotoxic response in patients.	[Chen, Zheng; Pittman, Eric F.; McCarty, Nami] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell & Regenerat Dis, Brown Fdn Inst Mol Med Prevent Human Dis IMM, Houston, TX 77030 USA; [Romaguera, Jorge; Fayad, Luis; Wang, Michael; Neelapu, Sattva S.; Mclaughlin, Peter; Kwak, Larry] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	McCarty, N (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell & Regenerat Dis, Brown Fdn Inst Mol Med Prevent Human Dis IMM, Houston, TX 77030 USA.	nami.mccarty@uth.tmc.edu		Kwak, Larry/0000-0002-1884-5349	American Cancer Society	American Cancer Society(American Cancer Society)	NM is funded by American Cancer Society Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2001, SEMIN ONCOL, V28, P613, DOI 10.1053/sonc.2001.28609; Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Chen Z, 2012, BRIT J HAEMATOL, V159, P243, DOI 10.1111/bjh.12003; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; CHOU TC, 1976, J THEOR BIOL, V59, P253, DOI 10.1016/0022-5193(76)90169-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cortelazzo S, 2012, CRIT REV ONCOL HEMAT, V82, P78, DOI 10.1016/j.critrevonc.2011.05.001; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Goy A, 2005, J CLIN ONCOL, V23, P667, DOI 10.1200/JCO.2005.03.108; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hoshino H, 2000, J BIOL CHEM, V275, P15370, DOI 10.1074/jbc.275.20.15370; Jung HJ, 2012, EXP HEMATOL, V40, P107, DOI 10.1016/j.exphem.2011.10.004; Jung HJ, 2011, LEUKEMIA LYMPHOMA, V52, P1066, DOI 10.3109/10428194.2011.562570; Kamio T, 2003, BLOOD, V102, P3317, DOI 10.1182/blood-2002-12-3656; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kraus M, 2007, LEUKEMIA, V21, P84, DOI 10.1038/sj.leu.2404414; Leischner U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010391; Leonard JP, 2009, CLIN LYMPHOMA MYELOM, V9, P267, DOI 10.3816/CLM.2009.n.055; LOVEC H, 1994, EMBO J, V13, P3487, DOI 10.1002/j.1460-2075.1994.tb06655.x; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; O'Connor OA, 2005, J CLIN ONCOL, V23, P676, DOI 10.1200/JCO.2005.02.050; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Perez-Galan P, 2011, BLOOD, V117, P542, DOI 10.1182/blood-2010-02-269514; Premkumar DR, 2011, MOL CARCINOG; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Ruckrich T, 2009, LEUKEMIA, V23, P1098, DOI 10.1038/leu.2009.8; Sakane-Ishikawa E, 2005, J CLIN ONCOL, V23, P8012, DOI 10.1200/JCO.2005.02.1626; Salaverria I, 2006, HAEMATOLOGICA, V91, P11; Tashiro S, 2004, MOL CELL BIOL, V24, P3473, DOI 10.1128/MCB.24.8.3473-3484.2004; Weigert O, 2009, LEUKEMIA LYMPHOMA, V50, P1937, DOI 10.3109/10428190903288514; Weniger MA, 2011, CLIN CANCER RES, V17, P5101, DOI 10.1158/1078-0432.CCR-10-3367; Yang DT, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-40; Yoshida C, 2007, BLOOD, V109, P1211, DOI 10.1182/blood-2005-12-040972	41	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69126	10.1371/journal.pone.0069126	http://dx.doi.org/10.1371/journal.pone.0069126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936317	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800011
J	Harhausen, D; Sudmann, V; Khojasteh, U; Muller, J; Zille, M; Graham, K; Thiele, A; Dyrks, T; Dirnagl, U; Wunder, A				Harhausen, Denise; Sudmann, Violetta; Khojasteh, Uldus; Mueller, Jochen; Zille, Marietta; Graham, Keith; Thiele, Andrea; Dyrks, Thomas; Dirnagl, Ulrich; Wunder, Andreas			Specific Imaging of Inflammation with the 18kDa Translocator Protein Ligand DPA-714 in Animal Models of Epilepsy and Stroke	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PERIPHERAL BENZODIAZEPINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; 18 KDA; MULTIPLE-SCLEROSIS; INITIAL EVALUATION; PET; NEUROINFLAMMATION	Inflammation is a pathophysiological hallmark of many diseases of the brain. Specific imaging of cells and molecules that contribute to cerebral inflammation is therefore highly desirable, both for research and in clinical application. The 18 kDa translocator protein (TSPO) has been established as a suitable target for the detection of activated microglia/macrophages. A number of novel TSPO ligands have been developed recently. Here, we evaluated the high affinity TSPO ligand DPA-714 as a marker of brain inflammation in two independent animal models. For the first time, the specificity of radiolabeled DPA-714 for activated microglia/macrophages was studied in a rat model of epilepsy (induced using Kainic acid) and in a mouse model of stroke (transient middle cerebral artery occlusion, tMCAO) using high-resolution autoradiography and immunohistochemistry. Additionally, cold-compound blocking experiments were performed and changes in blood-brain barrier (BBB) permeability were determined. Target-to-background ratios of 2 and 3 were achieved in lesioned vs. unaffected brain tissue in the epilepsy and tMCAO models, respectively. In both models, ligand uptake into the lesion corresponded well with the extent of Ox42- or Iba1-immunoreactive activated microglia/macrophages. In the epilepsy model, ligand uptake was almost completely blocked by pre-injection of DPA-714 and FEDAA1106, another high-affinity TSPO ligand. Ligand uptake was independent of the degree of BBB opening and lesion size in the stroke model. We provide further strong evidence that DPA-714 is a specific ligand to image activated microglia/macrophages in experimental models of brain inflammation.	[Harhausen, Denise; Khojasteh, Uldus; Mueller, Jochen; Zille, Marietta; Dirnagl, Ulrich; Wunder, Andreas] Charite, Dept Expt Neurol, D-13353 Berlin, Germany; [Harhausen, Denise; Zille, Marietta; Dirnagl, Ulrich; Wunder, Andreas] Ctr Stroke Res Berlin CSB, Berlin, Germany; [Sudmann, Violetta; Graham, Keith; Thiele, Andrea; Dyrks, Thomas] Bayer Healthcare, Global Drug Discovery, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bayer AG; Bayer Healthcare Pharmaceuticals	Harhausen, D (corresponding author), Charite, Dept Expt Neurol, D-13353 Berlin, Germany.	denise.harhausen@charite.de	Zille, Marietta/P-1700-2018	Zille, Marietta/0000-0002-0609-8956; Dirnagl, Ulrich/0000-0003-0755-6119	European Union [201024, 202213]; Deutsche Forschungsgemeinschaft (NeuroCure Cluster of Excellence) [Exc 257]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin) [01 EO 08 01]; TSB grant entitled "Development of diagnostic markers for the diagnosis of stroke and establishment of a center for small animal imaging research at the Charite Berlin"; Bayer Pharma AG	European Union(European Commission); Deutsche Forschungsgemeinschaft (NeuroCure Cluster of Excellence)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)(Federal Ministry of Education & Research (BMBF)); TSB grant entitled "Development of diagnostic markers for the diagnosis of stroke and establishment of a center for small animal imaging research at the Charite Berlin"; Bayer Pharma AG	This work was supported by the European Union's Seventh Framework Programme (FP7/2008-2013) under Grant Agreements 201024 and 202213 (European Stroke Network); the Deutsche Forschungsgemeinschaft (NeuroCure Cluster of Excellence, Exc 257); and the Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 08 01) and the TSB grant entitled "Development of diagnostic markers for the diagnosis of stroke and establishment of a center for small animal imaging research at the Charite Berlin." Furthermore, this study was supported and conducted together with Bayer Pharma AG and relevant parties are co-authors. Thomas Dyrks, Andrea Thiele, Keith Graham, Violetta Sudmann are employees of Bayer Pharma AG, Berlin, Germany and they hereby declare that they participated in the preclinical preparation for this study as well as the manuscript preparation. They have seen and approved the final version. None of the products in the manuscript are under development or seeking patent approval. All the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourbeh G, 2012, J NEUROSCI, V32, P5728, DOI 10.1523/JNEUROSCI.2900-11.2012; Aktas O, 2007, ARCH NEUROL-CHICAGO, V64, P185, DOI 10.1001/archneur.64.2.185; Arlicot N, 2012, NUCL MED BIOL, V39, P570, DOI 10.1016/j.nucmedbio.2011.10.012; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Beckham JD, 2012, NEUROTHERAPEUTICS, V9, P124, DOI 10.1007/s13311-011-0086-5; Boutin H, 2007, GLIA, V55, P1459, DOI 10.1002/glia.20562; Cagnin A, 2007, NEUROTHERAPEUTICS, V4, P443, DOI 10.1016/j.nurt.2007.04.006; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6; DORMAN G, 1995, J ORG CHEM, V60, P2292, DOI 10.1021/jo00112a066; Engel O, 2011, JOVE-J VIS EXP, DOI 10.3791/2423; Gulyas B, 2005, J NEUROL SCI, V229, P219, DOI 10.1016/j.jns.2004.11.032; Hellier Jennifer L, 2005, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0919s31; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jacobs AH, 2012, J CEREBR BLOOD F MET, V32, P1393, DOI 10.1038/jcbfm.2012.53; James ML, 2008, J NUCL MED, V49, P814, DOI 10.2967/jnumed.107.046151; Klohs J, 2009, J CEREBR BLOOD F MET, V29, P1284, DOI 10.1038/jcbfm.2009.51; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; Martin A, J CEREB BLOOD FLOW M, V30, P230; Martin A, 2011, MOL IMAGING BIOL, V13, P10, DOI 10.1007/s11307-010-0324-y; Mattner F, 2005, EUR J NUCL MED MOL I, V32, P557, DOI 10.1007/s00259-004-1690-y; Scarf AM, 2011, J NUCL MED, V52, P667, DOI 10.2967/jnumed.110.086629; Stoll G, 2009, NEUROSCIENCE, V158, P1151, DOI 10.1016/j.neuroscience.2008.06.045; Thiel A, 2011, STROKE, V42, P507, DOI 10.1161/STROKEAHA.110.598821; Venneti S, 2012, GLIA; Vezzani A, 2012, NEUROPHARMACOLOGY; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009; Winkeler A, 2012, EUR J NUCL MED MOL I, V39, P811, DOI 10.1007/s00259-011-2041-4; Wunder A, 2009, NEUROSCIENCE, V158, P1161, DOI 10.1016/j.neuroscience.2008.10.005; Yanamoto K, 2009, SYNAPSE, V63, P961, DOI 10.1002/syn.20678; Zhang MR, 2003, BIOORG MED CHEM LETT, V13, P201, DOI 10.1016/S0960-894X(02)00886-7; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	34	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69529	10.1371/journal.pone.0069529	http://dx.doi.org/10.1371/journal.pone.0069529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936336	gold, Green Published, Green Submitted			2022-12-27	WOS:000324545800020
J	Thiebot, JB; Cherel, Y; Crawford, RJM; Makhado, AB; Trathan, PN; Pinaud, D; Bost, CA				Thiebot, Jean-Baptiste; Cherel, Yves; Crawford, Robert J. M.; Makhado, Azwianewi B.; Trathan, Philip N.; Pinaud, David; Bost, Charles-Andre			A Space Oddity: Geographic and Specific Modulation of Migration in Eudyptes Penguins	PLOS ONE			English	Article							ROCKHOPPER PENGUINS; MARION ISLAND; KING PENGUINS; CHRYSOCOME PENGUINS; WINTERING AREAS; FORAGING RANGE; MACARONI; POPULATION; BEHAVIOR; HABITAT	Post-breeding migration in land-based marine animals is thought to offset seasonal deterioration in foraging or other important environmental conditions at the breeding site. However the inter-breeding distribution of such animals may reflect not only their optimal habitat, but more subtle influences on an individual's migration path, including such factors as the intrinsic influence of each locality's paleoenvironment, thereby influencing animals' wintering distribution. In this study we investigated the influence of the regional marine environment on the migration patterns of a poorly known, but important seabird group. We studied the inter-breeding migration patterns in three species of Eudyptes penguins (E. chrysolophus, E. filholi and E. moseleyi), the main marine prey consumers amongst the World's seabirds. Using ultra-miniaturized logging devices (light-based geolocators) and satellite tags, we tracked 87 migrating individuals originating from 4 sites in the southern Indian Ocean (Marion, Crozet, Kerguelen and Amsterdam Islands) and modelled their wintering habitat using the MADIFA niche modelling technique. For each site, sympatric species followed a similar compass bearing during migration with consistent species-specific latitudinal shifts. Within each species, individuals breeding on different islands showed contrasting migration patterns but similar winter habitat preferences driven by sea-surface temperatures. Our results show that inter-breeding migration patterns in sibling penguin species depend primarily on the site of origin and secondly on the species. Such site-specific migration bearings, together with similar wintering habitat used by parapatrics, support the hypothesis that migration behaviour is affected by the intrinsic characteristics of each site. The paleo-oceanographic conditions (primarily, sea-surface temperatures) when the populations first colonized each of these sites may have been an important determinant of subsequent migration patterns. Based on previous chronological schemes of taxonomic radiation and geographical expansion of the genus Eudyptes, we propose a simple scenario to depict the chronological onset of contrasting migration patterns within this penguin group.	[Thiebot, Jean-Baptiste; Cherel, Yves; Pinaud, David; Bost, Charles-Andre] CNRS, Unite Propre Rech 1934, Ctr Etud Biol Chize, Villiers En Bois, France; [Crawford, Robert J. M.; Makhado, Azwianewi B.] Branch Oceans & Coasts, Dept Environm Affairs, Cape Town, South Africa; [Crawford, Robert J. M.; Makhado, Azwianewi B.] Univ Cape Town, Anim Demog Unit, ZA-7700 Rondebosch, South Africa; [Trathan, Philip N.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Centre National de la Recherche Scientifique (CNRS); Department of Environment, Forestry & Fisheries; University of Cape Town; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Thiebot, JB (corresponding author), Natl Inst Polar Res, Tachikawa, Tokyo, Japan.	jbthiebot@yahoo.fr	Pinaud, David/B-6326-2008	Pinaud, David/0000-0003-0815-9668	France's Agence Nationale de la Recherche; Zone Atelier Antarctique (INSU-CNRS); Institut Polaire Francais Paul-Emile Victor (IPEV) [394, 109]; South Africa's National Research Foundation (South African National Antarctic Programme)(SANAP programme); NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	France's Agence Nationale de la Recherche(French National Research Agency (ANR)); Zone Atelier Antarctique (INSU-CNRS); Institut Polaire Francais Paul-Emile Victor (IPEV); South Africa's National Research Foundation (South African National Antarctic Programme)(SANAP programme); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by France's Agence Nationale de la Recherche programme Biodiv 07 'GLIDES' (2008-2011), the Zone Atelier Antarctique (INSU-CNRS), the Institut Polaire Francais Paul-Emile Victor (IPEV, programmes no. 394 resp. C.-A. Bost and 109 resp. H. Weimeskirch) and the South Africa's National Research Foundation (South African National Antarctic Programme)(SANAP programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; ANDERSEN R, 1991, J APPL ECOL, V28, P102, DOI 10.2307/2404117; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Baker AJ, 2006, P ROY SOC B-BIOL SCI, V273, P11, DOI 10.1098/rspb.2005.3260; Ballard G, 2010, ECOLOGY, V91, P2056, DOI 10.1890/09-0688.1; Banks J, 2006, POLAR BIOL, V30, P61, DOI 10.1007/s00300-006-0160-3; Becquey S, 2002, PALAEOGEOGR PALAEOCL, V182, P221, DOI 10.1016/S0031-0182(01)00497-7; Belkin IM, 1996, J GEOPHYS RES-OCEANS, V101, P3675, DOI 10.1029/95JC02750; Berthold P, 1999, OSTRICH, V70, P1, DOI 10.1080/00306525.1999.9639744; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Boinski S., 2000, MOVE WHY ANIMALS TRA; Bost CA, 2009, BIOL LETTERS, V5, P473, DOI 10.1098/rsbl.2009.0265; Bost CA, 2004, MAR ECOL PROG SER, V283, P293, DOI 10.3354/meps283293; BOST CA, 2011, KERGUELEN PLATEAU MA, P199; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; BROWN CR, 1987, J FIELD ORNITHOL, V58, P118; CAIRNS DK, 1989, AM NAT, V134, P141, DOI 10.1086/284970; Calenge C, 2008, ECOLOGY, V89, P555, DOI 10.1890/06-1750.1; CHEREL Y, 1994, AM J PHYSIOL, V266, pR1182, DOI 10.1152/ajpregu.1994.266.4.R1182; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; CLARK CW, 1984, AM NAT, V123, P626, DOI 10.1086/284228; CLARKE A, 1988, COMP BIOCHEM PHYS B, V90, P461, DOI 10.1016/0305-0491(88)90285-4; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; CLS, 2011, ARG US MAN WORLDW TR; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Crawford RJM, 2003, AFR J MAR SCI, V25, P475, DOI 10.2989/18142320309504036; Crawford RJM, 2003, AFR J MAR SCI, V25, P487, DOI 10.2989/18142320309504037; Cresswell KA, 2008, POLAR BIOL, V31, P641, DOI 10.1007/s00300-007-0401-0; Crossin GT, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P185; de Dinechin M, 2009, J BIOGEOGR, V36, P693, DOI 10.1111/j.1365-2699.2008.02014.x; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DUROSELLE T, 1977, ADAPTATIONS ANTARCTI, P579; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Giret A., 2003, GEOLOGUES, V137, P15; GIRET A, 2003, GEOLOGUE, V137, P23; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Green JA, 2009, J AVIAN BIOL, V40, P529, DOI 10.1111/j.1600-048X.2009.04639.x; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Hamer Keith C., 2002, P217; Hill Roger D., 1994, P227; Hull CL, 1999, J ZOOL, V247, P507, DOI 10.1111/j.1469-7998.1999.tb01013.x; Hull CL, 1999, WILDLIFE RES, V26, P789, DOI 10.1071/WR98028; Hull CL, 2000, CAN J ZOOL, V78, P333, DOI 10.1139/cjz-78-3-333; IUCN, 2012, IUCN RED LIST THREAT; Kemp AES, 2010, QUATERNARY SCI REV, V29, P1993, DOI 10.1016/j.quascirev.2010.04.027; Martinson, 1991, NZ EXTINCT BIRDS; McDougall I, 2001, GEOL MAG, V138, P1, DOI 10.1017/S0016756801005039; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; NOUGIER J, 1982, ANTARCT GEOSCI, P755; Peron C, 2012, P ROY SOC B-BIOL SCI, V279, P2515, DOI 10.1098/rspb.2011.2705; PHILLIPS RA, 2005, ECOLOGY, P20239; Pinet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027663; Putz K, 2006, POLAR BIOL, V29, P735, DOI 10.1007/s00300-006-0110-0; R Core Team, 2020, R LANG ENV STAT COMP; Rey AR, 2007, MAR ECOL PROG SER, V330, P285; Ridoux Vincent, 1994, Marine Ornithology, V22, P1; Robson B, 2011, BIRD CONSERV INT, V21, P454, DOI 10.1017/S0959270911000013; Stahl J.-C., 1985, Oiseau et la Revue Francaise d'Ornithologie, V55, P27; STAHL JC, 1996, ATLAS SEABIRD DISTRI, P20239; Staniland IJ, 2012, MAR BIOL, V159, P291, DOI 10.1007/s00227-011-1807-3; Sutherland WJ, 1998, J AVIAN BIOL, V29, P441, DOI 10.2307/3677163; Thiebot JB, 2012, ECOLOGY, V93, P122, DOI 10.1890/11-0385.1; Thiebot JB, 2011, ANTARCT SCI, V23, P117, DOI 10.1017/S0954102010000957; Thiebot JB, 2011, MAR ECOL PROG SER, V421, P279, DOI 10.3354/meps08907; Thiebot Jean-Baptiste, 2010, Endangered Species Research, V10, P341; Trathan PN, 2006, MAR ECOL PROG SER, V323, P239, DOI 10.3354/meps323239; Tremblay Y, 1999, CONDOR, V101, P179, DOI 10.2307/1370462; Trivelpiece WZ, 2007, POLAR BIOL, V30, P1231, DOI 10.1007/s00300-007-0283-1; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Warham J., 1975, P189; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; Williams T.D., 1995, PENGUINS; Williams TD, 1995, PENGUINS, P81; Wilson R.P., 1992, P131; Wilson RP, 2010, FUNCT ECOL, V24, P646, DOI 10.1111/j.1365-2435.2009.01654.x; Wilson Rory P., 1998, Polar Record, V34, P107; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241	83	15	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71429	10.1371/journal.pone.0071429	http://dx.doi.org/10.1371/journal.pone.0071429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936507	Green Published, Green Accepted, gold			2022-12-27	WOS:000324545800064
J	Muhammad, W; Lee, SH				Muhammad, Wazir; Lee, Sang Hoon			New Empirical Equation for the Atomic Form Factor Function in the Momentum Transfer Range, q=0-50 angstrom(-1) for the Elements in the Range 1 <= Z <= 30	PLOS ONE			English	Article							COHERENTLY SCATTERED PHOTONS; RAYLEIGH-SCATTERING; ELASTIC-SCATTERING; ANALYTIC CONSTANTS; CROSS-SECTIONS; WAVE FUNCTIONS	The importance of Atomic Form Factors (f) is well-known to the scientific community. Tabulated values for f are mostly used in calculating cross-sections and Monte Carlo sampling for the coherent scattering of photons. The uses of these values are subjected to different approximations and interpolation techniques because the available data points for f in the literature for specified momentum-transfer-grids are very limited. In order to make it easier to accurately use the tabulated data, a mathematical expression for f functions would be a great achievement. Therefore, the current study was designed to suggest an empirical expression for the f functions. In the results, an empirical equation for Hubbell's tabulated data for f is created in the momentum transfer range, q = 0-50 angstrom(-1) for the elements in the range 1 <= Z <= 30. The number of applied parameters was seven. The fitting to f showed that the maximum deviation was within 3%, 4% and 5% for the element having, Z = 1-11, Z = 12-22 and Z = 23-30, respectively, while the average deviations were within 0.3-2.25% for all elements (i.e., Z = 1-30). The values generated by the analytical equation were used in the Monte Carlo code instead of Hubbell's tabulated values. The statistical noise in the Probability Distribution Functions of coherently scattered photons was efficiently removed. Furthermore, it also reduced the dependence on different interpolation techniques and approximations, and on the use of large tabulated data for f with the specified elements.	[Muhammad, Wazir] INOR, Dept Med Phys, Abbottabad, Pakistan; [Muhammad, Wazir] Kyungpook Natl Univ, Dept Phys, Taegu, South Korea; [Lee, Sang Hoon] Kyungpook Natl Univ, Sch Energy Engn, Taegu, South Korea	Kyungpook National University; Kyungpook National University	Lee, SH (corresponding author), Kyungpook Natl Univ, Sch Energy Engn, Taegu, South Korea.	lee@knu.ac.kr			Ministry of Education, Science Technology (MEST); National Research Foundation of Korea (NRF) through the Human Resource Training Project for Regional Innovation [2012H1B8A2026280]; second stage of the Brain Korea 21 Project	Ministry of Education, Science Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF) through the Human Resource Training Project for Regional Innovation(National Research Foundation of Korea); second stage of the Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was financially supported by the Ministry of Education, Science Technology (MEST) and National Research Foundation of Korea (NRF) through the Human Resource Training Project for Regional Innovation (2012H1B8A2026280) and by the second stage of the Brain Korea 21 Project in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chadwick MB, 2011, NUCL DATA SHEETS, V112, P2887, DOI 10.1016/j.nds.2011.11.002; Cianci M., 2005, CRYSTALLOGR REV, V11, P245, DOI DOI 10.1080/08893110500421268; Collaboration G, 2011, PHYS REF MAN; Cromer D. T., 1974, INT TABLES XRAY CRYS; CROMER DT, 1965, ACTA CRYSTALLOGR, V18, P104, DOI 10.1107/S0365110X6500018X; CROMER DT, 1968, ACTA CRYSTALL A-CRYS, VA 24, P321, DOI 10.1107/S0567739468000550; CROMER DT, 1964, ACTA CRYSTALLOGR, V17, P1044, DOI 10.1107/S0365110X6400264X; Cullen DE, 1997, EPDL97 EVALUATED PHO; Feng L, 1990, ADV XRAY ANAL, P509; FORSYTH JB, 1959, ACTA CRYSTALLOGR, V12, P412, DOI 10.1107/S0365110X59001219; HAJDU F, 1972, ACTA CRYSTALL A-CRYS, V28, P250, DOI 10.1107/S0567739472000671; Hubbell J. H., 1975, Journal of Physical and Chemical Reference Data, V4, P471, DOI 10.1063/1.555523; HUBBELL JH, 1979, J PHYS CHEM REF DATA, V8, P69, DOI 10.1063/1.555593; Kawrakow IM-H, 2010, EGSNRC CODE SYSTEM M; KISSEL L, 1995, ACTA CRYSTALLOGR A, V51, P271, DOI 10.1107/S010876739400886X; Kissel L, 2000, RADIAT PHYS CHEM, V59, P185, DOI 10.1016/S0969-806X(00)00290-5; LEE JD, 1969, ACTA CRYSTALL A-CRYS, VA 25, P712, DOI 10.1107/S0567739469001616; MOORE FH, 1963, ACTA CRYSTALLOGR, V16, P1169, DOI 10.1107/S0365110X63003054; Muhammad W, 2013, ACTA CRYSTALLOGR A, V69, P297, DOI 10.1107/S0108767313003607; Muhammad W, 2013, J RADIAT RES, V54, P190, DOI 10.1093/jrr/rrs069; Pratt RH, 1994, RESONANT ANOMALOUS X, P9; Roy SC, 1999, RADIAT PHYS CHEM, V56, P3, DOI 10.1016/S0969-806X(99)00286-8; ROY SC, 1993, RADIAT PHYS CHEM, V41, P725, DOI 10.1016/0969-806X(93)90320-T; Salvat F, 2011, WORKSHOP P, P384; SCHAUPP D, 1983, J PHYS CHEM REF DATA, V12, P467, DOI 10.1063/1.555690; Szaloki I, 1996, X-RAY SPECTROM, V25, P21; VAND V, 1957, ACTA CRYSTALLOGR, V10, P303, DOI 10.1107/S0365110X57000882; X-5 TMC, 2003, MCNP GEN MONT CARL N	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69608	10.1371/journal.pone.0069608	http://dx.doi.org/10.1371/journal.pone.0069608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936339	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400018
J	Wong, TT; Collodi, P				Wong, Ten-Tsao; Collodi, Paul			Dorsomorphin Promotes Survival and Germline Competence of Zebrafish Spermatogonial Stem Cells in Culture	PLOS ONE			English	Article							IN-VITRO; GENE-EXPRESSION; DIFFERENTIATION; LINE; SPERMATOGENESIS; PROLIFERATION; PROTEIN; VASA; MAINTENANCE; HOMOLOG	Zebrafish spermatogonial cell cultures were established from Tg(piwil1: neo); Tg(piwil1: DsRed) transgenic fish using a zebrafish ovarian feeder cell line (OFC3) that was engineered to express zebrafish Lif, Fgf2 and Gdnf. Primary cultures, initiated from testes, were treated with G418 to eliminate the somatic cells and select for the piwil1: neo expressing spermatogonia. Addition of dorsomorphin, a Bmp type I receptor inhibitor, prolonged spermatogonial stem cell (SSC) survival in culture and enhanced germline transmission of the SSCs following transplantation into recipient larvae. In contrast, dorsomorphin inhibited the growth and survival of zebrafish female germline stem cells (FGSCs) in culture. In the presence of dorsomorphin, the spermatogonia continued to express the germ-cell markers dazl, dnd, nanos3, vasa and piwil1 and the spermatogonial markers plzf and sox17 for at least six weeks in culture. Transplantation experiments revealed that 6 week-old spermatogonial cell cultures maintained in the presence of dorsomorphin were able to successfully colonize the gonad in 18% of recipient larvae and produce functional gametes in the resulting adult chimeric fish. Germline transmission was not successful when the spermatogonia were cultured 6 weeks in the absence of dorsomorphin before transplantation. The results indicate that Bmp signaling is detrimental to SSCs but required for the survival of zebrafish FGSCs in culture. Manipulation of Bmp signaling could provide a strategy to optimize culture conditions of germline stem cells from other species.	[Wong, Ten-Tsao; Collodi, Paul] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wong, TT (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	Wong20@purdue.edu	Wong, Ten-Tsao/J-7524-2017	Wong, Ten-Tsao/0000-0001-5573-9767	National Institutes of Health [NIH R01GM069384, R01GM069384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grant (NIH R01GM069384 and R01GM069384-7S1) from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Dranow DB, 2013, DEV BIOL, V376, P43, DOI 10.1016/j.ydbio.2013.01.016; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kawasaki T, 2012, GENES CELLS, V17, P316, DOI 10.1111/j.1365-2443.2012.01589.x; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kurita K, 2004, P NATL ACAD SCI USA, V101, P1263, DOI 10.1073/pnas.0304265101; Leal MC, 2009, BIOL REPROD, V81, P177, DOI 10.1095/biolreprod.109.076299; Leu DH, 2010, DEV DYNAM, V239, P2714, DOI 10.1002/dvdy.22404; Nagano M, 2003, BIOL REPROD, V68, P2207, DOI 10.1095/biolreprod.102.014050; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Neumann JC, 2011, P NATL ACAD SCI USA, V108, P13153, DOI 10.1073/pnas.1102311108; Nobrega RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012808; Ozaki Y, 2011, GENE EXPR PATTERNS, V11, P309, DOI 10.1016/j.gep.2011.03.002; Pellegrini M, 2003, J CELL SCI, V116, P3363, DOI 10.1242/jcs.00650; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Sakai N, 2002, DEVELOPMENT, V129, P3359; Sawatari E, 2007, DEV BIOL, V301, P266, DOI 10.1016/j.ydbio.2006.10.001; Shikina S, 2010, BIOL REPROD, V83, P268, DOI 10.1095/biolreprod.109.082123; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Tan CH, 2002, MECH DEVELOP, V119, pS221, DOI 10.1016/S0925-4773(03)00120-5; Vinas J, 2008, BIOL REPROD, V79, P738, DOI 10.1095/biolreprod.108.069708; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062660; Wong TT, 2011, BIOL REPROD, V84, P1190, DOI 10.1095/biolreprod.110.088427; Wong TT, 2004, ENDOCRINOLOGY, V145, P5210, DOI 10.1210/en.2004-0558; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yoshikawa H, 2009, BIOL REPROD, V80, P973, DOI 10.1095/biolreprod.108.075150; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	34	13	14	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71332	10.1371/journal.pone.0071332	http://dx.doi.org/10.1371/journal.pone.0071332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936500	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400103
J	Krueger, S; Bernhardt, A; Kalinski, T; Baldensperger, M; Zeh, M; Teller, A; Adolf, D; Reinheckel, T; Roessner, A; Kuester, D				Krueger, Sabine; Bernhardt, Anja; Kalinski, Thomas; Baldensperger, Martin; Zeh, Michael; Teller, Anne; Adolf, Daniela; Reinheckel, Thomas; Roessner, Albert; Kuester, Doerthe			Induction of Premalignant Host Responses by Cathepsin X/Z-Deficiency in Helicobacter Pylori-Infected Mice	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; MATRIX METALLOPROTEINASE-7; UP-REGULATION; IV SECRETION; ACTIVATION; INTEGRIN; CANCER; CAGA; MATRIX-METALLOPROTEINASE-9; CARBOXYPEPTIDASE	Helicobacter pylori are responsible for the induction of chronic gastric inflammation progressing to atrophy, metaplasia, and gastric cancer. The overexpression of Cathepsin X/Z (Ctsz) in H. pylori-infected mucosa and gastric cancer is mediated predominantly by an augmented migration of ctsz(-/-) positive macrophages and the up-regulation of Ctsz in tumor epithelium. To explore the Ctsz-function in the context of chronic inflammation and the development of preneoplastic lesions, we used Ctsz-deficient mice in a H. pylori gastritis model. Ctsz(-/-) and wild-type (wt) mice were infected with H. pylori strain SS1. The mice were sacrificed at 24, 36, and 50 weeks post infection (wpi). The stomach was removed, and gastric strips were snap-frozen or embedded and stained with H&E. Tissue sections were scored for epithelial lesions and inflammation. Ki-67 and F4/80 immunostaining were used to measure epithelial cell proliferation and macrophage infiltration, respectively. The upregulation of compensating cathepsins and cytokines were confirmed by Western blotting and quantitative RT-PCR. SS1-infected wt and ctsz(-/-) mice showed strong inflammation, foveolar hyperplasia, atrophy, and cystically-dilated glands. However, at 50 wpi, ctsz(-/-) mice developed significantly more severe spasmolytic polypeptide-expressing metaplasia (SPEM), showed enhanced epithelial proliferation, and higher levels of infiltrating macrophages. Induction of cytokines was higher and significantly prolonged in ctsz(-/-) mice compared to wt. Ctsz deficiency supports H. pylori-dependent development of chronic gastritis up to metaplasia, indicating a protective, but not proteolytic, function of Ctsz in inflammatory gastric disease.	[Krueger, Sabine; Bernhardt, Anja; Kalinski, Thomas; Baldensperger, Martin; Zeh, Michael; Teller, Anne; Roessner, Albert; Kuester, Doerthe] Otto Von Guericke Univ, Dept Pathol, Magdeburg, Germany; [Adolf, Daniela] Otto Von Guericke Univ, Dept Biometry & Med Informat, Magdeburg, Germany; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; [Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Stud, D-79106 Freiburg, Germany	Otto von Guericke University; Otto von Guericke University; University of Freiburg; University of Freiburg	Krueger, S (corresponding author), Otto Von Guericke Univ, Dept Pathol, Magdeburg, Germany.	sabine.krueger@med.ovgu.de	Reinheckel, Thomas/AAL-9761-2021; Jechorek, Doerthe/J-4716-2014	Reinheckel, Thomas/0000-0001-9866-9105; Jechorek, Doerthe/0000-0002-1480-5200	Deutsche Forschungsgemeinschaft [DFG KR 1901/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft DFG KR 1901/4-1 (to SK and DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Bernhardt A, 2010, J BIOL CHEM, V285, P33691, DOI 10.1074/jbc.M110.146183; Buhling F, 2004, BIOL CHEM, V385, P439, DOI 10.1515/BC.2004.051; Conradi J, 2012, AMINO ACIDS, V43, P219, DOI 10.1007/s00726-011-1066-0; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Jevnikar Z, 2011, J LEUKOCYTE BIOL, V90, P99, DOI 10.1189/jlb.1110622; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kraus S, 2011, EUR J CELL BIOL, V90, P678, DOI 10.1016/j.ejcb.2011.03.008; Krueger S, 2006, J BIOL CHEM, V281, P2868, DOI 10.1074/jbc.m511053200; Krueger S, 2005, J PATHOL, V207, P32, DOI 10.1002/path.1820; Krueger S, 2007, PATHOL RES PRACT, V203, P433, DOI 10.1016/j.prp.2007.04.003; Krueger S, 2011, PATHOL RES PRACT, V207, P599, DOI 10.1016/j.prp.2011.09.005; Krueger S, 2009, J PATHOL, V217, P581, DOI 10.1002/path.2485; Kundu P, 2006, J BIOL CHEM, V281, P34651, DOI 10.1074/jbc.M604574200; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lechner AM, 2006, J BIOL CHEM, V281, P39588, DOI 10.1074/jbc.M513439200; Mori N, 2003, GASTROENTEROLOGY, V124, P983, DOI 10.1053/gast.2003.50152; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P12648, DOI 10.1021/bi991371z; Nagler DK, 2010, INT IMMUNOPHARMACOL, V10, P134, DOI 10.1016/j.intimp.2009.09.018; Nascimento FD, 2005, ARCH BIOCHEM BIOPHYS, V436, P323, DOI 10.1016/j.abb.2005.01.013; Obermajer N, 2009, CELL MOL LIFE SCI, V66, P1126, DOI 10.1007/s00018-009-8829-8; Ogden SR, 2010, CANCER RES, V70, P30, DOI 10.1158/0008-5472.CAN-09-2899; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; Pillinger MH, 2007, J BIOL CHEM, V282, P18722, DOI 10.1074/jbc.M703022200; Rogers AB, 2005, CANCER RES, V65, P10709, DOI 10.1158/0008-5472.CAN-05-1846; Ruiz-Bustos E, 2001, J MED MICROBIOL, V50, P215, DOI 10.1099/0022-1317-50-3-215; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Sewald X, 2008, CELL HOST MICROBE, V3, P20, DOI 10.1016/j.chom.2007.11.003; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794	35	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70242	10.1371/journal.pone.0070242	http://dx.doi.org/10.1371/journal.pone.0070242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936173	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200068
J	Moyne, AL; Harris, LJ; Marco, ML				Moyne, Anne-Laure; Harris, Linda J.; Marco, Maria L.			Assessments of Total and Viable Escherichia coli O157:H7 on Field and Laboratory Grown Lettuce	PLOS ONE			English	Article							PROPIDIUM MONOAZIDE; LISTERIA-MONOCYTOGENES; ETHIDIUM MONOAZIDE; O157-H7; SALMONELLA; PCR; PATHOGENS; O157/H7; PLANTS; CELLS	Leafy green produce has been associated with numerous outbreaks of foodborne illness caused by strains of Escherichia coli O157:H7. While the amounts of culturable E. coli O157:H7 rapidly decline after introduction onto lettuce in the field, it remains to be determined whether the reduction in cell numbers is due to losses in cell viability, cell injury and a subsequent inability to be detected by standard laboratory culturing methods, or a lack of adherence and hence rapid removal of the organism from the plants during application. To assess which of these options is most relevant for E. coli O157:H7 on leafy green produce, we developed and applied a propidium monoazide (PMA) real-time PCR assay to quantify viable (with PMA) and total (without PMA) E. coli O157:H7 cells on growth chamber and field-grown lettuce. E. coli O157:H7, suspended in 0.1% peptone, was inoculated onto 4-week-old lettuce plants at a level of approximately 10 6 CFU/plant. In the growth chamber at low relative humidity (30%), culturable amounts of the nontoxigenic E. coli O157:H7 strain ATCC 700728 and the virulent strain EC4045 declined 100 to 1000-fold in 24 h. Fewer E. coli O157:H7 cells survived when applied onto plants in droplets with a pipette compared with a fine spray inoculation. Total cells for both strains were equivalent to inoculum levels for 7 days after application, and viable cell quantities determined by PMA real-time PCR were approximately 10 4 greater than found by colony enumeration. Within 2 h after application onto plants in the field, the number of culturable E. coli ATCC 700728 was reduced by up to 1000-fold, whereas PCR-based assessments showed that total cell amounts were equivalent to inoculum levels. These findings show that shortly after inoculation onto plants, the majority of E. coli O157:H7 cells either die or are no longer culturable.	[Moyne, Anne-Laure; Harris, Linda J.; Marco, Maria L.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Moyne, Anne-Laure; Harris, Linda J.] Univ Calif Davis, Western Ctr Food Safety, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Marco, ML (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.	mmarco@ucdavis.edu	Harris, Linda J/B-5030-2011; Marco, Maria/H-2322-2014	Harris, Linda J/0000-0002-1911-752X; 	Agriculture and Food Research Initiative Grant from the USDA National Institute of Food and Agriculture [2010-65201-20572]; California Leafy Greens Research Board; U.S. Food and Drug Administration [U01-003-572]	Agriculture and Food Research Initiative Grant from the USDA National Institute of Food and Agriculture; California Leafy Greens Research Board; U.S. Food and Drug Administration	This project was supported by Agriculture and Food Research Initiative Grant 2010-65201-20572 from the USDA National Institute of Food and Agriculture. The field trials were supported by funds from the California Leafy Greens Research Board and the U.S. Food and Drug Administration (Project No. U01-003-572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruscavage D, 2006, J FOOD SCI, V71, pR89, DOI 10.1111/j.1750-3841.2006.00157.x; Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Bettelheim KA, 1998, J APPL MICROBIOL, V85, P425, DOI 10.1046/j.1365-2672.1998.853469.x; Bezanson G, 2012, J FOOD PROTECT, V75, P480, DOI 10.4315/0362-028X.JFP-11-306; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128/AEM.01073-08; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P2298, DOI 10.1128/AEM.02459-07; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P929; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1045; Chang B, 2010, JPN J INFECT DIS, V63, P119; Contreras PJ, 2011, J MICROBIOL METH, V87, P89, DOI 10.1016/j.mimet.2011.07.016; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Delaquis P, 2007, J FOOD PROTECT, V70, P1966, DOI 10.4315/0362-028X-70.8.1966; Dinu LD, 2011, APPL ENVIRON MICROB, V77, P8295, DOI 10.1128/AEM.05020-11; Dreux N, 2007, J APPL MICROBIOL, V103, P1272, DOI 10.1111/j.1365-2672.2007.03351.x; Elizaquivel P, 2008, FOOD MICROBIOL, V25, P705, DOI 10.1016/j.fm.2008.03.002; Erickson MC, 2010, J FOOD PROTECT, V73, P1023, DOI 10.4315/0362-028X-73.6.1023; Franz E, 2008, CRIT REV MICROBIOL, V34, P143, DOI [10.1080/10408410802357432, 10.1080/10408410802357432 ]; Gourabathini P, 2008, APPL ENVIRON MICROB, V74, P2518, DOI 10.1128/AEM.02709-07; Grey BN, 2001, APPL ENVIRON MICROB, V67, P5325, DOI 10.1128/AEM.67.11.5325-5327.2001; Hirneisen KA, 2012, FOODBORNE PATHOG DIS, V9, P396, DOI 10.1089/fpd.2011.1044; Islam M, 2004, J FOOD PROTECT, V67, P1365, DOI 10.4315/0362-028X-67.7.1365; Jablasone J, 2005, INT J FOOD MICROBIOL, V99, P7, DOI 10.1016/j.ijfoodmicro.2004.06.011; Kotewicz ML, 2008, MICROBIOL-SGM, V154, P3518, DOI 10.1099/mic.0.2008/019026-0; Liang NJ, 2011, J FOOD SCI, V76, pM234, DOI 10.1111/j.1750-3841.2011.02123.x; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lovdal T, 2011, J MICROBIOL METH, V85, P164, DOI 10.1016/j.mimet.2011.01.027; Luo JF, 2010, APPL MICROBIOL BIOT, V86, P377, DOI 10.1007/s00253-009-2373-1; Maurer JJ, 2006, FOOD MICROBIOL FOOD, P27, DOI 10.1007/0-387-31702-3_2; Meric G, 2013, ENVIRON MICROBIOL, V15, P487, DOI 10.1111/j.1462-2920.2012.02852.x; Moyne AL, 2011, FOOD MICROBIOL, V28, P1417, DOI 10.1016/j.fm.2011.02.001; Nocker A, 2009, FEMS MICROBIOL LETT, V291, P137, DOI 10.1111/j.1574-6968.2008.01429.x; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Pan Y, 2007, APPL ENVIRON MICROB, V73, P8028, DOI 10.1128/AEM.01198-07; Quilliam RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033842; Sanchez G, 2012, INT J FOOD MICROBIOL, V152, P9, DOI 10.1016/j.ijfoodmicro.2011.10.002; Sharma VK, 2010, MICROBIOL-SGM, V156, P1303, DOI 10.1099/mic.0.034330-0; Tyler HL, 2008, ANNU REV PHYTOPATHOL, V46, P53, DOI 10.1146/annurev.phyto.011708.103102; van Frankenhuyzen JK, 2011, J MICROBIOL METH, V87, P263, DOI 10.1016/j.mimet.2011.09.007; Varma M, 2009, WATER RES, V43, P4790, DOI 10.1016/j.watres.2009.05.031; Wang GH, 2002, J CLIN MICROBIOL, V40, P3613, DOI 10.1128/JCM.40.10.3613-3619.2002	42	29	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70643	10.1371/journal.pone.0070643	http://dx.doi.org/10.1371/journal.pone.0070643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936235	Green Published, gold			2022-12-27	WOS:000323114200098
J	Trego, ML; Kellar, NM; Danil, K				Trego, Marisa L.; Kellar, Nicholas M.; Danil, Kerri			Validation of Blubber Progesterone Concentrations for Pregnancy Determination in Three Dolphin Species and a Porpoise	PLOS ONE			English	Article							REPRODUCTIVE STATUS; SERUM PROGESTERONE; STEROID-HORMONES	Recent studies have validated the use of biopsies as a minimally invasive way to identify pregnant females in several species of wild cetaceans: Balaenaptera acutorostrata, Delphinus delphis, Lissodelphis borealis, and Lagenorhynchus obliquidens. These studies found that progesterone (P4) concentrations quantified from blubber attached to biopsy samples is diagnostic of pregnancy. Here we examine a broader group of cetacean species in efforts to investigate how progesterone levels vary between species with respect to pregnancy status. We compared P4 concentrations in blubber collected from fishery bycatch and beach-stranded specimens for 40 females of known reproductive condition from Delphinus capensis (n = 18), Stenella attenuata (n = 8), S. longirostris (n = 6), and Phocoenoides dalli (n = 8). The P4 concentrations were different (t = -7.1, p = 1.79E-08) between pregnant and non-regnant animals in all species, with the mean blubber P4 concentration for pregnant animals 164 times higher than that of non-pregnant animals. There was no overlap in concentration levels between sexually immature or non-regnant sexually mature animals and pregnant animals. No significant differences (F = 0.354, p = 0.559) were found between mature non-pregnant and immature D. capensis and P dalli, suggesting P4 level is not indicative of maturity state in female delphinoids. P4 concentrations in relation to reproductive state were remarkably similar across species. All samples were analyzed with two different enzyme immunoassay kits to gauge assay sensitivity to measure progesterone in small samples, such as biopsies. With the technique now validated for these cetacean species, blubber P4 is a reliable diagnostic of pregnancies across multiple species, and thus expands the utility of this method to study reproduction in free-ranging cetaceans using biopsies.	[Trego, Marisa L.; Kellar, Nicholas M.; Danil, Kerri] NOAA, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Trego, ML (corresponding author), NOAA, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA.	marisa.trego@noaa.gov	Kellar, Nicholas/AAA-4606-2021	Danil, Kerri/0000-0001-6985-4678	National Marine Fisheries Service	National Marine Fisheries Service	The work presented in this manuscript was supported by the National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferrero RC, 1999, MAR MAMMAL SCI, V15, P273, DOI 10.1111/j.1748-7692.1999.tb00803.x; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Hao YJ, 2007, THERIOGENOLOGY, V67, P673, DOI 10.1016/j.theriogenology.2006.06.014; Heyning John E., 1994, Contributions in Science (Los Angeles), V442, P1; Hogg CJ, 2009, MAR MAMMAL SCI, V25, P605, DOI 10.1111/j.1748-7692.2008.00277.x; JEFFERSON TA, 1994, NOAATMNMFSSWFSC198; Kellar NM, 2006, MAR MAMMAL SCI, V22, P1, DOI 10.1111/j.1748-7692.2006.00001.x; Larese JP, 2009, CAN J ZOOL, V87, P537, DOI 10.1139/Z09-038; Mansour AAH, 2002, MAR MAMMAL SCI, V18, P112, DOI 10.1111/j.1748-7692.2002.tb01022.x; PEREZ S, 2011, MAR BIOL, V150, P1011; PERRIN WF, 1976, FISH B-NOAA, V74, P229; PROCKNOR M, 1986, J ANIM SCI, V62, P191, DOI 10.2527/jas1986.621191x; Robeck TR, 2005, REPRODUCTION, V129, P659, DOI 10.1530/rep.1.00516; Rolland RM, 2005, GEN COMP ENDOCR, V142, P308, DOI 10.1016/j.ygcen.2005.02.002; SAWYERSTEFFAN JE, 1983, BIOL REPROD, V28, P897, DOI 10.1095/biolreprod28.4.897; TEMTE JL, 1991, FISH B-NOAA, V89, P161; TEMTE JL, 1985, J WILDLIFE MANAGE, V49, P51, DOI 10.2307/3801842; WELLS RS, 1981, REPROD WHALES DOLPHI; WELLS RS, 1981, REPORTS INT WHALING, P465; WEST KL, 2000, GEN COMP ENDOCR, DOI DOI 10.1006/GCEN.2000.7404.PUBMED:10642444; YOSHIOKA M, 1989, NIPPON SUISAN GAKK, V55, P475; YOSHIOKA M, 1994, CAN J ZOOL, V72, P368, DOI 10.1139/z94-051	22	40	42	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69709	10.1371/journal.pone.0069709	http://dx.doi.org/10.1371/journal.pone.0069709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936083	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200043
J	Rovira-Vallbona, E; Monteiro, I; Bardaji, A; Serra-Casas, E; Neafsey, DE; Quelhas, D; Valim, C; Alonso, P; Dobano, C; Ordi, J; Menendez, C; Mayor, A				Rovira-Vallbona, Eduard; Monteiro, Isadora; Bardaji, Azucena; Serra-Casas, Elisa; Neafsey, Daniel E.; Quelhas, Diana; Valim, Clarissa; Alonso, Pedro; Dobano, Carlota; Ordi, Jaume; Menendez, Clara; Mayor, Alfredo			VAR2CSA Signatures of High Plasmodium falciparum Parasitemia in the Placenta	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; BINDING-LIKE DOMAINS; INFECTED ERYTHROCYTES; PREGNANT-WOMEN; VAR GENES; DIVERSIFYING SELECTION; GESTATIONAL-AGE; PFEMP1 GENES; MALARIA; ANTIBODIES	Plasmodium falciparum infected erythrocytes (IE) accumulate in the placenta through the interaction between Duffy-binding like (DBL) domains of parasite-encoded ligand VAR2CSA and chondroitin sulphate-A (CSA) receptor. Polymorphisms in these domains, including DBL2X and DBL3X, may affect their antigenicity or CSA-binding affinity, eventually increasing parasitemia and its adverse effects on pregnancy outcomes. A total of 373 DBL2X and 328 DBL3X sequences were obtained from transcripts of 20 placental isolates infecting Mozambican women, resulting in 176 DBL2X and 191 DBL3X unique sequences at the protein level. Sequence alignments were divided in segments containing combinations of correlated polymorphisms and the association of segment sequences with placental parasite density was tested using Bonferroni corrected regression models, taking into consideration the weight of each sequence in the infection. Three DBL2X and three DBL3X segments contained signatures of high parasite density (P<0.003) that were highly prevalent in the parasite population (49-91%). Identified regions included a flexible loop that contributes to DBL3X-CSA interaction and two DBL3X motifs with evidence of positive natural selection. Limited antibody responses against signatures of high parasite density among malaria-exposed pregnant women could not explain the increased placental parasitemia. These results suggest that a higher binding efficiency to CSA rather than reduced antigenicity might provide a biological advantage to parasites with high parasite density signatures in VAR2CSA. Sequences contributing to high parasitemia may be critical for the functional characterization of VAR2CSA and the development of tools against placental malaria.	[Rovira-Vallbona, Eduard; Monteiro, Isadora; Bardaji, Azucena; Serra-Casas, Elisa; Alonso, Pedro; Dobano, Carlota; Ordi, Jaume; Menendez, Clara; Mayor, Alfredo] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Bardaji, Azucena; Quelhas, Diana; Alonso, Pedro; Dobano, Carlota; Menendez, Clara; Mayor, Alfredo] CISM, Maputo, Mozambique; [Neafsey, Daniel E.] Broad Inst, Cambridge, MA USA; [Valim, Clarissa] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Ordi, Jaume] Univ Barcelona, Hosp Clin, Dept Pathol, Barcelona, Spain	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Barcelona; Hospital Clinic de Barcelona	Mayor, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	AGMAYOR@clinic.ub.es	Alonso, Azucena Bardají/V-5978-2018; Mayor, Alfredo/H-7488-2017; Alonso, Pedro L/AAZ-3645-2020; Rovira-Vallbona, Eduard/D-3053-2015; Menéndez, Clara/Q-3446-2016; Ordi, Jaume/X-4524-2018; Bardají, Azucena/AAE-9145-2019; Dobaño, Carlota/N-4119-2014	Alonso, Azucena Bardají/0000-0002-5135-0540; Mayor, Alfredo/0000-0003-3890-2897; Alonso, Pedro L/0000-0003-3292-3443; Menéndez, Clara/0000-0002-2641-6907; Ordi, Jaume/0000-0002-4820-7954; Dobaño, Carlota/0000-0002-6751-4060; Rovira-Vallbona, Eduard/0000-0002-4765-1076; Neafsey, Daniel/0000-0002-1665-9323	Instituto de Salud Carlos III [PS09/01113, FI06/00019, CP-04/00220]; Ministerio de Ciencia e Innovacion [RYC-2008-02631]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	The study received financial support from the Instituto de Salud Carlos III (project PS09/01113; grant FI06/00019 to E.R.V.; salary support CP-04/00220 to A.M.) and the Ministerio de Ciencia e Innovacion (salary support RYC-2008-02631 to C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-36; Avril M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016622; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; Barfod L, 2010, J IMMUNOL, V185, P7553, DOI 10.4049/jimmunol.1002390; Beeson JG, 2007, J BIOL CHEM, V282, P22426, DOI 10.1074/jbc.M700231200; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Bordbar B, 2012, VACCINE, V30, P1343, DOI 10.1016/j.vaccine.2011.12.065; Brolin KJM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r117; Brown A, 2010, CURR OPIN STRUC BIOL, V20, P560, DOI 10.1016/j.sbi.2010.06.008; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Cox SE, 2005, INFECT IMMUN, V73, P2841, DOI 10.1128/IAI.73.5.2841-2847.2005; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fievet N, 2006, INFECT GENET EVOL, V6, P459, DOI 10.1016/j.meegid.2006.02.006; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gangnard S, 2010, MOL BIOCHEM PARASIT, V173, P115, DOI 10.1016/j.molbiopara.2010.05.014; Gill J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-67; Gnidehou S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013105; Guitard J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-165; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Hurst LD, 2009, NAT REV GENET, V10, P83, DOI 10.1038/nrg2506; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; Mayor A, 2011, INFECT IMMUN, V79, P1654, DOI 10.1128/IAI.01000-10; McHenry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020192; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polley SD, 2001, GENETICS, V158, P1505; Rovira-Vallbona E, 2011, J INFECT DIS, V204, P27, DOI 10.1093/infdis/jir217; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Sander AF, 2011, J INFECT DIS, V203, P1679, DOI 10.1093/infdis/jir168; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Serra-Casas E, 2010, J INFECT DIS, V201, P123, DOI 10.1086/648595; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Srivastava A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020270; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Talundzic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031565; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609	63	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69753	10.1371/journal.pone.0069753	http://dx.doi.org/10.1371/journal.pone.0069753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936092	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300062
J	Yamaguchi, M; Kashiwakura, I				Yamaguchi, Masaru; Kashiwakura, Ikuo			Role of Reactive Oxygen Species in the Radiation Response of Human Hematopoietic Stem/Progenitor Cells	PLOS ONE			English	Article							PERSISTENT OXIDATIVE STRESS; ELECTRON-TRANSPORT CHAIN; UMBILICAL-CORD BLOOD; DNA-DAMAGE; STEM-CELLS; FREE-RADICALS; SELF-RENEWAL; MITOCHONDRIAL; DIFFERENTIATION; CYCLE	Hematopoietic stem/progenitor cells (HSPCs), which are present in small numbers in hematopoietic tissues, can differentiate into all hematopoietic lineages and self-renew to maintain their undifferentiated phenotype. HSPCs are extremely sensitive to oxidative stressors such as anti-cancer agents, radiation, and the extensive accumulation of reactive oxygen species (ROS). The quiescence and stemness of HSPCs are maintained by the regulation of mitochondrial biogenesis, ROS, and energy homeostasis in a special microenvironment called the stem cell niche. The present study evaluated the relationship between the production of intracellular ROS and mitochondrial function during the proliferation and differentiation of X-irradiated CD34(+) cells prepared from human placental/umbilical cord blood HSPCs. Highly purified CD34(+) HSPCs exposed to X-rays were cultured in liquid and semi-solid medium supplemented with hematopoietic cytokines. X-irradiated CD34(+) HSPCs treated with hematopoietic cytokines, which promote their proliferation and differentiation, exhibited dramatically suppressed cell growth and clonogenic potential. The amount of intracellular ROS in X-irradiated CD34(+) HSPCs was significantly higher than that in non-irradiated cells during the culture period. However, neither the intracellular mitochondrial content nor the mitochondrial superoxide production was elevated in X-irradiated CD34(+) HSPCs compared with non-irradiated cells. Radiation-induced gamma-H2AX expression was observed immediately following exposure to 4 Gy of X-rays and gradually decreased during the culture period. This study reveals that X-irradiation can increase persistent intracellular ROS in human CD34(+) HSPCs, which may not result from mitochondrial ROS due to mitochondrial dysfunction, and indicates that substantial DNA double-strand breakage can critically reduce the stem cell function.	[Yamaguchi, Masaru; Kashiwakura, Ikuo] Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan	Hirosaki University	Kashiwakura, I (corresponding author), Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan.	ikashi@cc.hirosaki-u.ac.jp						Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen C, 2009, CELL CYCLE, V8, P1158, DOI 10.4161/cc.8.8.8139; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Hayashi T, 2004, MUTAT RES-FUND MOL M, V556, P83, DOI 10.1016/j.mrfmmm.2004.07.002; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014; Iiyama M, 2006, CELL SIGNAL, V18, P174, DOI 10.1016/j.cellsig.2005.04.002; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Inoue SI, 2010, FEBS LETT, V584, P3402, DOI 10.1016/j.febslet.2010.06.036; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kuo LJ, 2008, IN VIVO, V22, P305; Mandal PK, 2012, CELL, V148, P847, DOI 10.1016/j.cell.2012.02.011; Mantel C, 2010, CELL CYCLE, V9, P2008, DOI 10.4161/cc.9.10.11733; Nagayama H, 2002, BONE MARROW TRANSPL, V29, P197, DOI 10.1038/sj.bmt.1703356; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Pendergrass W, 2010, MOL VIS, V16, P1496; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Piccoli C, 2007, BIOCHEM BIOPH RES CO, V353, P965, DOI 10.1016/j.bbrc.2006.12.148; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Presley AD, 2003, J CHROMATOGR B, V793, P141, DOI 10.1016/S1570-0232(03)00371-4; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Sardina JL, 2012, CRIT REV ONCOL HEMAT, V81, P257, DOI 10.1016/j.critrevonc.2011.03.005; Takahashi K, 2010, RADIAT RES, V173, P184, DOI 10.1667/RR1839.1; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yoshida T, 2012, FREE RADICAL RES, V46, P147, DOI 10.3109/10715762.2011.645207; Zheng YH, 2005, ONCOGENE, V24, P3339, DOI 10.1038/sj.onc.1208484; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004; Zhou X, 2011, MITOCHONDRION, V11, P886, DOI 10.1016/j.mito.2011.07.005	40	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70503	10.1371/journal.pone.0070503	http://dx.doi.org/10.1371/journal.pone.0070503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936220	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300105
J	Gurzu, S; Ciortea, D; Munteanu, T; Kezdi-Zaharia, I; Jung, I				Gurzu, Simona; Ciortea, Diana; Munteanu, Teodora; Kezdi-Zaharia, Iringo; Jung, Ioan			Mesenchymal-to-Endothelial Transition in Kaposi Sarcoma: A Histogenetic Hypothesis Based on a Case Series and Literature Review	PLOS ONE			English	Review							PLURIPOTENT STEM-CELLS; DERMAL DENDRITIC CELLS; TUMOR ANGIOGENESIS; COLORECTAL-CANCER; GROWTH-FACTORS; SPINDLE CELLS; PHASE-II; C-KIT; EXPRESSION; CD105	Objectives: Although several studies have been conducted regarding Kaposi sarcoma (KS), its histogenesis still remains to be elucidated. The aim of our study was to analyze the immunophenotype of Kaposi sarcoma and to present a hypothesis about the histogenesis of this tumor, based on a case series and a review of relevant literature. Methods: In 15 cases of KSs diagnosed during 2000-2011, the clinicopathological features were correlated with the immunoexpression of c-Kit, SMA, CD34, CD31, vascular endothelial growth factor (VEGF), COX-2, c-KIT, smooth muscle antigen (SMA), and stem cell surface marker CD105. Results: Both CD105 and c-KIT rate of the spindle-shaped tumor cell positivity increased in parallel to the pathological stage. All cases displayed CD105 and weak c-KIT positivity in the endothelial cells. SMA, VEGF, and COX-2 were focally expressed in all cases. CD34 marked both endothelium and spindle-shaped tumor cells. No c-KIT expression was noticed in KS of the internal organs. Conclusions: KS seems to be a variant of myofibroblastic tumors that originates from the viral modified pluripotent mesenchymal cells of the connective tissue transformed in spindle-shaped KS cells, followed by a mesenchymal-endothelial transition and a myofibroblastic-like differentiation. This paper mailnly showed that KS cannot be considered a pure vascular tumor.	[Gurzu, Simona; Munteanu, Teodora; Jung, Ioan] Univ Med & Pharm Tirgu Mures, Dept Pathol, Targu Mures, Romania; [Ciortea, Diana] Univ Med & Pharm Tirgu Mures, Dept Dermatol, Targu Mures, Romania; [Kezdi-Zaharia, Iringo] Univ Med & Pharm Tirgu Mures, Dept Infect Dis, Targu Mures, Romania	George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures	Gurzu, S (corresponding author), Univ Med & Pharm Tirgu Mures, Dept Pathol, Targu Mures, Romania.	simonagurzu@yahoo.com	GURZU, SIMONA/AAD-2710-2019	Zaharia Kezdi, Erzsebet Iringo/0000-0002-8422-5850; gurzu, simona/0000-0003-3968-5118	L'Oreal-Unesco National Fellowship "For women in science''; Sectoral Operational Programme Human Resources Development (SOP HRD); European Social Fund; Romanian Government [POSDRU 80641]	L'Oreal-Unesco National Fellowship "For women in science''(L'Oreal Group); Sectoral Operational Programme Human Resources Development (SOP HRD); European Social Fund(European Social Fund (ESF)); Romanian Government(Romanian Government)	This work was partially supported by the L'Oreal-Unesco National Fellowship "For women in science'' and the Sectoral Operational Programme Human Resources Development (SOP HRD), financed from the European Social Fund and by the Romanian Government under the contract number POSDRU 80641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud ER, 2013, OCHSNER J, V13, P66; Agulnik M, 2013, ANN ONCOL, V24, P257, DOI 10.1093/annonc/mds237; Babal P, 2003, J EUR ACAD DERMATOL, V17, P377, DOI 10.1046/j.1468-3083.2003.00746.x; Balan R, 2011, ROM J MORPHOL EMBRYO, V52, P1187; Bauer G, 2008, MOL THER, V16, P1308, DOI 10.1038/mt.2008.93; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Castrechini NM, 2012, REPROD SCI, V19, P1302, DOI 10.1177/1933719112450334; Ceafalan L, 2012, J CELL MOL MED, V16, P1405, DOI 10.1111/j.1582-4934.2012.01580.x; CERIO R, 1989, BRIT J DERMATOL, V121, P421, DOI 10.1111/j.1365-2133.1989.tb15509.x; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Ciernik IF, 1995, CLIN CANCER RES, V1, P1119; Fierro FA, 2011, STEM CELLS, V29, P1727, DOI 10.1002/stem.720; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gao SJ, 1996, NEW ENGL J MED, V335, P233, DOI 10.1056/NEJM199607253350403; Garfias Y, 2012, MOL VIS, V18, P2087; Gerlach JC, 2012, STEM CELLS DEV, V21, P3258, DOI 10.1089/scd.2012.0296; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gurzu S, 2012, AM J MENS HEALTH, V6, P344, DOI 10.1177/1557988312441817; Headington J T, 1986, Adv Dermatol, V1, P159; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jung I, 2009, ROM J MORPHOL EMBRYO, V50, P239; Jung YJ, 2012, STEM CELLS, V30, P42, DOI 10.1002/stem.727; Kaiserling E, 2004, PATHOLOGE, V25, P362, DOI 10.1007/s00292-004-0693-6; Kandemir NO, 2010, CLIN EXP DERMATOL, V35, P525, DOI 10.1111/j.1365-2230.2009.03661.x; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07; Lee KS, 2013, RES VET SCI, V94, P144, DOI 10.1016/j.rvsc.2012.07.033; Li C, 2003, BRIT J CANCER, V88, P1424, DOI 10.1038/sj.bjc.6600874; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Maio M, 2006, CARDIOVASC RES, V69, P781, DOI 10.1016/j.cardiores.2006.01.007; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Miettinen M, 2000, MODERN PATHOL, V13, P536, DOI 10.1038/modpathol.3880093; Miettinen M, 2000, MODERN PATHOL, V13, P1134, DOI 10.1038/modpathol.3880210; NICKOLOFF BJ, 1991, ARCH DERMATOL, V127, P523, DOI 10.1001/archderm.127.4.523; Pyakurel P, 2006, INT J CANCER, V119, P1262, DOI 10.1002/ijc.21969; Ramirez-Amador V, 2009, J ORAL PATHOL MED, V38, P328, DOI 10.1111/j.1600-0714.2008.00740.x; Roy D, 2013, CANCER RES, V73, P2235, DOI 10.1158/0008-5472.CAN-12-1851; Simonart T, 2002, J CUTAN PATHOL, V29, P72; Takasu S, 2008, CANCER SCI, V99, P2356, DOI 10.1111/j.1349-7006.2008.00983.x; Uldrick TS, 2012, J CLIN ONCOL, V30, P1476, DOI 10.1200/JCO.2011.39.6853; Vaculik C, 2012, J INVEST DERMATOL, V132, P563, DOI 10.1038/jid.2011.355; Wu AW, 2004, WORLD J GASTROENTERO, V10, P2323; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128	46	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71530	10.1371/journal.pone.0071530	http://dx.doi.org/10.1371/journal.pone.0071530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936513	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500076
J	Petersen, CL; Timothy, M; Kim, DS; Bhandiwad, AA; Mohr, RA; Sisneros, JA; Forlano, PM				Petersen, Christopher L.; Timothy, Miky; Kim, D. Spencer; Bhandiwad, Ashwin A.; Mohr, Robert A.; Sisneros, Joseph A.; Forlano, Paul M.			Exposure to Advertisement Calls of Reproductive Competitors Activates Vocal-Acoustic and Catecholaminergic Neurons in the Plainfin Midshipman Fish, Porichthys notatus	PLOS ONE			English	Article							RAPID NEUROENDOCRINE RESPONSES; MIDBRAIN PERIAQUEDUCTAL GRAY; SOUND-SOURCE LOCALIZATION; SOCIAL-BEHAVIOR NETWORK; EARLY GENE-EXPRESSION; AUDITORY MIDBRAIN; INNERVATION PATTERNS; DOPAMINERGIC SYSTEM; MESSENGER-RNA; TELEOST FISH	While the neural circuitry and physiology of the auditory system is well studied among vertebrates, far less is known about how the auditory system interacts with other neural substrates to mediate behavioral responses to social acoustic signals. One species that has been the subject of intensive neuroethological investigation with regard to the production and perception of social acoustic signals is the plainfin midshipman fish, Porichthys notatus, in part because acoustic communication is essential to their reproductive behavior. Nesting male midshipman vocally court females by producing a long duration advertisement call. Females localize males by their advertisement call, spawn and deposit all their eggs in their mate's nest. As multiple courting males establish nests in close proximity to one another, the perception of another male's call may modulate individual calling behavior in competition for females. We tested the hypothesis that nesting males exposed to advertisement calls of other males would show elevated neural activity in auditory and vocal-acoustic brain centers as well as differential activation of catecholaminergic neurons compared to males exposed only to ambient noise. Experimental brains were then double labeled by immunofluorescence (-ir) for tyrosine hydroxylase (TH), an enzyme necessary for catecholamine synthesis, and cFos, an immediate-early gene product used as a marker for neural activation. Males exposed to other advertisement calls showed a significantly greater percentage of TH-ir cells colocalized with cFos-ir in the noradrenergic locus coeruleus and the dopaminergic periventricular posterior tuberculum, as well as increased numbers of cFos-ir neurons in several levels of the auditory and vocal-acoustic pathway. Increased activation of catecholaminergic neurons may serve to coordinate appropriate behavioral responses to male competitors. Additionally, these results implicate a role for specific catecholaminergic neuronal groups in auditory-driven social behavior in fishes, consistent with a conserved function in social acoustic behavior across vertebrates.	[Petersen, Christopher L.; Timothy, Miky; Kim, D. Spencer; Forlano, Paul M.] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Bhandiwad, Ashwin A.; Mohr, Robert A.; Sisneros, Joseph A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Sisneros, Joseph A.] Virginia Bloedel Hearing Res Ctr, Seattle, WA USA; [Forlano, Paul M.] Brooklyn Coll, Aquat Res & Environm Assessment Ctr, Brooklyn, NY USA; [Forlano, Paul M.] CUNY, Grad Ctr, Program Neurosci, New York, NY USA; [Forlano, Paul M.] CUNY, Grad Ctr, Program Ecol Evolut & Behav, New York, NY USA	City University of New York (CUNY) System; Brooklyn College (CUNY); University of Washington; University of Washington Seattle; City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Forlano, PM (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	pforlano@brooklyn.cuny.edu	Sisneros, Joseph/AAU-9965-2020; Timothy, Miky/AAJ-4279-2020	Timothy, Miky/0000-0002-4266-2403; Sisneros, Joseph/0000-0002-3114-773X; Forlano, Paul/0000-0003-4258-5708; Petersen, Christopher/0000-0002-8552-9709	National Institutes of Health (NIH) [SC2DA034996]; National Science Foundation (NSF) [IOS-0642214]; PSC-CUNY Award [64519-00 42]; Professional Staff Congress; City University of New York; Sigma Xi; Leonard G. Worley Scholarship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [SC2DA034996] Funding Source: NIH RePORTER; SBE Off Of Multidisciplinary Activities [1156870] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); PSC-CUNY Award; Professional Staff Congress; City University of New York; Sigma Xi; Leonard G. Worley Scholarship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by National Institutes of Health (NIH) SC2DA034996 to PMF (www.nih.gov), National Science Foundation (NSF) IOS-0642214 to JAS (www.nsf.gov), PSC-CUNY Award 64519-00 42 jointly funded by The Professional Staff Congress and The City University of New York to PMF (www.rfcuny.org), Sigma Xi Grant-In-Aid of Research Award to CLP (www.sigmaxi.org), and Leonard G. Worley Scholarship to CLP (www.brooklyn.cuny.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltants D, 2002, BEHAV BRAIN RES, V133, P221, DOI 10.1016/S0166-4328(02)00005-0; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; Bass AH, 2000, J COMP NEUROL, V419, P505, DOI 10.1002/(SICI)1096-9861(20000417)419:4<505::AID-CNE7>3.0.CO;2-3; Bass AH, 2003, SPR HDB AUD, V16, P15; Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; Bass AH, 1996, AM SCI, V84, P352; BASS AH, 1994, J NEUROSCI, V14, P4025; Bass AH, 2008, SCIENCE, V321, P417, DOI 10.1126/science.1157632; Bass Andrew H., 2008, V32, P253, DOI 10.1007/978-0-387-73029-5_8; Berridge CW, 2008, BRAIN RES REV, V58, P1, DOI 10.1016/j.brainresrev.2007.10.013; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bharati IS, 2006, NEUROSCIENCE, V143, P661, DOI 10.1016/j.neuroscience.2006.08.046; Bodnar DA, 2001, J ACOUST SOC AM, V109, P809, DOI 10.1121/1.1340646; Bodnar DA, 1997, J NEUROSCI, V17, P7553; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; Burmeister SS, 2008, BRAIN RES, V1190, P105, DOI 10.1016/j.brainres.2007.11.008; Carrera I, 2012, J COMP NEUROL, V520, P3574, DOI 10.1002/cne.23114; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Castelino CB, 2010, J CHEM NEUROANAT, V39, P96, DOI 10.1016/j.jchemneu.2009.08.003; Chagnaud BP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1349; Chakraborty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012898; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; Endepols H, 2004, J NEUROBIOL, V60, P395, DOI 10.1002/neu.20047; Endepols H, 2000, BRAIN RES REV, V33, P179, DOI 10.1016/S0165-0173(00)00029-1; FENG AS, 1991, J COMP NEUROL, V306, P613, DOI 10.1002/cne.903060407; Fernald RD, 2012, P NATL ACAD SCI USA, V109, P17194, DOI 10.1073/pnas.1202552109; Forlano PM, 2011, HORM BEHAV, V59, P616, DOI 10.1016/j.yhbeh.2010.10.006; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; Forlano Paul M., 2007, P25; Forlano PM, 2005, J COMP NEUROL, V483, P91, DOI 10.1002/cne.20397; Genova RM, 2012, HORM BEHAV, V62, P426, DOI 10.1016/j.yhbeh.2012.07.010; Goodson JL, 2009, FRONT NEUROENDOCRIN, V30, P429, DOI 10.1016/j.yfrne.2009.05.007; Goodson JL, 2009, P NATL ACAD SCI USA, V106, P8737, DOI 10.1073/pnas.0811821106; Goodson JL, 2000, BRAIN RES, V865, P107, DOI 10.1016/S0006-8993(00)02232-0; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Goodson JL, 2000, J COMP NEUROL, V422, P363, DOI 10.1002/1096-9861(20000703)422:3<363::AID-CNE4>3.0.CO;2-8; Goodson JL, 2005, P ROY SOC B-BIOL SCI, V272, P227, DOI 10.1098/rspb.2004.2892; Goodson JL, 2000, NATURE, V403, P769, DOI 10.1038/35001581; Goodson JL, 2002, J COMP NEUROL, V448, P298, DOI 10.1002/cne.10258; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Heimovics SA, 2006, HORM BEHAV, V50, P726, DOI 10.1016/j.yhbeh.2006.06.013; Heimovics SA, 2011, HORM BEHAV, V60, P529, DOI 10.1016/j.yhbeh.2011.08.001; HIGHSTEIN SM, 1992, J COMP NEUROL, V319, P501, DOI 10.1002/cne.903190404; Hoke KL, 2007, P ROY SOC B-BIOL SCI, V274, P641, DOI 10.1098/rspb.2006.0038; Hoke KL, 2005, P NATL ACAD SCI USA, V102, P10712, DOI 10.1073/pnas.0502361102; Hoke KL, 2004, J NEUROSCI, V24, P11264, DOI 10.1523/JNEUROSCI.2079-04.2004; Howell DC., 2012, STAT METHODS PSYCHOL; HULL EM, 1995, J NEUROSCI, V15, P7465; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Kelley DB, 2004, CURR OPIN NEUROBIOL, V14, P751, DOI 10.1016/j.conb.2004.10.015; Kittelberger JM, 2006, J NEUROPHYSIOL, V96, P71, DOI 10.1152/jn.00067.2006; Kittelberger JM, 2013, J COMP NEUROL, V521, P791, DOI 10.1002/cne.23202; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; LeBlanc MM, 2007, BRAIN RES, V1171, P93, DOI 10.1016/j.brainres.2007.06.086; Ling TJ, 2010, PHYSIOL BEHAV, V99, P571, DOI 10.1016/j.physbeh.2010.01.025; LU Z, 1995, J COMP PHYSIOL A, V176, P747; Lynch KS, 2008, PHYSIOL BEHAV, V93, P870, DOI 10.1016/j.physbeh.2007.12.004; Lynch KS, 2012, BRAIN BEHAV EVOLUT, V79, P252, DOI 10.1159/000337533; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; MA PM, 1994, J COMP NEUROL, V344, P242, DOI 10.1002/cne.903440206; MA PM, 1994, J COMP NEUROL, V344, P256, DOI 10.1002/cne.903440207; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; Maney DL, 2003, J NEUROBIOL, V56, P163, DOI 10.1002/neu.10227; Mangiamele LA, 2008, BRAIN BEHAV EVOLUT, V72, P239, DOI 10.1159/000171481; Maruska KP, 2013, J NEUROENDOCRINOL, V25, P145, DOI 10.1111/j.1365-2826.2012.02382.x; Karen PM, 2009, J COMP NEUROL, V512, P628, DOI 10.1002/cne.21923; Matragrano LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039388; Matragrano LL, 2011, EUR J NEUROSCI, V34, P416, DOI 10.1111/j.1460-9568.2011.07751.x; Matsui H, 2009, NEUROSCI RES, V65, P263, DOI 10.1016/j.neures.2009.07.010; McCormick CA, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P283; McCormick Catherine A., 1999, Springer Handbook of Auditory Research, V11, P155; McKibben JR, 1998, J ACOUST SOC AM, V104, P3520, DOI 10.1121/1.423938; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; O'Connell LA, 2012, HORM BEHAV, V61, P725, DOI 10.1016/j.yhbeh.2012.03.009; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Okuyama T, 2011, BIOCHEM BIOPH RES CO, V404, P453, DOI 10.1016/j.bbrc.2010.11.143; PINAUD R, 2006, IMM EARL GEN SENS, pR7; Remage-Healey L, 2005, HORM BEHAV, V47, P297, DOI 10.1016/j.yhbeh.2004.11.017; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Riters LV, 2007, GEN COMP ENDOCR, V154, P137, DOI 10.1016/j.ygcen.2007.05.029; Saito H, 2000, HEARING RES, V145, P37, DOI 10.1016/S0378-5955(00)00070-8; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; Schlinger BA, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P897; Schweitzer J, 2012, DEV NEUROBIOL, V72, P256, DOI 10.1002/dneu.20911; Sewall KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059857; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Sisneros JA, 2009, INTEGR ZOOL, V4, P33, DOI 10.1111/j.1749-4877.2008.00133.x; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Steele SL, 2011, J COMP PHYSIOL B, V181, P527, DOI 10.1007/s00360-010-0544-0; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Tomchik SM, 2005, J COMP NEUROL, V481, P96, DOI 10.1002/cne.20363; Watt MJ, 2007, PHYSIOL BEHAV, V90, P567, DOI 10.1016/j.physbeh.2006.11.006; Weeg MS, 2000, J COMP NEUROL, V418, P41; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1989, J COMP PHYSIOL A, V166, P189; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Yamamoto K, 2011, J COMP NEUROL, V519, P576, DOI 10.1002/cne.22535; Zeddies DG, 2012, J EXP BIOL, V215, P152, DOI 10.1242/jeb.064998; Zeddies DG, 2010, J ACOUST SOC AM, V127, P3104, DOI 10.1121/1.3365261	106	27	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70474	10.1371/journal.pone.0070474	http://dx.doi.org/10.1371/journal.pone.0070474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936438	Green Published, gold			2022-12-27	WOS:000324401500040
J	Zhu, Q; Li, ZM; Liu, JX; Fan, ZZ; Yu, L; Chen, Y				Zhu, Qi; Li, Zhengming; Liu, Jinxing; Fan, Zizhu; Yu, Lei; Chen, Yan			Improved Minimum Squared Error Algorithm with Applications to Face Recognition	PLOS ONE			English	Article							KERNEL MSE ALGORITHM; DISCRIMINANT-ANALYSIS; 2-DIMENSIONAL PCA; REPRESENTATION; EIGENFACES; COARSE	Minimum squared error based classification (MSEC) method establishes a unique classification model for all the test samples. However, this classification model may be not optimal for each test sample. This paper proposes an improved MSEC (IMSEC) method, which is tailored for each test sample. The proposed method first roughly identifies the possible classes of the test sample, and then establishes a minimum squared error (MSE) model based on the training samples from these possible classes of the test sample. We apply our method to face recognition. The experimental results on several datasets show that IMSEC outperforms MSEC and the other state-of-the-art methods in terms of accuracy.	[Zhu, Qi; Li, Zhengming; Fan, Zizhu] Harbin Inst Technol, Biocomp Ctr, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Zhu, Qi] Shanghai Univ Sci & Technol, Sch Opt Elect & Comp Engn, Shanghai 201800, Peoples R China; [Zhu, Qi; Li, Zhengming] Key Lab Network Oriented Intelligent Computat, Shenzhen, Peoples R China; [Li, Zhengming] Guangdong Polytech Normal Univ, Guangdong Ind Training Ctr, Guangzhou, Guangdong, Peoples R China; [Liu, Jinxing] Qufu Normal Univ, Coll Informat & Commun Technol, Rizhao, Peoples R China; [Fan, Zizhu] East China Jiaotong Univ, Sch Basic Sci, Nanchang, Peoples R China; [Yu, Lei] Harbin Inst Technol, Sch Urban Planning & Management, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Chen, Yan] Shenzhen Sunwin Intelligent Co Ltd, Shenzhen, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen; University of Shanghai for Science & Technology; Guangdong Polytechnic Normal University; Qufu Normal University; East China Jiaotong University; Harbin Institute of Technology; University Town of Shenzhen	Chen, Y (corresponding author), Shenzhen Sunwin Intelligent Co Ltd, Shenzhen, Peoples R China.	yanchenhitsz@163.com	Liu, Jin-Xing/AAU-7257-2020		National Nature Science Committee of China [61071179]; Shenzhen Key Laboratory of Network Oriented Intelligent Computation	National Nature Science Committee of China; Shenzhen Key Laboratory of Network Oriented Intelligent Computation	This work was supported by National Nature Science Committee of China under grant number 61071179 and the Shenzhen Key Laboratory of Network Oriented Intelligent Computation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit Y, 2004, IEEE T PATTERN ANAL, V26, P1606, DOI 10.1109/TPAMI.2004.111; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Chen S, 2009, NEUROCOMPUTING, V72, P2670, DOI 10.1016/j.neucom.2008.10.002; DUDA RO, 2001, PATTERN CLASSIFICATI; Gangaputra S, 2006, IEEE C COMP VIS PATT; Lai ZH, 2012, IEEE T NEUR NET LEAR, V23, P1948, DOI 10.1109/TNNLS.2012.2217154; Lin ZC, 2008, INT J COMPUT VISION, V80, P406, DOI 10.1007/s11263-008-0148-2; Liu G., 2010, P INT C MACH LEARN, P663, DOI DOI 10.1109/ICDMW.2010.64; Liu RS, 2012, PROC CVPR IEEE, P598, DOI 10.1109/CVPR.2012.6247726; Naseem I, 2010, IEEE T PATTERN ANAL, V32, P2106, DOI 10.1109/TPAMI.2010.128; Pham TV, 2006, IEEE T PATTERN ANAL, V28, P555, DOI 10.1109/TPAMI.2006.84; Qi YF, 2009, APPL MATH COMPUT, V213, P1, DOI 10.1016/j.amc.2009.03.014; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wagner A, 2009, NEURAL COMPUTING APP; Wang JH, 2012, PATTERN RECOGN, V45, P1136, DOI 10.1016/j.patcog.2011.09.004; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Xiong HL, 2005, PATTERN RECOGN, V38, P1121, DOI 10.1016/j.patcog.2004.12.003; Xu JH, 2001, IEEE IJCNN, P1486, DOI 10.1109/IJCNN.2001.939584; Xu Y, 2006, PATTERN RECOGN, V39, P1026, DOI 10.1016/j.patcog.2005.10.029; Xu Y, 2013, NEURAL COMPUT APPL, V22, P1543, DOI 10.1007/s00521-012-0833-5; Xu Y, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.1.017205; Xu Y, 2011, NEUROCOMPUTING, V74, P3946, DOI 10.1016/j.neucom.2011.08.011; Xu Y, 2011, IEEE T CIRC SYST VID, V21, P1255, DOI 10.1109/TCSVT.2011.2138790; Xu Y, 2011, OPT ENG, V50, DOI 10.1117/1.3554740; Xu Y, 2009, INT J INNOV COMPUT I, V5, P2439; Yang H, 2003, IMAGE VISION COMPUT, V21, P1037, DOI 10.1016/j.imavis.2003.07.005; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yang M, 2011, IEEE T PATTERN ANAL; Ye Y., 2007, P 24 INT C MACH LEAR, P1087, DOI DOI 10.1145/1273496.1273633; Zhang DQ, 2005, NEUROCOMPUTING, V69, P224, DOI 10.1016/j.neucom.2005.06.004; Zhang L, 2011, IEEE I CONF COMP VIS, P471, DOI 10.1109/ICCV.2011.6126277; Zheng WS, 2008, PATTERN RECOGN, V41, P2156, DOI 10.1016/j.patcog.2007.11.025; Zhu Q, 2013, NEURAL COMPUT APPL, V23, P947, DOI 10.1007/s00521-012-1019-x; Zhu Q, 2010, NEUROCOMPUTING, V73, P3334, DOI 10.1016/j.neucom.2010.04.007; Zuo WM, 2011, IEEE T IMAGE PROCESS, V20, P2748, DOI 10.1109/TIP.2011.2131665; Zuo WM, 2010, PROC CVPR IEEE, P2265, DOI 10.1109/CVPR.2010.5539909	37	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70370	10.1371/journal.pone.0070370	http://dx.doi.org/10.1371/journal.pone.0070370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936418	gold, Green Published, Green Submitted			2022-12-27	WOS:000324401500029
J	Akter, S; Jesmin, S; Rahman, MM; Islam, MM; Khatun, MT; Yamaguchi, N; Akashi, H; Mizutani, T				Akter, Shamima; Jesmin, Subrina; Rahman, Md Mizanur; Islam, Md Majedul; Khatun, Most Tanzila; Yamaguchi, Naoto; Akashi, Hidechika; Mizutani, Taro			Higher Gravidity and Parity Are Associated with Increased Prevalence of Metabolic Syndrome among Rural Bangladeshi Women	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; CORONARY-HEART-DISEASE; BLOOD-PRESSURE; PREGNANCY; HYPERTENSION; OBESITY; WEIGHT; HEALTH	Background: Parity increases the risk for coronary heart disease; however, its association with metabolic syndrome among women in low-income countries is still unknown. Objective: This study investigates the association between parity or gravidity and metabolic syndrome in rural Bangladeshi women. Methods: A cross-sectional study was conducted in 1,219 women aged 15-75 years from rural Bangladesh. Metabolic syndrome was defined according to the standard NCEP-ATP III criteria. Logistic regression was used to estimate the association between parity and gravidity and metabolic syndrome, with adjustment of potential confounding variables. Results: Subjects with the highest gravidity (> = 4) had 1.66 times higher odds of having metabolic syndrome compared to those in the lowest gravidity (0-1) (P-trend = 0.02). A similar association was found between parity and metabolic syndrome (P-trend = 0.04), i.e., subjects in the highest parity (> = 4) had 1.65 times higher odds of having metabolic syndrome compared to those in the lowest parity (0-1). This positive association of parity and gravidity with metabolic syndrome was confined to pre-menopausal women (P-trend < 0.01). Among the components of metabolic syndrome only high blood pressure showed positive association with parity and gravidity (P-trend = 0.01 and < 0.001). Neither Parity nor gravidity was appreciably associated with other components of metabolic syndrome. Conclusions: Multi parity or gravidity may be a risk factor for metabolic syndrome.	[Akter, Shamima; Jesmin, Subrina; Rahman, Md Mizanur; Islam, Md Majedul; Khatun, Most Tanzila; Yamaguchi, Naoto] Probal Housing Ltd, HDRCRP, Dhaka, Bangladesh; [Jesmin, Subrina; Mizutani, Taro] Univ Tsukuba, Grad Sch Med, Fac Med, Tsukuba, Ibaraki, Japan; [Akter, Shamima; Akashi, Hidechika] Natl Ctr Global Hlth & Med NCGM, Shinjuku Ku, Tokyo, Japan; [Rahman, Md Mizanur] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	University of Tsukuba; University of Tokyo	Jesmin, S (corresponding author), Probal Housing Ltd, HDRCRP, Dhaka, Bangladesh.	jsubrina@hdrcrp.org			Ministry of Education, Culture, Sports, Science and Technology of Japan [22406025, 23406037, 23406016, 23406029, 24406026, 25305034]; Japan Society for the promotion of Science; World Diabetes Foundation, Denmark; Grants-in-Aid for Scientific Research [24406026, 23406016] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Diabetes Foundation, Denmark; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (overseas academic) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22406025, 23406037, 23406016, 23406029, 24406026, 25305034), and Japan Society for the promotion of Science. Current project on diabetes from World Diabetes Foundation, Denmark to Human and Diseases Research Center for Rural Peoples has also supported a part of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-99; BERNSTEIN L, 1985, J NATL CANCER I, V74, P741; Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Cohen A, 2006, J WOMENS HEALTH, V15, P763, DOI 10.1089/jwh.2006.15.763; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Gholap N, 2011, PRIM CARE DIABETES, V5, P45, DOI 10.1016/j.pcd.2010.08.002; Giubertoni E, 2013, J HYPERTENS, V31, P501, DOI 10.1097/HJH.0b013e32835c1742; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gunderson EP, 2004, AM J EPIDEMIOL, V159, P1028, DOI 10.1093/aje/kwh146; Gunderson EP, 2004, INT J OBESITY, V28, P525, DOI 10.1038/sj.ijo.0802551; Gunderson EP, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.031; Jesmin S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-49; Jesmin S, 2012, DIABETES RES CLIN PR, V95, pE7, DOI 10.1016/j.diabres.2011.09.025; KRITZSILVERSTEIN D, 1992, J CLIN EPIDEMIOL, V45, P761, DOI 10.1016/0895-4356(92)90053-P; Lao XQ, 2006, CLIN ENDOCRINOL, V65, P460, DOI 10.1111/j.1365-2265.2006.02615.x; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; Lewis CE, 1996, AM J EPIDEMIOL, V144, P247, DOI 10.1093/oxfordjournals.aje.a008919; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Mousavi E, 2009, METAB SYNDR RELAT D, V7, P519, DOI 10.1089/met.2008.0076; NESS RB, 1993, EPIDEMIOLOGY, V4, P303, DOI 10.1097/00001648-199307000-00005; NESS RB, 1994, EPIDEMIOL REV, V16, P298, DOI 10.1093/oxfordjournals.epirev.a036155; ROSSNER S, 1992, INT J OBESITY, V16, P145; SMITH DE, 1994, JAMA-J AM MED ASSOC, V271, P1747, DOI 10.1001/jama.271.22.1747; Taylor JY, 2012, ETHNIC DIS, V22, P360; Taylor Jacquelyn Y, 2008, J Natl Black Nurses Assoc, V19, P12; VANSTIPHOUT WAHJ, 1987, AM J EPIDEMIOL, V126, P922; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; World Health Organization, 2008, GLOB BURD DIS 2004 U	31	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e68319	10.1371/journal.pone.0068319	http://dx.doi.org/10.1371/journal.pone.0068319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936302	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800005
J	Mutsaers, HAM; Engelke, UFH; Wilmer, MJG; Wetzels, JFM; Wevers, RA; van den Heuvel, LP; Hoenderop, JG; Masereeuw, R				Mutsaers, Henricus A. M.; Engelke, Udo F. H.; Wilmer, Martijn J. G.; Wetzels, Jack F. M.; Wevers, Ron A.; van den Heuvel, Lambertus P.; Hoenderop, Joost G.; Masereeuw, Rosalinde			Optimized Metabolomic Approach to Identify Uremic Solutes in Plasma of Stage 3-4 Chronic Kidney Disease Patients	PLOS ONE			English	Article							DIMETHYL SULFONE; P-CRESOL; METABOLITES; TOXINS; DIMETHYLSULFOXIDE; SERUM; H-1; TOXICOKINETICS; ACCUMULATION; SULFOXIDE	Background: Chronic kidney disease (CKD) is characterized by the progressive accumulation of various potential toxic solutes. Furthermore, uremic plasma is a complex mixture hampering accurate determination of uremic toxin levels and the identification of novel uremic solutes. Methods: In this study, we applied H-1-nuclear magnetic resonance (NMR) spectroscopy, following three distinct deproteinization strategies, to determine differences in the plasma metabolic status of stage 3-4 CKD patients and healthy controls. Moreover, the human renal proximal tubule cell line (ciPTEC) was used to study the influence of newly indentified uremic solutes on renal phenotype and functionality. Results: Protein removal via ultrafiltration and acetonitrile precipitation are complementary techniques and both are required to obtain a clear metabolome profile. This new approach, revealed that a total of 14 metabolites were elevated in uremic plasma. In addition to confirming the retention of several previously identified uremic toxins, including p-cresyl sulphate, two novel uremic retentions solutes were detected, namely dimethyl sulphone (DMSO2) and 2-hydroxyisobutyric acid (2-HIBA). Our results show that these metabolites accumulate in non-dialysis CKD patients from 9 +/- 7 mu M (control) to 51 +/- 29 mu M and from 7 (0-9) mu M (control) to 32 +/- 15 mu M, respectively. Furthermore, exposure of ciPTEC to clinically relevant concentrations of both solutes resulted in an increased protein expression of the mesenchymal marker vimentin with more than 10% (p < 0.05). Moreover, the loss of epithelial characteristics significantly correlated with a loss of glucuronidation activity (Pearson r = -0.63; p<0.05). In addition, both solutes did not affect cell viability nor mitochondrial activity. Conclusions: This study demonstrates the importance of sample preparation techniques in the identification of uremic retention solutes using H-1-NMR spectroscopy, and provide insight into the negative impact of DMSO2 and 2-HIBA on ciPTEC, which could aid in understanding the progressive nature of renal disease.	[Mutsaers, Henricus A. M.; Wilmer, Martijn J. G.; Masereeuw, Rosalinde] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands; [Mutsaers, Henricus A. M.; Hoenderop, Joost G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6525 ED Nijmegen, Netherlands; [Engelke, Udo F. H.; Wevers, Ron A.; van den Heuvel, Lambertus P.] Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Dis, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [van den Heuvel, Lambertus P.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands; [van den Heuvel, Lambertus P.] Catholic Univ Louvain, Dept Pediat, B-3000 Louvain, Belgium	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Universite Catholique Louvain	Masereeuw, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands.	r.masereeuw@pharmtox.umcn.nl	Hoenderop, Joost G.J./H-8047-2014; Masereeuw, Roos/N-3582-2014; Wilmer, Martijn J/I-7455-2015; van den Heuvel, L.P.W.J./H-8044-2014; Engelke, U.F.H./L-4293-2015; Wetzels, Jack F.M./A-1720-2014; Mutsaers, Henricus/AAK-6321-2020; van den Heuvel, Lambertus/AAM-1772-2021; Masereeuw, Roos/I-5276-2016; Wevers, Ron A./H-8116-2014	Hoenderop, Joost G.J./0000-0002-1816-8544; Wilmer, Martijn J/0000-0003-4832-105X; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Wetzels, Jack F.M./0000-0002-0650-6921; Mutsaers, Henricus/0000-0002-9553-8860; van den Heuvel, Lambertus/0000-0003-3917-6727; Masereeuw, Roos/0000-0002-1560-1074; Wevers, Ron A./0000-0003-2278-9746	Dutch Kidney Foundation [IK08.03]; Dutch government [FES0908]; EURYI award from the European Science Foundation	Dutch Kidney Foundation; Dutch government; EURYI award from the European Science Foundation	This work was supported by the Dutch Kidney Foundation (grant number IK08.03; www.nierstichting.nl). M.J.G. Wilmer was supported by a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, grant No. FES0908; www.nirm.nl) and J.G. Hoenderop was supported by an EURYI award from the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg A, 2001, TOXICOL SCI, V61, P62, DOI 10.1093/toxsci/61.1.62; Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; BEILKE MA, 1987, J LAB CLIN MED, V110, P91; Choi JY, 2011, NEPHROL DIAL TRANSPL, V26, P1304, DOI 10.1093/ndt/gfq554; Daykin CA, 2002, ANAL BIOCHEM, V304, P220, DOI 10.1006/abio.2002.5637; de Loor H, 2005, CLIN CHEM, V51, P1535, DOI 10.1373/clinchem.2005.050781; Dekant W, 2001, TOXICOL LETT, V124, P37, DOI 10.1016/S0378-4274(00)00284-8; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Eloot S, 2011, CLIN J AM SOC NEPHRO, V6, P1266, DOI 10.2215/CJN.09981110; Engelke UFH, 2005, NMR BIOMED, V18, P331, DOI 10.1002/nbm.966; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Feigenbaum J, 1941, J AM CHEM SOC, V63, P3529, DOI 10.1021/ja01857a508; Ferreira ACS, 2003, J AGR FOOD CHEM, V51, P727, DOI 10.1021/jf025934g; Herget-Rosenthal S, 2009, SEMIN DIALYSIS, V22, P445, DOI 10.1111/j.1525-139X.2009.00598.x; JACOB SW, 1983, ANN NY ACAD SCI, V411, pR13, DOI 10.1111/j.1749-6632.1983.tb47276.x; Kloesch B, 2011, LIFE SCI, V89, P473, DOI 10.1016/j.lfs.2011.07.015; LAYMAN DL, 1985, LIFE SCI, V37, P2431, DOI 10.1016/0024-3205(85)90111-0; LAYMAN DL, 1987, IN VITRO CELL DEV B, V23, P422; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Moghadasali R, 2013, EXP TOXICOL PATHOL, V65, P595, DOI 10.1016/j.etp.2012.06.002; Mutsaers HAM, 2013, BBA-MOL BASIS DIS, V1832, P142, DOI 10.1016/j.bbadis.2012.09.006; Mutsaers HAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018438; Neirynck N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044201; Niwa T, 1998, KIDNEY INT, V53, P1801, DOI 10.1046/j.1523-1755.1998.00944.x; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Raj DSC, 2000, BLOOD PURIFICAT, V18, P97, DOI 10.1159/000014431; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Shah VO, 2013, CLIN J AM SOC NEPHRO, V8, P363, DOI 10.2215/CJN.05540512; Shaykhutdinov RA, 2009, METABOLOMICS, V5, P307, DOI 10.1007/s11306-009-0155-5; Suhre K, 2011, NAT GENET, V43, P565, DOI 10.1038/ng.837; Tiziani S, 2008, ANAL BIOCHEM, V377, P16, DOI 10.1016/j.ab.2008.01.037; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2011, NEPHROL DIAL TRANSPL, V26, P1464, DOI 10.1093/ndt/gfr056; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; WILLIAMS KI, 1966, ARCH BIOCHEM BIOPHYS, V113, P251, DOI 10.1016/0003-9861(66)90182-2; WILLIAMS KI, 1966, P SOC EXP BIOL MED, V122, P865, DOI 10.3181/00379727-122-31272; Wilmer MJ, 2011, BBA-MOL BASIS DIS, V1812, P643, DOI 10.1016/j.bbadis.2011.02.010; Wilmer MJ, 2010, CELL TISSUE RES, V339, P449, DOI 10.1007/s00441-009-0882-y; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wittgen HGM, 2012, DRUG METAB DISPOS, V40, P1076, DOI 10.1124/dmd.111.044438	42	51	52	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71199	10.1371/journal.pone.0071199	http://dx.doi.org/10.1371/journal.pone.0071199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936492	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800060
J	Zhao, B; Dong, ST; Zhang, JW; Liu, P				Zhao, Bin; Dong, Shuting; Zhang, Jiwang; Liu, Peng			Effects of Controlled-Release Fertiliser on Nitrogen Use Efficiency in Summer Maize	PLOS ONE			English	Article							PHOTOSYNTHESIS; ACCUMULATION; MANAGEMENT; GROWTH	Nitrogen (N) is a nutrient element necessary for plant growth and development. However, excessive inputs of N will lead to inefficient use and large N losses to the environment, which can adversely affect air and water quality, biodiversity and human health. To examine the effects of controlled-release fertilisers (CRF) on yield, we measured ammonia volatilisation, N use efficiency (NUE) and photosynthetic rate after anthesis in summer maize hybrid cultivar Zhengdan958. Maize was grown using common compound fertiliser (CCF), the same amount of resin-coated controlled release fertiliser (CRFIII), the same amount of sulphur-coated controlled release fertiliser (SCFIII) as CCF, 75% CRF (CRFII) and SCF (SCFII), 50% CRF (CRFI) and SCF (SCFI), and no fertiliser. We found that treatments CRFIII, SCFIII, CRFII and SCFII produced grain yields that were 13.15%, 14.15%, 9.69% and 10.04% higher than CCF. There were no significant differences in grain yield among CRFI, SCFI and CCF. We also found that the ammonia volatilisation rates of CRF were significantly lower than those of CCF. The CRF treatments reduced the emission of ammonia by 51.34% to 91.34% compared to CCF. In addition, after treatment with CRF, maize exhibited a higher net photosynthetic rate than CCF after anthesis. Agronomic NUE and apparent N recovery were higher in the CRF treatment than in the CCF treatment. The N uptake and physiological NUE of the four yield-enhanced CRF treatments were higher than those of CCF. These results suggest that the increase in NUE in the CRF treatments was generally attributable to the higher photosynthetic rate and lower ammonia volatilisation compared to CCF-treated maize.	[Zhao, Bin; Dong, Shuting; Zhang, Jiwang; Liu, Peng] Shandong Agr Univ, Coll Agron, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Dong, ST (corresponding author), Shandong Agr Univ, Coll Agron, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	stdong@sdau.edu.cn			National Natural Science Foundation of China [31171497, 31071358]; System of Maize Modern Industrial Technologies [nyhyzx07-003]; Ministry of Agriculture System of Maize Industrial Technologies [CARS-02]; Major State Basic Research Development Program of China (973 Program) [2011CB100105]; Special Fund for Agro-scientific Research in the Public Interest [20120306, HY1203096]; "Five-twelfth" National Science and Technology Support Program [2011BAD16B14, 2011BAD11B01, 2011BAD11B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); System of Maize Modern Industrial Technologies; Ministry of Agriculture System of Maize Industrial Technologies; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; "Five-twelfth" National Science and Technology Support Program(Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (31171497, 31071358), System of Maize Modern Industrial Technologies (nyhyzx07-003), Ministry of Agriculture System of Maize Industrial Technologies (CARS-02), The Major State Basic Research Development Program of China (973 Program) (2011CB100105), Special Fund for Agro-scientific Research in the Public Interest (20120306, HY1203096), "Five-twelfth" National Science and Technology Support Program (2011BAD16B14, 2011BAD11B01, 2011BAD11B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya T, 2006, PLANT CELL PHYSIOL, V47, P644, DOI 10.1093/pcp/pcj033; Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098; Bao S. D., 2005, AGR SOIL ANAL; Dawson JC, 2008, FIELD CROP RES, V107, P89, DOI 10.1016/j.fcr.2008.01.001; Ding L, 2005, FIELD CROP RES, V93, P108, DOI 10.1016/j.fcr.2004.09.008; Dobrahner J, 2007, SOIL SCI, V172, P242, DOI 10.1097/ss.0b013e31803063e2; Donnison IS, 2007, NEW PHYTOL, V173, P481, DOI 10.1111/j.1469-8137.2006.01928.x; Du C, 2008, BIOSYST ENG, V99, P478, DOI 10.1016/j.biosystemseng.2007.12.003; DWYER LM, 1989, CAN J PLANT SCI, V69, P81, DOI 10.4141/cjps89-010; Foulkes MJ, 2009, FIELD CROP RES, V114, P329, DOI 10.1016/j.fcr.2009.09.005; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Goulding K, 2008, PHILOS T R SOC B, V363, P667, DOI 10.1098/rstb.2007.2177; HARPER LA, 1995, AGRON J, V87, P669, DOI 10.2134/agronj1995.00021962008700040011x; Ju XT, 2004, AMBIO, V33, P300, DOI 10.1639/0044-7447(2004)033[0300:NFSNAA]2.0.CO;2; Liao XL, 1983, PROGR SOIL SCI, V11, P49; Medina LC, 2008, HORTTECHNOLOGY, V18, P475, DOI 10.21273/HORTTECH.18.3.475; Milich L, 1999, GLOBAL ENVIRON CHANG, V9, P179, DOI 10.1016/S0959-3780(98)00037-5; Motavalli PP, 2008, CROP MANAGEMENT, DOI [10.1094/CM-2008-0730-02-RV, DOI 10.1094/CM-2008-0730-02-RV]; NEWBOULD P, 1989, PLANT SOIL, V115, P297, DOI 10.1007/BF02202596; Oliet J, 2004, SCI HORTIC-AMSTERDAM, V103, P113, DOI 10.1016/j.scienta.2004.04.019; Reuss JO, 1986, ECOL STUDIES, V59; Tang ShuanHu, 2007, Agricultural Sciences in China, V6, P586, DOI 10.1016/S1671-2927(07)60087-X; Wang RF, 2011, CROP PASTURE SCI, V62, P504, DOI 10.1071/CP10383; Wang RF, 2009, IND CROP PROD, V29, P182, DOI 10.1016/j.indcrop.2008.04.025; Wang ZH, 2004, COMMUN SOIL SCI PLAN, V35, P2917, DOI [10.1081/LCSS-200036499, 10.1081/CSS-200036499]; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067; Zotarelli L, 2008, J ENVIRON QUAL, V37, P1271, DOI 10.2134/jeq2007.0460	28	44	55	3	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70569	10.1371/journal.pone.0070569	http://dx.doi.org/10.1371/journal.pone.0070569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936449	gold, Green Submitted, Green Published			2022-12-27	WOS:000324545800044
J	Chiyomaru, T; Yamamura, S; Fukuhara, S; Yoshino, H; Kinoshita, T; Majid, S; Saini, S; Chang, I; Tanaka, Y; Enokida, H; Seki, N; Nakagawa, M; Dahiya, R				Chiyomaru, Takeshi; Yamamura, Soichiro; Fukuhara, Shinichiro; Yoshino, Hirofumi; Kinoshita, Takashi; Majid, Shahana; Saini, Sharanjot; Chang, Inik; Tanaka, Yuichiro; Enokida, Hideki; Seki, Naohiko; Nakagawa, Masayuki; Dahiya, Rajvir			Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR	PLOS ONE			English	Article							LONG NONCODING RNA; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAYS; EXPRESSION; BETA; MICRORNA-27A; PROGRESSION; SOX17; RISK	Objective: Genistein is a soy isoflavone that has antitumor activity both in vitro and in vivo. It has been shown that genistein inhibits many type of cancers including prostate cancer (PCa) by regulating several cell signaling pathways and microRNAs (miRNAs). Recent studies suggest that the long non-coding RNAs (lncRNAs) are also involved in many cellular processes. At present there are no reports about the relationship between gensitein, miRNAs and lncRNAs. In this study, we focused on miRNAs, lncRNA that are regulated by genistein and investigated their functional role in PCa. Method: Microarray (SurePrint G3 Human GE 8x60K) was used for expression profiling of genistein treated and control PCa cells (PC3 and DU145). Functional assay (cell proliferation, migration, invasion, apoptosis and cell cycle assays) were performed with the PCa cell lines, PC3 and DU145. Both in vitro and in vivo (nude mouse) models were used for growth assays. Luciferase reporter assays were used for binding of miR-34a to HOTAIR. Results: LncRNA profiling showed that HOTAIR was highly regulated by genistein and its expression was higher in castration-resistant PCa cell lines than in normal prostate cells. Knockdown (siRNA) of HOTAIR decreased PCa cell proliferation, migration and invasion and induced apoptosis and cell cycle arrest. miR-34a was also up-regulated by genistein and may directly target HOTAIR in both PC3 and DU145 PCa cells. Conclusions: Our results indicated that genistein inhibited PCa cell growth through down-regulation of oncogenic HOTAIR that is also targeted by tumor suppressor miR-34a. These findings enhance understanding of how genistein regulates lncRNA HOTAIR and miR-34a in PCa.	[Chiyomaru, Takeshi; Yamamura, Soichiro; Fukuhara, Shinichiro; Majid, Shahana; Saini, Sharanjot; Chang, Inik; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA; [Chiyomaru, Takeshi; Yamamura, Soichiro; Fukuhara, Shinichiro; Majid, Shahana; Saini, Sharanjot; Chang, Inik; Tanaka, Yuichiro; Dahiya, Rajvir] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yoshino, Hirofumi; Enokida, Hideki] Kagoshima Univ, Dept Urol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Kinoshita, Takashi; Seki, Naohiko; Nakagawa, Masayuki] Chiba Univ, Dept Funct Genom, Grad Sch Med, Chiba, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Kagoshima University; Chiba University	Dahiya, R (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health [R01CA160079, R01CA138642, T32DK007790]; VA Merit Review and VA Program Project; NATIONAL CANCER INSTITUTE [R01CA160079, R01CA138642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review and VA Program Project(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Center for Research Resources of the National Institutes of Health through Grant Number R01CA160079, R01CA138642, T32DK007790 and VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058929; Chiyomaru T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043812; Cui Z, 2012, UROL ONCOL; de Souza PL, 2010, NUTR REV, V68, P542, DOI 10.1111/j.1753-4887.2010.00314.x; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geng YJ, 2011, J INT MED RES, V39, P2119, DOI 10.1177/147323001103900608; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hwang YW, 2009, NUTR CANCER, V61, P598, DOI 10.1080/01635580902825639; Jia Y, 2010, EPIGENETICS-US, V5, P743, DOI 10.4161/epi.5.8.13104; Kim EK, 2007, MOL CELL ENDOCRINOL, V278, P18, DOI 10.1016/j.mce.2007.08.003; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lai YL, 2013, INT J ONCOL, V42, P776, DOI 10.3892/ijo.2012.1743; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Li YW, 2002, CLIN CANCER RES, V8, P2369; Liss Michael A., 2010, Cancer Genomics & Proteomics, V7, P245; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Sun QM, 2009, ONCOL REP, V22, P563, DOI 10.3892/or_00000472; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Vader P, 2011, ANGIOGENESIS, V14, P457, DOI 10.1007/s10456-011-9229-x; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Xue Y, 2013, PROSTATE CANCER P D, V16, P139, DOI 10.1038/pcan.2013.6; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Yan GR, 2011, J PROTEOMICS, V75, P695, DOI 10.1016/j.jprot.2011.09.008; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	44	195	204	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70372	10.1371/journal.pone.0070372	http://dx.doi.org/10.1371/journal.pone.0070372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936419	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400062
J	Li, DD; Qin, YJ; Sun, J; Li, JR; Fang, F; Du, QR; Qian, Y; Gong, HB; Zhu, HL				Li, Dong-Dong; Qin, Ya-Juan; Sun, Jian; Li, Jing-Ran; Fang, Fei; Du, Qian-Ru; Qian, Yong; Gong, Hai-Bin; Zhu, Hai-Liang			Optimization of Substituted 6-Salicyl-4-Anilinoquinazoline Derivatives as Dual EGFR/HER2 Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; BIOLOGICAL EVALUATION; EGFR; 4-ANILINOQUINAZOLINES; THERAPY; BINDING; MODE	4-Anilinoquinazolines as an important class of protein kinase inhibitor are widely investigated for epidermal growth factor receptor (EGFR) tyrosine kinase or epidermal growth factor receptor 2 (HER2) inhibition. A series of novel 6-salicyl-4-anilinoquinazoline derivatives 9-27 were prepared and evaluated for their EGFR/HER2 tyrosine kinase inhibitory activity as well as their antiproliferative properties on three variant cancer cell lines (A431, MCF-7, and A549). The bioassay results showed most of the designed compounds exhibited moderate to potent in vitro inhibitory activity in the enzymatic and cellular assays, of which compound 21 revealed the most potent dual EGFR/HER2 inhibitory activity, with IC50 values of 0.12 mu M and 0.096 mu M, respectively, comparable to the control compounds Erlotinib and Lapatinib. Furthermore, the kinase selectivity profile of 21 was accessed and demonstrated its good selectivity over the majority of the close kinase targets. Docking simulation was performed to position compound 21 into the EGFR/HER2 active site to determine the probable binding pose. These new findings along with molecular docking observations could provide an important basis for further development of compound 21 as a potent EGFR/HER2 dual kinase inhibitor.	[Li, Dong-Dong; Qin, Ya-Juan; Sun, Jian; Li, Jing-Ran; Fang, Fei; Du, Qian-Ru; Qian, Yong; Zhu, Hai-Liang] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Gong, Hai-Bin] Xuzhou Cent Hosp, Xuzhou, Peoples R China	Nanjing University	Gong, HB (corresponding author), Xuzhou Cent Hosp, Xuzhou, Peoples R China.	ghbxzh@yahoo.com.cn; zhuhl@nju.edu.cn	du, qian/GYJ-7090-2022	Qian, Yong/0000-0003-3788-3575; Li, Dong-Dong/0000-0002-8085-9557	Jiangsu National Science Foundation [BK2009239]; Fundamental Research Fund for the Central Universities [1092020804]	Jiangsu National Science Foundation; Fundamental Research Fund for the Central Universities	The authors gratefully acknowledge Jiangsu National Science Foundation (No. BK2009239) and the Fundamental Research Fund for the Central Universities (No. 1092020804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuschat R, 2004, EUR J MED CHEM, V39, P1001, DOI 10.1016/j.ejmech.2004.03.010; Barker AJ, 2001, BIOORG MED CHEM LETT, V11, P1911, DOI 10.1016/S0960-894X(01)00344-4; Carmi C, 2012, J MED CHEM, V55, P2251, DOI 10.1021/jm201507x; Cha MY, 2012, J MED CHEM, V55, P2846, DOI 10.1021/jm201758g; Deng W, 2006, BIOORG MED CHEM LETT, V16, P469, DOI 10.1016/j.bmcl.2005.06.088; Domarkas J, 2006, J MED CHEM, V49, P3544, DOI 10.1021/jm0600390; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Eskens F, 2008, BRIT J CANCER, V98, P80, DOI 10.1038/sj.bjc.6604108; Higa GM, 2007, EXPERT REV ANTICANC, V7, P1183, DOI 10.1586/14737140.7.9.1183; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ishikawa T, 2011, J MED CHEM, V54, P8030, DOI 10.1021/jm2008634; Kettle JG, 2010, J CHEM INF MODEL, V50, P525, DOI 10.1021/ci9004767; Levitzki A, 2003, ACCOUNTS CHEM RES, V36, P462, DOI 10.1021/ar0201207; Li DD, 2012, BIOORG MED CHEM LETT, V22, P5870, DOI 10.1016/j.bmcl.2012.07.079; Li DD, 2011, BIOORGAN MED CHEM, V19, P5012, DOI 10.1016/j.bmc.2011.06.044; Madhusudan S, 2004, CLIN BIOCHEM, V37, P618, DOI 10.1016/j.clinbiochem.2004.05.006; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Ou SHI, 2012, CRIT REV ONCOL HEMAT, V83, P407, DOI 10.1016/j.critrevonc.2011.11.010; Pawar VG, 2010, J MED CHEM, V53, P2892, DOI 10.1021/jm901877j; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sridhar SS, 2003, LANCET ONCOL, V4, P397, DOI 10.1016/S1470-2045(03)01137-9; Traxler P, 2003, EXPERT OPIN THER TAR, V7, P215, DOI 10.1517/14728222.7.2.215; Tsou HR, 2001, J MED CHEM, V44, P2719, DOI 10.1021/jm0005555; Vansteenkiste Johan, 2004, Expert Rev Anticancer Ther, V4, P5, DOI 10.1586/14737140.4.1.5; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	26	13	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69427	10.1371/journal.pone.0069427	http://dx.doi.org/10.1371/journal.pone.0069427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936329	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400014
J	Lukoye, D; Adatu, F; Musisi, K; Kasule, GW; Were, W; Odeke, R; Kalamya, JN; Awor, A; Date, A; Joloba, ML				Lukoye, Deus; Adatu, Francis; Musisi, Kenneth; Kasule, George William; Were, Willy; Odeke, Rosemary; Kalamya, Julius Namonyo; Awor, Ann; Date, Anand; Joloba, Moses L.			Anti-Tuberculosis Drug Resistance among New and Previously Treated Sputum Smear-Positive Tuberculosis Patients in Uganda: Results of the First National Survey	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; HIV-INFECTION; SUSCEPTIBILITY; COHORT	Background: Multidrug resistant and extensively drug resistant tuberculosis (TB) have become major threats to control of tuberculosis globally. The rates of anti-TB drug resistance in Uganda are not known. We conducted a national drug resistance survey to investigate the levels and patterns of resistance to first and second line anti-TB drugs among new and previously treated sputum smear-positive TB cases. Methods: Sputum samples were collected from a nationally representative sample of new and previously treated sputum smear-positive TB patients registered at TB diagnostic centers during December 2009 to February 2011 using a weighted cluster sampling method. Culture and drug susceptibility testing was performed at the national TB reference laboratory. Results: A total of 1537 patients (1397 new and 140 previously treated) were enrolled in the survey from 44 health facilities. HIV test result and complete drug susceptibility testing (DST) results were available for 1524 (96.8%) and 1325 (85.9%) patients, respectively. Of the 1209 isolates from new cases, resistance to any anti-TB drug was 10.3%, 5% were resistant to isoniazid, 1.9% to rifampicin, and 1.4% were multi drug resistant. Among the 116 isolates from previously treated cases, the prevalence of resistance was 25.9%, 23.3%, 12.1% and 12.1% respectively. Of the 1524 patients who had HIV testing 469 (30.7%) tested positive. There was no association between anti-TB drug resistance (including MDR) and HIV infection. Conclusion: The prevalence of anti-TB drug resistance among new patients in Uganda is low relative to WHO estimates. The higher levels of MDR-TB (12.1%) and resistance to any drug (25.3%) among previously treated patients raises concerns about the quality of directly observed therapy (DOT) and adherence to treatment. This calls for strengthening existing TB control measures, especially DOT, routine DST among the previously treated TB patients or periodic drug resistance surveys, to prevent and monitor development and transmission of drug resistant TB.	[Lukoye, Deus; Adatu, Francis] Minist Hlth, Natl TB Leprosy Program, Kampala, Uganda; [Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Musisi, Kenneth; Kasule, George William; Joloba, Moses L.] Natl TB Reference Lab, Kampala, Uganda; [Were, Willy; Odeke, Rosemary; Kalamya, Julius Namonyo; Awor, Ann; Date, Anand] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA	Makerere University; Centers for Disease Control & Prevention - USA	Joloba, ML (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.	Moses.joloba@case.edu		Lukoye, Deus/0000-0002-5362-9924; Joloba, Moses/0000-0002-0334-9983; Kasule, George William/0000-0002-2123-9614	US Centers for Disease Control and Prevention; Global AIDS Program under President's Emergency Plan for AIDS Relief (PEPFAR) through, AIDS Information Centre, Uganda	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global AIDS Program under President's Emergency Plan for AIDS Relief (PEPFAR) through, AIDS Information Centre, Uganda	This survey was supported by the US Centers for Disease Control and Prevention, and the Global AIDS Program under President's Emergency Plan for AIDS Relief (PEPFAR) through, AIDS Information Centre, Uganda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasis D, 1997, INT J TUBERC LUNG D, V1, P220; [Anonymous], 2009, GUID SURV DRUG RES T; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Bretzel G, 1999, INT J TUBERC LUNG D, V3, P810; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Chum HJ, 1996, AIDS, V10, P299, DOI 10.1097/00002030-199603000-00009; Coker RJ, 2004, TROP MED INT HEALTH, V9, P25, DOI 10.1046/j.1365-3156.2003.01156.x; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; DUPON M, 1995, AIDS, V9, P577, DOI 10.1097/00002030-199506000-00008; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Joloba ML, 2000, E AFR MED J, V77, P111; Kenyon TA, 1999, INT J TUBERC LUNG D, V3, P4; LAMBREGTSVANWEEZENBEEK CSB, 1995, TUBERCLE LUNG DIS, V76, P455, DOI 10.1016/0962-8479(95)90014-4; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Menzies D, 2009, PLOS MED, V6, pe1000; MOH, 2010, MAN NAT TUB REF PROG, P60; MOH, 2011, UG AIDS IND SURV AIS, P25; Murray J, 2000, S AFR MED J, V90, P381; PATEL KB, 1995, NEW ENGL J MED, V332, P336, DOI 10.1056/NEJM199502023320518; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Rao JN, 1992, SIMPLE METHOD ANAL C, P577; Sandman L, 1999, AM J RESP CRIT CARE, V159, P468, DOI 10.1164/ajrccm.159.2.9805097; Surveillance, 2001, NEW ENGL J MED, V344, P1294; Umubyeyi AN, 2007, INT J TUBERC LUNG D, V11, P189; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2003, WHOTB320, VWHO/TB/320; WHO, 2011, RAP IMPL XPERT MTB R, V8; WHO/IUATLD, 2008, GLOB PROJ ANT DRUG R; World Health Organization, 2011, WHOHTMTB2011; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599	36	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70763	10.1371/journal.pone.0070763	http://dx.doi.org/10.1371/journal.pone.0070763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936467	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400082
J	Setoyama, D; Iwasa, K; Seta, H; Shimizu, H; Fujimura, Y; Miura, D; Wariishi, H; Nagai, C; Nakahara, K				Setoyama, Daiki; Iwasa, Keiko; Seta, Harumichi; Shimizu, Hiroaki; Fujimura, Yoshinori; Miura, Daisuke; Wariishi, Hiroyuki; Nagai, Chifumi; Nakahara, Koichi			High-Throughput Metabolic Profiling of Diverse Green Coffea arabica Beans Identified Tryptophan as a Universal Discrimination Factor for Immature Beans	PLOS ONE			English	Article							REFLECTANCE	The maturity of green coffee beans is the most influential determinant of the quality and flavor of the resultant coffee beverage. However, the chemical compounds that can be used to discriminate the maturity of the beans remain uncharacterized. We herein analyzed four distinct stages of maturity (immature, semi-mature, mature and overripe) of nine different varieties of green Coffea arabica beans hand-harvested from a single experimental field in Hawaii. After developing a high-throughput experimental system for sample preparation and liquid chromatography-mass spectrometry (LC-MS) measurement, we applied metabolic profiling, integrated with chemometric techniques, to explore the relationship between the metabolome and maturity of the sample in a non-biased way. For the multivariate statistical analyses, a partial least square (PLS) regression model was successfully created, which allowed us to accurately predict the maturity of the beans based on the metabolomic information. As a result, tryptophan was identified to be the best contributor to the regression model; the relative MS intensity of tryptophan was higher in immature beans than in those after the semi-mature stages in all arabica varieties investigated, demonstrating a universal discrimination factor for diverse arabica beans. Therefore, typtophan, either alone or together with other metabolites, may be utilized for traders as an assessment standard when purchasing qualified trading green arabica bean products. Furthermore, our results suggest that the tryptophan metabolism may be tightly linked to the development of coffee cherries and/or beans.	[Setoyama, Daiki; Fujimura, Yoshinori; Miura, Daisuke; Wariishi, Hiroyuki] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Iwasa, Keiko; Seta, Harumichi; Shimizu, Hiroaki; Nakahara, Koichi] Suntory Business Expert Ltd, Frontier Ctr Value Creat, Osaka, Japan; [Nagai, Chifumi] Hawaii Agr Res Ctr, Kunia, HI USA	Kyushu University; Suntory Holdings Ltd	Miura, D (corresponding author), Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan.	daipon@agr.kyushu-u.ac.jp; Koichi_Nakahara@suntory.co.jp	Fujimura, Yoshinori/AAG-4403-2019; Miura, Daisuke/H-1517-2019; NAKAHARA, KOICHI/Q-8665-2019	Fujimura, Yoshinori/0000-0003-0798-0649	Project for Developing Innovation Systems Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology of Japan	Project for Developing Innovation Systems Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Project for Developing Innovation Systems Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, COFFEE RECENT DEV, DOI DOI 10.1016/j.bmc.2009.01.046; Bertrand B, 2005, J SCI FOOD AGR, V85, P955, DOI 10.1002/jsfa.2049; Cell TP, 1995, PLANT CELL, V7, P921; Craig AP, 2011, J FOOD SCI, V76, pC1162, DOI 10.1111/j.1750-3841.2011.02359.x; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; DEMENEZES HC, 1994, FOOD CHEM, V50, P293, DOI 10.1016/0308-8146(94)90136-8; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; El-Abassy RM, 2011, FOOD CHEM, V126, P1443, DOI 10.1016/j.foodchem.2010.11.132; Eriksson L., 2006, MULTI MEGAVARIATE 1; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Leroy Thierry, 2006, Braz. J. Plant Physiol., V18, P229, DOI 10.1590/S1677-04202006000100016; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Mendonca JCF, 2008, FOOD CHEM, V111, P490, DOI 10.1016/j.foodchem.2008.03.080; Nagai C., 2001, 19eme Colloque Scientifique International sur le Cafe, Trieste, Italy, 14-18 mai 2001, P1; Oliveira SD, 2005, FOOD CHEM, V90, P287, DOI 10.1016/j.foodchem.2004.03.056; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Santos JR, 2012, FOOD CHEM, V135, P1828, DOI 10.1016/j.foodchem.2012.06.059; Steiger DL, 2002, THEOR APPL GENET, V105, P209, DOI 10.1007/s00122-002-0939-8; Wei FF, 2010, MAGN RESON CHEM, V48, P857, DOI 10.1002/mrc.2678; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	20	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70098	10.1371/journal.pone.0070098	http://dx.doi.org/10.1371/journal.pone.0070098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936381	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400037
J	te Beest, M; Elschot, K; Olff, H; Etienne, RS				te Beest, Mariska; Elschot, Kelly; Olff, Han; Etienne, Rampal S.			Invasion Success in a Marginal Habitat: An Experimental Test of Competitive Ability and Drought Tolerance in Chromolaena odorata	PLOS ONE			English	Article							BIOMASS ALLOCATION; PLANT; NICHE; EVOLUTION; ECOLOGY; DOMINANCE; WEED	Climatic niche models based on native-range climatic data accurately predict invasive-range distributions in the majority of species. However, these models often do not account for ecological and evolutionary processes, which limit the ability to predict future range expansion. This might be particularly problematic in the case of invaders that occupy environments that would be considered marginal relative to the climatic niche in the native range of the species. Here, we assess the potential for future range expansion in the shrub Chromolaena odorata that is currently invading mesic savannas (>650 mm MAP) in South Africa that are colder and drier than most habitats in its native range. In a greenhouse experiment we tested whether its current distribution in South Africa can be explained by increased competitive ability and/or differentiation in drought tolerance relative to the native population. We compared aboveground biomass, biomass allocation, water use efficiency and relative yields of native and invasive C. odorata and the resident grass Panicum maximum in wet and dry conditions. Surprisingly, we found little differentiation between ranges. Invasive C. odorata showed no increased competitive ability or superior drought tolerance compared to native C. odorata. Moreover we found that P. maximum was a better competitor than either native or invasive C. odorata. These results imply that C. odorata is unlikely to expand its future range towards more extreme, drier, habitats beyond the limits of its current climatic niche and that the species' invasiveness most likely depends on superior light interception when temporarily released from competition by disturbance. Our study highlights the fact that species can successfully invade habitats that are at the extreme end of their ranges and thereby contributes towards a better understanding of range expansion during species invasions.	[te Beest, Mariska; Elschot, Kelly; Olff, Han; Etienne, Rampal S.] Univ Groningen, Community & Conservat Ecol Grp, Groningen, Netherlands; [te Beest, Mariska] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	University of Groningen; Umea University	te Beest, M (corresponding author), Univ Groningen, Community & Conservat Ecol Grp, Groningen, Netherlands.	mariskatebeest@hotmail.com	Olff, Han/A-8516-2008; Etienne, Rampal S./F-5835-2012	Olff, Han/0000-0003-2154-3576; Etienne, Rampal S./0000-0003-2142-7612; te Beest, Mariska/0000-0003-3673-4105	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by the Netherlands Organization for Scientific Research (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2002, OIKOS, V96, P531, DOI 10.1034/j.1600-0706.2002.960314.x; Alexander JM, 2010, OIKOS, V119, P1377, DOI 10.1111/j.1600-0706.2009.17977.x; Archer S, 1996, ECOL STU AN, V121, P207; Barney JN, 2009, PLANT ECOL, V202, P275, DOI 10.1007/s11258-008-9481-3; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; de Wit CT, 1965, NETHERLANDS J AGRICU, V13, P212, DOI DOI 10.18174/NJAS.V13I2.17501; Feng YL, 2007, ACTA OECOL, V31, P40, DOI 10.1016/j.actao.2006.03.009; Foxcroft LC, 2009, DIVERS DISTRIB, V15, P367, DOI 10.1111/j.1472-4642.2008.00544.x; Raimundo RLG, 2007, WEED SCI, V55, P41, DOI 10.1614/WS-06-083.1; Goodall JM, 1996, AGR ECOSYST ENVIRON, V56, P151, DOI 10.1016/0167-8809(95)00647-8; HEWITT EJ, 1967, NEW PHYTOL, V66, P141; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hulme PE, 2013, J ECOL, V101, P68, DOI 10.1111/1365-2745.12009; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Li YP, 2012, PLANT ECOL, V213, P1157, DOI 10.1007/s11258-012-0073-x; MCFADYEN RE, 1996, AGR ECOSYST ENVIRON, V59, P1; McKenney JL, 2007, PLANT ECOL, V193, P293, DOI 10.1007/s11258-007-9268-y; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Olff H, 2000, OECOLOGIA, V125, P45, DOI 10.1007/PL00008890; Oliver T, 2009, ECOL LETT, V12, P1091, DOI 10.1111/j.1461-0248.2009.01367.x; Pan XY, 2012, BIOL INVASIONS, V14, P1, DOI 10.1007/s10530-011-9941-x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; R Development Core Team, 2008, R LANG ENV STAT COMP; Robertson MP, 2008, BIOL CONTROL, V46, P442, DOI 10.1016/j.biocontrol.2008.04.002; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Senger I. von, 2002, Proceedings of the Fifth International Workshop on Biological Control and Management of Chromolaena odorata, Durban, South Africa, 23-25 October 2000, P90; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SNAYDON RW, 1991, J APPL ECOL, V28, P930, DOI 10.2307/2404218; te Beest M, 2010, THESIS U GRONINGEN N; te Beest M, 2012, BIOL INVASIONS, V14, P607, DOI 10.1007/s10530-011-0102-z; te Beest M, 2009, J ECOL, V97, P1281, DOI 10.1111/j.1365-2745.2009.01574.x; Weigelt A, 2003, J ECOL, V91, P707, DOI 10.1046/j.1365-2745.2003.00805.x; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Witkowski ETF, 2001, PLANT ECOL, V152, P13, DOI 10.1023/A:1011409004004; Zachariades C, 2004, ACIAR TECHNICAL REPO, V55, P25	41	24	24	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e68274	10.1371/journal.pone.0068274	http://dx.doi.org/10.1371/journal.pone.0068274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936301	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400008
J	Zablotskii, V; Dejneka, A; Kubinova, S; Le-Roy, D; Dumas-Bouchiat, F; Givord, D; Dempsey, NM; Sykova, E				Zablotskii, Vitalii; Dejneka, Alexandr; Kubinova, Sarka; Le-Roy, Damien; Dumas-Bouchiat, Frederic; Givord, Dominique; Dempsey, Nora M.; Sykova, Eva			Life on Magnets: Stem Cell Networking on Micro-Magnet Arrays	PLOS ONE			English	Article							LIVING CELLS; DIFFERENTIATION; SCAFFOLDS; ADHESION; STRESS; FIELDS	Interactions between a micro-magnet array and living cells may guide the establishment of cell networks due to the cellular response to a magnetic field. To manipulate mesenchymal stem cells free of magnetic nanoparticles by a high magnetic field gradient, we used high quality micro-patterned NdFeB films around which the stray field's value and direction drastically change across the cell body. Such micro-magnet arrays coated with parylene produce high magnetic field gradients that affect the cells in two main ways: i) causing cell migration and adherence to a covered magnetic surface and ii) elongating the cells in the directions parallel to the edges of the micro-magnet. To explain these effects, three putative mechanisms that incorporate both physical and biological factors influencing the cells are suggested. It is shown that the static high magnetic field gradient generated by the micro-magnet arrays are capable of assisting cell migration to those areas with the strongest magnetic field gradient, thereby allowing the build up of tunable interconnected stem cell networks, which is an elegant route for tissue engineering and regenerative medicine.	[Zablotskii, Vitalii; Dejneka, Alexandr; Kubinova, Sarka] AS CR, Inst Phys, Vvi, Prague, Czech Republic; [Kubinova, Sarka; Sykova, Eva] AS CR, Inst Expt Med, Vvi, Prague, Czech Republic; [Le-Roy, Damien; Dumas-Bouchiat, Frederic; Givord, Dominique; Dempsey, Nora M.] UJF, CNRS, Inst Neel, Grenoble, France	Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Zablotskii, V (corresponding author), AS CR, Inst Phys, Vvi, Prague, Czech Republic.	zablot@fzu.cz	Dumas-Bouchiat, Frederic/ABA-2648-2021; Zablotskyy, Vitaliy/H-2081-2014; Sykova, Eva/H-2659-2014; Dejneka, Alexandr/G-6384-2014; Kubinova, Sarka/G-9922-2014	Dumas-Bouchiat, Frederic/0000-0001-8004-4529; Dejneka, Alexandr/0000-0002-5116-8781; Kubinova, Sarka/0000-0003-1674-4779; Zablotskii, Vitalii/0000-0001-8027-7461; Dempsey, Nora/0000-0003-0402-0992; LE ROY, Damien/0000-0002-3111-6044	Academy of Sciences of the Czech Republic [M100101219]; French Agence Nationale de la Recherche (ANR) [ANR-11-BSV5-014 02]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	GACR: P304/11/0653, P304/12/1370; Academy of Sciences of the Czech Republic: grant M100101219 and the French Agence Nationale de la Recherche (ANR, grant ANR-11-BSV5-014 02). Substrate Patterning was carried out at the Plateforme Technologique Amont (PTA-Grenoble). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bausch AR, 2006, NAT PHYS, V2, P231, DOI 10.1038/nphys260; Beduer A, 2012, BIOMATERIALS, V33, P504, DOI 10.1016/j.biomaterials.2011.09.073; Colbert MJ, 2009, EUR PHYS J E, V30, P117, DOI 10.1140/epje/i2009-10514-7; Dempsey NM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2710771; Dumas-Bouchiat F, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3341190; Dunne P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.024501; Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029; Gov N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.228101; Holle AW, 2010, NAT MATER, V9, P4, DOI 10.1038/nmat2589; Hu SH, 2003, AM J PHYSIOL-CELL PH, V285, pC1082, DOI 10.1152/ajpcell.00159.2003; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/nnano.2010.125, 10.1038/NNANO.2010.125]; Juneja JS, 2006, THIN SOLID FILMS, V504, P239, DOI 10.1016/j.tsf.2005.09.164; Kauffmann P, 2011, LAB CHIP, V11, P3153, DOI 10.1039/c1lc20232d; Kubinova S, 2010, BIOMATERIALS, V31, P5966, DOI 10.1016/j.biomaterials.2010.04.040; Kubinova S, 2009, BIOMATERIALS, V30, P4601, DOI 10.1016/j.biomaterials.2009.05.007; Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053; Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054; Kustov M, 2010, J APPL PHYS, V108, DOI 10.1063/1.3486513; Lin LAG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2928229; Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306; Miyakoshi J, 2005, PROG BIOPHYS MOL BIO, V87, P213, DOI 10.1016/j.pbiomolbio.2004.08.008; Mutschke G, 2010, ELECTROCHIM ACTA, V55, P9060, DOI 10.1016/j.electacta.2010.08.046; Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079; Oliveira FTP, 2010, P NATL ACAD SCI USA, V107, P17751, DOI 10.1073/pnas.1006223107; Osman O, 2012, BIOMED MICRODEVICES, V14, P947, DOI 10.1007/s10544-012-9673-4; Polte TR, 2007, BIOMATERIALS, V28, P2783, DOI 10.1016/j.biomaterials.2007.01.045; Popescu G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218101; Rahimzadeh J, 2011, AM J PHYSIOL-CELL PH, V301, pC646, DOI 10.1152/ajpcell.00099.2011; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sapir Y, 2012, BIOMATERIALS, V33, P4100, DOI 10.1016/j.biomaterials.2012.02.037; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Voldman J, 2009, NAT PHYS, V5, P536, DOI 10.1038/nphys1349; Weston MC, 2010, ANAL CHEM, V82, P3411, DOI 10.1021/ac901783n; Zablotskii V, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3656020; Zablotskii V, 2010, AIP CONF PROC, V1311, P152, DOI 10.1063/1.3530005; Zanini LF, 2012, J APPL PHYS, V111, DOI 10.1063/1.3675067; Zborowski M, 2011, ANAL CHEM, V83, P8050, DOI 10.1021/ac200550d	37	38	39	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70416	10.1371/journal.pone.0070416	http://dx.doi.org/10.1371/journal.pone.0070416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936425	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400065
J	Giabicani, E; Allali, S; Durand, A; Sommet, J; Couto-Silva, AC; Brauner, R				Giabicani, Eloiese; Allali, Slimane; Durand, Adelaiede; Sommet, Julie; Couto-Silva, Ana-Claudia; Brauner, Raja			Presentation of 493 Consecutive Girls with Idiopathic Central Precocious Puberty: A Single-Center Study	PLOS ONE			English	Article							BODY-MASS INDEX; PREMATURE THELARCHE; YOUNG GIRLS; ONSET; AGE; CHILDREN; PUBARCHE; ADRENARCHE; HORMONE; OBESITY	Background: Despite the number of reported data concerning idiopathic central precocious puberty (CPP) in girls, major questions remain including its diagnosis, factors, and indications of gonadotropin releasing hormone (GnRH) analog treatment. Methods: A retrospective, single-center study was carried out on 493 girls with CPP. Results: Eleven girls (2.2%) were aged less than 3 years. Breast development was either isolated (Group 0, n = 99), or associated with one sign, pubic hair development, growth rate greater than 2 standard deviation score (SDS) or bone age (BA) >2 years above chronological age, (Group 1, n = 187), two signs (Group 2, n = 142) or three signs (Group 3, n = 65). The interval between onset of puberty and evaluation, body mass index (BMI) SDS, plasma luteinising hormone (LH) concentrations (basal and peak) and LH/follicle-stimulating hormone (FSH) peak ratio after GnRH test, plasma estradiol and uterus length were significantly greater in Groups 2 and 3 than in Groups 0 and 1 respectively. 211 (42.8%) patients were obese and/or had excessive weight gain during the year before puberty. Obese girls more often had BA advance of >2 years (p = 0.0004) and pubic hair development (p = 0.003) than the others. BMI did not correlate with LH or with LH/FSH peak ratio. Girls with familial history of early puberty (41.4%) had greater frequencies of pubertal LH/FSH peak ratios (p = 0.02) than the others. During the 31 years of the study, there was no increase in the frequency of CPP or variation in its characteristics. Conclusion: Obesity is associated with a higher BA advance and higher frequency of pubic or axillary hair development but not with LH secretion, suggesting that obesity accelerates adrenarche but not the maturation of the hypothalamic-pituitary-ovarian axis. The LH/FSH peak ratio was more frequently pubertal in girls with a familial history of early puberty, suggesting that this maturation depends on genetic factors.	[Brauner, Raja] Univ Paris 05, Paris, France; Fdn Ophtalmol Adolphe de Rothschild, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Brauner, R (corresponding author), Univ Paris 05, Paris, France.	raja.brauner@wanadoo.fr	Allali, Slimane/AGW-0037-2022; Giabicani, Eloïse/AAM-8783-2020	GIABICANI, Eloise/0000-0001-5360-8616; Allali, Slimane/0000-0001-7068-4530				Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Allali S, 2011, MED SCI MONITOR, V17, pPH41, DOI 10.12659/MSM.881794; Armengaud JB, 2009, J CLIN ENDOCR METAB, V94, P2835, DOI 10.1210/jc.2009-0314; Brauner R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011282; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Chalumeau M, 2003, J PEDIATR-US, V143, P445, DOI 10.1067/S0022-3476(03)00328-7; Charkaluk ML, 2004, EUR J PEDIATR, V163, P89, DOI 10.1007/s00431-003-1358-9; Chemaitilly W, 2001, CLIN ENDOCRINOL, V54, P289, DOI 10.1046/j.1365-2265.2001.01229.x; Cisternino M, 2000, J PEDIATR ENDOCR MET, V13, P695; Davison KK, 2003, PEDIATRICS, V111, P815, DOI 10.1542/peds.111.4.815; de Vries L, 2004, J CLIN ENDOCR METAB, V89, P1794, DOI 10.1210/jc.2003-030361; de Vries L, 2006, EUR J ENDOCRINOL, V154, P891, DOI 10.1530/eje.1.02151; de Vries L, 2010, J PEDIATR-US, V156, P466, DOI 10.1016/j.jpeds.2009.09.071; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Kaplowitz P, 2004, J CLIN ENDOCR METAB, V89, P3644, DOI 10.1210/jc.2003-031532; Kaplowitz PB, 2009, CURR OPIN ENDOCRINOL, V16, P31, DOI 10.1097/MED.0b013e328320a650; Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347; Kaplowitz PB, 1999, PEDIATRICS, V104, P936, DOI 10.1542/peds.104.4.936; Klein KO, 1998, J CLIN ENDOCR METAB, V83, P3469, DOI 10.1210/jc.83.10.3469; Klein KO, 1999, J CLIN ENDOCR METAB, V84, P411, DOI 10.1210/jc.84.2.411; Lee JM, 2007, PEDIATRICS, V119, pE624, DOI 10.1542/peds.2006-2188; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Midyett LK, 2003, PEDIATRICS, V111, P47, DOI 10.1542/peds.111.1.47; Mogensen SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029829; Mogensen SS, 2011, J CLIN ENDOCR METAB, V96, P1393, DOI 10.1210/jc.2010-2745; Neville KA, 2005, ARCH DIS CHILD, V90, P258, DOI 10.1136/adc.2004.053959; OERTER KE, 1990, J CLIN ENDOCR METAB, V71, P1251, DOI 10.1210/jcem-71-5-1251; Palmert MR, 2001, J CLIN ENDOCR METAB, V86, P2364, DOI 10.1210/jc.86.6.2364; Palmert MR, 1999, J CLIN ENDOCR METAB, V84, P415, DOI 10.1210/jc.84.2.415; PASQUINO AM, 1995, J PEDIATR-US, V126, P11, DOI 10.1016/S0022-3476(95)70492-2; PESCOVITZ OH, 1988, J CLIN ENDOCR METAB, V67, P474, DOI 10.1210/jcem-67-3-474; Prete G, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-27; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Sempe A, 1979, AUXOLOGIE METHODE SE; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Taylor M, 2012, J PEDIATR-US, V161, P855, DOI 10.1016/j.jpeds.2012.05.014; Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012	37	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70931	10.1371/journal.pone.0070931	http://dx.doi.org/10.1371/journal.pone.0070931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936254	Green Submitted, gold, Green Published			2022-12-27	WOS:000323114200108
J	Boehler, CJ; Raines, AM; Sunde, RA				Boehler, Christopher J.; Raines, Anna M.; Sunde, Roger A.			Deletion of Thioredoxin Reductase and Effects of Selenite and Selenate Toxicity in Caenorhabditis elegans	PLOS ONE			English	Article							EARLY EMBRYONIC LETHALITY; MESSENGER-RNA LEVELS; CANCER PREVENTION; ESCHERICHIA-COLI; SELENOCYSTEINE INCORPORATION; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS; RAT-LIVER; LIFE-SPAN	Thioredoxin reductase-1 (TRXR-1) is the sole selenoprotein in C. elegans, and selenite is a substrate for thioredoxin reductase, so TRXR-1 may play a role in metabolism of selenium (Se) to toxic forms. To study the role of TRXR in Se toxicity, we cultured C. elegans with deletions of trxr-1, trxr-2, and both in axenic media with increasing concentrations of inorganic Se. Wild-type C. elegans cultured for 12 days in Se-deficient axenic media grow and reproduce equivalent to Se-supplemented media. Supplementation with 0-2 mM Se as selenite results in inverse, sigmoidal response curves with an LC50 of 0.20 mM Se, due to impaired growth rather than reproduction. Deletion of trxr-1, trxr-2 or both does not modulate growth or Se toxicity in C. elegans grown axenically, and Se-75 labeling showed that TRXR-1 arises from the trxr-1 gene and not from bacterial genes. Se response curves for selenide (LC50 0.23 mM Se) were identical to selenite, but selenate was 1/4th as toxic (LC50 0.95 mM Se) as selenite and not modulated by TRXR deletion. These nutritional and genetic studies in axenic media show that Se and TRXR are not essential for C. elegans, and that TRXR alone is not essential for metabolism of inorganic Se to toxic species.	[Boehler, Christopher J.; Raines, Anna M.; Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu			Wisconsin Agricultural Experiment Station [WIS-01435]; UW Foundation Selenium Nutrition Research [12046295]	Wisconsin Agricultural Experiment Station; UW Foundation Selenium Nutrition Research	This work was supported by the Wisconsin Agricultural Experiment Station project WIS-01435 and by the UW Foundation Selenium Nutrition Research fund no. 12046295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun Z, 2005, HDB C ELEGANS ANATOM; Bjornstedt M, 2010, EPMA J, V1, P389, DOI 10.1007/s13167-010-0033-2; BRENNER S, 1974, GENETICS, V77, P71; Buettner C, 1999, J BIOL CHEM, V274, P21598, DOI 10.1074/jbc.274.31.21598; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Conrad M, 2009, BBA-GEN SUBJECTS, V1790, P1575, DOI 10.1016/j.bbagen.2009.05.001; Fernandes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050727; GANTHER HE, 1971, BIOCHEMISTRY-US, V10, P4089, DOI 10.1021/bi00798a013; GERRARD TL, 1974, J BACTERIOL, V119, P1057, DOI 10.1128/JB.119.3.1057-1060.1974; Gladyshev VN, 1999, BIOCHEM BIOPH RES CO, V259, P244, DOI 10.1006/bbrc.1999.0765; Greenwald P, 2004, J NUTR, V134, p3507S, DOI 10.1093/jn/134.12.3507S; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Izquierdo A, 2010, MICROBIOL-SGM, V156, P2608, DOI 10.1099/mic.0.039719-0; Jee C, 2005, GENES CELLS, V10, P1203, DOI 10.1111/j.1365-2443.2005.00913.x; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LEE M, 1969, CAN J BIOCHEM CELL B, V47, P791, DOI 10.1139/o69-121; Lenaerts I, 2008, J GERONTOL A-BIOL, V63, P242, DOI 10.1093/gerona/63.3.242; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacFarquhar JK, 2010, ARCH INTERN MED, V170, P256, DOI 10.1001/archinternmed.2009.495; MASSEY V, 1965, J BIOL CHEM, V240, P4470; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; McDermott JR, 2010, MOL BIOL CELL, V21, P3934, DOI 10.1091/mbc.E10-06-0513; Morgan KL, 2010, TOXICOL SCI, V118, P530, DOI 10.1093/toxsci/kfq273; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Raspor P, 2003, APPL MICROBIOL BIOT, V63, P89, DOI 10.1007/s00253-003-1336-1; SCALA J, 1962, ARCH BIOCHEM BIOPHYS, V99, P363, DOI 10.1016/0003-9861(62)90280-1; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Stranges S, 2006, AM J EPIDEMIOL, V163, P694, DOI 10.1093/aje/kwj097; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Sunde R. A., 1997, Handbook of nutritionally essential mineral elements., P493; SUNDE RA, 1987, J BIOL CHEM, V262, P933; SUNDE RA, 1980, BIOCHEM BIOPH RES CO, V93, P1181, DOI 10.1016/0006-291X(80)90614-2; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Tobe R, 2012, BIOCHEM J, V445, P423, DOI 10.1042/BJ20120618; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Turner RJ, 1998, BIOMETALS, V11, P223, DOI 10.1023/A:1009290213301; Wallenberg M, 2010, BIOCHEM J, V429, P85, DOI 10.1042/BJ20100368; Wen W, 1998, J BIOL CHEM, V273, P28533, DOI 10.1074/jbc.273.43.28533; WILBER CG, 1980, CLIN TOXICOL, V17, P171, DOI 10.3109/15563658008985076; YANG GQ, 1983, AM J CLIN NUTR, V37, P872, DOI 10.1093/ajcn/37.5.872; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581	50	22	24	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71525	10.1371/journal.pone.0071525	http://dx.doi.org/10.1371/journal.pone.0071525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936512	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500075
J	Kappert, K; Meyborg, H; Fritzsche, J; Urban, D; Kruger, J; Wellnhofer, E; Kintscher, U; Fleck, E; Stawowy, P				Kappert, Kai; Meyborg, Heike; Fritzsche, Jan; Urban, Daniel; Krueger, Janine; Wellnhofer, Ernst; Kintscher, Ulrich; Fleck, Eckart; Stawowy, Philipp			Proprotein Convertase Subtilisin/Kexin Type 3 Promotes Adipose Tissue-Driven Macrophage Chemotaxis and Is Increased in Obesity	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; ADIPOCYTE DIFFERENTIATION; MATRIX-METALLOPROTEINASE; INSULIN-RESISTANCE; BREFELDIN-A; FURIN; ATHEROSCLEROSIS; INHIBITION; ACTIVATION; CELLS	Background: Matrix metalloproteinase (MMP)-dependent extracellular matrix (ECM) remodeling is a key feature in cardiometabolic syndrome-associated adipogenesis and atherosclerosis. Activation of membrane-tethered (MT) 1-MMP depends on furin (PCSK3). However, the regulation and function of the natural furin-inhibitor serpinB8 and thus furin/MT1-MMP-activity in obesity-related tissue inflammation/remodeling is unknown. Here we aimed to determine the role of serpinB8/furin in obesity-associated chronic inflammation. Methods and Results: Monocyte -> macrophage transformation was characterized by decreases in serpinB8 and increases in furin/MT1-MMP. Rescue of serpinB8 by protein overexpression inhibited furin-dependent pro-MT1-MMP activation in macrophages, supporting its role as a furin-inhibitor. Obese white adipose tissue-facilitated macrophage migration was inhibited by furin- and MMP-inhibition, stressing the importance of the furin-MMP axis in fat tissue inflammation/remodeling. Monocytes from obese patients (body mass index (BMI) >30kg/m(2)) had higher furin, MT1-MMP, and resistin gene expression compared to normal weight individuals (BMI<25kg/m(2)) with significant correlations of BMI/furin and furin/MT1-MMP. In vitro, the adipocytokine resistin induced furin and MT1-MMP in mononuclear cells (MNCs), while MCP-1 had no effect. Conclusions: Acquisition of the inflammatory macrophage phenotype is characterized by an imbalance in serpinB8/furin, leading to MT1-MMP activation, thereby enhancing migration. Increases in MT1-MMP and furin are present in MNCs from obese patients. Dissecting the regulation of furin and its inhibitor serpinB8 should facilitate targeting inflammation/remodeling in cardiometabolic diseases.	[Kappert, Kai; Meyborg, Heike; Fritzsche, Jan; Urban, Daniel; Wellnhofer, Ernst; Fleck, Eckart; Stawowy, Philipp] Deutsch Herzzentrum Berlin, Dept Med Cardiol, Berlin, Germany; [Kappert, Kai; Krueger, Janine] Charite, Cardiovasc Res Ctr, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany; [Kintscher, Ulrich] Charite, Cardiovasc Res Ctr, Dept Translat Pharmacol, D-13353 Berlin, Germany	German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stawowy, P (corresponding author), Deutsch Herzzentrum Berlin, Dept Med Cardiol, Berlin, Germany.	stawowy@dhzb.de	Wellnhofer, Ernst/L-1829-2015; Kappert, Kai/H-4116-2017	Wellnhofer, Ernst/0000-0003-4517-5149; Kappert, Kai/0000-0001-6976-0428; Kintscher, Ulrich/0000-0001-7386-0990	Zukunftsfond Berlin/TSB Medici; Deutsche Forschungsgemeinschaft [KA1820/4-1]; Marga und Walter Boll-Stiftung [210-04-10]	Zukunftsfond Berlin/TSB Medici; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marga und Walter Boll-Stiftung	HM, JF, DU, EF, and PS are supported by the Zukunftsfond Berlin/TSB Medici. KK was supported from the Deutsche Forschungsgemeinschaft (KA1820/4-1) and receives funding from the Marga und Walter Boll-Stiftung (210-04-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher E, 2006, KIDNEY INT, V69, P1570, DOI 10.1038/sj.ki.5000316; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Chun TH, 2010, DIABETES, V59, P2484, DOI 10.2337/db10-0073; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; Croissandeau G, 2002, J CELL SCI, V115, P1203; Dahlen JR, 1998, J BIOL CHEM, V273, P1851, DOI 10.1074/jbc.273.4.1851; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Gillard A, 2006, AM J NEPHROL, V26, P34, DOI 10.1159/000091784; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Ito A, 2008, J BIOL CHEM, V283, P35715, DOI 10.1074/jbc.M804220200; Jaworski DM, 2011, ENDOCRINOLOGY, V152, P1300, DOI 10.1210/en.2010-1029; Johnson JL, 2008, ARTERIOSCL THROM VAS, V28, P1647, DOI 10.1161/ATVBAHA.108.170548; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; LADINSKY MS, 1992, EUR J CELL BIOL, V59, P92; Leblond J, 2006, THROMB HAEMOSTASIS, V95, P243, DOI 10.1160/TH05-08-0561; Menghini R, 2012, DIABETES, V61, P454, DOI 10.2337/db11-0613; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Stawowy P, 2005, CIRCULATION, V111, P2820, DOI 10.1161/CIRCULATIONAHA.104.502617; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Strik MC, 2002, J HISTOCHEM CYTOCHEM, V50, P1443, DOI 10.1177/002215540205001103; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Van Hul M, 2010, THROMB HAEMOSTASIS, V104, P165, DOI 10.1160/TH09-10-0739; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70542	10.1371/journal.pone.0070542	http://dx.doi.org/10.1371/journal.pone.0070542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936445	gold, Green Submitted, Green Published			2022-12-27	WOS:000324401500042
J	Bella, SD; Bialunska, A; Sowinski, J				Bella, Simone Dalla; Bialunska, Anita; Sowinski, Jakub			Why Movement Is Captured by Music, but Less by Speech: Role of Temporal Regularity	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; COORDINATION DYNAMICS; AUDITORY SEQUENCES; LINGUISTIC RHYTHM; PHASE ATTRACTION; ENTRAINMENT; BEAT; TIME; PERCEPTION; ENGLISH	Music has a pervasive tendency to rhythmically engage our body. In contrast, synchronization with speech is rare. Music's superiority over speech in driving movement probably results from isochrony of musical beats, as opposed to irregular speech stresses. Moreover, the presence of regular patterns of embedded periodicities (i.e., meter) may be critical in making music particularly conducive to movement. We investigated these possibilities by asking participants to synchronize with isochronous auditory stimuli (target), while music and speech distractors were presented at one of various phase relationships with respect to the target. In Exp. 1, familiar musical excerpts and fragments of children poetry were used as distractors. The stimuli were manipulated in terms of beat/stress isochrony and average pitch to achieve maximum comparability. In Exp. 2, the distractors were well-known songs performed with lyrics, on a reiterated syllable, and spoken lyrics, all having the same meter. Music perturbed synchronization with the target stimuli more than speech fragments. However, music superiority over speech disappeared when distractors shared isochrony and the same meter. Music's peculiar and regular temporal structure is likely to be the main factor fostering tight coupling between sound and movement.	[Bella, Simone Dalla] Univ Montpellier I, Movement Hlth Lab EuroMov, Montpellier, France; [Bella, Simone Dalla] Inst Univ France, Paris, France; [Bella, Simone Dalla; Bialunska, Anita; Sowinski, Jakub] Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland	Universite de Montpellier; Institut Universitaire de France; University of Finance & Management Warsaw	Bella, SD (corresponding author), Univ Montpellier I, Movement Hlth Lab EuroMov, Montpellier, France.	simone.dalla-bella@univ-montp1.fr		Dalla Bella, Simone/0000-0001-9813-7408; Sowinski, Jakub/0000-0002-8075-7120	European Commission [14847]	European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding provided by International Reintegration Grant (n. 14847) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie D., 1967, ELEMENTS GEN PHONETI; Arvaniti A, 2009, PHONETICA, V66, P46, DOI 10.1159/000208930; Aschersleben G, 2003, INT J PSYCHOPHYSIOL, V50, P157, DOI 10.1016/S0167-8760(03)00131-4; Aschersleben G, 2002, ATTENTION PERFORM, V19, P227; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Benzon W, 2001, BEETHOVENS ANVIL MUS; Bergeson TR, 2006, MUSIC PERCEPT, V23, P345, DOI 10.1525/mp.2006.23.4.345; BISKUPSKA M, 1998, LATWE PIOSENKI FORTE, P20239; Boersma P., 1993, P I PHONETIC SCI, V17, P97; Boersma P., 2008, PRAAT DOING PHONETIC; BOLTZ M, 1986, COGNITIVE PSYCHOL, V18, P389, DOI 10.1016/0010-0285(86)90005-8; Brown S, 2000, ORIGINS OF MUSIC, P3; BRZECHWA J, 1980, BRZECHWA DZIECIOM, P20239; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Cooper G., 1960, RHYTHMIC STRUCTURE M; Corriveau K, 2007, J SPEECH LANG HEAR R, V50, P647, DOI 10.1044/1092-4388(2007/046); Cummins F, 2009, PHONETICA, V66, P15, DOI 10.1159/000208928; Dalla Bella S, 2003, ANN NY ACAD SCI, V999, P166, DOI 10.1196/annals.1284.021; DAUER RM, 1983, J PHONETICS, V11, P51, DOI 10.1016/S0095-4470(19)30776-4; Dissanayake E, 2000, ORIGINS OF MUSIC, P389; Drake C, 2001, ANN NY ACAD SCI, V930, P17, DOI 10.1111/j.1749-6632.2001.tb05722.x; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Ellis RJ, 2009, J EXP PSYCHOL HUMAN, V35, P264, DOI 10.1037/a0013482; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hayes B, 1985, ADV NONLINEAR PHONOL, P59; Hove MJ, 2013, PSYCHOL RES-PSYCH FO, V77, P388, DOI 10.1007/s00426-012-0441-0; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Jones M., 2009, OXFORD HDB MUSIC PSY, P81, DOI DOI 10.1093/OXFORDHB/9780199298457.013.0008; Jones M. R., 1993, PSYCHOL MUSIC UNDERS, P67; Jones Mari Riess, 2010, ATTENTION TIME, P317; Jones MR, 1997, CAN J EXP PSYCHOL, V51, P271, DOI 10.1037/1196-1961.51.4.271; JONES MR, 1987, PERCEPT PSYCHOPHYS, V41, P621, DOI 10.3758/BF03210494; Kelso JAS, 2002, J EXP PSYCHOL HUMAN, V28, P776, DOI 10.1037//0096-1523.28.4.776; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lehiste I., 1977, J PHONET, V5, P253, DOI [DOI 10.1016/S0095-4470, 10.1016/S0095-4470]; Lerdahl F, 2001, ANN NY ACAD SCI, V930, P337, DOI 10.1111/j.1749-6632.2001.tb05743.x; Lerdahl F., 1983, GENERATIVE THEORY TO; Lerdahl Fred, 2003, COGNITIVE NEUROSCIEN, P413; LIBERMAN M, 1977, LINGUIST INQ, V8, P249; Lidji P, 2011, PSYCHON B REV, V18, P1035, DOI 10.3758/s13423-011-0163-0; London J., 2004, HEARING TIME; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P294, DOI 10.1162/jocn.2010.21413; McDermott J, 2005, MUSIC PERCEPT, V23, P29, DOI 10.1525/mp.2005.23.1.29; McNeill W. H., 1995, KEEPING TOGETHER TIM; Merker B, 2000, ORIGINS OF MUSIC, P315; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Mithen S, 2006, SINGING NEANDERTHALS; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Muller Frank E., 1999, LANGUAGE TIME THE RH; Nettl B, 2000, ORIGINS OF MUSIC, P463; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Patel AD, 2003, COGNITION, V87, pB35, DOI 10.1016/S0010-0277(02)00187-7; Patel AD, 2006, J ACOUST SOC AM, V119, P3034, DOI 10.1121/1.2179657; Patel AD, 2006, MUSIC PERCEPT, V24, P99, DOI 10.1525/mp.2006.24.1.99; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Peelle JE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00320; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2011, NEUROPSYCHOLOGIA, V49, P961, DOI 10.1016/j.neuropsychologia.2011.02.002; Phillips-Silver J, 2010, MUSIC PERCEPT, V28, P3, DOI 10.1525/MP.2010.28.1.3; Pike K., 1945, INTONATION AM ENGLIS, DOI DOI 10.HTTPS://D0I.0RG/10.1111/J.1360-6441; Port RF, 2003, J PHONETICS, V31, P599, DOI 10.1016/j.wocn.2003.08.001; Pressing J, 1999, PSYCHOL REV, V106, P714, DOI 10.1037/0033-295X.106.4.714; Provasi JL, 2003, INT J BEHAV DEV, V27, P220, DOI 10.1080/01650250244000290; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; Repp B. H., 2006, MUSIC MOTOR CONTROL, P55, DOI DOI 10.1093/ACPROF:OSO/9780199298723.003.0004; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; Repp BH, 2004, HUM MOVEMENT SCI, V23, P389, DOI 10.1016/j.humov.2004.08.014; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2003, J EXP PSYCHOL HUMAN, V29, P290, DOI 10.1037/0096-1523.29.2.290; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 1998, J ACOUST SOC AM, V104, P1085, DOI 10.1121/1.423325; Roach P. J., 1982, LINGUISTIC CONTROVER, P73; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; Selkirk Elisabeth, 1984, PHONOLOGY SYNTAX REL; Snyder J, 2001, MUSIC PERCEPT, V18, P455, DOI 10.1525/mp.2001.18.4.455; Sowinski J, 2013, NEUROPSYCHOLOGIA, V51, P1952, DOI 10.1016/j.neuropsychologia.2013.06.027; Stevens C., 2009, OXFORD HDB MUSIC PSY, P14; Tillmann B, 2007, MEM COGNITION, V35, P628, DOI 10.3758/BF03193301; TUWIM J, 1980, WIERSZE DLA DZIECI, P20239; Villing RC, 2011, ATTEN PERCEPT PSYCHO, V73, P1614, DOI 10.3758/s13414-011-0110-1; Vorberg D, 2002, J MATH PSYCHOL, V46, P56, DOI 10.1006/jmps.2001.1375; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; Wing AM, 2002, BRAIN COGNITION, V48, P7, DOI 10.1006/brcg.2001.1301; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Zanone PG, 1997, J EXP PSYCHOL HUMAN, V23, P1454, DOI 10.1037/0096-1523.23.5.1454; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	94	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71945	10.1371/journal.pone.0071945	http://dx.doi.org/10.1371/journal.pone.0071945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XU	23936534	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800073
J	Boerkamp, KM; van der Kooij, M; van Steenbeek, FG; van Wolferen, ME; Koerkamp, MJAG; van Leenen, D; Grinwis, GCM; Penning, LC; Wiemer, EAC; Rutteman, GR				Boerkamp, Kim M.; van der Kooij, Marieke; van Steenbeek, Frank G.; van Wolferen, Monique E.; Koerkamp, Marian J. A. Groot; van Leenen, Dik; Grinwis, Guy C. M.; Penning, Louis C.; Wiemer, Erik A. C.; Rutteman, Gerard R.			Gene Expression Profiling of Histiocytic Sarcomas in a Canine Model: The Predisposed Flatcoated Retriever Dog	PLOS ONE			English	Article							FLAT-COATED RETRIEVERS; SYSTEMATIC VARIATION; CELL-ADHESION; LUMICAN; CANCER; TUMOR; CLASSIFICATION; IDENTIFICATION; NEOPLASIA; DIAGNOSIS	Background: The determination of altered expression of genes in specific tumor types and their effect upon cellular processes may create insight in tumorigenesis and help to design better treatments. The Flatcoated retriever is a dog breed with an exceptionally high incidence of histiocytic sarcomas. The breed develops two distinct entities of histiocytic neoplasia, a soft tissue form and a visceral form. Gene expression studies of these tumors have value for comparable human diseases such as histiocytic/dendritic cell sarcoma for which knowledge is difficult to accrue due to their rare occurrence. In addition, such studies may help in the search for genetic aberrations underlying the genetic predisposition in this dog breed. Methods: Microarray analysis and pathway analyses were performed on fresh-frozen tissues obtained from Flatcoated retrievers with localized, soft tissue histiocytic sarcomas (STHS) and disseminated, visceral histiocytic sarcomas (VHS) and on normal canine spleens from various breeds. Expression differences of nine genes were validated with quantitative real-time PCR (qPCR) analyses. Results: QPCR analyses identified the significantly altered expression of nine genes; PPBP, SpiC, VCAM1, ENPEP, ITGAD (down-regulated), and GTSF1, Col3a1, CD90 and LUM (up-regulated) in the comparison of both the soft tissue and the visceral form with healthy spleen. DAVID pathway analyses revealed 24 pathways that were significantly involved in the development of HS in general, most of which were involved in the DNA repair and replication process. Conclusions: This study identified altered expression of nine genes not yet implicated in histiocytic sarcoma manifestations in the dog nor in comparable human histiocytic/dendritic sarcomas. Exploration of the downside effect of canine inbreeding strategies for the study of similar sarcomas in humans might also lead to the identification of genes related to these rare malignancies in the human.	[Boerkamp, Kim M.; van der Kooij, Marieke; van Steenbeek, Frank G.; van Wolferen, Monique E.; Penning, Louis C.; Rutteman, Gerard R.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot; van Leenen, Dik] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Wiemer, Erik A. C.] Erasmus Univ, Med Ctr, Daniel den Hoed Canc Ctr, Dept Med Oncol, Rotterdam, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Boerkamp, KM (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	K.M.Boerkamp@uu.nl	van Steenbeek, F.G./AFL-0046-2022; Penning, Louis/AAC-7524-2019	van Steenbeek, F.G./0000-0001-5460-6540; Grinwis, Guy/0000-0002-1583-9648; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Wiemer, Erik/0000-0002-0673-7236	European Commission [LUPA-GA-201370]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was partly funded by the European Commission (LUPA-GA-201370). Intervet International BV (Boxmeer, The Netherlands) provided a gift to the study in order to help finance the purchase of micro-arrays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A part from the two funders named, no additional external funding was received for this study.	Abadie J, 2009, J HERED, V100, pS19, DOI 10.1093/jhered/esp039; Affolter VK, 2002, VET PATHOL, V39, P74, DOI 10.1354/vp.39-1-74; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Berner JM, 2006, SCAND J LAB ANIM SCI, V33, P17; Beverley PCL, 2005, NAT REV CANCER, V5, P488, DOI 10.1038/nrc1632; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Constantino-Casas F, 2011, VET PATHOL, V48, P764, DOI 10.1177/0300985810385153; D'Onofrio MF, 2008, BIOCHEM BIOPH RES CO, V365, P266, DOI 10.1016/j.bbrc.2007.10.155; Davies FE, 2003, BLOOD, V102, P4504, DOI 10.1182/blood-2003-01-0016; Dobson J, 2009, VET COMP ONCOL, V7, P115, DOI 10.1111/j.1476-5829.2009.00181.x; FALKENBURG JHF, 1986, EXP HEMATOL, V14, P90; Fidel J, 2006, VET COMP ONCOL, V4, P63, DOI 10.1111/j.1476-5810.2006.00090.x; Fulmer AK, 2007, CAN VET J, V48, P1041; Gueugnon F, 2011, AM J PATHOL, V178, P1033, DOI 10.1016/j.ajpath.2010.12.014; He JT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hoffman MM, 2007, MOL BIOL EVOL, V24, P522, DOI 10.1093/molbev/msl179; Ishiwata T, 2007, ONCOL REP, V18, P537; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lu JW, 2011, ACTA HISTOCHEM, V113, P833, DOI 10.1016/j.acthis.2011.01.001; Mahoney JA, 2010, MAMM GENOME, V21, P577, DOI 10.1007/s00335-010-9298-y; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Matsubara J, 2011, CANCER EPIDEM BIOMAR, V20, P160, DOI 10.1158/1055-9965.EPI-10-0397; Mercati F, 2009, EUR J HISTOCHEM, V53, P159, DOI 10.4081/ejh.2009.e19; Meuten D.J., 2020, TUMORS DOMESTIC ANIM; Moore PF, 2006, VET PATHOL, V43, P632, DOI 10.1354/vp.43-5-632; Mori H, 2008, J HARD TISSUE BIOL, V17, P125, DOI 10.2485/jhtb.17.125; Nikitovic D, 2008, IUBMB LIFE, V60, P818, DOI 10.1002/iub.131; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Parry PV, 2012, NEUROSURGERY, V70, pN23, DOI 10.1227/01.neu.0000413227.80467.92; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schlotter YM, 2009, VET IMMUNOL IMMUNOP, V129, P115, DOI 10.1016/j.vetimm.2008.12.004; SCOTT DW, 1979, CORNELL VET, V69, P176; Seya T, 2006, ONCOL REP, V16, P1225; Shearin AL, 2012, CANCER EPIDEM BIOMAR, V21, P1019, DOI 10.1158/1055-9965.EPI-12-0190-T; Shinji S, 2005, INT J ONCOL, V26, P873; Sifaki M, 2006, IUBMB LIFE, V58, P606, DOI 10.1080/15216540600951605; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sterenczak KA, 2011, ANTICANCER RES, V31, P1541; Tamburini BA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-619; Tamburini BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005549; Troup S, 2003, CLIN CANCER RES, V9, P207; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Kester MS, 2012, J INVEST DERMATOL, V132, P2050, DOI 10.1038/jid.2012.117; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057662; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057973; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vuillermoz B, 2004, EXP CELL RES, V296, P294, DOI 10.1016/j.yexcr.2004.02.005; WU H, 2003, ANAL GENE EXPRESSION; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; J IMMUNOL, V155, P35	57	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71094	10.1371/journal.pone.0071094	http://dx.doi.org/10.1371/journal.pone.0071094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936488	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400094
J	Botta, A; Laher, I; Beam, J; DeCoffe, D; Brown, K; Halder, S; Devlin, A; Gibson, DL; Ghosh, S				Botta, Amy; Laher, Ismail; Beam, Julianne; DeCoffe, Daniella; Brown, Kirsty; Halder, Swagata; Devlin, Angela; Gibson, Deanna L.; Ghosh, Sanjoy			Short Term Exercise Induces PGC-1 alpha, Ameliorates Inflammation and Increases Mitochondrial Membrane Proteins but Fails to Increase Respiratory Enzymes in Aging Diabetic Hearts	PLOS ONE			English	Article							MODERATE-INTENSITY EXERCISE; DIET-INDUCED OBESITY; OXIDATIVE STRESS; TRANSCRIPTIONAL CONTROL; HYPERGLYCEMIC STATUS; WEIGHT-LOSS; BIOGENESIS; ACTIVATION; HOMEOSTASIS; PATHWAYS	PGC-1 alpha, a transcriptional coactivator, controls inflammation and mitochondrial gene expression in insulin-sensitive tissues following exercise intervention. However, attributing such effects to PGC-1 alpha is counfounded by exercise-induced fluctuations in blood glucose, insulin or bodyweight in diabetic patients. The goal of this study was to investigate the role of PGC-1 alpha on inflammation and mitochondrial protein expressions in aging db/db mice hearts, independent of changes in glycemic parameters. In 8-month-old db/db mice hearts with diabetes lasting over 22 weeks, short-term, moderate-intensity exercise upregulated PGC-1 alpha without altering body weight or glycemic parameters. Nonetheless, such a regimen lowered both cardiac (macrophage infiltration, iNOS and TNF alpha) and systemic (circulating chemokines and cytokines) inflammation. Curiously, such an anti-inflammatory effect was also linked to attenuated expression of downstream transcription factors of PGC-1 alpha such as NRF-1 and several respiratory genes. Such mismatch between PGC-1 alpha and its downstream targets was associated with elevated mitochondrial membrane proteins like Tom70 but a concurrent reduction in oxidative phosphorylation protein expressions in exercised db/db hearts. As mitochondrial oxidative stress was predominant in these hearts, in support of our in vivo data, increasing concentrations of H2O2 dose-dependently increased PGC-1 alpha expression while inhibiting expression of inflammatory genes and downstream transcription factors in H9c2 cardiomyocytes in vitro. We conclude that short-term exercise-induced oxidative stress may be key in attenuating cardiac inflammatory genes and impairing PGC-1 alpha mediated gene transcription of downstream transcription factors in type 2 diabetic hearts at an advanced age.	[Botta, Amy; Beam, Julianne; DeCoffe, Daniella; Brown, Kirsty; Halder, Swagata; Gibson, Deanna L.; Ghosh, Sanjoy] Univ British Columbia Okanagan, IK Barber Sch Arts & Sci, Dept Biol, Kelowna, BC, Canada; [Laher, Ismail] Univ British Columbia, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1W5, Canada; [Devlin, Angela] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia	Ghosh, S (corresponding author), Univ British Columbia Okanagan, IK Barber Sch Arts & Sci, Dept Biol, Kelowna, BC, Canada.	sanjoy.ghosh@ubc.ca	Gibson, Deanna L/CAF-4166-2022; Laher, Ismail/X-3323-2019; Laher, Ismail/L-3947-2013	Gibson, Deanna L/0000-0003-0052-7550; Laher, Ismail/0000-0002-3917-4417; Devlin, Angela/0000-0002-1390-6587; Brown, Kirsty/0000-0003-1410-4532	Canadian Diabetes Association; Crohn's and Colitis Foundation; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of British Columbia and Yukon	Canadian Diabetes Association; Crohn's and Colitis Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of British Columbia and Yukon	This work was supported by an operating grant from the Canadian Diabetes Association to SG, operating grants from the Crohn's and Colitis Foundation to DLG, a Canadian Institutes of Health Research Doctoral award to AB, a Natural Sciences and Engineering Research Council of Canada Masters award to JB and Grants-In-Aid from the Heart and Stroke Foundation of British Columbia and Yukon to AMD and IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Branco AF, 2011, CARDIOVASC TOXICOL, V11, P191, DOI 10.1007/s12012-011-9111-5; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chen Q, 2006, FREE RADICAL BIO MED, V40, P976, DOI 10.1016/j.freeradbiomed.2005.10.043; Cuenca J, 2006, AM J PATHOL, V169, P1567, DOI 10.2353/ajpath.2006.060109; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Derbre F, 2011, AGE DORDR, V34, P669; Edwards JL, 2010, DIABETOLOGIA, V53, P160, DOI 10.1007/s00125-009-1553-y; Eisele JC, 2008, BASIC RES CARDIOL, V103, P12, DOI 10.1007/s00395-007-0684-x; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; Ghosh S, 2009, AM J PHYSIOL-RENAL, V296, pF700, DOI 10.1152/ajprenal.90548.2008; Ghosh S, 2013, BR J NUTR, P1; Ghosh S, 2007, AM J PHYSIOL-HEART C, V293, pH2919, DOI 10.1152/ajpheart.00324.2007; Ghosh S, 2011, J BIOL CHEM, V286, P42483, DOI 10.1074/jbc.M111.304592; Ghosh S, 2010, CLIN SCI, V119, P57, DOI 10.1042/CS20090389; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Haram PM, 2009, CARDIOVASC RES, V81, P723, DOI 10.1093/cvr/cvn332; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Joseph AM, 2012, EXP DIABETES RES, DOI 10.1155/2012/642038; Kadoglou NP, 2007, DIABETES CARE, V30, P719, DOI 10.2337/dc06-1149; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kingwell BA, 1996, AM J PHYSIOL-HEART C, V270, pH2008, DOI 10.1152/ajpheart.1996.270.6.H2008; Laher I, 2013, FREE RADICAL RES, V47, P44, DOI 10.3109/10715762.2012.737463; Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9; Liu YM, 2012, CARDIOVASC TOXICOL, V12, P123, DOI 10.1007/s12012-011-9148-5; Menshikova EV, 2007, J APPL PHYSIOL, V103, P21, DOI 10.1152/japplphysiol.01228.2006; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Moien-Afshari F, 2008, DIABETOLOGIA, V51, P1327, DOI 10.1007/s00125-008-0996-x; Moien-Afshari F, 2008, AM J PHYSIOL-HEART C, V295, pH1470, DOI 10.1152/ajpheart.00016.2008; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Pagel-Langenickel I, 2008, J BIOL CHEM, V283, P22464, DOI 10.1074/jbc.M800842200; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Pohjoismaki JLO, 2012, NUCLEIC ACIDS RES, V40, P6595, DOI 10.1093/nar/gks301; Public Health Agency of Canada, 2011, DIAB CAN FACTS FIG P; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Schilling J, 2011, CIRC-HEART FAIL, V4, P474, DOI 10.1161/CIRCHEARTFAILURE.110.959833; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Spiegelman Bruce M, 2007, Novartis Found Symp, V286, P3; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Summermatter S, 2013, DIABETES, V62, P85, DOI 10.2337/db12-0291; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Wing RR, 2001, DIABETES CARE, V24, P117, DOI 10.2337/diacare.24.1.117; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zoppini G, 2006, NUTR METAB CARDIOVAS, V16, P543, DOI 10.1016/j.numecd.2005.09.004	51	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70248	10.1371/journal.pone.0070248	http://dx.doi.org/10.1371/journal.pone.0070248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936397	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400047
J	Kimani, K; Lindfield, R; Senyonjo, L; Mwaniki, A; Schmidt, E				Kimani, Kahaki; Lindfield, Robert; Senyonjo, Laura; Mwaniki, Alex; Schmidt, Elena			Prevalence and Causes of Ocular Morbidity in Mbeere District, Kenya. Results of a Population-Based Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; IMPACT; PRESBYOPIA; NIGERIA; ADULTS; EYE	Purpose: Ocular morbidity (OM) describes any eye disease regardless of resultant visual loss. Ocular morbidity may affect large numbers of people in low income countries and could lead to many episodes of care. However there is limited evidence about the prevalence of ocular morbidity or resulting health-seeking behavior. This study in Mbeere District, Kenya, set out to explore both these issues. Methods: A cross-sectional household survey was conducted in 2011. Trained teams moved from house to house examining and questioning residents on ocular morbidity and health-seeking behavior. Data were collected on standardized proformas and entered into a database for analysis. Results: 3,691 people were examined (response rate 91.7%). 15.52% (95% CI 13.86-16.92) had at least one ocular morbidity in at least one eye. The leading cause was presbyopia which affected 25.11% (95% CI 22.05-28.45) of participants over 35 and increased with age. Other leading causes of OM were conditions that affected the lens (32.58%) and the conjunctiva (31.31%). No association was found between educational attainment or employment and OM. 9.63% (7.87-11.74) selfreported an ocular morbidity in the previous six months and 45.94% (95% CI 37.1-55.04) stated that they had sought treatment for the condition. Conclusion: A large number of people were affected by an ocular morbidity in this survey. Most of these people could potentially be managed in their own communities through primary care services (e.g. those with presbyopia). Further work is required to understand the best way of providing an effective, equitable service for ocular morbidity.	[Kimani, Kahaki] Univ Nairobi, Dept Ophthalmol, Nairobi, Kenya; [Lindfield, Robert] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England; [Senyonjo, Laura; Schmidt, Elena] Sightsavers, Haywards Hlth, W Sussex, England; [Mwaniki, Alex] Govt Kenya, Minist Planning, Nairobi, Kenya	University of Nairobi; University of London; London School of Hygiene & Tropical Medicine	Lindfield, R (corresponding author), London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England.	robert.lindfield@lshtm.ac.uk	kimani, kahaki/AAC-9898-2020		Sightsavers	Sightsavers	This study was funded by Sightsavers. Both LS and ES are full time employees of Sightsavers. Both KK and RL have received salary contributions from Sightsavers for this, and other, work.	Adegbehingbe BO, 2007, AUST J RURAL HEALTH, V15, P269, DOI 10.1111/j.1440-1584.2007.00906.x; Fafowora O F, 1998, Afr J Med Med Sci, V27, P35; Hussain A, 2004, OPHTHAL EPIDEMIOL, V11, P413, DOI 10.1080/09286580490888799; Kamali A, 1999, Ophthalmic Epidemiol, V6, P41, DOI 10.1076/opep.6.1.41.1572; Karimurio J, 2008, E AFRICAN J OPHTHALM, V14, P41; Laviers HR, 2010, INVEST OPHTH VIS SCI, V51, P1234, DOI 10.1167/iovs.08-3154; Nirmalan PK, 2004, BRIT J OPHTHALMOL, V88, P1237, DOI 10.1136/bjo.2004.042606; Nwosu SNN, 1998, INT OPHTHALMOL, V22, P259, DOI 10.1023/A:1006338013075; Patel I, 2006, OPHTHALMOLOGY, V113, P728, DOI 10.1016/j.ophtha.2006.01.028; Pitt AD, 2004, OPHTHAL EPIDEMIOL, V11, P17, DOI 10.1076/opep.11.1.17.26437; Singh M. Meghachandra, 1997, Indian Journal of Ophthalmology, V45, P61; The Kenya National Bureau of Statistics, 2009, POP HOUS CENS; Tong L, 2010, EYE, V24, P1486, DOI 10.1038/eye.2010.67; World Health Organisation, 1996, GLOB IN EL AV BLINDN	14	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70009	10.1371/journal.pone.0070009	http://dx.doi.org/10.1371/journal.pone.0070009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936369	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000324518400030
J	Mavroconstanti, T; Johansson, S; Winge, I; Knappskog, PM; Haavik, J				Mavroconstanti, Thegna; Johansson, Stefan; Winge, Ingeborg; Knappskog, Per M.; Haavik, Jan			Functional Properties of Rare Missense Variants of Human CDH13 Found in Adult Attention Deficit/Hyperactivity Disorder (ADHD) Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VASCULAR ENDOTHELIAL-CELLS; SINGLE-POINT MUTATIONS; ANCHORED T-CADHERIN; ADIPONECTIN LEVELS; GENE; PROTEIN; IMPACT; GROWTH; BRAIN	The CDH13 gene codes for T-cadherin, a GPI-anchored protein with cell adhesion properties that is highly expressed in the brain and cardiovascular system. Previous studies have suggested that CDH13 may be a promising candidate gene for Attention Deficit/Hyperactivity Disorder (ADHD). The aims of this study were to identify, functionally characterize, and estimate the frequency of coding CDH13 variants in adult ADHD patients and controls. We performed sequencing of the CDH13 gene in 169 Norwegian adult ADHD patients and 63 controls and genotyping of the identified variants in 641 patients and 668 controls. Native and green fluorescent protein tagged wild type and variant CDH13 proteins were expressed and studied in CHO and HEK293 cells, respectively. Sequencing identified seven rare missense CDH13 variants, one of which was novel. By genotyping, we found a cumulative frequency of these rare variants of 2.9% in controls and 3.2% in ADHD patients, implying that much larger samples are needed to obtain adequate power to study the genetic association between ADHD and rare CDH13 variants. Protein expression and localization studies in CHO cells and HEK293 cells showed that the wild type and mutant proteins were processed according to the canonical processing of GPI-anchored proteins. Although some of the mutations were predicted to severely affect protein secondary structure and stability, no significant differences were observed between the expression levels and distribution of the wild type and mutant proteins in either HEK293 or CHO cells. This is the first study where the frequency of coding CDH13 variants in patients and controls is reported and also where the functional properties of these variants are examined. Further investigations are needed to conclude whether CDH13 is involved in the pathogenesis of ADHD or other conditions.	[Mavroconstanti, Thegna; Johansson, Stefan; Winge, Ingeborg; Knappskog, Per M.; Haavik, Jan] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway; [Mavroconstanti, Thegna; Haavik, Jan] Haukeland Hosp, Div Psychiat, N-5021 Bergen, Norway; [Mavroconstanti, Thegna; Johansson, Stefan; Winge, Ingeborg; Haavik, Jan] Univ Bergen, Dept Biomed, Bergen, Norway; [Knappskog, Per M.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Johansson, Stefan; Knappskog, Per M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Mavroconstanti, T (corresponding author), Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway.	tma079@biomed.uib.no	Haavik, Jan/ABE-1535-2020; Haavik, Jan/AAI-3974-2020; Johansson, Stefan/C-4394-2011	Haavik, Jan/0000-0001-7865-2808; Johansson, Stefan/0000-0002-2298-7008; Winge, Ingeborg/0000-0001-6139-5999	Helse Vest RHF PhD grant [911542]; Research Council of Norway; University of Bergen; K.G. Jebsen Foundation	Helse Vest RHF PhD grant; Research Council of Norway(Research Council of Norway); University of Bergen; K.G. Jebsen Foundation	This study was funded by Helse Vest RHF (http://www.helse-vest.no) PhD grant 911542, the Research Council of Norway (http://www.forskningsradet.no), the University of Bergen (http://www.uib.no) and the K.G. Jebsen Foundation (http://www.stiftkgj.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andreeva AV, 2009, AM J PHYSIOL-CELL PH, V297, pC1168, DOI 10.1152/ajpcell.00237.2009; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Ciatto C, 2010, NAT STRUCT MOL BIOL, V17, P339, DOI 10.1038/nsmb.1781; Dames Sonja A, 2008, J Biol Chem, V283, P23485, DOI 10.1074/jbc.M708335200; Daoud H, 2011, ARCH NEUROL-CHICAGO, V68, P587, DOI 10.1001/archneurol.2010.351; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Doss CGP, 2012, INTERDISCIP SCI, V4, P103, DOI 10.1007/s12539-012-0122-0; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Fava C, 2011, AM J CARDIOL, V108, P1432, DOI 10.1016/j.amjcard.2011.06.068; Franke B, 2012, MOL PSYCHIATR, V17, P960, DOI 10.1038/mp.2011.138; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Fredette BJ, 1996, DEVELOPMENT, V122, P3163; Halmoy A, 2009, J ATTEN DISORD, V13, P175, DOI 10.1177/1087054708329777; Hinney A, 2011, AM J MED GENET B, V156B, P888, DOI 10.1002/ajmg.b.31246; Johansson S, 2008, AM J MED GENET B, V147B, P1470, DOI 10.1002/ajmg.b.30662; Joshi MB, 2009, FASEB J, V23, P4011, DOI 10.1096/fj.09-133611; Kleppe R, 2001, Tidsskr Nor Laegeforen, V121, P2717; Kohannim O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00115; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuzmenko YS, 1998, BIOCHEM BIOPH RES CO, V246, P489, DOI 10.1006/bbrc.1998.8645; Kyriakakis E, 2010, CELL SIGNAL, V22, P1308, DOI 10.1016/j.cellsig.2010.04.008; Landaas ET, 2010, GENES BRAIN BEHAV, V9, P449, DOI 10.1111/j.1601-183X.2010.00567.x; Lantieri F, 2010, AM J MED GENET B, V153B, P1127, DOI 10.1002/ajmg.b.31110; Lepagnol-Bestel AM, 2010, PSYCHIAT GENET, V20, P298, DOI 10.1097/YPG.0b013e32833aa5c4; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Masoodi TA, 2012, NEUROL RES INT, V2012; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Mouaffak F, 2011, PHARMACOGENOMICS J, V11, P267, DOI 10.1038/tpj.2010.40; Mousavi M, 2012, CHEM COMMUN, V48, P10028, DOI 10.1039/c2cc33877g; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; Poelmans G, 2011, AM J PSYCHIAT, V168, P365, DOI 10.1176/appi.ajp.2010.10070948; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quadri SK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2107; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; Resink TJ, 1999, FEBS LETT, V463, P29, DOI 10.1016/S0014-5793(99)01594-X; Rivero O, 2013, EUR NEUROPSYCHOPHARM, V23, P492, DOI 10.1016/j.euroneuro.2012.06.009; Rubina Kseniya, 2007, Angiogenesis, V10, P183, DOI 10.1007/s10456-007-9072-2; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; VESTAL DJ, 1992, J CELL BIOL, V119, P451, DOI 10.1083/jcb.119.2.451; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878; Zhou SX, 2002, J INVEST DERMATOL, V118, P1080, DOI 10.1046/j.1523-1747.2002.01795.x; Zuppinger C, 2000, J MOL CELL CARDIOL, V32, P539, DOI 10.1006/jmcc.1999.1086	58	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71445	10.1371/journal.pone.0071445	http://dx.doi.org/10.1371/journal.pone.0071445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936508	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400107
J	Redzic, JS; Kendrick, AA; Bahmed, K; Dahl, KD; Pearson, CG; Robinson, WA; Robinson, SE; Graner, MW; Eisenmesser, EZ				Redzic, Jasmina S.; Kendrick, Agnieszka A.; Bahmed, Karim; Dahl, Kristin D.; Pearson, Chad G.; Robinson, William A.; Robinson, Steven E.; Graner, Michael W.; Eisenmesser, Elan Z.			Extracellular Vesicles Secreted from Cancer Cell Lines Stimulate Secretion of MMP-9, IL-6, TGF-beta 1 and EMMPRIN	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; RELEASED EXOSOMES; DENDRITIC CELLS; TUMOR EXOSOMES; MICROVESICLES; PROGRESSION; COMMUNICATION; MECHANISM; METASTASIS; EXPRESSION	Extracellular vesicles (EVs) are key contributors to cancer where they play an integral role in cell-cell communication and transfer pro-oncogenic molecules to recipient cells thereby conferring a cancerous phenotype. Here, we purified EVs using straightforward biochemical approaches from multiple cancer cell lines and subsequently characterized these EVs via multiple biochemical and biophysical methods. In addition, we used fluorescence microscopy to directly show internalization of EVs into the recipient cells within a few minutes upon addition of EVs to recipient cells. We confirmed that the transmembrane protein EMMPRIN, postulated to be a marker of EVs, was indeed secreted from all cell lines studied here. We evaluated the response to EV stimulation in several different types of recipient cells lines and measured the ability of these purified EVs to induce secretion of several factors highly upregulated in human cancers. Our data indicate that purified EVs preferentially stimulate secretion of several proteins implicated in driving cancer in monocytic cells but only harbor limited activity in epithelial cells. Specifically, we show that EVs are potent stimulators of MMP-9, IL-6, TGF-beta 1 and induce the secretion of extracellular EMMPRIN, which all play a role in driving immune evasion, invasion and inflammation in the tumor microenvironment. Thus, by using a comprehensive approach that includes biochemical, biological, and spectroscopic methods, we have begun to elucidate the stimulatory roles.	[Redzic, Jasmina S.; Kendrick, Agnieszka A.; Bahmed, Karim; Eisenmesser, Elan Z.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Dahl, Kristin D.; Pearson, Chad G.] Univ Colorado Denver, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA; [Robinson, William A.; Robinson, Steven E.] Univ Colorado Denver, Sch Med, Div Med Oncol, Aurora, CO USA; [Graner, Michael W.] Univ Colorado Denver, Sch Med, Dept Neurosurg, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Eisenmesser, EZ (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA.	Elan.Eisenmesser@ucdenver.edu		Robinson, William/0000-0003-1875-9691; Kendrick, Agnieszka/0000-0003-3254-4582	NIH [1R01GM096019-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096019, R01GM099820] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded through NIH application number 1R01GM096019-01A1 to E.Z.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Bahmed K, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-19; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Breakefield XO, 2011, MOL THER, V19, P1574, DOI 10.1038/mt.2011.169; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Castellana D, 2010, THROMB RES, V125, pS84, DOI 10.1016/S0049-3848(10)70021-9; Chapuis F, 1997, EUR J IMMUNOL, V27, P431, DOI 10.1002/eji.1830270213; Colombo E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00063; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Huet E, 2008, CONNECT TISSUE RES, V49, P175, DOI 10.1080/03008200802151722; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Inal JM, 2012, ARCH IMMUNOL THER EX, V60, P107, DOI 10.1007/s00005-012-0165-2; Johansson N, 2000, CELL MOL LIFE SCI, V57, P5, DOI 10.1007/s000180050495; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, pS42, DOI 10.1007/s002800051097; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Lopez-Verrilli MA, 2013, BIOL RES, V46, P5, DOI 10.4067/S0716-97602013000100001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Redzic JS, 2011, J MOL BIOL, V411, P68, DOI 10.1016/j.jmb.2011.04.060; Sidhu SS, 2004, ONCOGENE, V23, P956, DOI 10.1038/sj.onc.1207070; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Tang Y, 2004, MOL CANCER RES, V2, P73; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Kilsdonk JWJ, 2010, EUR J CELL BIOL, V89, P415, DOI 10.1016/j.ejcb.2009.11.026; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yu WW, 2009, PATHOL RES PRACT, V205, P709, DOI 10.1016/j.prp.2009.05.010; Zhong WD, 2008, ONCOLOGY-BASEL, V75, P230, DOI 10.1159/000163852; Zwaagstra JC, 2001, J BIOL CHEM, V276, P27237, DOI 10.1074/jbc.M100033200	53	31	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71225	10.1371/journal.pone.0071225	http://dx.doi.org/10.1371/journal.pone.0071225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936495	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400099
J	Kahler, A; Sticht, H; Horn, AHC				Kahler, Anna; Sticht, Heinrich; Horn, Anselm H. C.			Conformational Stability of Fibrillar Amyloid-Beta Oligomers via Protofilament Pair Formation - A Systematic Computational Study	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; REPLICA EXCHANGE SIMULATIONS; PARTICLE MESH EWALD; ALZHEIMER A-BETA; EXPERIMENTAL CONSTRAINTS; LIQUID WATER; PEPTIDE; SHEET; MODEL; AGGREGATION	Amyloid-beta (A beta) oligomers play a crucial role in Alzheimer's disease due to their neurotoxic aggregation properties. Fibrillar A beta oligomerization can lead to protofilaments and protofilament pairs via oligomer elongation and oligomer association, respectively. Small fibrillar oligomers adopt the protofilament topology, whereas fibrils contain at least protofilament pairs. To date, the underlying growth mechanism from oligomers to the mature fibril still remains to be elucidated. Here, we performed all-atom molecular dynamics simulations in explicit solvent on single layer-like protofilaments and fibril-like protofilament pairs of different size ranging from the tetramer to the 48-mer. We found that the initial U-shaped topology per monomer is maintained over time in all oligomers. The observed deviations of protofilaments from the starting structure increase significantly with size due to the twisting of the in-register parallel beta-sheets. This twist causes long protofilaments to be unstable and leads to a breakage. Protofilament pairs, which are stabilized by a hydrophobic interface, exhibit more fibril-like properties such as the overall structure and the twist angle. Thus, they can act as stable conformational templates for further fibril growth. Key properties like the twist angle, shape complementarity, and energetics show a size-dependent behavior so that small oligomers favor the protofilament topology, whereas large oligomers favor the protofilament pair topology. The region for this conformational transition is at the size of approximately twelve A beta monomers. From that, we propose the following growth mechanism from A beta oligomers to fibrils: (1) elongation of short protofilaments; (2) breakage of large protofilaments; (3) formation of short protofilament pairs; and (4) elongation of protofilament pairs.	[Kahler, Anna; Sticht, Heinrich; Horn, Anselm H. C.] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Horn, AHC (corresponding author), Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany.	anselm.horn@biochem.uni-erlangen.de		Horn, Anselm/0000-0003-3539-8103; Sticht, Heinrich/0000-0001-5644-045X	Alzheimer-Forschung-Initiative e.V.; Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg	Alzheimer-Forschung-Initiative e.V.; Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg	AHCH thanks the Alzheimer-Forschung-Initiative e.V. (http://www.alzheimer-forschung.de/) for a Pilot Grant. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; [Anonymous], TRIPOS 1991 2008 SYB; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Berhanu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041479; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Buchete NV, 2007, BIOPHYS J, V92, P3032, DOI 10.1529/biophysj.106.100404; Buchete NV, 2005, J MOL BIOL, V353, P804, DOI 10.1016/j.jmb.2005.08.066; Case D, 2010, AMBER, V11; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; CHOTHIA C, 1973, J MOL BIOL, V75, P295, DOI 10.1016/0022-2836(73)90022-3; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103; Fandrich M, 2009, PRION, V3, P89; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Horn AHC, 2010, J PHYS CHEM B, V114, P2219, DOI 10.1021/jp100023q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lakdawala AS, 2002, J AM CHEM SOC, V124, P15150, DOI 10.1021/ja0273290; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li MS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2989981; Lublin AL, 2010, MT SINAI J MED, V77, P43, DOI 10.1002/msj.20160; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Ma BY, 2002, PROTEIN SCI, V11, P2335, DOI 10.1110/ps.4270102; Mahoney MW, 2001, J CHEM PHYS, V114, P363, DOI 10.1063/1.1329346; MANTYH PW, 1993, J NEUROCHEM, V61, P1171, DOI 10.1111/j.1471-4159.1993.tb03639.x; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Parthasarathy S, 2011, J AM CHEM SOC, V133, P3390, DOI 10.1021/ja1072178; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Srivastava A, 2012, BBA-PROTEINS PROTEOM, V1824, P963, DOI 10.1016/j.bbapap.2012.05.003; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Takeda T, 2009, J PHYS CHEM B, V113, P11848, DOI 10.1021/jp904070w; Takeda T, 2009, BIOPHYS J, V96, P4428, DOI 10.1016/j.bpj.2009.03.015; Takeda T, 2009, BIOPHYS J, V96, P442, DOI 10.1016/j.bpj.2008.10.008; Tarus B, 2006, J AM CHEM SOC, V128, P16159, DOI 10.1021/ja064872y; Vakser IA, 1992, GRAMM GLOBAL RANGE M; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000693; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700; Zheng J, 2006, PHYS BIOL, V3, pP1, DOI 10.1088/1478-3975/3/3/P01	74	56	56	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70521	10.1371/journal.pone.0070521	http://dx.doi.org/10.1371/journal.pone.0070521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936224	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700078
J	Lemaitre, PH; Vokaer, B; Charbonnier, LM; Iwakura, Y; Estenne, M; Goldman, M; Leo, O; Remmelink, M; Le Moine, A				Lemaitre, Philippe H.; Vokaer, Benoit; Charbonnier, Louis-Marie; Iwakura, Yoichiro; Estenne, Marc; Goldman, Michel; Leo, Oberdan; Remmelink, Myriam; Le Moine, Alain			IL-17A Mediates Early Post-Transplant Lesions after Heterotopic Trachea Allotransplantation in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; BRONCHIOLITIS OBLITERANS; TH17 CELLS; ALLOGRAFT-REJECTION; LUNG; TRANSPLANTATION; INJURY; INTERLEUKIN-17; RECRUITMENT; DYSFUNCTION	Primary graft dysfunction (PGD) and bronchiolitis obliterans (BO) are the leading causes of morbidity and mortality after lung transplantation. Reports from clinical and rodent models suggest the implication of IL-17A in either PGD or BO. We took advantage of the heterotopic trachea transplantation model in mice to study the direct role of IL-17A in post-transplant airway lesions. Across full MHC barrier, early lesions were controlled in IL-17A(-/-) or anti-IL17 treated recipients. In contrast, IL-17A deficiency did not prevent subsequent obliterative airway disease (OAD). Interestingly, this early protection occurred also in syngeneic grafts and was accompanied by a decrease in cellular stress, as attested by lower HSP70 mRNA levels, suggesting the involvement of IL-17A in ischemia-reperfusion injury (IRI). Furthermore, persistence of multipotent CK14(+) epithelial stem cells underlined allograft protection afforded by IL-17A deficiency or neutralisation. Recipient-derived gamma delta(+) and CD4(+) T cells were the major source of IL-17A. However, lesions still occurred in the absence of each subset, suggesting a high redundancy between the innate and adaptive IL-17A producing cells. Notably, a double depletion significantly diminished lesions. In conclusion, this work implicated IL-17A as mediator of early post-transplant airway lesions and could be considered as a potential therapeutic target in clinical transplantation.	[Lemaitre, Philippe H.; Vokaer, Benoit; Charbonnier, Louis-Marie; Leo, Oberdan; Le Moine, Alain] Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Goldman, Michel] Innovat Med Initiat, Brussels, Belgium; [Estenne, Marc; Remmelink, Myriam; Le Moine, Alain] Univ Libre Bruxelles, Erasme Hosp, Brussels, Belgium	Universite Libre de Bruxelles; University of Tokyo; Universite Libre de Bruxelles	Lemaitre, PH (corresponding author), Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium.	plemaitr@ulb.ac.be	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Charbonnier, Louis-Marie/0000-0002-4594-7893	Walloon Region, the FNRS-Belgium; FNRS (Fonds National de la Recherche Scientifique, Belgium); Fonds Erasme (Universite Libre de Bruxelles, Brussels, Belgium)	Walloon Region, the FNRS-Belgium; FNRS (Fonds National de la Recherche Scientifique, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme (Universite Libre de Bruxelles, Brussels, Belgium)	The Institute for Medical Immunology is funded by research grants of the Walloon Region, the FNRS-Belgium. P. H. L. is a doctoral researcher funded by the FNRS (Fonds National de la Recherche Scientifique, Belgium) and the Fonds Erasme (Universite Libre de Bruxelles, Brussels, Belgium). The grants are directly dedicated to the researcher or the lab. (http://www.wallonie.be, http://www1.frs-fnrs.be, http://www.fondserasme.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobadilla JL, 2008, AM J RESP CRIT CARE, V177, P660, DOI 10.1164/rccm.200612-1901OC; Chen Y, 2007, TRANSPLANTATION, V84, P1071, DOI 10.1097/01.tp.0000287126.12083.48; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1231, DOI 10.1016/j.healun.2010.05.013; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1104, DOI 10.1016/j.healun.2010.08.004; Daud SA, 2007, AM J RESP CRIT CARE, V175, P507, DOI 10.1164/rccm.200608-1079OC; den Hengst WA, 2010, AM J PHYSIOL-HEART C, V299, pH1283, DOI 10.1152/ajpheart.00251.2010; Dodd-O JM, 2006, J APPL PHYSIOL, V100, P1590, DOI 10.1152/japplphysiol.00681.2005; Estenne M, 2002, AM J RESP CRIT CARE, V166, P440, DOI 10.1164/rccm.200201-003PP; Fan L, 2011, AM J TRANSPLANT, V11, P911, DOI 10.1111/j.1600-6143.2011.03482.x; Fernandez FG, 2004, AM J TRANSPLANT, V4, P319, DOI 10.1111/j.1600-6143.2004.00333.x; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HERTZ MI, 1993, AM J PATHOL, V142, P1945; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Kono H, 2011, J IMMUNOL, V187, P4818, DOI 10.4049/jimmunol.1100490; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Le Moine A, 2002, TRANSPLANTATION, V73, P1373, DOI 10.1097/00007890-200205150-00001; Lee James C, 2009, Proc Am Thorac Soc, V6, P39, DOI 10.1513/pats.200808-082GO; Lemaitre PH, 2013, AM J TRANSPLANT, V13, P611, DOI 10.1111/ajt.12067; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Lodhi SA, 2011, AM J TRANSPLANT, V11, P1226, DOI 10.1111/j.1600-6143.2011.03539.x; Loong CC, 2002, J PATHOL, V197, P322, DOI 10.1002/path.1117; Murakawa T, 2005, J IMMUNOL, V174, P3869, DOI 10.4049/jimmunol.174.7.3869; Neuringer IP, 2002, AM J TRANSPLANT, V2, P410, DOI 10.1034/j.1600-6143.2002.20503.x; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Pockley AG, 2005, CONTRIB NEPHROL, V148, P122, DOI 10.1159/000086057; Sharma AK, 2011, AM J RESP CRIT CARE, V183, P1539, DOI 10.1164/rccm.201007-1173OC; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Vanaudenaerde BM, 2008, AM J TRANSPLANT, V8, P1911, DOI 10.1111/j.1600-6143.2008.02321.x; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang ZQ, 2009, J THORAC CARDIOV SUR, V137, P695, DOI 10.1016/j.jtcvs.2008.10.044; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937	42	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70236	10.1371/journal.pone.0070236	http://dx.doi.org/10.1371/journal.pone.0070236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936171	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200066
J	Li, X; Niu, JZ; Xie, BY				Li, Xiang; Niu, Jianzhi; Xie, Baoyuan			Study on Hydrological Functions of Litter Layers in North China	PLOS ONE			English	Article							RAINFALL INTERCEPTION; FLOOR INTERCEPTION; FOREST; CANOPY; WATER; VEGETATION; STORAGE; MULCH	Canopy interception, throughfall, stemflow, and runoff have received considerable attention during the study of water balance and hydrological processes in forested ecosystems. Past research has either neglected or underestimated the role of hydrological functions of litter layers, although some studies have considered the impact of various characteristics of rainfall and litter on litter interception. Based on both simulated rainfall and litter conditions in North China, the effect of litter mass, rainfall intensity and litter type on the maximum water storage capacity of litter (S) and litter interception storage capacity (C) were investigated under five simulated rainfall intensities and four litter masses for two litter types. The results indicated: 1) the S values increased linearly with litter mass, and the S values of broadleaf litter were on average 2.65 times larger than the S values of needle leaf litter; 2) rainfall intensity rather than litter mass determined the maximum interception storage capacity (C-max); C-max increased linearly with increasing rainfall intensity; by contrast, the minimum interception storage capacity (C-min) showed a linear relationship with litter mass, but a poor correlation with rainfall intensity; 3) litter type impacted C-max and C-min; the values of C-max and C-min for broadleaf litter were larger than those of needle leaf litter, which indicated that broadleaf litter could intercepte and store more water than needle leaf litter; 4) a gap existed between C-max and C-min, indicating that litter played a significant role by allowing rainwater to infiltrate or to produce runoff rather than intercepting it and allowing it to evaporate after the rainfall event; 5) C-min was always less than S at the same litter mass, which should be considered in future interception predictions. Vegetation and precipitation characteristics played important roles in hydrological characteristics.	[Li, Xiang; Niu, Jianzhi; Xie, Baoyuan] Beijing Forestry Univ, Educ Minist, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China	Beijing Forestry University	Niu, JZ (corresponding author), Beijing Forestry Univ, Educ Minist, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China.	nexk@bjfu.edu.cn			National Natural Science Fund of China [41171028]; National Advanced Project of the 12th Plan, China [2011BAD38B05]; National Forestry Public Welfare Industry Research Project [201104005]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Advanced Project of the 12th Plan, China; National Forestry Public Welfare Industry Research Project	This study was funded by National Natural Science Fund of China (41171028), National Advanced Project of the 12th Plan, China (2011BAD38B05) and National Forestry Public Welfare Industry Research Project (201104005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENKOBI L, 1993, J ENVIRON QUAL, V22, P657, DOI 10.2134/jeq1993.00472425002200040003x; BUSSIERE F, 1994, AGR FOREST METEOROL, V68, P1, DOI 10.1016/0168-1923(94)90066-3; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Geddes N, 1999, CATENA, V36, P303, DOI 10.1016/S0341-8162(99)00050-8; Gerrits AMJ, 2007, HYDROL EARTH SYST SC, V11, P695, DOI 10.5194/hess-11-695-2007; Gerrits AMJ, 2010, HYDROL PROCESS, V24, P3011, DOI 10.1002/hyp.7712; Guevara-Escobar A, 2007, HYDROL EARTH SYST SC, V11, P1703, DOI 10.5194/hess-11-1703-2007; Guevara-Escobar A, 2000, TREE PHYSIOL, V20, P97; HELVEY JD, 1965, WATER RESOUR RES, V1, P193, DOI 10.1029/WR001i002p00193; Keim RF, 2006, ADV WATER RESOUR, V29, P974, DOI 10.1016/j.advwatres.2005.07.017; Kimoto A, 2002, CATENA, V48, P217, DOI 10.1016/S0341-8162(02)00029-2; Li XY, 2000, J HYDROL, V228, P165, DOI 10.1016/S0022-1694(00)00152-9; Lundberg A, 1997, J ATMOS OCEAN TECH, V14, P1023, DOI 10.1175/1520-0426(1997)014<1023:NATTMO>2.0.CO;2; [马京津 Ma Jingjin], 2012, [气象, Meteorological Monthly], V38, P569; Marin CT, 2000, J HYDROL, V237, P40, DOI 10.1016/S0022-1694(00)00301-2; Marin CT, 2000, J HYDROL, V237, P169, DOI 10.1016/S0022-1694(00)00302-4; [莫菲 MO Fei], 2009, [生态学报, Acta Ecologica Sinica], V29, P2868; Morgan RPC, 2005, SOIL CONSERV, DOI [10.1111/j.1365-2389.2005.0756f.x., DOI 10.1111/J.1365-2389.2005.0756F.X]; Muria S., 2000, J JAPAN FORESTRY SOC, V82, P132; Owens MK, 2006, HYDROL PROCESS, V20, P3179, DOI 10.1002/hyp.6326; Pan CZ, 2010, EARTH SURF PROC LAND, V35, P1006, DOI 10.1002/esp.1997; PITMAN JI, 1989, J HYDROL, V111, P281, DOI 10.1016/0022-1694(89)90265-5; Putuhena WM, 1996, J HYDROL, V180, P283, DOI 10.1016/0022-1694(95)02883-8; Sato Y, 2004, HYDROL PROCESS, V18, P3007, DOI 10.1002/hyp.5746; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; WALSH RPD, 1977, J BIOGEOGR, V4, P253, DOI 10.2307/3038060; [王佳丽 Wang Jiali], 2012, [应用气象学报, Journal of Applied Meteorolgical Science], V23, P265; [谢云 XIE YUN], 2008, [水土保持通报, Bulletin of Soil and Water Conservation], V28, P1; [张光辉 ZHANG Guanghui], 2007, [水土保持通报, Bulletin of Soil and Water Conservation], V27, P56	29	41	42	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70328	10.1371/journal.pone.0070328	http://dx.doi.org/10.1371/journal.pone.0070328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936188	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200075
J	Wang, P; Zhang, J; Su, JB; Wang, P; Liu, J; Liu, B; Feng, DR; Wang, JF; Wang, HB				Wang, Peng; Zhang, Jie; Su, Jianbin; Wang, Peng; Liu, Jun; Liu, Bing; Feng, Dongru; Wang, Jinfa; Wang, Hongbin			The Chloroplast Min System Functions Differentially in Two Specific Nongreen Plastids in Arabidopsis thaliana	PLOS ONE			English	Article							DIVISION SITE PLACEMENT; PROTEIN; FTSZ; ARC6; BIOSYNTHESIS; MORPHOLOGY; MECHANISM; EVOLUTION; MEMBRANES; ALBINO3	The nongreen plastids, such as etioplasts, chromoplasts, etc., as well as chloroplasts, are all derived from proplastids in the meristem. To date, the Min system members in plants have been identified as regulators of FtsZ-ring placement, which are essential for the symmetrical division of chloroplasts. However, the regulation of FtsZ-ring placement in nongreen plastids is poorly understood. In this study, we investigated the division site placement of nongreen plastids by examining the etioplasts as representative in Arabidopsis Min system mutants. Surprisingly, the shape and number of etioplasts in cotyledons of arc3, arc11 and mcd1 mutants were similar to that observed in wild-type plants, whereas arc12 and parc6 mutants exhibited enlarged etioplasts that were reduced in number. In order to examine nongreen plastids in true leaves, we silenced the ALB3 gene in these Min system mutant backgrounds to produce immature chloroplasts without the thylakoidal network using virus induced gene silencing (VIGS). Interestingly, consistent with our observations in etioplasts, enlarged and fewer nongreen plastids were only detected in leaves of parc6 (VIGS-ALB3) and arc12 (VIGS-ALB3) plants. Further, the FtsZ-ring assembled properly at the midpoint in nongreen plastids of arc3, arc11 and mcd1 (VIGS-ALB3) plants, but organized into multiple rings in parc6 (VIGS-ALB3) and presented fragmented filaments in arc12 (VIGS-ALB3) plants, suggesting that division site placement in nongreen plastids requires fewer components of the plant Min system. Taken together, these results suggest that division site placement in nongreen plastids is different from that in chloroplasts.	[Wang, Hongbin] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wang, HB (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China.	wanghb@mail.sysu.edu.cn	Su, Jianbin/L-6647-2019; Liu, Jun/AAS-1421-2021; wang, peng/AAV-1896-2020	Liu, Jun/0000-0002-8671-0040; wang, peng/0000-0001-8420-5326; Zhang, Jie/0000-0001-8130-2243; Wang, Hong-Bin/0000-0003-4957-0509	National Natural Science Foundation of China [31171173]; Natural Science Foundation of Guangdong Province, PR China [S2012010010533]; Fundamental Research Funds for the Central Universities [10lgpy34]; Open Research Fund Program of Guangdong Key Laboratory of Plant Resources [plant01k18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, PR China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Research Fund Program of Guangdong Key Laboratory of Plant Resources	This investigation was supported by the National Natural Science Foundation of China (No. 31171173), the Natural Science Foundation of Guangdong Province, PR China (No. S2012010010533), the Fundamental Research Funds for the Central Universities (10lgpy34), and the Open Research Fund Program of Guangdong Key Laboratory of Plant Resources (plant01k18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Araki Y, 2003, PROTOPLASMA, V221, P163, DOI 10.1007/s00709-002-0080-1; Bellafiore S, 2002, PLANT CELL, V14, P2303, DOI 10.1105/tpc.003442; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Chan CX, 2011, PLANT PHYSIOL, V155, P1552, DOI 10.1104/pp.111.173500; Colletti KS, 2000, CURR BIOL, V10, P507, DOI 10.1016/S0960-9822(00)00466-8; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; Forth D, 2006, J EXP BOT, V57, P1971, DOI 10.1093/jxb/erj144; Fujiwara MT, 2004, J CELL SCI, V117, P2399, DOI 10.1242/jcs.01092; Glynn JM, 2008, PLANT CELL, V20, P2460, DOI 10.1105/tpc.108.061440; Glynn JM, 2007, TRAFFIC, V8, P451, DOI 10.1111/j.1600-0854.2007.00545.x; Glynn JM, 2009, PLANT J, V59, P700, DOI 10.1111/j.1365-313X.2009.03905.x; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Holzinger A, 2008, PHOTOCHEM PHOTOBIOL, V84, P1324, DOI 10.1111/j.1751-1097.2008.00437.x; Itoh R, 2001, PLANT PHYSIOL, V127, P1644, DOI 10.1104/pp.010386; Karamoko M, 2011, FEBS LETT, V585, P1203, DOI 10.1016/j.febslet.2011.03.041; LEECH RM, 1977, BIOCHEM SOC T, V5, P81, DOI 10.1042/bst0050081; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Luo T, 2012, PLANT PHYSIOL, V159, P118, DOI 10.1104/pp.112.195446; MACKENDER RO, 1978, PLANT PHYSIOL, V62, P499, DOI 10.1104/pp.62.4.499; Maple J, 2002, PLANT J, V31, P269, DOI 10.1046/j.1365-313X.2002.01358.x; Maple J, 2007, ANN BOT-LONDON, V99, P565, DOI 10.1093/aob/mcl249; Maple J, 2007, EMBO REP, V8, P293, DOI 10.1038/sj.embor.7400902; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Miyagishima SY, 2008, P NATL ACAD SCI USA, V105, P15202, DOI 10.1073/pnas.0802412105; Miyagishima S, 2011, PLANT PHYSIOL, V155, P1533, DOI 10.1104/pp.110.170688; Miyagishima S, 2010, CURR OPIN MICROBIOL, V13, P738, DOI 10.1016/j.mib.2010.10.004; Nakanishi H, 2009, CURR BIOL, V19, P151, DOI 10.1016/j.cub.2008.12.018; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Pflieger S, 2008, PLANT J, V56, P678, DOI 10.1111/j.1365-313X.2008.03620.x; Pogson BJ, 2011, PLANT PHYSIOL, V155, P1545, DOI 10.1104/pp.110.170365; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; Pyke KA, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq016; Quadrana L, 2011, PLANT PHYSIOL, V156, P1278, DOI 10.1104/pp.111.177345; RASCIO N, 1979, J ULTRA MOL STRUCT R, V68, P325, DOI 10.1016/S0022-5320(79)90164-3; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Robertson EJ, 1996, PLANT PHYSIOL, V112, P149, DOI 10.1104/pp.112.1.149; ROBERTSON EJ, 1995, J CELL SCI, V108, P2937; Rothfield L, 1999, ANNU REV GENET, V33, P423, DOI 10.1146/annurev.genet.33.1.423; Shimada H, 2004, PLANT CELL PHYSIOL, V45, P960, DOI 10.1093/pcp/pch130; Sperling U, 1998, PLANT CELL, V10, P283, DOI 10.1105/tpc.10.2.283; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Yang Y, 2008, CURR OPIN PLANT BIOL, V11, P577, DOI 10.1016/j.pbi.2008.10.001; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yi L, 2005, MOL MEMBR BIOL, V22, P101, DOI 10.1080/09687860500041718; Yoshida Y, 2010, SCIENCE, V329, P949, DOI 10.1126/science.1190791; Zhang M, 2009, CELL RES, V19, P877, DOI 10.1038/cr.2009.78	52	4	4	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71190	10.1371/journal.pone.0071190	http://dx.doi.org/10.1371/journal.pone.0071190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936263	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200116
J	Dehmer, M; Mowshowitz, A				Dehmer, Matthias; Mowshowitz, Abbe			The Discrimination Power of Structural SuperIndices	PLOS ONE			English	Article							TOPOLOGICAL INDEXES; GRAPHS; COMPLEXITY; ENTROPY	In this paper, we evaluate the discrimination power of structural superindices. Superindices for graphs represent measures composed of other structural indices. In particular, we compare the discrimination power of the superindices with those of individual graph descriptors. In addition, we perform a statistical analysis to generalize our findings to large graphs.	[Dehmer, Matthias] Inst Bioinformat & Translat Res, Hall In Tirol, Austria; [Mowshowitz, Abbe] CUNY City Coll, Dept Comp Sci, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Dehmer, M (corresponding author), Inst Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at			Austrian Science Funds [P22029-N13]; Standortagentur Tirol; United States Army Research Laboratory; United Kingdom Ministry of Defence [W911NF-06-3-0001]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Standortagentur Tirol; United States Army Research Laboratory; United Kingdom Ministry of Defence; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	MD thanks the Austrian Science Funds for supporting this work (project P22029-N13). MD also gratefully acknowledges funding from the Standortagentur Tirol (formerly Tiroler Zukunftsstiftung). Also, research was sponsored by the United States Army Research Laboratory and the United Kingdom Ministry of Defence and was accomplished under Agreement Number W911NF-06-3-0001. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the United States Army Research Laboratory, the United States Government, the United Kingdom Ministry of Defence or the United Kingdom Government. The United States and United Kingdom Governments are authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation hereon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER M, 1994, DISCRETE MATH, V136, P3, DOI 10.1016/0012-365X(94)00104-Q; [Anonymous], [No title captured]; Antiqueira L, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013058; Balaban AT, 2006, SAR QSAR ENVIRON RES, V17, P429, DOI 10.1080/10629360600884421; BALABAN AT, 1999, TOPOLOGICAL INDICES, P21; Basak SC, 2000, J CHEM INF COMP SCI, V40, P891, DOI 10.1021/ci990114y; Bollobas B, 2004, COMBINATORICA, V24, P5, DOI 10.1007/s00493-004-0002-2; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; BONCHEV D, 1995, THEOCHEM-J MOL STRUC, V336, P137, DOI 10.1016/0166-1280(94)04081-3; Bonchev D, 1983, INFORM THEORETIC IND; Borgwardt M, 2007, THESIS LUDWIG MAXIMI; Bunke H., 1983, Bulletin of the European Association for Theoretical Computer Science, P35; Dehmer M, 2012, ADV COMPUTATIONAL MA; Dehmer M., 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008057; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2012, MATCH-COMMUN MATH CO, V68, P889; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038564; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031214; Dehmer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015733; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Dehmer MM, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-18; Devillers J., 1999, TOPOLOGICAL INDICES; Diudea M.V., 2001, MOL TOPOLOGY; Diudea MV, 2011, COMPLEXITY, V16, P32, DOI 10.1002/cplx.20363; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Emmert-Streib F., 2006, P DMIN 05 INT C DAT, P200; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; HALIN R, 1989, GRAPHENTHEORIE; Hansen K, 2009, J CHEM INF MODEL, V49, P2077, DOI 10.1021/ci900161g; Ivanciuc O, 1996, CROAT CHEM ACTA, V69, P9; Kaden F., 1990, TOPICS COMBINATORICS, P397; Kier L., 1976, MOL CONNECTIVITY CHE; Klein DJ, 1997, MATCH-COMMUN MATH CO, P7; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; LIU X, 1991, J COMPUT CHEM, V12, P1243, DOI 10.1002/jcc.540121012; Mckay B. D., 1981, C NUMERANTIUM, V30, P45, DOI DOI 10.1016/J.JSC.2013.09.003; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Mueller LAJ, 2011, BIOINFORMATICS, V27, P140, DOI 10.1093/bioinformatics/btq606; Muller L, 2012, QUACN QUANTITATIVE A; Pogliani L, 2011, CARBON MATER-CHEM PH, V5, P117, DOI 10.1007/978-94-007-1733-6_7; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; RANDIC M, 1984, J CHEM INF COMP SCI, V24, P164, DOI 10.1021/ci00043a009; RAYCHAUDHURY C, 1984, J COMPUT CHEM, V5, P581, DOI 10.1002/jcc.540050612; Raymond JW, 2003, J MOL GRAPH MODEL, V21, P421, DOI 10.1016/S1093-3263(02)00188-2; Sobik F, 1986, ZKI INFORM AKAD WISS, V4, P104; Sobik F, 1982, AKAD WISS DDR, V2, P63; Todeschini R., 2002, HDB MOL DESCRIPTORS; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Zelinka A, 1975, CASOPIS PEST MAT, V100, P371, DOI DOI 10.21136/CPM.1975.117890; Zhou B, 2008, CROAT CHEM ACTA, V81, P319	52	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70551	10.1371/journal.pone.0070551	http://dx.doi.org/10.1371/journal.pone.0070551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936227	Green Published, gold			2022-12-27	WOS:000322433300108
J	Vieira, E; Marroqui, L; Figueroa, ALC; Merino, B; Fernandez-Ruiz, R; Nadal, A; Burris, TP; Gomis, R; Quesada, I				Vieira, Elaine; Marroqui, Laura; Figueroa, Ana Lucia C.; Merino, Beatriz; Fernandez-Ruiz, Rebeca; Nadal, Angel; Burris, Thomas P.; Gomis, Ramon; Quesada, Ivan			Involvement of the Clock Gene Rev-erb alpha in the Regulation of Glucagon Secretion in Pancreatic Alpha-Cells	PLOS ONE			English	Article							CIRCADIAN CLOCK; BETA-CELL; IDENTIFIED ALPHA; GLUCOSE; EXPRESSION; MOUSE; SIRT1; AMPK; ISLETS; HEME	Disruption of pancreatic clock genes impairs pancreatic beta-cell function, leading to the onset of diabetes. Despite the importance of pancreatic alpha-cells in the regulation of glucose homeostasis and in diabetes pathophysiology, nothing is known about the role of clock genes in these cells. Here, we identify the clock gene Rev-erb alpha as a new intracellular regulator of glucagon secretion. Rev-erb alpha down-regulation by siRNA (60-70% inhibition) in alphaTC1-9 cells inhibited low-glucose induced glucagon secretion (p<0.05) and led to a decrease in key genes of the exocytotic machinery. The Reverb alpha agonist GSK4112 increased glucagon secretion (1.6 fold) and intracellular calcium signals in alphaTC1-9 cells and mouse primary alpha-cells, whereas the Rev-erb alpha antagonist SR8278 produced the opposite effect. At 0.5 mM glucose, alphaTC1-9 cells exhibited intrinsic circadian Rev-erb alpha expression oscillations that were inhibited by 11 mM glucose. In mouse primary alpha-cells, glucose induced similar effects (p<0.001). High glucose inhibited key genes controlled by AMPK such as Nampt, Sirt1 and PGC-1 alpha in alphaTC1-9 cells (p<0.05). AMPK activation by metformin completely reversed the inhibitory effect of glucose on Nampt-Sirt1-PGC-1 alpha and Rev-erb alpha. Nampt inhibition decreased Sirt1, PGC-1 alpha and Rev-erb alpha mRNA expression (p<0.01) and glucagon release (p<0.05). These findings identify Rev-erb alpha as a new intracellular regulator of glucagon secretion via AMPK/Nampt/Sirt1 pathway.	[Vieira, Elaine; Marroqui, Laura; Merino, Beatriz; Nadal, Angel; Quesada, Ivan] Univ Miguel Hernandez Elche, Inst Bioingn, Elche, Spain; [Vieira, Elaine; Marroqui, Laura; Merino, Beatriz; Fernandez-Ruiz, Rebeca; Nadal, Angel; Gomis, Ramon; Quesada, Ivan] CIBER Diabet & Enfermedades Metab Asociadas, Barcelona, Spain; [Figueroa, Ana Lucia C.; Fernandez-Ruiz, Rebeca; Gomis, Ramon] Inst Invest Biomed August Pi & Sunyer, Diabet & Obes Lab, Barcelona, Spain; [Gomis, Ramon] Univ Barcelona, Hosp Clin, Endocrinol & Diabet Unit, Barcelona, Spain; [Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; Scripps Research Institute	Vieira, E (corresponding author), Univ Miguel Hernandez Elche, Inst Bioingn, Elche, Spain.	evieira@ciberdem.org; ivanq@umh.es	MERINO, BEATRIZ/V-4121-2017; Vieira, Elaine/AAG-1127-2020; Burris, Thomas P/B-3886-2016; Nadal, Angel/G-6721-2014; Vieira, Elaine/F-7273-2019; Ivan, Quesada/P-6541-2014; Marroqui, Laura/B-4942-2016	MERINO, BEATRIZ/0000-0002-4761-3977; Vieira, Elaine/0000-0002-0621-9367; Burris, Thomas P/0000-0003-2922-4449; Nadal, Angel/0000-0003-4178-2152; Vieira, Elaine/0000-0002-0621-9367; Ivan, Quesada/0000-0002-9808-514X; Marroqui, Laura/0000-0003-2931-9317; Fernandez-Ruiz, Rebeca/0000-0002-9692-6697; Castillo-Figueroa, Ana/0000-0002-6036-2770	FP7-Marie Curie program, Ministerio de Educacion y Ciencia [BFU2010-21773, BFU2011-28358]; Generalitat Valenciana [PROMETEO/2011/080]; European Foundation for the Study of Diabetes [94553]; CIBERDEM is an initiative of the Instituto de Salud Carlos III. Spanish Ministry of Science and Innovation grant [SAF 2010-19527]; Government of Catalonia, grant [2009 SGR 1426]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093429] Funding Source: NIH RePORTER	FP7-Marie Curie program, Ministerio de Educacion y Ciencia(German Research Foundation (DFG)); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Foundation for the Study of Diabetes; CIBERDEM is an initiative of the Instituto de Salud Carlos III. Spanish Ministry of Science and Innovation grant; Government of Catalonia, grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	FP7-Marie Curie program, Ministerio de Educacion y Ciencia (BFU2010-21773; BFU2011-28358), Generalitat Valenciana (PROMETEO/2011/080) and European Foundation for the Study of Diabetes (Ref.: 94553). CIBERDEM is an initiative of the Instituto de Salud Carlos III. Spanish Ministry of Science and Innovation grant agreement number SAF 2010-19527. Government of Catalonia, grant agreement number 2009 SGR 1426. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SA, PFLUGERS ARCH, V462, P443; Ando H, 2011, ENDOCRINOLOGY; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Caton PW, 2011, DIABETES OBES METAB, V13, P1097, DOI 10.1111/j.1463-1326.2011.01466.x; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Kohler M, 2012, INTEGR BIOL-UK, V4, P209, DOI 10.1039/c2ib00125j; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Leclerc I, 2011, DIABETOLOGIA, V54, P125, DOI 10.1007/s00125-010-1929-z; Liu YJ, 2004, CELL CALCIUM, V35, P357, DOI 10.1016/j.ceca.2003.10.002; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marroqui L, 2011, DIABETOLOGI IN PRESS, DOI 101007/s00125-010-2024-1; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Muhlbauer E, 2004, FEBS LETT, V564, P91, DOI 10.1016/S0014-5793(04)00322-9; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Nagoshi E, 2005, METHOD ENZYMOL, V393, P543, DOI 10.1016/S0076-6879(05)93028-0; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Soriano S, 2010, ENDOCRINOLOGY, V151, P3543, DOI 10.1210/en.2010-0008; Tuduri E, 2008, AM J PHYSIOL-ENDOC M, V294, pE952, DOI 10.1152/ajpendo.00641.2007; Um JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018450; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Vieira E, 2004, N-S ARCH PHARMACOL, V369, P179, DOI 10.1007/s00210-003-0858-5; Vieira E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1032, DOI 10.1152/ajpendo.90510.2008; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	53	47	52	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69939	10.1371/journal.pone.0069939	http://dx.doi.org/10.1371/journal.pone.0069939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936124	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300079
J	Jansen, PW; Mensah, FK; Nicholson, JM; Wake, M				Jansen, Pauline W.; Mensah, Fiona K.; Nicholson, Jan M.; Wake, Melissa			Family and Neighbourhood Socioeconomic Inequalities in Childhood Trajectories of BMI and Overweight: Longitudinal Study of Australian Children	PLOS ONE			English	Article							BODY-MASS INDEX; DEVELOPMENTAL TRAJECTORIES; SCHOOL-CHILDREN; UNITED-STATES; OBESITY; PREVALENCE; ADIPOSITY; RISK; CONSEQUENCES; ENVIRONMENTS	Background: Socioeconomic inequalities in longitudinal patterning of childhood overweight could cause marked differentials in total burden by adulthood. This study aims to determine timing and strength of the association between socioeconomic status (SES) and children's body mass index (BMI) in the pre- and primary school years, and to examine socioeconomic differences in overweight trajectories across childhood. Methods: Participants were 4949 children from the Longitudinal Study of Australian Children. BMI was measured at four biennial waves starting at age 4-5 years in 2004. Developmental trajectories of childhood overweight were identified with latent class analyses. Composite variables of family and neighbourhood SES were used. Results: Socioeconomic differences in mean BMI z-scores already present at age 4-5 more than doubled by age 10-11 years, reflecting decreasing mean BMI among advantaged rather than increasing means among disadvantaged children. Latent class analysis identified children with 'stable normal weight' (68%), and with 'persistent' (15%), 'late-onset' (14%), and 'resolving' overweight (3%). Risks of persistent and late-onset childhood overweight were highest among low SES families (e. g. most disadvantaged quintile: ORpersistent = 2.51, 95%CI: 1.83-3.43), and only partly explained by birth weight and parental overweight. Relationships with neighbourhood SES were weaker and attenuated fully on adjustment for family SES. No socioeconomic gradient was observed for resolving overweight. Conclusions: Childhood has become the critical period when socioeconomic inequalities in overweight emerge and strengthen. Although targeting disadvantaged children with early overweight must be a top priority, the presence of childhood overweight even among less-disadvantaged families suggests only whole-society approaches will eliminate overweight-associated morbidity.	[Jansen, Pauline W.; Mensah, Fiona K.; Nicholson, Jan M.; Wake, Melissa] Erasmus MC Univ Med Ctr Rotterdam, Murdoch Childrens Res Inst, Rotterdam, Netherlands; [Jansen, Pauline W.] Erasmus MC Univ Med Ctr Rotterdam, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Mensah, Fiona K.] Royal Childrens Hosp, Clin Epidemiol & Biostat Unit, Melbourne, Vic, Australia; [Mensah, Fiona K.; Wake, Melissa] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Nicholson, Jan M.] Royal Childrens Hosp, Parenting Res Ctr, Melbourne, Vic, Australia; [Wake, Melissa] Royal Childrens Hosp, Ctr Community Child Hlth, Melbourne, Vic, Australia	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne	Jansen, PW (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Murdoch Childrens Res Inst, Rotterdam, Netherlands.	p.w.jansen@erasmusmc.nl	Wake, Melissa/J-1396-2012; Mensah, Fiona K/G-3382-2018	Wake, Melissa/0000-0001-7501-9257; Mensah, Fiona K/0000-0002-6951-9949; Nicholson, Jan/0000-0002-0305-0017; Jansen, Pauline/0000-0001-7747-5803	Netherlands Organisation for Scientific Research(NWO); Marie Cofund Action (Rubicon grant) [446-11-010]; Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences (KNAW); NHMRC Population Health Career Development Awards [284556, 546405]; NHMRC Public Health Capacity Building Grant [436914]; NHMRC Early Career Fellowship [1037449]; Victorian Government's Operational Infrastructure Program; "Parenting Australia's Children" research group at the Parenting Research Centre	Netherlands Organisation for Scientific Research(NWO)(Netherlands Organization for Scientific Research (NWO)); Marie Cofund Action (Rubicon grant); Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences (KNAW); NHMRC Population Health Career Development Awards(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Public Health Capacity Building Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Program; "Parenting Australia's Children" research group at the Parenting Research Centre	This work was supported by the Netherlands Organisation for Scientific Research(NWO) and the Marie Cofund Action (Rubicon grant 446-11-010), and by the Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences (KNAW), both awarded to PWJ. MW was supported by NHMRC Population Health Career Development Awards (grants 284556, 546405), and FKM by an NHMRC Public Health Capacity Building Grant (grant 436914) and an NHMRC Early Career Fellowship (grant 1037449). All research at the Murdoch Childrens Research Institute is supported by the Victorian Government's Operational Infrastructure Program. This work received support from the "Parenting Australia's Children" research group at the Parenting Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari P., 2006, SOCIOECONOMIC INDEXE; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Anderson CB, 2009, HEALTH PSYCHOL, V28, P428, DOI 10.1037/a0014522; Balistreri KS, 2011, MATERN CHILD HLTH J, V15, P610, DOI 10.1007/s10995-010-0622-7; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Blackmore T., 2006, ACSPRI SOC SCI METH; Booth ML, 2001, AUST NZ J PUBL HEAL, V25, P162, DOI 10.1111/j.1753-6405.2001.tb01840.x; Bradbury B, 2007, CHILD OUTCOMES FAMIL; Carter MA, 2010, HEALTH PLACE, V16, P616, DOI 10.1016/j.healthplace.2009.12.012; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daraganova G, 2011, 9 AUSTR I FAM STUD; Finkelstein DM, 2008, PEDIATRICS, V122, pE251, DOI 10.1542/peds.2007-2814; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Gray M, 2008, FAMILY MATTERS, P5; Howe LD, 2011, INT J PEDIATR OBES, V6, pE144, DOI 10.3109/17477166.2010.500387; Jansen PW, 2009, PAEDIATR PERINAT EP, V23, P216, DOI 10.1111/j.1365-3016.2009.01023.x; King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Lindsay AC, 2006, FUTURE CHILD, V16, P169, DOI 10.1353/foc.2006.0006; Marmot M, 2010, FAIR SOC HLTH LIVES; Molaodi OR, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-75; MPlus Technical Appendices, 2010, MPLUS TECHNICAL APPE; Muthen L, 2007, MUTH N MUTH N; Nicholson JM, 2010, J EPIDEMIOL COMMUNIT, V66, P81; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Oliver LN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-16; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Simmons R, 2008, SEMIN PERINATOL, V32, P371, DOI 10.1053/j.semperi.2008.08.004; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Timperio A, 2006, AM J PREV MED, V30, P45, DOI 10.1016/j.amepre.2005.08.047; Trewin D, 2005, 2004 2101 POPULATION; Veitch J, 2008, HEALTH EDUC RES, V23, P870, DOI 10.1093/her/cym074; Ventura AK, 2009, OBESITY, V17, P2067, DOI 10.1038/oby.2009.123; Wake M, 2007, INT J OBESITY, V31, P1044, DOI 10.1038/sj.ijo.0803503; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wardle J, 2006, BRIT MED J, V332, P1130, DOI 10.1136/bmj.38807.594792.AE; Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38; Westwood M, 2007, ARCH DIS CHILD, V92, P416, DOI 10.1136/adc.2006.113589; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002	47	53	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69676	10.1371/journal.pone.0069676	http://dx.doi.org/10.1371/journal.pone.0069676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23936075	Green Published, gold			2022-12-27	WOS:000325211000146
J	Kimura, Y; Jacobs, LL; Cerling, TE; Uno, KT; Ferguson, KM; Flynn, LJ; Patnaik, R				Kimura, Yuri; Jacobs, Louis L.; Cerling, Thure E.; Uno, Kevin T.; Ferguson, Kurt M.; Flynn, Lawrence J.; Patnaik, Rajeev			Fossil Mice and Rats Show Isotopic Evidence of Niche Partitioning and Change in Dental Ecomorphology Related to Dietary Shift in Late Miocene of Pakistan	PLOS ONE			English	Article							STABLE-ISOTOPE; UNGULATE MAMMALS; OXYGEN ISOTOPES; GREAT-PLAINS; CARBON; RECONSTRUCTION; FRACTIONATION; EVOLUTION; ECOLOGY; RECORD	Stable carbon isotope analysis in tooth enamel is a well-established approach to infer C-3 and C-4 dietary composition in fossil mammals. The bulk of past work has been conducted on large herbivorous mammals. One important finding is that their dietary habits of fossil large mammals track the late Miocene ecological shift from C-3 forest and woodland to C-4 savannah. However, few studies on carbon isotopes of fossil small mammals exist due to limitations imposed by the size of rodent teeth, and the isotopic ecological and dietary behaviors of small mammals to climate change remain unknown. Here we evaluate the impact of ecological change on small mammals by fine-scale comparisons of carbon isotope ratios (delta C-13) with dental morphology of murine rodents, spanning 13.8 to similar to 2.0 Ma, across the C-3 to C-4 vegetation shift in the Miocene Siwalik sequence of Pakistan. We applied in-situ laser ablation GC-IRMS to lower first molars and measured two grazing indices on upper first molars. Murine rodents yield a distinct, but related, record of past ecological conditions from large herbivorous mammals, reflecting available foods in their much smaller home ranges. In general, larger murine species show more positive delta C-13 values and have higher grazing indices than smaller species inhabiting the same area at any given age. Two clades of murine rodents experienced different rates of morphological change. In the faster-evolving clade, the timing and trend of morphological innovations are closely tied to consumption of C-4 diet during the vegetation shift. This study provides quantitative evidence of linkages among diet, niche partitioning, and dental morphology at a more detailed level than previously possible.	[Kimura, Yuri; Jacobs, Louis L.; Ferguson, Kurt M.] So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA; [Cerling, Thure E.; Uno, Kevin T.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Flynn, Lawrence J.] Harvard Univ, Peabody Museum, Cambridge, MA 02138 USA; [Flynn, Lawrence J.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Patnaik, Rajeev] Panjab Univ, Ctr Adv Study Geol, Chandigarh 160014, India	Southern Methodist University; Utah System of Higher Education; University of Utah; Harvard University; Harvard University; Panjab University	Kimura, Y (corresponding author), So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA.	ykimura@mail.smu.edu	Uno, Kevin/F-5177-2012; Uno, Kevin/K-5788-2019	Uno, Kevin/0000-0001-6882-0900; Uno, Kevin/0000-0001-6882-0900; Cerling, Thure/0000-0002-3590-294X; Kimura, Yuri/0000-0002-7621-9901; Jacobs, Louis/0000-0002-7735-3678	Society of Vertebrate Paleontology; Geological Society of America; ISEM at Southern Methodist University; NSF [EAR-0959093, EAR-0958178]; PURSE grant; Directorate For Geosciences [0959093] Funding Source: National Science Foundation	Society of Vertebrate Paleontology; Geological Society of America; ISEM at Southern Methodist University; NSF(National Science Foundation (NSF)); PURSE grant; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the Society of Vertebrate Paleontology (Mary R. Dawson Grant to YK), the Geological Society of America (Graduate Student Research Grant to YK), and ISEM (travel grants to YK) at Southern Methodist University. Other financial support was provided by NSF EAR-0959093 to TEC, NSF EAR-0958178 to LJF, and PURSE grant to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANG ENV STAT COMP; [Anonymous], 1999, WALKERS MAMMALS WORL; Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; Badgley C, 2008, P NATL ACAD SCI USA, V105, P12145, DOI 10.1073/pnas.0805592105; Behrensmeyer AK, 2007, GEOL SOC AM BULL, V119, P1486, DOI 10.1130/B26064.1; Canty A, 2012, BOOT BOOTSTRAP R S P; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Cerling Thure E., 2003, P583; Cernusak LA, 2002, PLANT CELL ENVIRON, V25, P893, DOI 10.1046/j.1365-3040.2002.00875.x; Cernusak LA, 2009, FUNCT PLANT BIOL, V36, P199, DOI 10.1071/FP08216; Cheema Iqbal Umer, 2000, Bulletin of the National Science Museum Series C (Geology and Paleontology), V26, P57; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; CRAIG H, 1954, J GEOL, V62, P115, DOI 10.1086/626141; Damuth J, 2011, BIOL REV, V86, P733, DOI 10.1111/j.1469-185X.2011.00176.x; Feranec RS, 2007, EVOL ECOL RES, V9, P555; Feranec RS, 2003, PALEOBIOLOGY, V29, P230, DOI 10.1666/0094-8373(2003)029<0230:SIHATP>2.0.CO;2; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; Fox DL, 2004, PALAEOGEOGR PALAEOCL, V207, P305, DOI 10.1016/j.palaeo.2003.09.030; Fox DL, 2003, GEOLOGY, V31, P809, DOI 10.1130/G19580.1; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Gehler A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049531; Grimes ST, 2004, PALAEOGEOGR PALAEOCL, V208, P103, DOI 10.1016/j.palaeo.2004.02.031; Grimes ST, 2003, GEOCHIM COSMOCHIM AC, V67, P4033, DOI 10.1016/S0016-7037(03)00173-X; Grimes ST, 2008, PALAEOGEOGR PALAEOCL, V266, P39, DOI 10.1016/j.palaeo.2008.03.014; Hopley PJ, 2006, PALAEOGEOGR PALAEOCL, V233, P235, DOI 10.1016/j.palaeo.2005.09.011; Hynek SA, 2012, EARTH PLANET SC LETT, V321, P177, DOI 10.1016/j.epsl.2011.12.038; Iacumin P, 1996, EARTH PLANET SC LETT, V142, P1, DOI 10.1016/0012-821X(96)00093-3; JACOBS L L, 1989, Natural History Museum of Los Angeles County Science Series, P157; Jacobs L. L., 1977, PaleoBios, VNo. 25, P1; Jacobs L.L., 1978, MUS NO ARIZONA PRESS, V52, P1; Jacobs LL, 2005, INTERPRETING ESSAYS, P63; Jacobs LL, 1990, NATO ASI SER, P573; Jacobs Louis L., 1994, National Science Museum Monographs, V8, P149; Janis C.M., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P367; Keeling R.F., 2010, TRENDS COMPENDIUM DA; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; Latorre C, 1997, EARTH PLANET SC LETT, V146, P83, DOI 10.1016/S0012-821X(96)00231-2; Lazzari V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003607; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; MacFadden BJ, 1997, TRENDS ECOL EVOL, V12, P182, DOI 10.1016/S0169-5347(97)01049-5; MARINO BD, 1992, NATURE, V357, P461, DOI 10.1038/357461a0; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McLean BS, 2012, QUATERNARY RES, V77, P408, DOI 10.1016/j.yqres.2012.02.001; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; OGG JG, 2004, GEOLOGIC TIME SCALE, P63, DOI [DOI 10.1017/CBO9780511536045.006, DOI 10.2277/0511074050]; Passey BH, 2006, CHEM GEOL, V235, P238, DOI 10.1016/j.chemgeo.2006.07.002; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Patnaik R, 2003, PALAEOGEOGR PALAEOCL, V197, P133, DOI 10.1016/S0031-0182(03)00390-0; Patnaik Rajeev, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V261, P55; Patnaik Rajeev, 1997, Palaeovertebrata (Montpellier), V26, P129; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; QUADE J, 1992, CHEM GEOL, V94, P183, DOI 10.1016/0168-9622(92)90011-X; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; Rogers KL, 2002, QUATERNARY RES, V57, P200, DOI 10.1006/qres.2001.2309; Shiels AB, 2010, THESIS U HAWAII; SPSS Inc. Released, 2009, PASW STAT WIND VERS; THORP JL, 1987, S AFR J SCI, V83, P712; Van Dam Jan A., 1997, Geologica Ultraiectina, V156, P1; Yeakel JD, 2007, P ROY SOC B-BIOL SCI, V274, P1723, DOI 10.1098/rspb.2007.0330; YONEYAMA T, 1983, PLANT CELL PHYSIOL, V24, P971	63	28	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69308	10.1371/journal.pone.0069308	http://dx.doi.org/10.1371/journal.pone.0069308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936324	Green Submitted, gold, Green Published			2022-12-27	WOS:000324545800014
J	Perroud, B; Jafar-Nejad, P; Wikoff, WR; Gatchel, JR; Wang, L; Barupal, DK; Crespo-Barreto, J; Fiehn, O; Zoghbi, HY; Kaddurah-Daouk, R				Perroud, Bertrand; Jafar-Nejad, Paymaan; Wikoff, William R.; Gatchel, Jennifer R.; Wang, Lu; Barupal, Dinesh K.; Crespo-Barreto, Juan; Fiehn, Oliver; Zoghbi, Huda Y.; Kaddurah-Daouk, Rima			Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CEREBROTENDINOUS XANTHOMATOSIS; GLUCOSE-METABOLISM; RAT-BRAIN; PROTEIN; METABOLOMICS; NEURONS; DISEASE; PURINE; NEURODEGENERATION	We have shown that lithium treatment improves motor coordination in a spinocerebellar ataxia type 1 (SCA1) disease mouse model (Sca1(154Q/+)). To learn more about disease pathogenesis and molecular contributions to the neuroprotective effects of lithium, we investigated metabolomic profiles of cerebellar tissue and plasma from SCA1-model treated and untreated mice. Metabolomic analyses of wild-type and Sca1(154Q/+) mice, with and without lithium treatment, were performed using gas chromatography time-of-flight mass spectrometry and BinBase mass spectral annotations. We detected 416 metabolites, of which 130 were identified. We observed specific metabolic perturbations in Sca1(154Q/+) mice and major effects of lithium on metabolism, centrally and peripherally. Compared to wild-type, Sca1(154Q/+) cerebella metabolic profile revealed changes in glucose, lipids, and metabolites of the tricarboxylic acid cycle and purines. Fewer metabolic differences were noted in Sca1(154Q/+) mouse plasma versus wild-type. In both genotypes, the major lithium responses in cerebellum involved energy metabolism, purines, unsaturated free fatty acids, and aromatic and sulphur-containing amino acids. The largest metabolic difference with lithium was a 10-fold increase in ascorbate levels in wild-type cerebella (p < 0.002), with lower threonate levels, a major ascorbate catabolite. In contrast, Sca1(154Q/+) mice that received lithium showed no elevated cerebellar ascorbate levels. Our data emphasize that lithium regulates a variety of metabolic pathways, including purine, oxidative stress and energy production pathways. The purine metabolite level, reduced in the Sca1(154Q/+) mice and restored upon lithium treatment, might relate to lithium neuroprotective properties.	[Perroud, Bertrand; Wikoff, William R.; Barupal, Dinesh K.; Fiehn, Oliver] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Jafar-Nejad, Paymaan; Gatchel, Jennifer R.; Crespo-Barreto, Juan; Zoghbi, Huda Y.] Texas Childrens Hosp, Baylor Coll Med, Dept Mol & Human Genet, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Wang, Lu] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	University of California System; University of California Davis; Baylor College of Medicine; University of California System; University of California Los Angeles; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Duke University	Zoghbi, HY (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Mol & Human Genet, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu; kaddu001@mc.duke.edu	Barupal, Dinesh K/A-9341-2010	Gatchel, Jennifer/0000-0002-3892-9742; Kaddurah-Daouk, Rima/0000-0003-1858-5732; barupal, dinesh/0000-0002-9954-8628; Zoghbi, Huda/0000-0002-0700-3349	NIH "Pharmacometabolomics Research Network" [R24 GM078233, RC2 5RC2GM092729]; NIH [1U24DK097154]; NINDS [NS27699]; HHMI; NICHD [HD24064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233, RC2GM092729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027699, T32NS043124, R01NS027699] Funding Source: NIH RePORTER	NIH "Pharmacometabolomics Research Network"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HHMI(Howard Hughes Medical Institute); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by funding from NIH R24 GM078233, and RC2 5RC2GM092729 "Pharmacometabolomics Research Network", both directed by RKD as well as by grant NIH 1U24DK097154 to OF. This work was also in part supported by NINDS grant NS27699 and HHMI to HYZ and NICHD grant HD24064 to BCM-IDDRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2000, NEUROREPORT, V11, P3261, DOI 10.1097/00001756-200009280-00042; Basselin M, 2006, PSYCHOPHARMACOLOGY, V187, P303, DOI 10.1007/s00213-006-0425-0; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Bourke CA, 2012, AUST VET J, V90, P272, DOI 10.1111/j.1751-0813.2012.00947.x; Chen G, 2000, BIPOLAR DISORD, V2, P217, DOI 10.1034/j.1399-5618.2000.20303.x; Chiu CT, 2010, PHARMACOL THERAPEUT, V128, P281, DOI 10.1016/j.pharmthera.2010.07.006; Cordeiro ML, 2003, J NEUROSCI RES, V73, P865, DOI 10.1002/jnr.10707; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Guix FX, 2009, BRAIN, V132, P1335, DOI 10.1093/brain/awp023; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; HONCHAR MP, 1989, J NEUROCHEM, V53, P590, DOI 10.1111/j.1471-4159.1989.tb07374.x; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; HOYER S, 1988, J NEUROL, V235, P143, DOI 10.1007/BF00314304; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kaddurah-Daouk R, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.22; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; KASAMA T, 1987, J CHROMATOGR, V400, P241, DOI 10.1016/S0021-9673(01)81617-4; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kirkwood JS, 2012, J BIOL CHEM, V287, P3833, DOI 10.1074/jbc.M111.316018; Knafo L, 2005, CLIN CHEM, V51, P1462, DOI 10.1373/clinchem.2005.050427; Lakshmanan J, 2012, J PROTEOM BIOINFORM, V5, P140; Lee S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-8; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Levin J, 2010, DEMENT GERIATR COGN, V29, P553, DOI 10.1159/000314841; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Liou HL, 2006, J BIOL CHEM, V281, P36710, DOI 10.1074/jbc.M608743200; Macko Antoni R., 2008, Archives of Physiology and Biochemistry, V114, P331, DOI [10.1080/13813450802536067, 10.1080/13813450802536067 ]; Mannelli P, 2009, HUM PSYCHOPHARM CLIN, V24, P666, DOI 10.1002/hup.1068; NIKLASSON F, 1983, J NEUROL NEUROSUR PS, V46, P255, DOI 10.1136/jnnp.46.3.255; Patkar AA, 2009, PSYCHOPHARMACOLOGY, V206, P479, DOI 10.1007/s00213-009-1625-1; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; SALEN G, 1972, J CLIN INVEST, V51, P134, DOI 10.1172/JCI106783; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Shaltiel G, 2009, J NEURAL TRANSM, V116, P1543, DOI 10.1007/s00702-009-0298-6; SKREDE S, 1985, SCAND J CLIN LAB INV, V45, P15; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	46	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70610	10.1371/journal.pone.0070610	http://dx.doi.org/10.1371/journal.pone.0070610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936457	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800048
J	You, YA; Ali, M; Kanungo, S; Sah, B; Manna, B; Puri, M; Nair, GB; Bhattacharya, SK; Convertino, M; Deen, JL; Lopez, AL; Wierzba, TF; Clemens, J; Sur, D				You, Young Ae; Ali, Mohammad; Kanungo, Suman; Sah, Binod; Manna, Byomkesh; Puri, Mahesh; Nair, G. Balakrish; Bhattacharya, Sujit Kumar; Convertino, Matteo; Deen, Jacqueline L.; Lopez, Anna Lena; Wierzba, Thomas F.; Clemens, John; Sur, Dipika			Risk Map of Cholera Infection for Vaccine Deployment: The Eastern Kolkata Case	PLOS ONE			English	Article							UPPER CAPE-COD; COMMUNITY; CANCER; BURDEN; MODELS; SLUMS; INDIA	Background: Despite advancement of our knowledge, cholera remains a public health concern. During March-April 2010, a large cholera outbreak afflicted the eastern part of Kolkata, India. The quantification of importance of socio-environmental factors in the risk of cholera, and the calculation of the risk is fundamental for deploying vaccination strategies. Here we investigate socio-environmental characteristics between high and low risk areas as well as the potential impact of vaccination on the spatial occurrence of the disease. Methods and Findings: The study area comprised three wards of Kolkata Municipal Corporation. A mass cholera vaccination campaign was conducted in mid-2006 as the part of a clinical trial. Cholera cases and data of the trial to identify high risk areas for cholera were analyzed. We used a generalized additive model (GAM) to detect risk areas, and to evaluate the importance of socio-environmental characteristics between high and low risk areas. During the one-year pre-vaccination and two-year post-vaccination periods, 95 and 183 cholera cases were detected in 111,882 and 121,827 study participants, respectively. The GAM model predicts that high risk areas in the west part of the study area where the outbreak largely occurred. High risk areas in both periods were characterized by poor people, use of unsafe water, and proximity to canals used as the main drainage for rain and waste water. Cholera vaccine uptake was significantly lower in the high risk areas compared to low risk areas. Conclusion: The study shows that even a parsimonious model like GAM predicts high risk areas where cholera outbreaks largely occurred. This is useful for indicating where interventions would be effective in controlling the disease risk. Data showed that vaccination decreased the risk of infection. Overall, the GAM-based risk map is useful for policymakers, especially those from countries where cholera remains to be endemic with periodic outbreaks.	[You, Young Ae; Ali, Mohammad; Sah, Binod; Puri, Mahesh; Lopez, Anna Lena; Wierzba, Thomas F.; Clemens, John] Int Vaccine Inst, Seoul, South Korea; [Kanungo, Suman; Manna, Byomkesh; Nair, G. Balakrish; Bhattacharya, Sujit Kumar; Sur, Dipika] Natl Inst Cholera & Enter Dis, Kolkata, India; [Bhattacharya, Sujit Kumar] Indian Council Med Res, New Delhi, India; [Convertino, Matteo] Virginia Tech, Dept Biol Syst Engn, HumNat Lab, Blacksburg, VA USA; [Convertino, Matteo] Virginia Tech, Bioinformat Inst, Blacksburg, VA USA; [Convertino, Matteo] Virginia Tech, Inst Crit Technol & Appl Sci, Blacksburg, VA USA; [Deen, Jacqueline L.] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Lopez, Anna Lena] Univ Philippines Manila, Natl Inst Hlth, Manila, Philippines; [Clemens, John] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA	International Vaccine Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Charles Darwin University; Menzies School of Health Research; University of the Philippines System; University of the Philippines Manila; University of California System; University of California Los Angeles	Ali, M (corresponding author), Int Vaccine Inst, Seoul, South Korea.	mali@ivi.int	Lopez, Anna Lena/AAF-6481-2019; Ali, Mohammad/E-2365-2017; Convertino, Matteo/ABD-5828-2021; Convertino, Matteo/J-1365-2016; Kanungo, Sloka/HHM-7508-2022	Lopez, Anna Lena/0000-0003-0013-620X; Ali, Mohammad/0000-0003-1410-388X; Convertino, Matteo/0000-0001-7003-7587; Kanungo, Suman/0000-0003-4441-4443	Bill & Melinda Gates Foundation through the Diseases of the Most Impoverished Program; Cholera Vaccine Initiative; Swedish International Development Cooperation Agency; Government of South Korea; Government of Sweden; Government of Kuwait	Bill & Melinda Gates Foundation through the Diseases of the Most Impoverished Program; Cholera Vaccine Initiative; Swedish International Development Cooperation Agency; Government of South Korea(Korean Government); Government of Sweden; Government of Kuwait	This study is supported by the Bill & Melinda Gates Foundation through the Diseases of the Most Impoverished Program and the Cholera Vaccine Initiative. Additional funding is provided by the Swedish International Development Cooperation Agency and the Governments of South Korea, Sweden, and Kuwait. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOU-GAREEB A. H., 1960, JOUR HYG, V58, P21; Ali M, 2001, Int J Infect Dis, V5, P214, DOI 10.1016/S1201-9712(01)90074-8; Ali M, 2005, B WORLD HEALTH ORGAN, V83, P604; ALI M, 2004, INT J HEALTH GEOGR, V3, P20; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Ali M, 2011, VACCINE, V29, P9051, DOI 10.1016/j.vaccine.2011.09.027; Bhunia R, 2009, INDIAN J GASTROENTER, V28, P62, DOI 10.1007/s12664-009-0020-5; Bopp CA, 1999, LAB METHODS DIAGNOSI; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HUGHES JM, 1982, B WORLD HEALTH ORGAN, V60, P395; Kelsall J, 2002, J AM STAT ASSOC, V97, P692, DOI 10.1198/016214502388618438; Lawson AB, 2001, STAT MED, V20, P2183, DOI 10.1002/sim.933; Snow J., 1855, MODE COMMUNICATION C; Sur D, 2006, INDIAN J MED RES, V123, P31; Sur D, 2005, ARCH DIS CHILD, V90, P1175, DOI 10.1136/adc.2004.071316; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; THOMAS FC, 1997, CALCUTTA HUMAN FACE, P3; Vieira V, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-3; Vieira VM, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-46; Webster Thomas, 2006, Int J Health Geogr, V5, P26, DOI 10.1186/1476-072X-5-26; WHO, 2010, WKLY EPIDEMIOL REC, V85, P117; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World Health Organization, 2011, 64 WORLD HLTH ASS; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	24	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71173	10.1371/journal.pone.0071173	http://dx.doi.org/10.1371/journal.pone.0071173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936491	gold, Green Submitted, Green Published			2022-12-27	WOS:000324545800059
J	Audet, CM; Salato, J; Blevins, M; Amsalem, D; Vermund, SH; Gaspar, F				Audet, Carolyn M.; Salato, Jose; Blevins, Meridith; Amsalem, David; Vermund, Sten H.; Gaspar, Felisbela			Educational Intervention Increased Referrals to Allopathic Care by Traditional Healers in Three High HIV-Prevalence Rural Districts in Mozambique	PLOS ONE			English	Article							SEEKING BEHAVIOR; HEALTH-CARE; ANTIRETROVIRAL THERAPY; TUBERCULOSIS-CONTROL; PREVENTION; PROGRAM; AIDS; MALARIA; ACCESS; DETERMINANTS	Introduction: Delayed uptake of clinical services impedes favorable clinical outcomes in Mozambique. Care is delayed among patients who initiate care with traditional healers; patients with conditions like human immunodeficiency virus (HIV) or tuberculosis are rarely referred to the health system in a timely fashion. Methods: We conducted a pre-post educational intervention with traditional healers, assessing healer referral rates and HIV knowledge in three rural districts in Zambezia Province. Results: The median monthly referral rate prior to the intervention was 0.25 patients (interquartile range [IQR]: 0-0.54) compared with a post-intervention rate of 0.34 patients (IQR: 0-0.71), a 35% increase (p = 0.046). A median HIV knowledge score of 67% (IQR: 59-78) was noted 4-months pre-intervention and a median score of 81% (IQR: 74-89) was recorded 2K months post-intervention (p<0.001). One hundred and eleven healers referred 127 adults, 36 pregnant women, and 188 children to health facilities. Referred patients were most likely to be diagnosed with bronchopneumonia (20% adults; 13% children) and/or malaria (15% adults; 37% children). Of 315 non-pregnant persons referred, 3.5% were tested for HIV and 2.5% were tested for tuberculosis. Discussion: We engaged traditional healers with some success; referral rates were low, but increased post-intervention. Once seen in the clinics, patients were rarely tested for HIV or tuberculosis, though symptoms suggested screening was indicated. We found increased referral rates through an inexpensive intervention with traditional healers, a viable, cost-effective method of directing patients to health facilities. However, quality improvement within the clinics is necessary before a substantial impact can be expected.	[Audet, Carolyn M.; Blevins, Meridith; Amsalem, David; Vermund, Sten H.] Vanderbilt Univ, Sch Med, Inst Global Hlth, Nashville, TN 37212 USA; [Audet, Carolyn M.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; [Blevins, Meridith] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Vermund, Sten H.] Friends Global Hlth, Quelimane, Mozambique; [Gaspar, Felisbela] Minist Hlth, Maputo, Mozambique	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Audet, CM (corresponding author), Vanderbilt Univ, Sch Med, Inst Global Hlth, Nashville, TN 37212 USA.	carolyn.m.audet@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Blevins, Meridith/0000-0002-3861-9859	Amos Christie Chair Endowment at Vanderbilt University; Clinician and Translational Science Award (CTSA)/Vanderbilt Clinical & Translational Research Scholars (VCTRS) grant [2UL1TR000445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER	Amos Christie Chair Endowment at Vanderbilt University; Clinician and Translational Science Award (CTSA)/Vanderbilt Clinical & Translational Research Scholars (VCTRS) grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research funds were provided by a grant from the Amos Christie Chair Endowment at Vanderbilt University. CMA is supported in part by Clinician and Translational Science Award (CTSA)/Vanderbilt Clinical & Translational Research Scholars (VCTRS) grant (2UL1TR000445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Anglemyer A, 2011, COCHRANE DATABASE SY; [Anonymous], 1998, Sex Health Exch, P8; [Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003510; Audet C, 2012, 19 INT AIDS C WASH C; Audet CM, 2012, SAHARA J-J SOC ASP H, V9, P41, DOI 10.1080/17290376.2012.665257; Audet CM, 2012, J ALTERN COMPLEM MED, V18, P1; Babb Dale A, 2007, Psychol Health Med, V12, P314, DOI 10.1080/13548500600621511; Bassett IV, 2010, CLIN INFECT DIS, V50, pS77, DOI 10.1086/651477; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; BERGER RA, 1994, AIDS, V8, P1511, DOI 10.1097/00002030-199410000-00028; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Burnett A, 1999, AIDS CARE, V11, P481, DOI 10.1080/09540129947875; Bwambale FM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-263; Ciampa PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048676; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colvin M, 2003, INT J TUBERC LUNG D, V7, pS86; Cu-Uvin S, 2000, AIDS, V14, P415, DOI 10.1097/00002030-200003100-00015; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Fitzwater SP, 2010, CLIN INFECT DIS, V51, P371, DOI 10.1086/655127; Fleming J, 1995, J Int Assoc Physicians AIDS Care, V1, P32; Furin J, 2011, J COMMUN HEALTH, V36, P849, DOI 10.1007/s10900-011-9385-3; Getahun A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-320; Gqaleni N, 2011, BIOMEDICAL TRADITION; Green EC, 2000, J ALTERN COMPLEM MED, V6, P1, DOI 10.1089/acm.2000.6.1; GREEN EC, 1995, SOC SCI MED, V40, P503, DOI 10.1016/0277-9536(94)E0105-2; Green Edward C, 1994, AIDS STDS AFRICA BRI; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Harper ME, 2004, INT J TUBERC LUNG D, V8, P1266; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; Hensen B, 2012, TROP MED INT HEALTH, V17, P59, DOI 10.1111/j.1365-3156.2011.02893.x; Hopkins H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2606; INSIDA, 2009, NAT SURV PREV BEH RI; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008, REP GOLB HIV AIDS EP; KAMBO IP, 1994, STUD FAMILY PLANN, V25, P32, DOI 10.2307/2137987; Kayombo EJ, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-6; King R., 2000, COLLABORATION TRADIT; Liverpool J, 2004, J NATL MED ASSOC, V96, P822; Madamombe I., 2006, AFRICAN RENEWAL JANU, V19, P10, DOI DOI 10.18356/C58EE076-EN; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Mbeh George N, 2010, Glob Health Promot, V17, P17, DOI 10.1177/1757975910363925; McMillen H, 2004, SOC SCI MED, V59, P889, DOI 10.1016/j.socscimed.2003.12.008; Nations MK, 1997, TROP DOCT, V27, P60, DOI 10.1177/00494755970270S118; Njau IW, 2012, PAN AFR MED J, V12; OSWALD IH, 1983, SOC SCI MED, V17, P255, DOI 10.1016/0277-9536(83)90327-1; Pinkoane M G, 2005, Curationis, V28, P20; PlusNews, 2010, PLUSNEWS; Poudel KC, 2005, TROP MED INT HEALTH, V10, P640, DOI 10.1111/j.1365-3156.2005.01443.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raviglione MC, 2007, B WORLD HEALTH ORGAN, V85, P327, DOI 10.2471/BLT.06.038513; Rudolph M J, 2007, Curationis, V30, P56; Somse P, 1998, AIDS EDUC PREV, V10, P558; Ssali A, 2005, AIDS BEHAV, V9, P485, DOI 10.1007/s10461-005-9019-9; Stekelenburg J, 2005, HEALTH POLICY, V71, P67, DOI 10.1016/j.healthpol.2004.05.008; van Dyk A C, 2003, Curationis, V26, P4; Vermund SH, 2012, 19 INT AIDS C WASH D; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; WARREN DM, 1982, SOC SCI MED, V16, P1873, DOI 10.1016/0277-9536(82)90448-8; World Health Organization, 2012, MAL DIAGN TREATM; Zachariah R, 2010, T ROY SOC TROP MED H, V104, P387, DOI 10.1016/j.trstmh.2010.01.004	62	74	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70326	10.1371/journal.pone.0070326	http://dx.doi.org/10.1371/journal.pone.0070326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219PB	23936407	gold, Green Submitted, Green Published			2022-12-27	WOS:000324518400054
J	Gianfagna, F; Cugino, D; Ahrens, W; Bailey, MES; Bammann, K; Herrmann, D; Koni, AC; Kourides, Y; Marild, S; Molnar, D; Moreno, LA; Pitsiladis, YP; Russo, P; Siani, A; Sieri, S; Sioen, I; Veidebaum, T; Iacoviello, L				Gianfagna, Francesco; Cugino, Daniela; Ahrens, Wolfgang; Bailey, Mark E. S.; Bammann, Karin; Herrmann, Diana; Koni, Anna C.; Kourides, Yiannis; Marild, Staffan; Molnar, Denes; Moreno, Luis A.; Pitsiladis, Yannis P.; Russo, Paola; Siani, Alfonso; Sieri, Sabina; Sioen, Isabelle; Veidebaum, Toomas; Iacoviello, Licia		IDEFICS Consortium	Understanding the Links among neuromedin U Gene, beta2-adrenoceptor Gene and Bone Health: An Observational Study in European Children	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; X-RAY ABSORPTIOMETRY; QUANTITATIVE ULTRASOUND; CALCANEUS ULTRASOUND; BIOLOGICAL MARKERS; CHILDHOOD OBESITY; MINERAL DENSITY; OS CALCIS; IDEFICS; ADOLESCENTS	Neuromedin U, encoded by the NMU gene, is a hypothalamic neuropeptide that regulates both energy metabolism and bone mass. The beta-2 adrenergic receptor, encoded by the ADRB2 gene, mediates several effects of catecholamine hormones and neurotransmitters in bone. We investigated whether NMU single nucleotide polymorphisms (SNPs) and haplotypes, as well as functional ADRB2 SNPs, are associated with bone stiffness in children from the IDEFICS cohort, also evaluating whether NMU and ADRB2 interact to affect this trait. A sample of 2,274 subjects (52.5% boys, age 6.2 +/- 1.8 years) from eight European countries, having data on calcaneus bone stiffness index (SI, mean of both feet) and genotyping (NMU gene: rs6827359, rs12500837, rs9999653; ADRB2 gene: rs1042713, rs1042714), was studied. After false discovery rate adjustment, SI was significantly associated with all NMU SNPs. rs6827359 CC homozygotes showed the strongest association (recessive model, Delta = -1.8, p = 0.006). Among the five retrieved haplotypes with frequencies higher than 1% (range 2.0-43.9%), the CCT haplotype (frequency = 39.7%) was associated with lower SI values (dominant model, Delta = -1.0, p = 0.04) as compared to the most prevalent haplotype. A non-significant decrease in SI was observed in in ADRB2 rs1042713 GG homozygotes, while subjects carrying SI-lowering genotypes at both SNPs (frequency = 8.4%) showed much lower SI than non-carriers (Delta = -3.9, p<0.0001; p for interaction = 0.025). The association was more evident in preschool girls, in whom SI showed a curvilinear trend across ages. In subgroup analyses, rs9999653 CC NMU or both GG ADRB2 genotypes were associated with either lower serum calcium or beta-CrossLaps levels (p = 0.01). This study in European children shows, for the first time in humans, a role for NMU gene through interaction with ADRB2 gene in bone strength regulation, more evident in preschool girls.	[Gianfagna, Francesco] Univ Cattolica Sacro Cuore, Res Labs, Fdn Ric & Cura Giovanni Paolo II, Campobasso, Italy; [Cugino, Daniela; Iacoviello, Licia] Casa Cura Montevergine, Mercogliano, AV, Italy; [Ahrens, Wolfgang; Bammann, Karin; Herrmann, Diana] Leibniz Inst Prevent Res & Epidemiol BIPS GmbH, Dept Epidemiol Methods & Etiol Res, Bremen, Germany; [Ahrens, Wolfgang] Univ Bremen, Dept Math & Comp Sci, D-28359 Bremen, Germany; [Bailey, Mark E. S.] Univ Glasgow, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Bammann, Karin] Univ Bremen, Inst Publ Hlth & Nursing Res, D-28359 Bremen, Germany; [Koni, Anna C.; Pitsiladis, Yannis P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Kourides, Yiannis] Res & Educ Inst Child Hlth, Strovolos, Cyprus; [Marild, Staffan] Univ Gothenburg, Sahlgrenska Acad, Queen Silvia Childrens Hosp, Dept Pediat,Inst Clin Sci, Gothenburg, Sweden; [Molnar, Denes] Univ Pecs, Dept Pediat, Pecs, Hungary; [Moreno, Luis A.] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Russo, Paola; Siani, Alfonso] CNR, Inst Food Sci, Avellino, Italy; [Sieri, Sabina] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Nutr Epidemiol Unit, Milan, Italy; [Sioen, Isabelle] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Sioen, Isabelle] Res Fdn Flanders, FWO, Brussels, Belgium; [Veidebaum, Toomas] Natl Inst Hlth Dev, Ctr Hlth & Behav Sci, Tallinn, Estonia; [Iacoviello, Licia] IRCCS Ist Neurol Mediterraneo Neuromed, Dept Epidemiol & Prevent, Pozzilli, IS, Italy	Catholic University of the Sacred Heart; IRCCS Istituto Tumori Bari Giovanni Paolo II; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; University of Glasgow; University of Bremen; University of Glasgow; Queen Silvia Children's Hospital; University of Gothenburg; University of Pecs; University of Zaragoza; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Fondazione IRCCS Istituto Nazionale Tumori Milan; Ghent University; National Institute for Health Development - Estonia; IRCCS Neuromed	Iacoviello, L (corresponding author), Casa Cura Montevergine, Mercogliano, AV, Italy.	licia.iacoviello@moli-sani.org	Iacoviello, Licia/K-4676-2016; Russo, Paola/AAW-8308-2020; Molnár, Dénes/AAB-6820-2022; Gianfagna, Francesco/K-4561-2016; Siani, Alfonso/B-7925-2015; Moreno, Luis/S-1780-2019; Sieri, Sabina/K-4667-2016; Iacoviello, Licia/AGX-7071-2022; Ahrens, Wolfgang/A-2740-2012	Iacoviello, Licia/0000-0003-0514-5885; Gianfagna, Francesco/0000-0003-4615-0816; Moreno, Luis/0000-0003-0454-653X; Sieri, Sabina/0000-0001-5201-172X; Iacoviello, Licia/0000-0003-0514-5885; Marild, Staffan/0000-0001-6517-2020; Pitsiladis, Yannis/0000-0001-6210-2449; Ahrens, Wolfgang/0000-0003-3777-570X; Bailey, Mark E. S./0000-0002-9788-2278; Bammann, Karin/0000-0002-5623-8160	European Community [016181 (FOOD)]; EU	European Community(European Commission); EU(European Commission)	This study is supported by the European Community within the Sixth RTD Framework Programme Contract no. 016181 (FOOD) and by the grant from EU for the IDEFICS study (http://www.idefics.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens W, 2006, NUTR METAB CARDIOVAS, V16, P302, DOI 10.1016/j.numecd.2006.01.011; Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; Alwis G, 2010, CALCIFIED TISSUE INT, V87, P493, DOI 10.1007/s00223-010-9425-5; Baroncelli GI, 2008, PEDIATR RES, V63, P220, DOI 10.1203/PDR.0b013e318163a286; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cugino D, 2013, INT J OBES IN PRESS; De Henauw S, 2011, INT J OBESITY, V35, pS16, DOI 10.1038/ijo.2011.31; Delwiche LD, 2008, P W US SAS SOFTW C U; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; Economos CD, 2007, BRIT J RADIOL, V80, P919, DOI 10.1259/bjr/33589854; Fielding KT, 2003, J CLIN DENSITOM, V6, P7, DOI 10.1385/JCD:6:1:7; Fukue Y, 2006, FEBS LETT, V580, P3485, DOI 10.1016/j.febslet.2006.05.025; Gianfagna F, 2012, THROMB RES, V129, P320, DOI 10.1016/j.thromres.2011.11.014; GLUER CC, 1994, CALCIFIED TISSUE INT, V55, P46, DOI 10.1007/BF00310168; HANS D, 1994, CALCIFIED TISSUE INT, V55, P94, DOI 10.1007/BF00297182; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Ingallinella P, 2012, BIOORGAN MED CHEM, V20, P4751, DOI 10.1016/j.bmc.2012.06.003; Jalba MS, 2008, OBESITY, V16, P2096, DOI 10.1038/oby.2008.327; JAWORSKI M, 1995, CALCIFIED TISSUE INT, V56, P368, DOI 10.1007/BF00301604; Koni AC, 2011, INT J OBESITY, V35, pS113, DOI 10.1038/ijo.2011.43; Lee M, 2012, J NUTR HEALTH AGING, V16, P8, DOI 10.1007/s12603-011-0080-y; Marin F, 2006, J BONE MINER RES, V21, P1126, DOI 10.1359/JBMR.060417; Meirhaeghe A, 2000, INT J OBESITY, V24, P382, DOI 10.1038/sj.ijo.0801168; Nohara T, 2009, TOHOKU J EXP MED, V219, P63, DOI 10.1620/tjem.219.63; Peier AM, 2011, ENDOCRINOLOGY, V152, P2644, DOI 10.1210/en.2010-1463; Peplies J, 2011, INT J OBESITY, V35, pS104, DOI 10.1038/ijo.2011.41; Portero NR, 2005, CALCIFIED TISSUE INT, V77, P195, DOI 10.1007/s00223-004-1260-0; Prins SH, 1998, CLIN PHYSIOL, V18, P3; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Rosen CJ, 2008, CELL METAB, V7, P7, DOI 10.1016/j.cmet.2007.12.004; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Sawyer A, 2001, J CLIN DENSITOM, V4, P111, DOI 10.1385/JCD:4:2:111; Schoenau E, 2004, HORM RES, V61, P257, DOI 10.1159/000076635; Sioen I, 2012, CALCIFIED TISSUE INT, V91, P276, DOI 10.1007/s00223-012-9640-3; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Teti Anna, 2011, Curr Osteoporos Rep, V9, P264, DOI 10.1007/s11914-011-0078-8; Tubic B, 2011, INT J OBESITY, V35, pS119, DOI 10.1038/ijo.2011.42; Wunsche K, 2000, CALCIFIED TISSUE INT, V67, P349, DOI 10.1007/s002230001143; Zebaze RMD, 2003, J ULTRAS MED, V22, P1337, DOI 10.7863/jum.2003.22.12.1337	41	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70632	10.1371/journal.pone.0070632	http://dx.doi.org/10.1371/journal.pone.0070632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936460	Green Accepted, Green Published, gold			2022-12-27	WOS:000324518400079
J	Huang, WJ; Sun, W; Lv, HY; Luo, M; Zeng, SH; Pattanaik, S; Yuan, L; Wang, Y				Huang, Wenjun; Sun, Wei; Lv, Haiyan; Luo, Ming; Zeng, Shaohua; Pattanaik, Sitakanta; Yuan, Ling; Wang, Ying			A R2R3-MYB Transcription Factor from Epimedium sagittatum Regulates the Flavonoid Biosynthetic Pathway	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; PROANTHOCYANIDIN BIOSYNTHESIS; RED COLORATION; MYB DOMAIN; GENE-EXPRESSION; COLORFUL MODEL; DNA-BINDING; ARABIDOPSIS; PROTEIN; BIOCHEMISTRY	Herba epimedii (Epimedium), a traditional Chinese medicine, has been widely used as a kidney tonic and antirheumatic medicine for thousands of years. The bioactive components in herba epimedii are mainly prenylated flavonol glycosides, end-products of the flavonoid pathway. Epimedium species are also used as garden plants due to the colorful flowers and leaves. Many R2R3-MYB transcription factors (TFs) have been identified to regulate the flavonoid and anthocyanin biosynthetic pathways. However, little is known about the R2R3-MYB TFs involved in regulation of the flavonoid pathway in Epimedium. Here, we reported the isolation and functional characterization of the first R2R3-MYB TF (EsMYBA1) from Epimedium sagittatum (Sieb. Et Zucc.) Maxim. Conserved domains and phylogenetic analysis showed that EsMYBA1 belonged to the subgroup 6 clade (anthocyanin-related MYB clade) of R2R3-MYB family, which includes Arabidopsis AtPAP1, apple MdMYB10 and legume MtLAP1. EsMYBA1 was preferentially expressed in leaves, especially in red leaves that contain higher content of anthocyanin. Alternative splicing of EsMYBA1 resulted in three transcripts and two of them encoded a MYB-related protein. Yeast two-hybrid and transient luciferase expression assay showed that EsMYBA1 can interact with several bHLH regulators of the flavonoid pathway and activate the promoters of dihydroflavonol 4-reductase (DFR) and anthocyanidin synthase (ANS). In both transgenic tobacco and Arabidopsis, overexpression of EsMYBA1 induced strong anthocyanin accumulation in reproductive and/or vegetative tissues via up-regulation of the main flavonoid-related genes. Furthermore, transient expression of EsMYBA1 in E. sagittatum leaves by Agrobacterium infiltration also induced anthocyanin accumulation in the wounded area. This first functional characterization of R2R3-MYB TFs in Epimedium species will promote further studies of the flavonoid biosynthesis and regulation in medicinal plants.	[Huang, Wenjun; Lv, Haiyan; Wang, Ying] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China; [Sun, Wei; Luo, Ming; Zeng, Shaohua] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Pattanaik, Sitakanta; Yuan, Ling] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Kentucky	Wang, Y (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China.	yingwang@wbgcas.cn	HUANG, WENJUN/GXM-9167-2022	Pattanaik, Sitakanta/0000-0001-7702-8341	National Natural Science Foundation of China [31270340, 31200225]; CAS/SAFEA International Partnership Program for Creative Research Teams Project; Knowledge Innovation Project of The Chinese Academy of Sciences [KSCX2-EW-J-20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams Project; Knowledge Innovation Project of The Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This study was supported by grants from the National Natural Science Foundation of China (No. 31270340, 31200225), and CAS/SAFEA International Partnership Program for Creative Research Teams Project and Knowledge Innovation Project of The Chinese Academy of Sciences (KSCX2-EW-J-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Bai YH, 2011, PLANTA, V234, P363, DOI 10.1007/s00425-011-1407-y; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Guo Bao-lin, 2003, Zhongguo Zhongyao Zazhi, V28, P303; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kobayashi S, 2005, J JPN SOC HORTIC SCI, V74, P196, DOI 10.2503/jjshs.74.196; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li JG, 2006, J EXP BOT, V57, P1263, DOI 10.1093/jxb/erj094; [李作洲 Li Zuozhou], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P289; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; LLOYD AM, 1992, SCIENCE, V258, P1773, DOI 10.1126/science.1465611; Locatelli F, 2000, J BIOL CHEM, V275, P17619, DOI 10.1074/jbc.M000647200; Ma HP, 2011, J ETHNOPHARMACOL, V134, P519, DOI 10.1016/j.jep.2011.01.001; Magaraggia F, 1997, PLANT MOL BIOL, V35, P1003, DOI 10.1023/A:1005821518242; MANCINELLI AL, 1990, PLANT PHYSIOL, V92, P1191, DOI 10.1104/pp.92.4.1191; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; MOONEY M, 1995, PLANT J, V7, P333, DOI 10.1046/j.1365-313X.1995.7020333.x; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Pharmacopoeia Commission of PRC, 2005, PHARMACOPOEIA PEOPLE; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Sainz MB, 1997, PLANT CELL, V9, P611, DOI 10.1105/tpc.9.4.611; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Simon M, 2007, DEV BIOL, V311, P566, DOI 10.1016/j.ydbio.2007.09.001; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu H, 2003, PROG DRUG RES, V60, P1; Xie PS, 2010, J PHARMACEUT BIOMED, V52, P452, DOI 10.1016/j.jpba.2010.01.025; Yamagishi M, 2010, PLANT CELL PHYSIOL, V51, P463, DOI 10.1093/pcp/pcq011; Yao LH, 2004, PLANT FOODS HUM NUTR, V59; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	68	54	64	9	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70778	10.1371/journal.pone.0070778	http://dx.doi.org/10.1371/journal.pone.0070778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936468	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400083
J	Ibanes, S; Kremer, EJ				Ibanes, Sandy; Kremer, Eric J.			Canine Adenovirus Type 2 Vector Generation via I-Sce1-Mediated Intracellular Genome Release	PLOS ONE			English	Article							GENE-TRANSFER; IN-VIVO; MRE11-RAD50-NBS1 COMPLEX; CELLS; REPAIR; ACTIVATION; EXPRESSION; INHIBITOR; TRANSDUCTION; TRANSGENE	When canine adenovirus type 2 (CAdV-2, or also commonly referred to as CAV-2) vectors are injected into the brain parenchyma they preferentially transduce neurons, are capable of efficient axonal transport to afferent regions, and allow transgene expression for at last >1 yr. Yet, translating these data into a user-friendly vector platform has been limited because CAV-2 vector generation is challenging. Generation of E1-deleted adenovirus vectors often requires transfection of linear DNA fragments of >30 kb containing the vector genome into an E1-transcomplementing cell line. In contrast to human adenovirus type 5 vector generation, CAV-2 vector generation is less efficient due, in part, to a reduced ability to initiate replication and poor transfectibility of canine cells with large, linear DNA fragments. To improve CAV-2 vector generation, we generated an E1-transcomplementing cell line expressing the estrogen receptor (ER) fused to I-SceI, a yeast meganuclease, and plasmids containing the I-SceI recognition sites flanking the CAV-2 vector genome. Using transfection of supercoiled plasmid and intracellular genome release via 4-OH-tamoxifen-induced nuclear translocation of I-SceI, we improved CAV-2 vector titers 1,000 fold, and in turn increased the efficacy of CAV-2 vector generation.	[Ibanes, Sandy; Kremer, Eric J.] CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Ibanes, Sandy; Kremer, Eric J.] Univ Montpellier I, Montpellier, France; [Ibanes, Sandy; Kremer, Eric J.] Univ Montpellier 2, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Kremer, EJ (corresponding author), CNRS, Inst Genet Mol Montpellier, Montpellier, France.	eric.kremer@igmm.cnrs.fr	Kremer, EJ/P-9838-2019; Kremer, Eric J/D-3734-2013	Kremer, EJ/0000-0001-6114-7530; 	European Commission through European Community's 7th Framework Program [222992]; Region Languedoc Roussillon (ARPE) [CTP 115277]; Fondation de France [2008005416]; Vaincre les Maladies Lysosomales (VML)	European Commission through European Community's 7th Framework Program; Region Languedoc Roussillon (ARPE)(Region Occitanie); Fondation de France(Fondation de France); Vaincre les Maladies Lysosomales (VML)	Funding was provided by European Commission through European Community's 7th Framework Program (FP7/2007-2013; grant 222992, BrainCAV), the Region Languedoc Roussillon (ARPE and CTP 115277), the Fondation de France (grant number 2008005416), Vaincre les Maladies Lysosomales (VML). Motor Neurone Disease Association and Agence National de la Recherche (program Blanc, E-RARE and MNP), and the Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brito C, 2012, METHODS, V56, P452, DOI 10.1016/j.ymeth.2012.03.005; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Courilleau C, 2012, J CELL BIOL, V199, P1067, DOI 10.1083/jcb.201205059; Du EQ, 2010, J GENE MED, V12, P840, DOI 10.1002/jgm.1505; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Fernandes P, 2013, GENE THER, V20, P353, DOI 10.1038/gt.2012.52; Gao G, 2003, GENE THER, V10, P1926, DOI 10.1038/sj.gt.3302088; Garner KM, 2009, NAT CHEM BIOL, V5, P129, DOI 10.1038/nchembio0309-129; GRAHAM FL, 1974, COLD SPRING HARB SYM, V39, P637, DOI 10.1101/SQB.1974.039.01.077; GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331; Henaff D, 2011, FUTURE MICROBIOL, V6, P179, DOI 10.2217/FMB.10.162; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Keriel A, 2003, M S-MED SCI, V19, P1048, DOI 10.1051/medsci/200319111048; KETNER G, 1994, P NATL ACAD SCI USA, V91, P6186, DOI 10.1073/pnas.91.13.6186; Kissa K, 2002, MOL CELL NEUROSCI, V20, P627, DOI 10.1006/mcne.2002.1141; Klonjkowski B, 1997, HUM GENE THER, V8, P2103, DOI 10.1089/hum.1997.8.17-2103; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Kremer EJ, 2005, CURR GENOMICS, V6, P13, DOI 10.2174/1389202053202111; Kremer EJ, 2004, J GENE MED, V6, pS139, DOI 10.1002/jgm.497; Lau AA, 2012, GENE, V491, P53, DOI 10.1016/j.gene.2011.09.004; Ord ENJ, 2013, J CEREBR BLOOD F MET, V33, P1215, DOI 10.1038/jcbfm.2013.70; Paillard F, 1997, HUM GENE THER, V8, P2007, DOI 10.1089/hum.1997.8.17-2007; Perreau M, 2005, J VIROL, V79, P14595, DOI 10.1128/JVI.79.23.14595-14605.2005; Perreau M, 2007, MOL THER, V15, P1998, DOI 10.1038/sj.mt.6300289; Perreau M, 2007, J VIROL, V81, P3272, DOI 10.1128/JVI.01530-06; Salinas S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000442; Soudais C, 2003, FASEB J, V17, P391, DOI 10.1096/fj.03-0438fje; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Soudais C, 2001, MOL THER, V3, P631, DOI 10.1006/mthe.2001.0263; Stanton RJ, 2008, BIOTECHNIQUES, V45, P659, DOI 10.2144/000112993; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	40	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71032	10.1371/journal.pone.0071032	http://dx.doi.org/10.1371/journal.pone.0071032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936483	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400089
J	Lee, D; Lee, KH; Park, H; Kim, SH; Jin, T; Cho, S; Chung, JH; Lim, S; Park, S				Lee, Dajeong; Lee, Kyung Hye; Park, Hyelim; Kim, Soo Hyuk; Jin, Taewon; Cho, Soyoung; Chung, Ji Hyung; Lim, Soyeon; Park, Sungha			RETRACTED: The Effect of Soluble RAGE on Inhibition of Angiotensin II-Mediated Atherosclerosis in Apolipoprotein E Deficient Mice (Retracted article. See vol. 9, e108684, 2014)	PLOS ONE			English	Article; Retracted Publication							GLYCOSYLATION END-PRODUCTS; RECEPTOR; PROTEIN; INFLAMMATION; EXPRESSION; CELLS; PROLIFERATION; ADHESION; PATHWAY; SYSTEM	Background: The cross talk between RAGE and angiotensin II (AngII) activation may be important in the development of atherosclerosis. Soluble RAGE (sRAGE), a truncated soluble form of the receptor, acts as a decoy and prevents the inflammatory response mediated by RAGE activation. In this study, we sought to determine the effect of sRAGE in inhibiting AngII-induced atherosclerosis in apolipoprotein E knockout mice (Apo E KO). Methods and Results: 9 week old Apo E KO mice were infused subcutaneously with AngII (1 mu g/min/kg) and saline for 4 weeks using osmotic mini-pumps. The mice were divided into 4 groups 1. saline infusion and saline injection; 2. saline infusion and sRAGE injection; 3. AngII infusion and saline injection; 4. AngII infusion and sRAGE injection. Saline or 0.5 mu g, 1 mu g, to 2 mu g/day/mouse of sRAGE were injected intraperitoneally daily for 28 days. We showed that atherosclerotic plaque areas in the AngII-infused Apo E KO mice and markers of inflammation such as RAGE, ICAM-1, VCAM-1, and MCP-1 were increased in aorta compared to that of the Apo E KO mice. However, the treatment of 0.5 mu g, 1 mu g, and 2 mu g of sRAGE in AngII group resulted in the dose-dependent decrease in atherosclerotic plaque area. We also demonstrated that sRAGE decreased RAGE expression level as well as inflammatory cytokines and cell adhesion molecules in AngII or HMGB1 treated-rat aorta vascular smooth muscle cells. Conclusion: The results demonstrated that partical blockade of RAGE activation by sRAGE prevent AngII -induced atherosclerosis. Therefore these results suggested that first, RAGE activation may be important in mediating AngII-induced atherogenesis, and second, AngII activation is a major pathway in the development of atherosclerosis. Taken together, results from this study may provide the basis for future anti-atherosclerotic drug development mediated through RAGE activation.	[Lee, Dajeong; Kim, Soo Hyuk; Jin, Taewon; Chung, Ji Hyung] Yonsei Univ, Grad Program Sci Aging, Seoul 120749, South Korea; [Lee, Dajeong; Kim, Soo Hyuk; Jin, Taewon; Chung, Ji Hyung] Yonsei Univ, Yonsei Res Inst Aging Sci, Seoul 120749, South Korea; [Lee, Kyung Hye] Kyung Hee Univ, Med Ctr, Med Sci Res Inst, Seoul, South Korea; [Lee, Dajeong; Park, Hyelim; Kim, Soo Hyuk; Jin, Taewon; Cho, Soyoung; Chung, Ji Hyung; Lim, Soyeon; Park, Sungha] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea; [Park, Sungha] Yonsei Univ, Coll Med, Div Cardiol, Seoul, South Korea; [Cho, Soyoung; Lim, Soyeon] Yonsei Univ, Coll Med, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Park, Hyelim; Park, Sungha] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120749, South Korea	Yonsei University; Yonsei University; Kyung Hee University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Lim, S (corresponding author), Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.	slim724@yuhs.ac; shpark0530@yuhs.ac		Park, Hyelim/0000-0002-1420-7526	National Research Foundation [NRF-2010-0003855]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A085136]	National Research Foundation; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This work was supported by grants from the National Research Foundation Grant (NRF-2010-0003855) and the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A085136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985; Brewster UC, 2003, AM J MED SCI, V326, P15, DOI 10.1097/00000441-200307000-00003; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen CY, 2012, J BIOL CHEM, V287, P44498, DOI 10.1074/jbc.M112.399790; Cheng ZJ, 2005, MED SCI MONITOR, V11, pRA194; Choi JW, 2011, BIOCHEM BIOPH RES CO, V410, P525, DOI 10.1016/j.bbrc.2011.06.016; Dourron HM, 2005, AM J PHYSIOL-HEART C, V288, pH946, DOI 10.1152/ajpheart.00413.2004; Dzau V, 2005, J HYPERTENS, V23, pS9, DOI 10.1097/01.hjh.0000165623.72310.dd; Ihara Y, 2007, J MOL CELL CARDIOL, V43, P455, DOI 10.1016/j.yjmcc.2007.07.044; Jandeleit-Dahm K, 2008, CLIN EXP PHARMACOL P, V35, P329, DOI 10.1111/j.1440-1681.2007.04875.x; Lee HW, 2008, REGUL PEPTIDES, V147, P72, DOI 10.1016/j.regpep.2008.01.004; Lee SW, 2013, ARTHRITIS RHEUM; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Ling HP, 2013, J SURG RES, V179, pE227, DOI 10.1016/j.jss.2012.03.030; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Patole PS, 2005, KIDNEY INT, V68, P2582, DOI 10.1111/j.1523-1755.2005.00729.x; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Radeke HH, 2002, J BIOL CHEM, V277, P27535, DOI 10.1074/jbc.M200419200; Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Vazzana N, 2009, INTERN EMERG MED, V4, P389, DOI 10.1007/s11739-009-0300-1; Weaver M, 2006, AM J PHYSIOL-HEART C, V290, pH1933, DOI 10.1152/ajpheart.00690.2005; Weiss D, 2001, CIRCULATION, V103, P448; WOOLEY PH, 1993, J IMMUNOL, V151, P6602; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Yusuf S, 2000, NEW ENGL J MED, V342, P145	33	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69669	10.1371/journal.pone.0069669	http://dx.doi.org/10.1371/journal.pone.0069669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936343	Green Published, gold			2022-12-27	WOS:000324518400020
J	Rickard, DJ; Sehon, CA; Kasparcova, V; Kallal, LA; Zeng, X; Montoute, MN; Chordia, T; Poore, DD; Li, H; Wu, ZN; Eidam, PM; Haile, PA; Yu, J; Emery, JG; Marquis, RW; Gough, PJ; Bertin, J				Rickard, David J.; Sehon, Clark A.; Kasparcova, Viera; Kallal, Lorena A.; Zeng, Xin; Montoute, Monica N.; Chordia, Tushar; Poore, Derek D.; Li, Hu; Wu, Zining; Eidam, Patrick M.; Haile, Pamela A.; Yu, Jong; Emery, John G.; Marquis, Robert W.; Gough, Peter J.; Bertin, John			Identification of Benzimidazole Diamides as Selective Inhibitors of the Nucleotide-Binding Oligomerization Domain 2 (NOD2) Signaling Pathway	PLOS ONE			English	Article							KAPPA-B ACTIVATION; INNATE IMMUNE-RESPONSES; CROHNS-DISEASE; MURAMYL DIPEPTIDE; GENE-EXPRESSION; FAMILY-MEMBER; CELLS	NOD2 is an intracellular pattern recognition receptor that assembles with receptor-interacting protein (RIP)-2 kinase in response to the presence of bacterial muramyl dipeptide (MDP) in the host cell cytoplasm, thereby inducing signals leading to the production of pro-inflammatory cytokines. The dysregulation of NOD2 signaling has been associated with various inflammatory disorders suggesting that small-molecule inhibitors of this signaling complex may have therapeutic utility. To identify inhibitors of the NOD2 signaling pathway, we utilized a cell-based screening approach and identified a benzimidazole diamide compound designated GSK669 that selectively inhibited an MDP-stimulated, NOD2-mediated IL-8 response without directly inhibiting RIP2 kinase activity. Moreover, GSK669 failed to inhibit cytokine production in response to the activation of Toll-like receptor (TLR)-2, tumor necrosis factor receptor (TNFR)-1 and closely related NOD1, all of which share common downstream components with the NOD2 signaling pathway. While the inhibitors blocked MDP-induced NOD2 responses, they failed to block signaling induced by NOD2 over-expression or single stranded RNA, suggesting specificity for the MDP-induced signaling complex and activator-dependent differences in NOD2 signaling. Investigation of structure-activity relationship allowed the identification of more potent analogs that maintained NOD2 selectivity. The largest boost in activity was achieved by N-methylation of the C2-ethyl amide group. These findings demonstrate that the NOD2 signaling pathway is amenable to modulation by small molecules that do not target RIP2 kinase activity. The compounds we identified should prove useful tools to investigate the importance of NOD2 in various inflammatory processes and may have potential clinical utility.	[Rickard, David J.; Sehon, Clark A.; Kasparcova, Viera; Eidam, Patrick M.; Haile, Pamela A.; Yu, Jong; Emery, John G.; Marquis, Robert W.; Gough, Peter J.; Bertin, John] GlaxoSmithKline, Immunoinflammat Therapeut Area, Pattern Recognit Receptor Discovery Performance U, Collegeville, PA USA; [Kallal, Lorena A.; Chordia, Tushar; Poore, Derek D.; Li, Hu] GlaxoSmithKline, Platform Technol Sci, Biol Reagents & Assay Dev, Collegeville, PA USA; [Zeng, Xin; Montoute, Monica N.; Wu, Zining] GlaxoSmithKline, Platform Technol Sci, Screening & Compound Profiling, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Rickard, DJ (corresponding author), GlaxoSmithKline, Immunoinflammat Therapeut Area, Pattern Recognit Receptor Discovery Performance U, Collegeville, PA USA.	David.J.Rickard@gsk.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding support for this research was provided entirely by GlaxoSmithKline. Only the authors, who are or were full-time employees of GSK, were involved in the study design, data analysis, decision to publish and manuscript preparation. No individuals employed or contracted by the funder, other than the named authors, were involved in these tasks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari N, 2012, J BIOTECHNOL, V157, P75, DOI 10.1016/j.jbiotec.2011.10.007; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Correa RG, 2011, CHEM BIOL, V18, P825, DOI 10.1016/j.chembiol.2011.06.009; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Huang S, 2008, MOL PHARMACOL, V74, P274, DOI 10.1124/mol.108.046169; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Khan PM, 2011, ACS MED CHEM LETT, V2, P780, DOI 10.1021/ml200158b; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lecat A, 2010, BIOCHEM PHARMACOL, V80, P2021, DOI 10.1016/j.bcp.2010.07.016; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Rose CD, 2011, CURR OPIN RHEUMATOL, V23, P411, DOI 10.1097/BOR.0b013e328349c430; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sato H, 2010, EUR RESPIR J, V35, P324, DOI 10.1183/09031936.00010209; Strober W, 2011, MUCOSAL IMMUNOL, V4, P484, DOI 10.1038/mi.2011.29; van Heel DA, 2005, GUT, V54, P1553, DOI 10.1136/gut.2005.065888; Zhao L, 2007, J BIOL CHEM, V282, P11618, DOI 10.1074/jbc.M608644200; Zurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041255	28	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69619	10.1371/journal.pone.0069619	http://dx.doi.org/10.1371/journal.pone.0069619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936340	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400019
J	Curl, CL; Beresford, SAA; Hajat, A; Kaufman, JD; Moore, K; Nettleton, JA; Diez-Roux, AV				Curl, Cynthia L.; Beresford, Shirley A. A.; Hajat, Anjum; Kaufman, Joel D.; Moore, Kari; Nettleton, Jennifer A.; Diez-Roux, Ana V.			Associations of Organic Produce Consumption with Socioeconomic Status and the Local Food Environment: Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDE EXPOSURE; PRENATAL EXPOSURE; DIET QUALITY; ATTITUDES; HEALTH; PERCEPTIONS; METABOLITES; CHILDREN; WEIGHT	Neighborhood characteristics, such as healthy food availability, have been associated with consumption of healthy food. Little is known about the influence of the local food environment on other dietary choices, such as the decision to consume organic food. We analyzed the associations between organic produce consumption and demographic, socioeconomic and neighborhood characteristics in 4,064 participants aged 53-94 in the Multi-Ethnic Study of Atherosclerosis using log-binomial regression models. Participants were classified as consuming organic produce if they reported eating organic fruits and vegetables either "sometimes" or "often or always". Women were 21% more likely to consume organic produce than men (confidence interval [CI]: 1.12-1.30), and the likelihood of organic produce consumption was 13% less with each additional 10 years of age (CI: 0.84-0.91). Participants with higher education were significantly more likely to consume organic produce (prevalence ratios [PR] were 1.05 with a high school education, 1.39 with a bachelor's degree and 1.68 with a graduate degree, with less than high school as the reference group [1.00]). Per capita household income was marginally associated with produce consumption (p = 0.06), with the highest income category more likely to consume organic produce. After adjustment for these individual factors, organic produce consumption was significantly associated with self-reported assessment of neighborhood produce availability (PR: 1.07, CI: 1.02-1.11), with an aggregated measure of community perception of the local food environment (PR: 1.08, CI: 1.00-1.17), and, to a lesser degree, with supermarket density (PR: 1.02: CI: 0.99-1.05). This research suggests that both individual-level characteristics and qualities of the local food environment are associated with having a diet that includes organic food.	[Curl, Cynthia L.; Hajat, Anjum; Kaufman, Joel D.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Beresford, Shirley A. A.; Kaufman, Joel D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Kaufman, Joel D.] Univ Washington, Dept Med, Seattle, WA USA; [Moore, Kari; Diez-Roux, Ana V.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Nettleton, Jennifer A.] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston	Curl, CL (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	ccurl@uw.edu	Kaufman, Joel D/B-5761-2008	Kaufman, Joel D/0000-0003-4174-9037; Curl, Cynthia/0000-0002-2478-2292	United States Environmental Protection Agency's Science to Achieve Results (STAR) Fellowship Program [FP917129]; National Institutes of Health [R01 HL071759]; National Institute of Environmental Health Sciences [ES013195, 5P30ES007033]; National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95165, N01-HC-95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095165, N01HC095169] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K24ES013195, P50ES015915, P30ES007033] Funding Source: NIH RePORTER	United States Environmental Protection Agency's Science to Achieve Results (STAR) Fellowship Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the United States Environmental Protection Agency's Science to Achieve Results (STAR) Fellowship Program (FP917129), by contract R01 HL071759 from the National Institutes of Health, by grants ES013195 and 5P30ES007033 from the National Institute of Environmental Health Sciences, and by contracts N01-HC-95159 through N01-HC-95165 and N01-HC-95169 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barr DB, 2011, INT J ENV RES PUB HE, V8, P3063, DOI 10.3390/ijerph8083063; Bellows AC, 2010, APPETITE, V55, P540, DOI 10.1016/j.appet.2010.09.002; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P1189, DOI 10.1289/ehp.1003185; Bouchard MF, 2010, PEDIATRICS, V125, pE1270, DOI 10.1542/peds.2009-3058; Curl CL, 2003, ENVIRON HEALTH PERSP, V111, P377, DOI 10.1289/ehp.5754; Dettmann RL, 2010, J FOOD PROD MARK, V16, P79, DOI 10.1080/10454440903415709; Dimitri C., 2009, Economic Information Bulletin - USDA Economic Research Service; Drewnowski Adam, 2012, Am J Public Health, V102, pe74, DOI 10.2105/AJPH.2012.300660; Dubowitz T, 2012, OBESITY, V20, P862, DOI 10.1038/oby.2011.141; Engel SM, 2011, ENVIRON HEALTH PERSP, V119, P1182, DOI 10.1289/ehp.1003183; Forman J, 2012, PEDIATRICS, V130, pE1406, DOI 10.1542/peds.2012-2579; Gibson DM, 2011, AM J PUBLIC HEALTH, V101, P71, DOI 10.2105/AJPH.2009.187567; Goldman B. J., 1991, American Journal of Alternative Agriculture, V6, P89, DOI 10.1017/S0889189300003933; Govindasamy R., 1999, Journal of Food Distribution Research, V30, P44; Huang CL, 1996, EUR REV AGRIC ECON, V23, P331, DOI 10.1093/erae/23.3.331; Inagami S, 2006, AM J PREV MED, V31, P10, DOI 10.1016/j.amepre.2006.03.019; Kriwy P, 2012, INT J CONSUM STUD, V36, P30, DOI 10.1111/j.1470-6431.2011.01004.x; Laraia BA, 2004, PREV MED, V39, P869, DOI 10.1016/j.ypmed.2004.03.018; Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025; Li J., 2007, J FOOD DISTRIBUTION, V38, P54; Lu CS, 2008, ENVIRON HEALTH PERSP, V116, P537, DOI 10.1289/ehp.10912; Lu CS, 2006, ENVIRON HEALTH PERSP, V114, P260, DOI 10.1289/ehp.8418; Macdonald L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-454; Magkos F, 2006, CRIT REV FOOD SCI, V46, P23, DOI 10.1080/10408690490911846; Marks AR, 2010, ENVIRON HEALTH PERSP, V118, P1768, DOI 10.1289/ehp.1002056; Moore LV, 2008, AM J EPIDEMIOL, V167, P917, DOI 10.1093/aje/kwm394; Moore LV, 2008, J URBAN HEALTH, V85, P206, DOI 10.1007/s11524-008-9259-x; Morland K, 2002, AM J PUBLIC HEALTH, V92, P1761, DOI 10.2105/AJPH.92.11.1761; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Nielsen Company, 2008, RET SIT DAT ULT SOUR; Onyango BM, 2007, BRIT FOOD J, V109, P399, DOI 10.1108/00070700710746803; Organic Trade Association, 2012, IND STAT PROJ GROWTH; Rauch SA, 2012, ENVIRON HEALTH PERSP, V120, P1055, DOI 10.1289/ehp.1104615; Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160; Smith T. A., 2009, Journal of Agricultural and Applied Economics, V41, P731; Thompson GD, 1998, AM J AGR ECON, V80, P277, DOI 10.2307/1244500; United States Department of Agriculture (USDA), 2000, ORG FOOD STAND LAB F; *US EPA, 2006, ORG CUM RISK ASS 200; Walls & Associates, 2010, NAT EST TIM SER NETS; Williams LK, 2012, PUBLIC HEALTH NUTR, V15, P291, DOI 10.1017/S1368980011001947; Williams PRD, 2001, RISK ANAL, V21, P319, DOI 10.1111/0272-4332.212114; Xie B, 2003, J AGR ENVIRON ETHIC, V16, P297, DOI 10.1023/A:1023632201788; Zepeda L., 2007, Journal of Agricultural and Applied Economics, V39, P17; Zhang F, 2008, AGRIBUSINESS, V24, P510, DOI 10.1002/agr.20176	45	39	40	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69778	10.1371/journal.pone.0069778	http://dx.doi.org/10.1371/journal.pone.0069778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936098	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700043
J	Sodhi, RK; Singh, N				Sodhi, Rupinder K.; Singh, Nirmal			Defensive Effect of Lansoprazole in Dementia of AD Type in Mice Exposed to Streptozotocin and Cholesterol Enriched Diet	PLOS ONE			English	Article							LIVER-X RECEPTORS; ALZHEIMERS-DISEASE; MEMORY DEFICITS; INTRACEREBROVENTRICULAR INJECTION; OXIDATIVE STRESS; BRAIN; EXPRESSION; MYELOPEROXIDASE; IMPAIRMENT; PATHOLOGY	The present study investigates the potential of lansoprazole (a proton pump inhibitor and agonist of liver x receptors) in experimental dementia of AD type. Streptozotocin [STZ, 3 mg/kg, injected intracerebroventricular (i.c.v), and high fat diet (HFD, administered for 90 days)] were used to induce dementia in separate groups of Swiss mice. Morris water maze (MWM) test was performed to assess learning and memory of the animals. A battery of biochemical and histopathological studies were also performed. Extent of oxidative stress was measured by estimating the levels of brain reduced glutathione (GSH) and thiobarbituric acid reactive species (TBARS). Brain acetylcholinestrase (AChE) activity and serum cholesterol levels were also estimated. The brain level of myeloperoxidase (MPO) was measured as a marker of inflammation. STZ and HFD produced a marked decline in MWM performance of the animals, reflecting impairment of learning and memory. STZ/HFD treated mice exhibited a marked accentuation of AChE activity, TBARS and MPO levels along with a fall in GSH levels. Further, the stained micrographs of STZ/HFD treated mice indicated pathological changes, severe neutrophilic infiltration and amyloid deposition. Lansoprazole treatment significantly attenuated STZ and HFD -induced memory deficits, biochemical and histopathological alterations. It also prevented HFD-induced rise in the cholesterol level. Therefore, the findings demonstrate potential of lansoprazole in memory dysfunctions which may probably be attributed to its anticholinesterase, anti-oxidative and anti-inflammatory effects. Moreover, both cholesterol-dependent as well as cholesterol-independent effects of lansoprazole appear to play a role. In addition study indicates the role of liver x receptors in dementia.	[Sodhi, Rupinder K.; Singh, Nirmal] Punjabi Univ, Fac Med, Dept Pharmaceut Sci & Drug Res, Div Pharmacol, Patiala, Punjab, India	Punjabi University	Singh, N (corresponding author), Punjabi Univ, Fac Med, Dept Pharmaceut Sci & Drug Res, Div Pharmacol, Patiala, Punjab, India.	nirmal_puru@rediffmail.com	Singh, Nouratan/N-9377-2017; Singh, Nirmal/ABA-2264-2020	Singh, Nouratan/0000-0002-8063-8375; 	Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala	Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala	The authors are grateful to the Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala for providing funding and technical facilities for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Banchroft AS, 1996, THEORY PRACTICE HIST; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; Beutler E, 1996, J LB CLIN MED, V61, P82; Blandizzi C, 2005, WORLD J GASTROENTERO, V11, P4052, DOI 10.3748/wjg.v11.i26.4052; Chan CW, 1999, ALZHEIMERS REP, V2, P113; Cronican AA, 2010, BIOCHEM PHARMACOL, V79, P1310, DOI 10.1016/j.bcp.2009.12.018; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Ellis JM, 2005, J AM OSTEOPATH ASSOC, V105, P145; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Green PS, 2004, J NEUROCHEM, V90, P724, DOI 10.1111/j.1471-4159.2004.02527.x; Grunblatt E, 2006, J ALZHEIMERS DIS, V9, P261; Haley RW, 2000, ARCH NEUROL-CHICAGO, V57, P1410, DOI 10.1001/archneur.57.10.1410; Hampel H, 2012, INT PSYCHOGERIATR, V24, pS10, DOI 10.1017/S1041610212000579; Hashioka S, 2011, GLIA, V59, P833, DOI 10.1002/glia.21157; Hashioka S, 2009, EXP NEUROL, V217, P177, DOI 10.1016/j.expneurol.2009.02.002; Herrmann N, 2011, DRUGS, V71, P2031, DOI 10.2165/11595870-000000000-00000; Hoyer S, 2002, J NEURAL TRANSM, V109, P341, DOI 10.1007/s007020200028; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Ishrat T, 2006, BEHAV BRAIN RES, V171, P9, DOI 10.1016/j.bbr.2006.03.009; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Karantzoulis S, 2011, EXPERT REV NEUROTHER, V11, P1579, DOI [10.1586/ERN.11.155, 10.1586/ern.11.155]; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova R, 2010, BBA-MOL CELL BIOL L, V1801, P824, DOI 10.1016/j.bbalip.2010.02.010; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mandrekar-Colucci S, 2011, EXPERT OPIN THER TAR, V15, P1085, DOI 10.1517/14728222.2011.594043; Mequid S, 2004, PHARMAZIE, V59, P733; Micheal SR, 2009, BMC MED S7, V7, pS7; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parle M., 2004, Asia Pacific Journal of Pharmacology, V16, P101; Parle M, 2007, YAKUGAKU ZASSHI, V127, P1125, DOI 10.1248/yakushi.127.1125; Pathan AR, 2006, LIFE SCI, V79, P2209, DOI 10.1016/j.lfs.2006.07.018; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Rai K, 2011, J CLIN BIOCHEM NUTR, V49, P25, DOI 10.3164/jcbn.10-133; Rojo LE, 2010, J ALZHEIMERS DIS, V19, P573, DOI 10.3233/JAD-2010-1262; Sharma M, 2001, LIFE SCI, V68, P1021, DOI 10.1016/S0024-3205(00)01005-5; Singh B, 2012, J RENIN ANGIOTENSIN; Sodhi RK, 2013, PROG NEURO-PSYCHOPH, V40, P38, DOI 10.1016/j.pnpbp.2012.09.012; Tahirovic I, 2007, NEUROCHEM RES, V32, P1709, DOI 10.1007/s11064-007-9410-1; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Whitney KD, 2002, MOL ENDOCRINOL, V16, P1378, DOI 10.1210/me.16.6.1378; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Yamasaki T, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/719056; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011	51	28	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70487	10.1371/journal.pone.0070487	http://dx.doi.org/10.1371/journal.pone.0070487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936214	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700075
J	Ando, K; Nishimura, R; Tsujino, D; Seo, C; Utsunomiya, K				Ando, Kiyotaka; Nishimura, Rimei; Tsujino, Daisuke; Seo, Chiaki; Utsunomiya, Kazunori			24-Hour Glycemic Variations in Drug-Naive Patients with Type 2 Diabetes: A Continuous Glucose Monitoring (CGM)-Based Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HYPERGLYCEMIA; TOLERANCE; MORTALITY	Objective: To investigate a 24-hour glycemic variation in drug-naive, type 2 diabetic patients by using CGM. Methods: A total of 30 inpatients with type 2 diabetes were included in the study to analyze the 24-hour CGM data. Results: The patients' median age was 58 years old (interquartile range: 42-66 years), and their median HbA1c value was 7.6 (6.7-8.8)%. The median time to postprandial peak glucose levels(Peak Time) for each meal was 70-85 minutes, with the range of postprandial glucose increases(Increase Range) for each meal being 83-109 mg/dL. There was a significant positive correlation between the HbA1c values and Increases Range, Peak Time observed after breakfast and dinner, respectively. When the patients were stratified by a median HbA1c value of 7.6% into 2 groups, Increases Range and Peak Time, after breakfast, were shown to be significantly higher in the high-HbA1c group (H) than in the low-HbA1c (L) group. When the subjects were divided into four groups according to HbA1c levels: 1 (<7.0%, n = 8), 2 (7.0-7.9%, n = 8), 3 (8.0-8.9%, n = 8), and 4 (>= 9%, n = 6), the average glucose level, pre-meal glucose level and postprandial peak glucose level increased steadily from group 1 to 4 in a stepwise manner. Conclusions: In drug-naive, Japanese type 2 diabetic patients, the Peak Time and the Increase Range were maximal after dinner. It was shown that the greater the HbA1c values, the longer Peak time and the higher Increase Range after breakfast and dinner. The average glucose level, pre meal glucose level and postprandial peak glucose level increased steadily as HbA1c level increased.	[Ando, Kiyotaka; Nishimura, Rimei; Tsujino, Daisuke; Seo, Chiaki; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Nishimura, Rimei] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Jikei University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ando, K (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan.	dyan@jikei.ac.jp						Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Monnier L, 2007, DIABETES CARE, V30, P263, DOI 10.2337/dc06-1612; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Tsujino D, 2009, DIABETES TECHNOL THE, V11, P457, DOI 10.1089/dia.2008.0083; Wang JS, 2011, DIABETES-METAB RES, V27, P79, DOI 10.1002/dmrr.1149; Woerle HJ, 2007, DIABETES RES CLIN PR, V77, P280, DOI 10.1016/j.diabres.2006.11.011; Zhou J, 2009, DIABETES CARE, V32, P1188, DOI 10.2337/dc09-0076	11	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71102	10.1371/journal.pone.0071102	http://dx.doi.org/10.1371/journal.pone.0071102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936258	Green Published, Green Accepted, gold			2022-12-27	WOS:000323114200111
J	Wolkers, CPB; Barbosa, A; Menescal-de-Oliveira, L; Hoffmann, A				Bejo Wolkers, Carla Patricia; Barbosa Junior, Augusto; Menescal-de-Oliveira, Leda; Hoffmann, Anette			Stress-Induced Antinociception in Fish Reversed by Naloxone	PLOS ONE			English	Article							ENKEPHALIN-LIKE IMMUNOREACTIVITY; INDUCED ANALGESIA; IMMOBILIZATION STRESS; ONCORHYNCHUS-MYKISS; PAIN PERCEPTION; RAINBOW-TROUT; FORMALIN TEST; TELEOST FISH; RECEPTORS; MORPHINE	Pain perception in non-mammalian vertebrates such as fish is a controversial issue. We demonstrate that, in the fish Leporinus macrocephalus, an imposed restraint can modulate the behavioral response to a noxious stimulus, specifically the subcutaneous injection of 3% formaldehyde. In the first experiment, formaldehyde was applied immediately after 3 or 5 min of the restraint. Inhibition of the increase in locomotor activity in response to formaldehyde was observed, which suggests a possible restraint-induced antinociception. In the second experiment, the noxious stimulus was applied 0, 5, 10 and 15 min after the restraint, and both 3 and 5 min of restraint promoted short-term antinociception of approximately 5 min. In experiments 3 and 4, an intraperitoneal injection of naloxone (30 mg. kg 21) was administered 30 min prior to the restraint. The 3-minute restraint-induced antinociception was blocked by pretreatment with naloxone, but the corresponding 5-minute response was not. One possible explanation for this result is that an opioid and a non-preferential m-opioid and/or non-opioid mechanism participate in this response modulation. Furthermore, we observed that both the 3- and 5-minutes restraint were severely stressful events for the organism, promoting marked increases in serum cortisol levels. These data indicate that the response to a noxious stimulus can be modulated by an environmental stressor in fish, as is the case in mammals. To our knowledge, this study is the first evidence for the existence of an endogenous antinociceptive system that is activated by an acute standardized stress in fish. Additionally, it characterizes the antinociceptive response induced by stress in terms of its time course and the opioid mediation, providing information for understanding the evolution of nociception modulation.	[Bejo Wolkers, Carla Patricia; Barbosa Junior, Augusto; Menescal-de-Oliveira, Leda; Hoffmann, Anette] Univ Sao Paulo, Dept Physiol, Sch Med Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo	Wolkers, CPB (corresponding author), Univ Sao Paulo, Dept Physiol, Sch Med Ribeirao Preto, Sao Paulo, Brazil.	carlawolkers@yahoo.com.br	Wolkers, Carla Patricia/B-3181-2015; Júnior, Augusto Barbosa/B-9153-2012		National Council of Technological and Scientific Development (CNPq)	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the National Council of Technological and Scientific Development (CNPq). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FL, 2013, PHYSIOL BEHAV, V110, P58, DOI 10.1016/j.physbeh.2012.12.003; Alves FL, 2007, COMP BIOCH PHYSL A, ps15; AMIR S, 1978, LIFE SCI, V23, P1143, DOI 10.1016/0024-3205(78)90348-X; AMIR S, 1979, LIFE SCI, V24, P439, DOI 10.1016/0024-3205(79)90216-9; Ashley PJ, 2007, BRAIN RES, V1166, P47, DOI 10.1016/j.brainres.2007.07.011; Ashley PJ, 2006, NEUROSCI LETT, V410, P165, DOI 10.1016/j.neulet.2006.08.047; Ashley PJ, 2009, ANIM BEHAV, V77, P403, DOI 10.1016/j.anbehav.2008.10.015; BHATTACHARYA SK, 1978, EUR J PHARMACOL, V50, P83, DOI 10.1016/0014-2999(78)90257-1; BODNAR RJ, 1978, PHARMACOL BIOCHEM BE, V8, P667, DOI 10.1016/0091-3057(78)90264-2; BUATTI MC, 1981, BRAIN RES, V218, P400, DOI 10.1016/0006-8993(81)91319-6; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; CHANCE WT, 1979, PHARMACOL BIOCHEM BE, V11, P643, DOI 10.1016/0091-3057(79)90256-9; Chervova L S, 2000, Dokl Biol Sci, V375, P590, DOI 10.1023/A:1026681519613; COOPER K, 1982, NEUROSCI LETT, V31, P165, DOI 10.1016/0304-3940(82)90110-0; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Dunlop R, 2006, APPL ANIM BEHAV SCI, V97, P255, DOI 10.1016/j.applanim.2005.06.018; de Velasco EMF, 2009, ZEBRAFISH, V6, P259, DOI 10.1089/zeb.2009.0594; FINGER TE, 1981, NEUROSCIENCE, V6, P2747, DOI 10.1016/0306-4522(81)90117-2; Finn DP, 2004, EUR J NEUROSCI, V20, P848, DOI 10.1111/j.1460-9568.2004.03509.x; FITZGERALD M, 1986, TRENDS NEUROSCI, V9, P51, DOI 10.1016/0166-2236(86)90019-6; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; IZUMI R, 1983, JPN J PHARMACOL, V33, P1104, DOI 10.1254/jjp.33.1104; Jones SG, 2012, J VET PHARMACOL THER, V35, P563, DOI 10.1111/j.1365-2885.2011.01363.x; JORGENSEN HA, 1984, PHARMACOL BIOCHEM BE, V20, P289, DOI 10.1016/0091-3057(84)90256-9; LEWIS JW, 1980, SCIENCE, V208, P623, DOI 10.1126/science.7367889; Mettam JJ, 2012, J EXP BIOL, V215, P685, DOI 10.1242/jeb.060350; Millsopp S, 2008, APPL ANIM BEHAV SCI, V113, P247, DOI 10.1016/j.applanim.2007.11.004; Nordgreen J, 2009, APPL ANIM BEHAV SCI, V119, P101, DOI 10.1016/j.applanim.2009.03.015; Parikh D, 2011, EUR J PHARMACOL, V650, P563, DOI 10.1016/j.ejphar.2010.10.050; PEZALLA PD, 1984, BRAIN RES, V296, P356, DOI 10.1016/0006-8993(84)90073-8; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Roques JAC, 2010, PHYSIOL BEHAV, V101, P533, DOI 10.1016/j.physbeh.2010.08.001; Rose JD, 2014, FISH FISH, V15, P97, DOI 10.1111/faf.12010; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; SCHULMAN JA, 1981, NEUROSCIENCE, V6, P2407, DOI 10.1016/0306-4522(81)90026-9; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Sneddon LU, 2011, J CONSCIOUSNESS STUD, V18, P209; Sneddon LU, 2009, ILAR J, V50, P338, DOI 10.1093/ilar.50.4.338; STEVENS CW, 1995, PHARMACOL BIOCHEM BE, V51, P675, DOI 10.1016/0091-3057(94)00436-M; TERMAN GW, 1986, BRAIN RES, V372, P167, DOI 10.1016/0006-8993(86)91472-1; TIERNEY G, 1991, PAIN, V46, P89, DOI 10.1016/0304-3959(91)90038-Y; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; VECINO E, 1992, J ANAT, V180, P435; WATKINS LR, 1982, BRAIN RES, V243, P119, DOI 10.1016/0006-8993(82)91125-8; Yoshimura M, 2006, J PHARMACOL SCI, V101, P107, DOI 10.1254/jphs.CRJ06008X	50	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71175	10.1371/journal.pone.0071175	http://dx.doi.org/10.1371/journal.pone.0071175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936261	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200114
J	Bomsztyk, K; Flanagin, S; Mar, D; Mikula, M; Johnson, A; Zager, R; Denisenko, O				Bomsztyk, Karol; Flanagin, Steve; Mar, Daniel; Mikula, Michal; Johnson, Ali; Zager, Richard; Denisenko, Oleg			Synchronous Recruitment of Epigenetic Modifiers to Endotoxin Synergistically Activated Tnf-alpha Gene in Acute Kidney Injury	PLOS ONE			English	Article							RNA-POLYMERASE-II; ACUTE-RENAL-FAILURE; HISTONE H3 PHOSPHORYLATION; TRANSCRIPTION ELONGATION; CHROMATIN; EXPRESSION; COMPLEX; RECEPTOR; KINASE; CODE	Background: As a consequence of acute kidney injury (AKI), proximal tubular cells hyperrespond to endotoxin (lipopolysaccharide, LPS) by exaggerated renal Tnf-alpha Production. This LPS hyperresponsiveness is transcriptionally mediated. The epigenetic pathways that control these responses are unknown. Methods/Findings: We applied multiplex chromatin immunoprecipitation platform (Matrix ChIP) to explore epigenetic pathways that underlie endotoxin hyperresponsiveness in the setting of preceding unilateral renal ischemia/reperfusion (I/R) in mouse AKI model. Endotoxin exposure after I/R resulted in enhanced transcription, manifested by hyperresponsive recruitment of RNA polymerase II (Pol II) at the Tnf-alpha gene. At this locus, LPS but not I/R increased levels of Pol II C-terminal domain (CTD) phosho-serine2 &5 and induced dephosphorylation of the transcription-repressive histone H4 phospho-serine-1. In contrast, I/R but not LPS increased the transcription-permissive histone phosphorylation (H3 phospho-serine-10, H3.3 phospho-serine-31) at the Tnf-alpha gene. In agreement with these observations, I/R but not LPS increased activity of cognate kinases (Erk1/2, Msk1/2 and Aurora A) at the Tnf-alpha locus. Cross-talk of histone phosphorylation and acetylation synergize to active gene expression. I/R and LPS increased histone acetylation. (H3K9/14Ac, H4K5/8/12/16Ac, H2KA5Ac, H2BK4/7Ac). Levels of some histone acetyltransferases at this gene (PCAF and MOF) were increased by I/R but not by LPS, while others were induced by either I/R or LPS and exhibited endotoxin hyperresponsive patterns (GCN5, CBP and p300). The adaptor protein 14-3-3 couples histone phosphorylation with acetylation, and tethers chromatin modifiers/transcription elongation factors to target genes. Both I/R and LPS increased levels of 14-3-3 and several chromatin/transcription modifiers (BRD4, BRG1, HP-1 gamma and IKK alpha) at the Tnf-alpha gene, all exhibiting endotoxin hyperresponsive recruitment patterns similar to Pol II. Conclusions: Our results suggest that I/R and LPS differentially trigger phosphorylation (Pol II and histone) and acetylation (histone) epigenetic pathways that interact at the Tnf-alpha gene to generate endotoxin hyperresponse in AKI.	[Bomsztyk, Karol; Flanagin, Steve; Mar, Daniel; Mikula, Michal; Denisenko, Oleg] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Johnson, Ali; Zager, Richard] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Bomsztyk, K (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	karolb@u.washington.edu	Mikula, Michal/G-8276-2011	Mikula, Michal/0000-0003-3447-7328	NIH [R01 DK083310, R37 DK45978, R21 DK09881]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045978, R21DK098817, R01DK083310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01 DK083310, R37 DK45978, R21 DK09881, and an anonymous private donation to UW Medicine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Banerjee T, 2011, MOL CELL BIOL, V31, P4858, DOI 10.1128/MCB.05631-11; Ben Mkaddem S, 2009, J BIOL CHEM, V284, P12541, DOI 10.1074/jbc.M808376200; Beutler E, 2001, BLOOD CELL MOL DIS, V27, P728, DOI 10.1006/bcmd.2001.0441; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bonventre JV, 2002, CURR OPIN NEPHROL HY, V11, P43, DOI 10.1097/00041552-200201000-00007; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Dear JW, 2006, KIDNEY INT, V69, P832, DOI 10.1038/sj.ki.5000165; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Devaiah BN, 2012, J BIOL CHEM, V287, P38755, DOI 10.1074/jbc.M112.412015; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Doi K, 2008, KIDNEY INT, V73, P1266, DOI 10.1038/ki.2008.97; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Edmunds JW, 2006, SCIENCE, V313, P449, DOI 10.1126/science.1131158; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Govin J, 2010, NUCLEIC ACIDS RES, V38, P4599, DOI 10.1093/nar/gkq218; Grigoryev DN, 2008, J AM SOC NEPHROL, V19, P547, DOI 10.1681/ASN.2007040469; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Healy S, 2011, DISCOV MED, V11, P349; Heidemann M., 2012, BIOCH BIOPHYS ACTA; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Karam CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000975; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Kelly KJ, 2006, SEMIN NEPHROL, V26, P105, DOI 10.1016/j.semnephrol.2005.09.003; KELLY KJ, 1994, P NATL ACAD SCI USA, V91, P812, DOI 10.1073/pnas.91.2.812; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon SH, 2010, GENE DEV, V24, P2133, DOI 10.1101/gad.1959110; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu M, 2008, J AM SOC NEPHROL; Lu CY, 2012, PEDIATR NEPHROL, V27, P1847, DOI 10.1007/s00467-011-2029-0; Mikula M, 2011, J BIOL CHEM, V286, P9763, DOI 10.1074/jbc.M110.213330; Naito M, 2008, J AM SOC NEPHROL, V19, P1321, DOI 10.1681/ASN.2007121368; Naito M, 2009, J AM SOC NEPHROL, V20, P1787, DOI 10.1681/ASN.2009010118; Nath KA, 2007, KIDNEY INT, V71, P477, DOI 10.1038/sj.ki.5002150; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Nelson JD, 2008, AM J PHYSIOL-RENAL, V294, pF525, DOI 10.1152/ajprenal.00299.2007; Nelson JD, 2011, DIABETES, V60, P127, DOI 10.2337/db09-1806; Ramesh G, 2004, KIDNEY INT, V66, pS56, DOI 10.1111/j.1523-1755.2004.09109.x; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Ramesh G, 2007, AM J PHYSIOL-RENAL, V293, pF325, DOI 10.1152/ajprenal.00158.2007; Ramesh G, 2007, AM J PHYSIOL-RENAL, V292, pF812, DOI 10.1152/ajprenal.00277.2006; Ramesh G, 2006, RENAL FAILURE, V28, P583, DOI 10.1080/08860220600843839; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Shilatifard A, 2004, BBA-GENE STRUCT EXPR, V1677, P79, DOI 10.1016/j.bbaexp.2003.11.013; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thorne JL, 2012, NUCLEIC ACIDS RES, V40, P7676, DOI 10.1093/nar/gks509; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Tracz MJ, 2007, AM J PATHOL, V170, P1820, DOI 10.2353/ajpath.2007.061093; Utley RT, 2005, MOL CELL BIOL, V25, P8179, DOI 10.1128/MCB.25.18.8179-8190.2005; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang YX, 2009, J AM SOC NEPHROL, V20, P1544, DOI 10.1681/ASN.2008080843; Wendt KD, 2006, GENE DEV, V20, P2487, DOI 10.1101/gad.1477706; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Yu JJ, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-49; Yuan H, 2013, BIOPOLYMERS, V99, P98, DOI 10.1002/bip.22128; Zager RA, 2006, KIDNEY INT, V69, P1181, DOI 10.1038/sj.ki.5000022; Zager RA, 2005, AM J PHYSIOL-RENAL, V289, pF289, DOI 10.1152/ajprenal.00023.2005; Zager RA, 2005, AM J PHYSIOL-RENAL, V288, pF290, DOI 10.1152/ajprenal.00342.2004; Zager RA, 2006, AM J PHYSIOL-RENAL, V291, pF546, DOI 10.1152/ajprenal.00072.2006; Zager RA, 2009, AM J PHYSIOL-RENAL, V296, pF1032, DOI 10.1152/ajprenal.00061.2009; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005	75	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70322	10.1371/journal.pone.0070322	http://dx.doi.org/10.1371/journal.pone.0070322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936185	Green Submitted, gold, Green Published			2022-12-27	WOS:000323114200073
J	Ishida, H; Fornia, L; Grandi, LC; Umilta, MA; Gallese, V				Ishida, Hiroaki; Fornia, Luca; Grandi, Laura Clara; Umilta, Maria Alessandra; Gallese, Vittorio			Somato-Motor Haptic Processing in Posterior Inner Perisylvian Region (SII/pIC) of the Macaque Monkey	PLOS ONE			English	Article							2ND SOMATOSENSORY CORTEX; RECEPTIVE-FIELD PROPERTIES; GRASP MOVEMENT REPRESENTATION; TACTILE OBJECT RECOGNITION; VENTRAL PREMOTOR CORTEX; PARIETAL CORTEX; NEURONAL-ACTIVITY; CORTICAL CONNECTIONS; SELECTIVE ATTENTION; INFERIOR PARIETAL	The posterior inner perisylvian region including the secondary somatosensory cortex (area SII) and the adjacent region of posterior insular cortex (pIC) has been implicated in haptic processing by integrating somato-motor information during hand-manipulation, both in humans and in non-human primates. However, motor-related properties during hand-manipulation are still largely unknown. To investigate a motor-related activity in the hand region of SII/pIC, two macaque monkeys were trained to perform a hand-manipulation task, requiring 3 different grip types (precision grip, finger exploration, side grip) both in light and in dark conditions. Our results showed that 70% (n = 33/48) of task related neurons within SII/pIC were only activated during monkeys' active hand-manipulation. Of those 33 neurons, 15 (45%) began to discharge before hand-target contact, while the remaining neurons were tonically active after contact. Thirty-percent (n = 15/48) of studied neurons responded to both passive somatosensory stimulation and to the motor task. A consistent percentage of task-related neurons in SII/pIC was selectively activated during finger exploration (FE) and precision grasping (PG) execution, suggesting they play a pivotal role in control skilled finger movements. Furthermore, hand-manipulation-related neurons also responded when visual feedback was absent in the dark. Altogether, our results suggest that somato-motor neurons in SII/pIC likely contribute to haptic processing from the initial to the final phase of grasping and object manipulation. Such motor-related activity could also provide the somato-motor binding principle enabling the translation of diachronic somatosensory inputs into a coherent image of the explored object.	[Ishida, Hiroaki; Gallese, Vittorio] IIT, Brain Ctr Motor & Social Cognit BCSMC, Parma, Italy; [Fornia, Luca; Grandi, Laura Clara; Umilta, Maria Alessandra; Gallese, Vittorio] Univ Parma, Unit Physiol, Dept Neurosci, I-43100 Parma, Italy	Istituto Italiano di Tecnologia - IIT; University of Parma	Ishida, H (corresponding author), IIT, Brain Ctr Motor & Social Cognit BCSMC, Parma, Italy.	hiroaki.ishida@iit.it	Gallese, Vittorio/ABD-5097-2021; Fornia, Luca/AAS-3166-2020	Gallese, Vittorio/0000-0003-4815-3607; Ishida, Hiroaki/0000-0002-6750-2107; Umilta', Maria Alessandra/0000-0003-0180-6818; Grandi, Laura Clara/0000-0001-8174-5394; FORNIA, LUCA/0000-0002-8332-2886	Rete Tecnologica Mulidisciplinare, Italian Institute of Technology; European Grant "Cogsystem"	Rete Tecnologica Mulidisciplinare, Italian Institute of Technology; European Grant "Cogsystem"	This work was supported by Rete Tecnologica Mulidisciplinare, Italian Institute of Technology, and by European Grant "Cogsystem". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann MA, 2009, J NEUROSCI, V29, P6436, DOI 10.1523/JNEUROSCI.5479-08.2009; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Bonini L, 2012, J NEUROPHYSIOL, V108, P1607, DOI 10.1152/jn.01158.2011; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Borra E, 2011, J NEUROSCI, V31, P12351, DOI 10.1523/JNEUROSCI.1745-11.2011; Brochier T, 2004, J NEUROPHYSIOL, V92, P1770, DOI 10.1152/jn.00976.2003; Brochier T, 1999, EXP BRAIN RES, V128, P31, DOI 10.1007/s002210050814; BURTON H, 1995, J COMP NEUROL, V355, P539, DOI 10.1002/cne.903550405; Burton H, 1997, SOMATOSENS MOT RES, V14, P237, DOI 10.1080/08990229770971; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; CASELLI RJ, 1991, MAYO CLIN PROC, V66, P129, DOI 10.1016/S0025-6196(12)60484-4; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; Christensen MS, 2007, NAT NEUROSCI, V10, P417, DOI 10.1038/nn1873; Disbrow E, 2003, J COMP NEUROL, V462, P382, DOI 10.1002/cne.10731; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P2978, DOI 10.1152/jn.00958.2002; Eimer M, 2005, NEUROPSYCHOLOGIA, V43, P957, DOI 10.1016/j.neuropsychologia.2004.08.011; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6485, DOI 10.1523/JNEUROSCI.5061-05.2006; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Fitzgerald PJ, 2004, J NEUROSCI, V24, P11193, DOI 10.1523/JNEUROSCI.3481-04.2004; Fluet MC, 2010, J NEUROSCI, V30, P15175, DOI 10.1523/JNEUROSCI.3343-10.2010; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Forss N, 2012, HUM BRAIN MAPP, V33, P534, DOI 10.1002/hbm.21230; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; GARCHA HS, 1980, CORTEX, V16, P397, DOI 10.1016/S0010-9452(80)80041-4; Gardner EP, 1999, EXP BRAIN RES, V127, P329, DOI 10.1007/s002210050803; Gardner EP, 2007, J NEUROPHYSIOL, V97, P387, DOI 10.1152/jn.00558.2006; Gardner EP, 2007, J NEUROPHYSIOL, V97, P1656, DOI 10.1152/jn.01031.2006; Gerbella M, 2013, CEREB CORTEX, V23, P967, DOI 10.1093/cercor/bhs096; Gerbella M, 2011, BRAIN STRUCT FUNCT, V216, P43, DOI 10.1007/s00429-010-0293-6; Gharbawie OA, 2011, J NEUROSCI, V31, P11660, DOI 10.1523/JNEUROSCI.1777-11.2011; Gibson, 1962, PSYCHOL REV, V69, P477; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; HIKOSAKA O, 1985, BRAIN RES, V325, P375, DOI 10.1016/0006-8993(85)90344-0; Hollmann M, 2013, CURR OPIN LIPIDOL, V24, P18, DOI 10.1097/MOL.0b013e32835b61a4; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; Hsiao S, 2008, CURR OPIN NEUROBIOL, V18, P418, DOI 10.1016/j.conb.2008.09.001; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; Iwamura Y, 1996, NEUROSCI LETT, V214, P147, DOI 10.1016/0304-3940(96)12911-6; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jezzini A, 2012, P NATL ACAD SCI USA, V109, P10077, DOI 10.1073/pnas.1200143109; Jiang W, 1997, J NEUROPHYSIOL, V77, P1656, DOI 10.1152/jn.1997.77.3.1656; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Kappler D, 2010, REPRESENTATION PREGR, P617; KLATZKY RL, 1992, PERCEPT PSYCHOPHYS, V52, P661, DOI 10.3758/BF03211702; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; LEDERMAN SJ, 1993, ACTA PSYCHOL, V84, P29, DOI 10.1016/0001-6918(93)90070-8; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; Meftah EM, 2009, J NEUROPHYSIOL, V101, P2649, DOI 10.1152/jn.91121.2008; Meftah EM, 2002, J NEUROPHYSIOL, V88, P3133, DOI 10.1152/jn.00121.2002; Mima T, 1999, BRAIN, V122, P1989, DOI 10.1093/brain/122.10.1989; MISHKIN M, 1979, NEUROPSYCHOLOGIA, V17, P139, DOI 10.1016/0028-3932(79)90005-8; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; MURRAY EA, 1984, BEHAV BRAIN RES, V11, P67, DOI 10.1016/0166-4328(84)90009-3; Nelissen K, 2011, J NEUROSCI, V31, P8220, DOI 10.1523/JNEUROSCI.0623-11.2011; Nelissen K, 2011, J NEUROSCI, V31, P3743, DOI 10.1523/JNEUROSCI.4803-10.2011; NELSON RJ, 1987, BRAIN RES, V406, P402, DOI 10.1016/0006-8993(87)90815-8; Oztop E, 2002, BIOL CYBERN, V87, P116, DOI 10.1007/s00422-002-0318-1; Pleger B, 2008, J NEUROSCI, V28, P8161, DOI 10.1523/JNEUROSCI.1093-08.2008; Pleger B, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000164; Pruett JR, 2000, J NEUROPHYSIOL, V84, P780, DOI 10.1152/jn.2000.84.2.780; Pruett JR, 2001, J NEUROPHYSIOL, V86, P2069, DOI 10.1152/jn.2001.86.4.2069; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Reed CL, 2004, HUM BRAIN MAPP, V21, P236, DOI 10.1002/hbm.10162; REED CL, 1994, NEUROPSYCHOLOGIA, V32, P527, DOI 10.1016/0028-3932(94)90142-2; Reed CL, 1996, BRAIN, V119, P875, DOI 10.1093/brain/119.3.875; Revesz Geza, 1950, PSYCHOL ART BLIND; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; ROBINSON CJ, 1980, J COMP NEUROL, V192, P69, DOI 10.1002/cne.901920105; Roland PE, 1987, BRAIN RES, V434, P43; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Salimi I, 1999, J NEUROPHYSIOL, V81, P835, DOI 10.1152/jn.1999.81.2.835; Salimi I, 1999, J NEUROPHYSIOL, V81, P825, DOI 10.1152/jn.1999.81.2.825; SAVAKI HE, 1993, J NEUROSCI, V13, P2772; SCHNEIDER RJ, 1993, BRAIN RES, V621, P116, DOI 10.1016/0006-8993(93)90305-7; SINCLAIR RJ, 1993, J NEUROPHYSIOL, V70, P331, DOI 10.1152/jn.1993.70.1.331; SOSO MJ, 1980, J NEUROPHYSIOL, V43, P1090, DOI 10.1152/jn.1980.43.4.1090; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Taylor M., 1974, HDB PERCEPTION, V3, P251; Thakur PH, 2006, J NEUROSCI, V26, P13567, DOI 10.1523/JNEUROSCI.3990-06.2006; Wasaka T, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-138; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	92	25	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69931	10.1371/journal.pone.0069931	http://dx.doi.org/10.1371/journal.pone.0069931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936121	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200050
J	Bengtsson, A; Joergensen, L; Barbati, ZR; Craig, A; Hviid, L; Jensen, ATR				Bengtsson, Anja; Joergensen, Louise; Barbati, Zachary R.; Craig, Alister; Hviid, Lars; Jensen, Anja T. R.			Transfected HEK293 Cells Expressing Functional Recombinant Intercellular Adhesion Molecule 1 (ICAM-1) - A Receptor Associated with Severe Plasmodium falciparum Malaria	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; RHINOVIRUS RECEPTOR; BINDING; DOMAIN; PFEMP1; SITE; CD54	Intercellular adhesion molecule 1 (ICAM-1) is a membrane-bound glycoprotein expressed on endothelial cells and cells of the immune system. Human ICAM-1 mediates adhesion and migration of leucocytes, and is implicated in inflammatory pathologies, autoimmune diseases and in many cancer processes. Additionally, ICAM-1 acts as receptor for pathogens like human rhinovirus and Plasmodium falciparum malaria parasites. A group of related P. falciparum erythrocyte membrane protein 1 (PfEMP1) domains, the DBL beta, mediates ICAM-1 binding of P. falciparum-infected erythrocytes. This ICAM-1-binding phenotype has been suggested to be involved in the development of cerebral malaria. However, more studies identifying cross-reactive antibody and ICAM-1-binding epitopes and the establishment of a clinical link between DBL beta expression and e.g. cerebral malaria are needed before the DBL beta domains can be put forward as vaccine candidates and go into clinical trials. Such studies require availability of functional recombinant ICAM-1 in large quantities. In this study, we compared recombinant ICAM-1 expressed in HEK293 and COS-7 cells with mouse myeloma NS0 ICAM-1 purchased from a commercial vendor in terms of protein purity, yield, fold, ability to bind DBL beta, and relative cost. We present a HEK293 cell-based, high-yield expression and purification scheme for producing inexpensive, functional ICAM-1. ICAM-1 expressed in HEK293 is applicable to malaria research and can also be useful in other research fields.	[Bengtsson, Anja; Joergensen, Louise; Barbati, Zachary R.; Hviid, Lars; Jensen, Anja T. R.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Bengtsson, Anja; Joergensen, Louise; Barbati, Zachary R.; Hviid, Lars; Jensen, Anja T. R.] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Craig, Alister] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Copenhagen; Rigshospitalet; University of Copenhagen; Liverpool School of Tropical Medicine; University of Liverpool	Jensen, ATR (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	atrj@sund.ku.dk	Jensen, Anja Tatiana TR Ramstedt/T-3583-2017; Hviid, Lars/G-3705-2012; Jensen, Anja Ramstedt/AAL-3119-2021	Jensen, Anja Tatiana TR Ramstedt/0000-0002-4004-7554; Hviid, Lars/0000-0002-1698-4927; Jensen, Anja Ramstedt/0000-0002-4004-7554; Craig, Alister/0000-0003-0914-6164; Bengtsson, Anja/0000-0001-9523-8369	University of Copenhagen; Novo Nordisk Foundation	University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by grants from the University of Copenhagen (Programme of Excellence in Membrane Topology and Quaternary Structure of Key Membrane Proteins Involved in Plasmodium falciparum Malaria Pathogenesis and Immunity) and The Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, INFECT IMMUN, V68, P264, DOI 10.1128/IAI.68.1.264-269.2000; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Bengtsson A, 2013, J IMMUNOL, V190, P240, DOI 10.4049/jimmunol.1202578; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; Bloom JW, 1996, BIOCHEMISTRY-US, V35, P1856, DOI 10.1021/bi952354m; Brown A, 2013, J BIOL CHEM M, V112; Craig AG, 1997, INFECT IMMUN, V65, P4580, DOI 10.1128/IAI.65.11.4580-4585.1997; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Geisse Sabine, 2012, Methods Mol Biol, V899, P203, DOI 10.1007/978-1-61779-921-1_13; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Lindenthal C, 2003, PARASITOL RES, V91, P363, DOI 10.1007/s00436-003-0975-6; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Nallet S, 2012, NEW BIOTECHNOL, V29, P471, DOI 10.1016/j.nbt.2012.02.003; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; Owens RM, 2010, J BIOL CHEM, V285, P15906, DOI 10.1074/jbc.M110.104349; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Springer AL, 2004, MOL BIOCHEM PARASIT, V137, P55, DOI 10.1016/j.molbiopara.2004.03.019; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; TOMASSINI JE, 1989, P NATL ACAD SCI USA, V86, P4907, DOI 10.1073/pnas.86.13.4907; Tse MT, 2004, MOL MICROBIOL, V51, P1039, DOI 10.1046/j.1365-2958.2003.03895.x; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Victor ME, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-325; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Zhang JB, 2009, PROTEIN EXPRES PURIF, V65, P77, DOI 10.1016/j.pep.2008.10.011; Zimmerman T, 2008, CURR PHARM DESIGN, V14, P2128, DOI 10.2174/138161208785740225	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69999	10.1371/journal.pone.0069999	http://dx.doi.org/10.1371/journal.pone.0069999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936131	gold, Green Accepted, Green Published			2022-12-27	WOS:000322433300081
J	Frans, I; Dierckens, K; Crauwels, S; Van Assche, A; Leisner, J; Larsen, MH; Michiels, CW; Willems, KA; Lievens, B; Bossier, P; Rediers, H				Frans, Ingeborg; Dierckens, Kristof; Crauwels, Sam; Van Assche, Ado; Leisner, Jorgen; Larsen, Marianne H.; Michiels, Chris W.; Willems, Kris A.; Lievens, Bart; Bossier, Peter; Rediers, Hans			Does Virulence Assessment of Vibrio anguillarum Using Sea Bass (Dicentrarchus labrax) Larvae Correspond with Genotypic and Phenotypic Characterization?	PLOS ONE			English	Article							MEDIATED IRON UPTAKE; FISH PATHOGEN; GENE-CLUSTER; HEMOLYSIN GENE; AMIB GENE; PLASMID; IDENTIFICATION; STRAINS; VANCHROBACTIN; CHALLENGE	Background: Vibriosis is one of the most ubiquitous fish diseases caused by bacteria belonging to the genus Vibrio such as Vibrio (Listonella) anguillarum. Despite a lot of research efforts, the virulence factors and mechanism of V. anguillarum are still insufficiently known, in part because of the lack of standardized virulence assays. Methodology/Principal Findings: We investigated and compared the virulence of 15 V. anguillarum strains obtained from different hosts or non-host niches using a standardized gnotobiotic bioassay with European sea bass (Dicentrarchus labrax L.) larvae as model hosts. In addition, to assess potential relationships between virulence and genotypic and phenotypic characteristics, the strains were characterized by random amplified polymorphic DNA (RAPD) and repetitive extragenic palindromic PCR (rep-PCR) analyses, as well as by phenotypic analyses using Biolog's Phenotype MicroArray (TM) technology and some virulence factor assays. Conclusions/Significance: Virulence testing revealed ten virulent and five avirulent strains. While some relation could be established between serotype, genotype and phenotype, no relation was found between virulence and genotypic or phenotypic characteristics, illustrating the complexity of V. anguillarum virulence. Moreover, the standardized gnotobiotic system used in this study has proven its strength as a model to assess and compare the virulence of different V. anguillarum strains in vivo. In this way, the bioassay contributes to the study of mechanisms underlying virulence in V. anguillarum.	[Frans, Ingeborg; Crauwels, Sam; Van Assche, Ado; Willems, Kris A.; Lievens, Bart; Rediers, Hans] KU Leuven Assoc, Dept Microbial & Mol Syst M2S, Lab Proc Microbial Ecol & Bioinspirat Management, St Katelijne Waver, Belgium; [Frans, Ingeborg; Crauwels, Sam; Van Assche, Ado; Willems, Kris A.; Lievens, Bart; Rediers, Hans] Scientia Terrae Res Inst, St Katelijne Waver, Belgium; [Leisner, Jorgen; Larsen, Marianne H.] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Frans, Ingeborg; Michiels, Chris W.] Katholieke Univ Leuven, Ctr Food & Microbial Technol, M2S, Heverlee, Belgium; [Frans, Ingeborg; Dierckens, Kristof; Bossier, Peter] Univ Ghent, Dept Anim Prod, Lab Aquaculture & Artemia Reference Ctr, B-9000 Ghent, Belgium	KU Leuven; University of Copenhagen; KU Leuven; Ghent University	Rediers, H (corresponding author), KU Leuven Assoc, Dept Microbial & Mol Syst M2S, Lab Proc Microbial Ecol & Bioinspirat Management, Campus De Nayer, St Katelijne Waver, Belgium.	hans.rediers@biw.kuleuven.be	dierckens, kristof/GWM-4184-2022; Michiels, Chris/I-6847-2013; Rediers, Hans/C-4933-2016; Willems, Kris A./Y-7750-2019; Lievens, Bart/B-3339-2019; Leisner, Jørgen/L-7835-2018; Bossier, Peter GM/A-8118-2008; Rediers, Hans/AAJ-7396-2020	Michiels, Chris/0000-0002-7710-6802; Rediers, Hans/0000-0001-8645-107X; Willems, Kris A./0000-0003-4984-221X; Bossier, Peter GM/0000-0002-6165-9111; Larsen, Marianne Halberg/0000-0001-6242-6937; Van Assche, Ado/0000-0002-5016-0489	European FP7 project 'Promicrobe - Microbes as positive actors for more sustainable aquaculture' [227197]; Ghent University [BOF12/GOA/022]; Agency for Innovation by Science and Technology in Flanders (IWT)	European FP7 project 'Promicrobe - Microbes as positive actors for more sustainable aquaculture'; Ghent University(Ghent University); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was supported by European FP7 project 'Promicrobe - Microbes as positive actors for more sustainable aquaculture' (Project Reference 227197) and by Ghent University project "Host microbial interactions in aquatic production" (BOF12/GOA/022). This work was financially supported by the "Agency for Innovation by Science and Technology in Flanders (IWT)(www.iwt.be)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis LA, 1999, FISH DISEASES AND DISORDERS, VOL 3, P523; Aguirre-Guzman G, 2004, AQUAC RES, V35, P1395, DOI 10.1111/j.1365-2109.2004.01165.x; Ahn SH, 2006, J MICROBIOL BIOTECHN, V16, P1416; AUSTIN B, 1995, SYST APPL MICROBIOL, V18, P285, DOI 10.1016/S0723-2020(11)80400-5; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Bagni M, 2005, 20052012 FAO FISH AQ; Balado M, 2008, MICROBIOL-SGM, V154, P1400, DOI 10.1099/mic.0.2008/016618-0; Balado M, 2006, MICROBIOL-SGM, V152, P3517, DOI 10.1099/mic.0.29298-0; Bay L, 2007, SYST APPL MICROBIOL, V30, P85, DOI 10.1016/j.syapm.2006.03.006; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Boesen HT, 1999, INFECT IMMUN, V67, P294, DOI 10.1128/IAI.67.1.294-301.1999; CONCHAS RF, 1991, APPL ENVIRON MICROB, V57, P2956, DOI 10.1128/AEM.57.10.2956-2962.1991; Denkin SM, 2004, APPL ENVIRON MICROB, V70, P4193, DOI 10.1128/AEM.70.7.4193-4204.2004; Dierckens K, 2009, ENVIRON MICROBIOL, V11, P526, DOI 10.1111/j.1462-2920.2008.01794.x; Flemming L, 2007, RES MICROBIOL, V158, P18, DOI 10.1016/j.resmic.2006.09.001; Frans I, 2008, ISR J AQUACULT-BAMID, V60, P213; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Gomez-Diaz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003007; Grisez L, 1996, DIS AQUAT ORGAN, V26, P181, DOI 10.3354/dao026181; Hirono I, 1996, MICROB PATHOGENESIS, V21, P173, DOI 10.1006/mpat.1996.0052; Hong GE, 2007, FEMS MICROBIOL LETT, V269, P201, DOI 10.1111/j.1574-6968.2006.00618.x; IMO, 2016, GUID DEV SHIP EN EFF; Keymer DP, 2007, APPL ENVIRON MICROB, V73, P3705, DOI 10.1128/AEM.02736-06; Koo BS, 2007, INT J MOL MED, V20, P913; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LARSEN JL, 1994, J FISH DIS, V17, P259, DOI 10.1111/j.1365-2761.1994.tb00221.x; Li L, 2008, INFECT IMMUN, V76, P2620, DOI 10.1128/IAI.01308-07; Lievens B, 2003, FEMS MICROBIOL LETT, V223, P113, DOI 10.1016/S0378-1097(03)00352-5; Lindell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037678; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Mikkelsen H, 2007, AQUACULTURE, V266, P16, DOI 10.1016/j.aquaculture.2007.02.041; Mo ZL, 2010, CHIN J OCEANOL LIMN, V28, P55, DOI 10.1007/s00343-010-9246-4; Naka H, 2008, ENVIRON MICROBIOL, V10, P265, DOI 10.1111/j.1462-2920.2007.01450.x; Naka H, 2011, FISH PATHOL, V46, P1, DOI 10.3147/jsfp.46.1; Natrah FMI, 2011, VET MICROBIOL, V154, P124, DOI 10.1016/j.vetmic.2011.06.024; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P477, DOI 10.1051/alr:2004054; Pedersen K, 1999, CURR MICROBIOL, V38, P183, DOI 10.1007/PL00006784; Pedersen K, 1997, J APPL MICROBIOL, V82, P365, DOI 10.1046/j.1365-2672.1997.00373.x; PEDERSEN K, 1995, APPL ENVIRON MICROB, V61, P2292, DOI 10.1128/AEM.61.6.2292-2296.1995; Ravelo C, 2003, J CLIN MICROBIOL, V41, P751, DOI 10.1128/JCM.41.2.751-756.2003; Rock JL, 2006, INFECT IMMUN, V74, P2777, DOI 10.1128/IAI.74.5.2777-2786.2006; Rodkhum C, 2006, J FISH DIS, V29, P157, DOI 10.1111/j.1365-2761.2006.00692.x; Rodkhum C, 2005, MICROB PATHOGENESIS, V39, P109, DOI 10.1016/j.micpath.2005.06.004; Romalde JL, 1999, FEMS MICROBIOL LETT, V179, P297, DOI 10.1111/j.1574-6968.1999.tb08741.x; Russek-Cohen E, 1996, MOL MICROBIAL ECOLOG; SKOV MN, 1995, APPL ENVIRON MICROB, V61, P1540, DOI 10.1128/AEM.61.4.1540-1545.1995; Soengas RG, 2006, TETRAHEDRON LETT, V47, P7113, DOI 10.1016/j.tetlet.2006.07.104; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Stork M, 2002, PLASMID, V48, P222, DOI 10.1016/S0147-619X(02)00111-7; Swain P, 2010, VACCINE, V28, P4626, DOI 10.1016/j.vaccine.2010.04.078; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiainen T, 1997, J APPL MICROBIOL, V82, P211, DOI 10.1111/j.1365-2672.1997.tb02853.x; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Vandenberghe J, 2003, AQUACULTURE, V219, P9, DOI 10.1016/S0044-8486(02)00312-5; Vauterin L., 1992, EUROPEAN MICROBIOLOG, V1, P37; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Welch TJ, 2005, INFECT IMMUN, V73, P5864, DOI 10.1128/IAI.73.9.5864-5872.2005; Wong HC, 2001, J CLIN MICROBIOL, V39, P4233, DOI 10.1128/JCM.39.12.4233-4240.2001; Xiao P, 2009, J FISH DIS, V32, P293, DOI 10.1111/j.1365-2761.2008.00984.x	60	22	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70477	10.1371/journal.pone.0070477	http://dx.doi.org/10.1371/journal.pone.0070477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936439	gold, Green Published, Green Submitted			2022-12-27	WOS:000324401500041
J	Kaito, M; Araya, SI; Gondo, Y; Fujita, M; Minato, N; Nakanishi, M; Matsui, M				Kaito, Muichi; Araya, Shin-Ichi; Gondo, Yuichiro; Fujita, Michiyo; Minato, Naomi; Nakanishi, Megumi; Matsui, Makoto			Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients	PLOS ONE			English	Article							INFECTION; INFLAMMATION; EXPRESSION; CELLS; IMMUNODEPRESSION; IMMUNOLOGY; MECHANISMS; PROGNOSIS	Background and Purpose: The most common strategy for treating patients with acute ischemic stroke is thrombolytic therapy, though only a few patients receive benefits because of the narrow time window. Inflammation occurring in the central nervous system (CNS) in association with ischemia is caused by immune cells including monocytes and involved in lesion expansion. If the specific roles of monocyte subsets in stroke can be revealed, they may become an effective target for new treatment strategies. Methods: We performed immunological examinations of 36 consecutive ischemic stroke patients within 2 days of onset and compared the results with 24 age-matched patients with degenerative disorders. The stroke patients were repeatedly tested for the proportions of monocyte subsets in blood, and serum levels of pro-and anti-inflammatory cytokines immediately after admission, on days 3-7 and 12-16 after stroke onset, and on the day of discharge. In addition, immunological measurements were analyzed for relationships to stroke subtypes and complications, including progressive infarction (PI) and stroke-associated infection (SAI). Results: Monocyte count was significantly increased from 0-16 days after stroke as compared to the controls (p<0.05). CD14(high)CD16(-) classical and CD14(high)CD16(+) intermediate monocytes were significantly increased from 0-7 and 3-16 days after stroke, respectively (p<0.05), whereas CD14 (dim)CD16(high) non-classical monocytes were decreased from 0-7 days (p<0.05). Cardioembolic infarction was associated with a persistent increase in intermediate monocytes. Furthermore, intermediate monocytes were significantly increased in patients with PI (p<0.05), while non-classical monocytes were decreased in those with SAI (p<0.05). IL-17A levels were positively correlated with monocyte count (r=0.485, p=0.012) as well as the percentage of non-classical monocytes (r=0.423, p=0.028), and negatively with that of classical monocytes (r=-0.51, p=0.007) during days 12-16. Conclusions: Our findings suggest that CD14(high)CD16(+) intermediate monocytes have a role in CNS tissue damage during acute and subacute phases in ischemic stroke especially in relation to cardioembolism.	[Kaito, Muichi; Araya, Shin-Ichi; Gondo, Yuichiro; Fujita, Michiyo; Minato, Naomi; Nakanishi, Megumi; Matsui, Makoto] Kanazawa Med Univ, Dept Neurol, Uchinada, Ishikawa 92002, Japan	Kanazawa Medical University	Matsui, M (corresponding author), Kanazawa Med Univ, Dept Neurol, Uchinada, Ishikawa 92002, Japan.	veritasm@kanazawa-med.ac.jp			Health Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan	Health Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan	This work was supported in part by a Health Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan (http://nimmunol.umin.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bao Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-92; Birschel P, 2004, CEREBROVASC DIS, V17, P242, DOI 10.1159/000076161; Castellanos M, 2002, STROKE, V33, P982, DOI 10.1161/hs0402.105339; Chamorro A, 2005, STROKE, V36, P1495, DOI 10.1161/01.STR.0000170644.15504.49; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; Kitagawa K, 2005, STROKE, V36, P2270, DOI 10.1161/01.STR.0000181075.77897.0e; Kostulas N, 1999, STROKE, V30, P2174, DOI 10.1161/01.STR.30.10.2174; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Shinohara Yukito, 2010, Rinsho Shinkeigaku, V50, P808; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Stowe AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-33; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Urra X, 2009, J CEREBR BLOOD F MET, V29, P994, DOI 10.1038/jcbfm.2009.25; Urra X, 2009, STROKE, V40, P1262, DOI 10.1161/STROKEAHA.108.532085; Vogelgesang A, 2011, J NEUROIMMUNOL, V231, P105, DOI 10.1016/j.jneuroim.2010.09.023; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Yan J, 2012, J NEUROIMMUNOL, V246, P78, DOI 10.1016/j.jneuroim.2012.02.013; Zhang DP, 2009, EUR J NEUROL, V16, P498, DOI 10.1111/j.1468-1331.2008.02512.x; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	34	61	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69409	10.1371/journal.pone.0069409	http://dx.doi.org/10.1371/journal.pone.0069409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936327	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800017
J	Klopfstein, S; Vilhelmsen, L; Heraty, JM; Sharkey, M; Ronquist, F				Klopfstein, Seraina; Vilhelmsen, Lars; Heraty, John M.; Sharkey, Michael; Ronquist, Fredrik			The Hymenopteran Tree of Life: Evidence from Protein-Coding Genes and Objectively Aligned Ribosomal Data	PLOS ONE			English	Article							MULTIPLE ALIGNMENT; MOLECULAR PHYLOGENY; APOCRITA INSECTA; EARLY EVOLUTION; CHALCIDOIDEA; SUPERFAMILY; DIVERSITY; SEQUENCES; INFERENCE; RESOLVE	Previous molecular analyses of higher hymenopteran relationships have largely been based on subjectively aligned ribosomal sequences (18S and 28S). Here, we reanalyze the 18S and 28S data (unaligned about 4.4 kb) using an objective and a semi-objective alignment approach, based on MAFFT and BAli-Phy, respectively. Furthermore, we present the first analyses of a substantial protein-coding data set (4.6 kb from one mitochondrial and four nuclear genes). Our results indicate that previous studies may have suffered from inflated support values due to subjective alignment of the ribosomal sequences, but apparently not from significant biases. The protein data provide independent confirmation of several earlier results, including the monophyly of non-xyelid hymenopterans, Pamphilioidea + Unicalcarida, Unicalcarida, Vespina, Apocrita, Proctotrupomorpha and core Proctotrupomorpha. The protein data confirm that Aculeata are nested within a paraphyletic Evaniomorpha, but cast doubt on the monophyly of Evanioidea. Combining the available morphological, ribosomal and protein-coding data, we examine the total-evidence signal as well as congruence and conflict among the three data sources. Despite an emerging consensus on many higher-level hymenopteran relationships, several problems remain unresolved or contentious, including rooting of the hymenopteran tree, relationships of the woodwasps, placement of Stephanoidea and Ceraphronoidea, and the sister group of Aculeata.	[Klopfstein, Seraina; Ronquist, Fredrik] Swedish Museum Nat Hist, Dept Biodivers Informat, S-10405 Stockholm, Sweden; [Vilhelmsen, Lars] Nat Hist Museum Denmark, Copenhagen, Denmark; [Heraty, John M.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Sharkey, Michael] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Swedish Museum of Natural History; University of California System; University of California Riverside; University of Kentucky	Klopfstein, S (corresponding author), Swedish Museum Nat Hist, Dept Biodivers Informat, S-10405 Stockholm, Sweden.	klopfstein@nmbe.ch	Vilhelmsen, Lars/A-3396-2013; Ronquist, Fredrik/Q-2013-2015; Vilhelmsen, Lars/AAC-6747-2020	Vilhelmsen, Lars/0000-0002-5593-5722; Ronquist, Fredrik/0000-0002-3929-251X; Vilhelmsen, Lars/0000-0002-5593-5722	Swiss National Science Foundation [PBBEP3_130173]; Swedish Research Council [VR-2011-5622]; National Science Foundation [DEB-0337220, DEB-0341149, DEB-070616]; Swedish National Infrastructure for Computing [001/12-149, 001/12-150]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Science Foundation(National Science Foundation (NSF)); Swedish National Infrastructure for Computing	This work was supported by the Swiss National Science Foundation [PBBEP3_130173 to SK, www.snf.ch], the Swedish Research Council [VR-2011-5622 to FR, www.vr.se], and the National Science Foundation [HymAToL grants DEB-0337220 to MS, and DEB-0341149 and DEB-070616 to JMH., www.nsf.gov]. Computing resources were provided by the Swedish National Infrastructure for Computing (projects 001/12-149 and 001/12-150, www.snic.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERER AJ, 2013, SYST BIOL, V62, DOI DOI 10.1093/SYSBI0/SYS1078; Bacher S, 2012, TRENDS ECOL EVOL, V27, P65, DOI 10.1016/j.tree.2011.11.003; Beutel RG, 2007, ORG DIVERS EVOL, V7, P207, DOI 10.1016/j.ode.2006.06.003; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Castro LR, 2006, INVERTEBR SYST, V20, P603, DOI 10.1071/IS06002; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Davis RB, 2010, P ROY SOC B-BIOL SCI, V277, P1597, DOI 10.1098/rspb.2009.2299; Debevec AH, 2012, ZOOL SCR, V41, P527, DOI 10.1111/j.1463-6409.2012.00549.x; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Fleissner R, 2005, SYST BIOL, V54, P548, DOI 10.1080/10635150590950371; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; GIBSON GAP, 1986, CAN ENTOMOL, V118, P205, DOI 10.4039/Ent118205-3; GOREMYKIN VV, 2013, SYST BIOL; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Grissell E. Eric, 1999, American Entomologist, V45, P235; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Heraty J, 2011, MOL PHYLOGENET EVOL, V60, P73, DOI 10.1016/j.ympev.2011.04.003; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; HUBER JT, 2009, INSECT BIODIVERSITY; Katoh K, 2012, BIOINFORMATICS, V28, P3144, DOI 10.1093/bioinformatics/bts578; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Klopfstein S, 2013, MOL PHYLOGENET EVOL, V67, P266, DOI 10.1016/j.ympev.2013.01.015; Klopfstein S, 2010, SYST BIOL, V59, P226, DOI 10.1093/sysbio/syp105; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lunter G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-83; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Morrison DA, 2009, SYST BIOL, V58, P150, DOI 10.1093/sysbio/syp009; Moulton JK, 2004, MOL PHYLOGENET EVOL, V31, P363, DOI 10.1016/S1055-7903(03)00284-7; Munro JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027023; Notredame C, 2007, PLOS COMPUT BIOL, V3, P1405, DOI 10.1371/journal.pcbi.0030123; Oeser R., 1961, Mitteilungen aus dem Zoologischen Museum in Berlin, V37, P3; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peters RS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-55; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pilgrim EM, 2008, ZOOL SCR, V37, P539, DOI 10.1111/j.1463-6409.2008.00340.x; R Core Team, 2020, R LANG ENV STAT COMP; Rasnitsyn AP, 2006, PALEONTOL J+, V40, pS679, DOI 10.1134/S003103010612001X; Rasnitsyn AP, 2010, ACTA GEOL SIN-ENGL, V84, P834, DOI 10.1111/j.1755-6724.2010.00254.x; RASNITSYN AP, 1988, ORIENT INSECTS, V22, P115, DOI 10.1080/00305316.1988.11835485; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Redelings BD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-40; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 1999, ZOOL SCR, V28, P13, DOI 10.1046/j.1463-6409.1999.00023.x; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAURABH K, 2013, SYST BIOL, DOI DOI 10.1093/SYSBI0/SYS043; Schulmeister S, 2002, CLADISTICS, V18, P455, DOI 10.1111/j.1096-0031.2002.tb00287.x; Sharanowski BJ, 2010, MOL PHYLOGENET EVOL, V57, P101, DOI 10.1016/j.ympev.2010.07.006; Sharkey MJ, 2007, ZOOTAXA, P521, DOI 10.11646/zootaxa.1668.1.25; Sharkey MJ, 2012, CLADISTICS, V28, P80, DOI 10.1111/j.1096-0031.2011.00366.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stork N.E., 1996, BIODIVERSITY 2, P41; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Vilhelmsen L, 2011, ARTHROPOD STRUCT DEV, V40, P2, DOI 10.1016/j.asd.2010.10.001; Vilhelmsen L, 2010, ZOOL J LINN SOC-LOND, V159, P22, DOI 10.1111/j.1096-3642.2009.00576.x; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067	66	100	101	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69344	10.1371/journal.pone.0069344	http://dx.doi.org/10.1371/journal.pone.0069344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936325	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800015
J	Suez, M; Gidoin, C; Lefevre, F; Candau, JN; Chalon, A; Boivin, T				Suez, Marie; Gidoin, Cindy; Lefevre, Francois; Candau, Jean-Noel; Chalon, Alain; Boivin, Thomas			Temporal Population Genetics of Time Travelling Insects: A Long Term Study in a Seed-Specialized Wasp	PLOS ONE			English	Article							ZOOPLANKTON EGG BANKS; ALLELE FREQUENCY DATA; PROLONGED DIAPAUSE; MEGASTIGMUS-SPERMOTROPHUS; MICROSATELLITE LOCI; COMPUTER-PROGRAM; CHESTNUT WEEVIL; HYMENOPTERA; VARIABILITY; STRATEGIES	Many animal species experiencing spatial or interannual fluctuations of their environment are capable of prolonged diapause, a kind of dormancy that extends over more than one year. Such a prolonged diapause is commonly perceived as a temporal demographic refuge in stochastic environments, but empirical evidence is still lacking of its consequences on temporal population genetic structures. In this long-term study, we investigated how a particular pattern of prolonged diapause may influence the temporal population genetics of the invasive seed-specialized wasp Megastigmus schimitscheki (Hymenoptera: Torymidae) in southeastern France. We characterized the diapause strategy of M. schimitscheki using records of emergence from diapause in 97 larval cohorts, and we conducted a temporal population genetic study on a natural invasive wasp population sampled during ten consecutive years (1999-2008) using polymorphic microsatellite markers. We found that M. schimitscheki can undergo a prolonged diapause of up to five years and displays two main adult emergence peaks after two and four years of diapause. Such a bimodal and atypical pattern did not disrupt temporal gene flow between cohorts produced in even and in odd years during the period of the study. Unexpectedly, we found that this wasp population consisted of two distinct genetic sub-populations that strongly diverged in their diapause strategies, with very few admixed individuals. One of the sub-populations displayed both short and prolonged diapause (2 and 4 years respectively) in equal proportions, whereas the other sub-population displayed mainly short diapause. This study provided empirical evidence that prolonged diapause phenotypes can substantially contribute to reproduction and impact temporal genetic structures. Prolonged diapause is likely to act as both demographic and genetic refuges for insect populations living in fluctuating environments.	[Suez, Marie; Gidoin, Cindy; Lefevre, Francois; Candau, Jean-Noel; Chalon, Alain; Boivin, Thomas] INRA, UR Rech Forestieres Mediterraneennes 629, Avignon, France; [Candau, Jean-Noel] Nat Resources Canada, Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada	INRAE; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Boivin, T (corresponding author), INRA, UR Rech Forestieres Mediterraneennes 629, Avignon, France.	boivin@avignon.inra.fr	Lefèvre, François/E-1184-2017	Lefèvre, François/0000-0003-2242-7251; Candau, Jean-Noel/0000-0001-9356-3950	French Agence Nationale pour la Recherche [ANR-10-INTB-1705-04-MACBI]	French Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was part of the ANR-10-INTB-1705-04-MACBI project funded by the French Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger-Rozenberg MA, 2012, MOL ECOL, V21, P6086, DOI 10.1111/mec.12077; Auger-Rozenberg MA, 2006, SYST ENTOMOL, V31, P47, DOI 10.1111/j.1365-3113.2005.00310.x; Auger-Rozenberg MA, 2012, INTEGR ZOOL, V7, P228, DOI 10.1111/j.1749-4877.2012.00308.x; Belkhir K, 1996, 5000 CNRS UMR; Bohonak AJ, 2006, ARCH HYDROBIOL, V167, P183, DOI 10.1127/0003-9136/2006/0167-0183; Boivin S, 2003, MOL ECOL NOTES, V3, P363, DOI 10.1046/j.1471-8286.2003.00451.x; Boivin T, 2008, BIOL INVASIONS, V10, P1013, DOI 10.1007/s10530-007-9180-3; Cabin RJ, 1998, AM J BOT, V85, P1098, DOI 10.2307/2446343; Carcreff E, 1998, MOL ECOL, V7, P251; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Corley JC, 2004, THEOR POPUL BIOL, V65, P193, DOI 10.1016/j.tpb.2003.09.005; Cornuet JM, 1996, GENETICS, V144, P2001; Cote SD, 2002, MOL ECOL, V11, P1923, DOI 10.1046/j.1365-294X.2002.01582.x; Croitoru L, 2005, VALUING MEDITERRANEAN FORESTS: TOWARDS TOTAL ECONOMIC VALUE, P279, DOI 10.1079/9780851999975.0279; Danforth BN, 1999, P ROY SOC B-BIOL SCI, V266, P1985, DOI 10.1098/rspb.1999.0876; Danks HV, 2004, INTEGR COMP BIOL, V44, P85, DOI 10.1093/icb/44.2.85; Danks HV, 1987, TERRESTRIAL ARTHROPO; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ELLNER S, 1994, AM NAT, V143, P403, DOI 10.1086/285610; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans MEK, 2005, Q REV BIOL, V80, P431, DOI 10.1086/498282; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabre JP, 2004, BIOL INVASIONS, V6, P11, DOI 10.1023/B:BINV.0000010119.51131.19; GOUDET J, 2002, FSTAT SOFTWARE ESTIM; Gourbiere S, 2009, EVOLUTION, V63, P1879, DOI 10.1111/j.1558-5646.2009.00731.x; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; Hairston NG, 2002, INTEGR COMP BIOL, V42, P481, DOI 10.1093/icb/42.3.481; HANSKI I, 1988, ANN ZOOL FENN, V25, P37; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kelly D, 2000, OIKOS, V90, P477, DOI 10.1034/j.1600-0706.2000.900306.x; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Krouchi F, 2004, FOREST ECOL MANAG, V197, P181, DOI 10.1016/j.foreco.2004.05.013; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Mahdjoub T, 2008, J THEOR BIOL, V251, P317, DOI 10.1016/j.jtbi.2007.12.002; Matsuo Y, 2006, FUNCT ECOL, V20, P300, DOI 10.1111/j.1365-2435.2006.01097.x; MENU F, 1993, OECOLOGIA, V96, P383, DOI 10.1007/BF00317509; Menu F, 2000, AM NAT, V155, P724, DOI 10.1086/303355; Menu F, 2002, OECOLOGIA, V132, P167, DOI 10.1007/s00442-002-0969-6; Nicholls JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-322; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; PHILIPPI T, 1993, AM NAT, V142, P474, DOI 10.1086/285550; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Puurtinen M, 2011, EVOLUTION, V65, P1501, DOI 10.1111/j.1558-5646.2010.01217.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robinson SP, 2012, J EVOLUTION BIOL, V25, P716, DOI 10.1111/j.1420-9101.2012.02466.x; Roff Derek A., 1992; Roques A, 2003, J NAT HIST, V37, P127, DOI 10.1080/713834669; Roques A, 1988, P 3 CON SEED INS IUF, P64; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roux G, 1997, OECOLOGIA, V111, P172, DOI 10.1007/PL00008815; Roux G, 1998, P 4 CON SEED INS IUF; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sherman CDH, 2008, P R SOC B, V275, P971, DOI 10.1098/rspb.2007.1626; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Soula B, 2003, OIKOS, V100, P574, DOI 10.1034/j.1600-0706.2003.11858.x; SOULA B, 2002, THESIS U C BERNARD L; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Toth J., 1978, THESIS FS TECHNIQUES; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; TURGEON JJ, 1994, ANNU REV ENTOMOL, V39, P179, DOI 10.1146/annurev.en.39.010194.001143; Vitalis R, 2004, AM NAT, V163, P295, DOI 10.1086/381041; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; Waldbauer G.P., 1978, P127; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Werren John H., 1993, P42; Widenfalk O, 2005, OIKOS, V108, P618, DOI 10.1111/j.0030-1299.2005.13620.x	74	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70818	10.1371/journal.pone.0070818	http://dx.doi.org/10.1371/journal.pone.0070818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936470	gold, Green Submitted, Green Published			2022-12-27	WOS:000324545800051
J	Zhu, AZX; Zhou, Q; Cox, LS; Ahluwalia, JS; Benowitz, NL; Tyndale, RF				Zhu, Andy Z. X.; Zhou, Qian; Cox, Lisa Sanderson; Ahluwalia, Jasjit S.; Benowitz, Neal L.; Tyndale, Rachel F.			Variation in Trans-3 '-Hydroxycotinine Glucuronidation Does Not Alter the Nicotine Metabolite Ratio or Nicotine Intake	PLOS ONE			English	Article							HUMAN LIVER-MICROSOMES; COPY-NUMBER-VARIATION; CIGARETTE-SMOKING; TRANSDERMAL NICOTINE; DISPOSITION KINETICS; CARCINOGEN EXPOSURE; N-GLUCURONIDATION; CYP2A6 GENOTYPE; COTININE; UGT2B17	Background: CYP2A6 metabolizes nicotine to its primary metabolite cotinine and also mediates the metabolism of cotinine to trans-3'-hydroxycotinine (3HC). The ratio of 3HC to cotinine (the "nicotine metabolite ratio", NMR) is an in vivo marker for the rate of CYP2A6 mediated nicotine metabolism, and total nicotine clearance, and has been associated with differences in numerous smoking behaviors. The clearance of 3HC, which affects the NMR, occurs via renal excretion and metabolism by UGT2B17, and possibly UGT2B10, to 3HC-glucuronide. We investigated whether slower 3HC glucuronidation alters NMR, altering its ability to predict CYP2A6 activity and reducing its clinical utility. Methods: Plasma NMR, three urinary NMRs, three urinary 3HC glucuronidation phenotypes and total nicotine equivalents were examined in 540 African American smokers. The UGT2B17 gene deletion and UGT2B10*2 were genotyped. Results: The UGT2B17 gene deletion, but not UGT2B10*2 genotype, was associated with slower 3HC glucuronidation (indicated by three 3HC-glucuronidation phenotypes), indicating its role in this glucuronidation pathway. However, neither lower rates of 3HC glucuronidation, nor the presence of a UGT2B17 and UGT2B10 reduced function allele, altered plasma or urinary NMRs or levels of smoking. Conclusions: Variation in 3HC glucuronidation activity, including these caused by UGT2B17 gene deletions, did not significantly alter NMR and is therefore unlikely to affect the clinical utility of NMR in smoking behavior and cessation studies. This study demonstrates that NMR is not altered by differences in the rate of 3HC glucuronidation, providing further support that NMR is a reliable indicator of CYP2A6 mediated nicotine metabolism.	[Zhu, Andy Z. X.; Zhou, Qian; Tyndale, Rachel F.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A1, Canada; [Cox, Lisa Sanderson] Univ Kansas, Sch Med, Dept Prevent Med & Publ Hlth, Kansas City, KS USA; [Ahluwalia, Jasjit S.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Ahluwalia, Jasjit S.] Univ Minnesota, Sch Med, Ctr Hlth Equ, Minneapolis, MN 55455 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA 94143 USA; [Tyndale, Rachel F.] Univ Toronto, Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON M5S 1A1, Canada; [Tyndale, Rachel F.] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Kansas; University of Kansas Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Tyndale, RF (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A1, Canada.	r.tyndale@utoronto.ca		Tyndale, Rachel/0000-0003-1297-2053	National Institutes of Health (NIH) [CA091912]; National Center for Minority Health Disparities [1P60MD003422]; Endowed Chair in Addiction for the Department of Psychiatry; CIHR [MOP86471, TMH 109787]; Ontario Graduate Scholarship; CAMH; CAMH foundation; PGRN NIH [DA020830]; NIH [DA012353]; Canada Foundation for Innovation [20289, 16014]; Ontario Ministry of Research and Innovation; NATIONAL CANCER INSTITUTE [R01CA091912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD003422] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Minority Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Endowed Chair in Addiction for the Department of Psychiatry; CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); CAMH; CAMH foundation; PGRN NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The authors acknowledge the support of National Institutes of Health (NIH) grant CA091912 (LSC) to fund this study, National Center for Minority Health Disparities grant 1P60MD003422 (JSA), the Endowed Chair in Addiction for the Department of Psychiatry (RFT), CIHR grants MOP86471 and TMH 109787 (RFT), Ontario Graduate Scholarship (AZZ), CAMH and the CAMH foundation (RFT), PGRN NIH grant DA020830 (RFT, NB) and NIH grant DA012353 (NB), the Canada Foundation for Innovation (#20289 and #16014) and the Ontario Ministry of Research and Innovation (RFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz NL, 2011, NICOTINE TOB RES, V13, P772, DOI 10.1093/ntr/ntr072; Benowitz NL, 2010, CANCER EPIDEM BIOMAR, V19, P3013, DOI 10.1158/1055-9965.EPI-10-0706; BENOWITZ NL, 1994, CLIN PHARMACOL THER, V56, P483, DOI 10.1038/clpt.1994.169; BENOWITZ NL, 1985, J PHARMACOL EXP THER, V234, P153; BENOWITZ NL, 1994, J PHARMACOL EXP THER, V268, P296; BENOWITZ NL, 1983, CLIN PHARMACOL THER, V34, P604, DOI 10.1038/clpt.1983.222; Benowitz NL, 2002, J NATL CANCER I, V94, P108, DOI 10.1093/jnci/94.2.108; Benowitz NL, 2001, BRIT J CLIN PHARMACO, V51, P53, DOI 10.1046/j.1365-2125.2001.01309.x; Berg JZ, 2010, J PHARMACOL EXP THER, V332, P202, DOI 10.1124/jpet.109.159855; Binnington MJ, 2012, PHARMACOGENET GENOM, V22, P429, DOI 10.1097/FPC.0b013e3283527c1c; Chen G, 2007, CANCER RES, V67, P9024, DOI 10.1158/0008-5472.CAN-07-2245; Chen G, 2012, PHARMACOGENET GENOM, V22, P183, DOI 10.1097/FPC.0b013e32834ff3a5; Chen G, 2010, CANCER RES, V70, P7543, DOI 10.1158/0008-5472.CAN-09-4582; Cox L. S., 2012, JNCI-J NATL CANCER I, V104, P1; Dempsey D, 2004, CLIN PHARMACOL THER, V76, P64, DOI 10.1016/j.clpt.2004.02.011; Derby KS, 2008, CANCER EPIDEM BIOMAR, V17, P3526, DOI 10.1158/1055-9965.EPI-08-0424; Helen GS, 2012, CANCER EPIDEM BIOMAR, V21, P1105, DOI 10.1158/1055-9965.EPI-12-0236; Ho MK, 2009, CLIN PHARMACOL THER, V85, P635, DOI 10.1038/clpt.2009.19; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Kuehl GE, 2003, CHEM RES TOXICOL, V16, P1502, DOI 10.1021/tx034173o; Lazarus P, 2005, PHARMACOGENET GENOM, V15, P769, DOI 10.1097/01.fpc.0000175596.52443.ef; Lea RA, 2006, J ANAL TOXICOL, V30, P386, DOI 10.1093/jat/30.6.386; Lerman C, 2010, CLIN PHARMACOL THER, V87, P553, DOI 10.1038/clpt.2010.3; Lerman C, 2006, CLIN PHARMACOL THER, V79, P600, DOI 10.1016/j.clpt.2006.02.006; Messina ES, 1997, J PHARMACOL EXP THER, V282, P1608; Nakajima M, 1996, J PHARMACOL EXP THER, V277, P1010; Patterson F, 2008, CLIN PHARMACOL THER, V84, P320, DOI 10.1038/clpt.2008.57; Pianezza ML, 1998, NATURE, V393, P750, DOI 10.1038/31623; Strasser AA, 2007, NICOTINE TOB RES, V9, P511, DOI 10.1080/14622200701239605; Strasser AA, 2011, CANCER EPIDEM BIOMAR, V20, P234, DOI 10.1158/1055-9965.EPI-10-0674; Swan GE, 2009, PHARMACOGENET GENOM, V19, P388, DOI 10.1097/FPC.0b013e32832a404f; Xue YL, 2008, AM J HUM GENET, V83, P337, DOI 10.1016/j.ajhg.2008.08.004; Yamanaka H, 2005, DRUG METAB DISPOS, V33, P1811, DOI 10.1124/dmd.105.006254; Yamanaka H, 2005, DRUG METAB DISPOS, V33, P23, DOI 10.1124/dmd.104.001701; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Zhu AZX, 2013, CANCER EPIDEM BIOMAR, V22, P708, DOI 10.1158/1055-9965.EPI-12-1234-T; Zhu AZX, 2013, CARCINOGENESIS, V34, P93, DOI 10.1093/carcin/bgs306; Zhu AZX, 2012, NICOTINE METABOLISM, P465	38	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70938	10.1371/journal.pone.0070938	http://dx.doi.org/10.1371/journal.pone.0070938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936477	gold, Green Submitted, Green Published			2022-12-27	WOS:000324545800056
J	Achiron, A; Chapman, J; Magalashvili, D; Dolev, M; Lavie, M; Bercovich, E; Polliack, M; Doniger, GM; Stern, Y; Khilkevich, O; Menascu, S; Hararai, G; Gurevich, M; Barak, Y				Achiron, Anat; Chapman, Joab; Magalashvili, David; Dolev, Mark; Lavie, Mor; Bercovich, Eran; Polliack, Michael; Doniger, Glen M.; Stern, Yael; Khilkevich, Olga; Menascu, Shay; Hararai, Gil; Gurevich, Micharel; Barak, Yoram			Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL ASSESSMENT; DYSFUNCTION; MS; DECLINE; PATTERNS; RISK	Background/Aims: Large-scale population studies measuring rates and dynamics of cognitive decline in multiple sclerosis (MS) are lacking. In the current cross-sectional study we evaluated the patterns of cognitive impairment in MS patients with disease duration of up to 30 years. Methods: 1,500 patients with MS were assessed by a computerized cognitive battery measuring verbal and non-verbal memory, executive function, visual spatial perception, verbal function, attention, information processing speed and motor skills. Cognitive impairment was defined as below one standard deviation (SD) and severe cognitive impairment as below 2SD for age and education matched healthy population norms. Results: Cognitive performance in our cohort was poorer than healthy population norms. The most frequently impaired domains were information processing speed and executive function. MS patients with secondary-progressive disease course performed poorly compared with clinically isolated syndrome, relapsing-remitting and primary progressive MS patients. By the fifth year from disease onset, 20.9% of patients performed below the 1SD cutoff for impairment, p = 0.005, and 6.0% performed below the 2SD cutoff for severe cognitive impairment, p = 0.002. By 10 years from onset 29.3% and 9.0% of patients performed below the 1SD and 2SD cutoffs, respectively, p = 0.0001. Regression modeling suggested that cognitive impairment may precede MS onset by 1.2 years. Conclusions: The rates of cognitive impairment in this large sample of MS patients were lower than previously reported and severe cognitive impairment was evident only in a relatively small group of patients. Cognitive impairment differed significantly from expected normal distribution only at five years from onset, suggesting the existence of a therapeutic window during which patients may benefit from interventions to maintain cognitive health.	[Achiron, Anat; Chapman, Joab; Magalashvili, David; Dolev, Mark; Lavie, Mor; Bercovich, Eran; Polliack, Michael; Stern, Yael; Khilkevich, Olga; Menascu, Shay; Hararai, Gil; Gurevich, Micharel; Barak, Yoram] Chaim Sheba Med Ctr, Multiple Sclerosis Ctr, IL-52621 Tel Hashomer, Israel; [Achiron, Anat; Chapman, Joab] Chaim Sheba Med Ctr, Dept Neurol, IL-52621 Tel Hashomer, Israel; [Achiron, Anat; Chapman, Joab; Polliack, Michael; Menascu, Shay; Barak, Yoram] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Doniger, Glen M.] NeuroTrax Corp, Ono Acad Coll, Kiryat Ono, Israel; [Hararai, Gil] MediStat Ltd, Tel Aviv, Israel; [Barak, Yoram] Abarbanel Mental Hlth Ctr, Bat Yam, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Achiron, A (corresponding author), Chaim Sheba Med Ctr, Multiple Sclerosis Ctr, IL-52621 Tel Hashomer, Israel.	Anat.Achiron@sheba.health.gov.il	Gurevich, Michael/H-1157-2014; Chapman, Joab/E-4598-2010	Chapman, Joab/0000-0002-2161-9764; Doniger, Glen M/0000-0003-2690-3569; Gurevich, Michael/0000-0003-1529-4876; Barak, Yoram/0000-0002-8271-4255	Sheba Medical Center research grant for excellency in medicine	Sheba Medical Center research grant for excellency in medicine	The study was funded by Sheba Medical Center research grant for excellency in medicine. The funders as well as NeuroTrax Corp. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch A, 2012, J NEUROPSYCHOL, V6, P161, DOI 10.1111/j.1748-6653.2011.02021.x; Achiron A, 2007, EUR J NEUROL, V14, P1102, DOI 10.1111/j.1468-1331.2007.01909.x; Achiron A, 2006, J NEUROL SCI, V245, P47, DOI 10.1016/j.jns.2005.05.019; Achiron A, 2005, J NEUROL NEUROSUR PS, V76, P744, DOI 10.1136/jnnp.2004.045518; Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Achiron A, 2010, NEUROBIOL DIS, V38, P201, DOI 10.1016/j.nbd.2009.12.029; Achiron A, 2013, BRAIN STRUCT FUNCT, V218, P943, DOI 10.1007/s00429-012-0440-3; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Aupperle RL, 2002, MULT SCLER J, V8, P382, DOI 10.1191/1352458502ms832oa; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Benedict RHB, 2011, NAT REV NEUROL, V7, P332, DOI 10.1038/nrneurol.2011.61; Benedict RHB, 2010, J INT NEUROPSYCH SOC, V16, P829, DOI 10.1017/S1355617710000688; Benedict RHB, 2003, MULT SCLER J, V9, P95, DOI 10.1191/1352458503ms861oa; Bergendal G, 2007, EUR NEUROL, V57, P193, DOI 10.1159/000099158; Calabrese P, 2006, J NEUROL, V253, P10, DOI 10.1007/s00415-006-1103-1; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Coles AJ, 2011, LANCET NEUROL, V10, P338, DOI 10.1016/S1474-4422(11)70020-5; Crook TH, 2009, NEUROPSYCHOLOGICAL A; Doniger G, 2011, ALZHEIMERS DEMENT; Drew M, 2008, ARCH CLIN NEUROPSYCH, V23, P1, DOI 10.1016/j.acn.2007.09.005; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Friedman SM, 2010, INT J MS CARE S1, P1; Gudesblatt M, 2010, NEUROLOGY S2, V70, pA370; Gudesblatt M, 2011, NEUROLOGY, V76, pA482; Huijbregts SCJ, 2006, J NEUROL SCI, V245, P187, DOI 10.1016/j.jns.2005.07.018; Jonsson A, 2006, J NEUROL SCI, V245, P77, DOI 10.1016/j.jns.2005.09.016; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Lebrun C, 2010, MULT SCLER J, V16, P919, DOI 10.1177/1352458510375707; MAURELLI M, 1992, ACTA NEUROL SCAND, V86, P124, DOI 10.1111/j.1600-0404.1992.tb05052.x; MCINTOSHMICHAELIS SA, 1991, BRIT J CLIN PSYCHOL, V30, P333, DOI 10.1111/j.2044-8260.1991.tb00954.x; MEDAER R, 1984, ACTA NEUROL SCAND, V70, P65; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Piras MR, 2003, J NEUROL NEUROSUR PS, V74, P878, DOI 10.1136/jnnp.74.7.878; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Potagas C, 2008, J NEUROL SCI, V267, P100, DOI 10.1016/j.jns.2007.10.002; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rogers JM, 2007, J CLIN NEUROSCI, V14, P919, DOI 10.1016/j.jocn.2007.02.006; Sasson E, 2012, BRAIN STRUCT FUNCT, V217, P503, DOI 10.1007/s00429-011-0344-7; Schweiger A., 2003, ACTA NEUROPSYCHOL, V1, P407, DOI [10.1016/S0028-3932(02)00173-2, 10.1186/1471-2318-3-4, DOI 10.1186/1471-2318-3-4]; Siva A, 2009, MULT SCLER J, V15, P918, DOI 10.1177/1352458509106214; Smestad C, 2010, EUR J NEUROL, V17, P499, DOI 10.1111/j.1468-1331.2009.02889.x; Spain R, 2011, CURR NEUROL NEUROSCI, V11, P498, DOI 10.1007/s11910-011-0213-z; STAPLES D, 1979, RHEUMATOL REHABIL, V18, P153, DOI 10.1093/rheumatology/18.3.153; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; White RF, 2003, ASSESSMENT, V10, P86, DOI 10.1177/1073191102250185	46	86	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71058	10.1371/journal.pone.0071058	http://dx.doi.org/10.1371/journal.pone.0071058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936485	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400091
J	Luo, RZ; Zhang, MF; Liu, LL; Lu, SX; Zhang, CZ; Yun, JP				Luo, Rongzhen; Zhang, Meifang; Liu, Lili; Lu, Shixun; Zhang, Chris Zhiyi; Yun, Jingping			Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; PROMOTER METHYLATION; GLIOMA GROWTH; LUNG-CANCER; EFEMP1; EXPRESSION; GENE; DIAGNOSIS; BIOMARKER	Fibulin-3, originally identified in senescent and Werner syndrome fibroblasts, has been implicated in cell morphology, growth, adhesion and motility. Fibulin-3 exhibits both antitumor and oncogenic activities towards human cancers; however, the role of Fibulin-3 in hepatocellular carcinoma (HCC) remains elusive. In this study, we showed that both the mRNA and protein levels of Fibulin-3 were remarkably downregulated in HCC cell lines and fresh tissues. Immunohistochemical data revealed that Fibulin-3 was decreased in tumorous tissues in 67.1% (171/255) of cases compared to the corresponding adjacent nontumorous tissues. The results of statistical analysis indicated that low Fibulin-3 expression, defined by the receiver operating characteristic curve (ROC), was significantly associated with tumor differentiation (P = 0.008), clinical stage (P = 0.014) and serum AFP levels (P < 0.01). Furthermore, Kaplan-Meier and multivariate analysis suggested that Fibulin-3 is an independent negative prognostic indicator for both overall (P < 0.001) and recurrence-free (P = 0.036) survival. In addition, an in vitro study demonstrated that knockdown of Fibulin-3 by siRNA markedly increased cell viability and promoted cell invasion in HCC cells. Collectively, our data suggest that Fibulin-3 exhibits antitumor effects towards HCC and serves as a biomarker of unfavorable prognosis for this deadly disease.	[Luo, Rongzhen; Zhang, Meifang; Liu, Lili; Lu, Shixun; Zhang, Chris Zhiyi; Yun, Jingping] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Rongzhen; Zhang, Meifang; Liu, Lili; Lu, Shixun; Zhang, Chris Zhiyi; Yun, Jingping] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Zhang, CZ (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.; Zhang, CZ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China.	zhangzhy@sysucc.org.cn; yunjp@sysucc.org.cn	Liu, Lili/HHC-6357-2022; Zhang, Chris Zhiyi/F-9862-2013		National Natural Science Foundation of China [81172345]; China Postdoctoral Science Foundation [2012M511867]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (No. 81172345) and China Postdoctoral Science Foundation (No. 2012M511867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Breuhahn K, 2011, HEPATOLOGY, V53, P2111, DOI 10.1002/hep.24313; Camaj P, 2009, BIOL CHEM, V390, P1293, DOI 10.1515/BC.2009.140; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Diersch S, 2013, ONCOTARGET, V4, P277; Ehlermann J, 2003, GENE EXPR PATTERNS, V3, P441, DOI 10.1016/S1567-133X(03)00084-X; Erichsen R, 2008, EUR J GASTROEN HEPAT, V20, P104, DOI 10.1097/MEG.0b013e3282f17517; Hu B, 2012, CANCER RES, V72, P3873, DOI 10.1158/0008-5472.CAN-12-1060; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu YJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-123; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Kim YJ, 2011, CLIN CANCER RES, V17, P4523, DOI 10.1158/1078-0432.CCR-10-2817; Liu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041293; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Narendran N, 2005, EYE, V19, P11, DOI 10.1038/sj.eye.6701435; Nomoto S, 2010, ANN SURG ONCOL, V17, P923, DOI 10.1245/s10434-009-0790-0; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Riordan JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003441; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Sercu S, 2009, MATRIX BIOL, V28, P160, DOI 10.1016/j.matbio.2009.02.003; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Song EL, 2010, GYNECOL ONCOL, V117, P417, DOI 10.1016/j.ygyno.2009.12.016; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tong JD, 2011, NEOPLASMA, V58, P441, DOI 10.4149/neo_2011_05_441; Wong DKH, 2011, HEPATOLOGY, V54, P829, DOI 10.1002/hep.24551; Yue W, 2007, CLIN CANCER RES, V13, P4336, DOI 10.1158/1078-0432.CCR-07-0015; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051703	33	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70511	10.1371/journal.pone.0070511	http://dx.doi.org/10.1371/journal.pone.0070511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936443	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400072
J	Pou, C; Codoner, FM; Thielen, A; Bellido, R; Perez-Alvarez, S; Cabrera, C; Dalmau, J; Curriu, M; Lie, YLD; Noguera-Julian, M; Puig, J; Martinez-Picado, J; Blanco, J; Coakley, E; Daumer, M; Clotet, B; Paredes, R				Pou, Christian; Codoner, Francisco M.; Thielen, Alexander; Bellido, Rocio; Perez-Alvarez, Susana; Cabrera, Cecilia; Dalmau, Judith; Curriu, Marta; Lie, Yolanda; Noguera-Julian, Marc; Puig, Jordi; Martinez-Picado, Javier; Blanco, Julia; Coakley, Eoin; Daeumer, Martin; Clotet, Bonaventura; Paredes, Roger			HIV-1 Tropism Testing in Subjects Achieving Undetectable HIV-1 RNA: Diagnostic Accuracy, Viral Evolution and Compartmentalization	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; CORECEPTOR TROPISM; TYPE-1 TROPISM; MARAVIROC; VIRUS; ASSAY; PHYLOGENIES; VICRIVIROC; PREDICTION; EMERGENCE	Background: Technically, HIV-1 tropism can be evaluated in plasma or peripheral blood mononuclear cells (PBMCs). However, only tropism testing of plasma HIV-1 has been validated as a tool to predict virological response to CCR5 antagonists in clinical trials. The preferable tropism testing strategy in subjects with undetectable HIV-1 viremia, in whom plasma tropism testing is not feasible, remains uncertain. Methods & Results: We designed a proof-of-concept study including 30 chronically HIV-1-infected individuals who achieved HIV-1 RNA <50 copies/mL during at least 2 years after first-line ART initiation. First, we determined the diagnostic accuracy of 454 and population sequencing of gp120 V3-loops in plasma and PBMCs, as well as of MT-2 assays before ART initiation. The Enhanced Sensitivity Trofile Assay (ESTA) was used as the technical reference standard. 454 sequencing of plasma viruses provided the highest agreement with ESTA. The accuracy of 454 sequencing decreased in PBMCs due to reduced specificity. Population sequencing in plasma and PBMCs was slightly less accurate than plasma 454 sequencing, being less sensitive but more specific. MT-2 assays had low sensitivity but 100% specificity. Then, we used optimized 454 sequence data to investigate viral evolution in PBMCs during viremia suppression and only found evolution of R5 viruses in one subject. No de novo CXCR4-using HIV-1 production was observed over time. Finally, Slatkin-Maddison tests suggested that plasma and cell-associated V3 forms were sometimes compartmentalized. Conclusions: The absence of tropism shifts during viremia suppression suggests that, when available, testing of stored plasma samples is generally safe and informative, provided that HIV-1 suppression is maintained. Tropism testing in PBMCs may not necessarily produce equivalent biological results to plasma, because the structure of viral populations and the diagnostic performance of tropism assays may sometimes vary between compartments. Thereby, proviral DNA tropism testing should be specifically validated in clinical trials before it can be applied to routine clinical decision-making.	[Pou, Christian; Codoner, Francisco M.; Bellido, Rocio; Perez-Alvarez, Susana; Cabrera, Cecilia; Dalmau, Judith; Curriu, Marta; Noguera-Julian, Marc; Martinez-Picado, Javier; Blanco, Julia; Clotet, Bonaventura; Paredes, Roger] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Inst Recerca SIDA irsiCaixa HIVACAT, Catalonia, Spain; [Puig, Jordi; Clotet, Bonaventura; Paredes, Roger] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Fdn Lluita SIDA, HIV Unit, Catalonia, Spain; [Thielen, Alexander] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Martinez-Picado, Javier] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Lie, Yolanda] Monogram Biosci Inc, San Francisco, CA USA; [Daeumer, Martin] Inst Immunol & Genet, Kaiserslautern, Germany	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Max Planck Society; ICREA	Pou, C (corresponding author), Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Inst Recerca SIDA irsiCaixa HIVACAT, Catalonia, Spain.	cpou@irsicaixa.es; rparedes@irsicaixa.es	Blanco, Julià/A-5347-2008; Perez-Alvarez, Susana/AAF-4333-2021; Martinez-Picado, Javier/G-5507-2012; Pou, Christian/B-2932-2015; Noguera-Julian, Marc/F-8651-2016; Cabrera, Cecilia/S-1113-2019; Dalmau, Judith/I-7065-2016	Blanco, Julià/0000-0002-2225-0217; Perez-Alvarez, Susana/0000-0003-2724-5131; Martinez-Picado, Javier/0000-0002-4916-2129; Pou, Christian/0000-0003-3932-788X; Noguera-Julian, Marc/0000-0002-6194-1395; Cabrera, Cecilia/0000-0002-9941-6828; Dalmau, Judith/0000-0001-7513-3711	Pfizer; CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network [223131]; European Commission; Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA' [RD06/0006]; Gala contra la sida - Barcelona; Marie Curie European Reintegration Grant [238885]; ICREA Funding Source: Custom	Pfizer(Pfizer); CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA'; Gala contra la sida - Barcelona; Marie Curie European Reintegration Grant(European Commission); ICREA(ICREA)	This study was supported through an unrestricted research grant from Pfizer, 'CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network', Integrated Project number 223131, funded by the European Commission Framework 7 Program, the Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA' (RD06/0006), and the 'Gala contra la sida - Barcelona 2011'. FMC was supported by the Marie Curie European Reintegration Grant number 238885, 'HIV Coevolution', European Commission Framework 7 Program. None of the funding bodies had any role in the design, collection, analysis, or interpretation of data, in the writing of the manuscript, or in the decision to submit the manuscript for publication.	Abbate I, 2010, CLIN MICROBIOL INFEC; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Coakley E, 2009, ANTIMICROB AGENTS CH, V53, P4686, DOI 10.1128/AAC.00229-09; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Gulick RM, 2007, J INFECT DIS, V196, P304, DOI 10.1086/518797; Heera J, 2011, 18 C RETR OPP INF BO; Hosoya N, 2009, J CLIN MICROBIOL, V47, P2604, DOI 10.1128/JCM.00632-09; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; KOOT M, 1992, AIDS, V6, P49, DOI 10.1097/00002030-199201000-00006; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; R Core Team, 2021, R LANGUAGE ENV STAT; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Saag M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1493, DOI 10.1093/jac/dkq156; Sing T, 2007, ANTIVIR THER, V12, P1097; SLATKIN M, 1989, GENETICS, V123, P603; Soulie C, 2011, AIDS, V25, P537, DOI 10.1097/QAD.0b013e32834345d3; Svicher V, 2010, NEW MICROBIOL, V33, P195; Swenson LC, 2011, 18 C RETR OPP INF BO; Swenson LC, 2010, 17 C RETR OPP INF SA; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thielen A, 2011, ANTIVIR THER, V16, P319, DOI 10.3851/IMP1769; Tsibris AMN, 2008, J VIROL, V82, P8210, DOI 10.1128/JVI.00444-08; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006	33	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e67085	10.1371/journal.pone.0067085	http://dx.doi.org/10.1371/journal.pone.0067085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936293	gold, Green Submitted, Green Published			2022-12-27	WOS:000324518400004
J	Puri, RV; Singh, N; Gupta, RK; Tyagi, AK				Puri, Rupangi Verma; Singh, Nisha; Gupta, Rakesh K.; Tyagi, Anil K.			Endonuclease IV Is the Major Apurinic/Apyrimidinic Endonuclease in Mycobacterium tuberculosis and Is Important for Protection against Oxidative Damage	PLOS ONE			English	Article							BASE EXCISION-REPAIR; 3'-5' EXONUCLEASE ACTIVITY; ABASIC SITE ANALOGS; DIVALENT METAL-IONS; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; APURINIC ENDONUCLEASE; SUBSTRATE SPECIFICITIES; GENOME SEQUENCE	During the establishment of an infection, bacterial pathogens encounter oxidative stress resulting in the production of DNA lesions. Majority of these lesions are repaired by base excision repair (BER) pathway. Amongst these, abasic sites are the most frequent lesions in DNA. Class II apurinic/apyrimidinic (AP) endonucleases play a major role in BER of damaged DNA comprising of abasic sites. Mycobacterium tuberculosis, a deadly pathogen, resides in the human macrophages and is continually subjected to oxidative assaults. We have characterized for the first time two AP endonucleases namely Endonuclease IV (End) and Exonuclease III (XthA) that perform distinct functions in M. tuberculosis. We demonstrate that M. tuberculosis End is a typical AP endonuclease while XthA is predominantly a 3'-> 5' exonuclease. The AP endonuclease activity of End and XthA was stimulated by Mg2+ and Ca2+ and displayed a preferential recognition for abasic site paired opposite to a cytosine residue in DNA. Moreover, End exhibited metal ion independent 3'-> 5' exonuclease activity while in the case of XthA this activity was metal ion dependent. We demonstrate that End is not only a more efficient AP endonuclease than XthA but it also represents the major AP endonuclease activity in M. tuberculosis and plays a crucial role in defense against oxidative stress.	[Puri, Rupangi Verma; Singh, Nisha; Gupta, Rakesh K.; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India	University of Delhi	Tyagi, AK (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in	Singh, Nisha/AAS-5583-2020	Singh, Nisha/0000-0002-1950-815X	Department of Biotechnology, Ministry of Science and Technology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a research grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India. The Council of Scientific and Industrial Research, Government of India, is acknowledged for Junior/Senior research fellowships to RVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 1996, J BACTERIOL, V178, P6571, DOI 10.1128/jb.178.22.6571-6578.1996; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Bourn WR, 2007, TUBERCULOSIS, V87, P481, DOI 10.1016/j.tube.2007.08.003; Burkovics P, 2006, NUCLEIC ACIDS RES, V34, P2508, DOI 10.1093/nar/gkl259; Carpenter EP, 2007, EMBO J, V26, P1363, DOI 10.1038/sj.emboj.7601593; Castillo-Acosta VM, 2009, NUCLEIC ACIDS RES, V37, P1829, DOI 10.1093/nar/gkp021; Chastain PD, 2010, FASEB J, V24, P3674, DOI 10.1096/fj.09-145276; Chou KM, 2002, NATURE, V415, P655, DOI 10.1038/415655a; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DASGUPTA SK, 1993, J BACTERIOL, V175, P5186, DOI 10.1128/JB.175.16.5186-5192.1993; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Ferrari CKB, 2011, ARCH IMMUNOL THER EX, V59, P441, DOI 10.1007/s00005-011-0144-z; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Guo Y, 2010, DNA REPAIR, V9, P177, DOI 10.1016/j.dnarep.2009.11.008; GUYER RB, 1985, BIOCHIM BIOPHYS ACTA, V824, P304, DOI 10.1016/0167-4781(85)90036-3; Hadi MZ, 2002, J MOL BIOL, V316, P853, DOI 10.1006/jmbi.2001.5382; Hardeland U, 2003, NUCLEIC ACIDS RES, V31, P2261, DOI 10.1093/nar/gkg344; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480; Ishchenko AA, 2005, MOL CELL BIOL, V25, P6380, DOI 10.1128/MCB.25.15.6380-6390.2005; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; Ishchenko AA, 1999, IUBMB LIFE, V48, P613, DOI 10.1080/713803570; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Jain R, 2007, DNA REPAIR, V6, P1774, DOI 10.1016/j.dnarep.2007.06.009; JOHNSON AW, 1988, J BIOL CHEM, V263, P18017; Johnson RE, 1998, GENE DEV, V12, P3137, DOI 10.1101/gad.12.19.3137; Kerins SM, 2003, J BIOL CHEM, V278, P3048, DOI 10.1074/jbc.M210750200; KOW YW, 1989, BIOCHEMISTRY-US, V28, P3280, DOI 10.1021/bi00434a024; Krokan HE, 1997, BIOCHEM J, V325, P1; Kumar P, 2011, TUBERCULOSIS, V91, P212, DOI 10.1016/j.tube.2011.02.001; Kurthkoti K, 2011, TUBERCULOSIS, V91, P533, DOI 10.1016/j.tube.2011.06.005; Kurthkoti K, 2010, MICROBIOL-SGM, V156, P88, DOI 10.1099/mic.0.033621-0; Lebedeva NA, 2003, BIOCHEM BIOPH RES CO, V300, P182, DOI 10.1016/S0006-291X(02)02808-5; LEVIN JD, 1991, J BIOL CHEM, V266, P22893; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; Lindahl T, 2001, PROG NUCLEIC ACID RE, V68, pXVII; Liu XP, 2005, BBA-PROTEINS PROTEOM, V1753, P217, DOI 10.1016/j.bbapap.2005.09.009; LJUNGQUIST S, 1976, J BACTERIOL, V126, P646, DOI 10.1128/JB.126.2.646-653.1976; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; LOEB LA, 1985, CELL, V40, P483, DOI 10.1016/0092-8674(85)90191-6; Marenstein DR, 2004, DNA REPAIR, V3, P527, DOI 10.1016/j.dnarep.2004.01.010; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Olsen I, 2009, FEMS IMMUNOL MED MIC, V56, P151, DOI 10.1111/j.1574-695X.2009.00562.x; Onyango DO, 2011, DNA REPAIR, V10, P466, DOI 10.1016/j.dnarep.2011.01.011; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P2204, DOI 10.1093/nar/gki518; Parsons JL, 2004, NUCLEIC ACIDS RES, V32, P3531, DOI 10.1093/nar/gkh676; POPOFF SC, 1990, P NATL ACAD SCI USA, V87, P4193, DOI 10.1073/pnas.87.11.4193; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Ribar B, 2004, NUCLEIC ACIDS RES, V32, P115, DOI 10.1093/nar/gkh151; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Soldati T, 2012, TRAFFIC, V13, P1042, DOI 10.1111/j.1600-0854.2012.01358.x; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Srinath T, 2007, DNA REPAIR, V6, P1517, DOI 10.1016/j.dnarep.2007.05.001; Suvarnapunya AE, 2003, MOL MICROBIOL, V48, P549, DOI 10.1046/j.1365-2958.2003.03460.x; TAKEUCHI M, 1994, J BIOL CHEM, V269, P21907; THIELMANN HW, 1981, BIOCHEM J, V195, P407, DOI 10.1042/bj1950407; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomanicek SJ, 2010, ACTA CRYSTALLOGR F, V66, P1003, DOI 10.1107/S1744309110028575; UHLIN BE, 1977, PLASMID, V1, P1, DOI 10.1016/0147-619X(77)90003-8; Unk I, 2000, J BIOL CHEM, V275, P22427, DOI 10.1074/jbc.M002845200; Unk I, 2002, MOL CELL BIOL, V22, P6480, DOI 10.1128/MCB.22.18.6480-6486.2002; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; WHO, 2012, TUB GLOB FACTS 2011; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002	71	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71535	10.1371/journal.pone.0071535	http://dx.doi.org/10.1371/journal.pone.0071535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936515	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400112
J	Strand, J; Honarvar, H; Perols, A; Orlova, A; Selvaraju, RK; Karlstrom, AE; Tolmachev, V				Strand, Joanna; Honarvar, Hadis; Perols, Anna; Orlova, Anna; Selvaraju, Ram Kumar; Karlstrom, Amelie Eriksson; Tolmachev, Vladimir			Influence of Macrocyclic Chelators on the Targeting Properties of Ga-68-Labeled Synthetic Affibody Molecules: Comparison with In-111-Labeled Counterparts	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; SOMATOSTATIN ANALOG; MOUSE MODEL; IN-111; DOTA; BIODISTRIBUTION; AFFINITY; EXPRESSION; HER2	Affibody molecules are a class of small (7 kDa) non-immunoglobulin scaffold-based affinity proteins, which have demonstrated substantial potential as probes for radionuclide molecular imaging. The use of positron emission tomography (PET) would further increase the resolution and quantification accuracy of Affibody-based imaging. The rapid in vivo kinetics of Affibody molecules permit the use of the generator-produced radionuclide Ga-68 (T-1/2 = 67.6 min). Earlier studies have demonstrated that the chemical nature of chelators has a substantial influence on the biodistribution properties of Affibody molecules. To determine an optimal labeling approach, the macrocyclic chelators 1,4,7,10-tetraazacylododecane-1,4,7,10-tetraacetic acid (DOTA), 1,4,7-triazacyclononane-N,N,N-triacetic acid (NOTA) and 1-(1,3-carboxypropyl)-1,4,7- triazacyclononane-4,7-diacetic acid (NODAGA) were conjugated to the N-terminus of the synthetic Affibody molecule Z(HER2:S1) targeting HER2. Affibody molecules were labeled with Ga-68, and their binding specificity and cellular processing were evaluated. The biodistribution of Ga-68-DOTA-Z(HER2:S1), Ga-68-NOTA-Z(HER2:S1) and Ga-68-NODAGA-Z(HER2:S1), as well as that of their In-111-labeled counterparts, was evaluated in BALB/C nu/nu mice bearing HER2-expressing SKOV3 xenografts. The tumor uptake for Ga-68-DOTA-Z(HER2:S1) (17.9 +/- 0.7%IA/g) was significantly higher than for both Ga-68-NODAGA-Z(HER2:S1) (16.13 +/- 0.67%IA/g) and Ga-68-NOTA-Z(HER2:S1) (13 +/- 3%IA/g) at 2 h after injection. Ga-68-NODAGA-Z(HER2:S1) had the highest tumor-to-blood ratio (60 +/- 10) in comparison with both Ga-68-DOTA-Z(HER2:S1) (28 +/- 4) and Ga-68-NOTA-Z(HER2:S1) (42 +/- 11). The tumor-to-liver ratio was also higher for Ga-68-NODAGA-Z(HER2:S1) (7 +/- 2) than the DOTA and NOTA conjugates (5.5 +/- 0.6 vs. 3.3 +/- 0.6). The influence of chelator on the biodistribution and targeting properties was less pronounced for Ga-68 than for In-111. The results of this study demonstrate that macrocyclic chelators conjugated to the N-terminus have a substantial influence on the biodistribution of HER2-targeting Affibody molecules labeled with Ga-68. This can be utilized to enhance the imaging contrast of PET imaging using Affibody molecules and improve the sensitivity of molecular imaging. The study demonstrated an appreciable difference of chelator influence for Ga-68 and In-111.	[Strand, Joanna; Honarvar, Hadis; Tolmachev, Vladimir] Uppsala Univ, Rudbeck Lab, Unit Biomed Radiat Sci, Uppsala, Sweden; [Perols, Anna; Karlstrom, Amelie Eriksson] KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden; [Orlova, Anna; Selvaraju, Ram Kumar] Uppsala Univ, Dept Med Chem, Preclin PET Platform, Uppsala, Sweden	Uppsala University; Royal Institute of Technology; Uppsala University	Tolmachev, V (corresponding author), Uppsala Univ, Rudbeck Lab, Unit Biomed Radiat Sci, Uppsala, Sweden.	Vladimir.tolmachev@bms.uu.se	Eriksson Karlström, Amelie/F-6654-2010; Orlova, Anna/S-9692-2019; Selvaraju, Ram Kumar/AAZ-5507-2020; Tolmachev, Vladimir/U-3107-2019; Tolmachev, Vladimir/T-3722-2017	Eriksson Karlström, Amelie/0000-0002-0695-5188; Orlova, Anna/0000-0001-6120-2683; Selvaraju, Ram Kumar/0000-0001-9219-1497; Tolmachev, Vladimir/0000-0002-6122-1734; Tolmachev, Vladimir/0000-0002-6122-1734	Swedish Cancer Society (Cancerfonden); Swedish Research Council (Vetenskapsradet)	Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	This study was supported by grants from Swedish Cancer Society (Cancerfonden) and Swedish Research Council (Vetenskapsradet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren S, 2010, CURR PHARM BIOTECHNO, V11, P581, DOI 10.2174/138920110792246609; Altai M, 2013, BIOCONJUGATE CHEM, V24, P1102, DOI 10.1021/bc300678y; Altai M, 2012, NUCL MED BIOL, V39, P518, DOI 10.1016/j.nucmedbio.2011.10.013; Andre JP, 1998, CHEM COMMUN, P1301, DOI 10.1039/a801294f; Antunes P, 2007, EUR J NUCL MED MOL I, V34, P982, DOI 10.1007/s00259-006-0317-x; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; BROAN CJ, 1991, J CHEM SOC PERK T 2, P87, DOI 10.1039/p29910000087; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Carlsson J, 2012, TUMOR BIOL, V33, P653, DOI 10.1007/s13277-011-0307-x; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Decristoforo C, 2008, EUR J NUCL MED MOL I, V35, P1507, DOI 10.1007/s00259-008-0757-6; Eisenwiener KP, 2002, BIOCONJUGATE CHEM, V13, P530, DOI 10.1021/bc010074f; Ekblad T, 2008, EUR J NUCL MED MOL I, V35, P2245, DOI 10.1007/s00259-008-0845-7; Engfeldt T, 2007, EUR J NUCL MED MOL I, V34, P1843, DOI 10.1007/s00259-007-0474-6; Feldwisch Joachim, 2012, Methods Mol Biol, V899, P103, DOI 10.1007/978-1-61779-921-1_7; Fournier P, 2012, BIOCONJUGATE CHEM, V23, P1687, DOI 10.1021/bc3002437; Hackel BJ, 2012, PROTEIN ENG DES SEL, V25, P639, DOI 10.1093/protein/gzs036; Heppeler A, 1999, CHEM-EUR J, V5, P1974, DOI 10.1002/(SICI)1521-3765(19990702)5:7<1974::AID-CHEM1974>3.3.CO;2-O; Heskamp S, 2012, J NUCL MED, V53, P146, DOI 10.2967/jnumed.111.093047; Hofstrom C, 2013, J MED CHEM, V56, P4966, DOI 10.1021/jm400218y; Hofstrom C, 2011, J MED CHEM, V54, P3817, DOI 10.1021/jm200065e; Honarvar H, 2013, NUCL MED BIOL, V40, P378, DOI 10.1016/j.nucmedbio.2012.12.009; Kelloff GJ, 2005, CLIN CANCER RES, V11, P7967, DOI 10.1158/1078-0432.CCR-05-1302; Kramer-Marek G, 2011, EUR J NUCL MED MOL I, V38, P1967, DOI 10.1007/s00259-011-1810-4; Lindborg M, 2011, J MOL BIOL, V407, P298, DOI 10.1016/j.jmb.2011.01.033; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Malm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062791; Malmberg J, 2012, EUR J NUCL MED MOL I, V39, P481, DOI 10.1007/s00259-011-1992-9; Malmberg J, 2011, NUCL MED BIOL, V38, P1093, DOI 10.1016/j.nucmedbio.2011.04.005; McLarty K, 2007, CLIN PHARMACOL THER, V81, P420, DOI 10.1038/sj.clpt.6100096; Nielsen CH, 2010, CANCER RES, V70, P9022, DOI 10.1158/0008-5472.CAN-10-1338; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Orlova A, 2013, EUR J NUCL MED MOL I, V40, P439, DOI 10.1007/s00259-012-2284-8; Orlova A, 2009, J NUCL MED, V50, P417, DOI 10.2967/jnumed.108.057919; Perols A, 2012, BIOCONJUGATE CHEM, V23, P1661, DOI 10.1021/bc3002369; Pusztai L, 2010, ONCOLOGIST, V15, P1164, DOI 10.1634/theoncologist.2010-0059; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tolmachev V, 2008, CURR PHARM DESIGN, V14, P2999, DOI 10.2174/138161208786404290; Tolmachev V, 2012, J NUCL MED, V53, P953, DOI 10.2967/jnumed.111.101527; Tolmachev V, 2011, BIOCONJUGATE CHEM, V22, P894, DOI 10.1021/bc100470x; Tolmachev V, 2010, EUR J NUCL MED MOL I, V37, P1356, DOI 10.1007/s00259-009-1367-7; Tolmachev V, 2009, J NUCL MED, V50, P274, DOI 10.2967/jnumed.108.055525; Tran TA, 2008, BIOCONJUGATE CHEM, V19, P2568, DOI 10.1021/bc800244b; Wallberg H, 2008, CANCER BIOTHER RADIO, V23, P435, DOI 10.1089/cbr.2008.0464; Wallberg H, 2010, MOL IMAGING BIOL, V12, P54, DOI 10.1007/s11307-009-0238-8; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724; Zhang HW, 2007, EUR J NUCL MED MOL I, V34, P1198, DOI 10.1007/s00259-006-0347-4	51	46	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70028	10.1371/journal.pone.0070028	http://dx.doi.org/10.1371/journal.pone.0070028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936372	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400033
J	Wang, JM; Bai, ZK; Yang, PL				Wang, Jinman; Bai, Zhongke; Yang, Peiling			Effect of Byproducts of Flue Gas Desulfurization on the Soluble Salts Composition and Chemical Properties of Sodic Soils	PLOS ONE			English	Article							GYPSUM; RECLAMATION; AMELIORATION; RESTORATION; IMPACTS; GROWTH; YIELD; WATER	The byproducts of flue gas desulfurization (BFGD) are a useful external source of Ca2+ for the reclamation of sodic soils because they are comparatively cheap, generally available and have high gypsum content. The ion solution composition of sodic soils also plays an important role in the reclamation process. The effect of BFGD on the soluble salts composition and chemical properties of sodic soils were studied in a soil column experiment. The experiment consisted of four treatments using two different sodic soils (sodic soil I and sodic soil II) and two BFGD rates. After the application of BFGD and leaching, the soil soluble salts were transformed from sodic salts containing Na2CO3 and NaHCO3 to neutral salts containing NaCl and Na2SO4. The sodium adsorption ratio (SAR), pH and electrical conductivity (EC) decreased at all soil depths, and more significantly in the top soil depth. At a depth of 0-40 cm in both sodic soil I and sodic soil II, the SAR, EC and pH were less than 13, 4 dS m(-1) and 8.5, respectively. The changes in the chemical properties of the sodic soils reflected the changes in the ion composition of soluble salts. Leaching played a key role in the reclamation process and the reclamation effect was positively associated with the amount of leaching. The soil salts did not accumulate in the top soil layer, but there was a slight increase in the middle and bottom soil depths. The results demonstrate that the reclamation of sodic soils using BFGD is promising.	[Wang, Jinman; Bai, Zhongke] China Univ Geosci, Coll Land Sci & Technol, Beijing, Peoples R China; [Wang, Jinman; Bai, Zhongke] Minist Land & Resources, Key Lab Land Consolidat & Rehabil, Beijing, Peoples R China; [Yang, Peiling] China Agr Univ, Coll Hydraul & Civil Engn, Beijing 100094, Peoples R China	China University of Geosciences; Ministry of Natural Resources of the People's Republic of China; China Agricultural University	Wang, JM (corresponding author), China Univ Geosci, Coll Land Sci & Technol, Beijing, Peoples R China.	wangjinman2002@163.com		Wang, Jinman/0000-0002-8140-997X	Fundamental Research Funds for the Central Universities of China [2652012072]; National Natural Science Foundation of China [50749032]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Fundamental Research Funds for the Central Universities of China (2652012072), and the National Natural Science Foundation of China (50749032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLSON CL, 1993, J ENVIRON QUAL, V22, P227, DOI 10.2134/jeq1993.00472425002200020002x; Carter M. R., 1989, Arid Soil Research and Rehabilitation, V3, P1, DOI 10.1080/15324988909381184; Chen LM, 2009, FUEL, V88, P1167, DOI 10.1016/j.fuel.2008.07.015; Chi CM, 2012, GEODERMA, V187, P24, DOI 10.1016/j.geoderma.2012.04.005; Chorom M, 1994, AUSTR J SOIL RES, V32, P1152; Chun S, 2001, ENVIRON POLLUT, V114, P453, DOI 10.1016/S0269-7491(00)00226-8; Clark RB, 2001, FUEL, V80, P821, DOI 10.1016/S0016-2361(00)00162-9; FRENKEL H, 1989, J SOIL SCI, V40, P599, DOI 10.1111/j.1365-2389.1989.tb01301.x; Gharaibeh MA, 2010, SOIL USE MANAGE, V26, P141, DOI 10.1111/j.1475-2743.2010.00260.x; Ilyas M, 1997, SOIL TECHNOL, V10, P247, DOI 10.1016/S0933-3630(96)00121-3; Katerji N, 1997, AGR WATER MANAGE, V34, P57, DOI 10.1016/S0378-3774(96)01294-2; MASHHADY AS, 1978, J SOIL SCI, V29, P65, DOI 10.1111/j.1365-2389.1978.tb02032.x; Minashina NG, 2005, EURASIAN SOIL SCI+, V38, P718; Ministry of Agriculture and Fisheries, 1987, GB817387 MIN AGR FIS; Ministry of Agriculture and Fisheries, 1984, GB428484 MIN AGR FIS; Muhammad D, 2011, J CHEM SOC PAKISTAN, V33, P82; OSTER JD, 1980, SOIL SCI SOC AM J, V44, P41, DOI 10.2136/sssaj1980.03615995004400010010x; Pandey V. C., 2011, Ecological Restoration, V29, P322, DOI 10.3368/er.29.4.322; Reading LP, 2012, SOIL SCI, V177, P165, DOI 10.1097/SS.0b013e3182408f4f; Rhoades J. D., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P149; Rhoton FE, 2011, SOIL SCI, V176, P190, DOI 10.1097/SS.0b013e318212143d; Ritvo G, 1999, J WORLD AQUACULT SOC, V30, P26, DOI 10.1111/j.1749-7345.1999.tb00314.x; Sakai Y, 2004, SOIL SEDIMENT CONTAM, V13, P65, DOI 10.1080/10588330490269840; Sakai Y, 2010, KAGAKU KOGAKU RONBUN, V36, P275, DOI 10.1252/kakoronbunshu.36.275; Shannon MC, 1997, ADV AGRON, V60, P75, DOI 10.1016/S0065-2113(08)60601-X; Simon M, 1999, GEODERMA, V90, P99, DOI 10.1016/S0016-7061(98)00098-6; Singh K, 2012, CATENA, V96, P57, DOI 10.1016/j.catena.2012.04.007; Sloan JJ, 1999, FUEL, V78, P169, DOI 10.1016/S0016-2361(98)00135-5; Stuczynski TI, 1998, SOIL SCI, V163, P952, DOI 10.1097/00010694-199812000-00005; Truman CC, 2010, CATENA, V81, P234, DOI 10.1016/j.catena.2010.04.003; USLS, 1954, DIAGNOSIS IMPROVEMEN; Wang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052437; Wang JinMan, 2005, Acta Pedologica Sinica, V42, P98; Wang JM, 2004, Land and Water Management: Decision Tools and Practices, Vols 1 and 2, P1015; Wang SJ, 2008, ENVIRON POLLUT, V151, P200, DOI 10.1016/j.envpol.2007.02.014	35	15	18	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71011	10.1371/journal.pone.0071011	http://dx.doi.org/10.1371/journal.pone.0071011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936481	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400087
J	Wong, HK; Ong, KL; Leung, RYH; Cheung, TT; Xu, AM; Lam, TH; Lam, KSL; Cheung, BMY				Wong, Hoi Kin; Ong, Kwok Leung; Leung, Raymond Y. H.; Cheung, Tommy T.; Xu, Aimin; Lam, Tai Hing; Lam, Karen S. L.; Cheung, Bernard M. Y.			Plasma Level of Adrenomedullin Is Influenced by a Single Nucleotide Polymorphism in the Adiponectin Gene	PLOS ONE			English	Article							HONG-KONG CHINESE; METABOLIC SYNDROME; LIPID-METABOLISM; HYPERTENSION; ASSOCIATION; ADIPOCYTES; DISEASE; GLUCOSE; POPULATION; EXPRESSION	Objective: Adrenomedullin (ADM) and adiponectin are both involved in inflammation and cardiovascular diseases. The plasma levels of these peptides are influenced by single nucleotide polymorphisms (SNPs) in the ADM and ADIPOQ genes respectively. There is some evidence that ADM may regulate adiponectin gene expression, but whether adiponectin can regulate ADM expression is unclear, and was therefore investigated. Methods: Plasma ADM level was measured in 476 subjects in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). We genotyped them for 2 ADIPOQ SNPs that are known to be associated with plasma adiponectin level. Results: The minor allele frequencies of ADIPOQ SNPs rs182052 and rs12495941 were 40.6% and 42.2% respectively. Plasma ADM level was significantly associated with rs182052 after adjusting for age and sex (beta = 0.104, P = 0.023) but not with rs12495941 (beta = 0.071, P = 0.120). In multivariate analysis, plasma ADM level increased with the number of minor alleles of rs182052 (P = 0.013). Compared to subjects with GG genotype, subjects with AA genotype had 17.7% higher plasma ADM level (95% CI: 3.6%-33.7%). Subgroup analysis revealed that the association was significant in diabetic patients (beta = 0.344, P = 0.001) but not in non-diabetic subjects. Conclusion: Plasma ADM level is related to SNP rs182052 in the ADIPOQ gene. Our findings provide new evidence of the interplay between these two important peptides in cardiovascular disease and diabetes. Knowing the genotype may help to refine the interpretation of these biomarkers.	[Wong, Hoi Kin; Leung, Raymond Y. H.; Cheung, Tommy T.; Xu, Aimin; Lam, Karen S. L.; Cheung, Bernard M. Y.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ong, Kwok Leung] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Lam, Tai Hing] Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of New South Wales Sydney; University of Hong Kong; University of Hong Kong	Cheung, BMY (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mycheung@hku.hk	Ong, Kwok Leung/B-9018-2009; Lam, Tai Hing/C-4317-2009; /I-3847-2012; /E-9829-2010; /C-4315-2009	Ong, Kwok Leung/0000-0001-7229-7614; Lam, Tai Hing/0000-0002-2033-9971; /0000-0001-6575-9497; /0000-0001-9106-7363; /0000-0001-5757-541X	Hong Kong Research Grants Council [HKU7626/07M, HKU7802/10M]; Sun Chieh Yeh Heart Foundation; Li Ka Shing Faculty of Medicine, the University of Hong Kong	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Sun Chieh Yeh Heart Foundation; Li Ka Shing Faculty of Medicine, the University of Hong Kong	BMY Cheung received support from the Hong Kong Research Grants Council (grant number HKU7626/07M and HKU7802/10M), the Sun Chieh Yeh Heart Foundation, and the Faculty Development Fund, Li Ka Shing Faculty of Medicine, the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bunton DC, 2004, PHARMACOL THERAPEUT, V103, P179, DOI 10.1016/j.pharmthera.2004.07.002; Cheng KY, 2006, BIOMED REV, V17, P11; Cheung B, 1997, CLIN SCI, V92, P59, DOI 10.1042/cs0920059; Cheung BMY, 2008, AM J HYPERTENS, V21, P17, DOI 10.1038/ajh.2007.19; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Cheung Bernard M Y, 2004, Semin Vasc Med, V4, P129, DOI 10.1055/s-2004-835370; Cheung BMY, 2011, EUR J ENDOCRINOL, V165, P571, DOI 10.1530/EJE-11-0513; Cheung BMY, 2011, CLIN CHIM ACTA, V412, P1326, DOI 10.1016/j.cca.2011.03.030; Cheung BMY, 2004, J ENDOCRINOL, V181, P339, DOI 10.1677/joe.0.1810339; Cromwell William C, 2004, Curr Atheroscler Rep, V6, P381, DOI 10.1007/s11883-004-0050-5; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Finelli C, 2013, WORLD J GASTROENTERO, V19, P802, DOI 10.3748/wjg.v19.i6.802; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Hashimoto N, 2006, METABOLISM, V55, P1653, DOI 10.1016/j.metabol.2006.08.005; Henneman P, 2010, DIABETES CARE, V33, P908, DOI 10.2337/dc09-1385; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Iemura-Inaba C, 2008, AM J PHYSIOL-REG I, V295, pR1376, DOI 10.1152/ajpregu.90467.2008; ISHIMITSU T, 1994, J CLIN INVEST, V94, P2158, DOI 10.1172/JCI117573; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kaser S, 2008, EUR J CLIN INVEST, V38, P827, DOI 10.1111/j.1365-2362.2008.02028.x; Li Y, 2007, PEPTIDES, V28, P1129, DOI 10.1016/j.peptides.2007.03.005; Liao SB, 2012, HORM METAB RES  0906, V6; Lim SC, 2007, DIABETES CARE, V30, P1513, DOI 10.2337/dc06-1899; Mok MY, 2007, J RHEUMATOL, V34, P2224; Nishida H, 2008, PEPTIDES, V29, P599, DOI 10.1016/j.peptides.2007.12.006; Ong KL, 2010, EUR J ENDOCRINOL, V163, P251, DOI 10.1530/EJE-10-0251; Potocki Mihael, 2012, Curr Heart Fail Rep, V9, P244, DOI 10.1007/s11897-012-0096-6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sanghera DK, 2010, METABOLISM, V59, P492, DOI 10.1016/j.metabol.2009.07.043; Torigoe M, 2007, CLIN ENDOCRINOL, V67, P276, DOI 10.1111/j.1365-2265.2007.02876.x; Tso AWK, 2006, DIABETOLOGIA, V49, P1806, DOI 10.1007/s00125-006-0324-2; Tsukinoki Rumi, 2005, Lipids Health Dis, V4, P27, DOI 10.1186/1476-511X-4-27; Vasseur F, 2010, J HUM GENET, V55, P227, DOI 10.1038/jhg.2010.10; Wong HK, 2013, CLIN ENDOCRINOL, V79, P504, DOI 10.1111/cen.12078; Wong LYF, 2005, ENDOCRINOLOGY, V146, P1321, DOI 10.1210/en.2004-1080; Woo YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036868; Xu AM, 2012, AM J PHYSIOL-HEART C, V302, pH1231, DOI 10.1152/ajpheart.00765.2011; Yu CM, 2001, HEART, V86, P155, DOI 10.1136/heart.86.2.155; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70335	10.1371/journal.pone.0070335	http://dx.doi.org/10.1371/journal.pone.0070335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936408	gold, Green Published			2022-12-27	WOS:000324518400055
J	Wang, KY; Li, LL; Song, Y; Ye, XC; Fu, SL; Jiang, J; Li, S				Wang, Kaiyu; Li, Linlin; Song, Yan; Ye, Xiaocui; Fu, Shaolian; Jiang, Jie; Li, Sha			Improvement of Pharmacokinetics Behavior of Apocynin by Nitrone Derivatization: Comparative Pharmacokinetics of Nitrone-Apocynin and its Parent Apocynin in Rats	PLOS ONE			English	Article							NADPH OXIDASE INHIBITION; BIOAVAILABILITY; METABOLISM; ACTIVATION; INJURY; DRUG	Apocynin, a potent inhibitor of NADPH-oxidase, was widely studied for activities in diseases such as inflammation-mediated disorders, asthma and cardiovascular diseases. In our recent study, a novel nitrone derivative of apocynin, AN-1, demonstrated potent inhibition to oxidative injury and to high expression of gp91(phox) subunit of NADPH-oxidase induced by tert-butyl hydroperoxide (t-BHP) in RAW 264.7 macrophage cells, and displayed promising preclinical protective effect against lipopolysaccharide (LPS)-induced acute lung injury in rats. In this work, the pharmacokinetic behaviors of AN-1 in Sprague-Dawley rats with single intravenous and intragastric doses were investigated for further development. Furthermore, apocynin's pharmacokinetics remain lacking, even though its pharmacological action has been extensively evaluated. The pharmacokinetics of parent apocynin were also comparatively characterized. A simple HPLC method was developed and validated to determine both AN-1 and apocynin in rat plasma. The chromatographic separation was achieved on an Agilent HC-C18 column (250 mmx4.6 mm, 5 mu m) at an isocratic flow rate of 1.0 mL/min, with the mobile phase of methanol and water (53:47, v/v) and the UV detection set at 279 nm. Good linearity was established over the concentration range of 0.1-500 mu g/mL for AN-1 and 0.2-100 mu g/mL for apocynin. The absolute recovery, precision and accuracy were satisfactory. Compared with the parent compound apocynin, AN-1 yielded a much longer T-1/2 (AN-1 179.8 min, apocynin 6.1 min) and higher AUC(0-t) (AN-1 61.89 mmol/L.min, apocynin 2.49 mmol/L.min) after equimolar intravenous dosing (0.302 mmol/kg). The absolute bioavailability of oral AN-1 was 78%, but that of apocynin was only 2.8%. The significant improvement of pharmacokinetic behavior might be accounted for the effective pharmacodynamic results we documented for the novel nitrone derivative AN-1.	[Wang, Kaiyu; Li, Linlin; Song, Yan; Ye, Xiaocui; Fu, Shaolian; Li, Sha] Jinan Univ, Coll Pharm, Dept Pharmaceut, Guangzhou, Guangdong, Peoples R China; [Jiang, Jie] Jinan Univ, Coll Pharm, Inst New Drug Res, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Jiang, J (corresponding author), Jinan Univ, Coll Pharm, Inst New Drug Res, Guangzhou, Guangdong, Peoples R China.	jiejiang2008@gmail.com; tlisha@jnu.edu.cn			Guangdong Provincial Department of Education [CXZD1012]; Guangzhou Science and Technology Program [Y 1-00017-10]; 211 Project of Jinan University	Guangdong Provincial Department of Education; Guangzhou Science and Technology Program; 211 Project of Jinan University(Jinan University)	This study was supported by grants from the Guangdong Provincial Department of Education Funds (2010, CXZD1012 to Jiang J), Guangzhou Science and Technology Program (2011, Y 1-00017-10 to Jiang J), and 211 Project of Jinan University to Li S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dodd-o JM, 2004, AM J PHYSIOL-HEART C, V287, pH927, DOI 10.1152/ajpheart.01138.2003; Dodd-O JM, 2000, AM J PHYSIOL-HEART C, V279, pH303, DOI 10.1152/ajpheart.2000.279.1.H303; Holland JA., 1999, US patent, Patent No. 5902831; Hougee S, 2006, EUR J PHARMACOL, V531, P264, DOI 10.1016/j.ejphar.2005.11.061; Hurst S, 2007, EXPERT OPIN DRUG MET, V3, P469, DOI 10.1517/17425225.3.4.469; Impellizzeri D, 2011, FREE RADICAL RES, V45, P221, DOI 10.3109/10715762.2010.526604; Lafeber FPJG, 1999, RHEUMATOLOGY, V38, P1088, DOI 10.1093/rheumatology/38.11.1088; Lees KR, 2001, STROKE, V32, P675, DOI 10.1161/01.STR.32.3.675; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Li S, 2011, EUR J DRUG METAB PH, V36, P95, DOI 10.1007/s13318-011-0032-2; Lo W, 2007, NEUROSCI LETT, V414, P228, DOI 10.1016/j.neulet.2006.12.055; Lu XY, 2011, EUR J MED CHEM, V46, P2691, DOI 10.1016/j.ejmech.2011.03.056; Peters EA, 2001, FREE RADICAL BIO MED, V31, P1442, DOI 10.1016/S0891-5849(01)00725-0; Stefanska J, 2012, EXP LUNG RES, V38, P90, DOI 10.3109/01902148.2011.649823; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; STOLK J, 1994, AM J RESP CRIT CARE, V150, P1628, DOI 10.1164/ajrccm.150.6.7952625; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Trudeau-Lame ME, 2003, DRUG METAB DISPOS, V31, P147, DOI 10.1124/dmd.31.2.147; Wan Sai-nan, 2011, Zhongguo Yaolixue Tongbao, V27, P243; Wang Q, 2008, PHYTOMEDICINE, V15, P496, DOI 10.1016/j.phymed.2007.09.019; WANG XZ, 1994, AM J RESP CRIT CARE, V150, P1449, DOI 10.1164/ajrccm.150.5.7952574; Ximenes VF, 2007, ARCH BIOCHEM BIOPHYS, V457, P134, DOI 10.1016/j.abb.2006.11.010; Zhou R, 2002, ACTA PHARMACOL SIN, V23, P1023	23	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70189	10.1371/journal.pone.0070189	http://dx.doi.org/10.1371/journal.pone.0070189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936162	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200063
J	Tran, ENH; Doyle, MT; Morona, R				Elizabeth Ngoc Hoa Tran; Doyle, Matthew Thomas; Morona, Renato			LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles	PLOS ONE			English	Article							ANTIGEN CHAIN-LENGTH; ESCHERICHIA-COLI K-12; ACTIN-BASED MOTILITY; O-ANTIGEN; UNIPOLAR LOCALIZATION; POLAR LOCALIZATION; LIPOPOLYSACCHARIDE; SURFACE; VIRULENCE; PROTEINS	The Shigella flexneri outer membrane (OM) protease IcsP (SopA) is a member of the enterobacterial Omptin family of proteases which cleaves the polarly localised OM protein IcsA that is essential for Shigella virulence. Unlike IcsA however, the specific localisation of IcsP on the cell surface is unknown. To determine the distribution of IcsP, a haemagglutinin (HA) epitope was inserted into the non-essential IcsP OM loop 5 using Splicing by Overlap Extension (SOE) PCR, and IcsP(HA) was characterised. Quantum Dot (QD) immunofluorescence (IF) surface labelling of IcsP(HA) was then undertaken. Quantitative fluorescence analysis of S. flexneri 2a 2457T treated with and without tunicaymcin to deplete lipopolysaccharide (LPS) O antigen (Oag) showed that IcsP(HA) was asymmetrically distributed on the surface of septating and non-septating cells, and that this distribution was masked by LPS Oag in untreated cells. Double QD IF labelling of IcsP(HA) and IcsA showed that IcsP(HA) preferentially localised to the new pole of non-septating cells and to the septum of septating cells. The localisation of IcsP(HA) in a rough LPS S. flexneri 2457T strain (with no Oag) was also investigated and a similar distribution of IcsP(HA) was observed. Complementation of the rough LPS strain with rmlD resulted in restored LPS Oag chain expression and loss of IcsP(HA) detection, providing further support for LPS Oag masking of surface proteins. Our data presents for the first time the distribution for the Omptin OM protease IcsP, relative to IcsA, and the effect of LPS Oag masking on its detection.	[Elizabeth Ngoc Hoa Tran; Doyle, Matthew Thomas; Morona, Renato] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Microbiol & Immunol, Adelaide, SA, Australia	University of Adelaide	Morona, R (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Discipline Microbiol & Immunol, Adelaide, SA, Australia.	renato.morona@adelaide.edu.au	Doyle, Matthew Thomas/K-2609-2015; Morona, Renato/B-7746-2013	Doyle, Matthew Thomas/0000-0002-1876-1209; Morona, Renato/0000-0001-7009-7440; Tran, Elizabeth Ngoc Hoa/0000-0003-1644-2287	National Health and Medical Research Council (NHMRC) of Australia [565526]; University of Adelaide	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide	This work is supported by a Program Grant (565526) from the National Health and Medical Research Council (NHMRC) of Australia. MTD is a recipient of a Master of Philosophy scholarship at the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; BROSIUS J, 1989, DNA-J MOLEC CELL BIO, V8, P759, DOI 10.1089/dna.1989.8.759; Chatterjee S, 2012, VIRUSES-BASEL, V4, P3162, DOI 10.3390/v4113162; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; dHauteville H, 1996, INFECT IMMUN, V64, P511, DOI 10.1128/IAI.64.2.511-517.1996; Dworkin J, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003368; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Egile C, 1997, MOL MICROBIOL, V23, P1063, DOI 10.1046/j.1365-2958.1997.2871652.x; FEHNIGER TE, 1986, INFECT IMMUN, V52, P586, DOI 10.1128/IAI.52.2.586-593.1986; FUKUDA I, 1995, J BACTERIOL, V177, P1719, DOI 10.1128/jb.177.7.1719-1726.1995; Ghosh AS, 2005, J BACTERIOL, V187, P1913, DOI 10.1128/JB.187.6.1913-1922.2005; Gibbs KA, 2004, MOL MICROBIOL, V53, P1771, DOI 10.1111/j.1365-2958.2004.04242.x; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jain S, 2006, J BACTERIOL, V188, P4841, DOI 10.1128/JB.00326-06; KAUFMANN A, 1994, J BACTERIOL, V176, P359, DOI 10.1128/JB.176.2.359-367.1994; LABREC EH, 1964, J BACTERIOL, V88, P1503, DOI 10.1128/JB.88.5.1503-1518.1964; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Lynne AM, 2007, J APPL MICROBIOL, V102, P660, DOI 10.1111/j.1365-2672.2006.03133.x; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Morona R, 2003, FEMS MICROBIOL LETT, V221, P173, DOI 10.1016/S0378-1097(03)00210-6; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Osborn M J, 1974, Methods Enzymol, V31, P642; Papadopoulos M, 2010, J BACTERIOL, V192, P3385, DOI 10.1128/JB.01134-09; Purins L, 2008, MICROBIOL-SGM, V154, P1104, DOI 10.1099/mic.0.2007/014225-0; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Robbins JR, 2001, MOL MICROBIOL, V41, P861, DOI 10.1046/j.1365-2958.2001.02552.x; ROSE RE, 1988, NUCLEIC ACIDS RES, V16, P355, DOI 10.1093/nar/16.1.355; SANDLIN RC, 1995, INFECT IMMUN, V63, P229, DOI 10.1128/IAI.63.1.229-237.1995; Shere KD, 1997, MOL MICROBIOL, V25, P451, DOI 10.1046/j.1365-2958.1997.4681827.x; Steinhauer J, 1999, MOL MICROBIOL, V32, P367, DOI 10.1046/j.1365-2958.1999.01356.x; Suzuki T, 2001, INFECT IMMUN, V69, P5959, DOI 10.1128/IAI.69.10.5959-5966.2001; TAMAKI S, 1980, J BACTERIOL, V141, P52, DOI 10.1128/JB.141.1.52-57.1980; Teh MY, 2012, MICROBIOL-SGM, V158, P2835, DOI 10.1099/mic.0.062471-0; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Ursell TS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002680; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; VANDERLEY P, 1986, J BACTERIOL, V168, P449, DOI 10.1128/jb.168.1.449-451.1986; VANDERLEY P, 1986, MICROB PATHOGENESIS, V1, P43, DOI 10.1016/0882-4010(86)90030-6; VOORHIS DL, 1991, MOL MICROBIOL, V5, P317, DOI 10.1111/j.1365-2958.1991.tb02112.x	47	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70508	10.1371/journal.pone.0070508	http://dx.doi.org/10.1371/journal.pone.0070508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936222	gold, Green Published			2022-12-27	WOS:000322433300106
J	Koskiniemi, S; Gibbons, HS; Sandegren, L; Anwar, N; Ouellette, G; Broomall, S; Karavis, M; McGregor, P; Liem, A; Fochler, E; McNew, L; Rosenzweig, CN; Rhen, M; Skowronski, EW; Andersson, DI				Koskiniemi, Sanna; Gibbons, Henry S.; Sandegren, Linus; Anwar, Naeem; Ouellette, Gary; Broomall, Stacey; Karavis, Mark; McGregor, Paul; Liem, Alvin; Fochler, Ed; McNew, Lauren; Rosenzweig, Carolyn Nicole; Rhen, Mikael; Skowronski, Evan W.; Andersson, Dan I.			Pathoadaptive Mutations in Salmonella enterica Isolated after Serial Passage in Mice	PLOS ONE			English	Article							VIRULENCE GENE-REGULATION; SENSOR PROTEIN PHOQ; H-NS; ESCHERICHIA-COLI; SIGMA-FACTOR; TYPHIMURIUM; EXPRESSION; GENOME; STPA; RPOS	How pathogenic bacteria adapt and evolve in the complex and variable environment of the host remains a largely unresolved question. Here we have used whole genome sequencing of Salmonella enterica serovar Typhimurium LT2 populations serially passaged in mice to identify mutations that adapt bacteria to systemic growth in mice. We found unique pathoadaptive mutations in two global regulators, phoQ and stpA, which increase the competitive indexes of the bacteria 3- to 5-fold. Also, all mouse-adapted lineages had changed the orientation of the hin invertable element, resulting in production of a FliC type of flagellum. Competition experiments in mice with locked flagellum mutants showed that strains expressing the FliC type of flagellum had a 5-fold increase in competitive index as compared to those expressing FljB type flagellum. Combination of the flagellum cassette inversion with the stpA mutation increased competitive indexes up to 20-fold. These experiments show that Salmonella can rapidly adapt to a mouse environment by acquiring a few mutations of moderate individual effect that when combined confer substantial increases in growth.	[Koskiniemi, Sanna; Sandegren, Linus; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Gibbons, Henry S.; Ouellette, Gary; Broomall, Stacey; Karavis, Mark; McGregor, Paul; McNew, Lauren; Rosenzweig, Carolyn Nicole; Skowronski, Evan W.] US Army Edgewood Chem Biol Ctr, Aberdeen, MD USA; [Anwar, Naeem; Rhen, Mikael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden; [Ouellette, Gary; McGregor, Paul] Sci Applicat Int Corp, Aberdeen, MD USA; [Liem, Alvin; Fochler, Ed] OptiMetrics Inc, Abingdon, MD USA	Uppsala University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Karolinska Institutet; Science Applications International Corporation (SAIC)	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Dan.Andersson@imbim.uu.se	Sandegren, Linus/K-4638-2013; Anwar, Naeem/A-6945-2011	Sandegren, Linus/0000-0001-7382-9782; Anwar, Naeem/0000-0001-8638-2158; Andersson, Dan/0000-0001-6640-2174; Gibbons, Henry/0000-0002-5603-8679	Swedish Research Council; Defense Threat Reduction Agency [CB2847]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	Work in this report was funded by the Swedish Research Council (to DIA) and by the Defense Threat Reduction Agency (to ES and HG) under project CB2847. Opinions presented are those of the authors and do not represent the official policy of the US Government or any of its agencies. This work has been cleared for public release. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARICO B, 1989, P NATL ACAD SCI USA, V86, P6671, DOI 10.1073/pnas.86.17.6671; Bertin P, 2001, BIOCHIMIE, V83, P235, DOI 10.1016/S0300-9084(01)01247-0; Bianconi I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001270; Bonifield HR, 2003, J BACTERIOL, V185, P3567, DOI 10.1128/JB.185.12.3567-3574.2003; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; CHEN CY, 1995, J BACTERIOL, V177, P5303, DOI 10.1128/jb.177.18.5303-5309.1995; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Clements M, 2001, ANN MED, V33, P178, DOI 10.3109/07853890109002075; Cusick ME, 1998, MOL MICROBIOL, V28, P847, DOI 10.1046/j.1365-2958.1998.00848.x; Darling Aaron E., 2007, V396, P135; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Ernst RK, 1999, J INFECT DIS, V179, pS326, DOI 10.1086/513850; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Freiflder D., 1994, MICROBIAL GENETICS; GILLEN KL, 1991, J BACTERIOL, V173, P2301, DOI 10.1128/JB.173.7.2301-2310.1991; Grob P, 1996, J BACTERIOL, V178, P1813, DOI 10.1128/jb.178.7.1813-1820.1996; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Haneda T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-324; Heithoff DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002647; Jacobson MA, 1927, J BACTERIOL, V13, P191, DOI 10.1128/JB.13.3.191-201.1927; Johansson J, 2001, J BACTERIOL, V183, P2343, DOI 10.1128/JB.183.7.2343-2347.2001; KRAUSE M, 1992, J BACTERIOL, V174, P4482, DOI 10.1128/JB.174.13.4482-4489.1992; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Lucchini S, 2009, MOL MICROBIOL, V74, P1169, DOI 10.1111/j.1365-2958.2009.06929.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MILLER JF, 1989, J BACTERIOL, V171, P6345, DOI 10.1128/jb.171.11.6345-6348.1989; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Muller CM, 2006, J BACTERIOL, V188, P5428, DOI 10.1128/JB.01956-05; Nash JHE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-667; NIGG C, 1956, J BACTERIOL, V71, P530, DOI 10.1128/JB.71.5.530-541.1956; Nilsson AI, 2004, GENETICS, V168, P1119, DOI 10.1534/genetics.104.030304; Plaut RD, 2012, INFECT IMMUN, V80, P3189, DOI 10.1128/IAI.00515-12; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; RobbeSaule V, 1997, MOL GEN GENET, V256, P333, DOI 10.1007/s004380050577; ROBINSBROWNE RM, 1989, J CLIN MICROBIOL, V27, P644, DOI 10.1128/JCM.27.4.644-650.1989; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Swords WE, 1997, INFECT IMMUN, V65, P2451, DOI 10.1128/IAI.65.6.2451-2453.1997; Tettelin H, 2009, GENOME DYNAM, V6, P35, DOI 10.1159/000235761; Troy EB, 2013, INFECT IMMUN, V81, P2347, DOI 10.1128/IAI.00266-13; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Vescovi EG, 1997, J BIOL CHEM, V272, P1440, DOI 10.1074/jbc.272.3.1440; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; WilmesRiesenberg MR, 1997, INFECT IMMUN, V65, P203, DOI 10.1128/IAI.65.1.203-210.1997; Zhang AX, 1996, EMBO J, V15, P1340, DOI 10.1002/j.1460-2075.1996.tb00476.x	50	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70147	10.1371/journal.pone.0070147	http://dx.doi.org/10.1371/journal.pone.0070147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936152	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300090
J	Walker, LC; McDonald, M; Wells, JE; Harris, GC; Robinson, BA; Morris, CM				Walker, Logan C.; McDonald, Margaret; Wells, J. Elisabeth; Harris, Gavin C.; Robinson, Bridget A.; Morris, Christine M.			Dual-Color Fluorescence In Situ Hybridization Reveals an Association of Chromosome 8q22 but Not 8p21 Imbalance with High Grade Invasive Breast Carcinoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER ALTERATIONS; CANCER CELL-LINES; MOLECULAR CYTOGENETIC ANALYSIS; ESTROGEN-RECEPTOR; ARRAY-CGH; HISTOLOGICAL GRADE; PROGNOSTIC-FACTORS; GENETIC PATHWAYS; EXPRESSION	We previously reported molecular karyotype analysis of invasive breast tumour core needle biopsies by comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) (Walker et al, Genes Chromosomes Cancer, 2008 May; 47(5):405-17). That study identified frequently recurring gains and losses involving chromosome bands 8q22 and 8p21, respectively. Moreover, these data highlighted an association between 8q22 gain and typically aggressive grade 3 tumors. Here we validate and extend our previous investigations through FISH analysis of tumor touch imprints prepared from excised breast tumor specimens. Compared to post-surgical tumor excisions, core needle biopsies are known to be histologically less precise when predicting tumor grade. Therefore investigating these chromosomal aberrations in tumor samples that offer more reliable pathological assessment is likely to give a better overall indication of association. A series of 60 breast tumors were screened for genomic copy number changes at 8q22 and 8p21 by dual-color FISH. Results confirm previous findings that 8p loss (39%) and 8q gain (74%) occur frequently in invasive breast cancer. Both absolute quantification of 8q22 gain across the sample cohort, and a separate relative assessment by 8q22: 8p21 copy number ratio, showed that the incidence of 8q22 gain significantly increased with grade (p = 0.004, absolute and p = 0.02, relative). In contrast, no association was found between 8p21 loss and tumor grade. These findings support the notion that 8q22 is a region of interest for invasive breast cancer pathogenesis, potentially harboring one or more genes that, when amplified, precipitate the molecular events that define high tumor grade.	[Walker, Logan C.; McDonald, Margaret; Morris, Christine M.] Univ Otago, Dept Pathol, Canc Genet Res Grp, Christchurch, New Zealand; [Walker, Logan C.; Robinson, Bridget A.] Univ Otago, Dept Pathol, Mackenzie Canc Res Grp, Christchurch, New Zealand; [Wells, J. Elisabeth] Univ Otago, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand; [Harris, Gavin C.] Canterbury Hlth Labs, Dept Anat Pathol, Christchurch, New Zealand	University of Otago; University of Otago; University of Otago; Canterbury Health Laboratories	Walker, LC (corresponding author), Univ Otago, Dept Pathol, Canc Genet Res Grp, Christchurch, New Zealand.	logan.walker@otago.ac.nz	robinson, bridget/K-7619-2019	Robinson, Bridget/0000-0001-9483-9146; Walker, Logan/0000-0003-0018-3719	New Zealand Breast Cancer Foundation; Lottery Health Research; Cancer Society of New Zealand	New Zealand Breast Cancer Foundation; Lottery Health Research; Cancer Society of New Zealand	The authors thank the New Zealand Breast Cancer Foundation, Lottery Health Research, and Cancer Society of New Zealand for funding that has enabled completion of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Allred DC, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2164; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Armes JE, 2004, ONCOGENE, V23, P5697, DOI 10.1038/sj.onc.1207740; Barnes DM, 1996, BRIT J CANCER, V74, P1445, DOI 10.1038/bjc.1996.563; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Buerger H, 1999, J PATHOL, V189, P521, DOI 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B; Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L; Buerger H, 2001, J PATHOL, V194, P165, DOI 10.1002/path.875; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Colombo PE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2890; Cooke SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-288; Cummings MC, 2011, PATHOLOGY, V43, P1, DOI 10.1097/PAT.0b013e328341e0b5; Curtis C., 2012, NATURE; Davidson JM, 2000, BRIT J CANCER, V83, P1309, DOI 10.1054/bjoc.2000.1458; Dean AG, OPENEPI OPEN SOURCE; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farabegoli F, 2004, MODERN PATHOL, V17, P449, DOI 10.1038/modpathol.3800059; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Geyer FC, 2009, PATHOLOGY, V41, P77, DOI 10.1080/00313020802563536; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hermsen MAJA, 1998, J PATHOL, V186, P356; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hislop RG, 2002, BRIT J SURG, V89, P1581, DOI 10.1046/j.1365-2168.2002.02270.x; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Hwang ES, 2004, CLIN CANCER RES, V10, P5160, DOI 10.1158/1078-0432.CCR-04-0165; Hwang KT, 2008, INT J CANCER, V123, P1807, DOI 10.1002/ijc.23672; Ioannidis P, 2003, INT J CANCER, V104, P54, DOI 10.1002/ijc.10794; ISOLA JJ, 1995, AM J PATHOL, V147, P905; Janssen EAM, 2003, J PATHOL, V201, P555, DOI 10.1002/path.1475; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KARLSEDER J, 1994, GENE CHROMOSOME CANC, V9, P42, DOI 10.1002/gcc.2870090108; Komaki Kansei, 2006, Breast Cancer, V13, P249, DOI 10.2325/jbcs.13.249; Korsching E, 2004, BRIT J CANCER, V90, P1422, DOI 10.1038/sj.bjc.6601658; Kytola S, 2000, GENE CHROMOSOME CANC, V28, P308, DOI 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B; Lee AHS, 2008, PATHOL ONCOL RES, V14, P113, DOI 10.1007/s12253-008-9067-3; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Loo LWM, 2008, GENE CHROMOSOME CANC, V47, P1049, DOI 10.1002/gcc.20610; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Loveday RL, 2000, INT J CANCER, V86, P494, DOI 10.1002/(SICI)1097-0215(20000515)86:4<494::AID-IJC8>3.3.CO;2-F; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Paradiso A, 2009, J CLIN PATHOL, V62, P279, DOI 10.1136/jcp.2008.061036; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Rakha EA, 2011, ADV ANAT PATHOL, V18, P255, DOI 10.1097/PAP.0b013e318220f5d1; Reis JS, 2005, PATHOL RES PRACT, V201, P713, DOI 10.1016/j.prp.2005.05.013; Rennstam K, 2003, CANCER RES, V63, P8861; Richard F, 2000, INT J CANCER, V89, P305; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Roylance R, 1999, CANCER RES, V59, P1433; Roylance R, 2006, ONCOGENE, V25, P6544, DOI 10.1038/sj.onc.1209659; Rummukainen J, 2001, CANCER GENET CYTOGEN, V126, P1, DOI 10.1016/S0165-4608(00)00387-3; Simpson PT, 2005, J PATHOL, V205, P248, DOI 10.1002/path.1691; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sloane JP, 1999, VIRCHOWS ARCH, V434, P3; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Staradub VL, 2002, ANN SURG ONCOL, V9, P982, DOI 10.1245/ASO.2002.03.056; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; van Beers EH, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1510; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Vos CBJ, 1999, BRIT J CANCER, V81, P1410, DOI 10.1038/sj.bjc.6693372; Walker LC, 2008, GENE CHROMOSOME CANC, V47, P405, DOI 10.1002/gcc.20545; Weber-Mangal S, 2003, INT J CANCER, V107, P583, DOI 10.1002/ijc.11460; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083	70	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70790	10.1371/journal.pone.0070790	http://dx.doi.org/10.1371/journal.pone.0070790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936250	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300116
J	Belousova, EA; Vasil'eva, IA; Moor, NA; Zatsepin, TS; Oretskaya, TS; Lavrik, OI				Belousova, Ekaterina A.; Vasil'eva, Inna A.; Moor, Nina A.; Zatsepin, Timofey S.; Oretskaya, Tatiana S.; Lavrik, Olga I.			Clustered DNA Lesions Containing 5-Formyluracil and AP Site: Repair via the BER System	PLOS ONE			English	Article							BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; POLYMERASE-BETA; ABASIC SITES; ESCHERICHIA-COLI; OXIDATIVE DAMAGE; IN-VITRO; THYMINE; LAMBDA; PROTEINS	Lesions in the DNA arise under ionizing irradiation conditions or various chemical oxidants as a single damage or as part of a multiply damaged site within 1-2 helical turns (clustered lesion). Here, we explored the repair opportunity of the apurinic/apyrimidinic site (AP site) composed of the clustered lesion with 5-formyluracil (5-foU) by the base excision repair (BER) proteins. We found, that if the AP site is shifted relative to the 5-foU of the opposite strand, it could be repaired primarily via the short-patch BER pathway. In this case, the cleavage efficiency of the AP site-containing DNA strand catalyzed by human apurinic/apyrimidinic endonuclease 1 (hAPE1) decreased under AP site excursion to the 3'-side relative to the lesion in the other DNA strand. DNA synthesis catalyzed by DNA polymerase lambda was more accurate in comparison to the one catalyzed by DNA polymerase beta. If the AP site was located exactly opposite 5-foU it was expected to switch the repair to the long-patch BER pathway. In this situation, human processivity factor hPCNA stimulates the process.	[Belousova, Ekaterina A.; Vasil'eva, Inna A.; Moor, Nina A.; Lavrik, Olga I.] Inst Chem Biol & Fundamental Med, Lab Bioorgan Chem Enzymes, Novosibirsk, Russia; [Zatsepin, Timofey S.; Oretskaya, Tatiana S.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Zatsepin, Timofey S.; Oretskaya, Tatiana S.] AN Belozersky Inst Physicochem Biol, Moscow, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Lomonosov Moscow State University; Lomonosov Moscow State University	Lavrik, OI (corresponding author), Inst Chem Biol & Fundamental Med, Lab Bioorgan Chem Enzymes, Novosibirsk, Russia.	lavrik@niboch.nsc.ru	Belousova, Ekaterina/AAI-2957-2021; Vasil'eva, Inna/G-8450-2013; Zatsepin, Timofei S/I-2821-2012; Oretskaya, Tatiana S/E-2556-2012; Belousova, Ekaterina/I-9376-2014; Moor, Nina A/G-7097-2013; Lavrik, Olga I/G-4641-2013	Belousova, Ekaterina/0000-0002-4361-3793; Vasil'eva, Inna/0000-0002-8613-8144; Zatsepin, Timofei S/0000-0003-0030-9174; Moor, Nina/0000-0002-2460-0217	Russian Foundation for Basic Research [12-04-00178-a, 11-04-00559-a, 13-04-00555]; program of the Russian Academy of Science "Molecular and Cellular Biology"	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); program of the Russian Academy of Science "Molecular and Cellular Biology"	This work was supported by a grant from the Russian Foundation for Basic Research (Nos. 12-04-00178-a, 11-04-00559-a, 13-04-00555), and the program of the Russian Academy of Science "Molecular and Cellular Biology." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706; Belousova EA, 2010, MOL BIOL+, V44, P839, DOI 10.1134/S0026893310060014; Belousova EA, 2010, BIOCHEMISTRY-US, V49, P4695, DOI 10.1021/bi901792c; Bjelland S, 2001, MUTAT RES-DNA REPAIR, V486, P147, DOI 10.1016/S0921-8777(01)00085-4; BJELLAND S, 1995, BIOCHEMISTRY-US, V34, P14758, DOI 10.1021/bi00045a017; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; DATE T, 1988, BIOCHEMISTRY-US, V27, P2983, DOI 10.1021/bi00408a048; de los Santos C, 2004, BIOCHEMISTRY-US, V43, P15349, DOI 10.1021/bi048400c; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Dohno C, 2005, J AM CHEM SOC, V127, P16681, DOI 10.1021/ja054618q; Eot-Houllier G, 2005, NUCLEIC ACIDS RES, V33, P260, DOI 10.1093/nar/gki165; Guerniou V, 2005, BIOCHIMIE, V87, P151, DOI 10.1016/j.biochi.2004.12.001; Irie D, 2006, NUCLEOS NUCLEOT NUCL, V25, P439, DOI 10.1080/01457630600684138; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kamiya H, 2002, MUTAT RES-GEN TOX EN, V513, P213, DOI 10.1016/S1383-5718(01)00312-6; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kino K, 2004, BIOCHEMISTRY-US, V43, P2682, DOI 10.1021/bi0361416; Knaevelsrud I, 2009, INT J RADIAT BIOL, V85, P413, DOI 10.1080/09553000902818915; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; LESKOVAC V, 2004, COMPREHENSIVE ENZYME, P31; Lin P, 2008, P NATL ACAD SCI USA, V105, P5670, DOI 10.1073/pnas.0801257105; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Mazin A, 1990, NOVOSIBIRSK SCI SBRA, P25; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; Paap B, 2008, NUCLEIC ACIDS RES, V36, P2717, DOI 10.1093/nar/gkn118; Sambrook J., 2002, MOL CLONING LAB MANU; Semenenko VA, 2004, RADIAT RES, V161, P451, DOI 10.1667/RR3140; Shimazaki N, 2005, GENES CELLS, V10, P705, DOI 10.1111/j.1365-2443.2005.00868.x; Sukhanova MV, 2005, NUCLEIC ACIDS RES, V33, P1222, DOI 10.1093/nar/gki266; Tsunoda M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/107289; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Volk DE, 2007, ORG BIOMOL CHEM, V5, P1554, DOI 10.1039/b702755a; Zatsepin TS, 2002, BIOCONJUGATE CHEM, V13, P822, DOI 10.1021/bc020016+; Zhang QM, 2001, J RADIAT RES, V42, P11, DOI 10.1269/jrr.42.11	37	18	21	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e68576	10.1371/journal.pone.0068576	http://dx.doi.org/10.1371/journal.pone.0068576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936307	Green Submitted, Green Published, gold			2022-12-27	WOS:000324401500004
J	Friedlander, T; Mayo, AE; Tlusty, T; Alon, U				Friedlander, Tamar; Mayo, Avraham E.; Tlusty, Tsvi; Alon, Uri			Mutation Rules and the Evolution of Sparseness and Modularity in Biological Systems	PLOS ONE			English	Article							GENE NETWORKS; MODEL; ENVIRONMENTS; PLASTICITY; EMERGENCE; SHAPES	Biological systems exhibit two structural features on many levels of organization: sparseness, in which only a small fraction of possible interactions between components actually occur; and modularity - the near decomposability of the system into modules with distinct functionality. Recent work suggests that modularity can evolve in a variety of circumstances, including goals that vary in time such that they share the same subgoals (modularly varying goals), or when connections are costly. Here, we studied the origin of modularity and sparseness focusing on the nature of the mutation process, rather than on connection cost or variations in the goal. We use simulations of evolution with different mutation rules. We found that commonly used sum-rule mutations, in which interactions are mutated by adding random numbers, do not lead to modularity or sparseness except for in special situations. In contrast, product-rule mutations in which interactions are mutated by multiplying by random numbers - a better model for the effects of biological mutations - led to sparseness naturally. When the goals of evolution are modular, in the sense that specific groups of inputs affect specific groups of outputs, product-rule mutations also lead to modular structure; sum-rule mutations do not. Product-rule mutations generate sparseness and modularity because they tend to reduce interactions, and to keep small interaction terms small.	[Friedlander, Tamar; Mayo, Avraham E.; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Tlusty, Tsvi] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Tlusty, Tsvi] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Weizmann Institute of Science; Weizmann Institute of Science; Institute for Advanced Study - USA	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	mayo, avi/N-3756-2019; Tlusty, Tsvi/A-9880-2008; Friedlander, Tamar/AAX-5700-2020	mayo, avi/0000-0002-4479-3423; Tlusty, Tsvi/0000-0002-9662-3725; Friedlander, Tamar/0000-0002-2121-7933	Israel Science Foundation; European Research Council under the European Union [249919]	Israel Science Foundation(Israel Science Foundation); European Research Council under the European Union(European Research Council (ERC))	The research leading to these results has received funding from the Israel Science Foundation (http://www.isf.org.il/english/) and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 249919 (http://erc.europa.eu/funding-and-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Alon U, 2007, MATH COMPUTATIONAL B, V10; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Azevedo RBR, 2002, GENETICS, V162, P755; Borenstein E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000202; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Burda Z, 2011, P NATL ACAD SCI USA, V108, P17263, DOI 10.1073/pnas.1109435108; Burda Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011908; Callahan B, 2009, P NATL ACAD SCI USA, V106, P19410, DOI 10.1073/pnas.0902364106; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; Cormen Thomas H., 2009, INTRO ALGORITHMS; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Espinosa-Soto C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000719; Fisher RA, 1930, GENETICAL THEORY NAT; Force A, 2005, GENETICS, V170, P433, DOI 10.1534/genetics.104.027607; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Good BH, 2012, P NATL ACAD SCI USA, V109, P4950, DOI 10.1073/pnas.1119910109; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Haykin S, 1999, P842; He JK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031907; Heo MY, 2011, P NATL ACAD SCI USA, V108, P4258, DOI 10.1073/pnas.1009392108; Herbert S., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kashtan N, 2007, P NATL ACAD SCI USA, V104, P13711, DOI 10.1073/pnas.0611630104; Kashtan N, 2009, EVOLUTION, V63, P1964, DOI 10.1111/j.1558-5646.2009.00684.x; Kashtan N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000355; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; Lampert A, 2009, J THEOR BIOL, V261, P414, DOI 10.1016/j.jtbi.2009.08.027; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Leroi AM, 2000, EVOL DEV, V2, P67, DOI 10.1046/j.1525-142x.2000.00044.x; Lipson H, 2002, EVOLUTION, V56, P1549, DOI 10.1111/j.0014-3820.2002.tb01466.x; Lipson Hod, 2007, Journal of Biological Physics and Chemistry, V7, P125, DOI 10.4024/40701.jbpc.07.04; Lorenz DM, 2011, PHYS LIFE REV, V8, P129, DOI 10.1016/j.plrev.2011.02.003; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Maslov S, 2007, P NATL ACAD SCI USA, V104, P13655, DOI 10.1073/pnas.0702905104; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pan RK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.045103; Parter M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000206; Rainey PB, 2004, RES MICROBIOL, V155, P370, DOI 10.1016/j.resmic.2004.01.011; REINITZ J, 1995, MECH DEVELOP, V49, P133, DOI 10.1016/0925-4773(94)00310-J; REINITZ J, 1995, J EXP ZOOL, V271, P47, DOI 10.1002/jez.1402710106; Rorick M, 2012, BIOSYSTEMS; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Sole RV, 2008, J R SOC INTERFACE, V5, P129, DOI 10.1098/rsif.2007.1108; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Spall J. C., 2003, INTRO STOCHASTIC SEA; Takemoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061348; Takemoto K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036107; Thompson A., 1996, Towards Evolvable Hardware. The Evolutionary Engineering Approach, P136; Thompson A, 1997, LECT NOTES COMPUT SC, V1259, P390; Variano EA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.188701; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; Wacholder S, 2011, J NATL CANCER I, V103, DOI [10.1093/jnci/djr144, 10.1093/jnci/djq510]; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106; Wunderlich Z, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.35; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Zhang JS, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.48; Zykov V, 2005, NATURE, V435, P163, DOI 10.1038/435163a	74	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70444	10.1371/journal.pone.0070444	http://dx.doi.org/10.1371/journal.pone.0070444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936433	Green Submitted, gold, Green Published			2022-12-27	WOS:000324401500036
J	Jilaveanu, LB; Zhao, FM; Zito, CR; Kirkwood, JM; Nathanson, KL; D'Andrea, K; Wilson, M; Rimm, DL; Flaherty, KT; Lee, SJ; Kluger, HM				Jilaveanu, Lucia B.; Zhao, Fengmin; Zito, Christopher R.; Kirkwood, John M.; Nathanson, Katherine L.; D'Andrea, Kurt; Wilson, Melissa; Rimm, David L.; Flaherty, Keith T.; Lee, Sandra J.; Kluger, Harriet M.			Expression of Drug Targets in Patients Treated with Sorafenib, Carboplatin and Paclitaxel	PLOS ONE			English	Article							RAF/MEK/ERK PATHWAY; METASTATIC MELANOMA; IMPROVED SURVIVAL; PHASE-III; APOPTOSIS; GROWTH; INHIBITOR; CELLS; TRIAL; ANGIOGENESIS	Introduction: Sorafenib, a multitarget kinase inhibitor, targets members of the mitogen-activated protein kinase (MAPK) pathway and VEGFR kinases. Here we assessed the association between expression of sorafenib targets and biomarkers of taxane sensitivity and response to therapy in pre-treatment tumors from patients enrolled in ECOG 2603, a phase III comparing sorafenib, carboplatin and paclitaxel (SCP) to carboplatin, paclitaxel and placebo (CP). Methods: Using a method of automated quantitative analysis (AQUA) of in situ protein expression, we quantified expression of VEGF-R2, VEGF-R1, VEGF-R3, FGF-R1, PDGF-Rb, c-Kit, B-Raf, C-Raf, MEK1, ERK1/2, STMN1, MAP2, EB1 and Bcl-2 in pretreatment specimens from 263 patients. Results: An association was found between high FGF-R1 and VEGF-R1 and increased progression-free survival (PFS) and overall survival (OS) in our combined cohort (SCP and CP arms). Expression of FGF-R1 and VEGF-R1 was higher in patients who responded to therapy ((CR+PR) vs. (SD+PD+ un-evaluable)). Conclusions: In light of the absence of treatment effect associated with sorafenib, the association found between FGF-R1 and VEGF-R1 expression and OS, PFS and response might reflect a predictive biomarker signature for carboplatin/paclitaxel-based therapy. Seeing that carboplatin and pacitaxel are now widely used for this disease, corroboration in another cohort might enable us to improve the therapeutic ratio of this regimen.	[Jilaveanu, Lucia B.; Zito, Christopher R.; Kluger, Harriet M.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Zhao, Fengmin; Lee, Sandra J.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Zito, Christopher R.] Univ St Joseph, Dept Biol, Sch Hlth & Nat Sci, Hartford, CT USA; [Kirkwood, John M.] Univ Pittsburgh, Pittsburgh Hillman Canc Ctr, Pittsburgh, PA USA; [Nathanson, Katherine L.; D'Andrea, Kurt; Wilson, Melissa; Flaherty, Keith T.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Dept Med, Ctr Canc, Boston, MA 02114 USA	Yale University; Harvard University; Dana-Farber Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; Yale University; Harvard University; Massachusetts General Hospital	Kluger, HM (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA.	Harriet.Kluger@yale.edu		Nathanson, Katherine/0000-0002-6740-0901; Wilson, Melissa/0000-0002-5391-7838; Rimm, David/0000-0001-5820-4397	National Institutes of Health [CA115756]; NATIONAL CANCER INSTITUTE [T32CA009615, P50CA121973, R01CA115756, U24CA114737, U10CA021115, K24CA172123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA115756 (to H. Kluger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Arkenau HT, 2011, BRIT J CANCER, V104, P392, DOI 10.1038/sj.bjc.6606030; Camp RL, 2003, CANCER RES, V63, P1445; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Coleman AB, 2000, MOL PHARMACOL, V57, P324; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Flaherty KT, 2008, CLIN CANCER RES, V14, P4836, DOI 10.1158/1078-0432.CCR-07-4123; Flaherty KT, 2013, J CLIN ONCOL, V31, P373, DOI 10.1200/JCO.2012.42.1529; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; FLAHERTY KT, 2010, J CLIN ONCOL S, V28, pS15; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hauschild A, 2009, J CLIN ONCOL, V27, P2823, DOI 10.1200/JCO.2007.15.7636; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jilaveanu L, 2009, CLIN CANCER RES, V15, P1076, DOI 10.1158/1078-0432.CCR-08-2280; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kluger HM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-6; Lang L, 2008, GASTROENTEROLOGY, V134, P379, DOI 10.1053/j.gastro.2007.12.038; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; McCarthy MM, 2006, CLIN CANCER RES, V12, P3856, DOI 10.1158/1078-0432.CCR-06-0190; Mehnert JM, 2010, HUM PATHOL, V41, P375, DOI 10.1016/j.humpath.2009.08.016; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; Niessner H, 2011, J INVEST DERMATOL, V131, P468, DOI 10.1038/jid.2010.297; Ott PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015588; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Scolyer RA, 2011, MOL ONCOL, V5, P124, DOI 10.1016/j.molonc.2011.03.002; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stein MN, 2007, CLIN CANCER RES, V13, P3765, DOI 10.1158/1078-0432.CCR-06-2844; Wang Q, 1998, EXP CELL RES, V238, P177, DOI 10.1006/excr.1997.3820; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yayon A, 1997, ONCOGENE, V14, P2999, DOI 10.1038/sj.onc.1201159; Zhang SL, 2011, ANTICANCER RES, V31, P3259	37	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69748	10.1371/journal.pone.0069748	http://dx.doi.org/10.1371/journal.pone.0069748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936348	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000324401500017
J	Sachdeva, R; Darbinian, N; Khalili, K; Amini, S; Gonzalez, D; Djeghader, A; Chabriere, E; Suh, A; Scott, K; Simm, M				Sachdeva, Rakhee; Darbinian, Nune; Khalili, Kamel; Amini, Shohreh; Gonzalez, Daniel; Djeghader, Ahmed; Chabriere, Eric; Suh, Andrew; Scott, Ken; Simm, Malgorzata			DING Proteins from Phylogenetically Different Species Share High Degrees of Sequence and Structure Homology and Block Transcription of HIV-1 LTR Promoter	PLOS ONE			English	Article							NF-KAPPA-B; ST-JOHNS-WORT; CELL-LINE; T-CELLS; ACTIVATION; EXPRESSION; INDUCTION; TARGET; SUPPRESSION; PHOSPHATASE	Independent research groups reported that DING protein homologues isolated from bacterial, plant and human cells demonstrate the anti-HIV-1 activity. This might indicate that diverse organisms utilize a DING-mediated broad-range protective innate immunity response to pathogen invasion, and that this mechanism is effective also against HIV-1. We performed structural analyses and evaluated the anti-HIV-1 activity for four DING protein homologues isolated from different species. Our data show that bacterial PfluDING, plant p38SJ (pDING), human phosphate binding protein (HPBP) and human extracellular DING from CD4 T cells (X-DING-CD4) share high degrees of structure and sequence homology. According to earlier reports on the anti-HIV-1 activity of pDING and X-DING-CD4, other members of this protein family from bacteria and humans were able to block transcription of HIV-1 and replication of virus in cell based assays. The efficacy studies for DING-mediated HIV-1 LTR and HIV-1 replication blocking activity showed that the LTR transcription inhibitory concentration 50 (IC50) values ranged from 0.052-0.449 ng/ml; and the HIV-1 replication IC50 values ranged from 0.075-0.311 ng/ml. Treatment of cells with DING protein alters the interaction between p65-NF-kappa B and HIV-1 LTR. Our data suggest that DING proteins may be part of an innate immunity defense against pathogen invasion; the conserved structure and activity makes them appealing candidates for development of a novel therapeutics targeting HIV-1 transcription.	[Sachdeva, Rakhee; Simm, Malgorzata] Columbia Univ, Div Mol Virol, St Lukes Roosevelt Inst Hlth Sci, New York, NY 10027 USA; [Darbinian, Nune; Khalili, Kamel; Amini, Shohreh] Temple Univ, Dept Neurosci, Sch Med, Philadelphia, PA 19122 USA; [Amini, Shohreh] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Gonzalez, Daniel; Djeghader, Ahmed; Chabriere, Eric] Univ Mediterranee, Fac Med, Marseille, France; [Suh, Andrew; Scott, Ken] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; UDICE-French Research Universities; Aix-Marseille Universite; University of Auckland	Simm, M (corresponding author), Columbia Univ, Div Mol Virol, St Lukes Roosevelt Inst Hlth Sci, New York, NY 10027 USA.	ms130@columbia.edu		Sachdeva, Rakhee/0000-0001-9624-5624	NIH [RO1NS062649, PO1NS43980, RO1MH074392, RO1MH086358, RO1MH092371]; ANRS [12264]; Auckland Medical Research Foundation; Pennsylvania Department of Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074392, R01MH086358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062649, P01NS043980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANRS(ANRSFrench National Research Agency (ANR)); Auckland Medical Research Foundation; Pennsylvania Department of Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds: RO1NS062649 (NIH) awarded to MS; 12264 (ANRS) awarded to EC; Research Grant (Auckland Medical Research Foundation) awarded to KS, Pennsylvania Department of Health Research Grant awarded to ND; PO1NS43980 and RO1MH074392 (NIH) awarded to SA; RO1MH086358 and RO1MH092371 (NIH) awarded to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adams L, 2002, BBA-MOL BASIS DIS, V1586, P254, DOI 10.1016/S0925-4439(01)00104-1; AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Ball G, 2012, RES MICROBIOL, V163, P457, DOI 10.1016/j.resmic.2012.07.007; Belenky M, 2003, J NUTR, V133, p2497S, DOI 10.1093/jn/133.7.2497S; Berna A, 2002, FEBS LETT, V524, P6, DOI 10.1016/S0014-5793(02)03053-3; Berna A, 2008, INT J BIOCHEM CELL B, V40, P170, DOI 10.1016/j.biocel.2007.02.004; Berna A, 2009, BIOESSAYS, V31, P570, DOI 10.1002/bies.200800174; Bush D, 1998, BIOL CHEM, V379, P225; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Cherrier T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-352; Darbinian N, 2008, ANTIVIR RES, V79, P136, DOI 10.1016/j.antiviral.2007.11.006; Darbinian N, 2011, J CELL BIOCHEM, V112, P225, DOI 10.1002/jcb.22915; Darbinian N, 2009, J CELL BIOCHEM, V107, P400, DOI 10.1002/jcb.22135; Darbinian-Sarkissian N, 2006, GENE THER, V13, P288, DOI 10.1038/sj.gt.3302649; Diemer H, 2008, PROTEINS, V71, P1708, DOI 10.1002/prot.21866; Djeghader A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033062; Elias M, 2012, NATURE; FRADE R, 1992, BIOCHEM BIOPH RES CO, V188, P833, DOI 10.1016/0006-291X(92)91132-A; Hain NAK, 1996, J IMMUNOL, V157, P1773; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hendriks ML, 2011, MOL REPROD DEV, V78, P292, DOI 10.1002/mrd.21305; Ivanova A, 2012, INNATE IMMUN-LONDON, V18, P571, DOI 10.1177/1753425911427065; Khan SA, 1997, GYNECOL ONCOL, V66, P501, DOI 10.1006/gyno.1997.4782; Kumar V, 2004, AM J PHYSIOL-RENAL, V287, pF373, DOI 10.1152/ajprenal.00418.2003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lesner A, 2005, J IMMUNOL, V175, P2548, DOI 10.4049/jimmunol.175.4.2548; Lesner A, 2009, BIOCHEM BIOPH RES CO, V389, P284, DOI 10.1016/j.bbrc.2009.08.140; Li GH, 2007, IMMUNOL CELL BIOL, V85, P603, DOI 10.1038/sj.icb.7100092; Li YC, 2008, IMMUNOL LETT, V117, P35, DOI 10.1016/j.imlet.2007.11.017; Liebschner D, 2009, J AM CHEM SOC, V131, P7879, DOI 10.1021/ja901900y; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; MAKINO K, 1988, J MOL BIOL, V203, P85, DOI 10.1016/0022-2836(88)90093-9; Morales R, 2006, STRUCTURE, V14, P601, DOI 10.1016/j.str.2005.12.012; Mukerjee R, 2008, MOL IMMUNOL, V45, P4028, DOI 10.1016/j.molimm.2008.06.001; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pantazaki AA, 2008, AMINO ACIDS, V34, P437, DOI 10.1007/s00726-007-0549-5; Patnaik Debasis, 2001, Indian Journal of Experimental Biology, V39, P191; Rochu D, 2007, BIOCHEM SOC T, V35, P1616, DOI 10.1042/BST0351616; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sachdeva R, 2013, INNATE IMMU IN PRESS; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Schrodinger L, 2012, PYMOL MOL GRAPHICS S; Scott K, 2005, BBA-MOL CELL RES, V1744, P234, DOI 10.1016/j.bbamcr.2005.02.003; Shilpi RY, 2012, INNATE IMMUN-LONDON, V18, P563, DOI 10.1177/1753425911426893; Simm M, 2002, VIROLOGY, V294, P1, DOI 10.1006/viro.2001.1300; Simm M, 2007, ARCH IMMUNOL THER EX, V55, P131, DOI 10.1007/s00005-007-0023-9; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; SWINGLER S, 1994, BIOCHEM BIOPH RES CO, V203, P623, DOI 10.1006/bbrc.1994.2228; Todorov PT, 2007, CANCER RES, V67, P11419, DOI 10.1158/0008-5472.CAN-07-2602; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	54	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69623	10.1371/journal.pone.0069623	http://dx.doi.org/10.1371/journal.pone.0069623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936341	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500014
J	Lunn, D; Goudie, RJB; Wei, C; Kaltz, O; Restif, O				Lunn, David; Goudie, Robert J. B.; Wei, Chen; Kaltz, Oliver; Restif, Olivier			Modelling the Dynamics of an Experimental Host-Pathogen Microcosm within a Hierarchical Bayesian Framework	PLOS ONE			English	Article							LIFE-HISTORY; TRANSMISSION; EVOLUTION; INFECTION; VIRULENCE; PARASITE; RESISTANCE; INFERENCE; GROWTH	The advantages of Bayesian statistical approaches, such as flexibility and the ability to acknowledge uncertainty in all parameters, have made them the prevailing method for analysing the spread of infectious diseases in human or animal populations. We introduce a Bayesian approach to experimental host-pathogen systems that shares these attractive features. Since uncertainty in all parameters is acknowledged, existing information can be accounted for through prior distributions, rather than through fixing some parameter values. The non-linear dynamics, multi-factorial design, multiple measurements of responses over time and sampling error that are typical features of experimental host-pathogen systems can also be naturally incorporated. We analyse the dynamics of the free-living protozoan Paramecium caudatum and its specialist bacterial parasite Holospora undulata. Our analysis provides strong evidence for a saturable infection function, and we were able to reproduce the two waves of infection apparent in the data by separating the initial inoculum from the parasites released after the first cycle of infection. In addition, the parameter estimates from the hierarchical model can be combined to infer variations in the parasite's basic reproductive ratio across experimental groups, enabling us to make predictions about the effect of resources and host genotype on the ability of the parasite to spread. Even though the high level of variability between replicates limited the resolution of the results, this Bayesian framework has strong potential to be used more widely in experimental ecology.	[Lunn, David; Goudie, Robert J. B.; Wei, Chen] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2BW, England; [Kaltz, Oliver] Univ Montpellier 2, Inst Sci Evolut, CNRS UMR 5554, F-34095 Montpellier, France; [Restif, Olivier] Univ Cambridge, Dis Dynam Unit, Dept Vet Med, Cambridge, England	MRC Biostatistics Unit; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Cambridge	Restif, O (corresponding author), Univ Cambridge, Dis Dynam Unit, Dept Vet Med, Cambridge, England.	or226@cam.ac.uk	, orestif/AAA-1532-2019	, orestif/0000-0001-9158-853X; Goudie, Robert/0000-0001-9554-1499	United Kingdom Medical Research Council [MRC:U105260557]; Centre National de la Recherche Scientique (France); Royal Society through a University Research Fellowship	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre National de la Recherche Scientique (France); Royal Society through a University Research Fellowship	DL, RJBG and CW are funded by the United Kingdom Medical Research Council [grant code MRC:U105260557], OK by the Centre National de la Recherche Scientique (France), and OR by the Royal Society through a University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Becker NG, 1999, J ROY STAT SOC B, V61, P287, DOI 10.1111/1467-9868.00177; Bize P, 2008, AM NAT, V171, P107, DOI 10.1086/523943; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown JKM, 2003, TRENDS GENET, V19, P667, DOI 10.1016/j.tig.2003.10.008; Civitello DJ, 2013, ECOL LETT, V16, P626, DOI 10.1111/ele.12089; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Dempster A.P., 1974, P C FDN QUEST STAT I, P335; Duncan AB, 2011, EVOLUTION, V65, P3462, DOI 10.1111/j.1558-5646.2011.01388.x; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Fels D, 2006, P ROY SOC B-BIOL SCI, V273, P1031, DOI 10.1098/rspb.2005.3404; Fokin SI, 1997, EUR J PROTISTOL, V33, P214, DOI 10.1016/S0932-4739(97)80039-9; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilligan CA, 1997, PHILOS T R SOC B, V352, P353, DOI 10.1098/rstb.1997.0026; Girolami M, 2008, THEOR COMPUT SCI, V408, P4, DOI 10.1016/j.tcs.2008.07.005; Huang YX, 2006, BIOMETRICS, V62, P413, DOI 10.1111/j.1541-0420.2005.00447.x; Kaltz O, 2003, EVOLUTION, V57, P1535, DOI 10.1111/j.0014-3820.2003.tb00361.x; Lunn D., 2012, BUGS BOOK PRACTICAL; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Magalon H, 2010, EVOLUTION, V64, P2126, DOI 10.1111/j.1558-5646.2010.00974.x; Mideo N, 2011, AM NAT, V178, P174, DOI 10.1086/662670; Miller MR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000946; Moustahfid H, 2010, OECOLOGIA, V163, P1059, DOI 10.1007/s00442-010-1596-2; Nidelet T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-65; O'Neill PD, 2002, MATH BIOSCI, V180, P103, DOI 10.1016/S0025-5564(02)00109-8; PARK T, 1948, ECOL MONOGR, V18, P265, DOI 10.2307/1948641; Pervez A, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.5; Regoes RR, 2003, EPIDEMIOL INFECT, V131, P957, DOI 10.1017/S0950268803008793; Restif O, 2006, OIKOS, V114, P148, DOI 10.1111/j.2006.0030-1299.14611.x; Ryder JJ, 2005, P NATL ACAD SCI USA, V102, P15140, DOI 10.1073/pnas.0505139102; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Yildiz FH, 2007, RES MICROBIOL, V158, P195, DOI 10.1016/j.resmic.2006.12.005	35	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69775	10.1371/journal.pone.0069775	http://dx.doi.org/10.1371/journal.pone.0069775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936351	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800024
J	Dultz, G; Seelhof, M; Herrmann, E; Welker, MW; Friedrich-Rust, M; Teuber, G; Kronenberger, B; von Wagner, M; Vermehren, J; Sarrazin, C; Zeuzem, S; Hofmann, WP				Dultz, Georg; Seelhof, Martin; Herrmann, Eva; Welker, Martin-Walter; Friedrich-Rust, Mireen; Teuber, Gerlinde; Kronenberger, Bernd; von Wagner, Michael; Vermehren, Johannes; Sarrazin, Christoph; Zeuzem, Stefan; Hofmann, Wolf Peter			Baseline MELD Score Predicts Hepatic Decompensation during Antiviral Therapy in Patients with Chronic Hepatitis C and Advanced Cirrhosis	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; PLUS RIBAVIRIN; HEPATOCELLULAR-CARCINOMA; PEGINTERFERON ALPHA-2B; LIVER-TRANSPLANTATION; PROTEASE INHIBITOR; PREVENT RECURRENCE; VIRUS; INFECTION; RISK	Background & Aims:In patients with advanced liver cirrhosis due to chronic hepatitis C virus (HCV) infection antiviral therapy with peginterferon and ribavirin is feasible in selected cases only due to potentially life-threatening side effects. However, predictive factors associated with hepatic decompensation during antiviral therapy are poorly defined. Methods: In a retrospective cohort study, 68 patients with HCV-associated liver cirrhosis (mean MELD score 9.18 +/- 2.72) were treated with peginterferon and ribavirin. Clinical events indicating hepatic decompensation (onset of ascites, hepatic encephalopathy, upper gastrointestinal bleeding, hospitalization) as well as laboratory data were recorded at baseline and during a follow up period of 72 weeks after initiation of antiviral therapy. To monitor long term sequelae of end stage liver disease an extended follow up for HCC development, transplantation and death was applied (240weeks, 6SD 136weeks). Results: Eighteen patients (26.5%) achieved a sustained virologic response. During the observational period a hepatic decompensation was observed in 36.8%. Patients with hepatic decompensation had higher MELD scores (10.84 vs. 8.23, p, 0.001) and higher mean bilirubin levels (26.74 vs. 14.63 mmol/l, p, 0.001), as well as lower serum albumin levels (38.2 vs. 41.1 g/l, p = 0.015), mean platelets (102.64 vs. 138.95/nl, p = 0.014) and mean leukocytes (4.02 vs. 5.68/nl, p = 0.002) at baseline as compared to those without decompensation. In the multivariate analysis the MELD score remained independently associated with hepatic decompensation (OR 1.56, 1.18-2.07; p = 0.002). When the patients were grouped according to their baseline MELD scores, hepatic decompensation occurred in 22%, 59%, and 83% of patients with MELD scores of 6-9, 10-13, and.14, respectively. Baseline MELD score was significantly associated with the risk for transplantation/death (p < 0.001). Conclusions: Our data suggest that the baseline MELD score predicts the risk of hepatic decompensation during antiviral therapy and thus contributes to decision making when antiviral therapy is discussed in HCV patients with advanced liver cirrhosis.	[Dultz, Georg; Seelhof, Martin; Welker, Martin-Walter; Friedrich-Rust, Mireen; Kronenberger, Bernd; von Wagner, Michael; Vermehren, Johannes; Sarrazin, Christoph; Zeuzem, Stefan] Klinikum Goethe Univ, Med Klin 1, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ Frankfurt, Inst Biostat & Math Modellierung, D-60054 Frankfurt, Germany; [Teuber, Gerlinde] Interdisziplinares Facharztzentrum Sachsenhause, Frankfurt, Germany; [Hofmann, Wolf Peter] POLIKUM Gesundheitszentren Berlin, Berlin, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Hofmann, WP (corresponding author), POLIKUM Gesundheitszentren Berlin, Berlin, Germany.	hofmann@med.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Dultz, Georg/AAE-2986-2019	Dultz, Georg/0000-0003-0775-0907				Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Carrion JA, 2009, J HEPATOL, V50, P719, DOI 10.1016/j.jhep.2008.11.015; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Crippin JS, 2002, LIVER TRANSPLANT, V8, P350, DOI 10.1053/jlts.2002.31748; Everson Gregory T, 2005, Clin Liver Dis, V9, P473, DOI 10.1016/j.cld.2005.05.011; Everson GT, 2013, HEPATOLOGY, V57, P1752, DOI 10.1002/hep.25976; Everson GT, 2005, HEPATOLOGY, V42, P255, DOI 10.1002/hep.20793; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fernandez-Rodriguez CM, 2010, AM J GASTROENTEROL, V105, P2164, DOI 10.1038/ajg.2010.294; Forns X, 2003, J HEPATOL, V39, P389, DOI 10.1016/S0168-8278(03)00310-6; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hezode C, 2013, J HEPATOL, DOI [10.1016/j.jhep.2013.04.035, DOI 10.1016/J.JHEP.2013.04.035.[]; Hofmann WP, 2012, NAT REV GASTRO HEPAT, V9, P67, DOI 10.1038/nrgastro.2011.249; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Iacobellis A, 2007, J HEPATOL, V46, P206, DOI 10.1016/j.jhep.2006.08.020; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Northup PG, 2005, ANN SURG, V242, P244, DOI 10.1097/01.sla.0000171327.29262.e0; Peveling-Oberhag J, 2010, MED MICROBIOL IMMUN, V199, P1, DOI 10.1007/s00430-009-0131-8; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Roomer R, 2010, HEPATOLOGY, V52, P1225, DOI 10.1002/hep.23842; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Teh SH, 2005, J GASTROINTEST SURG, V9, P1207, DOI 10.1016/j.gassur.2005.09.008; Thomas RM, 2003, LIVER TRANSPLANT, V9, P905, DOI 10.1053/jlts.2003.50166; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Zeuzem S, 2011, GASTROENTEROLOGY, V141, P2047, DOI 10.1053/j.gastro.2011.08.051; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	38	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71262	10.1371/journal.pone.0071262	http://dx.doi.org/10.1371/journal.pone.0071262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936497	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400100
J	Makhloufi, KM; Carre-Mlouka, A; Peduzzi, J; Lombard, C; van Reenen, CA; Dicks, LMT; Rebuffat, S				Makhloufi, Kahina Maya; Carre-Mlouka, Alyssa; Peduzzi, Jean; Lombard, Carine; van Reenen, Carol Ann; Dicks, Leon Milner Theodore; Rebuffat, Sylvie			Characterization of Leucocin B-KM432Bz from Leuconostoc pseudomesenteroides Isolated from Boza, and Comparison of its Efficiency to Pediocin PA-1	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; TRADITIONAL CEREAL BEVERAGE; LISTERIA-MONOCYTOGENES; MESENTERICIN Y105; IIA BACTERIOCINS; GENE; SENSITIVITY; PEPTIDE	A bacteriocin-producing bacterium was isolated from boza and identified as Leuconostoc pseudomesenteroides KM432Bz. The antimicrobial peptide was purified and shown to be identical to other class IIa bacteriocins: leucocin A from Leuconostoc gelidum UAL-187 and Leuconostoc pseudomesenteroides QU15 and leucocin B from Leuconostoc carnosum Ta11a. The bacteriocin was named leucocin B-KM432Bz. Leucocin B-KM432Bz gene cluster encodes the bacteriocin precursor (lcnB), the immunity protein (lcnI) and the dedicated export machinery (lcnD and lcnE). A gene of unknown and non-essential function (lcnC), which is interrupted by an insertion sequence of the IS30 family, is localized between lcnB and lcnD. The activity of leucocin B-KM432Bz requires subunit C of the EIIMant mannose permease, which is the receptor for entry into target cells. The determination of the minimum inhibitory concentrations revealed the lowest values for leucocin B-KM432Bz over Listeria strains, with 4 to 32 fold better efficiency than pediocin PA-1.	[Makhloufi, Kahina Maya; Carre-Mlouka, Alyssa; Peduzzi, Jean; Lombard, Carine; Rebuffat, Sylvie] Museum Natl Hist Nat, CNRS, Commun Mol & Adaptat Microorganisms MCAM, UMR 7245, Paris, France; [van Reenen, Carol Ann; Dicks, Leon Milner Theodore] Univ Stellenbosch, Dept Microbiol, ZA-7600 Stellenbosch, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Stellenbosch University	Peduzzi, J (corresponding author), Museum Natl Hist Nat, CNRS, Commun Mol & Adaptat Microorganisms MCAM, UMR 7245, Paris, France.	peduzzi@mnhn.fr	Rebuffat, Sylvie/AAO-2072-2020; Rebuffat, Sylvie/AAE-4194-2021; Dicks, Leon/X-6642-2019	Dicks, Leon/0000-0002-5157-9046; Carre-Mlouka, Alyssa/0000-0002-6141-8115; Rebuffat, Sylvie/0000-0002-5257-5039	CNRS (Centre National de la Recherche Scientifique, National Center for Scientific Research); MNHN (Museum National d'Histoire Naturelle, National Museum of Natural History)	CNRS (Centre National de la Recherche Scientifique, National Center for Scientific Research)(Centre National de la Recherche Scientifique (CNRS)); MNHN (Museum National d'Histoire Naturelle, National Museum of Natural History)	The funding was provided by CNRS (Centre National de la Recherche Scientifique, National Center for Scientific Research) and MNHN (Museum National d'Histoire Naturelle, National Museum of Natural History). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucher W, 2004, FEMS MICROBIOL LETT, V232, P15, DOI 10.1016/S0378-1097(04)00011-4; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; BULET P, 1992, EUR J BIOCHEM, V209, P977, DOI 10.1111/j.1432-1033.1992.tb17371.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Dalet K, 2001, MICROBIOL-SGM, V147, P3263, DOI 10.1099/00221287-147-12-3263; Deegan LH, 2006, INT DAIRY J, V16, P1058, DOI 10.1016/j.idairyj.2005.10.026; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drider D, 2006, MICROBIOL MOL BIOL R, V70, P564, DOI 10.1128/MMBR.00016-05; Eijsink VGH, 1998, APPL ENVIRON MICROB, V64, P3275; FARROW JAE, 1989, INT J SYST BACTERIOL, V39, P279, DOI 10.1099/00207713-39-3-279; FELIX JV, 1994, CURR MICROBIOL, V29, P207, DOI 10.1007/BF01570155; Fimland G, 2000, J BACTERIOL, V182, P2643, DOI 10.1128/JB.182.9.2643-2648.2000; FREMAUX C, 1995, MICROBIOL-SGM, V141, P1637, DOI 10.1099/13500872-141-7-1637; Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001; Hancioglu O, 1997, INT J FOOD MICROBIOL, V35, P271, DOI 10.1016/S0168-1605(96)01230-5; HASTINGS JW, 1991, J BACTERIOL, V173, P7491, DOI 10.1128/jb.173.23.7491-7500.1991; Ivanova I., 2000, BIOCATALYSIS, V41, P47; Kabadjova P, 2000, BIOTECHNOL BIOTEC EQ, V14, P56, DOI 10.1080/13102818.2000.10819063; Kabak B, 2011, CRIT REV FOOD SCI, V51, P248, DOI 10.1080/10408390903569640; Kaur K, 2004, BIOCHEMISTRY-US, V43, P9009, DOI 10.1021/bi036018e; Kjos M, 2010, J BACTERIOL, V192, P5906, DOI 10.1128/JB.00777-10; KLAENHAMMER TR, 1988, BIOCHIMIE, V70, P337, DOI 10.1016/0300-9084(88)90206-4; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Nishie M, 2012, BIOCONTROL SCI, V17, P1; Nissen-Meyer J, 2009, CURR PHARM BIOTECHNO, V10, P19, DOI 10.2174/138920109787048661; Rheims H, 1996, MICROBIOL-SGM, V142, P2863, DOI 10.1099/13500872-142-10-2863; Robichon D, 1997, J BACTERIOL, V179, P7591, DOI 10.1128/jb.179.23.7591-7594.1997; Rodriguez JM, 2002, CRIT REV FOOD SCI, V42, P91, DOI 10.1080/10408690290825475; Sahingil D, 2011, TURK J BIOL, V35, P21, DOI 10.3906/biy-0906-48; Sawa N, 2010, J APPL MICROBIOL, V109, P282, DOI 10.1111/j.1365-2672.2009.04653.x; Settanni L, 2008, INT J FOOD MICROBIOL, V121, P123, DOI 10.1016/j.ijfoodmicro.2007.09.001; Soomro A. H., 2002, Pakistan Journal of Nutrition, V1, P20; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todorov SD, 2008, J APPL MICROBIOL, V104, P465, DOI 10.1111/j.1365-2672.2007.03558.x; Todorov SD, 2006, PROCESS BIOCHEM, V41, P11, DOI 10.1016/j.procbio.2005.01.026; Todorov SD, 2005, PROCESS BIOCHEM, V40, P365, DOI 10.1016/j.procbio.2004.01.011; Todorov SD, 2004, J IND MICROBIOL BIOT, V31, P323, DOI 10.1007/s10295-004-0153-6; VANBELKUM MJ, 1995, APPL ENVIRON MICROB, V61, P3573, DOI 10.1128/AEM.61.10.3573-3579.1995; von Mollendorff JW, 2006, CURR MICROBIOL, V53, P209, DOI 10.1007/s00284-006-0075-9; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	41	20	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70484	10.1371/journal.pone.0070484	http://dx.doi.org/10.1371/journal.pone.0070484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936441	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400070
J	Su, J; Zhao, PJ; Kong, LM; Li, XY; Yan, JM; Zeng, Y; Li, Y				Su, Jia; Zhao, Peiji; Kong, Lingmei; Li, Xingyao; Yan, Juming; Zeng, Ying; Li, Yan			Trichothecin Induces Cell Death in NF-kappa B Constitutively Activated Human Cancer Cells via Inhibition of IKK beta Phosphorylation	PLOS ONE			English	Article							COLITIS-ASSOCIATED CANCER; MULTIPLE-MYELOMA CELLS; P65 PHOSPHORYLATION; ENDOPHYTIC FUNGUS; KINASE-ACTIVITY; TUMOR-GROWTH; IN-VITRO; PATHWAY; APOPTOSIS; INFLAMMATION	Constitutive activation of the transcription factor nuclear factor-kappa B (NF-kappa B) is involved in tumorigenesis and chemoresistance. As the key regulator of NF-kappa B, IKK beta is a major therapeutic target for various cancers. Trichothecin (TCN) is a metabolite isolated from an endophytic fungus of the herbal plant Maytenus hookeri Loes. In this study, we evaluated the anti-tumor activity of TCN and found that TCN markedly inhibits the growth of cancer cells with constitutively activated NF kappa B. TCN induces G0/G1 cell cycle arrest and apoptosis in cancer cells, activating pro-apoptotic proteins, including caspase-3, -8 and PARP-1, and decreasing the expression of anti-apoptotic proteins Bcl-2, Bcl-xL, and survivin. Reporter activity assay and target genes expression analysis illustrated that TCN works as a potent inhibitor of the NF-kappa B signaling pathway. TCN inhibits the phosphorylation and degradation of IkB alpha and blocks the nuclear translocation of p65, and thus inhibits the expression of NF-kappa B target genes XIAP, cyclin D1, and Bcl-xL. Though TCN does not directly interfere with IKK beta kinase, it suppresses the phosphorylation of IKK beta. Overexpression of constitutively activated IKK beta aborted TCN induced cancer cell apoptosis, whereas knockdown of endogenous IKK beta with siRNA sensitized cancer cells toward apoptosis induced by TCN. Moreover, TCN showed a markedly weaker effect on normal cells. These findings suggest that TCN may be a potential therapeutic candidate for cancer treatment, targeting NF-kappa B signaling.	[Su, Jia; Zhao, Peiji; Kong, Lingmei; Li, Xingyao; Yan, Juming; Zeng, Ying; Li, Yan] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Peoples R China; [Su, Jia; Kong, Lingmei; Li, Xingyao; Yan, Juming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, Y (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Peoples R China.	liyanb@mail.kib.ac.cn		Yan, Juming/0000-0003-0857-8870	Chinese Academy of Sciences; Major State Basic Research Development Program of China [2009CB522300]; Natural Science Foundation of China [81173076]; Recruited Top Talent of Sciences and Technology of Yunnan Province [2009CI120]	Chinese Academy of Sciences(Chinese Academy of Sciences); Major State Basic Research Development Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Recruited Top Talent of Sciences and Technology of Yunnan Province	This work was supported by the 100 Talents Program of the Chinese Academy of Sciences (Y. Li), the Major State Basic Research Development Program of China (No. 2009CB522300), the Natural Science Foundation of China (No. 81173076), and the Recruited Top Talent of Sciences and Technology of Yunnan Province (2009CI120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bernal-Mizrachi L, 2006, P NATL ACAD SCI USA, V103, P9220, DOI 10.1073/pnas.0507809103; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Boyraz B, 2013, CURR MED RES OPIN; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Chawla-Sarkar M, 2003, J BIOL CHEM, V278, P39461, DOI 10.1074/jbc.M306111200; Dai Y, 2004, BLOOD, V103, P2761, DOI 10.1182/blood-2003-09-3037; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Du RH, 2012, TOXICON, V59, P143, DOI 10.1016/j.toxicon.2011.11.003; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Han SS, 2005, J CELL BIOCHEM, V94, P695, DOI 10.1002/jcb.20337; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu J, 2005, MOL CARCINOGEN, V44, P274, DOI 10.1002/mc.20142; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kharwar RN, 2011, NAT PROD REP, V28, P1208, DOI 10.1039/c1np00008j; Konishi K, 2003, BIOORGAN MED CHEM, V11, P2511, DOI 10.1016/S0968-0896(03)00215-3; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P1354, DOI 10.1021/ja00759a054; Leung CH, 2006, MOL PHARMACOL, V70, P1946, DOI 10.1124/mol.106.028480; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mandrekar P, 2007, J IMMUNOL, V178, P7686, DOI 10.4049/jimmunol.178.12.7686; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mijatovic T, 2006, MOL CANCER THER, V5, P391, DOI 10.1158/1535-7163.MCT-05-0367; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Monks NR, 2006, J CELL BIOCHEM, V98, P221, DOI 10.1002/jcb.20789; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Park B, 2011, BIOCHEM PHARMACOL, V82, P1134, DOI 10.1016/j.bcp.2011.07.062; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; REMILLARD S, 1975, SCIENCE, V189, P1002, DOI 10.1126/science.1241159; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Twombly R, 2003, J NATL CANCER I, V95, P845, DOI 10.1093/jnci/95.12.845; Verma VC, 2009, NAT PROD COMMUN, V4, P1511; Wang W, 2011, CELL RES, V21, P730, DOI 10.1038/cr.2011.30; Wu JM, 2009, CANCER LETT, V278, P145, DOI 10.1016/j.canlet.2008.12.031; Xiao GT, 2011, AM J CANCER RES, V1, P192; Zhang XM, 2010, J MICROBIOL, V48, P784, DOI 10.1007/s12275-010-0173-z	46	14	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71333	10.1371/journal.pone.0071333	http://dx.doi.org/10.1371/journal.pone.0071333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936501	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400104
J	Olivieri, A; Pala, M; Gandini, F; Kashani, BH; Perego, UA; Woodward, SR; Grugni, V; Battaglia, V; Semino, O; Achilli, A; Richards, MB; Torroni, A				Olivieri, Anna; Pala, Maria; Gandini, Francesca; Kashani, Baharak Hooshiar; Perego, Ugo A.; Woodward, Scott R.; Grugni, Viola; Battaglia, Vincenza; Semino, Ornella; Achilli, Alessandro; Richards, Martin B.; Torroni, Antonio			Mitogenomes from Two Uncommon Haplogroups Mark Late Glacial/Postglacial Expansions from the Near East and Neolithic Dispersals within Europe	PLOS ONE			English	Article							BAYESIAN COALESCENT INFERENCE; MITOCHONDRIAL-DNA; MODERN HUMANS; ANCIENT DNA; POPULATION EXPANSION; HUNTER-GATHERERS; HUMAN PREHISTORY; GENETIC LEGACY; SOUTHERN ROUTE; MTDNA ANALYSIS	The current human mitochondrial (mtDNA) phylogeny does not equally represent all human populations but is biased in favour of representatives originally from north and central Europe. This especially affects the phylogeny of some uncommon West Eurasian haplogroups, including I and W, whose southern European and Near Eastern components are very poorly represented, suggesting that extensive hidden phylogenetic substructure remains to be uncovered. This study expanded and re-analysed the available datasets of I and W complete mtDNA genomes, reaching a comprehensive 419 mitogenomes, and searched for precise correlations between the ages and geographical distributions of their numerous newly identified subclades with events of human dispersal which contributed to the genetic formation of modern Europeans. Our results showed that haplogroups I (within N1a1b) and W originated in the Near East during the Last Glacial Maximum or pre-warming period (the period of gradual warming between the end of the LGM, similar to 19 ky ago, and the beginning of the first main warming phase similar to 15 ky ago) and, like the much more common haplogroups J and T, may have been involved in Late Glacial expansions starting from the Near East. Thus our data contribute to a better definition of the Late and postglacial re-peopling of Europe, providing further evidence for the scenario that major population expansions started after the Last Glacial Maximum but before Neolithic times, but also evidencing traces of diffusion events in several I and W subclades dating to the European Neolithic and restricted to Europe.	[Olivieri, Anna; Pala, Maria; Gandini, Francesca; Kashani, Baharak Hooshiar; Perego, Ugo A.; Grugni, Viola; Battaglia, Vincenza; Semino, Ornella; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Pala, Maria; Richards, Martin B.] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Perego, Ugo A.; Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Woodward, Scott R.] AncestryDNA, Provo, UT USA; [Achilli, Alessandro] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy	University of Pavia; University of Huddersfield; University of Perugia	Olivieri, A (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	anna.olivieri@unipv.it; antonio.torroni@unipv.it	Battaglia, Vincenza/F-6950-2017; Gandini, Francesca/H-8936-2015; Achilli, Alessandro/I-9236-2012; Perego, Ugo/AAG-9327-2019; Torroni, Antonio/E-1557-2011; OLIVIERI, ANNA/I-9235-2012	Gandini, Francesca/0000-0001-8930-8295; Achilli, Alessandro/0000-0001-6871-3451; Torroni, Antonio/0000-0002-4163-4478; OLIVIERI, ANNA/0000-0002-3941-8098; RICHARDS, MARTIN/0000-0003-3118-0967; Pala, Maria/0000-0001-9202-8331; SEMINO, Ornella/0000-0002-9675-9403	Leverhulme Trust [10 105/D]; Sorenson Molecular Genealogy Foundation; Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca [RBFR08U07M, RBFR126B8I]; Progetti Ricerca Interesse Nazionale	Leverhulme Trust(Leverhulme Trust); Sorenson Molecular Genealogy Foundation; Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)); Progetti Ricerca Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research received support from the Leverhulme Trust (research project grant 10 105/D)(to MBR), the Sorenson Molecular Genealogy Foundation (to UAP and SRW) and the Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca 2008 (RBFR08U07M) and 2012 (RBFR126B8I) (to AA and AO) and Progetti Ricerca Interesse Nazionale 2009 and 2012 (to AA, AT and OS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Adler CJ, 2012, THESIS U ADELAIDE; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Ammerman Albert J, 2006, Science, V312, P1875; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arenas M, 2013, MOL BIOL EVOL, V30, P57, DOI 10.1093/molbev/mss203; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Barbujani G, 2006, HEREDITY, V97, P84, DOI 10.1038/sj.hdy.6800852; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Behar DM, 2004, EUR J HUM GENET, V12, P355, DOI 10.1038/sj.ejhg.5201156; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bocquet-Appel JP, 2011, SCIENCE, V333, P560, DOI 10.1126/science.1208880; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Burger J, 2006, SCIENCE, V312, DOI 10.1126/science.1123984; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Deguilloux MF, 2012, EVOL ANTHROPOL, V21, P24, DOI 10.1002/evan.20341; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Hervella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034417; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Jobling MA, 2012, PHILOS T R SOC B, V367, P793, DOI 10.1098/rstb.2011.0297; Lalueza-Fox C, 2004, P ROY SOC B-BIOL SCI, V271, P941, DOI 10.1098/rspb.2004.2698; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lee EJ, 2012, AM J PHYS ANTHROPOL, V148, P571, DOI 10.1002/ajpa.22074; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Marjanovic D, 2005, ANN HUM GENET, V69, P757, DOI 10.1111/j.1529-8817.2005.00190.x; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2011, NATURE, V479, P483, DOI 10.1038/479483a; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2011, ANNU REV GENOM HUM G, V12, P245, DOI 10.1146/annurev-genom-090810-183123; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Pinhasi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006747; Richards M, 2000, Am J Hum Genet, V67, P1251; Richards M, 1996, AM J HUM GENET, V59, P185; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rose JI, 2010, CURR ANTHROPOL, V51, P849, DOI 10.1086/657397; Rowley-Conwy P, 2009, CURR BIOL, V19, pR948, DOI 10.1016/j.cub.2009.09.054; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares Pedro, 2011, Am J Hum Genet, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zheng HX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00745	74	35	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70492	10.1371/journal.pone.0070492	http://dx.doi.org/10.1371/journal.pone.0070492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936216	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000322633700076
J	Huang, ZH; Rivas, B; Agoulnik, AI				Huang, Zaohua; Rivas, Bryan; Agoulnik, Alexander I.			NOTCH1 Gain of Function in Germ Cells Causes Failure of Spermatogenesis in Male Mice	PLOS ONE			English	Article							CONSTITUTIVELY ACTIVE NOTCH1; MOUSE SPERMATOGENESIS; UNDIFFERENTIATED SPERMATOGONIA; SIGNALING SYSTEM; TRANSGENIC MICE; SERTOLI-CELLS; O-FUCOSE; EXPRESSION; PATHWAY; DIFFERENTIATION	NOTCH1 is a member of the NOTCH receptor family, a group of single-pass trans-membrane receptors. NOTCH signaling is highly conserved in evolution and mediates communication between adjacent cells. NOTCH receptors have been implicated in cell fate determination, as well as maintenance and differentiation of stem cells. In the mammalian testis expression of NOTCH1 in somatic and germ cells has been demonstrated, however its role in spermatogenesis was not clear. To study the significance of NOTCH1 in germ cells, we applied a cre/loxP approach in mice to induce NOTCH1 gain-or loss-of function specifically in male germ cells. Using a Stra8-icre transgene we produced mice with conditional activation of the NOTCH1 intracellular domain (NICD) in germ cells. Spermatogenesis in these mutants was progressively affected with age, resulting in decreased testis weight and sperm count. Analysis of downstream target genes of NOTCH1 signaling showed an increased expression of Hes5, with a reduction of the spermatogonial differentiation marker, Neurog3 expression in the mutant testis. Apoptosis was significantly increased in mouse germ cells with the corresponding elevation of pro-apoptotic Trp53 and Trp63 genes' expression. We also showed that the conditional germ cell-specific ablation of Notch1 had no effect on spermatogenesis or male fertility. Our data suggest the importance of NOTCH signaling regulation in male germ cells for their survival and differentiation.	[Huang, Zaohua; Rivas, Bryan; Agoulnik, Alexander I.] Florida Int Univ, Dept Human & Mol Genet, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Agoulnik, Alexander I.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	State University System of Florida; Florida International University; Baylor College of Medicine	Agoulnik, AI (corresponding author), Florida Int Univ, Dept Human & Mol Genet, Herbert Wertheim Coll Med, Miami, FL 33199 USA.	aagoulni@fiu.edu	Agoulnik, Alexander/AAK-3213-2020	Agoulnik, Alexander/0000-0001-6587-6845	Herbert Wertheim College of Medicine, Florida International University	Herbert Wertheim College of Medicine, Florida International University	Supported by the Herbert Wertheim College of Medicine, Florida International University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; Braydich-Stolle L, 2005, ANN NY ACAD SCI, V1061, P94, DOI 10.1196/annals.1336.010; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Dirami G, 2001, J ANDROL, V22, P944; Garcia TX, 2013, DEV BIOL; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Hayashi T, 2004, FERTIL STERIL, V81, P697, DOI 10.1016/j.fertnstert.2003.08.026; Hayashi T, 2001, J ANDROL, V22, P999; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Huang ZH, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103382; Kaftanovskaya EM, 2013, J PATHOL; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kitadate Y, 2010, P NATL ACAD SCI USA, V107, P14241, DOI 10.1073/pnas.1003462107; Liu J, 2007, GENESIS, V45, P259, DOI 10.1002/dvg.20282; Lupien M, 2006, DEV BIOL, V300, P497, DOI 10.1016/j.ydbio.2006.09.010; McCright B, 2001, DEVELOPMENT, V128, P491; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Morichika K, 2010, DEV GROWTH DIFFER, V52, P235, DOI 10.1111/j.1440-169X.2009.01164.x; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Shih HP, 2012, DEVELOPMENT, V139, P2488, DOI 10.1242/dev.078634; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	34	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71213	10.1371/journal.pone.0071213	http://dx.doi.org/10.1371/journal.pone.0071213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936265	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200117
J	Loland, KH; Bleie, O; Strand, E; Ueland, PM; Nordrehaug, JE; Garcia-Garcia, HM; Serruys, PW; Nygard, O				Loland, Kjetil H.; Bleie, Oyvind; Strand, Elin; Ueland, Per M.; Nordrehaug, Jan E.; Garcia-Garcia, Hector M.; Serruys, Patrick W.; Nygard, Ottar			Effect of Folic Acid Supplementation on Levels of Circulating Monocyte Chemoattractant Protein-1 and the Presence of Intravascular Ultrasound Derived Virtual Histology Thin-Cap Fibroatheromas in Patients with Stable Angina Pectoris	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; RADIOFREQUENCY DATA-ANALYSIS; CARDIOVASCULAR-DISEASE; TOTAL HOMOCYSTEINE; VULNERABLE PLAQUE; VASCULAR-DISEASE; PLASMA-LEVELS; ATHEROSCLEROSIS; ASSOCIATION; MECHANISMS	Background: Virtual Histology Intravascular Ultrasound (VH-IVUS) may be used to detect early signs of unstable coronary artery disease. Monocyte Chemoattractant Protein-1 (MCP-1) is linked with coronary atherosclerosis and plaque instability and could potentially be modified by folic acid treatment. Methods: In a randomized, prospective study, 102 patients with stable angina pectoris (SAP) received percutaneous coronary intervention and established medical treatment as well as either homocysteine-lowering folic acid/vitamin B-12 (+/- B-6) or placebo (+/- B-6) for 1 year before VH-IVUS was performed. The presence of VH-Thin-Cap Fibroatheroma (VH-TCFA) in non-intervened coronary vessels was registered and serum levels of MCP-1 were measured. The patients were subsequently followed for incident myocardial infarction (MI). Results: Patients treated with folic acid/vitamin B-12 had a geometric mean (SD) MCP-1 level of 79.95 (1.49) versus 86.00 (1.43) pg/mL for patients receiving placebo (p-value 0.34). VH-TCFA lesions were present in 7.8% of patients and did not differ between intervention arms (p-value 0.47). Serum levels of MCP-1 were 1.46 (95% CI 1.12 to 1.92) times higher in patients with VH-TCFA lesions than in those without (p-value 0.005). Afterwards, patients were followed for median 2.1 years and 3.8% experienced a myocardial infarction (MI), which in post-hoc Cox regression analyses was independently predicted by both MCP-1 (P-value 0.006) and VH-TCFA (p-value 0.01). Conclusions: In patients with SAP receiving established medical treatment, folic acid supplementation is not associated with either presence of VH-TCFA or levels of MCP-1. MCP-1 is however associated with VH-TCFA, a finding corroborated by increased risk for future MI.	[Loland, Kjetil H.; Strand, Elin; Ueland, Per M.; Nordrehaug, Jan E.; Nygard, Ottar] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Bleie, Oyvind; Nordrehaug, Jan E.; Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Ueland, Per M.] Haukeland Hosp, Lab Clin Biochem, N-5021 Bergen, Norway; [Garcia-Garcia, Hector M.] Cardialysis, Rotterdam, Netherlands; [Garcia-Garcia, Hector M.; Serruys, Patrick W.] Erasmus MC, Thoraxctr, Intervent Cardiol Dept, Rotterdam, Netherlands	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Cardialysis; Erasmus University Rotterdam; Erasmus MC	Loland, KH (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	kjetil.loland@gmail.com	Garcia-Garcia, Hector Manuel/AAG-7471-2020; Ueland, Per M/C-7340-2013; Stefanadis, Christodoulos/ABH-2232-2020	Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; Stefanadis, Christodoulos/0000-0001-5974-6454; Ueland, Per Magne/0000-0002-1903-0571	Norwegian Foundation for Health and Rehabilitation; Norwegian Heart and Lung Patient Organization; Norwegian Ministry of Health and Care Services; Western Norway Regional Health Authority; Department of Heart Disease at Haukeland University Hospital; Foundation to Promote Research Into Functional Vitamin B12 Deficiency, Bergen, Norway; Alpharma Inc, Copenhagen, Denmark	Norwegian Foundation for Health and Rehabilitation; Norwegian Heart and Lung Patient Organization; Norwegian Ministry of Health and Care Services; Western Norway Regional Health Authority; Department of Heart Disease at Haukeland University Hospital; Foundation to Promote Research Into Functional Vitamin B12 Deficiency, Bergen, Norway; Alpharma Inc, Copenhagen, Denmark	The study was funded by the Norwegian Foundation for Health and Rehabilitation, the Norwegian Heart and Lung Patient Organization, the Norwegian Ministry of Health and Care Services, the Western Norway Regional Health Authority, the Department of Heart Disease at Haukeland University Hospital, the Foundation to Promote Research Into Functional Vitamin B12 Deficiency, Bergen, Norway, and Alpharma Inc, Copenhagen, Denmark. The main sponsors were nonprofit organizations with no participating role in the trial. Alpharma Inc provided the study capsules, generated the randomization sequence, and concealed the randomization code free of charge and rendered a limited grant to finance the initial phase of the trial. However, Alpharma Inc had no role in the design or implementation of the trial, had no access to study data, and did not participate in data analysis or interpretation or in the preparation, review, or approval of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, EUR HEART J, V30, P6, DOI 10.1093/eurheartj/ehn515; Baigent C, 2007, JAMA-J AM MED ASSOC, V298, P1212, DOI 10.1001/jama.298.10.1212; Bleie O, 2011, CORONARY ARTERY DIS, V22, P270, DOI 10.1097/MCA.0b013e328344fff4; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cheruvu PK, 2007, J AM COLL CARDIOL, V50, P940, DOI 10.1016/j.jacc.2007.04.086; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; de Lemos JA, 2007, J AM COLL CARDIOL, V50, P2117, DOI 10.1016/j.jacc.2007.06.057; Deo R, 2004, J AM COLL CARDIOL, V44, P1812, DOI 10.1016/j.jacc.2004.07.047; Ebbing M, 2010, J INTERN MED, V268, P367, DOI 10.1111/j.1365-2796.2010.02259.x; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Economou EV, 2004, J CARDIOVASC PHARM, V44, P310, DOI 10.1097/01.fjc.0000133587.01718.59; Fleg JL, 2012, JACC-CARDIOVASC IMAG, V5, P941, DOI 10.1016/j.jcmg.2012.07.007; Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29; Gerszten RE, 2012, NEW ENGL J MED, V366, P1734, DOI 10.1056/NEJMcibr1200164; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Honaker J, 2010, AMELIA AMELIA 2 PROG; Hong MK, 2008, AM J CARDIOL, V101, P568, DOI 10.1016/j.amjcard.2007.09.113; Joseph J, 2009, CARDIOVASC TOXICOL, V9, P53, DOI 10.1007/s12012-009-9042-6; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kaul S, 2006, J AM COLL CARDIOL, V48, P914, DOI 10.1016/j.jacc.2006.04.086; Kim SH, 2011, SCAND J CLIN LAB INV, V71, P1, DOI 10.3109/00365513.2010.519047; Li JF, 2012, CIRC J, V76, P2167, DOI 10.1253/circj.CJ-11-1457; Li M, 2007, CARDIOVASC PATHOL, V16, P305, DOI 10.1016/j.carpath.2007.03.005; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Loland KH, 2010, AM J CARDIOL, V105, P1577, DOI 10.1016/j.amjcard.2010.01.019; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Nair Anuja, 2007, EuroIntervention, V3, P113; Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Nygard O, 1999, J INTERN MED, V246, P425, DOI 10.1046/j.1365-2796.1999.00512.x; Ortlepp JR, 2003, J MOL MED-JMM, V81, P363, DOI 10.1007/s00109-003-0435-x; Piemonti L, 2009, DIABETES CARE, V32, P2105, DOI 10.2337/dc09-0763; Poddar R, 2001, CIRCULATION, V103, P2717; R Development Core Team, 2012, R LANG ENV STAT COMP; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sanidas EA, 2011, AM J CARDIOL, V107, P1285, DOI 10.1016/j.amjcard.2010.12.037; Solini A, 2006, INT J OBESITY, V30, P1197, DOI 10.1038/sj.ijo.0803265; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; YU XH, 1992, P NATL ACAD SCI USA, V89, P6953, DOI 10.1073/pnas.89.15.6953; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	44	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70101	10.1371/journal.pone.0070101	http://dx.doi.org/10.1371/journal.pone.0070101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936148	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300088
J	Matthews, GA; Patel, R; Walsh, A; Davies, O; Martinez-Ricos, J; Brennan, PA				Matthews, Gillian A.; Patel, Ronak; Walsh, Alison; Davies, Owain; Martinez-Ricos, Joana; Brennan, Peter A.			Mating Increases Neuronal Tyrosine Hydroxylase Expression and Selectively Gates Transmission of Male Chemosensory Information in Female Mice	PLOS ONE			English	Article							ACCESSORY OLFACTORY-BULB; PREGNANCY-BLOCK; ARCUATE NUCLEI; MOUSE; DOPAMINE; FOS; RECOGNITION; COINCIDENT; PHEROMONE; PEPTIDES	Exposure to chemosensory signals from unfamiliar males can terminate pregnancy in recently mated female mice. The number of tyrosine hydroxylase-positive neurons in the main olfactory bulb has been found to increase following mating and has been implicated in preventing male-induced pregnancy block during the post-implantation period. In contrast, pre-implantation pregnancy block is mediated by the vomeronasal system, and is thought to be prevented by selective inhibition of the mate's pregnancy blocking chemosignals, at the level of the accessory olfactory bulb. The objectives of this study were firstly to identify the level of the vomeronasal pathway at which selective inhibition of the mate's pregnancy blocking chemosignals occurs. Secondly, to determine whether a post-mating increase in tyrosine hydroxylase-positive neurons is observed in the vomeronasal system, which could play a role in preventing pre-implantation pregnancy block. Immunohistochemical staining revealed that mating induced an increase in tyrosine-hydroxylase positive neurons in the arcuate hypothalamus of BALB/c females, and suppressed c-Fos expression in these neurons in response to mating male chemosignals. This selective suppression of c-Fos response to mating male chemosignals was not apparent at earlier levels of the pregnancy-blocking neural pathway in the accessory olfactory bulb or corticomedial amygdala. Immunohistochemical staining revealed an increase in the number of tyrosine hydroxylase-positive neurons in the accessory olfactory bulb of BALB/c female mice following mating. However, increased dopamine-mediated inhibition in the accessory olfactory bulb is unlikely to account for the prevention of pregnancy block to the mating male, as tyrosine hydroxylase expression did not increase in females of the C57BL/6 strain, which show normal mate recognition. These findings reveal an association of mating with increased dopaminergic modulation in the pregnancy block pathway and support the hypothesis that mate recognition prevents pregnancy block by suppressing the activation of arcuate dopamine release.	[Matthews, Gillian A.; Patel, Ronak; Walsh, Alison; Davies, Owain; Brennan, Peter A.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Martinez-Ricos, Joana] Univ Valencia, Dept Human Anat, Valencia, Spain	University of Bristol; University of Valencia	Brennan, PA (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	p.brennan@bristol.ac.uk		Martinez-Ricos, Joana/0000-0002-3030-5708; /0000-0001-6754-0333	BBSRC project grant [BB/E020283/1]; BBSRC [BB/E020283/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020283/1] Funding Source: researchfish	BBSRC project grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by BBSRC project grant BB/E020283/1. http://www.bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ARBOGAST LA, 1993, NEUROENDOCRINOLOGY, V58, P501, DOI 10.1159/000126583; ARBOGAST LA, 1991, ENDOCRINOLOGY, V128, P997, DOI 10.1210/endo-128-2-997; BAKER H, 1983, J NEUROSCI, V3, P832; BAKER H, 1986, J COMP NEUROL, V252, P206, DOI 10.1002/cne.902520206; BAKER H, 1983, J NEUROSCI, V3, P69; Baker H, 2001, J NEUROSCI, V21, P8505, DOI 10.1523/JNEUROSCI.21-21-08505.2001; BARKLEY MS, 1978, BIOL REPROD, V19, P291, DOI 10.1095/biolreprod19.2.291; Binns KE, 2005, EUR J NEUROSCI, V21, P2529, DOI 10.1111/j.1460-9568.2005.04090.x; BRENNAN P, 1990, SCIENCE, V250, P1223, DOI 10.1126/science.2147078; BRENNAN PA, 1992, NEUROSCIENCE, V49, P277, DOI 10.1016/0306-4522(92)90095-J; BRUCE HM, 1961, J REPROD FERTIL, V2, P138, DOI 10.1530/jrf.0.0020138; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Halem HA, 2001, EUR J NEUROSCI, V13, P389, DOI 10.1046/j.1460-9568.2001.01382.x; HOPPE PC, 1975, J REPROD FERTIL, V45, P109, DOI 10.1530/jrf.0.0450109; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Lerant A, 1996, ENDOCRINOLOGY, V137, P3621, DOI 10.1210/en.137.9.3621; LI CS, 1994, NEUROSCI LETT, V176, P5, DOI 10.1016/0304-3940(94)90857-5; LI CS, 1989, NEUROSCIENCE, V29, P201, DOI 10.1016/0306-4522(89)90343-6; LLOYDTHOMAS A, 1982, NEUROSCIENCE, V7, P907, DOI 10.1016/0306-4522(82)90051-3; Ma D, 2002, EUR J NEUROSCI, V16, P2317, DOI 10.1046/j.1460-9568.2002.02303.x; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Paxinos G., 2001, MOUSE BRAIN STEREOTA; ROSSER AE, 1986, J COMP NEUROL, V250, P352, DOI 10.1002/cne.902500308; ROSSER AE, 1989, J REPROD FERTIL, V87, P553, DOI 10.1530/jrf.0.0870553; Samuelsen CL, 2009, BRAIN RES, V1263, P33, DOI 10.1016/j.brainres.2009.01.048; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; Serguera C, 2008, NAT NEUROSCI, V11, P949, DOI 10.1038/nn.2154; Yokosuka M, 2012, EXP ANIM TOKYO, V61, P13, DOI 10.1538/expanim.61.13	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69943	10.1371/journal.pone.0069943	http://dx.doi.org/10.1371/journal.pone.0069943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936125	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300080
J	Kurtoglu, KY; Kantar, M; Lucas, SJ; Budak, H				Kurtoglu, Kuaybe Yucebilgili; Kantar, Melda; Lucas, Stuart J.; Budak, Hikmet			Unique and Conserved MicroRNAs in Wheat Chromosome 5D Revealed by Next-Generation Sequencing	PLOS ONE			English	Article							ABIOTIC STRESS RESPONSES; PLANT SMALL RNAS; REGULATORY ROLES; BARLEY MIRNAS; IDENTIFICATION; BIOGENESIS; GENOMICS; EVOLUTION; CLEAVAGE; TARGETS	MicroRNAs are a class of short, non-coding, single-stranded RNAs that act as post-transcriptional regulators in gene expression. miRNA analysis of Triticum aestivum chromosome 5D was performed on 454 GS FLX Titanium sequences of flow-sorted chromosome 5D with a total of 3,208,630 good quality reads representing 1.34x and 1.61x coverage of the short (5DS) and long (5DL) arms of the chromosome respectively. In silico and structural analyses revealed a total of 55 miRNAs; 48 and 42 miRNAs were found to be present on 5DL and 5DS respectively, of which 35 were common to both chromosome arms, while 13 miRNAs were specific to 5DL and 7 miRNAs were specific to 5DS. In total, 14 of the predicted miRNAs were identified in wheat for the first time. Representation (the copy number of each miRNA) was also found to be higher in 5DL (1,949) compared to 5DS (1,191). Targets were predicted for each miRNA, while expression analysis gave evidence of expression for 6 out of 55 miRNAs. Occurrences of the same miRNAs were also found in Brachypodium distachyon and Oryza sativa genome sequences to identify syntenic miRNA coding sequences. Based on this analysis, two other miRNAs: miR1133 and miR167 were detected in B. distachyon syntenic region of wheat 5DS. Five of the predicted miRNA coding regions (miR6220, miR5070, miR169, miR5085, miR2118) were experimentally verified to be located to the 5D chromosome and three of them : miR2118, miR169 and miR5085, were shown to be 5D specific. Furthermore miR2118 was shown to be expressed in Chinese Spring adult leaves. miRNA genes identified in this study will expand our understanding of gene regulation in bread wheat.	[Kurtoglu, Kuaybe Yucebilgili; Kantar, Melda; Budak, Hikmet] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey; [Lucas, Stuart J.; Budak, Hikmet] Sabanci Univ, Nanotechnol Res & Applicat Ctr SUNUM, Istanbul, Turkey	Sabanci University; Sabanci University	Budak, H (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	budak@sabanciuniv.edu	Budak, Hikmet/F-4708-2010; Kurtoglu, Kuaybe Yucebilgili/AAE-9731-2020; Budak, Hikmet/S-5835-2017; Lucas, Stuart J./AAW-5615-2020; Budak, Hikmet/U-8517-2019	Budak, Hikmet/0000-0002-2556-2478; Budak, Hikmet/0000-0002-2556-2478; Lucas, Stuart J./0000-0003-3059-7453; Budak, Hikmet/0000-0002-2556-2478	Sabanci University Internal Grant;  [TUBITAK1001]	Sabanci University Internal Grant(Sabanci University); 	This work was supported by Sabanci University Internal Grant and TUBITAK1001 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Budak H, 2011, OMICS, V15, P791, DOI 10.1089/omi.2011.0073; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen J, 2004, PLANT CELL, V16, P1302, DOI 10.1105/tpc.018986; Cheng ZQ, 2002, MOL BREEDING, V10, P71, DOI 10.1023/A:1020329401191; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Guleria Praveen, 2011, Genomics Proteomics & Bioinformatics, V9, P183, DOI 10.1016/S1672-0229(11)60022-3; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kantar M, 2012, FUNCT INTEGR GENOMIC, V12, P465, DOI 10.1007/s10142-012-0285-0; Kantar M, 2011, ADV BOT RES, V57, P445, DOI 10.1016/B978-0-12-387692-8.00013-8; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019212; Li YC, 2012, J PLANT BIOL, V55, P349, DOI 10.1007/s12374-011-0032-4; Liang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048951; Linkiewicz AM, 2004, GENETICS, V168, P665, DOI 10.1534/genetics.104.034835; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu YZ, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/128297; Lucas SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040859; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mette MF, 2002, PLANT PHYSIOL, V130, P6, DOI 10.1104/pp.007047; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Sabot F, 2005, MOL GENET GENOMICS, V274, P119, DOI 10.1007/s00438-005-0012-9; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shen QX, 2001, PLANT MOL BIOL, V45, P327, DOI 10.1023/A:1006460231978; Shivaprasad PV, 2012, PLANT CELL ONLINE; Singh K, 2012, FUNCT INTEGR GENOMIC, V12, P659, DOI 10.1007/s10142-012-0292-1; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; SMITH DB, 1975, CHROMOSOMA, V50, P223, DOI 10.1007/BF00283468; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Srivastava S, 2013, J EXP BOT, V64, P303, DOI 10.1093/jxb/ers333; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034092; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Unver T, 2009, INT J PLANT GENOMICS, V2009; Unver T, 2010, MOL GENET GENOMICS, V283, P397, DOI 10.1007/s00438-010-0526-7; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vitulo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026421; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Xu GY, 2011, PLANTA, V234, P47, DOI 10.1007/s00425-011-1386-z; Yan YS, 2011, PLANT J, V65, P820, DOI 10.1111/j.1365-313X.2010.04467.x; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yin ZJ, 2012, MOL BIOL REP, V39, P4961, DOI 10.1007/s11033-011-1292-2; Yuan ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017666; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	78	33	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69801	10.1371/journal.pone.0069801	http://dx.doi.org/10.1371/journal.pone.0069801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936103	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000156
J	He, HY; Wang, C; Shen, ZB; Fang, Y; Wang, XF; Chen, WD; Liu, FL; Qin, XY; Sun, YH				He, Hongyong; Wang, Cong; Shen, Zhenbin; Fang, Yong; Wang, Xuefei; Chen, Weidong; Liu, Fenglin; Qin, Xinyu; Sun, Yihong			Upregulated Expression of C-X-C Chemokine Receptor 4 Is an Independent Prognostic Predictor for Patients with Gastric Cancer	PLOS ONE			English	Article							CXCR4; MARKER; SENSITIVITY; SURVIVAL; THERAPY; CELLS; NODE	Aberrant chemokine (C-X-C motif) receptor CXCR4 expressions in malignant tissues have been reported, but its role in gastric cancer prognosis remains unknown. Our studies were designed to investigate the expression and prognostic significance of CXCR4 in patients with gastric cancer. CXCR4 expression was retrospectively analyzed by immunohistochemistry in 97 patients with gastric adenocarcinoma from China. Results were assessed for association with clinical features and overall survival by using Kaplan-Meier analysis. Prognostic values of CXCR4 expression and clinical outcomes were evaluated by Cox regression analysis. A molecular prognostic stratification scheme incorporating CXCR4 expression was determined by using receiver operating characteristic (ROC) analysis. The results show that CXCR4 predominantly localized in the cell membranes and cytoplasm. The protein level of CXCR4 was upregulation in gastric cancer tissues and upregulated expression of CXCR4 was only significantly associated with Lauren classification (P<0.001). Increased CXCR4 expression in gastric cancer tissues was positively correlated with poor overall survival of gastric cancer patients (P<0.001). Further multivariate Cox regression analysis suggested that intratumoral CXCR4 expression was an independent prognostic indicator for the disease. Applying the prognostic value of intratumoral CXCR4 density to TNM stage system showed a better prognostic value in patients with gastric cancer. In conclusion, intratumoral CXCR4 expression was recognized as an independent prognostic marker for the overall survival of patients with gastric cancer. On the basis of TNM stage, detection of CXCR4 expression will be helpful for predicting prognosis for patients with gastric cancer.	[He, Hongyong; Wang, Cong; Shen, Zhenbin; Fang, Yong; Wang, Xuefei; Chen, Weidong; Liu, Fenglin; Qin, Xinyu; Sun, Yihong] Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University	Sun, YH (corresponding author), Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China.	yihongsun@medmail.com.cn		HE, HONGYONG/0000-0001-7371-4133	Science and Technology Commission of Shanghai Municipality [09DZ1950101, 11411951000]; Shanghai Municipal Health Bureau Fund [20124290]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Health Bureau Fund	This work was supported by grants from Key Project of Science and Technology Commission of Shanghai Municipality (09DZ1950101, 11411951000) and Shanghai Municipal Health Bureau Fund (20124290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2013, APPL IMMUNOHISTO M M, V21, P79, DOI 10.1097/PAI.0b013e3182606f4d; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Balkwill F, 2003, SEMIN IMMUNOL, V15, P49, DOI 10.1016/S1044-5323(02)00127-6; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Demolin G, 2008, Rev Med Liege, V63, P532; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; He HY, 2012, CANCER SCI, V103, P1296, DOI 10.1111/j.1349-7006.2012.02295.x; Ishigami S, 2007, ANN SURG ONCOL, V14, P3154, DOI 10.1245/s10434-007-9521-6; Iwasa S, 2009, ANTICANCER RES, V29, P4751; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung SJ, 2011, KOREAN J UROL, V52, P607, DOI 10.4111/kju.2011.52.9.607; Kasaian K, 2011, FUTURE ONCOL, V7, P873, DOI [10.2217/FON.11.63, 10.2217/fon.11.63]; Kwak MK, 2005, TUMOR BIOL, V26, P65, DOI 10.1159/000085587; Lim L, 2005, J CLIN ONCOL, V23, P6220, DOI 10.1200/JCO.2005.11.593; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Parker CC, 2012, J SURG ONCOL, V106, P393, DOI 10.1002/jso.23113; Stock M, 2005, GENE, V360, P1, DOI 10.1016/j.gene.2005.06.026; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wang XF, 2013, CANCER SCI, V104, P185, DOI 10.1111/cas.12049; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; Xie L, 2010, ANTICANCER RES, V30, P2209; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Ying JE, 2012, MED ONCOL, V29, P1716, DOI 10.1007/s12032-011-9990-0; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	32	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71864	10.1371/journal.pone.0071864	http://dx.doi.org/10.1371/journal.pone.0071864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936528	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500083
J	Carr, C; Odell-Miller, H; Priebe, S				Carr, Catherine; Odell-Miller, Helen; Priebe, Stefan			A Systematic Review of Music Therapy Practice and Outcomes with Acute Adult Psychiatric In-Patients	PLOS ONE			English	Review							SCHIZOPHRENIA; ARTS	Background and Objectives: There is an emerging evidence base for the use of music therapy in the treatment of severe mental illness. Whilst different models of music therapy have been developed in mental health care, none have specifically accounted for the features and context of acute in-patient settings. This review aimed to identify how music therapy is provided for acute adult psychiatric in-patients and what outcomes have been reported. Review Methods: A systematic review using medical, psychological and music therapy databases. Papers describing music therapy with acute adult psychiatric in-patients were included. Analysis utilised narrative synthesis. Results: 98 papers were identified, of which 35 reported research findings. Open group work and active music making for nonverbal expression alongside verbal reflection was emphasised. Aims were engagement, communication and interpersonal relationships focusing upon immediate areas of need rather than longer term insight. The short stay, patient diversity and institutional structure influenced delivery and resulted in a focus on single sessions, high session frequency, more therapist direction, flexible use of musical activities, predictable musical structures, and clear realistic goals. Outcome studies suggested effectiveness in addressing a range of symptoms, but were limited by methodological shortcomings and small sample sizes. Studies with significant positive effects all used active musical participation with a degree of structure and were delivered in four or more sessions. Conclusions: No single clearly defined model exists for music therapy with adults in acute psychiatric in-patient settings, and described models are not conclusive. Greater frequency of therapy, active structured music making with verbal discussion, consistency of contact and boundaries, an emphasis on building a therapeutic relationship and building patient resources may be of particular importance. Further research is required to develop specific music therapy models for this patient group that can be tested in experimental studies.	[Carr, Catherine; Priebe, Stefan] Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England; [Odell-Miller, Helen] Anglia Ruskin Univ, Mus & Performing Arts Dept, Cambridge, England	University of London; Queen Mary University London; Anglia Ruskin University	Carr, C (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England.	c.e.carr@qmul.ac.uk		Priebe, Stefan/0000-0001-9864-3394	National Institute for Health Research Clinical Doctoral Research Fellowship for Allied Health Professionals [CAT-CDRF 10-006]; National Institute for Health Research (NIHR); National Institute for Health Research [CAT CDRF 10-006] Funding Source: researchfish	National Institute for Health Research Clinical Doctoral Research Fellowship for Allied Health Professionals; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Catherine Carr is funded by the National Institute for Health Research Clinical Doctoral Research Fellowship for Allied Health Professionals: CAT-CDRF 10-006; www.nihrtcc.nhs.uk. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abs B, 1983, MUSIKTHERAPEUTISCHE, V4, P266; Ansdell G., 2010, MUSIC MED, V2, P29, DOI [DOI 10.1177/1943862109352482, 10.47513/mmd.v2i1.237, DOI 10.47513/MMD.V2I1.237]; Arnason CLR, 1993, CANADIAN J MUSIC THE, V1, P77; Baumgarten H, 1986, MUSIKTHERAPEUTISCHE, V7, P51; Blake R., 1994, MUSIC THERAPY PERSPE, V12, P125, DOI DOI 10.1093/MTP/12.2.125; Bonde LO, 2012, MUSIKTERAPI PSYKIATR, V7; BRASWELL C, 1986, J MUSIC THER, V23, P126, DOI 10.1093/jmt/23.3.126; Bruscia KE, 1998, DEFINING MUSIC THERA, V2nd; Bunt L., 1987, BRIT J MUSIC THERAPY, V1, P22, DOI [10.1177/135945758700100205, DOI 10.1177/135945758700100205]; Cassity M., 2006, MULTIMODAL PSYCHIAT; CASSITY MD, 1976, J MUSIC THER, V13, P66, DOI 10.1093/jmt/13.2.66; CASSITY MD, 1994, J MUSIC THER, V31, P2, DOI 10.1093/jmt/31.1.2; Clemencic-Jones V, 1998, MUSICMEDICINE, P264; Cullen I, 1993, AUSTR J MUSIC THERAP, V4, P36; Davies A, 2010, GROUPS, V34, P21; Davies A, 1998, BRIT J MUSIC THERAPY, V12, P53; De Backer J, 2003, PSYCHODYNAMIC MUSIC, P273; De Backer J, 2006, THESIS AALBORG U AAL; Department of Health, 2001, MENT HLTH POL IMPL G; di Massimo G, 1998, MUSIC THERAPY DIALOG, P53; Dileo C., 2005, MUSIC THERAPY RES, P105; Dokter D., 2010, GROUP, V34, P67; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Drieschner K, 2002, MUSIC THERAPY TODAY; Dvorkin J, 2008, DYNAMICS MUSIC PSYCH, P287; Dye S, 1994, AUSTR J MUSIC THERAP, V5, P19; *EPPI CTR, 2002, GUID EXTR DAT QUAL A; Erkkila J, 2011, BRIT J PSYCHIAT, V199, P132, DOI 10.1192/bjp.bp.110.085431; Exner J, 1998, MUSIKTERAPI PSYKIATR, V1, P107; Eyre L, 2011, DEV MUSIC THERAPY PR, P385; Featherstone J, 2008, FORMATIVE EVAL UNPUB; Fenwick A, 1973, MUSIC THERAPY MENTAL, VII, P21; Frederiksen B, 1998, MUSIKTERAPI PSYKIATR, V1, P165; Gibson R, 2008, MENT HEALTH REV J, V13, P32, DOI 10.1108/13619322200800020; Gilbertson S, 2003, MUSIC THERAPY TODAY, V4; Gold C, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-39; Gold C, 2009, CLIN PSYCHOL REV, V29, P193, DOI 10.1016/j.cpr.2009.01.001; Goldberg F., 1994, J ASS MUSIC IMAGERY, V3, P18; Goldberg F.S., 1989, MUSIC THERAPY PERSPE, V6, P40, DOI https://doi.org/10.1093/mtp/6.1.40; GOLDBERG FS, 1988, GROUP, V12, P145, DOI 10.1007/BF01456564; Gough D, 2007, RES PAP EDUC, V22, P213, DOI [10.1080/02671520701296189, DOI 10.1080/02671520701296189]; Grandison S, 1991, ARTS THERAPIES UNPUB; Haase U, 2011, DEV MUSIC THERAPY PR, P453; Hannibal N, 2005, MUSIKTERAPI PSYKIATR, V4, P65; Hannibal N, 2002, MUSIKTERAPI PSYKIATR, V3, P57; Hannibal N, 2012, NORD J PSYCHIAT, V66, P376, DOI 10.3109/08039488.2012.655775; Hara G, 1999, MUSIC THERAPY GLOBAL, P17; HEANEY CJ, 1992, J MUSIC THER, V29, P70, DOI 10.1093/jmt/29.2.70; Hopster G, 2005, MUSIKTHERAPEUTISCHE, V26, P18; Hudson-Smith G, 1991, CASE STUDIES MUSIC T, P481; Jensen B, 2000, MUSIKTERAPI PSYKIATR, V2, P129; Jensen B, 2002, MUSIK TERAPI; Leite T, 2008, MUSICOTERAPIA EUROPE, P89; LIBBEY M, 1983, GROUP, V7, P27, DOI 10.1007/BF01456470; Lindvang C, 2008, MUSIKTERAPI PSYKIATR, V5, P123; Lindvang C, 1991, NORD J MUSIC THER, V8, P47, DOI [10.1080/08098139909477953, DOI 10.1080/08098139909477953]; Lindvang C, 2005, MUSIKTERAPI PSYCHIAT, V4, P107; Lund H, 2008, MUSIKTERAPI PSYKIATR, V5, P123; MALER T, 1994, PSYCHOTHER PSYCH MED, V44, P122; Maratos AS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004517.pub2; Meekums B, 2011, ART PSYCHOTHER, V38, P229, DOI 10.1016/j.aip.2011.06.003; Metzner S, 2003, PSYCHODYNAMIC MUSIC, P257; Metzner S, 2010, NORD J MUSIC THER, V19, P133, DOI 10.1080/08098131.2010.489996; Moe T., 2000, NORD J MUSIC THER, V9, P36, DOI [10.1080/08098130009478000, DOI 10.1080/08098130009478000]; Moe T., 2002, NORD J MUSIC THER, V11, P152, DOI [10.1080/08098130209478057, DOI 10.1080/08098130209478057]; Mossler K, 2011, BRIT J MUSIC THER, V25, P72; Moller AS, 1996, NORD J MUSIC THER, V5, P128, DOI [10.1080/08098139609477882, DOI 10.1080/08098139609477882]; Morgan K, 2011, ACTA PSYCHIAT SCAND, V124, P363, DOI 10.1111/j.1600-0447.2011.01739.x; Moss H, 1999, BRIT J MUSIC THERAPY, V13, P49; Mossler K, 2012, ART PSYCHOTHER, V39, P333, DOI 10.1016/j.aip.2012.05.002; Mossler K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004025.pub3; Moura Costa C, 2011, ACTION RELATIONSHIP, V11; Murphy ME, 1991, CASE STUDIES MUSIC T, P465; Murphy ME, 1992, MUSIC THERAPY, V11, P99; Nolan P, 1991, CASE STUDIES MUSIC T, P451; Nolan P, 2007, MUSIC THERAPY CHILDR, P45; Odell Helen, 1988, PSYCHOL MUSIC, V16, P52, DOI [10.1177/0305735688161005, DOI 10.1177/0305735688161005]; Odell-Miller H, 2006, PSYCHOTHER RES, V16, P122, DOI 10.1080/10503300500268342; Odell-Miller H, 2001, MUSICOTERAPIA EUROPA, P1464; Odell-Miller H, 1986, MUSIC THERAPY UNPUB; Odell-Miller H, 1992, COMMUNICAT UNPUB MAR; Odell-Miller H, 2007, THESIS AALBORG U AAL; PAVLICEVIC M, 1989, PSYCHOPATHOLOGY, V22, P325, DOI 10.1159/000284615; Pavlicevic M, 1987, BRIT J MUSIC THERAPY, V1, P22; Pawson R, 2003, ESRC UK CTR EVIDENCE, V18, P1; Popay J., 2006, GUIDANCE CONDUCT NAR; Priestley M., 1975, MUSIC THERAPY ACTION; Procter S, 2002, DIALOGUE DEBATE MUSI, P184; Ragland ZS, 1973, J MUSIC THER, V10, P194; Ready T, 2011, MUSIC MED, V3, P246; REKER T, 1991, PSYCHIAT PRAX, V18, P216; Ring NA, 2011, GUIDE SYNTHESISING Q; Rodgers M, 2009, EVALUATION, V15, P47, DOI DOI 10.1177/1356389008097871; Rolvsjord R., 2010, RESOURCE ORIENTED MU; Rowland C, 2011, BRIT J MUSIC THER, V25, P48, DOI 10.1177/135945751102500105; Sainsbury Centre for Mental Health (SCMH), 2006, SEARCH AC SOL IMPR Q; Saitoh T, 2011, MUSIC THERAPY TODAY, V9, P60; Seitz E, 2002, EINBLICKE BEITRAGE M, P53; Sekeles C, 1999, CLINICAL APPLICATIONS OF MUSIC THERAPY IN PSYCHIATRY, P176; Shultis CL, 1999, PSYCHIAT TIMES, V16, P46; Silverman MJ, 2007, J MUSIC THER, V44, P388, DOI 10.1093/jmt/44.4.388; Silverman MJ, 2009, J CREAT MENT HEALTH, V4, P17, DOI 10.1080/15401380802672518; Silverman MJ, 2011, J MUSIC THER, V48, P103, DOI 10.1093/jmt/48.1.103; Silverman MJ, 2011, ART PSYCHOTHER, V38, P125, DOI 10.1016/j.aip.2011.02.004; Silverman MJ, 2010, ART PSYCHOTHER, V37, P264, DOI 10.1016/j.aip.2010.05.002; Silverman MJ, 2009, J MUSIC THER, V46, P105, DOI 10.1093/jmt/46.2.105; Silverman MJ, 2004, ART PSYCHOTHER, V31, P291, DOI 10.1016/j.aip.2004.06.008; Silverman MJ, 2003, J MUSIC THER, V40, P27, DOI 10.1093/jmt/40.1.27; Silverman MJ, 2003, ART PSYCHOTHER, V30, P25, DOI 10.1016/S0197-4556(02)00231-9; Sloboda A, 2008, INTEGRATED TEAM WORK, P141; Smeijsters H., 2005, SOUNDING SELF ANALOG; SMITH SM, 1975, HOSP COMMUNITY PSYCH, V26, P420; Solli HP, 2008, NORD J MUSIC THER, V17, P67, DOI 10.1080/08098130809478197; Solli HP, 2009, MUSIKKTERAPI, V3, P8; Solli HP, 2009, SKRIFTSERIE SENTER M, P15; Solli HP, 2006, MUSIKK HELSE, P113; Solli HP, 2003, MUSIKKTERAPI, V2, P10; Spencer L., 2003, QUALITY QUALITATIVE; Stern D. N, 2010, FORMS VITALITY EXPLO; Stern D, 2010, NORD J MUSIC THER, V19, P88, DOI 10.1080/08098131.2010.497634; Stige B, 2011, DEV MUSIC THERAPY PR, P416; Storz D, 2005, MUSIC THERAPY TODAY, V6, P1514; Strehlow G, 2007, INT J PSYCHOTHER, V11, P25; Strunck R, 1986, MUSIKTHERAPEUTISCHE, V7, P209; Sullivan J, 2003, GROUP, V27, P31, DOI 10.1023/A:1022980603069; Talwar N, 2006, BRIT J PSYCHIAT, V189, P405, DOI 10.1192/bjp.bp.105.015073; Thomas C., 2007, MUSIC THERAPY CHILDR, P125; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Ulrich G, 2007, ACTA PSYCHIAT SCAND, V116, P362, DOI 10.1111/j.1600-0447.2007.01073.x; Unkefer RF, 2005, MUSIC THERAPY TREATM; Vogt-Schaeffer K, 1991, MUSIKTHER UMSCH, V12, P185; Wolfe DE, 1996, EFFECTIVENESS MUSIC, P106; Yalom ID, 1983, INN PATIENT GROUP PS; Yalom ID, 2005, THEORY PRACTICE GROU	134	102	102	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70252	10.1371/journal.pone.0070252	http://dx.doi.org/10.1371/journal.pone.0070252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XU	23936399	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800038
J	Guo, WB; Liu, F; Xue, ZM; Gao, KM; Liu, ZN; Xiao, CQ; Chen, HF; Zhao, JP				Guo, Wenbin; Liu, Feng; Xue, Zhimin; Gao, Keming; Liu, Zhening; Xiao, Changqing; Chen, Huafu; Zhao, Jingping			Decreased Interhemispheric Coordination in Treatment-Resistant Depression: A Resting-State fMRI Study	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; MAJOR DEPRESSION; FUNCTIONAL CONNECTIVITY; GENDER-DIFFERENCES; TREATMENT RESPONSE; REGIONAL HOMOGENEITY; HUMAN BRAIN; DRUG-NAIVE; 1ST-EPISODE; DISORDER	Background: Previous studies have demonstrated that patients with treatment-resistant depression (TRD) and treatment-sensitive depression (TSD) differed at neural level. However, it remains unclear if these two subtypes of depression differ in the interhemispheric coordination. This study was undertaken for two purposes: (1) to explore the differences in interhemispheric coordination between these two subtypes by using the voxel-mirrored homotopic connectivity (VMHC) method; and (2) to determine if the difference of interhemispheric coordination can be used as a biomarker(s) to differentiate TRD from both TSD and healthy subjects (HS). Methods: Twenty-three patients with TRD, 22 with TSD, and 19 HS participated in the study. Data of these participants were analyzed with the VMHC and seed-based functional connectivity (FC) approaches. Results: Compared to the TSD group, the TRD group showed significantly lower VMHC values in the calcarine cortex, fusiform gyrus, hippocampus, superior temporal gyrus, middle cingulum, and precentral gyrus. Lower VMHC values were also observed in the TRD group in the calcarine cortex relative to the HS group. However, the TSD group had no significant change in VMHC value in any brain region compared to the HS group. Receiver operating characteristic curves (ROC) analysis revealed that the VMHC values in the calcarine cortex had discriminatory function distinguishing patients with TRD from patients with TSD as well as those participants in the HS group. Conclusions: Lower VMHC values of patients with TRD relative to those with TSD and those in the HS group in the calcarine cortex appeared to be a unique feature for patients with TRD and it may be used as an imaging biomarker to separate patients with TRD from those with TSD or HS.	[Guo, Wenbin; Xue, Zhimin; Liu, Zhening; Zhao, Jingping] Cent South Univ, Mental Hlth Inst, Xiangya Hosp 2, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Guo, Wenbin; Xiao, Changqing] Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China; [Liu, Feng; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu, Sichuan, Peoples R China; [Gao, Keming] Case Western Reserve Univ, Sch Med, Dept Psychiat,Univ Hosp Case Med Ctr, Mood & Anxiety Clin,Mood Disorders Program, Cleveland, OH 44106 USA; [Zhao, Jingping] Xinxiang Med Univ, Affiliated Hosp 2, Henan Key Lab Biol Psychiat, Xinxiang, Henan, Peoples R China	Central South University; Guangxi Medical University; University of Electronic Science & Technology of China; Case Western Reserve University; Case Western Reserve University Hospital; Xinxiang Medical University	Zhao, JP (corresponding author), Cent South Univ, Mental Hlth Inst, Xiangya Hosp 2, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China.	Keming.Gao@UHhospitals.org; edsgwb@126.com	zhao, jing/B-3868-2019; Liu, Feng/W-7572-2019; Gao, Keming/W-6017-2019	Liu, Feng/0000-0002-3570-4222; Liu, Zhening/0000-0001-6893-2427	National Natural Science Foundations of China [30900483, 81260210, 61035006, 30971053]; "10th Five-year-plan" of National Key Technologies R&D Program of China [2004DA7210A21]; Ministry of Health of the peoples' Republic of China [201002003]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); "10th Five-year-plan" of National Key Technologies R&D Program of China; Ministry of Health of the peoples' Republic of China	The study was supported by grants from National Natural Science Foundations of China (grant no. 30900483, no. 81260210, no. 61035006 and no. 30971053) and the "10th Five-year-plan" of National Key Technologies R&D Program of China (grant no. 2004DA7210A21), and the special funding by Ministry of Health of the peoples' Republic of China (grant no. 201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Baskaran A, 2012, NEUROPHARMACOLOGY, V63, P507, DOI 10.1016/j.neuropharm.2012.04.021; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruder GE, 1997, BIOL PSYCHIAT, V41, P939, DOI 10.1016/S0006-3223(96)00260-0; Bschor T, 2010, EXPERT REV NEUROTHER, V10, P77, DOI 10.1586/ERN.09.137; Carvalho A, 2011, J AFFECT DISORDERS, V129, P143, DOI 10.1016/j.jad.2010.08.023; Chantiluke K, 2012, BIOL PSYCHIAT, V71, P59, DOI 10.1016/j.biopsych.2011.09.005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; de Asis JM, 2001, AM J PSYCHIAT, V158, P1321, DOI 10.1176/appi.ajp.158.8.1321; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fagiolini A, 2003, BIOL PSYCHIAT, V53, P640, DOI 10.1016/S0006-3223(02)01670-0; First M. B., 1997, STRUCTURED CLIN INTE; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frodl T, 2009, WORLD J BIOL PSYCHIA, V10, P202, DOI 10.1080/15622970701624603; Fu CHY, 2007, AM J PSYCHIAT, V164, P599, DOI 10.1176/appi.ajp.164.4.599; Furtado CP, 2008, PSYCHIAT RES-NEUROIM, V163, P133, DOI 10.1016/j.pscychresns.2007.11.005; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gilbert AM, 2010, PSYCHIAT RES-NEUROIM, V181, P9, DOI 10.1016/j.pscychresns.2009.07.006; Gildengers AG, 2005, J CLIN PSYCHOPHARM, V25, pS8, DOI 10.1097/01.jcp.0000161498.81137.12; Guo WB, 2012, J PSYCHIATR RES, V46, P1366, DOI 10.1016/j.jpsychires.2012.07.003; Guo WB, 2012, NEUROSCI LETT, V522, P139, DOI 10.1016/j.neulet.2012.06.027; Guo WB, 2012, PROG NEURO-PSYCHOPH, V38, P201, DOI 10.1016/j.pnpbp.2012.03.012; Guo WB, 2013, PROG NEURO-PSYCHOPH, V41, P24, DOI 10.1016/j.pnpbp.2012.11.003; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Holtzheimer PE, 2004, DEPRESS ANXIETY, V19, P24, DOI 10.1002/da.10147; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Katon W, 2010, DEPRESS ANXIETY, V27, P19, DOI 10.1002/da.20613; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kennedy SH, 2007, AM J PSYCHIAT, V164, P778, DOI 10.1176/appi.ajp.164.5.778; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; Little A, 2009, AM FAM PHYSICIAN, V80, P167; Liu DQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00024; Liu F, 2013, J AFFECT DISORDERS, V146, P401, DOI 10.1016/j.jad.2012.10.001; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040968; Liu TS, 2003, CEREB CORTEX, V13, P1334, DOI 10.1093/cercor/bhg080; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; NIERENBERG A A, 1990, Journal of Clinical Psychiatry, V51, P39; Petersen T, 2001, PSYCHOL MED, V31, P1223, DOI 10.1017/S0033291701004305; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Putnam KM, 2008, BIOL PSYCHOL, V77, P237, DOI 10.1016/j.biopsycho.2007.10.010; Riedel M, 2011, J AFFECT DISORDERS, V133, P137, DOI 10.1016/j.jad.2011.04.007; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Scheibe S, 2003, J AFFECT DISORDERS, V75, P223, DOI 10.1016/S0165-0327(02)00050-2; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Stimpson N, 2002, BRIT J PSYCHIAT, V181, P284, DOI 10.1192/bjp.181.4.284; Stuhrmann A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-10; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060191; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	61	39	47	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71368	10.1371/journal.pone.0071368	http://dx.doi.org/10.1371/journal.pone.0071368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936504	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800062
J	Bravo, G; Squazzoni, F				Bravo, Giangiacomo; Squazzoni, Flaminio			Exit, Punishment and Rewards in Commons Dilemmas: An Experimental Study	PLOS ONE			English	Article							PUBLIC-GOODS; HUMAN COOPERATION; CHOICE; SANCTIONS; CARROT; STICK; PROVISION; PEOPLE	Commons dilemmas are interaction situations where a common good is provided or exploited by a group of individuals so that optimal collective outcomes clash with private interests. Although in these situations, social norms and institutions exist that might help individuals to cooperate, little is known about the interaction effects between positive and negative incentives and exit options by individuals. We performed a modified public good game experiment to examine the effect of exit, rewards and punishment, as well as the interplay between exit and rewards and punishment. We found that punishment had a stronger effect than rewards on cooperation if considered by itself, whereas rewards had a stronger effect when combined with voluntary participation. This can be explained in terms of the 'framing effect', i.e., as the combination of exit and rewards might induce people to attach higher expected payoffs to cooperative strategies and expect better behaviour from others.	[Bravo, Giangiacomo] Linnaeus Univ, Dept Social Studies, Vaxjo, Sweden; [Bravo, Giangiacomo] Coll Carlo Alberto, Moncalieri, Italy; [Squazzoni, Flaminio] Univ Brescia, Dept Econ & Management, Brescia, Italy	Linnaeus University; Collegio Carlo Alberto; University of Brescia	Bravo, G (corresponding author), Linnaeus Univ, Dept Social Studies, Vaxjo, Sweden.	giangiacomo.bravo@lnu.se		Squazzoni, Flaminio/0000-0002-6503-6077; Bravo, Giangiacomo/0000-0003-2837-0137	Collegio Carlo Alberto	Collegio Carlo Alberto	The research was funded by the Collegio Carlo Alberto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A., 2002, DRAMA COMMONS, P41, DOI DOI 10.17226/10287; Andreoni J, 2003, AM ECON REV, V93, P893, DOI 10.1257/000282803322157142; ANDREONI J, 1988, J PUBLIC ECON, V37, P291, DOI 10.1016/0047-2727(88)90043-6; BATALI J, 1995, J THEOR BIOL, V175, P161, DOI 10.1006/jtbi.1995.0128; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Croson R., 2008, HDB EXPT EC RESULTS, P776, DOI DOI 10.1016/S1574-0722(07)00082-0; Dari-Mattiacci G, 2010, J LAW ECON ORGAN, V26, P365, DOI 10.1093/jleo/ewn026; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frey BS, 2001, J ECON SURV, V15, P589, DOI 10.1111/1467-6419.00150; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2004, J SOCIO-ECON, V33, P697; Greiner B., 2004, FORSCHUNG WISSENSCHA, V63, P79; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; ISAAC RM, 1985, J PUBLIC ECON, V26, P51; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; Kahneman D, 2000, CHOICES VALUES FRAME; Kosfeld M, 2009, AM ECON REV, V99, P1335, DOI 10.1257/aer.99.4.1335; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Milinski M, 2012, J THEOR BIOL, V299, P139, DOI 10.1016/j.jtbi.2011.03.014; North DC, 2005, PRINC ECON HIST W WO, P1; Okhuysen GA, 2002, ORGAN SCI, V13, P370, DOI 10.1287/orsc.13.4.370.2947; ORBELL JM, 1993, AM SOCIOL REV, V58, P787, DOI 10.2307/2095951; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E., 1994, RULES GAMES COMMON P; Ostrom E, 2006, J ECON BEHAV ORGAN, V61, P149, DOI 10.1016/j.jebo.2005.02.008; R Core Team, 2012, R LANG ENV STAT COMP; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Richerson PJ, 2001, EVOLUTION CAPACITY C, P186; Sasaki T, 2007, P ROY SOC B-BIOL SCI, V274, P2639, DOI 10.1098/rspb.2007.0673; Sefton M, 2007, ECON INQ, V45, P671, DOI 10.1111/j.1465-7295.2007.00051.x; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Shalvi S, 2011, J EXP SOC PSYCHOL, V47, P1096, DOI 10.1016/j.jesp.2011.04.015; SPICER MW, 1985, ACAD MANAGE REV, V10, P518, DOI 10.2307/258133; Sutter M, 2010, REV ECON STUD, V77, P1540, DOI 10.1111/j.1467-937X.2010.00608.x; Tenbrunsel AE, 1999, ADMIN SCI QUART, V44, P684, DOI 10.2307/2667052; Walker JM, 2004, EXP ECON, V7, P235, DOI 10.1023/B:EXEC.0000040559.08652.51; WALKER JM, 1990, J ENVIRON ECON MANAG, V19, P203, DOI 10.1016/0095-0696(90)90069-B; Walker JM, 2000, ECON J, V110, P212, DOI 10.1111/1468-0297.00497; Whitmeyer JM, 2002, SOC SCI RES, V31, P630, DOI 10.1016/S0049-089X(02)00017-0	53	6	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69871	10.1371/journal.pone.0069871	http://dx.doi.org/10.1371/journal.pone.0069871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219PB	23936356	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400025
J	Erro, R; Vitale, C; Amboni, M; Picillo, M; Moccia, M; Longo, K; Santangelo, G; De Rosa, A; Allocca, R; Giordano, F; Orefice, G; De Michele, G; Santoro, L; Pellecchia, MT; Barone, P				Erro, Roberto; Vitale, Carmine; Amboni, Marianna; Picillo, Marina; Moccia, Marcello; Longo, Katia; Santangelo, Gabriella; De Rosa, Anna; Allocca, Roberto; Giordano, Flavio; Orefice, Giuseppe; De Michele, Giuseppe; Santoro, Lucio; Pellecchia, Maria Teresa; Barone, Paolo			The Heterogeneity of Early Parkinson's Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients	PLOS ONE			English	Article							NONMOTOR SYMPTOMS; COGNITIVE IMPAIRMENT; FOLLOW-UP; EARLY-ONSET; DE-NOVO; COHORT; INCIDENT; ASSOCIATION; REPLACEMENT; DEMENTIA	Background: The variability in the clinical phenotype of Parkinson's disease seems to suggest the existence of several subtypes of the disease. To test this hypothesis we performed a cluster analysis using data assessing both motor and non-motor symptoms in a large cohort of newly diagnosed untreated PD patients. Methods: We collected data on demographic, motor, and the whole complex of non-motor symptoms from 100 consecutive newly diagnosed untreated outpatients. Statistical cluster analysis allowed the identification of different subgroups, which have been subsequently explored. Results: The data driven approach identified four distinct groups of patients, we have labeled: 1) Benign Pure Motor; 2) Benign mixed Motor-Non-Motor; 3) Non-Motor Dominant; and 4) Motor Dominant. Conclusion: Our results confirmed the existence of different subgroups of early PD patients. Cluster analysis revealed the presence of distinct subtypes of patients profiled according to the relevance of both motor and non-motor symptoms. Identification of such subtypes may have important implications for generating pathogenetic hypotheses and therapeutic strategies.	[Erro, Roberto] UCL, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Vitale, Carmine; Amboni, Marianna; Longo, Katia; Santangelo, Gabriella] IDC Hermitage Capodimonte, Naples, Italy; [Vitale, Carmine] Univ Parthenope, Naples, Italy; [Picillo, Marina; Moccia, Marcello; De Rosa, Anna; Allocca, Roberto; Orefice, Giuseppe; De Michele, Giuseppe; Santoro, Lucio] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; [Santangelo, Gabriella] Univ Naples 2, Dept Psychol, Neuropsychol Lab, Caserta, Italy; [Giordano, Flavio; Pellecchia, Maria Teresa; Barone, Paolo] Univ Salerno, Ctr Neurodegenerat Dis CEMAND, I-84100 Salerno, Italy	University of London; University College London; Parthenope University Naples; University of Naples Federico II; Universita della Campania Vanvitelli; University of Salerno	Barone, P (corresponding author), Univ Salerno, Ctr Neurodegenerat Dis CEMAND, I-84100 Salerno, Italy.	pbarone@unisa.it	Moccia, Marcello/N-6987-2015; picillo, marina/AAC-2210-2019; Pellecchia, Maria Teresa/AHH-4069-2022; Amboni, Marianna/AGK-4180-2022; Picillo, Marina/AAF-4297-2020; Erro, Roberto/GRJ-3466-2022; Erro, Roberto/AAC-2574-2019; Santangelo, Gabriella/K-3618-2016; Barone, Paolo/AAC-4886-2022; Amboni, Marianna/ABD-1421-2021	Moccia, Marcello/0000-0003-2613-3090; picillo, marina/0000-0001-9025-137X; Erro, Roberto/0000-0002-7800-7419; Santangelo, Gabriella/0000-0002-7728-852X; Vitale, Carmine/0000-0003-3015-1929; Santoro, Lucio/0000-0001-9507-2303; PELLECCHIA, MARIA TERESA/0000-0002-6217-313X; OREFICE, Giuseppe/0000-0002-7159-7815	Boehringer Ingelheim; Novartis; Schwarz Pharma/UCB; Merck-Serono; Solvay; Lundbeck	Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Schwarz Pharma/UCB(UCB Pharma SA); Merck-Serono(Merck & Company); Solvay(Solvay SA); Lundbeck(Lundbeck Corporation)	Dr. Carmine Vitale has received honoraria for symposia from Boehringer Ingelheim, Lundbeck, Novartis, Schwarz Pharma/UCB, GSK. Dr. Gabriella Santangelo has received honoraria for symposia from Lundbeck. Prof Paolo Barone has received honoraria as a Consultant & Advisory Board Memberships for Novartis, Schwarz Pharma/UCB, Merck-Serono, Eisai, Solvay, General Electric and Lundbeck. He has received research support from Boehringer Ingelheim, Novartis, Schwarz Pharma/UCB, Merck-Serono, Solvay, and Lundbeck. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Amboni M, 2010, MOVEMENT DISORD, V25, P800, DOI 10.1002/mds.23033; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Burn DJ, 2003, MOVEMENT DISORD, V18, P884, DOI 10.1002/mds.10455; COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095; Cubo E, 2010, MOVEMENT DISORD, V25, P70, DOI 10.1002/mds.22896; Erro R, 2013, PARKINSONISM RELAT D, V19, P256, DOI 10.1016/j.parkreldis.2012.10.020; Erro R, 2013, J NEUROL NEUROSUR PS, V84, P14, DOI 10.1136/jnnp-2012-303419; Erro R, 2012, PARKINSONISM RELAT D, V18, P1034, DOI 10.1016/j.parkreldis.2012.05.022; Erro R, 2012, J NEUROL, V259, P1808, DOI 10.1007/s00415-011-6407-0; Evans JR, 2011, J NEUROL NEUROSUR PS, V82, P1112, DOI 10.1136/jnnp.2011.240366; Fera F, 2007, BRAIN RES BULL, V74, P75, DOI 10.1016/j.brainresbull.2007.05.009; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Kulisevsky J, 2000, MOVEMENT DISORD, V15, P613, DOI 10.1002/1531-8257(200007)15:4<613::AID-MDS1005>3.0.CO;2-F; LESSER RP, 1979, NEUROLOGY, V29, P1253, DOI 10.1212/WNL.29.9_Part_1.1253; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; LUDIN SM, 1989, J NEUROL, V236, P203, DOI 10.1007/BF00314500; Marras C, 2012, J NEUROL NEUROSURG P; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586; Martinez-Martin P, 2012, J NEUROL, V259, P1639, DOI 10.1007/s00415-011-6392-3; MJONES HENRY, 1949, ACTA PSYCHIAT ET NEUROL [COPENHAGEN], V54, P1; MUTHANE UB, 1994, MOVEMENT DISORD, V9, P539, DOI 10.1002/mds.870090506; Nobili F, 2010, MOVEMENT DISORD, V25, P35, DOI 10.1002/mds.22899; Okun MS, 2002, ARCH NEUROL-CHICAGO, V59, P1750, DOI 10.1001/archneur.59.11.1750; Pappata S, 2011, NEUROLOGY, V77, P1357, DOI 10.1212/WNL.0b013e3182315259; Park A, 2009, J NEUROL, V256, pS293, DOI 10.1007/s00415-009-5240-1; Lloret SP, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/473579; Post B, 2008, J NEUROL, V255, P716, DOI 10.1007/s00415-008-0782-1; Reider CR, 2003, MOVEMENT DISORD, V18, P275, DOI 10.1002/mds.10391; Reijnders JSAM, 2009, PARKINSONISM RELAT D, V15, P379, DOI 10.1016/j.parkreldis.2008.09.003; Rektorova I, 2008, MOVEMENT DISORD, V23, P1580, DOI 10.1002/mds.22158; RICHARDS M, 1993, ANN NEUROL, V33, P267, DOI 10.1002/ana.410330307; Rohl A, 1994, Eur J Neurol, V1, P65, DOI 10.1111/j.1468-1331.1994.tb00052.x; SANTAMARIA J, 1986, NEUROLOGY, V36, P1130, DOI 10.1212/WNL.36.8.1130; Santangelo G, 2009, J NEUROL, V256, P632, DOI 10.1007/s00415-009-0146-5; Spica V, 2012, J NEUROL; Spinnler H., 1987, ITAL J NEUROL SCI, VS8, P6; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; van Rooden SM, 2010, MOVEMENT DISORD, V25, P969, DOI 10.1002/mds.23116; VIITANEN M, 1994, J NEUROL NEUROSUR PS, V57, P1203, DOI 10.1136/jnnp.57.10.1203; Wickremaratchi MM, 2011, MOVEMENT DISORD, V26, P457, DOI 10.1002/mds.23469; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; ZETUSKY WJ, 1985, NEUROLOGY, V35, P522, DOI 10.1212/WNL.35.4.522	46	127	128	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70244	10.1371/journal.pone.0070244	http://dx.doi.org/10.1371/journal.pone.0070244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936396	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400046
J	Strangman, GE; Li, Z; Zhang, Q				Strangman, Gary E.; Li, Zhi; Zhang, Quan			Depth Sensitivity and Source-Detector Separations for Near Infrared Spectroscopy Based on the Colin27 Brain Template	PLOS ONE			English	Article							ADULT HEAD MODEL; LIGHT-PROPAGATION; PHOTON MIGRATION; SUPERFICIAL TISSUE; SCATTERING; THICKNESS; TRANSPORT; SCALP; INTERFERENCE; SKULL	Understanding the spatial and depth sensitivity of non-invasive near-infrared spectroscopy (NIRS) measurements to brain tissue-i.e., near-infrared neuromonitoring (NIN) - is essential for designing experiments as well as interpreting research findings. However, a thorough characterization of such sensitivity in realistic head models has remained unavailable. In this study, we conducted 3,555 Monte Carlo (MC) simulations to densely cover the scalp of a well-characterized, adult male template brain (Colin27). We sought to evaluate: (i) the spatial sensitivity profile of NIRS to brain tissue as a function of source-detector separation, (ii) the NIRS sensitivity to brain tissue as a function of depth in this realistic and complex head model, and (iii) the effect of NIRS instrument sensitivity on detecting brain activation. We found that increasing the source-detector (SD) separation from 20 to 65 mm provides monotonic increases in sensitivity to brain tissue. For every 10 mm increase in SD separation (up to similar to 45 mm), sensitivity to gray matter increased an additional 4%. Our analyses also demonstrate that sensitivity in depth (S) decreases exponentially, with a "rule-of-thumb" formula S = 0.75*0.85(depth). Thus, while the depth sensitivity of NIRS is not strictly limited, NIN signals in adult humans are strongly biased towards the outermost 10-15 mm of intracranial space. These general results, along with the detailed quantitation of sensitivity estimates around the head, can provide detailed guidance for interpreting the likely sources of NIRS signals, as well as help NIRS investigators design and plan better NIRS experiments, head probes and instruments.	[Strangman, Gary E.; Li, Zhi; Zhang, Quan] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neural Syst Grp, Charlestown, MA USA	Harvard University; Massachusetts General Hospital	Strangman, GE (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neural Syst Grp, Charlestown, MA USA.	strang@nmr.mgh.harvard.edu		Strangman, Gary/0000-0001-8896-2164	National Space Biomedical Research Institute through NASA [NCC 9-58]	National Space Biomedical Research Institute through NASA	This work was supported by the National Space Biomedical Research Institute through NASA NCC 9-58. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELOYE A, 1975, AM J PHYS ANTHROPOL, V43, P23, DOI 10.1002/ajpa.1330430105; Arridge S, 1992, PHYS MED BIOL, V37, P30; Arridge S, 1993, P SOC PHOTO-OPT INS, V1888, P12; ARRIDGE SR, 1993, MED PHYS, V20, P299, DOI 10.1118/1.597069; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Babiloni F, 1997, ELECTROEN CLIN NEURO, V103, P486, DOI 10.1016/S0013-4694(97)00035-7; Bevilacqua F, 1999, APPL OPTICS, V38, P12; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; CUI WJ, 1992, IEEE T BIO-MED ENG, V39, P194, DOI 10.1109/10.121651; Custo A, 2006, APPL OPTICS, V45, P4747, DOI 10.1364/AO.45.004747; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Firbank M, 1996, PHYS MED BIOL, V41, P767, DOI 10.1088/0031-9155/41/4/012; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; GRATTON G, 1995, PSYCHOPHYSIOLOGY, V32, P292, DOI 10.1111/j.1469-8986.1995.tb02958.x; Haiyan Li, 2007, International Journal of Vehicle Safety, V2, P345, DOI 10.1504/IJVS.2007.016747; Hasan KM, 2007, NEUROREPORT, V18, P1735, DOI 10.1097/WNR.0b013e3282f0d40c; Haselgrove JC, 1992, APPL OPTICS, V31, P6; Hayashi T, 2003, APPL OPTICS, V42, P2888, DOI 10.1364/AO.42.002888; Hayashi T, 2003, OPT REV, V10, P5; Heiskala J, 2007, APPL OPTICS, V46, P1633, DOI 10.1364/AO.46.001633; Hielscher AH, 1998, PHYS MED BIOL, V43, P1285, DOI 10.1088/0031-9155/43/5/017; HIRAOKA M, 1993, PHYS MED BIOL, V38, P1859, DOI 10.1088/0031-9155/38/12/011; HORI H, 1972, J INVEST DERMATOL, V58, P396, DOI 10.1111/1523-1747.ep12540633; Hoshi Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2142325; Hueber DM, 2001, PHYS MED BIOL, V46, P41, DOI 10.1088/0031-9155/46/1/304; Ishimaru A, 1989, APPL OPTICS, V28, P6; Jacques S.L., 1995, OPTICAL THERMAL RESP, DOI 10.1007/978-1-4757-6092-7; Kawaguchi H, 2004, PHYS MED BIOL, V49, P2753, DOI 10.1088/0031-9155/49/12/019; Law Samuel K., 1993, Brain Topography, V6, P99, DOI 10.1007/BF01191074; Mansouri C, 2010, LASER MED SCI, V25, P431, DOI 10.1007/s10103-010-0754-4; Moulton JD, 1990, DIFFUSION MODELLING; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Okada E, 1995, PHYS MED BIOL, V40, P2093, DOI 10.1088/0031-9155/40/12/007; Okada E, 2000, OPT REV, V7, P375, DOI 10.1007/s10043-000-0375-4; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDENDORF WH, 1969, J NUCL MED, V10, P177; Patterson MS, 1989, APPL OPTICS, V28, P7; POGUE BW, 1994, PHYS MED BIOL, V39, P1157, DOI 10.1088/0031-9155/39/7/008; Profio AE, 1989, APPL OPTICS, V28, P7; Ren K, 2004, OPT LETT, V29, P578, DOI 10.1364/OL.29.000578; Saager R, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940587; Schweiger M., 1993, Journal of Mathematical Imaging and Vision, V3, P263, DOI 10.1007/BF01248356; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Todd TW, 1924, J ANAT, V58, P231; Torricelli A, 2001, PHYS MED BIOL, V46, P2227, DOI 10.1088/0031-9155/46/8/313; Van der Zee PF, 1987, ADV EXP MED BIOL, V215, P18; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Wang L, 1995, COMPUT METH PROG BIO, V47, P16; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; WANG LH, 1994, MED PHYS, V21, P1081, DOI 10.1118/1.597351; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; YODH A, 1995, PHYS TODAY, V48, P34, DOI 10.1063/1.881445; Zhang Q, 2007, ELECTROOPTICAL SYSTE; Zhang Q, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804706; Zhang Q, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2754714; Zhang Q, 2009, NEUROIMAGE, V45, P788, DOI 10.1016/j.neuroimage.2008.12.048; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x	63	132	132	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e66319	10.1371/journal.pone.0066319	http://dx.doi.org/10.1371/journal.pone.0066319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936292	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400003
J	Hanekom, M; Streicher, EM; Van de Berg, D; Cox, H; McDermid, C; Bosman, M; Gey van Pittius, NC; Victor, TC; Kidd, M; van Soolingen, D; van Helden, PD; Warren, RM				Hanekom, Madeleine; Streicher, Elizabeth M.; Van de Berg, Doreen; Cox, Helen; McDermid, Cheryl; Bosman, Marlein; Gey van Pittius, Nicolaas C.; Victor, Tommie C.; Kidd, Martin; van Soolingen, Dick; van Helden, Paul D.; Warren, Robin M.			Population Structure of Mixed Mycobacterium tuberculosis Infection Is Strain Genotype and Culture Medium Dependent	PLOS ONE			English	Article							MULTIPLE STRAINS; PULMONARY TUBERCULOSIS; REINFECTION	Background: Molecular genotyping methods have shown infection with more than one Mycobacterium tuberculosis strain genotype in a single sputum culture, indicating mixed infection. Aim: This study aimed to develop a PCR-based genotyping tool to determine the population structure of M. tuberculosis strain genotypes in primary Mycobacterial Growth Indicator Tubes (MGIT) and Lowenstein-Jensen (LJ) cultures to identify mixed infections and to establish whether the growth media influenced the recovery of certain strain genotypes. Method: A convenience sample of 206 paired MGIT and LJ M. tuberculosis cultures from pulmonary tuberculosis patients resident in Khayelitsha, South Africa were genotyped using an in-house PCR-based method to detect defined M. tuberculosis strain genotypes. Results: The sensitivity and specificity of the PCR-based method for detecting Beijing, Haarlem, S-family, and LAM genotypes was 100%, and 75% and 50% for detecting the Low Copy Clade, respectively. Thirty-one (15%) of the 206 cases showed the presence of more than one M. tuberculosis strain genotype. Strains of the Beijing and Haarlem genotypes were significantly more associated with a mixed infection (on both media) when compared to infections with a single strain (Beijing MGIT p = 0.02; LJ, p<0.01) and (Haarlem: MGIT p<0.01; LJ, p = 0.01). Strains with the Beijing genotype were less likely to be with "other genotype" strains (p<0.01) while LAM, Haarlem, S-family and LCC occurred independently with the Beijing genotype. Conclusion: The PCR-based method was able to identify mixed infection in at least 15% of the cases. LJ media was more sensitive in detecting mixed infections than MGIT media, implying that the growth characteristics of M. tuberculosis on different media may influence our ability to detect mixed infections. The Beijing and Haarlem genotypes were more likely to occur in a mixed infection than any of the other genotypes tested suggesting pathogen-pathogen compatibility.	[Hanekom, Madeleine] Univ Stellenbosch, Fac Hlth Sci, Div Anat & Histol, ZA-7600 Stellenbosch, Western Cape, South Africa; [Streicher, Elizabeth M.; Van de Berg, Doreen; Gey van Pittius, Nicolaas C.; Victor, Tommie C.; van Helden, Paul D.; Warren, Robin M.] Univ Stellenbosch, Div Mol Biol & Human Genet,Fac Hlth Sci, MRC,Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res, ZA-7600 Stellenbosch, Western Cape, South Africa; [Cox, Helen] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [McDermid, Cheryl] Med Sans Frontieres, Cape Town, South Africa; [Bosman, Marlein] Natl Hlth Lab Serv, Cape Town, Western Cape, South Africa; [Kidd, Martin] Univ Stellenbosch, Ctr Stat Consultat, ZA-7600 Stellenbosch, Western Cape, South Africa; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Natl TB Reference Lab, Bilthoven, Netherlands	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; University of Cape Town; Stellenbosch University; Netherlands National Institute for Public Health & the Environment	Hanekom, M (corresponding author), Univ Stellenbosch, Fac Hlth Sci, Div Anat & Histol, ZA-7600 Stellenbosch, Western Cape, South Africa.	hanekom@sun.ac.za	Streicher, Elizabeth/O-9597-2019; Streicher, Elizabeth M/I-7780-2018; van Pittius, Nicolaas C Gey/D-3434-2015	Streicher, Elizabeth/0000-0003-3901-1981; Streicher, Elizabeth M/0000-0003-3901-1981; van Pittius, Nicolaas C Gey/0000-0002-8807-4105; Warren, Robin/0000-0001-5741-7358; Cox, Helen/0000-0002-6538-7192	Centre of Excellence for Biomedical Tuberculosis Research; Medicine Research Council of South Africa; Medecins Sans Frontieres, Belgium	Centre of Excellence for Biomedical Tuberculosis Research; Medicine Research Council of South Africa; Medecins Sans Frontieres, Belgium	This study was funded by the Centre of Excellence for Biomedical Tuberculosis Research and the Medicine Research Council of South Africa. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The survey study was funded by Medecins Sans Frontieres, Belgium. The funder was involved in study design, data collection and analysis. However, final preparation of the manuscript and the decision to publish rests with the first author.	Behr MA, 2004, AM J RESP CRIT CARE, V169, P554, DOI 10.1164/rccm.2401001; Chaves F, 1999, AIDS, V13, P615, DOI 10.1097/00002030-199904010-00011; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Das S, 2004, INT J TUBERC LUNG D, V8, P267; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; Dickman KR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-349; du Plessis DG, 2001, TUBERCULOSIS, V81, P211, DOI 10.1054/tube.2000.0278; Fang RD, 2008, TUBERCULOSIS, V88, P469, DOI 10.1016/j.tube.2008.02.002; Huang HY, 2010, J CLIN MICROBIOL, V48, P4474, DOI 10.1128/JCM.00930-10; Mallard K, 2010, J CLIN MICROBIOL, V48, P4512, DOI 10.1128/JCM.01683-10; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Martin A, 2010, TUBERCULOSIS, V90, P201, DOI 10.1016/j.tube.2010.03.012; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Navarro Y, 2011, J CLIN MICROBIOL, V49, P4131, DOI 10.1128/JCM.05203-11; Patel NR, 2009, J LEUKOCYTE BIOL, V86, P53, DOI [10.1189/JLB.0908574, 10.1189/jlb.0908574]; Richardson M, 2002, J CLIN MICROBIOL, V40, P2750, DOI 10.1128/JCM.40.8.2750-2754.2002; Rishi S, 2007, Indian J Med Microbiol, V25, P383; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; THEISEN A, 1995, LANCET, V345, P1512, DOI 10.1016/S0140-6736(95)91073-5; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Uys PW, 2009, J R SOC INTERFACE, V6, P11, DOI 10.1098/rsif.2008.0184; van der Zanden Adri G. M., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P704; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC	26	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70178	10.1371/journal.pone.0070178	http://dx.doi.org/10.1371/journal.pone.0070178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936157	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200060
J	Mencel, M; Nash, M; Jacobson, C				Mencel, Malwina; Nash, Michelle; Jacobson, Christian			Neuregulin Upregulates Microglial alpha 7 Nicotinic Acetylcholine Receptor Expression in Immortalized Cell Lines: Implications for Regulating Neuroinflammation	PLOS ONE			English	Article							MISSING LINK; VAGUS NERVE; MOUSE MODEL; ERBB4; BRAIN; ACTIVATION; CYTOKINES; NEUROPROTECTION; STIMULATION; MACROPHAGES	Neuregulin, previously known as ARIA, is a signaling protein involved in cell survival, synaptic plasticity, cell communication and differentiation. Neuregulin has also been described as a potent inducer of acetylcholine receptor transcription in muscle and although both neuregulin and acetylcholine have been individually described to have neuroprotective roles, their relationship in the cholinergic anti-inflammatory pathway of the brain has not been examined. Using three cell lines, BV-2, EOC-20 and RAW 264.7, we investigated the role that neuregulin signaling through the Erb family of tyrosine kinases may play in the anti-inflammatory process mediated by the alpha 7 nicotinic acetylcholine receptors. Here we show that ErbB4 is expressed in all of our cell lines and is phosphorylated upon treatment with neuregulin. Neuregulin treatment further increases the expression of alpha 7 nicotinic acetylcholine receptors in the microglial lines tested. Given the central role of alpha 7 nicotinic acetylcholine receptors in regulating system inflammation we analyzed the expression of several pro-inflammatory cytokines in our system. Using ELISAs for TNF-alpha and IL-6 we show that treatment with NRG can produce a nearly a 33% decrease in the levels of tumor necrosis factor-alpha secreted by activated microglia and a nearly 88% decrease in IL-6. Given these results we propose a neuroprotective role for neuregulin wherein it modulates the expression of TNF-alpha and thus inflammation in the CNS via the upregulation of alpha 7 nicotinic acetylcholine receptor expression in microglia in vitro. We suggest that the disregulation of neuregulin expression may be pivotal in neurological disorders characterized by inflammation.	[Mencel, Malwina; Nash, Michelle; Jacobson, Christian] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Jacobson, Christian] Univ Namibia, Natl Sch Med, Pionierspark, Windhoek, Namibia	University of Waterloo; University of Namibia	Mencel, M (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	mmencel@uwaterloo.ca			Ontario Graduate Scholarship; Department of Biology	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Department of Biology	MM has been funded by Ontario Graduate Scholarship. Continued funding for MM has been provided by the Department of Biology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; Campos-Caro A, 2001, DNA CELL BIOL, V20, P657, DOI 10.1089/104454901753340640; Cannella B, 1999, J NEUROIMMUNOL, V100, P233, DOI 10.1016/S0165-5728(99)00201-5; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; Combs CK, 2001, J NEUROSCI, V21, P1179; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; De Simone R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-4; Dimayuga FO, 2003, J NEUROIMMUNOL, V136, P67, DOI 10.1016/S0165-5728(03)00003-1; Erlich S, 2001, NEUROSCIENCE, V107, P353, DOI 10.1016/S0306-4522(01)00350-5; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Fetler L, 2005, SCIENCE, V309, P392, DOI 10.1126/science.1114852; Gerecke KM, 2001, J COMP NEUROL, V433, P86, DOI 10.1002/cne.1127; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101; KARP HL, 1994, GLIA, V11, P284, DOI 10.1002/glia.440110310; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Meyer D, 1997, DEVELOPMENT, V124, P3575; Mielke JG, 2009, NEUROSCI RES, V65, P296, DOI 10.1016/j.neures.2009.08.003; Mograbi B, 1997, EUR CYTOKINE NETW, V8, P73; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; Rezaie Payam, 2002, J Hist Neurosci, V11, P325, DOI 10.1076/jhin.11.4.325.8531; Rimer M, 2003, J NEUROCYTOL, V32, P665, DOI 10.1023/B:NEUR.0000020615.79831.51; Salvi M, 2000, EUR J ENDOCRINOL, V143, P197, DOI 10.1530/eje.0.1430197; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wu CH, 1997, NEUROSCI RES, V27, P133, DOI 10.1016/S0168-0102(96)01140-6; Xu ZF, 2005, NEUROBIOL DIS, V19, P461, DOI 10.1016/j.nbd.2005.01.027; Xu ZF, 2005, NEUROSCI LETT, V375, P181, DOI 10.1016/j.neulet.2004.11.039; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	52	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70338	10.1371/journal.pone.0070338	http://dx.doi.org/10.1371/journal.pone.0070338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936190	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200076
J	Garcia-Pena, C; Garcia-Fabela, LC; Gutierrez-Robledo, LM; Garcia-Gonzalez, JJ; Arango-Lopera, VE; Perez-Zepeda, MU				Garcia-Pena, Carmen; Garcia-Fabela, Luis C.; Gutierrez-Robledo, Luis M.; Garcia-Gonzalez, Jose J.; Arango-Lopera, Victoria E.; Perez-Zepeda, Mario U.			Handgrip Strength Predicts Functional Decline at Discharge in Hospitalized Male Elderly: A Hospital Cohort Study	PLOS ONE			English	Article							GERIATRIC EVALUATION; OLDER-ADULTS; BODY-COMPOSITION; DISABILITY; TRAJECTORIES; VALIDATION; HEALTH; OUTCOMES; UNIT	Functional decline after hospitalization is a common adverse outcome in elderly. An easy to use, reproducible and accurate tool to identify those at risk would aid focusing interventions in those at higher risk. Handgrip strength has been shown to predict adverse outcomes in other settings. The aim of this study was to determine if handgrip strength measured upon admission to an acute care facility would predict functional decline (either incident or worsening of preexisting) at discharge among older Mexican, stratified by gender. In addition, cutoff points as a function of specificity would be determined. A cohort study was conducted in two hospitals in Mexico City. The primary endpoint was functional decline on discharge, defined as a 30-point reduction in the Barthel Index score from that of the baseline score. Handgrip strength along with other variables was measured at initial assessment, including: instrumental activities of daily living, cognition, depressive symptoms, delirium, hospitalization length and quality of life. All analyses were stratified by gender. Logistic regression to test independent association between handgrip strength and functional decline was performed, along with estimation of handgrip strength test values (specificity, sensitivity, area under the curve, etc.). A total of 223 patients admitted to an acute care facility between 2007 and 2009 were recruited. A total of 55 patients (24.7%) had functional decline, 23.46% in male and 25.6% in women. Multivariate analysis showed that only males with low handgrip strength had an increased risk of functional decline at discharge (OR 0.88, 95% CI 0.79-0.98, p = 0.01), with a specificity of 91.3% and a cutoff point of 20.65 kg for handgrip strength. Females had not a significant association between handgrip strength and functional decline. Measurement of handgrip strength on admission to acute care facilities may identify male elderly patients at risk of having functional decline, and intervene consequently.	[Garcia-Pena, Carmen] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Area Envejecimiento, Unidad Invest Epidemiol & Serv Salud, Mexico City, DF, Mexico; [Gutierrez-Robledo, Luis M.; Arango-Lopera, Victoria E.; Perez-Zepeda, Mario U.] Inst Nacl Geriatr, Mexico City, DF, Mexico; [Garcia-Gonzalez, Jose J.] Inst Mexicano Seguro Social, Hosp Reg 1, Queretaro, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Perez-Zepeda, MU (corresponding author), Inst Nacl Geriatr, Mexico City, DF, Mexico.	ulises.perez@salud.gob.mx	PEREZ-ZEPEDA, MARIO Ulises/B-7265-2011; García-Peña, Carmen/F-1468-2011	PEREZ-ZEPEDA, MARIO Ulises/0000-0003-4374-976X; García-Peña, Carmen/0000-0002-9380-6964; Gutierrez Robledo, Luis M/0000-0002-9728-6644	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [2004-CO2-020]; Mexican Institute of Social Security [IMSS 2005-3607-0016]	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Mexican Institute of Social Security	This work was supported by grants from CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico; 2004-CO2-020) and the Mexican Institute of Social Security (IMSS 2005-3607-0016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplund K, 2000, J AM GERIATR SOC, V48, P1381, DOI 10.1111/j.1532-5415.2000.tb02626.x; Avila-Funes JA, 2011, J NUTR HEALTH AGING, V15, P683, DOI 10.1007/s12603-011-0111-8; BLUMENAUER G, 1949, Hosp Prog, V30, P364; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CH, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-98; Cid-Ruzafa J, 1997, Rev Esp Salud Publica, V71, P127, DOI 10.1590/S1135-57271997000200004; Consejo Nacional de Poblacion (Mexico), 1997, SIT DEM MEX 1997, V6, P106; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; de Beaman SR, 2004, AGING NEUROPSYCHOL C, V11, P1, DOI 10.1076/anec.11.1.1.29366; Dodge HH, 2006, J GERONTOL A-BIOL, V61, P1330, DOI 10.1093/gerona/61.12.1330; Ensberg M, 2005, PRIMARY CARE, V32, P619, DOI 10.1016/j.pop.2005.06.008; Garcia-Pena C, 2008, J GEN INTERN MED, V23, P1973, DOI 10.1007/s11606-008-0799-2; Giampaoli S, 1999, AGE AGEING, V28, P283, DOI 10.1093/ageing/28.3.283; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Guigoz Y, 1996, NUTR REV, V54, pS59; Hicks GE, 2012, J GERONTOL A-BIOL, V67, P66, DOI 10.1093/gerona/glr055; Humphreys J, 2002, NUTRITION, V18, P616, DOI 10.1016/S0899-9007(02)00756-6; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Landi F, 2010, J AM MED DIR ASSOC, V11, P268, DOI 10.1016/j.jamda.2009.12.088; McAniff CM, 2002, J PHYS THER SCI, V14, P41, DOI DOI 10.1589/JPTS.14.41; Mehta KM, 2011, J AM GERIATR SOC, V59, P1206, DOI 10.1111/j.1532-5415.2011.03409.x; Miracle K, 1992, Perspectives, V16, P2; NAGI SZ, 1964, AM J PUBLIC HEALTH N, V54, P1568, DOI 10.2105/AJPH.54.9.1568; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Pedersen MM, 2012, J GERONTOL A; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rosner B, 2011, FUNDAMENTALS BIOSTAT, Vxvii; RUBENSTEIN LZ, 1995, AGING-CLIN EXP RES, V7, P212, DOI 10.1007/BF03324318; RUBENSTEIN LZ, 1984, NEW ENGL J MED, V311, P1664, DOI 10.1056/NEJM198412273112604; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Savino E, 2012, J FRALITY AGING, V1, P32, DOI 10.14283/jfa.2012.6; Sleiman I, 2009, J GERONTOL A-BIOL, V64, P659, DOI 10.1093/gerona/glp015; Social IMdS, 2011, ENT DEM EP OTR FACT; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Perez-Zepeda MU, 2012, ARCH GERONTOL GERIAT, V54, pE370, DOI 10.1016/j.archger.2011.05.028; Van Craen K, 2010, J AM GERIATR SOC, V58, P83, DOI 10.1111/j.1532-5415.2009.02621.x; WHO, 2011, WORLD REPORT ON DISABILITY, P1; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	41	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69849	10.1371/journal.pone.0069849	http://dx.doi.org/10.1371/journal.pone.0069849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191SQ	23936113	Green Submitted, gold, Green Published			2022-12-27	WOS:000322433300070
J	Macri, S; Sgarra, R; Ros, G; Maurizio, E; Zammitti, S; Milani, O; Onorati, M; Vignali, R; Manfioletti, G				Macri, Simone; Sgarra, Riccardo; Ros, Gloria; Maurizio, Elisa; Zammitti, Salvina; Milani, Ornella; Onorati, Marco; Vignali, Robert; Manfioletti, Guidalberto			Expression and Functional Characterization of Xhmg-at-hook Genes in Xenopus laevis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HMGA2; NEURAL CREST MIGRATION; INDUCTION; PROTEINS; MESODERM; CANCER; MICE; P53; DNA	High Mobility Group A proteins (HMGA1 and HMGA2) are architectural nuclear factors involved in development, cell differentiation, and cancer formation and progression. Here we report the cloning, developmental expression and functional analysis of a new multi-AT-hook factor in Xenopus laevis (XHMG-AT-hook) that exists in three different isoforms. Xhmg-at-hook1 and 3 isoforms, but not isoform 2, are expressed throughout the entire development of Xenopus, both in the maternal and zygotic phase. Localized transcripts are present in the animal pole in the early maternal phase; during the zygotic phase, mRNA can be detected in the developing central nervous system (CNS), including the eye, and in the neural crest. We show evidence that XHMG-AT-hook proteins differ from typical HMGA proteins in terms of their properties in DNA binding and in protein/protein interaction. Finally, we provide evidence that they are involved in early CNS development and in neural crest differentiation.	[Macri, Simone; Milani, Ornella; Onorati, Marco; Vignali, Robert] Univ Pisa, Dept Biol, Pisa, Italy; [Sgarra, Riccardo; Ros, Gloria; Maurizio, Elisa; Zammitti, Salvina; Manfioletti, Guidalberto] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Pisa; University of Trieste	Vignali, R (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	rvignali@biologia.unipi.it; manfiole@units.it	Onorati, Marco/K-3919-2018; Macrì, Simone/AAD-1489-2021; Onorati, Marco/T-7190-2019	Onorati, Marco/0000-0001-8517-930X; Macrì, Simone/0000-0001-7436-258X; Ros, Gloria/0000-0003-2214-5254; MANFIOLETTI, GUIDALBERTO/0000-0001-7913-2601; Sgarra, Riccardo/0000-0002-4496-2856	Universita degli Studi di Trieste, project "Rete Nazionale Proteomica'' FIRB (Fund for investment in basic research) [2008-RBRN07BMCT]; PRIN (Research Programmes of National Interest)	Universita degli Studi di Trieste, project "Rete Nazionale Proteomica'' FIRB (Fund for investment in basic research); PRIN (Research Programmes of National Interest)(Ministry of Education, Universities and Research (MIUR))	This work was supported by PRIN (Research Programmes of National Interest) 2007-2009 contribution to G.M. and to R.V., Universita degli Studi di Trieste, project "Rete Nazionale Proteomica'' FIRB (Fund for investment in basic research) 2008-RBRN07BMCT to G.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Ashar HR, 2010, BBA-GENE REGUL MECH, V1799, P55, DOI 10.1016/j.bbagrm.2009.11.013; Benini F, 2006, BIOCHEM BIOPH RES CO, V351, P392, DOI 10.1016/j.bbrc.2006.10.074; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brunel F, 1996, NUCLEIC ACIDS RES, V24, P1608, DOI 10.1093/nar/24.9.1608; Chiappetta G, 1996, ONCOGENE, V13, P2439; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedele M, 2010, BBA-GENE REGUL MECH, V1799, P48, DOI 10.1016/j.bbagrm.2009.11.007; Frasca F, 2006, CANCER RES, V66, P2980, DOI 10.1158/0008-5472.CAN-05-2637; Hardcastle Z, 2000, DEVELOPMENT, V127, P1303; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hirning-Folz U, 1998, GENE CHROMOSOME CANC, V23, P350, DOI 10.1002/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E; Hock R, 2006, EUR J CELL BIOL, V85, P519, DOI 10.1016/j.ejcb.2006.02.010; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li ZZ, 2012, DEV CELL, V23, P1176, DOI 10.1016/j.devcel.2012.10.019; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; Mari F, 2009, EUR J HUM GENET, V17, P1141, DOI 10.1038/ejhg.2009.27; Maurizio E, 2011, J PROTEOME RES, V10, P3283, DOI 10.1021/pr200116w; Monzen K, 2008, NAT CELL BIOL, V10, P567, DOI 10.1038/ncb1719; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Noro B, 2003, BIOCHEMISTRY-US, V42, P4569, DOI 10.1021/bi026605k; PANNESE M, 1995, DEVELOPMENT, V121, P707; Pasqualetti M, 2000, DEVELOPMENT, V127, P5367; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Sgarra R, 2010, BBA-GENE REGUL MECH, V1799, P37, DOI 10.1016/j.bbagrm.2009.08.009; Sgarra R, 2008, PROTEOMICS, V8, P4721, DOI 10.1002/pmic.200800193; Tessari MA, 2003, MOL CELL BIOL, V23, P9104, DOI 10.1128/MCB.23.24.9104-9116.2003; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69866	10.1371/journal.pone.0069866	http://dx.doi.org/10.1371/journal.pone.0069866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936116	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300072
J	Scholes, S; Bajekal, M; Norman, P; O'Flaherty, M; Hawkins, N; Kivimaki, M; Capewell, S; Raine, R				Scholes, Shaun; Bajekal, Madhavi; Norman, Paul; O'Flaherty, Martin; Hawkins, Nathaniel; Kivimaeki, Mika; Capewell, Simon; Raine, Rosalind			Quantifying Policy Options for Reducing Future Coronary Heart Disease Mortality in England: A Modelling Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; VASCULAR MORTALITY; INDIVIDUAL DATA; BLOOD-PRESSURE; TRENDS; ADULTS; ASSOCIATIONS; METAANALYSIS; PREVALENCE	Aims: To estimate the number of coronary heart disease (CHD) deaths potentially preventable in England in 2020 comparing four risk factor change scenarios. Methods and Results: Using 2007 as baseline, the IMPACT(SEC) model was extended to estimate the potential number of CHD deaths preventable in England in 2020 by age, gender and Index of Multiple Deprivation 2007 quintiles given four risk factor change scenarios: (a) assuming recent trends will continue; (b) assuming optimal but feasible levels already achieved elsewhere; (c) an intermediate point, halfway between current and optimal levels; and (d) assuming plateauing or worsening levels, the worst case scenario. These four scenarios were compared to the baseline scenario with both risk factors and CHD mortality rates remaining at 2007 levels. This would result in approximately 97,000 CHD deaths in 2020. Assuming recent trends will continue would avert approximately 22,640 deaths (95% uncertainty interval: 20,390-24,980). There would be some 39,720 (37,120-41,900) fewer deaths in 2020 with optimal risk factor levels and 22,330 fewer (19,850-24,300) in the intermediate scenario. In the worst case scenario, 16,170 additional deaths (13,880-18,420) would occur. If optimal risk factor levels were achieved, the gap in CHD rates between the most and least deprived areas would halve with falls in systolic blood pressure, physical inactivity and total cholesterol providing the largest contributions to mortality gains. Conclusions: CHD mortality reductions of up to 45%, accompanied by significant reductions in area deprivation mortality disparities, would be possible by implementing optimal preventive policies.	[Scholes, Shaun; Bajekal, Madhavi; Raine, Rosalind] UCL, Dept Appl Hlth Res, London, England; [Norman, Paul] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Liverpool Heart & Chest Hosp, Inst Cardiovasc Med & Sci, Liverpool L69 3BX, Merseyside, England; [Hawkins, Nathaniel] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London; University of Leeds; Liverpool Heart & Chest Hospital; University of Liverpool; University of Liverpool; University of London; University College London	Scholes, S (corresponding author), UCL, Dept Appl Hlth Res, London, England.	s.scholes@ucl.ac.uk	Norman, Paul D./I-4606-2016; Kivimaki, Mika/B-3607-2012; Shao, Ruitai/AAU-7642-2021; Hawkins, Nathaniel Mark/AAW-5093-2020	Norman, Paul D./0000-0002-6211-1625; Kivimaki, Mika/0000-0002-4699-5627; Hawkins, Nathaniel Mark/0000-0003-1286-2014; Scholes, Shaun/0000-0002-7865-5264; Raine, Rosalind/0000-0003-0904-749X; O'Flaherty, Martin/0000-0001-8944-4131	Legal and General Assurance Society Limited (L G); Higher Education Funding Council; National Institute for Health Research; UK Medical Research Council; European Community's Seventh Framework Programme grant [223075]; MedCHAMPS project; National Health Service; Medical Research Council; US National Institutes of Health [R01HL36310, R01AG034454]; Economic and Social Research Council, UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1, G0900847] Funding Source: researchfish; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [G0900847, MR/K013351/1] Funding Source: UKRI	Legal and General Assurance Society Limited (L G); Higher Education Funding Council(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Research(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's Seventh Framework Programme grant; MedCHAMPS project; National Health Service; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SS and MB are honorary research staff at University College London (UCL), funded by Legal and General Assurance Society Limited (L& G) as part of its wider research collaboration with UCL on longevity research. RR and SC are supported by the Higher Education Funding Council and RR is partly funded by the National Institute for Health Research. MOF is partly funded by the UK Medical Research Council and by the European Community's Seventh Framework Programme (FP7/2007-2013) grant agreement number 223075 - the MedCHAMPS project. NH is funded by the National Health Service. MK is supported by the Medical Research Council, the US National Institutes of Health (R01HL36310, R01AG034454) and a professorial fellowship from the Economic and Social Research Council, UK. The authors had access to all data sources and have the responsibility for the contents of the report and the decision to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado BE, 2009, CIRC-CARDIOVASC QUAL, V2, P598, DOI 10.1161/CIRCOUTCOMES.109.884601; [Anonymous], 2012, APHO DIABETES PREVAL; Bajekal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059608; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Barendregt JJ, 2010, VALUE HEALTH, V13, P388, DOI 10.1111/j.1524-4733.2009.00686.x; Bogers RP, 2006, EUR J EPIDEMIOL, V21, P107; BULL FC, 2004, COMP QUANTIFICATION, P729; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000248; Department for Culture Media and Sport/Strategy Unit., 2002, GAM PLAN STRAT DEL G; Department of Health, 2010, SMOK FUT COMPR TOB C; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Grundy E, 2001, J EPIDEMIOL COMMUN H, V55, P895, DOI 10.1136/jech.55.12.895; Hoffmann R, 2013, J EPIDEMIOL COMMUN H, V67, P56, DOI 10.1136/jech-2011-200886; James WPT, 2004, COMP QUANTIFICATION, P497; Kirkwood BR, 2003, ESSENTIAL MED STAT; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Noble M, 2008, ENGLISH INDICES DEPR; Norman P., 2010, APPL SPAT ANAL POLIC, V3, P107, DOI [10.1007/s12061-009-9036-6, DOI 10.1007/S12061-009-9036-6]; Rodgers A, 2004, PLOS MED, V1, P44, DOI 10.1371/journal.pmed.0010027; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; Stovring H, 2003, LANCET, V362, P537, DOI 10.1016/S0140-6736(03)14116-5; Taylor R, 2006, EUR J CARDIOV PREV R, V13, P760, DOI 10.1097/01.hjr.0000220581.42387.d4; Tobias M, 2008, LANCET, V372, P1612, DOI 10.1016/S0140-6736(08)61668-2; Tobias M, 2008, AUST NZ J PUBL HEAL, V32, P117, DOI 10.1111/j.1753-6405.2008.00186.x; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69935	10.1371/journal.pone.0069935	http://dx.doi.org/10.1371/journal.pone.0069935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936122	Green Published, Green Accepted, gold			2022-12-27	WOS:000322433300077
J	Ronzone, E; Paumet, F				Ronzone, Erik; Paumet, Fabienne			Two Coiled-Coil Domains of Chlamydia trachomatis IncA Affect Membrane Fusion Events during Infection	PLOS ONE			English	Article							OCCUPY NONFUSOGENIC INCLUSIONS; SNARE COMPLEX; AMINO-ACID; CRYSTAL-STRUCTURE; LATE ENDOSOMES; HOST-CELL; PSITTACI; PROTEINS; MOTIF; OLIGOMERIZATION	Chlamydia trachomatis replicates in a parasitophorous membrane-bound compartment called an inclusion. The inclusions corrupt host vesicle trafficking networks to avoid the degradative endolysosomal pathway but promote fusion with each other in order to sustain higher bacterial loads in a process known as homotypic fusion. The Chlamydia protein IncA (Inclusion protein A) appears to play central roles in both these processes as it participates to homotypic fusion and inhibits endocytic SNARE-mediated membrane fusion. How IncA selectively inhibits or activates membrane fusion remains poorly understood. In this study, we analyzed the spatial and molecular determinants of IncA's fusogenic and inhibitory functions. Using a cell-free membrane fusion assay, we found that inhibition of SNARE-mediated fusion requires IncA to be on the same membrane as the endocytic SNARE proteins. IncA displays two coiled-coil domains showing high homology with SNARE proteins. Domain swap and deletion experiments revealed that although both these domains are capable of independently inhibiting SNARE-mediated fusion, these two coiled-coil domains cooperate in mediating IncA multimerization and homotypic membrane interaction. Our results support the hypothesis that Chlamydia employs SNARE-like virulence factors that positively and negatively affect membrane fusion and promote infection.	[Ronzone, Erik; Paumet, Fabienne] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Paumet, F (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	Fabienne.Paumet@Jefferson.edu		Paumet, Fabienne/0000-0003-4466-6966	NCI Cancer Center Support Grant [P30 CA56036]; National Institutes of Health [RO1-AI073486]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073486] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in this publication includes work carried out at the Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility, which is supported in part by NCI Cancer Center Support Grant P30 CA56036. This project was funded by grant RO1-AI073486 to FP from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzhanov D, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-24; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; EISSENBERG LG, 1981, INFECT IMMUN, V32, P889, DOI 10.1128/IAI.32.2.889-896.1981; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Fields KA, 2002, INFECT IMMUN, V70, P3816, DOI 10.1128/IAI.70.7.3816-3823.2002; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; Geisler WM, 2001, J INFECT DIS, V184, P879, DOI 10.1086/323340; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; LAWN AM, 1973, J HYG-CAMBRIDGE, V71, P515, DOI 10.1017/S0022172400046507; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Moitra J, 1997, BIOCHEMISTRY-US, V36, P12567, DOI 10.1021/bi971424h; Mullock BM, 2000, MOL BIOL CELL, V11, P3137, DOI 10.1091/mbc.11.9.3137; Paumet F, 2005, J BIOL CHEM, V280, P21137, DOI 10.1074/jbc.M500841200; Paumet F, 2004, P NATL ACAD SCI USA, V101, P3376, DOI 10.1073/pnas.0400271101; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Rockey DD, 1997, MOL MICROBIOL, V24, P217, DOI 10.1046/j.1365-2958.1997.3371700.x; ROCKEY DD, 1995, MOL MICROBIOL, V15, P617, DOI 10.1111/j.1365-2958.1995.tb02371.x; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Slutsky MM, 2004, PROTEIN SCI, V13, P2244, DOI 10.1110/ps.04702104; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Suchland RJ, 2000, INFECT IMMUN, V68, P360, DOI 10.1128/IAI.68.1.360-367.2000; Suchland RJ, 2008, INFECT IMMUN, V76, P5438, DOI 10.1128/IAI.00984-08; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; vanOoij C, 1997, INFECT IMMUN, V65, P758, DOI 10.1128/IAI.65.2.758-766.1997; Varlamov O, 2004, J CELL BIOL, V164, P79, DOI 10.1083/jcb.200307066; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weir E, 2004, CAN MED ASSOC J, V170, P1225, DOI 10.1503/cmaj.1040286; WYRICK PB, 1978, INFECT IMMUN, V19, P1054, DOI 10.1128/IAI.19.3.1054-1060.1978; Xia MS, 2005, J INFECT DIS, V192, P1229, DOI 10.1086/444394	44	27	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69769	10.1371/journal.pone.0069769	http://dx.doi.org/10.1371/journal.pone.0069769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936096	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000153
J	Ahmed, S; Galagan, S; Scobie, H; Khyang, J; Prue, CS; Khan, WA; Ram, M; Alam, MS; Haq, MZ; Akter, J; Glass, G; Norris, DE; Nyunt, MM; Shields, T; Sullivan, DJ; Sack, DA				Ahmed, Sabeena; Galagan, Sean; Scobie, Heather; Khyang, Jacob; Prue, Chai Shwai; Khan, Wasif Ali; Ram, Malathi; Alam, Mohammad Shafiul; Haq, M. Zahirul; Akter, Jasmin; Glass, Gregory; Norris, Douglas E.; Nyunt, Myaing Myaing; Shields, Timothy; Sullivan, David J.; Sack, David A.			Malaria Hotspots Drive Hypoendemic Transmission in the Chittagong Hill Districts of Bangladesh	PLOS ONE			English	Article							PLASMODIUM INFECTION STATUS; RURAL BANDARBAN; FOREST MALARIA; AGE-PATTERNS; EPIDEMIOLOGY; AREA; PREVALENCE; ENDEMICITY; INTENSITY; DIVERSITY	Background: Malaria is endemic in 13 of 64 districts of Bangladesh, representing a population at risk of about 27 million people. The highest rates of malaria in Bangladesh occur in the Chittagong Hill Districts, and Plasmodium falciparum (predominately chloroquine resistant) is the most prevalent species. Methods: The objective of this research was to describe the epidemiology of symptomatic P. falciparum malaria in an area of Bangladesh following the introduction of a national malaria control program. We carried out surveillance for symptomatic malaria due to P. falciparum in two demographically defined unions of the Chittagong Hill Districts in Bangladesh, bordering western Myanmar, between October 2009 and May 2012. The association between sociodemographics and temporal and climate factors with symptomatic P. falciparum infection over two years of surveillance data was assessed. Risk factors for infection were determined using a multivariate regression model. Results: 472 cases of symptomatic P. falciparum malaria cases were identified among 23,372 residents during the study period. Greater than 85% of cases occurred during the rainy season from May to October, and cases were highly clustered geographically within these two unions with more than 80% of infections occurring in areas that contain approximately one-third of the total population. Risk factors statistically associated with infection in a multivariate logistic regression model were living in the areas of high incidence, young age, and having an occupation including jhum cultivation and/or daily labor. Use of long lasting insecticide-treated bed nets was high (89.3%), but its use was not associated with decreased incidence of infection. Conclusion: Here we show that P. falciparum malaria continues to be hypoendemic in the Chittagong Hill Districts of Bangladesh, is highly seasonal, and is much more common in certain geographically limited hot spots and among certain occupations.	[Ahmed, Sabeena; Khyang, Jacob; Prue, Chai Shwai; Khan, Wasif Ali; Alam, Mohammad Shafiul; Haq, M. Zahirul; Akter, Jasmin] Int Ctr Diarrhoeal Dis Res, Ctr Populat Urbanizat & Climate Change, Dhaka 1000, Bangladesh; [Galagan, Sean; Scobie, Heather; Ram, Malathi; Glass, Gregory; Norris, Douglas E.; Nyunt, Myaing Myaing; Shields, Timothy; Sullivan, David J.; Sack, David A.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sack, DA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA.	dsack@jhsph.edu	Alam, Mohammad Shafiul/C-2285-2011; Norris, Doug/GXV-3397-2022	Alam, Mohammad Shafiul/0000-0001-8330-5499; Akter, Jasmin/0000-0003-3685-0106; Norris, Douglas/0000-0002-4631-2777	Johns Hopkins Malaria Research Institute (JHMRI); faculty at Johns Hopkins	Johns Hopkins Malaria Research Institute (JHMRI); faculty at Johns Hopkins	This research activity was carried out with funding from the Johns Hopkins Malaria Research Institute (JHMRI) to cover costs at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) as well as partially support personnel costs of faculty at Johns Hopkins. The research was carried out through this joint project between the two institutions. After the JHMRI approved the general scope of work for the overall research activity ("Mapping Malaria in Bangladesh"), the JHMRI had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Ahmed S M, 2001, Asia Pac J Public Health, V13, P100, DOI 10.1177/101053950101300208; Alam MS, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-150; Alam MS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-175; Alam MS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-15; Borggaard OK, 2003, AMBIO, V32, P118, DOI 10.1639/0044-7447(2003)032[0118:SAOSCI]2.0.CO;2; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Fuehrer HP, 2012, INT J PARASITOL, V42, P693, DOI 10.1016/j.ijpara.2012.04.015; Gafur A, 2003, J HYDROLOGY, V274; Giha HA, 2000, T ROY SOC TROP MED H, V94, P645, DOI 10.1016/S0035-9203(00)90218-9; Gilles HM, 1993, ESSENTIAL MALARIOLOG, P124; Haque U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-367; Haque U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006737; Haque U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-185; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Hossain M, 2009, MIN HLTH FAM WELF AN; Khan WA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-124; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Maude RJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-323; Ministry of Health and Family Welfare GoB, 2008, STRAT PLAN MAL CONTR; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Rahman W, 2010, T ROY SOC TROP MED H, V104, P78, DOI 10.1016/j.trstmh.2009.06.014; Reid HL, 2012, MALARIA J, V11, P1; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P175, DOI 10.4269/ajtmh.1982.31.175; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P183, DOI 10.4269/ajtmh.1982.31.183; Singh N, 2006, AM J TROP MED HYG, V75, P812, DOI 10.4269/ajtmh.2006.75.812; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	32	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69713	10.1371/journal.pone.0069713	http://dx.doi.org/10.1371/journal.pone.0069713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936345	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500016
J	Luyirika, E; Towle, MS; Achan, J; Muhangi, J; Senyimba, C; Lule, F; Muhe, L				Luyirika, Emmanuel; Towle, Megan S.; Achan, Joyce; Muhangi, Justus; Senyimba, Catherine; Lule, Frank; Muhe, Lulu			Scaling Up Paediatric HIV Care with an Integrated, Family-Centred Approach: An Observational Case Study from Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED CHILDREN; CHALLENGES; SETTINGS; HIV/AIDS; SERVICES	Family-centred HIV care models have emerged as an approach to better target children and their caregivers for HIV testing and care, and further provide integrated health services for the family unit's range of care needs. While there is significant international interest in family-centred approaches, there is a dearth of research on operational experiences in implementation and scale-up. Our retrospective case study examined best practices and enabling factors during scale-up of family-centred care in ten health facilities and ten community clinics supported by a non-governmental organization, Mildmay, in Central Uganda. Methods included key informant interviews with programme management and families, and a desk review of hospital management information systems (HMIS) uptake data. In the 84 months following the scale-up of the family-centred approach in HIV care, Mildmay experienced a 50-fold increase of family units registered in HIV care, a 40-fold increase of children enrolled in HIV care, and nearly universal coverage of paediatric cotrimoxazole prophylaxis. The Mildmay experience emphasizes the importance of streamlining care to maximize paediatric capture. This includes integrated service provision, incentivizing care-seeking as a family, creating child-friendly service environments, and minimizing missed paediatric testing opportunities by institutionalizing early infant diagnosis and provider-initiated testing and counselling. Task-shifting towards nurse-led clinics with community outreach support enabled rapid scale-up, as did an active management structure that allowed for real-time review and corrective action. The Mildmay experience suggests that family-centred approaches are operationally feasible, produce strong coverage outcomes, and can be well-managed during rapid scale-up.	[Luyirika, Emmanuel; Achan, Joyce; Muhangi, Justus; Senyimba, Catherine] Mildmay Uganda, Kampala, Uganda; [Lule, Frank] World Hlth Org Reg Off Africa, Brazzaville, Rep Congo; [Muhe, Lulu] World Hlth Org Headquarters, Geneva, Switzerland	World Health Organization; World Health Organization	Muhe, L (corresponding author), World Hlth Org Headquarters, Geneva, Switzerland.	muhel@who.int		Muhe, Lulu M/0000-0002-2776-9923	World Health Organization Headquarters, Maternal, Newborn, Child and Adolescent Health Department	World Health Organization Headquarters, Maternal, Newborn, Child and Adolescent Health Department	World Health Organization Headquarters, Maternal, Newborn, Child and Adolescent Health Department provided financial support for the documentation of best practices at Mildmay Uganda by the team, with the support of an external consultant. Author Dr. Lulu Muhe is a staff member at the WHO Headquarters Maternal, Newborn, Child and Adolescent Health Department. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsey M., 2005, AIDS FAMILY POLICY O, P170; Betancourt Theresa S, 2010, J Int AIDS Soc, V13 Suppl 2, pS2, DOI 10.1186/1758-2652-13-S2-S2; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; De Baets AJ, 2007, PEDIATR INFECT DIS J, V26, P163, DOI 10.1097/01.inf.0000253040.82669.22; DeGennaro V, 2007, ADV SUMM CHILDR AIDS; DeGennaro V, 2009, GLOB PUBLIC HEALTH, P1; Eley B, 2007, ANN TROP PAEDIATR, V27, P1, DOI 10.1179/146532807X170448; Foster SD, 2010, AIDS CARE, V22, P35, DOI 10.1080/09540120903500027; Graf ZJ, 2006, NATL BUR EC RES WORK, V12689; Lallemant M, 2011, NEW ENGL J MED, V365, P581, DOI 10.1056/NEJMp1107275; Leeper Sarah C, 2010, J Int AIDS Soc, V13 Suppl 2, pS3, DOI 10.1186/1758-2652-13-S2-S3; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Orne-Gliemann J, 2008, AIDS, V22, P797, DOI 10.1097/QAD.0b013e3282f4f45a; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; Republic of Uganda, 2012, GLOB AIDS RESP PROGR; Richter LM, 2009, AIDS CARE, V21, P3, DOI 10.1080/09540120902923121; Sherman GG, 2004, SAMJ S AFR MED J, V94, P289; THIRUMURTHY H, 2006, 947 YAL U EC GROWTH; Tolle MA, 2009, TROP MED INT HEALTH, V14, P663, DOI 10.1111/j.1365-3156.2009.02282.x; UNAIDS, 2011, AIDS 30 NAT CROSSR; UNICEF UNAIDS WHO UNFPA, 2008, 3 UNICEF UNAIDS WHO; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Weigel R, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-80; [WHO UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; WHO UNICEF, 2008, SCAL HIV REL PREV DI	25	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69548	10.1371/journal.pone.0069548	http://dx.doi.org/10.1371/journal.pone.0069548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936337	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500013
J	Lamy, E; Hertrampf, A; Herz, C; Schuler, J; Erlacher, M; Bertele, D; Bakare, A; Wagner, M; Weiland, T; Lauer, U; Drognitz, O; Huber, R; Rohn, S; Giesemann, T; Mersch-Sundermann, V				Lamy, Evelyn; Hertrampf, Anke; Herz, Corinna; Schueler, Julia; Erlacher, Miriam; Bertele, Daniela; Bakare, Adekunle; Wagner, Meike; Weiland, Timo; Lauer, Ulrich; Drognitz, Oliver; Huber, Roman; Rohn, Sascha; Giesemann, Torsten; Mersch-Sundermann, Volker			Preclinical Evaluation of 4-Methylthiobutyl Isothiocyanate on Liver Cancer and Cancer Stem Cells with Different p53 Status	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CYCLE ARREST; IN-VITRO; APOPTOSIS INDUCTION; MUTANT P53; SULFORAPHANE; GROWTH; ALLYL; DEATH; EXPRESSION	Isothiocyanates from plants of the order Brassicales are considered promising cancer chemotherapeutic phytochemicals. However, their selective cytotoxicity on liver cancer has been barely researched. Therefore, in the present study, we systematically studied the chemotherapeutic potency of 4-methylthiobutyl isothiocyanate (MTBITC). Selective toxicity was investigated by comparing its effect on liver cancer cells and their chemoresistant subpopulations to normal primary hepatocytes and liver tissue slices. Additionally, in a first assessment, the in vivo tolerability of MTBITC was investigated in mice. Growth arrest at G2/M and apoptosis induction was evident in all in vitro cancer models treated with MTBITC, including populations with cancer initiating characteristics. This was found independent from TP53; however cell death was delayed in p53 compromised cells as compared to wt-p53 cells which was probably due to differential BH3 only gene regulation i.e. Noxa and its antagonist A1. In normal hepatocytes, no apoptosis or necrosis could be detected after repeated administration of up to 50 mu M MTBITC. In mice, orally applied MTBITC was well tolerated over 18 days of treatment for up to 50 mg/kg/day, the highest dose tested. In conclusion, we could show here that the killing effect of MTBITC has a definite selectivity for cancer cells over normal liver cells and its cytotoxicity even applies for chemoresistant cancer initiating cells. Our study could serve for a better understanding of the chemotherapeutic properties of isothiocyanates on human liver-derived cancer cells.	[Lamy, Evelyn; Hertrampf, Anke; Herz, Corinna; Huber, Roman; Mersch-Sundermann, Volker] Univ Freiburg, Med Ctr, Dept Environm Hlth Sci, Freiburg, Germany; [Hertrampf, Anke] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Schueler, Julia; Giesemann, Torsten] Oncotest GmbH, Dept Expt Oncol, Freiburg, Germany; [Erlacher, Miriam; Bertele, Daniela] Univ Freiburg, Med Ctr, Dept Paediat & Adolescent Med, Freiburg, Germany; [Bakare, Adekunle] Univ Ibadan, Dept Zool, Ibadan, Nigeria; [Wagner, Meike] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Translat Oncol, D-55122 Mainz, Germany; [Weiland, Timo; Lauer, Ulrich] Med Univ Hosp Tubingen, Dept Internal Med 1, Tubingen, Germany; [Drognitz, Oliver] Univ Freiburg, Med Ctr, Dept Surg, Freiburg, Germany; [Rohn, Sascha] Univ Hamburg, Inst Food Chem, Hamburg, Germany	University of Freiburg; University of Freiburg; Oncotest GmbH; University of Freiburg; University of Ibadan; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; University of Hamburg	Lamy, E (corresponding author), Univ Freiburg, Med Ctr, Dept Environm Hlth Sci, Freiburg, Germany.	evelyn.lamy@uniklinik-freiburg.de	Bakare, Adekunle A./AAI-8164-2020; Erlacher, Miriam/GRR-7418-2022	Bakare, Adekunle A./0000-0001-9829-1587; Erlacher, Miriam/0000-0002-7261-1447; Herz, Corinna/0000-0003-3837-0544	European Social Fond; Ministry of Science, Research and Arts Baden-Wurttemberg, Germany; Alexander von Humboldt Foundation; German Research Foundation (DFG); Albert Ludwig University, Freiburg	European Social Fond; Ministry of Science, Research and Arts Baden-Wurttemberg, Germany; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwig University, Freiburg	E. L. is funded by an academic grant from the European Social Fond and the Ministry of Science, Research and Arts Baden-Wurttemberg, Germany. A. B. was supported for this study by a grant from the Alexander von Humboldt Foundation Fellowship for Experienced Researchers. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwig University, Freiburg in the Funding Programme Open Access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2006, NATURE, V442, P742, DOI 10.1038/442742a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUGGEMAN IM, 1986, TOXICOL APPL PHARM, V83, P349, DOI 10.1016/0041-008X(86)90312-1; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Cengiz C, 2003, DIGEST DIS SCI, V48, P865, DOI 10.1023/A:1023031008757; Chan KT, 2004, CANCER CHEMOTH PHARM, V53, P519, DOI 10.1007/s00280-004-0767-4; Choi S, 2007, CARCINOGENESIS, V28, P151, DOI 10.1093/carcin/bgl144; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; Fimognari C, 2002, CARCINOGENESIS, V23, P581, DOI 10.1093/carcin/23.4.581; Fimognari C, 2009, ENVIRON MOL MUTAGEN, V50, P171, DOI 10.1002/em.20447; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gamet-Payrastre L, 1998, ANTI-CANCER DRUG, V9, P141, DOI 10.1097/00001813-199802000-00005; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Greten TF, 2006, Z GASTROENTEROL, V44, P43, DOI 10.1055/s-2005-858932; GUGUENGUILLOUZO C, 1986, PROG LIVER DIS, V8, P33; Huang ZZ, 2001, FASEB J, V15, P19, DOI 10.1096/fj.00-0445fje; Jeng KS, 2000, ARCH SURG-CHICAGO, V135, P1329, DOI 10.1001/archsurg.135.11.1329; Jones RJ, 2004, JNCI-J NATL CANCER I, V96, P583, DOI 10.1093/jnci/djh095; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kallifatidis G, 2011, MOL THER, V19, P188, DOI 10.1038/mt.2010.216; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamy E, 2011, DRUG METAB REV, V43, P387, DOI 10.3109/03602532.2011.569551; Lamy E, 2009, ENVIRON MOL MUTAGEN, V50, P190, DOI 10.1002/em.20448; Lamy E, 2009, ENVIRON MOL MUTAGEN, V50, P164, DOI 10.1002/em.20470; Lerche-Langrand C, 2000, TOXICOLOGY, V153, P221, DOI 10.1016/S0300-483X(00)00316-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li SH, 2013, MOL CELL BIOCHEM, V373, P217, DOI 10.1007/s11010-012-1493-6; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Mi LX, 2011, J PROTEOMICS, V74, P1036, DOI 10.1016/j.jprot.2011.04.015; MUSK SRR, 1995, NUTR CANCER, V24, P289, DOI 10.1080/01635589509514418; MUSK SRR, 1993, CARCINOGENESIS, V14, P2079, DOI 10.1093/carcin/14.10.2079; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Rausch V, 2010, CANCER RES, V70, P5004, DOI 10.1158/0008-5472.CAN-10-0066; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rose P, 2003, CELL MOL LIFE SCI, V60, P1489, DOI 10.1007/s00018-003-3150-4; ROTH T, 1999, RELEVANCE TUMOR MODE, P145; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; STROM S, 1982, CANCER RES, V42, P4519; TEMMINK JHM, 1986, ARCH TOXICOL, V59, P103, DOI 10.1007/BF00286732; Yeh CT, 2005, CARCINOGENESIS, V26, P2138, DOI 10.1093/carcin/bgi185; Zimmermann M, 2009, INT J ONCOL, V34, P1247, DOI 10.3892/ijo_00000253	48	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70846	10.1371/journal.pone.0070846	http://dx.doi.org/10.1371/journal.pone.0070846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936472	gold, Green Published, Green Submitted			2022-12-27	WOS:000324545800052
J	Seguier, S; Tartour, E; Guerin, C; Couty, L; Lemitre, M; Lallement, L; Folliguet, M; El Naderi, S; Terme, M; Badoual, C; Lafont, A; Coulomb, B				Seguier, Sylvie; Tartour, Eric; Guerin, Coralie; Couty, Ludovic; Lemitre, Mathilde; Lallement, Laetitia; Folliguet, Marysette; El Naderi, Samah; Terme, Magali; Badoual, Cecile; Lafont, Antoine; Coulomb, Bernard			Inhibition of the Differentiation of Monocyte-Derived Dendritic Cells by Human Gingival Fibroblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; T-CELLS; BIOLOGICAL-ACTIVITIES; BONE-MARROW; MATURATION; ACTIVATION; IMMUNOSUPPRESSION; PROLIFERATION; PROGENITORS	We investigated whether gingival fibroblasts (GFs) can modulate the differentiation and/or maturation of monocyte-derived dendritic cells (DCs) and analyzed soluble factors that may be involved in this immune modulation. Experiments were performed using human monocytes in co-culture with human GFs in Transwell (R) chambers or using monocyte cultures treated with conditioned media (CM) from GFs of four donors. The four CM and supernatants from cell culture were assayed by ELISA for cytokines involved in the differentiation of dendritic cells, such as IL-6, VEGF, TGF beta 1, IL-13 and IL-10. The maturation of monocyte-derived DCs induced by LPS in presence of CM was also studied. Cell surface phenotype markers were analyzed by flow cytometry. In co-cultures, GFs inhibited the differentiation of monocyte-derived DCs and the strength of this blockade correlated with the GF/monocyte ratio. Conditioned media from GFs showed similar effects, suggesting the involvement of soluble factors produced by GFs. This inhibition was associated with a lower stimulatory activity in MLR of DCs generated with GFs or its CM. Neutralizing antibodies against IL-6 and VEGF significantly (P < 0.05) inhibited the inhibitory effect of CM on the differentiation of monocytes-derived DCs and in a dose dependent manner. Our data suggest that IL-6 is the main factor responsible for the inhibition of DCs differentiation mediated by GFs but that VEGF is also involved and constitutes an additional mechanism.	[Seguier, Sylvie; Couty, Ludovic; Lemitre, Mathilde; Lallement, Laetitia; Lafont, Antoine; Coulomb, Bernard] Univ Paris 05, PARCC Hop Europeen Georges Pompidou, Sorbonne Paris Cite, INSERM,U970,Team Lab Arterial Repair, Paris, France; [Seguier, Sylvie; Folliguet, Marysette] Univ Paris 05, Sorbonne Paris Cite, Fac Odontol, Montrouge, France; [Seguier, Sylvie; Folliguet, Marysette] Hop Louis Mourier, Serv Odontol, F-92701 Colombes, France; [Tartour, Eric; El Naderi, Samah; Terme, Magali; Badoual, Cecile] Univ Paris 05, PARCC HEGP, INSERM, U970,Team Immunotherapy & Antiangiogen Therapy On, Paris, France; [Guerin, Coralie] Univ Paris 05, PARCC HEGP, INSERM, U970,Flow Cytometry Core Facil, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Seguier, S (corresponding author), Univ Paris 05, PARCC Hop Europeen Georges Pompidou, Sorbonne Paris Cite, INSERM,U970,Team Lab Arterial Repair, Paris, France.	sylvie.seguier@parisdescartes.fr	SYLVIE, SEGUIER/GQI-3289-2022; TERME, Magali/GZK-9661-2022; tartour, eric/O-7957-2017	TERME, Magali/0000-0003-0857-7237; tartour, eric/0000-0002-7323-468X; SEGUIER, SYLVIE/0000-0002-8591-4180; Badoual, Cecile/0000-0002-1143-3085; Guerin, Coralie/0000-0002-1840-4017	INSERM; Paris Descartes University; Ligue contre le Cancer; Association pour la Recherche sur le Cancer; Big [ANR-09-EBIO-005]; Capsule [ANR-2010-RFCS-006]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; Ligue contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Big; Capsule	This work was financially supported by grants from INSERM, Paris Descartes University, Ligue contre le Cancer, Association pour la Recherche sur le Cancer, Big (ANR-09-EBIO-005) and Capsule (ANR-2010-RFCS-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2010, J IMMUNOTHER, V33, P991, DOI 10.1097/CJI.0b013e3181f4c208; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Buckley CD, 2004, ANN RHEUM DIS, V63, P92, DOI 10.1136/ard.2004.028332; Carlier J, 2011, BLOOD, V118, P6783, DOI 10.1182/blood-2011-02-337956; Chapuis F, 1997, EUR J IMMUNOL, V27, P431, DOI 10.1002/eji.1830270213; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Davies LC, 2012, STEM CELLS DEV, V21, P1478, DOI 10.1089/scd.2011.0434; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Felker P, 2010, J IMMUNOL, V185, P5326, DOI 10.4049/jimmunol.0903950; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; Filer A, 2006, ARTHRITIS RHEUM, V54, P2096, DOI 10.1002/art.21930; Flavell SJ, 2008, BRIT J PHARMACOL, V153, pS241, DOI 10.1038/sj.bjp.0707487; Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gogly B, 2007, ARTERIOSCL THROM VAS, V27, P1984, DOI 10.1161/ATVBAHA.107.140640; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Jorgensen C, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt15; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Oyama T, 1998, J IMMUNOL, V160, P1224; Parsonage G, 2005, TRENDS IMMUNOL, V26, P150, DOI 10.1016/j.it.2004.11.014; Pinchuk IV, 2011, GASTROENTEROLOGY, V140, P2019, DOI 10.1053/j.gastro.2011.02.059; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Schirmer C, 2010, BLOOD, V116, P1715, DOI 10.1182/blood-2010-01-263509; Seguier S, 2000, ARCH ORAL BIOL, V45, P441, DOI 10.1016/S0003-9969(00)00018-2; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; SHIMABUKURO Y, 1992, IMMUNOLOGY, V76, P344; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Strobl H, 1996, J IMMUNOL, V157, P1499; Svensson M, 2004, IMMUNITY, V21, P805, DOI 10.1016/j.immuni.2004.10.012; Svensson M, 2006, TRENDS IMMUNOL, V27, P580, DOI 10.1016/j.it.2006.10.006; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; Terme M, 2013, CANCER RES, V73, P539, DOI 10.1158/0008-5472.CAN-12-2325; Wada N, 2009, J CELL PHYSIOL, V219, P667, DOI 10.1002/jcp.21710; WATANABE T, 1986, J CLIN MICROBIOL, V23, P1034, DOI 10.1128/JCM.23.6.1034-1038.1986; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xie Y, 2009, BIOCHEM BIOPH RES CO, V380, P243, DOI 10.1016/j.bbrc.2009.01.043; Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190	47	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70937	10.1371/journal.pone.0070937	http://dx.doi.org/10.1371/journal.pone.0070937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936476	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800055
J	Ogbi, M; Obi, I; Johnson, JA				Ogbi, Mourad; Obi, Ijeoma; Johnson, John A.			An Inhibitor of the delta PKC Interaction with the d Subunit of F(1)Fo ATP Synthase Reduces Cardiac Troponin I Release from Ischemic Rat Hearts: Utility of a Novel Ammonium Sulfate Precipitation Technique	PLOS ONE			English	Article							PROTEIN-KINASE-C; PERMEABILITY TRANSITION PORE; REPERFUSION INJURY; LABORATORY-ANIMALS; EPSILON INTERACTS; ENERGY-METABOLISM; OXIDASE ACTIVITY; MITOCHONDRIA; DEGRADATION; MECHANISMS	We have previously reported protection against hypoxic injury by a cell-permeable, mitochondrially-targeted delta PKC-d subunit of F(1)Fo ATPase (dF(1)Fo) interaction inhibitor [NH2-YGRKKRRQRRRMLA TRALSLIGKRAISTSVCAGRKLALKTIDWVSF-DYKDDDDK-COOH] in neonatal cardiac myo-cytes. In the present work we demonstrate the partitioning of this peptide to the inner membrane and matrix of mitochondria when it is perfused into isolated rat hearts. We also used ammonium sulfate ((NH4)(2)SO4) and chloroform/methanol precipitation of heart effluents to demonstrate reduced card-iac troponin I (cTnI) release from ischemic rat hearts perfused with this inhibitor. 50% (NH4)(2)SO4 saturation of perfusates collected from Langendorff rat heart preparations optimally precipitated cTnI, allowing its detection in Western blots. In hearts receiving 20 min of ischemia followed by 30, or 60 min of reperfusion, the Mean +/- S. E. (n = 5) percentage of maximal cTnI release was 3067 and 60617, respectively, with additional cTnI release occurring after 150 min of reperfusion. Perfusion of hearts with the delta PKC-dF(1)Fo interaction inhibitor, prior to 20 min of ischemia and 60-150 min of reperfusion, reduced cTnI release by 80%. Additionally, we found that when soybean trypsin inhibitor (SBTI), was added to rat heart effluents, it could also be precipitated using (NH4)(2)SO4 and detected in western blots. This provided a convenient method for normalizing protein recoveries between groups. Our results support the further development of the delta PKC-dF1Fo inhibitor as a potential therapeutic for combating cardiac ischemic injury. In addition, we have developed an improved method for the detection of cTnI release from perfused rat hearts.	[Johnson, John A.] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; Georgia Regents Univ, Program Regenerat Med, Inst Mol Med & Genet, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Johnson, JA (corresponding author), Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA USA.	jjohnson@gru.edu			American Heart Association, Greater Southeast Affiliate [11GRNT7950046]	American Heart Association, Greater Southeast Affiliate(American Heart Association)	This work was supported by an American Heart Association (http://americanheart.org), Greater Southeast Affiliate Grant-in Aid (#11GRNT7950046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2011, J CLIN HYPERTENS, V13, P551, DOI 10.1111/j.1751-7176.2011.00476.x; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; BEIER N, 1988, EUR J BIOCHEM, V176, P327, DOI 10.1111/j.1432-1033.1988.tb14285.x; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bertinchant JP, 1999, J TRAUMA, V47, P474, DOI 10.1097/00005373-199909000-00007; Bi SH, 2012, CLIN EXP PHARMACOL P, V39, P385, DOI 10.1111/j.1440-1681.2012.05683.x; Bozcali E, 2012, ACTA CARDIOL, V67, P87, DOI 10.1080/AC.67.1.2146570; Budas GR, 2010, CARDIOVASC RES, V88, P83, DOI 10.1093/cvr/cvq154; Christenson RH, 2011, PATHOLOGY, V43, P213, DOI 10.1097/PAT.0b013e328343762d; Costa ADT, 2005, CIRC RES, V97, P329, DOI 10.1161/01.RES.0000178451.08719.5b; Ferrera R, 2007, J HEART LUNG TRANSPL, V26, P604, DOI 10.1016/j.healun.2007.02.009; Fredericks S, 2001, CLIN CHIM ACTA, V304, P65, DOI 10.1016/S0009-8981(00)00409-5; Guo DH, 2007, AM J PHYSIOL-HEART C, V293, pH2219, DOI 10.1152/ajpheart.01306.2006; HITCHCOCK SE, 1981, J MOL BIOL, V147, P125, DOI 10.1016/0022-2836(81)90082-6; HORISBERGER M, 1979, BIOL CELLULAIRE, V36, P253; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; Inagaki K, 2006, CARDIOVASC RES, V70, P222, DOI 10.1016/j.cardiores.2006.02.015; Johnson JA, 2011, CURR MED CHEM, V18, P4684; Labugger R, 2000, CIRCULATION, V102, P1221, DOI 10.1161/01.CIR.102.11.1221; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; Li T, 2012, INT J SPORTS MED, V33, P338, DOI 10.1055/s-0031-1301311; Maas JE, 2010, J MOL CELL CARDIOL, V49, P886, DOI 10.1016/j.yjmcc.2010.08.015; McDonough JL, 1999, CIRC RES, V84, P9; McDonough JL, 2001, CIRCULATION, V103, P58; Meldrum DR, 1997, J SURG RES, V73, P1, DOI 10.1006/jsre.1997.5187; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NGUYEN T, 2007, CURR ENZ INHIB, V3, P143; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Nguyen TT, 2010, BIOCHEM J, V429, P335, DOI 10.1042/BJ20091927; Nguyen TT, 2010, J BIOL CHEM, V285, P22164, DOI 10.1074/jbc.M109.077578; O'Brien PJ, 2006, LAB ANIM-UK, V40, P153, DOI 10.1258/002367706776319042; Ogbi M, 2006, BIOCHEM J, V393, P191, DOI 10.1042/BJ20050757; Palmer BS, 2004, AM J PHYSIOL-HEART C, V287, pH1269, DOI 10.1152/ajpheart.00149.2004; Riess ML, 2002, AM J PHYSIOL-HEART C, V283, pH53, DOI 10.1152/ajpheart.01057.2001; Sawaya H, 2011, AM J CARDIOL, V107, P1375, DOI 10.1016/j.amjcard.2011.01.006; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Serra M, 2010, VET J, V185, P50, DOI 10.1016/j.tvjl.2010.04.013; Shi QW, 1999, CLIN CHEM, V45, P1018; Sigg DC, 2001, ANN THORAC SURG, V72, P1576, DOI 10.1016/S0003-4975(01)03084-3; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SMITH RM, 1993, HDB ENDOCRINE RES TE, P227; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Takeo S, 1999, CARDIOVASC RES, V43, P32, DOI 10.1016/S0008-6363(99)00079-6; Tate JR, 2010, PATHOLOGY, V42, P402, DOI 10.3109/00313025.2010.495246; Twerenbold R, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13202; Vogt AM, 2005, MOL CELL BIOCHEM, V278, P223, DOI 10.1007/s11010-005-7576-x; VUORINEN K, 1995, CIRCULATION, V91, P2810, DOI 10.1161/01.CIR.91.11.2810; Yu Q, 2008, AM J PHYSIOL-HEART C, V294, pH2637, DOI 10.1152/ajpheart.91476.2007	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70580	10.1371/journal.pone.0070580	http://dx.doi.org/10.1371/journal.pone.0070580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936451	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400074
J	Vogel, JP; Torloni, MR; Seuc, A; Betran, AP; Widmer, M; Souza, JP; Merialdi, M				Vogel, Joshua P.; Torloni, Maria Regina; Seuc, Armando; Betran, Ana Pilar; Widmer, Mariana; Souza, Joao Paulo; Merialdi, Mario			Maternal and Perinatal Outcomes of Twin Pregnancy in 23 Low- and Middle-Income Countries	PLOS ONE			English	Article							GLOBAL SURVEY; COMPLICATIONS; DELIVERY	Background: Twin pregnancies in low- and middle-income countries (LMICs) pose a high risk to mothers and newborns due to inherent biological risks and scarcity of health resources. We conducted a secondary analysis of the WHO Global Survey dataset to analyze maternal and perinatal outcomes in twin pregnancies and factors associated with perinatal morbidity and mortality in twins. Methods: We examined maternal and neonatal characteristics in twin deliveries in 23 LMICs and conducted multi-level logistic regression to determine the association between twins and adverse maternal and perinatal outcomes. Results: 279,425 mothers gave birth to 276,187 (98.8%) singletons and 6,476 (1.2%) twins. Odds of severe adverse maternal outcomes (death, blood transfusion, ICU admission or hysterectomy) (AOR 1.85, 95% CI 1.60-2.14) and perinatal mortality (AOR 2.46, 95% CI 1.40-4.35) in twin pregnancies were higher, however early neonatal death (AOR 2.50, 95% CI 0.95-6.62) and stillbirth (AOR 1.22, 95% CI 0.58-2.57) did not reach significance. Amongst twins alone, maternal age < 18, poor education and antenatal care, nulliparity, vaginal bleeding, non-cephalic presentations, birth weight discordance > 15%, born second, preterm birth and low birthweight were associated with perinatal mortality. Marriage and caesarean section were protective. Conclusions: Twin pregnancy is a significant risk factor for maternal and perinatal morbidity and mortality in low- resource settings; maternal risk and access to safe caesarean section may determine safest mode of delivery in LMICs. Improving obstetric care in twin pregnancies, particularly timely access to safe caesarean section, is required to reduce risk to mother and baby.	[Vogel, Joshua P.] Univ Western Australia, Sch Populat Hlth, Fac Med Dent & Hlth Sci, Perth, WA 6009, Australia; [Vogel, Joshua P.; Seuc, Armando; Betran, Ana Pilar; Widmer, Mariana; Souza, Joao Paulo; Merialdi, Mario] UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, World Hlth Org, Geneva, Switzerland; [Torloni, Maria Regina] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil; [Torloni, Maria Regina] Brazilian Cochrane Ctr, Sao Paulo, Brazil	University of Western Australia; The World Bank; United Nations Population Fund; World Health Organization; Universidade Federal de Sao Paulo (UNIFESP)	Vogel, JP (corresponding author), Univ Western Australia, Sch Populat Hlth, Fac Med Dent & Hlth Sci, Perth, WA 6009, Australia.	vogeljo@who.int	Vogel, Joshua/K-7649-2019; Souza, João Paulo/G-1982-2010	Vogel, Joshua/0000-0002-3214-7096; Souza, João Paulo/0000-0002-2288-4244	Australian Postgraduate Award; A & A Saw Scholarship	Australian Postgraduate Award(Australian Government); A & A Saw Scholarship	JPV is supported by an Australian Postgraduate Award and the A & A Saw Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisien A O, 2000, Med Sci Monit, V6, P945; Alam N, 2007, TROP MED INT HEALTH, V12, P1506, DOI 10.1111/j.1365-3156.2007.01959.x; Ananth CV, 2005, ANN EPIDEMIOL, V15, P293, DOI 10.1016/j.annepidem.2004.08.007; [Anonymous], LEV TRENDS CHILD MOR; [Anonymous], R LANG ENV STAT COMP; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026; Gyamfi C, 2005, CLIN PERINATOL, V32, P431, DOI 10.1016/j.clp.2005.02.004; Hogle KL, 2003, AM J OBSTET GYNECOL, V188, P220, DOI 10.1067/mob.2003.64; IBM Corporation, PASW STAT 20; Kapoor M, 2009, AM J MED GENET C, V151C, P128, DOI 10.1002/ajmg.c.30205; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Obiechina NJ, 2011, INT J WOMENS HEALTH, V3, P227, DOI 10.2147/IJWH.S22059; Olusanya BO, 2011, J HEALTH POPUL NUTR, V29, P639; Rao A, 2004, BEST PRACT RES CL OB, V18, P557, DOI 10.1016/j.bpobgyn.2004.04.007; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239; Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828; Sumathipala A, 2002, TWIN RES, V5, P424; UNICEF, 2012, STAT WORLDS CHILDR 2; Uthman Olalekan A, 2008, BMC Pregnancy Childbirth, V8, P41, DOI 10.1186/1471-2393-8-41; Walker MC, 2004, BJOG-INT J OBSTET GY, V111, P1294, DOI 10.1111/j.1471-0528.2004.00345.x; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	25	59	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70549	10.1371/journal.pone.0070549	http://dx.doi.org/10.1371/journal.pone.0070549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936446	Green Published, gold			2022-12-27	WOS:000324518400073
J	Wilby, A; Anglin, LA; Nesbit, CM				Wilby, Andrew; Anglin, Linda Anderson; Nesbit, Christopher M.			Plant Species Composition Alters the Sign and Strength of an Emergent Multi-Predator Effect by Modifying Predator Foraging Behaviour	PLOS ONE			English	Article							NATURAL ENEMY DIVERSITY; INTRAGUILD PREDATION; BIOLOGICAL-CONTROL; PREY SUPPRESSION; HERBIVORE SUPPRESSION; TROPHIC CASCADES; BIODIVERSITY; METAANALYSIS; COMPLEXITY; RICHNESS	The prediction of pest-control functioning by multi-predator communities is hindered by the non-additive nature of species functioning. Such non-additivity, commonly termed an emergent multi-predator effect, is known to be affected by elements of the ecological context, such as the structure and composition of vegetation, in addition to the traits of the predators themselves. Here we report mesocosm experiments designed to test the influence of plant density and species composition (wheat monoculture or wheat and faba bean polyculture) on the emergence of multi-predator effects between Adalia bipunctata and Chrysoperla carnea, in their suppression of populations of the aphid Metopolophium dirhodum. The mesocosm experiments were followed by a series of behavioural observations designed to identify how interactions among predators are modified by plant species composition and whether these effects are consistent with the observed influence of plant species composition on aphid population suppression. Although plant density was shown to have no influence on the multi-predator effect on aphid population growth, plant composition had a marked effect. In wheat monoculture, Adalia and Chrysoperla mixed treatments caused greater suppression of M. dirhodum populations than expected. However this positive emergent effect was reversed to a negative multi-predator effect in wheat and faba bean polyculture. The behavioural observations revealed that although dominant individuals did not respond to the presence of faba bean plants, the behaviour of sub-dominants was affected markedly, consistent with their foraging for extra-floral nectar produced by the faba bean. This interaction between plant composition and predator community composition on the foraging behaviour of sub-dominants is thought to underlie the observed effect of plant composition on the multi-predator effect. Thus, the emergence of multi-predator effects is shown to be strongly influenced by plant species composition, mediated, in this case, by the provision of extra-floral nectar by one of the plant species.	[Wilby, Andrew; Nesbit, Christopher M.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England; [Anglin, Linda Anderson] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England	Lancaster University; University of Reading	Wilby, A (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England.	a.wilby@lancaster.ac.uk	Wilby, Andrew/F-4618-2014	Wilby, Andrew/0000-0001-9984-4956	University of Reading Undergraduate Research Opportunities Programme; Lancaster University Friends Programme; Natural Environment Research Council [ceh010010] Funding Source: researchfish	University of Reading Undergraduate Research Opportunities Programme; Lancaster University Friends Programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the University of Reading Undergraduate Research Opportunities Programme and the Lancaster University Friends Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilino KM, 2005, OIKOS, V108, P275, DOI 10.1111/j.0030-1299.2005.13418.x; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; BILLICK I, 1994, ECOLOGY, V75, P1529, DOI 10.2307/1939614; Casula P, 2006, ECOL LETT, V9, P995, DOI 10.1111/j.1461-0248.2006.00945.x; Crawley M.J., 2007, R BOOK; Finke DL, 2006, OECOLOGIA, V149, P265, DOI 10.1007/s00442-006-0443-y; Finke DL, 2010, BIOL CONSERV, V143, P2260, DOI 10.1016/j.biocon.2010.03.022; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Griffen BD, 2006, J ANIM ECOL, V75, P959, DOI 10.1111/j.1365-2656.2006.01115.x; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Griffiths GJK, 2008, ECOLOGY, V89, P2986, DOI 10.1890/08-0685.1; Janssen A, 2007, ECOLOGY, V88, P2713, DOI 10.1890/06-1408.1; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; Losey JE, 1998, OECOLOGIA, V115, P245, DOI 10.1007/s004420050513; Losey JE, 1998, ECOLOGY, V79, P2143, DOI 10.2307/176717; Ma CS, 2004, EUR J ENTOMOL, V101, P327, DOI 10.14411/eje.2004.042; Northfield TD, 2012, ECOLOGY, V93, P411, DOI 10.1890/11-0399.1; Osenberg CW, 1997, AM NAT, V150, P798, DOI 10.1086/286095; Philpott SM, 2006, ECOL ENTOMOL, V31, P369, DOI 10.1111/j.1365-2311.2006.00793.x; R Development Core Team, 2012, R LANG ENV STAT COMP; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SOLUK DA, 1988, OIKOS, V52, P94, DOI 10.2307/3565987; Straub CS, 2008, ECOLOGY, V89, P1605, DOI 10.1890/07-0657.1; Straub CS, 2008, BIOL CONTROL, V45, P225, DOI 10.1016/j.biocontrol.2007.05.013; Swisher BJ, 1998, OIKOS, V81, P30, DOI 10.2307/3546464; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Tylianakis JM, 2010, BASIC APPL ECOL, V11, P657, DOI 10.1016/j.baae.2010.08.005; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1; Vonesh JR, 2003, ECOL LETT, V6, P503, DOI 10.1046/j.1461-0248.2003.00470.x; Wackers FL, 2005, PLANT PROVIDED MUTUA; Warfe DM, 2004, OECOLOGIA, V141, P171, DOI 10.1007/s00442-004-1644-x; Wilby A, 2005, ECOL ENTOMOL, V30, P497, DOI 10.1111/j.0307-6946.2005.00717.x; Wilby A, 2002, ECOL LETT, V5, P353, DOI 10.1046/j.1461-0248.2002.00331.x; Wilby A, 2007, MANAGING BIODIVERSIT, P225; Wilby A, 2013, OECOLOGIA, V172, P1167, DOI 10.1007/s00442-012-2573-8	38	6	6	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70258	10.1371/journal.pone.0070258	http://dx.doi.org/10.1371/journal.pone.0070258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936400	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000324518400049
J	Lin, B; Govindan, S; Lee, K; Zhao, PM; Han, RZ; Runte, KE; Craig, R; Palmer, BM; Sadayappan, S				Lin, Brian; Govindan, Suresh; Lee, Kyounghwan; Zhao, Piming; Han, Renzhi; Runte, K. Elisabeth; Craig, Roger; Palmer, Bradley M.; Sadayappan, Sakthivel			Cardiac Myosin Binding Protein-C Plays No Regulatory Role in Skeletal Muscle Structure and Function	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MYBP-C; DIFFERENTIAL EXPRESSION; ISOFORM TRANSITIONS; STRIATED-MUSCLE; TROPONIN-I; MUTATIONS; ADULT; PHOSPHORYLATION	Myosin binding protein-C (MyBP-C) exists in three major isoforms: slow skeletal, fast skeletal, and cardiac. While cardiac MyBP-C (cMyBP-C) expression is restricted to the heart in the adult, it is transiently expressed in neonatal stages of some skeletal muscles. However, it is unclear whether this expression is necessary for the proper development and function of skeletal muscle. Our aim was to determine whether the absence of cMyBP-C alters the structure, function, or MyBP-C isoform expression in adult skeletal muscle using a cMyBP-C null mouse model (cMyBP-C-(t/t)). Slow MyBP-C was expressed in both slow and fast skeletal muscles, whereas fast MyBP-C was mostly restricted to fast skeletal muscles. Expression of these isoforms was unaffected in skeletal muscle from cMyBP-C-(t/t) mice. Slow and fast skeletal muscles in cMyBP-C-(t/t) mice showed no histological or ultrastructural changes in comparison to the wild-type control. In addition, slow muscle twitch, tetanus tension, and susceptibility to injury were all similar to the wild-type controls. Interestingly, fMyBP-C expression was significantly increased in the cMyBP-C-(t/t) hearts undergoing severe dilated cardiomyopathy, though this does not seem to prevent dysfunction. Additionally, expression of both slow and fast isoforms was increased in myopathic skeletal muscles. Our data demonstrate that i) MyBP-C isoforms are differentially regulated in both cardiac and skeletal muscles, ii) cMyBP-C is dispensable for the development of skeletal muscle with no functional or structural consequences in the adult myocyte, and iii) skeletal isoforms can transcomplement in the heart in the absence of cMyBP-C.	[Lin, Brian; Govindan, Suresh; Zhao, Piming; Han, Renzhi; Sadayappan, Sakthivel] Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, Maywood, IL USA; [Lee, Kyounghwan; Craig, Roger] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Runte, K. Elisabeth; Palmer, Bradley M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT USA	Loyola University Chicago; University of Massachusetts System; University of Massachusetts Worcester; University of Vermont	Sadayappan, S (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, Maywood, IL USA.	ssadayappan@lumc.edu	Zhao, Piming/G-7318-2015	Sadayappan, Sakthivel/0000-0003-2006-7678; Han, Renzhi/0000-0002-8202-9186; Lee, Kyounghwan/0000-0003-1423-8952	National Institutes of Health [R01HL105826, K02HL114749, P01HL59408, R01AR034711]; American Heart Association [13POST14720024, 10SDG4140138]; Muscular Dystrophy Association [MDA171667]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105826, K02HL114749, P01HL059408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR034711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by National Institutes of Health grants R01HL105826 and K02HL114749 (Dr. Sadayappan) and P01HL59408 (Dr. Palmer and Dr. Craig), R01AR034711 (Dr. Craig), American Heart Association Midwest Fellowship 13POST14720024 (Dr. Govindan), and American Heart Association Midwest Scientist Development Grant 10SDG4140138 (Dr. Han) and Muscular Dystrophy Association grant MDA171667 (Dr. Han). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussein S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-262; Ackermann MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/652065; ANDERSON PAW, 1995, CIRC RES, V76, P681, DOI 10.1161/01.RES.76.4.681; BAHLER M, 1985, DEV BIOL, V112, P345, DOI 10.1016/0012-1606(85)90405-1; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Barton PJR, 2004, MOL CELL BIOCHEM, V263, P91, DOI 10.1023/B:MCBI.0000041851.53074.72; Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cardamone M, 2008, SEMIN NEUROL, V28, P250, DOI 10.1055/s-2008-1062269; Carrier L, 1997, CIRC RES, V80, P427, DOI 10.1161/01.res.0000435859.24609.b3; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; CRAIG R, 1976, PROC R SOC SER B-BIO, V192, P451, DOI 10.1098/rspb.1976.0023; DAMATTO RL, 2012, INT J CARDIOL, P64481; Dhoot GK, 2005, J MUSCLE RES CELL M, V26, P143, DOI 10.1007/s10974-005-3089-1; DHOOT GK, 1985, J MUSCLE RES CELL M, V6, P487, DOI 10.1007/BF00712585; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; EINHEBER S, 1990, P NATL ACAD SCI USA, V87, P2157, DOI 10.1073/pnas.87.6.2157; Flashman E, 2007, BIOCHEM J, V401, P97, DOI 10.1042/BJ20060500; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; Gautel M, 1998, CIRC RES, V82, P124; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Govindan S, 2012, J MOL CELL CARDIOL, V52, P154, DOI 10.1016/j.yjmcc.2011.09.011; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Gurnett CA, 2010, HUM MOL GENET, V19, P1165, DOI 10.1093/hmg/ddp587; Han R, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-35; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; HUNKELER NM, 1991, CIRC RES, V69, P1409, DOI 10.1161/01.RES.69.5.1409; KAWASHIMA M, 1986, J BIOCHEM-TOKYO, V99, P1037, DOI 10.1093/oxfordjournals.jbchem.a135567; Kurasawa M, 1999, MUSCLE NERVE, V22, P196, DOI 10.1002/(SICI)1097-4598(199902)22:2<196::AID-MUS7>3.0.CO;2-E; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Martinez PF, 2010, MED SCI MONITOR, V16, pBR374; McConnell BK, 1999, J CLIN INVEST, V104, P1235, DOI 10.1172/JCI7377; Miller MS, 2010, J PHYSIOL-LONDON, V588, P4039, DOI 10.1113/jphysiol.2010.191957; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Munkvik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022695; OBINATA T, 1984, DEV BIOL, V101, P116, DOI 10.1016/0012-1606(84)90122-2; Okada Y, 2008, J APPL PHYSIOL, V104, P952, DOI 10.1152/japplphysiol.01072.2007; Palmer BM, 2004, MOL CELL BIOCHEM, V263, P73, DOI 10.1023/B:MCBI.0000041849.60591.45; Palmer BM, 2004, CIRC RES, V94, P1615, DOI 10.1161/01.RES.0000132744.08754.f2; Palmer BM, 2004, CIRC RES, V94, P1249, DOI 10.1161/01.RES.0000126898.95550.31; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; REINACH FC, 1983, J CELL BIOL, V96, P297, DOI 10.1083/jcb.96.1.297; Richardson TW, 2003, J APPL PHYSIOL, V95, P1055, DOI 10.1152/japplphysiol.00308.2003; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan Sakthivel, 2012, Biophys Rev, V4, P93, DOI 10.1007/s12551-012-0067-x; SCHWARTZ K, 1986, CIRC RES, V59, P551, DOI 10.1161/01.RES.59.5.551; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Sullivan MJ, 1997, MED SCI SPORT EXER, V29, P860, DOI 10.1097/00005768-199707000-00004; Tajsharghi H, 2010, J MED GENET, V47, P575, DOI 10.1136/jmg.2009.072710; Toth MJ, 2012, J PHYSIOL-LONDON, V590, P1243, DOI 10.1113/jphysiol.2011.219659; Urboniene D, 2005, CIRC RES, V97, P70, DOI 10.1161/01.RES.0000173849.68636.1e; WARD SM, 1995, CELL TISSUE RES, V282, P399, DOI 10.1007/s004410050491; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; WEBER FE, 1993, EUR J BIOCHEM, V216, P661, DOI 10.1111/j.1432-1033.1993.tb18186.x; YASUDA M, 1995, J MOL CELL CARDIOL, V27, P2275, DOI 10.1016/S0022-2828(95)91731-4	57	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69671	10.1371/journal.pone.0069671	http://dx.doi.org/10.1371/journal.pone.0069671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936073	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700037
J	Sams, A; Hawks, J				Sams, Aaron; Hawks, John			Patterns of Population Differentiation and Natural Selection on the Celiac Disease Background Risk Network	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; GENOME-WIDE ASSOCIATION; MULTIPLE COMMON; VARIANTS; INSIGHTS; ORIGINS; HISTORY; SIGNALS; MODEL; LOCI	Celiac disease is a common small intestinal inflammatory condition induced by wheat gluten and related proteins from rye and barley. Left untreated, the clinical presentation of CD can include failure to thrive, malnutrition, and distension in juveniles. The disease can additionally lead to vitamin deficiencies, anemia, and osteoporosis. Therefore, CD potentially negatively affected fitness in past populations utilizing wheat, barley, and rye. Previous analyses of CD risk variants have uncovered evidence for positive selection on some of these loci. These studies also suggest the possibility that risk for common autoimmune conditions such as CD may be the result of positive selection on immune related loci in the genome to fight infection. Under this evolutionary scenario, disease phenotypes may be a trade-off from positive selection on immunity. If this hypothesis is generally true, we can expect to find a signal of natural selection when we survey across the network of loci known to influence CD risk. This study examines the non-HLA autosomal network of gene loci associated with CD risk in Europe. We reject the null hypothesis of neutrality on this network of CD risk loci. Additionally, we can localize evidence of selection in time and space by adding information from the genome of the Tyrolean Iceman. While we can show significant differentiation between continental regions across the CD network, the pattern of evidence is not consistent with primarily recent ( Holocene) selection across this network in Europe. Further localization of ancient selection on this network may illuminate the ecological pressures acting on the immune system during this critically interesting phase of our evolution.	[Sams, Aaron; Hawks, John] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Sams, Aaron] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	University of Wisconsin System; University of Wisconsin Madison; Cornell University	Sams, A (corresponding author), Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA.	as2847@cornell.edu	Hawks, John/H-5737-2015; Sams, Aaron/AAI-6691-2020	Hawks, John/0000-0003-3187-3755; Sams, Aaron/0000-0002-3800-4459				Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Albrechtsen A, 2010, GENETICS, V186, P295, DOI 10.1534/genetics.110.113977; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Armelagos GJ, 2005, EVOL ANTHROPOL, V14, P109, DOI 10.1002/evan.20048; Barker Jennifer M, 2008, Adv Pediatr, V55, P349, DOI 10.1016/j.yapd.2008.07.001; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fu QM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032473; Gasbarrini G, 2012, WORLD J GASTROENTERO, V18, P5300, DOI 10.3748/wjg.v18.i37.5300; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hancock AM, 2010, PHILOS T R SOC B, V365, P2459, DOI 10.1098/rstb.2010.0032; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Pagani L, 2012, HUM GENET, V131, P423, DOI 10.1007/s00439-011-1084-8; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Soni S, 2010, J REPROD MED, V55, P3; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Larsen CS, 2006, QUATERN INT, V150, P12, DOI 10.1016/j.quaint.2006.01.004; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wolters VM, 2008, AM J GASTROENTEROL, V103, P190, DOI 10.1111/j.1572-0241.2007.01471.x; Yu FL, 2009, HUM MOL GENET, V18, P4853, DOI 10.1093/hmg/ddp457; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004	37	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70564	10.1371/journal.pone.0070564	http://dx.doi.org/10.1371/journal.pone.0070564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936230	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700079
J	Ye, SP; Huang, H; Zheng, RQ; Zhang, JY; Yang, G; Xu, SX				Ye, Shupei; Huang, Hua; Zheng, Rongquan; Zhang, Jiayong; Yang, Guang; Xu, Shixia			Phylogeographic Analyses Strongly Suggest Cryptic Speciation in the Giant Spiny Frog (Dicroglossidae: Paa spinosa) and Interspecies Hybridization in Paa	PLOS ONE			English	Article							TRIBE PAINI AMPHIBIA; PHYLOGENETIC-RELATIONSHIPS; POPULATION-STRUCTURE; SPECIES-DIVERSITY; GENE FLOW; DNA; ANURA; EVOLUTIONARY; COMPLEX; RANIDAE	Species identification is one of the most basic yet crucial issues in biology with potentially far-reaching implications for fields such as conservation, population ecology, and epidemiology. The widely distributed but threatened frog Paa spinosa has been speculated to represent a complex of multiple species. In this study, 254 individuals representing species of the genus Paa were investigated along the entire range of P. spinosa: 196 specimens of P. spinosa, 8 specimens of P. jiulongensis, 5 specimens of P. boulengeri, 20 specimens of P. exilispinosa, and 25 specimens of P. shini. Approximately 1333 bp of mtDNA sequence data (genes 12S rRNA and 16S rRNA) were used. Phylogenetic analyses were conducted using maximum parsimony, maximum likelihood and Bayesian inference. BEAST was used to estimate divergence dates of major clades. Results suggest that P. spinosa can be divided into three distinct major lineages. Each major lineage totally corresponds to geographical regions, revealing the presence of three candidate cryptic species. Isolation and differentiation among lineages are further supported by the great genetic distances between the lineages. The bifurcating phylogenetic pattern also suggests an east-west dispersal trend during historic cryptic speciation. Dating analysis estimates that P. spinosa from Western China split from the remaining P. spinosa populations in the Miocene and that P. spinosa from Eastern China diverged from Central China in the Pliocene. We also found that P. exilispinosa from Mainland China and Hong Kong might have a complex of multiple species. After identifying cryptic lineages, we then determine the discrepancy between the mtDNA and the morphotypes in several individuals. This discrepancy may have been caused by introgressive hybridization between P. spinosa and P. shini.	[Ye, Shupei; Huang, Hua; Zheng, Rongquan; Zhang, Jiayong] Zhejiang Normal Univ, Inst Ecol, Jinhua, Zhejiang, Peoples R China; [Yang, Guang; Xu, Shixia] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China	Zhejiang Normal University; Nanjing Normal University	Zheng, RQ (corresponding author), Zhejiang Normal Univ, Inst Ecol, Jinhua, Zhejiang, Peoples R China.	zhengrq@zjnu.cn; zhang3599533@163.com	Zheng, Rongquan/AAR-5372-2021		Natural Science Foundation of China [31172116]; Major Science and Technology Specific Projects of Zhejiang Province of China [2010C12008, 2012C12907-9]; Science Technology Commission of Zhejiang Province of China [2011C22006]; fund for the science and technology innovation team of Zhejiang Province of China [2012R10026-07]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Specific Projects of Zhejiang Province of China; Science Technology Commission of Zhejiang Province of China; fund for the science and technology innovation team of Zhejiang Province of China	This research was supported by the Natural Science Foundation of China (No. 31172116), the Major Science and Technology Specific Projects of Zhejiang Province of China (No. 2010C12008; 2012C12907-9), the Project of Science Technology Commission of Zhejiang Province of China (No. 2011C22006), and the fund for the science and technology innovation team of Zhejiang Province of China (No. 2012R10026-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; Chen J., 2000, SCANDINAVIAN J NUTR, V44, P130; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubois A, 1975, B MUSEUM NATL DHISTO, V231, P1093; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; Fouquet A, 2012, MOL PHYLOGENET EVOL, V62, P826, DOI 10.1016/j.ympev.2011.11.023; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Gvozdik V, 2010, MOL PHYLOGENET EVOL, V55, P1146, DOI 10.1016/j.ympev.2010.03.015; HAFEZ M., 1954, CANADIAN ENT, V86, P90; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harkness J, 1998, CHINA QUART, P911; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Heraty JM, 2007, MOL PHYLOGENET EVOL, V45, P480, DOI 10.1016/j.ympev.2007.06.021; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hitchings SP, 1997, HEREDITY, V79, P117, DOI 10.1038/hdy.1997.134; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019817; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; Jiang JP, 2005, ZOOL SCI, V22, P353, DOI 10.2108/zsj.22.353; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kraaijeveld-Smit FJL, 2005, MOL ECOL, V14, P3307, DOI 10.1111/j.1365-294X.2005.02614.x; Lemmon EM, 2007, EVOLUTION, V61, P2086, DOI 10.1111/j.1558-5646.2007.00181.x; Liu C, 2007, HERPETOLOGICA SINICA, V11, P160; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mayden RL, 1995, SYSTEMATICS SPECIES; Mayr E., 1942, P1; Mayr E, 1970, POPULATONS SPECIES E; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; Ohler A, 2006, ZOOSYSTEMA, V28, P769; Palo JU, 2004, MOL ECOL, V13, P2631, DOI 10.1111/j.1365-294X.2004.02269.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ron SR, 2006, MOL PHYLOGENET EVOL, V39, P392, DOI 10.1016/j.ympev.2005.11.022; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING LAB MANU; SIMPSON GEORGE GAYLORD, 1961; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Veith M, 2002, FOLIA ZOOL, V51, P307; Velo-Anton G, 2007, MOL PHYLOGENET EVOL, V45, P716, DOI 10.1016/j.ympev.2007.06.025; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Wiens JJ, 2009, EVOLUTION, V63, P1217, DOI 10.1111/j.1558-5646.2009.00610.x; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; Xie F, 2007, SCI CHINA SER C, V50, P265, DOI 10.1007/s11427-007-0021-5; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; [俞宝根 YU BaoGeng], 2008, [生态学报, Acta Ecologica Sinica], V28, P6371; Zhao E., 1998, CHINA RED DATA BOOK; Zhou Y, 2009, GENE, V447, P86, DOI 10.1016/j.gene.2009.07.009	60	18	20	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70403	10.1371/journal.pone.0070403	http://dx.doi.org/10.1371/journal.pone.0070403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936199	gold, Green Submitted, Green Published			2022-12-27	WOS:000322633700070
J	Alvares, GA; Quintana, DS; Kemp, AH; Van Zwieten, A; Balleine, BW; Hickie, IB; Guastella, AJ				Alvares, Gail A.; Quintana, Daniel S.; Kemp, Andrew H.; Van Zwieten, Anita; Balleine, Bernard W.; Hickie, Ian B.; Guastella, Adam J.			Reduced Heart Rate Variability in Social Anxiety Disorder: Associations with Gender and Symptom Severity	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; BODY-MASS INDEX; PSYCHOMETRIC PROPERTIES; STRESS SCALES; POLAR RS800; AGE; DEPRESSION; CAPACITY; MONITOR; DISEASE	Background: Polyvagal theory emphasizes that autonomic nervous system functioning plays a key role in social behavior and emotion. The theory predicts that psychiatric disorders of social dysfunction are associated with reduced heart rate variability, an index of autonomic control, as well as social inhibition and avoidance. The purpose of this study was to examine whether heart rate variability was reduced in treatment-seeking patients diagnosed with social anxiety disorder, a disorder characterized by social fear and avoidance. Methods: Social anxiety patients (n = 53) were recruited prior to receiving psychological therapy. Healthy volunteers were recruited through the University of Sydney and the general community and were matched by gender and age (n = 53). Heart rate variability was assessed during a five-minute recording at rest, with participants completing a range of self-report clinical symptom measures. Results: Compared to controls, participants with social anxiety exhibited significant reductions across a number of heart rate variability measures. Reductions in heart rate variability were observed in females with social anxiety, compared to female controls, and in patients taking psychotropic medication compared to non-medicated patients. Finally, within the clinical group, we observed significant associations between reduced heart rate variability and increased social interaction anxiety, psychological distress, and harmful alcohol use. Conclusions: The results of this study confirm that social anxiety disorder is associated with reduced heart rate variability. Resting state heart rate variability may therefore be considered a marker for social approach-related motivation and capacity for social engagement. Additionally, heart rate variability may provide a useful biomarker to explain underlying difficulties with social approach, impaired stress regulation, and behavioral inhibition, especially in disorders associated with significant impairments in these domains.	[Alvares, Gail A.; Quintana, Daniel S.; Van Zwieten, Anita; Balleine, Bernard W.; Hickie, Ian B.; Guastella, Adam J.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Kemp, Andrew H.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Kemp, Andrew H.] Univ Sao Paulo, Univ Hosp, Sao Paulo, Brazil	University of Sydney; University of Sydney; Universidade de Sao Paulo	Guastella, AJ (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	adam.guastella@sydney.edu.au	Hickie, Ian B/K-8975-2015; Alvares, Gail/I-1724-2014; Quintana, Daniel S./H-2726-2019; Alvares, Gail/C-1154-2018; van Zwieten, Anita/ABC-7544-2020; Kemp, Andrew Haddon/C-7984-2012	Hickie, Ian B/0000-0001-8832-9895; Alvares, Gail/0000-0003-3351-5919; Quintana, Daniel S./0000-0003-2876-0004; Alvares, Gail/0000-0003-3351-5919; van Zwieten, Anita/0000-0003-4564-5825; Kemp, Andrew Haddon/0000-0003-1146-3791; Balleine, Bernard/0000-0001-8618-7950	Australian Research Council (ARC) Linkage Grant [LP110200562]; National Health and Medical Research Council Career Development Award [571101]; Australian Rotary Health/Hooton family scholarship	Australian Research Council (ARC) Linkage Grant(Australian Research Council); National Health and Medical Research Council Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Australian Rotary Health/Hooton family scholarship	This research was supported by an Australian Research Council (ARC) Linkage Grant to author AJG (LP110200562). Author AHK is supported by a National Health and Medical Research Council Career Development Award (571101) and author DSQ is supported by an Australian Rotary Health/Hooton family scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelink MW, 2001, CLIN AUTON RES, V11, P99, DOI 10.1007/BF02322053; Ahs F, 2009, NEUROIMAGE, V47, P815, DOI 10.1016/j.neuroimage.2009.05.091; Antelmi I, 2004, AM J CARDIOL, V93, P381, DOI 10.1016/j.amjcard.2003.09.065; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Byrne EA, 1996, J APPL PHYSIOL, V81, P743, DOI 10.1152/jappl.1996.81.2.743; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Clarke PJF, 2012, EARLY INTERV PSYCHIA, V6, P256, DOI 10.1111/j.1751-7893.2012.00364.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dart AM, 2002, CARDIOVASC RES, V53, P678, DOI 10.1016/S0008-6363(01)00508-9; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; DiNardo P.A., 1994, ANXIETY DISORDER INT; First M. B., 1997, STRUCTURED CLIN INTE; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Garakani A, 2009, DEPRESS ANXIETY, V26, P251, DOI 10.1002/da.20533; Grossman P, 2001, PSYCHOSOM MED, V63, P765, DOI 10.1097/00006842-200109000-00010; HEIMBERG RG, 1992, BEHAV THER, V23, P53, DOI 10.1016/S0005-7894(05)80308-9; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Kemp AH, 2011, BIOL PSYCHIAT, V69, pE25, DOI 10.1016/j.biopsych.2010.10.035; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koskinen T, 2009, AUTON NEUROSCI-BASIC, V145, P81, DOI 10.1016/j.autneu.2008.10.011; Kubzansky LD, 1997, CIRCULATION, V95, P818; Licht CMM, 2009, PSYCHOSOM MED, V71, P508, DOI 10.1097/PSY.0b013e3181a292a6; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mathewson KJ, 2013, INT J PSYCHOPHYSIOL, V88, P171, DOI 10.1016/j.ijpsycho.2013.03.016; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MIDDLETON HC, 1995, ACTA PSYCHIAT SCAND, V91, P108, DOI 10.1111/j.1600-0447.1995.tb09749.x; Morris EP, 2005, CLIN PSYCHOL REV, V25, P734, DOI 10.1016/j.cpr.2005.05.004; Murata T, 2004, NEUROPSYCHOBIOLOGY, V50, P189, DOI 10.1159/000079113; Pittig A, 2013, INT J PSYCHOPHYSIOL, V87, P19, DOI 10.1016/j.ijpsycho.2012.10.012; PORGES SW, 1995, PSYCHOPHYSIOLOGY, V32, P301, DOI 10.1111/j.1469-8986.1995.tb01213.x; Porges SW, 2006, ANN NY ACAD SCI, V807, P62; Quintana DS, 2013, ALCOHOL CLIN EXP RES, V37, pE23, DOI 10.1111/j.1530-0277.2012.01913.x; Quintana DS, 2012, EUR J APPL PHYSIOL, V112, P4179, DOI 10.1007/s00421-012-2453-2; Roberson-Nay R, 2007, PSYCHOL ASSESSMENT, V19, P133, DOI 10.1037/1040-3590.19.1.133; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schry AR, 2012, PSYCHOL ASSESSMENT, V24, P846, DOI 10.1037/a0027398; Shrive Fiona M, 2006, BMC Med Res Methodol, V6, P57, DOI 10.1186/1471-2288-6-57; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Vogelzangs N, 2010, J AFFECT DISORDERS, V125, P241, DOI 10.1016/j.jad.2010.02.112; Wallen MB, 2012, EUR J APPL PHYSIOL, V112, P1153, DOI 10.1007/s00421-011-2079-9; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; Wells R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046597; Zhang J, 2007, J MANIP PHYSIOL THER, V30, P374, DOI 10.1016/j.jmpt.2007.04.001	49	79	79	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70468	10.1371/journal.pone.0070468	http://dx.doi.org/10.1371/journal.pone.0070468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201AX	23936207	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200084
J	Zhou, D; Guan, WB; Wang, JD; Zhang, Y; Gong, W; Quan, ZW				Zhou, Di; Guan, Wen-bin; Wang, Jian-dong; Zhang, Yong; Gong, Wei; Quan, Zhi-wei			A Comparative Study of Clinicopathological Features between Chronic Cholecystitis Patients with and without Helicobacter pylori Infection in Gallbladder Mucosa	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INTESTINAL METAPLASIA; GASTRIC METAPLASIA; EXPRESSION; BILE; ADENOMYOMATOSIS; ASSOCIATION; CARCINOMA; DNA; DIAGNOSIS	Background: Helicobacter pylori has been isolated from 10%-20% of human chronic cholecystitis specimens but the characteristics of "Helicobacter pylori positive cholecystitis" remains unclear. This study aims to compare the clinicopathological features between chronic cholecystitis patients with and without Helicobacter pylori infection in gallbladder mucosa. Methods: Three hundred and twenty-six chronic cholecystitis patients were divided into two groups according to whether Helicobacter pylori could be detected by culture, staining or PCR for Helicobacter 16s rRNA gene in gallbladder mucosa. Positive samples were sequenced for Helicobacter pylori-specific identification. Clinical parameters as well as pathological characteristics including some premalignant lesions and the expression levels of iNOS and ROS in gallbladder were compared between the two groups. Results: Helicobacter pylori infection in gallbladder mucosa was detected in 20.55% of cholecystitis patients. These patients had a higher prevalence of acid regurgitation symptoms (p = 0.001), more histories of chronic gastritis (p = 0.005), gastric ulcer (p = 0.042), duodenal ulcer (p = 0.026) and higher presence of Helicobacter pylori in the stomach as compared to patients without Helicobacter pylori infection in the gallbladder mucosa. Helicobacter pylori 16s rRNA in gallbladder and gastric-duodenal mucosa from the same individual patient had identical sequences. Also, higher incidences of adenomyomatosis (p = 0.012), metaplasia (p = 0.022) and higher enhanced expressions of iNOS and ROS were detected in Helicobacter pylori infected gallbladder mucosa (p<0.05). Conclusions: Helicobacter pylori infection in gallbladder mucosa is strongly associated with Helicobacter pylori existed in stomach. Helicobacter pylori is also correlated with gallbladder premalignant lesions including metaplasia and adenomyomatosis. The potential mechanism might be related with higher ROS/RNS production but needs further investigation.	[Zhou, Di; Wang, Jian-dong; Zhang, Yong; Gong, Wei; Quan, Zhi-wei] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai 200030, Peoples R China; [Guan, Wen-bin] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Pathol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, JD (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai 200030, Peoples R China.	wangjiandongdr@yahoo.com.cn; zhiwquan@yahoo.com.cn			National "Twelfth Five-Year" special science and technology major project [2012ZX10002016]; College Fund of Shanghai Jiaotong University School of Medicine [10XJ22003]	National "Twelfth Five-Year" special science and technology major project; College Fund of Shanghai Jiaotong University School of Medicine	This work was supported by the National "Twelfth Five-Year" special science and technology major project (No.2012ZX10002016), (http://www.nmp.gov.cn/zxjs/crb/201012/t20101208_2127.htm); and the College Fund of Shanghai Jiaotong University School of Medicine (No.10XJ22003) (http://kjc.shsmu.edu.cn/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayli B, 2005, J CLIN GASTROENTEROL, V39, P134; Meirelles-Costa ALA, 2010, CLINICS, V65, P143, DOI 10.1590/S1807-59322010000200005; Andreotti G, 2011, CANCER CAUSE CONTROL, V22, P1289, DOI 10.1007/s10552-011-9802-z; ARNAOUT AH, 1990, J PATHOL, V160, P333, DOI 10.1002/path.1711600410; Arora VK, 2005, CANCER CYTOPATHOL, V105, P277, DOI 10.1002/cncr.21320; Barcia Juan Jose, 2003, Ann Diagn Pathol, V7, P147, DOI 10.1016/S1092-9134(03)00011-X; Bechi P, 1996, AM J GASTROENTEROL, V91, P271; Boonyanugomol W, 2011, DIGEST DIS SCI, V56, P1682, DOI 10.1007/s10620-010-1512-y; Bulajic M, 2002, CANCER-AM CANCER SOC, V95, P1946, DOI 10.1002/cncr.10893; CETTA F, 1993, ARCH SURG-CHICAGO, V128, P329; Chen DF, 2007, WORLD J GASTROENTERO, V13, P1608, DOI 10.3748/wjg.v13.i10.1608; Chen DF, 2007, WORLD J GASTROENTERO, V13, P1119, DOI 10.3748/wjg.v13.i7.1119; Cho SO, 2010, DIGEST DIS SCI, V55, P988, DOI 10.1007/s10620-009-0828-y; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; DUARTE I, 1993, CANCER-AM CANCER SOC, V72, P1878, DOI 10.1002/1097-0142(19930915)72:6<1878::AID-CNCR2820720615>3.0.CO;2-2; Handa O, 2010, INFLAMM RES, V59, P997, DOI 10.1007/s00011-010-0245-x; Hsing AW, 2007, BRIT J CANCER, V97, P1577, DOI 10.1038/sj.bjc.6604047; JUTRAS JA, 1960, AMER J ROENTGENOL RA, V83, P795; Karagin PH, 2010, WORLD J GASTROENTERO, V16, P4817, DOI 10.3748/wjg.v16.i38.4817; Kasper HU, 2004, WORLD J GASTROENTERO, V10, P1918; Kawaguchi M, 1996, J GASTROENTEROL, V31, P294, DOI 10.1007/BF02389534; Khan MR, 2011, INT J SURG, V9, P482, DOI 10.1016/j.ijsu.2011.07.001; LARY MA, 1983, SURGERY, V93, P538; Lee JS, 2007, ANN NY ACAD SCI, V1095, P527, DOI 10.1196/annals.1397.057; Lee JW, 2010, GUT LIVER, V4, P60, DOI 10.5009/gnl.2010.4.1.60; Misra V, 2007, PATHOLOGY, V39, P419, DOI 10.1080/00313020701444473; Naito Y, 2008, J GASTROEN HEPATOL, V23, pS250, DOI 10.1111/j.1440-1746.2008.05412.x; OOTANI T, 1992, CANCER, V69, P2647, DOI 10.1002/1097-0142(19920601)69:11<2647::AID-CNCR2820691105>3.0.CO;2-0; Pandey Manoj, 2007, World J Surg Oncol, V5, P94, DOI 10.1186/1477-7819-5-94; Pellicano R, 2008, LANCET INFECT DIS, V8, P254, DOI 10.1016/S1473-3099(08)70066-5; Poonam Y, 2008, SINGAP MED J, V49, P262; Roa I, 2006, J SURG ONCOL, V93, P615, DOI 10.1002/jso.20527; Shukla HS, 2012, INDIAN J GASTROENTER, V31, P55, DOI 10.1007/s12664-012-0178-0; Stancu Manuela, 2007, Rom J Morphol Embryol, V48, P335; Stunell H, 2008, J MED IMAG RADIAT ON, V52, P109, DOI 10.1111/j.1440-1673.2008.01926.x; Tanno S, 1998, J GASTROEN HEPATOL, V13, P175, DOI 10.1111/j.1440-1746.1998.tb00634.x; Tiwari SK, 2006, WORLD J GASTROENTERO, V12, P2181, DOI 10.3748/wjg.v12.i14.2181; Tonkic A, 2012, HELICOBACTER, V17, P1, DOI 10.1111/j.1523-5378.2012.00975.x; Fernandes JEV, 2008, SAO PAULO MED J, V126, P220, DOI 10.1590/S1516-31802008000400004; Yakoob J, 2011, BRIT J BIOMED SCI, V68, P59, DOI 10.1080/09674845.2011.11730324; Zhang M, 2003, ANN ANAT, V185, P549, DOI 10.1016/S0940-9602(03)80125-5; Zhou D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027390	42	22	25	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70265	10.1371/journal.pone.0070265	http://dx.doi.org/10.1371/journal.pone.0070265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936177	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200071
J	Sukla, KK; Tiwari, PK; Kumar, A; Raman, R				Sukla, Krishna Kishore; Tiwari, Pankaj Kumar; Kumar, Ashok; Raman, Rajiva			Low Birthweight (LBW) and Neonatal Hyperbilirubinemia (NNH) in an Indian Cohort: Association of Homocysteine, Its Metabolic Pathway Genes and Micronutrients as Risk Factors	PLOS ONE			English	Article							PREGNANT-WOMEN; FOLATE STATUS; VITAMIN-B-12; DEFICIENCY; POLYMORPHISM; COBALAMIN; MTHFR; ACID	Background & Aims: Indian subcontinent has the highest child mortality rates along with a very high frequency of low birthweight (LBW). Folate and vitamin B12 (Vit-B12) are necessary during foetal development and their deficiency prevalence in Indians is very high. The objective of the present paper is to assess whether foetal homocysteine (Hcy)/folate metabolic pathway genes, their cofactors and homocysteine level independently (or collectively) predispose children to Low birth weight. Methods: Cord blood was collected for the study. Frequency of 5 SNPs in 4-Hcy-pathway genes, and levels of Hcy, Vit-B12 and folate were evaluated. Results: Of the 421 newborns recruited for the study, 38% showed low birth weight (<2.5kg) and 16% were preterm babies. 101 neonates developed neonatal hyperbilirubinemia (NNH). High prevalence of Vit-B12 (65%) and folate (27%) deficiency was observed in newborns along with hyperhomocystinemia (hypHcy-25%). Preterm delivery, micronutrient deficiency, hypHcy and MTHFR 677T SNP are associated as risk factor while G allele of TCN2 C776G is protective against LBW. MTHFR 677T allele and folate deficiency are also independent risk factors for NNH. Conclusion: We record the highest incidence of Vit-B12, folate deficiency and elevated Hcy levels, of all the studies so far reported on neonates. These together with MTHFR 677T are potential risk factors for LBW. Association of impaired folate/Hcy metabolism with NNH is reported for the first time and the possible way of interaction is discussed. It appears that proper nutritional management during pregnancy would reduce the risk of complex clinical outcomes.	[Sukla, Krishna Kishore; Raman, Rajiva] Banaras Hindu Univ, Inst Med Sci, Cytogenet Lab, Dept Zool, Varanasi 221005, Uttar Pradesh, India; [Sukla, Krishna Kishore; Raman, Rajiva] Banaras Hindu Univ, Inst Med Sci, Ctr Genet Disorders, Varanasi 221005, Uttar Pradesh, India; [Tiwari, Pankaj Kumar; Kumar, Ashok] Banaras Hindu Univ, Inst Med Sci, Dept Pediat, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Raman, R (corresponding author), Banaras Hindu Univ, Inst Med Sci, Cytogenet Lab, Dept Zool, Varanasi 221005, Uttar Pradesh, India.	rajiva.raman@yahoo.com	Kumar, Ashok/AAX-3875-2020	Kumar, Ashok/0000-0003-2054-8463	Department of Biotechnology, New Delhi, India; DST-FIST; DBT; CSIR	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); DST-FIST(Department of Science & Technology (India)); DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Financial support was received as DBT Programme Support to RR and AK from the Department of Biotechnology, New Delhi, India. HPLC in the Department of Zoology has been procured through the DST-FIST grant. DBT and CSIR are acknowledged for fellowships to KK and PKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba Y, 2011, EUR J CLIN NUTR, V65, P480, DOI 10.1038/ejcn.2010.294; Black MM, 2008, FOOD NUTR BULL, V29, pS126, DOI 10.1177/15648265080292S117; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Couto FD, 2007, EUR J CLIN NUTR, V61, P382, DOI 10.1038/sj.ejcn.1602528; Fredriksen A, 2007, HUM MUTAT, V28, P856, DOI 10.1002/humu.20522; Godbole K, 2011, BIRTH DEFECTS RES A, V91, P848, DOI 10.1002/bdra.20841; Guerra-Shinohara EM, 2002, BJOG-INT J OBSTET GY, V109, P784, DOI 10.1111/j.1471-0528.2002.01307.x; Hay G, 2010, J NUTR, V140, P557, DOI 10.3945/jn.109.117424; Jain V, 2012, REV ENDOCR METAB DIS, V13, P83, DOI 10.1007/s11154-012-9218-4; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Karademir F, 2007, J INT MED RES, V35, P384, DOI 10.1177/147323000703500313; KAWADE N, 1981, BIOCHEM J, V196, P257, DOI 10.1042/bj1960257; Khanduri U, 2007, NATL MED J INDIA, V20, P172; Koc A, 2006, EUR J NUTR, V45, P291, DOI 10.1007/s00394-006-0598-7; Kumar J, 2009, CLIN CHEM LAB MED, V47, P334, DOI 10.1515/CCLM.2009.074; Maisels MJ, 2004, PEDIATRICS, V114, P297; Miller JW, 2002, BLOOD, V100, P718, DOI 10.1182/blood-2002-01-0209; Minet JC, 2000, AM J CLIN NUTR, V72, P751; Murphy MM, 2011, ADV CLIN CHEM, V53, P105, DOI 10.1016/S0065-2423(11)53005-7; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Pavlikova M, 2012, J NUTR, V142, P1403, DOI 10.3945/jn.112.160549; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395; Sukla KK, 2012, EUR J CLIN NUTR, V66, P111, DOI 10.1038/ejcn.2011.152; TaneJa S, 2007, AM J CLIN NUTR, V86, P1302, DOI 10.1093/ajcn/86.5.1302; Wallace JMW, 2008, AM J CLIN NUTR, V87, P391, DOI 10.1093/ajcn/87.2.391; Yajnik CS, 2005, ASIA PAC J CLIN NUTR, V14, P179; Yakub M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033222	28	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71587	10.1371/journal.pone.0071587	http://dx.doi.org/10.1371/journal.pone.0071587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936521	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500079
J	Bajaj, M; Srayko, M				Bajaj, Megha; Srayko, Martin			Laulimalide Induces Dose-Dependent Modulation of Microtubule Behaviour in the C. elegans Embryo	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CELL-DEATH; DYNAMIC INSTABILITY; MITOTIC BLOCK; BINDING-SITE; TAXOID SITE; HELA-CELLS; PACLITAXEL; TUBULIN; AGENTS	Laulimalide is a microtubule-binding drug that was originally isolated from marine sponges. High concentrations of laulimalide stabilize microtubules and inhibit cell division similarly to paclitaxel; however, there are important differences with respect to the nature of the specific cellular defects between these two drugs and their binding sites on the microtubule. In this study, we used Caenorhabditis elegans embryos to investigate the acute effects of laulimalide on microtubules in vivo, with a direct comparison to paclitaxel. We observed surprising dose-dependent effects for laulimalide, whereby microtubules were stabilized at concentrations above 100 nM, but destabilized at concentrations between 50 and 100 nM. Despite this behaviour at low concentrations, laulimalide acted synergistically with paclitaxel to stabilize microtubules when both drugs were used at sub-effective concentrations, consistent with observations of synergistic interactions between these two drugs in other systems. Our results indicate that laulimalide induces a concentration-dependent, biphasic change in microtubule polymer dynamics in the C. elegans embryo.	[Bajaj, Megha; Srayko, Martin] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Srayko, M (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	srayko@ualberta.ca	Srayko, Martin/A-3755-2014	Srayko, Martin/0000-0003-0196-0364	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by an operating grant from the Canadian Institutes of Health Research as well as scholar awards from Alberta Heritage Foundation for Medical Research and the Canadian Institutes of Health Research to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMODT EJ, 1986, J CELL BIOL, V103, P23, DOI 10.1083/jcb.103.1.23; Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; Bennett MJ, 2012, CELL CYCLE, V11, P3045, DOI 10.4161/cc.21411; Bennett MJ, 2010, CHEM BIOL, V17, P725, DOI 10.1016/j.chembiol.2010.05.019; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024656; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; Clark EA, 2006, MOL PHARMACEUT, V3, P457, DOI 10.1021/mp060016h; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Gapud EJ, 2004, MOL PHARMACOL, V66, P113, DOI 10.1124/mol.66.1.113; Gardner MK, 2013, CURR OPIN CELL BIOL, V25, P14, DOI 10.1016/j.ceb.2012.09.006; Hamel E, 2006, MOL PHARMACOL, V70, P1555, DOI 10.1124/mol.106.027847; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Jordan MA, 1996, CANCER RES, V56, P816; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kaestner P, 2010, J CELL BIOCHEM, V111, P258, DOI 10.1002/jcb.22721; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Meunier S, 2012, J CELL SCI, V125, P2805, DOI 10.1242/jcs.092429; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mooberry SL, 1999, CANCER RES, V59, P653; Muller-Reichert T, 2010, CELL MOL LIFE SCI, V67, P2195, DOI 10.1007/s00018-010-0324-8; Nguyen TL, 2010, J CHEM INF MODEL, V50, P2019, DOI 10.1021/ci1002894; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Paoletti A, 1997, J CELL SCI, V110, P2403; Pryor DE, 2002, BIOCHEMISTRY-US, V41, P9109, DOI 10.1021/bi020211b; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Torres K, 1998, CANCER RES, V58, P3620; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	34	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71889	10.1371/journal.pone.0071889	http://dx.doi.org/10.1371/journal.pone.0071889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936530	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800069
J	Li, CH; Li, Z; Zou, Y; Wicht, O; van Kuppeveld, FJM; Rottier, PJM; Bosch, BJ				Li, Chunhua; Li, Zhen; Zou, Yong; Wicht, Oliver; van Kuppeveld, Frank J. M.; Rottier, Peter J. M.; Bosch, Berend Jan			Manipulation of the Porcine Epidemic Diarrhea Virus Genome Using Targeted RNA Recombination	PLOS ONE			English	Article							LENGTH INFECTIOUS CDNA; REVERSE GENETICS; CORONAVIRUS GENOME; SEQUENCE-ANALYSIS; PROTEIN; PEDV; EFFICACY; CLONING; STRAIN; DR13	Porcine epidemic diarrhea virus (PEDV) causes severe economic losses in the swine industry in China and other Asian countries. Infection usually leads to an acute, often lethal diarrhea in piglets. Despite the impact of the disease, no system is yet available to manipulate the viral genome which has severely hampered research on this virus until today. We have established a reverse genetics system for PEDV based on targeted RNA recombination that allows the modification of the 3'-end of the viral genome, which encodes the structural proteins and the ORF3 protein. Using this system, we deleted the ORF3 gene entirely from the viral genome and showed that the ORF3 protein is not essential for replication of the virus in vitro. In addition, we inserted heterologous genes (i.e. the GFP and Renilla luciferase genes) at two positions in the viral genome, either as an extra expression cassette or as a replacement for the ORF3 gene. We demonstrated the expression of both GFP and Renilla luciferase as well as the application of these viruses by establishing a convenient and rapid virus neutralization assay. The new PEDV reverse genetics system will enable functional studies of the structural proteins and the accessory ORF3 protein and will allow the rational design and development of next generation PEDV vaccines.	[Li, Chunhua; Li, Zhen; Zou, Yong] Shanghai Acad Agr Sci, Inst Anim Sci & Vet Med, Shanghai, Peoples R China; [Wicht, Oliver; van Kuppeveld, Frank J. M.; Rottier, Peter J. M.; Bosch, Berend Jan] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands	Shanghai Academy of Agricultural Sciences; Utrecht University	Bosch, BJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands.	b.j.bosch@uu.nl	Bosch, Berend/ABD-8740-2021; Wicht, Oliver/L-8714-2013	van Kuppeveld, Frank/0000-0001-5800-749X; Wicht, Oliver/0000-0003-3266-8075	Royal Dutch Academy of Sciences; Shanghai City Committee of Science and Technology [08490709000]	Royal Dutch Academy of Sciences; Shanghai City Committee of Science and Technology	This work was supported by financial aid from the Royal Dutch Academy of Sciences and Shanghai City Committee of Science and Technology (08490709000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Casais R, 2001, J VIROL, V75, P12359, DOI 10.1128/JVI.75.24.12359-12369.2001; de Haan CAM, 2003, J VIROL, V77, P11312, DOI 10.1128/JVI.77.21.11312-11323.2003; de Haan CAM, 2002, J VIROL, V76, P12491, DOI 10.1128/JVI.76.24.12491-12502.2002; Dijkman R, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-106; Donaldson EF, 2008, J VIROL, V82, P11948, DOI 10.1128/JVI.01804-08; Haijema BJ, 2003, J VIROL, V77, P4528, DOI 10.1128/JVI.77.8.4528-4538.2003; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Kweon CH, 1999, VACCINE, V17, P2546, DOI 10.1016/S0264-410X(99)00059-6; Li BX, 2007, VIROLOGY, V365, P166, DOI 10.1016/j.virol.2007.03.031; Muller MA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-6; Park SJ, 2008, VIRUS GENES, V36, P95, DOI 10.1007/s11262-007-0164-2; Park SJ, 2007, VIRUS GENES, V35, P55, DOI 10.1007/s11262-006-0036-1; Park SJ, 2011, ARCH VIROL, V156, P577, DOI 10.1007/s00705-010-0892-9; ROTTIER PJM, 1981, J VIROL, V38, P20, DOI 10.1128/JVI.38.1.20-26.1981; Sato T, 2011, VIRUS GENES, V43, P72, DOI 10.1007/s11262-011-0617-5; Shirato K, 2011, J VIROL, V85, P7872, DOI 10.1128/JVI.00464-11; Shirato K, 2010, ARCH VIROL, V155, P1989, DOI 10.1007/s00705-010-0790-1; Song DS, 2007, RES VET SCI, V82, P134, DOI 10.1016/j.rvsc.2006.03.007; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Tekes G, 2012, J VIROL, V86, P6994, DOI 10.1128/JVI.00023-12; Thiel V, 2001, J GEN VIROL, V82, P1273, DOI 10.1099/0022-1317-82-6-1273; Tobler K, 1995, Adv Exp Med Biol, V380, P541; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Wang K, 2012, FEBS LETT, V586, P384, DOI 10.1016/j.febslet.2012.01.005; Woods RD, 2001, CAN J VET RES, V65, P28; Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Yount B, 2002, J VIROL, V76, P11065, DOI 10.1128/JVI.76.21.11065-11078.2002	32	51	55	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69997	10.1371/journal.pone.0069997	http://dx.doi.org/10.1371/journal.pone.0069997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936367	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800030
J	Onitilo, AA; Berg, RL; Engel, JM; Glurich, I; Stankowski, RV; Williams, G; Doi, SA				Onitilo, Adedayo A.; Berg, Richard L.; Engel, Jessica M.; Glurich, Ingrid; Stankowski, Rachel V.; Williams, Gail; Doi, Suhail A.			Increased Risk of Colon Cancer in Men in the Pre-Diabetes Phase	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; COLORECTAL-CANCER; SEX-HORMONES; METAANALYSIS; INSULIN; ASSOCIATIONS; PEOPLE; GENDER	Background: Historically, studies exploring the association between type 2 diabetes mellitus (DM) and cancer lack accurate definition of date of DM onset, limiting temporal analyses. We examined the temporal relationship between colon cancer risk and DM using an electronic algorithm and clinical, administrative, and laboratory data to pinpoint date of DM onset. Methods: Subjects diagnosed with DM (N = 11,236) between January 1, 1995 and December 31, 2009 were identified and matched at a 5:1 ratio with 54 365 non-diabetic subjects by age, gender, smoking history, residence, and diagnosis reference date. Colon cancer incidence relative to the reference date was used to develop Cox regression models adjusted for matching variables, body mass index, insurance status, and comorbidities. Primary outcomes measures included hazard ratio (HR) and number needed to be exposed for one additional person to be harmed (NNEH). Results: The adjusted HR for colon cancer in men before DM onset was 1.28 (95% CI 1.04-1.58, P = 0.0223) and the NNEH decreased with time, reaching 263 at DM onset. No such difference was observed in women. After DM onset, DM did not appear to alter colon cancer risk in either gender. Conclusions: Colon cancer risk is increased in diabetic men, but not women, before DM onset. DM did not alter colon cancer risk in men or women after clinical onset. In pre-diabetic men, colon cancer risk increased as time to DM onset decreased, suggesting that the effects of the pre-diabetes phase on colon cancer risk in men are cumulative.	[Onitilo, Adedayo A.] Marshfield Clin Weston Ctr, Dept Hematol Oncol, Weston, WI USA; [Onitilo, Adedayo A.; Williams, Gail; Doi, Suhail A.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Berg, Richard L.; Glurich, Ingrid; Stankowski, Rachel V.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Engel, Jessica M.] Marshfield Clin Canc Care, Dept Hematol Oncol, Stevens Point, WI USA	University of Queensland	Onitilo, AA (corresponding author), Marshfield Clin Weston Ctr, Dept Hematol Oncol, Weston, WI USA.	onitilo.adedayo@marshfieldclinic.org	Doi, Suhail/E-2770-2010; Williams, Gail/S-8833-2019; Glurich, Ingrid/AAO-1758-2020	Williams, Gail/0000-0002-4822-5263; Glurich, Ingrid/0000-0001-5988-569X; Doi, Suhail/0000-0002-2630-2125	Marshfield Clinic Research Foundation Disease Specific Funds	Marshfield Clinic Research Foundation Disease Specific Funds	Financial support for this study was provided by the Marshfield Clinic Research Foundation Disease Specific Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Barratt AL, 2005, CAN MED ASSOC J, V172, P613, DOI 10.1503/cmaj.1041709; Bertram MY, 2010, AUST NZ J PUBL HEAL, V34, P311, DOI 10.1111/j.1753-6405.2010.00532.x; Brandstedt J, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-23; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Clendenen TV, 2009, CANCER EPIDEM BIOMAR, V18, P275, DOI 10.1158/1055-9965.EPI-08-0777; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Harriss DJ, 2009, COLORECTAL DIS, V11, P547, DOI 10.1111/j.1463-1318.2009.01766.x; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; Jinjuvadia R, 2013, J CLIN GASTROENTEROL, V47, P33, DOI 10.1097/MCG.0b013e3182688c15; Kramer HU, 2012, EUR J CANCER, V48, P1269, DOI 10.1016/j.ejca.2011.07.010; Kramer HU, 2012, EUR J EPIDEMIOL, V27, P341, DOI 10.1007/s10654-012-9686-6; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Lin JH, 2010, JNCI-J NATL CANCER I, V102, P1746, DOI 10.1093/jnci/djq444; Luo W, 2012, COLORECTAL DIS, V14, P1307, DOI 10.1111/j.1463-1318.2012.02875.x; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Nguyen SP, 2009, CLIN GASTROENTEROL H, V7, P676, DOI 10.1016/j.cgh.2009.01.008; Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x; Niv Y, 2008, DIGEST DIS SCI, V53, P3049, DOI 10.1007/s10620-008-0286-y; Onitilo AA, 2012, CANCER CAUSE CONTROL, V23, P991, DOI 10.1007/s10552-012-9971-4; Ritenbaugh C, 2008, CANCER EPIDEM BIOMAR, V17, P2609, DOI 10.1158/1055-9965.EPI-08-0385; Saydah SH, 2003, AM J EPIDEMIOL, V157, P1092, DOI 10.1093/aje/kwg100; Siddiqui AA, 2008, DIGEST DIS SCI, V53, P2486, DOI 10.1007/s10620-008-0264-4; Sun L, 2012, DIGEST DIS SCI, V57, P1586, DOI 10.1007/s10620-012-2059-x; Tran TT, 2006, ENDOCRINOLOGY, V147, P1830, DOI 10.1210/en.2005-1012; Vu HT, 2012, DDW 2012; Wilke RA, 2007, CLIN MED RES, V5, P1, DOI 10.3121/cmr.2007.726; Wilkinson JE, 2011, PREV CHRONIC DIS, V8; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301	36	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70426	10.1371/journal.pone.0070426	http://dx.doi.org/10.1371/journal.pone.0070426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936428	gold, Green Submitted, Green Published			2022-12-27	WOS:000324545800041
J	Qian, NS; Liu, WH; Lv, WP; Xiang, X; Su, M; Raut, V; Chen, YL; Dong, JH				Qian, Nian-Song; Liu, Wei-Hui; Lv, Wen-Ping; Xiang, Xin; Su, Ming; Raut, Vikram; Chen, Yong-Liang; Dong, Jia-Hong			Upregulated MicroRNA-92b Regulates the Differentiation and Proliferation of EpCAM-Positive Fetal Liver Cells by Targeting C/EBP beta	PLOS ONE			English	Article							CANCER STEM-CELLS; HEPATOCELLULAR-CARCINOMA CELLS; BREAST-CANCER; TRANSDIFFERENTIATED HEPATOCYTES; SUPPRESSOR GENE; EXPRESSION; PANCREAS; FEATURES; THERAPY; MIR-21	microRNAs (miRNAs) are short noncoding RNAs that negatively regulate gene expression. Although recent evidences have been indicated that their aberrant expression may play an important role in cancer stem cells, the mechanism of their deregulation in neoplastic transformation of liver cancer stem cells (LCSCs) has not been explored. In our study, the HCC model was established in F344 rats by DEN induction. The EpCAM(+) cells were sorted out from unfractionated fetal liver cells and liver cancer cells using the FACS analysis and miRNA expression profiles of two groups were screened through microarray platform. Gain-of-function studies were performed in vitro and in vivo to determine the role of miR-92b on proliferation and differentiation of the hepatic progenitors. In addition, luciferase reporter system and gene function analysis were used to predict miR-92b target. we found that miR-92b was highly downregulated in EpCAM(+) fetal liver cells in expression profiling studies. RT-PCR analysis demonstrated reverse correlation between miR-92b expression and differentiation degree in human HCC samples. Overexpression of miR-92b in EpCAM(+) fetal liver cells significantly increased proliferation and inhibited differentiation as well as in vitro and in vivo studies. Moreover, we verified that C/EBP beta is a direct target of miR-92b and contributes to its effects on proliferation and differentiation. We conclude that aberrant expression of miR-92b can result in proliferation increase and differentiation arrest of hepatic progenitors by targeting C/EBP beta.	[Qian, Nian-Song; Lv, Wen-Ping; Xiang, Xin; Su, Ming; Chen, Yong-Liang; Dong, Jia-Hong] Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Qian, Nian-Song; Lv, Wen-Ping; Xiang, Xin; Su, Ming; Chen, Yong-Liang] Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Hainan Branch, Sanya, Peoples R China; [Liu, Wei-Hui] Gen Hosp Chengdu Mil Reg, Dept Hepatobiliary Surg, Chengdu, Peoples R China; [Raut, Vikram] Kyoto Univ, Dept Hepatobiliary Surg, Grad Sch Med, Kyoto, Japan	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Kyoto University	Qian, NS (corresponding author), Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China.	qianniansong1@163.com; 1027702480@qq.com	Raut, Vikram/H-8700-2019		Scientific Supporting Funds of PLA General Hospital [2012FC-CXYY-4008]; Postdoctoral Science Foundation [2012M521875, 2012M521864]; National Natural Science Foundation of China [81200324]; Bureau of Health Medical Scientific Research Foundation of Hainan Province [PT-70]	Scientific Supporting Funds of PLA General Hospital; Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Health Medical Scientific Research Foundation of Hainan Province	The study was supported by the supported by the Scientific Supporting Funds of PLA General Hospital (2012FC-CXYY-4008), Postdoctoral Science Foundation (2012M521875 and 2012M521864), National Natural Science Foundation of China (81200324), and Bureau of Health Medical Scientific Research Foundation of Hainan Province (Qiongwei 2012 PT-70). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2005, STEM CELL REV, V1, P253, DOI 10.1385/SCR:1:3:253; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Buck M, 2003, HEPATOLOGY, V37, P731, DOI 10.1053/jhep.2003.50155; Buechner J, 2011, DIFFERENTIATION, V81, P25, DOI 10.1016/j.diff.2010.09.184; Burke ZD, 2006, J CELL PHYSIOL, V206, P147, DOI 10.1002/jcp.20438; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen HF, 2011, STEM CELL REV REP, V7, P722, DOI 10.1007/s12015-011-9233-y; Chen Qiong-Rong, 2007, Ai Zheng, V26, P719; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Fong D, 2009, CANCER SCI, V100, P1414, DOI 10.1111/j.1349-7006.2009.01208.x; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Kurash JK, 2004, EXP CELL RES, V292, P342, DOI 10.1016/j.yexcr.2003.09.002; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li R, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-169; Lim IK, 2003, MECH AGEING DEV, V124, P697, DOI 10.1016/S0047-6374(03)00010-1; Liu WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035720; Liu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023311; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Plante BJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-15; Qian NS, 2010, LIFE SCI, V87, P64, DOI 10.1016/j.lfs.2010.05.014; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Sengupta S, 2009, STEM CELLS, V27, P1524, DOI 10.1002/stem.84; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Shen CN, 2003, BIOCHEM J, V375, P41, DOI 10.1042/BJ20030140; Sivaramakrishnan V, 2010, CHEM-BIOL INTERACT, V183, P284, DOI 10.1016/j.cbi.2009.11.011; Soto-Gutierrez A, 2007, NAT PROTOC, V2, P347, DOI 10.1038/nprot.2007.18; Sun W, 2010, CELL RES, V20, P1158, DOI 10.1038/cr.2010.134; Sun YF, 2012, HEPATOLOGY; Terris B, 2010, J HEPATOL, V52, P280, DOI 10.1016/j.jhep.2009.10.026; Veeck J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-217; Westmacott A, 2006, INT J DEV BIOL, V50, P653, DOI 10.1387/ijdb.062146aw; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Yamashita T, 2012, HEPATOLOGY; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhong ZW, 2012, J CANCER RES CLIN, V138, P1781, DOI 10.1007/s00432-012-1287-y	50	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e68004	10.1371/journal.pone.0068004	http://dx.doi.org/10.1371/journal.pone.0068004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936298	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800002
J	Montes, I; Conklin, D; Albaina, A; Creer, S; Carvalho, GR; Santos, M; Estonba, A				Montes, Iratxe; Conklin, Darrell; Albaina, Aitor; Creer, Simon; Carvalho, Gary R.; Santos, Maria; Estonba, Andone			SNP Discovery in European Anchovy (Engraulis encrasicolus, L) by High-Throughput Transcriptome and Genome Sequencing	PLOS ONE			English	Article							POPULATION; NORMALIZATION; ATLANTIC; PROGRAM; ECOLOGY; MARKERS	Increased throughput in sequencing technologies has facilitated the acquisition of detailed genomic information in non-model species. The focus of this research was to discover and validate SNPs derived from the European anchovy (Engraulis encrasicolus) transcriptome, a species with no available reference genome, using next generation sequencing technologies. A cDNA library was constructed from four tissues of ten fish individuals corresponding to three populations of E. encrasicolus, and Roche 454 GS FLX Titanium sequencing yielded 19,367 contigs. Additionally, the European anchovy genome was sequenced for the same ten individuals using an Illumina HiSeq2000. Using a computational pipeline for combining transcriptome and genome information, a total of 18,994 SNPs met the necessary minor allele frequency and depth filters. A series of further stringent filters were applied to identify those SNPs likely to succeed in genotyping assays, and for filtering of those in potential duplicated genome regions. A novel method for detecting potential intron-exon boundaries in areas of putative SNPs has also been applied in silico to improve genotyping success. In all, 2,317 filtered putative transcriptome SNPs suitable for genotyping primer design were identified. From those, a subset of 530 were selected, with the genotyping results showing the highest reported conversion and validation rates (91.3% and 83.2%, respectively) reported to date for a non-model species. This study represents a promising strategy to discover genotypable SNPs in the exome of non-model organisms. The genomic resource generated for E. encrasicolus, both in terms of sequences and novel markers, will be informative for research into this species with applications including traceability studies, population genetic analyses and aquaculture.	[Montes, Iratxe; Albaina, Aitor; Estonba, Andone] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Conklin, Darrell] Univ Basque Country UPV EHU, Dept Comp Sci & Artificial Intelligence, San Sebastian, Spain; [Conklin, Darrell] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Creer, Simon; Carvalho, Gary R.] Bangor Univ, Environm Ctr Wales, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales; [Santos, Maria] AZTI Tecnalia, Div Marine Res, Pasaia, Spain	University of Basque Country; University of Basque Country; Basque Foundation for Science; Bangor University; AZTI	Estonba, A (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	andone.estonba@ehu.es	Montes Asperilla, Iratxe/J-3127-2016; Albaina, Aitor/E-6267-2015	Montes Asperilla, Iratxe/0000-0002-6341-8768; Albaina, Aitor/0000-0003-3353-6090; SANTOS MOKOROA, MARIA/0000-0002-1974-6369; Estonba, Andone/0000-0003-2851-5201	project ECOGENBAY [MICINN CTM2009-13570-C02-02]; Ministry of Science and Research of the Government of Spain; University of the Basque Country UPV/EHU [3571/2008]; Natural Environment Research Council [NBAF010002] Funding Source: researchfish; NERC [NBAF010002] Funding Source: UKRI	project ECOGENBAY; Ministry of Science and Research of the Government of Spain; University of the Basque Country UPV/EHU; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the project ECOGENBAY (MICINN CTM2009-13570-C02-02) funded by the Ministry of Science and Research of the Government of Spain, and by a Research Grant (3571/2008) from the University of the Basque Country UPV/EHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AG, 2012, MOL ECOL RESOUR, V12, P374, DOI 10.1111/j.1755-0998.2011.03109.x; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanca JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-285; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conklin D, 2013, PROCEEDINGS IWBBIO 2013: INTERNATIONAL WORK-CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, P127; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Foll M, 2008, GENOME SCAN METHOD I; Grant WS, 2005, GENETICA, V125, P293, DOI 10.1007/s10709-005-0717-z; Gut IG, 2004, NAT GENET, V36, P789, DOI 10.1038/ng0804-789; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Helyar SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042089; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Hyman Richard W, 2010, BMC Res Notes, V3, P257, DOI 10.1186/1756-0500-3-257; Jerome M, 2008, J AGR FOOD CHEM, V56, P3460, DOI 10.1021/jf703704m; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Landi M, 2005, MOL ECOL NOTES, V5, P266, DOI 10.1111/j.1471-8286.2005.00892.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-568; Magoulas A, 2006, MOL PHYLOGENET EVOL, V39, P734, DOI 10.1016/j.ympev.2006.01.016; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Milano I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028008; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Moen T, 2009, ANIM GENET, V40, P993, DOI 10.1111/j.1365-2052.2009.01938.x; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Nielsen Rasmus, 2004, Human Genomics, V1, P218; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Rea S, 2009, FOOD CONTROL, V20, P515, DOI 10.1016/j.foodcont.2008.08.001; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Roberts SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030908; Rosenblum EB, 2007, J HERED, V98, P331, DOI 10.1093/jhered/esm031; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Slate J, 2009, GENETICA, V136, P97, DOI 10.1007/s10709-008-9317-z; Studer B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-140; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Vera M, 2011, AQUACULTURE, V313, P31, DOI 10.1016/j.aquaculture.2011.01.038; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Warnes G, 2012, GENETICS POPULATION; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201; Zarraonaindia I, 2009, ICES J MAR SCI, V66, P2176, DOI 10.1093/icesjms/fsp187; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	62	29	30	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70051	10.1371/journal.pone.0070051	http://dx.doi.org/10.1371/journal.pone.0070051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936375	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400035
J	Naess, MW; Bardsen, BJ				Naess, Marius Warg; Bardsen, Bard-Jorgen			Why Herd Size Matters - Mitigating the Effects of Livestock Crashes	PLOS ONE			English	Article							COOPERATIVE PASTORAL PRODUCTION; REINDEER HUSBANDRY; RISK-MANAGEMENT; CLIMATE-CHANGE; REPRODUCTIVE ALLOCATION; STRATEGIES; VULNERABILITY; PREDATION; NORWAY	Analysing the effect of pastoral risk management strategies provides insights into a system of subsistence that have persevered in marginal areas for hundreds to thousands of years and may shed light into the future of around 200 million households in the face of climate change. This study investigated the efficiency of herd accumulation as a buffer strategy by analysing changes in livestock holdings during an environmental crisis in the Saami reindeer husbandry in Norway. We found a positive relationship between: (1) pre- and post-collapse herd size; and (2) pre-collapse herd size and the number of animals lost during the collapse, indicating that herd accumulation is an effective but costly strategy. Policies that fail to incorporate the risk-beneficial aspect of herd accumulation will have a limited effect and may indeed fail entirely. In the context of climate change, official policies that incorporate pastoral risk management strategies may be the only solution for ensuring their continued existence.	[Naess, Marius Warg] Fram Ctr, Ctr Int Climate & Environm Res Oslo CICERO, Tromso, Norway; [Bardsen, Bard-Jorgen] Fram Ctr, Arctic Ecol Dept, Norwegian Inst Nat Res NINA, Tromso, Norway	Norwegian Institute Nature Research	Naess, MW (corresponding author), Fram Ctr, Ctr Int Climate & Environm Res Oslo CICERO, Tromso, Norway.	m.w.nass@cicero.tromso.no	Bårdsen, Bård-Jørgen/B-6984-2015	Bårdsen, Bård-Jørgen/0000-0001-6818-5249; Naess, Marius Warg/0000-0002-2973-5954	Research Council of Norway (the FRISAM program) [204174]	Research Council of Norway (the FRISAM program)(Research Council of Norway)	The present study is part of the ECOPAST project financed by the Research Council of Norway (the FRISAM program, project number 204174). Webpage: http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BROWSING FENCES PAST; [Anonymous], 2010, TOTALREGNSKAP REINDR; [Anonymous], 2012, RIKSREVISJONENS UNDE, V14, P89; [Anonymous], 2007, ST PRP NR 74 REINDR, P36; [Anonymous], 2004, TOTALREGNSKAP REINDR; [Anonymous], 2001, TOTALREGNSKAP REINDR; [Anonymous], 2009, SLUTTRAPPORT PROSJEK; Bardsen BJ, 2012, J ANIM ECOL, V81, P364, DOI 10.1111/j.1365-2656.2011.01913.x; Bardsen BJ, 2011, OIKOS, V120, P245, DOI 10.1111/j.1600-0706.2010.18597.x; Bardsen BJ, 2010, OECOLOGIA, V162, P627, DOI 10.1007/s00442-009-1537-0; BARDSEN BJ, 2009, RISK SENSITIVE REPRO; Benestad RE, 2011, J CLIMATE, V24, P2080, DOI 10.1175/2010JCLI3687.1; Berg, 2008, NORDLANDS KULTURELLE, P151; BJORKLUND I, 1990, DEV CHANGE, V21, P75, DOI 10.1111/j.1467-7660.1990.tb00368.x; Blackwell PJ, 2010, THIRD WORLD Q, V31, P1321, DOI 10.1080/01436597.2010.541085; Bollig M., 1997, NOMADIC PEOPLES, V1, P5, DOI DOI 10.3167/082279497782384712; Bostedt G, 2001, AGR ECON-BLACKWELL, V26, P217, DOI 10.1111/j.1574-0862.2001.tb00065.x; Brannlund I, 2011, GLOBAL ENVIRON CHANG, V21, P1095, DOI 10.1016/j.gloenvcha.2011.03.005; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Dong SK, 2011, ECOL SOC, V16; FRATKIN E, 1990, HUM ECOL, V18, P385, DOI 10.1007/BF00889464; Galvin KA, 2009, ANNU REV ANTHROPOL, V38, P185, DOI 10.1146/annurev-anthro-091908-164442; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hatfield R., 2006, GLOBAL REV EC PASTOR; Hausner VH, 2011, ECOL SOC, V16, DOI 10.5751/ES-04193-160304; Herskovits MJ, 1926, AM ANTHROPOL, V28, P633, DOI 10.1525/aa.1926.28.4.02a00040; Janes CR, 2010, ASIA-PAC J PUBLIC HE, V22, p236S, DOI 10.1177/1010539510373008; Johannesen AB, 2011, ENVIRON RESOUR ECON, V48, P679, DOI 10.1007/s10640-010-9421-2; Little PD, 2001, CLIM RES, V19, P149, DOI 10.3354/cr019149; Lybbert TJ, 2004, ECON J, V114, P750, DOI 10.1111/j.1468-0297.2004.00242.x; MACE R, 1989, AGR SYST, V31, P185, DOI 10.1016/0308-521X(89)90020-6; Marin A, 2010, GLOBAL ENVIRON CHANG, V20, P162, DOI 10.1016/j.gloenvcha.2009.10.004; McCabe J. Terrence, 2004, CATTLE BRING US OUR; McPeak J, 2005, HUM ECOL, V33, P171, DOI 10.1007/s10745-005-2431-Y; McPeak J, 2005, STUD HUM ECOL ADAPT, V1, P87; Miller Daniel, 2000, NOMAD PEOPLES, V4, P83, DOI DOI 10.3167/082279400782310674; Naess MW, 2012, COMM ENV DISAST RISK, V11, P95, DOI 10.1108/S2040-7262(2012)0000011012; Naess MW, 2013, INT J SUST DEV WORLD, V20, P123, DOI 10.1080/13504509.2013.779615; Naess MW, 2012, EVOL HUM BEHAV, V33, P696, DOI 10.1016/j.evolhumbehav.2012.05.004; Naess MW, 2012, AM ANTHROPOL, V114, P309, DOI 10.1111/j.1548-1433.2012.01427.x; Naess MW, 2011, HUM ECOL, V39, P489, DOI 10.1007/s10745-011-9398-7; Naess MW, 2010, EVOL HUM BEHAV, V31, P246, DOI 10.1016/j.evolhumbehav.2009.12.004; Naess MW, 2010, HUM ECOL, V38, P3, DOI 10.1007/s10745-009-9288-4; Naess MW, 2009, HUM ECOL, V37, P193, DOI 10.1007/s10745-009-9226-5; Neely C., 2009, REV EVIDENCE DRYLAND; NILSEN R, 1994, INN VIDDA HUSHOLD OK; Nkedianye D, 2011, PASTORALISM, V1, DOI 10.1186/2041-7136-1-17; Nss Marius W., 2009, PASTORAL RISK MANAGE; Paine, 2009, CAMPS TUNDRA POLITIC; Paine, 1994, HERDS TUNDRA PORTRAI; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reid Robin S., 2008, P1, DOI 10.1007/978-1-4020-4906-4_1; Riseth JA, 2009, LAND ECON, V85, P87, DOI 10.3368/le.85.1.87; Riseth Jan Age, 2004, Rangifer, P65; Riseth JuO., 2003, INDIGENOUS PEOPLES R, P229; Secretariat of the Convention on Biological Diversity, 2009, SECR CONV BIOL DIV T, V41; Sun Y, 2007, J CLIMATE, V20, P4801, DOI 10.1175/JCLI4263.1; Templer G., 1993, Nomadic Peoples, P105; Tommervik H, 2011, 672 NINA; Tveraa T, 2003, OECOLOGIA, V137, P370, DOI 10.1007/s00442-003-1373-6; Tveraa T, 2007, OIKOS, V116, P706, DOI [10.1111/j.2006.0030-1299.15257.x, 10.1111/j.0030-1299.2007.15257.x]; Ulvevadet Birgitte, 2008, Rangifer, V28, P53; Ulvevadet B, 2011, J ENVIRON MANAGE, V92, P2794, DOI 10.1016/j.jenvman.2011.06.026; Vorren O., 1978, 18A NOU UNIV, P145; Xie YN, 2008, NOMAD PEOPLES, V12, P35, DOI 10.3167/np.2008.120203; Zuur Alain F., 2009, P1; 2008, RESSURSREGNSKAP REIN	67	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70161	10.1371/journal.pone.0070161	http://dx.doi.org/10.1371/journal.pone.0070161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219PB	23936386	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400040
J	Tababat-Khani, P; Berglund, LM; Agardh, CD; Gomez, MF; Agardh, E				Tababat-Khani, Poya; Berglund, Lisa M.; Agardh, Carl-David; Gomez, Maria F.; Agardh, Elisabet			Photocoagulation of Human Retinal Pigment Epithelial Cells In Vitro: Evaluation of Necrosis, Apoptosis, Cell Migration, Cell Proliferation and Expression of Tissue Repairing and Cytoprotective Genes	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; LASER PHOTOCOAGULATION; ARPE-19; HSP70; LINE	Aims: Sight-threatening diabetic retinopathy has been treated with photocoagulation for decades but the mechanisms behind the beneficial clinical effects are poorly understood. One target of irradiation and a potential player in this process is the retinal pigment epithelium (RPE). Here we establish an in vitro model for photocoagulation of human RPE cells. Methods: ARPE-19 cells were exposed to photocoagulation and studied at various time points up to 168h. Lesion morphology, necrosis and apoptosis were investigated by light microscopy; LIVE/DEAD staining and measurements of lactate dehydrogenase activity; and TUNEL-and ELISA-based quantification of DNA fragments, respectively. Cell migration and proliferation were explored using docetaxel and mitomycin C; temporal and spatial changes in proliferation were assessed by confocal immunofluorescence of proliferating cell nuclear antigen. Gene expression was measured by qPCR. Results: Photocoagulation of ARPE-19 resulted in denaturation of proteins and reproducible lesion formation. A transient peak in necrosis, followed by a peak in apoptosis was observed in cells within the lesions at 6h and 24h, respectively after photocoagulation. Cell proliferation was depressed during the first hours after photocoagulation, back to control levels at 24h and augmented in the following days. These effects were not limited to cells in the lesions, but also evident in neighbouring cells. Changes in cell proliferation during lesion repair were preceded by changes in cell migration. Altered mRNA expression of genes previously implicated in the regulation of cell proliferation (FOS, IL-1b, IL-8, HMGA2), migration and tissue repairing (TGFBR2, ADAMTS6, TIMP3, CTGF) was observed, as well as increased expression of the alarmin IL33 and the cytoprotective gene HSPA6. Conclusions: Using a laser system and experimental settings that comply with standards used in clinical practice, we have established a suitable model for in vitro photocoagulation of human RPE cells to isolate their contribution to the beneficial effects of laser treatment.	[Tababat-Khani, Poya; Agardh, Carl-David; Agardh, Elisabet] Lund Univ, Unit Vasc Diabet Complicat, Dept Clin Sci Malmo, Malmo, Sweden; [Berglund, Lisa M.; Gomez, Maria F.] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden	Lund University; Lund University	Tababat-Khani, P (corresponding author), Lund Univ, Unit Vasc Diabet Complicat, Dept Clin Sci Malmo, Malmo, Sweden.	poya.t-khani@med.lu.se	Segerstad, Poya Hård af/P-8332-2017; Gomez, Maria F/D-3696-2014	Segerstad, Poya Hård af/0000-0001-8293-3856; Gomez, Maria F/0000-0001-6210-3142; Berglund, Lisa/0000-0001-6440-116X	Lund University; Swedish Medical Society; Eye Foundation; Jarnhardt Foundation; Skane University Hospital Foundation; Foundation for Visually Impaired in Former Malmohus lan; Knut and Alice Wallenberg Foundation; Swedish Research Council [2011-3900]; Lund University Diabetes Centre and Exodiab [2009-1039]	Lund University; Swedish Medical Society; Eye Foundation; Jarnhardt Foundation; Skane University Hospital Foundation; Foundation for Visually Impaired in Former Malmohus lan; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Diabetes Centre and Exodiab	This study was supported by Lund University, the Swedish Medical Society, the Eye Foundation, Jarnhardt Foundation, the Skane University Hospital Foundation and the Foundation for Visually Impaired in Former Malmohus lan. It was also supported by the Knut and Alice Wallenberg Foundation, the Swedish Research Council (number 2011-3900), Lund University Diabetes Centre and Exodiab (number 2009-1039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Barak A, 2005, INVEST OPHTH VIS SCI, V46, P2587, DOI 10.1167/iovs.04-0920; Bellmann K, 2010, CELL STRESS CHAPERON, V15, P101, DOI 10.1007/s12192-009-0126-9; Bevitt DJ, 2003, BBA-GENE STRUCT EXPR, V1626, P83, DOI 10.1016/S0167-4781(03)00047-2; Carr L W 3rd, 1995, Optom Clin, V4, P17; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Graham CE, 2006, ADV EXP MED BIOL, V572, P195; Hattenbach LO, 2005, OPHTHALMIC RES, V37, P341, DOI 10.1159/000088263; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Javey G, 2012, EXP DIABETES RES, DOI 10.1155/2012/548732; Johnen S, 2011, INVEST OPHTH VIS SCI, V52, P5400, DOI 10.1167/iovs.10-6178; Krishna Y, 2007, J BIOMED MATER RES A, V80A, P669, DOI 10.1002/jbm.a.30953; Liu XC, 2012, INFLAMMATION, V35, P776, DOI 10.1007/s10753-011-9379-4; MATSUMOTO M, 1994, INVEST OPHTH VIS SCI, V35, P4245; MELLERIO J, 1966, EXP EYE RES, V5, P242, DOI 10.1016/S0014-4835(66)80033-7; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P393, DOI 10.1379/CSC-278e.1; NOYORI KS, 1963, ARCH OPHTHALMOL-CHIC, V70, P817; Ogata N, 2001, GRAEF ARCH CLIN EXP, V239, P87, DOI 10.1007/s004170000235; Palanker D, 2011, RETINA-J RET VIT DIS, V31, P1664, DOI 10.1097/IAE.0b013e3182115679; Parrales A, 2010, J CELL PHYSIOL, V222, P302, DOI 10.1002/jcp.21951; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; ROIDER J, 1992, ARCH OPHTHALMOL-CHIC, V110, P1786, DOI 10.1001/archopht.1992.01080240126045; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; von Leithner PL, 2010, MOL VIS, V16, P570; Xie PY, 2012, BIOL PHARM BULL, V35, P1447, DOI 10.1248/bpb.b110706; YOSHIMURA N, 1995, INVEST OPHTH VIS SCI, V36, P1686; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3; Zhong YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038616	33	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70465	10.1371/journal.pone.0070465	http://dx.doi.org/10.1371/journal.pone.0070465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936435	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400069
J	Wu, HH; Li, IJ; Weng, CH; Lee, CC; Chen, YC; Chang, MY; Fang, JT; Hung, CC; Yang, CW; Tian, YC				Wu, Hsin-Hsu; Li, I-Jung; Weng, Cheng-Hao; Lee, Cheng-Chia; Chen, Yung-Chang; Chang, Ming-Yang; Fang, Ji-Tseng; Hung, Cheng-Chieh; Yang, Chih-Wei; Tian, Ya-Chung			Prophylactic Antibiotics for Endoscopy-Associated Peritonitis in Peritoneal Dialysis Patients	PLOS ONE			English	Article							INFECTIONS RECOMMENDATIONS; FUNGAL PERITONITIS; COLONOSCOPY; OUTCOMES; CAPD; CYCLOPHILIN; ALISPORIVIR; RISKS	Introduction: Continuous ambulatory peritoneal dialysis (CAPD) peritonitis may develop after endoscopic procedures, and the benefit of prophylactic antibiotics is unclear. In the present study, we investigated whether prophylactic antibiotics reduce the incidence of peritonitis in these patients. Patients and methods: We retrospectively reviewed all endoscopic procedures, including esophagogastroduodenoscopy (EGD), colonoscopy, sigmoidoscopy, cystoscopy, hysteroscopy, and hysteroscopy-assisted intrauterine device (IUD) implantation/removal, performed in CAPD patients at Chang Gung Memorial Hospital, Taiwan, between February 2001 and February 2012. Results: Four hundred and thirty-three patients were enrolled, and 125 endoscopies were performed in 45 patients. Eight (6.4%) peritonitis episodes developed after the examination. Antibiotics were used in 26 procedures, and none of the patients had peritonitis (0% vs. 8.1% without antibiotic use; p = 0.20). The peritonitis rate was significantly higher in the non-EGD group than in the EGD group (15.9% [7/44] vs. 1.2% [1/81]; p<0.005). Antibiotic use prior to non-EGD examinations significantly reduced the endoscopy-associated peritonitis rate compared to that without antibiotic use (0% [0/16] vs. 25% [7/28]; p<0.05). Peritonitis only occurred if invasive procedures were performed, such as biopsy, polypectomy, or IUD implantation, (noninvasive procedures, 0% [0/20] vs. invasive procedures, 30.4% [7/23]; p<0.05). No peritonitis was noted if antibiotics were used prior to examination with invasive procedures (0% [0/10] vs. 53.8% [7/13] without antibiotic use; p<0.05). Although not statistically significant, antibiotics may play a role in preventing gynecologic procedure- related peritonitis (antibiotics, 0% [0/4] vs. no antibiotics, 55.6% [5/9]; p = 0.10). Conclusion: Antibiotic prophylaxis significantly reduced endoscopy- associated PD peritonitis in the non-EGD group. Endoscopically assisted invasive procedures, such as biopsy, polypectomy, IUD implantation/removal, and dilatation and curettage (D&C), pose a high risk for peritonitis. Prophylactic antibiotics for peritonitis prevention may be required in colonoscopic procedures and gynecologic procedures.	[Wu, Hsin-Hsu; Li, I-Jung; Weng, Cheng-Hao; Lee, Cheng-Chia; Chen, Yung-Chang; Chang, Ming-Yang; Fang, Ji-Tseng; Hung, Cheng-Chieh; Yang, Chih-Wei; Tian, Ya-Chung] Taiwan & Chang Gung Univ, Kidney Res Ctr, Dept Nephrol, Lin Kou Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Wu, Hsin-Hsu; Li, I-Jung; Weng, Cheng-Hao] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Tian, YC (corresponding author), Taiwan & Chang Gung Univ, Kidney Res Ctr, Dept Nephrol, Lin Kou Chang Gung Mem Hosp, Tao Yuan, Taiwan.	dryctian@adm.cgmh.org.tw	Chang, Ming-Yang/AGH-5397-2022	Chang, Ming-Yang/0000-0001-8899-0376; Lee, Cheng-Chia/0000-0002-6973-5908; Wu, Hsin Hsu/0000-0002-0028-7836				Bunke CM, 1997, KIDNEY INT, V52, P524, DOI 10.1038/ki.1997.363; GIANNELLA RA, 1972, GUT, V13, P251, DOI 10.1136/gut.13.4.251; HILL MJ, 1975, GUT, V16, P318, DOI 10.1136/gut.16.4.318; Husebye E, 2005, CHEMOTHERAPY, V51, P1, DOI 10.1159/000081988; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; LEVISON ME, 1977, AM J OBSTET GYNECOL, V127, P80, DOI 10.1016/0002-9378(77)90318-0; LI PKT, 1993, AM J KIDNEY DIS, V21, P446; Lin YC, 2012, INTERNAL MED, V51, P1841, DOI 10.2169/internalmedicine.51.7485; Ma TL, 2012, PERITON DIALYSIS INT, V32, P113, DOI 10.3747/pdi.2011.00038; Maruyama H, 1997, PERITON DIALYSIS INT, V17, P404; Nikitidou O, 2012, INT UROL NEPHROL, V44, P593, DOI 10.1007/s11255-011-9995-9; PETERSEN JH, 1987, AM J GASTROENTEROL, V82, P171; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; Piraino B, 2011, PERITON DIALYSIS INT, V31, P614, DOI 10.3747/pdi.2011.00057; Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514; RAY SM, 1990, PERITON DIALYSIS INT, V10, P97; SCHWEINBURG FB, 1950, NEW ENGL J MED, V242, P747, DOI 10.1056/NEJM195005112421903; Singharetnam W, 1996, PERITON DIALYSIS INT, V16, P423; Strippoli GFM, 2004, AM J KIDNEY DIS, V44, P591, DOI [10.1016/S0272-6386(04)00941-2, 10.1053/j.ajkd.2004.05.043]; Strippoli GFM, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004679.PUB2; Suh H, 1996, ADV PERIT D, V12, P192; Troidle L, 1998, AM J KIDNEY DIS, V32, P623, DOI 10.1016/S0272-6386(98)70026-5; VERGER C, 1987, GASTROINTEST ENDOSC, V33, P334, DOI 10.1016/S0016-5107(87)71620-4; Watashi K, 2010, CURR OPIN INVEST DR, V11, P213; Yap DYH, 2009, PERITON DIALYSIS INT, V29, P237; Yip T, 2007, PERITON DIALYSIS INT, V27, P560	26	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71532	10.1371/journal.pone.0071532	http://dx.doi.org/10.1371/journal.pone.0071532			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936514	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400111
J	Craddock, M; Martinovic, J; Muller, MM				Craddock, Matt; Martinovic, Jasna; Mueller, Matthias M.			Task and Spatial Frequency Modulations of Object Processing: An EEG Study	PLOS ONE			English	Article							TOP-DOWN FACILITATION; GAMMA BAND RESPONSES; TIME-COURSE; BASIC-LEVEL; BIOELECTRIC EVENTS; EFFECT SIZE; CATEGORIZATION; PERCEPTION; FACE; RECOGNITION	Visual object processing may follow a coarse-to-fine sequence imposed by fast processing of low spatial frequencies (LSF) and slow processing of high spatial frequencies (HSF). Objects can be categorized at varying levels of specificity: the superordinate (e.g. animal), the basic (e.g. dog), or the subordinate (e.g. Border Collie). We tested whether superordinate and more specific categorization depend on different spatial frequency ranges, and whether any such dependencies might be revealed by or influence signals recorded using EEG. We used event-related potentials (ERPs) and time-frequency (TF) analysis to examine the time course of object processing while participants performed either a grammatical gender-classification task (which generally forces basic-level categorization) or a living/non-living judgement (superordinate categorization) on everyday, real-life objects. Objects were filtered to contain only HSF or LSF. We found a greater positivity and greater negativity for HSF than for LSF pictures in the P1 and N1 respectively, but no effects of task on either component. A later, fronto-central negativity (N350) was more negative in the gender-classification task than the superordinate categorization task, which may indicate that this component relates to semantic or syntactic processing. We found no significant effects of task or spatial frequency on evoked or total gamma band responses. Our results demonstrate early differences in processing of HSF and LSF content that were not modulated by categorization task, with later responses reflecting such higher-level cognitive factors.	[Craddock, Matt; Mueller, Matthias M.] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany; [Martinovic, Jasna] Univ Aberdeen, Sch Psychol, Aberdeen AB9 1FX, Scotland	Leipzig University; University of Aberdeen	Muller, MM (corresponding author), Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany.	matt.craddock@uni-leipzig.de	Craddock, Matt/G-2633-2010; martinovic, jasna/AAH-9926-2019; Martinovic, Jasna/C-7633-2009	Craddock, Matt/0000-0002-2199-3705; martinovic, jasna/0000-0001-9141-2577; Martinovic, Jasna/0000-0001-9141-2577	Deutsche Forschungsgemeinschaft (German Research Foundation)	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation), http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaki D, 2007, NEUROIMAGE, V37, P1407, DOI 10.1016/j.neuroimage.2007.05.054; BADCOCK JC, 1990, PERCEPTION, V19, P617, DOI 10.1068/p190617; Baguley T, 2012, SERIOUS STATS GUIDE; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; FINTZI AR, 2013, CEREB CORTEX; Goffaux V, 2003, COGNITIVE BRAIN RES, V16, P416, DOI 10.1016/S0926-6410(03)00056-9; Goffaux V, 2003, COGNITIVE SCI, V27, P313, DOI 10.1016/S0364-0213(03)00002-8; GOFFAUX V, 2010, CEREBRAL CORTEX; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Harel A, 2009, J EXP PSYCHOL HUMAN, V35, P1264, DOI 10.1037/a0013621; Hassler U, 2011, NEUROIMAGE, V57, P1411, DOI 10.1016/j.neuroimage.2011.05.062; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; Hughes H C, 1990, J Cogn Neurosci, V2, P272, DOI 10.1162/jocn.1990.2.3.272; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; Mace MJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005927; Mack ML, 2009, VISION RES, V49, P1961, DOI 10.1016/j.visres.2009.05.005; Marr D., 1982, VISION COMPUTATIONAL; Martinovic J, 2007, J COGNITIVE NEUROSCI, V19, P921, DOI 10.1162/jocn.2007.19.6.921; Martinovic J, 2011, INT J PSYCHOPHYSIOL, V79, P32, DOI 10.1016/j.ijpsycho.2010.07.004; Martinovic J, 2009, PSIHOLOGIJA, V42, P27, DOI 10.2298/PSI0901027M; Martinovic J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003781; Mazerolle EL, 2007, INT J PSYCHOPHYSIOL, V66, P81, DOI 10.1016/j.ijpsycho.2007.06.003; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Morrison DJ, 2001, PSYCHON B REV, V8, P454, DOI 10.3758/BF03196180; Navon D, 2003, ACTA PSYCHOL, V114, P273, DOI 10.1016/j.actpsy.2003.06.002; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; Rogers TT, 2007, J EXP PSYCHOL GEN, V136, P451, DOI 10.1037/0096-3445.136.3.451; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Schendan HE, 2008, CEREB CORTEX, V18, P1695, DOI 10.1093/cercor/bhm197; Schendan HE, 2010, BRAIN RES, V1329, P124, DOI 10.1016/j.brainres.2010.01.062; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; SHULMAN GL, 1987, PERCEPTION, V16, P89, DOI 10.1068/p160089; Sowden PT, 2006, TRENDS COGN SCI, V10, P538, DOI 10.1016/j.tics.2006.10.007; Steinhauer K, 2010, NEUROPSYCHOLOGIA, V48, P1525, DOI 10.1016/j.neuropsychologia.2010.01.013; Tanaka J, 1999, NEUROREPORT, V10, P829, DOI 10.1097/00001756-199903170-00030; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; VANRIJN AC, 1991, MED BIOL ENG COMPUT, V29, P433, DOI 10.1007/BF02441666; VANRIJN ACM, 1990, MED BIOL ENG COMPUT, V28, P389, DOI 10.1007/BF02441961; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Vanrullen Rufin, 2008, Adv Cogn Psychol, V3, P167, DOI 10.2478/v10053-008-0022-3; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	62	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70293	10.1371/journal.pone.0070293	http://dx.doi.org/10.1371/journal.pone.0070293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936181	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000322633700064
J	Subramanian, M; Lim, J; Dobson, J				Subramanian, Mahendran; Lim, Jenson; Dobson, Jon			Enhanced Nanomagnetic Gene Transfection of Human Prenatal Cardiac Progenitor Cells and Adult Cardiomyocytes	PLOS ONE			English	Article							MAGNETIC NANOPARTICLES; IN-VIVO; STEM-CELLS; DELIVERY; MAGNETOFECTION; THERAPY; HEART; EFFICIENCY; DNA; OPTIMIZATION	Magnetic nanoparticle-based gene transfection has been shown to be an effective, non-viral technique for delivery of both plasmid DNA and siRNA into cells in culture. It has several advantages over other non-viral delivery techniques, such as short transfection times and high cell viability. These advantages have been demonstrated in a number of primary cells and cell lines. Here we report that oscillating magnet array-based nanomagnetic transfection significantly improves transfection efficiency in both human prenatal cardiac progenitor cells and adult cardiomyocytes when compared to static magnetofection, cationic lipid reagents and electroporation, while maintaining high cell viability. In addition, transfection of adult cardiomyocytes was improved further by seeding the cells onto Collagen I-coated plates, with transfection efficiencies of up to 49% compared to 24% with lipid reagents and 19% with electroporation. These results demonstrate that oscillating nanomagnetic transfection far outperforms other non-viral transfection techniques in these important cells.	[Subramanian, Mahendran; Lim, Jenson] Keele Univ, NanoTherics Ltd, Newcastle Under Lyme, Staffs, England; [Lim, Jenson] Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham, W Midlands, England; [Dobson, Jon] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA; [Dobson, Jon] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA; [Dobson, Jon] Univ Florida, Inst Cell Engn & Regenerat Med, Gainesville, FL 32611 USA; [Dobson, Jon] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England	Keele University; University of Birmingham; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Keele University	Dobson, J (corresponding author), Keele Univ, NanoTherics Ltd, Sci & Business Pk, Newcastle Under Lyme, Staffs, England.	jdobson@ufl.edu	Dobson, Jon P/C-8323-2009	Dobson, Jon P/0000-0002-8108-5362; Lim, Jenson/0000-0001-7417-356X; Subramanian, Mahendran/0000-0003-2447-8693	nanoTherics limited	nanoTherics limited	This research was funded by nanoTherics limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmet I, 2002, J THORAC CARDIOV SUR, V124, P957, DOI 10.1067/mtc.2002.126655; Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bird SD, 2003, CARDIOVASC RES, V58, P423, DOI 10.1016/S0008-6363(03)00253-0; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen SY, 2003, J AM COLL CARDIOL, V42, P301, DOI 10.1016/S0735-1097(03)00627-2; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; Djurovic S, 2004, MOL BIOTECHNOL, V28, P21, DOI 10.1385/MB:28:1:21; Dobson J, 2006, GENE THER, V13, P283, DOI 10.1038/sj.gt.3302720; Dobson J, 2008, NAT NANOTECHNOL, V3, P139, DOI 10.1038/nnano.2008.39; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fouriki A, 2013, TISSUE ENG IN PRESS, DOI [10.1002/term.1508, DOI 10.1002/TERM.1508)]; Fouriki A, 2010, NANO REV, DOI [10.3402/nano.v1i0.5167, DOI 10.3402/NAN0.V1I0.5167]; Frank KF, 2005, J MOL CELL CARDIOL, V38, P607, DOI 10.1016/j.yjmcc.2005.01.011; Harrison RL, 1998, FEBS LETT, V435, P1, DOI 10.1016/S0014-5793(98)00987-9; Huth S, 2004, J GENE MED, V6, P923, DOI 10.1002/jgm.577; Ikeda Y, 2002, CIRCULATION, V105, P502, DOI 10.1161/hc0402.102953; Jayakumar J, 2000, CIRCULATION, V102, P302; Jenkins SI, 2011, ACS NANO, V5, P6527, DOI 10.1021/nn2018717; Kami D, 2011, INT J MOL SCI, V12, P3705, DOI 10.3390/ijms12063705; Katz MG, 2010, HUM GENE THER, V21, P371, DOI 10.1089/hum.2009.164; Kawaguchi H, 1997, CIRCULATION, V95, P2441, DOI 10.1161/01.CIR.95.10.2441; Kohout TA, 1996, CIRC RES, V78, P971, DOI 10.1161/01.RES.78.6.971; Labhasetwar V, 1998, J PHARM SCI, V87, P1347, DOI 10.1021/js980077+; Lan F, 2012, CIRCULATION, V126, pS20, DOI 10.1161/CIRCULATIONAHA.111.084913; Lim CC, 2000, J MOL CELL CARDIOL, V32, P2075, DOI 10.1006/jmcc.2000.1239; Lim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051350; Lim J, 2012, J GENET, V91, P223, DOI 10.1007/s12041-012-0164-4; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; McBain SC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/40/405102; Mykhaylyk O, 2007, J MAGN MAGN MATER, V311, P275, DOI 10.1016/j.jmmm.2006.10.1178; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Peran M, 2010, CYTOTHERAPY, V12, P332, DOI 10.3109/14653240903548202; Pickard M, 2010, NANOMEDICINE-UK, V5, P217, DOI [10.2217/nnm.09.109, 10.2217/NNM.09.109]; Pickard MR, 2011, TISSUE ENG PART C-ME, V17, P89, DOI [10.1089/ten.tec.2010.0170, 10.1089/ten.TEC.2010.0170]; Pickard MR, 2011, BIOMATERIALS, V32, P2274, DOI 10.1016/j.biomaterials.2010.12.007; Plank C, 2009, COLD SPRING HARB SYM, DOI [10.1101/pdb.prot5230, DOI 10.1101/PDB.PR0T5230]; Poston RS, 1999, TRANSPLANTATION, V68, P825, DOI 10.1097/00007890-199909270-00015; Preuss AK, 2000, CYTOTECHNOLOGY, V33, P139, DOI 10.1023/A:1008150402616; Richards AA, 2010, CURR CARDIOL REV, V6, P91, DOI 10.2174/157340310791162703; Sapet C, 2011, BIOTECHNIQUES, V50, P187, DOI 10.2144/000113628; Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj.gt.3301624; SCHWARZ G, 1992, J PHYSIOL-LONDON, V458, P527, DOI 10.1113/jphysiol.1992.sp019432; Shi W, 2012, HUM GENE THER METHOD, V23, P1; Shubayev VI, 2009, ADV DRUG DELIVER REV, V61, P467, DOI 10.1016/j.addr.2009.03.007; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Takemoto M, 2001, J CLIN INVEST, V108, P1429, DOI 10.1172/JCI200113350; Wei F, 2012, CELL BIOL INT REP, V19, P45; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	54	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69812	10.1371/journal.pone.0069812	http://dx.doi.org/10.1371/journal.pone.0069812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936108	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000322633700046
J	Urbain, C; Bourguignon, M; Op de Beeck, M; Schmitz, R; Galer, S; Wens, V; Marty, B; De Tiege, X; Van Bogaert, P; Peigneux, P				Urbain, Charline; Bourguignon, Mathieu; Op de Beeck, Marc; Schmitz, Remy; Galer, Sophie; Wens, Vincent; Marty, Brice; De Tiege, Xavier; Van Bogaert, Patrick; Peigneux, Philippe			MEG Correlates of Learning Novel Objects Properties in Children	PLOS ONE			English	Article							RIGHT-HEMISPHERE; BRAIN ACTIVITY; LANGUAGE; NAMES; LATERALIZATION; REPRESENTATION; ACQUISITION; MODULATION; ACTIVATION; PLASTICITY	Learning the functional properties of objects is a core mechanism in the development of conceptual, cognitive and linguistic knowledge in children. The cerebral processes underlying these learning mechanisms remain unclear in adults and unexplored in children. Here, we investigated the neurophysiological patterns underpinning the learning of functions for novel objects in 10-year-old healthy children. Event-related fields (ERFs) were recorded using magnetoencephalography (MEG) during a picture-definition task. Two MEG sessions were administered, separated by a behavioral verbal learning session during which children learned short definitions about the "magical" function of 50 unknown non-objects. Additionally, 50 familiar real objects and 50 other unknown non-objects for which no functions were taught were presented at both MEG sessions. Children learned at least 75% of the 50 proposed definitions in less than one hour, illustrating children's powerful ability to rapidly map new functional meanings to novel objects. Pre- and post-learning ERFs differences were analyzed first in sensor then in source space. Results in sensor space disclosed a learning-dependent modulation of ERFs for newly learned non-objects, developing 500-800 msec after stimulus onset. Analyses in the source space windowed over this late temporal component of interest disclosed underlying activity in right parietal, bilateral orbito-frontal and right temporal regions. Altogether, our results suggest that learning-related evolution in late ERF components over those regions may support the challenging task of rapidly creating new semantic representations supporting the processing of the meaning and functions of novel objects in children.	[Urbain, Charline; Schmitz, Remy; Galer, Sophie; Peigneux, Philippe] CRCN, Neuropsychol & Funct Neuroimaging Res Grp UR2NF, Brussels, Belgium; [Urbain, Charline; Schmitz, Remy; Galer, Sophie; Peigneux, Philippe] ULB, UNI ULB Neurosci Inst, Brussels, Belgium; [Urbain, Charline; Bourguignon, Mathieu; Op de Beeck, Marc; Galer, Sophie; Wens, Vincent; Marty, Brice; De Tiege, Xavier; Van Bogaert, Patrick] Free Univ Brussels, Hop Erasme, LCFC, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Urbain, C (corresponding author), CRCN, Neuropsychol & Funct Neuroimaging Res Grp UR2NF, Brussels, Belgium.	curbain@ulb.ac.be; philippe.peigneux@ulb.ac.be	Bourguignon, Mathieu/I-6967-2012; Schmitz, Remy/A-6592-2012	Bourguignon, Mathieu/0000-0003-1694-5087; Schmitz, Remy/0000-0002-6303-1846; Marty, Brice/0000-0002-0522-8245; Peigneux, Philippe/0000-0003-4745-1434; De Tiege, Xavier/0000-0003-0127-089X; Urbain, Charline/0000-0002-4787-6291	Universite Libre de Bruxelles (Vigneron Foundation); ULB-ARC project "Pathophysiology of Memory Consolidation Processes"; Fund for Scientific Research (F.R.S.-FNRS); Fund for Research Training in Industry and Agriculture (FRIA)	Universite Libre de Bruxelles (Vigneron Foundation); ULB-ARC project "Pathophysiology of Memory Consolidation Processes"; Fund for Scientific Research (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fund for Research Training in Industry and Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	CU was supported by a special grant of the Universite Libre de Bruxelles (Vigneron Foundation) and the ULB-ARC project "Pathophysiology of Memory Consolidation Processes". RS, XDT and SG are supported by Fund for Scientific Research (F.R.S.-FNRS). MB is supported by Fund for Research Training in Industry and Agriculture (FRIA). VW was supported by the ULB-ARC project "Pathophysiology of Memory Consolidation Processes". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev YG, 1997, PSYCHOL SCI, V8, P56, DOI 10.1111/j.1467-9280.1997.tb00544.x; Alt M, 2009, J COMMUN DISORD, V42, P347, DOI 10.1016/j.jcomdis.2009.03.004; Beeman MJ, 2000, BRAIN LANG, V71, P310, DOI 10.1006/brln.1999.2268; Bloom P, 2001, BEHAV BRAIN SCI, V24, P1095, DOI 10.1017/S0140525X01000139; Blumenfeld HK, 2006, BRAIN LANG, V99, P226, DOI 10.1016/j.bandl.2005.07.004; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Booth AE, 2002, DEV PSYCHOL, V38, P948, DOI 10.1037//0012-1649.38.6.948; Bowden EM, 1998, PSYCHOL SCI, V9, P435, DOI 10.1111/1467-9280.00082; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Buxbaum LJ, 2002, BRAIN LANG, V82, P179, DOI 10.1016/S0093-934X(02)00014-7; Carey S., 1978, P STANFORD CHILD LAN, V15, P17; Clark EV, 2004, TRENDS COGN SCI, V8, P472, DOI 10.1016/j.tics.2004.08.012; Cornelissen K, 2004, BRAIN LANG, V89, P617, DOI 10.1016/j.bandl.2003.12.007; Cornelissen K, 2003, J COGNITIVE NEUROSCI, V15, P444, DOI 10.1162/089892903321593153; De Tiege X, 2008, EPILEPSY RES, V82, P227; Donnelly KM, 2011, BRAIN RES, V1419, P105, DOI 10.1016/j.brainres.2011.08.065; Faust M, 2003, COGNITIVE BRAIN RES, V17, P585, DOI 10.1016/S0926-6410(03)00172-1; Friston KJ, 2008, NEUROIMAGE, V39, P181, DOI 10.1016/j.neuroimage.2007.08.013; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Furl N, 2010, CEREB CORTEX, V20, P694, DOI 10.1093/cercor/bhp140; Furl N, 2011, NEUROIMAGE, V54, P2267, DOI 10.1016/j.neuroimage.2010.10.038; GOLDBERG E, 1981, BRAIN LANG, V14, P144, DOI 10.1016/0093-934X(81)90072-9; GOLDBERG E, 1995, BIOL PSYCHIAT, V38, P569, DOI 10.1016/0006-3223(95)00445-8; GOLDBERG E, 1994, J NEUROPSYCH CLIN N, V6, P371; Gronholm P, 2005, COGNITIVE BRAIN RES, V25, P359, DOI 10.1016/j.cogbrainres.2005.06.010; Hart J, 2007, J INT NEUROPSYCH SOC, V13, P865, DOI 10.1017/S135561770707110X; Hulten A, 2010, J NEUROSCI, V30, P15160, DOI 10.1523/JNEUROSCI.1278-10.2010; Hulten A, 2009, HUM BRAIN MAPP, V30, P976, DOI 10.1002/hbm.20561; Ishibashi R, 2011, NEUROPSYCHOLOGIA, V49, P1128, DOI 10.1016/j.neuropsychologia.2011.01.004; Jaswal VK, 2006, COGNITION, V99, pB83, DOI 10.1016/j.cognition.2005.07.006; Kiefer M., 2011, CORTEX, P1; Kilner JM, 2005, NEUROSCI LETT, V374, P174, DOI 10.1016/j.neulet.2004.10.052; KROLL JF, 1984, J VERB LEARN VERB BE, V23, P39, DOI 10.1016/S0022-5371(84)90499-7; Kuriki S, 1999, NEUROREPORT, V10, P765, DOI 10.1097/00001756-199903170-00019; Lambon Ralph MA, 2009, CEREB CORTEX, V19, P832, DOI DOI 10.1093/CERC0R/BHN131; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Markson L, 1997, NATURE, V385, P813, DOI 10.1038/385813a0; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mattout J, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P367, DOI 10.1016/B978-012372560-8/50029-2; Mattout J, 2006, NEUROIMAGE, V30, P753, DOI 10.1016/j.neuroimage.2005.10.037; Mattout J, 2007, COMPUTATIONAL INTELL, V2007; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Nelson DGK, 2000, CHILD DEV, V71, P1271, DOI 10.1111/1467-8624.00228; New B, 2001, ANN PSYCHOL, V101, P447; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Oakes LM, 2008, ADV CHILD DEV BEHAV, V36, P135, DOI 10.1016/S0065-2407(08)00004-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penny W., 2003, HUMAN BRAIN FUNCTION; Pobric G, 2010, NEUROPSYCHOLOGIA, V48, P1336, DOI 10.1016/j.neuropsychologia.2009.12.036; Ralph MAL, 2007, BRAIN, V130, P1127, DOI 10.1093/brain/awm025; Richardson MP, 2003, NEUROIMAGE, V20, pS112, DOI 10.1016/j.neuroimage.2003.09.008; SALMELIN R, 1994, NATURE, V368, P463, DOI 10.1038/368463a0; Schmitz R, 2013, BRAIN COGNITION, V81, P1, DOI 10.1016/j.bandc.2012.09.002; Seger CA, 2000, NEUROPSYCHOLOGY, V14, P361, DOI 10.1037//0894-4105.14.3.361; Taulu S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1935742; Taulu S, 2005, IEEE T SIGNAL PROCES, V53, P3359, DOI 10.1109/TSP.2005.853302; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Ware EA, 2010, COGNITIVE DEV, V25, P124, DOI 10.1016/j.cogdev.2009.10.003; Wehner DT, 2008, NEUROIMAGE, V40, P541, DOI 10.1016/j.neuroimage.2007.12.026; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Whatmough C, 2002, NEUROPSYCHOLOGIA, V40, P174, DOI 10.1016/S0028-3932(01)00083-5; Yee E, 2010, NEUROIMAGE, V50, P753, DOI 10.1016/j.neuroimage.2009.12.036	67	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69696	10.1371/journal.pone.0069696	http://dx.doi.org/10.1371/journal.pone.0069696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936082	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700041
J	Dombrovsky, A; Glanz, E; Lachman, O; Sela, N; Doron-Faigenboim, A; Antignus, Y				Dombrovsky, Aviv; Glanz, Eyal; Lachman, Oded; Sela, Noa; Doron-Faigenboim, Adi; Antignus, Yehezkel			The Complete Genomic Sequence of Pepper Yellow Leaf Curl Virus (PYLCV) and Its Implications for Our Understanding of Evolution Dynamics in the Genus Polerovirus	PLOS ONE			English	Article							VECTOR SPECIFICITY; APHID TRANSMISSION; READTHROUGH DOMAIN; MOSAIC STRUCTURE; RECOMBINATION; LUTEOVIRUS; PROTEIN; DISEASE; P0; SUPPRESSOR	We determined the complete sequence and organization of the genome of a putative member of the genus Polerovirus tentatively named Pepper yellow leaf curl virus (PYLCV). PYLCV has a wider host range than Tobacco vein-distorting virus (TVDV) and has a close serological relationship with Cucurbit aphid-borne yellows virus (CABYV) (both poleroviruses). The extracted viral RNA was subjected to SOLiD next-generation sequence analysis and used as a template for reverse transcription synthesis, which was followed by PCR amplification. The ssRNA genome of PYLCV includes 6,028 nucleotides encoding six open reading frames (ORFs), which is typical of the genus Polerovirus. Comparisons of the deduced amino acid sequences of the PYLCV ORFs 2-4 and ORF5, indicate that there are high levels of similarity between these sequences to ORFs 2-4 of TVDV (84-93%) and to ORF5 of CABYV (87%). Both PYLCV and Pepper vein yellowing virus (PeVYV) contain sequences that point to a common ancestral polerovirus. The recombination breakpoint which is located at CABYV ORF3, which encodes the viral coat protein (CP), may explain the CABYV-like sequences found in the genomes of the pepper infecting viruses PYLCV and PeVYV. Two additional regions unique to PYLCV (PY1 and PY2) were identified between nucleotides 4,962 and 5,061 (ORF 5) and between positions 5,866 and 6,028 in the 3' NCR. Sequence analysis of the pepper-infecting PeVYV revealed three unique regions (Pe1-Pe3) with no similarity to other members of the genus Polerovirus. Genomic analyses of PYLCV and PeVYV suggest that the speciation of these viruses occurred through putative recombination event(s) between poleroviruses co-infecting a common host(s), resulting in the emergence of PYLCV, a novel pathogen with a wider host range.	[Dombrovsky, Aviv; Glanz, Eyal; Lachman, Oded; Sela, Noa; Doron-Faigenboim, Adi; Antignus, Yehezkel] Agr Res Org, Volcani Ctr, Dept Plant Pathol, IL-50250 Bet Dagan, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Dombrovsky, A (corresponding author), Agr Res Org, Volcani Ctr, Dept Plant Pathol, IL-50250 Bet Dagan, Israel.	aviv@volcani.agri.gov.il	Sela, Noa/C-5133-2008	Sela, Noa/0000-0002-8282-215X	ARO, The Volcani Center	ARO, The Volcani Center	This work was supported by a grant from the ARO, The Volcani Center (for AD) a new researcher scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Antignus Y, 2001, PHYTOPARASITICA, V29, P255; ANTIGNUS Y, 2003, Z PFLANZENKRANKHEITE, V110, P89; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; BRAULT V, 1995, EMBO J, V14, P650, DOI 10.1002/j.1460-2075.1995.tb07043.x; BRAULT V, 2011, ENCY LIFE SCI; Brault W, 2005, J VIROL, V79, P9685, DOI 10.1128/JVI.79.15.9685-9693.2005; Buzkan N, 2012, CAN J PLANT PATHOL, V34, P298, DOI 10.1080/07060661.2012.670138; Chay CA, 1996, VIROLOGY, V219, P57, DOI 10.1006/viro.1996.0222; Dombrovsky A, 2010, PHYTOPARASITICA, V38, P477, DOI 10.1007/s12600-010-0120-x; Domier L.L., 2012, VIRUS TAXONOMY, P1045; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUNN LV, 1990, J PHYTOPATHOL, V129, P210, DOI 10.1111/j.1439-0434.1990.tb04587.x; KNIERIM D, 2013, ARCH VIROL; Koev G, 2002, VIROLOGY, V292, P114, DOI 10.1006/viro.2001.1268; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Kozlowska-Makulska A, 2010, J GEN VIROL, V91, P1082, DOI 10.1099/vir.0.016360-0; LECOQ H, 1992, PLANT PATHOL, V41, P749, DOI 10.1111/j.1365-3059.1992.tb02559.x; Li X, 2000, J GEN VIROL, V81, P1857, DOI 10.1099/0022-1317-81-7-1857; Mangwende T, 2009, VIROLOGY, V384, P38, DOI 10.1016/j.virol.2008.10.034; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mo XH, 2010, VIRUS GENES, V41, P425, DOI 10.1007/s11262-010-0524-1; Moonan F, 2000, VIROLOGY, V269, P156, DOI 10.1006/viro.1999.0162; Murakami R, 2011, ARCH VIROL, V156, P921, DOI 10.1007/s00705-011-0956-5; Mutterer JD, 1999, J GEN VIROL, V80, P2771, DOI 10.1099/0022-1317-80-10-2771; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Pfeffer S, 2002, J VIROL, V76, P6815, DOI 10.1128/JVI.76.13.6815-6824.2002; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; PRUFER D, 1992, EMBO J, V11, P1111, DOI 10.1002/j.1460-2075.1992.tb05151.x; RACCAH B, 2009, INSECT TRANSMISSION, DOI DOI 10.1002/9780470015902.A0021525.A0000760.PUB2; ROSNER A, 1983, PHYTOPATHOLOGY, V73, P699, DOI 10.1094/Phyto-73-699; ROWHANI A, 1979, VIROLOGY, V98, P45, DOI 10.1016/0042-6822(79)90523-3; Smith GR, 2000, J GEN VIROL, V81, P1865, DOI 10.1099/0022-1317-81-7-1865; SMITH JM, 1992, J MOL EVOL, V34, P126; Terauchi H, 2003, PHYTOPATHOLOGY, V93, P1560, DOI 10.1094/PHYTO.2003.93.12.1560; Terauchi H, 2001, ARCH VIROL, V146, P1885, DOI 10.1007/s007050170040; Yonaha Tetsuyoshi, 1995, Annals of the Phytopathological Society of Japan, V61, P178, DOI 10.3186/jjphytopath.61.178; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	44	20	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70722	10.1371/journal.pone.0070722	http://dx.doi.org/10.1371/journal.pone.0070722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936244	Green Submitted, gold, Green Published			2022-12-27	WOS:000323114200103
J	Lim, TT; Geisen, C; Hesse, M; Fleischmann, BK; Zimmermann, K; Pfeifer, A				Lim, Tiong-Ti; Geisen, Caroline; Hesse, Michael; Fleischmann, Bernd K.; Zimmermann, Katrin; Pfeifer, Alexander			Lentiviral Vector Mediated Thymidine Kinase Expression in Pluripotent Stem Cells Enables Removal of Tumorigenic Cells	PLOS ONE			English	Article							GENE-THERAPY; SUICIDE GENE; ES CELLS; IN-VIVO; CYTOTOXIC ANTIBODY; CANCER; TRANSGENESIS; EMBRYOS; CARDIOMYOCYTES; SELECTION	Embryonic stem cells (ES) and induced pluripotent stem (iPS) cells represent promising tools for cell-based therapies and regenerative medicine. Nevertheless, implantation of ES cell derived differentiated cells holds the risk of teratoma formation due to residual undifferentiated cells. In order to tackle this problem, we used pluripotent stem cells consisting of ES and iPS cells of mouse genetically modified by lentiviral vectors (LVs) carrying herpes simplex virus thymidine kinase (HSV-TK) under the control of different promoters of pluripotency genes. Cells expressing TK in turn are eliminated upon administration of the prodrug ganciclovir (GCV). Our aim was to study the conditions required for a safe mechanism to clear residual undifferentiated cells but using low MOIs of lentiviruses to reduce the risk of insertional mutagenesis. Our in vitro data demonstrated that TK expression in pluripotent stem cells upon treatment with GCV led to elimination of undifferentiated cells. However, introduction of hygromycin resistance in the LV transduced ES cells followed by pre-selection with hygromycin and GCV treatment was required to abolish undifferentiated cells. Most importantly, transplantation of pre-selected ES cells that had been transduced with low MOI LV in mice resulted in no teratoma development after GCV treatment in vivo. Taken together, our data show that pre-selection of ES cells prior to in vivo application is necessary if vector integration events are minimized. The study presented here gives rise to safer use of pluripotent stem cells as promising cell sources in regenerative medicine in the future.	[Lim, Tiong-Ti; Zimmermann, Katrin; Pfeifer, Alexander] Univ Bonn, Inst Pharmacol & Toxicol, Bonn, Germany; [Lim, Tiong-Ti; Fleischmann, Bernd K.; Zimmermann, Katrin; Pfeifer, Alexander] PHARMA, NRW Int Grad Res Sch Biotech, Bonn, Germany; [Geisen, Caroline; Hesse, Michael; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, D-53115 Bonn, Germany; [Fleischmann, Bernd K.; Pfeifer, Alexander] Univ Bonn, PharmaCtr Bonn, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Zimmermann, K (corresponding author), Univ Bonn, Inst Pharmacol & Toxicol, Bonn, Germany.	katrin.zimmermann@uni-bonn.de; alexander.pfeifer@uni-bonn.de	Hesse, Michael/AAV-9285-2021	Hesse, Michael/0000-0002-7518-0224	NRW International Graduate Research School BIOTECH-PHARMA, Bonn, Germany	NRW International Graduate Research School BIOTECH-PHARMA, Bonn, Germany	This work was supported by funds provided by the NRW International Graduate Research School BIOTECH-PHARMA, Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala G, 2006, MOL THER, V13, P716, DOI 10.1016/j.ymthe.2005.11.022; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Goff S, 2001, FIELDS VIROLOGY, P1871; Gropp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045532; Hamaguchi I, 2000, J VIROL, V74, P10778, DOI 10.1128/JVI.74.22.10778-10784.2000; Hasenburg A, 2001, GYNECOL ONCOL, V83, P549, DOI 10.1006/gyno.2001.6442; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; JOHNSON KA, 1995, NUCLEIC ACIDS RES, V23, P1273, DOI 10.1093/nar/23.7.1273; Jung J, 2007, HUM GENE THER, V18, P1182, DOI 10.1089/hum.2007.078; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Li ZB, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-66; Malan D, 2011, CIRC RES, V109, P841, DOI 10.1161/CIRCRESAHA.111.243139; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naujok O, 2010, STEM CELL REV REP, V6, P450, DOI 10.1007/s12015-010-9148-z; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Pfeifer A, 2001, ANNU REV GENOM HUM G, V2, P177, DOI 10.1146/annurev.genom.2.1.177; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; PFEIFER A, 2001, VIROLOGY, P469; Pfeifer A, 2010, METHOD ENZYMOL, V477, P3, DOI 10.1016/S0076-6879(10)77001-4; Pfeifer Alexander, 2009, V530, P391, DOI 10.1007/978-1-59745-471-1_21; Portsmouth D, 2007, MOL ASPECTS MED, V28, P4, DOI 10.1016/j.mam.2006.12.001; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rong ZL, 2012, J BIOL CHEM, V287, P32338, DOI 10.1074/jbc.M112.383810; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tanaka Mika, 2009, V530, P287, DOI 10.1007/978-1-59745-471-1_15; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zielske SP, 2004, MOL THER, V9, P923, DOI 10.1016/j.ymthe.2004.02.017	49	10	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70543	10.1371/journal.pone.0070543	http://dx.doi.org/10.1371/journal.pone.0070543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936225	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200093
J	Carreira, VP; Imberti, MA; Mensch, J; Fanara, JJ				Paula Carreira, Valeria; Imberti, Marcos A.; Mensch, Julian; Jose Fanara, Juan			Gene-by-Temperature Interactions and Candidate Plasticity Genes for Morphological Traits in Drosophila melanogaster	PLOS ONE			English	Article							P-ELEMENT INSERTIONS; LIFE-HISTORY TRAITS; BODY-SIZE; PHENOTYPIC PLASTICITY; WING SHAPE; DEVELOPMENTAL TIME; ENVIRONMENT INTERACTIONS; QUANTITATIVE TRAITS; LATITUDINAL CLINES; STRESS RESISTANCE	Understanding the genetic architecture of any quantitative trait requires identifying the genes involved in its expression in different environmental conditions. This goal can be achieved by mutagenesis screens in genetically tractable model organisms such as Drosophila melanogaster. Temperature during ontogenesis is an important environmental factor affecting development and phenotypic variation in holometabolous insects. In spite of the importance of phenotypic plasticity and genotype by environment interaction (GEI) for fitness related traits, its genetic basis has remained elusive. In this context, we analyzed five different adult morphological traits (face width, head width, thorax length, wing size and wing shape) in 42 co-isogenic single P-element insertional lines of Drosophila melanogaster raised at 17 degrees C and 25 degrees C. Our analyses showed that all lines differed from the control for at least one trait in males or females at either temperature. However, no line showed those differences for all traits in both sexes and temperatures simultaneously. In this sense, the most pleiotropic candidate genes were CG34460, Lsd-2 and Spn. Our analyses also revealed extensive genetic variation for all the characters mostly indicated by strong GEIs. Further, our results indicate that GEIs were predominantly explained by changes in ranking order in all cases suggesting that a moderate number of genes are involved in the expression of each character at both temperatures. Most lines displayed a plastic response for at least one trait in either sex. In this regard, P-element insertions affecting plasticity of a large number of traits were associated to the candidate genes Btk29A, CG43340, Drak and jim. Further studies will help to elucidate the relevance of these genes on the morphogenesis of different body structures in natural populations of D. melanogaster.	[Paula Carreira, Valeria; Imberti, Marcos A.; Mensch, Julian; Jose Fanara, Juan] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Ecol Genet & Evoluc Buenos Aires, Consejo Nacl Invest Cient & Tecn,Dept Ecol Genet, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Carreira, VP (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Ecol Genet & Evoluc Buenos Aires, Consejo Nacl Invest Cient & Tecn,Dept Ecol Genet, Buenos Aires, DF, Argentina.	vpcarreira@ege.fcen.uba.ar	MENSCH, JULIAN/GYD-5497-2022; Carreira, Valeria/AAG-2196-2020	MENSCH, JULIAN/0000-0002-2298-4309; 	University of Buenos Aires [UBACyT 20020100300039, UBACyT 20020100100482]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220080102042]	University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the University of Buenos Aires (grants UBACyT 20020100300039 and UBACyT 20020100100482) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas (grant PIP 11220080102042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 1996, GENETICS, V143, P293; Arthur AL, 2008, J EVOLUTION BIOL, V21, P1470, DOI 10.1111/j.1420-9101.2008.01617.x; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Azevedo RBR, 1998, EVOLUTION, V52, P1353, DOI [10.1111/j.1558-5646.1998.tb02017.x, 10.2307/2411305]; Barker JSF, 1995, J EVOLUTION BIOL, V8, P689, DOI 10.1046/j.1420-9101.1995.8060689.x; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Betran E, 1998, EVOLUTION, V52, P144, DOI [10.2307/2410929, 10.1111/j.1558-5646.1998.tb05147.x]; Birdsall K, 2000, EVOL DEV, V2, P16, DOI 10.1046/j.1525-142x.2000.00034.x; Bitner-Mathe BC, 1999, GENETICA, V105, P203, DOI 10.1023/A:1003765106652; BITNERMATHE BC, 1995, HEREDITY, V75, P54, DOI 10.1038/hdy.1995.103; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Breuker CJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000007; Carreira VP, 2006, J EVOLUTION BIOL, V19, P1275, DOI 10.1111/j.1420-9101.2005.01078.x; Carreira VP, 2009, HEREDITY, V102, P246, DOI 10.1038/hdy.2008.117; Carreira VP, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-32; CAVICCHI S, 1981, GENETICA, V56, P189, DOI 10.1007/BF00057559; COWLEY DE, 1990, AM NAT, V135, P242, DOI 10.1086/285041; David JR, 2006, J GENET, V85, P9, DOI 10.1007/BF02728965; De Jong G, 2003, J GENET, V82, P207, DOI 10.1007/BF02715819; Debat V, 2003, EVOLUTION, V57, P2773, DOI 10.1111/j.0014-3820.2003.tb01519.x; Debat V, 2009, EVOLUTION, V63, P2864, DOI 10.1111/j.1558-5646.2009.00774.x; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Dreyer AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028278; Dworkin I, 2006, GENETICS, V173, P1417, DOI 10.1534/genetics.105.053868; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Fanara JJ, 2006, J EVOLUTION BIOL, V19, P900, DOI 10.1111/j.1420-9101.2006.01084.x; Fernandez Iriarte PE, 2000, EVOLUTION, V54, P743; Folguera G, 2008, BIOL J LINN SOC, V95, P233, DOI 10.1111/j.1095-8312.2008.01053.x; GEBHARDT MD, 1993, J EVOLUTION BIOL, V6, P1, DOI 10.1046/j.1420-9101.1993.6010001.x; Gilchrist AS, 2000, EVOL DEV, V2, P114, DOI 10.1046/j.1525-142x.2000.00041.x; Gilchrist GW, 2004, INTEGR COMP BIOL, V44, P461, DOI 10.1093/icb/44.6.461; Guerra D, 1997, HEREDITY, V79, P564, DOI 10.1038/hdy.1997.200; Hallas R, 2002, GENET RES, V79, P141, DOI 10.1017/S0016672301005523; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Imasheva AG, 2000, GENET RES, V76, P237, DOI 10.1017/S0016672300004717; IMASHEVA AG, 1995, GENETICA, V96, P303, DOI 10.1007/BF01439584; Kjaersgaard A, 2007, J THERM BIOL, V32, P59, DOI 10.1016/j.jtherbio.2006.10.001; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; Loeschcke V, 1999, J EVOLUTION BIOL, V12, P605, DOI 10.1046/j.1420-9101.1999.00060.x; Lukacsovich T, 2001, GENETICS, V157, P727; Lyman RF, 1996, GENETICS, V143, P277; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Matta BP, 2004, HEREDITY, V93, P330, DOI 10.1038/sj.hdy.6800508; Mensch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011229; Mensch J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-78; MISRA RK, 1964, GENET RES, V5, P240, DOI 10.1017/S0016672300001208; Moreteau B., 1998, RUSS J GENET, V34, P183; Morin JP, 1997, EVOLUTION, V51, P1140, DOI 10.1111/j.1558-5646.1997.tb03961.x; Noach EJK, 1996, J EVOLUTION BIOL, V9, P831, DOI 10.1046/j.1420-9101.1996.9060831.x; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Nunney L, 1997, EVOLUTION, V51, P1529, DOI [10.2307/2411205, 10.1111/j.1558-5646.1997.tb01476.x]; Parkash R, 1999, J ZOOL SYST EVOL RES, V37, P13, DOI 10.1046/j.1439-0469.1999.95093.x; PARTRIDGE L, 1993, EVOLUTION, V47, P213, DOI 10.1111/j.1558-5646.1993.tb01211.x; ROBERTSON A, 1959, BIOMETRICS, V15, P219, DOI 10.2307/2527670; Roff Derek A., 1992; Rohlf F.J., 2001, TPSDIG VERSION 1 31; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2004, TPSSPLIN VERSION 1 1; Rohlf FJ, 2003, TPSRELW VERSION 1 31; Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574; SCHEINER SM, 1991, J EVOLUTION BIOL, V4, P51, DOI 10.1046/j.1420-9101.1991.4010051.x; Schlichting CD, 2002, EVOL ECOL, V16, P189, DOI 10.1023/A:1019624425971; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Serra F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001093; Shingleton AW, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P43; Shingleton AW, 2009, P ROY SOC B-BIOL SCI, V276, P2625, DOI 10.1098/rspb.2008.1796; SOKOLOFF A, 1966, EVOLUTION, V20, P49, DOI 10.1111/j.1558-5646.1966.tb03342.x; STALKER HD, 1948, EVOLUTION, V2, P295, DOI 10.2307/2405520; StatSoft Inc, 2004, STAT VERS 7; Stearns S.C., 1992, pi; THOMAS RH, 1993, THEOR APPL GENET, V85, P598, DOI 10.1007/BF00220919; Ungerer MC, 2003, GENETICS, V165, P353; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Weber K, 2005, GENETICS, V169, P1461, DOI 10.1534/genetics.104.027748; WEBER KE, 1992, GENETICS, V130, P345; WEBER KE, 1990, GENETICS, V126, P975; West-Eberhard Mary Jane, 2003, pi; Wolf LL, 2000, HEREDITY, V85, P521, DOI 10.1046/j.1365-2540.2000.00763.x; Zhou SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002593	85	12	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70851	10.1371/journal.pone.0070851	http://dx.doi.org/10.1371/journal.pone.0070851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936253	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200107
J	Pickett, SRA; Weber, SB; McGraw, KJ; Norris, KJ; Evans, MR				Pickett, Simon R. A.; Weber, Sam B.; McGraw, Kevin J.; Norris, Ken J.; Evans, Matthew R.			Environmental and Parental Influences on Offspring Health and Growth in Great Tits (Parus major)	PLOS ONE			English	Article							PLUMAGE COLORATION; IMMUNE-RESPONSE; FEMALE CHOICE; GOOD-GENES; CAROTENOID AVAILABILITY; COLLARED FLYCATCHER; MALE ATTRACTIVENESS; HERITABLE VARIATION; PIED FLYCATCHERS; SEXUAL SELECTION	Sexual selection requires both that there is heritable variation in traits related to fitness, and that either some of this variation is linked to traits of the parents, and/or that there are direct benefits of choosing particular individuals as mates. This suggests that if direct benefits are important offspring performance should be predicted by traits of the rearing adults. But if indirect benefits are more significant offspring performance should be predicted by traits of the adults at the nest-of-origin. We conducted cross-fostering experiments in great tits (Parus major) over four years, in two of which we manipulated environmental conditions by providing supplemental food. In a third year, some nestlings were directly supplemented with carotenoids. Nestlings in broods whose rearing adults received supplemental food were heavier and had improved immune responses even when controlling for body mass. Nestling immune function was related to measures of the yellow plumage color of both the rearing male and the putative father. Nestling body mass was influenced by the coloration of both the rearing female and the genetic mother. Our results suggest that features of both their social and putative genetic parents influence nestling health and growth. From this it would appear that females could be gaining both direct and indirect benefits through mate choice of male plumage traits and that it would be possible for males to similarly gain through mate choice of female traits.	[Pickett, Simon R. A.; Weber, Sam B.; Evans, Matthew R.] Univ Exeter, Sch Biosci, Penryn, Cornwall, England; [McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Norris, Ken J.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England	University of Exeter; Arizona State University; Arizona State University-Tempe; University of Reading	Evans, MR (corresponding author), Univ Exeter, Sch Biosci, Penryn, Cornwall, England.	m.evans@qmul.ac.uk		Evans, Matthew/0000-0002-5630-7621	Natural Environment Research Council; CJ Wildbird foods LTD.	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CJ Wildbird foods LTD.	This research was primarily funded by the Natural Environment Research Council and case funded by CJ Wildbird foods LTD. CJ Wildbird foods also provided the Peanut tubes used to supplement adults in this experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Andersson Malte, 1994; Andersson Staffan, 2006, P41; Ardia DR, 2006, EVOL ECOL, V20, P491, DOI 10.1007/s10682-006-0016-x; Ardia DR, 2005, OECOLOGIA, V145, P327, DOI 10.1007/s00442-005-0120-6; Arnold KE, 2007, P ROY SOC B-BIOL SCI, V274, P2563, DOI 10.1098/rspb.2007.0687; Bates D, 2012, LME4 LINEAR MIXED EF; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; Birkhead TR, 1998, BEHAV ECOL SOCIOBIOL, V44, P179, DOI 10.1007/s002650050530; BLAKEY JK, 1994, IBIS, V136, P457, DOI 10.1111/j.1474-919X.1994.tb01122.x; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Blount JD, 2002, P ROY SOC B-BIOL SCI, V269, P29, DOI 10.1098/rspb.2001.1840; Bonato M, 2009, ANIM BEHAV, V77, P1027, DOI 10.1016/j.anbehav.2008.12.019; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Broggi J, 2009, IBIS, V151, P588, DOI 10.1111/j.1474-919X.2009.00946.x; Calsbeek R, 2002, P NATL ACAD SCI USA, V99, P14897, DOI 10.1073/pnas.242645199; CHEW BP, 1993, J DAIRY SCI, V76, P2804, DOI 10.3168/jds.S0022-0302(93)77619-5; Cichon M, 2006, J EVOLUTION BIOL, V19, P1701, DOI 10.1111/j.1420-9101.2006.01110.x; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Drobniak SM, 2010, J EVOLUTION BIOL, V23, P1286, DOI 10.1111/j.1420-9101.2010.01993.x; Encabo SI, 2002, IBIS, V144, P623, DOI 10.1046/j.1474-919X.2002.00099.x; Fitze PS, 2007, AM NAT, V169, pS137, DOI 10.1086/510094; Fitze PS, 2003, OECOLOGIA, V137, P148, DOI 10.1007/s00442-003-1323-3; Garant D, 2004, AM NAT, V164, pE115, DOI 10.1086/424764; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Grafen A., 2002, MODERN STAT LIFE SCI; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; Hill GE, 1998, J FIELD ORNITHOL, V69, P353; HOELZER GA, 1989, ANIM BEHAV, V38, P1067, DOI 10.1016/S0003-3472(89)80146-0; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Horak P, 2001, OECOLOGIA, V126, P166, DOI 10.1007/s004420000513; JARVI T, 1984, ANIM BEHAV, V32, P590, DOI 10.1016/S0003-3472(84)80296-1; Kilpimaa J, 2005, EVOLUTION, V59, P2483, DOI 10.1554/04-678.1; Kilpimaa J, 2007, J EVOLUTION BIOL, V20, P717, DOI 10.1111/j.1420-9101.2006.01239.x; Kinnard TB, 2009, AUK, V126, P884, DOI 10.1525/auk.2009.08119; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LOCHMILLER RL, 1993, AUK, V110, P503, DOI 10.2307/4088414; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Mand R, 2005, EVOL ECOL RES, V7, P1013; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Merila J, 1997, EVOLUTION, V51, P526, DOI 10.1111/j.1558-5646.1997.tb02440.x; Merino S, 1999, ANIM BEHAV, V58, P219, DOI 10.1006/anbe.1999.1127; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Morrison ES, 2009, J AVIAN BIOL, V40, P573, DOI 10.1111/j.1600-048X.2009.04910.x; Moss GP, 1999, CHEM BIOCH PLANT PIG, P149; Naguib M, 2004, P ROY SOC B-BIOL SCI, V271, P833, DOI 10.1098/rspb.2003.2673; Nilsson JA, 2000, OIKOS, V88, P351, DOI 10.1034/j.1600-0706.2000.880214.x; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; NORRIS KJ, 1990, BEHAV ECOL SOCIOBIOL, V27, P275; NORRIS KJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P129; NORRIS KJ, 1989, IBIS, V131, P436, DOI 10.1111/j.1474-919X.1989.tb02794.x; OJANEN M, 1979, ORNIS SCAND, V10, P22, DOI 10.2307/3676340; PARTALI V, 1987, COMP BIOCHEM PHYS B, V87, P885, DOI 10.1016/0305-0491(87)90408-1; Patrick SC, 2012, P ROY SOC B-BIOL SCI, V279, P1724, DOI 10.1098/rspb.2011.1820; PERRINS CM, 1991, IBIS, V133, P49, DOI 10.1111/j.1474-919X.1991.tb07668.x; Perrins CM, 2001, ARDEA, V89, P135; Pike TW, 2007, BEHAV ECOL, V18, P1100, DOI 10.1093/beheco/arm084; Pitala N, 2007, BIOL LETTERS, V3, P418, DOI 10.1098/rsbl.2007.0135; PRICE T, 1991, OECOLOGIA, V86, P535, DOI 10.1007/BF00318320; Quesada J, 2007, ETHOLOGY, V113, P640, DOI 10.1111/j.1439-0310.2007.01364.x; R Core Team, 2018, R LANG ENV STAT COMP; Rauter CM, 2002, J EVOLUTION BIOL, V15, P407, DOI 10.1046/j.1420-9101.2002.00412.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Senar JC, 2008, BEHAVIOUR, V145, P1195, DOI 10.1163/156853908785387638; Senar JC, 2003, NATURWISSENSCHAFTEN, V90, P234, DOI 10.1007/s00114-003-0414-7; Senar JC, 2002, P ROY SOC B-BIOL SCI, V269, P257, DOI 10.1098/rspb.2001.1882; SMITH HG, 1995, GENETICS, V141, P657; Soler JJ, 2003, EVOL ECOL RES, V5, P259; Sorci G, 1997, TRENDS ECOL EVOL, V12, P196, DOI 10.1016/S0169-5347(97)01056-2; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Tschirren B, 2003, J EVOLUTION BIOL, V16, P91, DOI 10.1046/j.1420-9101.2003.00483.x; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Velando A, 2005, BEHAV ECOL SOCIOBIOL, V58, P175, DOI 10.1007/s00265-005-0911-0; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	87	6	6	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69695	10.1371/journal.pone.0069695	http://dx.doi.org/10.1371/journal.pone.0069695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936081	Green Published, gold			2022-12-27	WOS:000323114200042
J	Ye, XH; Fu, JJ; Yang, Y; Gao, YH; Liu, L; Chen, SD				Ye, Xiaohua; Fu, Jinjian; Yang, Yi; Gao, Yanhui; Liu, Li; Chen, Sidong			Frequency-Risk and Duration-Risk Relationships between Aspirin Use and Gastric Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLORECTAL-CANCER; ESOPHAGEAL; ADENOCARCINOMAS; PROGNOSIS; FEATURES; NSAIDS; TRIAL	Background: Although previous meta-analyses have suggested an association between aspirin use and risk of gastric cancer, current evidence is inconsistent. Additionally, it remains unclear whether there are frequency-risk and duration-risk relationships and if a threshold of effect exists. Methods: We identified studies by searching MEDLINE and PUBMED databases and reviewing relevant articles. We derived the summary risk estimates using fixed-effects or random-effects model based on homogeneity analysis. The dose-response meta-analysis was performed by linear trend regression and restricted cubic spline regression. Potential heterogeneity was tested using the Q statistic and quantified with the I 2 statistic. Subgroup analyses and Galbraith plots were used to explore the potential sources of heterogeneity. Publication bias was evaluated with funnel plots and quantified by the Begg's and Egger's test. Results: Fifteen studies were included in this meta-analysis. There was an overall 29% reduced risk of gastric cancer corresponding to aspirin use (RR = 0.71, 95% CI 0.60-0.82). We found there are nonlinear frequency-risk and linear duration-risk relations between aspirin use and gastric cancer. A monotonically decreasing relation was observed only for low-frequency (<= 4.5 times/week) aspirin intake (10% decreased risk for once/week, 19% for twice/week and 29% for 4.5 times/week), and the frequency threshold of aspirin use is 4.5 times per week. Regarding those with duration of aspirin use, there was a tendency towards stronger risk reduction of gastric cancer for longer aspirin use (10% decreased risk for 4 years, 19% for 8 years and 28% for 12 years), and no duration threshold was observed. Conclusion: Our findings suggest that long-term (>= 4 years) and low-frequency (1-4.5 times per week) aspirin use is associated with a statistically significant, dose-dependent reduction in the risk of gastric cancer.	[Ye, Xiaohua] Guangdong Pharmaceut Univ, Guangdong Key Lab Mol Epidemiol, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Ye, Xiaohua; Yang, Yi; Gao, Yanhui; Liu, Li; Chen, Sidong] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Fu, Jinjian] Liuzhou Municipal Matern & Child Healthcare Hosp, Liuzhou, Guangxi, Peoples R China	Guangdong Pharmaceutical University; Southern Medical University - China	Chen, SD (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.	chensidong1@126.com			Guangzhou Science and Technology Bureau [2011J5200017]	Guangzhou Science and Technology Bureau	This work was supported by funds from International cooperation project of the Guangzhou Science and Technology Bureau (No. 2011J5200017). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2009, BRIT J CANCER, V100, P551, DOI 10.1038/sj.bjc.6604880; Akre K, 2001, BRIT J CANCER, V84, P965, DOI 10.1054/bjoc.2001.1702; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Bai Y, 2011, J GASTROEN HEPATOL, V26, P1626, DOI 10.1111/j.1440-1746.2011.06759.x; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bertuccio P, 2010, EUR J CANCER PREV, V19, P426, DOI 10.1097/CEJ.0b013e32833ecbdc; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Choi AL, 2008, CRIT REV TOXICOL, V38, P877, DOI [10.1080/10408440802273164, 10.1080/10408440802273164 ]; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Duan L, 2008, CANCER EPIDEM BIOMAR, V17, P126, DOI 10.1158/1055-9965.EPI-07-0664; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Epplein M, 2009, AM J EPIDEMIOL, V170, P507, DOI 10.1093/aje/kwp162; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Farrow DC, 1998, CANCER EPIDEM BIOMAR, V7, P97; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Figueroa JD, 2009, CANCER CAUSE CONTROL, V20, P361, DOI 10.1007/s10552-008-9250-6; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Fortuny J, 2007, CLIN GASTROENTEROL H, V5, P1154, DOI 10.1016/j.cgh.2007.05.022; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gillies M, 1968, Med J Aust, V2, P1132; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015721; Ishikawa S, 2008, ACTA MED OKAYAMA, V62, P29; Jana NR, 2008, CELL MOL LIFE SCI, V65, P1295, DOI 10.1007/s00018-008-7511-x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Lee J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-596; Lindblad M, 2005, CANCER EPIDEM BIOMAR, V14, P444, DOI 10.1158/1055-9965.EPI-04-0467; Marrelli D, 2009, ANN SURG, V250, P43, DOI 10.1097/SLA.0b013e3181ad6487; Meade TW, 1998, LANCET, V351, P233; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Ratnasinghe LD, 2004, ANTICANCER RES, V24, P3177; Rota M, 2010, STAT MED, V29, P2679, DOI 10.1002/sim.4041; Rothwell PM, 2011, OBSTET GYNECOL SURV, V66, P222, DOI 10.1097/OGX.0b013e318225cec2; Sadeghi S, 2008, CANCER EPIDEM BIOMAR, V17, P1169, DOI 10.1158/1055-9965.EPI-07-2852; Sample DA, 2002, CANCER EPIDEM BIOMAR, V11, P281; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538; THUN MJ, 1993, CANCER RES, V53, P1322; Tian WJ, 2010, EUR J CANCER PREV, V19, P288, DOI 10.1097/CEJ.0b013e328339648c; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106; Yang P, 2010, DIGEST DIS SCI, V55, P1533, DOI 10.1007/s10620-009-0915-0; Ye XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057578; Zaridze D, 1999, INT J CANCER, V82, P473, DOI 10.1002/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K; Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014	51	39	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71522	10.1371/journal.pone.0071522	http://dx.doi.org/10.1371/journal.pone.0071522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936269	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200119
J	Hsu, CR; Lin, TL; Pan, YJ; Hsieh, PF; Wang, JT				Hsu, Chun-Ru; Lin, Tzu-Lung; Pan, Yi-Jiun; Hsieh, Pei-Fang; Wang, Jin-Town			Isolation of a Bacteriophage Specific for a New Capsular Type of Klebsiella pneumoniae and Characterization of Its Polysaccharide Depolymerase	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; VIRULENCE GENE; SEROTYPE K1; SEROEPIDEMIOLOGY; EPIDEMIOLOGY; INFECTIONS; BACTEREMIA; DEPOLYMERIZATION; PREVALENCE; PATTERNS	Background: Klebsiella pneumoniae is one of the major pathogens causing hospital-acquired multidrug-resistant infections. The capsular polysaccharide (CPS) is an important virulence factor of K. pneumoniae. With 78 capsular types discovered thus far, an association between capsular type and the pathogenicity of K. pneumoniae has been observed. Methodology/Principal Findings: To investigate an initially non-typeable K. pneumoniae UTI isolate NTUH-K1790N, the cps gene region was sequenced. By NTUH-K1790N cps-PCR genotyping, serotyping and determination using a newly isolated capsular type-specific bacteriophage, we found that NTUH-K1790N and three other isolates Ca0507, Ca0421 and C1975 possessed a new capsular type, which we named KN2. Analysis of a KN2 CPS- mutant confirmed the role of capsule as the target recognized by the antiserum and the phage. A newly described lytic phage specific for KN2 K. pneumoniae, named 0507-KN2-1, was isolated and characterized using transmission electron microscopy. Whole-genome sequencing of 0507-KN2-1 revealed a 159 991 bp double-stranded DNA genome with a G+C content of 46.7% and at least 154 open reading frames. Based on its morphological and genomic characteristics, 0507-KN2-1 was classified as a member of the Myoviridae phage family. Further analysis of this phage revealed a 3738-bp gene encoding a putative polysaccharide depolymerase. A recombinant form of this protein was produced and assayed to confirm its enzymatic activity and specificity to KN2 capsular polysaccharides. KN2 K. pneumoniae strains exhibited greater sensitivity to this depolymerase than these did to the cognate phage, as determined by spot analysis. Conclusions/Significance: Here we report that a group of clinical strains possess a novel Klebsiella capsular type. We identified a KN2-specific phage and its polysaccharide depolymerase, which could be used for efficient capsular typing. The lytic phage and depolymerase also have potential as alternative therapeutic agents to antibiotics for treating K. pneumoniae infections, especially against antibiotic-resistant strains.	[Hsu, Chun-Ru; Lin, Tzu-Lung; Pan, Yi-Jiun; Hsieh, Pei-Fang; Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wang, JT (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan.	wangjt@ntu.edu.tw	Hsu, Chun-Ru/ABF-8475-2020	Pan, Yi-Jiun/0000-0002-2522-7805	National Science Council; National Taiwan University; National Taiwan University Hospital in Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Taiwan University Hospital in Taiwan(National Taiwan University)	This study was supported by grants from the National Science Council, National Taiwan University, and National Taiwan University Hospital in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H., 1987, VIRUSES PROKARYOTES, V1; ALTMANN F, 1990, EUR J BIOCHEM, V189, P307, DOI 10.1111/j.1432-1033.1990.tb15491.x; AYLINGSMITH B, 1990, J HOSP INFECT, V16, P287, DOI 10.1016/0195-6701(90)90001-5; BLANCHETTE EA, 1980, J CLIN MICROBIOL, V11, P474, DOI 10.1128/JCM.11.5.474-478.1980; CASEWELL MW, 1978, J HYG-CAMBRIDGE, V80, P295, DOI 10.1017/S0022172400053651; Chang SC, 2000, DIAGN MICR INFEC DIS, V37, P279, DOI 10.1016/S0732-8893(00)00157-7; CHENG DL, 1991, ARCH INTERN MED, V151, P1557; Chhibber S, 2008, J MED MICROBIOL, V57, P1508, DOI 10.1099/jmm.0.2008/002873-0; CHIU CT, 1988, J CLIN GASTROENTEROL, V10, P524, DOI 10.1097/00004836-198810000-00009; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Coque TM, 2008, EURO SURVEILL, V13; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; CRYZ SJ, 1986, J CLIN MICROBIOL, V23, P687, DOI 10.1128/JCM.23.4.687-690.1986; DebRoy C, 2005, APPL ENVIRON MICROB, V71, P4919, DOI 10.1128/AEM.71.8.4919-4924.2005; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Fang FC, 2005, J CLIN MICROBIOL, V43, P991, DOI 10.1128/JCM.43.2.991-992.2005; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; GASTON MA, 1987, J CLIN MICROBIOL, V25, P1228, DOI 10.1128/JCM.25.7.1228-1232.1987; Gniadkowski M, 2001, CLIN MICROBIOL INFEC, V7, P597, DOI 10.1046/j.1198-743x.2001.00330.x; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Jenney AW, 2006, J CLIN MICROBIOL, V44, P102, DOI 10.1128/JCM.44.1.102-107.2006; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; Karamoddini MK, 2011, THESCIENTIFICWORLDJO, V11, P1332, DOI 10.1100/tsw.2011.114; Keynan Y, 2007, SCAND J INFECT DIS, V39, P828, DOI 10.1080/00365540701266763; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Kong FR, 2005, J MED MICROBIOL, V54, P351, DOI 10.1099/jmm.0.45924-0; LEGAKIS NJ, 1995, J HOSP INFECT, V31, P177, DOI 10.1016/0195-6701(95)90064-0; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; Miriagou V, 2010, ANTIMICROB AGENTS CH, V54, P4497, DOI 10.1128/AAC.00665-10; MIZUTA K, 1983, INFECT IMMUN, V40, P56, DOI 10.1128/IAI.40.1.56-61.1983; Mushtaq N, 2004, ANTIMICROB AGENTS CH, V48, P1503, DOI 10.1128/AAC.48.5.1503-1508.2004; Nadasy KA, 2007, CLIN INFECT DIS, V45, pE25, DOI 10.1086/519424; NIEMANN H, 1977, CARBOHYD RES, V59, P165, DOI 10.1016/S0008-6215(00)83303-0; NIEMANN H, 1977, J BACTERIOL, V130, P366, DOI 10.1128/JB.130.1.366-374.1977; Nijssen S, 2004, INT J ANTIMICROB AG, V24, P585, DOI 10.1016/j.ijantimicag.2004.08.008; Orskov I, 1979, INT J SYST BACTERIOL, V27, P2; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; PIERONI P, 1994, J MED MICROBIOL, V41, P423, DOI 10.1099/00222615-41-6-423; PODSCHUN R, 1986, ZBL BAKT-INT J MED M, V262, P335; PODSCHUN R, 1990, ZBL HYG UMWELTMED, V189, P527; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; RIEGERHUG D, 1981, VIROLOGY, V113, P363, DOI 10.1016/0042-6822(81)90162-8; RISER E, 1981, J CLIN PATHOL, V34, P552, DOI 10.1136/jcp.34.5.552; Sakandelidze V M, 1974, Zh Mikrobiol Epidemiol Immunobiol, V51, P135; Sambrook J., 2001, MOL CLONING LAB MANU; Scorpio A, 2008, ANTIMICROB AGENTS CH, V52, P1014, DOI 10.1128/AAC.00741-07; Sechter I, 2000, CLIN MICROBIOL INFEC, V6, P233, DOI 10.1046/j.1469-0691.2000.00070.x; Shu HY, 2009, MICROBIOL-SGM, V155, P4170, DOI 10.1099/mic.0.029017-0; SLOPEK S, 1984, ARCH IMMUNOL THER EX, V32, P317; SMITH SM, 1982, J CLIN MICROBIOL, V16, P868, DOI 10.1128/JCM.16.5.868-873.1982; Struve C, 2005, J MED MICROBIOL, V54, P1111, DOI 10.1099/jmm.0.46165-0; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Verma V, 2010, BIOFOULING, V26, P729, DOI 10.1080/08927014.2010.511196; Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y; Vinodkumar C. S., 2005, Journal of Communicable Diseases, V37, P18; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Yang Ching-Cheng, 2004, Journal of Microbiology Immunology and Infection, V37, P176	63	79	87	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70092	10.1371/journal.pone.0070092	http://dx.doi.org/10.1371/journal.pone.0070092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936379	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800034
J	Ostensson, M; Monten, C; Bacelis, J; Gudjonsdottir, AH; Adamovic, S; Ek, J; Ascher, H; Pollak, E; Arnell, H; Browaldh, L; Agardh, D; Wahlstrom, J; Nilsson, S; Torinsson-Naluai, A				Ostensson, Malin; Monten, Caroline; Bacelis, Jonas; Gudjonsdottir, Audur H.; Adamovic, Svetlana; Ek, Johan; Ascher, Henry; Pollak, Elisabet; Arnell, Henrik; Browaldh, Lars; Agardh, Daniel; Wahlstrom, Jan; Nilsson, Staffan; Torinsson-Naluai, Asa			A Possible Mechanism behind Autoimmune Disorders Discovered By Genome-Wide Linkage and Association Analysis in Celiac Disease	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; RISK VARIANTS; APPL1; MAPK; DISEQUILIBRIUM; PHOSPHATASE; ACTIVATION; PROLINE; REGION; MODEL	Celiac disease is a common autoimmune disorder characterized by an intestinal inflammation triggered by gluten, a storage protein found in wheat, rye and barley. Similar to other autoimmune diseases such as type 1 diabetes, psoriasis and rheumatoid arthritis, celiac disease is the result of an immune response to self-antigens leading to tissue destruction and production of autoantibodies. Common diseases like celiac disease have a complex pattern of inheritance with inputs from both environmental as well as additive and non-additive genetic factors. In the past few years, Genome Wide Association Studies (GWAS) have been successful in finding genetic risk variants behind many common diseases and traits. To complement and add to the previous findings, we performed a GWAS including 206 trios from 97 nuclear Swedish and Norwegian families affected with celiac disease. By stratifying for HLA-DQ, we identified a new genome-wide significant risk locus covering the DUSP10 gene. To further investigate the associations from the GWAS we performed pathway analyses and two-locus interaction analyses. These analyses showed an over-representation of genes involved in type 2 diabetes and identified a set of candidate mechanisms and genes of which some were selected for mRNA expression analysis using small intestinal biopsies from 98 patients. Several genes were expressed differently in the small intestinal mucosa from patients with celiac autoimmunity compared to intestinal mucosa from control patients. From top-scoring regions we identified susceptibility genes in several categories: 1) polarity and epithelial cell functionality; 2) intestinal smooth muscle; 3) growth and energy homeostasis, including proline and glutamine metabolism; and finally 4) innate and adaptive immune system. These genes and pathways, including specific functions of DUSP10, together reveal a new potential biological mechanism that could influence the genesis of celiac disease, and possibly also other chronic disorders with an inflammatory component.	[Ostensson, Malin; Nilsson, Staffan] Chalmers Univ Technol, Dept Math Sci, S-41296 Gothenburg, Sweden; [Monten, Caroline; Agardh, Daniel] Lund Univ, Dept Clin Sci, Diabet & Celiac Dis Unit, Malmo, Sweden; [Bacelis, Jonas; Adamovic, Svetlana; Pollak, Elisabet; Wahlstrom, Jan; Torinsson-Naluai, Asa] Univ Gothenburg, Sahlgrenska Acad, Dept Med & Clin Genet, Inst Biomed, Gothenburg, Sweden; [Gudjonsdottir, Audur H.] Univ Gothenburg, Sahlgrenska Acad, Queen Silvia Childrens Hosp, Dept Pediat, Gothenburg, Sweden; [Ek, Johan] Buskerud Cent Hosp, Dept Pediat, Drammen, Norway; [Ascher, Henry] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Unit Social Med, Gothenburg, Sweden; [Arnell, Henrik] Karolinska Univ Hosp, Dept Pediat Gastroenterol Hepatol & Nutr, Stockholm, Sweden; [Arnell, Henrik] Karolinska Inst, CLINTEC, Div Pediat, Stockholm, Sweden; [Browaldh, Lars] Karolinska Inst, Soder Sjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Torinsson-Naluai, Asa] Univ Skovde, Sch Life Sci, Syst Biol Res Ctr, Skovde, Sweden	Chalmers University of Technology; Lund University; University of Gothenburg; Queen Silvia Children's Hospital; University of Gothenburg; University of Gothenburg; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; University of Skovde	Torinsson-Naluai, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Med & Clin Genet, Inst Biomed, Gothenburg, Sweden.	asa.torinsson.naluai@gu.se	Naluai, Åsa Torinsson/P-3269-2015; Naluai, Åsa Torinsson/AAB-2166-2021; Östensson, Malin/AHC-4642-2022	Naluai, Åsa Torinsson/0000-0002-0504-6492; Naluai, Åsa Torinsson/0000-0002-0504-6492; Bacelis, Jonas/0000-0002-2450-732X; Nilsson, Staffan/0000-0003-4748-0446	Gothenburg County Council; Gothenburg University	Gothenburg County Council; Gothenburg University	The principal funding for this study was provided through the regional agreement on medical training and clinical research (ALF) between Gothenburg County Council and Gothenburg University. We also thank Bengt Ihre's, Claes Groschinsky's, Magnus Bergvall's, Nilsson-Ehle's, Tore Nilson's and Professor Nanna Svartz Foundations, Kungliga fysiografiska sallskapet in Lund, Frimurare barnhusdirektionen, Ruth and Richard Julin Foundation and the Swedish Society of Medicine. The Swedish Medical Research Council and the Celiac Disease Foundation supported family sample collections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Awasthi A, 2003, J EXP MED, V197, P1037, DOI 10.1084/jem.20022033; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Bayardo M, 2012, CLIN EXP IMMUNOL, V168, P95, DOI 10.1111/j.1365-2249.2011.04545.x; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; D'Alessandro G, 2011, NEUROBIOL DIS, V43, P346, DOI 10.1016/j.nbd.2011.04.003; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Goto S, 1997, Pac Symp Biocomput, P175; GRUBIN CE, 1994, DIABETOLOGIA, V37, P344, DOI 10.1007/BF00408469; Gudjonsdottir AH, 2004, J PEDIATR GASTR NUTR, V38, P338, DOI 10.1097/00005176-200403000-00020; Holmes B, 2012, CELL SIGNAL, V24, P309, DOI 10.1016/j.cellsig.2011.09.015; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Kjelleras J, 2011, SCAND J CLIN LAB INV, V71, P701, DOI 10.3109/00365513.2011.619564; Kotti S, 2007, HUM HERED, V63, P85, DOI 10.1159/000099180; Kumar V, 2012, SEMIN IMMUNOPATHOL, V34, P567, DOI 10.1007/s00281-012-0312-1; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Mangala LS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-33; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Naluai AT, 2001, EUR J HUM GENET, V9, P938, DOI 10.1038/sj.ejhg.5200752; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Pandhare J, 2009, J CELL BIOCHEM, V107, P759, DOI 10.1002/jcb.22174; Paterson AD, 2010, DIABETES, V59, P539, DOI 10.2337/db09-0653; Pina-Vazquez Carolina, 2012, Journal of Parasitology Research, P748206, DOI 10.1155/2012/748206; Ploski R, 1996, SCAND J GASTROENTERO, V31, P1092, DOI 10.3109/00365529609036892; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rice JP, 2005, GENETIC EPIDEMIOLOGY, V9, P347; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Srivastava N, 2011, J IMMUNOL, V186, P5863, DOI 10.4049/jimmunol.1003957; Takizawa N, 2006, J CELL BIOL, V174, P447, DOI 10.1083/jcb.200512051; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Wang K, 2011, MOL PSYCHIATR, V16, P949, DOI 10.1038/mp.2010.107; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Xin X, 2011, AM J PHYSIOL-ENDOC M, V300, pE103, DOI 10.1152/ajpendo.00427.2010; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	52	38	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70174	10.1371/journal.pone.0070174	http://dx.doi.org/10.1371/journal.pone.0070174			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936387	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800037
J	Yu, YH; Zhao, XY; Wang, W; Wu, H; Chen, M; Hua, WH; Wang, HZ; Wei, T; Jiao, YM; Sun, GZ; Li, W				Yu, Yanhua; Zhao, Xiuying; Wang, Wen; Wu, Hao; Chen, Ming; Hua, Wenhao; Wang, Huizhu; Wei, Ting; Jiao, Yanmei; Sun, Guizhen; Li, Wei			Diagnostic Performance of Interferon-Gamma Releasing Assay in HIV-Infected Patients in China	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; MYCOBACTERIUM-TUBERCULOSIS; RAPID DETECTION; T-CELLS; INDIVIDUALS; ENUMERATION; ADULTS; RISK; BCG	Background: Active tuberculosis infection represents a very common and significant threat to HIV-infected patients. But measures to accurately detect it are limited. Objective: To compare and analyze the diagnostic efficacy of T-SPOT. TB alone and in combination with TST in HIV-infected patients in China. Method: TST (tuberculin skin test) and T-SPOT. TB were performed on 131 HIV-infected patients admitted in Beijing You'an Hospital and Beijing Ditan Hospital between Oct, 2010 and Jul, 2012, who were initially diagnosed as suspected ATB (active TB). The patients were further categorized into ATB and Not ATB based on clinical and cultural evidences. The performance of TST and T-SPOT. TB were analyzed and compared. Results: The sensitivity and specificity of T-SPOT. TB were 41.3% and 94.6%, respectively, both higher than TST (12.9% and 91.8%). By combining T-SPOT. TB and TST, the sensitivity did not increase, but specificity was elevated to 100%. TST, T-SPOT. TB and their combinations all performed better in patients with extra-pulmonary diseases than with pulmonary disorders. False-positive T-SPOT. TB results were found to be associated with history of prior TB. In addition, concomitant bacterial infections and low CD4 counts were associated with increased ATB risk. Conclusions: T-SPOT. TB is superior in screening ATB in HIV-infected patients in China over traditional TST. Additional TST would help to confirm a positive T-SPOT. TB result. Both tests work better for patients with extra-pulmonary conditions.	[Yu, Yanhua; Zhao, Xiuying; Chen, Ming; Sun, Guizhen] Capital Med Univ, Beijing Youan Hosp, Dept Clin Lab, Beijing, Peoples R China; [Wang, Wen; Wu, Hao; Jiao, Yanmei; Li, Wei] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Hua, Wenhao; Wang, Huizhu] Capital Med Univ, Beijing Ditan Hosp, Dept Clin Lab, Beijing, Peoples R China; [Wei, Ting] Queensland Inst Med Res, Mol Virol Grp, Brisbane, Qld 4006, Australia	Capital Medical University; Capital Medical University; Capital Medical University; QIMR Berghofer Medical Research Institute	Li, W (corresponding author), Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	liwei8798@gmail.com	Li, Wei/I-8060-2014	Li, Wei/0000-0002-9991-7892	You'an AIDS and Liver Disease Research Project [BJYAH-2011-019]; Capital Medical University Key Laboratory Open Project [2012AZYJ02]; Capital Medical University Science Development Grant [2009-1057]; Project of Beijing Municipal Science and Technology Commission [D09050703590901]; Beijing Key Laboratory [BZ0089]	You'an AIDS and Liver Disease Research Project; Capital Medical University Key Laboratory Open Project; Capital Medical University Science Development Grant; Project of Beijing Municipal Science and Technology Commission; Beijing Key Laboratory	This work was supported by You'an AIDS and Liver Disease Research Project [BJYAH-2011-019], Capital Medical University Key Laboratory Open Project [2012AZYJ02], Capital Medical University Science Development Grant [2009-1057], Project of Beijing Municipal Science and Technology Commission [D09050703590901], and Beijing Key Laboratory [BZ0089]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; ALLEN S, 1992, AM REV RESPIR DIS, V146, P1439, DOI 10.1164/ajrccm/146.6.1439; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dockrell HM, 2009, AM J RESP CRIT CARE, V179, P628, DOI 10.1164/rccm.200901-0144ED; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Feng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032652; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jiang WM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-31; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2010, ENFERM INFEC MICR CL, V28, P245, DOI 10.1016/j.eimc.2009.05.012; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Siu GKH, 2011, J ANTIMICROB CHEMOTH, V66, P730, DOI 10.1093/jac/dkq519; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15	24	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70957	10.1371/journal.pone.0070957	http://dx.doi.org/10.1371/journal.pone.0070957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936478	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800057
J	Gonze, D; Abou-Jaoude, W				Gonze, Didier; Abou-Jaoude, Wassim			The Goodwin Model: Behind the Hill Function	PLOS ONE			English	Article							MULTISITE PROTEIN-PHOSPHORYLATION; NEUROSPORA CIRCADIAN CLOCK; YEAST-CELL-CYCLE; TRANSCRIPTION FACTORS; REGULATORY NETWORKS; SIGNAL-TRANSDUCTION; BIOLOGICAL-SYSTEMS; NEGATIVE FEEDBACK; MOLECULAR-MODEL; OSCILLATOR	The Goodwin model is a 3-variable model demonstrating the emergence of oscillations in a delayed negative feedback-based system at the molecular level. This prototypical model and its variants have been commonly used to model circadian and other genetic oscillators in biology. The only source of non-linearity in this model is a Hill function, characterizing the repression process. It was mathematically shown that to obtain limit-cycle oscillations, the Hill coefficient must be larger than 8, a value often considered unrealistic. It is indeed difficult to explain such a high coefficient with simple cooperative dynamics. We present here molecular models of the standard Goodwin model, based on single or multisite phosphorylation/dephosphorylation processes of a transcription factor, which have been previously shown to generate switch-like responses. We show that when the phosphorylation/dephosphorylation processes are fast enough, the limit-cycle obtained with a multisite phosphorylation-based mechanism is in very good quantitative agreement with the oscillations observed in the Goodwin model. Conditions in which the detailed mechanism is well approximated by the Goodwin model are given. A variant of the Goodwin model which displays sharp thresholds and relaxation oscillations is also explained by a double phosphorylation/dephosphorylation-based mechanism through a bistable behavior. These results not only provide rational support for the Goodwin model but also highlight the crucial role of the speed of post-translational processes, whose response curve are usually established at a steady state, in biochemical oscillators.	[Gonze, Didier] Univ Libre Brussels, Fac Sci, Brussels, Belgium; [Abou-Jaoude, Wassim] Ecole Normale Super, Inst Biol, F-75231 Paris, France	Universite Libre de Bruxelles; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Gonze, D (corresponding author), Univ Libre Brussels, Fac Sci, Brussels, Belgium.	dgonze@ulb.ac.be			LabEx MemoLife; Institut de Biologie de l'Ecole Normale Superieure; Centre Interdisciplinaire de Recherche en Biologie du College de France; Laboratoire de Neurobiologie de l'Ecole Superieure de Physique Chimie Industrielle	LabEx MemoLife; Institut de Biologie de l'Ecole Normale Superieure; Centre Interdisciplinaire de Recherche en Biologie du College de France; Laboratoire de Neurobiologie de l'Ecole Superieure de Physique Chimie Industrielle	This work was supported by the LabEx MemoLife, which gathers the Institut de Biologie de l'Ecole Normale Superieure, the Centre Interdisciplinaire de Recherche en Biologie du College de France, and the Laboratoire de Neurobiologie de l'Ecole Superieure de Physique Chimie Industrielle (www.memolife.biologie.ens.fr). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allright JD, 1977, J MATH BIOL, V4, P363; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Cheng Z, 2009, BIOPHYS J, V97, P2867, DOI 10.1016/j.bpj.2009.09.008; Chickarmane V, 2007, J THEOR BIOL, V244, P68, DOI 10.1016/j.jtbi.2006.05.013; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Edelstein SJ, 2013, J MOL BIOL, V425, P1424, DOI 10.1016/j.jmb.2013.03.011; Ermentout B, 2002, SIMULATING ANAL ANIM; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Francois P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002585; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gonze D, 2011, METHOD ENZYMOL, P171, DOI [10.1016/S0076-6879(11)87007-2, 10.1016/B978-0-12-381270-4.00007-X]; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Jolley CC, 2012, CELL REP, V2, P938, DOI 10.1016/j.celrep.2012.09.006; KELLER AD, 1995, J THEOR BIOL, V172, P169, DOI 10.1006/jtbi.1995.0014; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Liu XF, 2010, BIOPHYS J, V98, P1396, DOI 10.1016/j.bpj.2009.12.4307; Lu LX, 2012, P NATL ACAD SCI USA, V109, P9899, DOI 10.1073/pnas.1201366109; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ortega F, 2006, FEBS J, V273, P3915, DOI 10.1111/j.1742-4658.2006.05394.x; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Saithong T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013867; Salazar C, 2010, TRENDS CELL BIOL, V20, P634, DOI 10.1016/j.tcb.2010.08.012; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; Santillan M, 2008, MATH MODEL NAT PHENO, V3, P85, DOI 10.1051/mmnp:2008056; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Segel IH, 1975, ENZYME KINETICS BEHA; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Smolen P, 2001, J NEUROSCI, V21, P6644, DOI 10.1523/JNEUROSCI.21-17-06644.2001; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; TYSON JJ, 1979, J THEOR BIOL, V80, P27, DOI 10.1016/0022-5193(79)90177-2; WALTER CF, 1974, J THEOR BIOL, V44, P219, DOI 10.1016/0022-5193(74)90158-1; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Woller A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032722; Zeiser S, 2007, J COMPUT BIOL, V14, P984, DOI 10.1089/cmb.2007.0029	47	67	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69573	10.1371/journal.pone.0069573	http://dx.doi.org/10.1371/journal.pone.0069573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936338	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400017
J	Liu, K; Yuan, Y; Huang, JY; Wei, Q; Pang, MS; Xiong, CY; Fang, J				Liu, Kai; Yuan, Yuan; Huang, Jianyong; Wei, Qiong; Pang, Mingshu; Xiong, Chunyang; Fang, Jing			Improved-Throughput Traction Microscopy Based on Fluorescence Micropattern for Manual Microscopy	PLOS ONE			English	Article							SUBSTRATE TOPOGRAPHY; FLEXIBLE SUBSTRATA; CELL; FORCE; MIGRATION; BEHAVIOR; REVEALS; GROWTH	Traction force microscopy (TFM) is a quantitative technique for measuring cellular traction force, which is important in understanding cellular mechanotransduction processes. Traditional TFM has a significant limitation in that it has a low measurement throughput, commonly one per TFM dish, due to a lack of cell position information. To obtain enough cellular traction force data, an onerous workload is required including numerous TFM dish preparations and heavy cell-seeding activities, creating further difficulty in achieving identical experimental conditions among batches. In this paper, we present an improved-throughput TFM method using the well-developed microcontact printing technique and chemical modifications of linking microbeads to the gel surface to address these limitations. Chemically linking the microbeads to the gel surface has no significant influence on cell proliferation, morphology, cytoskeleton, and adhesion. Multiple pairs of force loaded and null force fluorescence images can be easily acquired by means of manual microscope with the aid of a fluorescence micropattern made by microcontact printing. Furthermore, keeping the micropattern separate from cells by using gels effectively eliminates the potential negative effect of the micropattern on the cells. This novel design greatly improves the analysis throughput of traditional TFM from one to at least twenty cells per petri dish without losing unique advantages, including a high spatial resolution of traction measurements. This newly developed method will boost the investigation of cell-matrix mechanical interactions.	[Liu, Kai; Huang, Jianyong; Xiong, Chunyang; Fang, Jing] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Yuan, Yuan; Huang, Jianyong; Wei, Qiong; Pang, Mingshu; Xiong, Chunyang; Fang, Jing] Peking Univ, Coll Engn, Dept Mech & Aerosp Engn, Beijing 100871, Peoples R China	Peking University; Peking University	Xiong, CY (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.	cyxiong@pku.edu.cn	Xiong, Chunyang/GLT-8212-2022; Xiong, Chunyang/C-2647-2009	Xiong, Chunyang/0000-0002-8821-2643; Xiong, Chunyang/0000-0002-8821-2643	National Basic Research Program of China [2013CB933702, 2011CB809106]; National Natural Science Foundation of China [11002003, 11072004]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work reported here was supported by the National Basic Research Program of China (Grant Nos. 2013CB933702 and 2011CB809106) and the National Natural Science Foundation of China (Grant Nos. 11002003 and 11072004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha R, 2011, J SURG RES, V171, P700, DOI 10.1016/j.jss.2011.07.007; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704; Califano JP, 2010, J BIOMECH, V43, P79, DOI 10.1016/j.jbiomech.2009.09.012; Chen WLK, 2010, BIOMATERIALS, V31, P2489, DOI 10.1016/j.biomaterials.2009.12.002; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024; Gutierrez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023807; Huang JY, 2012, CELL MOL BIOENG, V5, P205, DOI 10.1007/s12195-012-0224-0; Huang JY, 2010, OPT LASER ENG, V48, P1058, DOI 10.1016/j.optlaseng.2009.12.009; Huang JY, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/3/035101; Huang JY, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118767; Laird EG, 2012, PLOS ONE, V7; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; Luna C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051688; Mann C, 2010, CELL MOL BIOENG, V3, P40, DOI 10.1007/s12195-010-0108-0; Marganski WA, 2003, METHOD ENZYMOL, V361, P197; Marinkovic A, 2012, AM J PHYSIOL-LUNG C, V303, pL169, DOI 10.1152/ajplung.00108.2012; Mayer M, 2004, PROTEOMICS, V4, P2366, DOI 10.1002/pmic.200300748; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; OLIVER T, 1995, CELL MOTIL CYTOSKEL, V31, P225, DOI 10.1002/cm.970310306; Polio SR, 2012, ACTA BIOMATER, V8, P82, DOI 10.1016/j.actbio.2011.08.013; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Qin L, 2007, BIOCHEM BIOPH RES CO, V360, P352, DOI 10.1016/j.bbrc.2007.06.060; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Ricart BG, 2011, BIOPHYS J, V101, P2620, DOI 10.1016/j.bpj.2011.09.022; Tang X, 2010, BIOPHYS J, V99, P2460, DOI 10.1016/j.bpj.2010.08.034; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Tolic-Norrelykke IM, 2002, AM J PHYSIOL-CELL PH, V283, pC1254, DOI 10.1152/ajpcell.00169.2002; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; Willcox PJ, 2005, BIOMATERIALS, V26, P4757, DOI 10.1016/j.biomaterials.2004.11.060; Xing SG, 2010, ELECTROPHORESIS, V31, P3144, DOI 10.1002/elps.201000133; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539	41	11	12	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70122	10.1371/journal.pone.0070122	http://dx.doi.org/10.1371/journal.pone.0070122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936383	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400038
J	Muller, R; Misund, K; Holien, T; Bachke, S; Gilljam, KM; Vatsveen, TK; Ro, TB; Bellacchio, E; Sundan, A; Otterlei, M				Mueller, Rebekka; Misund, Kristine; Holien, Toril; Bachke, Siri; Gilljam, Karin M.; Vatsveen, Thea K.; Ro, Torstein B.; Bellacchio, Emanuele; Sundan, Anders; Otterlei, Marit			Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells	PLOS ONE			English	Article							PCNA-BINDING; REPLICATION; DNA; IDENTIFICATION; SENSITIVITY; INHIBITOR; THERAPIES; DISRUPTS; SURVIVAL; DISEASE	Multiple myeloma is a hematological cancer that is considered incurable despite advances in treatment strategy during the last decade. Therapies targeting single pathways are unlikely to succeed due to the heterogeneous nature of the malignancy. Proliferating cell nuclear antigen (PCNA) is a multifunctional protein essential for DNA replication and repair that is often overexpressed in cancer cells. Many proteins involved in the cellular stress response interact with PCNA through the five amino acid sequence AlkB homologue 2 PCNA-interacting motif (APIM). Thus inhibiting PCNA's protein interactions may be a good strategy to target multiple pathways simultaneously. We initially found that overexpression of peptides containing the APIM sequence increases the sensitivity of cancer cells to contemporary therapeutics. Here we have designed a cell-penetrating APIM-containing peptide, ATX-101, that targets PCNA and show that it has anti-myeloma activity. We found that ATX-101 induced apoptosis in multiple myeloma cell lines and primary cancer cells, while bone marrow stromal cells and primary healthy lymphocytes were much less sensitive. ATX-101-induced apoptosis was caspase-dependent and cell cycle phase-independent. ATX-101 also increased multiple myeloma cells' sensitivity against melphalan, a DNA damaging agent commonly used for treatment of multiple myeloma. In a xenograft mouse model, ATX-101 was well tolerated and increased the anti-tumor activity of melphalan. Therefore, targeting PCNA by ATX-101 may be a novel strategy in multiple myeloma treatment.	[Mueller, Rebekka; Misund, Kristine; Holien, Toril; Bachke, Siri; Gilljam, Karin M.; Vatsveen, Thea K.; Ro, Torstein B.; Sundan, Anders; Otterlei, Marit] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Otterlei, Marit] APIM Therapeut AS, Trondheim, Norway; [Bellacchio, Emanuele] IRCCS, Bambino Gesu Childrens Hosp, Res Labs, Rome, Italy; [Misund, Kristine; Holien, Toril; Vatsveen, Thea K.; Ro, Torstein B.; Sundan, Anders] KG Jebsen Ctr Myeloma Res, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); IRCCS Bambino Gesu	Otterlei, M (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	marit.otterlei@ntnu.no; marit.otterlei@ntnu.no	Holien, Toril/M-6253-2018; Våtsveen, Thea Kristin/G-9186-2017; Våtsveen, Thea Kristin/AAX-5456-2020; Bellacchio, Emanuele/AAH-9255-2019	Holien, Toril/0000-0002-2051-5824; Våtsveen, Thea Kristin/0000-0002-4158-0617; Våtsveen, Thea Kristin/0000-0002-4158-0617; Otterlei, Marit/0000-0002-5232-1186; Ro, Torstein/0000-0002-5258-500X; Bellacchio, Emanuele/0000-0002-2757-849X	APIM Therapeutics A/S; Norwegian University of Science and Technology; Liaison Comitee; K.G. Jepsen Center for Multiple Myeloma Research; Norwegian Cancer Society; Cancer Fond at St. Olavs University Hospital; Norwegian Reserach Council	APIM Therapeutics A/S; Norwegian University of Science and Technology; Liaison Comitee; K.G. Jepsen Center for Multiple Myeloma Research; Norwegian Cancer Society(Norwegian Cancer Society); Cancer Fond at St. Olavs University Hospital; Norwegian Reserach Council	This work was supported by APIM Therapeutics A/S, The Norwegian University of Science and Technology, The Liaison Comitee between St. Olavs University Hosiptal and The Norwegian University of Science and Technology, K.G. Jepsen Center for Multiple Myeloma Research, Norwegian Cancer Society, The Cancer Fond at St. Olavs University Hospital and The Norwegian Reserach Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Alexandrakis MG, 2004, INT J IMMUNOPATH PH, V17, P49, DOI 10.1177/039463200401700107; Avet-Loiseau H, 2011, J CLIN ONCOL, V29, P1893, DOI 10.1200/JCO.2010.32.8435; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Despras E, 2012, ENVIRON MOL MUTAGEN, V53, P752, DOI 10.1002/em.21741; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Gilljam KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049199; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; MATYUS L, 1992, J PHOTOCH PHOTOBIO B, V12, P323, DOI 10.1016/1011-1344(92)85039-W; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Misund K, 2013, J BIOMOL SCREEN, V18, P637, DOI 10.1177/1087057113478168; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Naryzhny SN, 2010, FEBS LETT, V584, P4292, DOI 10.1016/j.febslet.2010.09.021; Otterlei M, 2006, J CELL SCI, V119, P5137, DOI 10.1242/jcs.03291; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Punchihewa C, 2012, J BIOL CHEM, V287, P14289, DOI 10.1074/jbc.M112.353201; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Tan ZQ, 2012, MOL PHARMACOL, V81, P811, DOI 10.1124/mol.112.077735; Uwada J, 2010, BIOCHEM BIOPH RES CO, V391, P407, DOI 10.1016/j.bbrc.2009.11.071; Warbrick E, 2006, ONCOGENE, V25, P2850, DOI 10.1038/sj.onc.1209320; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	34	62	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70430	10.1371/journal.pone.0070430	http://dx.doi.org/10.1371/journal.pone.0070430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936203	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700073
J	Sorensen, JPR; Maurice, L; Edwards, FK; Lapworth, DJ; Read, DS; Allen, D; Butcher, AS; Newbold, LK; Townsend, BR; Williams, PJ				Sorensen, James P. R.; Maurice, Louise; Edwards, Francois K.; Lapworth, Daniel J.; Read, Daniel S.; Allen, Debbie; Butcher, Andrew S.; Newbold, Lindsay K.; Townsend, Barry R.; Williams, Peter J.			Using Boreholes as Windows into Groundwater Ecosystems	PLOS ONE			English	Article							ORGANIC-CARBON; AQUIFERS; BIODIVERSITY; DIVERSITY; OXYGEN; FAUNA; INVERTEBRATES; PICOPLANKTON; COMMUNITIES; EFFICIENCY	Groundwater ecosystems remain poorly understood yet may provide ecosystem services, make a unique contribution to biodiversity and contain useful bio-indicators of water quality. Little is known about ecosystem variability, the distribution of invertebrates within aquifers, or how representative boreholes are of aquifers. We addressed these issues using borehole imaging and single borehole dilution tests to identify three potential aquifer habitats (fractures, fissures or conduits) intercepted by two Chalk boreholes at different depths beneath the surface (34 to 98 m). These habitats were characterised by sampling the invertebrates, microbiology and hydrochemistry using a packer system to isolate them. Samples were taken with progressively increasing pumped volume to assess differences between borehole and aquifer communities. The study provides a new conceptual framework to infer the origin of water, invertebrates and microbes sampled from boreholes. It demonstrates that pumping 5 m(3) at 0.4-1.8 l/sec was sufficient to entrain invertebrates from five to tens of metres into the aquifer during these packer tests. Invertebrates and bacteria were more abundant in the boreholes than in the aquifer, with associated water chemistry variations indicating that boreholes act as sites of enhanced biogeochemical cycling. There was some variability in invertebrate abundance and bacterial community structure between habitats, indicating ecological heterogeneity within the aquifer. However, invertebrates were captured in all aquifer samples, and bacterial abundance, major ion chemistry and dissolved oxygen remained similar. Therefore the study demonstrates that in the Chalk, ecosystems comprising bacteria and invertebrates extend from around the water table to 70 m below it. Hydrogeological techniques provide excellent scope for tackling outstanding questions in groundwater ecology, provided an appropriate conceptual hydrogeological understanding is applied.	[Sorensen, James P. R.; Maurice, Louise; Lapworth, Daniel J.; Allen, Debbie; Butcher, Andrew S.; Townsend, Barry R.; Williams, Peter J.] British Geol Survey, Wallingford OX10 8BB, Oxon, England; [Edwards, Francois K.; Read, Daniel S.; Newbold, Lindsay K.] Ctr Ecol & Hydrol, Wallingford, Oxon, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; UK Centre for Ecology & Hydrology (UKCEH)	Sorensen, JPR (corresponding author), British Geol Survey, Wallingford OX10 8BB, Oxon, England.	jare1@bgs.ac.uk	Read, Daniel Steven/B-5446-2008; Newbold, Lindsay/E-6733-2012	Read, Daniel Steven/0000-0001-8546-5154; Newbold, Lindsay/0000-0001-8895-1406; Lapworth, Daniel/0000-0001-7838-7960; Sorensen, James/0000-0002-2157-990X	NERC (National Environmental Research Council); Natural Environment Research Council [bgs05007, ceh010010] Funding Source: researchfish; NERC [bgs05007] Funding Source: UKRI	NERC (National Environmental Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by NERC (National Environmental Research Council) core science budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allford A, 2008, INVERTEBR SYST, V22, P127, DOI 10.1071/IS07058; [Anonymous], 1993, BRIT FRESHWATER CRUS; BALKWILL DL, 1985, APPL ENVIRON MICROB, V50, P580, DOI 10.1128/AEM.50.3.580-588.1985; Bloomfield J, 1997, HYDROL EARTH SYST SC, V1, P19, DOI 10.5194/hess-1-19-1997; Boulton AJ, 2003, ARCH HYDROBIOL, V156, P431, DOI 10.1127/0003-9136/2003/0156-0431; Boulton AJ, 2008, INVERTEBR SYST, V22, P103, DOI 10.1071/IS07024; Brinkhurst RO., 1971, AQUATIC OLIGOCHAETA; Butler AP, 2009, HYDROGEOL J, V17, P1849, DOI 10.1007/s10040-009-0477-4; Chapelle FH, 2012, GROUND WATER, V50, P230, DOI 10.1111/j.1745-6584.2011.00835.x; Danielopol DL, 2003, ENVIRON CONSERV, V30, P104, DOI 10.1017/S0376892903000109; DANIELOPOL DL, 1987, STYGOLOGIA, V3, P252; Downing R.A., 1993, HYDROGEOLOGY CHALK N; Eberhard SM, 2009, FRESHWATER BIOL, V54, P885, DOI 10.1111/j.1365-2427.2007.01863.x; Edmunds WM, 2003, SCI TOTAL ENVIRON, V310, P25, DOI 10.1016/S0048-9697(02)00620-4; EISENREICH SJ, 1975, ENVIRON LETT, V9, P43, DOI 10.1080/00139307509437455; Flynn TM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011568; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Ginet R, 1960, ECOLOGIE ETHOLOGIE B; Goldscheider N, 2006, HYDROGEOL J, V14, P926, DOI 10.1007/s10040-005-0009-9; Griebler C, 2009, FRESHWATER BIOL, V54, P649, DOI 10.1111/j.1365-2427.2008.02013.x; Griebler C, 2010, ECOL ENG, V36, P1174, DOI 10.1016/j.ecoleng.2010.01.010; Gutjahr S, 2013, LIMNOLOGICA, V43, P43, DOI 10.1016/j.limno.2012.08.001; Hahn HJ, 2005, LIMNOLOGICA, V35, P31, DOI 10.1016/j.limno.2004.09.002; Hahn HR, 2005, LIMNOLOGICA, V35, P248, DOI 10.1016/j.limno.2005.04.004; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hancock PJ, 2005, HYDROGEOL J, V13, P98, DOI 10.1007/s10040-004-0421-6; HIRSCH P, 1988, MICROB ECOL, V16, P99, DOI 10.1007/BF02097408; Humphreys WF, 2009, HYDROGEOL J, V17, P5, DOI 10.1007/s10040-008-0349-3; Hvorslev MJ, 1951, US ARMY B, V36; Knight LRFD, 2010, ZOOTAXA, P52; Kwon MJ, 2008, GROUND WATER, V46, P286, DOI 10.1111/j.1745-6584.2007.00401.x; LAAKSOHARJU M, 1995, GROUND WATER MONIT R, V15, P125, DOI 10.1111/j.1745-6592.1995.tb00523.x; Lapworth DJ, 2008, APPL GEOCHEM, V23, P3384, DOI 10.1016/j.apgeochem.2008.07.011; Larned ST, 2012, FRESHWATER BIOL, V57, P885, DOI 10.1111/j.1365-2427.2012.02769.x; Lehman RM, 2007, GEOMICROBIOL J, V24, P331, DOI 10.1080/01490450701456941; Lehman RM, 2001, APPL ENVIRON MICROB, V67, P2095, DOI 10.1128/AEM.67.5.2095-2106.2001; Malard F, 1999, FRESHWATER BIOL, V41, P1, DOI 10.1046/j.1365-2427.1999.00379.x; Malard F, 1997, ARCH HYDROBIOL, V138, P401; Malard F., 2002, SAMPLING MANUAL ASSE; Maurice L, 2011, GROUND WATER, V49, P227, DOI 10.1111/j.1745-6584.2010.00708.x; Maurice LD, 2006, J HYDROL, V330, P63, DOI 10.1016/j.jhydrol.2006.04.012; Maurice LD, 2012, J HYDROL, V438, P3, DOI 10.1016/j.jhydrol.2011.11.050; Maurice LD, 2009, INVESTIGATIONS RAPID; Maurice Lou, 2012, Freshwater Reviews, V5, P51, DOI 10.1608/FRJ-5.1.443; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Neal C, 2000, SCI TOTAL ENVIRON, V251, P511, DOI 10.1016/S0048-9697(00)00402-2; Newbold LK, 2012, ENVIRON MICROBIOL, V14, P2293, DOI 10.1111/j.1462-2920.2012.02762.x; Pedersen K, 2008, ISME J, V2, P760, DOI 10.1038/ismej.2008.43; Pospisil P., 1994, P347; PRICE M, 1982, J HYDROL, V54, P401, DOI 10.1016/0022-1694(82)90165-2; Rivett MO, 2008, WATER RES, V42, P4215, DOI 10.1016/j.watres.2008.07.020; Robertson AL, 2009, Q J ENG GEOL HYDROGE, V42, P359, DOI 10.1144/1470-9236/08-046; Roudnew B, 2012, GROUND WATER MONIT R, V32, P72, DOI 10.1111/j.1745-6592.2011.01393.x; Shani N, 2013, GROUND WATER MONIT R, V33, P31, DOI 10.1111/j.1745-6592.2012.01420.x; Stein H, 2010, J ENVIRON MONITOR, V12, P242, DOI [10.1039/b913484k, 10.1039/B913484K]; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Williams A, 2006, J HYDROL, V330, P53, DOI 10.1016/j.jhydrol.2006.04.036	57	37	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70264	10.1371/journal.pone.0070264	http://dx.doi.org/10.1371/journal.pone.0070264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936176	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000322633700062
J	Hernandez-Leon, S; Gernandt, DS; de la Rosa, JAP; Jardon-Barbolla, L				Hernandez-Leon, Sergio; Gernandt, David S.; Perez de la Rosa, Jorge A.; Jardon-Barbolla, Lev			Phylogenetic Relationships and Species Delimitation in Pinus Section Trifoliae Inferrred from Plastid DNA	PLOS ONE			English	Article							PINES PINUS; RETICULATE EVOLUTION; MOLECULAR PHYLOGENY; CHLOROPLAST GENOME; SUBGENUS PINUS; GENUS PINUS; PINACEAE; BIOGEOGRAPHY; SEQUENCES; BARCODE	Recent diversification followed by secondary contact and hybridization may explain complex patterns of intra-and interspecific morphological and genetic variation in the North American hard pines (Pinus section Trifoliae), a group of approximately 49 tree species distributed in North and Central America and the Caribbean islands. We concatenated five plastid DNA markers for an average of 3.9 individuals per putative species and assessed the suitability of the five regions as DNA bar codes for species identification, species delimitation, and phylogenetic reconstruction. The ycf1 gene accounted for the greatest proportion of the alignment (46.9%), the greatest proportion of variable sites (74.9%), and the most unique sequences (75 haplotypes). Phylogenetic analysis recovered clades corresponding to subsections Australes, Contortae, and Ponderosae. Sequences for 23 of the 49 species were monophyletic and sequences for another 9 species were paraphyletic. Morphologically similar species within subsections usually grouped together, but there were exceptions consistent with incomplete lineage sorting or introgression. Bayesian relaxed molecular clock analyses indicated that all three subsections diversified relatively recently during the Miocene. The general mixed Yule-coalescent method gave a mixed model estimate of only 22 or 23 evolutionary entities for the plastid sequences, which corresponds to less than half the 49 species recognized based on morphological species assignments. Including more unique haplotypes per species may result in higher estimates, but low mutation rates, recent diversification, and large effective population sizes may limit the effectiveness of this method to detect evolutionary entities.	[Hernandez-Leon, Sergio; Gernandt, David S.] Univ Nacl Autonoma Mexico, Dept Bot, Inst Biol, Mexico City 04510, DF, Mexico; [Perez de la Rosa, Jorge A.] Univ Guadalajara, Inst Bot, Zapopan, Jalisco, Mexico; [Jardon-Barbolla, Lev] Univ Nacl Autonoma Mexico, Dept Ecol Evolut, Inst Ecol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad de Guadalajara; Universidad Nacional Autonoma de Mexico	Gernandt, DS (corresponding author), Univ Nacl Autonoma Mexico, Dept Bot, Inst Biol, Mexico City 04510, DF, Mexico.	dgernandt@ib.unam.mx		Jardon Barbolla, Lev/0000-0002-3555-1211; Hernandez-Leon, Sergio/0000-0001-5892-6066	Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica of the Universidad Nacional Autonoma de Mexico (DGAPA-PAPIIT) [IN228209]; United Nations Development Programme; National Commission for Knowledge and Use of Biodiversity (CONABIO) [GE021]; National Council on Science and Technology (CONACYT; The Barcodes of Life Thematic Network)	Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica of the Universidad Nacional Autonoma de Mexico (DGAPA-PAPIIT); United Nations Development Programme; National Commission for Knowledge and Use of Biodiversity (CONABIO); National Council on Science and Technology (CONACYT; The Barcodes of Life Thematic Network)	This study was supported by the Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica of the Universidad Nacional Autonoma de Mexico (DGAPA-PAPIIT; IN228209), the United Nations Development Programme, the National Commission for Knowledge and Use of Biodiversity (CONABIO; GE021), and the National Council on Science and Technology (CONACYT; The Barcodes of Life Thematic Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz-Abarca N, 2006, P BIOL SOC WASH, V119, P426, DOI 10.2988/0006-324X(2006)119[426:FFDPLA]2.0.CO;2; Alvin KL, 1960, FURTHER CONIFERS PIN; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; AXELROD DI, 1986, ANN MO BOT GARD, V73, P565, DOI 10.2307/2399194; Azuma H, 2001, AM J BOT, V88, P2275, DOI 10.2307/3558389; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Brower AVZ, 1999, SYST BIOL, V48, P199, DOI 10.1080/106351599260535; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Conkle MT, 1988, GENETIC VARIATION HY, P27; Core R Team, 2012, R LANG ENV STAT COMP; Critchfield WB, 1966, GEOGRAPHIC DISTRIBUT, p[97, v]; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; de la Rosa JAP, 2009, BRITTONIA, V61, P56, DOI 10.1007/s12228-008-9061-9; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Delgado P, 2007, INT J PLANT SCI, V168, P861, DOI 10.1086/518260; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DUFFIELD J. W., 1952, ZEITSCHR FORSTGENETIK U FORSTPFLANZENZIICHT, V1, P93; Eckenwalder JE, 2009, CONIFERS WORLD COMPL; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Ezard T, 2009, SPLITS SPECIES LLMIT; Farjon A, 2010, HANDBOOK OF THE WORLD'S CONIFERS, VOL 1, P1, DOI 10.1163/9789047430629; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gernandt DS, 2011, SYST BOT, V36, P583, DOI 10.1600/036364411X583565; Gernandt DS, 2009, SYST BOT, V34, P481, DOI 10.1600/036364409789271290; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Gradstein FM, 2008, NEWSL STRATIGR, V43, P5, DOI 10.1127/0078-0421/2008/0043-0005; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HALLER J. R., 1965, BRITTONIA, V17, P354, DOI 10.2307/2805029; Handy SM, 2011, J AGR FOOD CHEM, V59, P10995, DOI 10.1021/jf203215v; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HONG YP, 1993, MOL PHYLOGENET EVOL, V2, P322, DOI 10.1006/mpev.1993.1031; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Krupkin AB, 1996, AM J BOT, V83, P489, DOI 10.2307/2446218; Le Maitre D. C., 1998, P407; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIDHOLM J, 1991, MOL GEN GENET, V226, P345, DOI 10.1007/BF00260645; Liston A, 2003, ACTA HORTIC, P107, DOI 10.17660/ActaHortic.2003.615.7; Liston A, 2007, MOL ECOL, V16, P3926, DOI 10.1111/j.1365-294X.2007.03461.x; Little EL, 1969, SUBDIVISIONS GENUS P; Lopez GG, 2002, INT J PLANT SCI, V163, P737, DOI 10.1086/342213; MADDISON W, 1995, MONOG SYST BOTAN, V53, P273; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Matos JA, 2000, EVOLUTION, V54, P1218, DOI 10.1111/j.0014-3820.2000.tb00556.x; Meijer JJF, 2000, REV PALAEOBOT PALYNO, V112, P297, DOI 10.1016/S0034-6667(00)00007-5; MIROV N. T., 1967; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-100; Parks M, 2011, AM J BOT, V98, pE185, DOI 10.3732/ajb.1100088; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Powell JR, 2012, METHODS ECOL EVOL, V3, P1, DOI 10.1111/j.2041-210X.2011.00122.x; Price Robert A., 1998, P49; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryberg PE, 2012, INT J PLANT SCI, V173, P917, DOI 10.1086/667228; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; SAYLOR LC, 1966, AM J BOT, V53, P453, DOI 10.2307/2440344; Shaw GR, 1914, GENUS PINUS, V4, pl; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Tsutsui K, 2009, J PLANT RES, V122, P509, DOI 10.1007/s10265-009-0246-4; VANDERBURGH J, 1973, REV PALAEOBOT PALYNO, V15, P73, DOI 10.1016/0034-6667(73)90001-8; WAGNER DB, 1987, P NATL ACAD SCI USA, V84, P2097, DOI 10.1073/pnas.84.7.2097; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wang XR, 1999, AM J BOT, V86, P1742, DOI 10.2307/2656672; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zwickl D. J, 2006, GENETIC ALGORITHM AP	90	69	70	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70501	10.1371/journal.pone.0070501	http://dx.doi.org/10.1371/journal.pone.0070501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936218	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200091
J	Davidson, T; Tremblay, F				Davidson, Travis; Tremblay, Francois			Hemispheric Differences in Corticospinal Excitability and in Transcallosal Inhibition in Relation to Degree of Handedness	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; CORTICAL SILENT PERIOD; INTERHEMISPHERIC INHIBITION; ASYMMETRY; HAND; CONNECTIONS; PERFORMANCE; THRESHOLD; BRAIN	In this study, we examined hemispheric differences in corticospinal excitability and in transcallosal inhibition in a selected group of young adults (n = 34) grouped into three handedness categories (RH: strongly right-handed, n = 17; LH: strongly left-handed, n = 10; MH: mixed-handed, n = 7) based on laterality quotients (LQ) derived from the Edinburgh Handedness Inventory. Performance measures were also used to derive a laterality index reflecting right-left asymmetries in manual dexterity (Dext(li)) and in finger tapping speed (Speed(li)). Corticospinal excitability was assessed in each hemisphere by means of transcranial magnetic stimulation (TMS) using the first dorsal interosseus as the target muscle. TMS measures consisted of resting motor threshold (rMT), motor evoked potential (MEP) recruitment curve (RC) and the contralateral silent period (cSP) with the accompanying MEP facilitation. Hemispheric interactions were assessed by means of the ipsilateral silent period (iSP) to determine the onset latency and the duration of transcallosal inhibition (i.e., LTI and DTI). Analysis of hemispheric variations in measures of corticospinal excitability revealed no major asymmetries in relation to degrees of laterality or handedness, with the exception of a rightward increase in rMTs in the LH group. Similarly, no clear asymmetries were found when looking at hemispheric variations in measures of transcallosal inhibition. However, a large group effect was detected for LTI measures, which were found to be significantly shorter in the MH group than in either the LH or RH group. MH participants also tended to show longer DTI than the other participants. Further inspection of overall variations in LTI and DTI measures as a function of LQs revealed that both variables followed a non-linear relationship, which was best described by a 2nd order polynomial function. Overall, these findings provide converging evidence for a link between -handedness and more efficient interhemispheric communication when compared to either right- or left-handedness.	[Davidson, Travis] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Tremblay, Francois] Univ Ottawa, Sch Rehabil Sci, Ottawa, ON, Canada; [Davidson, Travis; Tremblay, Francois] Bruyere Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Tremblay, F (corresponding author), Univ Ottawa, Sch Rehabil Sci, Ottawa, ON, Canada.	ftrembla@uottawa.ca	Tremblay, François/D-4378-2009	Tremblay, François/0000-0001-5450-8035	Faculty of Health Sciences and Bruyere Research Institute	Faculty of Health Sciences and Bruyere Research Institute	This study was supported through internal funding provided by the Faculty of Health Sciences and Bruyere Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Baumer T, 2007, EXP BRAIN RES, V180, P195, DOI 10.1007/s00221-007-0866-7; Bernard JA, 2011, J NEUROPHYSIOL, V105, P88, DOI 10.1152/jn.00512.2010; Braune HJ, 1996, ACTA NEUROL SCAND, V93, P168; Brouwer B, 2001, EXP BRAIN RES, V138, P467, DOI 10.1007/s002210100730; Brown S, 2006, MAMM GENOME, V17, P1, DOI 10.1007/s00335-005-0900-7; Chen R, 2000, MUSCLE NERVE, pS26; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Civardi C, 2000, CLIN NEUROPHYSIOL, V111, P624, DOI 10.1016/S1388-2457(99)00301-6; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Daligadu J, 2013, EXP BRAIN RES, V224, P411, DOI 10.1007/s00221-012-3320-4; Dassonville P, 1997, P NATL ACAD SCI USA, V94, P14015, DOI 10.1073/pnas.94.25.14015; De Gennaro L, 2004, CLIN NEUROPHYSIOL, V115, P1305, DOI 10.1016/j.clinph.2004.01.014; Doeltgen SH, 2010, CLIN NEUROPHYSIOL, V121, P448, DOI 10.1016/j.clinph.2009.11.085; Dragovic M, 2004, ACTA NEUROPSYCHIATR, V16, P212, DOI 10.1111/j.0924-2708.2004.00087.x; Dragovic M, 2007, BRIT J PSYCHOL, V98, P375, DOI 10.1348/000712606X146197; Giovannelli F, 2009, J PHYSIOL-LONDON, V587, P5393, DOI 10.1113/jphysiol.2009.175885; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Hammond G, 2002, NEUROSCI BIOBEHAV R, V26, P285, DOI 10.1016/S0149-7634(02)00003-9; Herve PY, 2009, HUM BRAIN MAPP, V30, P3151, DOI 10.1002/hbm.20734; Herve PV, 2005, NEUROIMAGE, V25, P1133, DOI 10.1016/j.neuroimage.2004.12.062; Herve PY, 2006, NEUROIMAGE, V29, P1066, DOI 10.1016/j.neuroimage.2005.08.031; Ho KH, 1998, EXP BRAIN RES, V122, P433, DOI 10.1007/s002210050531; Livingston SC, 2010, J CLIN MONIT COMPUT, V24, P427, DOI 10.1007/s10877-010-9267-8; Luders E, 2010, NEUROIMAGE, V52, P43, DOI 10.1016/j.neuroimage.2010.04.016; Martin K, 2011, NEUROIMAGE, V57, P502, DOI 10.1016/j.neuroimage.2011.04.036; Mills KR, 1997, MUSCLE NERVE, V20, P570, DOI 10.1002/(SICI)1097-4598(199705)20:5<570::AID-MUS5>3.3.CO;2-F; NETZ J, 1995, EXP BRAIN RES, V104, P527; Nielsen JF, 1996, J CLIN NEUROPHYSIOL, V13, P423, DOI 10.1097/00004691-199609000-00005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; Priori A, 1999, EXP BRAIN RES, V128, P390, DOI 10.1007/s002210050859; Ray JR, 2002, MUSCLE NERVE, V25, P202, DOI 10.1002/mus.10020; Rossini PM, 2008, CLIN NEUROPHYSIOL, V119, P2421, DOI 10.1016/j.clinph.2008.07.006; Semmler JG, 1998, J NEUROPHYSIOL, V79, P1246, DOI 10.1152/jn.1998.79.3.1246; Steenhuis R E, 1999, Laterality, V4, P3, DOI 10.1080/135765099397079; Triggs WJ, 1997, NEUROPSYCHOLOGIA, V35, P1355, DOI 10.1016/S0028-3932(97)00077-8	38	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70286	10.1371/journal.pone.0070286	http://dx.doi.org/10.1371/journal.pone.0070286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936180	gold, Green Published			2022-12-27	WOS:000322433300097
J	Zhu, L; Zhang, DY				Zhu, Li; Zhang, Da-Yong			Donald's Ideotype and Growth Redundancy: A Pot Experimental Test Using an Old and a Modern Spring Wheat Cultivar	PLOS ONE			English	Article							RECOGNITION; TRAGEDY; COMMONS; PLANTS; ROOTS	Human selection for high crop yield under water-limited conditions should have led modern cereal cultivars to invest less in root biomass, be it unconsciously. To test this hypothesis we conducted a pot experiment with two spring wheat cultivars, one old and one modern, both widely grown in the semi-arid regions of China. Using the replacement series method introduced by de Wit, we showed that the older landrace (Monkhead) was significantly more competitive than the more-modern cultivar (92-46). However, when grown in pure stand, old Monkhead had grown root biomass 3.5 times modern 92-46, whereas modern 92-46 gained a 20% higher grain yield. We also found modern 92-46 significantly increased root biomass per plant and root allocation (i.e., root biomass/total individual biomass) as its frequency in mixtures decreased, whereas old Monkhead did not respond in a similar way. This result suggests that the roots of modern cultivars may have gained an ability to recognize neighboring root systems and show more plastic self-restraining response to intra-cultivar competition.	[Zhang, Da-Yong] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; Beijing Normal Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Zhang, DY (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	zhangdy@bnu.edu.cn	Zhang, Da-Yong/B-3078-2011	Zhang, Da-Yong/0000-0003-1056-8735	National Natural Science Foundation of China [31030014, 31121003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31030014 and 31121003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen BJW, 2012, PLANT SCI, V195, P157, DOI 10.1016/j.plantsci.2012.07.006; Denison R.F., 2012, DARWINIAN AGR; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Evans LT., 1993, CROP EVOLUTION ADAPT; Fang SQ, 2013, P NATL ACAD SCI USA, V110, P2670, DOI 10.1073/pnas.1222821110; Fang Y, 2011, PLANT SOIL, V347, P7, DOI 10.1007/s11104-011-0780-4; Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Harper J. L, 1977, POPULATION BIOL PLAN; JENNINGS PETER R., 1964, CROP SCI, V4, P13, DOI 10.2135/cropsci1964.0011183X000400010005x; MARSHALL DR, 1991, FIELD CROP RES, V26, P171, DOI 10.1016/0378-4290(91)90034-S; McNickle GG, 2013, ECOL LETT, V16, P545, DOI 10.1111/ele.12071; SIDDIQUE KHM, 1990, PLANT SOIL, V121, P89, DOI 10.1007/BF00013101; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Waines JG, 2007, ANN BOT-LONDON, V100, P991, DOI 10.1093/aob/mcm180; Weiner J, 2010, EVOL APPL, V3, P473, DOI 10.1111/j.1752-4571.2010.00144.x; Zhang DY, 1999, FIELD CROP RES, V61, P179, DOI 10.1016/S0378-4290(98)00156-7; Zhang R., 2000, ACTA PHYTOECCOL SIN, V24, P298, DOI [10.1088/0256-307X/17/9/008, DOI 10.1088/0256-307X/17/9/008]; Zhang R., 1999, ACTA PHYTOECOL SIN, V23, P205; [No title captured]	22	23	24	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70006	10.1371/journal.pone.0070006	http://dx.doi.org/10.1371/journal.pone.0070006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936133	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300082
J	Chatterjee, S; Levin, C; Laxminarayan, R				Chatterjee, Susmita; Levin, Carol; Laxminarayan, Ramanan			Unit Cost of Medical Services at Different Hospitals in India	PLOS ONE			English	Article							DISTRICT; THAILAND	Institutional care is a growing component of health care costs in low-and middle-income countries, but local health planners in these countries have inadequate knowledge of the costs of different medical services. In India, greater utilisation of hospital services is driven both by rising incomes and by government insurance programmes that cover the cost of inpatient services; however, there is still a paucity of unit cost information from Indian hospitals. In this study, we estimated operating costs and cost per outpatient visit, cost per inpatient stay, cost per emergency room visit, and cost per surgery for five hospitals of different types across India: a 57-bed charitable hospital, a 200-bed private hospital, a 400-bed government district hospital, a 655-bed private teaching hospital, and a 778-bed government tertiary care hospital for the financial year 2010-11. The major cost component varied among human resources, capital costs, and material costs, by hospital type. The outpatient visit cost ranged from Rs. 94 (district hospital) to Rs. 2,213 (private hospital) (USD 1 = INR 52). The inpatient stay cost was Rs. 345 in the private teaching hospital, Rs. 394 in the district hospital, Rs. 614 in the tertiary care hospital, Rs. 1,959 in the charitable hospital, and Rs. 6,996 in the private hospital. Our study results can help hospital administrators understand their cost structures and run their facilities more efficiently, and we identify areas where improvements in efficiency might significantly lower unit costs. The study also demonstrates that detailed costing of Indian hospital operations is both feasible and essential, given the significant variation in the country's hospital types. Because of the size and diversity of the country and variations across hospitals, a large-scale study should be undertaken to refine hospital costing for different types of hospitals so that the results can be used for policy purposes, such as revising payment rates under government-sponsored insurance schemes.	[Chatterjee, Susmita; Laxminarayan, Ramanan] Publ Hlth Fdn India, New Delhi, India; [Levin, Carol] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA	Public Health Foundation of India; University of Washington; University of Washington Seattle; Princeton University	Laxminarayan, R (corresponding author), Publ Hlth Fdn India, New Delhi, India.	ramanan@phfi.org	Laxminarayan, Ramanan/ABD-5050-2021		Public Health Foundation of India	Public Health Foundation of India	The study was supported by the research fund of Public Health Foundation of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2006, SOC SCI MED, V63, P1700, DOI 10.1016/j.socscimed.2006.04.023; Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Anand K, 1993, Natl Med J India, V6, P160; Barnum H., 1993, PUBLIC HOSP DEV COUN; Conteh L, 2004, HEALTH POLICY PLANN, V19, P127, DOI 10.1093/heapol/czh015; Creese A., 2000, COST ANAL PRIMARY HL; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Edejer T, 2003, MAKING CHOICES HLTH; Government of India, 2010, GOV IND ANN REP PEOP; Government of India, 2011, REP WORK GROUP TERT; Green A, 2001, HEALTH POLICY PLANN, V16, P180, DOI 10.1093/heapol/16.2.180; John Snow Inc, 1990, PAP NEW GUIN HLTH SE, VII; Krishnan Anand, 2005, Indian Journal of Pediatrics, V72, P657, DOI 10.1007/BF02724072; Kruk ME, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000242; Kutzin J, 1989, JAMAICAN HOSP RESTOR; Lewis MA, 1996, SOC SCI MED, V43, P221, DOI 10.1016/0277-9536(95)00364-9; Maggie HR, 1992, DZONGKHAG COSTING ST; Maggie HR, 1992, FINANCIAL STUDY THIM; Mathur Neeta, 2010, Indian J Community Med, V35, P153, DOI 10.4103/0970-0218.62585; Mills A., 1990, HLTH POLICY PLANNING, V5, P203, DOI DOI 10.1093/HEAPOL/5.3.203; MILLS AJ, 1993, B WORLD HEALTH ORGAN, V71, P329; Ministry of Health Gambia/World Health Organization, 1995, COST AN HLTH CAR SEC; Newbrander William, 1992, HOSP EC FINANCING DE; Olukoga A., 2007, SMJ Singapore Medical Journal, V48, P143; Oostenbrink JB, 2003, PHARMACOECONOMICS, V21, P263, DOI 10.2165/00019053-200321040-00004; Riewpaiboon A, 2010, COST ANAL HLTH CARE; Riewpaiboon A, 2008, VALUE HEALTH, V11, pS75, DOI 10.1111/j.1524-4733.2008.00370.x; Riewpaiboon Arthorn, 2011, Int J Pharm Pract, V19, P342, DOI 10.1111/j.2042-7174.2011.00131.x; Russell S, 1988, HLTH CARE FINANCING; Shepard DS, 1998, ANAL HOSP COSTS MANU, P1; Sur D, 2009, J HEALTH POPUL NUTR, V27, P725; Van Minh H, 2010, INT J HEALTH PLAN M, V25, P63, DOI 10.1002/hpm.970; Vander Plaetse B, 2005, HEALTH POLICY PLANN, V20, P243, DOI 10.1093/heapol/czi028; Walker D, 2002, HEALTH POLICY PLANN, V17, P112, DOI 10.1093/heapol/17.1.112; Wong H, 1993, 11 ABT ASS; Wong H, 1989, COST ANAL NIAMEY HOS; *WORLD BANK, 1993, WORLD DEV REP	37	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69728	10.1371/journal.pone.0069728	http://dx.doi.org/10.1371/journal.pone.0069728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23936088	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000150
J	Kan, WC; Wang, JJ; Wang, SY; Sun, YM; Hung, CY; Chu, CC; Lu, CL; Weng, SF; Chio, CC; Chien, CC				Kan, Wei-Chih; Wang, Jhi-Joung; Wang, Shuo-Yu; Sun, Yih-Min; Hung, Chien-Ya; Chu, Chin-Chen; Lu, Chin-Li; Weng, Shih-Feng; Chio, Chung-Ching; Chien, Chih-Chiang			The New Comorbidity Index for Predicting Survival in Elderly Dialysis Patients: A Long-Term Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONSERVATIVE MANAGEMENT; STARTING DIALYSIS; DECISION-MAKING; HEMODIALYSIS; OUTCOMES; DISEASE; OCTOGENARIANS; INITIATION; CARE	Background: The worldwide elderly (>= 65 years old) dialysis population has grown significantly. This population is expected to have more comorbid conditions and shorter life expectancies than the general elderly population. Predicting outcomes for this population is important for decision-making. Recently, a new comorbidity index (nCI) with good predictive value for patient outcomes was developed and validated in chronic dialysis patients regardless of age. Our study examined the nCI outcome predictability in elderly dialysis patients. Methods and Findings: For this population-based cohort study, we used Taiwan's National Health Insurance Research Database of enrolled elderly patients, who began maintenance dialysis between January 1999 and December 2005. A total of 21,043 incident dialysis patients were divided into 4 groups by nCI score (intervals <= 3, 4-6, 7-9, >= 10) and followed nearly for 10 years. All-cause mortality and life expectancy were analyzed. During the follow-up period, 11272 (53.55%) patients died. Kaplan-Meier curves showed significant group difference in survival (log-rank: P < 0.001). After stratification by age, life expectancy was found to be significantly longer in groups with lower nCI scores. Conclusion: The nCI, even without the age component, is a strong predictor of mortality in elderly dialysis patients. Because patients with lower nCI scores may predict better survival, more attention should paid to adequate dialysis rather than palliative care, especially in those without obvious functional impairments.	[Kan, Wei-Chih; Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Kan, Wei-Chih] Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Kan, Wei-Chih] Southern Taiwan Univ, Tainan, Taiwan; [Wang, Jhi-Joung; Chu, Chin-Chen; Lu, Chin-Li; Weng, Shih-Feng] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Shuo-Yu] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan; [Sun, Yih-Min] Chung Hwa Univ Med Technol, Dept Occupat Safety & Hlth, Tainan, Taiwan; [Hung, Chien-Ya; Chien, Chih-Chiang] Chung Hwa Univ Med Technol, Dept Food Nutr, Tainan, Taiwan; [Chio, Chung-Ching] Chi Mei Med Ctr, Dept Neurol Surg, Tainan, Taiwan	Chi Mei Hospital; Chung Hua University; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Chi Mei Hospital; Chung Hua University; Chung Hua University; Chi Mei Hospital	Chien, CC (corresponding author), Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan.	ccchien58@yahoo.com.tw		Chu, Chin-Chen/0000-0001-8745-239X; Lu, Chin-Li/0000-0002-0818-4823; Weng, Shih-Feng/0000-0001-8684-3487	Chi-Mei Medical Center [CMFHR10016]; National Health Research Institutes in Taiwan [NHRI-NHIRD-99182]	Chi-Mei Medical Center; National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	The study was supported by grant CMFHR10016 from the Chi-Mei Medical Center and grant NHRI-NHIRD-99182 from the National Health Research Institutes in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athienites NV, 2000, SEMIN DIALYSIS, V13, P320, DOI 10.1046/j.1525-139x.2000.00095.x; Burns A, 2003, NEPHRON CLIN PRACT, V95, pC37, DOI 10.1159/000073667; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; Chandna SM, 2011, NEPHROL DIAL TRANSPL, V26, P1608, DOI 10.1093/ndt/gfq630; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chien CC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-43; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Combe C, 2009, AM J KIDNEY DIS, V54, P680, DOI 10.1053/j.ajkd.2009.04.035; Couchoud C, 2009, NEPHROL DIAL TRANSPL, V24, P1553, DOI 10.1093/ndt/gfn698; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; Department of Statistics Ministry of the Interior, 2009, STAT B TAIW; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Di Iorio B, 2004, INT J ARTIF ORGANS, V27, P330, DOI 10.1177/039139880402700409; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fried L, 2001, AM J KIDNEY DIS, V37, P337, DOI 10.1053/ajkd.2001.21300; Goodkin DA, 2004, AM J KIDNEY DIS, V44, pS16, DOI 10.1053/j.akjd.2004.08.006; Jassal SV, 2009, CLIN J AM SOC NEPHRO, V4, P2008, DOI 10.2215/CJN.04610709; Joly D, 2003, J AM SOC NEPHROL, V14, P1012, DOI 10.1097/01.ASN.0000054493.04151.80; KHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; MCCORMICK TR, 1995, WESTERN J MED, V163, P236; Miskulin DC, 2004, NEPHROL DIAL TRANSPL, V19, P413, DOI 10.1093/ndt/gfg571; Moss AH, 2001, AM J KIDNEY DIS, V37, P1081; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Renal Physicians Association, 2000, SHAR DEC MAK APPR IN; Stevens LA, 2010, AM J KIDNEY DIS, V55, pS23, DOI 10.1053/j.ajkd.2009.09.035; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916; Werb R, 2011, PRIMARY CARE, V38, P299, DOI 10.1016/j.pop.2011.03.009	31	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e68748	10.1371/journal.pone.0068748	http://dx.doi.org/10.1371/journal.pone.0068748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936310	gold, Green Submitted, Green Published			2022-12-27	WOS:000324401500007
J	Li, CT; Chen, LF; Tu, PC; Wang, SJ; Chen, MH; Su, TP; Hsieh, JC				Li, Cheng-Ta; Chen, Li-Fen; Tu, Pei-Chi; Wang, Shyh-Jen; Chen, Mu-Hong; Su, Tung-Ping; Hsieh, Jen-Chuen			Impaired Prefronto-Thalamic Functional Connectivity as a Key Feature of Treatment-Resistant Depression: A Combined MEG, PET and rTMS Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; EEG; ASYMMETRY; METABOLISM; PATTERNS; BASE	Prefrontal left-right functional imbalance and disrupted prefronto-thalamic circuitry are plausible mechanisms for treatment-resistant depression (TRD). Add-on repetitive transcranial magnetic stimulation (rTMS), effective in treating antidepressant-refractory TRD, was administered to verify the core mechanisms underlying the refractoriness to antidepressants. Thirty TRD patients received a 2-week course of 10-Hz rTMS to the left dorsolateral prefrontal cortex (DLPFC). Depression scores were evaluated at baseline (W0), and the ends of weeks 1, 2, and 14 (W14). Responders were defined as those who showed an objective improvement in depression scores >= 50% after rTMS. Left-right frontal alpha asymmetry (FAA) was measured by magnetoencephalography at each time point as a proxy for left-right functional imbalance. Prefronto-thalamic connections at W0 and W14 were assessed by studying couplings between prefrontal alpha waves and thalamic glucose metabolism (PWTMC, reflecting intact thalamo-prefrontal connectivity). A group of healthy control subjects received magnetoencephalography at W0 (N = 50) to study whether FAA could have a diagnostic value for TRD, or received both magnetoencephalography and positron-emission-tomography at W0 (N = 10) to confirm the existence of PWTMC in the depression-free state. We found that FAA changes cannot differentiate between TRD and healthy subjects or between responders and non-responders. No PWTMC were found in the TRD group at W0, whereas restitution of the PWTMC was demonstrated only in the sustained responders at W14 and euthymic healthy controls. In conclusion, we affirmed impaired prefronto-thalamic functional connections, but not frontal functional imbalance, as a core deficit in TRD.	[Li, Cheng-Ta; Tu, Pei-Chi; Chen, Mu-Hong; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Li, Cheng-Ta; Chen, Li-Fen; Su, Tung-Ping; Hsieh, Jen-Chuen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Li, Cheng-Ta; Tu, Pei-Chi; Su, Tung-Ping] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei 112, Taiwan; [Chen, Li-Fen; Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Integrated Brain Res Unit, Taipei, Taiwan; [Hsieh, Jen-Chuen] Natl Hlth & Res Inst, Ctr Neuropsychiat Res, Chunan, South Korea; [Wang, Shyh-Jen] Taipei Vet Gen Hosp, Dept Nucl Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Hsieh, JC (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan.	jchsieh@ym.edu.tw	Chen, MuHong/ACJ-6131-2022; Li, Cheng-Ta/AAI-5759-2021	Chen, MuHong/0000-0001-6516-1073; Li, Cheng-Ta/0000-0002-0670-1153	Taipei Veterans General Hospital [V100B-016]; National Science Council [NSC 98-2752-B-010-001-PAE, NSC 98-2752-B-010-003-PAE]; Yen Tjing Ling Medical Foundation [CI-100-6]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Yen Tjing Ling Medical Foundation	The study was sponsored by grants from Taipei Veterans General Hospital (V100B-016), National Science Council (NSC 98-2752-B-010-001-PAE & NSC 98-2752-B-010-003-PAE) and Yen Tjing Ling Medical Foundation (CI-100-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJB, 2004, PSYCHOPHYSIOLOGY, V41, P269, DOI 10.1111/j.1469-8986.2003.00149.x; Alper KR, 2006, PSYCHIAT RES-NEUROIM, V146, P271, DOI 10.1016/j.pscychresns.2005.06.008; Armstrong E, 1990, LIMBIC THALAMUS ANTE, P469; Cook IA, 1998, J AFFECT DISORDERS, V49, P89, DOI 10.1016/S0165-0327(97)00192-4; Cook IA, 1998, ELECTROEN CLIN NEURO, V107, P408, DOI 10.1016/S0013-4694(98)00092-3; Daskalakis ZJ, 2008, CAN J PSYCHIAT, V53, P555, DOI 10.1177/070674370805300902; Daskalakis ZJ, 2006, EXP BRAIN RES, V174, P403, DOI 10.1007/s00221-006-0472-0; DAVIDSON RJ, 1988, INT J NEUROSCI, V39, P71, DOI 10.3109/00207458808985694; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Fekadu A, 2009, J AFFECT DISORDERS, V116, P4, DOI 10.1016/j.jad.2008.10.014; Fitzgerald PB, 2011, EXPERT REV MED DEVIC, V8, P85, DOI [10.1586/erd.10.57, 10.1586/ERD.10.57]; Fuggetta G, 2012, EXPT NEUROLOGY; George MS, 2013, CURR OPIN PSYCHIATR, V26, P13, DOI 10.1097/YCO.0b013e32835ab46d; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Holthoff VA, 2004, ACTA PSYCHIAT SCAND, V110, P184, DOI 10.1111/j.1600-0447.2004.00351.x; Hwang RJ, 2008, HORM BEHAV, V54, P28, DOI 10.1016/j.yhbeh.2007.11.007; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P1603, DOI 10.1016/S0006-3223(99)00195-X; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Lee DS, 2008, EUR J NUCL MED MOL I, V35, P1681, DOI 10.1007/s00259-008-0808-z; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Li CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046818; Li CT, 2010, J AFFECT DISORDERS, V127, P219, DOI 10.1016/j.jad.2010.05.028; Lindgren KA, 1999, BIOL PSYCHIAT, V45, P943, DOI 10.1016/S0006-3223(98)00350-3; Lindsley DB, 1974, ELECTROENCEPHALOGRAM; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Milak MS, 2009, PSYCHIAT RES-NEUROIM, V173, P63, DOI 10.1016/j.pscychresns.2008.09.004; Mu J, 2007, NEUROSCI LETT, V425, P49, DOI 10.1016/j.neulet.2007.08.004; Osipova D, 2005, NEUROIMAGE, V27, P835, DOI 10.1016/j.neuroimage.2005.05.011; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rush AJ, 2007, J CLIN PSYCHIAT, V68, P8; Spronk D, 2008, CLIN EEG NEUROSCI, V39, P118, DOI 10.1177/155005940803900305; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; Stewart JL, 2010, J ABNORM PSYCHOL, V119, P502, DOI 10.1037/a0019196; Su TP, 2005, J CLIN PSYCHIAT, V66, P930, DOI 10.4088/JCP.v66n0718; Teneback CC, 1999, J NEUROPSYCH CLIN N, V11, P426; Thase ME, 1997, J CLIN PSYCHIAT, V58, P23; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144	40	43	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70089	10.1371/journal.pone.0070089	http://dx.doi.org/10.1371/journal.pone.0070089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XU	23936378	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800033
J	Nolan, D; Kraus, WE; Hauser, E; Li, YJ; Thompson, DK; Johnson, J; Chen, HC; Nelson, S; Haynes, C; Gregory, SG; Kraus, VB; Shah, SH				Nolan, Daniel; Kraus, William E.; Hauser, Elizabeth; Li, Yi-Ju; Thompson, Dana K.; Johnson, Jessica; Chen, Hsiang-Cheng; Nelson, Sarah; Haynes, Carol; Gregory, Simon G.; Kraus, Virginia B.; Shah, Svati H.			Genome-Wide Linkage Analysis of Cardiovascular Disease Biomarkers in a Large, Multigenerational Family	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; C-REACTIVE-PROTEIN; BODY-MASS INDEX; SUSCEPTIBILITY LOCI; COMMON VARIANTS; GENETIC-LINKAGE; HEART-DISEASE; RECEPTOR GENE; FOLLOW-UP; SCAN	Given the importance of cardiovascular disease (CVD) to public health and the demonstrated heritability of both disease status and its related risk factors, identifying the genetic variation underlying these susceptibilities is a critical step in understanding the pathogenesis of CVD and informing prevention and treatment strategies. Although one can look for genetic variation underlying susceptibility to CVD per se, it can be difficult to define the disease phenotype for such a qualitative analysis and CVD itself represents a convergence of diverse etiologic pathways. Alternatively, one can study the genetics of intermediate traits that are known risk factors for CVD, which can be measured quantitatively. Using the latter strategy, we have measured 21 cardiovascular-related biomarkers in an extended multigenerational pedigree, the CARRIAGE family (Carolinas Region Interaction of Aging, Genes, and Environment). These biomarkers belong to inflammatory and immune, connective tissue, lipid, and hemostasis pathways. Of these, 18 met our quality control standards. Using the pedigree and biomarker data, we have estimated the broad sense heritability (H2) of each biomarker (ranging from 0.09-0.56). A genome-wide panel of 6,015 SNPs was used subsequently to map these biomarkers as quantitative traits. Four showed noteworthy evidence for linkage in multipoint analysis (LOD score >= 2.6): paraoxonase (chromosome 8p11, 21), the chemokine RANTES (22q13.33), matrix metalloproteinase 3 (MMP3, 17p13.3), and granulocyte colony stimulating factor (GCSF, 8q22.1). Identifying the causal variation underlying each linkage score will help to unravel the genetic architecture of these quantitative traits and, by extension, the genetic architecture of cardiovascular risk.	[Nolan, Daniel; Hauser, Elizabeth; Li, Yi-Ju; Johnson, Jessica; Haynes, Carol; Gregory, Simon G.; Shah, Svati H.] Duke Univ, Ctr Human Genet, Durham, NC 27706 USA; [Kraus, William E.; Thompson, Dana K.; Kraus, Virginia B.; Shah, Svati H.] Duke Univ, Dept Med, Durham, NC USA; [Chen, Hsiang-Cheng] Triserv Gen Hosp, Div Rheumatol Immunol & Allergy, Taipei, Taiwan; [Nelson, Sarah] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Duke University; Duke University; Tri-Service General Hospital; University of Washington; University of Washington Seattle	Shah, SH (corresponding author), Duke Univ, Ctr Human Genet, Durham, NC 27706 USA.	svati.shah@duke.edu	Chen, Hsiang-Cheng/O-1312-2016; Chen, Hsiang-Cheng/CAG-3864-2022; Chen, Hsiang-Cheng/AGQ-6364-2022; Nelson, Sarah Catherine/AAN-9814-2020	Chen, Hsiang-Cheng/0000-0002-0753-6161; Chen, Hsiang-Cheng/0000-0002-0753-6161; Chen, Hsiang-Cheng/0000-0002-0753-6161; Nelson, Sarah Catherine/0000-0002-2109-6465; Gregory, Simon/0000-0002-7805-1743; Li, Yi-Ju/0000-0001-6996-4834; Nolan, Daniel/0000-0003-3584-6148; Kraus, William E/0000-0003-1930-9684; Hauser, Elizabeth/0000-0003-0367-9189; Johnson, Jessica/0000-0002-4519-3120	National Institutes of Health (NIH) National Institutes on Aging [P30AG028716-01, R01HL095987-01]; Hartford Center award; Mary Duke Biddle Foundation; Trent Foundation; NIH NHLBI [P01-HL036587]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095987, P01HL036587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institutes on Aging; Hartford Center award; Mary Duke Biddle Foundation; Trent Foundation; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by National Institutes of Health (NIH) National Institutes on Aging grant P30AG028716-01 (Cohen), R01HL095987-01 (SHS), Hartford Center award (SHS), Mary Duke Biddle Foundation, and the Trent Foundation, NIH NHLBI P01-HL036587 (Williams). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg K, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-107; Abilleira S, 2006, J MED GENET, V43, P897, DOI 10.1136/jmg.2006.040808; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Bell JT, 2006, HUM MOL GENET, V15, P1365, DOI 10.1093/hmg/ddl058; Benjamin EJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S11; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bielinski SJ, 2007, GENES IMMUN, V8, P684, DOI 10.1038/sj.gene.6364434; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Bosse Y, 2003, CIRCULATION, V107, P2361, DOI 10.1161/01.CIR.0000065577.60129.F5; Chen HC, 2010, ARTHRITIS RHEUM-US, V62, P781, DOI 10.1002/art.27288; Ciullo M, 2006, HUM MOL GENET, V15, P1735, DOI 10.1093/hmg/ddl097; Condra JA, 2007, PSYCHIAT GENET, V17, P292, DOI 10.1097/YPG.0b013e3281ac2345; Cukier HN, 2009, AUTISM RES, V2, P258, DOI 10.1002/aur.96; Dai F, 2008, ANN HUM GENET, V72, P780, DOI 10.1111/j.1469-1809.2008.00462.x; Dupuis J, 2005, ATHEROSCLEROSIS, V182, P307, DOI 10.1016/j.atherosclerosis.2005.02.015; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Fox ER, 2008, AM J CARDIOL, V102, P835, DOI 10.1016/j.amjcard.2008.05.049; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Hartikainen JM, 2005, CANCER EPIDEM BIOMAR, V14, P75; Heath SC, 1997, J COMPUT BIOL, V4, P505, DOI 10.1089/cmb.1997.4.505; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Jiang Y, 2004, AM J HUM GENET, V75, P220, DOI 10.1086/422699; Kim SH, 2004, DIABETES, V53, P1375, DOI 10.2337/diabetes.53.5.1375; KOJIMA H, 2010, BLOOD, P20239; Lakka TA, 2006, PHYSIOL GENOMICS, V27, P103, DOI 10.1152/physiolgenomics.00054.2005; Liu X, 2011, PROSTATE, V71, P682, DOI 10.1002/pros.21284; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; Mayosi BM, 2008, EUR HEART J, V29, P525, DOI 10.1093/eurheartj/ehn028; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MCELVEEN J, 1986, CLIN CHEM, V32, P671; Meyre D, 2004, DIABETES, V53, P803, DOI 10.2337/diabetes.53.3.803; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Pattaro C, 2009, KIDNEY INT, V76, P297, DOI 10.1038/ki.2009.135; Peacock M, 2009, BONE, V45, P443, DOI 10.1016/j.bone.2009.05.002; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rainwater DL, 2009, HEREDITY, V102, P147, DOI 10.1038/hdy.2008.110; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ruchat SM, 2008, J HUM GENET, V53, P629, DOI 10.1007/s10038-008-0291-1; Rybicki BA, 2011, GENES IMMUN, V12, P67, DOI 10.1038/gene.2010.56; Sammalisto S, 2005, J MED GENET, V42, P932, DOI 10.1136/jmg.2005.031278; Sanghera DK, 1998, AM J HUM GENET, V62, P36, DOI 10.1086/301669; Schonberger J, 2005, HUM GENET, V118, P451, DOI 10.1007/s00439-005-0064-2; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Simonic I, 2001, AM J MED GENET, V105, P163, DOI 10.1002/ajmg.1192; Thomis MA, 2011, SCAND J MED SCI SPOR, V21, P580, DOI 10.1111/j.1600-0838.2009.01082.x; Ukkola O, 2002, J CLIN ENDOCR METAB, V87, P3708, DOI 10.1210/jc.87.8.3708; VORUGANTI VS, 2011, OBESITY SILVER SPRIN, V20, P1122; Winnier DA, 2006, HUM BIOL, V78, P341, DOI 10.1353/hub.2006.0050; Wu XD, 2002, AM J HUM GENET, V70, P1247, DOI 10.1086/340362; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x; Zintzaras E, 2007, HYPERTENSION, V50, P557, DOI 10.1161/HYPERTENSIONAHA.107.090316; Zintzaras E, 2006, J HUM GENET, V51, P1015, DOI 10.1007/s10038-006-0053-x	58	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71779	10.1371/journal.pone.0071779	http://dx.doi.org/10.1371/journal.pone.0071779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936524	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800067
J	Mokuda, S; Murata, Y; Sawada, N; Matoba, K; Yamada, A; Onishi, M; Okuda, Y; Jouyama, K; Sugiyama, E; Takasugi, K				Mokuda, Sho; Murata, Yosuke; Sawada, Naoya; Matoba, Kenichiro; Yamada, Akihiro; Onishi, Makoto; Okuda, Yasuaki; Jouyama, Kazuo; Sugiyama, Eiji; Takasugi, Kiyoshi			Tocilizumab Induced Acquired Factor XIII Deficiency in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							COAGULATION FACTOR-XIII; BLOOD-COAGULATION; B-SUBUNIT; FIBRINOLYSIS; IL-6	Factor XIII is one of the twelve coagulation factors and also known as a fibrin-stabilizing factor. In 2012, we encountered a male RA patient with hemorrhagic factor XIII deficiency who had been treated with tocilizumab for two years. There are few reports regarding the relationship between tocilizumab (a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R)) and factor XIII. We measured the factor XIII activity levels in the plasma of 40 RA patients (10 patients treated without biologics, 30 patients treated with biologics (15 patients treated with necrosis factor inhibitors and 15 patients treated with tocilizumab)) and 19 healthy controls. Consequently, the tocilizumab group exhibited lower levels than the other three groups according to the Steel-Dwass test (P < 0.01). Furthermore, we compared the plasma factor XIII activity levels and the plasma factor XIII concentrations in the RA patients treated with biologics. Pearson's correlation test was used to assess the relationship between the factor XIII activity levels and the plasma factor XIII concentrations (r = 0.449, P = 0.019). According to the multiple regression analysis, the treatment with tocilizumab is an independent risk factor for plasma factor XIII reduction in RA patients. In conclusion, RA patients treated with tocilizumab, an IL-6R blocker, are at risk of developing acquired factor XIII deficiency. The mechanisms underlying the reduced factor XIII activity observed in RA patients treated with tocilizumab may result from the quantitative reduction in the plasma. These data imply that IL-6 plays an important role in maintaining the factor XIII activity level.	[Mokuda, Sho; Sugiyama, Eiji] Hiroshima Univ Hosp, Dept Clin Immunol & Rheumatol, Hiroshima, Japan; [Mokuda, Sho; Murata, Yosuke; Sawada, Naoya; Matoba, Kenichiro; Yamada, Akihiro; Onishi, Makoto; Okuda, Yasuaki; Jouyama, Kazuo; Takasugi, Kiyoshi] Dohgo Spa Hosp, Ctr Rheumat Dis, Dept Internal Med, Matsuyama, Ehime, Japan	Hiroshima University	Mokuda, S (corresponding author), Hiroshima Univ Hosp, Dept Clin Immunol & Rheumatol, Hiroshima, Japan.	bachblau_since2001@yahoo.co.jp						ADANY R, 1987, BRIT J HAEMATOL, V67, P167, DOI 10.1111/j.1365-2141.1987.tb02321.x; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; FICKENSCHER K, 1991, THROMB HAEMOSTASIS, V65, P535; GRUNDMANN U, 1986, P NATL ACAD SCI USA, V83, P8024, DOI 10.1073/pnas.83.21.8024; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P4633, DOI 10.1021/bi00364a027; Ichinose A, 2001, THROMB HAEMOSTASIS, V86, P57; Ichinose A, 2012, INT J HEMATOL, V95, P362, DOI 10.1007/s12185-012-1064-3; Ivaskevicius V, 2010, HAEMOPHILIA, V16, P675, DOI 10.1111/j.1365-2516.2010.02207.x; Koike T, 2011, ANN RHEUM DIS, V70, P2148, DOI 10.1136/ard.2011.151092; Komaromi I, 2011, J THROMB HAEMOST, V9, P9, DOI 10.1111/j.1538-7836.2010.04070.x; Koseki S, 2001, BLOOD, V97, P2667, DOI 10.1182/blood.V97.9.2667; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Lovejoy AE, 2006, BLOOD, V108, P57, DOI 10.1182/blood-2005-02-0788; Luo YY, 2011, HAEMOPHILIA, V17, P393, DOI 10.1111/j.1365-2516.2010.02459.x; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Matsuoka M, 2012, INT J HEMATOL, V96, P781, DOI 10.1007/s12185-012-1191-x; MUSZBEK L, 1985, THROMB RES, V37, P401, DOI 10.1016/0049-3848(85)90069-6; Muszbek L, 1999, THROMB RES, V94, P271, DOI 10.1016/S0049-3848(99)00023-7; Muszbek L., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P190, DOI 10.2174/187152508784871990; NAGY JA, 1986, BLOOD, V68, P1272; Nguyen MT, 2013, BMJ CASE REP; Nishimoto N, 2004, CURR OPIN PHARMACOL, V4, P386, DOI 10.1016/j.coph.2004.03.005; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Sarvary A, 2004, CELL IMMUNOL, V228, P81, DOI 10.1016/j.cellimm.2004.04.007; van de Sande MG, 2012, RHEUMATOLOGY, V51, P7; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763	26	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69944	10.1371/journal.pone.0069944	http://dx.doi.org/10.1371/journal.pone.0069944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936360	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400028
J	Myers, FB; Henrikson, RH; Bone, J; Lee, LP				Myers, Frank B.; Henrikson, Richard H.; Bone, Jennifer; Lee, Luke P.			A Handheld Point-of-Care Genomic Diagnostic System	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; MYCOBACTERIUM-TUBERCULOSIS; RAPID DETECTION; GLOBAL HEALTH; MICROSCOPY; LAMP; RESISTANCE; PCR	The rapid detection and identification of infectious disease pathogens is a critical need for healthcare in both developed and developing countries. As we gain more insight into the genomic basis of pathogen infectivity and drug resistance, point-of-care nucleic acid testing will likely become an important tool for global health. In this paper, we present an inexpensive, handheld, battery-powered instrument designed to enable pathogen genotyping in the developing world. Our Microfluidic Biomolecular Amplification Reader (mBAR) represents the convergence of molecular biology, microfluidics, optics, and electronics technology. The mBAR is capable of carrying out isothermal nucleic acid amplification assays with real-time fluorescence readout at a fraction of the cost of conventional benchtop thermocyclers. Additionally, the mBAR features cell phone data connectivity and GPS sample geotagging which can enable epidemiological surveying and remote healthcare delivery. The mBAR controls assay temperature through an integrated resistive heater and monitors real-time fluorescence signals from 60 individual reaction chambers using LEDs and phototransistors. Assays are carried out on PDMS disposable microfluidic cartridges which require no external power for sample loading. We characterize the fluorescence detection limits, heater uniformity, and battery life of the instrument. As a proof-of-principle, we demonstrate the detection of the HIV-1 integrase gene with the mBAR using the Loop-Mediated Isothermal Amplification (LAMP) assay. Although we focus on the detection of purified DNA here, LAMP has previously been demonstrated with a range of clinical samples, and our eventual goal is to develop a microfluidic device which includes on-chip sample preparation from raw samples. The mBAR is based entirely around open source hardware and software, and in the accompanying online supplement we present a full set of schematics, bill of materials, PCB layouts, CAD drawings, and source code for the mBAR instrument with the goal of spurring further innovation toward low-cost genetic diagnostics.	[Myers, Frank B.; Henrikson, Richard H.; Lee, Luke P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Myers, Frank B.; Henrikson, Richard H.; Lee, Luke P.] Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA; [Bone, Jennifer] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lee, LP (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	lplee@berkeley.edu	Lee, Luke/AAN-6695-2021		DSO of Defense Advanced Research Project Agency (DxOD project); Bill & Melinda Gates Foundation; NDSEG; Siebel Scholarship	DSO of Defense Advanced Research Project Agency (DxOD project); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NDSEG; Siebel Scholarship	This work was supported by the DSO of Defense Advanced Research Project Agency (DxOD project) and the Bill & Melinda Gates Foundation (Grand Challenges). Additional support was provided by the NDSEG fellowship and the Siebel Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2005, CLIN MICROBIOL INFEC, V11, P122, DOI 10.1111/j.1469-0691.2004.01034.x; Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Berg ES, 2013, PCR TECHNOLOGY: CURRENT INNOVATIONS, 3RD EDITION, P19; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Dimov IK, 2011, LAB CHIP, V11, P845, DOI [10.1039/c0lc00403k, 10.1039/c01c00403k]; Dimov IK, 2008, LAB CHIP, V8, P2071, DOI 10.1039/b812515e; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Eddings MA, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/6/067001; Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hosaka N, 2009, J VIROL METHODS, V157, P195, DOI 10.1016/j.jviromet.2009.01.004; Jung-Hao Wang, 2012, 2012 IEEE 25th International Conference on Micro Electro Mechanical Systems (MEMS), P961, DOI 10.1109/MEMSYS.2012.6170346; Liu DY, 1996, J AM CHEM SOC, V118, P1587, DOI 10.1021/ja952786k; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Myers FB, 2011, IEEE ENG MED BIO, P3668, DOI 10.1109/IEMBS.2011.6090619; Myers FB, 2008, LAB CHIP, V8, P2015, DOI 10.1039/b812343h; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Perkins M, 2006, DIAGNOSTICS TUBERCUL; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Poschl B, 2010, AM J TROP MED HYG, V83, P56, DOI 10.4269/ajtmh.2010.09-0630; Robertson BH, 2005, ANNU REV PUBL HEALTH, V26, P281, DOI 10.1146/annurev.publhealth.26.021304.144522; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Wilson PE, 2005, TRENDS PARASITOL, V21, P278, DOI 10.1016/j.pt.2005.04.007	28	68	70	1	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70266	10.1371/journal.pone.0070266	http://dx.doi.org/10.1371/journal.pone.0070266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936402	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400051
J	Nomura, K; Yonezawa, T; Mano, S; Kawakami, S; Shedlock, AM; Hasegawa, M; Amano, T				Nomura, Koh; Yonezawa, Takahiro; Mano, Shuhei; Kawakami, Shigehisa; Shedlock, Andrew M.; Hasegawa, Masami; Amano, Takashi			Domestication Process of the Goat Revealed by an Analysis of the Nearly Complete Mitochondrial Protein-Encoding Genes	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; CAPRA-HIRCUS; PHYLOGEOGRAPHIC STRUCTURE; DNA DIVERSITY; ORIGIN; POLYMORPHISM; SEQUENCES; SELECTION; TIME; COALESCENT	Goats (Capra hircus) are one of the oldest domesticated species, and they are kept all over the world as an essential resource for meat, milk, and fiber. Although recent archeological and molecular biological studies suggested that they originated in West Asia, their domestication processes such as the timing of population expansion and the dynamics of their selection pressures are little known. With the aim of addressing these issues, the nearly complete mitochondrial protein-encoding genes were determined from East, Southeast, and South Asian populations. Our coalescent time estimations suggest that the timing of their major population expansions was in the Late Pleistocene and significantly predates the beginning of their domestication in the Neolithic era (approximate to 10,000 years ago). The v (ratio of non-synonymous rate/synonymous substitution rate) for each lineage was also estimated. We found that the v of the globally distributed haplogroup A which is inherited by more than 90% of goats examined, turned out to be extremely low, suggesting that they are under severe selection pressure probably due to their large population size. Conversely, the v of the Asian-specific haplogroup B inherited by about 5% of goats was relatively high. Although recent molecular studies suggest that domestication of animals may tend to relax selective constraints, the opposite pattern observed in our goat mitochondrial genome data indicates the process of domestication is more complex than may be presently appreciated and cannot be explained only by a simple relaxation model.	[Nomura, Koh; Amano, Takashi] Tokyo Univ Agr, Fac Agr, Kanagawa, Japan; [Yonezawa, Takahiro; Hasegawa, Masami] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Yonezawa, Takahiro; Mano, Shuhei; Hasegawa, Masami] Inst Stat Math, Tokyo, Japan; [Kawakami, Shigehisa] Gunma Safari World Co Ltd, Gunma, Japan; [Shedlock, Andrew M.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Shedlock, Andrew M.] Med Univ S Carolina, Coll Grad Studies, Charleston, SC 29425 USA	Tokyo University of Agriculture; Fudan University; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; College of Charleston; Medical University of South Carolina	Yonezawa, T (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	cyclotis@gmail.com		Yonezawa, Takahiro/0000-0002-0012-1887	Advanced Research Project Type A, Tokyo University of Agriculture [02, 2006-2008]; Japan Society for Promotion of Science [19405043]; Grants-in-Aid for Scientific Research [25440219] Funding Source: KAKEN	Advanced Research Project Type A, Tokyo University of Agriculture; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was sponsored in part by the Advanced Research Project Type A, Tokyo University of Agriculture, No 02, 2006-2008, and the Grant-in Aid for Scientific Research (B) no. 19405043, 2007-2009 from Japan Society for Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 1996, J MOL EVOL, V42, P459; Amills M, 2009, ANIM GENET, V40, P315, DOI 10.1111/j.1365-2052.2008.01837.x; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bjornerfeldt S, 2006, GENOME RES, V16, P990, DOI 10.1101/gr.5117706; Carroll R. L., 1988, VERTEBRATE PALAEONTO; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; Dingle RV, 1998, J GEOL SOC LONDON, V155, P433, DOI 10.1144/gsjgs.155.3.0433; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Epstein H, 1984, EVOLUTION DOMESTICAT, P145; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fordyce R.E., 1989, Geological Society Special Publication, P269; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; Hassanin A, 2004, MOL PHYLOGENET EVOL, V33, P896, DOI 10.1016/j.ympev.2004.08.009; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2010, P NATL ACAD SCI USA, V107, P5382; Mannen H, 2001, BIOCHEM GENET, V39, P145, DOI 10.1023/A:1010266207735; MITCHELL ED, 1989, CAN J FISH AQUAT SCI, V46, P2219, DOI 10.1139/f89-273; Murata Y, 2009, GENE, V441, P176, DOI 10.1016/j.gene.2009.01.014; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; Nomura K, 2012, ANIM GENET, V43, P760, DOI 10.1111/j.1365-2052.2012.02334.x; OHTA T, 1992, GENETICS, V130, P917; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; OHTA T, 1990, GENETICS, V126, P219; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki T, 2005, SYST BIOL, V54, P77, DOI 10.1080/10635150590905939; Savage DE, 1983, MAMMALIAN PALEOFAUNA; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sultana S, 2003, ANIM GENET, V34, P417, DOI 10.1046/j.0268-9146.2003.01040.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Wang ZF, 2011, MOL BIOL EVOL, V28, P1553, DOI 10.1093/molbev/msq336; Williamson S, 2002, MOL BIOL EVOL, V19, P1376, DOI 10.1093/oxfordjournals.molbev.a004199; Wilson DE, 2011, HDB MAMMALS WORLD, V2, P719; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yonezawa T, 2007, GENE, V396, P1, DOI 10.1016/j.gene.2006.12.040; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; [No title captured]	57	34	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e67775	10.1371/journal.pone.0067775	http://dx.doi.org/10.1371/journal.pone.0067775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936295	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400006
J	Wong, EHM; Ng, CL; Lui, VCH; So, MT; Cherny, SS; Sham, PC; Tam, PKH; Garcia-Barcelo, MM				Wong, Emily H. M.; Ng, Chun-Laam; Lui, Vincent Chi-Hang; So, Man-ting; Cherny, Stacey S.; Sham, Pak-Chung; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce			Gene Network Analysis of Candidate Loci for Human Anorectal Malformations	PLOS ONE			English	Article							PLANAR CELL POLARITY; ZEBRAFISH; DEFECTS	Anorectal malformations (ARMs) are birth defects that require surgery and carry significant chronic morbidity. Our earlier genome-wide copy number variation (CNV) study had provided a wealth of candidate loci. To find out whether these candidate loci are related to important developmental pathways, we have performed an extensive literature search coupled with the currently available bioinformatics tools. This has allowed us to assign both genic and non-genic CNVs to interrelated pathways known to govern the development of the anorectal region. We have linked 11 candidate genes to the WNT signalling pathway and 17 genes to the cytoskeletal network. Interestingly, candidate genes with similar functions are disrupted by the same type of CNV. The gene network we discovered provides evidence that rare mutations in different interrelated genes may lead to similar phenotypes, accounting for genetic heterogeneity in ARMs. Classification of patients according to the affected pathway and lesion type should eventually improve the diagnosis and the identification of common genes/molecules as therapeutic targets.	[Wong, Emily H. M.; So, Man-ting; Cherny, Stacey S.; Sham, Pak-Chung; Tam, Paul Kwong-Hang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ng, Chun-Laam; Lui, Vincent Chi-Hang; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Lui, Vincent Chi-Hang; Sham, Pak-Chung; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Cherny, Stacey S.; Sham, Pak-Chung] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Garcia-Barcelo, MM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	mmgarcia@hku.hk	Cherny, Stacey S/B-3315-2008; /C-4405-2009; /C-4359-2009	Cherny, Stacey S/0000-0002-0269-3352; /0000-0001-6231-3035; /0000-0002-1758-8854	Hong Kong Research Grants Council [HKU 775608M]; HKU seed funding programme for basic research [200911159060]; University of Hong Kong Strategic Research Theme on Genomics	Hong Kong Research Grants Council(Hong Kong Research Grants Council); HKU seed funding programme for basic research; University of Hong Kong Strategic Research Theme on Genomics	This work was supported by the research grant from the Hong Kong Research Grants Council (HKU 775608M to PT) and the HKU seed funding programme for basic research (200911159060 to VCH). Support was also received from the University of Hong Kong Strategic Research Theme on Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Guo YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031489; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Li YH, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011014, 10.1371/journal.pone.0015219]; Li ZQ, 2012, J BIOL CHEM, V287, P13005, DOI 10.1074/jbc.M112.347419; Macdonald LJ, 2011, MOL HUM REPROD, V17, P626, DOI 10.1093/molehr/gar031; Mo R, 2001, AM J PATHOL, V159, P765, DOI 10.1016/S0002-9440(10)61747-6; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; Pyati UJ, 2006, DEVELOPMENT, V133, P2275, DOI 10.1242/dev.02388; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Wen J, 2010, J BIOL CHEM, V285, P11023, DOI 10.1074/jbc.M109.085381; Wong EH, 2012, HUM MOL GENET	14	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69142	10.1371/journal.pone.0069142	http://dx.doi.org/10.1371/journal.pone.0069142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936318	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400011
J	St-Pierre, J; Ostergaard, HL				St-Pierre, Joelle; Ostergaard, Hanne L.			A Role for the Protein Tyrosine Phosphatase CD45 in Macrophage Adhesion through the Regulation of Paxillin Degradation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INTEGRIN-MEDIATED ADHESION; ENDOTHELIAL-CELL APOPTOSIS; SRC-FAMILY KINASES; T-CELLS; B-CELL; CD4(+)CD8(+) THYMOCYTES; NEGATIVE REGULATION; CYTOKINE PRODUCTION; FOCAL ADHESIONS	CD45 is a protein tyrosine phosphatase expressed on all cells of hematopoietic origin that is known to regulate Src family kinases. In macrophages, the absence of CD45 has been linked to defects in adhesion, however the molecular mechanisms involved remain poorly defined. In this study, we show that bone marrow derived macrophages from CD45-deficient mice exhibit abnormal cell morphology and defective motility. These defects are accompanied by substantially decreased levels of the cytoskeletal-associated protein paxillin, without affecting the levels of other proteins. Degradation of paxillin in CD45-deficient macrophages is calpain-mediated, as treatment with a calpain inhibitor restores paxillin levels in these cells and enhances cell spreading. Inhibition of the tyrosine kinases proline-rich tyrosine kinase (Pyk2) and focal adhesion kinase (FAK), kinases that are capable of mediating tyrosine phosphorylation of paxillin, also restored paxillin levels, indicating a role for these kinases in the CD45-dependent regulation of paxillin. These data demonstrate that CD45 functions to regulate Pyk2/FAK activity, likely through the activity of Src family kinases, which in turn regulates the levels of paxillin to modulate macrophage adhesion and migration.	[Ostergaard, Hanne L.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Ostergaard, HL (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	hanne.ostergaard@ualberta.ca		St-Pierre, Joelle/0000-0002-7393-4950	Canadian Cancer Society [01711]; Alberta Innovates - Health Solutions	Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Innovates - Health Solutions	This Research was funded by the Canadian Cancer Society (http://cancer.ca/Research.aspx) grant # 01711. HLO was supported by a Scientist Award from Alberta Innovates - Health Solutions (http://www.aihealthsolutions.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achuthan A, 2006, CELL SIGNAL, V18, P2252, DOI 10.1016/j.cellsig.2006.05.007; Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; ARROYO AG, 1994, J CELL BIOL, V126, P1277, DOI 10.1083/jcb.126.5.1277; Ashwell JD, 1999, IMMUNOL TODAY, V20, P412, DOI 10.1016/S0167-5699(99)01505-4; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Bijian K, 2007, MOL IMMUNOL, V44, P3682, DOI 10.1016/j.molimm.2007.04.005; Blaylock MG, 1999, J ALLERGY CLIN IMMUN, V104, P1244, DOI 10.1016/S0091-6749(99)70020-5; BRISSETTE WH, 1995, CYTOKINE, V7, P291, DOI 10.1006/cyto.1995.0035; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; Chay KO, 2002, J BIOL CHEM, V277, P14521, DOI 10.1074/jbc.M111639200; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; D'Oro U, 1999, J IMMUNOL, V162, P1879; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deszo EL, 2001, J BIOL CHEM, V276, P10212, DOI 10.1074/jbc.M010589200; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N; Dupere-Minier G, 2010, APOPTOSIS, V15, P1, DOI 10.1007/s10495-009-0413-z; FALK LA, 1988, J LEUKOCYTE BIOL, V43, P471, DOI 10.1002/jlb.43.5.471; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Ferguson BV, 2010, IMMUNOBIOLOGY, V215, P458, DOI 10.1016/j.imbio.2009.08.005; Fernandis AZ, 2003, J BIOL CHEM, V278, P9536, DOI 10.1074/jbc.M211803200; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Harrington EO, 2001, AM J PHYSIOL-LUNG C, V280, pL342, DOI 10.1152/ajplung.2001.280.2.L342; Hatch WC, 1998, BLOOD, V91, P3967, DOI 10.1182/blood.V91.10.3967.3967_3967_3973; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Herzog H, 1996, GENOMICS, V32, P484, DOI 10.1006/geno.1996.0149; Hesslein DGT, 2006, P NATL ACAD SCI USA, V103, P7012, DOI 10.1073/pnas.0601851103; Hiregowdara D, 1997, J BIOL CHEM, V272, P10804; Klaus SJ, 1996, J IMMUNOL, V156, P2743; Korade-Mirnics Z, 2000, J LEUKOCYTE BIOL, V68, P603; Kuranaga Erina, 2007, Tanpakushitsu Kakusan Koso, V52, P1337; Lesage S, 1997, J IMMUNOL, V159, P4762; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; Li RH, 2001, J BIOL CHEM, V276, P28767, DOI 10.1074/jbc.M100158200; Li X, 1997, J BIOL CHEM, V272, P14341, DOI 10.1074/jbc.272.22.14341; Liu XL, 2003, J PHARMACOL EXP THER, V304, P63, DOI 10.1124/jpet.102.043406; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; OGIMOTO M, 1994, INT IMMUNOL, V6, P647, DOI 10.1093/intimm/6.4.647; Ogimoto M, 2001, FEBS LETT, V490, P97, DOI 10.1016/S0014-5793(00)02416-9; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Roach J, 1998, GENE, V208, P117, DOI 10.1016/S0378-1119(97)00609-4; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Roach TIA, 1998, CURR BIOL, V8, P1035, DOI 10.1016/S0960-9822(07)00426-5; Robertson LK, 2011, J IMMUNOL, V187, P5824, DOI 10.4049/jimmunol.1003690; Robertson LK, 2005, J IMMUNOL, V175, P8138, DOI 10.4049/jimmunol.175.12.8138; Romanova LY, 2011, CELL ADHES MIGR, V5, P457, DOI 10.4161/cam.5.6.18219; Romanova LY, 2004, J CELL SCI, V117, P3759, DOI 10.1242/jcs.01206; Rose DM, 2006, EXP MOL MED, V38, P191, DOI 10.1038/emm.2006.23; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Shenoi H, 1999, J IMMUNOL, V162, P7120; Shim SR, 2001, BIOCHEM BIOPH RES CO, V286, P601, DOI 10.1006/bbrc.2001.5441; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 2000, J CELL SCI, V113, P4139; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; WENG ZG, 1993, J BIOL CHEM, V268, P14956; Wong NKY, 2008, J IMMUNOL, V181, P7033, DOI 10.4049/jimmunol.181.10.7033; Wong NKY, 2011, CELL SIGNAL, V23, P812, DOI 10.1016/j.cellsig.2011.01.003; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; Zhang M, 2005, J IMMUNOL, V174, P1479, DOI 10.4049/jimmunol.174.3.1479; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	88	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e71531	10.1371/journal.pone.0071531	http://dx.doi.org/10.1371/journal.pone.0071531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936270	Green Submitted, gold, Green Published			2022-12-27	WOS:000322633700086
J	Huang, CJ; Wu, CF; Lan, CY; Sung, FY; Lin, CL; Liu, CJ; Liu, HF; Yu, MW				Huang, Chi-Jung; Wu, Chih-Feng; Lan, Chia-Ying; Sung, Feng-Yu; Lin, Chih-Lin; Liu, Chun-Jen; Liu, Hsin-Fu; Yu, Ming-Whei			Impact of Genetic Heterogeneity in Polymerase of Hepatitis B Virus on Dynamics of Viral Load and Hepatitis B Progression	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ANTIGEN SEROCONVERSION; MOLECULAR VIROLOGY; NATURAL-HISTORY; INFECTION; EVOLUTION; POPULATION; MUTATIONS; ADAPTATION; GENOTYPE	Objective: The hepatitis B virus (HBV)-polymerase region overlaps pre-S/S genes with high epitope density and plays an essential role in viral replication. We investigated whether genetic variation in the polymerase region determined long-term dynamics of viral load and the risk of hepatitis B progression in a population-based cohort study. Methods: We sequenced the HBV-polymerase region using baseline plasma from treatment-naive individuals with HBV-DNA levels >= 1000 copies/mL in a longitudinal viral-load study of participants with chronic HBV infection followed-up for 17 years, and obtained sequences from 575 participants (80% with HBV genotype Ba and 17% with Ce). Results: Patterns of viral sequence diversity across phases (i.e., immune-tolerant, immune-clearance, non/low replicative, and hepatitis B e antigen (HBeAg)-negative hepatitis phases) of HBV-infection, which were associated with viral and clinical features at baseline and during follow-up, were similar between HBV genotypes, despite greater diversity for genotype Ce vs. Ba. Irrespective of genotypes, however, HBeAg-negative participants had 1.5-to-2-fold higher levels of sequence diversity than HBeAg-positive participants (P<0.0001). Furthermore, levels of viral genetic divergence from the population consensus sequence, estimated by numbers of nucleotide substitutions, were inversely associated with long-term viral load even in HBeAg-negative participants. A mixed model developed through analysis of the entire HBV-polymerase region identified 153 viral load-associated single nucleotide polymorphisms in overall and 136 in HBeAg-negative participants, with distinct profiles between HBV genotypes. These polymorphisms were most evident at sites within or flanking T-cell epitopes. Seven polymorphisms revealed associations with both enhanced viral load and a more than 4-fold increased risk of hepatocellular carcinoma and/or liver cirrhosis. Conclusions: The data highlight a role of viral genetic divergence in the natural course of HBV-infection. Interindividual differences in the long-term dynamics of viral load is not only associated with accumulation of mutations in HBV-polymerase region, but differences in specific viral polymorphisms which differ between genotypes.	[Huang, Chi-Jung; Wu, Chih-Feng; Lan, Chia-Ying; Sung, Feng-Yu; Yu, Ming-Whei] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Chih-Lin] Taipei City Hosp, Ren Ai Branch, Dept Gastroenterol, Taipei, Taiwan; [Liu, Chun-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei 100, Taiwan; [Liu, Chun-Jen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan	National Taiwan University; Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Mackay Memorial Hospital	Yu, MW (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	yumw@ntu.edu.tw	Liu, Hsin-Fu/AAR-5960-2020	Liu, Hsin-Fu/0000-0003-0082-2269; LIU, CHUN-JEN/0000-0002-6202-0993; Yu, Ming-Whei/0000-0002-8371-6236	National Science Council, Taiwan [NSC 98-2628-B-002-089-MY3, NSC 100-2325-B-002-025, NSC 101-2314-B-002-077]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants NSC 98-2628-B-002-089-MY3, NSC 100-2325-B-002-025 and NSC 101-2314-B-002-077 from the National Science Council, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Chou YC, 2008, GUT, V57, P91, DOI 10.1136/gut.2006.114066; Desmond CP, 2008, ANTIVIR THER, V13, P161; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Huang HH, 2011, GUT, V60, P99, DOI 10.1136/gut.2010.207670; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lim SG, 2007, GASTROENTEROLOGY, V133, P951, DOI 10.1053/j.gastro.2007.06.011; Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Merani S, 2011, HEPATOLOGY, V53, P396, DOI 10.1002/hep.24076; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Ngo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002573; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Ramachandran S, 2011, J VIROL, V85, P6369, DOI 10.1128/JVI.02204-10; Rauch A, 2009, HEPATOLOGY, V50, P1017, DOI 10.1002/hep.23101; Sung FY, 2009, GASTROENTEROLOGY, V137, P1687, DOI 10.1053/j.gastro.2009.07.063; Tester I, 2005, J EXP MED, V201, P1725, DOI 10.1084/jem.20042284; Thompson A, 2007, GASTROENTEROLOGY, V133, P1031, DOI 10.1053/j.gastro.2007.07.038; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-5; Volz T, 2007, GASTROENTEROLOGY, V133, P843, DOI 10.1053/j.gastro.2007.06.057; Wu CF, 2008, CARCINOGENESIS, V29, P106, DOI 10.1093/carcin/bgm252; Wu SA, 2011, J HEPATOL, V54, P19, DOI 10.1016/j.jhep.2010.06.018; YAMAMOTO K, 1994, J VIROL, V68, P2671, DOI 10.1128/JVI.68.4.2671-2676.1994; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Yuen MF, 2003, GUT, V52, P416, DOI 10.1136/gut.52.3.416	31	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70169	10.1371/journal.pone.0070169	http://dx.doi.org/10.1371/journal.pone.0070169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936156	Green Submitted, gold, Green Published			2022-12-27	WOS:000323114200059
J	Jensen, K; Brusletto, BS; Aass, HCD; Olstad, OK; Kierulf, P; Gautvik, KM				Jensen, Kristin; Brusletto, Berit Sletbakk; Aass, Hans Christian Dalsbotten; Olstad, Ole K.; Kierulf, Peter; Gautvik, Kaare M.			Transcriptional Profiling of mRNAs and microRNAs in Human Bone Marrow Precursor B Cells Identifies Subset- and Age-Specific Variations	PLOS ONE			English	Article							MICROENVIRONMENTAL CHANGES; PROGENITOR CELLS; EXPRESSION; BINDING; MICE; DIFFERENTIATION; LEUKEMIA; GENERATION; PROTEINS; LINEAGE	Background: Molecular mechanisms explaining age-related changes in the bone marrow with reduced precursor B cell output are poorly understood. Methods: We studied the transcriptome of five precursor B cell subsets in individual bone marrow samples from 4 healthy children and 4 adults employing GeneChip (R) Human Exon 1.0 ST Arrays (Affymetrix (R)) and TaqMan (R) Array MicroRNA Cards (Life Technologies (TM)). Results: A total of 1796 mRNAs (11%) were at least once differentially expressed between the various precursor B cell subsets in either age group (FDR 0.1%, p <= 1.13x10(-4)) with more marked cell stage specific differences than those related to age. In contrast, microRNA profiles of the various precursor B cell subsets showed less hierarchical clustering as compared to the corresponding mRNA profiles. However, 17 of the 667 microRNA assays (2.5%) were at least once differentially expressed between the subsets (FDR 10%, p <= 0.004). From target analysis (Ingenuity (R) Systems), functional assignment between postulated interacting mRNAs and microRNAs showed especially association to cellular growth, proliferation and cell cycle regulation. One functional network connected up-regulation of the differentiation inhibitor ID2 mRNA to downregulation of the hematopoiesis- or cell cycle regulating miR-125b-5p, miR-181a-5p, miR-196a-5p, miR-24-3p and miR-320d in adult PreBII large cells. Noteworthy was also the stage-dependent expression of the growth promoting miR-17-92 cluster, showing a partly inverse trend with age, reaching statistical significance at the PreBII small stage (up 3.1-12.9 fold in children, p = 0.0084-0.0270). Conclusions: The global mRNA profile is characteristic for each precursor B cell developmental stage and largely similar in children and adults. The microRNA profile is much cell stage specific and not changing much with age. Importantly, however, specific age-dependent differences involving key networks like differentiation and cellular growth may indicate biological divergence and possibly also altered production potential with age.	[Jensen, Kristin; Brusletto, Berit Sletbakk; Aass, Hans Christian Dalsbotten; Olstad, Ole K.; Kierulf, Peter; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Jensen, Kristin] Oslo Univ Hosp, Dept Pediat, Oslo, Norway; [Gautvik, Kaare M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Jensen, K (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.	kristin.jensen@medisin.uio.no		Brusletto, Berit Sletbakk/0000-0002-1042-1365	Torsteds legat; Rakel og Otto Kr. Bruuns legat; Olav Raagholt og Gerd Meidel Raagholts stiftelse for forskning	Torsteds legat; Rakel og Otto Kr. Bruuns legat; Olav Raagholt og Gerd Meidel Raagholts stiftelse for forskning	This work was supported by Torsteds legat, http://www.legatsiden.no/innhold/visettlegat.php?id = 2298; Rakel og Otto Kr. Bruuns legat, http://www.legatsiden.no/innhold/visettlegat.php?id = 2939; and Olav Raagholt og Gerd Meidel Raagholts stiftelse for forskning, http://www.raagholtstiftelsen.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter-Wolf S, 2009, J IMMUNOL, V182, P138, DOI 10.4049/jimmunol.182.1.138; Arnold CP, 2011, GENOME RES, V21, P798, DOI 10.1101/gr.111385.110; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fernando TR, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-7; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Frasca D, 2003, FRONT BIOSCI, V8, pA110, DOI 10.2741/1059; Frasca D, 2003, J IMMUNOL, V170, P719, DOI 10.4049/jimmunol.170.2.719; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Frasca D, 2011, AGING DIS, V2, P361; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Jensen K, 2010, PEDIATR HEMAT ONCOL, V27, P31, DOI 10.3109/08880010903420687; King RL, 2009, HUM PATHOL, V40, P1699, DOI 10.1016/j.humpath.2009.05.003; KIRSHENBAUM AS, 1992, J IMMUNOL, V148, P772; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kong KY, 2010, EXP HEMATOL, V38, P629, DOI 10.1016/j.exphem.2010.04.004; Labrie JE, 2005, SEMIN IMMUNOL, V17, P347, DOI 10.1016/j.smim.2005.05.012; Labrie JE, 2004, J EXP MED, V200, P411, DOI 10.1084/jem.20040845; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Li YM, 2012, BLOOD, V119, P4486, DOI 10.1182/blood-2011-09-378687; Li ZJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1681; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melamed D, 2012, BLOOD, V120, P4143, DOI 10.1182/blood-2012-07-444711; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Spierings DC, 2011, BLOOD, V117, P5340, DOI 10.1182/blood-2010-10-316034; Van der Put E, 2004, J IMMUNOL, V173, P818, DOI 10.4049/jimmunol.173.2.818; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	45	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70721	10.1371/journal.pone.0070721	http://dx.doi.org/10.1371/journal.pone.0070721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936243	gold, Green Submitted, Green Published			2022-12-27	WOS:000323114200102
J	Lamontagne, M; Couture, C; Postma, DS; Timens, W; Sin, DD; Pare, PD; Hogg, JC; Nickle, D; Laviolette, M; Bosse, Y				Lamontagne, Maxime; Couture, Christian; Postma, Dirkje S.; Timens, Wim; Sin, Don D.; Pare, Peter D.; Hogg, James C.; Nickle, David; Laviolette, Michel; Bosse, Yohan			Refining Susceptibility Loci of Chronic Obstructive Pulmonary Disease with Lung eqtls	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; COPD; SMOKING; POLYMORPHISMS; TISSUE	Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of mortality worldwide. Recent genome-wide association studies (GWAS) have identified robust susceptibility loci associated with COPD. However, the mechanisms mediating the risk conferred by these loci remain to be found. The goal of this study was to identify causal genes/variants within susceptibility loci associated with COPD. In the discovery cohort, genome-wide gene expression profiles of 500 non-tumor lung specimens were obtained from patients undergoing lung surgery. Blood-DNA from the same patients were genotyped for 1,2 million SNPs. Following genotyping and gene expression quality control filters, 409 samples were analyzed. Lung expression quantitative trait loci (eQTLs) were identified and overlaid onto three COPD susceptibility loci derived from GWAS; 4q31 (HHIP), 4q22 (FAM13A), and 19q13 (RAB4B, EGLN2, MIA, CYP2A6). Significant eQTLs were replicated in two independent datasets (n = 363 and 339). SNPs previously associated with COPD and lung function on 4q31 (rs1828591, rs13118928) were associated with the mRNA expression of HHIP. An association between mRNA expression level of FAM13A and SNP rs2045517 was detected at 4q22, but did not reach statistical significance. At 19q13, significant eQTLs were detected with EGLN2. In summary, this study supports HHIP, FAM13A, and EGLN2 as the most likely causal COPD genes on 4q31, 4q22, and 19q13, respectively. Strong lung eQTL SNPs identified in this study will need to be tested for association with COPD in case-control studies. Further functional studies will also be needed to understand the role of genes regulated by disease-related variants in COPD.	[Lamontagne, Maxime; Couture, Christian; Laviolette, Michel; Bosse, Yohan] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res, Inst Dept Pulmonol, Groningen, Netherlands; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Dept Pathol & Med Biol, Groningen, Netherlands; [Sin, Don D.; Pare, Peter D.; Hogg, James C.] Univ British Columbia, St Pauls Hosp, James Hogg Res Ctr, Ctr Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Sin, Don D.; Pare, Peter D.] Univ British Columbia, Div Resp, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Hogg, James C.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Nickle, David] Merck & Co Inc, Rahway, NJ 07065 USA; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada	Laval University; University of Groningen; University of Groningen; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; University of British Columbia; Merck & Company; Laval University	Bosse, Y (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.	yohan.bosse@criucpq.ulaval.ca	Sin, Don/AAC-2219-2021; Nickle, David/ABF-2727-2020; Timens, Wim/K-5570-2013; Pare, Peter D/C-7425-2011	Timens, Wim/0000-0002-4146-6363; Lamontagne, Maxime/0000-0001-6674-4983	Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS	Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS	YB is a research scholar from the Heart and Stroke Foundation of Canada. This study was partly supported by the Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval, the Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec, and the Respiratory Health Network of the FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JC, 1976, JAMA-J AM MED ASSOC, V235, P1975; [Anonymous], 2008, WORLD HLTH STAT 2008; Bosse Y, 2010, WEBMEDCENTRAL, V1; Bosse Y, 2012, INT J CHRONIC OBSTR, V7, P607, DOI 10.2147/COPD.S35294; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Bosse Y, 2009, PHARMACOGENOMICS, V10, P655, DOI 10.2217/PGS.09.10; Celedon JC, 2004, HUM MOL GENET, V13, P1649, DOI 10.1093/hmg/ddh171; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Curjuric I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040175; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Fukuda I, 1998, J MED SYST, V22, P89, DOI 10.1023/A:1022643102208; GANROT PO, 1967, SCAND J CLIN LAB INV, V19, P205, DOI 10.3109/00365516709090627; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Ito M, 2008, INTERNAL MED, V47, P1387, DOI 10.2169/internalmedicine.47.1116; KUEPPERS F, 1977, AM J MED, V63, P336, DOI 10.1016/0002-9343(77)90270-4; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mannino David M, 2002, Respir Care, V47, P1184; Marciniuk DD, 2012, CAN RESPIR J, V19, P109, DOI 10.1155/2012/920918; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Nguyen JDU, SUSCEPTIBILITY UNPUB; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024395; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; van Durme YMTA, 2010, EUR RESPIR J, V36, P89, DOI 10.1183/09031936.00129509; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429	38	49	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70220	10.1371/journal.pone.0070220	http://dx.doi.org/10.1371/journal.pone.0070220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936167	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200065
J	Ota, K; Jaiswal, MK; Ramu, S; Jeyendran, R; Kwak-Kim, J; Gilman-Sachs, A; Beaman, KD				Ota, Kuniaki; Jaiswal, Mukesh Kumar; Ramu, Sivakumar; Jeyendran, Rajasinjham; Kwak-Kim, Joanne; Gilman-Sachs, Alice; Beaman, Kenneth D.			Expression of a2 Vacuolar ATPase in Spermatozoa is Associated with Semen Quality and Chemokine-Cytokine Profiles in Infertile Men	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; V-ATPASE; SEMINAL PLASMA; MONOCYTE CHEMOATTRACTANT; SPERM MORPHOLOGY; IMMUNE-SYSTEM; H+-ATPASE; ISOFORM; CELLS; LOCALIZATION	Background: A number of laboratory tests have been developed to determine properties of spermatozoa quality but few have been adopted into routine clinical use in place of the WHO semen analysis. We investigated whether Atp6v0a2 (a2 isoform of vacuolar ATPase) is associated with abnormal semen quality and changes in chemokine-cytokine profiles in infertile men. Patients and Methods: Semen samples were collected from 35 healthy donors and 35 infertile men at the Andrology laboratory from August 2011 to June 2012. The levels of Atp6v0a2 mRNA and protein, and its localization in spermatozoa were determined. a2NTD (the N-terminal portion of Atp6v0a2) and secreted chemokine-cytokine profiles in seminal fluid were measured. Results: Atp6v0a2 protein (P<0.05) and mRNA (P<0.05) in spermatozoa from infertile men were significantly lower than those from fertile men. Fluorescent microscopy revealed that Atp6v0a2 is mainly expressed in the acrosomal region. Infertile men's seminal fluid had significantly lower G-CSF (P<0.01), GM-CSF (P<0.01), MCP-1 (P<0.05), MIP-1 alpha (P<0.01) and TGF-beta 1 (P<0.01) levels when compared to the seminal fluid from fertile men. Seminal fluid a2NTD levels were significantly correlated with G-CSF (P<0.01), GM-CSF (P<0.01), MCP-1 (P<0.05), MIP-1 alpha (P<0.01) and TGF-beta 1 (P<0.01) which are key molecules during the onset of pregnancy. Conclusion: These results suggested that a critical level of Atp6v0a2 is required for the fertile spermatozoa and its decreased level in spermatozoa could be used to predict male infertility. This study provides a possibility that Atp6v0a2 could be potentially used as a diagnostic marker for the evaluation of male infertility.	[Ota, Kuniaki; Jaiswal, Mukesh Kumar; Kwak-Kim, Joanne; Gilman-Sachs, Alice; Beaman, Kenneth D.] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, N Chicago, IL USA; [Ota, Kuniaki; Kwak-Kim, Joanne] Rosalind Franklin Univ Med & Sci, Dept Obstet & Gynecol, Vernon Hills, IL USA; [Ramu, Sivakumar; Jeyendran, Rajasinjham] Androl Lab Serv Inc, Chicago, IL USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Beaman, KD (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, N Chicago, IL USA.	kenneth.beaman@rosalindfranklin.edu	Kwak-Kim, Joanne/G-2750-2019	Kwak-Kim, Joanne/0000-0002-8409-1645	Clinical Laboratory, Rosalind Franklin University of Medical and Science, North Chicago, IL	Clinical Laboratory, Rosalind Franklin University of Medical and Science, North Chicago, IL	The authors thank the Clinical Laboratory, Rosalind Franklin University of Medical and Science, North Chicago, IL for the grant support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth C, 2005, NATURE, V436, P770, DOI 10.1038/436770a; Andersen AN, 2005, HUM REPROD, V20, P1158, DOI 10.1093/humrep/deh755; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chu TM, 1996, FERTIL STERIL, V66, P327, DOI 10.1016/S0015-0282(16)58461-1; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Curnow EC, 2010, HUM REPROD, V25, P2465, DOI 10.1093/humrep/deq225; Futai M, 2000, J EXP BIOL, V203, P107; Garcia-Velasco JA, 1999, FERTIL STERIL, V71, P983, DOI 10.1016/S0015-0282(99)00120-X; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Handelsman DJ, 2010, ASIAN J ANDROL, V12, P7, DOI 10.1038/aja.2009.49; He YY, 2012, CLIN IMMUNOL, V145, P161, DOI 10.1016/j.clim.2012.07.017; Jaiswal MK, 2012, REPRODUCTION, V143, P713, DOI 10.1530/REP-12-0036; Kauma SW, 2000, J REPROD FERTIL, P31; Kelly RW, 1997, PROSTAG LEUKOTR ESS, V57, P113, DOI 10.1016/S0952-3278(97)90000-4; Kolettis PN, 2003, AM FAM PHYSICIAN, V67, P2165; KRUGER TF, 1988, FERTIL STERIL, V49, P112; Kwong C, 2011, J IMMUNOL, V186, P1781, DOI 10.4049/jimmunol.1002998; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Loras B, 1999, HUM REPROD, V14, P1534, DOI 10.1093/humrep/14.6.1534; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; NOCERA M, 1993, AM J REPROD IMMUNOL, V30, P1; Ntrivalas E, 2007, AM J REPROD IMMUNOL, V57, P201, DOI 10.1111/j.1600-0897.2006.00463.x; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Pollard JW, 1997, MOL REPROD DEV, V46, P54, DOI 10.1002/(SICI)1098-2795(199701)46:1&lt;54::AID-MRD9&gt;3.0.CO;2-Q; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Robertson SA, 2002, J REPROD IMMUNOL, V57, P109, DOI 10.1016/S0165-0378(02)00015-3; Robertson SA, 2007, CYTOKINE GROWTH F R, V18, P287, DOI 10.1016/j.cytogfr.2007.04.008; ROMERO R, 1989, OBSTET GYNECOL, V73, P31; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sugita K, 2003, AM J REPROD IMMUNOL, V50, P83, DOI 10.1034/j.1600-0897.2003.00024.x; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365	41	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70470	10.1371/journal.pone.0070470	http://dx.doi.org/10.1371/journal.pone.0070470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936208	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200085
J	Andersson, D; Wilhelmsson, U; Nilsson, M; Kubista, M; Stahlberg, A; Pekna, M; Pekny, M				Andersson, Daniel; Wilhelmsson, Ulrika; Nilsson, Michael; Kubista, Mikael; Stahlberg, Anders; Pekna, Marcela; Pekny, Milos			Plasticity Response in the Contralesional Hemisphere after Subtle Neurotrauma: Gene Expression Profiling after Partial Deafferentation of the Hippocampus	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; SYNAPSE FORMATION; MICE DEFICIENT; THROMBOSPONDIN-4; RAT; TRANSCRIPTOME; ASTROCYTES; ABSENCE; STROKE; MODEL	Neurotrauma or focal brain ischemia are known to trigger molecular and structural responses in the uninjured hemisphere. These responses may have implications for tissue repair processes as well as for the recovery of function. To determine whether the plasticity response in the uninjured hemisphere occurs even after a subtle trauma, we subjected mice to a partial unilateral deafferentation of the hippocampus induced by stereotactically performed entorhinal cortex lesion (ECL). The expression of selected genes was assessed by quantitative real-time PCR in the hippocampal tissue at the injured side and the contralesional side at day 4 and 14 after injury. We observed that expression of genes coding for synaptotagmin 1, ezrin, thrombospondin 4, and C1q proteins, that have all been implicated in the synapse formation, re-arrangement and plasticity, were upregulated both in the injured and the contralesional hippocampus, implying a plasticity response in the uninjured hemisphere. Several of the genes, the expression of which was altered in response to ECL, are known to be expressed in astrocytes. To test whether astrocyte activation plays a role in the observed plasticity response to ECL, we took advantage of mice deficient in two intermediate filament (nanofilament) proteins glial fibrillary acidic protein (GFAP) and vimentin (GFAP(-/-) Vim(-/-)) and exhibiting attenuated astrocyte activation and reactive gliosis. The absence of GFAP and vimentin reduced the ECL-induced upregulation of thrombospondin 4, indicating that this response to ECL depends on astrocyte activation and reactive gliosis. We conclude that even a very limited focal neurotrauma triggers a distinct response at the contralesional side, which at least to some extent depends on astrocyte activation.	[Andersson, Daniel; Wilhelmsson, Ulrika; Nilsson, Michael; Stahlberg, Anders; Pekna, Marcela; Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, Gothenburg, Sweden; [Nilsson, Michael] Hunter Med Res Inst, Newcastle, NSW, Australia; [Kubista, Mikael] Acad Sci Czech Republ, Inst Biotechnol, Prague, Czech Republic; [Kubista, Mikael] TATAA Bioctr, Gothenburg, Sweden; [Stahlberg, Anders] Univ Gothenburg, Dept Pathol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Hunter Medical Research Institute; University of Newcastle; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University of Gothenburg	Pekny, M (corresponding author), Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, Gothenburg, Sweden.	milos.pekny@neuro.gu.se	Pekna, Marcela/AAM-3249-2021; Kubista, Mikael/A-5689-2008; NILSSON, MICHAEL/ABE-7821-2020; Pekna, Marcela/AAM-3261-2021	Pekna, Marcela/0000-0003-2734-8237; Kubista, Mikael/0000-0002-2940-352X; NILSSON, MICHAEL/0000-0002-8826-1621; Pekna, Marcela/0000-0003-2734-8237; Stahlberg, Anders/0000-0003-4243-0191; Andersson, Daniel/0000-0002-4564-6652; Wilhelmsson, Ulrika/0000-0003-3227-2687	Swedish Medical Research Council [11548]; AFA Insurance; ALF Goteborg [11392]; Sten A. Olsson Foundation for Research and Culture; VINNOVA Health Program; Swedish Stroke Foundation; Swedish Society of Medicine; Free Mason Foundation; Wilhelm and Martina Lundgren Foundations; NanoNet COST Action [279017]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); AFA Insurance; ALF Goteborg; Sten A. Olsson Foundation for Research and Culture; VINNOVA Health Program(Vinnova); Swedish Stroke Foundation; Swedish Society of Medicine; Free Mason Foundation; Wilhelm and Martina Lundgren Foundations; NanoNet COST Action(European Cooperation in Science and Technology (COST))	This work was supported by the Swedish Medical Research Council (project 11548), AFA Insurance, ALF Goteborg (project 11392), Sten A. Olsson Foundation for Research and Culture, VINNOVA Health Program, the Swedish Stroke Foundation, the Swedish Society of Medicine, the Free Mason Foundation, Wilhelm and Martina Lundgren Foundations, NanoNet COST Action (BM1002), the EU FP 7 Program EduGlia (237956) and the EU FP 7 Program TargetBraIn (279017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; Buga AM, 2008, J CELL MOL MED, V12, P2731, DOI 10.1111/j.1582-4934.2008.00252.x; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Deller T, 2007, PROG BRAIN RES, V163, P501, DOI 10.1016/S0079-6123(07)63027-1; Dunkle ET, 2007, EXP EYE RES, V84, P707, DOI 10.1016/j.exer.2006.12.014; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Gardzinski P, 2007, J PHYSIOL-LONDON, V581, P75, DOI 10.1113/jphysiol.2006.127472; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Hori M, 2012, DIS MODEL MECH, V5, P270, DOI 10.1242/dmm.008276; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; Kim MW, 2005, BRAIN RES, V1052, P16, DOI 10.1016/j.brainres.2005.05.070; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Lavialle M, 2011, P NATL ACAD SCI USA, V108, P12915, DOI 10.1073/pnas.1100957108; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Pekna M, 2012, STROKE, V43, P2819, DOI 10.1161/STROKEAHA.112.654228; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M., 2013, CYTOSKELETON IMAGING, P299, DOI DOI 10.1007/978-1-62703-266-7_13; PFENNINGER KH, 1991, MOL NEUROBIOL, V5, P143, DOI 10.1007/BF02935543; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Turner DA, 1998, PROG NEUROBIOL, V55, P537, DOI 10.1016/S0301-0082(98)00019-7; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	37	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70699	10.1371/journal.pone.0070699	http://dx.doi.org/10.1371/journal.pone.0070699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936241	Green Published, gold			2022-12-27	WOS:000322433300112
J	De Filippis, F; La Storia, A; Villani, F; Ercolini, D				De Filippis, Francesca; La Storia, Antonietta; Villani, Francesco; Ercolini, Danilo			Exploring the Sources of Bacterial Spoilers in Beefsteaks by Culture-Independent High-Throughput Sequencing	PLOS ONE			English	Article							SPOILAGE-RELATED MICROBIOTA; PSEUDOMONAS-FRAGI; BEEF CARCASSES; PACKAGED BEEF; MEAT SPOILAGE; CONTAMINATION; BEHAVIOR; PRODUCT; SLAUGHTER; STORAGE	Microbial growth on meat to unacceptable levels contributes significantly to change meat structure, color and flavor and to cause meat spoilage. The types of microorganisms initially present in meat depend on several factors and multiple sources of contamination can be identified. The aims of this study were to evaluate the microbial diversity in beefsteaks before and after aerobic storage at 4 degrees C and to investigate the sources of microbial contamination by examining the microbiota of carcasses wherefrom the steaks originated and of the processing environment where the beef was handled. Carcass, environmental (processing plant) and meat samples were analyzed by culture-independent high-throughput sequencing of 16S rRNA gene amplicons. The microbiota of carcass swabs was very complex, including more than 600 operational taxonomic units (OTUs) belonging to 15 different phyla. A significant association was found between beef microbiota and specific beef cuts (P<0.01) indicating that different cuts of the same carcass can influence the microbial contamination of beef. Despite the initially high complexity of the carcass microbiota, the steaks after aerobic storage at 4 degrees C showed a dramatic decrease in microbial complexity. Pseudomonas sp. and Brochothrix thermosphacta were the main contaminants, and Acinetobacter, Psychrobacter and Enterobacteriaceae were also found. Comparing the relative abundance of OTUs in the different samples it was shown that abundant OTUs in beefsteaks after storage occurred in the corresponding carcass. However, the abundance of these same OTUs clearly increased in environmental samples taken in the processing plant suggesting that spoilage-associated microbial species originate from carcasses, they are carried to the processing environment where the meat is handled and there they become a resident microbiota. Such microbiota is then further spread on meat when it is handled and it represents the starting microbial association wherefrom the most efficiently growing microbial species take over during storage and can cause spoilage.	[De Filippis, Francesca; La Storia, Antonietta; Villani, Francesco; Ercolini, Danilo] Univ Naples Federico II, Dept Agr Sci, Div Microbiol, Portici, Italy	University of Naples Federico II	Ercolini, D (corresponding author), Univ Naples Federico II, Dept Agr Sci, Div Microbiol, Portici, Italy.	ercolini@unina.it	De Filippis, Francesca/K-3816-2016; Ercolini, Danilo/B-2431-2009; La Storia, Antonietta/K-8570-2016	De Filippis, Francesca/0000-0002-3474-2884; Ercolini, Danilo/0000-0003-3061-9560; Villani, Francesco/0000-0001-6475-2189; La Storia, Antonietta/0000-0002-8318-9376				Abdalla M. A., 2010, Assiut Veterinary Medical Journal, V56, P86; Aslam M, 2004, J APPL MICROBIOL, V97, P78, DOI 10.1111/j.1365-2672.2004.02277.x; Bell RG, 1997, J APPL MICROBIOL, V82, P292, DOI 10.1046/j.1365-2672.1997.00356.x; Bjorkroth KJ, 1997, APPL ENVIRON MICROB, V63, P448; Bokulich NA, 2012, BMB REP, V45, P377, DOI 10.5483/BMBRep.2012.45.7.148; Buys EM, 2000, INT J FOOD MICROBIOL, V56, P239, DOI 10.1016/S0168-1605(00)00158-6; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Chenoll E, 2007, J APPL MICROBIOL, V102, P498, DOI 10.1111/j.1365-2672.2006.03081.x; Cornu M, 2011, FOOD MICROBIOL, V28, P639, DOI 10.1016/j.fm.2010.08.007; Doulgeraki AI, 2012, INT J FOOD MICROBIOL, V157, P130, DOI 10.1016/j.ijfoodmicro.2012.05.020; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisel WG, 1997, FOOD MICROBIOL, V14, P273, DOI 10.1006/fmic.1996.0094; Ercolini D, 2007, APPL ENVIRON MICROB, V73, P2354, DOI 10.1128/AEM.02603-06; Ercolini D, 2006, APPL ENVIRON MICROB, V72, P4663, DOI 10.1128/AEM.00468-06; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Ercolini D, 2012, APPL ENVIRON MICROB, V78, P8142, DOI 10.1128/AEM.02218-12; Ercolini D, 2011, APPL ENVIRON MICROB, V77, P7372, DOI 10.1128/AEM.05521-11; Ercolini D, 2010, INT J FOOD MICROBIOL, V142, P120, DOI 10.1016/j.ijfoodmicro.2010.06.012; Ercolini D, 2010, FOOD MICROBIOL, V27, P137, DOI 10.1016/j.fm.2009.09.006; Fung DYC, 2010, HDB MEAT PROCESSING, V1st, P481; Galland JC, 1997, REV SCI TECH OIE, V16, P395, DOI 10.20506/rst.16.2.1023; Gram L, 2002, INT J FOOD MICROBIOL, V78, P79, DOI 10.1016/S0168-1605(02)00233-7; Habimana O, 2010, APPL ENVIRON MICROB, V76, P4557, DOI 10.1128/AEM.02707-09; Labadie J, 1999, MEAT SCI, V52, P299, DOI 10.1016/S0309-1740(99)00006-6; Liao CH, 2006, WOODHEAD PUBL FOOD S, P507, DOI 10.1533/9781845691417.5.507; Lindblad M, 2013, FOOD CONTROL, V30, P101, DOI 10.1016/j.foodcont.2012.07.040; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nychas GJE, 2008, MEAT SCI, V78, P77, DOI 10.1016/j.meatsci.2007.06.020; Nychas GJE, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P105; Olsson C, 2003, INT J FOOD MICROBIOL, V83, P245, DOI 10.1016/S0168-1605(02)00372-0; Pennacchia C, 2011, FOOD MICROBIOL, V28, P84, DOI 10.1016/j.fm.2010.08.010; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Russo F, 2006, FOOD MICROBIOL, V23, P797, DOI 10.1016/j.fm.2006.02.004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakala RM, 2002, INT J FOOD MICROBIOL, V74, P87, DOI 10.1016/S0168-1605(01)00732-2; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheridan JJ, 1998, J FOOD SAFETY, V18, P321, DOI 10.1111/j.1745-4565.1998.tb00223.x; Steele TM, 2007, J ANIM VET ADV, V6, P927; Vihavainen E, 2007, APPL ENVIRON MICROB, V73, P1136, DOI 10.1128/AEM.01644-06; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yalcin S, 2001, J FOOD SAFETY, V21, P225, DOI 10.1111/j.1745-4565.2001.tb00321.x	44	142	144	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70222	10.1371/journal.pone.0070222	http://dx.doi.org/10.1371/journal.pone.0070222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936168	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300095
J	Silva, VTCE; Liano, F; Muriel, A; Diez, R; de Castro, I; Yu, L				Costa e Silva, Veronica Torres; Liano, Fernando; Muriel, Alfonso; Diez, Rafael; de Castro, Isac; Yu, Luis			Nephrology Referral and Outcomes in Critically Ill Acute Kidney Injury Patients	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; PROPENSITY-SCORE; FAILURE; CONSULTATION; MODELS	Background: Delayed nephrology consultation (NC) seems to be associated with worse prognosis in critically ill acute kidney injury (AKI) patients. Design, Setting, Participants, & Measurements: The aims of this study were to analyze factors related with timing of NC and its relation with AKI patients' outcome in intensive care units of a tertiary hospital. AKI was defined as an increase >= 50% in baseline serum creatinine (SCr). Early NC and delayed NC were defined as NC performed before and two days after AKI diagnosis day. Multivariable logistic regression and propensity scores (PS) were used to adjust for confounding and selection biases. Hospital mortality and dialysis dependence on hospital discharge were the primary outcomes. Results: A total of 366 AKI patients were analyzed and NCs were carried out in 53.6% of the patients. Hospital mortality was 67.8% and dialysis required in 31.4% patients (115/366). Delayed NCs (34%) occurred two days after AKI diagnosis day. This group presented higher mortality (OR: 4.04/CI: 1.60-10.17) and increased dialysis dependence (OR: 3.00/CI: 1.43-6.29) on hospital discharge. Four variables were retained in the PS model for delayed NC: diuresis (1000 ml/24 h-OR: 1.92/CI: 1.27-2.90), SCr (OR: 0.49/CI: 0.32-0.75), surgical AKI (OR: 3.67/CI: 1.65-8.15), and mechanical ventilation (OR: 2.82/CI: 1.06-7.44). After correction by PS, delayed NC was still associated with higher mortality (OR: 3.39/CI: 1.24-9.29) and increased dialysis dependence (OR: 3.25/CI: 1.41-7.51). Delayed NC was associated with increased mortality either in dialyzed patients (OR: 1.54/CI: 1.35-1.78) or non-dialyzed patients (OR: 2.89/CI: 1.00-8.35). Conclusion: Delayed NC was associated with higher mortality and increased dialysis dependence rates in critically ill AKI patients at hospital discharge. Further studies are necessary to ascertain whether this effect is due to delayed nephrology intervention or residual confounding factors.	[Costa e Silva, Veronica Torres; de Castro, Isac; Yu, Luis] Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil; [Liano, Fernando] Hosp Univ Ramo y Cajal, Dept Nephrol, Madrid, Spain; [Muriel, Alfonso] Hosp Univ Ramo y Cajal, Madrid, Spain; [Diez, Rafael] Inst Nacl Invest Agr, Madrid, Spain	Universidade de Sao Paulo; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Yu, L (corresponding author), Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	luisyu@usp.br	MODESTO-RAFAEL, DÍEZ-BARRA/F-2171-2015; de Castro, Isac/AAA-8990-2021; Muriel, Alfonso AM/F-9948-2015; Castro, Isac de/J-1984-2015	MODESTO-RAFAEL, DÍEZ-BARRA/0000-0002-9206-4866; Muriel, Alfonso AM/0000-0002-4805-4011; Castro, Isac de/0000-0002-1160-3064; Yu, Luis/0000-0001-9102-0063; Torres Costa e Silva, Veronica/0000-0001-8211-018X				Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, STAT MED, V26, P754, DOI 10.1002/sim.2618; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1146; Balasubramanian G, 2011, AM J KIDNEY DIS, V57, P228, DOI 10.1053/j.ajkd.2010.08.026; Barnieh L, 2011, J NEPHROL, V24, P256, DOI 10.5301/JN.2011.6429; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Belsley D. A., 1991, CONDITIONING DIAGNOS; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Cerda J, 2010, BLOOD PURIFICAT, V29, P331, DOI 10.1159/000287776; Cerda J, 2009, SEMIN DIALYSIS, V22, P114, DOI 10.1111/j.1525-139X.2008.00549.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Silva VTCE, 2011, NEPHROL DIAL TRANSPL, V26, P3894, DOI 10.1093/ndt/gfr201; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hosmer DW, 1997, STAT MED, V16, P965; Hoste EAJ, 2008, CRIT CARE MED, V36, pS146, DOI 10.1097/CCM.0b013e318168c590; Jun M, 2010, CLIN J AM SOC NEPHRO, V5, P956, DOI 10.2215/CJN.09111209; Koyner JL, 2008, CLIN J AM SOC NEPHRO, V3, P562, DOI 10.2215/CJN.03090707; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu KD, 2008, CLIN J AM SOC NEPHRO, V3, P578, DOI 10.2215/CJN.01630407; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2011, CLIN J AM SOC NEPHRO, V6, P2102, DOI 10.2215/CJN.07720811; Mehta RL, 2002, AM J MED, V113, P456, DOI 10.1016/S0002-9343(02)01230-5; Meier P, 2011, CLIN J AM SOC NEPHRO, V6, P2215, DOI 10.2215/CJN.01880211; Perez-Valdivieso Jose Ramon, 2007, BMC Nephrol, V8, P14, DOI 10.1186/1471-2369-8-14; Ponce D, 2011, NEPHROL DIAL TRANSPL, V26, P3202, DOI 10.1093/ndt/gfr359; Prowle JR, 2010, NAT REV NEPHROL, V6, P521, DOI 10.1038/nrneph.2010.100; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Rubin DB, 2004, PHARMACOEPIDEM DR S, V13, P855, DOI 10.1002/pds.968; Rubin DB, 2010, AM J OPHTHALMOL, V149, P7, DOI 10.1016/j.ajo.2009.08.024; Schrier RW, 2010, CLIN J AM SOC NEPHRO, V5, P733, DOI 10.2215/CJN.00060110; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	34	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70482	10.1371/journal.pone.0070482	http://dx.doi.org/10.1371/journal.pone.0070482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936440	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800042
J	Duc, AKH; Modat, M; Leung, KK; Cardoso, MJ; Barnes, J; Kadir, T; Ourselin, S				Duc, Albert K. Hoang; Modat, Marc; Leung, Kelvin K.; Cardoso, M. Jorge; Barnes, Josephine; Kadir, Timor; Ourselin, Sebastien		Alzheimer's Dis Neuroimaging Initi	Using Manifold Learning for Atlas Selection in Multi-Atlas Segmentation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AUTOMATIC SEGMENTATION; IMAGE SEGMENTATION; HIPPOCAMPUS SEGMENTATION; DIMENSIONALITY REDUCTION; MR-IMAGES; REGISTRATION; CLASSIFICATION; VALIDATION; STRATEGIES	Multi-atlas segmentation has been widely used to segment various anatomical structures. The success of this technique partly relies on the selection of atlases that are best mapped to a new target image after registration. Recently, manifold learning has been proposed as a method for atlas selection. Each manifold learning technique seeks to optimize a unique objective function. Therefore, different techniques produce different embeddings even when applied to the same data set. Previous studies used a single technique in their method and gave no reason for the choice of the manifold learning technique employed nor the theoretical grounds for the choice of the manifold parameters. In this study, we compare side-by-side the results given by 3 manifold learning techniques (Isomap, Laplacian Eigenmaps and Locally Linear Embedding) on the same data set. We assess the ability of those 3 different techniques to select the best atlases to combine in the framework of multi-atlas segmentation. First, a leave-one-out experiment is used to optimize our method on a set of 110 manually segmented atlases of hippocampi and find the manifold learning technique and associated manifold parameters that give the best segmentation accuracy. Then, the optimal parameters are used to automatically segment 30 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI). For our dataset, the selection of atlases with Locally Linear Embedding gives the best results. Our findings show that selection of atlases with manifold learning leads to segmentation accuracy close to or significantly higher than the state-of-the-art method and that accuracy can be increased by fine tuning the manifold learning process.	[Duc, Albert K. Hoang; Modat, Marc; Cardoso, M. Jorge; Ourselin, Sebastien] UCL, Ctr Med Image Comp, London, England; [Leung, Kelvin K.; Barnes, Josephine] UCL, Dementia Res Ctr, London, England; [Kadir, Timor] Mirada Med, Oxford, England	University of London; University College London; University of London; University College London	Duc, AKH (corresponding author), UCL, Ctr Med Image Comp, London, England.	albert.hoang.duc.10@ucl.ac.uk	Barnes, Josesphine/P-5698-2014; Ourselin, Sebastien/K-6960-2015; Cardoso, M. Jorge/N-5511-2018	Ourselin, Sebastien/0000-0002-5694-5340; Cardoso, M. Jorge/0000-0003-1284-2558; Barnes, Josephine/0000-0003-3178-025X; Modat, Marc/0000-0002-5277-8530	Department of Health's NIHR Biomedical Research Centres; IMPACT studentship; MIRADA MEDICAL; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/43894/2008]; ARUK; NIHR; Alzheimer's Research Trust (ART, UK); Kirby Laing Foundation; Medical Research Council (UK); CBRC [168]; EPSRCCRUK Comprehensive Cancer Imaging Centre of UCL; KCL [C1519AO]; EPSRC [EP/H046410/1]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; MRC; Alzheimers Research UK [ART-EG2010B-1] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, P30AG010129, K01AG030514] Funding Source: NIH RePORTER	Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); IMPACT studentship; MIRADA MEDICAL; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); ARUK(Alzheimer's Research UK (ARUK)); NIHR(National Institute for Health Research (NIHR)); Alzheimer's Research Trust (ART, UK); Kirby Laing Foundation; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CBRC; EPSRCCRUK Comprehensive Cancer Imaging Centre of UCL(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); KCL; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was undertaken at UCL/UCLH which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The Dementia Research Centre is an Alzheimer's Research Trust Co-ordinating centre and has also received equipment founded by the Alzheimers Research Trust. AKHD is supported by an IMPACT studentship with a part of the funding from MIRADA MEDICAL. MJC is supported by a scholarship from the Fundacao para a Ciencia e a Tecnologia, Portugal (Scholarship number SFRH/BD/43894/2008). KKL acknowledges support from the MRC, ARUK and the NIHR. JB is supported by an Alzheimer's Research Trust (ART, UK) Research Fellowship partly supported by the Kirby Laing Foundation. NCF is funded by the Medical Research Council (UK). MM and SO are supported by CBRC number 168. SO is also supported by EPSRCCRUK Comprehensive Cancer Imaging Centre of UCL and KCL (grant number C1519AO) and EPSRC EP/H046410/1. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorx Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pzer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The authors would like to thank the ADNI study subjects and investigators for their participation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljabar P, 2008, NEUROIMAGE, V43, P225, DOI 10.1016/j.neuroimage.2008.07.055; Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Awate Suyash P, 2012, Med Image Comput Comput Assist Interv, V7509, P103, DOI 10.1007/978-3-642-33530-3_9; Barnes J, 2008, NEUROBIOL AGING, V29, P1199, DOI 10.1016/j.neurobiolaging.2007.02.011; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bengio Y, 2004, ADV NEUR IN, V16, P177; Chupin M, 2008, I S BIOMED IMAGING, P97, DOI 10.1109/ISBI.2008.4540941; Collins DL, 2010, NEUROIMAGE, V52, P1355, DOI 10.1016/j.neuroimage.2010.04.193; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fletcher PT, 2009, NEUROIMAGE, V45, pS143, DOI 10.1016/j.neuroimage.2008.10.052; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gerber S, 2010, MED IMAGE ANAL, V14, P643, DOI 10.1016/j.media.2010.05.008; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Gunter J, 2006, VALIDATION TESTING M; Hamm J, 2010, MED IMAGE ANAL, V14, P633, DOI 10.1016/j.media.2010.06.001; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Isgum I, 2009, IEEE T MED IMAGING, V28, P1000, DOI 10.1109/TMI.2008.2011480; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Klein S, 2008, MED PHYS, V35, P1407, DOI 10.1118/1.2842076; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Morra JH, 2008, NEUROIMAGE, V43, P59, DOI 10.1016/j.neuroimage.2008.07.003; NARAYANA PA, 1988, MAGN RESON IMAGING, V6, P271, DOI 10.1016/0730-725X(88)90401-8; Pan YZ, 2008, CONF CYBERN INTELL S, P822; Pless R, 2004, C COMP VIS PATT REC, V1; Pohl KM, 2007, IEEE T MED IMAGING, V26, P1201, DOI 10.1109/TMI.2007.901433; Powell S, 2008, NEUROIMAGE, V39, P238, DOI 10.1016/j.neuroimage.2007.05.063; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sabuncu MR, 2010, IEEE T MED IMAGING, V29, P1714, DOI 10.1109/TMI.2010.2050897; Sdika M, 2010, MED IMAGE ANAL, V14, P219, DOI 10.1016/j.media.2009.12.004; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Souvenir R., 2005, 7 IEEE WORKSH APPL C, P195; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; van der Lijn F, 2008, NEUROIMAGE, V43, P708, DOI 10.1016/j.neuroimage.2008.07.058; van Rikxoort EM, 2010, MED IMAGE ANAL, V14, P39, DOI 10.1016/j.media.2009.10.001; Wachinger C, 2010, MICCAI; Wachinger C, 2012, MED IMAGE ANAL, V16, P806, DOI 10.1016/j.media.2011.11.008; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Wolz R, 2010, LECT NOTES COMPUT SC, V6357, P116, DOI 10.1007/978-3-642-15948-0_15; Wolz R, 2010, NEUROIMAGE, V49, P1316, DOI 10.1016/j.neuroimage.2009.09.069; Wu MJ, 2007, NEUROIMAGE, V34, P1612, DOI 10.1016/j.neuroimage.2006.07.050; Zhang Q., 2006, P IEEE C COMP VIS PA, V1, P1092, DOI [10.1109/CVPR.2006.214, DOI 10.1109/CVPR.2006.214]	51	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70059	10.1371/journal.pone.0070059	http://dx.doi.org/10.1371/journal.pone.0070059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936376	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800032
J	Lowe, DM; Rangaka, MX; Gordon, F; James, CD; Miller, RF				Lowe, David M.; Rangaka, Molebogeng X.; Gordon, Fabiana; James, Chris D.; Miller, Robert F.			Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; COMMUNITY-ACQUIRED PNEUMONIA; AIDS-DEFINING ILLNESSES; SOUTH-AFRICAN CHILDREN; INTENSIVE-CARE-UNIT; CARINII-PNEUMONIA; OPPORTUNISTIC INFECTIONS; CLINICAL PRESENTATION	Objective: Pneumocystis jirovecii pneumonia (PCP), the commonest opportunistic infection in HIV-infected patients in the developed world, is less commonly described in tropical and low and middle income countries (LMIC). We sought to investigate predictors of PCP in these settings. Design: Systematic review and meta-regression. Methods: Meta-regression of predictors of PCP diagnosis (33 studies). Qualitative and quantitative assessment of recorded CD4 counts, receipt of prophylaxis and antiretrovirals, sensitivity and specificity of clinical signs and symptoms for PCP, co-infection with other pathogens, and case fatality (117 studies). Results: The most significant predictor of PCP was per capita Gross Domestic Product, which showed strong linear association with odds of PCP diagnosis (p<0.0001). This was not explained by study design or diagnostic quality. Geographical area, population age, study setting and year of study also contributed to risk of PCP. Co-infection was common (444 episodes/1425 PCP cases), frequently with virulent organisms. The predictive value of symptoms, signs or simple tests in LMIC settings for diagnosis of PCP was poor. Case fatality was >30%; treatment was largely appropriate. Prophylaxis appeared to reduce the risk for development of PCP, however 24% of children with PCP were receiving prophylaxis. CD4 counts at presentation with PCP were usually <200 x 10(3/) ml. Conclusions: There is a positive relationship between GDP and risk of PCP diagnosis. Although failure to diagnose infection in poorer countries may contribute to this, we also hypothesise that poverty exposes at-risk patients to a wide range of infections and that the relatively non-pathogenic P. jirovecii is therefore under-represented. As LMIC develop economically they eliminate the conditions underlying transmission of virulent infection: P. jirovecii, ubiquitous in all settings, then becomes a greater relative threat.	[Lowe, David M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Wellcome Trust Ctr Res Clin Trop Med, London, England; [Lowe, David M.; Rangaka, Molebogeng X.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Gordon, Fabiana] Univ London Imperial Coll Sci Technol & Med, Stat Advisory Serv, London, England; [James, Chris D.] WHO, Western Pacific Reg Off, Manila, Philippines; [Miller, Robert F.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Miller, Robert F.] UCL, Inst Epidemiol & Healthcare, Res Dept Infect & Populat Hlth, London, England	Imperial College London; University of Cape Town; Imperial College London; WHO Western Pacific Regional Office; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Lowe, DM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Wellcome Trust Ctr Res Clin Trop Med, London, England.	d.lowe@imperial.ac.uk	Rangaka, Molebogeng/E-4116-2015	RANGAKA, Molebogeng/0000-0001-9594-188X; Miller, Robert/0000-0003-2067-4291	Wellcome Trust [WT087754]	Wellcome Trust(Wellcome TrustEuropean Commission)	Wellcome Trust (Grant WT087754 to Dr DML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUYA YL, 1992, AM REV RESPIR DIS, V145, P617, DOI 10.1164/ajrccm/145.3.617; Aderaye G, 2007, SCAND J INFECT DIS, V39, P1045, DOI 10.1080/00365540701474508; Al-Haddad M. K., 1997, Journal of Communicable Diseases, V29, P321; Anekthananon Thanomsak, 2004, Journal of the Medical Association of Thailand, V87, P173; ATZORI C, 1993, T ROY SOC TROP MED H, V87, P55, DOI 10.1016/0035-9203(93)90418-P; Bakeera-Kitaka S, 2004, ANN TROP PAEDIATR, V24, P227, DOI 10.1179/027249304225019046; BATUNGWANAYO J, 1994, AM J RESP CRIT CARE, V149, P1591, DOI 10.1164/ajrccm.149.6.8004318; Bedri A, 2001, Ethiop Med J, V39, P203; Bellamy R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-47; CARME B, 1991, T ROY SOC TROP MED H, V85, P80, DOI 10.1016/0035-9203(91)90167-W; Chakaya J M, 2003, East Afr Med J, V80, P30; Chariyalertsak S, 2001, CLIN INFECT DIS, V32, P955, DOI 10.1086/319348; Chokephaibulkit K, 1999, PEDIATR INFECT DIS J, V18, P147, DOI 10.1097/00006454-199902000-00012; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Daly KR, 2002, J INFECT DIS, V186, P644, DOI 10.1086/341565; de la Hoz RE, 2002, J CLIN VIROL, V25, pS1, DOI 10.1016/S1386-6532(02)00091-4; Delport SD, 2002, SAMJ S AFR MED J, V92, P907; Fallo Aurelia A., 2002, International Journal of Infectious Diseases, V6, P9, DOI 10.1016/S1201-9712(02)90129-3; Fang CT, 2000, J FORMOS MED ASSOC, V99, P123; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; George Jacob, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P686; Giri T K, 1995, J Commun Dis, V27, P131; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Hargreaves NJ, 2001, T ROY SOC TROP MED H, V95, P402, DOI 10.1016/S0035-9203(01)90197-X; HU DJ, 1995, J ACQ IMMUN DEF SYND, V10, P374; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; Huang L, 2009, RESPIROLOGY, V14, P474, DOI 10.1111/j.1440-1843.2009.01534.x; Hung CC, 2000, J ACQ IMMUN DEF SYND, V24, P378, DOI 10.1097/00126334-200008010-00013; Inverarity Donald, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P822; Ismail R, 1995, Med J Malaysia, V50, P298; Janssens JP, 2008, EUR RESPIR J, V32, P1415, DOI 10.1183/09031936.00078708; Kamiya Y, 1997, ANN TROP PAEDIATR, V17, P121, DOI 10.1080/02724936.1997.11747874; Kibiki G S, 2007, East Afr Med J, V84, P420; Kim JM, 2003, YONSEI MED J, V44, P363, DOI 10.3349/ymj.2003.44.3.363; Knauer A, 2005, WIEN KLIN WOCHENSCHR, V117, P49, DOI 10.1007/s00508-005-0448-2; Kong B. N., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P62; Kouakoussui A, 2004, Paediatr Respir Rev, V5, P311, DOI 10.1016/j.prrv.2004.07.008; Kumarasamy N, 2003, CLIN INFECT DIS, V36, P79, DOI 10.1086/344756; Lambertucci J. Roberto, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P27, DOI 10.1590/S0036-46651999000100006; Le Minor O, 2008, JAIDS-J ACQ IMM DEF, V48, P620, DOI 10.1097/QAI.0b013e31817efb3c; Lee C. C., 1997, Annals Academy of Medicine Singapore, V26, P731; Lian YLA, 2007, CURR HIV RES, V5, P484, DOI 10.2174/157016207781662425; Louie JK, 2004, INT J STD AIDS, V15, P758, DOI 10.1258/0956462042395159; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; MACHIELS G, 1992, T ROY SOC TROP MED H, V86, P399, DOI 10.1016/0035-9203(92)90237-7; Madhi SA, 2002, CLIN INFECT DIS, V35, P1120, DOI 10.1086/343049; Madhivanan Purnima, 2003, Indian Journal of Pediatrics, V70, P615, DOI 10.1007/BF02724249; MALIN AS, 1995, LANCET, V346, P1258, DOI 10.1016/S0140-6736(95)91862-0; MANALOTO CR, 1994, J ACQ IMMUN DEF SYND, V7, P1157; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; Merchant R H, 2001, Indian Pediatr, V38, P239; Miller RF, 2005, T ROY SOC TROP MED H, V99, P202, DOI 10.1016/j.trstmh.2004.09.005; Mootsikapun Piroon, 1996, Journal of the Medical Association of Thailand, V79, P477; MOREIRA ED, 1993, AM J TROP MED HYG, V48, P687, DOI 10.4269/ajtmh.1993.48.687; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Morrow BM, 2010, PEDIATR INFECT DIS J, V29, P535, DOI 10.1097/INF.0b013e3181ce871e; Moses AE, 1996, ISRAEL J MED SCI, V32, P716; Narata Roongtiva, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P528; Nissapatorn V, 2003, JPN J INFECT DIS, V56, P187; Nissapatorn V, 2004, SE ASIAN J TROP M S2, P26; Nkinin SW, 2009, ACTA TROP, V112, P219, DOI 10.1016/j.actatropica.2009.07.030; Oh MD, 1999, CLIN INFECT DIS, V29, P1524, DOI 10.1086/313516; Parkhurst JO, 2010, B WORLD HEALTH ORGAN, V88, P519, DOI 10.2471/BLT.09.070185; Rabie H, 2007, J TROP PEDIATRICS, V53, P270, DOI 10.1093/tropej/fmm036; Rai-Mra Kay-Thwe-Han, 2003, SE ASIAN J TROP MED, V34, P577; Rajasekaran S, 2009, INDIAN J MED RES, V129, P42; Respaldiza N, 2004, CLIN MICROBIOL INFEC, V10, P1029, DOI 10.1111/j.1469-0691.2004.00974.x; Soares VYR, 2008, REV INST MED TROP SP, V50, P327, DOI 10.1590/S0036-46652008000600003; Ruffini DD, 2002, AIDS, V16, P105, DOI 10.1097/00002030-200201040-00013; Rupali P, 2003, NATL MED J INDIA, V16, P193; SANTOS B, 1994, INT J STD AIDS, V5, P279, DOI 10.1177/095646249400500410; Saraceni V, 2008, INT J TUBERC LUNG D, V12, P769; Senya C, 2003, INT J STD AIDS, V14, P411, DOI 10.1258/095646203765371312; Serraino D, 2003, AIDS, V17, P2109, DOI 10.1097/00002030-200309260-00012; Shah I, 2005, J TROP PEDIATRICS, V51, P300, DOI 10.1093/tropej/fmi018; Sharma SK, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-52; SIEGMANIGRA Y, 1988, ISRAEL J MED SCI, V24, P131; Siika A M, 2006, East Afr Med J, V83, P295; Singh A, 2003, Indian J Med Sci, V57, P16; SMULIAN AG, 1993, J INFECT DIS, V167, P1243, DOI 10.1093/infdis/167.5.1243; Solomon SS, 2006, AIDS CARE, V18, P366, DOI 10.1080/09540120500201755; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Swasdisevi Anuswasdi, 1994, Journal of the Medical Association of Thailand, V77, P440; Tan B. H., 1997, Annals Academy of Medicine Singapore, V26, P566; Tansuphasawadikul S, 1999, J ACQ IMMUN DEF SYND, V21, P326, DOI 10.1097/00126334-199908010-00011; Tansuphasawadikul Somsit, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1469; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Udwadia Z F, 2005, J Assoc Physicians India, V53, P437; Uriyo J, 2006, ANN TROP MED PARASIT, V100, P245, DOI [10.1179/136485906X91477, 10.1179/136485913X13789813917580]; Usha M M, 2000, Indian J Pathol Microbiol, V43, P291; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; van Oosterhout JJG, 2007, EMERG INFECT DIS, V13, P325, DOI 10.3201/eid1302.060462; Vithayasai Prakong, 1993, Journal of Dermatology (Tokyo), V20, P389, DOI 10.1111/j.1346-8138.1993.tb01305.x; Weinberg Adriana, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P129, DOI 10.1590/S0036-46651993000200004; Wong K. H., 1998, SMJ, V39, P236; Wong ML, 2006, INT J TUBERC LUNG D, V10, P756; Wood E, 1998, INT J CLIN PRACT, V52, P23; Yazdanpanah Y, 2001, INT J EPIDEMIOL, V30, P864, DOI 10.1093/ije/30.4.864; Yoong KY, 1997, INT J STD AIDS, V8, P118, DOI 10.1258/0956462971919660; Zar Heather J., 2001, Pediatr Crit Care Med, V2, P108, DOI 10.1097/00130478-200104000-00003; Zar HJ, 2000, PEDIATR INFECT DIS J, V19, P603, DOI 10.1097/00006454-200007000-00004; Zar HJ, 2001, ACTA PAEDIATR, V90, P119, DOI 10.1080/080352501300049163	102	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69969	10.1371/journal.pone.0069969	http://dx.doi.org/10.1371/journal.pone.0069969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936365	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800029
J	Suzuki, T; Shimoda, M; Ito, K; Hanai, S; Aizawa, H; Kato, T; Kawasaki, K; Yamaguchi, T; Ryoo, HD; Goto-Inoue, N; Setou, M; Tsuji, S; Ishida, N				Suzuki, Takahiro; Shimoda, Masami; Ito, Kumpei; Hanai, Shuji; Aizawa, Hidenobu; Kato, Tomoki; Kawasaki, Kazunori; Yamaguchi, Terumi; Ryoo, Hyung Don; Goto-Inoue, Naoko; Setou, Mitsutoshi; Tsuji, Shoji; Ishida, Norio			Expression of Human Gaucher Disease Gene GBA Generates Neurodevelopmental Defects and ER Stress in Drosophila Eye	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISORDERS; UNFOLDED PROTEIN RESPONSE; GLUCOCEREBROSIDASE GENE; MUTATION; MODEL; NEURODEGENERATION; IDENTIFICATION; MELANOGASTER; HETEROGENEITY; RECEPTOR	Gaucher disease (GD) is the most common of the lysosomal storage disorders and is caused by defects in the GBA gene encoding glucocerebrosidase (GlcCerase). The accumulation of its substrate, glucocylceramide (GlcCer) is considered the main cause of GD. We found here that the expression of human mutated GlcCerase gene (hGBA) that is associated with neuronopathy in GD patients causes neurodevelopmental defects in Drosophila eyes. The data indicate that endoplasmic reticulum (ER) stress was elevated in Drosophila eye carrying mutated hGBAs by using of the ER stress markers dXBP1 and dBiP. We also found that Ambroxol, a potential pharmacological chaperone for mutated hGBAs, can alleviate the neuronopathic phenotype through reducing ER stress. We demonstrate a novel mechanism of neurodevelopmental defects mediated by ER stress through expression of mutants of human GBA gene in the eye of Drosophila.	[Suzuki, Takahiro; Ito, Kumpei; Hanai, Shuji; Aizawa, Hidenobu; Kato, Tomoki; Kawasaki, Kazunori; Ishida, Norio] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Suzuki, Takahiro; Ito, Kumpei; Ishida, Norio] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Shimoda, Masami; Yamaguchi, Terumi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Ryoo, Hyung Don] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Goto-Inoue, Naoko] Tokyo Metropolitan Univ, Grad Sch Hlth Promot Sci, Tokyo 158, Japan; [Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan; [Tsuji, Shoji] Univ Tokyo, Dept Neurol, Grad Sch Med, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; National Institute of Agrobiological Sciences - Japan; New York University; Tokyo Metropolitan University; Hamamatsu University School of Medicine; University of Tokyo	Ishida, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	n.ishida@aist.go.jp	Kawasaki, Kazunori/L-7007-2018	Kawasaki, Kazunori/0000-0001-8708-2261	National Institute of Advanced Industrial Science and Technology; Nihon Advanced Agri Corporation	National Institute of Advanced Industrial Science and Technology; Nihon Advanced Agri Corporation	This work was supported by an internal grant from National Institute of Advanced Industrial Science and Technology (http://www.aist.go.jp/) and by a grant from Nihon Advanced Agri Corporation (http://www.adv-agri.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JMFG, 2011, J INHERIT METAB DIS, V34, P605, DOI 10.1007/s10545-011-9308-6; Bendikov-Bar I, 2011, BLOOD CELL MOL DIS, V46, P4, DOI 10.1016/j.bcmd.2010.10.012; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan HYE, 2000, CELL DEATH DIFFER, V7, P1075, DOI 10.1038/sj.cdd.4400757; Choy FYM, 2007, BLOOD CELL MOL DIS, V38, P287, DOI 10.1016/j.bcmd.2006.11.003; DAHL N, 1990, AM J HUM GENET, V47, P275; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Enquist IB, 2006, P NATL ACAD SCI USA, V103, P13819, DOI 10.1073/pnas.0606016103; Farfel-Becker T, 2011, DIS MODEL MECH, V4, P746, DOI 10.1242/dmm.008185; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; GINNS EI, 1985, P NATL ACAD SCI USA, V82, P7101, DOI 10.1073/pnas.82.20.7101; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Ida H, 1999, HUM GENET, V105, P120, DOI 10.1007/s004390051073; Inoue TA, 2006, ZOOL SCI, V23, P169, DOI 10.2108/zsj.23.169; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; Lu BW, 2009, ANNU REV PATHOL-MECH, V4, P315, DOI 10.1146/annurev.pathol.3.121806.151529; Maegawa GHB, 2009, J BIOL CHEM, V284, P23502, DOI 10.1074/jbc.M109.012393; Nishinokubi I, 2003, GENE, V307, P183, DOI 10.1016/S0378-1119(03)00468-2; Plongthongkum N, 2007, BIOCHEM BIOPH RES CO, V354, P789, DOI 10.1016/j.bbrc.2007.01.056; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Schiffmann R, 1997, ANN NEUROL, V42, P613, DOI 10.1002/ana.410420412; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Wan L, 2006, BLOOD CELL MOL DIS, V36, P422, DOI 10.1016/j.bcmd.2006.02.001; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324	35	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69147	10.1371/journal.pone.0069147	http://dx.doi.org/10.1371/journal.pone.0069147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936319	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800012
J	Hunter, RM; Davie, C; Rudd, A; Thompson, A; Walker, H; Thomson, N; Mountford, J; Schwamm, L; Deanfield, J; Thompson, K; Dewan, B; Mistry, M; Quoraishi, S; Morris, S				Hunter, Rachael Maree; Davie, Charles; Rudd, Anthony; Thompson, Alan; Walker, Hilary; Thomson, Neil; Mountford, James; Schwamm, Lee; Deanfield, John; Thompson, Kerry; Dewan, Bikash; Mistry, Minesh; Quoraishi, Sadik; Morris, Stephen			Impact on Clinical and Cost Outcomes of a Centralized Approach to Acute Stroke Care in London: A Comparative Effectiveness Before and After Model	PLOS ONE			English	Article								Background: In July 2010 a new multiple hub-and-spoke model for acute stroke care was implemented across the whole of London, UK, with continuous specialist care during the first 72 hours provided at 8 hyper-acute stroke units (HASUs) compared to the previous model of 30 local hospitals receiving acute stroke patients. We investigated differences in clinical outcomes and costs between the new and old models. Methods: We compared outcomes and costs 'before' (July 2007-July 2008) vs. 'after' (July 2010-June 2011) the introduction of the new model, adjusted for patient characteristics and national time trends in mortality and length of stay. We constructed 90-day and 10-year decision analytic models using data from population based stroke registers, audits and published sources. Mortality and length of stay were modelled using survival analysis. Findings: In a pooled sample of 307 patients 'before' and 3156 patients 'after', survival improved in the 'after' period (age adjusted hazard ratio 0.54; 95% CI 0.41-0.72). The predicted survival rates at 90 days in the deterministic model adjusted for national trends were 87.2% 'before' % (95% CI 86.7%-87.7%) and 88.7% 'after' (95% CI 88.6%-88.8%); a relative reduction in deaths of 12% (95% CI 8%-16%). Based on a cohort of 6,438 stroke patients, the model produces a total cost saving of 5.2 pound million per year at 90 days (95% CI 4.9- pound 5.5 pound million; 811 pound per patient). Conclusion: A centralized model for acute stroke care across an entire metropolitan city appears to have reduced mortality for a reduced cost per patient, predominately as a result of reduced hospital length of stay.	[Hunter, Rachael Maree] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Davie, Charles; Thompson, Kerry; Dewan, Bikash] Royal Free London NHS Fdn Trust, Dept Clin Neurosci, London, England; [Rudd, Anthony] Kings Coll London, Div Hlth & Social Care Res, London, England; [Rudd, Anthony] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London, England; [Thompson, Alan] UCL, Inst Neurol, London, England; [Walker, Hilary] North Cent London CardioVasc & Stroke Network, London, England; [Thomson, Neil] London Ambulance Serv NHS Trust, London, England; [Mountford, James] UCLPartners, London, England; [Schwamm, Lee] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Deanfield, John] UCL, Ctr Cardiovasc Prevent & Outcomes, London, England; [Mistry, Minesh; Quoraishi, Sadik] UCL, UCL Med Sch, London, England; [Morris, Stephen] UCL, Dept Appl Hlth Res, London, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; University of London; University College London; Harvard University; Massachusetts General Hospital; University of London; University College London; University of London; University College London; University of London; University College London	Hunter, RM (corresponding author), UCL, Res Dept Primary Care & Populat Hlth, London, England.	r.hunter@ucl.ac.uk	Hunter, Rachael Maree/H-7846-2019; Thompson, Alan J/C-2654-2008	Hunter, Rachael Maree/0000-0002-7447-8934; Thompson, Alan J/0000-0002-4333-8496; Morris, Stephen/0000-0002-5828-3563; Schwamm, Lee/0000-0003-0592-9145; Deanfield, John/0000-0001-8806-6052	NHS London; National Institute for Health Research (NIHR) [RP-PG-0407-10184]; Department of Health's NIHR Biomedical Research Centres funding scheme	NHS London; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	The study was funded by NHS London. This study uses data obtained via independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10184). The views expressed are not necessarily those of the NHS, the NIHR or the Department of Health. This work was undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID METH TECHN APPR; Briggs A, 2006, DECISION MODELLING H; Healthcare for London, 2007, FRAM ACT; Healthcare for London, 2008, STROK STRAT LOND; Healthcare for London, 2009, STROK AC COMM TAR GU; Hensage U, 2011, NATL SENTINEL AUDIT; Hoffman A, 2009, NATL SENTINEL AUDIT; Kaambwa B, 2013, EUR J HEALTH ECON, V14, P231, DOI 10.1007/s10198-011-0364-5; Mackay J, 2004, ATLAS HEART DIS STRO; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; National Audit Office, 2010, PROGR IMPR STROK CAR; NHS Information Centre, 2011, EM HOSP ADM STROK IN; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Saka O, 2009, STROKE, V40, P24, DOI 10.1161/STROKEAHA.108.518043; Sarker SJ, 2008, J NEUROL NEUROSUR PS, V79, P260, DOI 10.1136/jnnp.2007.129189; Sheehan J., 2009, PRECONSULTATION BUSI; Stroke Unit Trialists' Collaboration, 2002, COCHRANE DB SYST REV, V4; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; XE. COM INC, 2012, XE CURR CONV; Xian Y, 2011, JAMA-J AM MED ASSOC, V305, P373, DOI 10.1001/jama.2011.22; Youman P, 2003, PHARMACOECONOMICS, V21, P43, DOI 10.2165/00019053-200321001-00005	21	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70420	10.1371/journal.pone.0070420	http://dx.doi.org/10.1371/journal.pone.0070420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936427	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400066
J	Kapur, N; Steeg, S; Webb, R; Haigh, M; Bergen, H; Hawton, K; Ness, J; Waters, K; Cooper, J				Kapur, Nav; Steeg, Sarah; Webb, Roger; Haigh, Matthew; Bergen, Helen; Hawton, Keith; Ness, Jennifer; Waters, Keith; Cooper, Jayne			Does Clinical Management Improve Outcomes following Self-Harm? Results from the Multicentre Study of Self-Harm in England	PLOS ONE			English	Article							PSYCHOSOCIAL ASSESSMENT; SUICIDE; REPETITION	Background: Evidence to guide clinical management of self-harm is sparse, trials have recruited selected samples, and psychological treatments that are suggested in guidelines may not be available in routine practice. Aims: To examine how the management that patients receive in hospital relates to subsequent outcome. Methods: We identified episodes of self-harm presenting to three UK centres (Derby, Manchester, Oxford) over a 10 year period (2000 to 2009). We used established data collection systems to investigate the relationship between four aspects of management (psychosocial assessment, medical admission, psychiatric admission, referral for specialist mental health follow up) and repetition of self-harm within 12 months, adjusted for differences in baseline demographic and clinical characteristics. Results: 35,938 individuals presented with self-harm during the study period. In two of the three centres, receiving a psychosocial assessment was associated with a 40% lower risk of repetition, Hazard Ratios (95% CIs): Centre A 0.99 (0.90-1.09); Centre B 0.59 (0.48-0.74); Centre C 0.59 (0.52-0.68). There was little indication that the apparent protective effects were mediated through referral and follow up arrangements. The association between psychosocial assessment and a reduced risk of repetition appeared to be least evident in those from the most deprived areas. Conclusion: These findings add to the growing body of evidence that thorough assessment is central to the management of self-harm, but further work is needed to elucidate the possible mechanisms and explore the effects in different clinical subgroups.	[Kapur, Nav; Steeg, Sarah; Webb, Roger; Haigh, Matthew; Cooper, Jayne] Univ Manchester, Ctr Mental Hlth & Risk, Ctr Suicide Prevent, Manchester, Lancs, England; [Bergen, Helen; Hawton, Keith] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford, England; [Ness, Jennifer; Waters, Keith] Derbyshire Healthcare NHS Fdn Trust, Royal Derby Hosp, Derby, England	University of Manchester; University of Oxford; University of Nottingham	Kapur, N (corresponding author), Univ Manchester, Ctr Mental Hlth & Risk, Ctr Suicide Prevent, Manchester, Lancs, England.	nav.kapur@manchester.ac.uk	Waters, Keith/AAH-5503-2019; Haigh, Matthew/AAF-6920-2020	Waters, Keith/0000-0002-5031-0870; Webb, Roger/0000-0001-8532-2647; Haigh, Matthew/0000-0003-1549-697X; Steeg, Sarah/0000-0002-7935-1414; Ness, Jennifer/0000-0002-7445-4510; Kapur, Nav/0000-0002-3100-3234	Department of Health under the NHS RD Programme; National Institute for Health Research [NF-SI-0508-10053] Funding Source: researchfish	Department of Health under the NHS RD Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge financial support from the Department of Health under the NHS R&D Programme (DH/DSH2008). KH is a National Institute for Health Research Senior Investigator. The Department of Health and the National Institute for Health Research had no role in study design, the collection, analysis and interpretation of data, the writing of the report, and the decision to submit the paper for publication. The views and opinions expressed within this paper are those of the authors and do not necessarily reflect those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651; Bergen H, 2010, J AFFECT DISORDERS, V127, P257, DOI 10.1016/j.jad.2010.05.001; Department for Communities and Local Government, 2008, ENGLISH INDICES DEPR; Hawton K, 2001, PSYCHOL MED, V31, P827, DOI 10.1017/S0033291701003993; Hawton K, 2007, SOC PSYCH PSYCH EPID, V42, P513, DOI 10.1007/s00127-007-0199-7; Hunter C, 2013, J AFFECT DISORDERS, V145, P315, DOI 10.1016/j.jad.2012.08.009; Jenkins GR, 2002, BRIT MED J, V325, P1155, DOI 10.1136/bmj.325.7373.1155; Johnston A, 2006, BRIT J PSYCHIAT, V189, P416, DOI 10.1192/bjp.bp.105.018085; Kapur N, 2004, GEN HOSP PSYCHIAT, V26, P36, DOI 10.1016/j.genhosppsych.2003.06.002; Kapur N, 2002, BMJ-BRIT MED J, V325, P866, DOI 10.1136/bmj.325.7369.866; Kapur N, 2008, J AFFECT DISORDERS, V106, P285, DOI 10.1016/j.jad.2007.07.010; Kapur N, 2006, J CLIN PSYCHIAT, V67, P1599, DOI 10.4088/JCP.v67n1016; Kendall T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7073; Multicentre Study of Self-Harm in England, 2013, MULT STUD SELF HARM; National Institute for Clinical Excellence (NICE), 2011, SELF HARM LONG TERM; National Institute for Clinical Excellence (NICE), 2004, SELF HARM SHORT TERM; Ougrin D, 2011, ARCH DIS CHILD, V96, P148, DOI 10.1136/adc.2010.188755; Royal College of Psychiatrists, 2010, 158 ROYAL COLL PSYCH; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Saunders KEA, 2012, J AFFECT DISORDERS, V139, P205, DOI 10.1016/j.jad.2011.08.024; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; While D, 2012, LANCET, V379, P1005, DOI 10.1016/S0140-6736(11)61712-1; Whitehead L, 2002, THESIS OXFORD BROOKE; Zahl DL, 2004, BRIT J PSYCHIAT, V185, P70, DOI 10.1192/bjp.185.1.70	24	70	72	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70434	10.1371/journal.pone.0070434	http://dx.doi.org/10.1371/journal.pone.0070434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219PB	23936430	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000324518400067
J	Peng, XJ; Li, WP; Yuan, L; Mehta, RG; Kopelovich, L; McCormick, DL				Peng, Xinjian; Li, Wenping; Yuan, Liang; Mehta, Rajendra G.; Kopelovich, Levy; McCormick, David L.			Inhibition of Proliferation and Induction of Autophagy by Atorvastatin in PC3 Prostate Cancer Cells Correlate with Downregulation of Bcl2 and Upregulation of miR-182 and p21	PLOS ONE			English	Article							VITAMIN-D; STATINS; EXPRESSION; GENE; MICRORNA-182; PROGRESSION; CELECOXIB; INVASION; PATHWAY; TARGETS	The epidemiologic association between statin use and decreased risk of advanced prostate cancer suggests that statins may inhibit prostate cancer development and/or progression. Studies were performed to determine the effects of a model statin, atorvastatin ( ATO), on the proliferation and differentiation of prostate cancer cells, and to identify possible mechanisms of ATO action. ATO inhibited the in vitro proliferation of both LNCaP and PC3 human prostate cancer cells in a dose- and time-dependent fashion. The greater inhibitory activity of ATO in PC3 cells was associated with induction of autophagy in that cell line, as demonstrated by increased expression of LC3-II. miR-182 was consistently upregulated by ATO in PC3 cells, but not in LNCaP cells. ATO upregulation of miR-182 in PC3 cells was p53-independent and was reversed by geranylgeraniol. Transfection of miR-182 inhibitors decreased expression of miR-182 by > 98% and attenuated the antiproliferative activity of ATO. miR-182 expression in PC3 cells was also increased in response to stress induced by serum withdrawal, suggesting that miR-182 upregulation can occur due to nutritional stress. Bcl2 and p21 were identified to be potential target genes of miR-182 in PC3 cells. Bcl2 was downregulated and p21 was upregulated in PC3 cells exposed to ATO. These data suggest that miR-182 may be a stress-responsive miRNA that mediates ATO action in prostate cancer cells.	[Peng, Xinjian; Li, Wenping; Yuan, Liang; Mehta, Rajendra G.; McCormick, David L.] IIT Res Inst, Life Sci Grp, Chicago, IL USA; [Kopelovich, Levy] NCI, Chemoprevent Agent Dev Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA	Illinois Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peng, XJ (corresponding author), IIT Res Inst, Life Sci Grp, Chicago, IL USA.	xpeng@iitri.org		Li, Wenping/0000-0001-5917-5380	Division of Cancer Prevention, National Cancer Institute, Department of Health and Human Services [N01-CN-43303]	Division of Cancer Prevention, National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by contract N01-CN-43303 from the Division of Cancer Prevention, National Cancer Institute, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Bansal D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046691; Davis CD, 2008, NUTR REV, V66, P477, DOI 10.1111/j.1753-4887.2008.00080.x; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garcia-Ruiz C, 2012, ANTI-CANCER AGENT ME, V12, P303, DOI 10.2174/187152012800228715; Schoof CRG, 2012, AM J CANCER RES, V2, P414; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hu Wenwei, 2012, Genes Cancer, V3, P199, DOI 10.1177/1947601912454734; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kong WQ, 2012, FEBS J, V279, P1252, DOI 10.1111/j.1742-4658.2012.08519.x; Lages E, 2012, FRONT BIOSCI-LANDMRK, V17, P2508, DOI 10.2741/4068; Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Li MX, 2012, N-S ARCH PHARMACOL, V385, P961, DOI 10.1007/s00210-012-0768-5; Li X, 2012, INT J BIOL SCI, V8, P901, DOI 10.7150/ijbs.4554; Lin YC, 2008, CANCER RES, V68, P2375, DOI 10.1158/0008-5472.CAN-07-5807; Marino ML, 2012, J BIOL CHEM, V287, P30664, DOI 10.1074/jbc.M112.339127; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Peng XJ, 2006, CANCER RES, V66, P7361, DOI 10.1158/0008-5472.CAN-06-1004; Peng XJ, 2012, J ENDOCRINOL, V212, P207, DOI 10.1530/JOE-11-0305; Peng XJ, 2010, J CELL BIOCHEM, V110, P1324, DOI 10.1002/jcb.22646; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Rasheed SAK, 2013, J BIOL CHEM, V288, P7986, DOI 10.1074/jbc.M112.437749; Reboulleau A, 2012, J MOL CELL CARDIOL, V53, P196, DOI 10.1016/j.yjmcc.2012.05.015; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Roy M, 2011, AM J CANCER RES, V1, P542; Sassano A, 2008, CANCER LETT, V260, P11, DOI 10.1016/j.canlet.2007.11.036; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Shi Z, 2012, P NATL ACAD SCI USA, V109, P4568, DOI 10.1073/pnas.1202421109; Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Toepfer N, 2011, CANCER BIOL THER, V12, P691, DOI 10.4161/cbt.12.8.15978; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Ware JH, 2007, ANTICANCER RES, V27, P1; Yan DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040967; Zhang LF, 2011, INT J MOL MED, V28, P381, DOI 10.3892/ijmm.2011.679; Zhang MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041412; Zhang Y, 2013, UROL INT, V90, P259, DOI 10.1159/000341977; Zheng X, 2011, EXP THER MED, V2, P221, DOI 10.3892/etm.2011.203; Zheng X, 2010, CANCER PREV RES, V3, P114, DOI 10.1158/1940-6207.CAPR-09-0059; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	45	68	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70442	10.1371/journal.pone.0070442	http://dx.doi.org/10.1371/journal.pone.0070442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936432	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400068
J	Tuduri, E; Bruin, JE; Denroche, HC; Fox, JK; Johnson, JD; Kieffer, TJ				Tuduri, Eva; Bruin, Jennifer E.; Denroche, Heather C.; Fox, Jessica K.; Johnson, James D.; Kieffer, Timothy J.			Impaired Ca2+ Signaling in beta-Cells Lacking Leptin Receptors by Cre-loxP Recombination	PLOS ONE			English	Article							INSULIN-SECRETION; CYTOPLASMIC CA2+; GENE-EXPRESSION; OSCILLATIONS; ISLETS; OBESE; MICE; RESISTANCE; AUTOPHAGY; SUPPRESSION	Obesity is a major risk factor for diabetes and is typically associated with hyperleptinemia and a state of leptin resistance. The impact of chronically elevated leptin levels on the function of insulin-secreting beta-cells has not been elucidated. We previously generated mice lacking leptin signaling in beta-cells by using the Cre-loxP strategy and showed that these animals develop increased body weight and adiposity, hyperinsulinemia, impaired glucose-stimulated insulin secretion and insulin resistance. Here, we performed several in vitro studies and observed that beta-cells lacking leptin signaling in this model are capable of properly metabolizing glucose, but show impaired intracellular Ca2+ oscillations and lack of synchrony within the islets in response to glucose, display reduced response to tolbutamide and exhibit morphological abnormalities including increased autophagy. Defects in intracellular Ca2+ signaling were observed even in neonatal islets, ruling out the possible contribution of obesity to the beta-cell irregularities observed in adults. In parallel, we also detected a disrupted intracellular Ca2+ pattern in response to glucose and tolbutamide in control islets from adult transgenic mice expressing Cre recombinase under the rat insulin promoter, despite these animals being glucose tolerant and secreting normal levels of insulin in response to glucose. This unexpected observation impeded us from discerning the consequences of impaired leptin signaling as opposed to long-term Cre expression in the function of insulin-secreting cells. These findings highlight the need to generate improved Cre-driver mouse models or new tools to induce Cre recombination in beta-cells.	[Tuduri, Eva; Bruin, Jennifer E.; Denroche, Heather C.; Fox, Jessica K.; Johnson, James D.; Kieffer, Timothy J.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Johnson, James D.; Kieffer, Timothy J.] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Kieffer, TJ (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	tim.kieffer@ubc.ca	Tudurí, Eva/I-2652-2015	Tudurí, Eva/0000-0001-8999-2605; Bruin, Jennifer/0000-0003-2326-7819; Denroche, Heather/0000-0002-0976-2656	Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Canadian Diabetes Association postdoctoral fellowships; Juvenile Diabetes Research Foundation postdoctoral fellowship; L'Oreal Canada for Women in Science Research Excellence Fellowship; CIHR Transplantation Training Program; National Science and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Diabetes Association postdoctoral fellowships; Juvenile Diabetes Research Foundation postdoctoral fellowship(Juvenile Diabetes Research Foundation); L'Oreal Canada for Women in Science Research Excellence Fellowship; CIHR Transplantation Training Program(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research (CIHR). TJK is grateful for a senior scholarship from the Michael Smith Foundation for Health Research (MSFHR). ET has been supported by MSFHR and Canadian Diabetes Association postdoctoral fellowships. JEB is supported by a Juvenile Diabetes Research Foundation postdoctoral fellowship, L'Oreal Canada for Women in Science Research Excellence Fellowship, and the CIHR Transplantation Training Program. HCD is supported by the dNational Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2011, FASEB J, V25, P3884, DOI 10.1096/fj.10-180349; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Bloomgarden ZT, 2000, DIABETES CARE, V23, P118, DOI 10.2337/diacare.23.1.118; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Dabernat S, 2009, DIABETOLOGIA, V52, P1608, DOI 10.1007/s00125-009-1411-y; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Fex M, 2007, J ENDOCRINOL, V194, P551, DOI 10.1677/JOE-07-0161; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; GarciaBarrado MJ, 1996, EUR J PHARMACOL, V298, P279, DOI 10.1016/0014-2999(95)00806-3; GILON P, 1993, J BIOL CHEM, V268, P22265; Gustavsson N, 2006, J ENDOCRINOL, V190, P461, DOI 10.1677/joe.1.06794; HALBAN PA, 1991, DIABETOLOGIA, V34, P767, DOI 10.1007/BF00408349; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Jung UJ, 2007, FOOD CHEM TOXICOL, V45, P2022, DOI 10.1016/j.fct.2007.04.021; Kieffer TJ, 1996, BIOCHEM BIOPH RES CO, V224, P522, DOI 10.1006/bbrc.1996.1059; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Liang Y, 2001, INT J OBESITY, V25, P698, DOI 10.1038/sj.ijo.0801614; Marroqui L, 2011, DIABETOLOGIA, V54, P843, DOI 10.1007/s00125-010-2024-1; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; McMinn JE, 2004, MAMM GENOME, V15, P677, DOI 10.1007/s00335-004-2340-1; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ravier MA, 2002, DIABETOLOGIA, V45, P1154, DOI 10.1007/s00125-002-0883-9; ROE MW, 1994, J BIOL CHEM, V269, P18279; Roe MW, 1996, AM J PHYSL, V270, pE133; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; ROSARIO LM, 1985, Q J EXP PHYSIOL CMS, V70, P137, DOI 10.1113/expphysiol.1985.sp002885; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152; Seufert J, 1999, J CLIN ENDOCR METAB, V84, P670, DOI 10.1210/jc.84.2.670; Seufert J, 1999, P NATL ACAD SCI USA, V96, P674, DOI 10.1073/pnas.96.2.674; SKOGLUND G, 1987, DIABETES RES CLIN EX, V6, P81; Tuduri E, 2009, DIABETES, V58, P1616, DOI 10.2337/db08-1787; Uchizono Y, 2007, DIABETES OBES METAB, V9, P56, DOI 10.1111/j.1463-1326.2007.00774.x; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vishesh A, 2008, DIABETES OBES METAB, V10, P973, DOI 10.1111/j.1463-1326.2008.00852.x; Widdowson PS, 1997, DIABETES, V46, P1782, DOI 10.2337/diabetes.46.11.1782	43	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71075	10.1371/journal.pone.0071075	http://dx.doi.org/10.1371/journal.pone.0071075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936486	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400092
J	Brunkhorst, R; Kanaan, N; Koch, A; Ferreiros, N; Mirceska, A; Zeiner, P; Mittelbronn, M; Derouiche, A; Steinmetz, H; Foerch, C; Pfeilschifter, J; Pfeilschifter, W				Brunkhorst, Robert; Kanaan, Nathalie; Koch, Alexander; Ferreiros, Nerea; Mirceska, Ana; Zeiner, Pia; Mittelbronn, Michel; Derouiche, Amin; Steinmetz, Helmuth; Foerch, Christian; Pfeilschifter, Josef; Pfeilschifter, Waltraud			FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; SPHINGOSINE 1-PHOSPHATE; MATRIX METALLOPROTEINASES; DENDRITIC SPINES; SPHINGOSINE-1-PHOSPHATE; AREA; PLASTICITY; ANGIOGENESIS; ACTIVATION	Background: The Sphingosine-1-phosphate (S1P) signaling pathway is known to influence pathophysiological processes within the brain and the synthetic S1P analog FTY720 has been shown to provide neuroprotection in experimental models of acute stroke. However, the effects of a manipulation of S1P signaling at later time points after experimental stroke have not yet been investigated. We examined whether a relatively late initiation of a FTY720 treatment has a positive effect on long-term neurological outcome with a focus on reactive astrogliosis, synapses and neurotrophic factors. Methods: We induced photothrombotic stroke (PT) in adult C57BL/6J mice and allowed them to recover for three days. Starting on post-stroke day 3, mice were treated with FTY720 (1 mg/kg b.i.d.) for 5 days. Behavioral outcome was observed until day 31 after photothrombosis and periinfarct cortical tissue was analyzed using tandem mass-spectrometry, TaqMan (R) analysis and immunofluorescence. Results: FTY720 treatment results in a significantly better functional outcome persisting up to day 31 after PT. This is accompanied by a significant decrease in reactive astrogliosis and larger post-synaptic densities as well as changes in the expression of vascular endothelial growth factor alpha (VEGF alpha). Within the periinfarct cortex, S1P is significantly increased compared to healthy brain tissue. Conclusion: Besides its known neuroprotective effects in the acute phase of experimental stroke, the initiation of FTY720 treatment in the convalescence period has a positive impact on long-term functional outcome, probably mediated through reduced astrogliosis, a modulation in synaptic morphology and an increased expression of neurotrophic factors.	[Brunkhorst, Robert; Kanaan, Nathalie; Zeiner, Pia; Steinmetz, Helmuth; Foerch, Christian; Pfeilschifter, Waltraud] Goethe Univ Hosp, Dept Neurol, Frankfurt, Germany; [Brunkhorst, Robert; Kanaan, Nathalie; Koch, Alexander; Mirceska, Ana; Pfeilschifter, Josef; Pfeilschifter, Waltraud] Goethe Univ Hosp, Dept Gen Pharmacol & Toxicol, Frankfurt, Germany; [Ferreiros, Nerea] Goethe Univ Hosp, Dept Clin Pharmacol, Frankfurt, Germany; [Zeiner, Pia; Mittelbronn, Michel] Goethe Univ Hosp, Dept Neuropathol, Frankfurt, Germany; [Derouiche, Amin] Goethe Univ Hosp, Dept Anat 2, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Brunkhorst, R (corresponding author), Goethe Univ Hosp, Dept Neurol, Frankfurt, Germany.	robert.brunkhorst@kgu.de	Koch, Alexander/C-6532-2014; Derouiche, Amin/G-7390-2015	Derouiche, Amin/0000-0002-7309-2044; Mittelbronn, Michel/0000-0002-2998-052X	Medical Faculty of the Goethe-University (Patenschaftsmodell); German Research Foundation [FOG 784, PF361/7-1]; Hans Kroner Graduate School	Medical Faculty of the Goethe-University (Patenschaftsmodell); German Research Foundation(German Research Foundation (DFG)); Hans Kroner Graduate School	R. Brunkhorst was supported by a stipend of the Medical Faculty of the Goethe-University (Patenschaftsmodell). J. Pfeilschifter was supported by the German Research Foundation (FOG 784 and PF361/7-1). J. Pfeilschifter and W. Pfeilschifter were supported by the Hans Kroner Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Barouk S, 2011, ENDOCRINOLOGY, V152, P1745, DOI 10.1210/en.2010-1290; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chang YY, 1999, NEUROSCI LETT, V277, P61, DOI 10.1016/S0304-3940(99)00799-5; Choi JW, 2010, P NATL ACAD SCI USA; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Dumitriu D, 2012, J NEUROSCI METH, V209, P97, DOI 10.1016/j.jneumeth.2012.05.031; Fischer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023905; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Hermann DM, 2009, J CEREBR BLOOD F MET, V29, P1620, DOI 10.1038/jcbfm.2009.100; Karetko-Sysa M, 2011, EXP NEUROL, V231, P113, DOI 10.1016/j.expneurol.2011.05.022; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; KHARLAMOV A, 1993, J NEUROSCI, V13, P2483, DOI 10.1523/JNEUROSCI.13-06-02483.1993; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kimura A, 2008, STROKE, V39, P3411, DOI 10.1161/STROKEAHA.108.514612; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Masuko K, 2012, INT J RHEUM DIS, V15, P366, DOI 10.1111/j.1756-185X.2012.01756.x; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Norimatsu Y, 2012, AM J PATHOL, V180, P1625, DOI 10.1016/j.ajpath.2011.12.012; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Pebay A, 2001, Eur J Neurosci, V13, P2067; Porritt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041090; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schmid G, 2007, J CELL BIOCHEM, V101, P259, DOI 10.1002/jcb.21181; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; SNAPE MF, 1993, NEUROSCIENCE, V53, P837, DOI 10.1016/0306-4522(93)90628-S; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Sun HY, 2010, BIOCHEM BIOPH RES CO, V395, P361, DOI 10.1016/j.bbrc.2010.04.019; Van Hoecke M, 2005, EUR J NEUROSCI, V22, P1045, DOI 10.1111/j.1460-9568.2005.04297.x; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Yatomi Y, 1997, J BIOCHEM, V121, P969; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	44	44	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70124	10.1371/journal.pone.0070124	http://dx.doi.org/10.1371/journal.pone.0070124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936150	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700055
J	Henriques, A; Alves, E; Barros, H; Azevedo, A				Henriques, Ana; Alves, Elisabete; Barros, Henrique; Azevedo, Ana			Women's Satisfaction with Body Image before Pregnancy and Body Mass Index 4 Years after Delivery in the Mothers of Generation XXI	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; PREPREGNANCY OBESITY; PREVALENCE; DISSATISFACTION; POSTPARTUM; OVERWEIGHT; EPIDEMIOLOGY; TRENDS; IMPACT; ADULTS	Background: Body image satisfaction (BIS) influences body weight regulation and may contribute to long-term healthier lifestyle after pregnancy. Thus, we aimed to assess the association between BIS before pregnancy and body mass index (BMI) 4 years after the index pregnancy. Methods: As part of the follow-up of a birth cohort, 3612 women with prepregnancy BMI >18.5 kg/m(2) were reevaluated 4 years after the birth of a child. BIS was defined as the difference between perceived and ideal body size before pregnancy, assessed by Stunkard Silhouettes after birth. The associations of BIS with BMI change (continuous) and BMI classes at 4 years, based on measured weight and height, were estimated using linear and multinomial regression, respectively. Results: Among women with normal prepregnancy BMI, those who felt too small, regarding their ideal, had a 0.25 kg/m(2) smaller increase in BMI within 4 years and a lower likelihood of becoming overweight or obese [multivariate-adjusted odds ratio (OR) = 0.63; 95% confidence interval (95% CI): 0.44-0.91 and OR = 0.21; 95% CI: 0.05-0.91, respectively) than those satisfied with body image. Feeling too large was associated with a 0.41 kg/m(2) larger increase in BMI and a higher risk of becoming overweight or obese (OR = 2.12; 95% CI: 1.73-2.59 and OR = 3.42; 95% CI: 2.02-5.79, respectively). A similar, nonsignificant, trend was observed for overweight women. Obese women who felt too large had a non-significant decrease in BMI. Conclusions: BIS plays a role in maternal body weight after delivery. Realistic body size goals may promote the motivation to lose weight and contribute to higher success in attaining them.	[Henriques, Ana; Alves, Elisabete; Barros, Henrique; Azevedo, Ana] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal; [Henriques, Ana; Alves, Elisabete; Barros, Henrique; Azevedo, Ana] Univ Porto, Inst Publ Hlth, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Henriques, A (corresponding author), Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	alhenriques@med.up.pt	Azevedo, Ana/AAA-2287-2020; Barros, Henrique/Q-8609-2019; Barros, Henrique/A-5488-2008	Azevedo, Ana/0000-0002-7368-9609; Barros, Henrique/0000-0003-4699-6571; Henriques, Ana/0000-0001-9484-1887; Alves, Elisabete/0000-0002-7738-0887	Programa Operacional de Saude, Saude XXI, Quadro Comunitario de Apoio III; Administracao Regional de Saude Norte; Fundacao Calouste Gulbenkian; Fundacao para a Ciencia e a Tecnologia [PIC/IC/83038/2007, SFRH/BD/72723/2010]	Programa Operacional de Saude, Saude XXI, Quadro Comunitario de Apoio III; Administracao Regional de Saude Norte; Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The cohort Generation XXI was funded by 'Programa Operacional de Saude, Saude XXI, Quadro Comunitario de Apoio III', by the 'Administracao Regional de Saude Norte' and by 'Fundacao Calouste Gulbenkian'. Grants from 'Fundacao para a Ciencia e a Tecnologia' (PIC/IC/83038/2007 and SFRH/BD/72723/2010) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTABE M, 1993, INT J EAT DISORDER, V13, P323; Alves E, 2012, INT J PUBLIC HEALTH, V57, P837, DOI 10.1007/s00038-012-0340-6; Baceviciene M, 2009, MEDICINA-LITHUANIA, V45, P565, DOI 10.3390/medicina45070075; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Benkeser R M, 2012, Ghana Med J, V46, P66; Boscaglia N, 2003, AUST NZ J OBSTET GYN, V43, P41, DOI 10.1046/j.0004-8666.2003.00016.x; Bulik CM, 2001, INT J OBESITY, V25, P1517, DOI 10.1038/sj.ijo.0801742; Carpenter KM, 2000, AM J PUBLIC HEALTH, V90, P251, DOI 10.2105/AJPH.90.2.251; Carreno-Luengo H., 2012, PUBLIC HEALTH NUTR, P1; Carryer J, 2001, Nurs Inq, V8, P90, DOI 10.1046/j.1440-1800.2001.00094.x; Cash TF, 2004, INT J EAT DISORDER, V35, P305, DOI 10.1002/eat.10264; Clark A, 2009, J HEALTH PSYCHOL, V14, P27, DOI 10.1177/1359105308097940; do Carmo I, 2008, OBES REV, V9, P11, DOI 10.1111/j.1467-789X.2007.00422.x; Dummer TJB, 2012, J OBES, V2012, DOI 10.1155/2012/934895; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gardner RM, 2009, J CLIN PSYCHOL, V65, P113, DOI 10.1002/jclp.20526; Gardner RM, 2000, PERCEPT MOTOR SKILL, V91, P819, DOI 10.2466/PMS.91.7.819-820; Gavin AR, 2010, J PSYCHOSOM RES, V69, P573, DOI 10.1016/j.jpsychores.2010.05.001; Gunderson EP, 2000, EPIDEMIOL REV, V22, P261, DOI 10.1093/oxfordjournals.epirev.a018038; Harris HE, 1997, INT J OBESITY, V21, P747, DOI 10.1038/sj.ijo.0800466; Harris HE, 1999, J PSYCHOSOM OBST GYN, V20, P65, DOI 10.3109/01674829909075579; Herring Sharon J, 2008, BMC Pregnancy Childbirth, V8, P54, DOI 10.1186/1471-2393-8-54; Hinkle SN, 2012, MATERN CHILD HLTH J, V16, P1339, DOI 10.1007/s10995-011-0898-2; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Instituto Nacional de Estatistica Instituto Nacional de Saude Doutor Ricardo Jorge, 2009, INQ NAC SAUD 2005 20; Janssen I, 2012, OBESITY, V20, P916, DOI 10.1038/oby.2011.122; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Linne Y, 2003, INT J OBESITY, V27, P1516, DOI 10.1038/sj.ijo.0802441; Lynch E, 2009, AM J EPIDEMIOL, V169, P857, DOI 10.1093/aje/kwn412; Mamun AA, 2010, AM J CLIN NUTR, V91, P1336, DOI 10.3945/ajcn.2009.28950; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mehta UJ, 2011, MATERN CHILD HLTH J, V15, P324, DOI 10.1007/s10995-010-0578-7; Morotti E, 2013, J SEX MED, V10, P1034, DOI 10.1111/jsm.12045; Olson CM, 2003, INT J OBESITY, V27, P117, DOI 10.1038/sj.ijo.0802156; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Pinto E, 2010, ANN EPIDEMIOL, V20, P599, DOI 10.1016/j.annepidem.2010.05.004; Ratcliff MB, 2012, SURG OBES RELAT DIS, V8, P470, DOI 10.1016/j.soard.2011.10.017; Rauff EL, 2011, ANN BEHAV MED, V42, P381, DOI 10.1007/s12160-011-9300-2; Santos AC, 2003, PUBLIC HEALTH, V117, P430, DOI 10.1016/S0033-3506(03)00139-2; Silva DAS, 2011, BODY IMAGE, V8, P427, DOI 10.1016/j.bodyim.2011.05.009; Schwartz Marlene B, 2004, Body Image, V1, P43, DOI 10.1016/S1740-1445(03)00007-X; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; STUNKARD AJ, 1992, AM J CLIN NUTR, V55, P524, DOI 10.1093/ajcn/55.2.524s; Teixeira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060168; Thompson J Kevin, 2004, Body Image, V1, P7, DOI 10.1016/S1740-1445(03)00004-4; Tiggemann Marika, 2004, Body Image, V1, P29, DOI 10.1016/S1740-1445(03)00002-0; Wade TD, 2003, PSYCHOL MED, V33, P1395, DOI 10.1017/S0033291703008572	47	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70230	10.1371/journal.pone.0070230	http://dx.doi.org/10.1371/journal.pone.0070230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936169	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700061
J	Lee, SJ; Han, BG; Cho, JW; Choi, JS; Lee, J; Song, HJ; Koh, JS; Lee, BI				Lee, Sang Jae; Han, Byeong-Gu; Cho, Jea-Won; Choi, Jang-Sik; Lee, Jaekyoo; Song, Ho-Juhn; Koh, Jong Sung; Lee, Byung Il			Crystal Structure of Pim1 Kinase in Complex with a Pyrido[4,3-D]Pyrimidine Derivative Suggests a Unique Binding Mode	PLOS ONE			English	Article							PROTOONCOGENE PIM-1; INHIBITORS; POTENT; DESIGN; TARGET	Human Pim1 kinase is a serine/threonine protein kinase that plays important biological roles in cell survival, apoptosis, proliferation, and differentiation. Moreover, Pim1 is up-regulated in various hematopoietic malignancies and solid tumors. Thus, Pim1 is an attractive target for cancer therapeutics, and there has been growing interest in developing small molecule inhibitors for Pim1. Here, we describe the crystal structure of Pim1 in complex with a newly developed pyrido[4,3-d]pyrimidine-derivative inhibitor (SKI-O-068). Our inhibitor exhibits a half maximum inhibitory concentration (IC50) of 123 (+/- 14) nM and has an unusual binding mode in complex with Pim1 kinase. The interactions between SKI-O-068 and the Pim1 active site pocket residue are different from those of other scaffold inhibitor-bound structures. The binding mode analysis suggests that the SKI-O-068 inhibitor can be improved by introducing functional groups that facilitate direct interaction with Lys67, which aid in the design of an optimized inhibitor.	[Lee, Sang Jae; Han, Byeong-Gu; Cho, Jea-Won; Lee, Byung Il] Natl Canc Ctr, Res Inst, Biomol Funct Res Branch, Goyang, Gyeonggi, South Korea; [Choi, Jang-Sik; Koh, Jong Sung] Oscotec Inc, Songnam, Gyeonggi, South Korea; [Lee, Jaekyoo; Song, Ho-Juhn; Koh, Jong Sung] Genosco, Cambridge, MA USA; [Lee, Sang Jae] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea	National Cancer Center - Korea (NCC); Seoul National University (SNU)	Koh, JS (corresponding author), Oscotec Inc, Songnam, Gyeonggi, South Korea.	jskob777@genosco.com; bilee@ncc.re.kr	Lee, Sang Jae/AAX-7611-2021	Lee, Sang Jae/0000-0002-5366-2900	National Cancer Center in Korea [1310400]; National Research Foundation (NRF) [NRF-2011-0029294, NRF-2011-0030032]; Ministry of Science, ICT & Future Planning of Korea; Fostering Next-Generation Researchers program; Ministry of Education [NRF-2011-355-C00118]	National Cancer Center in Korea; National Research Foundation (NRF); Ministry of Science, ICT & Future Planning of Korea; Fostering Next-Generation Researchers program; Ministry of Education	BIL was supported by a National Cancer Center Research Grant (1310400) from the National Cancer Center in Korea, and Mid-career Researcher Program (NRF-2011-0029294) and Bio & Medical Technology Development Program (NRF-2011-0030032) through the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning of Korea. SJL was supported by the Fostering Next-Generation Researchers program funded by the Ministry of Education (NRF-2011-355-C00118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheney IW, 2007, BIOORG MED CHEM LETT, V17, P1679, DOI 10.1016/j.bmcl.2006.12.086; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; FRIEDMANN M, 1992, ARCH BIOCHEM BIOPHYS, V298, P594, DOI 10.1016/0003-9861(92)90454-5; Grey R, 2009, BIOORG MED CHEM LETT, V19, P3019, DOI 10.1016/j.bmcl.2009.04.061; Holder S, 2007, MOL CANCER THER, V6, P163, DOI 10.1158/1535-7163.MCT-06-0397; Huber K, 2012, J MED CHEM, V55, P403, DOI 10.1021/jm201286z; Jacobs MD, 2005, J BIOL CHEM, V280, P13728, DOI 10.1074/jbc.M413155200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2005, J MOL BIOL, V348, P183, DOI 10.1016/j.jmb.2005.02.039; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lopez-Ramos M, 2010, FASEB J, V24, P3171, DOI 10.1096/fj.09-143743; Merkel Anna Lena, 2012, Expert Opin Investig Drugs, V21, P425, DOI 10.1517/13543784.2012.668527; MIURA O, 1994, BLOOD, V84, P4135, DOI 10.1182/blood.V84.12.4135.bloodjournal84124135; Morwick T, 2010, EXPERT OPIN THER PAT, V20, P193, DOI 10.1517/13543770903496442; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastor J, 2012, BIOORG MED CHEM LETT, V22, P1591, DOI 10.1016/j.bmcl.2011.12.130; Pierce AC, 2008, J MED CHEM, V51, P1972, DOI 10.1021/jm701248t; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846; Schenone S, 2010, CURR PHARM DESIGN, V16, P3964, DOI 10.2174/138161210794454996; Schulz MN, 2011, ACTA CRYSTALLOGR D, V67, P156, DOI 10.1107/S0907444910054144; Shafer CM, 2008, BIOORG MED CHEM LETT, V18, P4482, DOI 10.1016/j.bmcl.2008.07.061; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang Z, 2001, J Vet Sci, V2, P167; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Yan B, 2012, GASTRIC CANCER, V15, P188, DOI 10.1007/s10120-011-0097-2	36	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70358	10.1371/journal.pone.0070358	http://dx.doi.org/10.1371/journal.pone.0070358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936194	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700068
J	Bang, J; Jeon, WK; Lee, IS; Han, JS; Kim, BY				Bang, Jihye; Jeon, Won Kyung; Lee, In Sun; Han, Jung-Soo; Kim, Bu-Yeo			Biphasic Functional Regulation in Hippocampus of Rat with Chronic Cerebral Hypoperfusion Induced by Permanent Occlusion of Bilateral Common Carotid Artery	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; EXPRESSION; MODEL; TOOL; PATHWAYS; DEMENTIA; PROTEINS; DAMAGE; CELLS	Background: Chronic cerebral hypoperfusion induced by permanent occlusion of the bilateral common carotid artery (BCCAO) in rats has been commonly used for the study of Alzheimer's disease and vascular dementia. Despite the apparent cognitive dysfunction in rats with BCCAO, the molecular markers or pathways involved in the pathological alternation have not been clearly identified. Methods: Temporal changes (sham, 21, 35, 45, 55 and 70 days) in gene expression in the hippocampus of rats after BCCAO were measured using time-course microarray analysis. Gene Ontology (GO) and pathway analyses were performed to identify the functional involvement of temporally regulated genes in BCCAO. Results: Two major gene expression patterns were observed in the hippocampus of rats after BCCAO. One pattern, which was composed of 341 early up-regulated genes after the surgical procedure, was dominantly involved in immune-related biological functions (false discovery rate [FDR]<0.01). Another pattern composed of 182 temporally delayed down-regulated genes was involved in sensory perception such as olfactory and cognition functions (FDR<0.01). In addition to the two gene expression patterns, the temporal change of GO and the pathway activities using all differentially expressed genes also confirmed that an immune response was the main early change, whereas sensory functions were delayed responses. Moreover, we identified FADD and SOCS3 as possible core genes in the sensory function loss process using text-based mining and interaction network analysis. Conclusions: The biphasic regulatory mechanism first reported here could provide molecular evidence of BCCAO-induced impaired memory in rats as well as mechanism of the development of vascular dementia.	[Bang, Jihye; Jeon, Won Kyung; Lee, In Sun; Kim, Bu-Yeo] Korea Inst Oriental Med, Herbal Med Res Div, Taejon, South Korea; [Han, Jung-Soo] Konkuk Univ, Dept Biol Sci, Seoul, South Korea	Korea Institute of Oriental Medicine (KIOM); Konkuk University	Kim, BY (corresponding author), Korea Inst Oriental Med, Herbal Med Res Div, Taejon, South Korea.	buykim@kiom.re.kr		Han, Jung-Soo/0000-0001-8447-4518	Inter-Institutional Collaboration Research Program under the Korea Research Council of Fundamental Science & Technology (KRCF) [kiom-2010-2]	Inter-Institutional Collaboration Research Program under the Korea Research Council of Fundamental Science & Technology (KRCF)	This study was supported by a grant (kiom-2010-2) from the Inter-Institutional Collaboration Research Program under the Korea Research Council of Fundamental Science & Technology (KRCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Akhtar LN, 2010, J IMMUNOL, V185, P2393, DOI 10.4049/jimmunol.0903563; Alvaro-Bartolome M, 2011, NEUROSCIENCE, V196, P1, DOI 10.1016/j.neuroscience.2011.08.074; Becker KG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-61; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Choi Bo-Ryoung, 2011, Exp Neurobiol, V20, P92, DOI 10.5607/en.2011.20.2.92; Cosentino M, 2009, ALZ DIS ASSOC DIS, V23, P88, DOI 10.1097/WAD.0b013e318184807d; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Francis PJ, 2011, CLIN OPHTHALMOL, V5, P1127, DOI 10.2147/OPTH.S11627; Gisselbrecht S, 1999, EUR CYTOKINE NETW, V10, P463; He XL, 2012, EUR J PHARMACOL, V680, P41, DOI 10.1016/j.ejphar.2012.01.025; Johnson SA, 1996, EXP NEUROL, V138, P198, DOI 10.1006/exnr.1996.0058; Kasparova S, 2005, NEUROCHEM INT, V46, P601, DOI 10.1016/j.neuint.2005.02.006; Kitamura A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.033; Klegeris A, 2001, EXP GERONTOL, V36, P1179, DOI 10.1016/S0531-5565(00)00265-5; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Larsen KB, 2009, INT J DEV NEUROSCI, V27, P485, DOI 10.1016/j.ijdevneu.2009.04.004; Lee SY, 2012, GENOMICS, V99, P347, DOI 10.1016/j.ygeno.2012.04.004; NI JW, 1994, BRAIN RES, V653, P231, DOI 10.1016/0006-8993(94)90394-8; Pellicano M, 2012, J NEUROIMMUNOL, V242, P52, DOI 10.1016/j.jneuroim.2011.11.005; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ramos-Miguel A, 2010, EUR NEUROPSYCHOPHARM, V20, P49, DOI 10.1016/j.euroneuro.2009.08.005; Roman GC, 2002, MED CLIN N AM, V86, P477, DOI 10.1016/S0025-7125(02)00008-1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sloan CD, 2010, AM J MED GENET B, V153B, P1060, DOI 10.1002/ajmg.b.31078; Stevens WD, 2002, STROKE, V33, P1107, DOI 10.1161/01.STR.0000014204.05597.0C; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; van de Ven JP, 2013, NAT GENET, DOI [10.1038/ng.2640, DOI 10.1038/NG.2640.[]; Watanabe T, 2006, STROKE, V37, P1539, DOI 10.1161/01.STR.0000221783.08037.a9; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168	36	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70093	10.1371/journal.pone.0070093	http://dx.doi.org/10.1371/journal.pone.0070093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936146	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200057
J	Chang, HW; Lin, YW; Ho, HM; Lin, MH; Liu, CC; Shao, HY; Chong, P; Sia, C; Chow, YH				Chang, Hsuen-Wen; Lin, Yi-Wen; Ho, Hui-Min; Lin, Min-Han; Liu, Chia-Chyi; Shao, Hsiao-Yun; Chong, Pele; Sia, Charles; Chow, Yen-Hung			Protective Efficacy of VP1-Specific Neutralizing Antibody Associated with a Reduction of Viral Load and Pro-Inflammatory Cytokines in Human SCARB2-Transgenic Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LETHAL ENTEROVIRUS-71 INFECTION; INTRAVENOUS IMMUNOGLOBULIN; CYNOMOLGUS MONKEYS; NEWBORN MICE; CELL-CULTURE; VIRUS; CHILDREN; TAIWAN; ENCEPHALITIS	Hand-foot-mouth diseases (HFMD) caused by enterovirus 71 (EV71) and coxsackievirus 16 (CVA16) in children have now become a severe public health issue in the Asian-Pacific region. Recently we have successfully developed transgenic mice expressing human scavenger receptor class B member 2 (hSCARB2, a receptor of EV71 and CVA16) as an animal model for evaluating the pathogenesis of enterovirus infections. In this study, hSCARB2-transgenic mice were used to investigate the efficacy conferred by a previously described EV71 neutralizing antibody, N3. A single injection of N3 effectively inhibited the HFMD-like skin scurfs in mice pre-infected with clinical isolate of EV71 E59 (B4 genotype) or prevented severe limb paralysis and death in mice pre-inoculated with 5746 (C2 genotype). This protection was correlated with remarkable reduction of viral loads in the brain, spinal cord and limb muscles. Accumulated viral loads and the associated pro-inflammatory cytokines were all reduced. The protective efficacy of N3 was not observed in animals challenged with CVA16. This could be due to dissimilarity sequences of the neutralizing epitope found in CVA16. These results indicate N3 could be useful in treating severe EV71 infections and the hSCARB2-transgenic mouse could be used to evaluate the protective efficacy of potential anti-enterovirus agent candidates.	[Chang, Hsuen-Wen; Lin, Yi-Wen; Ho, Hui-Min; Lin, Min-Han; Liu, Chia-Chyi; Shao, Hsiao-Yun; Chong, Pele; Sia, Charles; Chow, Yen-Hung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan; [Lin, Yi-Wen] Natl Tsing Hua Univ, Inst Mol Med, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Chong, Pele; Sia, Charles] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Sia, C (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan.	siady@nhri.org.tw; choeyenh@nhri.org.tw	Chong, Pele/E-3855-2010; Sia, Dwo-Yuan/E-3860-2010; Liu, Chia-Chyi/A-8215-2012; Chow, Yen-Hung/E-3863-2010	Liu, Chia-Chyi/0000-0002-6257-0389; 	Taiwan National Science Council [100-2311-B-400-003-, 101-2311-B-400-002-]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Taiwan National Science Council's fundings (http://web1.nsc.gov.tw/), 100-2311-B-400-003- and 101-2311-B-400-002-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chang HW, 2011, J VIROL METHODS, V173, P189, DOI 10.1016/j.jviromet.2011.02.003; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Chou AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831282; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Fuller H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004883; GELLER TJ, 1995, J NEUROL SCI, V129, P131, DOI 10.1016/0022-510X(94)00261-L; HASHIMOTO I, 1978, ARCH VIROL, V56, P257, DOI 10.1007/BF01317855; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang YC, 2001, EUR J PEDIATR, V160, P91, DOI 10.1007/s004310000640; Hunt AR, 2006, J GEN VIROL, V87, P2467, DOI 10.1099/vir.0.81925-0; Jia CS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-47; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Khong WX, 2012, J VIROL; KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057591; Lin YW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030507, 10.1371/journal.pone.0052490]; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Liu QW, 2013, J VIROL METHODS, V187, P127, DOI 10.1016/j.jviromet.2012.09.024; Liu QW, 2011, J VIROL METHODS, V173, P115, DOI 10.1016/j.jviromet.2011.01.016; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Meng J, 1997, J CLIN MICROBIOL, V35, P1373, DOI 10.1128/JCM.35.6.1373-1377.1997; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; PULLI T, 1995, VIROLOGY, V212, P30, DOI 10.1006/viro.1995.1450; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Yajima T, 2011, FUTURE MICROBIOL, V6, P551, DOI [10.2217/FMB.11.40, 10.2217/fmb.11.40]; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yuan J, 2009, CIRC RES, V104, P628, DOI 10.1161/CIRCRESAHA.108.192179	43	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69858	10.1371/journal.pone.0069858	http://dx.doi.org/10.1371/journal.pone.0069858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936115	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200049
J	Kapur, NK; Paruchuri, V; Aronovitz, MJ; Qiao, XY; Mackey, EE; Daly, GH; Ughreja, K; Levine, J; Blanton, R; Hill, NS; Karas, RH				Kapur, Navin K.; Paruchuri, Vikram; Aronovitz, Mark J.; Qiao, Xiaoying; Mackey, Emily E.; Daly, Gerard H.; Ughreja, Kishan; Levine, Jonathan; Blanton, Robert; Hill, Nicholas S.; Karas, Richard H.			Biventricular Remodeling in Murine Models of Right Ventricular Pressure Overload	PLOS ONE			English	Article							RIGHT-HEART-FAILURE; GROWTH-FACTOR-BETA; TGF-BETA; CARDIAC-HYPERTROPHY; FIBROSIS; HYPERTENSION; DYSFUNCTION; INFARCTION; PATHWAY; DISEASE	Right ventricular (RV) failure is a major cause of mortality in acute or chronic lung disease and left heart failure. The objective of this study was to demonstrate a percutaneous approach to study biventricular hemodynamics in murine models of primary and secondary RV pressure overload (RVPO) and further explore biventricular expression of two key proteins that regulate cardiac remodeling: calcineurin and transforming growth factor beta 1 (TGF beta 1). Methods: Adult, male mice underwent constriction of the pulmonary artery or thoracic aorta as models of primary and secondary RVPO, respectively. Conductance catheterization was performed followed by tissue analysis for changes in myocyte hypertrophy and fibrosis. Results: Both primary and secondary RVPO decreased biventricular stroke work however RV instantaneous peak pressure (dP/dt(max)) and end-systolic elastance (Ees) were preserved in both groups compared to controls. In contrast, left ventricular (LV) dP/dt(max) and LV-Ees were unchanged by primary, but reduced in the secondary RVPO group. The ratio of RV: LV ventriculo-arterial coupling was increased in primary and reduced in secondary RVPO. Primary and secondary RVPO increased RV mass, while LV mass decreased in primary and increased in the secondary RVPO groups. RV fibrosis and hypertrophy were increased in both groups, while LV fibrosis and hypertrophy were increased in secondary RVPO only. RV calcineurin expression was increased in both groups, while LV expression increased in secondary RVPO only. Biventricular TGFb1 expression was increased in both groups. Conclusion: These data identify distinct effects of primary and secondary RVPO on biventricular structure, function, and expression of key remodeling pathways.	[Kapur, Navin K.; Paruchuri, Vikram; Aronovitz, Mark J.; Qiao, Xiaoying; Mackey, Emily E.; Daly, Gerard H.; Ughreja, Kishan; Levine, Jonathan; Blanton, Robert; Hill, Nicholas S.; Karas, Richard H.] Tufts Univ, Sch Med, Mol Cardiol Res Inst, Boston, MA 02111 USA	Tufts University	Kapur, NK (corresponding author), Tufts Univ, Sch Med, Mol Cardiol Res Inst, Boston, MA 02111 USA.	Nkapur@tuftsmedicalcenter.org			National Institutes of Health [K08HL094909-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL094909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant from the National Institutes of Health (K08HL094909-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANOI H, 1989, CIRC RES, V65, P483, DOI 10.1161/01.RES.65.2.483; Bartelds B, 2011, EUR J HEART FAIL, V13, P1275, DOI 10.1093/eurjhf/hfr134; Bi WR, 2012, HEPATO-GASTROENTEROL, V59, P1960, DOI 10.5754/hge11750; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Bristow MR, 1998, CHEST, V114, p101S, DOI 10.1378/chest.114.1_Supplement.101S; Bursi F, 2012, J AM COLL CARDIOL, V59, P222, DOI 10.1016/j.jacc.2011.06.076; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; DELLITALIA LJ, 1984, J AM COLL CARDIOL, V4, P931, DOI 10.1016/S0735-1097(84)80053-4; Drake JI, 2011, AM J RESP CELL MOL, V45, P1239, DOI 10.1165/rcmb.2010-0412OC; Feagins LA, 2010, INFLAMM BOWEL DIS, V16, P1963, DOI 10.1002/ibd.21281; Fiedler B, 2005, EXPERT OPIN THER TAR, V9, P963, DOI 10.1517/14728222.9.5.963; Frantz S, 2008, BASIC RES CARDIOL, V103, P485, DOI 10.1007/s00395-008-0739-7; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Georgescu SP, 2011, AM J PHYSIOL-CELL PH, V301, pC1046, DOI 10.1152/ajpcell.00211.2011; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Haddad F, 2011, CIRC-HEART FAIL, V4, P692, DOI 10.1161/CIRCHEARTFAILURE.110.949933; Hardziyenka M, 2011, J AM COLL CARDIOL, V57, P921, DOI 10.1016/j.jacc.2010.08.648; Hatton N, 2011, INT J CLIN PRACT, V65, P35, DOI 10.1111/j.1742-1241.2011.02726.x; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Johnson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020828; Kapur NK, 2012, CIRCULATION, V125, P2728, DOI 10.1161/CIRCULATIONAHA.111.080002; KASS DA, 1986, CIRCULATION, V73, P586, DOI 10.1161/01.CIR.73.3.586; KASS DA, 1987, CIRCULATION, V76, P1422, DOI 10.1161/01.CIR.76.6.1422; KONO A, 1984, CIRCULATION, V70, P1057, DOI 10.1161/01.CIR.70.6.1057; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MAUGHAN WL, 1987, AM J PHYSIOL, V253, pH1381, DOI 10.1152/ajpheart.1987.253.6.H1381; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Patten RD, 2008, J CARD FAIL, V14, P245, DOI 10.1016/j.cardfail.2007.10.024; ROCKMAN HA, 1994, P NATL ACAD SCI USA, V91, P2694, DOI 10.1073/pnas.91.7.2694; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; SUNAGAWA K, 1983, AM J PHYSIOL, V245, pH773, DOI 10.1152/ajpheart.1983.245.5.H773; Urashima T, 2008, AM J PHYSIOL-HEART C, V295, pH1351, DOI 10.1152/ajpheart.91526.2007; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381	37	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70802	10.1371/journal.pone.0070802	http://dx.doi.org/10.1371/journal.pone.0070802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936252	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200106
J	Boerma, M; Wang, JR; Sridharan, V; Herbert, JM; Hauer-Jensen, M				Boerma, Marjan; Wang, Junru; Sridharan, Vijayalakshmi; Herbert, Jean-Marc; Hauer-Jensen, Martin			Pharmacological Induction of Transforming Growth Factor-Beta1 in Rat Models Enhances Radiation Injury in the Intestine and the Heart	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; TGF-BETA IMMUNOREACTIVITY; GAMMA-IRRADIATION; MOLECULAR-BASIS; II RECEPTOR; ENTEROPATHY; FIBROSIS; TGF-BETA-1; ACTIVATION; INHIBITION	Radiation therapy in the treatment of cancer is dose limited by radiation injury in normal tissues such as the intestine and the heart. To identify the mechanistic involvement of transforming growth factor-beta 1 (TGF-beta 1) in intestinal and cardiac radiation injury, we studied the influence of pharmacological induction of TGF-beta 1 with xaliproden (SR 57746A) in rat models of radiation enteropathy and radiation-induced heart disease (RIHD). Because it was uncertain to what extent TGF-beta induction may enhance radiation injury in heart and intestine, animals were exposed to irradiation schedules that cause mild to moderate (acute) radiation injury. In the radiation enteropathy model, male Sprague-Dawley rats received local irradiation of a 4-cm loop of rat ileum with 7 once-daily fractions of 5.6 Gy, and intestinal injury was assessed at 2 weeks and 12 weeks after irradiation. In the RIHD model, male Sprague-Dawley rats received local heart irradiation with a single dose of 18 Gy and were followed for 6 months after irradiation. Rats were treated orally with xaliproden starting 3 days before irradiation until the end of the experiments. Treatment with xaliproden increased circulating TGF-beta 1 levels by 300% and significantly induced expression of TGF-beta 1 and TGF-beta 1 target genes in the irradiated intestine and heart. Various radiation-induced structural changes in the intestine at 2 and 12 weeks were significantly enhanced with TGF-beta 1 induction. Similarly, in the RIHD model induction of TGF-beta 1 augmented radiation-induced changes in cardiac function and myocardial fibrosis. These results lend further support for the direct involvement of TGF-beta 1 in biological mechanisms of radiation-induced adverse remodeling in the intestine and the heart.	[Boerma, Marjan; Wang, Junru; Sridharan, Vijayalakshmi; Hauer-Jensen, Martin] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Herbert, Jean-Marc] Sanofi Aventis, Paris, France; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Surg Serv, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; Sanofi-Aventis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Boerma, M (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.	mboerma@uams.edu			National Institutes of Health [CA148679, CA71382]; American Cancer Society [RSG-10-125-01-CCE]; NATIONAL CANCER INSTITUTE [R37CA071382, R01CA071382, R01CA148679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (CA148679, CA71382) and the American Cancer Society (RSG-10-125-01-CCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Algranati D, 2011, AM J PHYSIOL-HEART C, V300, pH1090, DOI 10.1152/ajpheart.00473.2010; Anscher MS, 2008, INT J RADIAT ONCOL, V71, P829, DOI 10.1016/j.ijrobp.2008.02.046; BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Barcellos-Hoff MH, 1998, RADIAT RES, V150, pS109, DOI 10.2307/3579813; BARNARD JA, 1989, P NATL ACAD SCI USA, V86, P1578, DOI 10.1073/pnas.86.5.1578; Boerma M, 2005, CANCER RES, V65, P3100, DOI 10.1158/0008-5472.CAN-04-4333; Boerma M, 2004, ONCOL REP, V12, P213; Bourrie B, 1999, P NATL ACAD SCI USA, V96, P12855, DOI 10.1073/pnas.96.22.12855; CROCI T, 1995, BRIT J PHARMACOL, V115, P203, DOI 10.1111/j.1476-5381.1995.tb16340.x; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Ehrhart EJ, 1997, FASEB J, V11, P991, DOI 10.1096/fasebj.11.12.9337152; Flechsig P, 2012, CLIN CANCER RES, V18, P3616, DOI 10.1158/1078-0432.CCR-11-2855; Fleenor BS, 2010, J PHYSIOL-LONDON, V588, P3971, DOI 10.1113/jphysiol.2010.194753; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Hamama S, 2012, RADIOTHER ONCOL, V105, P305, DOI 10.1016/j.radonc.2012.08.023; Hauer-Jensen Martin, 2007, Curr Opin Support Palliat Care, V1, P23, DOI 10.1097/SPC.0b013e3281108014; HAUERJENSEN M, 1988, INT J RADIAT ONCOL, V14, P1205, DOI 10.1016/0360-3016(88)90399-9; Imaizumi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011084; JEWELL BR, 1968, ANNU REV PHARMACOLOG, V8, P113, DOI 10.1146/annurev.pa.08.040168.000553; KIRK ES, 1964, AM J PHYSIOL, V207, P361, DOI 10.1152/ajplegacy.1964.207.2.361; Konkel JE, 2011, TRENDS MOL MED, V17, P668, DOI 10.1016/j.molmed.2011.07.002; Kruse JJCM, 2009, RADIAT RES, V171, P188, DOI 10.1667/RR1526.1; KUROKOWA M, 1987, BIOCHEM BIOPH RES CO, V142, P775, DOI 10.1016/0006-291X(87)91481-1; Langberg CW, 1996, ACTA ONCOL, V35, P81, DOI 10.3109/02841869609098484; LANGBERG CW, 1994, CANCER-AM CANCER SOC, V73, P2663, DOI 10.1002/1097-0142(19940515)73:10<2663::AID-CNCR2820731031>3.0.CO;2-C; LAUK S, 1990, INT J RADIAT BIOL, V57, P1017, DOI 10.1080/09553009014551131; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Milliat F, 2006, AM J PATHOL, V169, P1484, DOI 10.2353/ajpath.2006.060116; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Pejchal J, 2012, INT J RADIAT BIOL, V88, P348, DOI 10.3109/09553002.2012.654044; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Porzner M, 2009, EXPERT OPIN INV DRUG, V18, P1765, DOI 10.1517/13543780903329089; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; Richter KK, 1997, INT J RADIAT ONCOL, V39, P187, DOI 10.1016/S0360-3016(97)00290-3; Richter KK, 1996, RADIOTHER ONCOL, V39, P243, DOI 10.1016/0167-8140(95)01735-6; Rodemann HP, 1996, KIDNEY INT, V49, pS32; Scharpfenecker M, 2012, RADIOTHER ONCOL, V105, P313, DOI 10.1016/j.radonc.2012.08.021; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sie MPS, 2007, J HUM HYPERTENS, V21, P431, DOI 10.1038/sj.jhh.1002175; Theis VS, 2010, CLIN ONCOL-UK, V22, P70, DOI 10.1016/j.clon.2009.10.003; Vallance BA, 2005, AM J PHYSIOL-GASTR L, V289, pG116, DOI 10.1152/ajpgi.00051.2005; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Wang J, 2004, J THROMB HAEMOST, V2, P2027, DOI 10.1111/j.1538-7836.2004.00960.x; Wang JR, 1998, AM J PATHOL, V153, P1531, DOI 10.1016/S0002-9440(10)65741-0; Wang JR, 2006, INT J RADIAT ONCOL, V64, P1528, DOI 10.1016/j.ijrobp.2005.12.035; Wang JR, 1999, RADIOTHER ONCOL, V50, P205, DOI 10.1016/S0167-8140(98)00113-3; Wang JR, 2001, J PHARMACOL EXP THER, V297, P35; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yamada Y, 2013, DIG DIS SCI IN PRESS; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zheng H, 2000, GASTROENTEROLOGY, V119, P1286, DOI 10.1053/gast.2000.19282	59	39	49	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70479	10.1371/journal.pone.0070479	http://dx.doi.org/10.1371/journal.pone.0070479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936211	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300102
J	Liang, YW; Pan, JM				Liang, Yinwen; Pan, Junmin			Regulation of Flagellar Biogenesis by a Calcium Dependent Protein Kinase in Chlamydomonas reinhardtii	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT; GENE-EXPRESSION; PRIMARY CILIUM; CYCLIC-AMP; IFT CARGO; REGENERATION; LENGTH; PHOSPHORYLATION; ELONGATION; CALMODULIN	Chlamydomonas reinhardtii, a bi-flagellated green alga, is a model organism for studies of flagella or cilia related activities including cilia-based signaling, flagellar motility and flagellar biogenesis. Calcium has been shown to be a key regulator of these cellular processes whereas the signaling pathways linking calcium to these cellular functions are less understood. Calcium-dependent protein kinases (CDPKs), which are present in plants but not in animals, are also present in ciliated microorganisms which led us to examine their possible functions and mechanisms in flagellar related activities. By in silico analysis of Chlamydomonas genome we have identified 14 CDPKs and studied one of the flagellar localized CDPKs - CrCDPK3. CrCDPK3 was a protein of 485 amino acids and predicted to have a protein kinase domain at the N-terminus and four EF-hand motifs at the C-terminus. In flagella, CrCDPK3 was exclusively localized in the membrane matrix fraction and formed an unknown 20 S protein complex. Knockdown of CrCDPK3 expression by using artificial microRNA did not affect flagellar motility as well as flagellar adhesion and mating. Though flagellar shortening induced by treatment with sucrose or sodium pyrophosphate was not affected in RNAi strains, CrCDPK3 increased in the flagella, and pre-formed protein complex was disrupted. During flagellar regeneration, CrCDPK3 also increased in the flagella. When extracellular calcium was lowered to certain range by the addition of EGTA after deflagellation, flagellar regeneration was severely affected in RNAi cells compared with wild type cells. In addition, during flagellar elongation induced by LiCl, RNAi cells exhibited early onset of bulbed flagella. This work expands new functions of CDPKs in flagellar activities by showing involvement of CrCDPK3 in flagellar biogenesis in Chlamydomonas.	[Liang, Yinwen; Pan, Junmin] Tsinghua Univ, Sch Life Sci, Key Lab Prot Sci, Minist Environm, Beijing 100084, Peoples R China	Tsinghua University	Pan, JM (corresponding author), Tsinghua Univ, Sch Life Sci, Key Lab Prot Sci, Minist Environm, Beijing 100084, Peoples R China.	panjunmin@tsinghua.edu.cn	Liang, Yinwen/U-2734-2019; Pan, Junmin/H-2673-2014	Liang, Yinwen/0000-0002-9945-3768	National Basic Research Program of China (973 program) [2012CB945003, 2013CB910700]; National Natural Science Foundation of China [30830057, 30988004]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 program) (2012CB945003, 2013CB910700) and National Natural Science Foundation of China (Grants 30830057, 30988004) (to JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; BLOODGOOD RA, 1986, J CELL BIOL, V102, P1797, DOI 10.1083/jcb.102.5.1797; BLOODGOOD RA, 1992, EXP CELL RES, V198, P228, DOI 10.1016/0014-4827(92)90375-I; BLOODGOOD RA, 1990, J CELL SCI, V96, P27; Boesger J, 2009, EUKARYOT CELL, V8, P922, DOI 10.1128/EC.00067-09; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Cao MQ, 2009, METHOD CELL BIOL, V94, P333, DOI 10.1016/S0091-679X(08)94017-6; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; CHESHIRE JL, 1991, J CELL BIOL, V115, P1651, DOI 10.1083/jcb.115.6.1651; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GOODENOUGH UW, 1993, J CELL BIOL, V121, P365, DOI 10.1083/jcb.121.2.365; GUNDERSEN RE, 1987, J BIOL CHEM, V262, P4602; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; KAMIYA R, 1984, J CELL BIOL, V98, P97, DOI 10.1083/jcb.98.1.97; KOOIJMAN R, 1990, PLANTA, V181, P529, DOI 10.1007/BF00193006; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; LEFEBVRE PA, 1986, ANNU REV CELL BIOL, V2, P517, DOI 10.1146/annurev.cb.02.110186.002505; LEFEBVRE PA, 1978, J CELL BIOL, V78, P8, DOI 10.1083/jcb.78.1.8; LEWIN RA, 1953, ANN NY ACAD SCI, V56, P1091, DOI 10.1111/j.1749-6632.1953.tb30293.x; Lipp P, 2011, COLD SPRING HARB PER, P3; Luo MN, 2011, CURR BIOL, V21, P586, DOI 10.1016/j.cub.2011.02.046; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; NAKAMURA S, 1987, CELL STRUCT FUNCT, V12, P369, DOI 10.1247/csf.12.369; Olivier-Mason A, 2013, DEVELOPMENT, V140, P1560, DOI 10.1242/dev.086249; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; Pan JM, 1996, PLANT PHYSIOL, V112, P303, DOI 10.1104/pp.112.1.303; Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4; Pan JM, 2003, J CELL SCI, V116, P2179, DOI 10.1242/jcs.00438; Pan JM, 2011, J PROTEOME RES, V10, P3830, DOI 10.1021/pr200428n; PASQUALE SM, 1987, J CELL BIOL, V105, P2279, DOI 10.1083/jcb.105.5.2279; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Periz G, 2007, EUKARYOT CELL, V6, P1411, DOI 10.1128/ec.00167-07; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; PORTZEHL H, 1964, BIOCHIM BIOPHYS ACTA, V79, P581, DOI 10.1016/0926-6577(64)90224-4; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; QUADER H, 1978, EXP CELL RES, V113, P295, DOI 10.1016/0014-4827(78)90369-5; Quarmby LM, 2004, INT REV CYTOL, V233, P47, DOI 10.1016/S0074-7696(04)33002-0; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; ROSENBAUM JL, 1967, J CELL BIOL, V34, P345, DOI 10.1083/jcb.34.1.345; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; SALISBURY JL, 1987, J CELL BIOL, V105, P1799, DOI 10.1083/jcb.105.4.1799; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Shimogawara K, 1998, GENETICS, V148, P1821; Siderius M, 1997, PLANTA, V202, P76, DOI 10.1007/s004250050105; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Smith EF, 2002, MOL BIOL CELL, V13, P3303, DOI 10.1091/mbc.E02-04-0185; SNELL WJ, 1982, J CELL BIOL, V94, P607, DOI 10.1083/jcb.94.3.607; SOLTER KM, 1978, NATURE, V275, P651, DOI 10.1038/275651a0; SON M, 1993, J BIOL CHEM, V268, P5940; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; TAM LW, 2013, MOL BIOL CELL, P83985; WANG L, 2013, J CELL SCI, P18346; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Wilson NF, 2004, EUKARYOT CELL, V3, P1307, DOI 10.1128/EC.3.5.1307-1319.2004; Witman George B., 1993, Trends in Cell Biology, V3, P403, DOI 10.1016/0962-8924(93)90091-E; ZHANG YH, 1991, J BIOL CHEM, V266, P22954; ZHANG YH, 1993, J BIOL CHEM, V268, P1786	75	33	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69902	10.1371/journal.pone.0069902	http://dx.doi.org/10.1371/journal.pone.0069902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936117	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300073
J	Yang, YX; Ma, W; Wu, D; Huang, Y; Li, HG; Zou, JH; Zhang, YJ; Feng, MF; Luo, JY				Yang, Yuxia; Ma, Wei; Wu, Dan; Huang, Yu; Li, Hongge; Zou, Junhua; Zhang, Yanju; Feng, Meifu; Luo, Jianyuan			MiR-17 Partly Promotes Hematopoietic Cell Expansion through Augmenting HIF-1 alpha in Osteoblasts	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; MICRORNAS; ERYTHROPOIESIS; IDENTIFICATION; OSTEOGENESIS; HYPOXIA; TARGET; OXYGEN; VIVO	Background: Hematopoietic stem cell (HSC) regulation is highly dependent on interactions with the marrow microenvironment, of which osteogenic cells play a crucial role. While evidence is accumulating for an important role of intrinsic miR-17 in regulating HSCs and HPCs, whether miR-17 signaling pathways are also necessary in the cell-extrinsic control of hematopoiesis hereto remains poorly understood. Methodology/Principal Findings: Using the immortalized clone with the characteristics of osteoblasts, FBMOB-hTERT, in vitro expansion, long-term culture initiating cell (LTC-IC) and non-obese diabetic/severe combined immunodeficient disease (NOD/SCID) mice repopulating cell (SRC) assay revealed that the ectopic expression of miR-17 partly promoted the ability of FBMOB-hTERT to support human cord blood (CB) CD34(+) cell expansion and maintain their multipotency. It also seemed that osteoblastic miR-17 was prone to cause a specific expansion of the erythroid lineage. Conversely, deficient expression of miR-17 partly inhibited the hematopoietic supporting ability of FBMOB-hTERT. We further identified that HIF-1 alpha is responsible for, at least in part, the promoted hematopoietic supporting ability of FBMOB-hTERT caused by miR-17. HIF-1 alpha expression is markedly enhanced in miR-17 overexpressed FBMOB-hTERT upon interaction with CB CD34(+) cells compared to other niche associated factors. More interestingly, the specific erythroid lineage expansion of CB CD34(+) cells caused by osteoblastic miR-17 was abrogated by HIF-1 alpha knock down. Conclusion/Significance: Our data demonstrated that CB CD34(+) cell expansion can be partly promoted by osteoblastic miR-17, and in particular, ectopic miR-17 can cause a specific expansion of the erythroid lineage through augmenting HIF-1 alpha in osteoblasts.	[Yang, Yuxia; Wu, Dan; Huang, Yu; Zou, Junhua; Luo, Jianyuan] Peking Univ, Sch Basic Med Sci, Dept Med Genet, Beijing 100871, Peoples R China; [Ma, Wei; Feng, Meifu] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Ma, Wei] Capital Univ Med Sci, Dept Histol & Embryol, Beijing, Peoples R China; [Li, Hongge] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Zhang, Yanju] Tianjin Cent Hosp Obstet & Gynecol, Tianjin, Peoples R China; [Luo, Jianyuan] Univ Maryland, Sch Med, Dept Pathol, Dept Med & Res Technol, Baltimore, MD 21201 USA	Peking University; Chinese Academy of Sciences; Institute of Zoology, CAS; Capital Medical University; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Maryland; University of Maryland Baltimore	Feng, MF (corresponding author), Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.	meifu41@gmail.com; JLuo@som.umaryland.edu	yang, yx/GZM-0464-2022; Li, Hongge/G-7594-2015; Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	National Natural Science Foundation of China [31201019]; Beijing Natural Science Foundation [5122022]; Leading Academic Discipline Project of Beijing Education Bureau [8910026970103004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Leading Academic Discipline Project of Beijing Education Bureau	This project was supported by the National Natural Science Foundation of China (31201019), Beijing Natural Science Foundation (5122022) and Leading Academic Discipline Project of Beijing Education Bureau (8910026970103004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; He M, 2013, CELL DEATH DIFFER, V20, P408, DOI 10.1038/cdd.2012.130; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Hu Y, 2012, BIOMATERIALS, V33, P3515, DOI 10.1016/j.biomaterials.2012.01.040; Ivanovic Z, 2000, TRANSFUSION, V40, P1482, DOI 10.1046/j.1537-2995.2000.40121482.x; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Lekli I, 2009, CAN J PHYSIOL PHARM, V87, P989, DOI 10.1139/Y09-102; Liu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.65; Meenhuis A, 2011, BLOOD, V118, P916, DOI 10.1182/blood-2011-02-336487; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Pillai MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014304; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Ratajczak MZ, 2013, THERANOSTICS, V3, P3, DOI 10.7150/thno.4621; Roy S, 2012, EUR J HAEMATOL, V88, P396, DOI 10.1111/j.1600-0609.2012.01759.x; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Takagi S, 2012, BLOOD, V119, P2768, DOI 10.1182/blood-2011-05-353201; van Solingen C, 2011, CARDIOVASC RES, V92, P449, DOI 10.1093/cvr/cvr227; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yamashita A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009663; Yang YX, 2007, DIFFERENTIATION, V75, P24, DOI 10.1111/j.1432-0436.2006.00111.x; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	40	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70232	10.1371/journal.pone.0070232	http://dx.doi.org/10.1371/journal.pone.0070232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936170	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300096
J	Morocz, M; Gali, H; Rasko, I; Downes, CS; Haracska, L				Morocz, Monika; Gali, Himabindu; Rasko, Istvan; Downes, C. Stephen; Haracska, Lajos			Single Cell Analysis of Human RAD18-Dependent DNA Post-Replication Repair by Alkaline Bromodeoxyuridine Comet Assay	PLOS ONE			English	Article							HEAT-LABILE SITES; UV-DAMAGED DNA; TRANSLESION SYNTHESIS; UBIQUITIN LIGASE; REPLICATION FORK; HOMOLOGOUS RECOMBINATION; NUCLEAR ANTIGEN; HUMAN RAD18; S-PHASE; REQUIREMENT	Damage to DNA can block replication progression resulting in gaps in the newly synthesized DNA. Cells utilize a number of post-replication repair (PRR) mechanisms such as the RAD18 controlled translesion synthesis or template switching to overcome the discontinuities formed opposite the DNA lesions and to complete DNA replication. Gaining more insights into the role of PRR genes promotes better understanding of DNA damage tolerance and of how their malfunction can lead to increased genome instability and cancer. However, a simple and efficient method to characterise gene specific PRR deficiencies at a single cell level has not been developed. Here we describe the so named BrdU comet PRR assay to test the contribution of human RAD18 to PRR at a single cell level, by which we kinetically characterized the consequences of the deletion of human RAD18 on the replication of UV-damaged DNA. Moreover, we demonstrate the capability of our method to evaluate PRR at a single cell level in unsynchronized cell population.	[Morocz, Monika; Gali, Himabindu; Rasko, Istvan; Haracska, Lajos] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Downes, C. Stephen] Univ Ulster, Biomed Sci Res Inst, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Ulster University	Haracska, L (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary.	haracska@brc.hu	t, lf/AAJ-4924-2020		Hungarian Science Foundation [OTKA 101225, GOP-1.1.1-11-2012-0030, GOP-1.1.1-11-2012-0384]; IPA Cross-border Co-operation Programme [HUSRB/1002/214/126]	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); IPA Cross-border Co-operation Programme	This work was supported by the Hungarian Science Foundation grants (OTKA 101225, GOP-1.1.1-11-2012-0030 and GOP-1.1.1-11-2012-0384), and IPA Cross-border Co-operation Programme (HUSRB/1002/214/126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; CHRISTIE NT, 1984, CANCER RES, V44, P3665; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CLARK JM, 1984, MUTAT RES, V132, P1, DOI 10.1016/0167-8817(84)90061-0; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Collins Andrew R, 2002, Methods Mol Biol, V203, P163; Collins AR, 2011, METHODS MOL BIOL, V691, P137, DOI 10.1007/978-1-60761-849-2_8; Collins AR, 2009, MUTAT RES-REV MUTAT, V681, P24, DOI 10.1016/j.mrrev.2007.10.002; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Collins AR, 1997, MUTAT RES-FUND MOL M, V375, P183, DOI 10.1016/S0027-5107(97)00013-4; Collins AR, 2011, MUTAT RES; Dextraze ME, 2007, BIOCHEMISTRY-US, V46, P9089, DOI 10.1021/bi062114e; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gangavarapu V, 2007, MOL CELL BIOL, V27, P7758, DOI 10.1128/MCB.01331-07; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Gangavarapu V, 2011, MBIO, V2, DOI 10.1128/mBio.00079-11; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; HUTCHINSON F, 1973, Q REV BIOPHYS, V6, P201, DOI 10.1017/S0033583500001141; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jansen JG, 2009, CELL CYCLE, V8, P2857, DOI 10.4161/cc.8.18.9409; Jansen JG, 2009, MOL CELL BIOL, V29, P3113, DOI 10.1128/MCB.00071-09; Johansson F, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh154; Juhasz S, 2012, NUCL ACIDS RES; Karlsson KH, 2008, RADIAT RES, V169, P506, DOI 10.1667/RR1076.1; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Leva V, 2012, NUCLEIC ACIDS RES, V40, P1106, DOI 10.1093/nar/gkr837; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Magavi Sanjay S., 2008, V438, P335, DOI 10.1007/978-1-59745-133-8_25; McGlynn AP, 2003, BRIT J CANCER, V88, P895, DOI 10.1038/sj.bjc.6600836; McGlynn AP, 1999, CANCER RES, V59, P5912; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rothaeusler K., 2007, CURR PROTOC CYTOM; Rydberg B, 2000, RADIAT RES, V153, P805, DOI 10.1667/0033-7587(2000)153[0805:RIHLST]2.0.CO;2; Shaposhnikov SA, 2008, ELECTROPHORESIS, V29, P3005, DOI 10.1002/elps.200700921; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Smirnova M, 2003, MUTAT RES-FUND MOL M, V532, P117, DOI 10.1016/j.mrfmmm.2003.08.026; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; TorresRamos CA, 1996, P NATL ACAD SCI USA, V93, P9676, DOI 10.1073/pnas.93.18.9676; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Varga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052472; Yamada K, 1996, MUTAT RES-DNA REPAIR, V364, P125, DOI 10.1016/0921-8777(96)00033-X; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yoon JH, 2012, P NATL ACAD SCI USA, V109, P7799, DOI 10.1073/pnas.1204105109	59	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70391	10.1371/journal.pone.0070391	http://dx.doi.org/10.1371/journal.pone.0070391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936422	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500031
J	Geyer, T; Mueller, HJ; Assumpcao, L; Gais, S				Geyer, Thomas; Mueller, Hermann J.; Assumpcao, Leonardo; Gais, Steffen			Sleep-Effects on Implicit and Explicit Memory in Repeated Visual Search	PLOS ONE			English	Article							SPATIAL CONTEXT; CONSOLIDATION; AWARENESS; CONFIGURATION; INFORMATION; HIPPOCAMPUS; ATTENTION; GUIDES; NIGHT; CUES	In repeated visual search tasks, facilitation of reaction times (RTs) due to repetition of the spatial arrangement of items occurs independently of RT facilitation due to improvements in general task performance. Whereas the latter represents typical procedural learning, the former is a kind of implicit memory that depends on the medial temporal lobe (MTL) memory system and is impaired in patients with amnesia. A third type of memory that develops during visual search is the observers' explicit knowledge of repeated displays. Here, we used a visual search task to investigate whether procedural memory, implicit contextual cueing, and explicit knowledge of repeated configurations, which all arise independently from the same set of stimuli, are influenced by sleep. Observers participated in two experimental sessions, separated by either a nap or a controlled rest period. In each of the two sessions, they performed a visual search task in combination with an explicit recognition task. We found that (1) across sessions, MTL-independent procedural learning was more pronounced for the nap than rest group. This confirms earlier findings, albeit from different motor and perceptual tasks, showing that procedural memory can benefit from sleep. (2) Likewise, the sleep group compared with the rest group showed enhanced context-dependent configural learning in the second session. This is a novel finding, indicating that the MTL-dependent, implicit memory underlying contextual cueing is also sleep-dependent. (3) By contrast, sleep and wake groups displayed equivalent improvements in explicit recognition memory in the second session. Overall, the current study shows that sleep affects MTL-dependent as well as MTL-independent memory, but it affects different, albeit simultaneously acquired, forms of MTL-dependent memory differentially.	[Geyer, Thomas; Mueller, Hermann J.; Gais, Steffen] Univ Munich, Dept Psychol, Munich, Germany; [Mueller, Hermann J.; Assumpcao, Leonardo] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England	University of Munich; University of London; Birkbeck University London	Geyer, T (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	geyer@lmu.de			Deutsche Forschungsgemeinschaft (DFG) [GE 1889/1-1, GA 730/3-1]; CoTeSys (Cognition for Technical Systems) Excellence Cluster 142	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); CoTeSys (Cognition for Technical Systems) Excellence Cluster 142	This research was supported by Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) Research Grants GE 1889/1-1 (TG), GA 730/3-1 (SG), and CoTeSys (Cognition for Technical Systems) Excellence Cluster 142 (HM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; Brady TF, 2007, J EXP PSYCHOL HUMAN, V33, P798, DOI 10.1037/0096-1523.33.4.798; Bruyneel M, 2011, J SLEEP RES, V20, P201, DOI 10.1111/j.1365-2869.2010.00859.x; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 2003, J EXP PSYCHOL LEARN, V29, P224, DOI 10.1037/0278-7393.29.2.224; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Geyer T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00272; Geyer T, 2010, J VISION, V10, DOI 10.1167/10.5.20; Geyer T, 2010, J EXP PSYCHOL HUMAN, V36, P515, DOI 10.1037/a0017448; Greene AJ, 2007, LEARN MEMORY, V14, P548, DOI 10.1101/lm.609807; Hannula DE, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00080; Iber C, 2004, SLEEP, V27, P536, DOI 10.1093/sleep/27.3.536; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jiang YH, 2005, PERCEPT PSYCHOPHYS, V67, P1128, DOI 10.3758/BF03193546; Jiang YH, 2004, PERCEPT PSYCHOPHYS, V66, P454, DOI 10.3758/BF03194893; Jiang YH, 2001, Q J EXP PSYCHOL-A, V54, P1105, DOI 10.1080/02724980042000516; Johnson JS, 2007, PSYCHON B REV, V14, P834, DOI 10.3758/BF03194108; Macmillan NA, 1991, SIGNAL DETECTION THE; Manginelli AA, 2009, PSYCHOL RES-PSYCH FO, V73, P212, DOI 10.1007/s00426-008-0211-1; Manns JR, 2001, HIPPOCAMPUS, V11, P776, DOI 10.1002/hipo.1093; Mednick SC, 2009, VISION RES, V49, P2557, DOI 10.1016/j.visres.2009.04.011; Nabeta T, 2003, PERCEPTION, V32, P1351, DOI 10.1068/p5135; Peterson RS, 2001, PERCEPT PSYCHOPHYS, V63, P1239, DOI 10.3758/BF03194537; Preston AR, 2008, CEREB CORTEX, V18, P2192, DOI 10.1093/cercor/bhm245; R Core Team, 2012, R LANG ENV STAT COMP; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rieth CA, 2010, BEHAV BRAIN RES, V214, P470, DOI 10.1016/j.bbr.2010.05.052; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Schlagbauer B, 2012, J VISION, V12, DOI 10.1167/12.11.25; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Smyth AC, 2008, MEM COGNITION, V36, P403, DOI 10.3758/MC.36.2.403; van Asselen M, 2009, ATTEN PERCEPT PSYCHO, V71, P76, DOI 10.3758/APP.71.1.76; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WEIBEL L, 1995, SLEEP, V18, P549; Westerberg CE, 2011, NEUROPSYCHOLOGIA, V49, P3439, DOI 10.1016/j.neuropsychologia.2011.08.019; Zellin M, 2011, ATTEN PERCEPT PSYCHO, V73, P2065, DOI 10.3758/s13414-011-0175-x	43	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69953	10.1371/journal.pone.0069953	http://dx.doi.org/10.1371/journal.pone.0069953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XU	23936363	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000324545800028
J	Kaur, T; Hussain, K; Koul, S; Vishwakarma, R; Vyas, D				Kaur, Tarandeep; Hussain, Khadim; Koul, Sushma; Vishwakarma, Ram; Vyas, Dhiraj			Evaluation of Nutritional and Antioxidant Status of Lepidium latifolium Linn.: A Novel Phytofood from Ladakh	PLOS ONE			English	Article							OXIDATIVE STRESS; ALLYL ISOTHIOCYANATE; EXTRACT; SULFUR; L.; BIOAVAILABILITY; AVAILABILITY; PHENOLICS; CANCER; PLANTS	Lepidium latifolium Linn. (perennial pepperweed) is one of the preferred phytofoods among cold arid region of Ladakh, India and its leaves contribute significantly to people's diet. This study was conducted to determine its nutritive value and antioxidant activity. Plant samples from three different locations were selected in the present study. Results showed that this plant is an excellent source of glucosinolates, notably sinigrin that is present in very high amount (similar to 70-90%). Its value ranged from 149 to 199 mu g per g fresh weight. Fatty acid composition analysis showed that its leaves were abundant in unsaturated fatty acids, specifically linolenic acid (18:3) whose percentage is about 50%. Higher glucose and crude protein along with higher nitrogen to sulfur ratio, supplements the nutritive value of this plant. Based on total phenol, flavanoids, free radical scavenging activity and DNA protective activity showed that this ecotype of perennial pepperweed contains high antioxidant properties. The percentage inhibition for O-2(-) scavenging activity ranged from 41.3% to 83.9%. Higher content of phenols (26.89 to 50.51 mg gallic acid equivalents per g dry weight) and flavanoids (38.66 to 76.00 mg quercetin equivalents per g dry weight) in leaves could be responsible for the free radical scavenging activity of this plant. Depending upon the location of the plants, variations were observed in different activities. Based on the systematic evaluation in this study, preparations of Lepidium latifolium from Ladakh can be promoted as substitute to dietary requirements.	[Kaur, Tarandeep; Hussain, Khadim; Vyas, Dhiraj] Indian Inst Integrat Med CSIR, Acad Sci & Innovat Res, Jammu, India; [Kaur, Tarandeep; Hussain, Khadim; Koul, Sushma; Vyas, Dhiraj] Indian Inst Integrat Med CSIR, Biodivers & Appl Bot Div, Jammu, India; [Vishwakarma, Ram] Indian Inst Integrat Med CSIR, Div Med Chem, Jammu, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Vyas, D (corresponding author), Indian Inst Integrat Med CSIR, Acad Sci & Innovat Res, Canal Rd, Jammu, India.	dhirajvyas@rediffmail.com			Council of Scientific and Industrial Research (CSIR), Government of India under CSIR-networking project [BSC-0109]	Council of Scientific and Industrial Research (CSIR), Government of India under CSIR-networking project	Financial support to the present study was provided by Council of Scientific and Industrial Research (CSIR), Government of India, under CSIR-networking project (BSC-0109) on 'Plant Diversity: Studying adaptation biology and understanding/exploiting medicinally important plants for useful bioactives (SIMPLE)'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol E, 2012, ACTA PHYSIOL PLANT, V34, P541, DOI 10.1007/s11738-011-0851-4; ALLAWAY WH, 1966, SOIL SCI, V101, P240, DOI 10.1097/00010694-196604000-00003; Aslam M, 2012, MOL BIOL REP, V39, P9629, DOI 10.1007/s11033-012-1828-0; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Chung YC, 2002, J AGR FOOD CHEM, V50, P2454, DOI 10.1021/jf011369q; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; Duh PD, 1999, FOOD SCI TECHNOL-LEB, V32, P269; Elena Cartea Maria, 2008, Phytochemistry Reviews, V7, P213, DOI 10.1007/s11101-007-9072-2; FATEMI SH, 1980, LIPIDS, V15, P379, DOI 10.1007/BF02533555; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P3, DOI 10.1016/j.mrfmmm.2010.03.007; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; Geetha S, 2003, J ETHNOPHARMACOL, V87, P247, DOI 10.1016/S0378-8741(03)00154-5; Guleria S, 2011, J FOOD SCI, V76, pC959, DOI 10.1111/j.1750-3841.2011.02284.x; Gupta S, 2012, BASICS, P1; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Halliwell B, 2012, NUTR REV, V70, P257, DOI 10.1111/j.1753-4887.2012.00476.x; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hulten E, 1986, ATLAS N EUROPEAN V 1; Kaur C, 2001, INT J FOOD SCI TECH, V36, P703, DOI 10.1046/j.1365-2621.2001.00513.x; Kaur T, 2013, ACTA PHYSIOL PLANT, V35, P2501, DOI 10.1007/s11738-013-1286-x; Li HB, 2008, LWT-FOOD SCI TECHNOL, V41, P385, DOI 10.1016/j.lwt.2007.03.011; MEIR S, 1995, J AGR FOOD CHEM, V43, P1813, DOI 10.1021/jf00055a012; Mithen RF, 2000, J SCI FOOD AGR, V80, P967, DOI [10.1002/(SICI)1097-0010(20000515)80:7<967::AID-JSFA597>3.0.CO;2-V, 10.1002/(SICI)1097-0010(20000515)80:7&lt;967::AID-JSFA597&gt;3.0.CO;2-V]; NAVARRO E, 1994, J ETHNOPHARMACOL, V41, P65, DOI 10.1016/0378-8741(94)90059-0; Pal MM, 2010, INDIAN J TRADIT KNOW, V9, P303; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Rana JC, 2012, GENET RESOUR CROP EV, V59, P135, DOI 10.1007/s10722-011-9765-7; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Schreiner M, 2005, EUR J NUTR, V44, P85, DOI 10.1007/s00394-004-0498-7; Schultze-Motel W., 1986, LEPIDIUM LATIFOLIUM; Sexton PJ, 1998, CROP SCI, V38, P983, DOI 10.2135/cropsci1998.0011183X003800040017x; Sheikh G.G., 2011, INDIAN J ANIM NUTR, V28, P427; Shimoi K, 1996, MUTAT RES-FUND MOL M, V350, P153, DOI 10.1016/0027-5107(95)00116-6; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; Sultana T, 2002, J SCI FOOD AGR, V82, P1477, DOI 10.1002/jsfa.1218; Tabassum Nahida, 2011, Pharmacogn Rev, V5, P30, DOI 10.4103/0973-7847.79097; Trabelsi H, 2012, FOOD CHEM, V131, P434, DOI 10.1016/j.foodchem.2011.08.083; Traka M, 2009, PHYTOCHEM REV, V8, P269, DOI 10.1007/s11101-008-9103-7; Uematsu Y, 2002, J FOOD HYG SOC JPN, V43, P10, DOI 10.3358/shokueishi.43.10; Velasco P, 2011, PHYTOCHEM ANALYSIS, V22, P144, DOI 10.1002/pca.1259; Vyas D, 2005, BIOCHEM BIOPH RES CO, V329, P831, DOI 10.1016/j.bbrc.2005.02.051; Wassef W. N., 1985, FOOD CHEM, P140; Xavier J. R., 2011, Journal of Medicinal and Aromatic Plant Sciences, V33, P21; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323	48	27	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69112	10.1371/journal.pone.0069112	http://dx.doi.org/10.1371/journal.pone.0069112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936316	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800010
J	Liu, JL; Gao, W; Kang, QM; Zhang, XJ; Yang, SG				Liu, Jin Long; Gao, Wei; Kang, Qing Min; Zhang, Xue Jun; Yang, Shu Guang			Prognostic Value of Survivin in Patients with Gastric Cancer: A Systematic Review with Meta-Analysis	PLOS ONE			English	Review							POOR-PROGNOSIS; CELL-SURVIVAL; EXPRESSION; APOPTOSIS; ASSOCIATION; BIOMARKERS; PROTEIN	Objective: The prognostic significance of survivin for the survival of patients with gastric cancer remains controversial. Thus, the objective of this study was to conduct a systematic review of the literature evaluating survivin expression in gastric cancer as a prognostic indicator. Methods: Relevant literature was searched using PubMed, EMBASE, and Chinese biomedicine databases. A meta-analysis of the association between survivin expression and overall survival in patients with gastric cancer was performed. Studies were pooled and summary hazard ratios (HRs) were calculated. Subgroup analyses were also conducted. Results: Final analysis of 1365 patients from 16 eligible studies was performed. Combined HR suggested that survivin expression had an unfavorable impact on survival of gastric cancer patients (HR=1.39, 95% CI: 1.16-1.68). The unfavorable impact also appeared significant when stratified according to the studies categorized by patients' ethnicity, detection methods, type of sample, and HR estimate. The combined HR in the English literature showed an inverse effect on survival (HR=1.40, 95% CI: 1.13-1.75), while HR in the non-English literature did not (HR=1.38, 95% CI: 0.93-2.05). When stratified according to the location of survivin expression, combined HR showed that expression in cytoplasm was significantly associated with poor prognosis of gastric cancer patients (HR=1.46, 95% CI: 1.12-1.90). While expression in nucleus was not significantly associated with poor prognosis (HR=1.29, 95% CI: 0.72-2.31), the heterogeneity was highly significant (chi-squared=11.5, I-2=74%, p=0.009). Conclusions: This study showed that survivin expression was associated with a poor prognosis in patients with gastric cancer. Cytoplasmic expression of survivin may be regarded as a prognostic factor for gastric cancer patients. In contrast, survivin expression in nucleus did not have a significant impact on patients' overall survival.	[Liu, Jin Long; Kang, Qing Min; Zhang, Xue Jun; Yang, Shu Guang] Chengde Med Coll, Affiliated Hosp, Dept Gen Surg 1, Chengde City, Hebei Province, Peoples R China; [Gao, Wei] Chinese Peoples Liberat Army 264th Hosp, Dept Gastroenterol, Taiyuan, Shanxi Province, Peoples R China	Chengde Medical University	Liu, JL (corresponding author), Chengde Med Coll, Affiliated Hosp, Dept Gen Surg 1, Chengde City, Hebei Province, Peoples R China.	liujl800813@163.com						Averbach AM, 1996, BRIT J SURG, V83, P726, DOI 10.1002/bjs.1800830605; Bertazza L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-111; Bury Jaroslaw, 2012, Pol Przegl Chir, V84, P341, DOI 10.2478/v10035-012-0057-5; Chang JL, 2006, EXP CELL RES, V312, P962, DOI 10.1016/j.yexcr.2005.12.015; [陈世耀 Chen Shiyao], 2005, [中华消化杂志, Chinese Journal of Digestion], V25, P280; CHENG P, 2008, WORLD CHIN J DIGESTO, V16, P850; Deng JY, 2010, WORLD J GASTROENTERO, V16, P5380, DOI 10.3748/wjg.v16.i42.5380; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Greene FL, 2002, J SURG ONCOL, V80, P119, DOI 10.1002/jso.10114; Hattori M, 2001, CANCER LETT, V169, P155, DOI 10.1016/S0304-3835(01)00499-2; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; JACQUEMIER J, 1994, BRIT J CANCER, V69, P846, DOI 10.1038/bjc.1994.164; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee GH, 2006, EUR J GASTROEN HEPAT, V18, P957, DOI 10.1097/01.meg.0000230086.83792.56; Li CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044764; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li Y, 2010, HEPATO-GASTROENTEROL, V57, P1435; MENG JR, 2012, CLIN EXP MED, P96285; Nakamura M, 2004, CANCER SCI, V95, P44, DOI 10.1111/j.1349-7006.2004.tb03169.x; Okada E, 2001, CANCER LETT, V163, P109, DOI 10.1016/S0304-3835(00)00677-7; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007; Samuel T, 2005, CANCER RES, V65, P210; Song KY, 2009, JPN J CLIN ONCOL, V39, P290, DOI 10.1093/jjco/hyp020; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; SUN J, 2008, INT J DIG DIS, V28, P246; SUN YH, 2003, CHIN J GASTROINTEST, V6, P191; Tamm I, 1998, CANCER RES, V58, P5315; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Vallbohmer D, 2009, J SURG ONCOL, V99, P409, DOI 10.1002/jso.21271; WANG TM, 2007, CHIN J CLIN GASTROEN, V19, P35; YANG QC, 2006, CHINA ONCOLOGY, V16, P817; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; YU JW, 2007, INT J SURG, V34, P156; ZHANG JN, 2007, PRACT J CANC, V22, P350; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034100; ZOU DM, 2009, CHINA MOD DOCT, V2, P30	43	47	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71930	10.1371/journal.pone.0071930	http://dx.doi.org/10.1371/journal.pone.0071930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936532	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800071
J	Stancevic, B; Varda-Bloom, N; Cheng, J; Fuller, JD; Rotolo, JA; Garcia-Barros, M; Feldman, R; Rao, S; Weichselbaum, RR; Harats, D; Haimovitz-Friedman, A; Fuks, Z; Sadelain, M; Kolesnick, R				Stancevic, Branka; Varda-Bloom, Nira; Cheng, Jin; Fuller, John D.; Rotolo, Jimmy A.; Garcia-Barros, Monica; Feldman, Regina; Rao, Shyam; Weichselbaum, Ralph R.; Harats, Dror; Haimovitz-Friedman, Adriana; Fuks, Zvi; Sadelain, Michel; Kolesnick, Richard			Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; FIBROBLAST-GROWTH-FACTOR; BODY RADIATION-THERAPY; SELECTIVE ENHANCEMENT; GENE-THERAPY; GLIOMA-CELLS; IN-VITRO; APOPTOSIS; VECTOR; ACTIVATION	These studies define a new mechanism-based approach to radiosensitize tumor cure by single dose radiotherapy (SDRT). Published evidence indicates that SDRT induces acute microvascular endothelial apoptosis initiated via acid sphingomyelinase (ASMase) translocation to the external plasma membrane. Ensuing microvascular damage regulates radiation lethality of tumor stem cell clonogens to effect tumor cure. Based on this biology, we engineered an ASMase-producing vector consisting of a modified pre-proendothelin-1 promoter, PPE1(3x), and a hypoxia-inducible dual-binding HIF-2 alpha-Ets-1 enhancer element upstream of the asmase gene, inserted into a replication-deficient adenovirus yielding the vector Ad5H2E-PPE1(3x)-ASMase. This vector confers ASMase over-expression in cycling angiogenic endothelium in vitro and within tumors in vivo, with no detectable enhancement in endothelium of normal tissues that exhibit a minute fraction of cycling cells or in non-endothelial tumor or normal tissue cells. Intravenous pretreatment with Ad5H2E-PPE1(3x)-ASMase markedly increases SDRT cure of inherently radiosensitive MCA/129 fibrosarcomas, and converts radiation-incurable B16 melanomas into biopsy-proven tumor cures. In contrast, Ad5H2E-PPE1(3x)-ASMase treatment did not impact radiation damage to small intestinal crypts as non-dividing small intestinal microvessels did not overexpress ASMase and were not radiosensitized. We posit that combination of genetic up-regulation of tumor microvascular ASMase and SDRT provides therapeutic options for currently radiation-incurable human tumors.	[Stancevic, Branka; Varda-Bloom, Nira; Cheng, Jin; Fuller, John D.; Garcia-Barros, Monica; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; [Rotolo, Jimmy A.; Feldman, Regina; Rao, Shyam; Haimovitz-Friedman, Adriana; Fuks, Zvi] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA; [Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Weichselbaum, Ralph R.] Ludwig Ctr Metastasis Res, Chicago, IL USA; [Harats, Dror] Vasc Biogen Ltd, Or Yehuda, Israel	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Chicago	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org		Rotolo, Jim/0000-0003-4195-6167; Cheng, Jin/0000-0002-4364-9657	National Institutes of Health [R01-CA085704]; MSKCC Experimental Therapeutics Center; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA085704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Experimental Therapeutics Center; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01-CA085704 and MSKCC Experimental Therapeutics Center funded by William H. Goodwin and Alice Goodwin to R. Kolesnick, and a gift from the Virginia and D. K. Ludwig Fund for Cancer Research to Z. Fuks. This work is also supported in part by funds provided by David H. Koch through the Prostate Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT N, 1987, RADIAT RES, V112, P331, DOI 10.2307/3577260; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Bentzen SM, 2007, NAT CLIN PRACT ONCOL, V4, P172, DOI 10.1038/ncponc0744; Brown JM, 2008, INT J RADIAT ONCOL, V71, P324, DOI 10.1016/j.ijrobp.2008.02.003; Brown JM, 2007, METHOD ENZYMOL, V435, P297, DOI 10.1016/S0076-6879(07)35015-5; Cox BW, 2012, INT J RADIAT ONCOL, V83, pE661, DOI 10.1016/j.ijrobp.2012.01.080; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; EZZEDDINE ZD, 1991, NEW BIOL, V3, P608; Fowler JF, 2004, INT J RADIAT ONCOL, V60, P1241, DOI 10.1016/j.ijrobp.2004.07.691; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garcia-Barros M, 2010, CANCER RES, V70, P8179, DOI 10.1158/0008-5472.CAN-10-1871; Garzotto M, 1999, CANCER RES, V59, P5194; Greco C, 2011, INT J RADIAT ONCOL, V79, P1151, DOI 10.1016/j.ijrobp.2009.12.038; Grimm Jimm, 2011, J Appl Clin Med Phys, V12, P3368; HAIMOVITZFRIEDMAN A, 1991, CANCER RES, V51, P2552; Hall E J, 2006, RADIOBIOLOGY RADIOLO, P378; Hoppe RT, 2010, LEIBEL PHILLIPS TXB, P40; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; KIM JH, 1986, CANCER RES, V46, P1120; KIM JH, 1994, CANCER RES, V54, P6053; KIM JH, 1995, INT J RADIAT ONCOL, V33, P861, DOI 10.1016/0360-3016(95)00134-9; LEIBEL SA, 1991, INT J RADIAT ONCOL, V21, P805, DOI 10.1016/0360-3016(91)90701-5; Lo SS, 2009, EXPERT REV ANTICANC, V9, P621, DOI 10.1586/ERA.09.15; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; MOOLTEN FL, 1990, J NATL CANCER I, V82, P297, DOI 10.1093/jnci/82.4.297; Moriuchi S, 2000, GENE THER, V7, P1483, DOI 10.1038/sj.gt.3301265; Nemunaitis J, 2007, CANCER GENE THER, V14, P885, DOI 10.1038/sj.cgt.7701080; Niranjan A, 2000, MOL THER, V2, P114, DOI 10.1006/mthe.2000.0101; OKUNIEFF P, 1995, INT J RADIAT ONCOL, V32, P1227, DOI 10.1016/0360-3016(94)00475-Z; Page P, 2010, ANTICANCER RES, V30, P3675; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; Ronicke V, 1996, CIRC RES, V79, P277, DOI 10.1161/01.RES.79.2.277; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Rotolo J, 2012, J CLIN INVEST, V122, P1786, DOI 10.1172/JCI59920; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; Smith EL, 2008, MOL THER, V16, P1565, DOI 10.1038/mt.2008.145; Spalding AC, 2006, CANCER INVEST, V24, P444, DOI 10.1080/07357900600705706; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Timmerman RD, 2009, CA-CANCER J CLIN, V59, P145, DOI 10.3322/caac.20013; Tolcher AW, 2006, J CLIN ONCOL, V24, P2052, DOI 10.1200/JCO.2005.03.6756; Triozzi P, 2010, PHASE 1 TRAIL VB 111; Truman JP, 2010, PLOS ONE, V5, DOI [10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897, 10.1371/journal.pone.0012310]; Varda-Bloom N, 2008, PATHOBIOLOGY, V75, P346, DOI 10.1159/000164219; Varda-Bloom N, 2001, GENE THER, V8, P819, DOI 10.1038/sj.gt.3301472; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Yamada Y, 2008, INT J RADIAT ONCOL, V71, P484, DOI 10.1016/j.ijrobp.2007.11.046	55	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69025	10.1371/journal.pone.0069025	http://dx.doi.org/10.1371/journal.pone.0069025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936314	gold, Green Submitted, Green Published			2022-12-27	WOS:000324545800008
J	Doba, K; Pezard, L; Berna, G; Vignau, J; Nandrino, JL				Doba, Karyn; Pezard, Laurent; Berna, Guillaume; Vignau, Jean; Nandrino, Jean-Louis			Affiliative Behaviour and Conflictual Communication during Brief Family Therapy of Patients with Anorexia Nervosa	PLOS ONE			English	Article							INDIVIDUAL THERAPY; ADOLESCENT; PATTERNS; DISORDER; GAZE	Objective: Although patients with anorexia nervosa (AN) present positive responses to family therapy, the key features of therapeutic changes still require identification. This study explores the role of conflictual communication and affiliative nonverbal behaviour in therapeutic change in brief strategic family therapy (BSFT) for AN patients. Methods: Ten female AN patients and their parents were included in the sample and took part in a 6-month follow-up of BSFT. The durations of conflictual communication and of affiliative nonverbal behaviour estimated by eye contact were compared between the first and the last sessions of family-based treatment using nonparametric statistical tests. Results: An increase of the Body Mass Index associated with an increase in the conflictual communication expressed during BSFT sessions were observed. Moreover, affiliative nonverbal behaviour expressed by the father and the patient decrease, after a BSFT follow-up, in conflictual situations only. By contrast, no significant difference was observed in affiliative nonverbal behaviour expressed by the mother. Conclusion: The present study demonstrates that the impact of the BSFT differs between members of a family: the AN patient and the father have established a new form of emotional functioning with a decrease in emotional involvement. The study of the combination between verbal and nonverbal communication can represent an important step in the understanding of the mechanisms of therapeutic change.	[Doba, Karyn; Berna, Guillaume; Nandrino, Jean-Louis] Univ North France, Dept Psychol, Res Unit Cognit & Affect Sci, Villeneuve Dascq, France; [Doba, Karyn; Nandrino, Jean-Louis] Fdn Hlth Students France, Med & Psychol Clin, Villeneuve Dascq, France; [Pezard, Laurent] Aix Marseille Univ, INSERM, INS, UMR 1106, Marseille, France; [Vignau, Jean] CHU Lille, Addictol Dept, F-59037 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Lille - ISITE; CHU Lille	Doba, K (corresponding author), Univ North France, Dept Psychol, Res Unit Cognit & Affect Sci, Villeneuve Dascq, France.	karyn.doba@univ-lille3.fr	Nandrino, Jean-Louis/O-8900-2017	Nandrino, Jean-Louis/0000-0003-2339-9432; Berna, Guillaume/0000-0001-5470-380X				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], SOCIAL CONTEXT NONVE; Botta RA, 2002, HEALTH COMMUN, V14, P199, DOI 10.1207/S15327027HC1402_3; Bowen M, 1978, FAMILY THERAPY CLIN; Cahn DD, 1990, INTIMATES CONFLICT C, P1; Casper RC, 2001, INT J EAT DISORDER, V30, P338, DOI 10.1002/eat.1093; Choi SH, 2010, J NERV MENT DIS, V198, P829, DOI 10.1097/NMD.0b013e3181f97c0d; Dallos R., 2010, INTRO FAMILY THERAPY, V3rd edition; DARE C, 1994, INT J EAT DISORDER, V16, P211, DOI 10.1002/1098-108X(199411)16:3&lt;211::AID-EAT2260160302&gt;3.0.CO;2-X; Dare C, 2000, EUR EAT DISORD REV, V8, P4, DOI 10.1002/(SICI)1099-0968(200002)8:1<4::AID-ERV330>3.0.CO;2-P; Eisler I, 2000, J CHILD PSYCHOL PSYC, V41, P727, DOI 10.1111/1469-7610.00660; Eisler I, 1997, ARCH GEN PSYCHIAT, V54, P1025; EKMAN P, 1972, J COMMUN, V22, P353, DOI 10.1111/j.1460-2466.1972.tb00163.x; Feeney F, 1999, SOCIAL CONTEXT NONVE, P348; FLEISS JL, 1981, APPL PSYCH MEAS, V5, P105, DOI 10.1177/014662168100500115; Godart N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028249; Goossens L, 2006, HANDBOOK OF ADOLESCENT DEVELOPMENT, P135; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Kerr M. E., 1988, FAMILY EVALUATION; Kyriacou O, 2008, INT J EAT DISORDER, V41, P233, DOI 10.1002/eat.20488; Langdon R, 2006, NEUROPSYCHOLOGIA, V44, P417, DOI 10.1016/j.neuropsychologia.2005.05.020; Latzer Y, 1998, CONTEMP FAM THER, V20, P539, DOI 10.1023/A:1021636401563; Levenson R. W., 1994, NATURE EMOTION FUNDA, P273; LOCHMAN JE, 1981, J RES PERS, V15, P253, DOI 10.1016/0092-6566(81)90024-6; MAGANA AB, 1986, PSYCHIAT RES, V17, P203, DOI 10.1016/0165-1781(86)90049-1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Minuchin S., 1981, FAMILY THERAPY TECHN; Minuchin S., 1978, PSYCHOSOMATIC FAMILI; MORGAN HG, 1988, BRIT J PSYCHIAT, V152, P367, DOI 10.1192/bjp.152.3.367; MORGAN HG, 1975, PSYCHOL MED, V5, P355, DOI 10.1017/S0033291700056981; Newton D.A., 1990, INTIMATES CONFLICT C, P77, DOI DOI 10.1002/1098-2337(1992)18:5<LESSTHAN>383::AID-AB2480180509<GREATERTHAN>3.0.C0;2-9; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Patterson M.L., 1983, NONVERBAL BEHAV FUNC; Paulson-Karlsson Gunilla, 2009, Eat Disord, V17, P72, DOI 10.1080/10640260802570130; Petrican R, 2011, J PERS SOC PSYCHOL, V13, P1; Raymond L., 1993, J FAMILY PSYCHOL, V6, P308, DOI [10.1037/0893-3200.6.3.308, DOI 10.1037/0893-3200.6.3.308]; Robbins MS, 2009, CONTEMP CLIN TRIALS, V30, P269, DOI 10.1016/j.cct.2009.01.004; Robin AL, 1998, CLIN PSYCHOL REV, V18, P421, DOI 10.1016/S0272-7358(98)00013-0; ROBIN AL, 1995, INT J EAT DISORDER, V17, P313, DOI 10.1002/1098-108X(199505)17:4<313::AID-EAT2260170402>3.0.CO;2-8; RUSSELL GFM, 1987, ARCH GEN PSYCHIAT, V44, P1047; Santisteban DA, 2003, J FAM PSYCHOL, V17, P121, DOI 10.1037/0893-3200.17.1.121; Seys B., 1984, EC STAT, V174, P159; Shearman SM, 2008, J FAM COMMUN, V8, P186, DOI 10.1080/15267430802182456; SHUGAR G, 1995, INT J EAT DISORDER, V17, P23, DOI 10.1002/1098-108X(199501)17:1<23::AID-EAT2260170103>3.0.CO;2-8; Sillars A, 2004, LEA COMMUN SER, P413; Sim LA, 2009, INT J EAT DISORDER, V42, P531, DOI 10.1002/eat.20654; Simoneau T, 1996, FAM PROCESS, V102, P35; Simoneau TL, 1999, J ABNORM PSYCHOL, V108, P588, DOI 10.1037/0021-843X.108.4.588; Stephens P, 1986, ED RES Q, V10, P60; SZAPOCZNIK J, 1991, J MARITAL FAM THER, V17, P295, DOI 10.1111/j.1752-0606.1991.tb00897.x; vanFurth EF, 1996, INT J EAT DISORDER, V20, P19, DOI 10.1002/(SICI)1098-108X(199607)20:1<19::AID-EAT3>3.0.CO;2-7; VAUGHN CE, 1976, BRIT J PSYCHIAT, V129, P125, DOI 10.1192/bjp.129.2.125	53	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70389	10.1371/journal.pone.0070389	http://dx.doi.org/10.1371/journal.pone.0070389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219PB	23936421	gold, Green Published			2022-12-27	WOS:000324518400063
J	Ellsworth, KA; Eckloff, BW; Li, L; Moon, I; Fridley, BL; Jenkins, GD; Carlson, E; Brisbin, A; Abo, R; Bamlet, W; Petersen, G; Wieben, ED; Wang, LW				Ellsworth, Katarzyna A.; Eckloff, Bruce W.; Li, Liang; Moon, Irene; Fridley, Brooke L.; Jenkins, Gregory D.; Carlson, Erin; Brisbin, Abra; Abo, Ryan; Bamlet, William; Petersen, Gloria; Wieben, Eric D.; Wang, Liewei			Contribution of FKBP5 Genetic Variation to Gemcitabine Treatment and Survival in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							ASSOCIATION; CANCER; PHARMACOGENOMICS; INHIBITOR; VARIANTS; SEQUENCE; THERAPY; PROTEIN	Purpose: FKBP51, (FKBP5), is a negative regulator of Akt. Variability in FKBP5 expression level is a major factor contributing to variation in response to chemotherapeutic agents including gemcitabine, a first line treatment for pancreatic cancer. Genetic variation in FKBP5 could influence its function and, ultimately, treatment response of pancreatic cancer. Experimental Design: We set out to comprehensively study the role of genetic variation in FKBP5 identified by Next Generation DNA resequencing on response to gemcitabine treatment of pancreatic cancer by utilizing both tumor and germline DNA samples from 43 pancreatic cancer patients, including 19 paired normal-tumor samples. Next, genotype-phenotype association studies were performed with overall survival as well as with FKBP5 gene expression in tumor using the same samples in which resequencing had been performed, followed by functional genomics studies. Results: In-depth resequencing identified 404 FKBP5 single nucleotide polymorphisms (SNPs) in normal and tumor DNA. SNPs with the strongest associations with survival or FKBP5 expression were subjected to functional genomic study. Electromobility shift assay showed that the rs73748206 "A(T)" SNP altered DNA-protein binding patterns, consistent with significantly increased reporter gene activity, possibly through its increased binding to Glucocorticoid Receptor (GR). The effect of rs73748206 was confirmed on the basis of its association with FKBP5 expression by affecting the binding to GR in lymphoblastoid cell lines derived from the same patients for whom DNA was used for resequencing. Conclusion: This comprehensive FKBP5 resequencing study provides insights into the role of genetic variation in variation of gemcitabine response.	[Ellsworth, Katarzyna A.; Eckloff, Bruce W.; Li, Liang; Moon, Irene; Abo, Ryan; Wieben, Eric D.; Wang, Liewei] Mayo Clin, Rochester, MN 55905 USA; [Fridley, Brooke L.; Jenkins, Gregory D.; Carlson, Erin; Brisbin, Abra; Bamlet, William; Petersen, Gloria] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Wang, LW (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	wang.liewei@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956; Li, Liang/0000-0003-1893-1965; Bamlet, William/0000-0003-2903-1284	U.S. National Institutes of Health [K22 CA130828, R01 CA138461, U19 GM61388, CA102701]; Pancreatic Cancer Specialized Research Programs of Excellence [CA102701]; Mayo Center for Individualized Medicine;  [R21 GM86689]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA138461, P20CA102701, K22CA130828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474, R21GM086689, U19GM061388] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Specialized Research Programs of Excellence; Mayo Center for Individualized Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. National Institutes of Health grants K22 CA130828 (to L. Wang), R01 CA138461 (to L. Wang), U19 GM61388 (The Pharmacogenomics Research Network) (to L. Wang), CA102701 (The Pancreatic Cancer Specialized Research Programs of Excellence (to G. Petersen and L. Wang), R21 GM86689 (to B. Fridley) and the Mayo Center for Individualized Medicine (to L. Wang). (www.nih.gov) (http://intranet.mayo.edu/charlie/center-individualized-medicine/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baughman G, 1997, BIOCHEM BIOPH RES CO, V232, P437, DOI 10.1006/bbrc.1997.6307; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Breslin MB, 2001, MOL ENDOCRINOL, V15, P1381, DOI 10.1210/me.15.8.1381; Brisbin Abra, 2012, Frontiers in Genetics, V3, P173, DOI 10.3389/fgene.2012.00173; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Denny WB, 2005, ENDOCRINOLOGY, V146, P3194, DOI 10.1210/en.2005-0027; Ellsworth KA, 2013, PHARMACOGENET GENOM, V23, P156, DOI 10.1097/FPC.0b013e32835dc133; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Geng CD, 2008, MOL ENDOCRINOL, V22, P2624, DOI 10.1210/me.2008-0157; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Gilbert JA, 2006, CLIN CANCER RES, V12, P1794, DOI 10.1158/1078-0432.CCR-05-1969; GOVINDAN MV, 1991, J STEROID BIOCHEM, V40, P317, DOI 10.1016/0960-0760(91)90197-D; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Hou JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036252; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Institute NC, 2012, I NC SURVEILLANCE EP; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li L, 2008, CANCER RES, V68, P7050, DOI 10.1158/0008-5472.CAN-08-0405; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Mitra AK, 2011, LEUKEMIA, V25, P1354, DOI 10.1038/leu.2011.74; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; Pelleymounter LL, 2011, MOL GENET METAB, V104, P457, DOI 10.1016/j.ymgme.2011.08.019; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Turner JD, 2010, BIOCHEM PHARMACOL, V80, P1860, DOI 10.1016/j.bcp.2010.06.037; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Wang LW, 2010, CANCER RES, V70, P319, DOI 10.1158/0008-5472.CAN-09-3224; Weinshilboum R, 2004, CLIN PHARMACOL THER, V75, P253, DOI 10.1016/j.clpt.2003.12.002; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	31	26	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70216	10.1371/journal.pone.0070216	http://dx.doi.org/10.1371/journal.pone.0070216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936393	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400044
J	Paumier, KL; Rizzo, SJS; Berger, Z; Chen, Y; Gonzales, C; Kaftan, E; Li, L; Lotarski, S; Monaghan, M; Shen, W; Stolyar, P; Vasilyev, D; Zaleska, M; Hirst, WD; Dunlop, J				Paumier, Katrina L.; Rizzo, Stacey J. Sukoff; Berger, Zdenek; Chen, Yi; Gonzales, Cathleen; Kaftan, Edward; Li, Li; Lotarski, Susan; Monaghan, Michael; Shen, Wei; Stolyar, Polina; Vasilyev, Dmytro; Zaleska, Margaret; Hirst, Warren D.; Dunlop, John			Behavioral Characterization of A53T Mice Reveals Early and Late Stage Deficits Related to Parkinson's Disease	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; INCLUSION-BODY FORMATION; SYNAPTIC PLASTICITY; MOUSE MODEL; DOPAMINERGIC MIDBRAIN; POTENTIATED STARTLE; COVARIANCE ANALYSIS; NONMOTOR SYMPTOMS; PREMOTOR SYMPTOMS; EARLY-DIAGNOSIS	Parkinson's disease (PD) pathology is characterized by the formation of intra-neuronal inclusions called Lewy bodies, which are comprised of alpha-synuclein (alpha-syn). Duplication, triplication or genetic mutations in alpha-syn (A53T, A30P and E46K) are linked to autosomal dominant PD; thus implicating its role in the pathogenesis of PD. In both PD patients and mouse models, there is increasing evidence that neuronal dysfunction occurs before the accumulation of protein aggregates (i.e., alpha-syn) and neurodegeneration. Characterization of the timing and nature of symptomatic dysfunction is important for understanding the impact of alpha-syn on disease progression. Furthermore, this knowledge is essential for identifying pathways and molecular targets for therapeutic intervention. To this end, we examined various functional and morphological endpoints in the transgenic mouse model expressing the human A53T alpha-syn variant directed by the mouse prion promoter at specific ages relating to disease progression (2, 6 and 12 months of age). Our findings indicate A53T mice develop fine, sensorimotor, and synaptic deficits before the onset of age-related gross motor and cognitive dysfunction. Results from open field and rotarod tests show A53T mice develop age-dependent changes in locomotor activity and reduced anxiety-like behavior. Additionally, digigait analysis shows these mice develop an abnormal gait by 12 months of age. A53T mice also exhibit spatial memory deficits at 6 and 12 months, as demonstrated by Y-maze performance. In contrast to gross motor and cognitive changes, A53T mice display significant impairments in fine-and sensorimotor tasks such as grooming, nest building and acoustic startle as early as 1-2 months of age. These mice also show significant abnormalities in basal synaptic transmission, paired-pulse facilitation and long-term depression (LTD). Combined, these data indicate the A53T model exhibits early-and late-onset behavioral and synaptic impairments similar to PD patients and may provide useful endpoints for assessing novel therapeutic interventions for PD.	[Paumier, Katrina L.; Rizzo, Stacey J. Sukoff; Berger, Zdenek; Chen, Yi; Gonzales, Cathleen; Kaftan, Edward; Li, Li; Lotarski, Susan; Monaghan, Michael; Shen, Wei; Stolyar, Polina; Vasilyev, Dmytro; Zaleska, Margaret; Hirst, Warren D.; Dunlop, John] Pfizer Global Res & Dev, Neurosci Res Unit, Cambridge, MA USA	Pfizer	Hirst, WD (corresponding author), Pfizer Global Res & Dev, Neurosci Res Unit, Cambridge, MA USA.	warren.hirst@pfizer.com	Rizzo, Stacey/AAU-1145-2021	Sukoff Rizzo, Stacey J./0000-0002-1460-8127	Michael J. Fox Foundation; Pfizer, Inc.	Michael J. Fox Foundation; Pfizer, Inc.(Pfizer)	Funding for this work was provided by the Michael J. Fox Foundation and Pfizer, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2004, PHYSIOL BEHAV, V83, P401, DOI 10.1016/j.physbeh.2004.08.029; Adler CH, 2011, INT J NEUROSCI, V121, P3, DOI 10.3109/00207454.2011.620192; Antonini A, 2012, J NEUROL, V259, P2621, DOI 10.1007/s00415-012-6557-8; Bakke M, 2011, EUR J ORAL SCI, V119, P27, DOI 10.1111/j.1600-0722.2010.00802.x; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Bouwknecht JA, 2007, BRAIN RES BULL, V72, P32, DOI 10.1016/j.brainresbull.2006.12.009; Brockmann HJ, 2010, ADV STUDY BEHAV, V41; BROWN RG, 1984, J NEUROL NEUROSUR PS, V47, P454, DOI 10.1136/jnnp.47.5.454; BROWN RG, 1984, LANCET, V2, P1262, DOI 10.1016/S0140-6736(84)92807-1; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chesselet Marie-Francoise, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS84, DOI 10.1016/j.parkreldis.2008.04.004; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Commissaris RL, 2004, DEPRESS ANXIETY, V19, P146, DOI 10.1002/da.20006; Daher JPL, 2012, HUM MOL GENET, V21, P2420, DOI 10.1093/hmg/dds057; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Emmer KL, 2012, NEUROSCI LETT, V507, P137, DOI 10.1016/j.neulet.2011.12.005; Erro R, 2012, PARKINSONISM RELAT D, V18, P1034, DOI 10.1016/j.parkreldis.2012.05.022; Fleming SM, 2009, INT REV NEUROBIOL, V89, P57, DOI 10.1016/S0074-7742(09)89003-X; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; George S, 2008, EXP NEUROL, V210, P788, DOI 10.1016/j.expneurol.2007.12.017; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gironell A, 2003, MOVEMENT DISORD, V18, P1273, DOI 10.1002/mds.10529; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Glajch KE, 2012, BEHAV BRAIN RES, V230, P309, DOI 10.1016/j.bbr.2011.12.007; Graham DR, 2010, J NEUROSCI RES, V88, P1777, DOI 10.1002/jnr.22331; Grillon C, 2007, NEUROPSYCHOPHARMACOL, V32, P225, DOI 10.1038/sj.npp.1301204; Gureviciene I, 2007, NEUROBIOL DIS, V28, P83, DOI 10.1016/j.nbd.2007.06.016; Gureviciene I, 2009, J NEURAL TRANSM, V116, P13, DOI 10.1007/s00702-008-0149-x; Hsu CG, 2011, EXAMINATION NEST CON; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; KOCH GG, 1982, BIOMETRICS, V38, P563, DOI 10.2307/2530041; Koch GG, 1998, STAT MED, V17, P1863, DOI 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1863::AID-SIM989>3.0.CO;2-M; Kofler M, 2001, MOVEMENT DISORD, V16, P62, DOI 10.1002/1531-8257(200101)16:1<62::AID-MDS1002>3.0.CO;2-V; Koshikawa N, 2011, INT REV NEUROBIOL, V97, P1, DOI 10.1016/B978-0-12-385198-7.00001-1; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kurz A, 2011, CELL MOL LIFE SCI, V68, P721, DOI 10.1007/s00018-010-0483-7; Kurz A, 2012, J NEURAL TRANSM, V119, P297, DOI 10.1007/s00702-011-0717-3; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; Lang AE, 2011, MOVEMENT DISORD, V26, P775, DOI 10.1002/mds.23609; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lundblad M, 2012, P NATL ACAD SCI USA, V109, P3213, DOI 10.1073/pnas.1200575109; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; MENZA MA, 1993, BIOL PSYCHIAT, V34, P465, DOI 10.1016/0006-3223(93)90237-8; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Muller B, 2011, MOVEMENT DISORD, V26, P65, DOI 10.1002/mds.23387; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Oksman M, 2009, NEUROPHARMACOLOGY, V56, P647, DOI 10.1016/j.neuropharm.2008.11.004; Park SN, 2011, NEUROSCI RES, V71, P303, DOI 10.1016/j.neures.2011.07.1835; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Raggi A, 2011, INT J REHABIL RES, V34, P316, DOI 10.1097/MRR.0b013e32834d4b66; Rektorova I, 2007, MOVEMENT DISORD, V22, P2043, DOI 10.1002/mds.21548; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Roof R., 2010, USE ETHOLOGICAL RODE; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Sanchez-Ferro A, 2011, J NEUROL SCI, V310, P211, DOI 10.1016/j.jns.2011.05.007; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Shiba M, 2000, MOVEMENT DISORD, V15, P669, DOI 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Stolze H, 2001, J NEUROL NEUROSUR PS, V70, P289, DOI 10.1136/jnnp.70.3.289; Tozzi A, 2012, NEUROBIOL AGING, V33, P1792, DOI 10.1016/j.neurobiolaging.2011.05.002; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Unger EL, 2006, NEUROBIOL DIS, V21, P431, DOI 10.1016/j.nbd.2005.08.005; von Coelln R, 2006, J NEUROSCI, V26, P3685, DOI 10.1523/JNEUROSCI.0414-06.2006; Weintraub D, 2005, J NUCL MED, V46, P227; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wu N, 2010, J NEUROSCI RES, V88, P1764, DOI 10.1002/jnr.22327; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	82	113	119	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70274	10.1371/journal.pone.0070274	http://dx.doi.org/10.1371/journal.pone.0070274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936403	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400052
J	Holleczek, B; Jansen, L; Brenner, H				Holleczek, Bernd; Jansen, Lina; Brenner, Hermann			Breast Cancer Survival in Germany: A Population-Based High Resolution Study from Saarland	PLOS ONE			English	Article							UP-TO-DATE; LONG-TERM SURVIVAL; PERIOD ANALYSIS; EMPIRICAL-EVALUATION; TRENDS; AGE; EUROPE; RISK; CERTIFICATION; MANAGEMENT	Population-based survival studies of breast cancer patients are commonly restricted to age-and stage-specific analyses. This study from Germany aimed at extending available population-based survival data on further prognostic cancer characteristics such as tumor grade, hormone receptor status and human epidermal growth factor receptor type 2 (HER2/neu) expression. Data from the population-based Saarland Cancer Registry including female patients diagnosed with invasive breast cancer between 2000 and 2009 were included. Period analysis methodology and regression modelling were used to obtain estimates of 5-year relative survival and tumor related excess risks in 2005-2009. Overall age standardized 5-year relative survival was 83%. In addition to age and stage, tumor grade and hormone receptor status were independent predictors of 5-year relative survival. Detailed analyses by age, stage, morphology, tumor grade, hormone receptor status and HER2/neu expression consistently revealed lower survival of patients with high grade, hormone receptor negative or HER2/neu positive cancers and patients aged 70 years or older. This high resolution study extends available population-based survival data of breast cancer patients. Particular efforts should be made to overcome the persisting large survival deficits, which were observed for elderly patients in all clinical subgroups.	[Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Holleczek, Bernd; Jansen, Lina; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Holleczek, B (corresponding author), Saarland Canc Registry, Saarbrucken, Germany.	b.holleczek@gbe-ekr.saarland.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017; Jansen, Lina/D-7255-2016	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Jansen, Lina/0000-0001-8004-4940	German Cancer Aid (Deutsche Krebshilfe) [70-3166-Br5, 108257]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	BH, LJ and HB were funded through their institutions. The study was funded in part by the German Cancer Aid (Deutsche Krebshilfe; grants 70-3166-Br5 and 108257; URL: https://www.krebshilfe.de). The funders had no role in study design, data collection and analysis, to publish, or preparation of the manuscript.	ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Allemani C, 2004, BRIT J CANCER, V91, P1263, DOI 10.1038/sj.bjc.6602153; Allemani C, 2013, INT J CANCER, V132, P1170, DOI 10.1002/ijc.27725; [Anonymous], 1991, IARC Sci Publ, P1; Arriagada R, 2006, CANCER-AM CANCER SOC, V106, P743, DOI 10.1002/cncr.21659; *ASS POP BAS CANC, 2013, ATL CANC INC MORT GE; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Berrino F., 2002, ENCR RECOMMENDATIONS; Bouchardy C, 2003, J CLIN ONCOL, V21, P3580, DOI 10.1200/JCO.2003.02.046; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Brenner H, 2002, INT J EPIDEMIOL, V31, P456, DOI 10.1093/ije/31.2.456; Brenner H, 2002, J CLIN ONCOL, V20, P826, DOI 10.1200/JCO.20.3.826; BRENNER H, 1995, J EPIDEMIOL COMMUN H, V49, P426, DOI 10.1136/jech.49.4.426; Brenner H, 2006, AM J EPIDEMIOL, V164, P689, DOI 10.1093/aje/kwj243; Brenner H, 2011, CANCER EPIDEM BIOMAR, V20, P2480, DOI 10.1158/1055-9965.EPI-11-0697; Brenner H, 2009, INT J CANCER, V124, P1384, DOI 10.1002/ijc.24021; Brucker SY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-228; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Costa SD, 2002, EUR J CANCER, V38, P1329, DOI 10.1016/S0959-8049(02)00067-9; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Ederer F., 1959, INSTRUCTIONS IBM 650; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Eisemann N, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-129; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fritz A, 2000, INT CLASSIFICATION D; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; *GERM CANC SOC, 2008, INT S3 GUID DIAGN TR; Gondos A, 2008, EUR J CANCER, V44, P1463, DOI 10.1016/j.ejca.2008.03.010; Gondos A, 2007, ANN ONCOL, V18, P1253, DOI 10.1093/annonc/mdm126; Gondos A, 2007, INT J CANCER, V121, P395, DOI 10.1002/ijc.22683; Greenwood M, 1926, REPORTS PUBLIC HLTH, P26; Holleczek B, 2009, METHOD INFORM MED, V48, P123, DOI 10.3414/ME0563; HOLLECZEK B, 2012, COMPUT METH PROG BIO, V110, P192, DOI DOI 10.1016/J.CMPB.2012.1010.1004; Holleczek B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-317; Holleczek B, 2011, CANCER EPIDEMIOL, V35, P399, DOI 10.1016/j.canep.2011.01.008; Janssen-Heijnen MLG, 2007, EUR J CANCER, V43, P2179, DOI 10.1016/j.ejca.2007.06.008; Jayasinghe UW, 2005, ANZ J SURG, V75, P762, DOI 10.1111/j.1445-2197.2005.03515.x; *KOCH R I, 2008, CANC GERM 2003 2004; *KOCH R I, 2012, CANC GERM 2007 2008; Lavelle K, 2007, BRIT J CANCER, V96, P1197, DOI 10.1038/sj.bjc.6603709; Li CI, 2003, ARCH INTERN MED, V163, P2149, DOI 10.1001/archinte.163.18.2149; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Menard S, 2002, CLIN CANCER RES, V8, P520; MENG XL, 1992, BIOMETRIKA, V79, P103, DOI 10.1093/biomet/79.1.103; Nur U, 2010, INT J EPIDEMIOL, V39, P118, DOI 10.1093/ije/dyp309; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Passage KJ, 2007, INTERN MED J, V37, P181, DOI 10.1111/j.1445-5994.2007.01269.x; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rubin DB, 2004, MULTIPLE IMPUTATION; RUDER AM, 1989, CANCER, V64, P196, DOI 10.1002/1097-0142(19890701)64:1<196::AID-CNCR2820640134>3.0.CO;2-3; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Sobin, 2009, UICC TNM CLASSIFICAT; Suissa S, 1999, AM J EPIDEMIOL, V150, P279; Talback M, 2004, EUR J CANCER, V40, P1361, DOI 10.1016/j.ejca.2004.02.004; Taran FA, 2009, BREAST CARE, V4, P219, DOI 10.1159/000229540; UICC, 2017, TNM CLASSIFICATION M; 2012, CERT BREAST UN SAARL	61	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70680	10.1371/journal.pone.0070680	http://dx.doi.org/10.1371/journal.pone.0070680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936237	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700080
J	Zhu, LC; Kuang, ZZ; Wilson, BA; Lau, GW				Zhu, Luchang; Kuang, Zhizhou; Wilson, Brenda A.; Lau, Gee W.			Competence-Independent Activity of Pneumococcal Enda Mediates Degradation of Extracellular DNA and Nets and Is Important for Virulence	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE VIRULENCE; SUBSTANCE INDUCING TRANSFORMATION; GENETIC-TRANSFORMATION; DIPLOCOCCUS-PNEUMONIAE; CHEMICAL NATURE; ACID; DEOXYRIBONUCLEASE; INDUCTION; PHEROMONE; POLYSACCHARIDE	Membrane surface localized endonuclease EndA of the pulmonary pathogen Streptococcus pneumoniae (pneumococcus) is required for both genetic transformation and virulence. Pneumococcus expresses EndA during growth. However, it has been reported that EndA has no access to external DNA when pneumococcal cells are not competent for genetic transformation, and thus, unable to degrade extracellular DNA. Here, by using both biochemical and genetic methods, we demonstrate the existence of EndA-mediated nucleolytic activity independent of the competence state of pneumococcal cells. Pneumococcal mutants that are genetically deficient in competence development and genetic transformation have extracellular nuclease activity comparable to their parental wild type, including their ability to degrade neutrophil extracellular traps (NETs). The autolysis deficient Delta lytA mutant and its isogenic choline-treated parental wild-type strain D39 degrade extracellular DNA readily, suggesting that partial cell autolysis is not required for DNA degradation. We show that EndA molecules are secreted into the culture medium during the growth of pneumococcal cells, and contribute substantially to competence-independent nucleolytic activity. The competence-independent activity of EndA is responsible for the rapid degradation of DNA and NETs, and is required for the full virulence of Streptococcus pneumoniae during lung infection.	[Zhu, Luchang; Kuang, Zhizhou; Lau, Gee W.] Univ Illinois, Dept Pathobiol, Urbana, IL USA; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lau, GW (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL USA.	geelau@illinois.edu	Zhu, Luchang/C-9784-2017; Lau, Gee W/H-4073-2018	Zhu, Luchang/0000-0002-4064-5781; 	University of Illinois Research Board; American Lung Association [DS-192835-N]; National Institutes of Health [HL090699]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090699] Funding Source: NIH RePORTER	University of Illinois Research Board; American Lung Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the University of Illinois Research Board Arnold O. Beckman Award, the American Lung Association DeSouza Research Award (DS-192835-N) and the National Institutes of Health (HL090699) to GWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; AVERY OT, 1979, J EXP MED, V149, P297, DOI 10.1084/jem.149.2.297; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Berge M, 2002, MOL MICROBIOL, V45, P411, DOI 10.1046/j.1365-2958.2002.03013.x; BRIESE T, 1985, EUR J BIOCHEM, V146, P417, DOI 10.1111/j.1432-1033.1985.tb08668.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CHEN JD, 1987, J GEN MICROBIOL, V133, P1959; Garcia P, 1999, MOL MICROBIOL, V31, P1275, DOI 10.1046/j.1365-2958.1999.01238.x; HALLICK RB, 1977, NUCLEIC ACIDS RES, V4, P3055, DOI 10.1093/nar/4.9.3055; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; JEFFRIES CD, 1957, J BACTERIOL, V73, P590, DOI 10.1128/JB.73.4.590-591.1957; Johnsborg O, 2006, J BACTERIOL, V188, P1744, DOI 10.1128/JB.188.5.1744-1749.2006; KOHOUTOVA D, 1961, NATURE, V190, P1171, DOI 10.1038/1901171a0; LACKS S, 1962, J MOL BIOL, V5, P119, DOI 10.1016/S0022-2836(62)80067-9; LACKS S, 1974, P NATL ACAD SCI USA, V71, P2305, DOI 10.1073/pnas.71.6.2305; LACKS S, 1973, J BACTERIOL, V114, P152; LACKS S, 1975, J BACTERIOL, V123, P222, DOI 10.1128/JB.123.1.222-232.1975; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Luo P, 2003, MOL MICROBIOL, V50, P623, DOI 10.1046/j.1365-2958.2003.03714.x; Mellroth P, 2012, J BIOL CHEM; Mellroth P, 2012, J BIOL CHEM, V287, P11018, DOI 10.1074/jbc.M111.318584; MORRISON DA, 1984, J BACTERIOL, V159, P870, DOI 10.1128/JB.159.3.870-876.1984; Moscoso M, 2004, MOL MICROBIOL, V54, P783, DOI 10.1111/j.1365-2958.2004.04305.x; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; ROSENTHAL AL, 1980, J MOL BIOL, V141, P133, DOI 10.1016/0022-2836(80)90381-2; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Sung CK, 2005, J BACTERIOL, V187, P3052, DOI 10.1128/JB.187.9.3052-3061.2005; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tran TDH, 2011, ANTIMICROB AGENTS CH, V55, P2714, DOI 10.1128/AAC.01383-10; Zhu LC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002241	35	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70363	10.1371/journal.pone.0070363	http://dx.doi.org/10.1371/journal.pone.0070363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936195	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700069
J	Brown, NJ; Marjanovic, M; Luders, J; Stracker, TH; Costanzo, V				Brown, Nicola J.; Marjanovic, Marko; Lueders, Jens; Stracker, Travis H.; Costanzo, Vincenzo			Cep63 and Cep152 Cooperate to Ensure Centriole Duplication	PLOS ONE			English	Article							CENTROSOME AMPLIFICATION; HUMAN-CELLS; PROCENTRIOLE FORMATION; MITOTIC ENTRY; PROTEIN; CYCLE; CPAP; STIL; PLK4; PERICENTRIOLAR	Centrosomes consist of two centrioles embedded in pericentriolar material and function as the main microtubule organising centres in dividing animal cells. They ensure proper formation and orientation of the mitotic spindle and are therefore essential for the maintenance of genome stability. Centrosome function is crucial during embryonic development, highlighted by the discovery of mutations in genes encoding centrosome or spindle pole proteins that cause autosomal recessive primary microcephaly, including Cep63 and Cep152. In this study we show that Cep63 functions to ensure that centriole duplication occurs reliably in dividing mammalian cells. We show that the interaction between Cep63 and Cep152 can occur independently of centrosome localisation and that the two proteins are dependent on one another for centrosomal localisation. Further, both mouse and human Cep63 and Cep152 cooperate to ensure efficient centriole duplication by promoting the accumulation of essential centriole duplication factors upstream of SAS-6 recruitment and procentriole formation. These observations describe the requirement for Cep63 in maintaining centriole number in dividing mammalian cells and further establish the order of events in centriole formation.	[Brown, Nicola J.; Costanzo, Vincenzo] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, S Mimms EN6 3LD, Herts, England; [Marjanovic, Marko; Lueders, Jens; Stracker, Travis H.] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Marjanovic, Marko] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia	Cancer Research UK; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Rudjer Boskovic Institute	Stracker, TH (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona, Spain.	travis.stracker@irbbarcelona.org; vincenzo.costanzo@ifom.eu	Lüders, Jens/H-2812-2015; Stracker, Travis H/I-2815-2015; Marjanović, Marko/X-3622-2018	Lüders, Jens/0000-0002-9018-7977; Stracker, Travis H/0000-0002-8650-2081; Marjanović, Marko/0000-0001-9850-0561; Costanzo, Vincenzo/0000-0002-2920-9508; Dynes, Nicola J/0000-0002-1400-8455	Cancer Research UK; European Research Council (ERC) [206281]; European Molecular Biology Organization (EMBO) Young Investigator Program (YIP); Lister Institute of Preventive Medicine; AIRC-Associazione Italiana per la Ricerca sul Cancro; Armenise-Harvard foundation; AICR - Association for International Cancer Research; Ministerio de Ciencia e Innovacion [SAF2009-10023, BFU2009-08522]; FP7 Marie Curie Action-People (COFUND)	Cancer Research UK(Cancer Research UK); European Research Council (ERC)(European Research Council (ERC)European Commission); European Molecular Biology Organization (EMBO) Young Investigator Program (YIP); Lister Institute of Preventive Medicine; AIRC-Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Armenise-Harvard foundation; AICR - Association for International Cancer Research; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FP7 Marie Curie Action-People (COFUND)	This work was funded by Cancer Research UK. V. C. is also supported by the European Research Council (ERC) startup grant (206281), the European Molecular Biology Organization (EMBO) Young Investigator Program (YIP), the Lister Institute of Preventive Medicine, the AIRC-Associazione Italiana per la Ricerca sul Cancro, the Armenise-Harvard foundation and the AICR - Association for International Cancer Research. T. H. S. and J.L. are Ramon y Cajal investigators and supported by grants from the Ministerio de Ciencia e Innovacion (SAF2009-10023 and BFU2009-08522). M. M. is supported by a FP7 Marie Curie Action-People (COFUND) (http://erc.europa.eu, www.lister-institute.org.uk, www.embo.org, www.airc.it, www.aicr.org, www.micinn.es, http://ec.europa.eu/research/mariecurieactions.)	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; CELIS JE, 1986, LEUKEMIA RES, V10, P237, DOI 10.1016/0145-2126(86)90021-4; Cizmecioglu O, 2008, CELL CYCLE, V7, P3548, DOI 10.4161/cc.7.22.7071; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Gul A, 2006, J HUM GENET, V51, P760, DOI 10.1007/s10038-006-0017-1; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016; Kitagawa D, 2011, J CELL SCI, V124, P3884, DOI 10.1242/jcs.089888; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56; Loffler H, 2011, CANCER RES, V71, P2129, DOI 10.1158/0008-5472.CAN-10-2684; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Paoletti A, 1996, J CELL SCI, V109, P3089; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Prosser SL, 2012, J CELL SCI, V125, P5353, DOI 10.1242/jcs.106096; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Steere N, 2011, CYTOSKELETON, V68, P446, DOI 10.1002/cm.20523; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	45	59	61	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69986	10.1371/journal.pone.0069986	http://dx.doi.org/10.1371/journal.pone.0069986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936128	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200052
J	Loh, DH; Kudo, T; Truong, D; Wu, YF; Colwell, CS				Loh, Dawn H.; Kudo, Takashi; Danny Truong; Wu, Yingfei; Colwell, Christopher S.			The Q175 Mouse Model of Huntington's Disease Shows Gene Dosage- and Age-Related Decline in Circadian Rhythms of Activity and Sleep	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; MUTANT HUNTINGTIN; EARLY MOTOR; MICE; EXPRESSION; CLOCK; REPEAT; DISRUPTION; ANOMALIES; BEHAVIOR	Sleep and circadian disruptions are commonly reported by patients with neurodegenerative diseases, suggesting these may be an endophenotype of the disorders. Several mouse models of Huntington's disease (HD) that recapitulate the disease progression and motor dysfunction of HD also exhibit sleep and circadian rhythm disruption. Of these, the strongest effects are observed in the transgenic models with multiple copies of mutant huntingtin gene. For developing treatments of the human disease, knock-in (KI) models offer advantages of genetic precision of the insertion and control of mutation copy number. Therefore, we assayed locomotor activity and immobility-defined sleep in a new model of HD with an expansion of the KI repeats (Q175). We found evidence for gene dose- and age-dependent circadian disruption in the behavior of the Q175 line. We did not see evidence for loss of cells or disruption of the molecular oscillator in the master pacemaker, the suprachiasmatic nucleus (SCN). The combination of the precise genetic targeting in the Q175 model and the observed sleep and circadian disruptions make it tractable to study the interaction of the underlying pathology of HD and the mechanisms by which the disruptions occur.	[Loh, Dawn H.; Kudo, Takashi; Danny Truong; Wu, Yingfei; Colwell, Christopher S.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Lab Circadian & Sleep Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Colwell, CS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Lab Circadian & Sleep Med, Los Angeles, CA 90024 USA.	ccolwell@mednet.ucla.edu	Colwell, Chris/AAM-6111-2020; Kudo, Takashi/K-2491-2016	Truong, Danny/0000-0003-4946-8969; Colwell, Christopher/0000-0002-1059-184X; Loh, Dawn/0000-0001-7876-5757; Kudo, Takashi/0000-0002-9003-0099	CHDI Foundation	CHDI Foundation	This study was supported by the CHDI Foundation (http://chdifoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Cambras T, 2000, PHYSIOL BEHAV, V70, P227, DOI 10.1016/S0031-9384(00)00241-9; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Duff K, 2010, NEUROLOGY, V75, P500, DOI 10.1212/WNL.0b013e3181eccfa2; Fahrenkrug J, 2007, J MOL NEUROSCI, V31, P139, DOI 10.1385/JMN/31:02:139; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Goodman AOG, 2011, CURR NEUROL NEUROSCI, V11, P211, DOI 10.1007/s11910-010-0163-x; Graham RK, 2006, NEUROBIOL DIS, V21, P444, DOI 10.1016/j.nbd.2005.08.007; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Kudo T, 2011, EXP NEUROL, V232, P66, DOI 10.1016/j.expneurol.2011.08.003; Kudo T, 2011, EXP NEUROL, V228, P80, DOI 10.1016/j.expneurol.2010.12.011; Lerner RP, 2012, BRAIN RES BULL, V87, P571, DOI 10.1016/j.brainresbull.2012.01.012; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; Loh DH, 2011, J BIOL RHYTHM, V26, P200, DOI 10.1177/0748730411401740; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marshall J, 2007, ARCH NEUROL-CHICAGO, V64, P116, DOI 10.1001/archneur.64.1.116; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Maywood ES, 2010, J NEUROSCI, V30, P10199, DOI 10.1523/JNEUROSCI.1694-10.2010; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mestre TA, 2012, PARKINSONISM RELAT D, V18, P316, DOI 10.1016/j.parkreldis.2011.10.021; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Nance MA, 2012, CURR NEUROL NEUROSCI, V12, P359, DOI 10.1007/s11910-012-0277-4; Oakeshott Stephen, 2011, PLoS Curr, V3, pRRN1225, DOI 10.1371/currents.RRN1225; Orth Michael, 2010, PLoS Curr, V2, DOI 10.1371/currents.RRN1184; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Pallier PN, 2007, J NEUROSCI, V27, P7869, DOI 10.1523/JNEUROSCI.0649-07.2007; Pallier PN, 2009, BRAIN RES, V1279, P90, DOI 10.1016/j.brainres.2009.03.072; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Vaccarino AL, 2011, MOVEMENT DISORD, V26, P877, DOI 10.1002/mds.23574; van Wamelen DJ, 2013, SLEEP, V36, P117, DOI 10.5665/sleep.2314; Videnovic A, 2009, PARKINSONISM RELAT D, V15, P471, DOI 10.1016/j.parkreldis.2008.10.002; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; WIEGAND M, 1991, EUR ARCH PSY CLIN N, V240, P148, DOI 10.1007/BF02190755	47	52	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69993	10.1371/journal.pone.0069993	http://dx.doi.org/10.1371/journal.pone.0069993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936129	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200053
J	Montrone, C; Kokkaliaris, KD; Loeffler, D; Lechner, M; Kastenmuller, G; Schroeder, T; Ruepp, A				Montrone, Corinna; Kokkaliaris, Konstantinos D.; Loeffler, Dirk; Lechner, Martin; Kastenmueller, Gabi; Schroeder, Timm; Ruepp, Andreas			HSC-Explorer: A Curated Database for Hematopoietic Stem Cells	PLOS ONE			English	Article							BONE-MARROW NICHE; SELF-RENEWAL CAPACITY; PROGENITOR CELLS; IN-VIVO; DIFFERENTIATION; REPRESENTATION; RECONSTITUTION; QUIESCENCE; NETWORKS; RESOURCE	HSC-Explorer (http://mips.helmholtz-muenchen.de/HSC/) is a publicly available, integrative database containing detailed information about the early steps of hematopoiesis. The resource aims at providing fast and easy access to relevant information, in particular to the complex network of interacting cell types and molecules, from the wealth of publications in the field through visualization interfaces. It provides structured information on more than 7000 experimentally validated interactions between molecules, bioprocesses and environmental factors. Information is manually derived by critical reading of the scientific literature from expert annotators. Hematopoiesis-relevant interactions are accompanied with context information such as model organisms and experimental methods for enabling assessment of reliability and relevance of experimental results. Usage of established vocabularies facilitates downstream bioinformatics applications and to convert the results into complex networks. Several predefined datasets (Selected topics) offer insights into stem cell behavior, the stem cell niche and signaling processes supporting hematopoietic stem cell maintenance. HSC-Explorer provides a versatile web-based resource for scientists entering the field of hematopoiesis enabling users to inspect the associated biological processes through interactive graphical presentation.	[Montrone, Corinna; Lechner, Martin; Kastenmueller, Gabi; Ruepp, Andreas] Res Ctr Environm Hlth GmbH, Inst Bioinformat & Syst Biol IBIS, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Kokkaliaris, Konstantinos D.; Loeffler, Dirk; Schroeder, Timm] German Res Ctr Environm Hlth GmbH, Stem Cell Dynam Res Unit, Helmholtz Zentrum Munchen, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ruepp, A (corresponding author), Res Ctr Environm Hlth GmbH, Inst Bioinformat & Syst Biol IBIS, Helmholtz Zentrum Munchen, Neuherberg, Germany.	andreas.ruepp@helmholtz-muenchen.de	Kastenmüller, Gabi/ABF-5987-2020; Schroeder, Timm/F-8448-2010; Kokkaliaris, Konstantinos/GWQ-3400-2022	Schroeder, Timm/0000-0001-9320-0252; KOKKALIARIS, KONSTANTINOS/0000-0002-9952-3463; Loeffler, Dirk/0000-0001-9870-0088; Kastenmuller, Gabi/0000-0002-2368-7322				Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chou AP, 2012, JNCI-J NATL CANCER I, V104, P1458, DOI 10.1093/jnci/djs357; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kajiume T, 2004, EXP HEMATOL, V32, P571, DOI 10.1016/j.exphem.2004.03.001; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klauke K, 2013, NAT CELL BIOL, V15, P353, DOI 10.1038/ncb2701; Lechner M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r62; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Pillai MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014304; Pohar TT, 2004, NUCLEIC ACIDS RES, V32, pD86, DOI 10.1093/nar/gkh056; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sandie Reatha, 2009, BMC Res Notes, V2, P39, DOI 10.1186/1756-0500-2-39; Schaniel C, 2011, BLOOD, V118, P2420, DOI 10.1182/blood-2010-09-305664; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schwermann J, 2009, EMBO J, V28, P1392, DOI 10.1038/emboj.2009.100; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Sharma M, 2011, STEM CELLS DEV, V20, P933, DOI 10.1089/scd.2010.0263; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; SPANGRUDE GJ, 1992, BLOOD, V80, P1957; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Vogel G, 2003, SCIENCE, V302, P371; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639	44	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70348	10.1371/journal.pone.0070348	http://dx.doi.org/10.1371/journal.pone.0070348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936191	gold, Green Submitted, Green Published			2022-12-27	WOS:000323114200077
J	Hung, SC; Choi, CH; Said-Sadier, N; Johnson, L; Atanasova, KR; Sellami, H; Yilmaz, O; Ojcius, DM				Hung, Shu-Chen; Choi, Chul Hee; Said-Sadier, Najwane; Johnson, Larry; Atanasova, Kalina Rosenova; Sellami, Hanen; Yilmaz, Oezlem; Ojcius, David M.			P2X(4) Assembles with P2X(7) and Pannexin-1 in Gingival Epithelial Cells and Modulates ATP-induced Reactive Oxygen Species Production and Inflammasome Activation	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; NALP3 INFLAMMASOME; MOLECULAR PLATFORM; OXIDATIVE STRESS; P2X4 RECEPTOR; INFECTION; EXPRESSION; SECRETION; NLRS; RECOGNITION	We have previously reported that Porphyromonas gingivalis infection of gingival epithelial cells (GEC) requires an exogenous danger signal such as ATP to activate an inflammasome and caspase-1, thereby inducing secretion of interleukin (IL)-1 beta. Stimulation with extracellular ATP also stimulates production of reactive oxygen species (ROS) in GEC. However, the mechanism by which ROS is generated in response to ATP, and the role that different purinergic receptors may play in inflammasome activation, is still unclear. In this study, we revealed that the purinergic receptor P2X(4) is assembled with the receptor P2X(7) and its associated pore, pannexin-1. ATP induces ROS production through a complex consisting of the P2X(4), P2X(7), and pannexin-1. P2X(7)-mediated ROS production can activate the NLRP3 inflammasome and caspase-1. Furthermore, separate depletion or inhibition of P2X(4), P2X(7), or pannexin-1 complex blocks IL-1 beta secretion in P. gingivalis-infected GEC following ATP treatment. However, activation via P2X(4) alone induces ROS generation but not inflammasome activation. These results suggest that ROS is generated through stimulation of a P2X(4)/P2X(7)/pannexin-1 complex, and reveal an unexpected role for P2X(4), which acts as a positive regulator of inflammasome activation during microbial infection.	[Hung, Shu-Chen; Said-Sadier, Najwane; Johnson, Larry; Sellami, Hanen; Ojcius, David M.] Univ Calif Merced, Dept Mol Cell Biol, Merced, CA USA; [Hung, Shu-Chen; Said-Sadier, Najwane; Johnson, Larry; Sellami, Hanen; Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Choi, Chul Hee; Atanasova, Kalina Rosenova; Yilmaz, Oezlem] Univ Florida, Dept Periodontol, Gainesville, FL USA; [Yilmaz, Oezlem] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Sellami, Hanen] Univ Sfax, Med Sch Sfax, Habib Bourguiba Univ Hosp, Dept Microbiol, Sfax, Tunisia	University of California System; University of California Merced; University of California System; University of California Merced; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universite de Sfax; Hopital Habib Bourguiba	Ojcius, DM (corresponding author), Univ Calif Merced, Dept Mol Cell Biol, Merced, CA USA.	dojcius@ucmerced.edu	Yilmaz, Ozlem/ABG-5367-2021; Atanasova, Kalina/V-6497-2018; Ojcius, David/ABE-6557-2020	Yilmaz, Ozlem/0000-0003-3487-7217; Atanasova, Kalina/0000-0002-2396-6196; Choi, Chul Hee/0000-0003-2373-048X; Ojcius, David/0000-0003-1461-4495; SELLAMI, Hanen/0000-0001-5479-1707	NIDCR [R01DE019444, R01DE016593]; University of California Presidential Chair; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016593, R01DE019444] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of California Presidential Chair; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIDCR grants R01DE019444 (to DMO) and R01DE016593 (to OY), and a University of California Presidential Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; Boumechache M, 2009, J BIOL CHEM, V284, P13446, DOI 10.1074/jbc.M901255200; Bowler JW, 2003, BRIT J PHARMACOL, V140, P567, DOI 10.1038/sj.bjp.0705459; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chamaillard M, 2004, TRENDS MICROBIOL, V12, P529, DOI 10.1016/j.tim.2004.10.001; Choi CH, 2012, CELLULAR MI IN PRESS; Choi CH, 2013, CELL MICROBIOL, V15, P961, DOI 10.1111/cmi.12089; CHRISTERSSON LA, 1987, J PERIODONTOL, V58, P540, DOI 10.1902/jop.1987.58.8.540; Ciraci C, 2012, MICROBES INFECT, V14, P1263, DOI 10.1016/j.micinf.2012.07.007; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dvoriantchikova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031991; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornef MW, 2005, J ENDOTOXIN RES, V11, P124, DOI 10.1179/096805105X35224; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang PR, 2010, BBA-MOL CELL RES, V1803, P1164, DOI 10.1016/j.bbamcr.2010.06.003; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kawano A, 2012, BIOCHEM BIOPH RES CO, V419, P374, DOI 10.1016/j.bbrc.2012.01.156; Kawano A, 2012, BIOCHEM BIOPH RES CO, V420, P102, DOI 10.1016/j.bbrc.2012.02.122; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Lich JD, 2006, IMMUNITY, V24, P241, DOI 10.1016/j.immuni.2006.03.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Lupfer C, 2012, VIRULENCE, V3; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McMahon L, 2011, INFECT IMMUN, V79, P2250, DOI 10.1128/IAI.00099-11; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Negulyaev YA, 2000, NEUROSCI LETT, V279, P165, DOI 10.1016/S0304-3940(99)00976-3; Nisapakultorn K, 2001, INFECT IMMUN, V69, P4242, DOI 10.1128/IAI.69.7.4242-4247.2001; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oda D, 1996, EXP CELL RES, V226, P164, DOI 10.1006/excr.1996.0215; Philpott DJ, 2001, CURR OPIN IMMUNOL, V13, P410; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rayah A, 2012, MICROBES INFECT, V14, P1254, DOI 10.1016/j.micinf.2012.07.006; Said-Sadier Najwane, 2012, Biomed J, V35, P437, DOI 10.4103/2319-4170.104408; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Tassi S, 2009, J IMMUNOL, V183, P1456, DOI 10.4049/jimmunol.0900578; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang H, 2013, PROTEIN CELL; Yilmaz O, 2004, INFECT IMMUN, V72, P3743, DOI 10.1128/IAI.72.7.3743-3751.2004; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Yilmaz O, 2010, CELL MICROBIOL, V12, P188, DOI 10.1111/j.1462-5822.2009.01390.x; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	66	118	122	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70210	10.1371/journal.pone.0070210	http://dx.doi.org/10.1371/journal.pone.0070210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936165	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300094
J	Bedi, H; Goltz, HC; Wong, AMF; Chandrakumar, M; Niechwiej-Szwedo, E				Bedi, Harleen; Goltz, Herbert C.; Wong, Agnes M. F.; Chandrakumar, Manokaraananthan; Niechwiej-Szwedo, Ewa			Error Correcting Mechanisms during Antisaccades: Contribution of Online Control during Primary Saccades and Offline Control via Secondary Saccades	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUOMOTOR BEHAVIOR; ANISOMETROPIC AMBLYOPIA; SOMATOSENSORY CORTEX; OCULOMOTOR CONTROL; INTERNAL FEEDBACK; EXPRESS SACCADES; ADAPTIVE-CONTROL; NEURAL PROCESSES; TASK	Errors in eye movements can be corrected during the ongoing saccade through in-flight modifications (i.e., online control), or by programming a secondary eye movement (i.e., offline control). In a reflexive saccade task, the oculomotor system can use extraretinal information (i.e., efference copy) online to correct errors in the primary saccade, and offline retinal information to generate a secondary corrective saccade. The purpose of this study was to examine the error correction mechanisms in the antisaccade task. The roles of extraretinal and retinal feedback in maintaining eye movement accuracy were investigated by presenting visual feedback at the spatial goal of the antisaccade. We found that online control for antisaccade is not affected by the presence of visual feedback; that is whether visual feedback is present or not, the duration of the deceleration interval was extended and significantly correlated with reduced antisaccade endpoint error. We postulate that the extended duration of deceleration is a feature of online control during volitional saccades to improve their endpoint accuracy. We found that secondary saccades were generated more frequently in the antisaccade task compared to the reflexive saccade task. Furthermore, we found evidence for a greater contribution from extraretinal sources of feedback in programming the secondary "corrective" saccades in the antisaccade task. Nonetheless, secondary saccades were more corrective for the remaining antisaccade amplitude error in the presence of visual feedback of the target. Taken together, our results reveal a distinctive online error control strategy through an extension of the deceleration interval in the antisaccade task. Target feedback does not improve online control, rather it improves the accuracy of secondary saccades in the antisaccade task.	[Bedi, Harleen; Goltz, Herbert C.; Wong, Agnes M. F.; Chandrakumar, Manokaraananthan] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Goltz, Herbert C.; Wong, Agnes M. F.] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Niechwiej-Szwedo, Ewa] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Waterloo	Niechwiej-Szwedo, E (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	eniechwi@uwaterloo.ca	Chandrakumar, Manokaraananthan/AHD-0133-2022	Goltz, Herbert/0000-0002-6496-754X	Canadian Institute of Health Research (CIHR) [MOP 106663]; Canadian Foundation for Innovation (CFI); Department of Ophthalmology and Vision Sciences and Research Training Centre at The Hospital for Sick Children; Comprehensive Research Experience for Medical Students (CREMS) at University of Toronto	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Department of Ophthalmology and Vision Sciences and Research Training Centre at The Hospital for Sick Children; Comprehensive Research Experience for Medical Students (CREMS) at University of Toronto	This work was supported by grant MOP 106663 from the Canadian Institute of Health Research (CIHR), Leaders Opportunity Fund from the Canadian Foundation for Innovation (CFI), the Department of Ophthalmology and Vision Sciences and Research Training Centre at The Hospital for Sick Children, and Comprehensive Research Experience for Medical Students (CREMS) at University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL AT, 1981, INVEST OPHTH VIS SCI, V21, P116; Becker W, 1972, Bibl Ophthalmol, V82, P233; BECKER W, 1969, VISION RES, V9, P1247, DOI 10.1016/0042-6989(69)90112-6; BRIDGEMAN B, 1995, ANN BIOMED ENG, V23, P409, DOI 10.1007/BF02584441; Chahine G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006900; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; DEUBEL H, 1982, VISION RES, V22, P353, DOI 10.1016/0042-6989(82)90151-1; Elliott D, 1999, HUM MOVEMENT SCI, V18, P121, DOI 10.1016/S0167-9457(99)00004-4; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Evdokimidis I, 2006, EXP BRAIN RES, V174, P304, DOI 10.1007/s00221-006-0462-2; Everling S, 1998, J NEUROPHYSIOL, V80, P1584, DOI 10.1152/jn.1998.80.3.1584; FINDLAY JM, 1984, THEORETICAL APPL ASP, P71, DOI DOI 10.1016/S0166-4115(08)61820-8; Fischer B, 1997, EXP BRAIN RES, V116, P191, DOI 10.1007/PL00005749; Fischer B, 1996, EXP BRAIN RES, V109, P507; FISCHER B, 1986, EXP BRAIN RES, V64, P569, DOI 10.1007/BF00340494; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Gaveau V, 2003, NEUROREPORT, V14, P875, DOI 10.1097/00001756-200305060-00020; Gaveau V, 2008, NEUROPSYCHOLOGIA, V46, P475, DOI 10.1016/j.neuropsychologia.2007.08.028; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Heath M, 2005, MOTOR CONTROL, V9, P281, DOI 10.1123/mcj.9.3.281; Heath M, 2010, EXPT BRAIN RES, V203, P473; JEANNEROD M, 1991, LIFE SCI R, V50, P277; Khan MA, 2003, ACTA PSYCHOL, V113, P83, DOI 10.1016/S0001-6918(02)00156-7; Krappmann P, 1998, VISION RES, V38, P2979, DOI 10.1016/S0042-6989(98)00101-1; Lavergne L, 2008, BRAIN RES, V1245, P82, DOI 10.1016/j.brainres.2008.09.065; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lisberger SG, 2009, NEUROSCIENCE, V162, P763, DOI 10.1016/j.neuroscience.2009.03.059; Ludwig CJH, 2007, J NEUROPHYSIOL, V97, P795, DOI 10.1152/jn.00652.2006; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Niechwiej-Szwedo E, 2012, INVEST OPHTH VIS SCI, V53, P7458, DOI 10.1167/iovs.12-10550; Niechwiej-Szwedo E, 2011, INVEST OPHTH VIS SCI, V52, P795, DOI 10.1167/iovs.10-6092; Niechwiej-Szwedo E, 2010, INVEST OPHTH VIS SCI, V51, P6348, DOI 10.1167/iovs.10-5882; Optican LM, 2002, ANN NY ACAD SCI, V956, P164, DOI 10.1111/j.1749-6632.2002.tb02817.x; Ploner CJ, 2005, BIOL PSYCHIAT, V57, P1159, DOI 10.1016/j.biopsych.2005.02.017; PRABLANC C, 1975, VISION RES, V15, P465, DOI 10.1016/0042-6989(75)90022-X; PRABLANC C, 1978, VISION RES, V18, P557, DOI 10.1016/0042-6989(78)90202-X; ROBINSON DA, 1973, KYBERNETIK, V14, P71, DOI 10.1007/BF00288906; Ross J, 1996, BEHAV BRAIN RES, V80, P1, DOI 10.1016/0166-4328(96)00012-5; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SMIT AC, 1987, VISION RES, V27, P1745, DOI 10.1016/0042-6989(87)90104-0; Smyrnis N, 2002, EXP BRAIN RES, V147, P53, DOI 10.1007/s00221-002-1207-5; STEINBACH MJ, 1987, VISION RES, V27, P1737, DOI 10.1016/0042-6989(87)90103-9; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007; Van Loon EM, 2002, P ROY SOC B-BIOL SCI, V269, P1571, DOI 10.1098/rspb.2002.2062; Vergilino-Perez D, 2003, EXP BRAIN RES, V150, P255, DOI 10.1007/s00221-003-1418-4; Wang XL, 2007, NAT NEUROSCI, V10, P640, DOI 10.1038/nn1878; Weiler J, 2011, J MOTOR BEHAV, V43, P375, DOI 10.1080/00222895.2011.604656; WENBANSMITH MG, 1991, EXP BRAIN RES, V87, P218; West GL, 2009, J MOTOR BEHAV, V41, P117, DOI 10.3200/JMBR.41.2.117-127; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; Xu YX, 2011, J NEUROPHYSIOL, V106, P71, DOI 10.1152/jn.00668.2010; Xu-Wilson M, 2011, J NEUROSCI, V31, P11537, DOI 10.1523/JNEUROSCI.1584-11.2011; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009	54	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e68613	10.1371/journal.pone.0068613	http://dx.doi.org/10.1371/journal.pone.0068613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217ZG	23936308	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500005
J	DeSantis, LRG; Scott, JR; Schubert, BW; Donohue, SL; McCray, BM; Van Stolk, CA; Winburn, AA; Greshko, MA; O'Hara, MC				DeSantis, Larisa R. G.; Scott, Jessica R.; Schubert, Blaine W.; Donohue, Shelly L.; McCray, Brian M.; Van Stolk, Courtney A.; Winburn, Amanda A.; Greshko, Michael A.; O'Hara, Mackie C.			Direct Comparisons of 2D and 3D Dental Microwear Proxies in Extant Herbivorous and Carnivorous Mammals	PLOS ONE			English	Article							TEXTURE ANALYSIS; LATE MIOCENE; ERROR RATES; DIET; QUANTIFICATION; MAGNIFICATION; EXTINCTION; MICROSCOPY; CHIMPANZEE; ECOLOGY	The analysis of dental microwear is commonly used by paleontologists and anthropologists to clarify the diets of extinct species, including herbivorous and carnivorous mammals. Currently, there are numerous methods employed to quantify dental microwear, varying in the types of microscopes used, magnifications, and the characterization of wear in both two dimensions and three dimensions. Results from dental microwear studies utilizing different methods are not directly comparable and human quantification of wear features (e. g., pits and scratches) introduces interobserver error, with higher error being produced by less experienced individuals. Dental microwear texture analysis (DMTA), which analyzes microwear features in three dimensions, alleviates some of the problems surrounding two-dimensional microwear methods by reducing observer bias. Here, we assess the accuracy and comparability within and between 2D and 3D dental microwear analyses in herbivorous and carnivorous mammals at the same magnification. Specifically, we compare observer-generated 2D microwear data from photosimulations of the identical scanned areas of DMTA in extant African bovids and carnivorans using a scanning white light confocal microscope at 100x magnification. Using this magnification, dental microwear features quantified in 2D were able to separate grazing and frugivorous bovids using scratch frequency; however, DMTA variables were better able to discriminate between disparate dietary niches in both carnivorous and herbivorous mammals. Further, results demonstrate significant interobserver differences in 2D microwear data, with the microwear index remaining the least variable between experienced observers, consistent with prior research. Overall, our results highlight the importance of reducing observer error and analyzing dental microwear in three dimensions in order to consistently interpret diets accurately.	[DeSantis, Larisa R. G.; Donohue, Shelly L.; Van Stolk, Courtney A.; Greshko, Michael A.] Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA; [Scott, Jessica R.; O'Hara, Mackie C.] Univ Arkansas, Dept Sociol & Anthropol, Little Rock, AR 72204 USA; [Schubert, Blaine W.] E Tennessee State Univ, Ctr Excellence Paleontol, Johnson City, TN 37614 USA; [Schubert, Blaine W.] E Tennessee State Univ, Dept Geosci, Johnson City, TN 37614 USA; [McCray, Brian M.; Winburn, Amanda A.] Vanderbilt Univ, Dept Anthropol, Nashville, TN 37235 USA	Vanderbilt University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; East Tennessee State University; East Tennessee State University; Vanderbilt University	DeSantis, LRG (corresponding author), Vanderbilt Univ, Dept Earth & Environm Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	larisa.desantis@vanderbilt.edu	O'Hara, Mackie/W-8980-2019	O'Hara, Mackie/0000-0002-1221-0668; DeSantis, Larisa/0000-0003-1159-9154	Vanderbilt University; University of Arkansas at Little Rock; East Tennessee State University; National Science Foundation [EAR 1053839]	Vanderbilt University; University of Arkansas at Little Rock; East Tennessee State University; National Science Foundation(National Science Foundation (NSF))	Financial support was provided by Vanderbilt University, University of Arkansas at Little Rock, East Tennessee State University, and the National Science Foundation (EAR 1053839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty BL, 2012, J VERTEBR PALEONTOL, V32, P61; DeSantis LRG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052453; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Fraser D, 2011, J MORPHOL, V272, P1513, DOI 10.1002/jmor.11001; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Galbany J, 2005, SCANNING, V27, P23; Goillot C, 2009, PALAEOGEOGR PALAEOCL, V271, P13, DOI 10.1016/j.palaeo.2008.09.004; GORDON KD, 1988, SCANNING MICROSCOPY, V2, P1139; GORDON KD, 1984, ARCH ORAL BIOL, V29, P783, DOI 10.1016/0003-9969(84)90007-4; GORDON KD, 1982, AM J PHYS ANTHROPOL, V59, P195, DOI 10.1002/ajpa.1330590208; GRINE FE, 1981, S AFR J SCI, V77, P203; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; Haupt RJ, 2013, J MAMMAL, V94, P856, DOI 10.1644/12-MAMM-A-204.1; MacFadden BJ, 1999, SCIENCE, V283, P824, DOI 10.1126/science.283.5403.824; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2005, PALAEOGEOGR PALAEOCL, V217, P173, DOI 10.1016/j.palaeo.2004.11.019; Mihlbachler MC, 2012, PALAEONTOL ELECTRON, V15; Mihlbachler MC, 2012, PALAEONTOL ELECTRON, V15; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; Rodrigues HG, 2009, NATURWISSENSCHAFTEN, V96, P537, DOI 10.1007/s00114-008-0501-x; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Schubert BW, 2006, PALAEOGEOGR PALAEOCL, V241, P301, DOI 10.1016/j.palaeo.2006.04.004; Scott JR, 2012, MAMMALIA, V76, P157, DOI 10.1515/mammalia-2011-0083; Scott R, 2008, J VERTEBR PALEONTOL, V28, p139A; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semprebon GM, 2004, J HUM EVOL, V47, P115, DOI 10.1016/j.jhevol.2004.06.004; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; Solounias N, 2010, PALEOBIOLOGY, V36, P113, DOI 10.1666/0094-8373-36.1.113; TEAFORD MF, 1992, AM J PHYS ANTHROPOL, V88, P347, DOI 10.1002/ajpa.1330880308; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Ungar P.S., 2008, TECHNIQUE APPL DENT, P389, DOI DOI 10.1017/CBO9780511542442.017; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; VANVALKENBURGH B, 1990, J ZOOL, V222, P319; WALKER A, 1984, AM J PHYS ANTHROPOL, V65, P47, DOI 10.1002/ajpa.1330650108; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415	37	76	76	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71428	10.1371/journal.pone.0071428	http://dx.doi.org/10.1371/journal.pone.0071428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936506	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000324401500071
J	Giugno, R; Pulvirenti, A; Cascione, L; Pigola, G; Ferro, A				Giugno, Rosalba; Pulvirenti, Alfredo; Cascione, Luciano; Pigola, Giuseppe; Ferro, Alfredo			MIDClass: Microarray Data Classification by Association Rules and Gene Expression Intervals	PLOS ONE			English	Article							CANCER; ESTROGEN; PREDICTION; PROTEIN; CELLS	We present a new classification method for expression profiling data, called MIDClass (Microarray Interval Discriminant CLASSifier), based on association rules. It classifies expressions profiles exploiting the idea that the transcript expression intervals better discriminate subtypes in the same class. A wide experimental analysis shows the effectiveness of MIDClass compared to the most prominent classification approaches.	[Giugno, Rosalba; Pulvirenti, Alfredo; Pigola, Giuseppe; Ferro, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Cascione, Luciano] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University of Catania; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Giugno, R (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Catania, Italy.	giugno@dmi.unict.it; apulvirenti@dmi.unict.it	Pulvirenti, Alfredo/I-7272-2018; Cascione, Luciano/X-3115-2019	Pulvirenti, Alfredo/0000-0002-9764-0295; Cascione, Luciano/0000-0002-4606-0637; Giugno, Rosalba/0000-0001-9843-7638	PO grant - FESR Linea di intervento 4.1.1.2 [CUP G23F11000840004]	PO grant - FESR Linea di intervento 4.1.1.2	This work has been partially founded by PO grant - FESR 2007-2013 Linea di intervento 4.1.1.2, CUP G23F11000840004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonie L, 2011, ACM S APPL COMP, P94; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Becquet C, 2002, GENOME BIOL, V3; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Bortfeld M, 2006, NEUROSCIENCE, V137, P1247, DOI 10.1016/j.neuroscience.2005.10.025; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brin S., 1997, SIGMOD Record, V26, P255, DOI [10.1145/253262.253327, 10.1145/253262.253325]; Burdick D, 2005, IEEE T KNOWL DATA EN, V17, P1490, DOI 10.1109/TKDE.2005.183; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Duda R., 1995, PATTERN CLASSIFICATI; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Dudoit S, 2002, STAT SINICA, V12, P111; FIX E, 1989, INT STAT REV, V57, P238, DOI 10.2307/1403797; Garcia S, 2013, IEEE T KNOWL DATA EN, V25, P734, DOI 10.1109/TKDE.2012.35; Georgii E, 2005, BIOINFORMATICS, V21, P123, DOI 10.1093/bioinformatics/bti1121; Ghilardi G, 2005, CLIN CHEM, V51, P452, DOI 10.1373/clinchem.2004.041657; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Honorat M, 2008, ENDOCR-RELAT CANCER, V15, P125, DOI 10.1677/ERC-07-0189; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kurokawa H, 2000, CANCER RES, V60, P5887; Lebrecht A, 2004, TUMOR BIOL, V25, P14, DOI 10.1159/000077718; Ma X, 2006, J CLIN ONCOLOGY, V24; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Mclntosh T, 2007, IEEE ACM T COMPUT BI, V4, P611, DOI [10.1109/tcbb.2007.1050, 10.1109/TCBB.2007.1050]; McNamara S, 1999, Nurs Times, V95, P54; Onskog J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-390; Pique-Regi R., 2005, 2005 IEEE Computational Systems Bioinformatics Conference Workshops and Poster Abstracts, P112, DOI 10.1109/CSBW.2005.124; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Smyth GK., 2005, LIMMA LINEAR MODELS; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang Z, 2007, CLIN CANC RES, V13; Yao BP, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-14	42	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69873	10.1371/journal.pone.0069873	http://dx.doi.org/10.1371/journal.pone.0069873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936357	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500019
J	Henry, MJ; McAuley, JD				Henry, Molly J.; McAuley, J. Devin			Perceptual Distortions in Pitch and Time Reveal Active Prediction and Support for an Auditory Pitch-Motion Hypothesis	PLOS ONE			English	Article							SUBJECTIVE DURATION; VELOCITY MODEL; RESPONSES; ATTENTION; INTERVAL; CONTEXT; BIAS; TAU	A number of accounts of human auditory perception assume that listeners use prior stimulus context to generate predictions about future stimulation. Here, we tested an auditory pitch-motion hypothesis that was developed from this perspective. Listeners judged either the time change (i.e., duration) or pitch change of a comparison frequency glide relative to a standard (referent) glide. Under a constant-velocity assumption, listeners were hypothesized to use the pitch velocity (Delta f/Delta t) of the standard glide to generate predictions about the pitch velocity of the comparison glide, leading to perceptual distortions along the to-be-judged dimension when the velocities of the two glides differed. These predictions were borne out in the pattern of relative points of subjective equality by a significant three-way interaction between the velocities of the two glides and task. In general, listeners' judgments along the task-relevant dimension (pitch or time) were affected by expectations generated by the constant-velocity standard, but in an opposite manner for the two stimulus dimensions. When the comparison glide velocity was faster than the standard, listeners overestimated time change, but underestimated pitch change, whereas when the comparison glide velocity was slower than the standard, listeners underestimated time change, but overestimated pitch change. Perceptual distortions were least evident when the velocities of the standard and comparison glides were matched. Fits of an imputed velocity model further revealed increasingly larger distortions at faster velocities. The present findings provide support for the auditory pitch-motion hypothesis and add to a larger body of work revealing a role for active prediction in human auditory perception.	[Henry, Molly J.] Michigan State Univ, E Lansing, MI 48824 USA; [Henry, Molly J.; McAuley, J. Devin] Bowling Green State Univ, Bowling Green, OH 43403 USA	Michigan State University; University System of Ohio; Bowling Green State University	Henry, MJ (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	henry@cbs.mpg.de			National Science Foundation [BCS 1010592]; Bowling Green State University Graduate College	National Science Foundation(National Science Foundation (NSF)); Bowling Green State University Graduate College	A portion of this research was supported by a grant from the National Science Foundation (BCS 1010592) to JDM and support from the Bowling Green State University Graduate College to MJH. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alink A, 2010, J NEUROSCI, V30, P2960, DOI 10.1523/JNEUROSCI.3730-10.2010; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; den Ouden HEM, 2010, J NEUROSCI, V30; Dilley LC, 2008, J MEM LANG, V59, P294, DOI 10.1016/j.jml.2008.06.006; FRICK RW, 1985, PSYCHOL BULL, V97, P412, DOI 10.1037/0033-2909.97.3.412; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gibson J.J., 1966, SENSES CONSIDERED PE; Grassi M, 2006, PERCEPT PSYCHOPHYS, V68, P1382, DOI 10.3758/BF03193737; Henry MJ, 2011, ATTEN PERCEPT PSYCHO, V73, P172, DOI 10.3758/s13414-010-0009-2; Henry MJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1399, DOI 10.3758/APP.71.6.1399; Henry MJ, 2009, J EXP PSYCHOL HUMAN, V35, P551, DOI 10.1037/0096-1523.35.2.551; Ishihara M, 2008, CORTEX, V44, P454, DOI 10.1016/j.cortex.2007.08.010; JONES B, 1982, PSYCHOL BULL, V91, P128, DOI 10.1037/0033-2909.91.1.128; Jones MR, 1997, CAN J EXP PSYCHOL, V51, P271, DOI 10.1037/1196-1961.51.4.271; Jones MR, 2006, COGNITIVE PSYCHOL, V53, P59, DOI 10.1016/j.cogpsych.2006.01.003; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; JONES MR, 1993, THINKING SOUND COGNI, P69; Keller P. E., 2006, ADV COGN PSYCHOL, V2, P269, DOI [10.2478/v10053-008-0061-9, DOI 10.2478/V10053-008-0061-9]; Kiebel SJ, 2007, NEUROIMAGE, V36, P332, DOI 10.1016/j.neuroimage.2007.02.046; Klein JM, 1996, PERCEPT PSYCHOPHYS, V58, P34, DOI 10.3758/BF03205473; KRUMHANSL CL, 1991, ANNU REV PSYCHOL, V42, P277; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lejeune H, 2009, EUR J COGN PSYCHOL, V21, P941, DOI 10.1080/09541440802453006; Lidji P, 2007, J EXP PSYCHOL HUMAN, V33, P1189, DOI 10.1037/0096-1523.33.5.1189; MacKenzie N, 2007, KAPPA EFFECT PITCH T; Macmillan NA, 2005, DETECTION THEORY USE; McAuley JD, 2003, J EXP PSYCHOL HUMAN, V29, P1102, DOI 10.1037/0096-1523.29.6.1102; Miller NS, 2005, PERCEPT PSYCHOPHYS, V67, P1150, DOI 10.3758/BF03193548; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Rao RPN, 1999, VISION RES, V39, P1963, DOI 10.1016/S0042-6989(98)00279-X; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Schlauch RS, 2001, J ACOUST SOC AM, V109, P2880, DOI 10.1121/1.1372913; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; Vierordt K., 1868, ZEITSINN NACH VERSUC; Werner S., 1994, FUNDAMENTALS SPEECH, P23; Woodrow H, 1934, J EXP PSYCHOL, V17, P167, DOI 10.1037/h0070235	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70646	10.1371/journal.pone.0070646	http://dx.doi.org/10.1371/journal.pone.0070646			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217ZG	23936462	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500046
J	Saidj, M; Jorgensen, T; Jacobsen, RK; Linneberg, A; Aadahl, M				Saidj, Madina; Jorgensen, Torben; Jacobsen, Rikke K.; Linneberg, Allan; Aadahl, Mette			Separate and Joint Associations of Occupational and Leisure-Time Sitting with Cardio-Metabolic Risk Factors in Working Adults: A Cross-Sectional Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SEDENTARY BEHAVIORS; PHYSICAL-ACTIVITY; SELF-REPORT; MORTALITY; OBESITY; VALIDATION; CANCER; SPENT	Background: The workplace is a main setting for prolonged sitting for some occupational groups. Convincing evidence has recently accumulated on the detrimental cardio-metabolic health effects of leisure-time sitting. Yet, much less is known about occupational sitting, and the potential health risk attached compared to leisure-time sitting. Objective: To explore the separate and joint associations of occupational and leisure-time sitting with cardio-metabolic risk factors in working adults. Methods: All working adults (N = 2544) from the Health2006, a Danish population-based study, were included in this cross-sectional study. Participants reported hours of sitting during work, during leisure-time along with socio-demographic and behavioral characteristics, including physical activity. Cardio-metabolic risk factors (waist circumference, body mass index, body fat percentage, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, insulin, hemoglobin A1c and plasma glucose) were measured. Associations were explored by linear regression for leisure-time, occupational, and overall sitting time. Results: Statistically significant (p<.05) detrimental associations of leisure-time sitting were observed with all cardio-metabolic risk factors, except hemoglobin A1c and plasma glucose. Similarly, occupational sitting time was significantly detrimentally associated with HDL cholesterol, triglycerides, and insulin. For categories of sitting time, a joint adverse association of sitting much during both work-time and leisure-time was observed. Conclusion: The associations of occupational sitting time with cardio-metabolic risk factors were fewer and weaker compared to leisure-time sitting. Yet, the joint associations of occupational and leisure-time sitting with cardio-metabolic risk factors were higher than the separate. Our findings amplify the need for further focus in this area prior to making assumptions about equivalent health risks across sedentary behaviors. To our knowledge, this is the first study to contrast the deleterious associations of prolonged occupational and leisure-time sitting, both separately and jointly.	[Saidj, Madina; Jorgensen, Torben; Jacobsen, Rikke K.; Linneberg, Allan; Aadahl, Mette] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Aalborg, Denmark	University of Copenhagen; University of Copenhagen; Aalborg University	Saidj, M (corresponding author), Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	madina.saidj@regionh.dk	Jørgensen, Torben/Z-1335-2018	Jacobsen, Rikke Kart/0000-0003-4677-2973; Aadahl, Mette/0000-0001-5904-9747; Linneberg, Allan/0000-0002-0994-0184; Jorgensen, Torben/0000-0001-9453-2830	Health Insurance Foundation (Helsefonden) [2012B233]	Health Insurance Foundation (Helsefonden)	This work has been supported by the Health Insurance Foundation (Helsefonden) Grant number 2012B233, URL: http://www.helsefonden.dk/pages.asp?id = 63). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14; Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P422, DOI 10.1097/HJR.0b013e3280128d00; Andersen LG, 2010, SCAND J PUBLIC HEALT, V38, P707, DOI 10.1177/1403494810380099; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Biddle S., 2010, SEDENTARY BEHAV OBES; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Ekelund U, 2008, AM J CLIN NUTR, V88, P612, DOI 10.1093/ajcn/88.3.612; Ekelund U, 2012, INT J EPIDEMIOL, V41, P1353, DOI 10.1093/ije/dys128; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Forskningscenter for Forebyggelse og Sundhed, 2011, SUNDH REG KOMM 2010; Frydenlund G, 2012, EUR J PREV CARDIOL, V19, P1111, DOI 10.1177/1741826711419999; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Larsson CA, 2012, METABOLISM, V61, P590, DOI 10.1016/j.metabol.2011.09.010; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Plotnikoff R, 2012, ARCH ENVIRON OCCUP H, V67, P125, DOI 10.1080/19338244.2012.697407; Stamatakis E, 2012, INT J EPIDEMIOL, V41, P1328, DOI 10.1093/ije/dys077; Thuesen BH, 2013, INT J EPIDEMIOL; Toft U, 2007, EUR J CLIN NUTR, V61, P270, DOI 10.1038/sj.ejcn.1602503; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; van Uffelen JGZ, 2012, J PHYS ACT HEALTH, V9, P270, DOI 10.1123/jpah.9.2.270; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; VicHealth, 2012, RED PROL SITT WORKPL; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Zhang M, 2004, CANCER CAUSE CONTROL, V15, P83, DOI 10.1023/B:CACO.0000016633.47025.2a	33	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70213	10.1371/journal.pone.0070213	http://dx.doi.org/10.1371/journal.pone.0070213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936391	gold, Green Published, Green Submitted			2022-12-27	WOS:000324401500024
J	Miko, E; Meggyes, M; Bogar, B; Schmitz, N; Barakonyi, A; Varnagy, A; Farkas, B; Tamas, P; Bodis, J; Szekeres-Bartho, J; Illes, Z; Szereday, L				Miko, Eva; Meggyes, Matyas; Bogar, Barbara; Schmitz, Nora; Barakonyi, Aliz; Varnagy, Akos; Farkas, Balint; Tamas, Peter; Bodis, Jozsef; Szekeres-Bartho, Julia; Illes, Zsolt; Szereday, Laszlo			Involvement of Galectin-9/TIM-3 Pathway in the Systemic Inflammatory Response in Early-Onset Preeclampsia	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; INNATE IMMUNE CELLS; T-CELLS; NK CELLS; ELEVATED FREQUENCIES; MULTIPLE-SCLEROSIS; HUMAN-PREGNANCY; TIM-3 LIGAND; CD56(BRIGHT); EXPRESSION	Background: Preeclampsia is a common obstetrical disease affecting 3-5% of pregnancies and representing one of the leading causes of both maternal and fetal mortality. Maternal symptoms occur as an excessive systemic inflammatory reaction in response to the placental factors released by the oxidatively stressed and functional impaired placenta. The T-cell immunoglobulin domain and mucin domain (TIM) family is a relatively newly described group of molecules with a conserved structure and important immunological functions. Identification of Galectin-9 as a ligand for TIM-3 has established the Galectin-9/TIM-3 pathway as an important regulator of Th1 immunity and tolerance induction. Methods: The aim of our study was to investigate the expression and function of Galectin-9 and TIM-3 molecules by peripheral blood mononuclear cells and the possible role of Galectin-9/TIM-3 pathway in the immunoregulation of healthy pregnancy and early-onset preeclampsia. We determined TIM-3 and Gal-9 expression and cytotoxicicty of peripheral lymphocytes of early-onset preeclamptic women and healthy pregnant woman using flow cytometry. Results: Investigating peripheral lymphocytes of women with early-onset preeclampsia, our results showed a decreased TIM-3 expression by T cells, cytotoxic T cells, NK cells and CD56(dim) NK cells compared to healthy pregnant women. Interestingly, we found a notably increased frequency of Galectin-9 positive cells in each investigated lymphocyte population in the case of early-onset preeclamptic patients. We further demonstrated increased cytotoxic activity by cytotoxic T and CD56(dim) NK cells in women with early-onset preeclampsia. Our findings showed that the strongest cellular cytotoxic response of lymphocytes occurred in the TIM-3 positive subpopulations of different lymphocytes subsets in early-onset preeclampsia. Conclusion: These data suggest that Gal-9/TIM-3 pathway could play an important role in the immune regulation during pregnancy and the altered Galectin-9 and TIM-3 expression could result an enhanced systemic inflammatory response including the activation of Th1 lymphocytes in preeclampsia.	[Miko, Eva; Meggyes, Matyas; Bogar, Barbara; Schmitz, Nora; Barakonyi, Aliz; Szekeres-Bartho, Julia; Szereday, Laszlo] Univ Pecs, Dept Med Microbiol & Immunol, Ctr Clin, Pecs, Hungary; [Varnagy, Akos; Farkas, Balint; Tamas, Peter; Bodis, Jozsef] Univ Pecs, Dept Obstet & Gynaecol, Ctr Clin, Pecs, Hungary; [Illes, Zsolt] Odense Univ Hosp, Dept Neurol, DK-5000 Odense, Denmark; [Illes, Zsolt] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Miko, Eva; Meggyes, Matyas; Barakonyi, Aliz; Szekeres-Bartho, Julia; Szereday, Laszlo] Janos Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Szereday, L (corresponding author), Univ Pecs, Dept Med Microbiol & Immunol, Ctr Clin, Pecs, Hungary.	szereday.laszlo@pte.hu	Szereday, Laszlo/AAR-5741-2021; Farkas, Balint/AAF-9137-2019; Barakonyi, Aliz/ABF-7186-2021; Liu, FU-TONG/A-5749-2019	Szereday, Laszlo/0000-0002-1208-2969; Farkas, Balint/0000-0003-0638-2057; Liu, FU-TONG/0000-0002-3354-1001; Illes, Zsolt/0000-0001-9655-0450; Tamas, Peter/0000-0002-5612-8869	Hungarian National Research Fund [OTKA K104960, OTKA K77892]; Pecs University Research Fund [34039/KA-OTKA/11-19, 34039/KA-OTKA/11-14]; Social Renewal Operational Programme [TAMOP-4.2.1. B-10/2/KONV-2010-0002, TAMOP -4.2.2/B-10/1-2010-0029, TAMOP-4.2.2. A-11/1/KONV-2012-0053]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Pecs University Research Fund; Social Renewal Operational Programme	This work was supported by grants from Hungarian National Research Fund (OTKA K104960 and OTKA K77892), Pecs University Research Fund (34039/KA-OTKA/11-19 and 11-14) and Social Renewal Operational Programme (TAMOP-4.2.1. B-10/2/KONV-2010-0002, TAMOP -4.2.2/B-10/1-2010-0029 and TAMOP-4.2.2. A-11/1/KONV-2012-0053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benyo DF, 2001, J CLIN ENDOCR METAB, V86, P2505, DOI 10.1210/jc.86.6.2505; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; He WT, 2009, TRANSPLANTATION, V88, P782, DOI 10.1097/TP.0b013e3181b47f25; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Jiang WZ, 2011, J IMMUNOL, V187, P781, DOI 10.4049/jimmunol.1100789; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2010, J HEPATOL, V52, P322, DOI 10.1016/j.jhep.2009.12.005; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Miko E, 2008, AM J REPROD IMMUNOL, V60, P118, DOI 10.1111/j.1600-0897.2008.00603.x; Miko E, 2009, J REPROD IMMUNOL, V80, P100, DOI 10.1016/j.jri.2009.01.003; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Naka EL, 2009, INT IMMUNOPHARMACOL, V9, P658, DOI 10.1016/j.intimp.2008.11.013; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Powers RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013263; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Saito S, 2007, J REPROD IMMUNOL, V76, P30, DOI 10.1016/j.jri.2007.08.002; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sakai M, 2004, J REPROD IMMUNOL, V61, P133, DOI 10.1016/j.jri.2004.01.001; Sakhdari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040146; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sargent IL, 2006, TRENDS IMMUNOL, V27, P399, DOI 10.1016/j.it.2006.06.009; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Toldi G, 2012, AM J REPROD IMMUNOL, V68, P175, DOI 10.1111/j.1600-0897.2012.01145.x; Trotta R, 2005, BLOOD, V105, P3011, DOI 10.1182/blood-2004-10-4072; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; VINCE GS, 1995, BRIT J OBSTET GYNAEC, V102, P20, DOI 10.1111/j.1471-0528.1995.tb09020.x; Wang F, 2008, TRANSPL IMMUNOL, V19, P12, DOI 10.1016/j.trim.2008.01.008; Wang F, 2007, CELL IMMUNOL, V250, P68, DOI 10.1016/j.cellimm.2008.01.006; Zhao J, 2009, J IMMUNOL, V182, P6618, DOI 10.4049/jimmunol.0803876	44	41	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71811	10.1371/journal.pone.0071811	http://dx.doi.org/10.1371/journal.pone.0071811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936526	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000324545800068
J	Bobbert, MF				Bobbert, Maarten F.			Effects of Isometric Scaling on Vertical Jumping Performance	PLOS ONE			English	Article							SHORTENING VELOCITY; GALAGO-SENEGALENSIS; MICROCEBUS-MURINUS; MUSCLE PROPERTIES; LIMB MUSCLES; COUNTERMOVEMENT; MAMMALS; HEIGHT; HUMANS; FIBERS	Jump height, defined as vertical displacement in the airborne phase, depends on vertical takeoff velocity. For centuries, researchers have speculated on how jump height is affected by body size and many have adhered to what has come to be known as Borelli's law, which states that jump height does not depend on body size per se. The underlying assumption is that the amount of work produced per kg body mass during the push-off is independent of size. However, if a big body is isometrically downscaled to a small body, the latter requires higher joint angular velocities to achieve a given takeoff velocity and work production will be more impaired by the force-velocity relationship of muscle. In the present study, the effects of pure isometric scaling on vertical jumping performance were investigated using a biologically realistic model of the human musculoskeletal system. The input of the model, muscle stimulation over time, was optimized using jump height as criterion. It was found that when the human model was miniaturized to the size of a mouse lemur, with a mass of about one-thousandth that of a human, jump height dropped from 40 cm to only 6 cm, mainly because of the force-velocity relationship. In reality, mouse lemurs achieve jump heights of about 33 cm. By implication, the unfavourable effects of the small body size of mouse lemurs on jumping performance must be counteracted by favourable effects of morphological and physiological adaptations. The same holds true for other small jumping animals. The simulations for the first time expose and explain the sheer magnitude of the isolated effects of isometric downscaling on jumping performance, to be counteracted by morphological and physiological adaptations.	Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Bobbert, MF (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	M_F_Bobbert@fbw.vu.nl			Dutch Government	Dutch Government	The author has an appointment in a Dutch University, funded by the Dutch Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts P, 1998, PHILOS T R SOC B, V353, P1607, DOI 10.1098/rstb.1998.0313; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; ALEXANDER RM, 1995, PHILOS T R SOC B, V347, P235, DOI 10.1098/rstb.1995.0024; Alexander RM, 2000, SCALING BIOL; Bennet-Clark HC, 1977, SCALE EFFECTS ANIMAL; Bobbert M F, 2001, Exerc Sport Sci Rev, V29, P95, DOI 10.1097/00003677-200107000-00002; Bobbert MF, 2008, J APPL PHYSIOL, V105, P1428, DOI 10.1152/japplphysiol.90571.2008; Bobbert MF, 2005, MED SCI SPORT EXER, V37, P440, DOI 10.1249/01.MSS.0000155389.34538.97; Bobbert MF, 1996, MED SCI SPORT EXER, V28, P1402, DOI 10.1097/00005768-199611000-00009; Bobbert MF, 2001, J EXP BIOL, V204, P533; Borelli GA, 1680, DE MOTU ANIMALIUM; DEMES B, 1989, FOLIA PRIMATOL, V53, P125, DOI 10.1159/000156412; Demes B, 1999, J HUM EVOL, V37, P279, DOI 10.1006/jhev.1999.0311; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; EDGERTON VR, 1975, EXP NEUROL, V46, P115, DOI 10.1016/0014-4886(75)90036-9; Haldane J.B.S., 1928, POSSIBLE WORLDS; Hill A. V., 1950, Science Progress London, V38, P209; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; James RS, 2007, J EXP BIOL, V210, P923, DOI 10.1242/jeb.02731; James RS, 1998, J EXP BIOL, V201, P901; Lees A, 2004, J BIOMECH, V37, P1929, DOI 10.1016/j.jbiomech.2004.02.021; Legreneur P, 2010, J EXP BIOL, V213, P1320, DOI 10.1242/jeb.041079; Marx JO, 2006, PFLUG ARCH EUR J PHY, V452, P222, DOI 10.1007/s00424-005-0017-6; Medler S, 2002, AM J PHYSIOL-REG I, V283, pR368, DOI 10.1152/ajpregu.00689.2001; Newton I, 1687, PHILOS NATURALIS PRI; PETTER A, 1993, PRIMATES, V34, P181, DOI 10.1007/BF02381389; POUSSON M, 1991, PFLUG ARCH EUR J PHY, V419, P127, DOI 10.1007/BF00372997; Roberts TJ, 2003, J EXP BIOL, V206, P2567, DOI 10.1242/jeb.00452; Scholz MN, 2006, P R SOC B, V273, P2177, DOI 10.1098/rspb.2006.3568; Scholz MN, 2006, J THEOR BIOL, V240, P554, DOI 10.1016/j.jtbi.2005.10.015; SEOW CY, 1991, J GEN PHYSIOL, V97, P541, DOI 10.1085/jgp.97.3.541; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; van Soest AJK, 2000, MED SCI SPORT EXER, V32, P1927, DOI 10.1097/00005768-200011000-00017; van Soest AJK, 2003, J BIOMECH ENG-T ASME, V125, P141, DOI 10.1115/1.1537735; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; VANSOEST AJ, 1993, J BIOMECH, V26, P1, DOI 10.1016/0021-9290(93)90608-H; WALKER SM, 1974, ANAT RECORD, V178, P63, DOI 10.1002/ar.1091780107	39	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71209	10.1371/journal.pone.0071209	http://dx.doi.org/10.1371/journal.pone.0071209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936494	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400098
J	Chen, JW; Feng, G; Guo, Q; Wardenburg, JB; Lin, S; Inoshima, I; Deaton, R; Yuan, JXJ; Garcia, JGN; Machado, RF; Otto, M; Wunderink, RG				Chen, Jiwang; Feng, Gang; Guo, Qiang; Wardenburg, Juliane B.; Lin, Simon; Inoshima, Ichiro; Deaton, Ryan; Yuan, Jason X. J.; Garcia, Joe G. N.; Machado, Roberto F.; Otto, Michael; Wunderink, Richard G.			Transcriptional Events during the Recovery from MRSA Lung Infection: A Mouse Pneumonia Model	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS-AUREUS; ILLUMINA MICROARRAY; DISEASE-ONTOLOGY; HOST-DEFENSE; CELL-GROWTH; PROTEIN; GENE; INHIBITOR; RECEPTOR	Community associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging threat to human health throughout the world. Rodent MRSA pneumonia models mainly focus on the early innate immune responses to MRSA lung infection. However, the molecular pattern and mechanisms of recovery from MRSA lung infection are largely unknown. In this study, a sublethal mouse MRSA pneumonia model was employed to investigate late events during the recovery from MRSA lung infection. We compared lung bacterial clearance, bronchoalveolar lavage fluid (BALF) characterization, lung histology, lung cell proliferation, lung vascular permeability and lung gene expression profiling between days 1 and 3 post MRSA lung infection. Compared to day 1 post infection, bacterial colony counts, BALF total cell number and BALF protein concentration significantly decreased at day 3 post infection. Lung cDNA microarray analysis identified 47 significantly upregulated and 35 down-regulated genes (p<0.01, 1.5 fold change [up and down]). The pattern of gene expression suggests that lung recovery is characterized by enhanced cell division, vascularization, wound healing and adjustment of host adaptive immune responses. Proliferation assay by PCNA staining further confirmed that at day 3 lungs have significantly higher cell proliferation than at day 1. Furthermore, at day 3 lungs displayed significantly lower levels of vascular permeability to albumin, compared to day 1. Collectively, this data helps us elucidate the molecular mechanisms of the recovery after MRSA lung infection.	[Chen, Jiwang; Wunderink, Richard G.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Chen, Jiwang; Guo, Qiang; Yuan, Jason X. J.; Garcia, Joe G. N.; Machado, Roberto F.] Univ Illinois, Sect Pulm Crit Care Med Allergy & Sleep, Chicago, IL USA; [Feng, Gang; Lin, Simon] Northwestern Univ, Biomed Informat Ctr, Chicago, IL 60611 USA; [Wardenburg, Juliane B.; Inoshima, Ichiro] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Lin, Simon] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Deaton, Ryan] Univ Illinois, Dept Pathol, Chicago, IL USA; [Otto, Michael] NIAID, Bethesda, MD 20892 USA	Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chen, JW (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.	chenjw@uic.edu		Machado, Roberto/0000-0002-3722-5954; Otto, Michael/0000-0002-2222-4115; Wunderink, Richard/0000-0002-8527-4195	Pfizer ASPIRE Award; Pfizer Investigator-Initiated Grant [WS1826185]; National Center for Advancing Translational Sciences Grant [8UL1TR000150]; NCI Cancer Center Support Grant [NCI CA060553]; Intramural Research Program of the NIAID; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	Pfizer ASPIRE Award; Pfizer Investigator-Initiated Grant; National Center for Advancing Translational Sciences Grant; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Pfizer ASPIRE Award, Pfizer Investigator-Initiated Grant (WS1826185, to Chen), the National Center for Advancing Translational Sciences Grant (8UL1TR000150) and the NCI Cancer Center Support Grant (NCI CA060553 to Feng and Lin) and the Intramural Research Program of the NIAID (to Otto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Albig W, 1997, GENOMICS, V40, P314, DOI 10.1006/geno.1996.4592; Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Beckers J, 2005, INT J CANCER, V114, P590, DOI 10.1002/ijc.20798; Boncela J, 2001, J BIOL CHEM, V276, P35305, DOI 10.1074/jbc.M104028200; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Chen ZM, 2007, FREE RADICAL BIO MED, V43, P628, DOI 10.1016/j.freeradbiomed.2007.05.024; Chueh AC, 2005, HUM MOL GENET, V14, P85, DOI 10.1093/hmg/ddi008; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; FLECKNER J, 1991, P NATL ACAD SCI USA, V88, P11520, DOI 10.1073/pnas.88.24.11520; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Herembert T, 1997, BIOCHEM J, V325, P123, DOI 10.1042/bj3250123; Hornebeck W, 2003, PATHOL BIOL, V51, P569, DOI 10.1016/j.patbio.2003.09.003; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Jurisic G, 2010, EXP CELL RES, V316, P2982, DOI 10.1016/j.yexcr.2010.06.013; Kalsheker NA, 1996, INT J BIOCHEM CELL B, V28, P961, DOI 10.1016/1357-2725(96)00032-5; Kondratyev AD, 1996, CANCER RES, V56, P1498; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lasbury ME, 2003, CLIN DIAGN LAB IMMUN, V10, P293, DOI 10.1128/CDLI.10.2.293-302.2003; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Levi M, 2003, CRIT CARE MED, V31, pS238, DOI 10.1097/01.CCM.0000057849.53689.65; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Moitra J, 2008, TRANSL RES, V151, P141, DOI 10.1016/j.trsl.2007.12.008; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; Morgan DO., 2007, CELL CYCLE PRINCIPLE, P30; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Oh JH, 2009, INHAL TOXICOL, V21, P347, DOI [10.1080/08958370802464281 , 10.1080/08958370802464281]; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Peerschke EIB, 1998, IMMUNOBIOLOGY, V199, P239, DOI 10.1016/S0171-2985(98)80030-2; PRELLNER K, 1981, SCAND J INFECT DIS, V13, P263, DOI 10.3109/inf.1981.13.issue-4.04; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Sambo P, 1996, BLOOD, V87, P1682; Schultz MJ, 2006, CRIT CARE MED, V34, P871, DOI 10.1097/01.CCM.0000202136.91651.34; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Tamm I, 1998, CANCER RES, V58, P5315; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; Ventura CL, 2008, INFECT IMMUN, V76, P5862, DOI 10.1128/IAI.00865-08; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; WEINSTEIN J, 1994, MOL CELL BIOL, V14, P3350, DOI 10.1128/MCB.14.5.3350; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998	57	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70176	10.1371/journal.pone.0070176	http://dx.doi.org/10.1371/journal.pone.0070176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936388	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400041
J	Krastinova, E; Seng, R; Yeni, P; Viard, JP; Vittecoq, D; Lascoux-Combe, C; Fourn, E; Pahlavan, G; Delfraissy, JF; Goujard, C; Meyer, L				Krastinova, Evguenia; Seng, Remonie; Yeni, Patrick; Viard, Jean-Paul; Vittecoq, Daniel; Lascoux-Combe, Caroline; Fourn, Erwan; Pahlavan, Golriz; Delfraissy, Jean Francois; Goujard, Cecile; Meyer, Laurence		ANRS PRIMO; COPANA Cohorts	Is Clinical Practice Concordant with the Changes in Guidelines for Antiretroviral Therapy Initiation during Primary and Chronic HIV-1 Infection? The ANRS PRIMO and COPANA Cohorts	PLOS ONE			English	Article							SOCIETY-USA PANEL; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; RECOMMENDATIONS; ADULTS; CARE	Objective: Guidelines for initiating HIV treatment are regularly revised. We explored how physicians in France have applied these evolving guidelines for ART initiation over the last decade in two different situations: chronic (CHI) and primary HIV-1 infection (PHI), since specific recommendations for PHI are also provided in France. Methods: Data came from the ANRS PRIMO (1267 patients enrolled during PHI in 1996-2010) and COPANA (800 subjects enrolled at HIV diagnosis in 2004-2008) cohorts. We defined as guidelines-inconsistent during PHI and CHI, patients meeting criteria for ART initiation and not treated in the following month and during the next 6 months, respectively. Results: ART initiation during PHI dramatically decreased from 91% of patients in 1996-99 to 22% in 2007 and increased to 60% in 2010, following changes in recommendations. In 2007, however, after the CD4 count threshold was raised to 350 cells/mm(3) in 2006, only 55% of the patients with CD4 <= 350 were treated and 66% in 2008. During CHI, ART was more frequently initiated in patients who met the criteria at entry (96%) than during follow-up: 83% when recommendation to treat was 200 and 73% when it was 350 cells/mm(3). Independent risk factors for not being treated during CHI despite meeting the criteria were lower viral load, lower educational level, and poorer living conditions. Conclusion: HIV ART initiation guidelines are largely followed by practitioners in France. What can still be improved, however, is time to treat when CD4 cell counts reach the threshold to treat. Risk factors for lack of timely treatment highlight the need to understand better how patients' living conditions and physicians' perceptions influence the decision to initiate treatment.	[Krastinova, Evguenia; Seng, Remonie; Goujard, Cecile; Meyer, Laurence] Univ Paris 11, INSERM, U1018, Epidemiol HIV & STI, Le Kremlin Bicetre, France; [Krastinova, Evguenia; Vittecoq, Daniel] Hop Bicetre, AP HP, Dept Infect & Trop Dis, Le Kremlin Bicetre, France; [Seng, Remonie; Meyer, Laurence] Hop Bicetre, AP HP, Dept Publ Hlth & Epidemiol, Le Kremlin Bicetre, France; [Yeni, Patrick; Pahlavan, Golriz] Bichat Claude Bernard Hosp, AP HP, Xavier Bichat Med Sch, Dept Infect & Trop Dis, Paris, France; [Viard, Jean-Paul] Hop Hotel Dieu, AP HP, Ctr Diagnost & Therapeut, Paris, France; [Lascoux-Combe, Caroline] St Louis Hosp, AP HP, Dept Infect & Trop Dis, Paris, France; [Fourn, Erwan; Delfraissy, Jean Francois; Goujard, Cecile] Univ Paris 11, Bicetre Hosp, AP HP, Dept Internal Med, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Krastinova, E (corresponding author), Univ Paris 11, INSERM, U1018, Epidemiol HIV & STI, Le Kremlin Bicetre, France.	krastinova@gmail.com	Viard, Jean-Paul/O-6467-2017; Revest, Matthieu/L-9533-2015; Gallien, Sébastien/F-9930-2015	Viard, Jean-Paul/0000-0001-5946-8896; Gallien, Sébastien/0000-0002-8033-0936; ABEL, Sylvie/0000-0002-3351-0547; Arvieux, Cedric/0000-0003-2332-2507; Cabie, Andre/0000-0003-0117-3061	ANRS	ANRS(ANRSFrench National Research Agency (ANR))	The ANRS PRIMO and COPANA cohorts are funded by the ANRS. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, FIN REP EUR COR IND; Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Backlund Lars, 2004, BMC Fam Pract, V5, P3, DOI 10.1186/1471-2296-5-3; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cabana MD, 2002, GEN HOSP PSYCHIAT, V24, P35, DOI 10.1016/S0163-8343(01)00169-4; Cabana Michael D, 2002, Manag Care, V11, P18; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Delfraissy JF, 2002, PRISE CHARGE MED PER; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; European AIDS Clinical Society, 2011, EUR AIDS CLIN SOC GU; Fervers B, 2010, J VISC SURG, V147, pE341, DOI 10.1016/j.jviscsurg.2010.10.010; Gnavi R, 2009, DIABETES CARE, V32, P1986, DOI 10.2337/dc09-0647; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Leung DY, 2007, INTERN MED J, V37, P699, DOI 10.1111/j.1445-5994.2007.01390.x; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUIDELINES USE ANTIR; Preau M, 2012, AIDS CARE, V24, P434, DOI 10.1080/09540121.2011.613909; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Rachas A, 2012, AIDS; Robert J., 2009, Bulletin Epidemiologique Hebdomadaire, P455; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef; Wandeler G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027903; WHO, 2010, ANT THER HIV INF AD; Wirtzfeld DA, 2009, CAN J SURG, V52, P92; Yeni P, 2008, PRISE CHARGE MED PER; Yeni P, 2010, PRISE CHARGE MED PER; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Yeni PG, 2006, PRISE CHARGE MED PER, P1	38	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71473	10.1371/journal.pone.0071473	http://dx.doi.org/10.1371/journal.pone.0071473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936509	gold, Green Published			2022-12-27	WOS:000324518400108
J	Nose, F; Yamaguchi, T; Kato, R; Aiuchi, T; Obama, T; Hara, S; Yamamoto, M; Itabe, H				Nose, Fuyuki; Yamaguchi, Tomohiro; Kato, Rina; Aiuchi, Toshihiro; Obama, Takashi; Hara, Shuntaro; Yamamoto, Matsuo; Itabe, Hiroyuki			Crucial Role of Perilipin-3 (TIP47) in Formation of Lipid Droplets and PGE(2) Production in HL-60-Derived Neutrophils	PLOS ONE			English	Article							FATTY-ACID; PAT-FAMILY; PROTEIN; EXPRESSION; DIFFERENTIATION; ADIPOPHILIN; METABOLISM; ACTIVATION; LEUKOCYTES; ORGANELLE	Cytosolic lipid droplets (LDs), which are now recognized as multifunctional organelles, accumulate in leukocytes under various inflammatory conditions. However, little is known about the characteristic features of LDs in neutrophils. In this study, we show that perilipin-3 (PLIN3; formerly called TIP47) is involved in LD formation and the inflammatory response in HL-60-derived neutrophils. HL-60, a promyelocytic cell line, was differentiated into neutrophils via treatment with all-trans retinoic acid. After differentiation, cells were stimulated with Porphyromonas gingivalis lipopolysaccharide (P.g-LPS), a major pathogen in adult periodontitis. When HL-60-derived neutrophils were stimulated with P.g-LPS, LDs increased in both number and size. In the differentiated cells, PLIN3 was induced while PLIN1, PLIN2 and PLIN5 were not detected. PGE(2) production and the PLIN3 protein level were increased by the P.g-LPS treatment of the cells in a dose-dependent manner. When PLIN3 was down-regulated with siRNA treatment, LDs essentially disappeared and the level of PGE(2) secreted in the cell culture medium decreased by 65%. In addition, the suppression of PLIN3 repressed the PGE(2) producing enzymes; i.e., microsomal PGE synthase-1, -2 and cyclooxygenase-2. These findings indicate that PLIN3 has a pivotal role in LD-biogenesis in HL-60-derived neutrophils, and that PLIN3 is associated with the synthesis and secretion of PGE(2).	[Nose, Fuyuki; Yamamoto, Matsuo] Showa Univ, Sch Dent, Dept Periodontol, Tokyo 142, Japan; [Nose, Fuyuki; Yamaguchi, Tomohiro; Kato, Rina; Aiuchi, Toshihiro; Obama, Takashi; Itabe, Hiroyuki] Showa Univ, Sch Pharm, Dept Mol Biol, Div Biol Chem, Tokyo, Japan; [Hara, Shuntaro] Showa Univ, Sch Pharm, Div Hlth Chem, Dept Healthcare & Regulatory Sci, Tokyo, Japan	Showa University; Showa University; Showa University	Itabe, H (corresponding author), Showa Univ, Sch Pharm, Dept Mol Biol, Div Biol Chem, Tokyo, Japan.	h-itabe@pharm.showa-u.ac.jp	板部板部, 洋之/ABC-7746-2020		Ministry of Education, Technology, Sports, Sciences and Technology of Japan (MEXT) [19590076, 20770160, 23790098]; Private University High Technology Research Center Project from the MEXT; Research on Publicly Essential Drugs and Medical Devices from Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research [25116720, 23790098] Funding Source: KAKEN	Ministry of Education, Technology, Sports, Sciences and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Private University High Technology Research Center Project from the MEXT; Research on Publicly Essential Drugs and Medical Devices from Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Technology, Sports, Sciences and Technology of Japan (MEXT) (No. 19590076, No. 20770160, No. 23790098), grants for the Private University High Technology Research Center Project from the MEXT, Research on Publicly Essential Drugs and Medical Devices from Japan Health Sciences Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHM JL, 1981, BLOOD, V58, P1119; Araujo-Santos T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000873; Asai Y, 2005, INFECT IMMUN, V73, P2157, DOI 10.1128/IAI.73.4.2157-2163.2005; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Buers I, 2009, ARTERIOSCL THROM VAS, V29, P767, DOI 10.1161/ATVBAHA.108.182675; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; COIMBRA A, 1971, J HISTOCHEM CYTOCHEM, V19, P551, DOI 10.1177/19.9.551; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Darveau RP, 1997, PERIODONTOL 2000, V14, P12, DOI 10.1111/j.1600-0757.1997.tb00190.x; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200; Fan B, 2013, METABOLISM; Fujii H, 2009, J ATHEROSCLER THROMB, V16, P893; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Gu JQ, 2010, AM J PHYSIOL-ENDOC M, V299, pE593, DOI 10.1152/ajpendo.00159.2010; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lu XY, 2001, MAMM GENOME, V12, P741, DOI 10.1007/s00335-01-2055-5; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; Meadows JW, 2005, J CLIN ENDOCR METAB, V90, P2344, DOI 10.1210/jc.2004-1199; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Ohsaki Y, 2006, BIOCHEM BIOPH RES CO, V347, P279, DOI 10.1016/j.bbrc.2006.06.074; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; WELLER PF, 1989, AM J PATHOL, V135, P947; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	45	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71542	10.1371/journal.pone.0071542	http://dx.doi.org/10.1371/journal.pone.0071542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936516	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400113
J	Stowhas, AC; Latshang, TD; Lo Cascio, CM; Lautwein, S; Stadelmann, K; Tesler, N; Ayers, L; Berneis, K; Gerber, PA; Huber, R; Achermann, P; Bloch, KE; Kohler, M				Stoewhas, Anne-Christin; Latshang, Tsogyal D.; Lo Cascio, Christian M.; Lautwein, Sina; Stadelmann, Katrin; Tesler, Noemi; Ayers, Lisa; Berneis, Kaspar; Gerber, Philipp A.; Huber, Reto; Achermann, Peter; Bloch, Konrad E.; Kohler, Malcolm			Effects of Acute Exposure to Moderate Altitude on Vascular Function, Metabolism and Systemic Inflammation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BLOOD-PRESSURE; LIPOPROTEIN CHOLESTEROL; INTERLEUKIN-6; INCREASES; STROKE	Background: Travel to mountain areas is popular. However, the effects of acute exposure to moderate altitude on the cardiovascular system and metabolism are largely unknown. Objectives: To investigate the effects of acute exposure to moderate altitude on vascular function, metabolism and systemic inflammation. Methods: In 51 healthy male subjects with a mean (SD) age of 26.9 (9.3) years, oxygen saturation, blood pressure, heart rate, arterial stiffness, lipid profiles, low density lipoprotein (LDL) particle size, insulin resistance (HOMA-index), highly-sensitive C-reactive protein and pro-inflammatory cytokines were measured at 490 m (Zurich) and during two days at 2590 m, (Davos Jakobshorn, Switzerland) in randomized order. The largest differences in outcomes between the two altitudes are reported. Results: Mean (SD) oxygen saturation was significantly lower at 2590 m, 91.0 (2.0)%, compared to 490 m, 96.0 (1.0)%, p<0.001. Mean blood pressure (mean difference +4.8 mmHg, p<0.001) and heart rate (mean difference +3.3 bpm, p<0.001) were significantly higher at 2590 m, compared to 490 m, but this was not associated with increased arterial stiffness. At 2590 m, lipid profiles improved (median difference triglycerides -0.14 mmol/l, p = 0.012, HDL +0.08 mmol/l, p<0.001, total cholesterol/HDL-ratio -0.25, p = 0.001), LDL particle size increased (median difference +0.45 nm, p = 0.048) and hsCRP decreased (median difference -0.18 mg/l, p = 0.024) compared to 490 m. No significant change in proinflammatory cytokines or insulin resistance was observed upon ascent to 2590 m. Conclusions: Short-term stay at moderate altitude is associated with increased blood pressure and heart rate likely due to augmented sympathetic activity. Exposure to moderate altitude improves the lipid profile and systemic inflammation, but seems to have no significant effect on glucose metabolism.	[Stoewhas, Anne-Christin; Latshang, Tsogyal D.; Lo Cascio, Christian M.; Lautwein, Sina; Bloch, Konrad E.; Kohler, Malcolm] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland; [Stadelmann, Katrin; Achermann, Peter] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Tesler, Noemi; Huber, Reto] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland; [Ayers, Lisa] Churchill Hosp, Dept Clin Immunol, Oxford OX3 7LJ, England; [Berneis, Kaspar; Gerber, Philipp A.] Univ Zurich Hosp, Dept Endocrinol Diabet & Nutr, CH-8091 Zurich, Switzerland; [Huber, Reto; Achermann, Peter; Bloch, Konrad E.; Kohler, Malcolm] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Children's Hospital Zurich; University of Oxford; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Kohler, M (corresponding author), Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland.	Malcolm.K@bluewin.ch	Gerber, Philipp/C-2145-2015; Achermann, Peter/N-1215-2014	Gerber, Philipp/0000-0002-2476-7076; Achermann, Peter/0000-0002-0208-3511	University of Zurich Research Priority Program (URPP Integrative Human Physiology); SUVA (Swiss Accident Insurance Fund), Switzerland	University of Zurich Research Priority Program (URPP Integrative Human Physiology); SUVA (Swiss Accident Insurance Fund), Switzerland	This study was supported by a research grant from the University of Zurich Research Priority Program (URPP Integrative Human Physiology) and the SUVA (Swiss Accident Insurance Fund), Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; Bailey DM, 2004, J APPL PHYSIOL, V96, P1459, DOI 10.1152/japplphysiol.00704.2003; Barnholt KE, 2006, AM J PHYSIOL-ENDOC M, V290, pE1078, DOI 10.1152/ajpendo.00449.2005; Bernardi L, 1998, CLIN SCI, V95, P565, DOI 10.1042/cs0950565; Clarenbach CF, 2012, HYPERTENS RES, V35, P228, DOI 10.1038/hr.2011.168; Coello SD, 2000, INT J EPIDEMIOL, V29, P65, DOI 10.1093/ije/29.1.65; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; D'ESTE D, 1991, Giornale Italiano di Cardiologia, V21, P643; FEREZOU J, 1988, EUR J APPL PHYSIOL O, V57, P740, DOI 10.1007/BF01075997; Greie S, 2006, J ENDOCRINOL INVEST, V29, P497, DOI 10.1007/BF03344138; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Kanstrup IL, 1999, J APPL PHYSIOL, V87, P2053, DOI 10.1152/jappl.1999.87.6.2053; Kelly KR, 2010, METABOLISM, V59, P200, DOI 10.1016/j.metabol.2009.07.014; Kohler M, 2009, THORAX, V64, P67, DOI 10.1136/thx.2008.097931; KRAUSS RM, 1982, J LIPID RES, V23, P97; Lee WC, 2003, HIGH ALT MED BIOL, V4, P81, DOI 10.1089/152702903321489013; Licht CMM, 2013, J CLIN ENDOCR METAB, V98, P2484, DOI 10.1210/jc.2012-3104; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzeo RS, 2001, J APPL PHYSIOL, V91, P2143; Rhodes HL, 2011, J ROY ARMY MED CORPS, V157, P110, DOI 10.1136/jramc-157-01-18; Rizzo M, 2006, EUR J INTERN MED, V17, P77, DOI 10.1016/j.ejim.2005.08.013; Roberts WL, 2001, CLIN CHEM, V47, P418; Schobersberger W, 2010, SLEEP BREATH, V14, P201, DOI 10.1007/s11325-009-0286-y; Smith JD, 2011, WILD ENVIRON MED, V22, P107, DOI 10.1016/j.wem.2011.01.003; Temte JL, 1996, WILD ENVIRON MED, V7, P216, DOI 10.1580/1080-6032(1996)007[0216:EOSCAH]2.3.CO;2; Vats P, 2013, HIGH ALT MED BIOL, V14, P45, DOI 10.1089/ham.2012.1071; VOGEL JA, 1967, J APPL PHYSIOL, V22, P1124, DOI 10.1152/jappl.1967.22.6.1124; WOLFEL EE, 1994, J APPL PHYSIOL, V76, P1643, DOI 10.1152/jappl.1994.76.4.1643; Wyss CA, 2003, CIRCULATION, V108, P1202, DOI 10.1161/01.CIR.0000087432.63671.2E	31	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70081	10.1371/journal.pone.0070081	http://dx.doi.org/10.1371/journal.pone.0070081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936377	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000324518400036
J	Monson, DH; Udevitz, MS; Jay, CV				Monson, Daniel H.; Udevitz, Mark S.; Jay, Chadwick V.			Estimating Age Ratios and Size of Pacific Walrus Herds on Coastal Haulouts using Video Imaging	PLOS ONE			English	Article							ODOBENUS-ROSMARUS; SEA; POPULATION; MORTALITY	During Arctic summers, sea ice provides resting habitat for Pacific walruses as it drifts over foraging areas in the eastern Chukchi Sea. Climate-driven reductions in sea ice have recently created ice-free conditions in the Chukchi Sea by late summer causing walruses to rest at coastal haulouts along the Chukotka and Alaska coasts, which provides an opportunity to study walruses at relatively accessible locations. Walrus age can be determined from the ratio of tusk length to snout dimensions. We evaluated use of images obtained from a gyro-stabilized video system mounted on a helicopter flying at high altitudes (to avoid disturbance) to classify the sex and age of walruses hauled out on Alaska beaches in 2010-2011. We were able to classify 95% of randomly selected individuals to either an 8- or 3-category age class, and we found measurement-based age classifications were more repeatable than visual classifications when using images presenting the correct head profile. Herd density at coastal haulouts averaged 0.88 walruses/m(2) (std. err. = 0.02), herd size ranged from 8,300 to 19,400 (CV 0.03-0.06) and we documented similar to 30,000 animals along similar to 1 km of beach in 2011. Within the herds, dependent walruses (0-2 yr-olds) tended to be located closer to water, and this tendency became more pronounced as the herd spent more time on the beach. Therefore, unbiased estimation of herd age-ratios will require a sampling design that allows for spatial and temporal structuring. In addition, randomly sampling walruses available at the edge of the herd for other purposes (e.g., tagging, biopsying) will not sample walruses with an age structure representative of the herd. Sea ice losses are projected to continue, and population age structure data collected with aerial videography at coastal haulouts may provide demographic information vital to ongoing efforts to understand effects of climate change on this species.	[Monson, Daniel H.; Udevitz, Mark S.; Jay, Chadwick V.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA	United States Department of the Interior; United States Geological Survey	Monson, DH (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA.	dmonson@usgs.gov	Monson, Daniel/N-4469-2013	Monson, Daniel/0000-0002-4593-5673; Udevitz, Mark/0000-0003-4659-138X	Wildlife Program of the USGS Ecosystem Mission Area	Wildlife Program of the USGS Ecosystem Mission Area	This work is part of the U.S. Geological Survey's Changing Arctic Ecosystem Initiative and is supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area. The USGS employs the authors and requires peer reviewed study plans and all manuscripts are reviewed as per the Fundamental Science Practices Policy of the USGS (http://www.usgs.gov/fsp/).	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; [Anonymous], [No title captured]; [Anonymous], 2006, SAS MIXED MODELS; BOWDEN DC, 1984, J WILDLIFE MANAGE, V48, P500, DOI 10.2307/3801182; CARRICK R., 1962, C S I R O WILDLIFE RES, V7, P119; Chivers SJ, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P239; Citta JJ, 2014, MAR MAMMAL SCI, V30, P20, DOI 10.1111/mms.12013; de la Mare W.K., 1990, International Whaling Commission Report of the Commission, V40, P525; Douglas D. C., 2010, 1176 US GEOL SURV; Fay F. H., 1984, OUTER CONTINENTAL SH, V37, P231; Fay F. H., 1989, 890012 OCS MMS; FAY FH, 1980, ARCTIC, V33, P226; Fay FH, 1997, MAR MAMMAL SCI, V13, P537, DOI 10.1111/j.1748-7692.1997.tb00083.x; Fay FH, 1982, N AM FAUNA, DOI DOI 10.3996/NAFA.74.0001; Fischbach A. S., 2009, 20091291 US GEOL SUR; Garlich-Miller J., 2011, STATUS REV PACIFIC W; Harris NC, 2008, J WILDLIFE MANAGE, V72, P1143, DOI 10.2193/2007-277; Hegel TM, 2010, J ANIM ECOL, V79, P471, DOI 10.1111/j.1365-2656.2009.01647.x; Jay C.V., 2008, FACT SHEET 2008 3041, DOI [10.3133/fs20083041, DOI 10.3133/FS20083041]; Jay CV, 2012, MAR ECOL PROG SER, V468, P1, DOI 10.3354/meps10057; Jay CV, 2011, POLAR BIOL, V34, P1065, DOI 10.1007/s00300-011-0967-4; Jay CV, 2006, MAR MAMMAL SCI, V22, P226, DOI 10.1111/j.1748-7692.2006.00018.x; Kavry V.I., 2008, MAR MAMM HOL 5 C OD, P248; Kavry VI, 2006, MARINE MAMMALS HOLAR, P227; Kenyon K. W., 1954, 12 US FISH WILDL SER; Kochnev AA, 2006, MARINE MAMMALS HOLAR, P266; Kochnev AA, 1999, PACIFIC WALRUS COAST, V126, P447; Kochnev AA, 2010, MARINE MAMMALS HOLAR, P281; Laws R. M., 1953, 8 FALKL ISL DEP SURV; Lydersen C, 2012, POLAR BIOL, V35, P1555, DOI 10.1007/s00300-012-1195-2; McCullagh P., 1999, GEN LINEAR MODELS; Meier WN, 2007, ANN GLACIOL-SER, V46, P428, DOI 10.3189/172756407782871170; Metcalf V, 2008, ECOL APPL, V18, pS148, DOI 10.1890/06-0642.1; Morris W. F., 2002, QUANTITATIVE CONSERV; Overland JE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030808; Ovsyanikov N. G, 2008, MAR MAMM HOL 5 C OD, P413; OVSYANIKOV NG, 1994, ZOOL ZH, V73, P80; Ray GC, 2006, J EXP MAR BIOL ECOL, V330, P403, DOI 10.1016/j.jembe.2005.12.043; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Tanaka S., 1990, International Whaling Commission Report of the Commission, V40, P531; THOMPSON SK, 2002, SAMPLING; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Udevitz MS, 2012, ECOLOGY, V93, P726, DOI 10.1890/11-1766.1; Wang MY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052868; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; White GC, 1996, J WILDLIFE MANAGE, V60, P37, DOI 10.2307/3802037	46	10	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69806	10.1371/journal.pone.0069806	http://dx.doi.org/10.1371/journal.pone.0069806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936106	gold, Green Submitted, Green Published			2022-12-27	WOS:000322633700045
J	Nilton, A; Sayin, VI; Staffas, A; Larsson, E; Rolf, J; Petit, MM; Palmqvist, L; Swolin, B; Cardell, S; Lindahl, P				Nilton, Anna; Sayin, Volkan I.; Staffas, Anna; Larsson, Erik; Rolf, Julia; Petit, Marleen M.; Palmqvist, Lars; Swolin, Birgitta; Cardell, Susanna; Lindahl, Per			Zinc Finger Protein 148 Is Dispensable for Primitive and Definitive Hematopoiesis in Mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; ZBP-89; CELL; PROMOTER; MUSCLE; BINDS; BOX	Hematopoiesis is regulated by transcription factors that induce cell fate and differentiation in hematopoietic stem cells into fully differentiated hematopoietic cell types. The transcription factor zinc finger protein 148 (Zfp148) interacts with the hematopoietic transcription factor Gata1 and has been implicated to play an important role in primitive and definitive hematopoiesis in zebra fish and mouse chimeras. We have recently created a gene-trap knockout mouse model deficient for Zfp148, opening up for analyses of hematopoiesis in a conventional loss-of-function model in vivo. Here, we show that Zfp148-deficient neonatal and adult mice have normal or slightly increased levels of hemoglobin, hematocrit, platelets and white blood cells, compared to wild type controls. Hematopoietic lineages in bone marrow, thymus and spleen from Zfp148(gt/gt) mice were further investigated by flow cytometry. There were no differences in T-cells (CD4 and CD8 single positive cells, CD4 and CD8 double negative/positive cells) in either organ. However, the fraction of CD69- and B220-positive cells among lymphocytes in spleen was slightly lower at postnatal day 14 in Zfp148(gt/gt) mice compared to wild type mice. Our results demonstrate that Zfp148-deficient mice generate normal mature hematopoietic populations thus challenging earlier studies indicating that Zfp148 plays a critical role during hematopoietic development.	[Nilton, Anna; Sayin, Volkan I.; Petit, Marleen M.; Lindahl, Per] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab, Gothenburg, Sweden; [Sayin, Volkan I.; Larsson, Erik; Lindahl, Per] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Staffas, Anna; Palmqvist, Lars; Swolin, Birgitta] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Rolf, Julia; Cardell, Susanna] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg	Lindahl, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab, Gothenburg, Sweden.	per.lindahl@wlab.gu.se	Larsson Lekholm, Erik/AHE-0932-2022; Cardell, Susanna/ABC-4944-2021; Larsson Lekholm, Erik/HDM-8032-2022	Larsson Lekholm, Erik/0000-0003-1400-0119; Larsson Lekholm, Erik/0000-0003-1400-0119	Assar Gabrielsson's Foundation; Swedish Research Council; Polysackaridforskning AB; Swedish Cancer Foundation; Swedish Heart-Lung Foundation; University of Gothenburg; Lymphangiogenomics, an Integrated Project; European Commission [LSHG-CT-2004-503573]	Assar Gabrielsson's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Polysackaridforskning AB; Swedish Cancer Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); University of Gothenburg; Lymphangiogenomics, an Integrated Project; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from Assar Gabrielsson's Foundation (V.I.S), the Swedish Research Council (P.L), Polysackaridforskning AB (P.L), the Swedish Cancer Foundation (P.L), the Swedish Heart-Lung Foundation (P.L), the University of Gothenburg (P.L), and by Lymphangiogenomics, an Integrated Project funded by the European Commission within its FP6 Program, under the thematic area "Life sciences, genomics and biotechnology for health" (contract no. LSHG-CT-2004-503573) (P.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LC, 2000, J BIOL CHEM, V275, P30725, DOI 10.1074/jbc.M004249200; Bai LC, 2006, GASTROENTEROLOGY, V131, P841, DOI 10.1053/j.gastro.2006.06.014; Crosby JR, 1998, NAT GENET, V18, P385, DOI 10.1038/ng0498-385; Eckardt S, 2011, CELL CYCLE, V10, P2091, DOI 10.4161/cc.10.13.16360; Feng YP, 2009, FEBS J, V276, P4197, DOI 10.1111/j.1742-4658.2009.07128.x; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; Li XG, 2006, DEVELOPMENT, V133, P3641, DOI 10.1242/dev.02540; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Merchant JL, 1996, MOL CELL BIOL, V16, P6644; Passantino R, 1998, J BIOL CHEM, V273, P484, DOI 10.1074/jbc.273.1.484; Sayin VI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055720; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Woo AJ, 2011, BLOOD, V118, P3684, DOI 10.1182/blood-2011-03-341446; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x	16	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70022	10.1371/journal.pone.0070022	http://dx.doi.org/10.1371/journal.pone.0070022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936136	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700051
J	Franca, FLS; Wells, TJ; Browning, DF; Nogueira, RT; Sarges, FS; Pereira, AC; Cunningham, AF; Lucheze, K; Rosa, ACP; Henderson, IR; de Luna, MD				Franca, Fernanda L. S.; Wells, Timothy J.; Browning, Douglas F.; Nogueira, Raquel Tayar; Sarges, Felipe Silva; Pereira, Ana Claudia; Cunningham, Adam F.; Lucheze, Kely; Paula Rosa, Ana Claudia; Henderson, Ian R.; de Luna, Maria das Gracas			Genotypic and Phenotypic Characterisation of Enteroaggregative Escherichia coli from Children in Rio de Janeiro, Brazil	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CAENORHABDITIS-ELEGANS; DISPERSIN PROTEIN; SHIGELLA-FLEXNERI; VIRULENCE FACTORS; STRAINS; OUTBREAK; COLONIZATION; INFECTION; GENES	Enteroaggregative Escherichia coli (EAEC) is a significant cause of diarrhoeal illness in both children and adults. Genetic heterogeneity and recovery of EAEC strains from both healthy and diseased individuals complicates our understanding of EAEC pathogenesis. We wished to establish if genetic or phenotypic attributes could be used to distinguish between strains asymptomatically colonising healthy individuals and those which cause disease. Genotypic screening of a collection of twenty four EAEC isolates from children with and without diarrhoea revealed no significant differences in the repertoire of putative virulence factors present in either group of strains. In contrast, EAEC strains from phylogroup A were more strongly associated with asymptomatic groups whereas strains from phylogroup D were more associated with cases of diarrhoea. Phenotypic screening revealed no differences in the ability of strains from either cohort of children to form biofilms, to adhere to and invade cells in tissue culture or to cause disease in the Caenorhabditis elegans model of infection. However, the latter assay did reveal significant reduction in nematode killing rates when specific virulence factors were deleted from human pathogenic strains. Our results suggest that current models of infection are not useful for distinguishing avirulent from pathogenic strains of EAEC but can be useful in studying the effect of specific virulence factors.	[Franca, Fernanda L. S.; Nogueira, Raquel Tayar; Sarges, Felipe Silva; Pereira, Ana Claudia; Lucheze, Kely; Paula Rosa, Ana Claudia; de Luna, Maria das Gracas] Univ Estado Rio de Janeiro, Fac Ciencias Med, Dept Microbiol Imunol & Parasitol, BR-20550011 Rio De Janeiro, Brazil; [Wells, Timothy J.; Browning, Douglas F.; Cunningham, Adam F.; Henderson, Ian R.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England	Universidade do Estado do Rio de Janeiro; University of Birmingham	Henderson, IR (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.	i.r.henderson@bham.ac.uk; graca.mgluna@gmail.com	Rosa, Ana Cláudia/AAL-9479-2021; Henderson, Ian/AAD-5369-2019; Wells, Timothy/AAG-3311-2021; Nogueira, Raquel Tayar/F-6475-2019; Wells, Timothy/M-2025-2016	Nogueira, Raquel Tayar/0000-0002-0581-763X; Wells, Timothy/0000-0001-7766-5404; Henderson, Ian/0000-0002-9954-4977; Browning, Douglas/0000-0003-4672-3514; Cunningham, Adam/0000-0003-0248-964X	CNPq; CAPES; FAPERJ; SR-2/UERJ; Programa de Nucleo de Excelencia (PRONEX) of the Brazilian Ministry of Science and Technology; BBSRC; MRC; MRC [G0801209] Funding Source: UKRI; Medical Research Council [G0801209] Funding Source: researchfish	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); SR-2/UERJ; Programa de Nucleo de Excelencia (PRONEX) of the Brazilian Ministry of Science and Technology; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from CNPq, CAPES, FAPERJ, SR-2/UERJ and Programa de Nucleo de Excelencia (PRONEX) of the Brazilian Ministry of Science and Technology. Work in the IRH lab was supported by grants from BBSRC and MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; BAUDRY B, 1990, J INFECT DIS, V161, P1249, DOI 10.1093/infdis/161.6.1249; Bhargava S, 2009, J BACTERIOL, V191, P4934, DOI 10.1128/JB.01831-08; Browning DF, 2013, MOL MICROBIOL; Chattaway MA, 2011, J INFECT DEV COUNTR, V5, P425, DOI 10.3855/jidc.2166; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Czeczulin JR, 1999, INFECT IMMUN, V67, P2692, DOI 10.1128/IAI.67.6.2692-2699.1999; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Elias WP, 1999, J BACTERIOL, V181, P1779, DOI 10.1128/JB.181.6.1779-1785.1999; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Estrada-Garcia T, 2012, FEMS IMMUNOL MED MIC, V66, P281, DOI 10.1111/j.1574-695X.2012.01008.x; FASANO A, 1995, J CLIN INVEST, V95, P2853, DOI 10.1172/JCI117991; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; Henderson IR, 1999, INFECT IMMUN, V67, P5338, DOI 10.1128/IAI.67.10.5338-5344.1999; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Henderson IR, 1997, FEMS MICROBIOL LETT, V149, P115, DOI 10.1016/S0378-1097(97)00065-7; Huang DB, 2006, J MED MICROBIOL, V55, P1303, DOI 10.1099/jmm.0.46674-0; Hwang J, 2010, INFECT IMMUN, V78, P4068, DOI 10.1128/IAI.00014-10; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; Jiang ZD, 2002, J CLIN MICROBIOL, V40, P4185, DOI 10.1128/JCM.40.11.4185-4190.2002; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Kahali S, 2004, J CLIN MICROBIOL, V42, P4111, DOI 10.1128/JCM.42.9.4111-4120.2004; Mellies JL, 2006, INFECT IMMUN, V74, P64, DOI 10.1128/IAI.74.1.64-72.2006; Mohamed JA, 2007, J CLIN MICROBIOL, V45, P121, DOI 10.1128/JCM.01128-06; Nataro JP, 2006, CLIN INFECT DIS, V43, P402, DOI 10.1086/505867; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nataro JP, 2005, CURR OPIN GASTROEN, V21, P4; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Okeke IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014093; Pereira ACM, 2008, MICROB PATHOGENESIS, V45, P310, DOI 10.1016/j.micpath.2008.07.001; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Regua-Mangia AH, 2009, J MED MICROBIOL, V58, P414, DOI 10.1099/jmm.0.006502-0; Rosa ACP, 1998, J MED MICROBIOL, V47, P781, DOI 10.1099/00222615-47-9-781; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Velarde JJ, 2007, MOL MICROBIOL, V66, P1123, DOI 10.1111/j.1365-2958.2007.05985.x; Wallace-Gadsden F, 2007, EMERG INFECT DIS, V13, P757, DOI 10.3201/eid1305.061057; Wilson A, 2001, EUR J EPIDEMIOL, V17, P1125, DOI 10.1023/A:1021224915322	45	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69971	10.1371/journal.pone.0069971	http://dx.doi.org/10.1371/journal.pone.0069971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936127	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200051
J	Larsen, AK; Nymo, IH; Boysen, P; Tryland, M; Godfroid, J				Larsen, Anett K.; Nymo, Ingebjorg H.; Boysen, Preben; Tryland, Morten; Godfroid, Jacques			Entry and Elimination of Marine Mammal Brucella spp. by Hooded Seal (Cystophora cristata) Alveolar Macrophages In Vitro	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; ABORTUS ROUGH MUTANTS; INTRACELLULAR LIFE; LYSOSOME FUSION; INFECTION; STRAINS; CETI; PINNIPEDIALIS; LUNGWORMS; EMPHASIS	A high prevalence of Brucella pinnipedialis serology and bacteriology positive animals has been found in the Northeast Atlantic stock of hooded seal (Cystophora cristata); however no associated gross pathological changes have been identified. Marine mammal brucellae have previously displayed different infection patterns in human and murine macrophages. To investigate if marine mammal Brucella spp. are able to invade and multiply in cells originating from a presumed host species, we infected alveolar macrophages from hooded seal with a B. pinnipedialis hooded seal isolate. Hooded seal alveolar macrophages were also challenged with B. pinnipedialis reference strain (NCTC 12890) from harbor seal (Phoca vitulina), B. ceti reference strain (NCTC 12891) from harbor porpoise (Phocoena phocoena) and a B. ceti Atlantic white-sided dolphin (Lagenorhynchus acutus) isolate (M83/07/1), to evaluate possible species-specific differences. Brucella suis 1330 was included as a positive control. Alveolar macrophages were obtained by post mortem bronchoalveolar lavage of euthanized hooded seals. Phenotyping of cells in the lavage fluid was executed by flow cytometry using the surface markers CD14 and CD18. Cultured lavage cells were identified as alveolar macrophages based on morphology, expression of surface markers and phagocytic ability. Alveolar macrophages were challenged with Brucella spp. in a gentamicin protection assay. Following infection, cell lysates from different time points were plated and evaluated quantitatively for colony forming units. Intracellular presence of B. pinnipedialis hooded seal isolate was verified by immunocytochemistry. Our results show that the marine mammal brucellae were able to enter hooded seal alveolar macrophages; however, they did not multiply intracellularly and were eliminated within 48 hours, to the contrary of B. suis that showed the classical pattern of a pathogenic strain. In conclusion, none of the four marine mammal strains tested were able to establish a persistent infection in primary alveolar macrophages from hooded seal.	[Larsen, Anett K.; Nymo, Ingebjorg H.; Tryland, Morten; Godfroid, Jacques] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Sect Arctic Vet Med, Tromso, Norway; [Boysen, Preben] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Sect Microbiol Immunol & Parasitol, Tromso, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Larsen, AK (corresponding author), Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Sect Arctic Vet Med, Tromso, Norway.	anett.larsen@nvh.no	Godfroid, Jacques/HCI-7835-2022; Boysen, Preben/C-5238-2013; Larsen, Anett Kristin/K-6020-2019; godfroid, jacques/U-3524-2017	Boysen, Preben/0000-0002-0084-1251; Larsen, Anett Kristin/0000-0002-2121-2286; Nymo, Ingebjorg Helena/0000-0002-4844-8344; godfroid, jacques/0000-0002-0782-7858; Tryland, Morten/0000-0001-5394-5196	Astri and Birger Torsteds grant; Fram Centre - High North Research Centre for Climate and the Environment, Tromso, Norway	Astri and Birger Torsteds grant; Fram Centre - High North Research Centre for Climate and the Environment, Tromso, Norway	This work was supported by Astri and Birger Torsteds grant and the Fram Centre - High North Research Centre for Climate and the Environment, Tromso, Norway. http://www.framsenteret.no. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton G G, 1975, Monogr Ser World Health Organ, P1; Bogdan C, 1997, Behring Inst Mitt, P58; Bohlin J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-249; Cloeckaert A, 2000, CLIN DIAGN LAB IMMUN, V7, P835, DOI 10.1128/CDLI.7.5.835-839.2000; Cloeckaert A, 2003, MICROBES INFECT, V5, P593, DOI 10.1016/S1286-4579(03)00091-1; DREVETS DA, 1994, INFECT IMMUN, V62, P2222, DOI 10.1128/IAI.62.6.2222-2228.1994; Eisenberg T, 2012, APPL ENVIRON MICROB, V78, P3753, DOI 10.1128/AEM.07509-11; El-Tras WF, 2010, VET MICROBIOL, V141, P321, DOI 10.1016/j.vetmic.2009.09.017; Esquivel-Solis H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063464; Eze MO, 2000, INFECT IMMUN, V68, P257, DOI 10.1128/IAI.68.1.257-263.2000; Fang FC, 2002, AM J PHYSIOL-LUNG C, V282, pL941, DOI 10.1152/ajplung.00017.2002; Fischer D, 2012, J ZOO WILDLIFE MED, V43, P625, DOI 10.1638/2011-0005R2.1; Foster G, 2002, VET MICROBIOL, V90, P563, DOI 10.1016/S0378-1135(02)00236-5; FOSTER G, 2011, BRUC 2011 INT RES C; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Garner MM, 1997, J VET DIAGN INVEST, V9, P298, DOI 10.1177/104063879700900311; Geiseler SJ, 2013, J EXP BIOL, V216, P1793, DOI 10.1242/jeb.082099; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Guzman-Verri C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00003; HAMMILL MO, 2006, 2006068 CAN GOV FISH; Hamrick TS, 2003, INFECT IMMUN, V71, P1016, DOI 10.1128/IAI.71.2.1016-1019.2003; *ICES, 2006, REP ICES ADV COMM FI, P1; *ICES, 2009, REPORT ICES NAFO WOR; Jahans KL, 1997, VET MICROBIOL, V57, P373, DOI 10.1016/S0378-1135(97)00118-1; KOVACS KM, 2009, ENCY MARINE MAMMALS, P580; KOVACS KM, 2012, IUCN 2012 INT UNION; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; LI XF, 2012, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0043512; Liautard Jean-Pierre, 1996, Microbiologia (Madrid), V12, P197; Maquart M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-145; Maquart M, 2009, MICROBES INFECT, V11, P361, DOI 10.1016/j.micinf.2008.12.012; Nielsen O, 2001, J WILDLIFE DIS, V37, P89, DOI 10.7589/0090-3558-37.1.89; Nymo IH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-93; *OIE, 2013, WORLD ORG AN HLTH BO; Panaro MA, 1998, IMMUNOPHARM IMMUNOT, V20, P147, DOI 10.3109/08923979809034814; Pei JW, 2008, MICROBES INFECT, V10, P582, DOI 10.1016/j.micinf.2008.01.005; Pei JW, 2006, INFECT IMMUN, V74, P2667, DOI 10.1128/IAI.74.5.2667-2675.2006; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Perrett LL, 2004, VET REC, V154, P800; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; ROSS HM, 1994, VET REC, V134, P359, DOI 10.1136/vr.134.14.359-b; Scholz HC, 2008, EMERG INFECT DIS, V14, P1316, DOI 10.3201/eid1408.080286; SERGEANT DE, 1966, POLAR REC, V12, P541; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Tryland M, 1999, VET REC, V144, P588, DOI 10.1136/vr.144.21.588; Tryland M, 2005, VET MICROBIOL, V105, P103, DOI 10.1016/j.vetmic.2004.11.001; von Bargen K, 2012, FEMS MICROBIOL REV, V36, P533, DOI 10.1111/j.1574-6976.2012.00334.x; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	53	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70186	10.1371/journal.pone.0070186	http://dx.doi.org/10.1371/journal.pone.0070186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936159	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300092
J	Neutelings, T; Lambert, CA; Nusgens, BV; Colige, AC				Neutelings, Thibaut; Lambert, Charles A.; Nusgens, Betty V.; Colige, Alain C.			Effects of Mild Cold Shock (25 degrees C) Followed by Warming Up at 37 degrees C on the Cellular Stress Response	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HEAT-SHOCK; INDUCED APOPTOSIS; MAMMALIAN-CELLS; LOW-TEMPERATURE; FREE-RADICALS; AUTOPHAGY; EXPRESSION; DEATH; TUMOR	Temperature variations in cells, tissues and organs may occur in a number of circumstances. We report here that reducing temperature of cells in culture to 25 degrees C for 5 days followed by a rewarming to 37 degrees C affects cell biology and induces a cellular stress response. Cell proliferation was almost arrested during mild hypothermia and not restored upon returning to 37 degrees C. The expression of cold shock genes, CIRBP and RBM3, was increased at 25 degrees C and returned to basal level upon rewarming while that of heat shock protein HSP70 was inversely regulated. An activation of proapoptotic pathways was evidenced by FACS analysis and increased Bax/Bcl2 and clX(S/L) ratios. Concomitant increased expression of the autophagosome-associated protein LC3II and AKT phosphorylation suggested a simultaneous activation of autophagy and pro-survival pathways. However, a large proportion of cells were dying 24 hours after rewarming. The occurrence of DNA damage was evidenced by the increased phosphorylation of p53 and H2AX, a hallmark of DNA breaks. The latter process, as well as apoptosis, was strongly reduced by the radical oxygen species (ROS) scavenger, N-acetylcysteine, indicating a causal relationship between ROS, DNA damage and cell death during mild cold shock and rewarming. These data bring new insights into the potential deleterious effects of mild hypothermia and rewarming used in various research and therapeutical fields.	[Neutelings, Thibaut; Lambert, Charles A.; Nusgens, Betty V.; Colige, Alain C.] Univ Liege, Lab Connect Tissue Biol, Interdisciplinary Grouping Appl Genoprote Res, Liege, Belgium	University of Liege	Neutelings, T (corresponding author), Univ Liege, Lab Connect Tissue Biol, Interdisciplinary Grouping Appl Genoprote Res, Liege, Belgium.	t.neutelings@ulg.ac.be			Prodex/BelSPo grant [PEA 4000102800]; Prodex 9 Belgian Fonds de la Recherche Scientifique medicale (FRNS) [3.4587.05]	Prodex/BelSPo grant; Prodex 9 Belgian Fonds de la Recherche Scientifique medicale (FRNS)	Prodex/BelSPo grant no PEA 4000102800 Prodex 9 Belgian Fonds de la Recherche Scientifique medicale (FRNS) no 3.4587.05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Al-Fageeh MB, 2006, BIOCHEM J, V397, P247, DOI 10.1042/BJ20060166; Al-Fageeh MB, 2009, RNA, V15, P1164, DOI 10.1261/rna.1179109; Ars E, 2000, NUCLEIC ACIDS RES, V28, P1307, DOI 10.1093/nar/28.6.1307; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Burdon R H, 1987, Symp Soc Exp Biol, V41, P113; Creagh EM, 2000, LEUKEMIA, V14, P1161, DOI 10.1038/sj.leu.2401841; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Ermolenko DN, 2002, CELL MOL LIFE SCI, V59, P1902, DOI 10.1007/PL00012513; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; GREGORY CD, 1994, INT J CANCER, V57, P419, DOI 10.1002/ijc.2910570321; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Hsu YL, 2011, EXP EYE RES, V93, P405, DOI 10.1016/j.exer.2011.06.005; Hunt L, 2005, BIOTECHNOL BIOENG, V89, P157, DOI 10.1002/bit.20320; Jian Z, 2011, J INVEST DERMATOL, V131, P1420, DOI 10.1038/jid.2011.56; Kaitsuka T, 2011, EMBO REP, V12, P673, DOI 10.1038/embor.2011.82; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kim HJ, 2005, FREE RADICAL RES, V39, P441, DOI 10.1080/10715760500066265; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Ladomery M, 1997, BIOESSAYS, V19, P903, DOI 10.1002/bies.950191010; Laios E, 1997, MOL CELL BIOCHEM, V173, P153, DOI 10.1023/A:1006844114348; Lambert CA, 2001, MATRIX BIOL, V20, P397, DOI 10.1016/S0945-053X(01)00156-1; Lambert CA, 2001, EUR J CELL BIOL, V80, P479, DOI 10.1078/0171-9335-00181; Lehr JE, 1998, J NATL CANCER I, V90, P118, DOI 10.1093/jnci/90.2.118; Li S, 2011, AM J PATHOL, V179, P2822, DOI 10.1016/j.ajpath.2011.08.013; LIU AYC, 1994, J BIOL CHEM, V269, P14768; Lu ZH, 2005, ARCH HISTOL CYTOL, V68, P71, DOI 10.1679/aohc.68.71; Mahrhofer H, 2006, INT J RADIAT ONCOL, V64, P573, DOI 10.1016/j.ijrobp.2005.09.037; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matijasevic Z, 1998, ONCOL RES, V10, P605; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mineur P, 2007, J CELL BIOL, V179, P1261, DOI 10.1083/jcb.200703052; Nicholls CD, 2004, J BIOL CHEM, V279, P24171, DOI 10.1074/jbc.M401049200; Nishiyama H, 1997, GENE, V204, P115, DOI 10.1016/S0378-1119(97)00530-1; Nivon M, 2009, AUTOPHAGY, V5, P766, DOI 10.4161/auto.8788; Plesofsky N, 1999, BBA-MOL CELL RES, V1449, P73, DOI 10.1016/S0167-4889(98)00172-4; Rauen U, 2000, FASEB J, V14, P1953, DOI 10.1096/fj.00-0071com; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Rieder CL, 2002, CELL CYCLE, V1, P169, DOI 10.4161/cc.1.3.119; Roobol A, 2009, FEBS J, V276, P286, DOI 10.1111/j.1742-4658.2008.06781.x; Russell DW S. J., 2001, MOL CLONING LAB MANU; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; SHAPIRO IM, 1968, EXP CELL RES, V49, P305, DOI 10.1016/0014-4827(68)90182-1; Shkreta L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Swanlund JM, 2008, AUTOPHAGY, V4, P936, DOI 10.4161/auto.6768; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yang Y, 2010, BIOCHEM BIOPH RES CO, V395, P190, DOI 10.1016/j.bbrc.2010.03.155; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	53	57	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69687	10.1371/journal.pone.0069687	http://dx.doi.org/10.1371/journal.pone.0069687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936078	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000148
J	Shiraishi, E; Hosseini, H; Kang, DK; Kitano, T; Akiyama, H				Shiraishi, Eri; Hosseini, Hamid; Kang, Dong K.; Kitano, Takeshi; Akiyama, Hidenori			Nanosecond Pulsed Electric Field Suppresses Development of Eyes and Germ Cells through Blocking Synthesis of Retinoic Acid in Medaka (Oryzias latipes)	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; MEIOTIC INITIATION; VERTEBRATE EYE; IN-VITRO; GENE; MOUSE; FISH; DIFFERENTIATION; EXPRESSION; MEIOSIS	Application of nanosecond pulsed electric fields (nsPEFs) has attracted rising attention in various scientific fields including medical, pharmacological, and biological sciences, although its effects and molecular mechanisms leading to the effects remain poorly understood. Here, we show that a single, high-intensity (10-30 kV/cm), 60-ns PEF exposure affects gene expression and impairs development of eyes and germ cells in medaka (Oryzias latipes). Exposure of early blastula stage embryos to nsPEF down-regulated the expression of several transcription factors which are essential for eye development, causing abnormal eye formation. Moreover, the majority of the exposed genetic female embryos showed a fewer number of germ cells similar to that of the control (unexposed) genetic male at 9 days post-fertilization (dpf). However, all-trans retinoic acid (atRA) treatment following the exposure rescued proliferation of germ cells and resumption of normal eye development, suggesting that the phenotypes induced by nsPEF are caused by a decrease of retinoic acid levels. These results confirm that nsPEFs induce novel effects during embryogenesis in medaka.	[Shiraishi, Eri; Hosseini, Hamid; Akiyama, Hidenori] Kumamoto Univ, Global Ctr Excellence Program Pulsed Power Engn, Kumamoto, Japan; [Hosseini, Hamid; Akiyama, Hidenori] Kumamoto Univ, Bioelect Res Ctr, Kumamoto, Japan; [Hosseini, Hamid; Kang, Dong K.; Akiyama, Hidenori] Kumamoto Univ, Grad Sch Sci & Technol, Dept Pulsed Power Sci, Kumamoto, Japan; [Kitano, Takeshi] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University	Hosseini, H (corresponding author), Kumamoto Univ, Global Ctr Excellence Program Pulsed Power Engn, Kumamoto, Japan.	hosseini@kumamoto-u.ac.jp	Kitano, Takeshi/AAZ-6398-2021	KITANO, TAKESHI/0000-0003-3642-3999; Akiyama, Hidenori/0000-0002-9675-1209	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23370030] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global COE program "Global Initiative Center for Pulsed Power Engineering" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2011, IEEE T DIELECT EL IN, V18, P1119, DOI 10.1109/TDEI.2011.5976104; Akiyama M, 2010, IEEE T PLASMA SCI, V38, P2588, DOI 10.1109/TPS.2010.2042463; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Beebe SJ, 2005, J BIOMED BIOTECHNOL, P297, DOI 10.1155/JBB.2005.297; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Carl M, 2002, DEVELOPMENT, V129, P4057; Chen C, 2006, MED BIOL ENG COMPUT, V44, P5, DOI 10.1007/s11517-005-0020-2; Dasmahapatra AK, 2005, COMP BIOCHEM PHYS B, V140, P657, DOI 10.1016/j.cbpc.2005.01.007; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Enwright JF, 2000, DEV BIOL, V221, P10, DOI 10.1006/dbio.2000.9652; Escoffre JM, 2009, MOL BIOTECHNOL, V41, P286, DOI 10.1007/s12033-008-9121-0; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; HAMAGUCHI S, 1982, CELL TISSUE RES, V227, P139; Hayashi Y, 2010, MOL REPROD DEV, V77, P679, DOI 10.1002/mrd.21203; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;487::AID-BIES11&gt;3.0.CO;2-8; Iwai T, 2006, EXP CELL RES, V312, P2528, DOI 10.1016/j.yexcr.2006.04.015; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kang DK, 2012, IEEE T PLASMA SCI, V40, P2379, DOI 10.1109/TPS.2012.2192506; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Li Z, 2009, IEEE T PLASMA SCI, V37, P1987, DOI 10.1109/TPS.2009.2025376; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Matsuda M, 2007, P NATL ACAD SCI USA, V104, P3865, DOI 10.1073/pnas.0611707104; Naruse K, 2004, MECH DEVELOP, V121, P619, DOI 10.1016/j.mod.2004.04.014; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; OZATO K, 1986, CELL DIFFER DEV, V19, P237, DOI 10.1016/0045-6039(86)90100-4; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; SATOH N, 1972, J EMBRYOL EXP MORPH, V28, P385; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-85; Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006; Wakamatsu Yuko, 2003, Environmental Sciences, V10, P291; Winkler S, 2000, DEVELOPMENT, V127, P1911	42	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70670	10.1371/journal.pone.0070670	http://dx.doi.org/10.1371/journal.pone.0070670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936463	gold, Green Published, Green Submitted			2022-12-27	WOS:000324401500047
J	van Ierssel, SH; Van Craenenbroeck, EM; Hoymans, VY; Vrints, CJ; Conraads, VM; Jorens, PG				van Ierssel, Sabrina H.; Van Craenenbroeck, Emeline M.; Hoymans, Vicky Y.; Vrints, Christiaan J.; Conraads, Viviane M.; Jorens, Philippe G.			Endothelium Dependent Vasomotion and In Vitro Markers of Endothelial Repair in Patients with Severe Sepsis: An Observational Study	PLOS ONE			English	Article							ORGAN DYSFUNCTION SYNDROME; PROGENITOR CELLS; SEPTIC SHOCK; MICROPARTICLES; FAILURE	Background: Outcome in sepsis is mainly defined by the degree of organ failure, for which endothelial dysfunction at the macro- and microvascular level is an important determinant. In this study we evaluated endothelial function in patients with severe sepsis using cellular endothelial markers and in vivo assessment of reactive hyperaemia. Materials and Methods: Patients with severe sepsis (n = 30) and 15 age-and gender-matched healthy volunteers were included in this study. Using flow cytometry, CD34+/KDR+ endothelial progenitor cells (EPC), CD31+ T-cells, and CD31+/CD42b- endothelial microparticles (EMP) were enumerated. Migratory capacity of cultured circulating angiogenic cells (CAC) was assessed in vitro. Endothelial function was determined using peripheral arterial tonometry at the fingertip. Results: In patients with severe sepsis, a lower number of EPC, CD31+ T-cells and a decreased migratory capacity of CAC coincided with a blunted reactive hyperaemia response compared to healthy subjects. The number of EMP, on the other hand, did not differ. The presence of organ failure at admission (SOFA score) was inversely related with the number of CD31+ T-cells. Furthermore, the number of EPC at admission was decreased in patients with progressive organ failure within the first week. Conclusion: In patients with severe sepsis, in vivo measured endothelial dysfunction coincides with lower numbers and reduced function of circulating cells implicated in endothelial repair. Our results suggest that cellular markers of endothelial repair might be valuable in the assessment and evolution of organ dysfunction.	[van Ierssel, Sabrina H.; Jorens, Philippe G.] Univ Antwerp UA, Dept Crit Care Med, Antwerp Univ Hosp UZA, Edegem, Belgium; [van Ierssel, Sabrina H.; Van Craenenbroeck, Emeline M.; Hoymans, Vicky Y.; Vrints, Christiaan J.; Conraads, Viviane M.] Univ Antwerp UA, Lab Cellular & Mol Cardiol, Antwerp Univ Hosp UZA, Edegem, Belgium; [Van Craenenbroeck, Emeline M.; Vrints, Christiaan J.; Conraads, Viviane M.] Univ Antwerp UA, Dept Cardiol, Antwerp Univ Hosp UZA, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	van Ierssel, SH (corresponding author), Univ Antwerp UA, Dept Crit Care Med, Antwerp Univ Hosp UZA, Edegem, Belgium.	sabrina.vanierssel@ua.ac.be	Van Craenenbroeck, Emeline/AAG-4540-2020	Van Craenenbroeck, Emeline/0000-0001-7686-2668	Research Foundation-Flanders, Belgium	Research Foundation-Flanders, Belgium(FWO)	This work was supported by a grant from the Research Foundation-Flanders, Belgium, to SVI and VMC (www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Becchi C, 2008, INT J IMMUNOPATH PH, V21, P697, DOI 10.1177/039463200802100324; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Burger D, 2012, J AM SOC HYPERTENS, V6, P85, DOI 10.1016/j.jash.2011.11.003; Cribbs SK, 2012, INTENS CARE MED, V38, P429, DOI 10.1007/s00134-012-2480-9; Cruz DN, 2009, JAMA-J AM MED ASSOC, V301, P2445, DOI 10.1001/jama.2009.856; Davis JS, 2009, CRIT CARE, V13, DOI 10.1186/cc8055; De Backer D, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-27; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Ding ZQ, 2006, CRIT CARE MED, V34, P3011, DOI 10.1097/01.CCM.0000247719.37793.43; Doerschug KC, 2007, AM J PHYSIOL-HEART C, V293, pH1065, DOI 10.1152/ajpheart.01237.2006; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Luo TH, 2009, CRIT CARE, V13, DOI 10.1186/cc7968; Mayr F B, 2007, Atherosclerosis, V195, pe202, DOI 10.1016/j.atherosclerosis.2007.04.003; Mortaza S, 2009, CRIT CARE MED, V37, P2045, DOI 10.1097/CCM.0b013e3181a00629; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Patschan SA, 2011, CRIT CARE, V15, DOI 10.1186/cc10100; Rafat N, 2007, CRIT CARE MED, V35, P1677, DOI 10.1097/01.CCM.0000269034.86817.59; Schmidt-Lucke C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013790; Soriano AO, 2005, CRIT CARE MED, V33, P2540, DOI 10.1097/01.CCM.0000186414.86162.03; Van Craenenbroeck EM, 2010, BASIC RES CARDIOL, V105, P665, DOI 10.1007/s00395-010-0105-4; van den Akker ELT, 2008, INTENS CARE MED, V34, P912, DOI 10.1007/s00134-007-0989-0; van Ierssel SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031496; van Ierssel SH, 2010, THROMB RES, V125, P332, DOI 10.1016/j.thromres.2009.12.019; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69499	10.1371/journal.pone.0069499	http://dx.doi.org/10.1371/journal.pone.0069499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936333	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500011
J	Wang, HI; Chang, CH; Lin, PH; Fu, HC; Tang, C; Yeh, HH				Wang, Hsiang-Iu; Chang, Chih-Hung; Lin, Po-Heng; Fu, Hui-Chuan; Tang, ChuanYi; Yeh, Hsin-Hung			Application of Motif-Based Tools on Evolutionary Analysis of Multipartite Single-Stranded DNA Viruses	PLOS ONE			English	Article							BUNCHY-TOP-VIRUS; DETECTING RECOMBINATION; GENOME ORGANIZATION; COMPUTER-PROGRAM; MOSAIC STRUCTURE; REPLICATION; SEQUENCE; COMPONENT; GEMINIVIRUSES; REASSORTMENT	Multipartite viruses contain more than one distinctive genome component, and the origin of multipartite viruses has been suggested to evolve from a non-segmented wild-type virus. To explore whether recombination also plays a role in the evolution of the genomes of multipartite viruses, we developed a systematic approach that employs motif-finding tools to detect conserved motifs from divergent genomic regions and applies statistical approaches to select high-confidence motifs. The information that this approach provides helps us understand the evolution of viruses. In this study, we compared our motif-based strategy with current alignment-based recombination-detecting methods and applied our methods to the analysis of multipartite single-stranded plant DNA viruses, including bipartite begomoviruses, Banana bunchy top virus (BBTV) (consisting of 6 genome components) and Faba bean necrotic yellows virus (FBNYV) (consisting of 8 genome components). Our analysis revealed that recombination occurred between genome components in some begomoviruses, BBTV and FBNYV. Our data also show that several unusual recombination events have contributed to the evolution of BBTV genome components. We believe that similar approaches can be applied to resolve the evolutionary history of other viruses.	[Wang, Hsiang-Iu; Chang, Chih-Hung; Lin, Po-Heng; Tang, ChuanYi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Tang, ChuanYi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan; [Fu, Hui-Chuan; Yeh, Hsin-Hung] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Yeh, Hsin-Hung] Natl Taiwan Univ, Res Ctr Plant Med, Taipei 10764, Taiwan	National Tsing Hua University; Providence University - Taiwan; National Taiwan University; National Taiwan University	Yeh, HH (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan.	hyeh@ntu.edu.tw	Yeh, Hsin-Hung/Z-2199-2019	Yeh, Hsin-Hung/0000-0001-6765-2853	National Science Council, Taiwan [97-2221-E-126-012-MY3, 98-2321-B-002-019-MY3, 98-2313-B-002-043-MY3]; Council of Agriculture, Taiwan [100 management-2.4-plant quarantine-02]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Council of Agriculture, Taiwan	This work was partially supported by the National Science Council, Taiwan (grant nos. 97-2221-E-126-012-MY3, 98-2321-B-002-019-MY3, and 98-2313-B-002-043-MY3), and the Council of Agriculture, Taiwan (grant no. 100 management-2.4-plant quarantine-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque LC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-241; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, J COMPUT BIOL, V5, P211, DOI 10.1089/cmb.1998.5.211; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bruyere A, 2000, J VIROL, V74, P4214, DOI 10.1128/JVI.74.9.4214-4219.2000; BURNS TM, 1995, J GEN VIROL, V76, P1471, DOI 10.1099/0022-1317-76-6-1471; CHAO L, 1991, J THEOR BIOL, V153, P229, DOI 10.1016/S0022-5193(05)80424-2; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Fu HC, 2009, PHYTOPATHOLOGY, V99, P812, DOI 10.1094/PHYTO-99-7-0812; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Grigoras I, 2010, J VIROL, V84, P9105, DOI 10.1128/JVI.00607-10; Gronenborn B, 2004, VET MICROBIOL, V98, P103, DOI 10.1016/j.vetmic.2003.10.015; Hafner GJ, 1997, J GEN VIROL, V78, P1795, DOI 10.1099/0022-1317-78-7-1795; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hanley-Bowdoin L, 2000, CRIT REV BIOCHEM MOL, V35, P105; HARDING RM, 1993, J GEN VIROL, V74, P323, DOI 10.1099/0022-1317-74-3-323; Harkins GW, 2009, J GEN VIROL, V90, P3066, DOI 10.1099/vir.0.015537-0; Horser CL, 2001, J GEN VIROL, V82, P459, DOI 10.1099/0022-1317-82-2-459; Hu JM, 2007, J VIROL, V81, P1746, DOI 10.1128/JVI.01390-06; Hyder MZ, 2011, INFECT GENET EVOL, V11, P1293, DOI 10.1016/j.meegid.2011.04.015; KARAN M, 1994, J GEN VIROL, V75, P3541, DOI 10.1099/0022-1317-75-12-3541; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Lin YC, 2005, J COMPUT BIOL, V12, P102, DOI 10.1089/cmb.2005.12.102; Lin YC, 2006, NUCLEIC ACIDS RES, V34, pW696, DOI 10.1093/nar/gkl169; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2011, VIRUSES-BASEL, V3, P1699, DOI 10.3390/v3091699; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; NEE S, 1987, J MOL EVOL, V25, P277, DOI 10.1007/BF02603110; Niu SN, 2009, ARCH VIROL, V154, P1775, DOI 10.1007/s00705-009-0515-5; ORLICH M, 1994, VIROLOGY, V204, P462, DOI 10.1006/viro.1994.1555; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Roossinck MJ, 1997, ANNU REV PHYTOPATHOL, V35, P191, DOI 10.1146/annurev.phyto.35.1.191; SANKOFF D, 1992, LECT NOTES COMPUT SC, V644, P121; Sankoff D, 1990, METHOD ENZYMOL, V183, P428; SMITH JM, 1992, J MOL EVOL, V34, P126; Stainton D, 2012, J GEN VIROL, V93, P1103, DOI 10.1099/vir.0.040337-0; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao XR, 2008, J GEN VIROL, V89, P306, DOI 10.1099/vir.0.83388-0	51	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71565	10.1371/journal.pone.0071565	http://dx.doi.org/10.1371/journal.pone.0071565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936517	gold, Green Published, Green Submitted			2022-12-27	WOS:000324401500077
J	Chiou, PY; Luo, CH; Chang, KC; Lin, NT				Chiou, Pei-Yu; Luo, Cheng-Hung; Chang, Kai-Chih; Lin, Nien-Tsung			Maintenance of the Cell Morphology by MinC in Helicobacter pylori	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; NEISSERIA-GONORRHOEAE; DIVISION; PROTEINS; SYSTEM; SHAPE; COLONIZATION; EXPRESSION; MOTILITY	In the model organism Escherichia coli, Min proteins are involved in regulating the division of septa formation. The computational genome analysis of Helicobacter pylori, a gram-negative microaerophilic bacterium causing gastritis and peptic ulceration, also identified MinC, MinD, and MinE. However, MinC (HP1053) shares a low identity with those of other bacteria and its function in H. pylori remains unclear. In this study, we used morphological and genetic approaches to examine the molecular role of MinC. The results were shown that an H. pylori mutant lacking MinC forms filamentous cells, while the wild-type strain retains the shape of short rods. In addition, a minC mutant regains the short rods when complemented with an intact minC(Hp) gene. The overexpression of MinC(Hp) in E. coli did not affect the growth and cell morphology. Immunofluorescence microscopy revealed that MinC(Hp) forms helix-form structures in H. pylori, whereas MinCHp localizes at cell poles and pole of new daughter cell in E. coli. In addition, co-immunoprecipitation showed MinC can interact with MinD but not with FtsZ during mid-exponential stage of H. pylori. Altogether, our results show that MinC(Hp) plays a key role in maintaining proper cell morphology and its function differs from those of MinC(Ec).	[Chiou, Pei-Yu; Luo, Cheng-Hung; Lin, Nien-Tsung] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chang, Kai-Chih] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Lin, Nien-Tsung] Tzu Chi Univ, Dept Microbiol, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; Tzu Chi University	Chang, KC (corresponding author), Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan.	kaichih@mail.tcu.edu.tw; ntlin@mail.tcu.edu.tw			Tzu Chi University [TCIRP 95009-04]	Tzu Chi University	This work was supported by a grant from Tzu Chi University (TCIRP 95009-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Andersen LP, 2001, HELICOBACTER PYLORI, P27; Barak I, 2007, FEMS MICROBIOL REV, V31, P311, DOI 10.1111/j.1574-6976.2007.00067.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Lee MJ, 2006, BIOCHEM BIOPH RES CO, V342, P744, DOI 10.1016/j.bbrc.2006.01.173; Luo CH, 2012, J VIROL, V86, P8781, DOI 10.1128/JVI.00446-12; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Olson JW, 2000, BIOCHEMISTRY-US, V39, P16213, DOI 10.1021/bi001744s; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pavlendova N, 2010, FEMS MICROBIOL LETT, V302, P58, DOI 10.1111/j.1574-6968.2009.01832.x; Ramirez-Arcos S, 2004, J BACTERIOL, V186, P2841, DOI 10.1128/JB.186.9.2841-2855.2004; Ramirez-Arcos S, 2001, MICROBIOL-SGM, V147, P225, DOI 10.1099/00221287-147-1-225; Rothfield L, 1999, ANNU REV GENET, V33, P423, DOI 10.1146/annurev.genet.33.1.423; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Specht M, 2013, J BACTERIOL, V195, P1411, DOI 10.1128/JB.01490-12; Specht M, 2011, J BACTERIOL, V193, P4523, DOI 10.1128/JB.00231-11; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Szeto J, 2001, J BACTERIOL, V183, P6253, DOI 10.1128/JB.183.21.6253-6264.2001; Tavva VS, 2006, PLANT CELL REP, V25, P341, DOI 10.1007/s00299-005-0086-1; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; WANG Y, 1993, J GEN MICROBIOL, V139, P2485, DOI 10.1099/00221287-139-10-2485; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	31	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71208	10.1371/journal.pone.0071208	http://dx.doi.org/10.1371/journal.pone.0071208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936493	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400097
J	Luu, C; Heinrich, EL; Duldulao, M; Arrington, AK; Fakih, M; Garcia-Aguilar, J; Kim, J				Luu, Carrie; Heinrich, Eileen L.; Duldulao, Marjun; Arrington, Amanda K.; Fakih, Marwan; Garcia-Aguilar, Julio; Kim, Joseph			TP53 and Let-7a micro-RNA Regulate K-Ras Activity in HCT116 Colorectal Cancer Cells	PLOS ONE			English	Article							RECTAL-CANCER; PREOPERATIVE CHEMORADIATION; TUMOR-SUPPRESSOR; PROGNOSTIC VALUE; GENE-MUTATIONS; P53; SURVIVAL; THERAPY; EXPRESSION; CETUXIMAB	Recent reports have indicated that KRAS and TP53 mutations predict response to therapy in colorectal cancer. However, little is known about the relationship between these two common genetic alterations. Micro-RNAs (miRNAs), a class of noncoding RNA implicated in cellular processes, have been increasingly linked to KRAS and TP53. We hypothesized that lethal-7a (let-7a) miRNA regulates KRAS through TP53. To investigate the relationship between KRAS, TP53, and let-7a, we used HCT116 KRAS(mut) human colorectal cancer cells with four different genotypic modifications in TP53 (TP53(-/-), TP53(+/-), TP53(mut/+), and TP53(mut/-)). Using these cells we observed that K-Ras activity was higher in cells with mutant or knocked out TP53 alleles, suggesting that wild-type TP53 may suppress K-Ras activity. Let-7a was present in HCT116 KRAS(mut) cells, though there was no correlation between let-7a level and TP53 genotype status. To explore how let-7a may regulate K-Ras in the different TP53 genotype cells we used let-7a inhibitor and demonstrated increased K-Ras activity across all TP53, thus corroborating prior reports that let-7a regulates K-Ras. To assess potential clinical implications of this regulatory network, we examined the influence of TP53 genotype and let-7a inhibition on colon cancer cell survival following chemoradiation therapy (CRT). We observed that cells with complete loss of wild-type TP53 alleles ((-/-) or (-/mut)) were resistant to CRT following treatment with 5-fluorouracil and radiation. Further increase in K-Ras activity with let-7a inhibition did not impact survival in these cells. In contrast, cells with single or double wild-type TP53 alleles were moderately responsive to CRT and exhibited resistance when let-7a was inhibited. In summary, our results show a complex regulatory system involving TP53, KRAS, and let-7a. Our results may provide clues to understand and target these interactions in colorectal cancer.	[Luu, Carrie; Heinrich, Eileen L.; Duldulao, Marjun; Arrington, Amanda K.; Kim, Joseph] City Hope Comprehens Canc Ctr, Dept Surg, Div Surg Oncol, Duarte, CA USA; [Fakih, Marwan] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA; [Garcia-Aguilar, Julio] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	City of Hope; City of Hope; Memorial Sloan Kettering Cancer Center	Garcia-Aguilar, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	jokim@coh.org; garciaaj@mskcc.org	Arrington, Amanda/J-7360-2013	Arrington, Amanda/0000-0001-8096-3373; Fakih, Marwan/0000-0002-6554-5488				Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bazan V, 2002, ANN ONCOL, V13, P1438, DOI 10.1093/annonc/mdf226; BELL SM, 1993, GASTROENTEROLOGY, V104, P57, DOI 10.1016/0016-5085(93)90835-Z; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garcia-Aguilar J, 2003, DIS COLON RECTUM, V46, P298, DOI 10.1007/s10350-004-6545-x; Garcia-Aguilar J, 2011, ANN SURG, V254, P486, DOI 10.1097/SLA.0b013e31822b8cfa; Han ZY, 2012, CARCINOGENESIS, V33, P131, DOI 10.1093/carcin/bgr226; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Janjan NA, 2001, AM J CLIN ONCOL-CANC, V24, P107, DOI 10.1097/00000421-200104000-00001; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Levy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027490; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lumachi F, 2012, ANTICANCER RES, V32, P3965; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Ruzzo A, 2012, ONCOLOGIST, V17, P823, DOI 10.1634/theoncologist.2012-0081; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Spitzner M, 2010, INT J RADIAT ONCOL, V78, P1184, DOI 10.1016/j.ijrobp.2010.06.023; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tie J, 2011, CLIN CANCER RES, V17, P1122, DOI 10.1158/1078-0432.CCR-10-1720; Tortola S, 1999, J CLIN ONCOL, V17, P1375, DOI 10.1200/JCO.1999.17.5.1375; Umeda Y, 2013, J HEPATO-BIL-PAN SCI, V20, P223, DOI 10.1007/s00534-012-0531-9; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	32	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70604	10.1371/journal.pone.0070604	http://dx.doi.org/10.1371/journal.pone.0070604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936455	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400076
J	Taliani, G; Spaziante, M; Biliotti, E; Borro, M; Palazzo, D; Grieco, S; Franchi, C; Iaiani, G; Furlan, C; Gallinaro, V; Simmaco, M				Taliani, Gloria; Spaziante, Martina; Biliotti, Elisa; Borro, Marina; Palazzo, Donatella; Grieco, Stefania; Franchi, Cristiana; Iaiani, Giancarlo; Furlan, Caterina; Gallinaro, Valentina; Simmaco, Maurizio			IL28B Gene Polymorphisms and US Liver Fatty Changes in Patients Who Spontaneously Cleared Hepatitis C Virus Infection	PLOS ONE			English	Article							SPONTANEOUS VIRAL CLEARANCE; METABOLIC SYNDROME; NATURAL-HISTORY; STEATOSIS; GENOTYPE; RESPONSES; VARIANTS; COHORT; HOST	Background: Recent clinical studies have shown that the presence of CC genotype in the rs12979860 region of IL28B gene is associated with an increase in the probability of spontaneous clearance of hepatitis C virus (HCV). Moreover, IL28B polymorphism seems to influence the probability of developing liver steatosis in chronic HCV patients. Aims: The aims of our clinical study were 1) to verify the distribution of IL28B genotypes (CC, CT or TT) among subjects with spontaneous clearance of HCV infection and 2) to examine the correlation between IL28B polymorphism and hepatic steatosis among these subjects. Methods and patients: We enrolled 41 subjects with spontaneous resolution of HCV infection (detectable serum anti-HCV but undetectable HCV-RNA) and 134 healthy controls from the same geographical area. The IL28B single-nucleotide polymorphism (SNP) rs12979860 was genotyped by using a Pyrosequencing (TM) technique. The presence of steatosis was assessed by liver biopsy or ultrasound examination in the 41 study subjects. Results: CC, CT and TT-genotypes of the SNP rs1979860 were found in 66%, 24% and 10% of the subjects who spontaneously cleared HCV and in 31%, 54% and 15% of controls, respectively (p = 0.0003). Among the study subjects, females with CC-genotype were significantly more represented (p = 0.02). Hepatic steatosis did not correlate with IL28B genotype (p = 0,14) but only with a high body mass index (BMI) value (p = 0.03). Conclusions: Female subjects carrying IL28B CC-genotype are significantly more represented among Italian patients who spontaneously cleared HCV infection. In addition, among these subjects, the presence of liver steatosis does not correlate with IL28B genotype but is solely related to the occurrence of high BMI. Thus, the association between IL28B polymorphism and steatosis in chronic HCV patients requires the presence of active HCV replication to occur, while in subjects who have cleared the infection, the mechanism(s) inducing liver steatosis are independent from IL28B profile.	[Taliani, Gloria; Spaziante, Martina; Biliotti, Elisa; Palazzo, Donatella; Grieco, Stefania; Franchi, Cristiana; Iaiani, Giancarlo; Furlan, Caterina; Gallinaro, Valentina] Univ Roma La Sapienza, Dept Clin Med, Policlin Umberto I, I-00185 Rome, Italy; [Borro, Marina; Simmaco, Maurizio] Univ Roma La Sapienza, Dipartimento Neurosci Salute Mentale Organi Senso, Adv Mol Diagnost Unit, St Andrea Hosp, I-00185 Rome, Italy	Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Taliani, G (corresponding author), Univ Roma La Sapienza, Dept Clin Med, Policlin Umberto I, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	gloria.taliani@uniroma1.it	BORRO, Marina/AAF-3773-2020; Borro, Marina/Q-1190-2016; Simmaco, Maurizio/AAC-2870-2019	BORRO, Marina/0000-0002-7839-9125; Borro, Marina/0000-0002-7839-9125; Simmaco, Maurizio/0000-0003-4164-1472				Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9; Barrett S, 2001, GUT, V49, P423, DOI 10.1136/gut.49.3.423; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bugianesi E, 2012, J HEPATOL, V56, pS56, DOI 10.1016/S0168-8278(12)60007-5; Clark PJ, 2012, DIGEST DIS SCI, V57, P2213, DOI 10.1007/s10620-012-2171-y; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Feld JJ, 2012, J HEPATOL, V57, P3, DOI 10.1016/j.jhep.2012.04.003; Fujiwara K, 2013, HEPATOLOGY, V57, P483, DOI 10.1002/hep.25921; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Li JH, 2010, HEPATOLOGY, V51, P1904, DOI 10.1002/hep.23592; McCullough AJ, 2011, J DIGEST DIS, V12, P333, DOI 10.1111/j.1751-2980.2010.00469.x; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Mustard CA, 1998, NEW ENGL J MED, V338, P1678, DOI 10.1056/NEJM199806043382307; Negro F, 2009, LIVER INT, V29, P26, DOI 10.1111/j.1478-3231.2008.01950.x; Ochi H, 2011, J GEN VIROL, V92, P1071, DOI 10.1099/vir.0.029124-0; Ohnishi M, 2012, J GASTROENTEROL, V47, P834, DOI 10.1007/s00535-012-0550-y; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Perz JF, 2004, ESTIMATED GLOBAL PRE; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Santantonio T, 2006, CLIN INFECT DIS, V43, P1154, DOI 10.1086/507640; Thio CL, 2008, CLIN LIVER DIS, V12, P713, DOI 10.1016/j.cld.2008.03.002; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; van den Berg CHBS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027555; Wietzke-Braun P, 2007, WORLD J GASTROENTERO, V13, P4224, DOI 10.3748/wjg.v13.i31.4224	38	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e67301	10.1371/journal.pone.0067301	http://dx.doi.org/10.1371/journal.pone.0067301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936294	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400005
J	Ontsouka, EC; Huang, X; Stieger, B; Albrecht, C				Ontsouka, Edgar Corneille; Huang, Xiao; Stieger, Bruno; Albrecht, Christiane			Characteristics and Functional Relevance of Apolipoprotein-A1 and Cholesterol Binding in Mammary Gland Tissues and Epithelial Cells	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; PLASMA-MEMBRANE; ADRENERGIC-RECEPTORS; LIPID TRANSPORTERS; A-I; ABCA1; EXPRESSION; BOVINE; SITES; LOCALIZATION	Cholesterol in milk is derived from the circulating blood through a complex transport process involving the mammary alveolar epithelium. Details of the mechanisms involved in this transfer are unclear. Apolipoprotein-AI (apoA-I) is an acceptor of cellular cholesterol effluxed by the ATP-binding cassette (ABC) transporter A1 (ABCA1). We aimed to 1) determine the binding characteristics of I-125-apoA-I and H-3-cholesterol to enriched plasma membrane vesicles (EPM) isolated from lactating and non-lactating bovine mammary glands (MG), 2) optimize the components of an in vitro model describing cellular H-3-cholesterol efflux in primary bovine mammary epithelial cells (MeBo), and 3) assess the vectorial cholesterol transport in MeBo using Transwell (R) plates. The amounts of isolated EPM and the maximal binding capacity of I-125-apoA-I to EPM differed depending on the MG's physiological state, while the kinetics of H-3-cholesterol and I-125-apoA-I binding were similar. H-3-cholesterol incorporated maximally to EPM after 25 +/- 9 min. The time to achieve the half-maximum binding of I-125-apoA-I at equilibrium was 3.3 +/- 0.6 min. The dissociation constant (K-D) of I-125-apoA-I ranged between 40-74 nmol/L. Cholesterol loading to EPM increased both cholesterol content and I-125-apoA-I binding. The ABCA1 inhibitor Probucol displaced I-125-apoA-I binding to EPM and reduced H-3-cholesterol efflux in MeBo. Time-dependent H-3-cholesterol uptake and efflux showed inverse patterns. The defined binding characteristics of cholesterol and apoA-I served to establish an efficient and significantly shorter cholesterol efflux protocol that had been used in MeBo. The application of this protocol in Transwell (R) plates with the upper chamber mimicking the apical (milk-facing) and the bottom chamber corresponding to the basolateral (blood-facing) side of cells showed that the degree of H-3-cholesterol efflux in MeBo differed significantly between the apical and basolateral aspects. Our findings support the importance of the apoA-I/ABCA1 pathway in MG cholesterol transport and suggest its role in influencing milk composition and directing cholesterol back into the bloodstream.	[Ontsouka, Edgar Corneille; Huang, Xiao; Albrecht, Christiane] Univ Bern, Fac Med, Inst Biochem & Mol Med, Bern, Switzerland; [Ontsouka, Edgar Corneille; Huang, Xiao; Stieger, Bruno; Albrecht, Christiane] Univ Bern, NCCR TransCure, Swiss Natl Ctr Competence Res, Bern, Switzerland; [Stieger, Bruno] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland	University of Bern; University of Geneva; University of Bern; University of Zurich; University Zurich Hospital	Albrecht, C (corresponding author), Univ Bern, Fac Med, Inst Biochem & Mol Med, Bern, Switzerland.	christiane.albrecht@ibmm.unibe.ch	Stieger, Bruno/U-6323-2017	Stieger, Bruno/0000-0002-7190-5785; Albrecht, Christiane/0000-0002-7846-6930	Swiss National Center of Competence in Research, NCCR TransCure, University of Bern, Switzerland [16-529]	Swiss National Center of Competence in Research, NCCR TransCure, University of Bern, Switzerland	The study was financially supported by the Swiss National Center of Competence in Research, NCCR TransCure, University of Bern, Switzerland (grant No. 16-529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, DIETARY NUT IN PRESS; BAUMRUCKER CR, 1988, TISSUE CELL, V20, P541, DOI 10.1016/0040-8166(88)90056-0; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Carron J, 2005, DOMEST ANIM ENDOCRIN, V28, P320, DOI 10.1016/j.domaniend.2004.12.002; Favari E, 2004, ARTERIOSCL THROM VAS, V24, P2345, DOI 10.1161/01.ATV.0000148706.15947.8a; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Fong BY, 2007, INT DAIRY J, V17, P275, DOI 10.1016/j.idairyj.2006.05.004; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Iatan I, 2011, J LIPID RES, V52, P2043, DOI 10.1194/jlr.M016196; KAMATH SA, 1972, BIOCHEM BIOPH RES CO, V49, P52, DOI 10.1016/0006-291X(72)90008-3; Lee J, 2002, BIOCHEM J, V364, P475, DOI 10.1042/BJ20011493; LIN PH, 1987, BIOCHEMISTRY-US, V26, P731, DOI 10.1021/bi00377a012; Low H, 2012, JOVE-J VIS EXP, DOI 10.3791/3810; Mani O, 2011, J DAIRY SCI, V94, P1265, DOI 10.3168/jds.2010-3521; Mani O, 2009, J DAIRY SCI, V92, P3744, DOI 10.3168/jds.2009-2063; Mani O, 2010, AM J PHYSIOL-REG I, V299, pR642, DOI 10.1152/ajpregu.00723.2009; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Muhlfeld Christian, 2007, Part Fibre Toxicol, V4, P11, DOI 10.1186/1743-8977-4-11; Nagao K, 2012, J LIPID RES, V53, P126, DOI 10.1194/jlr.M019976; Nikitina L, 2011, PLACENTA, V32, P420, DOI 10.1016/j.placenta.2011.03.003; Ohlsson L, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5124; Ontsouka EC, 2007, J RECEPT SIG TRANSD, V27, P147, DOI 10.1080/10799890701417741; Ontsouka EC, 2010, VET J, V186, P328, DOI 10.1016/j.tvjl.2009.08.029; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Orlowski S, 2007, EUR BIOPHYS J BIOPHY, V36, P869, DOI 10.1007/s00249-007-0193-8; OSBORNE JC, 1984, J BIOL CHEM, V259, P347; PATTERSON BW, 1986, BIOCHEMISTRY-US, V25, P4953, DOI 10.1021/bi00365a035; Reinhardt TA, 2006, J DAIRY RES, V73, P406, DOI 10.1017/S0022029906001889; Rochow N, 2010, CLIN NUTR, V29, P94, DOI 10.1016/j.clnu.2009.07.002; Rudnicka AR, 2007, PEDIATRICS, V119, pE1107, DOI 10.1542/peds.2006-2149; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Schenkman J B, 1978, Methods Enzymol, V52, P83; Schimanski S, 2010, HORM METAB RES, V42, P102, DOI 10.1055/s-0029-1241859; SHEPHERD J, 1977, BIOCHIM BIOPHYS ACTA, V489, P486, DOI 10.1016/0005-2760(77)90169-2; Tsujita M, 2005, J LIPID RES, V46, P154, DOI 10.1194/jlr.M400402-JLR200; Turck D, 2011, B ACAD NAT MED PARIS, V195, P487, DOI 10.1016/S0001-4079(19)32058-8; Vaziri ND, 2013, AM J NEPHROL, V37, P1, DOI 10.1159/000345969; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang Y, 2010, DOMEST ANIM ENDOCRIN, V39, P10, DOI 10.1016/j.domaniend.2009.12.001; Wu CA, 2004, J BIOL CHEM, V279, P30168, DOI 10.1074/jbc.M403765200; Yamamoto S, 2011, CIRCULATION, V124, P1382, DOI 10.1161/CIRCULATIONAHA.110.009704; Yoo JW, 2003, PHARMACEUT RES, V20, P1690, DOI 10.1023/A:1026112107100; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372	49	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70407	10.1371/journal.pone.0070407	http://dx.doi.org/10.1371/journal.pone.0070407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936200	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000322633700071
J	DebRoy, S; Kramarenko, II; Ghose, S; Oleinik, NV; Krupenko, SA; Krupenko, NI				DebRoy, Suchandra; Kramarenko, Inga I.; Ghose, Sampa; Oleinik, Natalia V.; Krupenko, Sergey A.; Krupenko, Natalia I.			A Novel Tumor Suppressor Function of Glycine N-Methyltransferase Is Independent of Its Catalytic Activity but Requires Nuclear Localization	PLOS ONE			English	Article							FOLATE-BINDING-PROTEIN; HEPATOCELLULAR-CARCINOMA; CYTOPLASMIC LOCALIZATION; SUSCEPTIBILITY GENE; CRYSTAL-STRUCTURE; EXPRESSION; DEFICIENCY; TRANSPORT; SARCOSINE; PROGRESSION	Glycine N-methyltransferase (GNMT), an abundant cytosolic enzyme, catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to glycine generating S-adenosylhomocysteine and sarcosine (N-methylglycine). This reaction is regulated by 5-methyltetrahydrofolate, which inhibits the enzyme catalysis. In the present study, we observed that GNMT is strongly down regulated in human cancers and is undetectable in cancer cell lines while the transient expression of the protein in cancer cells induces apoptosis and results in the activation of ERK1/2 as an early pro-survival response. The antiproliferative effect of GNMT can be partially reversed by treatment with the pan-caspase inhibitor zVAD-fmk but not by supplementation with high folate or SAM. GNMT exerts the suppressor effect primarily in cells originated from malignant tumors: transformed cell line of non-cancer origin, HEK293, was insensitive to GNMT. Of note, high levels of GNMT, detected in regenerating liver and in NIH3T3 mouse fibroblasts, do not produce cytotoxic effects. Importantly, GNMT, a predominantly cytoplasmic protein, was translocated into nuclei upon transfection of cancer cells. The presence of GNMT in the nuclei was also observed in normal human tissues by immunohistochemical staining. We further demonstrated that the induction of apoptosis is associated with the GNMT nuclear localization but is independent of its catalytic activity or folate binding. GNMT targeted to nuclei, through the fusion with nuclear localization signal, still exerts strong antiproliferative effects while its restriction to cytoplasm, through the fusion with nuclear export signal, prevents these effects (in each case the protein was excluded from cytosol or nuclei, respectively). Overall, our study indicates that GNMT has a secondary function, as a regulator of cellular proliferation, which is independent of its catalytic role.	[DebRoy, Suchandra; Kramarenko, Inga I.; Ghose, Sampa; Oleinik, Natalia V.; Krupenko, Sergey A.; Krupenko, Natalia I.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Krupenko, NI (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	krupenkn@musc.edu			National Institutes of Health [1R21DK083744]; NIH [CA095030, DK54388]; Cancer Center Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA095030, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388, R21DK083744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant 1R21DK083744 (to NK). Sergey Krupenko is supported by NIH grants CA095030 and DK54388. Flow Cytometry and Cell and Molecular Imaging Core Facilities were supported in part by Cancer Center Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augoustides-Savvopoulou P, 2003, J INHERIT METAB DIS, V26, P745, DOI 10.1023/B:BOLI.0000009978.17777.33; Banerjee D, 2002, BBA-MOL BASIS DIS, V1587, P164, DOI 10.1016/S0925-4439(02)00079-0; Bhat R, 1997, BIOCHEMISTRY-US, V36, P9906, DOI 10.1021/bi970159x; Bhat R, 1996, J BIOL CHEM, V271, P32551, DOI 10.1074/jbc.271.51.32551; Chen SY, 2004, CANCER RES, V64, P3617, DOI 10.1158/0008-5472.CAN-03-3726; Chen YMA, 1998, INT J CANCER, V75, P787, DOI 10.1002/(SICI)1097-0215(19980302)75:5<787::AID-IJC20>3.0.CO;2-2; Chen YMA, 2000, GENOMICS, V66, P43, DOI 10.1006/geno.2000.6188; COOK RJ, 1984, P NATL ACAD SCI-BIOL, V81, P3631, DOI 10.1073/pnas.81.12.3631; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Hoffmann L, 2013, AM J PHYSIOL-GASTR L, V304, pG835, DOI 10.1152/ajpgi.00332.2012; Huang YC, 2007, CLIN CANCER RES, V13, P1412, DOI 10.1158/1078-0432.CCR-06-1551; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Khan AP, 2013, NEOPLASIA, V15, P491, DOI 10.1593/neo.13314; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Krupenko NI, 1997, J BIOL CHEM, V272, P27140, DOI 10.1074/jbc.272.43.27140; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; Kumar N, 2013, BIOPHYS CHEM, V171, P9, DOI 10.1016/j.bpc.2012.11.004; Lee CM, 2006, TOXICOL APPL PHARM, V214, P126, DOI 10.1016/j.taap.2005.12.020; Liang CRMY, 2005, PROTEOMICS, V5, P2258, DOI 10.1002/pmic.200401256; Liao YJ, 2012, MOL MED, V18, P412, DOI 10.2119/molmed.2011.00258; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; Luka Z, 2003, BIOCHEM BIOPH RES CO, V312, P1067, DOI 10.1016/j.bbrc.2003.11.037; Luka Z, 2002, HUM GENET, V110, P68, DOI 10.1007/s00439-001-0648-4; Luka Z, 2007, J BIOL CHEM, V282, P4069, DOI 10.1074/jbc.M610384200; Luka Z, 2006, TRANSGENIC RES, V15, P393, DOI 10.1007/s11248-006-0008-1; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Martinez-Lopez N, 2012, GASTROENTEROLOGY, V143, P787, DOI 10.1053/j.gastro.2012.05.050; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Oleinik NV, 2006, BIOCHEM PHARMACOL, V72, P256, DOI 10.1016/j.bcp.2006.04.005; Pattanayek R, 1998, PROTEIN SCI, V7, P1326, DOI 10.1002/pro.5560070608; RAHA A, 1994, J BIOL CHEM, V269, P5750; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; Song YH, 2011, MODERN PATHOL, V24, P1272, DOI 10.1038/modpathol.2011.76; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stachowicz A, 2012, J PROTEOMICS, V77, P167, DOI 10.1016/j.jprot.2012.08.015; Strickland KC, 2013, CLIN CHEM LAB MED, V51, P607, DOI 10.1515/cclm-2012-0561; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Thomas T, 2003, J CELL MOL MED, V7, P113, DOI 10.1111/j.1582-4934.2003.tb00210.x; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tseng TL, 2003, CANCER RES, V63, P647; Varela-Rey M, 2009, HEPATOLOGY, V50, P443, DOI 10.1002/hep.23033; WAGNER C, 1985, BIOCHEM BIOPH RES CO, V127, P746, DOI 10.1016/S0006-291X(85)80006-1; Wagner C, 1995, FOLATE HLTH DIS, P23; Yen CH, 2009, TOXICOL APPL PHARM, V235, P296, DOI 10.1016/j.taap.2008.12.013; YEO EJ, 1994, P NATL ACAD SCI USA, V91, P210, DOI 10.1073/pnas.91.1.210; YEO EJ, 1992, J BIOL CHEM, V267, P24669; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	53	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70062	10.1371/journal.pone.0070062	http://dx.doi.org/10.1371/journal.pone.0070062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936142	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200056
J	Gaston, D; Roger, AJ				Gaston, Daniel; Roger, Andrew J.			Functional Divergence and Convergent Evolution in the Plastid-Targeted Glyceraldehyde-3-Phosphate Dehydrogenases of Diverse Eukaryotic Algae	PLOS ONE			English	Article							FRESH-WATER DIATOM; BACILLUS-STEAROTHERMOPHILUS; SECONDARY SYMBIOGENESIS; MIXTURE MODEL; NUCLEAR GENE; PROTEIN; GAPDH; ORIGIN; BINDING; SINGLE	Background: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key enzyme of the glycolytic pathway, reversibly catalyzing the sixth step of glycolysis and concurrently reducing the coenzyme NAD(+) to NADH. In photosynthetic organisms a GAPDH paralog (Gap2 in Cyanobacteria, GapA in most photosynthetic eukaryotes) functions in the Calvin cycle, performing the reverse of the glycolytic reaction and using the coenzyme NADPH preferentially. In a number of photosynthetic eukaryotes that acquired their plastid by the secondary endosymbiosis of a eukaryotic red alga (Alveolates, haptophytes, cryptomonads and stramenopiles) GapA has been apparently replaced with a paralog of the host's own cytosolic GAPDH (GapC1). Plastid GapC1 and GapA therefore represent two independent cases of functional divergence and adaptations to the Calvin cycle entailing a shift in subcellular targeting and a shift in binding preference from NAD(+) to NADPH. Methods: We used the programs FunDi, GroupSim, and Difference Evolutionary-Trace to detect sites involved in the functional divergence of these two groups of GAPDH sequences and to identify potential cases of convergent evolution in the Calvin-cycle adapted GapA and GapC1 families. Sites identified as being functionally divergent by all or some of these programs were then investigated with respect to their possible roles in the structure and function of both glycolytic and plastid-targeted GAPDH isoforms. Conclusions: In this work we found substantial evidence for convergent evolution in GapA/B and GapC1. In many cases sites in GAPDHs of these groups converged on identical amino acid residues in specific positions of the protein known to play a role in the function and regulation of plastid-functioning enzymes relative to their cytosolic counterparts. In addition, we demonstrate that bioinformatic software like FunDi are important tools for the generation of meaningful biological hypotheses that can then be tested with direct experimental techniques.	[Gaston, Daniel; Roger, Andrew J.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Gaston, Daniel; Roger, Andrew J.] Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Roger, AJ (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	andrew.roger@dal.ca			Natural Sciences and Engineering Research Council Discovery grant [227085-11]; Nova Scotia Health Research Foundation	Natural Sciences and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Health Research Foundation	This work was supported by Natural Sciences and Engineering Research Council Discovery grant 227085-11 awarded to AJR. DG was supported during this work by a Nova Scotia Health Research Foundation PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; BIESECKER G, 1977, NATURE, V266, P328, DOI 10.1038/266328a0; Boggetto N, 2007, J PHYCOL, V43, P1227, DOI 10.1111/j.1529-8817.2007.00409.x; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; BRINKMANN H, 1987, J MOL EVOL, V26, P320, DOI 10.1007/BF02101150; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; BUCHANAN BB, 1984, BIOSCIENCE, V34, P378, DOI 10.2307/1309730; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Burki F, 2009, GENOME BIOL EVOL, V1, P231, DOI 10.1093/gbe/evp022; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2003, PHILOS T R SOC B, V358, P109, DOI 10.1098/rstb.2002.1194; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; CERFF R, 1978, H-S Z PHYSIOL CHEM, V359, P769; CLERMONT S, 1993, BIOCHEMISTRY-US, V32, P10178, DOI 10.1021/bi00089a038; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; CORBIER C, 1990, BIOCHIMIE, V72, P545, DOI 10.1016/0300-9084(90)90119-2; Didierjean C, 1997, J MOL BIOL, V268, P739, DOI 10.1006/jmbi.1997.0998; Dumke R, 2011, MICROBIOL-SGM, V157, P2328, DOI 10.1099/mic.0.048298-0; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erales J, 2008, J PHYCOL, V44, P1455, DOI 10.1111/j.1529-8817.2008.00600.x; Eyschen J, 1996, BIOCHEMISTRY-US, V35, P6064, DOI 10.1021/bi952579x; Fagan T, 1998, J MOL EVOL, V47, P633, DOI 10.1007/PL00006420; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Fermani S, 2007, P NATL ACAD SCI USA, V104, P11109, DOI 10.1073/pnas.0611636104; Fermani S, 2001, J MOL BIOL, V314, P527, DOI 10.1006/jmbi.2001.5172; FERRI G, 1978, BIOCHIM BIOPHYS ACTA, V522, P19, DOI 10.1016/0005-2744(78)90318-2; Gaston D, 2011, BIOINFORMATICS, V27, P2655, DOI 10.1093/bioinformatics/btr470; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Groben R, 2010, PHOTOSYNTH RES, V103, P183, DOI 10.1007/s11120-010-9542-z; Gruber A, 2009, J BASIC MICROB, V49, P58, DOI 10.1002/jobm.200800339; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; HENZE K, 1995, P NATL ACAD SCI USA, V92, P9122, DOI 10.1073/pnas.92.20.9122; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lebreton S, 2006, FEBS J, V273, P3358, DOI 10.1111/j.1742-4658.2006.05342.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liaud MF, 1997, J MOL EVOL, V44, pS28, DOI 10.1007/PL00000050; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Maberly SC, 2010, J EXP BOT, V61, P735, DOI 10.1093/jxb/erp337; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; MARTIN W, 2004, PHOTOSYNTHESIS, V9, P9; Michels AK, 2005, PLANT PHYSIOL, V137, P911, DOI 10.1104/pp.104.055285; MORAS D, 1975, J BIOL CHEM, V250, P9137; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Patron NJ, 2004, EUKARYOT CELL, V3, P1169, DOI 10.1128/EC.3.5.1169-1175.2004; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Petersen J, 2006, J MOL EVOL, V62, P143, DOI 10.1007/s00239-004-0305-3; Petersen J, 2006, MOL BIOL EVOL, V23, P1109, DOI 10.1093/molbev/msj123; Pohlmeyer K, 1996, PLANT MOL BIOL, V32, P969, DOI 10.1007/BF00020493; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Raviscioni M, 2006, PROTEINS, V64, P1046, DOI 10.1002/prot.21074; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; SKARZYNSKI T, 1987, J MOL BIOL, V193, P171, DOI 10.1016/0022-2836(87)90635-8; Sparla F, 2004, J MOL BIOL, V340, P1025, DOI 10.1016/j.jmb.2004.06.005; Sparla F, 2005, PLANT PHYSIOL, V138, P2210, DOI 10.1104/pp.105.062117; Takishita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004737; Trost P, 2006, PHOTOSYNTH RES, V89, P263, DOI 10.1007/s11120-006-9099-z; Wang HC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-331; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; WOLOSIUK RA, 1978, PLANT PHYSIOL, V61, P669, DOI 10.1104/pp.61.4.669; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	79	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70396	10.1371/journal.pone.0070396	http://dx.doi.org/10.1371/journal.pone.0070396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936198	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200080
J	Jordana, X; Marin-Moratalla, N; Moncunill-Sole, B; Bover, P; Alcover, JA; Kohler, M				Jordana, Xavier; Marin-Moratalla, Nekane; Moncunill-Sole, Blanca; Bover, Pere; Antoni Alcover, Josep; Koehler, Meike			First Fossil Evidence for the Advance of Replacement Teeth Coupled with Life History Evolution along an Anagenetic Mammalian Lineage	PLOS ONE			English	Article							MYOTRAGUS-BALEARICUS BATE; 1909 ARTIODACTYLA; DENTAL ERUPTION; PERMANENT TEETH; MICROSTRUCTURE; CAPRINAE; PATTERN	In mammals that grow up more slowly and live longer, replacement teeth tend to appear earlier in sequence than in fast growing mammals. This trend, known as 'Schultz's Rule', is a useful tool for inferring life histories of fossil taxa. Deviations from this rule, however, suggest that in addition to the pace of life history, ecological factors may also drive dental ontogeny. Myotragus balearicus is an extinct insular caprine that has been proved to be an excellent test case to correlate morphological traits with life history. Here we show that Myotragus balearicus exhibits a slow signature of dental eruption sequence that is in agreement with the exceptionally slow life history of this species, thus conforming to 'Schultz's Rule'. However, our results also show an acceleration of the absolute pace of development of the permanent incisors in relation to that of the posterior teeth. The rodent-like incisors of Myotragus balearicus erupted early not only in relative but also in absolute terms (chronological age), suggesting that feeding characteristics also plays an important role in dental ontogeny. This is in agreement with ecological hypotheses based on primates. Our study documents a decoupling of the pace of development of teeth in mammals that is triggered by different selection pressures on dental ontogeny. Moreover, we show that Myotragus kopperi from the early Pleistocene (a direct ancestor of the late Pleistocene-Holocene M. balearicus) follows the pattern of first incisor replacement known in living bovids. Hence, the advance in the eruption sequence of the first incisors occurs along the Myotragus evolutionary lineage over a period of about 2.5 Myr. To our knowledge, this is the first fossil evidence of an advance of the emergence of the permanent first incisor along an anagenetic mammalian lineage.	[Jordana, Xavier; Marin-Moratalla, Nekane; Moncunill-Sole, Blanca] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont ICP, E-08193 Barcelona, Catalunya, Spain; [Bover, Pere; Antoni Alcover, Josep] UIB, CSIC, Inst Mediterrani Studis Avancats, Dept Biodiversitat & Conservacio, Esporles, Illes Balears, Spain; [Bover, Pere; Antoni Alcover, Josep] Amer Museum Nat Hist, Dept Mammal, Div Vertebrate Zool, New York, NY 10024 USA; [Koehler, Meike] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont ICP, ICREA Catalan Inst Res & Adv Studies, E-08193 Barcelona, Catalunya, Spain; [Koehler, Meike] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Catalunya, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; American Museum of Natural History (AMNH); Autonomous University of Barcelona; ICREA; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Barcelona	Jordana, X (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont ICP, E-08193 Barcelona, Catalunya, Spain.	xavier.jordana@icp.cat	Moncunill-Solé, Blanca/T-9986-2019; Jordana, Xavier/G-7537-2017; Jordana, Xavier/L-9301-2014; Alcover, Josep Antoni/Y-3796-2018	Moncunill-Solé, Blanca/0000-0001-8042-4257; Jordana, Xavier/0000-0002-6016-6630; Jordana, Xavier/0000-0001-8990-4388; Bover Arbos, Pedro/0000-0003-2942-2840; Kohler, Meike/0000-0001-9228-3164; Kohler, Meike/0000-0002-6816-6651; Alcover, Josep Antoni/0000-0001-9905-2588	Spanish Ministry of Economy and Competitiveness [CGL2012-34459, CGL2011-24685, JCI-2010-08157, BES-2009-02641]; Spanish Ministry of Education [AP2010-2393]; Junta para la Ampliacion de Estudios; ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education(Spanish Government); Junta para la Ampliacion de Estudios; ICREA(ICREA)	This work is supported by the Spanish Ministry of Economy and Competitiveness: CGL2012-34459 and CGL2011-24685 (PI: MK). XJ is supported by a "Juan de la Cierva" postdoctoral grant from the Spanish Ministry of Economy and Competitiveness (reference JCI-2010-08157). NMM is supported by a FPI grant from the Spanish Ministry of Economy and Competitiveness (reference BES-2009-02641). BMS is supported by a FPU grant from the Spanish Ministry of Education (reference AP2010-2393). PB is supported by a JAE-DOC (CSIC) contract, from the Junta para la Ampliacion de Estudios. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adloff P., 1898, Jenaische Zeitschrift, P347; Alcover JA, 1999, BIOL J LINN SOC, V66, P57, DOI 10.1006/bijl.1998.0260; Andrews CW, 1915, PHILOS T R SOC LON B, V206, P281, DOI 10.1098/rstb.1915.0006; Bover P, 1999, BIOL J LINN SOC, V68, P401; Godfrey LR, 2005, FOLIA PRIMATOL, V76, P77, DOI 10.1159/000083615; Godfrey LR, 2001, AM J PHYS ANTHROPOL, V114, P192, DOI 10.1002/1096-8644(200103)114:3<192::AID-AJPA1020>3.0.CO;2-Q; Guthrie EH, 2011, AM J PHYS ANTHROPOL, V145, P446, DOI 10.1002/ajpa.21525; Henderson E, 2007, AM J PHYS ANTHROPOL, V134, P226, DOI 10.1002/ajpa.20658; Hillson S., 2005, TEETH CAMBRIDGE MANU; Hogg RT, 2011, ANAT REC, V294, P2193, DOI 10.1002/ar.21503; Jordana X, 2012, P ROY SOC B-BIOL SCI, V279, P3339, DOI 10.1098/rspb.2012.0689; Jordana X, 2011, PALAEOGEOGR PALAEOCL, V300, P59, DOI 10.1016/j.palaeo.2010.12.008; Kohler M, 2004, BRAIN BEHAV EVOLUT, V63, P125, DOI 10.1159/000076239; Kohler Meike, 2010, P261; Kohler M, 2009, P NATL ACAD SCI USA, V106, P20354, DOI 10.1073/pnas.0813385106; Luckett W.P., 1985, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V92, P227; Marin-Moratalla N, 2011, CR PALEVOL, V10, P469, DOI 10.1016/j.crpv.2011.03.007; Miller G. S., 1924, Proceedings of the United States National Museum, V66, P1; MOYASOLA S, 2007, MONOGRAFIES SOC HIST, V14, P155; PerezBarberia FJ, 1996, ACTA THERIOL, V41, P217, DOI 10.4098/AT.arch.96-22; Schultz A.H., 1960, HUMAN GROWTH, P1; Schultz AH, 1935, AM J PHYS ANTHROPOL, V19, P489, DOI 10.1002/ajpa.1330190417; Schwartz GT, 2002, P NATL ACAD SCI USA, V99, P6124, DOI 10.1073/pnas.092685099; Smith B. Holly, 2000, P212, DOI 10.1017/CBO9780511542626.015; SMITH BH, 1994, AM J HUM BIOL, V6, P61, DOI 10.1002/ajhb.1310060110; van der Geer A, 2010, EVOLUTION OF ISLAND	26	20	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70743	10.1371/journal.pone.0070743	http://dx.doi.org/10.1371/journal.pone.0070743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936247	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300115
J	Vas, PRJ; Rayman, G				Vas, Prashanth R. J.; Rayman, Gerry			The Rate of Decline in Small Fibre Function Assessed Using Axon Reflex-Mediated Neurogenic Vasodilatation and the Importance of Age Related Centile Values to Improve the Detection of Clinical Neuropathy	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; DIABETIC-NEUROPATHY; NORMATIVE-REFERENCE; DENSITY; LDIFLARE	Background: The LDIflare technique (LDIflare) is a simple non-invasive test of small fibre function in dorsal foot skin involving skin heating and measuring the size of the resulting axon reflex-mediated vasodilator (flare) response using a laser Doppler imager (LDI). This study establishes age-related normative reference ranges for the test and determines the rate of decline in small fibre function per decade. Additionally, the potential value of using age related centiles rather than Receiver Operator Curves (ROC) was explored by comparison of the sensitivity and specificity of each analytic technique in identifying clinical neuropathy. Methods: LDIflare areas were assessed in 94 healthy controls and 66 individuals with diabetes with (DN+, n = 31) and without clinical neuropathy (DN-, n = 35); neuropathy defined as a Neuropathy Disability Score >= 3. The age specific 5th centile values were used as the ` cut-offs' for the diagnosis of neuropathy from which sensitivity and specificity were calculated. Results: There was a significant age dependant decrease in LDIflare size (r = -0.42, p<0.0001) with no significant gender differences. The LDIflare size reduced 0.56 cm(2) per decade which gives a percentage reduction of approximately 5.5% per decade. Using the normative 5th centiles as the cut-offs, the technique had a sensitivity of 77%, specificity of 90%, positive predictive value of 82% and negative predictive value of 87%. The ROC analysis gave a threshold of <3.66 cm(2) for the cut-off, resulting in a sensitivity of 75%, specificity of 85%, positive predictive value of 74% and negative predictive value of 86%. Conclusions: There is an age dependent decrease in small fibre function in the foot of 5.5% per decade. Both analytic techniques demonstrate good sensitivity and specificity for detecting clinical neuropathy but the technique based on age centiles offers better diagnostic accuracy and is therefore proposed as the method of choice.	[Vas, Prashanth R. J.; Rayman, Gerry] NHS Trust, Ipswich Hosp, Diabet Res Ctr, Ipswich, Suffolk, England	Ipswich Hospital NHS Trust; Ipswich Hospital	Rayman, G (corresponding author), NHS Trust, Ipswich Hosp, Diabet Res Ctr, Ipswich, Suffolk, England.	gerry.rayman@ipswichhospital.nhs.uk		Vas, Prashanth/0000-0001-7448-2995				Abbott CA, 2002, DIABETIC MED, V19, P377, DOI 10.1046/j.1464-5491.2002.00698.x; Bakkers M, 2009, NEUROLOGY, V73, P1142, DOI 10.1212/WNL.0b013e3181bacf05; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Blankenburg M, 2010, PAIN, V149, P76, DOI 10.1016/j.pain.2010.01.011; Boulton AJM, 2005, CLIN DIABETES, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9; Boulton AJM, 2010, DIABETES CARE, V33, P207, DOI 10.2337/dc09-1728; BRAVENBOER B, 1992, DIABETIC MED, V9, P546, DOI 10.1111/j.1464-5491.1992.tb01836.x; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Ebadi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042208; Freeman R, 2003, NEUROLOGY, V60, P465, DOI 10.1212/WNL.60.3.465; Gibbons CH, 2010, DIABETES CARE, V33, P2629, DOI 10.2337/dc10-0763; Green AQ, 2010, DIABETES CARE, V33, P174, DOI 10.2337/dc09-0101; Green AQ, 2009, MUSCLE NERVE, V40, P985, DOI 10.1002/mus.21333; Green AQ, 2010, SMALL FIBRE FUNCTION, P146; Krishnan STM, 2009, DIABETES CARE, V32, P451, DOI 10.2337/dc08-1453; Krishnan STM, 2004, DIABETES CARE, V27, P2930, DOI 10.2337/diacare.27.12.2930; Lauria G, 2010, J PERIPHER NERV SYST, V15, P202, DOI 10.1111/j.1529-8027.2010.00271.x; MASER RE, 1989, DIABETES CARE, V12, P270, DOI 10.2337/diacare.12.4.270; McArthur JC, 1998, ARCH NEUROL-CHICAGO, V55, P1513, DOI 10.1001/archneur.55.12.1513; Nouri MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034807; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Smith AG, 2006, DIABETES CARE, V29, P1294, DOI 10.2337/dc06-0224; Tavakoli M, 2009, EXP NEUROL; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Umapathi T, 2007, MUSCLE NERVE, V35, P591, DOI 10.1002/mus.20732; Vas PR, 2012, MUSCLE NERVE; Wright EM, 1999, STAT METHODS MED RES, V8, P93, DOI 10.1191/096228099672225506	28	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69920	10.1371/journal.pone.0069920	http://dx.doi.org/10.1371/journal.pone.0069920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936119	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300075
J	Loike, JD; Plitt, A; Kothari, K; Zumeris, J; Budhu, S; Kavalus, K; Ray, Y; Jacob, H				Loike, John D.; Plitt, Anna; Kothari, Komal; Zumeris, Jona; Budhu, Sadna; Kavalus, Kaitlyn; Ray, Yonatan; Jacob, Harold			Surface Acoustic Waves Enhance Neutrophil Killing of Bacteria	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; ULTRASOUND; MIGRATION; RECEPTOR	Biofilms are structured communities of bacteria that play a major role in the pathogenicity of bacteria and are the leading cause of antibiotic resistant bacterial infections on indwelling catheters and medical prosthetic devices. Failure to resolve these biofilm infections may necessitate the surgical removal of the prosthetic device which can be debilitating and costly. Recent studies have shown that application of surface acoustic waves to catheter surfaces can reduce the incidence of infections by a mechanism that has not yet been clarified. We report here the effects of surface acoustic waves (SAW) on the capacity of human neutrophils to eradicate S. epidermidis bacteria in a planktonic state and within biofilms. Utilizing a novel fibrin gel system that mimics a tissue-like environment, we show that SAW, at an intensity of 0.3 mW/cm(2), significantly enhances human neutrophil killing of S. epidermidis in a planktonic state and within biofilms by enhancing human neutrophil chemotaxis in response to chemoattractants. In addition, we show that the integrin CD18 plays a significant role in the killing enhancement observed in applying SAW. We propose from out data that this integrin may serve as mechanoreceptor for surface acoustic waves enhancing neutrophil chemotaxis and killing of bacteria.	[Loike, John D.; Budhu, Sadna; Kavalus, Kaitlyn; Ray, Yonatan] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Zumeris, Jona; Jacob, Harold] NanoVibronix, Nesher, Israel; [Plitt, Anna; Kothari, Komal] Harvard Univ, Sch Med, Boston, MA USA; [Budhu, Sadna] Sloan Kettering Inst, Dept Immunol, New York, NY USA; [Ray, Yonatan] Regeneron Pharmaceut Corp, Tarrytown, NY USA	Columbia University; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Regeneron	Loike, JD (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	jdl5@columbia.edu						Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Bandow K, 2007, J CELL PHYSIOL, V211, P392, DOI 10.1002/jcp.20944; Berger M, 2002, J LEUKOCYTE BIOL, V71, P798; Bredius R G, 1993, Immunodeficiency, V4, P51; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dwyer A, 2008, SEMIN DIALYSIS, V21, P542, DOI 10.1111/j.1525-139X.2008.00499.x; Fazli M, 2011, WOUND REPAIR REGEN, V19, P387, DOI 10.1111/j.1524-475X.2011.00681.x; Gurjala AN, 2011, WOUND REPAIR REGEN, V19, P400, DOI 10.1111/j.1524-475X.2011.00690.x; Hazan Z, 2006, ANTIMICROB AGENTS CH, V50, P4144, DOI 10.1128/AAC.00418-06; He NA, 2011, ANTIMICROB AGENTS CH, V55, P5331, DOI 10.1128/AAC.00542-11; Kopel M, 2011, BIOFOULING, V27, P701, DOI 10.1080/08927014.2011.597051; Kothari K, 2011, COLUMBIA UNDERGRADUA, V5, P35; Li YM, 2004, J EXP MED, V200, P613, DOI 10.1084/jem.20040725; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Li YM, 2002, J IMMUNOL, V168, P816, DOI 10.4049/jimmunol.168.2.816; Loike JD, 2004, ARTERIOSCL THROM VAS, V24, P2051, DOI 10.1161/01.ATV.0000143858.15909.29; LOIKE JD, 1995, J EXP MED, V181, P1763, DOI 10.1084/jem.181.5.1763; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; NEWMAN SL, 1979, J IMMUNOL, V123, P1839; Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c; Reher P, 1997, ULTRASOUND MED BIOL, V23, P1251, DOI 10.1016/S0301-5629(97)00031-8; Schlager A, 2010, ENDOSCOPY, V42, P1045, DOI 10.1055/s-0030-1255801; Simoes M, 2011, CURR MED CHEM, V18, P2129, DOI 10.2174/092986711795656216; Soderholm J, 2005, CHEM BIOL, V12, P263, DOI 10.1016/j.chembiol.2005.03.001; Stroh P, 2011, IMMUNOBIOLOGY, V216, P351, DOI 10.1016/j.imbio.2010.07.009; Thurlow LR, 2011, J IMMUNOL; Yakandawala N, 2007, J APPL MICROBIOL, V102, P722, DOI 10.1111/j.1365-2672.2006.03129.x	29	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e68334	10.1371/journal.pone.0068334	http://dx.doi.org/10.1371/journal.pone.0068334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936303	Green Submitted, Green Published, gold			2022-12-27	WOS:000324401500001
J	Rossi, MA; Fan, D; Barter, JW; Yin, HH				Rossi, Mark A.; Fan, David; Barter, Joseph W.; Yin, Henry H.			Bidirectional Modulation of Substantia Nigra Activity by Motivational State	PLOS ONE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; REWARD; REINFORCEMENT; SIGNALS; MECHANISMS; CIRCUITRY; STIMULI; HABITS; BRAIN	A major output nucleus of the basal ganglia is the substantia nigra pars reticulata, which sends GABAergic projections to brainstem and thalamic nuclei. The GABAergic (GABA) neurons are reciprocally connected with nearby dopaminergic neurons, which project mainly to the basal ganglia, a set of subcortical nuclei critical for goal-directed behaviors. Here we examined the impact of motivational states on the activity of GABA neurons in the substantia nigra pars reticulata and the neighboring dopaminergic (DA) neurons in the pars compacta. Both types of neurons show short-latency bursts to a cue predicting a food reward. As mice became sated by repeated consumption of food pellets, one class of neurons reduced cue-elicited firing, whereas another class of neurons progressively increased firing. Extinction or pre-feeding just before the test session dramatically reduced the phasic responses and their motivational modulation. These results suggest that signals related to the current motivational state bidirectionally modulate behavior and the magnitude of phasic response of both DA and GABA neurons in the substantia nigra.	[Rossi, Mark A.; Fan, David; Barter, Joseph W.; Yin, Henry H.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Yin, Henry H.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Barter, Joseph W.; Yin, Henry H.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; Duke University; Duke University	Yin, HH (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC USA.	hy43@duke.edu		Rossi, Mark/0000-0002-5724-3615	National Institutes of Health [AA021074]; National Science Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors' research is supported by National Institutes of Health grant AA021074 to HHY and National Science Foundation fellowships to MAR and JWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Bar-Gad I, 2001, J NEUROSCI METH, V107, P1, DOI 10.1016/S0165-0270(01)00339-9; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bunzeck N, 2009, CURR BIOL, V19, P1294, DOI 10.1016/j.cub.2009.06.021; Cagniard B, 2006, NEURON, V51, P541, DOI 10.1016/j.neuron.2006.07.026; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Coizet V, 2010, NEUROSCIENCE, V168, P263, DOI 10.1016/j.neuroscience.2010.03.049; de Araujo IE, 2006, NEURON, V51, P483, DOI 10.1016/j.neuron.2006.07.009; Doll BB, 2012, CURR OPIN NEUROBIOL, V22, P1075, DOI 10.1016/j.conb.2012.08.003; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fan D, 2012, J NEUROSCI, V32, P5534, DOI 10.1523/JNEUROSCI.5924-11.2012; Fan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022033; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Henny P, 2012, NAT NEUROSCI, V15, P613, DOI 10.1038/nn.3048; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Joshua M, 2009, NEURON, V62, P695, DOI 10.1016/j.neuron.2009.04.026; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Leblond M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025342; Lee CR, 2009, J NEURAL TRANSM-SUPP, P71, DOI 10.1007/978-3-211-92660-4_6; Lee D, 2012, ANN REV NEUROSCI; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Narayanan NS, 2010, FRONT NEUROENDOCRIN, V31, P104, DOI 10.1016/j.yfrne.2009.10.004; Niv Y, 2008, TRENDS COGN SCI, V12, P265, DOI 10.1016/j.tics.2008.03.006; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rossi M. A, 2012, CURR PROTOC NEUROSCI; Rossi MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065799; Rossi MA, 2012, J NEUROPHYSIOL, V108, P1211, DOI 10.1152/jn.01060.2011; Rossi MA, 2011, NEUROMETHODS, V62, P55, DOI 10.1007/978-1-61779-301-1_4; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Shiner T, 2012, BRAIN; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Vandecasteele M, 2005, J NEUROSCI, V25, P291, DOI 10.1523/JNEUROSCI.4167-04.2005; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yu CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050578; Zhou FW, 2009, J NEUROSCI, V29, P10424, DOI 10.1523/JNEUROSCI.4402-08.2009	48	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71598	10.1371/journal.pone.0071598	http://dx.doi.org/10.1371/journal.pone.0071598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936522	Green Submitted, Green Published, gold			2022-12-27	WOS:000324401500080
J	Greene, CJ; Chadwick, CM; Mandell, LM; Hu, JC; O'Hara, JM; Brey, RN; Mantis, NJ; Connell, TD				Greene, Christopher J.; Chadwick, Chrystal M.; Mandell, Lorrie M.; Hu, John C.; O'Hara, Joanne M.; Brey, Robert N., III; Mantis, Nicholas J.; Connell, Terry D.			LT-IIb(T13I), a Non-Toxic Type II Heat-Labile Enterotoxin, Augments the Capacity of a Ricin Toxin Subunit Vaccine to Evoke Neutralizing Antibodies and Protective Immunity	PLOS ONE			English	Article							VASCULAR LEAK SYNDROME; IN-VITRO; LT-IIB; ESCHERICHIA-COLI; BINDING SPECIFICITIES; DENDRITIC CELLS; CLINICAL-TRIAL; CHOLERA-TOXIN; A-CHAIN; MUCOSAL	Currently, there is a shortage of adjuvants that can be employed with protein subunit vaccines to enhance protection against biological threats. LT-IIb(T13I) is an engineered nontoxic derivative of LT-IIb, a member of the type II subfamily of heat labile enterotoxins expressed by Escherichia coli, that possesses potent mucosal adjuvant properties. In this study we evaluated the capacity of LT-IIb(T13I) to augment the potency of RiVax, a recombinant ricin toxin A subunit vaccine, when co-administered to mice via the intradermal (i.d.) and intranasal (i.n.) routes. We report that co-administration of RiVax with LT-IIb(T13I) by the i.d. route enhanced the levels of RiVax-specific serum IgG antibodies (Ab) and elevated the ratio of ricin-neutralizing to non-neutralizing Ab, as compared to RiVax alone. Protection against a lethal ricin challenge was also augmented by LT-IIb(T13I). While local inflammatory responses elicited by LT-IIb(T13I) were comparable to those elicited by aluminum salts (Imject (R)), LT-IIb(T13I) was more effective than aluminum salts at augmenting production of RiVax-specific serum IgG. Finally, i.n. administration of RiVax with LT-IIb(T13I) also increased levels of RiVax-specific serum and mucosal Ab and enhanced protection against ricin challenge. Collectively, these data highlight the potential of LT-IIb(T13I) as an effective next-generation i.d., or possibly i.n. adjuvant for enhancing the immunogenicity of subunit vaccines for biodefense.	[Greene, Christopher J.; Mandell, Lorrie M.; Hu, John C.; Connell, Terry D.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Greene, Christopher J.; Mandell, Lorrie M.; Hu, John C.; Connell, Terry D.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Chadwick, Chrystal M.; O'Hara, Joanne M.; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA; [O'Hara, Joanne M.; Mantis, Nicholas J.] SUNY Albany, Dept Biomed Sci, Albany, NY USA; [Brey, Robert N., III] Soligenix Inc, Princeton, NJ USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA.	nmantis@wadsworth.org; connell@buffalo.edu	Greene, Casey/L-2057-2015	Greene, Casey/0000-0001-8713-9213; Mantis, Nicholas/0000-0002-5083-8640	John R. Oishei Foundation; Public Health grant [R01 DE13833, R56 DE13833, AI097688, AI082210, U01 AI082210, T32 AI007614]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082210, T32AI007614, R03AI097688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE013833, R01DE013833] Funding Source: NIH RePORTER	John R. Oishei Foundation; Public Health grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by a grant from The John R. Oishei Foundation and Public Health grants R01 DE13833 and R56 DE13833 awarded to TDC. NJM acknowledges support from Public Health grants AI097688 and AI082210. RNB was supported by Public Health grant U01 AI082210. CJG was supported by the Public Health grant T32 AI007614. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce S, 2007, INFECT IMMUN, V75, P1413, DOI 10.1128/IAI.01367-06; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Berenson CS, 2010, GLYCOBIOLOGY, V20, P41, DOI 10.1093/glycob/cwp141; FISHMAN PH, 1978, BIOCHEMISTRY-US, V17, P711, DOI 10.1021/bi00597a024; Flacher V, 2010, J INVEST DERMATOL, V130, P755, DOI 10.1038/jid.2009.343; FUKUTA S, 1988, INFECT IMMUN, V56, P1748, DOI 10.1128/IAI.56.7.1748-1753.1988; Furukawa-Stoffer TL, 1999, HYBRIDOMA, V18, P505; HEWETSON JF, 1993, VACCINE, V11, P743, DOI 10.1016/0264-410X(93)90259-Z; Hewetson JF, 1996, FUNDAM APPL TOXICO S, V30, P59; Hewetson JF, 1995, VACCINE RES, V4, P179; Holmes RKJM, 1995, BACTERIAL TOXINS VIR; LEMLEY PV, 1994, HYBRIDOMA, V13, P417, DOI 10.1089/hyb.1994.13.417; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Lewis DJ, PLOS ONE, V4, pe6999; Liang S, 2009, VACCINE, V27, P4302, DOI 10.1016/j.vaccine.2009.05.027; Lindstrom AL, 2001, METH MOL B, V166, P125; LORD JM, 1994, FASEB J, V8, P201, DOI 10.1096/fasebj.8.2.8119491; Marconescu PS, 2010, VACCINE, V28, P5315, DOI 10.1016/j.vaccine.2010.05.045; Martin M, 2000, INFECT IMMUN, V68, P281, DOI 10.1128/IAI.68.1.281-287.2000; Mastri M, 2012, AM J PHYSL CELL PHYS; Mathias-Santos C, 2011, CLIN VACCINE IMMUNOL, V18, P1243, DOI 10.1128/CVI.00012-11; MURAGUCHI A, 1988, J EXP MED, V167, P332, DOI 10.1084/jem.167.2.332; Nawar HF, 2011, VACCINE, V29, P721, DOI 10.1016/j.vaccine.2010.11.020; Nawar HF, 2010, CLIN VACCINE IMMUNOL, V17, P969, DOI 10.1128/CVI.00076-10; Nawar HF, 2005, INFECT IMMUN, V73, P1330, DOI 10.1128/IAI.73.3.1330-1342.2005; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Olson MA, 2004, PROTEIN ENG DES SEL, V17, P391, DOI 10.1093/protein/gzh043; Ramasamy S, 2010, BRIT J PHARMACOL, V161, P721, DOI 10.1111/j.1476-5381.2010.00939.x; Roche JK, 2008, LAB INVEST, V88, P1178, DOI 10.1038/labinvest.2008.83; Romani N, 2010, IMMUNOL CELL BIOL, V88, P424, DOI 10.1038/icb.2010.39; Shabrawi-Caelen E, 2009, ALLERGY, V64, P965, DOI 10.1111/j.1398-9995.2009.01999.x; Smallshaw JE, 2005, VACCINE, V23, P4775, DOI 10.1016/j.vaccine.2005.04.037; Smallshaw JE, 2002, VACCINE, V20, P3422, DOI 10.1016/S0264-410X(02)00312-2; Smallshaw JE, 2007, VACCINE, V25, P7459, DOI 10.1016/j.vaccine.2007.08.018; Smallshaw JE, 2010, VACCINE, V28, P2428, DOI 10.1016/j.vaccine.2009.12.081; SOLERRODRIGUEZ AM, 1993, EXP CELL RES, V206, P227, DOI 10.1006/excr.1993.1142; Vitetta ES, 2012, CLIN VACCINE IMMUNOL, V19, P1697, DOI 10.1128/CVI.00381-12; Vitetta ES, 2006, P NATL ACAD SCI USA, V103, P2268, DOI 10.1073/pnas.0510893103; Vogelbruch M, 2000, ALLERGY, V55, P883; Wang YG, 2007, BIOTECHNOL LETT, V29, P1811, DOI 10.1007/s10529-007-9478-3	42	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69678	10.1371/journal.pone.0069678	http://dx.doi.org/10.1371/journal.pone.0069678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936344	gold, Green Submitted, Green Published			2022-12-27	WOS:000324545800021
J	Yan, LP; Cui, HY; Xiao, HP; Zhang, Q				Yan, Liping; Cui, Haiyan; Xiao, Heping; Zhang, Qing			Anergic Pulmonary Tuberculosis Is Associated with Contraction of the Vd2+T Cell Population, Apoptosis and Enhanced Inhibitory Cytokine Production	PLOS ONE			English	Article							DELTA T-CELLS; GAMMA; INTERLEUKIN-4; TH1	Objective: To study the association of anergic pulmonary tuberculosis with V delta 2(+) T cells and related cytokine levels. Methods: 82 pulmonary tuberculosis patients were divided into two groups according to their purified protein derivative tuberculin skin test (TST) results: 39 with TST-negative anergic pulmonary tuberculosis and 43 with TST-positive pulmonary tuberculosis, while 40 healthy volunteers were used as control. Based on chest X-ray results, the tuberculosis lesions were scored according to their severity, with a score of <= 2.5 ranking as mild, 2.5-6 as moderate and >= 6 as severe. The V delta 2(+) T cell percentage and their expression levels of the apoptosis-related membrane surface molecule FasL in peripheral blood and bronchoalveolar lavage fluids (BALF) were analyzed by flow cytometry, while IL-2, IL-4, IL-6 and IL-10 cytokine and Upsilon-interferon (Upsilon-IFN) concentrations in peripheral blood were determined by ELISA. Results: Most of the patients with chest X-ray lesion scores higher than 6 belonged to the anergic tuberculosis group (P<0.05). Anergic pulmonary tuberculosis patients displayed reduced peripheral blood V delta 2(+) T cell counts (P<0.05) and higher FasL expression in peripheral blood V delta 2(+) T cells (P<0.05). The V delta 2(+) T cell percentages in the BALF of all tuberculosis patients were lower than in their peripheral blood (P<0.05), and IL-4 and IL-10 concentrations in peripheral blood of anergic tuberculosis patients were higher than in TST-positive tuberculosis patients and healthy controls (P<0.05). Conclusion: Anergic pulmonary tuberculosis is accompanied by reduced V delta 2(+) T cell percentage, and elevated V delta 2(+) T cell FasL expression as well as enhanced IL-4 and IL-10 levels in peripheral blood.	[Yan, Liping; Cui, Haiyan; Xiao, Heping; Zhang, Qing] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept TB, Shanghai 200092, Peoples R China	Tongji University	Zhang, Q (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept TB, Shanghai 200092, Peoples R China.	ZhangingBM123@163.com						Al-Attiyah R, 2012, SCAND J IMMUNOL, V75, P623, DOI 10.1111/j.1365-3083.2012.02692.x; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; Casetti R, 2008, CELL MOL IMMUNOL, V5, P161, DOI 10.1038/cmi.2008.20; Cavalcanti YV, 2011, PULM MED, V2012; Furuhashi Kazuki, 2012, Kekkaku, V87, P1; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Grode L, 2013, VACCINE, V31, P1340, DOI 10.1016/j.vaccine.2012.12.053; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hussain R, 2011, J CLIN IMMUNOL, V31, P913, DOI 10.1007/s10875-011-9566-y; Kunzmann V, 2009, IMMUNOLOGY, V126, P256, DOI 10.1111/j.1365-2567.2008.02894.x; Li BQ, 1998, J IMMUNOL, V161, P1558; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Mahan CS, 2009, IMMUNOLOGY, V127, P398, DOI 10.1111/j.1365-2567.2008.02982.x; Meraviglia S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/587315; Meraviglia S, 2010, J IMMUNOL, V185, P1770, DOI 10.4049/jimmunol.1000966; Miko E, 2009, J REPROD IMMUNOL, V80, P100, DOI 10.1016/j.jri.2009.01.003; Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487; Pinheiro MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050923; Pitt JM, 2012, J IMMUNOL, V189, P4079, DOI 10.4049/jimmunol.1201061; Small Peter M, 2009, Kekkaku, V84, P721; Szereday L, 2008, INT J TUBERC LUNG D, V12, P262; Thillai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038083; Verma I, 2009, EXPERT REV VACCINES, V8, P1547, DOI [10.1586/erv.09.111, 10.1586/ERV.09.111]	23	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71245	10.1371/journal.pone.0071245	http://dx.doi.org/10.1371/journal.pone.0071245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936496	gold, Green Published, Green Submitted			2022-12-27	WOS:000324545800061
J	Zhou, S; Wright, JL; Liu, J; Sin, DD; Churg, A				Zhou, Steven; Wright, Joanne L.; Liu, Joseph; Sin, Don D.; Churg, Andrew			Aging does not Enhance Experimental Cigarette Smoke-Induced COPD in the Mouse	PLOS ONE			English	Article							INDUCED EMPHYSEMA; OXIDATIVE STRESS; OZONE EXPOSURE; LUNG; SENESCENCE; MICE; INFLAMMATION; AIRWAY; SUSCEPTIBILITY; DISEASE	It has been proposed that the development of COPD is driven by premature aging/premature senescence of lung parenchyma cells. There are data suggesting that old mice develop a greater inflammatory and lower anti-oxidant response after cigarette smoke compared to young mice, but whether these differences actually translate into greater levels of disease is unknown. We exposed C57Bl/6 female mice to daily cigarette smoke for 6 months starting at age 3 months (Ayoung@) or age 12 months (Aold@), with air-exposed controls. There were no differences in measures of airspace size between the two control groups and cigarette smoke induced exactly the same amount of emphysema in young and old. The severity of smoke-induced small airway remodeling using various measures was identical in both groups. Smoke increased numbers of tissue macrophages and neutrophils and levels of 8-hydroxyguanosine, a marker of oxidant damage, but there were no differences between young and old. Gene expression studies using laser capture microdissected airways and parenchyma overall showed a trend to lower levels in older animals and a somewhat lesser response to cigarette smoke in both airways and parenchyma but the differences were usually not marked. Telomere length was greatest in young control mice and was decreased by both smoking and age. The senescence marker p21(Waf1) was equally upregulated by smoke in young and old, but p16(INK4a), another senescence marker, was not upregulated at all. We conclude, in this model, animal age does not affect the development of emphysema and small airway remodeling.	[Zhou, Steven; Wright, Joanne L.; Churg, Andrew] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [Liu, Joseph; Sin, Don D.] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada; [Liu, Joseph; Sin, Don D.] Univ British Columbia, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Churg, A (corresponding author), Univ British Columbia, Dept Pathol, Vancouver, BC, Canada.	achurg@mail.ubc.ca	Sin, Don/AAC-2219-2021		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair-Kirk TL, 2008, AM J RESP CELL MOL, V39, P400, DOI 10.1165/rcmb.2007-0295OC; Aoshiba K, 2007, FEBS LETT, V581, P3512, DOI 10.1016/j.febslet.2007.06.075; Aoshiba Kazutetsu, 2009, Proc Am Thorac Soc, V6, P596, DOI 10.1513/pats.200904-017RM; Botelho FM, 2011, EUR RESPIR J, V38, P285, DOI 10.1183/09031936.00076210; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Calvi CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020712; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Fukuchi Yoshinosuke, 2009, Proc Am Thorac Soc, V6, P570, DOI 10.1513/pats.200909-099RM; Gordon CJ, 2013, INHAL TOXICOL, V25, P141, DOI 10.3109/08958378.2013.764946; Gould NS, 2010, AM J RESP CRIT CARE, V182, P1114, DOI 10.1164/rccm.201003-0442OC; HALBOWER AC, 1994, LAB INVEST, V71, P149; Hamade AK, 2010, INHAL TOXICOL, V22, P84, DOI 10.3109/08958378.2010.503974; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Huang KW, 2007, J APPL PHYSIOL, V102, P1632, DOI 10.1152/japplphysiol.00833.2006; Huang KW, 2007, J APPL PHYSIOL, V102, P200, DOI 10.1152/japplphysiol.00400.2006; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Lee J, 2011, CURR OPIN PULM MED, V17, P90, DOI 10.1097/MCP.0b013e328341cead; Lee J, 2009, AM J PHYSIOL-LUNG C, V296, pL57, DOI 10.1152/ajplung.90411.2008; MacNee W, 2011, AM J RESP CRIT CARE, V184, P1327, DOI 10.1164/rccm.201110-1764ED; Moriyama C, 2010, AM J RESP CELL MOL, V42, P304, DOI 10.1165/rcmb.2009-0025OC; Pinkerton K E, 1998, Res Rep Health Eff Inst, P1; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rangasamy T, 2009, AM J PHYSIOL-LUNG C, V296, pL888, DOI 10.1152/ajplung.90369.2008; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Shore SA, 2011, INHAL TOXICOL, V23, P878, DOI 10.3109/08958378.2011.622316; Tuder RM, 2008, CURR OPIN PHARMACOL, V8, P255, DOI 10.1016/j.coph.2008.03.003; Tuder Rubin M, 2012, Proc Am Thorac Soc, V9, P62, DOI 10.1513/pats.201201-012MS; Wang RD, 2005, AM J RESP CELL MOL, V33, P387, DOI 10.1165/rcmb.2005-0203OC; Wright JL, 2007, INHAL TOXICOL, V19, P915, DOI 10.1080/08958370701515563; WRIGHT JL, 1990, AM REV RESPIR DIS, V142, P1422, DOI 10.1164/ajrccm/142.6_Pt_1.1422; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zhou F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-78	35	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71410	10.1371/journal.pone.0071410	http://dx.doi.org/10.1371/journal.pone.0071410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936505	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800063
J	Ascenzi, P; Coletta, A; Cao, Y; Trezza, V; Leboffe, L; Fanali, G; Fasano, M; Pesce, A; Ciaccio, C; Marini, S; Coletta, M				Ascenzi, Paolo; Coletta, Andrea; Cao, Yu; Trezza, Viviana; Leboffe, Loris; Fanali, Gabriella; Fasano, Mauro; Pesce, Alessandra; Ciaccio, Chiara; Marini, Stefano; Coletta, Massimo			Isoniazid Inhibits the Heme-Based Reactivity of Mycobacterium tuberculosis Truncated Hemoglobin N	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; MONOAMINE-OXIDASE INHIBITORS; NITRIC-OXIDE; DRUG-RESISTANCE; CRYSTAL-STRUCTURE; BINDING; PEROXYNITRITE; MECHANISMS; DISCOVERY; ANTIDEPRESSANTS	Isoniazid represents a first-line anti-tuberculosis medication in prevention and treatment. This prodrug is activated by a mycobacterial catalase-peroxidase enzyme called KatG in Mycobacterium tuberculosis), thereby inhibiting the synthesis of mycolic acid, required for the mycobacterial cell wall. Moreover, isoniazid activation by KatG produces some radical species (e.g., nitrogen monoxide), that display anti-mycobacterial activity. Remarkably, the ability of mycobacteria to persist in vivo in the presence of reactive nitrogen and oxygen species implies the presence in these bacteria of (pseudo-)enzymatic detoxification systems, including truncated hemoglobins (trHbs). Here, we report that isoniazid binds reversibly to ferric and ferrous M. tuberculosis trHb type N (or group I; Mt-trHbN(III) and Mt-trHbN(II), respectively) with a simple bimolecular process, which perturbs the heme-based spectroscopic properties. Values of thermodynamic and kinetic parameters for isoniazid binding to Mt-trHbN(III) and Mt-trHbN(II) are K = (1.1 +/- 0.1) x 10(24) M, k(on) = (5.3 +/- 0.6) x 10(3) M-1 s(-1) and k(off) = (4.6 +/- 0.5) x 10(-1) s(-1); and D = (1.2 +/- 0.2) x 10(23) M, d(on) = (1.3 +/- 0.4) x 10(3) M-1 s(-1), and d(off) = 1.5 +/- 0.4 s(-1), respectively, at pH 7.0 and 20.0 degrees C. Accordingly, isoniazid inhibits competitively azide binding to Mt-trHbN(III) and Mt-trHbN(III)-catalyzed peroxynitrite isomerization. Moreover, isoniazid inhibits Mt-trHbN(II) oxygenation and carbonylation. Although the structure of the Mt-trHbN-isoniazid complex is not available, here we show by docking simulation that isoniazid binding to the heme-Fe atom indeed may take place. These data suggest a direct role of isoniazid to impair fundamental functions of mycobacteria, e.g. scavenging of reactive nitrogen and oxygen species, and metabolism.	[Ascenzi, Paolo; Cao, Yu; Leboffe, Loris] Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy; [Ascenzi, Paolo] CNR, Inst Prot Biochem, Naples, Italy; [Coletta, Andrea] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Trezza, Viviana; Leboffe, Loris] Univ Roma Tre, Dept Sci, Rome, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Struct & Funct Biol, Busto Arsizio, Varese, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Ctr Neurosci, Busto Arsizio, Varese, Italy; [Pesce, Alessandra] Univ Genoa, Dept Phys, Genoa, Italy; [Ciaccio, Chiara; Marini, Stefano; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Ciaccio, Chiara; Marini, Stefano; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy	Roma Tre University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Rome Tor Vergata; Italfarmaco; Roma Tre University; University of Insubria; University of Insubria; University of Genoa; University of Rome Tor Vergata	Ascenzi, P (corresponding author), Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy.	ascenzi@uniroma3.it	Marini, Stefano/B-1161-2012; Trezza, Viviana/K-4418-2016; Leboffe, Loris/K-7838-2016; Pesce, Alessandra/A-3660-2015; Coletta, Massimiliano/GSN-5927-2022; Fasano, Mauro/A-7100-2008; Coletta, Andrea/GXF-2972-2022; Coletta, Andrea/H-9856-2012; Coletta, Massimo/N-9049-2015	Marini, Stefano/0000-0003-1299-6696; Leboffe, Loris/0000-0001-8272-1896; Fasano, Mauro/0000-0003-0628-5871; Coletta, Andrea/0000-0003-4032-394X; COLETTA, Massimiliano/0000-0002-5489-9467	Ministry of Education, University and Research of Italy [PRIN-MIUR 200993WWF9]; University Roma Tre, Roma, Italy (CLAR)	Ministry of Education, University and Research of Italy(Ministry of Education, Universities and Research (MIUR)); University Roma Tre, Roma, Italy (CLAR)	This work was supported by the Ministry of Education, University and Research of Italy (PRIN-MIUR 200993WWF9 to MC) and the University Roma Tre, Roma, Italy (CLAR 2012 to PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao AO, 1998, ANN PHARMACOTHER, V32, P889, DOI 10.1345/aph.17377; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; [Anonymous], 2012, GEN ATOMIC MOL ELECT; [Anonymous], 2013, UCSF CHIM EXT MOL MO; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; ASCENZI P, 1987, BIOCHEM EDUC, V15, P134, DOI 10.1016/0307-4412(87)90043-4; Ascenzi P, 2008, METHOD ENZYMOL, V436, P317, DOI 10.1016/S0076-6879(08)36018-2; Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V415, P463, DOI 10.1016/j.bbrc.2011.10.094; Ascenzi P, 2011, J BIOL INORG CHEM, V16, P97, DOI 10.1007/s00775-010-0706-2; Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V404, P190, DOI 10.1016/j.bbrc.2010.11.091; Ascenzi P, 2010, IUBMB LIFE, V62, P776, DOI 10.1002/iub.381; Ascenzi P, 2009, J BIOL CHEM, V284, P31006, DOI 10.1074/jbc.M109.010736; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Blanchard JS, 1996, ANNU REV BIOCHEM, V65, P215, DOI 10.1146/annurev.bi.65.070196.001243; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Coker RJ, 2004, TROP MED INT HEALTH, V9, P25, DOI 10.1046/j.1365-3156.2003.01156.x; Cole ST, 2011, CURR OPIN MICROBIOL, V14, P570, DOI 10.1016/j.mib.2011.07.022; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; de Sanctis D, 2005, J BIOL CHEM, V280, P27222, DOI 10.1074/jbc.M503814200; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Desta Z, 2001, ANTIMICROB AGENTS CH, V45, P382, DOI 10.1128/AAC.45.2.382-392.2001; di Masi A, 2011, FEBS J, V278, P654, DOI 10.1111/j.1742-4658.2010.07986.x; Di Perri G, 2004, J ANTIMICROB CHEMOTH, V54, P593, DOI 10.1093/jac/dkh377; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; du Toit LC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-118; Fenner L, 2012, ANTIMICROB AGENTS CH, V56, P3047, DOI 10.1128/AAC.06460-11; Furin J, 2007, CURR OPIN PULM MED, V13, P212, DOI 10.1097/MCP.0b013e3280f3c0b2; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; GIBSON QH, 1986, J BIOL CHEM, V261, P228; Gumbo T, 2011, GOODMAN GILMANS PHAR; Gupta S, 2011, IUBMB LIFE, V63, P337, DOI 10.1002/iub.460; Herold S, 2004, J AM CHEM SOC, V126, P6945, DOI 10.1021/ja0493300; Herold S, 2003, BIOCHEMISTRY-US, V42, P14036, DOI 10.1021/bi0350349; Hussain T, 2007, CRIT REV MICROBIOL, V33, P15, DOI 10.1080/10408410601172271; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; JOSHI VG, 1976, DIS NERV SYST, V37, P106; Kass JS, 2010, CNS DRUGS, V24, P655, DOI 10.2165/11534340-000000000-00000; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lee ASG, 2001, ANTIMICROB AGENTS CH, V45, P2157, DOI 10.1128/AAC.45.7.2157-2159.2001; Leung ETY, 2006, ANTIMICROB AGENTS CH, V50, P1075, DOI 10.1128/AAC.50.3.1075-1078.2006; LIONETTI C, 1991, J MOL BIOL, V217, P409, DOI 10.1016/0022-2836(91)90744-Q; Lopez-Munoz F, 2007, J CLIN PSYCHOPHARM, V27, P555, DOI 10.1097/jcp.0b013e3181bb617; Lopez-Munoz F, 2009, CURR PHARM DESIGN, V15, P1563, DOI 10.2174/138161209788168001; Medical Economics, 2004, DRUG INF HLTH CAR PR, P1689; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; Miesel L, 1998, J BACTERIOL, V180, P2459, DOI 10.1128/JB.180.9.2459-2467.1998; Milani M, 2004, BIOCHEMISTRY-US, V43, P5213, DOI 10.1021/bi049870+; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Milani M, 2003, IUBMB LIFE, V55, P623, DOI 10.1080/15216540310001628708; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mitchison DA, 2005, EUR RESPIR J, V25, P376, DOI 10.1183/09031936.05.00075704; Mitchison Denis A, 2012, Handb Exp Pharmacol, P87, DOI 10.1007/978-3-642-28951-4_6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Nguyen L, 2009, ANNU REV PHARMACOL, V49, P427, DOI 10.1146/annurev-pharmtox-061008-103123; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pasipanodya JG, 2011, CURR OPIN PHARMACOL, V11, P457, DOI 10.1016/j.coph.2011.07.001; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PLETSCHER A, 1991, EXPERIENTIA, V47, P4, DOI 10.1007/BF02041242; Polasek TM, 2006, BRIT J CLIN PHARMACO, V61, P570, DOI 10.1111/j.1365-2125.2006.02627.x; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Potter B, 2005, AM FAM PHYSICIAN, V72, P2225; Prasad R, 2008, ANN THORAC MED, V3, P149, DOI 10.4103/1817-1737.43083; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrestha S, 2009, PSYCHOSOMATICS, V50, P640, DOI 10.1176/appi.psy.50.6.640-a; Sharma SK, 2004, INDIAN J MED RES, V120, P354; Shi R, 2007, MINI-REV MED CHEM, V7, P1177, DOI 10.2174/138955707782331740; Singh AK, 2010, J BIOL CHEM, V285, P1569, DOI 10.1074/jbc.M109.060327; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; Timmins GS, 2004, J BACTERIOL, V186, P5427, DOI 10.1128/JB.186.16.5427-5431.2004; Timmins GS, 2004, ANTIMICROB AGENTS CH, V48, P3006, DOI 10.1128/AAC.48.8.3006-3009.2004; Tripathi RP, 2012, CURR MED CHEM, V19, P488; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Wen X, 2002, EUR J CLIN PHARMACOL, V57, P799, DOI 10.1007/s00228-001-0396-3; Witkowski AE, 2007, GEN HOSP PSYCHIAT, V29, P85, DOI 10.1016/j.genhosppsych.2006.10.010; Wu GH, 2003, ADV MICROB PHYSIOL, V47, P255, DOI 10.1016/S0065-2911(03)47005-7; Zhao XB, 2007, BIOCHEMISTRY-US, V46, P3161, DOI 10.1021/bi062218p; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894; Zumla A, 2012, NAT REV DRUG DISCOV, V11, P170, DOI 10.1038/nrd3694	86	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69762	10.1371/journal.pone.0069762	http://dx.doi.org/10.1371/journal.pone.0069762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936350	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400022
J	Huang, J; Wang, SP; Jia, SW; Mo, DY; Chen, HC				Huang, Jian; Wang, Suiping; Jia, Shiwei; Mo, Deyuan; Chen, Hsuan-Chih			Cortical Dynamics of Semantic Processing during Sentence Comprehension: Evidence from Event-Related Optical Signals	PLOS ONE			English	Article							DEPTH-RECORDED POTENTIALS; INFERIOR FRONTAL GYRUS; MEDIAL TEMPORAL-LOBE; BRAIN ACTIVATION; WORD RECOGNITION; SPATIOTEMPORAL STAGES; LANGUAGE NETWORK; FIELD POTENTIALS; FUNCTIONAL MRI; EYE-MOVEMENTS	Using the event-related optical signal (EROS) technique, this study investigated the dynamics of semantic brain activation during sentence comprehension. Participants read sentences constituent-by-constituent and made a semantic judgment at the end of each sentence. The EROSs were recorded simultaneously with ERPs and time-locked to expected or unexpected sentence-final target words. The unexpected words evoked a larger N400 and a late positivity than the expected ones. Critically, the EROS results revealed activations first in the left posterior middle temporal gyrus (LpMTG) between 128 and 192 ms, then in the left anterior inferior frontal gyrus (LaIFG), the left middle frontal gyrus (LMFG), and the LpMTG in the N400 time window, and finally in the left posterior inferior frontal gyrus (LpIFG) between 832 and 864 ms. Also, expected words elicited greater activation than unexpected words in the left anterior temporal lobe (LATL) between 192 and 256 ms. These results suggest that the early lexical-semantic retrieval reflected by the LpMTG activation is followed by two different semantic integration processes: a relatively rapid and transient integration in the LATL and a relatively slow but enduring integration in the LaIFG/LMFG and the LpMTG. The late activation in the LpIFG, however, may reflect cognitive control.	[Huang, Jian; Wang, Suiping] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Huang, Jian; Wang, Suiping] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Huang, Jian; Wang, Suiping] S China Normal Univ, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Huang, Jian; Jia, Shiwei; Mo, Deyuan; Chen, Hsuan-Chih] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China	South China Normal University; South China Normal University; South China Normal University; Chinese University of Hong Kong	Wang, SP (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	suipingscnu@gmail.com; hcchen@psy.cuhk.edu.hk		Wang, Suiping/0000-0001-8726-169X	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK441008, 441811]; Science Foundation of China [NSF 31271086, NSF 30970894]; Guandong Province Universities and Colleges Pearl River Scheme	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guandong Province Universities and Colleges Pearl River Scheme	This work was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (CUHK441008 and 441811) to Hsuan-Chih Chen, and by grants from the Science Foundation of China (NSF 31271086 and NSF 30970894), Guandong Province Universities and Colleges Pearl River Scheme (GDUPS 2011) to Suiping Wang. The funders had no role in study design, data collection and analysis, design to publish, or preparation of the manuscript.	Baggio G, 2011, LANG COGNITIVE PROC, V26, P1338, DOI 10.1080/01690965.2010.542671; Bavelier D, 1997, J COGNITIVE NEUROSCI, V9, P664, DOI 10.1162/jocn.1997.9.5.664; Bemis DK, 2011, J NEUROSCI, V31, P2801, DOI 10.1523/JNEUROSCI.5003-10.2011; Binder JR, 2011, NEUROIMAGE, V54, P1465, DOI 10.1016/j.neuroimage.2010.09.048; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; BOTTINI G, 1994, BRAIN, V117, P1241, DOI 10.1093/brain/117.6.1241; Chee MWL, 1999, NEURON, V23, P127, DOI 10.1016/S0896-6273(00)80759-X; Dambacher M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005047; Delong KA, 2011, PSYCHOPHYSIOLOGY, V48, P1203, DOI 10.1111/j.1469-8986.2011.01199.x; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Federmeier KD, 2007, BRAIN RES, V1146, P75, DOI 10.1016/j.brainres.2006.06.101; Federmeier KD, 1999, COGNITIVE BRAIN RES, V8, P373, DOI 10.1016/S0926-6410(99)00036-1; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friederici AD, 2006, CEREB CORTEX, V16, P1709, DOI 10.1093/cercor/bhj106; Gratton G, 2000, PSYCHOPHYSIOLOGY, V37, pS44; GRATTON G, 1995, PSYCHOPHYSIOLOGY, V32, P292, DOI 10.1111/j.1469-8986.1995.tb02958.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GRATTON G, 1995, PSYCHOPHYSIOLOGY, V32, P505, DOI 10.1111/j.1469-8986.1995.tb02102.x; Gratton G, 2006, NEUROIMAGE, V32, P1576, DOI 10.1016/j.neuroimage.2006.05.030; Gratton G, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00052; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P., 2009, COGNITIVE NEUROSCIEN, V4th, P819, DOI [10.1002/int.4550070108, DOI 10.1002/INT.4550070108]; Hagoort P., 1999, NEUROCOGNITION LANGU, P273, DOI DOI 10.1093/ACPROF:OSO/9780198507932.001.0001; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Huang J, 2012, BRAIN RES, V1440, P56, DOI 10.1016/j.brainres.2011.11.060; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries C, 2001, NEUROREPORT, V12, P1749, DOI 10.1097/00001756-200106130-00046; Humphries C, 2007, NEUROIMAGE, V36, P924, DOI 10.1016/j.neuroimage.2007.03.059; Indefrey P, 2001, NEUROIMAGE, V14, P546, DOI 10.1006/nimg.2001.0867; Inouchi M, 2005, NEUROSCI LETT, V380, P116, DOI 10.1016/j.neulet.2005.01.033; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Kim A, 2012, J COGNITIVE NEUROSCI, V24, P1104, DOI 10.1162/jocn_a_00148; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kuperberg GR, 2008, NEUROIMAGE, V40, P367, DOI 10.1016/j.neuroimage.2007.10.009; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kwon H, 2005, NEUROSCI RES, V51, P349, DOI 10.1016/j.neures.2004.12.017; Lau E, 2009, BRAIN LANG, V111, P161, DOI 10.1016/j.bandl.2009.08.007; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; LEVELT WJM, 1992, COGNITION, V42, P1, DOI 10.1016/0010-0277(92)90038-J; Liu Y, 1990, MODERN FREQUENCY DIC; Luke KK, 2002, HUM BRAIN MAPP, V16, P133, DOI 10.1002/hbm.10029; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; MARSLENWILSON W, 1975, NATURE, V257, P784, DOI 10.1038/257784a0; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; Meyer M, 2000, COGNITIVE BRAIN RES, V9, P19, DOI 10.1016/S0926-6410(99)00039-7; Mo L, 2005, HUM BRAIN MAPP, V24, P305, DOI 10.1002/hbm.20091; Mummery CJ, 1999, NEUROIMAGE, V9, P516, DOI 10.1006/nimg.1999.0434; Nakajima T, 2001, NEUROIMAGE, V13, pS575; NOBRE AC, 1995, J NEUROSCI, V15, P1090; NORRIS D, 1994, COGNITION, V52, P189, DOI 10.1016/0010-0277(94)90043-4; Obleser J, 2011, NEUROIMAGE, V56, P2310, DOI 10.1016/j.neuroimage.2011.03.035; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2007, HDB PSYCHOLINGISTICS; Pylkkanen L, 2007, J COGNITIVE NEUROSCI, V19, P1905, DOI 10.1162/jocn.2007.19.11.1905; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rossell SL, 2001, NEUROPSYCHOLOGIA, V39, P1167, DOI 10.1016/S0028-3932(01)00049-5; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; Sereno SC, 2003, TRENDS COGN SCI, V7, P489, DOI 10.1016/j.tics.2003.09.010; Simos PG, 1997, BRAIN RES, V762, P29, DOI 10.1016/S0006-8993(97)00349-1; Stowe LA, 1998, NEUROREPORT, V9, P2995, DOI 10.1097/00001756-199809140-00014; Talairach J., 1988, COPLANAR STEREOTAXIC; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tan LH, 2000, HUM BRAIN MAPP, V10, P16; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; Tse CY, 2007, P NATL ACAD SCI USA, V104, P17157, DOI 10.1073/pnas.0707901104; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; Vandenberghe R, 2002, J COGNITIVE NEUROSCI, V14, P550, DOI 10.1162/08989290260045800; Visser M, 2010, J COGNITIVE NEUROSCI, V22, P1083, DOI 10.1162/jocn.2009.21309; Wang L, 2012, HUM BRAIN MAPP, V33, P2898, DOI 10.1002/hbm.21410; Wang SP, 2008, NEUROPSYCHOLOGIA, V46, P1371, DOI 10.1016/j.neuropsychologia.2007.12.020; Wolf U, 2000, OSA TRENDS OPT PHOTO, V38, P427; Ye Z, 2008, BRAIN RES, V1203, P103, DOI 10.1016/j.brainres.2008.01.090; Ye Z, 2009, NEUROSCI BIOBEHAV R, V33, P1168, DOI 10.1016/j.neubiorev.2009.03.003; Zhang JX, 2003, NEUROIMAGE, V20, P1531, DOI 10.1016/j.neuroimage.2003.07.016; Zhu ZD, 2012, NEUROIMAGE, V60, P2230, DOI 10.1016/j.neuroimage.2012.02.036; Zhu ZD, 2009, NEUROIMAGE, V47, P756, DOI 10.1016/j.neuroimage.2009.04.086	94	5	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70671	10.1371/journal.pone.0070671	http://dx.doi.org/10.1371/journal.pone.0070671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219PB	23936464	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400081
J	Neufeld, T; Ludwig, B; Barkai, U; Weir, GC; Colton, CK; Evron, Y; Balyura, M; Yavriyants, K; Zimermann, B; Azarov, D; Maimon, S; Shabtay, N; Rozenshtein, T; Lorber, D; Steffen, A; Willenz, U; Bloch, K; Vardi, P; Taube, R; de Vos, P; Lewis, EC; Bornstein, SR; Rotem, A				Neufeld, Tova; Ludwig, Barbara; Barkai, Uriel; Weir, Gordon C.; Colton, Clark K.; Evron, Yoav; Balyura, Maria; Yavriyants, Karina; Zimermann, Baruch; Azarov, Dmitri; Maimon, Shiri; Shabtay, Noa; Rozenshtein, Tania; Lorber, Dana; Steffen, Anja; Willenz, Udi; Bloch, Konstantine; Vardi, Pnina; Taube, Ran; de Vos, Paul; Lewis, Eli C.; Bornstein, Stefan R.; Rotem, Avi			The Efficacy of an Immunoisolating Membrane System for Islet Xenotransplantation in Minipigs	PLOS ONE			English	Article							PIG ISLETS; EDMONTON PROTOCOL; PANCREATIC-ISLETS; BLOOD-FLOW; TRANSPLANTATION; PRIMATES; IMMUNOSUPPRESSION; SURVIVAL; MONKEYS; GROWTH	Developing a device that protects xenogeneic islets to allow treatment and potentially cure of diabetes in large mammals has been a major challenge in the past decade. Using xenogeneic islets for transplantation is required in light of donor shortage and the large number of diabetic patients that qualify for islet transplantation. Until now, however, host immunoreactivity against the xenogeneic graft has been a major drawback for the use of porcine islets. Our study demonstrates the applicability of a novel immunoprotective membrane that allows successful xenotransplantation of rat islets in diabetic minipigs without immunosuppressive therapy. Rat pancreatic islets were encapsulated in highly purified alginate and integrated into a plastic macrochamber covered by a poly-membrane for subcutaneous transplantation. Diabetic Sinclair pigs were transplanted and followed for up to 90 days. We demonstrated a persistent graft function and restoration of normoglycemia without the need for immunosuppressive therapy. This concept could potentially offer an attractive strategy for a more widespread islet replacement therapy that would restore endogenous insulin secretion in diabetic patients without the need for immunosuppressive drugs and may even open up an avenue for safe utilization of xenogeneic islet donors.	[Neufeld, Tova; Evron, Yoav; Zimermann, Baruch; Azarov, Dmitri; Maimon, Shiri; Lorber, Dana; Rotem, Avi] Beta O2 Technol, Dept Technol, Rosh Haayin, Israel; [Ludwig, Barbara; Barkai, Uriel; Balyura, Maria; Steffen, Anja; Bornstein, Stefan R.] Univ Hosp Carl Gustav Carus, Dept Med 3, Dresden, Germany; [Barkai, Uriel; Balyura, Maria; Yavriyants, Karina; Shabtay, Noa; Rozenshtein, Tania] Beta O2 Technol, Islet Dept, Rosh Haayin, Israel; [Weir, Gordon C.] Joslin Diabet Ctr, Sect Islet Trasnplantat & Cell Biol, Boston, MA 02215 USA; [Colton, Clark K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Willenz, Udi] Lahav Res Inst, Vet Dept, Lahav, Israel; [Bloch, Konstantine; Vardi, Pnina] Tel Aviv Univ, Fac Med, Diabet & Obes Res Lab, IL-49100 Petah Tiqwa, Israel; [Taube, Ran] Ben Gurion Univ Negev, Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9713 AV Groningen, Netherlands; [Lewis, Eli C.] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Harvard University; Joslin Diabetes Center, Inc.; Massachusetts Institute of Technology (MIT); Tel Aviv University; Ben Gurion University; University of Groningen; Ben Gurion University	Weir, GC (corresponding author), Joslin Diabet Ctr, Sect Islet Trasnplantat & Cell Biol, Boston, MA 02215 USA.	gordon.weir@joslin.harvard.edu	TAUBE, RAN/F-2029-2012; Barkai, Uriel/I-6316-2019; de Vos, Paul/A-3170-2013; LEWIS, ELI C/F-1552-2012	TAUBE, RAN/0000-0002-2062-4537; LEWIS, ELI C/0000-0002-4189-2207; de vos, paul/0000-0001-9618-2408	Beta-O2; Deutsche Forschungsgemeinschaft [SFB TRR 127, BR 1179, KFO 252]; Dresden Centre of Excellence; Centre for Regenerative Therapies Dresden; Paul Langerhans Institute Dresden - The German Center for Diabetes Research	Beta-O2; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dresden Centre of Excellence; Centre for Regenerative Therapies Dresden; Paul Langerhans Institute Dresden - The German Center for Diabetes Research	This work was funded by Beta-O2 (http://www.beta-o2.com/), the Deutsche Forschungsgemeinschaft grants (http://www.dfg.de/en/) SFB TRR 127 "Biology of xenogeneic cell, tissue and organ transplantation" (to BL, SRB), BR 1179 (to BL), and KFO 252 (to BL, SRB), Dresden Centre of Excellence (http://ccoe-dresden.de/), Centre for Regenerative Therapies Dresden (http://www.crt-dresden.de/), Paul Langerhans Institute Dresden - The German Center for Diabetes Research (http://www.dzd-ev.de/en). The funders (except for Beta-O2) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beta-O2 had a role in study design, data collection, and analysis.	Barkai U, 2013, CELL TRANSPLANT, V22, P1463, DOI 10.3727/096368912X657341; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Barton FB, 2009, CELL TRANSPLANT, V18, P753, DOI 10.3727/096368909X470874; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; COOPER DKC, 1994, TRANSPLANT P, V26, P1331; Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20; Dufrane D, 2010, TRANSPLANTATION, V90, P1054, DOI 10.1097/TP.0b013e3181f6e267; Dulong JL, 2007, BIOTECHNOL BIOENG, V96, P990, DOI 10.1002/bit.21140; Elliott RB, 2005, TRANSPL P, V37, P466, DOI 10.1016/j.transproceed.2004.12.198; Gray DWR, 2001, ANN NY ACAD SCI, V944, P226; Gray DWR, 1997, BRIT MED BULL, V53, P777; Hyder A, 2005, TOXICOL IN VITRO, V19, P541, DOI 10.1016/j.tiv.2005.01.005; Jansson L, 2005, EUR J ENDOCRINOL, V153, P345, DOI 10.1530/eje.1.01966; JANSSON L, 1994, DIABETES METAB REV, V10, P407, DOI 10.1002/dmr.5610100405; Komoda H, 2004, XENOTRANSPLANTATION, V11, P237, DOI 10.1111/j.1399-3089.2004.00121.x; Kuzmina A, 2012, VIROLOGY, V426, P152, DOI 10.1016/j.virol.2012.01.033; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; Ludwig B, 2010, HORM METAB RES, V42, P918, DOI 10.1055/s-0030-1267916; Ludwig B, 2010, CURR DIABETES REP, V10, P506, DOI 10.1007/s11892-010-0146-y; Ludwig B, 2010, P NATL ACAD SCI USA, V107, P12623, DOI 10.1073/pnas.1005098107; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Specke V, 2009, XENOTRANSPLANTATION, V16, P34, DOI 10.1111/j.1399-3089.2009.00508.x; Storrs R, 2001, ANN NY ACAD SCI, V944, P252; Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929; Tam SK, 2009, J BIOMED MATER RES A, V89A, P609, DOI 10.1002/jbm.a.32002; Thompson DM, 2011, TRANSPLANTATION, V91, P373, DOI 10.1097/TP.0b013e31820437f3	28	76	80	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70150	10.1371/journal.pone.0070150	http://dx.doi.org/10.1371/journal.pone.0070150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936385	Green Published, gold			2022-12-27	WOS:000324518400039
J	Gil, LAF; da Cunha, CEP; Moreira, GMSG; Salvarani, FM; Assis, RA; Lobato, FCF; Mendonca, M; Dellagostin, OA; Conceicao, FR				Gil, Luciana A. F.; da Cunha, Carlos Eduardo P.; Moreira, Gustavo M. S. G.; Salvarani, Felipe M.; Assis, Ronnie A.; Lobato, Francisco Carlos F.; Mendonca, Marcelo; Dellagostin, Odir A.; Conceicao, Fabricio R.			Production and Evaluation of a Recombinant Chimeric Vaccine against Clostridium botulinum Neurotoxin Types C and D	PLOS ONE			English	Article							TOXIN B-SUBUNIT; HEAT-LABILE ENTEROTOXIN; CHOLERA-TOXIN; IMMUNE-RESPONSE; CATTLE; EXPRESSION; PROTECTION; SEROTYPE	Bovine botulism is a fatal disease that is caused by botulinum neurotoxins (BoNTs) produced by Clostridium botulinum serotypes C and D and that causes great economic losses, with nearly 100% lethality during outbreaks. It has also been considered a potential source of human food-borne illness in many countries. Vaccination has been reported to be the most effective way to control bovine botulism. However, the commercially available toxoid-based vaccines are difficult and hazardous to produce. Neutralizing antibodies targeted against the C-terminal fragment of the BoNT heavy chain (H-C) are known to confer efficient protection against lethal doses of BoNTs. In this study, a novel recombinant chimera, consisting of Escherichia coli heat-labile enterotoxin B subunit (LTB), a strong adjuvant of the humoral immune response, fused to the H-C of BoNT serotypes C and D, was produced in E. coli. Mice vaccinated with the chimera containing LTB and an equivalent molar ratio of the chimera without LTB plus aluminum hydroxide (Al(OH)(3)) developed 2 IU/mL of antitoxins for both serotypes. Guinea pigs immunized with the recombinant chimera with LTB plus Al(OH)(3) developed a protective immune response against both BoNT/C (5 IU/mL) and BoNT/D (10 IU/mL), as determined by a mouse neutralization bioassay with pooled sera. The results achieved with guinea pig sera fulfilled the requirements of commercial vaccines for prevention of botulism, as determined by the Brazilian Ministry of Agriculture, Livestock and Food, Supply. The presence of LTB was essential for the development of a strong humoral immune response, as it acted in synergism with Al(OH)(3). Thus, the vaccine described in this study is a strong candidate for the control of botulism in cattle.	[Gil, Luciana A. F.] Univ Fed Pelotas, Fac Vet, Pelotas, RS, Brazil; [da Cunha, Carlos Eduardo P.; Moreira, Gustavo M. S. G.; Mendonca, Marcelo; Dellagostin, Odir A.; Conceicao, Fabricio R.] Univ Fed Pelotas, Nucleo Biotecnol, Ctr Desenvolvimento Tecnol, Pelotas, RS, Brazil; [Salvarani, Felipe M.; Assis, Ronnie A.; Lobato, Francisco Carlos F.] Univ Fed Minas Gerais, Escola Vet, Belo Horizonte, MG, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Minas Gerais	Conceicao, FR (corresponding author), Univ Fed Pelotas, Nucleo Biotecnol, Ctr Desenvolvimento Tecnol, Pelotas, RS, Brazil.	fabricio.rochedo@ufpel.edu.br	Dellagostin, Odir/C-2331-2009; Salvarani, Felipe Masiero/AAE-5290-2022; Mendonça, Marcelo MM/I-6435-2013	Dellagostin, Odir/0000-0003-2803-4088; Salvarani, Felipe Masiero/0000-0002-7711-6437; Mendonça, Marcelo MM/0000-0001-7415-457X; , ronnie antunes de assis/0000-0001-9538-8594	CNPq [5.05.02.00-0]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CNPq (project 5.05.02.00-0), http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 1998, NAT BIOTECHNOL, V16, P934, DOI 10.1038/nbt1098-934; Arimitsu H, 2004, CLIN DIAGN LAB IMMUN, V11, P496, DOI 10.1128/CDLI.11.3.496-502.2004; Baldwin MR, 2008, INFECT IMMUN, V76, P1314, DOI 10.1128/IAI.01025-07; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Bie CQ, 2010, WORLD J HEPATOL, V2, P185, DOI 10.4254/wjh.v2.i5.185; Bohnel H, 2005, VET J, V169, P124, DOI 10.1016/j.tvjl.2004.01.006; Byrne MP, 2000, BIOCHIMIE, V82, P955, DOI 10.1016/S0300-9084(00)01173-1; da Costa GM, 2008, CIENC RURAL, V38, P2068, DOI 10.1590/S0103-84782008000700045; da Hora VP, 2011, VACCINE, V29, P1538, DOI 10.1016/j.vaccine.2010.11.091; Dang ZS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001842; DOBEREINER J, 1992, DEUT TIERARZTL WOCH, V99, P188; Dutra IS, 2005, PESQUISA VET BRASIL, V25, P115, DOI 10.1590/S0100-736X2005000200009; Dutra IS, 2001, PESQUISA VET BRASIL, V21, P43, DOI 10.1590/S0100-736X2001000200002; Dux MP, 2011, PROTEIN EXPRES PURIF, V75, P177, DOI 10.1016/j.pep.2010.09.016; Lobato FCF, 2008, CIENC RURAL, V38, P1176, DOI 10.1590/S0103-84782008000400046; Fischer G, 2010, WORLD J MICROB BIOT, V26, P489, DOI 10.1007/s11274-009-0195-z; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Gelzleichter TR, 1999, J APPL TOXICOL, V19, pS35, DOI 10.1002/(SICI)1099-1263(199912)19:1+<S35::AID-JAT612>3.0.CO;2-9; George-Chandy A, 2001, INFECT IMMUN, V69, P5716, DOI 10.1128/IAI.69.9.5716-5725.2001; Grassmann AA, 2012, CLIN VACCINE IMMUNOL, V19, P740, DOI 10.1128/CVI.05720-11; Hakami RM, 2010, TRENDS MICROBIOL, V18, P164, DOI 10.1016/j.tim.2010.02.001; Henkel JS, 2011, VACCINE, V29, P7688, DOI 10.1016/j.vaccine.2011.07.134; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; Hunter RL, 2002, VACCINE, V20, pS7, DOI 10.1016/S0264-410X(02)00164-0; Lee JC, 2007, MICROBIOL IMMUNOL, V51, P445, DOI 10.1111/j.1348-0421.2007.tb03919.x; Liljeqvist S, 1997, J IMMUNOL METHODS, V210, P125, DOI 10.1016/S0022-1759(97)00170-1; Livesey CT, 2004, VET REC, V154, P734; Maboni Franciele, 2010, Ciencia Animal Brasileira, V11, P962; Mansour AA, 2010, BIOLOGICALS, V38, P260, DOI 10.1016/j.biologicals.2009.09.008; Menezes Marcio A, 2011, BMC Res Notes, V4, P30, DOI 10.1186/1756-0500-4-30; Payne JH, 2011, VET REC, V168, DOI 10.1136/vr.d1846; Petrovska L, 2003, VACCINE, V21, P1445, DOI 10.1016/S0264-410X(02)00696-5; Ravichandran E, 2007, INFECT IMMUN, V75, P3043, DOI 10.1128/IAI.01893-06; Conceicao FR, 2006, VACCINE, V24, P5734, DOI 10.1016/j.vaccine.2006.04.036; Sakamoto S, 2011, APPL BIOCHEM BIOTECH, V164, P715, DOI 10.1007/s12010-011-9168-4; Sakamoto S, 2011, PROTEIN EXPRES PURIF, V77, P124, DOI 10.1016/j.pep.2011.01.010; Sambrook J., 2001, MOL CLONING; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Shone C, 2009, INFECT IMMUN, V77, P2795, DOI 10.1128/IAI.01252-08; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Skrlj N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015783; Smith LA, 2009, VACCINE, V27, pD33, DOI 10.1016/j.vaccine.2009.08.059; Steinman A, 2007, VACCINE, V25, P7636, DOI 10.1016/j.vaccine.2007.08.051; Takeda M, 2006, J VET MED SCI, V68, P325, DOI 10.1292/jvms.68.325; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Webb RP, 2007, VACCINE, V25, P4273, DOI 10.1016/j.vaccine.2007.02.081; Woodward LA, 2003, INFECT IMMUN, V71, P2941, DOI 10.1128/IAI.71.5.2941-2944.2003; Yari K, 2012, BIOPROC BIOSYST ENG, V35, P407, DOI 10.1007/s00449-011-0579-y; Yari K, 2010, BIOTECHNOL APPL BIOC, V56, P35, DOI 10.1042/BA20090315; Yu YZ, 2009, VACCINE, V27, P2816, DOI 10.1016/j.vaccine.2009.02.091; Zeng J, 2011, VACCINE, V29, P5459, DOI 10.1016/j.vaccine.2011.05.059	51	31	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69692	10.1371/journal.pone.0069692	http://dx.doi.org/10.1371/journal.pone.0069692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936080	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700040
J	Jensen, G; Altschul, D; Danly, E; Terrace, H				Jensen, Greg; Altschul, Drew; Danly, Erin; Terrace, Herbert			Transfer of a Serial Representation between Two Distinct Tasks by Rhesus Macaques	PLOS ONE			English	Article							MONKEYS CEBUS-APELLA; TRANSITIVE INFERENCE PERFORMANCE; CONJUNCTIVE REPRESENTATIONS; PARIETAL CORTEX; LIST LINKING; HUMANS; NUMBER; ORDER; FLEXIBILITY; HIPPOCAMPUS	Do animals form task-specific representations, or do those representations take a general form that can be applied to qualitatively different tasks? Rhesus monkeys (Macaca mulatta) learned the ordering of stimulus lists using two different serial tasks, in order to test whether prior experience in each task could be transfered to the other, enhancing performance. The simultaneous chaining paradigm delivered rewards only after subjects responded in the correct order to all stimuli displayed on a touch sensitive video monitor. The transitive inference paradigm presented pairs of items and delivered rewards when subjects selected the item with the lower ordinal rank. After learning a list in one paradigm, subjects' knowledge of that list was tested using the other paradigm. Performance was enhanced from the very start of transfer training. Transitive inference performance was characterized by 'symbolic distance effects,' whereby the ordinal distance between stimuli in the implied list ordering was strongly predictive of the probability of a correct response. The patterns of error displayed by subjects in both tasks were best explained by a spatially coded representation of list items, regardless of which task was used to learn the list. Our analysis permits properties of this representation to be investigated without the confound of verbal reasoning.	[Jensen, Greg; Altschul, Drew; Danly, Erin; Terrace, Herbert] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Columbia University	Jensen, G (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	greg.guichard.jensen@gmail.com; terrace@columbia.edu		Jensen, Greg/0000-0001-5050-4360	National Institute of Mental Health (NIMH) [R01 MH051153]	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This grant was supported by National Institute of Mental Health (NIMH) grant R01 MH051153 awarded to HT. NIMH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond AB, 2010, BEHAV PROCESS, V85, P283, DOI 10.1016/j.beproc.2010.08.003; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; BOYSEN ST, 1993, J COMP PSYCHOL, V107, P208, DOI 10.1037/0735-7036.107.2.208; BRESLOW L, 1981, PSYCHOL BULL, V89, P325, DOI 10.1037/0033-2909.89.2.325; Chafee MV, 2007, CEREB CORTEX, V17, P2914, DOI 10.1093/cercor/bhm017; CHALMERS M, 1984, J EXP CHILD PSYCHOL, V37, P355, DOI 10.1016/0022-0965(84)90009-2; Chen SF, 1997, PSYCHOL SCI, V8, P80, DOI 10.1111/j.1467-9280.1997.tb00687.x; Cooper RP, 2006, PSYCHOL REV, V113, P887, DOI 10.1037/0033-295X.113.4.887; DAMATO MR, 1990, ANIM LEARN BEHAV, V18, P133, DOI 10.3758/BF03205250; DAMATO MR, 1988, J EXP PSYCHOL ANIM B, V14, P131, DOI 10.1037/0097-7403.14.2.131; Day SB, 2011, J EXP PSYCHOL LEARN, V37, P551, DOI 10.1037/a0022333; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Frank MJ, 2005, MEM COGNITION, V33, P742, DOI 10.3758/BF03195340; Frank MJ, 2003, HIPPOCAMPUS, V13, P341, DOI 10.1002/hipo.10084; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Gentner D, 2001, ANALOGICAL MIND PERS; Green CD, 2001, THEOR PSYCHOL, V11, P97, DOI 10.1177/0959354301111008; Gross WL, 2007, MEMORY, V15, P838, DOI 10.1080/09658210701715469; JACQUEZ JA, 1968, BIOMETRICS, V24, P607, DOI 10.2307/2528321; Judge PG, 2005, J EXP PSYCHOL-ANIM B, V31, P79, DOI 10.1037/0097-7403.31.1.79; Maclean EL, 2008, ANIM BEHAV, V76, P479, DOI 10.1016/j.anbehav.2008.01.025; MCGONIGLE BO, 1977, NATURE, V267, P694, DOI 10.1038/267694a0; Moses SN, 2006, NEUROPSYCHOLOGIA, V44, P1370, DOI 10.1016/j.neuropsychologia.2006.01.004; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; Prado J, 2013, CEREB CORTEX, V23, P499, DOI 10.1093/cercor/bhr389; Reid AK, 2009, J EXP PSYCHOL ANIM B, V35, P293, DOI 10.1037/a0013926; Scarf D, 2008, BRAIN RES BULL, V76, P307, DOI 10.1016/j.brainresbull.2008.02.022; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Terrace HS, 2005, TRENDS COGN SCI, V9, P202, DOI 10.1016/j.tics.2005.02.003; Terrace HS, 2003, PSYCHOL SCI, V14, P66, DOI 10.1111/1467-9280.01420; Terrace HS, 2012, COMP COGNITION, P615; Terrace HS, 1984, QUANTITATIVE ANAL BE, V4, P115; THURSTONE LL, 1919, PSYCHOL MONOGR, V26, P1; Treichler FR, 2007, J COMP PSYCHOL, V121, P250, DOI 10.1037/0735-7036.121.3.250; Treichler FR, 1996, J EXP PSYCHOL ANIM B, V22, P105, DOI 10.1037/0097-7403.22.1.105; Van Elzakker M, 2003, HIPPOCAMPUS, V13, P334, DOI 10.1002/hipo.10083; Vasconcelos M, 2008, BEHAV PROCESS, V78, P313, DOI 10.1016/j.beproc.2008.02.017; Wasserman EA, 2012, COMP COGNITION; Watanabe S, 2006, ANIM COGN, V9, P235, DOI 10.1007/s10071-006-0043-6; Wright BC, 2001, DEV REV, V21, P375, DOI 10.1006/drev.2000.0525; WYNNE CDL, 1995, ANIM LEARN BEHAV, V23, P207, DOI 10.3758/BF03199936; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	43	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70285	10.1371/journal.pone.0070285	http://dx.doi.org/10.1371/journal.pone.0070285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936179	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700063
J	Kashofer, K; Viertler, C; Pichler, M; Zatloukal, K				Kashofer, Karl; Viertler, Christian; Pichler, Martin; Zatloukal, Kurt			Quality Control of RNA Preservation and Extraction from Paraffin-Embedded Tissue: Implications for RT-PCR and Microarray Analysis	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; GENE-EXPRESSION ANALYSIS; IN-SITU HYBRIDIZATION; MESSENGER-RNA; REVERSE TRANSCRIPTION; FORMALIN-FIXATION; NUCLEIC-ACIDS; PROTEOMIC ANALYSIS; BREAST-CANCER; TIME	Analysis of RNA isolated from fixed and paraffin-embedded tissues is widely used in biomedical research and molecular pathological diagnostics. We have performed a comprehensive and systematic investigation of the impact of factors in the pre-analytical workflow, such as different fixatives, fixation time, RNA extraction method and storage of tissues in paraffin blocks, on several downstream reactions including complementary DNA (cDNA) synthesis, quantitative reverse transcription polymerase chain reaction (qRT-PCR) and microarray hybridization. We compared the effects of routine formalin fixation with the non-crosslinking, alcohol-based Tissue Tek Xpress Molecular Fixative (TTXMF, Sakura Finetek), and cryopreservation as gold standard for molecular analyses. Formalin fixation introduced major changes into microarray gene expression data and led to marked gene-to-gene variations in delta-ct values of qRT-PCR. We found that qRT-PCR efficiency and gene-to-gene variations were mainly attributed to differences in the efficiency of cDNA synthesis as the most sensitive step. These differences could not be reliably detected by quality assessment of total RNA isolated from formalin-fixed tissues by electrophoresis or spectrophotometry. Although RNA from TTXMF fixed samples was as fragmented as RNA from formalin fixed samples, much higher cDNA yield and lower ct-values were obtained in qRT-PCR underlining the negative impact of crosslinking by formalin. In order to better estimate the impact of pre-analytical procedures such as fixation on the reliability of downstream analysis, we applied a qRT-PCR-based assay using amplicons of different length and an assay measuring the efficiency of cDNA generation. Together these two assays allowed better quality assessment of RNA extracted from fixed and paraffin-embedded tissues and should be used to supplement quality scores derived from automated electrophoresis. A better standardization of the pre-analytical workflow, application of additional quality controls and detailed sample information would markedly improve the comparability and reliability of molecular studies based on formalin-fixed and paraffin-embedded tissue samples.	[Kashofer, Karl; Viertler, Christian; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Pichler, Martin] Med Univ Graz, Div Oncol, Graz, Austria	Medical University of Graz; Medical University of Graz	Zatloukal, K (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	kurt.zatloukal@medunigraz.at		Pichler, Martin/0000-0002-8701-9462	SPIDIA [222916]; Austrian Genome Program [J20964]	SPIDIA; Austrian Genome Program	This work was supported by the following grants: SPIDIA (222916) (http://www.spidia.eu/); Austrian Genome Program GEN-AU (J20964) http://www.gen-au. at/index.jsp?lang = en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REP CARCINOG BACKGR; Apple S, 2011, AM J CLIN PATHOL, V135, P592, DOI 10.1309/AJCPB1RIT5YXMRIS; Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; Benchekroun M, 2004, DIAGN MOL PATHOL, V13, P116, DOI 10.1097/00019606-200406000-00008; Buesa RJ, 2008, ANN DIAGN PATHOL, V12, P387, DOI 10.1016/j.anndiagpath.2008.07.004; Bussolati G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021043; Chung JY, 2006, DIAGN MOL PATHOL, V15, P229, DOI 10.1097/01.pdm.0000213468.91139.2d; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Dotti I, 2010, DIAGN MOL PATHOL, V19, P112, DOI 10.1097/PDM.0b013e3181b520f8; Ergin B, 2010, J PROTEOME RES, V9, P5188, DOI 10.1021/pr100664e; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Florell SR, 2001, MODERN PATHOL, V14, P116, DOI 10.1038/modpathol.3880267; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; Glenn ST, 2010, J BIOMOL SCREEN, V15, P80, DOI 10.1177/1087057109355059; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; Groelz D, 2013, EXP MOL PATHOL, V94, P188, DOI 10.1016/j.yexmp.2012.07.002; HELANDER KG, 1994, BIOTECH HISTOCHEM, V69, P177, DOI 10.3109/10520299409106282; Kap M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027704; Koch I, 2006, DIAGN MOL PATHOL, V15, P149, DOI 10.1097/01.pdm.0000213450.99655.54; Krafft AE, 1997, MOL DIAGN, V2, P217, DOI 10.1016/S1084-8592(97)80032-X; Libus J, 2006, BIOTECHNIQUES, V41, P156, DOI 10.2144/000112232; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Miyatake Y, 2004, EXP MOL PATHOL, V77, P222, DOI 10.1016/j.yexmp.2004.07.004; Moatamed NA, 2011, AM J CLIN PATHOL, V136, P754, DOI 10.1309/AJCP99WZGBPKCXOQ; Nardon E, 2009, EXP MOL PATHOL, V87, P146, DOI 10.1016/j.yexmp.2009.07.005; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Paska C, 2004, DIAGN MOL PATHOL, V13, P234, DOI 10.1097/01.pdm.0000134778.37729.9f; Penland SK, 2007, LAB INVEST, V87, P383, DOI 10.1038/labinvest.3700529; Sanchez-Navarro I, 2010, BIOTECHNIQUES, V48, P389, DOI 10.2144/000113388; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Stanta G, 2006, DIAGN MOL PATHOL, V15, P115, DOI 10.1097/00019606-200606000-00009; Viertler C, 2012, J MOL DIAGN, V14, P458, DOI 10.1016/j.jmoldx.2012.05.002; Vincek V, 2003, LAB INVEST, V83, P1427, DOI 10.1097/01.LAB.0000090154.55436.D1; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; von Smolinski D, 2005, HISTOCHEM CELL BIOL, V124, P177, DOI 10.1007/s00418-005-0013-0; WILKENS L, 1994, DIAGN MOL PATHOL, V3, P156, DOI 10.1097/00019606-199409000-00004	39	46	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70714	10.1371/journal.pone.0070714	http://dx.doi.org/10.1371/journal.pone.0070714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936242	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700081
J	Mo, XX; Shi, LL; Zhang, YJ; Zhu, H; Slik, JWF				Mo, Xiao-Xue; Shi, Ling-Ling; Zhang, Yong-Jiang; Zhu, Hua; Slik, J. W. Ferry			Change in Phylogenetic Community Structure during Succession of Traditionally Managed Tropical Rainforest in Southwest China	PLOS ONE			English	Article							SPECIES COMPOSITION; PLANT DIVERSITY; WOOD DENSITY; SEED PLANTS; DISTURBANCE; TREE; CONSERVATION; ECOLOGY; BIODIVERSITY; EVOLUTION	Tropical rainforests in Southeast Asia are facing increasing and ever more intense human disturbance that often negatively affects biodiversity. The aim of this study was to determine how tree species phylogenetic diversity is affected by traditional forest management types and to understand the change in community phylogenetic structure during succession. Four types of forests with different management histories were selected for this purpose: old growth forests, understorey planted old growth forests, old secondary forests (similar to 200-years after slash and burn), and young secondary forests (15-50- years after slash and burn). We found that tree phylogenetic community structure changed from clustering to over-dispersion from early to late successional forests and finally became random in old-growth forest. We also found that the phylogenetic structure of the tree overstorey and understorey responded differentially to change in environmental conditions during succession. In addition, we show that slash and burn agriculture (swidden cultivation) can increase landscape level plant community evolutionary information content.	[Mo, Xiao-Xue; Shi, Ling-Ling; Zhang, Yong-Jiang; Zhu, Hua; Slik, J. W. Ferry] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Mengla, Yunnan, Peoples R China; [Mo, Xiao-Xue; Shi, Ling-Ling; Zhang, Yong-Jiang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhang, Yong-Jiang] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Harvard University	Slik, JWF (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Mengla, Yunnan, Peoples R China.	ferryslik@hotmail.com	Hua, Zhu/AFO-6233-2022		Bundesministerium fur Bildung und Forschung [0330797A]; Chinese Academy of Science [KSCX2-YW-N-066]; National Natural Science Foundation of China [30770158];  [2007 DFA (91660-5)]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This study was supported by Grant 2007 DFA (91660-5), Bundesministerium fur Bildung und Forschung (0330797A), Chinese Academy of Science (KSCX2-YW-N-066), and The National Natural Science Foundation of China (30770158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Baker PJ, 2005, ECOL MONOGR, V75, P317, DOI 10.1890/04-0488; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Ding Y, 2012, OIKOS, V121, P1263, DOI 10.1111/j.1600-0706.2011.19992.x; Dinnage R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007071; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FAO, 2012, STAT WORLDS FOR; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lawrence D, 2004, ECOL APPL, V14, P1855, DOI 10.1890/03-5321; Letcher SG, 2012, PERSPECT PLANT ECOL, V14, P79, DOI 10.1016/j.ppees.2011.09.005; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mo XX, 2011, BIOL CONSERV, V144, P1832, DOI 10.1016/j.biocon.2011.03.019; Nipperess DA, 2012, ARXIV12086552; Norden N, 2012, ECOLOGY, V93, pS70, DOI 10.1890/10-2179.1; Shi JP, 2009, ECOL RES, V24, P83, DOI 10.1007/s11284-008-0484-2; Slik JWF, 2006, J TROP ECOL, V22, P481, DOI 10.1017/S0266467406003324; Slik JWF, 2008, CONSERV BIOL, V22, P1299, DOI 10.1111/j.1523-1739.2008.00986.x; Slik JWF, 2005, FOREST ECOL MANAG, V205, P241, DOI 10.1016/j.foreco.2004.10.011; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Whitfeld TJS, 2012, ECOGRAPHY, V35, P821, DOI 10.1111/j.1600-0587.2011.07181.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Zanne A. E., 2009, DRYAD DATA REPOSITOR; Zhu H, 2005, BIODIVERS CONSERV, V14, P2855, DOI 10.1007/s10531-004-8220-x; Ziegler AD, 2009, SCIENCE, V324, P1024, DOI 10.1126/science.1173833	41	21	24	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e71464	10.1371/journal.pone.0071464	http://dx.doi.org/10.1371/journal.pone.0071464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936268	Green Submitted, gold, Green Published			2022-12-27	WOS:000322633700085
J	Rubin, BER; Gibbons, SM; Kennedy, S; Hampton-Marcell, J; Owens, S; Gilbert, JA				Rubin, Benjamin E. R.; Gibbons, Sean M.; Kennedy, Suzanne; Hampton-Marcell, Jarrad; Owens, Sarah; Gilbert, Jack A.			Investigating the Impact of Storage Conditions on Microbial Community Composition in Soil Samples	PLOS ONE			English	Article							DNA; METAGENOMICS; EXTRACTION; POPULATIONS; GENERATION; DIVERSITY; PATTERNS	Recent advances in DNA sequencing technologies have allowed scientists to probe increasingly complex biological systems, including the diversity of bacteria in the environment. However, despite a multitude of recent studies incorporating these methods, many questions regarding how environmental samples should be collected and stored still persist. Here, we assess the impact of different soil storage conditions on microbial community composition using Illumina-based 16S rRNA V4 amplicon sequencing. Both storage time and temperature affected bacterial community composition and structure. Frozen samples maintained the highest alpha diversity and differed least in beta diversity, suggesting the utility of cold storage for maintaining consistent communities. Samples stored for intermediate times (three and seven days) had both the highest alpha diversity and the largest differences in overall beta diversity, showing the degree of community change after sample collection. These divergences notwithstanding, differences in neither storage time nor storage temperature substantially altered overall communities relative to more than 500 previously examined soil samples. These results systematically support previous studies and stress the importance of methodological consistency for accurate characterization and comparison of soil microbiological assemblages.	[Rubin, Benjamin E. R.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Rubin, Benjamin E. R.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Gibbons, Sean M.; Hampton-Marcell, Jarrad; Owens, Sarah; Gilbert, Jack A.] Argonne Natl Lab, Argonne, IL 60439 USA; [Gibbons, Sean M.] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA; [Kennedy, Suzanne] MO BIO Labs Inc, Carlsbad, CA USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago; Field Museum of Natural History (Chicago); United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago	Rubin, BER (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	brubin@fieldmuseum.org	Gibbons, Sean M./ABH-2562-2020; Gilbert, Jack/AAF-3270-2019	Gibbons, Sean M./0000-0002-8724-7916; 	U.S. National Science Foundation; U.S. Environmental Protection Agency STAR Graduate Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency STAR Graduate Fellowship(United States Environmental Protection Agency); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	BERR was supported by a U.S. National Science Foundation Graduate Research Fellowship. SMG was supported by a U.S. Environmental Protection Agency STAR Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Burgmann H, 2001, J MICROBIOL METH, V45, P7, DOI 10.1016/S0167-7012(01)00213-5; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Franklin RB, 2003, FEMS MICROBIOL ECOL, V44, P335, DOI 10.1016/S0168-6496(03)00074-6; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; Gilbert Jack A, 2011, Microb Inform Exp, V1, P5, DOI 10.1186/2042-5783-1-5; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Harry M, 2000, EUR J SOIL BIOL, V36, P51, DOI 10.1016/S1164-5563(00)00044-3; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; Molbak Lars, 2006, Current Issues in Intestinal Microbiology, V7, P29; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Nunan N, 2002, MICROBIAL ECOL, V44, P296, DOI 10.1007/s00248-002-2021-0; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Reddy BVB, 2012, APPL ENVIRON MICROB, V78, P3744, DOI 10.1128/AEM.00102-12; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rissanen AJ, 2010, APPL MICROBIOL BIOT, V88, P977, DOI 10.1007/s00253-010-2838-2; Robe P, 2003, EUR J SOIL BIOL, V39, P183, DOI 10.1016/S1164-5563(03)00033-5; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394	32	83	86	3	158	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70460	10.1371/journal.pone.0070460	http://dx.doi.org/10.1371/journal.pone.0070460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936206	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700074
J	Solis, GP; Radon, Y; Sempou, E; Jechow, K; Stuermer, CAO; Malaga-Trillo, E				Solis, Gonzalo P.; Radon, Yvonne; Sempou, Emily; Jechow, Katharina; Stuermer, Claudia A. O.; Malaga-Trillo, Edward			Conserved Roles of the Prion Protein Domains on Subcellular Localization and Cell-Cell Adhesion	PLOS ONE			English	Article							SCRAPIE-LIKE PROPERTIES; PRP KNOCKOUT MICE; E-CADHERIN; NEURITE OUTGROWTH; TRANSGENIC MICE; CULTURED-CELLS; TRUNCATED PRP; EXPRESSION; TRAFFICKING; GLYCOSYLATION	Analyses of cultured cells and transgenic mice expressing prion protein (PrP) deletion mutants have revealed that some properties of PrP -such as its ability to misfold, aggregate and trigger neurotoxicity- are controlled by discrete molecular determinants within its protein domains. Although the contributions of these determinants to PrP biosynthesis and turnover are relatively well characterized, it is still unclear how they modulate cellular functions of PrP. To address this question, we used two defined activities of PrP as functional readouts: 1) the recruitment of PrP to cell-cell contacts in Drosophila S2 and human MCF-7 epithelial cells, and 2) the induction of PrP embryonic loss- and gain-of-function phenotypes in zebrafish. Our results show that homologous mutations in mouse and zebrafish PrPs similarly affect their subcellular localization patterns as well as their in vitro and in vivo activities. Among PrP's essential features, the N-terminal leader peptide was sufficient to drive targeting of our constructs to cell contact sites, whereas lack of GPI-anchoring and N-glycosylation rendered them inactive by blocking their cell surface expression. Importantly, our data suggest that the ability of PrP to homophilically trans-interact and elicit intracellular signaling is primarily encoded in its globular domain, and modulated by its repetitive domain. Thus, while the latter induces the local accumulation of PrPs at discrete punctae along cell contacts, the former counteracts this effect by promoting the continuous distribution of PrP. In early zebrafish embryos, deletion of either domain significantly impaired PrP's ability to modulate E-cadherin cell adhesion. Altogether, these experiments relate structural features of PrP to its subcellular distribution and in vivo activity. Furthermore, they show that despite their large evolutionary history, the roles of PrP domains and posttranslational modifications are conserved between mouse and zebrafish.	[Solis, Gonzalo P.; Radon, Yvonne; Sempou, Emily; Jechow, Katharina; Stuermer, Claudia A. O.; Malaga-Trillo, Edward] Univ Konstanz, Dept Biol, Constance, Germany	University of Konstanz	Malaga-Trillo, E (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	Edward.Malaga@uni-konstanz.de		Solis, Gonzalo P./0000-0002-2359-3780	German Research Foundation (DFG) [MA 2525/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG grant MA 2525/2-1 to EMT, and other grants to CAOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bodrikov V, 2011, J NEUROSCI, V31, P18013, DOI 10.1523/JNEUROSCI.4729-11.2011; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Cancellotti E, 2005, J BIOL CHEM, V280, P42909, DOI 10.1074/jbc.M509557200; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Chesebro B, 2005, J NEUROVIROL, V11, P476, DOI 10.1080/13550280500187583; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Flechsig E, 2003, EMBO J, V22, P3095, DOI 10.1093/emboj/cdg285; FRIXEN UH, 1993, CANCER RES, V53, P3618; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Hundt C, 2003, BIOL CHEM, V384, P791, DOI 10.1515/BC.2003.088; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Kim SJ, 2001, J BIOL CHEM, V276, P26132, DOI 10.1074/jbc.M101638200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Korth C, 2000, J GEN VIROL, V81, P2555, DOI 10.1099/0022-1317-81-10-2555; Le Pichon CE, 2009, NAT NEUROSCI, V12, P60, DOI 10.1038/nn.2238; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Li AM, 2007, EMBO J, V26, P2777, DOI 10.1038/sj.emboj.7601726; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Malaga-Trillo E, 2011, BBA-MOL BASIS DIS, V1812, P402, DOI 10.1016/j.bbadis.2010.09.013; Malaga-Trillo E, 2009, PRION, V3, P129, DOI 10.4161/pri.3.3.9651; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Morel E, 2004, J BIOL CHEM, V279, P1499, DOI 10.1074/jbc.M308578200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; Puig B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024624; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; RAEBER AJ, 1995, MECH DEVELOP, V51, P317, DOI 10.1016/0925-4773(95)00379-7; Rivera-Milla E, 2003, TRENDS GENET, V19, P72, DOI 10.1016/S0168-9525(02)00032-X; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; ROGERS M, 1990, Glycobiology, V1, P101, DOI 10.1093/glycob/1.1.101; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Schrock Y, 2009, FEBS LETT, V583, P389, DOI 10.1016/j.febslet.2008.12.038; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Solis GP, 2010, FRONT BIOSCI-LANDMRK, V15, P1075, DOI 10.2741/3662; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Stella R, 2010, MOL CELL BIOL, V30, P4864, DOI 10.1128/MCB.01040-09; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Turnbaugh JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025675; Uelhoff A, 2005, J BIOL CHEM, V280, P5137, DOI 10.1074/jbc.C400560200; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Westerfield M, 1993, ZEBRAFISH BOOK; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017	67	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70327	10.1371/journal.pone.0070327	http://dx.doi.org/10.1371/journal.pone.0070327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936187	gold, Green Submitted, Green Published			2022-12-27	WOS:000322633700066
J	Qian, K; Pietila, T; Ronty, M; Michon, F; Frilander, MJ; Ritari, J; Tarkkanen, J; Paulin, L; Auvinen, P; Auvinen, E				Qian, Kui; Pietila, Tuuli; Ronty, Mikko; Michon, Frederic; Frilander, Mikko J.; Ritari, Jarmo; Tarkkanen, Jussi; Paulin, Lars; Auvinen, Petri; Auvinen, Eeva			Identification and Validation of Human Papillomavirus Encoded microRNAs	PLOS ONE			English	Article							GENE-EXPRESSION; CERVICAL-CANCER; RETINOIC-ACID; SMALL RNAS; TYPE-16; KERATINOCYTES; TRANSCRIPTION; ADENOVIRUS; CARCINOMA; VIRUSES	We report here identification and validation of the first papillomavirus encoded microRNAs expressed in human cervical lesions and cell lines. We established small RNA libraries from ten human papillomavirus associated cervical lesions including cancer and two human papillomavirus harboring cell lines. These libraries were sequenced using SOLiD 4 technology. We used the sequencing data to predict putative viral microRNAs and discovered nine putative papillomavirus encoded microRNAs. Validation was performed for five candidates, four of which were successfully validated by qPCR from cervical tissue samples and cell lines: two were encoded by HPV 16, one by HPV 38 and one by HPV 68. The expression of HPV 16 microRNAs was further confirmed by in situ hybridization, and colocalization with p16INK4A was established. Prediction of cellular target genes of HPV 16 encoded microRNAs suggests that they may play a role in cell cycle, immune functions, cell adhesion and migration, development, and cancer. Two putative viral target sites for the two validated HPV 16 miRNAs were mapped to the E5 gene, one in the E1 gene, two in the L1 gene and one in the LCR region. This is the first report to show that papillomaviruses encode their own microRNA species. Importantly, microRNAs were found in libraries established from human cervical disease and carcinoma cell lines, and their expression was confirmed in additional tissue samples. To our knowledge, this is also the first paper to use in situ hybridization to show the expression of a viral microRNA in human tissue.	[Qian, Kui; Pietila, Tuuli; Michon, Frederic; Frilander, Mikko J.; Ritari, Jarmo; Paulin, Lars; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Pietila, Tuuli; Auvinen, Eeva] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Pietila, Tuuli; Auvinen, Eeva] Univ Helsinki, Dept Virol & Immunol, Hosp Lab, Helsinki, Finland; [Ronty, Mikko; Tarkkanen, Jussi] Univ Helsinki, Dept Pathol, Hosp Lab, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki	Qian, K (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	kui.qian@helsinki.fi	Auvinen, Petri/AAP-8117-2021; MICHON, Frédéric/ABH-6712-2020; Frilander, Mikko J/B-6660-2009; Auvinen, Petri/D-5044-2009; Qian, Kui/J-1942-2014; Ritari, Jarmo/G-4245-2016	Frilander, Mikko J/0000-0002-1732-4808; Auvinen, Petri/0000-0002-3947-4778; Qian, Kui/0000-0001-7170-533X; Ritari, Jarmo/0000-0002-3458-9314; Michon, Frederic/0000-0003-4305-305X; Auvinen, Eeva/0000-0002-2094-985X	University of Helsinki Funds; Viikki Doctoral Programme in Molecular Biosciences (VGSB) at the University of Helsinki	University of Helsinki Funds; Viikki Doctoral Programme in Molecular Biosciences (VGSB) at the University of Helsinki	This work was supported by a grant from the University of Helsinki Funds to EA. KQ was supported by the Viikki Doctoral Programme in Molecular Biosciences (VGSB) at the University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUVINEN E, 1992, AM J PATHOL, V141, P1217; Bauman Y, 2011, CELL HOST MICROBE, V9, P93, DOI 10.1016/j.chom.2011.01.008; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BERNARD HU, 1994, ARCH DERMATOL, V130, P210, DOI 10.1001/archderm.130.2.210; Borutinskaite VV, 2006, ANN NY ACAD SCI, V1091, P346, DOI 10.1196/annals.1378.079; Cai XZ, 2006, J VIROL, V80, P10890, DOI 10.1128/JVI.01175-06; Chandrasekaran R, 2006, PROTEIN EXPRES PURIF, V50, P111, DOI 10.1016/j.pep.2006.07.004; Chen CJ, 2011, J VIROL, V85, P4487, DOI 10.1128/JVI.02557-10; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Coupe VM, 2012, J CLIN PATHOL, V65, P164, DOI 10.1136/jclinpath-2011-200330; Darmochwal-Kolarz D, 2009, FOLIA HISTOCHEM CYTO, V47, P599, DOI 10.2478/v10042-009-0113-0; DURST M, 1992, VIROLOGY, V189, P132, DOI 10.1016/0042-6822(92)90688-L; DURST M, 1987, ONCOGENE, V1, P251; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; Greco D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021646; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Gu WY, 2011, ARCH VIROL, V156, P1161, DOI 10.1007/s00705-011-0974-3; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hussain M, 2008, J VIROL, V82, P9164, DOI 10.1128/JVI.01109-08; ISHIJI T, 1992, EMBO J, V11, P2271, DOI 10.1002/j.1460-2075.1992.tb05286.x; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Kivi N, 2008, ONCOGENE, V27, P2532, DOI 10.1038/sj.onc.1210916; Kivi N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-9; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lee JH, 2004, P NATL ACAD SCI USA, V101, P2094, DOI 10.1073/pnas.0308615100; Lee S, 2011, J CLIN VIROL, V52, P272, DOI 10.1016/j.jcv.2011.08.012; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Pyeon D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000318; Qian K, 2012, MOL CELL PROBES; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Ritari J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034211; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Seo GJ, 2009, VIROLOGY, V383, P183, DOI 10.1016/j.virol.2008.11.001; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Xie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046990; Xu N, 2007, J VIROL, V81, P10540, DOI 10.1128/JVI.00885-07; ZHENG J, 1995, J CELL BIOL, V129, P843, DOI 10.1083/jcb.129.3.843; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	53	53	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70202	10.1371/journal.pone.0070202	http://dx.doi.org/10.1371/journal.pone.0070202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936163	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200064
J	Brookshire, ENJ; Thomas, SA				Brookshire, E. N. Jack; Thomas, Steven A.			Ecosystem Consequences of Tree Monodominance for Nitrogen Cycling in Lowland Tropical Forest	PLOS ONE			English	Article							NORTHERN RANGE; RAIN-FORESTS; SOIL; MECHANISMS; NITRATE; MINERALOGY; DIVERSITY; FIXATION; AMMONIUM; LOSSES	Understanding how plant functional traits shape nutrient limitation and cycling on land is a major challenge in ecology. This is especially true for lowland forest ecosystems of the tropics which can be taxonomically and functionally diverse and rich in bioavailable nitrogen (N). In many tropical regions, however, diverse forests occur side-by-side with monodominant forest (one species > 60% of canopy); the long-term biogeochemical consequences of tree monodominance are unclear. Particularly uncertain is whether the monodominant plant-soil system modifies nutrient balance at the ecosystem level. Here, we use chemical and stable isotope techniques to examine N cycling in old-growth Mora excelsa and diverse watershed rainforests on the island of Trinidad. Across 26 small watershed forests and 4 years, we show that Mora monodominance reduces bioavailable nitrate in the plant-soil system to exceedingly low levels which, in turn, results in small hydrologic and gaseous N losses at the watershed-level relative to adjacent N-rich diverse forests. Bioavailable N in soils and streams remained low and remarkably stable through time in Mora forests; N levels in diverse forests, on the other hand, showed high sensitivity to seasonal and inter-annual rainfall variation. Total mineral N losses from diverse forests exceeded inputs from atmospheric deposition, consistent with N saturation, while losses from Mora forests did not, suggesting N limitation. Our measures suggest that this difference cannot be explained by environmental factors but instead by low internal production and efficient retention of bioavailable N in the Mora plant-soil system. These results demonstrate ecosystem-level consequences of a tree species on the N cycle opposite to cases where trees enhance ecosystem N supply via N-2 fixation and suggest that, over time, Mora monodominance may generate progressive N draw-down in the plant-soil system.	[Brookshire, E. N. Jack] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Thomas, Steven A.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA	Montana State University System; Montana State University Bozeman; University of Nebraska System; University of Nebraska Lincoln	Brookshire, ENJ (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	jbrookshire@montana.edu			NSF-FIBR [DEB-0623632]; Montana State University	NSF-FIBR(National Science Foundation (NSF)); Montana State University	Dr. Brookshire was supported entirely on faculty start-up funds through Montana State University. Dr. Thomas was supported by NSF-FIBR (DEB-0623632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AHMAD N, 1968, J SOIL SCI, V19, P9, DOI 10.1111/j.1365-2389.1968.tb01515.x; BAISDEN WT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI DOI 10.1029/2001GB001822; Barron AR, 2011, OECOLOGIA, V165, P511, DOI 10.1007/s00442-010-1838-3; BEARD JS, 1946, J ECOL, V33, P173, DOI 10.2307/2256464; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; Boudsocq S, 2012, AM NAT, V180, P60, DOI 10.1086/665997; Brooks JR, 2010, NAT GEOSCI, V3, P100, DOI 10.1038/NGEO722; Brookshire ENJ, 2012, ECOL LETT, V15, P9, DOI 10.1111/j.1461-0248.2011.01701.x; Brookshire ENJ, 2012, NAT GEOSCI, V5, P123, DOI 10.1038/NGEO1372; Compton JE, 2003, ECOSYSTEMS, V6, P773, DOI 10.1007/s10021-002-0207-4; CONNELL JH, 1989, AM NAT, V134, P88, DOI 10.1086/284967; CORNFORTH IS, 1970, J APPL ECOL, V7, P603, DOI 10.2307/2401982; Daufresne T, 2005, P NATL ACAD SCI USA, V102, P9212, DOI 10.1073/pnas.0406427102; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Davidson EA, 2007, NATURE, V447, P995, DOI 10.1038/nature05900; DEANGELIS DL, 1989, ANNU REV ECOL SYST, V20, P71, DOI 10.1146/annurev.es.20.110189.000443; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; FREY M, 1988, J GEOL SOC LONDON, V145, P563, DOI 10.1144/gsjgs.145.4.0563; HART TB, 1990, TRENDS ECOL EVOL, V5, P6, DOI 10.1016/0169-5347(90)90005-X; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Helmer EH, 2012, FOREST ECOL MANAG, V279, P147, DOI 10.1016/j.foreco.2012.05.016; Houlton BZ, 2009, P NATL ACAD SCI USA, V106, P21713, DOI 10.1073/pnas.0912111106; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McGuire KL, 2010, OECOLOGIA, V164, P785, DOI 10.1007/s00442-010-1686-1; Menge DNL, 2011, ECOSYSTEMS, V14, P519, DOI 10.1007/s10021-011-9426-x; Peh KSH, 2012, J VEG SCI, V23, P223, DOI 10.1111/j.1654-1103.2011.01352.x; Peh KSH, 2011, J ECOL, V99, P891, DOI 10.1111/j.1365-2745.2011.01827.x; Peh KS-H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016996, DOI 10.1371/J0URNAL.P0NE.0016996]; Perakis SS, 2001, ECOLOGY, V82, P2245, DOI 10.1890/0012-9658(2001)082[2245:FAFONI]2.0.CO;2; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; Rollenbeck R, 2007, J HYDROL, V337, P377, DOI 10.1016/j.jhydrol.2007.02.004; Shrivastava GS, 2003, J HYDROL ENG, V8, P35, DOI 10.1061/(ASCE)1084-0699(2003)8:1(35); Silver WL, 2001, ECOLOGY, V82, P2410, DOI 10.1890/0012-9658(2001)082[2410:DNRTAI]2.0.CO;2; Sprent JI, 2007, PLANT PHYSIOL, V144, P575, DOI 10.1104/pp.107.096156; Subbarao GV, 2007, PLANT SOIL, V294, P5, DOI 10.1007/s11104-006-9159-3; TILMAN D, 1980, AM NAT, V116, P362, DOI 10.1086/283633; Torti SD, 1997, J TROP ECOL, V13, P623, DOI 10.1017/S0266467400010762; Torti SD, 2001, AM NAT, V157, P141, DOI 10.1086/318629; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Townsend AR, 2011, FRONT ECOL ENVIRON, V9, P9, DOI 10.1890/100047; Vitousek, 2004, NUTR CYCLING LIMITAT; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; Wieder WR, 2013, BIOGEOCHEMISTRY, V113, P629, DOI 10.1007/s10533-012-9793-1; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; ZINKE PJ, 1962, ECOLOGY, V43, P130, DOI 10.2307/1932049	47	15	15	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70491	10.1371/journal.pone.0070491	http://dx.doi.org/10.1371/journal.pone.0070491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936215	Green Published, gold			2022-12-27	WOS:000322433300103
J	Gonzalez, E; Kish, LB; Balog, RS; Enjeti, P				Gonzalez, Elias; Kish, Laszlo B.; Balog, Robert S.; Enjeti, Prasad			Information Theoretically Secure, Enhanced Johnson Noise Based Key Distribution over the Smart Grid with Switched Filters	PLOS ONE			English	Article							ATTACK; DETECTOR	We introduce a protocol with a reconfigurable filter system to create non-overlapping single loops in the smart power grid for the realization of the Kirchhoff-Law-Johnson-(like)-Noise secure key distribution system. The protocol is valid for one-dimensional radial networks (chain-like power line) which are typical of the electricity distribution network between the utility and the customer. The speed of the protocol (the number of steps needed) versus grid size is analyzed. When properly generalized, such a system has the potential to achieve unconditionally secure key distribution over the smart power grid of arbitrary geometrical dimensions.	[Gonzalez, Elias; Kish, Laszlo B.; Balog, Robert S.; Enjeti, Prasad] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Kish, LB (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	Laszlo.Kish@ece.tamu.edu	Enjeti, Prasad N/C-3768-2019	Enjeti, Prasad N/0000-0001-8625-0526; Balog, Robert/0000-0002-0090-4259				Amin SM, 2008, IEEE POWER ENERGY M, P114; Balog RS, 2013, IEEE T POWER ELECTR, V28, P537, DOI 10.1109/TPEL.2012.2186828; Engleman E, 2013, BLOMBERG NEWS   0226; Gerhardt I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.170404; Gerhardt I, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1348; Jain N, 2011, PHYS REV LETT, V107, DOI [10.1103/PhysRevLett.107.11051, DOI 10.1103/PHYSREVLETT.107.11051]; Kezunovic M, 2011, IEEE T SMART GRID, V2, P11, DOI 10.1109/TSG.2011.2118774; Kim S, 2002, IEEE T POWER ELECTR, V17, P48, DOI 10.1109/63.988669; Kish LB, 2008, FLUCT NOISE LETT, V8, pL95, DOI 10.1142/S0219477508004362; Kish LB, 2006, FLUCT NOISE LETT, V6, pL447, DOI 10.1142/S0219477506003628; Kish LB, 2012, IEICE T COMMUN, VE95B, P1501, DOI 10.1587/transcom.E95.B.1501; Kish LB, 2013, METROL MEAS SYST, V20, P191, DOI 10.2478/mms-2013-0017; Kish LB, 2006, PHYS LETT A, V352, P178, DOI 10.1016/j.physleta.2005.11.062; Kish LB, 2006, FLUCT NOISE LETT, V6, pL57, DOI 10.1142/S0219477506003148; Kundur D, 2010, INT CONF SMART GRID, P244, DOI 10.1109/SMARTGRID.2010.5622049; Liang YB, 2008, FOUND TRENDS COMMUN, V5, P355, DOI 10.1561/0100000036; Lydersen L, 2011, J MOD OPTIC, V58, P680, DOI 10.1080/09500340.2011.565889; Lydersen L, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658806; Lydersen L, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113042; Lydersen L, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.032320; Lydersen L, 2010, OPT EXPRESS, V18, P27938, DOI 10.1364/OE.18.027938; Lydersen L, 2010, NAT PHOTONICS, V4, P801, DOI 10.1038/nphoton.2010.278; Lydersen L, 2010, NAT PHOTONICS, V4, P686, DOI 10.1038/NPHOTON.2010.214; Makarov V, 2008, QUANTUM INF COMPUT, V8, P622; Makarov V, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/065003; McDaniel P, 2009, IEEE SECUR PRIV, V7, P75, DOI 10.1109/MSP.2009.76; Mingesz R, 2008, PHYS LETT A, V372, P978, DOI 10.1016/j.physleta.2007.07.086; Mingesz R, 2013, METROL MEAS SYST, V20, P3, DOI 10.2478/mms-2013-0001; Sauge S, 2011, OPT EXPRESS, V19, P23590, DOI 10.1364/OE.19.023590; Wiechers C, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013043; Yuen HP, 2012, FDN QUANTUM KE UNPUB	31	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70206	10.1371/journal.pone.0070206	http://dx.doi.org/10.1371/journal.pone.0070206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936164	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300093
J	Zhao, Y; Li, CL; Wang, M; Su, LP; Qu, Y; Li, JF; Yu, BQ; Yan, M; Yu, YY; Liu, BY; Zhu, ZG				Zhao, Yu; Li, Chenglong; Wang, Ming; Su, Liping; Qu, Ying; Li, Jianfang; Yu, Beiqin; Yan, Min; Yu, Yingyan; Liu, Bingya; Zhu, Zhenggang			Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; SONIC HEDGEHOG; MEDIATED ACTIVATION; CELL-PROLIFERATION; LONG ARM; TARGET; IDENTIFICATION; MICRORNAS; GENE; GLI1	Emerging studies have indicated that microRNAs are involved in the development and progression of cancer. Here we found that miR-202-3p was frequently down-regulated in gastric cancer tissues. Overexpression of miR-202-3p in gastric cancer cells MKN-28 and BGC-823, markedly suppressed cell proliferation and induced cell apoptosis both in vitro and in vivo. Furthermore, Gli1 expression was frequently positive in gastric cancer tissues and inversely correlated with miR-133b expression. We demonstrate that the transcriptional factor Gli1 was a target of miR-202-3p and plays an essential role as a mediator of the biological effects of miR-202-3p in gastric cancer. MiR-202-3p also inhibited the expression of gamma-catenin and BCL-2. Taken together, these findings suggest that miR-202-3p may function as a novel tumor suppressor in gastric cancer and its anti-tumor activity may attribute the direct targeting and inhibition of Gli1.	[Zhao, Yu; Li, Chenglong; Wang, Ming; Su, Liping; Qu, Ying; Li, Jianfang; Yu, Beiqin; Yan, Min; Yu, Yingyan; Liu, Bingya; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Dept Surg, Shanghai Inst Digest Surg,Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Dept Surg, Shanghai Inst Digest Surg,Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China.	byliu@sjtu.edu.cn; zhuzg@shsmu.edu.cn	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81072012, 81101847, 81172324, 91229106, 81272749]; Science and Technology Commission of Shanghai Municipality [10jc1411100, 11jc1407602, 09DZ1950100, 09DZ2260200, 12XD1403700, 12PJ1406300]; Key Projects in the National Science and Technology Pillar Program of China [2011BA203191]; Research Fund for the Doctoral Program of Higher Education of China [20110073110071]; Key Project of Shanghai Education Committee [12ZZ102, 12ZZ105]; Innovation Foundation for PhD Graduates of Shanghai Jiao Tong University School of Medicine [BXJ201213]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Projects in the National Science and Technology Pillar Program of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Project of Shanghai Education Committee; Innovation Foundation for PhD Graduates of Shanghai Jiao Tong University School of Medicine	This study was supported by Grants from National Natural Science Foundation of China (Nos. 81072012, 81101847, 81172324, 91229106 and 81272749), Science and Technology Commission of Shanghai Municipality (Nos. 10jc1411100, 11jc1407602, 09DZ1950100, 09DZ2260200, 12XD1403700 and 12PJ1406300), Key Projects in the National Science and Technology Pillar Program of China (No. 2011BA203191), Research Fund for the Doctoral Program of Higher Education of China (No. 20110073110071), Key Project of Shanghai Education Committee (Nos. 12ZZ102, 12ZZ105) and Innovation Foundation for PhD Graduates of Shanghai Jiao Tong University School of Medicine (BXJ201213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buechner J, 2011, BRIT J CANCER, V105, P296, DOI 10.1038/bjc.2011.220; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Courtens W, 2006, AM J MED GENET A, V140A, P402, DOI 10.1002/ajmg.a.31053; Crone SG, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-71; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hoffman AE, 2013, CANCER EPIDEM BIOMAR, V22, P327, DOI 10.1158/1055-9965.EPI-12-1131-T; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jiang JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023271; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee SH, 2001, MAMM GENOME, V12, P157, DOI 10.1007/s003350010247; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Li CL, 2012, CANCER LETT, V320, P189, DOI 10.1016/j.canlet.2012.02.030; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Ma XL, 2006, WORLD J GASTROENTERO, V12, P3965, DOI 10.3748/wjg.v12.i25.3965; Ma XL, 2005, CARCINOGENESIS, V26, P1698, DOI 10.1093/carcin/bgi130; Mitas M, 2005, CLIN CANCER RES, V11, P2205, DOI 10.1158/1078-0432.CCR-04-1091; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; PEIFFER SL, 1995, CANCER RES, V55, P1922; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pizzimenti S, 2009, FREE RADICAL BIO MED, V46, P282, DOI 10.1016/j.freeradbiomed.2008.10.035; Ribeiro-dos-Santos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013205; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Stahlhut Espinosa Carlos E, 2006, Yale J Biol Med, V79, P131; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Wang M., 2013, J GASTROENTEROL; Wang M, 2012, FEBS LETT, V586, P2382, DOI 10.1016/j.febslet.2012.05.050; Xu Xuan-Fu, 2009, J Carcinog, V8, P13, DOI 10.4103/1477-3163.55429; Yao Q, 2013, CANC LETT; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yu BQ, 2012, MOL MED REP, V6, P821, DOI 10.3892/mmr.2012.1006; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhang YL, 2009, J OBSTET GYNAECOL RE, V35, P842, DOI 10.1111/j.1447-0756.2009.01055.x; Zhang YZ, 2011, WORLD J GASTROENTERO, V17, P1710, DOI 10.3748/wjg.v17.i13.1710; Zhou FY, 2012, DNA CELL BIOL, V31, P1290, DOI 10.1089/dna.2011.1596	45	72	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69756	10.1371/journal.pone.0069756	http://dx.doi.org/10.1371/journal.pone.0069756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936094	Green Submitted, gold, Green Published			2022-12-27	WOS:000322433300064
J	Cudalbu, C; McLin, VA; Lei, HX; Duarte, JMN; Rougemont, AL; Oldani, G; Terraz, S; Toso, C; Gruetter, R				Cudalbu, Cristina; McLin, Valerie A.; Lei, Hongxia; Duarte, Joao M. N.; Rougemont, Anne-Laure; Oldani, Graziano; Terraz, Sylvain; Toso, Christian; Gruetter, Rolf			The C57BL/6J Mouse Exhibits Sporadic Congenital Portosystemic Shunts	PLOS ONE			English	Article							MINIMAL HEPATIC-ENCEPHALOPATHY; PORTAL-VEIN THROMBOSIS; PORTACAVAL ANASTOMOSIS; NEUROCHEMICAL PROFILE; NMR-SPECTROSCOPY; SKELETAL-MUSCLE; MESSENGER-RNA; IN-VIVO; BRAIN; EXPRESSION	C57BL/6 mice are the most widely used strain of laboratory mice. Using in vivo proton Magnetic Resonance Spectroscopy (H-1 MRS), we have repeatedly observed an abnormal neurochemical profile in the brains of both wild-type and genetically modified mice derived from the C57BL/6J strain, consisting of a several fold increase in cerebral glutamine and two fold decrease in myo-inositol. This strikingly abnormal neurochemical "phenotype" resembles that observed in chronic liver disease or portosystemic shunting and appeared to be independent of transgene, origin or chow and was not associated with liver failure. As many as 25% of animals displayed the abnormal neurochemical profile, questioning the reliability of this model for neurobiology. We conducted an independent study to determine if this neurochemical profile was associated with portosystemic shunting. Our results showed that 100% of the mice with high brain glutamine displayed portosystemic shunting by concomitant portal angiography while all mice with normal brain glutamine did not. Since portosystemic shunting is known to cause alterations in gene expression in many organs including the brain, we conclude that portosystemic shunting may be the most significant problem associated with C57BL/6J inbreeding both for its effect on the central nervous system and for its systemic repercussions.	[Cudalbu, Cristina; Lei, Hongxia; Duarte, Joao M. N.; Gruetter, Rolf] Ecole Polytech Fed Lausanne, Ctr Biomed Imaging CIBM, Lab Funct & Metab Imaging LIFMET, CH-1015 Lausanne, Switzerland; [McLin, Valerie A.] HUG, Dept Enfant & Adolescent, Unite Gastroenterol Hepatol & Nutr, Geneva, Switzerland; [Lei, Hongxia] Univ Geneva UNIGE, Fac Med, Geneva, Switzerland; [Duarte, Joao M. N.] Univ Lausanne UNIL, Dept Radiol, Lausanne, Switzerland; [Rougemont, Anne-Laure] HUG, Serv Pathol Clin, Geneva, Switzerland; [Oldani, Graziano; Toso, Christian] Univ Geneva Hosp HUG, Div Transplantat, Dept Surg, Geneva, Switzerland; [Oldani, Graziano] Univ Pavia, Dept Surg, I-27100 Pavia, Italy; [Terraz, Sylvain] HUG, Serv Radiol, Unite Radiol Abdominale, Geneva, Switzerland; [Gruetter, Rolf] Univ Geneva UNIGE, Dept Radiol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; University of Lausanne; University of Geneva; University of Geneva; University of Pavia; University of Geneva; University of Geneva	Cudalbu, C (corresponding author), Ecole Polytech Fed Lausanne, Ctr Biomed Imaging CIBM, Lab Funct & Metab Imaging LIFMET, CH-1015 Lausanne, Switzerland.	cristina.cudalbu@epfl.ch; rolf.gruetter@epfl.ch	Rougemont, Anne-Laure/C-5612-2015; Duarte, João M.N./H-4887-2012; Gruetter, Rolf/H-6260-2011	Duarte, João M.N./0000-0001-5984-1574; Gruetter, Rolf/0000-0003-1870-4025; Rougemont, Anne-Laure/0000-0002-1785-792X; Lei, Hongxia/0000-0002-4065-9331; Cudalbu, Cristina/0000-0003-4582-2465	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation; SNF [131087, 122498]; Swiss National Science Foundation (SCORE grant) [3232230-126233]	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation; SNF; Swiss National Science Foundation (SCORE grant)	This study was supported by the Centre d'Imagerie BioMedicale (CIBM) of the UNIL, UNIGE, HUG, CHUV, EPFL and the Leenaards and Jeantet Foundations; SNF grant 131087; SNF grant 122498. CT was supported by the Swiss National Science Foundation (SCORE grant 3232230-126233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2011, GUT, V60, P1572, DOI 10.1136/gut.2010.236083; Berent AC, 2009, VET CLIN N AM-SMALL, V39, P513, DOI 10.1016/j.cvsm.2009.02.004; Braissant O, 2012, J INHERITED IN PRESS; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Bryant CD, 2011, ANN NY ACAD SCI, V1245, P31, DOI 10.1111/j.1749-6632.2011.06325.x; Bryant CD, 2008, J NEUROGENET, V22, P315, DOI 10.1080/01677060802357388; Butterworth RF, 2003, J HEPATOL, V39, P278, DOI 10.1016/S0168-8278(03)00267-8; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; Cordoba J, 1996, HEPATOLOGY, V24, P919, DOI 10.1002/hep.510240427; Cudalbu C, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104034; Cudalbu C, 2012, J ALZHEIMERS DIS, V31, pS101, DOI 10.3233/JAD-2012-120100; Cudalbu C, 2012, J CEREBR BLOOD F MET, V32, P696, DOI 10.1038/jcbfm.2011.173; Dagg C., 1966, BIOL LAB MOUSE; Dasarathy S, 2007, AM J PHYSIOL-GASTR L, V292, pG1105, DOI 10.1152/ajpgi.00529.2006; Desjardins P, 1999, METAB BRAIN DIS, V14, P273, DOI 10.1023/A:1020741226752; Desjardins P, 1999, NEUROCHEM INT, V35, P293, DOI 10.1016/S0197-0186(99)00075-3; Franchi-Abella S, 2010, J PEDIATR GASTR NUTR, V51, P322, DOI 10.1097/MPG.0b013e3181d9cb92; Gandhi CR, 2002, J HEPATOL, V37, P340, DOI 10.1016/S0168-8278(02)00165-4; Garcia C, 2011, CYTOKINE, V56, P680, DOI 10.1016/j.cyto.2011.08.033; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; KALTER H, 1968, TERATOLOGY, V1, P193, DOI 10.1002/tera.1420010208; Kellermayer R, 2010, AM J MED GENET A, V152A, P3022, DOI 10.1002/ajmg.a.33726; Kiselycznyk C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00010; Kostler H, 1998, METAB BRAIN DIS, V13, P291, DOI 10.1023/A:1020632708154; Kulak A, 2010, J NEUROCHEM, V115, P1466, DOI 10.1111/j.1471-4159.2010.07051.x; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Lisovsky M, 2011, AM J SURG PATHOL, V35, P1381, DOI 10.1097/PAS.0b013e3182230ce4; Mack CL, 2003, J PEDIATR-US, V142, P197, DOI 10.1067/mpd.2003.93; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; Minguez B, 2006, HEPATOLOGY, V43, P707, DOI 10.1002/hep.21126; Mlynarik V, 2008, J MAGN RESON; Nylander AG, 1997, PHARMACOL TOXICOL, V80, P147, DOI 10.1111/j.1600-0773.1997.tb00388.x; Rao VLR, 1997, BRAIN RES, V765, P169, DOI 10.1016/S0006-8993(97)00652-5; Rovira A, 2008, AM J NEURORADIOL, V29, P1612, DOI 10.3174/ajnr.A1139; Song GQ, 2002, J NEUROSCI RES, V68, P730, DOI 10.1002/jnr.10268; Spahr L, 2002, METAB BRAIN DIS, V17, P399, DOI 10.1023/A:1021974321874; Srivastava A, 2010, J PEDIATR GASTR NUTR, V51, P766, DOI 10.1097/MPG.0b013e3181ecaf62; Tivers MS, 2012, J SMALL ANIM PRACT, V53, P3, DOI 10.1111/j.1748-5827.2011.01144.x; Tivers M, 2011, J FELINE MED SURG, V13, P173, DOI 10.1016/j.jfms.2011.01.010; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Tkac I, 2011, LONGITUDINAL STUDY N, V2288; van Steenbeek FG, 2012, MAMM GENOME, V23, P76, DOI 10.1007/s00335-011-9364-0; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Zurita E, 2011, TRANSGENIC RES, V20, P481, DOI 10.1007/s11248-010-9403-8	44	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69782	10.1371/journal.pone.0069782	http://dx.doi.org/10.1371/journal.pone.0069782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936100	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000155
J	Liu, SJ; Hunt, L; Storrie, B				Liu, Shijie; Hunt, Lauren; Storrie, Brian			Rab41 Is a Novel Regulator of Golgi Apparatus Organization That Is Needed for ER-To-Golgi Trafficking and Cell Growth	PLOS ONE			English	Article							TRANSPORT; GTPASE; PROTEINS; COMPLEX; VESICLES; NETWORK; ROLES; RAB6A	Background: The 60(+) members of the mammalian Rab protein family group into subfamilies postulated to share common functionality. The Rab VI subfamily contains 5 Rab proteins, Rab6a/a', Rab6b, Rab6c and Rab41. High-level knockdown of Rab6a/a' has little effect on the tightly organized Golgi ribbon in HeLa cells as seen by fluorescence microscopy. In striking contrast, we found Rab41 was strongly required for normal Golgi ribbon organization. Methods/Results: Treatment of HeLa cells with Rab41 siRNAs scattered the Golgi ribbon into clustered, punctate Golgi elements. Overexpression of GDP-locked Rab41, but not wild type or GTP-locked Rab41, produced a similar Golgi phenotype. By electron microscopy, Rab41 depletion produced short, isolated Golgi stacks. Golgi-associated vesicles accumulated. At low expression levels, wild type and GTP-locked Rab41 showed little concentration in the Golgi region, but puncta were observed and most were in ruffled regions at the cell periphery. There was 25% co-localization of GTP-locked Rab41 with the ER marker, Sec61p. GDP-locked Rab41, as expected, displayed an entirely diffuse cytoplasmic distribution. Depletion of Rab41 or overexpression of GDP-locked Rab41 partially inhibited ER-to-Golgi transport of VSV-G protein. However, Rab41 knockdown had little, if any, effect on endosome-to-Golgi transport of SLTB. Additionally, after a 2-day delay, treatment with Rab41 siRNA inhibited cell growth, while overexpression of GDP-locked Rab41, but not wild type or GTP-locked Rab41, produced a rapid, progressive cell loss. In double knockdown experiments with Rab6, the Golgi ribbon was fragmented, a result consistent with Rab41 and Rab6 acting in parallel. Conclusion: We provide the first evidence for distinctive Rab41 effects on Golgi organization, ER-to-Golgi trafficking and cell growth. When combined with the evidence that Rab6a/a' and Rab6b have diverse roles in Golgi function, while Rab6c regulates mitotic function, our data indicate that Rab VI subfamily members, although related by homology and structure, share limited functional conservation.	[Liu, Shijie; Hunt, Lauren; Storrie, Brian] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Storrie, B (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	StorrieBrian@uams.edu			US NIH [1R01 GM 092960]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092960] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by a grant from the US NIH, 1R01 GM 092960. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANTONY C, 1992, J CELL SCI, V103, P785; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Jiang S, 2005, MOL BIOL CELL, V16, P2586, DOI 10.1091/mbc.e04-10-0861; Johannes L, 2011, TRAFFIC, V12, P956, DOI 10.1111/j.1600-0854.2011.01200.x; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu SJ, 2012, CELL MOL LIFE SCI, V69, P4093, DOI 10.1007/s00018-012-1021-6; Lowe M, 2011, CURR OPIN CELL BIOL, V23, P85, DOI 10.1016/j.ceb.2010.10.004; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; McDonald K, 2010, METHOD CELL BIOL, V96, P671, DOI 10.1016/S0091-679X(10)96028-7; Micaroni M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057034; Miserey-Lenkei S, 2006, EMBO J, V25, P278, DOI 10.1038/sj.emboj.7600929; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Opdam FJM, 2000, J CELL SCI, V113, P2725; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Sandvig K, 2004, INT J MED MICROBIOL, V293, P483, DOI 10.1078/1438-4221-00294; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Starr T, 2010, TRAFFIC, V11, P626, DOI 10.1111/j.1600-0854.2010.01051.x; Stein M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034870; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Storrie B, 2005, METHOD ENZYMOL, V404, P26, DOI 10.1016/S0076-6879(05)04004-8; Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Verkade P, 2008, J MICROSC-OXFORD, V230, P317, DOI 10.1111/j.1365-2818.2008.01989.x; Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009	35	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71886	10.1371/journal.pone.0071886	http://dx.doi.org/10.1371/journal.pone.0071886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936529	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500084
J	Yu, JM; Li, XY; Ao, YY; Li, LL; Liu, N; Li, JS; Duan, ZJ				Yu, Jie-mei; Li, Xiao-yue; Ao, Yuan-yun; Li, Li-li; Liu, Na; Li, Jin-song; Duan, Zhao-jun			Identification of a Novel Picornavirus in Healthy Piglets and Seroepidemiological Evidence of Its Presence in Humans	PLOS ONE			English	Article							ZOONOTIC LJUNGAN VIRUS; HUMAN PARECHOVIRUS; PROTEIN; FAMILY; ASSOCIATION; CALIFORNIA; HEPATITIS; SEQUENCE; MEMBER; RNA	In this study, we describe a novel porcine parechovirus-like virus (tentatively named PLV-CHN) from healthy piglets in China using 454 high-throughput sequencing. The complete genome of the virus comprises 6832 bp, encoding a predicted polyprotein of 2132 amino acids that is most similar to Ljungan virus (32% identity). A similar virus that belongs to a novel Picornaviridae genus, named swine pasivirus 1 (SPaV-1), was reported during the preparation of this paper. Sequence analysis revealed that PLV-CHN and SPaV1 shared 82% nucleotide identity and 89% amino acid identity. Further genomic and phylogenetic analyses suggested that both SPaV1 and PLV-CHN shared similar genomic characteristics and belong to the same novel Picornaviridae genus. A total of 36 (20.0%) fecal samples from 180 healthy piglets were positive for PLV-CHN by RT-PCR, while no fecal samples from 100 healthy children and 100 children with diarrhea, and no cerebrospinal fluid samples from 196 children with suspected viral encephalitis, was positive for the virus. However, Western blot and enzyme-linked immunosorbent assays using recombinant PLV-CHN VP1 polypeptide as an antigen showed a high seroprevalence of 63.5% in the healthy population. When grouped by age, the antibody-positivity rates showed that the majority of children under 12 years of age have been infected by the virus. It was suggested that PLV-CHN, SPaV1, or an as-yet-uncharacterized virus can infect humans early in life. Thus, investigation of the role of this novel virus is vital.	[Yu, Jie-mei; Ao, Yuan-yun; Li, Li-li; Liu, Na; Li, Jin-song; Duan, Zhao-jun] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Li, Xiao-yue] Anqing Municipal Hosp, Dept Clin Lab, Anqing, Anhui, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Duan, ZJ (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	zhaojund@126.com	Zhang, Hao/HHM-1940-2022; Ao, yuanyun/ABF-9640-2020		China Mega-Project for Infectious Disease [2011ZX10004]; National Natural Science Foundation of China [81290345]	China Mega-Project for Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Mega-Project for Infectious Disease (Grant No. 2011ZX10004) and by the National Natural Science Foundation of China (Grant No. 81290345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2007, J CLIN MICROBIOL, V45, P2037, DOI 10.1128/JCM.02432-06; AMBROS V, 1978, J BIOL CHEM, V253, P5263; HIGGINS RC, 1979, ANAL BIOCHEM, V93, P257, DOI 10.1016/S0003-2697(79)80077-9; Holtz LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86; Holtz LR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-159; Honkavuori KS, 2011, EMERG INFECT DIS, V17, P480, DOI 10.3201/eid1703.101410; Hughes PJ, 2000, J GEN VIROL, V81, P201, DOI 10.1099/0022-1317-81-1-201; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129, DOI 10.1086/514615; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Niklasson B, 1999, VIROLOGY, V255, P86, DOI 10.1006/viro.1998.9557; Niklasson B, 2007, BIRTH DEFECTS RES A, V79, P488, DOI 10.1002/bdra.20359; Niklasson B, 2011, J MED VIROL, V83, P1673, DOI 10.1002/jmv.22062; Niklasson B, 2009, BIRTH DEFECTS RES A, V85, P542, DOI 10.1002/bdra.20568; Pavio N, 2010, CURR OPIN INFECT DIS, V23, P521, DOI 10.1097/QCO.0b013e32833de683; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Picornaviridae study group, HUM PAR; Romero Jose R, 2011, Adv Pediatr, V58, P65, DOI 10.1016/j.yapd.2011.03.008; Ryan MD, 1997, J GEN VIROL, V78, P699, DOI 10.1099/0022-1317-78-4-699; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauvage V, 2012, J VIROL; Stanway G, 2005, VIRUS TAXONOMY, P757; Tauriainen S, 2007, J MED VIROL, V79, P457, DOI 10.1002/jmv.20831; Watanabe K, 2007, EMERG INFECT DIS, V13, P889, DOI 10.3201/eid1306.060896; Weiss RA, 2001, PHILOS T R SOC B, V356, P957, DOI 10.1098/rstb.2001.0838; Williams CH, 2009, J GEN VIROL, V90, P1702, DOI 10.1099/vir.0.008813-0; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; Yamashita T, 1998, J VIROL, V72, P8408, DOI 10.1128/JVI.72.10.8408-8412.1998; Yu JM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-39	34	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70137	10.1371/journal.pone.0070137	http://dx.doi.org/10.1371/journal.pone.0070137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936384	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500022
J	Eid, S; Maalouf, R; Jaffa, AA; Nassif, J; Hamdy, A; Rashid, A; Ziyadeh, FN; Eid, AA				Eid, Stephanie; Maalouf, Rita; Jaffa, Ayad A.; Nassif, Joseph; Hamdy, Ahmed; Rashid, Awad; Ziyadeh, Fuad N.; Eid, Assaad A.			20-HETE and EETs in Diabetic Nephropathy: A Novel Mechanistic Pathway	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; 20-HYDROXYEICOSATETRAENOIC ACID 20-HETE; CYTOCHROME-P450 4A EXPRESSION; ARACHIDONIC-ACID; HIGH GLUCOSE; OXIDATIVE STRESS; KIDNEY-DISEASE; ENDOTHELIAL DYSFUNCTION; RENAL INJURY; IGF-I	Diabetic nephropathy (DN), a major complication of diabetes, is characterized by hypertrophy, extracellular matrix accumulation, fibrosis and proteinuria leading to loss of renal function. Hypertrophy is a major factor inducing proximal tubular epithelial cells injury. However, the mechanisms leading to tubular injury is not well defined. In our study, we show that exposure of rats proximal tubular epithelial cells to high glucose (HG) resulted in increased extracellular matrix accumulation and hypertrophy. HG treatment increased ROS production and was associated with alteration in CYPs 4A and 2C11 expression concomitant with alteration in 20-HETE and EETs formation. HG-induced tubular injury were blocked by HET0016, an inhibitor of CYPs 4A. In contrast, inhibition of EETs promoted the effects of HG on cultured proximal tubular cells. Our results also show that alteration in CYPs 4A and 2C expression and 20 HETE and EETs formation regulates the activation of the mTOR/p70S6Kinase pathway, known to play a major role in the development of DN. In conclusion, we show that hyperglycemia in diabetes has a significant effect on the expression of Arachidonic Acid (AA)-metabolizing CYPs, manifested by increased AA metabolism, and might thus alter kidney function through alteration of type and amount of AA metabolites.	[Eid, Stephanie; Eid, Assaad A.] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol, Beirut, Lebanon; [Maalouf, Rita] Notre Dame Univ, Fac Nat & Appl Sci, Dept Sci, Zouk, Lebanon; [Jaffa, Ayad A.] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Nassif, Joseph] Amer Univ Beirut, Fac Med, Dept Obstet & Gynecol, Beirut, Lebanon; [Hamdy, Ahmed; Rashid, Awad] Hamad Med Corp, Dept Nephrol, Doha, Qatar; [Ziyadeh, Fuad N.] Amer Univ Beirut, Fac Med, Dept Internal Med, Beirut, Lebanon	American University of Beirut; Notre Dame University Lebanon; American University of Beirut; American University of Beirut; Hamad Medical Corporation; American University of Beirut	Eid, AA (corresponding author), Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol, Beirut, Lebanon.	ae49@aub.edu.lb	hamdi, ahmed/P-5901-2019	Maalouf, Rita/0000-0002-9379-7906; Nassif, Joseph/0000-0003-0937-6533; Eid, Stephanie/0000-0003-3775-7544	Lebanese National Scientific Research Center (CNRS); Qatar National Research Foundation [5-410-3-113]	Lebanese National Scientific Research Center (CNRS); Qatar National Research Foundation(National Research Foundation of Korea)	This work was supported by 1) Lebanese National Scientific Research Center (CNRS) [www.cnrs.edu.lb]; and 2) Qatar National Research Foundation, grant number 5-410-3-113 [www.qnrf.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bhaskaran M, 2003, AM J PHYSIOL-RENAL, V284, pF955, DOI 10.1152/ajprenal.00246.2002; Brezniceanu ML, 2007, KIDNEY INT, V71, P912, DOI 10.1038/sj.ki.5002188; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chen GZ, 2012, AM J PHYSIOL-ENDOC M, V303, pE563, DOI 10.1152/ajpendo.00591.2011; Chen GZ, 2011, PROSTAG OTH LIPID M, V96, P63, DOI 10.1016/j.prostaglandins.2011.06.009; Chen P, 2005, AM J PATHOL, V166, P615, DOI 10.1016/S0002-9440(10)62282-1; Christmas P, 2001, J BIOL CHEM, V276, P38166; CRAVEN PA, 1988, DIABETES, V37, P429, DOI 10.2337/diabetes.37.4.429; Dahly-Vernon AJ, 2005, HYPERTENSION, V45, P643, DOI 10.1161/01.HYP.0000153791.89776.43; Dey A, 2004, CLIN SCI, V107, P561, DOI 10.1042/CS20040125; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Flaquer M, 2010, LIFE SCI, V87, P147, DOI 10.1016/j.lfs.2010.06.004; Fleming I, 2001, CIRC RES, V88, P44, DOI 10.1161/01.RES.88.1.44; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Ha HJ, 2000, KIDNEY INT, V58, pS19, DOI 10.1046/j.1523-1755.2000.07704.x; Hall PM., 2006, DIABETES SPECTRUM, V19, P18, DOI DOI 10.2337/DIASPECT.19.1.18; Helvig C, 1998, BIOCHEMISTRY-US, V37, P12546, DOI 10.1021/bi981048g; Hoagland KM, 2003, HYPERTENSION, V42, P669, DOI 10.1161/01.HYP.0000084634.97353.1A; Hoagland KM, 2003, HYPERTENSION, V41, P697, DOI 10.1161/01.HYP.0000047881.15426.DC; Holla VR, 2001, P NATL ACAD SCI USA, V98, P5211, DOI 10.1073/pnas.081627898; IMAOKA S, 1988, BIOCHEM BIOPH RES CO, V152, P680, DOI 10.1016/S0006-291X(88)80092-5; Imaoka Susumu, 2005, Drug Metab Pharmacokinet, V20, P478, DOI 10.2133/dmpk.20.478; Ito O, 2006, MOL CELL BIOCHEM, V284, P141, DOI 10.1007/s11010-005-9038-x; Jones SC, 1999, DIABETIC MED, V16, P932, DOI 10.1046/j.1464-5491.1999.00174.x; Kalsotra A, 2005, BIOCHEM BIOPH RES CO, V338, P423, DOI 10.1016/j.bbrc.2005.08.101; Kuroki T, 2003, J AM SOC NEPHROL, V14, pS216, DOI 10.1097/01.ASN.0000077405.07888.07; Liu F, 2009, KIDNEY INT, V75, P156, DOI 10.1038/ki.2008.509; Liu L, 2011, J PHARMACOL EXP THER, V339, P451, DOI 10.1124/jpet.111.180505; Liu YM, 2012, J PHARMACOL EXP THER, V341, P725, DOI 10.1124/jpet.111.191247; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; McCarthy ET, 2005, KIDNEY INT, V67, P152, DOI 10.1111/j.1523-1755.2005.00065.x; Miyata Noriyuki, 2005, Journal of Smooth Muscle Research, V41, P175, DOI 10.1540/jsmr.41.175; Nakagawa K, 2003, AM J PHYSIOL-REG I, V284, pR1055, DOI 10.1152/ajpregu.00459.2002; Natarajan R, 2003, CURR OPIN PHARMACOL, V3, P198, DOI 10.1016/S1471-4892(03)00015-8; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; New DD, 2012, AM J PHYSIOL-CELL PH, V302, pC122, DOI 10.1152/ajpcell.00141.2011; Nieves D, 2007, APOPTOSIS, V12, P1979, DOI 10.1007/s10495-007-0123-3; Nilakantan V, 2008, AM J PHYSIOL-RENAL, V294, pF562, DOI 10.1152/ajprenal.00387.2007; ORCHARD TJ, 1990, DIABETES, V39, P1116, DOI 10.2337/diabetes.39.9.1116; Park SH, 2001, KIDNEY INT, V59, P1695, DOI 10.1046/j.1523-1755.2001.0590051695.x; Powell PK, 1996, ARCH BIOCHEM BIOPHYS, V335, P219, DOI 10.1006/abbi.1996.0501; Puntarulo S, 1998, FREE RADICAL BIO MED, V24, P1324, DOI 10.1016/S0891-5849(97)00463-2; Rhyu DY, 2012, TRANSPL P, V44, P625, DOI 10.1016/j.transproceed.2011.12.054; ROSELLOCATAFAU J, 1994, PROSTAG LEUKOTR ESS, V51, P411, DOI 10.1016/0952-3278(94)90057-4; Sarkis A, 2004, CURR DRUG METAB, V5, P245, DOI 10.2174/1389200043335603; Schwartzman ML, 1996, NEPHRON, V73, P652; Senthil D, 2002, AM J PHYSIOL-RENAL, V283, pF1226, DOI 10.1152/ajprenal.00109.2002; Shah AM, 2004, HEART, V90, P486, DOI 10.1136/hrt.2003.029389; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Singh H, 2008, PHARMACOL REP, V60, P29; Singh H, 2007, HYPERTENSION, V50, P123, DOI 10.1161/HYPERTENSIONAHA.107.089599; Wang JS, 2006, CIRC RES, V98, P962, DOI 10.1161/01.RES.0000217283.98806.a6; Williams JM, 2007, AM J PHYSIOL-RENAL, V293, pF501, DOI 10.1152/ajprenal.00131.2007; Yang Y, 2007, AM J NEPHROL, V27, P495, DOI 10.1159/000106782; YOUNG BA, 1995, KIDNEY INT, V47, P935, DOI 10.1038/ki.1995.139; Zeng QH, 2010, AM J PHYSIOL-HEART C, V299, pH1109, DOI 10.1152/ajpheart.00067.2010; Zhou YQ, 2005, AM J HYPERTENS, V18, P530, DOI 10.1016/j.amjhyper.2004.10.033	63	34	35	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70029	10.1371/journal.pone.0070029	http://dx.doi.org/10.1371/journal.pone.0070029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936373	gold, Green Published, Green Submitted			2022-12-27	WOS:000324545800031
J	Gao, YX; Li, HY; Liu, J				Gao, Yunxia; Li, Haiyan; Liu, Jing			Directly Writing Resistor, Inductor and Capacitor to Composite Functional Circuits: A Super-Simple Way for Alternative Electronics	PLOS ONE			English	Article							LOW-COST; PAPER; THIN; SEMITRANSPARENT; CONDUCTIVITY; TRANSPARENT; TRANSISTORS; SENSOR; FILMS	Background: The current strategies for making electronic devices are generally time, water, material and energy consuming. Here, the direct writing of composite functional circuits through comprehensive use of GaIn10-based liquid metal inks and matching material is proposed and investigated, which is a rather easy going and cost effective electronics fabrication way compared with the conventional approaches. Methods: Owing to its excellent adhesion and electrical properties, the liquid metal ink was demonstrated as a generalist in directly making various basic electronic components such as planar resistor, inductor and capacitor or their combination and thus composing circuits with expected electrical functions. For a precise control of the geometric sizes of the writing, a mask with a designed pattern was employed and demonstrated. Mechanisms for justifying the chemical components of the inks and the magnitudes of the target electronic elements so as to compose various practical circuits were disclosed. Results: Fundamental tests on the electrical components including capacitor and inductor directly written on paper with working time up to 48 h and elevated temperature demonstrated their good stability and potential widespread adaptability especially when used in some high frequency circuits. As the first proof-of-concept experiment, a typical functional oscillating circuit including an integrated chip of 74HC04 with a supply voltage of 5 V, a capacitor of 10 nF and two resistors of 5 k Omega and 1 k Omega respectively was directly composed on paper through integrating specific electrical elements together, which presented an oscillation frequency of 8.8 kHz. Conclusions: The present method significantly extends the roles of the metal ink in recent works serving as only a single electrical conductor or interconnecting wires. It opens the way for directly writing out complex functional circuits or devices on different substrates. Such circuit composition strategy has generalized purpose and can be extended to more areas, even daily pervasive electronics.	[Gao, Yunxia; Li, Haiyan; Liu, Jing] Chinese Acad Sci, Key Lab Cryogen, Tech Inst Phys & Chem, Beijing, Peoples R China; [Gao, Yunxia; Li, Haiyan; Liu, Jing] Chinese Acad Sci, Beijing Key Lab CryoBiomed Engn, Tech Inst Phys & Chem, Beijing, Peoples R China; [Liu, Jing] Tsinghua Univ, Dept Biomed Engn, Sch Med, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS; Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS; Tsinghua University	Liu, J (corresponding author), Chinese Acad Sci, Key Lab Cryogen, Tech Inst Phys & Chem, Beijing, Peoples R China.	jliu@mail.ipc.ac.cn			Technical Institute of Physics and Chemistry, the Chinese Academy of Sciences	Technical Institute of Physics and Chemistry, the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is partially supported by the Technical Institute of Physics and Chemistry, the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aernouts T, 2004, THIN SOLID FILMS, V451, P22, DOI 10.1016/j.tsf.2003.11.038; Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Blaiszik BJ, 2012, ADV MATER, V24, P398, DOI 10.1002/adma.201102888; Chun KY, 2010, NAT NANOTECHNOL, V5, P853, DOI 10.1038/NNANO.2010.232; Cohen-Karni T, 2009, P NATL ACAD SCI USA, V106, P7309, DOI 10.1073/pnas.0902752106; De S, 2009, ACS NANO, V3, P1767, DOI 10.1021/nn900348c; Eom SH, 2009, ORG ELECTRON, V10, P536, DOI 10.1016/j.orgel.2009.01.015; Fan ZY, 2009, ADV MATER, V21, P3730, DOI 10.1002/adma.200900860; Fan ZY, 2009, NAT MATER, V8, P648, DOI [10.1038/NMAT2493, 10.1038/nmat2493]; Gao YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045485; Gao YX, 2012, APPL PHYS A-MATER, V107, P701, DOI 10.1007/s00339-012-6887-5; Gates BD, 2009, SCIENCE, V323, P1566, DOI 10.1126/science.1171230; Green AA, 2008, NANO LETT, V8, P1417, DOI 10.1021/nl080302f; Holman ZC, 2010, NANO LETT, V10, P2661, DOI 10.1021/nl101413d; Hu LB, 2010, ACS NANO, V4, P5843, DOI 10.1021/nn1018158; Hu LB, 2009, P NATL ACAD SCI USA, V106, P21490, DOI 10.1073/pnas.0908858106; Jeong JA, 2010, SOL ENERG MAT SOL C, V94, P1840, DOI 10.1016/j.solmat.2010.05.052; Jurchescu OD, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2903508; Jurchescu OD, 2007, ADV MATER, V19, P688, DOI 10.1002/adma.200600929; Kaga M, 1996, J AM DENT ASSOC, V127, P1195, DOI 10.14219/jada.archive.1996.0411; Kim D, 2009, LANGMUIR, V25, P11149, DOI 10.1021/la901436p; Kim N. S., 2010, J APPL PHYS, V108; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; McComb D, 1998, J Can Dent Assoc, V64, P645; Miyata Y, 2008, J PHYS CHEM C, V112, P3591, DOI 10.1021/jp077709d; Nikitin PV, 2004, IEEE ANTENNAS AND PROPAGATION SOCIETY SYMPOSIUM, VOLS 1-4 2004, DIGEST, P2035, DOI 10.1109/APS.2004.1330607; Park SI, 2009, SCIENCE, V325, P977, DOI 10.1126/science.1175690; Pyatenko A, 2007, J PHYS CHEM C, V111, P7910, DOI 10.1021/jp071080x; Rida A, 2009, IEEE ANTENN PROPAG M, V51, P13, DOI 10.1109/MAP.2009.5251188; Russo A, 2011, ADV MATER, V23, P3426, DOI 10.1002/adma.201101328; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Seo SJ, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/035106; Siegel AC, 2010, ADV FUNCT MATER, V20, P28, DOI 10.1002/adfm.200901363; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Tai YL, 2011, APPL SURF SCI, V257, P7096, DOI 10.1016/j.apsusc.2011.03.056; Tai YL, 2011, J MATER CHEM, V21, P5938, DOI 10.1039/c0jm03065a; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/nnano.2011.36, 10.1038/NNANO.2011.36]; Yoon J, 2008, NAT MATER, V7, P907, DOI 10.1038/nmat2287; Yu ZB, 2011, ADV MATER, V23, P4453, DOI 10.1002/adma.201101992	39	37	39	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69761	10.1371/journal.pone.0069761	http://dx.doi.org/10.1371/journal.pone.0069761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936349	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800023
J	Guo, W; Wong, S; Bhasin, S				Guo, Wen; Wong, Siu; Bhasin, Shalender			AAV-Mediated Administration of Myostatin Pro-Peptide Mutant in Adult Ldlr Null Mice Reduces Diet-Induced Hepatosteatosis and Arteriosclerosis	PLOS ONE			English	Article							IMPROVES INSULIN SENSITIVITY; FATTY LIVER-DISEASE; SKELETAL-MUSCLE; GENE-EXPRESSION; SIGNALING PATHWAYS; ACTIVIN RECEPTORS; ADIPOSE-TISSUE; PROTEIN-KINASE; DEFICIENT MICE; SMAD PROTEINS	Genetic disruption of myostatin or its related signaling is known to cause strong protection against diet-induced metabolic disorders. The translational value of these prior findings, however, is dependent on whether such metabolically favorable phenotype can be reproduced when myostatin blockade begins at an adult age. Here, we reported that AAV-mediated delivery of a myostatin pro-peptide D76A mutant in adult mice attenuates the development of hepatic steatosis and arteriosclerosis, two common diet-induced metabolic diseases. A single dose of AAV-D76A in adult Ldlr null mice resulted in sustained expression of myostatin pro-peptide in the liver. Compared to vehicle-treated mice, D76A-treated mice gained similar amount of lean and fat mass when fed a high fat diet. However, D76A-treated mice displayed significantly reduced aortic lesions and liver fat, in association with a reduction in hepatic expression of lipogenic genes and improvement in liver insulin sensitivity. This suggests that muscle and fat may not be the primary targets of treatment under our experimental condition. In support to this argument, we show that myostatin directly up-regulated lipogenic genes and increased fat accumulation in cultured liver cells. We also show that both myostatin and its receptor were abundantly expressed in mouse aorta. Cultured aortic endothelial cells responded to myostatin with a reduction in eNOS phosphorylation and an increase in ICAM-1 and VCAM-1 expression. Conclusions: AAV-mediated expression of myostatin pro-peptide D76A mutant in adult Ldlr null mice sustained metabolic protection without remarkable impacts on body lean and fat mass. Further investigations are needed to determine whether direct impact of myostatin on liver and aortic endothelium may contribute to the related metabolic phenotypes.	[Guo, Wen; Wong, Siu] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Guo, Wen; Bhasin, Shalender] Harvard Univ, Brigham & Womens Hosp, Boston Claude D Pepper Older Amer Independence Ct, Res Program Mens Hlth Aging & Metab,Med Sch, Boston, MA 02115 USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Guo, W (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	wguo2@partners.org		Guo, Wen/0000-0002-4474-2837	National Institutes of Health [RO1 DK059261, DK078512]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059261, R01DK078512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG037859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant RO1 DK059261 (WG) and DK078512 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shady M, 1999, AM J SURG, V177, P209, DOI 10.1016/S0002-9610(99)00012-4; Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Allen DL, 2011, MED SCI SPORT EXER, V43, P1828, DOI 10.1249/MSS.0b013e3182178bb4; Bostick B, 2007, GENE THER, V14, P1605, DOI 10.1038/sj.gt.3303029; Brezniceanu ML, 2006, KIDNEY INT, V69, P1977, DOI 10.1038/sj.ki.5000396; Buday A, 2010, AM J PHYSIOL-HEART C, V299, pH386, DOI 10.1152/ajpheart.01042.2009; Bugianesi E, 2010, FRONT GASTROINT RES, V26, P1; Burgess K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017090; Chen W, 2000, ENDOCRINOLOGY, V141, P1263, DOI 10.1210/en.141.3.1263; Choudhury J, 2005, FRONT BIOSCI-LANDMRK, V10, P1520; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; DASHTI N, 1987, J LIPID RES, V28, P423; Dong C, 2002, J HEART LUNG TRANSPL, V21, P999, DOI 10.1016/S1053-2498(02)00403-5; Ehnert S, 2010, ALCOHOL CLIN EXP RES, V34, P708, DOI 10.1111/j.1530-0277.2009.01140.x; FEIJEN A, 1994, DEVELOPMENT, V120, P3621; Foster K, 2009, REJUV RES, V12, P85, DOI 10.1089/rej.2008.0815; Gentile CL, 2011, ANTIOXID REDOX SIGN, V15, P505, DOI 10.1089/ars.2010.3790; Gold EJ, 2003, MOL CELL ENDOCRINOL, V201, P143, DOI 10.1016/S0303-7207(02)00417-3; Guernec A, 2004, DOMEST ANIM ENDOCRIN, V26, P143, DOI 10.1016/j.domaniend.2003.10.001; Guo TQ, 2012, DIABETES, V61, P2414, DOI 10.2337/db11-0915; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Guo W, 2009, ARTERIOSCL THROM VAS, V29, P2028, DOI 10.1161/ATVBAHA.109.191304; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Jung J, 2012, IMMUNOLOGY, V137, P98, DOI 10.1111/j.1365-2567.2012.03618.x; Kardassis D, 2000, J BIOL CHEM, V275, P41405, DOI 10.1074/jbc.M007896200; Kohjima M, 2008, INT J MOL MED, V21, P507; Kotzka J, 2010, ATHEROSCLEROSIS, V213, P156, DOI 10.1016/j.atherosclerosis.2010.08.046; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li DY, 2006, BIOCHEM BIOPH RES CO, V344, P701, DOI 10.1016/j.bbrc.2006.04.010; Lyons JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012928; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217; Milan G, 2004, J CLIN ENDOCR METAB, V89, P2724, DOI 10.1210/jc.2003-032047; Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176; Ponnuswamy P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030193; Qiao CP, 2008, HUM GENE THER, V19, P241, DOI 10.1089/hum.2007.159; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Samuel W, 2002, J BIOL CHEM, V277, P59, DOI 10.1074/jbc.M108730200; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Tu P, 2009, DIABETES, V58, P1739, DOI 10.2337/db09-0349; Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yao Zemin, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P133; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71017	10.1371/journal.pone.0071017	http://dx.doi.org/10.1371/journal.pone.0071017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936482	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400088
J	Perez-Padilla, R; Wehrmeister, FC; Celli, BR; Lopez-Varela, MV; de Oca, MM; Muino, A; Talamo, C; Jardim, JR; Valdivia, G; Lisboa, C; Menezes, AMB				Perez-Padilla, Rogelio; Wehrmeister, Fernando C.; Celli, Bartolome R.; Victorina Lopez-Varela, Maria; Montes de Oca, Maria; Muino, Adriana; Talamo, Carlos; Jardim, Jose R.; Valdivia, Gonzalo; Lisboa, Carmen; Menezes, Ana Maria B.		PLATINO Team	Reliability of FEV1/FEV6 to Diagnose Airflow Obstruction Compared with FEV1/FVC: The PLATINO Longitudinal Study	PLOS ONE			English	Article							LATIN-AMERICAN CITIES; SPIROMETRIC REFERENCE VALUES; PULMONARY-DISEASE; COPD; PREVALENCE; PIKO-6(R); RATIO; FEV6; FVC	QUESTION: A 6-second spirometry test is easier than full exhalations. We compared the reliability of the ratio of the Forced expiratory volume in 1 second/Forced expiratory volume in 6 seconds (FEV1/FEV6) to the ratio of the FEV1/Forced vital capacity (FEV1/FVC) for the detection of airway obstruction. METHODS: The PLATINO population-based survey in individuals aged 40 years and over designed to estimate the prevalence of post-Bronchodilator airway obstruction repeated for the same study participants after 5-9 years in three Latin-American cities. RESULTS: Using the FEV1/FVC<Lower limit of normal (LLN) index, COPD prevalence apparently changed from 9.8 to 13.2% in Montevideo, from 9.7 to 6.0% in Sao Paulo and from 8.5 to 6.6% in Santiago, despite only slight declines in smoking prevalence (from 30.8% to 24.3%). These changes were associated with differences in Forced expiratory time (FET) between the two surveys. In contrast, by using the FEV1/FEV6 to define airway obstruction, the changes in prevalence were smaller: 9.7 to 10.6% in Montevideo, 8.6 to 9.0% in Sao Paulo, and 7.5 to 7.9% in Santiago. Changes in the prevalence of COPD with criteria based on FEV1/FVC correlated strongly with changes in the FET of the tests (R-2 0.92) unlike the prevalence based on a low FEV1/FEV6 (R-2 = 0.40). CONCLUSION: The FEV1/FEV6 is a more reliable index than FEV1/FVC because FVC varies with the duration of the forced exhalation. Reporting FET and FEV1/FEV6, LLN helps to understand differences in prevalence of COPD obtained from FEV1/FVC-derived indices.	[Perez-Padilla, Rogelio] Natl Inst Resp Dis INER, Mexico City, DF, Mexico; [Wehrmeister, Fernando C.; Menezes, Ana Maria B.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Celli, Bartolome R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Pulm & Crit Care Dept, Boston, MA 02115 USA; [Victorina Lopez-Varela, Maria; Muino, Adriana] Univ Republica, Fac Med, Montevideo, Uruguay; [Montes de Oca, Maria; Talamo, Carlos] Cent Univ Venezuela, Fac Med, Caracas, Venezuela; [Jardim, Jose R.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Valdivia, Gonzalo; Lisboa, Carmen] Pontificia Univ Catolica Chile, Santiago, Chile	Universidade Federal de Pelotas; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidad de la Republica, Uruguay; University of Central Venezuela; Universidade Federal de Sao Paulo (UNIFESP); Pontificia Universidad Catolica de Chile	Perez-Padilla, R (corresponding author), Natl Inst Resp Dis INER, Mexico City, DF, Mexico.	perezpad@gmail.com	Wehrmeister, Fernando/A-3006-2014; Menezes, Ana MB/G-7266-2012; Jardim, Jose R/E-3205-2016; de, Maria Montes/AAP-7687-2021	Wehrmeister, Fernando/0000-0001-7137-1747; Menezes, Ana MB/0000-0002-2996-9427; Rosa, Fernanda/0000-0002-5601-1898; Camelier, Aquiles/0000-0001-5410-5180; Moreno, Dolores/0000-0002-6481-1377	ALAT; Boehringer Ingelheim GmbH; Glaxo SmithKline; Novartis	ALAT; Boehringer Ingelheim GmbH(Boehringer Ingelheim); Glaxo SmithKline(GlaxoSmithKline); Novartis(Novartis)	Funding was provided by ALAT, Boehringer Ingelheim GmbH, Glaxo SmithKline, Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Enright PL, 2002, RESP MED, V96, P444, DOI 10.1053/rmed.2001.1270; Frith P, 2011, PRIM CARE RESP J, V20, P190, DOI 10.4104/pcrj.2011.00040; Hankinson JL, 2003, CHEST, V124, P1805, DOI 10.1378/chest.124.5.1805; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Jing JY, 2009, CHEST, V135, P991, DOI 10.1378/chest.08-0723; Kaufmann M, 2009, RESPIRATION, V78, P161, DOI 10.1159/000197466; Lamprecht B, 2007, AM J RESP CRIT CARE, V176, P460, DOI 10.1164/rccm.200702-337OC; Varela MVL, 2010, EUR RESPIR J, V36, P1034, DOI 10.1183/09031936.00165409; Lundgren Fernando Luiz Cavalcanti, 2007, J. bras. pneumol., V33, P148, DOI 10.1590/S1806-37132007000200008; Melbye Hasse, 2006, Prim Care Respir J, V15, P294, DOI 10.1016/j.pcrj.2006.07.002; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Menezes Ana M B, 2004, BMC Med Res Methodol, V4, P15, DOI 10.1186/1471-2288-4-15; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montes de Oca M, 2012, EUR RESP J, V2012; de Oca MM, 2009, RESP MED, V103, P1376, DOI 10.1016/j.rmed.2009.03.005; de Oca MM, 2009, CHEST, V136, P71, DOI 10.1378/chest.08-2081; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; Perez-Padilla Rogelio, 2007, COPD, V4, P113, DOI 10.1080/15412550701341012; Perez-Padilla R, 2006, RESP CARE, V51, P1167; Perez-Padilla R, 2006, ARCH BRONCONEUMOL, V42, P317, DOI 10.1157/13090581; Perez-Padilla R, 2008, RESP CARE, V53, P1019; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rosa FW, 2007, BRAZ J MED BIOL RES, V40, P1615, DOI 10.1590/S0100-879X2007001200004; Sichletidis L, 2011, PRIM CARE RESP J, V20, P184, DOI 10.4104/pcrj.2011.00038; Vandevoorde J, 2005, CHEST, V127, P1560, DOI 10.1378/chest.127.5.1560; Vollmer WM, 2009, EUR RESPIR J, V34, P588, DOI 10.1183/09031936.00164608	29	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e67960	10.1371/journal.pone.0067960	http://dx.doi.org/10.1371/journal.pone.0067960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936297	Green Published, gold			2022-12-27	WOS:000324518400007
J	Zhang, H; Holden-Wiltse, J; Wang, J; Liang, H				Zhang, Hui; Holden-Wiltse, Jeanne; Wang, Jiong; Liang, Hua			A Strategy to Model Nonmonotonic Dose-Response Curve and Estimate IC50	PLOS ONE			English	Article							HIV-1 INFECTION; RISK ASSESSMENT; EFAVIRENZ; THERAPY; PROTEIN; CELLS; MONOTONICITY; RESISTANCE; INHIBITORS; REGRESSION	The half-maximal inhibitory concentration IC50 is an important pharmacodynamic index of drug effectiveness. To estimate this value, the dose response relationship needs to be established, which is generally achieved by fitting monotonic sigmoidal models. However, recent studies on Human Immunodeficiency Virus (HIV) mutants developing resistance to antiviral drugs show that the dose response curve may not be monotonic. Traditional models can fail for nonmonotonic data and ignore observations that may be of biologic significance. Therefore, we propose a nonparametric model to describe the dose response relationship and fit the curve using local polynomial regression. The nonparametric approach is shown to be promising especially for estimating the IC50 of some HIV inhibitory drugs, in which there is a dose-dependent stimulation of response for mutant strains. This model strategy may be applicable to general pharmacologic, toxicologic, or other biomedical data that exhibits a nonmonotonic dose response relationship for which traditional parametric models fail.	[Zhang, Hui] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Holden-Wiltse, Jeanne; Liang, Hua] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Wang, Jiong] Univ Rochester, Med Ctr, Dept Med & Microbiol & Immunol, Rochester, NY 14642 USA	St Jude Children's Research Hospital; University of Rochester; University of Rochester	Zhang, H (corresponding author), St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA.	hui.zhang@stjude.org		Wang, Jiong/0000-0002-4938-5074; Zhang, Hui/0000-0001-6825-5649	National Institute of Allergy and Infectious Diseases/National Institutes of Health [HHSN272201000055C]; National Science Foundation [DMS-1007167, DMS-1207444]	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF))	The research of Holden-Wiltse and Liang was partially supported by the National Institute of Allergy and Infectious Diseases/National Institutes of Health grants HHSN272201000055C. Liang's research was also partially supported by National Science Foundation grants DMS-1007167 and DMS-1207444. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacheler L, 2001, J VIROL, V75, P4999, DOI 10.1128/JVI.75.11.4999-5008.2001; Bacheler LT, 2000, ANTIMICROB AGENTS CH, V44, P2475, DOI 10.1128/AAC.44.9.2475-2484.2000; Bliss CI, 1941, J ECON ENTOMOL, V34, P221, DOI 10.1093/jee/34.2.221; Bowman AW, 1998, J COMPUT GRAPH STAT, V7, P489, DOI 10.2307/1390678; DAVIS JM, 1990, J TOXICOL ENV HEALTH, V30, P71, DOI 10.1080/15287399009531412; Domaoal RA, 2006, JAIDS-J ACQ IMM DEF, V42, P405, DOI 10.1097/01.qai.0000222288.90201.33; Gallicchio M, 2006, BRIT J PHARMACOL, V147, P681, DOI 10.1038/sj.bjp.0706660; Gibbs BF, 2006, J ALLERGY CLIN IMMUN, V118, P1060, DOI 10.1016/j.jaci.2006.07.022; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hall P, 2000, ANN STAT, V28, P20; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; HUANG W, 2000, ANTIVIR THER S, V5, P24; Jianqing Fan, 1996, LOCAL POLYNOMIAL MOD, V66; KOHN MC, 1995, TOXICOLOGY, V102, P133, DOI 10.1016/0300-483X(95)03042-E; Koval CE, 2006, VIROLOGY, V353, P184, DOI 10.1016/j.virol.2006.05.021; Masuda K, 1999, BIOCHEM J, V342, P79, DOI 10.1042/0264-6021:3420079; Poland GA, 2005, MAYO CLIN PROC, V80, P601, DOI 10.4065/80.5.601; PRENTICE RL, 1976, BIOMETRICS, V32, P761, DOI 10.2307/2529262; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Ramsay J. O., 1988, STAT SCI, V3, P425, DOI DOI 10.1214/SS/1177012761; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; SAGAN LA, 1987, HEALTH PHYS, V52, P521; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; STEBBING ARD, 1982, SCI TOTAL ENVIRON, V22, P213, DOI 10.1016/0048-9697(82)90066-3; Visnjic D, 1999, BIOCHEM J, V344, P921, DOI 10.1042/0264-6021:3440921; Wang J, 2010, VIROLOGY, V402, P228, DOI 10.1016/j.virol.2010.03.018	26	56	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69301	10.1371/journal.pone.0069301	http://dx.doi.org/10.1371/journal.pone.0069301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936323	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400013
J	Ellison-Loschmann, L; McKenzie, F; Highnam, R; Cave, A; Walker, J; Jeffreys, M				Ellison-Loschmann, Lis; McKenzie, Fiona; Highnam, Ralph; Cave, Andrew; Walker, Jenny; Jeffreys, Mona			Age and Ethnic Differences in Volumetric Breast Density in New Zealand Women: A Cross-Sectional Study	PLOS ONE			English	Article							MAMMOGRAPHIC DENSITY; CANCER RISK; PARENCHYMAL PATTERNS; THERAPY; TRENDS; MAORI	Breast cancer incidence differs by ethnicity in New Zealand (NZ) with Maori (the indigenous people) women having the highest rates followed by Pakeha (people primarily of British/European descent), Pacific and Asian women, who experience the lowest rates. The reasons for these differences are unclear. Breast density, an important risk factor for breast cancer, has not previously been studied here. We used an automated system, Volpara (TM), to measure breast density volume from the medio-lateral oblique view of digital mammograms, by age (<= 50 years and >50 years) and ethnicity (Pakeha/Maori/Pacific/Asian) using routine data from the national screening programme: age; x-ray system and mammography details for 3,091 Pakeha, 716 Maori, 170 Pacific and 662 Asian (total n = 4,239) women. Linear regression of the natural logarithm of absolute and percent density values was used, back-transformed and expressed as the ratio of the geometric means. Covariates were age, x-ray system and, for absolute density, the natural log of the volume of non-dense tissue (a proxy for body mass index). Median age for Pakeha women was 55 years; Maori 53 years; and Pacific and Asian women, 52 years. Compared to Pakeha women (reference), Maori had higher absolute volumetric density (1.09; 95% confidence interval [95% CI] 1.03-1.15) which remained following adjustment (1.06; 95% CI 1.01-1.12) and was stronger for older compared to younger Maori women. Asian women had the greatest risk of high percentage breast density (1.35; 95% CI 1.27-1.43) while Pacific women in both the <= 50 and >50 year age groups (0.78; 95% CI 0.66-0.92 and 0.81; 95% CI 0.71-0.93 respectively) had the lowest percentage breast density compared to Pakeha. As well as expected age differences, we found differential patterns of breast density by ethnicity consistent with ethnic differences seen in breast cancer risk. Breast density may be a contributing factor to NZ's well-known, but poorly explained, inequalities in breast cancer incidence.	[Ellison-Loschmann, Lis; McKenzie, Fiona] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [McKenzie, Fiona] Int Agcy Res Canc, F-69372 Lyon, France; [Highnam, Ralph] Matakina Technol Ltd, Wellington, New Zealand; [Cave, Andrew; Walker, Jenny] Waitemata Dist Hlth Board, Auckland, New Zealand; [Jeffreys, Mona] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	Massey University; World Health Organization; International Agency for Research on Cancer (IARC); University of Bristol	Ellison-Loschmann, L (corresponding author), Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand.	l.ellison-loschmann@massey.ac.nz	Jeffreys, Mona/W-3425-2019	Jeffreys, Mona/0000-0002-2617-0361	Wellcome Trust (United Kingdom); Genesis Oncology Trust (New Zealand); Health Research Council of New Zealand	Wellcome Trust (United Kingdom)(Wellcome Trust); Genesis Oncology Trust (New Zealand); Health Research Council of New Zealand(Health Research Council of New Zealand)	MJ is currently a recipient of Wellcome Trust Institutional Strategic Support funding (United Kingdom). FM is currently funded through a Genesis Oncology Trust (New Zealand) post-doctoral fellowship. The Centre for Public Health Research, Massey University Wellington, is partly funded through a programme grant from the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM COLL RAD, 2003, AM COLL RAD ACR BREA; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Armstrong W, 1996, NEW ZEAL MED J, V109, P221; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 2006, CANCER EPIDEM BIOMAR, V15, P2086, DOI 10.1158/1055-9965.EPI-06-0345; Boyd NF, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2423; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Chen ZJ, 2004, AM J EPIDEMIOL, V159, P140, DOI 10.1093/aje/kwh028; Cox B, 2010, BREAST CANCER RES TR, V124, P793, DOI 10.1007/s10549-010-0893-0; Cunningham R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-674; Curtis E, 2005, NZ MED J, V118; del Carmen MG, 2007, AM J ROENTGENOL, V188, P1147, DOI 10.2214/AJR.06.0619; Habel LA, 2007, MENOPAUSE, V14, P891, DOI 10.1097/gme.0b013e318032569c; Highnam R, 2010, INT WORKSH DIG MAMM, P651; Lawton BA, 2008, CLIMACTERIC, V11, P467, DOI 10.1080/13697130802351094; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Maskarinec G, 2005, AM J EPIDEMIOL, V162, P743, DOI 10.1093/aje/kwi270; Maskarinec G, 2007, BREAST CANCER RES TR, V104, P47, DOI 10.1007/s10549-006-9387-5; McCormack VA, 2008, AM J EPIDEMIOL, V168, P412, DOI 10.1093/aje/kwn169; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; McCredie M, 1999, INT J EPIDEMIOL, V28, P189, DOI 10.1093/ije/28.2.189; McKenzie F, 2010, CANCER EPIDEMIOL, V34, P702, DOI 10.1016/j.canep.2010.07.007; McLeod M, 2011, DHB HOSP ADV COMM M; Ministry of Health, 2012, CANC NEW REG DEATHS; Ministry of Social Development, 2010, SOC REP 2010 TE PUR; Page A, 2011, BREASTSCREEN AOTEAOR; Roubidoux MA, 2003, CANCER EPIDEM BIOMAR, V12, P1081; Sauber N, 2011, 11 INT WORKSH BREAST, P466; Simmonds S, 2008, 1 U OT TE ROOP RANG; Statistics New Zealand, 2004, FERTILITY NZ WOMEN E; Statistics New Zealand, 2012, EST RES POP NZ; Stone J, 2009, AM J EPIDEMIOL, V170, P1571, DOI 10.1093/aje/kwp313; Tseng M, 2006, CANCER EPIDEM BIOMAR, V15, P1301, DOI 10.1158/1055-9965.EPI-06-0159; University of Otago, 2011, FOC NUTR KEY FIND 20; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829	37	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70217	10.1371/journal.pone.0070217	http://dx.doi.org/10.1371/journal.pone.0070217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936166	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700060
J	Paino, A; Ahlstrand, T; Nuutila, J; Navickaite, I; Lahti, M; Tuominen, H; Valimaa, H; Lamminmaki, U; Pollanen, MT; Ihalin, R				Paino, Annamari; Ahlstrand, Tuuli; Nuutila, Jari; Navickaite, Indre; Lahti, Maria; Tuominen, Heidi; Valimaa, Hannamari; Lamminmaki, Urpo; Pollanen, Marja T.; Ihalin, Riikka			Identification of a Novel Bacterial Outer Membrane Interleukin-1B-Binding Protein from Aggregatibacter actinomycetemcomitans	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT CELLS; MEDIATES BIOFILM FORMATION; HUMAN GINGIVAL FIBROBLASTS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; SIGNAL PEPTIDES; IN-VIVO; BINDING	Aggregatibacter actinomycetemcomitans is a gram-negative opportunistic oral pathogen. It is frequently associated with subgingival biofilms of both chronic and aggressive periodontitis, and the diseased sites of the periodontium exhibit increased levels of the proinflammatory mediator interleukin (IL)-1 beta. Some bacterial species can alter their physiological properties as a result of sensing IL-1 beta. We have recently shown that this cytokine localizes to the cytoplasm of A. actinomycetemcomitans in co-cultures with organotypic gingival mucosa. However, current knowledge about the mechanism underlying bacterial IL-1 beta sensing is still limited. In this study, we characterized the interaction of A. actinomycetemcomitans total membrane protein with IL-1 beta through electrophoretic mobility shift assays. The interacting protein, which we have designated bacterial interleukin receptor I (BilRI), was identified through mass spectrometry and was found to be Pasteurellaceae specific. Based on the results obtained using protein function prediction tools, this protein localizes to the outer membrane and contains a typical lipoprotein signal sequence. All six tested biofilm cultures of clinical A. actinomycetemcomitans strains expressed the protein according to phage display-derived antibody detection. Moreover, proteinase K treatment of whole A. actinomycetemcomitans cells eliminated BilRI forms that were outer membrane specific, as determined through immunoblotting. The protein was overexpressed in Escherichia coli in both the outer membrane-associated form and a soluble cytoplasmic form. When assessed using flow cytometry, the BilRI-overexpressing E. coli cells were observed to bind 2.5 times more biotinylated-IL-1 beta than the control cells, as detected with avidin-FITC. Overexpression of BilRI did not cause binding of a biotinylated negative control protein. In a microplate assay, soluble BilRI bound to IL-1 beta, but this binding was not specific, as a control protein for IL-1 beta also interacted with BilRI. Our findings suggest that A. actinomycetemcomitans expresses an IL-1 beta-binding surface-exposed lipoprotein that may be part of the bacterial IL-1 beta-sensing system.	[Paino, Annamari; Ahlstrand, Tuuli; Nuutila, Jari; Navickaite, Indre; Lahti, Maria; Tuominen, Heidi; Lamminmaki, Urpo; Ihalin, Riikka] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland; [Valimaa, Hannamari] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Valimaa, Hannamari] Helsinki Univ Hosp, Helsinki Univ Hosp Lab HUSLAB, Helsinki, Finland; [Pollanen, Marja T.] Univ Turku, Inst Dent, FIN-20014 Turku, Finland	University of Turku; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku	Ihalin, R (corresponding author), Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland.	riikka.ihalin@utu.fi	Ihalin, Riikka/I-4411-2019; Tuominen, Heidi/A-7075-2010	Ihalin, Riikka/0000-0003-4118-0370; Tuominen, Heidi/0000-0003-2412-7658; Valimaa, Hannamari/0000-0002-2187-2399; Koivunen, Tuuli/0000-0002-6720-0379; Nuutila, Jari/0000-0002-9077-0273	Academy of Finland; Paulo Foundation; Ella and Georg Ehrnrooth Foundation; Finnish Dental Society Apollonia	Academy of Finland(Academy of Finland); Paulo Foundation; Ella and Georg Ehrnrooth Foundation; Finnish Dental Society Apollonia	This work was supported by the grants form the Academy of Finland (http://www.aka.fi/en-GB/A/), the Paulo Foundation (http://www.paulo.fi/in-english), The Ella and Georg Ehrnrooth Foundation (http://www.ellageorg.fi/en/about), and the Finnish Dental Society Apollonia (http://www.apollonia.fi/Apollonia/www5.nsf/sp?open&cid=home) to RI, Biocenter Finland (http://www.biocenter.fi/) to UL and ML, and Erasmus to IN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; Bauer ME, 2009, J INFECT DIS, V199, P684, DOI 10.1086/596656; Belibasakis G, 2002, EUR J ORAL SCI, V110, P366, DOI 10.1034/j.1600-0722.2002.21350.x; Belibasakis GN, 2012, CYTOKINE, V59, P124, DOI 10.1016/j.cyto.2012.03.016; Belibasakis GN, 2004, APMIS, V112, P674, DOI 10.1111/j.1600-0463.2004.apm1121006.x; Belibasakis GN, 2005, INFECT IMMUN, V73, P342, DOI 10.1128/IAI.73.1.342-351.2005; BENZ R, 1981, BIOCHIM BIOPHYS ACTA, V646, P298, DOI 10.1016/0005-2736(81)90336-9; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Brockmann EC, 2011, PROTEIN ENG DES SEL, V24, P691, DOI 10.1093/protein/gzr023; Chang TW, 2012, J BIOL CHEM, V287, P418, DOI 10.1074/jbc.M111.290361; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Fine DH, 2006, PERIODONTOL 2000, V42, P114, DOI 10.1111/j.1600-0757.2006.00189.x; Frias-Lopez J, 2012, J BACTERIOL, V194, P2082, DOI 10.1128/JB.06328-11; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; HUOVINEN T, PROTEIN ENG DE UNPUB; Hyvarinen K, 2012, ATHEROSCLEROSIS, V223, P478, DOI 10.1016/j.atherosclerosis.2012.05.021; Imai K, 2008, BIOINFORMATION, V2, P417, DOI 10.6026/97320630002417; Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kanangat S, 2001, J INFECT DIS, V183, P65, DOI 10.1086/317645; Kanangat S, 2007, MICROBES INFECT, V9, P408, DOI 10.1016/j.micinf.2006.12.018; Kaplan JB, 2003, J BACTERIOL, V185, P1399, DOI 10.1128/JB.185.4.1399-1404.2003; Kaplan JB, 2001, INFECT IMMUN, V69, P5375, DOI 10.1128/IAI.69.9.5375-5384.2001; KARLYSHEV AV, 1992, FEBS LETT, V297, P77, DOI 10.1016/0014-5793(92)80331-A; Kelk P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.6; Kelk P, 2003, INFECT IMMUN, V71, P4448, DOI 10.1128/IAI.71.8.4448-4455.2003; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Krishnan S, 2012, FEBS J, V279, P919, DOI 10.1111/j.1742-4658.2012.08482.x; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUO GY, 1993, INFECT IMMUN, V61, P830, DOI 10.1128/IAI.61.3.830-835.1993; McLaughlin RA, 2006, MICROB PATHOGENESIS, V41, P67, DOI 10.1016/j.micpath.2006.04.005; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OConnell KL, 1997, ELECTROPHORESIS, V18, P349, DOI 10.1002/elps.1150180309; Paino A, 2012, CYTOKINE, V60, P565, DOI 10.1016/j.cyto.2012.07.024; Paino A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018929; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PORAT R, 1991, SCIENCE, V254, P430, DOI 10.1126/science.1833820; Rosen G, 2003, INFECT IMMUN, V71, P3652, DOI 10.1128/IAI.71.6.3652-3656.2003; Sanchez MC, 2011, J PERIODONTAL RES, V46, P252, DOI 10.1111/j.1600-0765.2010.01341.x; Shell DM, 2002, INFECT IMMUN, V70, P3744, DOI 10.1128/IAI.70.7.3744-3751.2002; STASHENKO P, 1991, J CLIN PERIODONTOL, V18, P548, DOI 10.1111/j.1600-051X.1991.tb00088.x; Suzuki N, 2001, J CLIN MICROBIOL, V39, P2002, DOI 10.1128/JCM.39.5.2002-2005.2001; TAICHMAN NS, 1980, INFECT IMMUN, V28, P258, DOI 10.1128/IAI.28.1.258-268.1980; Teles RP, 2010, J CLIN PERIODONTOL, V37, P313, DOI 10.1111/j.1600-051X.2010.01534.x; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; Weiss EI, 2000, ORAL MICROBIOL IMMUN, V15, P371, DOI 10.1034/j.1399-302x.2000.150606.x; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yu X, 2009, BIOCHEM J, V418, P541, DOI 10.1042/BJ20080992; Yuan LH, 2005, INFECT IMMUN, V73, P4146, DOI 10.1128/IAI.73.7.4146-4154.2005; Yuan L, 2008, MICROBIOL-SGM, V154, P1161, DOI 10.1099/mic.0.2007/015131-0; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x; ZAVYALOV V, 1995, IMMUNOL LETT, V45, P19, DOI 10.1016/0165-2478(94)00194-V; ZAVYALOV VP, 1995, FEBS LETT, V371, P65, DOI 10.1016/0014-5793(95)00878-D	66	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70509	10.1371/journal.pone.0070509	http://dx.doi.org/10.1371/journal.pone.0070509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936223	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700077
J	Blankevoort, CG; Scherder, EJA; Wieling, MB; Hortobagyi, T; Brouwer, WH; Geuze, RH; van Heuvelen, MJG				Blankevoort, Christiaan G.; Scherder, Erik J. A.; Wieling, Martijn B.; Hortobagyi, Tibor; Brouwer, Wiebo H.; Geuze, Reint H.; van Heuvelen, Marieke J. G.			Physical Predictors of Cognitive Performance in Healthy Older Adults: A Cross-Sectional Analysis	PLOS ONE			English	Article							MINI-MENTAL-STATE; GAIT SPEED; EXECUTIVE FUNCTION; GENDER-DIFFERENCES; INDIVIDUAL-DIFFERENCES; AEROBIC FITNESS; ELDERLY-PEOPLE; WALKING SPEED; AGE; STRENGTH	There is ample evidence that physical and cognitive performance are related, but the results of studies investigating this relationship show great variability. Both physical performance and cognitive performance are constructs consisting of several subdomains, but it is presently unknown if the relationship between physical and cognitive performance depends on subdomain of either construct and whether gender and age moderate this relationship. The aim of this study is to identify the strongest physical predictors of cognitive performance, to determine the specificity of these predictors for various cognitive subdomains, and to examine gender and age as potential moderators of the relationship between physical and cognitive performance in a sample of community-dwelling older adults. In total, 98 men and 122 women (average age 74.0 +/- 5.6 years) were subjected to a series of performance-based physical fitness and neuropsychological tests. Muscle strength, balance, functional reach, and walking ability (combined score of walking speed and endurance) were considered to predict cognitive performance across several domains (i.e. memory, verbal attention, visual attention, set-shifting, visuo-motor attention, inhibition and intelligence). Results showed that muscle strength was a significant predictor of cognitive performance for men and women. Walking ability and balance were significant predictors of cognitive performance for men, whereas only walking ability was significant for women. We did not find a moderating effect of age, nor did we find support for a differential effect of the physical predictors across different cognitive subdomains. In summary, our results showed a significant relationship between cognitive and physical performance, with a moderating effect of gender.	[Blankevoort, Christiaan G.; Scherder, Erik J. A.; Hortobagyi, Tibor; van Heuvelen, Marieke J. G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Scherder, Erik J. A.] Vrije Univ Amsterdam, Dept Neuropsychol, Amsterdam, Netherlands; [Wieling, Martijn B.] Univ Tubingen, Dept Quantitat Linguist, Tubingen, Germany; [Brouwer, Wiebo H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Geuze, Reint H.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands	University of Groningen; Vrije Universiteit Amsterdam; Eberhard Karls University of Tubingen; University of Groningen; University of Groningen	Blankevoort, CG (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	c.g.blankevoort@gmail.com	Wieling, Martijn/AAA-2462-2019	Wieling, Martijn/0000-0003-0434-1526	University Medical Center Groningen	University Medical Center Groningen	The research was funded by the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna E, 2004, ST CLASS DAT ANAL, P639; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anstey KJ, 1997, PSYCHOL AGING, V12, P137, DOI 10.1037/0882-7974.12.1.137; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Black SA, 2002, J AM GERIATR SOC, V50, P1978, DOI 10.1046/j.1532-5415.2002.50609.x; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Boban M, 2012, DEMENT GERIATR COGN, V33, P385, DOI 10.1159/000339596; Cleophas EP, 2011, AM J THER; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Desrosiers J, 1999, EXP GERONTOL, V34, P393, DOI 10.1016/S0531-5565(99)00018-2; Era Pertti, 2002, Aging Clin Exp Res, V14, P37; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Fitzpatrick AL, 2007, J GERONTOL A-BIOL, V62, P1244, DOI 10.1093/gerona/62.11.1244; FOLSOM AR, 1986, J CHRON DIS, V39, P505, DOI 10.1016/0021-9681(86)90195-5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Goldon CJ, 1978, STROOP COLOR WORD TE; Graaf A, 1991, COGNITIEVE SCREENING; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Hawkes TD, 2012, GAIT POSTURE, V35, P159, DOI 10.1016/j.gaitpost.2011.09.001; Huh Y, 2011, ARCH GERONTOL GERIAT, V52, pE156, DOI 10.1016/j.archger.2010.10.018; Jiang W, 2011, GERIATR GERONTOL INT; Kaushanskaya M, 2011, ACTA PSYCHOL, V137, P24, DOI 10.1016/j.actpsy.2011.02.002; Kempen GIJM, 1997, HEALTH PSYCHOL, V16, P539, DOI 10.1037/0278-6133.16.6.539; Kuo HK, 2007, GERONTOLOGY, V53, P102, DOI 10.1159/000096792; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Liu-Ambrose T, 2013, BRIT J SPORT MED, V47, P115, DOI 10.1136/bjsports-2011-090725; Liu-Ambrose T, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-25; Lynch GS, 2004, INTERN MED J, V34, P294, DOI 10.1111/j.1444-0903.2004.00568.x; Malmstrom TK, 2005, J AM GERIATR SOC, V53, P997, DOI 10.1111/j.1532-5415.2005.53318.x; Maylor EA, 2007, ARCH SEX BEHAV, V36, P235, DOI 10.1007/s10508-006-9155-y; McGough EL, 2011, PHYS THER, V91, P1198, DOI 10.2522/ptj.20100372; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; Miller DI, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.020; Misteli M, 2011, BRAIN COGNITION, V76, P123, DOI 10.1016/j.bandc.2011.02.009; Mura T, 2010, EUR J NEUROL, V17, P252, DOI 10.1111/j.1468-1331.2009.02783.x; Nakamura T, 1997, ALZ DIS ASSOC DIS, V11, P132, DOI 10.1097/00002093-199709000-00005; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Netz Y, 2011, INT PSYCHOGERIATR, V23, P114, DOI 10.1017/S1041610210000797; Pinheiro JC, 2000, MIXED EFFECTS MODESL; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reitan RM, 1985, HALSTEAD REITAN NEUR; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rosano C, 2005, NEUROEPIDEMIOLOGY, V24, P8, DOI 10.1159/000081043; Rosano C, 2010, NEUROBIOL AGING, V31, P1197, DOI 10.1016/j.neurobiolaging.2008.08.004; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Rubin DB, 2004, MULTIPLE IMPUTATION; RUDISILL ME, 1993, PERCEPT MOTOR SKILL, V77, P939, DOI 10.2466/pms.1993.77.3.939; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Scherder EJA, 2010, AM J PHYS MED REHAB, V89, P458, DOI 10.1097/PHM.0b013e3181d3e9f6; Schmidt M., 1996, W PSYCHOL SERVICES; Shim EY, 2011, KOREAN J FAM MED, V32, P249, DOI 10.4082/kjfm.2011.32.4.249; Shimada H, 2011, ARCH GERONTOL GERIAT, V53, P131, DOI 10.1016/j.archger.2010.11.003; Slaets JPJ, 2006, MED CLIN N AM, V90, P593, DOI 10.1016/j.mcna.2006.05.008; Sorond FA, 2011, ANN NEUROL, V70, P213, DOI 10.1002/ana.22433; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Statistics Netherlands, 2012, VERSCH LON UITK LAAT; Tabachnik B. G., 2001, USING MULTIVARIATE S; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; van Duin C, 2011, BEVOLKINGSPROGNOSE 2; van Heuvelen MJG, 2006, GERONTOLOGY, V52, P366, DOI 10.1159/000094986; van Heuvelen MJG, 2005, AGING CLIN EXP RES, V17, P236, DOI 10.1007/BF03324603; Van Heuvelen MJG, 1998, MED SCI SPORT EXER, V30, P434, DOI 10.1097/00005768-199803000-00015; Verkerke GJ, 2003, MED BIOL ENG COMPUT, V41, P283, DOI 10.1007/BF02348432; Voelcker-Rehage C, 2010, EUR J NEUROSCI, V31, P167, DOI 10.1111/j.1460-9568.2009.07014.x; Volkers KM, 2012, ARCH GERONTOL GERIAT, V54, P399, DOI 10.1016/j.archger.2011.04.018; Wang L, 2006, ARCH INTERN MED, V166, P1115, DOI 10.1001/archinte.166.10.1115; Waters D L, 2000, J Nutr Health Aging, V4, P133; Wechsler D., 2004, WECHSLER MEMORY SCAL; Weinstein AM, 2012, BRAIN BEHAV IMMUN, V26, P811, DOI 10.1016/j.bbi.2011.11.008; Wilson B. A., 1997, BEHAV ASSESSMENT DYS; Zelinski EM, 1998, PSYCHOL AGING, V13, P622, DOI 10.1037/0882-7974.13.4.622	75	35	36	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70799	10.1371/journal.pone.0070799	http://dx.doi.org/10.1371/journal.pone.0070799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201AX	23936251	Green Published, gold			2022-12-27	WOS:000323114200105
J	Bress, A; Han, J; Patel, SR; Desai, AA; Mansour, I; Groo, V; Progar, K; Shah, E; Stamos, TD; Wing, C; Garcia, JGN; Kittles, R; Cavallari, LH				Bress, Adam; Han, Jin; Patel, Shitalben R.; Desai, Ankit A.; Mansour, Ibrahim; Groo, Vicki; Progar, Kristin; Shah, Ebony; Stamos, Thomas D.; Wing, Coady; Garcia, Joe G. N.; Kittles, Rick; Cavallari, Larisa H.			Association of Aldosterone Synthase Polymorphism (CYP11B2-344T > C) and Genetic Ancestry with Atrial Fibrillation and Serum Aldosterone in African Americans with Heart Failure	PLOS ONE			English	Article							RISK-FACTORS; MINERALOCORTICOID RECEPTOR; ATHEROSCLEROSIS RISK; PLASMA-ALDOSTERONE; RACIAL-DIFFERENCES; PROSTATE-CANCER; PREVALENCE; RECOMMENDATIONS; SPIRONOLACTONE; HYPERTENSION	The objective of this study was to examine the extent to which aldosterone synthase genotype (CYP11B2) and genetic ancestry correlate with atrial fibrillation (AF) and serum aldosterone in African Americans with heart failure. Clinical data, echocardiographic measurements, and a genetic sample for determination of CYP11B2 -344T>C (rs1799998) genotype and genetic ancestry were collected from 194 self-reported African Americans with chronic, ambulatory heart failure. Genetic ancestry was determined using 105 autosomal ancestry informative markers. In a sub-set of patients (n = 126), serum was also collected for determination of circulating aldosterone. The CYP11B2 -344C allele frequency was 18% among the study population, and 19% of patients had AF. Multiple logistic regression revealed that the CYP11B2 -344CC genotype was a significant independent predictor of AF (OR 12.7, 95% CI 1.60-98.4, p = 0.0150, empirical p = 0.011) while holding multiple clinical factors, left atrial size, and percent European ancestry constant. Serum aldosterone was significantly higher among patients with AF (p = 0.036), whereas increased West African ancestry was inversely correlated with serum aldosterone (r = 20.19, p = 0.037). The CYP11B2 -344CC genotype was also overrepresented among patients with extreme aldosterone elevation (>= 90th percentile, p = 0.0145). In this cohort of African Americans with chronic ambulatory heart failure, the CYP11B2 -344T>C genotype was a significant independent predictor of AF while holding clinical, echocardiographic predictors, and genetic ancestry constant. In addition, increased West African ancestry was associated with decreased serum aldosterone levels, potentially providing an explanation for the lower risk for AF observed among African Americans.	[Bress, Adam; Han, Jin; Patel, Shitalben R.; Groo, Vicki; Progar, Kristin; Cavallari, Larisa H.] Univ Illinois, Dept Pharm Practice, Chicago, IL 60680 USA; [Desai, Ankit A.; Mansour, Ibrahim; Groo, Vicki; Stamos, Thomas D.] Univ Illinois, Cardiol Sect, Dept Med, Chicago, IL USA; [Desai, Ankit A.; Garcia, Joe G. N.] Univ Illinois, Dept Med, Inst Personalized Resp Med, Chicago, IL USA; [Shah, Ebony; Kittles, Rick] Univ Illinois, Dept Med, Hematol Oncol Sect, Chicago, IL USA; [Wing, Coady] Univ Illinois, Div Hlth Policy & Adm, Chicago, IL USA; [Garcia, Joe G. N.] Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cavallari, LH (corresponding author), Univ Illinois, Dept Pharm Practice, Chicago, IL 60680 USA.	humma@uic.edu		Bress, Adam/0000-0002-2259-5039; Patel, Shitalben/0000-0003-3710-0497; Progar, Kristin/0000-0002-7911-2771; Han, Jin/0000-0003-0662-006X; Desai, Ankit/0000-0001-6427-616X	National Institutes of Health, National Institute on Aging [AG033381-01]; National Center for Research Resources/National Center for Advancing Translational Sciences [UL1RR029879]; Office of the Vice Chancellor for Research, University of Illinois at Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG033381] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources/National Center for Advancing Translational Sciences; Office of the Vice Chancellor for Research, University of Illinois at Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health, National Institute on Aging (AG033381-01, LHC), National Center for Research Resources/National Center for Advancing Translational Sciences (UL1RR029879, AAD), and the Office of the Vice Chancellor for Research, University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni P, 2008, EUR HEART J, V29, P2367, DOI 10.1093/eurheartj/ehn361; Amir O, 2008, AM J CARDIOL, V102, P326, DOI 10.1016/j.amjcard.2008.03.063; [Anonymous], DAT SINGL NUCL POL D; Bassett MH, 2004, MOL CELL ENDOCRINOL, V217, P67, DOI 10.1016/j.mce.2003.10.011; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; Biolo A, 2007, AM J CARDIOL, V100, P285, DOI 10.1016/j.amjcard.2007.02.097; Calhoun DA, 2002, HYPERTENSION, V40, P892, DOI 10.1161/01.HYP.0000040261.30455.B6; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Carter JS, 1996, ANN INTERN MED, V125, P221, DOI 10.7326/0003-4819-125-3-199608010-00011; Catena C, 2012, HORM METAB RES, V44, P181, DOI 10.1055/s-0031-1291318; Cavallari LH, 2010, PHARMACOTHERAPY, V30, P1, DOI 10.1592/phco.30.1.1; Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Delaney JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032338; Delles C, 2001, J AM COLL CARDIOL, V37, P878, DOI 10.1016/S0735-1097(00)01174-8; Dini FL, 2011, AM HEART J, V161, P1088, DOI 10.1016/j.ahj.2011.03.027; Dixen U, 2007, CARDIOLOGY, V108, P35, DOI 10.1159/000095671; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Efron B., 1993, INTRO BOOTSTRAP, P436, DOI [10.1007/978-1-4899-4541-9, DOI 10.1007/978-1-4899-4541-9]; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Giri VN, 2009, CANCER PREV RES, V2, P244, DOI 10.1158/1940-6207.CAPR-08-0150; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Huang MF, 2009, CLIN CHEM LAB MED, V47, P32, DOI 10.1515/CCLM.2009.023; Hurwitz S, 2004, J APPL PHYSIOL, V96, P1406, DOI 10.1152/japplphysiol.00611.2003; Huxley RR, 2011, CIRCULATION, V123, P1501, DOI [10.1161/circulationaha.110.009035, 10.1161/CIRCULATIONAHA.110.009035]; Jones J, 2006, ETHNIC DIS, V16, pS10; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Kupari M, 1998, CIRCULATION, V97, P569; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050910; Libby P., 2008, BRAUNWALDS HEART DIS; Ling LH, 2012, J AM COLL CARDIOL, V60, P2402, DOI 10.1016/j.jacc.2012.07.065; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Marcus GM, 2010, CIRCULATION, V122, P2009, DOI 10.1161/CIRCULATIONAHA.110.958306; McNamara DM, 2006, J AM COLL CARDIOL, V48, P1277, DOI 10.1016/j.jacc.2006.07.030; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Pan L., 2009, Morbidity and Mortality Weekly Report, V58, P740; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pojoga L, 1998, AM J HYPERTENS, V11, P856, DOI 10.1016/S0895-7061(98)00048-X; Rosenbaum PR, 2002, OBSERVATIONAL STUDIE, V2, P375, DOI [10.1007/978-1-4757-3692-2, DOI 10.1007/978-1-4757-3692-2]; Ruo B, 2004, J AM COLL CARDIOL, V43, P429, DOI 10.1016/j.jacc.2003.09.035; Schnabel RB, 2011, CIRC-CARDIOVASC GENE, V4, P557, DOI 10.1161/CIRCGENETICS.110.959197; Schnabel RB, 2010, ARCH INTERN MED, V170, P1909, DOI 10.1001/archinternmed.2010.434; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Sun XJ, 2011, J RENIN-ANGIO-ALDO S, V12, P557, DOI 10.1177/1470320311417654; Swedberg K, 2012, J AM COLL CARDIOL, V59, P1598, DOI 10.1016/j.jacc.2011.11.063; Takai E, 2002, HEART, V88, P649, DOI 10.1136/heart.88.6.649; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tsai CT, 2010, J AM COLL CARDIOL, V55, P758, DOI 10.1016/j.jacc.2009.09.045; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Wang GJ, 2010, AM J MANAG CARE, V16, P769; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; White PC, 2005, J CLIN ENDOCR METAB, V90, P1252, DOI 10.1210/jc.2004-2452; White PC, 2003, J CLIN ENDOCR METAB, V88, P2376, DOI 10.1210/jc.2003-030373; WHITE PC, 1995, ENDOCR RES, V21, P437, DOI 10.3109/07435809509030459; Yancy CW, 2000, J CARD FAIL, V6, P183, DOI 10.1054/jcaf.2000.17610; Yancy CW, 2003, AM HEART J, V146, P203, DOI 10.1016/S0002-8703(03)00241-2; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	64	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71268	10.1371/journal.pone.0071268	http://dx.doi.org/10.1371/journal.pone.0071268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936266	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200118
J	Henriquez-Hernandez, LA; Valenciano, A; Foro-Arnalot, P; Alvarez-Cubero, MJ; Cozar, JM; Suarez-Novo, JF; Castells-Esteve, M; Ayala-Gil, A; Fernandez-Gonzalo, P; Ferrer, M; Guedea, F; Sancho-Pardo, G; Craven-Bartle, J; Ortiz-Gordillo, MJ; Cabrera-Roldan, P; Herrera-Ramos, E; Lara, PC				Alberto Henriquez-Hernandez, Luis; Valenciano, Almudena; Foro-Arnalot, Palmira; Jesus Alvarez-Cubero, Maria; Manuel Cozar, Jose; Francisco Suarez-Novo, Jose; Castells-Esteve, Manel; Ayala-Gil, Adriana; Fernandez-Gonzalo, Pablo; Ferrer, Montse; Guedea, Ferran; Sancho-Pardo, Gemma; Craven-Bartle, Jordi; Jose Ortiz-Gordillo, Maria; Cabrera-Roldan, Patricia; Herrera-Ramos, Estefania; Lara, Pedro C.			Polymorphisms in DNA-Repair Genes in a Cohort of Prostate Cancer Patients from Different Areas in Spain: Heterogeneity between Populations as a Confounding Factor in Association Studies	PLOS ONE			English	Article							NORMAL TISSUE TOXICITY; BREAST-CANCER; RADIOTHERAPY TOXICITY; RADIATION TOXICITY; STRATIFICATION; PREDICTION; METABOLISM; PATTERNS; GENOMICS; XRCC3	Background: Differences in the distribution of genotypes between individuals of the same ethnicity are an important confounder factor commonly undervalued in typical association studies conducted in radiogenomics. Objective: To evaluate the genotypic distribution of SNPs in a wide set of Spanish prostate cancer patients for determine the homogeneity of the population and to disclose potential bias. Design, Setting, and Participants: A total of 601 prostate cancer patients from Andalusia, Basque Country, Canary and Catalonia were genotyped for 10 SNPs located in 6 different genes associated to DNA repair: XRCC1 (rs25487, rs25489, rs1799782), ERCC2 (rs13181), ERCC1 (rs11615), LIG4 (rs1805388, rs1805386), ATM (rs17503908, rs1800057) and P53 (rs1042522). The SNP genotyping was made in a Biotrove OpenArray (R) NT Cycler. Outcome Measurements and Statistical Analysis: Comparisons of genotypic and allelic frequencies among populations, as well as haplotype analyses were determined using the web-based environment SNPator. Principal component analysis was made using the SnpMatrix and XSnpMatrix classes and methods implemented as an R package. Non-supervised hierarchical cluster of SNP was made using MultiExperiment Viewer. Results and Limitations: We observed that genotype distribution of 4 out 10 SNPs was statistically different among the studied populations, showing the greatest differences between Andalusia and Catalonia. These observations were confirmed in cluster analysis, principal component analysis and in the differential distribution of haplotypes among the populations. Because tumor characteristics have not been taken into account, it is possible that some polymorphisms may influence tumor characteristics in the same way that it may pose a risk factor for other disease characteristics. Conclusion: Differences in distribution of genotypes within different populations of the same ethnicity could be an important confounding factor responsible for the lack of validation of SNPs associated with radiation-induced toxicity, especially when extensive meta-analysis with subjects from different countries are carried out.	[Alberto Henriquez-Hernandez, Luis; Lara, Pedro C.] Hosp Univ Gran Canaria Dr Negrin, Dept Radiat Oncol, Las Palmas Gran Canaria, Spain; [Alberto Henriquez-Hernandez, Luis; Valenciano, Almudena; Lara, Pedro C.] Inst Canario Invest Canc, Las Palmas Gran Canaria, Spain; [Alberto Henriquez-Hernandez, Luis; Lara, Pedro C.] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Foro-Arnalot, Palmira] Hosp Esperanza, Inst Oncol Radioterap, Barcelona, Spain; [Jesus Alvarez-Cubero, Maria] Univ Granada, Fac Med, Legal Med & Toxicol Dept, Lab Genet Identificat, Granada, Spain; [Jesus Alvarez-Cubero, Maria] Pfizer Univ Granada Andalusian Govt Ctr Genom & O, GENYO, Granada, Spain; [Manuel Cozar, Jose] Hosp Univ Virgen de las Nieves, Dept Urol, Granada, Spain; [Francisco Suarez-Novo, Jose; Castells-Esteve, Manel] Hosp Univ Bellvite, Dept Urol, Barcelona, Spain; [Ayala-Gil, Adriana] Onkologikoa, Dept Radiat Oncol, Guipuzcoa, Spain; [Fernandez-Gonzalo, Pablo] Hosp Mar IMIM, Inst Recerca, Hlth Serv Res Grp, Barcelona, Spain; [Guedea, Ferran] ICO, Dept Radiat Oncol, Barcelona, Spain; [Sancho-Pardo, Gemma; Craven-Bartle, Jordi] Hosp Santa Creu & Sant Pau, Dept Radiat Oncol, Barcelona, Spain; [Jose Ortiz-Gordillo, Maria; Cabrera-Roldan, Patricia] Hosp Univ Virgen del Rocio, Dept Radiat Oncol, Seville, Spain; [Herrera-Ramos, Estefania] Hosp Univ Gran Canaria Dr Negrin, Immonol Dept, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; University of Granada; Pfizer; University of Granada; Hospital Universitario Virgen de las Nieves; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital of Santa Creu i Sant Pau; Virgen del Rocio University Hospital	Henriquez-Hernandez, LA (corresponding author), Hosp Univ Gran Canaria Dr Negrin, Dept Radiat Oncol, Las Palmas Gran Canaria, Spain.	lhenriquez@dcc.ulpgc.es	Henriquez-Hernandez, Luis Alberto/H-8981-2019; Cubero, Maria Jesus Alvarez/M-2892-2015; HERRERA-RAMOS, ESTEFANIA/J-9513-2018; IBIS, RADIOBIOLOGIA/H-7452-2016; Ferrer, Montse/A-5510-2010; Cabrera, P/L-4167-2014	Henriquez-Hernandez, Luis Alberto/0000-0003-3237-0316; Cubero, Maria Jesus Alvarez/0000-0002-5492-9355; Ferrer, Montse/0000-0001-9867-7391; Cabrera, P/0000-0001-6050-7354; Sancho-Pardo, Gemma/0000-0003-2266-6172; Foro, Palmira/0000-0001-8578-3777; HERRERA RAMOS, ESTEFANIA/0000-0002-5814-3931	Instituto de Salud Carlos III (Ministerio de Economia y Competitividad from Spain) [PI12/01867]; Instituto Canario de Investigacion del Cancer (ICIC)	Instituto de Salud Carlos III (Ministerio de Economia y Competitividad from Spain); Instituto Canario de Investigacion del Cancer (ICIC)	This work was subsidized by a grant from the Instituto de Salud Carlos III (Ministerio de Economia y Competitividad from Spain), ID: PI12/01867. Almudena Valenciano has a grant from the Instituto Canario de Investigacion del Cancer (ICIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Henriquez-Hernandez LA, 2012, SURG ONCOL, V21, P201, DOI 10.1016/j.suronc.2011.12.002; Henriquez-Hernandez LA, 2010, CANCER EPIDEMIOL, V34, P634, DOI 10.1016/j.canep.2010.06.013; Henriquez-Hernandez LA, 2010, CANCER EPIDEMIOL, V34, P490, DOI 10.1016/j.canep.2010.03.004; Andreassen CN, 2009, RADIOTHER ONCOL, V92, P299, DOI 10.1016/j.radonc.2009.06.015; [Anonymous], 2012, SNPSTATS SNPMATRIX X; Barnett GC, 2012, RADIOTHER ONCOL, V105, P289, DOI 10.1016/j.radonc.2012.10.017; Barnett GC, 2012, LANCET ONCOL, V13, P65, DOI 10.1016/S1470-2045(11)70302-3; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Bentzen, 1994, Semin Radiat Oncol, V4, P68, DOI 10.1016/S1053-4296(05)80034-7; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; Bracarda S, 2005, CRIT REV ONCOL HEMAT, V56, P379, DOI 10.1016/j.critrevonc.2005.03.010; Buchholz TA, 1999, INT J RADIAT ONCOL, V45, P547, DOI 10.1016/S0360-3016(99)00255-2; CALAFELL F, 1994, AM J PHYS ANTHROPOL, V93, P201, DOI 10.1002/ajpa.1330930205; Chang-Claude J, 2009, BRIT J CANCER, V100, P1680, DOI 10.1038/sj.bjc.6605036; CLAYTON D, 2001, HDB STAT GENETICS, P519; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fachal L, 2012, RADIOTHER ONCOL, V105, P321, DOI 10.1016/j.radonc.2012.09.013; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Johansson S, 2000, INT J RADIAT ONCOL, V48, P745, DOI 10.1016/S0360-3016(00)00674-X; Kupelian PA, 2004, INT J RADIAT ONCOL, V58, P25, DOI 10.1016/S0360-3016(03)00784-3; Laayouni H, 2010, HUM GENET, V127, P455, DOI 10.1007/s00439-010-0798-3; Langsenlehner T, 2011, RADIOTHER ONCOL, V98, P387, DOI 10.1016/j.radonc.2011.01.021; Mangoni M, 2011, INT J RADIAT ONCOL, V81, P52, DOI 10.1016/j.ijrobp.2010.04.023; Morcillo-Suarez C, 2008, BIOINFORMATICS, V24, P1643, DOI 10.1093/bioinformatics/btn241; Pino-Yanes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018389; Rando JC, 1999, ANN HUM GENET, V63, P413, DOI 10.1046/j.1469-1809.1999.6350413.x; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Sai K, 2011, EXPERT OPIN DRUG MET, V7, P967, DOI 10.1517/17425255.2011.585969; Tanteles GA, 2012, INT J RADIAT ONCOL, V84, P1031, DOI 10.1016/j.ijrobp.2012.02.018; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; West C, 2010, INT J RADIAT ONCOL, V76, P1295, DOI 10.1016/j.ijrobp.2009.12.017; West CM, 2011, GENOME MED, V3, DOI 10.1186/gm268; West CML, 2012, SEMIN RADIAT ONCOL, V22, P91, DOI 10.1016/j.semradonc.2011.12.007; Zelefsky MJ, 2011, EUR UROL, V60, P1133, DOI 10.1016/j.eururo.2011.08.029; Zhang L, 2010, RADIOTHER ONCOL, V97, P19, DOI 10.1016/j.radonc.2010.08.015	36	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69735	10.1371/journal.pone.0069735	http://dx.doi.org/10.1371/journal.pone.0069735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936089	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000151
J	Horsak, M; Lososova, Z; Cejka, T; Jurickova, L; Chytry, M				Horsak, Michal; Lososova, Zdenka; Cejka, Tomas; Jurickova, Lucie; Chytry, Milan			Diversity and Biotic Homogenization of Urban Land-Snail Faunas in Relation to Habitat Types and Macroclimate in 32 Central European Cities	PLOS ONE			English	Article							SPECIES RICHNESS; CONTRASTING PATTERNS; FLORAS; ALIEN; PLANTS; URBANIZATION; CONSERVATION; BIODIVERSITY; TERRESTRIAL; COMMUNITIES	The effects of non-native species invasions on community diversity and biotic homogenization have been described for various taxa in urban environments, but not for land snails. Here we relate the diversity of native and non-native land-snail urban faunas to urban habitat types and macroclimate, and analyse homogenization effects of non-native species across cities and within the main urban habitat types. Land-snail species were recorded in seven 1-ha plots in 32 cities of ten countries of Central Europe and Benelux (224 plots in total). Each plot represented one urban habitat type characterized by different management and a specific disturbance regime. For each plot, we obtained January, July and mean annual temperature and annual precipitation. Snail species were classified into either native or non-native. The effects of habitat type and macroclimate on the number of native and non-native species were analysed using generalized estimating equations; the homogenization effect of non-native species based on the Jaccard similarity index and homogenization index. We recorded 67 native and 20 non-native species. Besides being more numerous, native species also had much higher beta diversity than non-natives. There were significant differences between the studied habitat types in the numbers of native and non-native species, both of which decreased from less to heavily urbanized habitats. Macroclimate was more important for the number of non-native than native species; however in both cases the effect of climate on diversity was overridden by the effect of urban habitat type. This is the first study on urban land snails documenting that non-native land-snail species significantly contribute to homogenization among whole cities, but both the homogenization and diversification effects occur when individual habitat types are compared among cities. This indicates that the spread of non-native snail species may cause biotic homogenization, but it depends on scale and habitat type.	[Horsak, Michal; Lososova, Zdenka; Chytry, Milan] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Lososova, Zdenka] Masaryk Univ, Dept Biol, Brno, Czech Republic; [Cejka, Tomas] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Jurickova, Lucie] Charles Univ Prague, Dept Zool, Prague, Czech Republic	Masaryk University Brno; Masaryk University Brno; Slovak Academy of Sciences; Charles University Prague	Horsak, M (corresponding author), Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic.	horsak@sci.muni.cz	Lososová, Zdeňka/K-5752-2013; Jurickova, Lucie/R-8812-2017; Čejka, Tomáš/O-8830-2016; Chytrý, Milan/J-4954-2012; Lososová, Zdeňka/U-6141-2019	Jurickova, Lucie/0000-0001-5163-1222; Čejka, Tomáš/0000-0002-6485-5660; Chytrý, Milan/0000-0002-8122-3075; Lososová, Zdeňka/0000-0001-9152-7462; Horsak, Michal/0000-0003-2742-2740	Grant Agency of the Academy of Sciences of the Czech Republic [IAA601630803]; Grant Agency of the Slovak Academy of Sciences (VEGA) [2/0037/11]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Slovak Academy of Sciences (VEGA)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	This study was funded by the Grant Agency of the Academy of Sciences of the Czech Republic (IAA601630803) and Grant Agency of the Slovak Academy of Sciences (VEGA) No. 2/0037/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antrop M, 2004, LANDSCAPE URBAN PLAN, V67, P9, DOI 10.1016/S0169-2046(03)00026-4; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Blair RB, 1997, BIOL CONSERV, V80, P113, DOI 10.1016/S0006-3207(96)00056-0; Cameron RAD, 2005, J CONCHOL, V38, P529; Celesti-Grapow L, 1998, GLOBAL ECOL BIOGEOGR, V7, P367; Collins MD, 2002, EVOL ECOL RES, V4, P457; Core R Team, 2012, R LANG ENV STAT COMP; Cowie RH, 2001, BIOL CONSERV, V99, P207, DOI 10.1016/S0006-3207(00)00181-6; DAISIE, 2009, HDB ALIEN SPECIES EU, DOI [10.1007/978-1-4020-8280-1, DOI 10.1007/978-1-4020-8280-1]; Duncan JR, 2001, BIOTIC HOMOGENIZATION, P245; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hardin JW, 2012, GEN ESTIMATING EQUAT; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MO, 2002, J APPL ECOL, V39, P708, DOI 10.1046/j.1365-2664.2002.00746.x; Horsak M, 2008, J BIOGEOGR, V35, P1215, DOI 10.1111/j.1365-2699.2007.01856.x; Horsak Michal, 2010, Malacologica Bohemoslovaca, P1; Horsak M, 2009, BIODIVERS CONSERV, V18, P3453, DOI 10.1007/s10531-009-9654-y; Kerney M. P., 1983, LANDSCHNECKEN NORD M; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kuhn I, 2006, BIOL CONSERV, V127, P292, DOI 10.1016/j.biocon.2005.06.033; Kuhn I, 2004, EVOL ECOL RES, V6, P749; La Sorte FA, 2008, GLOBAL ECOL BIOGEOGR, V17, P363, DOI 10.1111/j.1466-8238.2007.00369.x; La Sorte FA, 2007, J BIOGEOGR, V34, P2159, DOI 10.1111/j.1365-2699.2007.01761.x; Lambdon PW, 2008, PRESLIA, V80, P101; Lososova Z, 2012, GLOBAL ECOL BIOGEOGR, V21, P545, DOI 10.1111/j.1466-8238.2011.00704.x; Lososova Z, 2012, BIOL CONSERV, V145, P179, DOI 10.1016/j.biocon.2011.11.003; Lososova Z, 2011, J BIOGEOGR, V38, P1152, DOI 10.1111/j.1365-2699.2011.02475.x; Lozek V, 1964, QUARTARMOLLUSKEN TSC, P374; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; McKinney ML, 2002, GLOBAL ECOL BIOGEOGR, V11, P343, DOI 10.1046/j.1466-822X.2002.00293.x; McKinney ML, 2004, BIOL INVASIONS, V6, P495, DOI 10.1023/B:BINV.0000041562.31023.42; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Meyer WM, 2010, BIOTROPICA, V42, P732, DOI 10.1111/j.1744-7429.2010.00629.x; Niemela J, 2002, LANDSCAPE ECOL, V17, P387, DOI 10.1023/A:1021270121630; Nobis MP, 2009, DIVERS DISTRIB, V15, P928, DOI 10.1111/j.1472-4642.2009.00610.x; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Pysek P, 1998, J BIOGEOGR, V25, P155, DOI 10.1046/j.1365-2699.1998.251177.x; Pysek P, 2010, GLOBAL ECOL BIOGEOGR, V19, P317, DOI 10.1111/j.1466-8238.2009.00514.x; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Reichard S.E., 1997, ASSESSMENT MANAGEMEN, P215, DOI DOI 10.1007/978-1-4612-1926-2; REJMANEK M, 2000, DIVERS DISTRIB, V6, P208, DOI DOI 10.1046/J.1472-4642.2000.00073-3.X; Riddle WA, 1983, MOLLUSCA, V6, P431; ROLLO CD, 1991, MALACOLOGIA, V33, P199; Roy DB, 1999, ECOGRAPHY, V22, P507, DOI 10.1111/j.1600-0587.1999.tb01279.x; Smart SM, 2006, P ROY SOC B-BIOL SCI, V273, P2659, DOI 10.1098/rspb.2006.3630; Tichy L, 2002, J VEG SCI, V13, P451, DOI 10.1111/j.1654-1103.2002.tb02069.x; Wang GM, 2007, BIODIVERS CONSERV, V16, P4025, DOI 10.1007/s10531-007-9205-3; Welter-Schultes F.W., 2012, EUROPEAN NON MARINE; Wilson, 1988, BIODIVERSITY, P170	52	23	29	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71783	10.1371/journal.pone.0071783	http://dx.doi.org/10.1371/journal.pone.0071783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936525	Green Submitted, Green Published, gold			2022-12-27	WOS:000324401500081
J	Herrmann, I; Jourak, A; Hedstrom, A; Lundstrom, TS; Viklander, M				Herrmann, Inga; Jourak, Amir; Hedstrom, Annelie; Lundstrom, T. Staffan; Viklander, Maria			The Effect of Hydraulic Loading Rate and Influent Source on the Binding Capacity of Phosphorus Filters	PLOS ONE			English	Article							WASTE-WATER TREATMENT; FILTRALITE-P; REMOVAL; PHOSPHATE; SORPTION; CALCIUM; PRECIPITATION; FLOW	Sorption by active filter media can be a convenient option for phosphorus (P) removal and recovery from wastewater for on-site treatment systems. There is a need for a robust laboratory method for the investigation of filter materials to enable a reliable estimation of their longevity. The objectives of this study were to (1) investigate and (2) quantify the effect of hydraulic loading rate and influent source (secondary wastewater and synthetic phosphate solution) on P binding capacity determined in laboratory column tests and (3) to study how much time is needed for the P to react with the filter material (reaction time). To study the effects of these factors, a 2(2) factorial experiment with 11 filter columns was performed. The reaction time was studied in a batch experiment. Both factors significantly (alpha = 0.05) affected the P binding capacity negatively, but the interaction of the two factors was not significant. Increasing the loading rate from 100 to 1200 L m(-2) d(-1) decreased P binding capacity from 1.152 to 0.070 g kg(-1) for wastewater filters and from 1.382 to 0.300 g kg(-1) for phosphate solution filters. At a loading rate of 100 L m(-2) d(-1), the average P binding capacity of wastewater filters was 1.152 g kg(-1) as opposed to 1.382 g kg(-1) for phosphate solution filters. Therefore, influent source or hydraulic loading rate should be carefully controlled in the laboratory. When phosphate solution and wastewater were used, the reaction times for the filters to remove P were determined to be 5 and 15 minutes, respectively, suggesting that a short residence time is required. However, breakthrough in this study occurred unexpectedly quickly, implying that more time is needed for the P that has reacted to be physically retained in the filter.	[Herrmann, Inga; Hedstrom, Annelie; Viklander, Maria] Lulea Univ Technol, Dept Civil Environm & Nat Resources Engn, S-95187 Lulea, Sweden; [Jourak, Amir; Lundstrom, T. Staffan] Lulea Univ Technol, Div Fluid & Expt Mech, S-95187 Lulea, Sweden	Lulea University of Technology; Lulea University of Technology	Herrmann, I (corresponding author), Lulea Univ Technol, Dept Civil Environm & Nat Resources Engn, S-95187 Lulea, Sweden.	Inga.Herrmann@ltu.se		Lundstrom, Staffan/0000-0002-1033-0244; Herrmann, Inga/0000-0003-0520-796X	Swedish Research Council Formas; J. Gust Richert Foundation	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); J. Gust Richert Foundation	This study was financed by the Swedish Research Council Formas and J. Gust Richert Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam K, 2006, WATER RES, V40, P1143, DOI 10.1016/j.watres.2006.01.009; Adam K, 2005, J ENVIRON SCI HEAL A, V40, P1239, DOI 10.1081/ESE-200055673; Adam K, 2007, ECOL ENG, V29, P200, DOI 10.1016/j.ecoleng.2006.09.021; Arias CA, 2003, WATER SCI TECHNOL, V48, P51, DOI 10.2166/wst.2003.0279; Brooks AS, 2000, ECOL ENG, V15, P121, DOI 10.1016/S0925-8574(99)00056-7; Drizo A, 2002, ENVIRON SCI TECHNOL, V36, P4642, DOI 10.1021/es011502v; Eveborn D, 2009, ENVIRON SCI TECHNOL, V43, P6515, DOI 10.1021/es901084z; FEENSTRA TP, 1979, J PHYS CHEM-US, V83, P475, DOI 10.1021/j100467a010; Hedstrom A, 2006, J ENVIRON ENG-ASCE, V132, P1431, DOI 10.1061/(ASCE)0733-9372(2006)132:11(1431); Heistad A, 2006, ECOL ENG, V28, P374, DOI 10.1016/j.ecoleng.2006.06.011; Li W, 2012, GEOCHIM COSMOCHIM AC, V85, P289, DOI 10.1016/j.gca.2012.02.021; Montgomery D., 2001, DESIGN ANAL EXPT, V5th; NARKIS N, 1980, WATER RES, V14, P1215, DOI 10.1016/0043-1354(80)90179-7; Song YH, 2002, CHEMOSPHERE, V48, P1029, DOI 10.1016/S0045-6535(02)00183-2; Song YH, 2006, J ENVIRON SCI-CHINA, V18, P852, DOI 10.1016/S1001-0742(06)60004-1; Suliman F, 2005, J ENVIRON SCI HEAL A, V40, P1403, DOI 10.1081/ESE-200055871; Swedish Standards Institute, 2005, 6878 SSEN SWED STAND; Swedish Standards Institute, 2005, 8722005 EN SWED STAN; Umetrics AB, 2006, MODDE 8 0 0 0; VILPAS R, 2005, REPORT PILOT PLANTS; Vohla C, 2011, ECOL ENG, V37, P70, DOI 10.1016/j.ecoleng.2009.08.003; Vrale L, 2005, RESULTS EXPERIENCES; Weber, 2008, UPP UVD WAST TREATM; Westholm LJ, 2006, WATER RES, V40, P23, DOI 10.1016/j.watres.2005.11.006	24	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69017	10.1371/journal.pone.0069017	http://dx.doi.org/10.1371/journal.pone.0069017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936313	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800007
J	Sun, P; Zhou, KW; Wang, S; Li, P; Chen, SJ; Lin, GP; Zhao, Y; Wang, TH				Sun, Peng; Zhou, Kewen; Wang, Sheng; Li, Ping; Chen, Sijuan; Lin, Guiping; Zhao, Yan; Wang, Tinghuai			Involvement of MAPK/NF-kappa B Signaling in the Activation of the Cholinergic Anti-Inflammatory Pathway in Experimental Colitis by Chronic Vagus Nerve Stimulation	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; HEART-RATE-VARIABILITY; INFLAMMATORY-BOWEL-DISEASE; PHOSPHORYLATION; RATS; SUPPRESSION; BIOFEEDBACK; THERAPIES; EFFICACY; PROTEIN	Background: Autonomic nervous system dysfunction is implicated in the etiopathogenesis of inflammatory bowel diseases (IBD). Therapies that increase cardiovagal activity, such as Mind-Body interventions, are currently confirmed to be effective in clinical trials in IBD. However, a poor understanding of pathophysiological mechanisms limits the popularization of therapies in clinical practice. The aim of the present study was to explore the mechanisms of these therapies against 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in rats using a chronic vagus nerve stimulation model in vivo, as well as the lipopolysaccharide (LPS)-induced inflammatory response in human epithelial colorectal adenocarcinoma cells (Caco-2) by acetylcholine in vitro. Methods and Results: Colitis was induced in rats with rectal instillation of TNBS, and the effect of chronic VNS (0.25 mA, 20 Hz, 500 ms) on colonic inflammation was evaluated. Inflammatory responses were assessed by disease activity index (DAI), histological scores, myeloperoxidase (MPO) activity, inducible nitric oxide synthase (iNOS), TNF-alpha and IL-6 production. The expression of Mitogen-activated protein kinases (MAPK) family members, I kappa B-alpha, and nuclear NF-kappa B p65 were studied by immunoblotting. Heart rate variability (HRV) analysis was also applied to assess the sympathetic-vagal balance. DAI, histological scores, MPO activity, iNOS, TNF-alpha and IL-6 levels were significantly decreased by chronic VNS. Moreover, both VNS and acetylcholine reduced the phosphorylation of MAPKs and prevented the nuclear translocation of NF-kappa B p65. Methyllycaconitine (MLA) only reversed the inhibitory effect on p-ERK and intranuclear NF-kappa B p65 expression by ACh in vitro, no significant change was observed in the expression of p-p38 MAPK or p-JNK by MLA. Conclusion: Vagal activity modification contributes to the beneficial effects of the cholinergic anti-inflammatory pathway in IBD-related inflamed colonic mucosa based on the activation of MAPKs and nuclear translocation of NF-kappa B. Our work may provide key pathophysiological mechanistic evidence for novel therapeutic strategies that increase the cardiovagal activity in IBD patients.	[Sun, Peng; Zhou, Kewen; Wang, Sheng; Li, Ping; Chen, Sijuan; Lin, Guiping; Zhao, Yan; Wang, Tinghuai] Sun Yat Sen Univ, Dept Physiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, TH (corresponding author), Sun Yat Sen Univ, Dept Physiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	wangth@mail.sysu.edu.cn			Science and technology projects in Guangdong Province [2008B030301098]; Science and technology projects in Guangzhou [2007J1-C0171]	Science and technology projects in Guangdong Province; Science and technology projects in Guangzhou	This work was supported by the funded projects of Science and technology projects in Guangdong Province (No.2008B030301098) and the Science and technology projects in Guangzhou (No.2007J1-C0171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rosillo MA, 2012, PHARMACOL RES, V66, P235, DOI 10.1016/j.phrs.2012.05.006; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Bengtsson M, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-16; Bevilacqua MA, 2002, ARCH BIOCHEM BIOPHYS, V407, P39, DOI 10.1016/S0003-9861(02)00436-8; Billman GE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00086; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bozkurt A, 2003, REGUL PEPTIDES, V116, P109, DOI 10.1016/S0167-0115(03)00194-0; BRENNA O, 2013, PLOS ONE IN PRESS, P20239; Broom OJ, 2009, CLIN EXP IMMUNOL, V158, P272, DOI 10.1111/j.1365-2249.2009.04033.x; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; COOPER HS, 1993, LAB INVEST, V69, P238; Coskun M, 2011, CLIN CHIM ACTA, V412, P513, DOI 10.1016/j.cca.2010.12.020; Cucina A, 2012, J SURG RES, V178, P233, DOI 10.1016/j.jss.2011.12.029; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG711, DOI 10.1152/ajpgi.00240.2007; Gubbins EJ, 2010, BRAIN RES, V1328, P1, DOI 10.1016/j.brainres.2010.02.083; Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190; Handforth A, 2001, MOVEMENT DISORD, V16, P84, DOI 10.1002/1531-8257(200101)16:1<84::AID-MDS1010>3.0.CO;2-S; Huang JA, 2010, J NEURAL TRANSM, V117, P729, DOI 10.1007/s00702-010-0407-6; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Langmead L, 2006, ALIMENT PHARM THER, V23, P341, DOI 10.1111/j.1365-2036.2006.02761.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li DL, 2011, J CELL PHYSIOL, V226, P1052, DOI 10.1002/jcp.22424; Lo Giudice P, 2002, DIABETES RES CLIN PR, V56, P173, DOI 10.1016/S0168-8227(01)00375-8; Manta S, 2013, INT J NEUROPSYCHOPH, V16, P459, DOI 10.1017/S1461145712000387; Maunder RG, 2012, INFLAMM BOWEL DIS, V18, P737, DOI 10.1002/ibd.21794; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN CF, 1989, BLOOD, V73, P301; Nishitani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062441; Nolan RP, 2012, J INTERN MED, V272, P161, DOI 10.1111/j.1365-2796.2012.02523.x; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Orr-Urtreger A, 2005, NEUROREPORT, V16, P1123, DOI 10.1097/00001756-200507130-00018; PATIL VK, 2007, J BASIC CLIN PHYSL P, V18, P307; Pellissier S, 2010, PSYCHONEUROENDOCRINO, V35, P653, DOI 10.1016/j.psyneuen.2009.10.004; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Reyt S, 2010, NEUROIMAGE, V52, P1456, DOI 10.1016/j.neuroimage.2010.05.021; Roncucci L, 2008, CANCER EPIDEM BIOMAR, V17, P2291, DOI 10.1158/1055-9965.EPI-08-0224; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; RYOYAMA K, 1993, CANCER IMMUNOL IMMUN, V37, P385, DOI 10.1007/BF01526795; Sackeim HA, 2001, NEUROPSYCHOPHARMACOL, V25, P713, DOI 10.1016/S0893-133X(01)00271-8; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7; Schroecksnadel S, 2013, THROMB RES, V131, pE264, DOI 10.1016/j.thromres.2013.02.012; Snoek SA, 2010, BRIT J PHARMACOL, V160, P322, DOI 10.1111/j.1476-5381.2010.00699.x; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Taylor CT, 2007, AUTON NEUROSCI-BASIC, V133, P104, DOI 10.1016/j.autneu.2006.11.005; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tsune I, 2003, GASTROENTEROLOGY, V125, P775, DOI 10.1016/S0016-5085(03)01067-9; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Van der Zanden EP, 2009, NEUROGASTROENT MOTIL, V21, P6, DOI 10.1111/j.1365-2982.2008.01252.x; Wang SZ, 2010, J ALTERN COMPLEM MED, V16, P1039, DOI 10.1089/acm.2009.0577; Xu XY, 2007, J HUM HYPERTENS, V21, P973, DOI 10.1038/sj.jhh.1002237; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	63	136	138	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69424	10.1371/journal.pone.0069424	http://dx.doi.org/10.1371/journal.pone.0069424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936328	gold, Green Published, Green Submitted			2022-12-27	WOS:000324545800018
J	Bishop, DA; Beier, CM				Bishop, Daniel A.; Beier, Colin M.			Assessing Uncertainty in High-Resolution Spatial Climate Data across the US Northeast	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; TEMPERATURE; PRECIPITATION; MODEL; INTERPOLATION; VARIABLES; SURFACES; NETWORK; TERRAIN; MAXIMUM	Local and regional-scale knowledge of climate change is needed to model ecosystem responses, assess vulnerabilities and devise effective adaptation strategies. High-resolution gridded historical climate (GHC) products address this need, but come with multiple sources of uncertainty that are typically not well understood by data users. To better understand this uncertainty in a region with a complex climatology, we conducted a ground-truthing analysis of two 4 km GHC temperature products (PRISM and NRCC) for the US Northeast using 51 Cooperative Network (COOP) weather stations utilized by both GHC products. We estimated GHC prediction error for monthly temperature means and trends (1980-2009) across the US Northeast and evaluated any landscape effects (e. g., elevation, distance from coast) on those prediction errors. Results indicated that station-based prediction errors for the two GHC products were similar in magnitude, but on average, the NRCC product predicted cooler than observed temperature means and trends, while PRISM was cooler for means and warmer for trends. We found no evidence for systematic sources of uncertainty across the US Northeast, although errors were largest at high elevations. Errors in the coarse-scale (4 km) digital elevation models used by each product were correlated with temperature prediction errors, more so for NRCC than PRISM. In summary, uncertainty in spatial climate data has many sources and we recommend that data users develop an understanding of uncertainty at the appropriate scales for their purposes. To this end, we demonstrate a simple method for utilizing weather stations to assess local GHC uncertainty and inform decisions among alternative GHC products.	[Bishop, Daniel A.; Beier, Colin M.] SUNY Coll Environm Sci & Forestry, Dept Forest & Nat Resources Management, Syracuse, NY 13210 USA; [Beier, Colin M.] SUNY Coll Environm Sci & Forestry, Adirondack Ecol Ctr, Newcomb, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Bishop, DA (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Forest & Nat Resources Management, Syracuse, NY 13210 USA.	dbishop@syr.edu		Bishop, Daniel/0000-0002-0394-5996	USDA-CSREES McIntire-Stennis Cooperative Forestry Program; National Aeronautic and Space Administration [NNX09AK16G]	USDA-CSREES McIntire-Stennis Cooperative Forestry Program; National Aeronautic and Space Administration(National Aeronautics & Space Administration (NASA))	This research was supported by the USDA-CSREES McIntire-Stennis Cooperative Forestry Program and National Aeronautic and Space Administration (#NNX09AK16G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Barnes Stanleya L., 1964, J APPL METEOROL, V3, P396, DOI [10.1175/1520-0450(1964)0032.0.CO;2, DOI 10.1175/1520-0450(1964)003<0396:ATFMDI>2.0.CO;2, 10.1175/1520-0450(1964)003<0396:ATFMDI>2.0.CO;2, DOI 10.1175/1520-0450(1964)0032.0.CO;2]; Bates D., 2011, PACKAGE LME4 LINEAR; Beier CM, 2012, LANDSCAPE ECOL, V27, P327, DOI 10.1007/s10980-011-9698-8; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; DeGaetano AT, 2007, J APPL METEOROL CLIM, V46, P1981, DOI 10.1175/2007JAMC1536.1; Di Luzio M, 2008, J APPL METEOROL CLIM, V47, P475, DOI 10.1175/2007JAMC1356.1; Hayhoe K, 2008, MITIG ADAPT STRAT GL, V13, P425, DOI 10.1007/s11027-007-9133-2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2011, RASTER GEOGRAPHIC AN; Hubbard KG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027069; Iverson LR, 2004, GLOBAL ECOL BIOGEOGR, V13, P209, DOI 10.1111/j.1466-822X.2004.00093.x; Jarvis CH, 2001, J APPL METEOROL, V40, P1075, DOI 10.1175/1520-0450(2001)040<1075:ACASFI>2.0.CO;2; Mahmood R, 2006, INT J CLIMATOL, V26, P1091, DOI 10.1002/joc.1298; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Ollinger SV, 2008, MITIG ADAPT STRAT GL, V13, P467, DOI 10.1007/s11027-007-9128-z; Pebesma EJ, 2005, R NEWS, V5, P2; Pielke RA, 2002, INT J CLIMATOL, V22, P421, DOI 10.1002/joc.706; Pielke RA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008229; Pierce D, 2011, NCDF INTERFACE UNIDA; R Development Core Team, 2010, R LANG ENV STAT COMP; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Vose RS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018111; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Warnes G.R., 2012, GDATA VARIOUS R PROG; WILLIAMS CN, 2004, ORNLCDIAC118; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e	34	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70260	10.1371/journal.pone.0070260	http://dx.doi.org/10.1371/journal.pone.0070260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936401	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400050
J	Dong, Y; Wang, WP; Cao, JY; Fan, PL; Lin, XY				Dong, Yi; Wang, Wenping; Cao, Jiaying; Fan, Peili; Lin, Xiyuan			Quantitative Evaluation of Contrast-Enhanced Ultrasonography in the Diagnosis of Chronic Ischemic Renal Disease in a Dog Model	PLOS ONE			English	Article							AMEROID RING CONSTRICTORS; CHRONIC KIDNEY-DISEASE; PORTOSYSTEMIC SHUNTS; BLOOD-FLOW; ULTRASOUND; QUANTIFICATION; SONOGRAPHY; PERFUSION; CATS; US	Objectives: The aim of this feasibility study was to prospectively explore in a dog model of chronic ischemic renal disease (CIRD) the hypothesis that real-time contrast-enhanced ultrasonography (CEUS) can quantitatively evaluate the early perfusion changes of renal cortex. Materials and Methods: In this animal care and use committee-approved study, the model of CIRD was carried out in healthy dogs (10.0 similar to 12.0 kg, n = 5), by placing the Ameroid ring constrictors on the distal portion of right renal artery through operation. CEUS monitoring of right kidney perfusion was performed by intravenous bolus injection of 0.6 ml Sulfur hexafluoride filled microbubbles (SonoVue; Bracco S.P.A., Milan, Italy) every week after operation. The slope rate of ascending curve (A) and descending curve (a), area under curve (AUC), derived peak intensity (DPI), and time to peak (TTP) were measured in renal cortex using commercial quantification software (Q-LAB version 6; Philips Medical Systems, Bothell, WA, USA). The sensitivity of CEUS was compared with blood serum urea nitrogen (BUN) and serum creatinine (SCr) level. Results: With the progression of CIRD, dogs showed delayed enhancement and perfusion in renal CEUS curve. Earliest significant changes happened 4 weeks after operation on DPI and TTP which changed from 13.04 +/- 2.71 to 15.58 +/- 4.75 dB and 9.03 +/- 2.01 to 10.62 +/- 6.04 sec, respectively (P <.05). Conclusions: CEUS can display the perfusion changes of CIRD in the early period.	[Dong, Yi; Wang, Wenping; Cao, Jiaying; Fan, Peili; Lin, Xiyuan] Fudan Univ, Zhongshan Hosp, Dept Ultrasound, Shanghai 200433, Peoples R China	Fudan University	Wang, WP (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Ultrasound, Shanghai 200433, Peoples R China.	puguang61@126.com	Fan, Pei-Li/GSN-0126-2022					Fernandes DRA, 2011, ECHOCARDIOGR-J CARD, V28, P342, DOI 10.1111/j.1540-8175.2010.01317.x; Artunc F, 2011, CURR OPIN NEPHROL HY, V20, P669, DOI 10.1097/MNH.0b013e32834ad579; Badea R, 2012, MED ULTRASON, V14, P307; Beddhu S, 2003, J AM SOC NEPHROL, V14, P1000, DOI 10.1097/01.ASN.0000057856.88335.DD; Correas Jean-Michel, 2006, Ultrasound Q, V22, P53; Cosgrove D, 2010, EUR J NUCL MED MOL I, V37, pS65, DOI 10.1007/s00259-010-1537-7; Dietrich CF, 2012, ULTRASCHALL MED, V33, P344, DOI 10.1055/s-0032-1313026; Gorg C, 2007, EUR J RADIOL, V64, P189, DOI 10.1016/j.ejrad.2007.06.036; Herget-Rosenthal S, 2011, SEMIN NEPHROL, V31, P283, DOI 10.1016/j.semnephrol.2011.05.011; Hoeffel C, 2010, ULTRASCHALL MED, V31, P363, DOI 10.1055/s-0029-1245238; Hunt GB, 2004, VET SURG, V33, P25, DOI 10.1111/j.1532-950x.2004.04011.x; Lassau Nathalie, 2007, Eur Radiol, V17 Suppl 6, pF89; Leshem SS, 2008, AM J VET RES, V69, P1520, DOI 10.2460/ajvr.69.11.1520; Leveille R, 2003, VET RADIOL ULTRASOUN, V44, P32, DOI 10.1111/j.1740-8261.2003.tb01445.x; Mehl ML, 2005, JAVMA-J AM VET MED A, V226, P2020, DOI 10.2460/javma.2005.226.2020; Meola M, 2008, J Ultrasound, V11, P55, DOI 10.1016/j.jus.2008.03.006; Mimae T, 2010, GEN THORAC CARDIOVAS, V58, P511, DOI 10.1007/s11748-010-0608-9; Mischi M, 2007, ULTRASOUND MED BIOL, V33, P439, DOI 10.1016/j.ultrasmedbio.2006.09.013; Novellas R, 2010, VET REC, V166, P618, DOI 10.1136/vr.b4820; Prakash A, 2011, MED ULTRASON, V13, P150; Salvatore V, 2012, CURR PHARM DESIGN, V18, P2236, DOI 10.2174/138161212800099892; Schneider A, 2011, CRIT CARE, V15, DOI 10.1186/cc10058; Sehgal CM, 1998, J ULTRAS MED, V17, P751, DOI 10.7863/jum.1998.17.12.751; Shoji T, 2012, J ATHEROSCLER THROMB, V19, P299, DOI 10.5551/jat.10454; Sodha NR, 2008, J CARDIAC SURG, V23, P312, DOI 10.1111/j.1540-8191.2008.00600.x; Sullivan JC, 2009, AM J PHYSIOL-RENAL, V297, pF228, DOI 10.1152/ajprenal.00016.2009; Wilson SR, 2010, RADIOLOGY, V257, P24, DOI 10.1148/radiol.10091210	27	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70337	10.1371/journal.pone.0070337	http://dx.doi.org/10.1371/journal.pone.0070337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936410	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400056
J	Goel, P; Mehta, A				Goel, Pranay; Mehta, Anita			Learning Theories Reveal Loss of Pancreatic Electrical Connectivity in Diabetes as an Adaptive Response	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; INSULIN-SECRETION; CALCIUM OSCILLATIONS; EUROPEAN-ASSOCIATION; CELL COMMUNICATION; BETA-CELLS; HYPERGLYCEMIA; ISLETS; CA2+; SYNCHRONIZATION	Cells of almost all solid tissues are connected with gap junctions which permit the direct transfer of ions and small molecules, integral to regulating coordinated function in the tissue. The pancreatic islets of Langerhans are responsible for secreting the hormone insulin in response to glucose stimulation. Gap junctions are the only electrical contacts between the beta-cells in the tissue of these excitable islets. It is generally believed that they are responsible for synchrony of the membrane voltage oscillations among beta-cells, and thereby pulsatility of insulin secretion. Most attempts to understand connectivity in islets are often interpreted, bottom-up, in terms of measurements of gap junctional conductance. This does not, however, explain systematic changes, such as a diminished junctional conductance in type 2 diabetes. We attempt to address this deficit via the model presented here, which is a learning theory of gap junctional adaptation derived with analogy to neural systems. Here, gap junctions are modelled as bonds in a beta-cell network, that are altered according to homeostatic rules of plasticity. Our analysis reveals that it is nearly impossible to view gap junctions as homogeneous across a tissue. A modified view that accommodates heterogeneity of junction strengths in the islet can explain why, for example, a loss of gap junction conductance in diabetes is necessary for an increase in plasma insulin levels following hyperglycemia.	[Goel, Pranay] Indian Insitute Sci Educ & Res Pune, Pune, Maharashtra, India; [Mehta, Anita] SN Bose Natl Ctr Basic Sci, Dept Phys, Kolkata, W Bengal, India	Indian Institute of Science Education & Research (IISER) Pune; Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS)	Goel, P (corresponding author), Indian Insitute Sci Educ & Res Pune, Pune, Maharashtra, India.	pgoel@iiserpune.ac.in	Goel, Pranay/D-1081-2013	Goel, Pranay/0000-0002-2249-0288				Bavamian S, 2007, DIABETES OBES METAB, V9, P118, DOI 10.1111/j.1463-1326.2007.00780.x; Benninger RKP, 2011, J PHYSIOL-LONDON, V589, P5453, DOI 10.1113/jphysiol.2011.218909; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2010, ADV EXP MED BIOL, V654, P261, DOI 10.1007/978-90-481-3271-3_12; Bhat AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025048; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Camerer CF, 2003, TRENDS COGN SCI, V7, P225, DOI 10.1016/S1364-6613(03)00094-9; Ermentrout B., 2008, SCHOLARPEDIA, V3, P5371; Goel P, 2009, SIAM J APPL DYN SYST, V8, P1664, DOI 10.1137/08074427X; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Haefliger JA, 2013, J MOL ENDOCRINOL, V51, P49, DOI 10.1530/JME-13-0054; Hamelin R, 2009, CURR PROTEIN PEPT SC, V10, P18, DOI 10.2174/138920309787315167; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Levin M, 2012, ANNU REV BIOMED ENG, V14, P295, DOI [10.1146/annurev-bioeng-071811-150114, 10.1146/annurev.bioeng-071811-150114]; Lin JM, 2002, DIABETES, V51, P988, DOI 10.2337/diabetes.51.4.988; MacDonald PE, 2006, PLOS BIOL, V4, P167, DOI 10.1371/journal.pbio.0040049; Mahajan G, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/69901; Meda P, 2012, DIABETES, V61, P1656, DOI 10.2337/db12-0336; Mehta A, 1999, PHYS REV E, V60, P5218, DOI 10.1103/PhysRevE.60.5218; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nicholson BJ, 2003, J CELL SCI, V116, P4479, DOI 10.1242/jcs.00821; Nunemaker CS, 2005, DIABETES, V54, P3517, DOI 10.2337/diabetes.54.12.3517; ORCI L, 1973, EXPERIENTIA, V29, P1015, DOI 10.1007/BF01930436; Paulauskas N, 2012, BIOPHYS J, V102, P2471, DOI 10.1016/j.bpj.2012.04.038; Paullauskas N, 2009, BIOPHYS J, V96, P3936, DOI 10.1016/j.bpj.2009.01.059; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Potolicchio I, 2012, BBA-BIOMEMBRANES, V1818, P1919, DOI 10.1016/j.bbamem.2011.09.022; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rocheleau JV, 2004, P NATL ACAD SCI USA, V101, P12899, DOI 10.1073/pnas.0405149101; Sherman A, 1997, ADV EXP MED BIOL, V426, P275; SHERMAN A, 1988, BIOPHYS J, V54, P411, DOI 10.1016/S0006-3495(88)82975-8; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Stozer A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002923; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076	43	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70366	10.1371/journal.pone.0070366	http://dx.doi.org/10.1371/journal.pone.0070366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936417	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400061
J	Irwin, ME; Nelson, LD; Santiago-O'Farrill, JM; Knouse, PD; Miller, CP; Palla, SL; Siwak, DR; Mills, GB; Estrov, Z; Li, SL; Kornblau, SM; Hughes, DP; Chandra, J				Irwin, Mary E.; Nelson, Laura D.; Santiago-O'Farrill, Janice M.; Knouse, Phillip D.; Miller, Claudia P.; Palla, Shana L.; Siwak, Doris R.; Mills, Gordon B.; Estrov, Zeev; Li, Shulin; Kornblau, Steven M.; Hughes, Dennis P.; Chandra, Joya			Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; LAPATINIB GW572016; CANCER-CELLS; PH PLUS; PHARMACOKINETICS; ARRAYS; ACTIVATION; IMATINIB; HER2; BIM	The presence of the Philadelphia chromosome in patients with acute lymphoblastic leukemia (Ph(+)ALL) is a negative prognostic indicator. Tyrosine kinase inhibitors (TKI) that target BCR/ABL, such as imatinib, have improved treatment of Ph(+)ALL and are generally incorporated into induction regimens. This approach has improved clinical responses, but molecular remissions are seen in less than 50% of patients leaving few treatment options in the event of relapse. Thus, identification of additional targets for therapeutic intervention has potential to improve outcomes for Ph(+)ALL. The human epidermal growth factor receptor 2 (ErbB2) is expressed in similar to 30% of B-ALLs, and numerous small molecule inhibitors are available to prevent its activation. We analyzed a cohort of 129 ALL patient samples using reverse phase protein array (RPPA) with ErbB2 and phospho-ErbB2 antibodies and found that activity of ErbB2 was elevated in 56% of Ph(+)ALL as compared to just 4.8% of Ph(-)ALL. In two human Ph(+)ALL cell lines, inhibition of ErbB kinase activity with canertinib resulted in a dose-dependent decrease in the phosphorylation of an ErbB kinase signaling target p70S6-kinase T389 (by 60% in Z119 and 39% in Z181 cells at 3 mu M). Downstream, phosphorylation of S6-kinase was also diminished in both cell lines in a dose-dependent manner (by 91% in both cell lines at 3 mu M). Canertinib treatment increased expression of the pro-apoptotic protein Bim by as much as 144% in Z119 cells and 49% in Z181 cells, and further produced caspase-3 activation and consequent apoptotic cell death. Both canertinib and the FDA-approved ErbB1/2-directed TKI lapatinib abrogated proliferation and increased sensitivity to BCR/ABL-directed TKIs at clinically relevant doses. Our results suggest that ErbB signaling is an additional molecular target in Ph(+)ALL and encourage the development of clinical strategies combining ErbB and BCR/ABL kinase inhibitors for this subset of ALL patients.	[Irwin, Mary E.; Nelson, Laura D.; Santiago-O'Farrill, Janice M.; Knouse, Phillip D.; Miller, Claudia P.; Li, Shulin; Hughes, Dennis P.; Chandra, Joya] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA; [Siwak, Doris R.; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Palla, Shana L.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Estrov, Zeev; Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Santiago-O'Farrill, Janice M.; Miller, Claudia P.; Hughes, Dennis P.; Chandra, Joya] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Chandra, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA.	jchandra@mdanderson.org	Li, Shulin/D-6478-2011; Chandra, Joya/ABC-7869-2021	Chandra, Joya/0000-0002-2077-9715	Jori Zemel Children's Bone Cancer foundation; National Institutes of Health through MD Anderson's Cancer Center Support Grant [CA16672, F32 CA171905, R01 CA115811]; NATIONAL CANCER INSTITUTE [P50CA098258, K08CA118730, R01CA115811, R01CA149501, P30CA016672, F32CA171905] Funding Source: NIH RePORTER	Jori Zemel Children's Bone Cancer foundation; National Institutes of Health through MD Anderson's Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Jori Zemel Children's Bone Cancer foundation (to L.D.N.) and by the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA16672, F32 CA171905 (to M.E.I.), and R01 CA115811 (to J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avivi I, 2003, BONE MARROW TRANSPL, V31, P623, DOI 10.1038/sj.bmt.1703899; BUHRING HJ, 1995, BLOOD, V86, P1916, DOI 10.1182/blood.V86.5.1916.bloodjournal8651916; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Chevallier P, 2004, HAEMATOLOGICA, V89, P1399; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Estrov Z, 1996, J CELL PHYSIOL, V166, P618, DOI 10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Hunyady B, 1996, J HISTOCHEM CYTOCHEM, V44, P1353, DOI 10.1177/44.12.8985127; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kornblau SM, 2006, BLOOD, V108, P2358, DOI 10.1182/blood-2006-02-003475; Kornblau SM, 2008, BLOOD, V112, P281; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Lee HJ, 2011, CANCER-AM CANCER SOC, V117, P1583, DOI 10.1002/cncr.25690; Lo YH, 2011, ANTICANCER RES, V31, P789; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Miller TW, 2009, CLIN CANCER RES, V15, P7266, DOI 10.1158/1078-0432.CCR-09-1665; Neeley ES, 2009, BIOINFORMATICS, V25, P1384, DOI 10.1093/bioinformatics/btp174; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; Rambal AA, 2009, LEUKEMIA, V23, P1744, DOI 10.1038/leu.2009.80; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Tanaka C, 2010, CLIN PHARMACOL THER, V87, P197, DOI 10.1038/clpt.2009.208; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Xing HY, 2012, LEUKEMIA RES, V36, P509, DOI 10.1016/j.leukres.2011.12.018	23	19	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70608	10.1371/journal.pone.0070608	http://dx.doi.org/10.1371/journal.pone.0070608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936456	Green Submitted, gold, Green Published			2022-12-27	WOS:000324518400077
J	Sekar, S; Karanth, P				Sekar, Sandhya; Karanth, Praveen			Flying between Sky Islands: The Effect of Naturally Fragmented Habitat on Butterfly Population Structure	PLOS ONE			English	Article							LENGTH POLYMORPHISM DATA; GENETIC DIVERSITY; MULTIVARIATE-ANALYSIS; SEQUENCE REPEATS; WESTERN-GHATS; R-PACKAGE; MARKERS; DISPERSAL; DIFFERENTIATION; DIVERGENCE	High elevation montane areas are called "sky islands'' when they occur as a series of high mountains separated by lowland valleys. Different climatic conditions at high elevations makes sky islands a specialized type of habitat, rendering them naturally fragmented compared to more continuous habitat at lower elevations. Species in sky islands face unsuitable climate in the intervening valleys when moving from one montane area to another. The high elevation shola-grassland mosaic in the Western Ghats of southern India form one such sky island complex. The fragmented patches make this area ideal to study the effect of the spatial orientation of suitable habitat patches on population genetic structure of species found in these areas. Past studies have suggested that sky islands tend to have genetically structured populations, possibly due to reduced gene flow between montane areas. To test this hypothesis, we adopted the comparative approach. Using Amplified Fragment Length Polymorphisms, we compared population genetic structures of two closely related, similar sized butterfly species: Heteropsis oculus, a high elevation shola-grassland specialist restricted to the southern Western Ghats, and Mycalesis patnia, found more continuously distributed in lower elevations. In all analyses, as per expectation the sky island specialist H. oculus exhibited a greater degree of population genetic structure than M. patnia, implying a difference in geneflow. This difference in geneflow in turn appears to be due to the natural fragmentation of the sky island complexes. Detailed analysis of a subset of H. oculus samples from one sky island complex (the Anamalais) showed a surprising genetic break. A possible reason for this break could be unsuitable conditions of higher temperature and lower rainfall in the intervening valley region. Thus, sky island species are not only restricted by lack of habitat continuity between montane areas, but also by the nature of the intervening habitat.	[Sekar, Sandhya; Karanth, Praveen] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Sekar, S (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	sandysek@gmail.com			Department of Biotechnology (DBT), Government of India [BT/24/NE/TBP/2010]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work used funding from the Department of Biotechnology (DBT), Government of India. Website: http://dbtindia.nic.in/index.asp. Grant number: BT/24/NE/TBP/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 2007, SYST BIOL, V56, P477, DOI 10.1080/10635150701427077; [Anonymous], 2010, DATA PAPER HIGH RESO; Arrigo N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-33; Bahulikar RA, 2004, CURR SCI INDIA, V86, P824; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Bawa K., 2007, ECOSYSTEM PROFILE W; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brommer JE, 1999, ECOL ENTOMOL, V24, P125, DOI 10.1046/j.1365-2311.1999.00190.x; Conord C, 2006, HEREDITY, V97, P46, DOI 10.1038/sj.hdy.6800837; DeChaine EG, 2005, AM J BOT, V92, P477, DOI 10.3732/ajb.92.3.477; Deshpande AU, 2001, MOL ECOL, V10, P2397, DOI 10.1046/j.0962-1083.2001.01379.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Groot AT, 2011, MOL ECOL, V20, P2676, DOI 10.1111/j.1365-294X.2011.05129.x; Haubrich K, 2007, MOL ECOL, V16, P3643, DOI 10.1111/j.1365-294X.2007.03424.x; He TH, 2004, MOL ECOL, V13, P1099, DOI 10.1111/j.1365-294X.2004.02120.x; Holycross AT, 2007, BIOL CONSERV, V134, P142, DOI 10.1016/j.biocon.2006.07.020; Irwin DE, 2011, MOL ECOL, V20, P3102, DOI 10.1111/j.1365-294X.2011.05159.x; Johannesen J, 1997, BIOCHEM SYST ECOL, V25, P419, DOI 10.1016/S0305-1978(97)00026-4; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kehimkar I., 2008, BOOK INDIAN BUTTERFL; Keyghobadi N, 2005, MOL ECOL, V14, P1897, DOI 10.1111/j.1365-294X.2005.02563.x; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; Kodandaramaiah U, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-172; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Maddison W, 2000, SYST BIOL, V49, P400, DOI 10.1080/10635159950127312; MAYR E, 1976, P NATL ACAD SCI USA, V73, P1765, DOI 10.1073/pnas.73.5.1765; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Meyer D., 2010, PROXY DISTANCE SIMIL; MUNIAPPAN R, 1993, CURR SCI INDIA, V64, P555; Muriel SB, 2009, CONSERV BIOL, V23, P948, DOI 10.1111/j.1523-1739.2009.01213.x; Pascal J.P., 1982, EXPLANATORY NOTES BI; R Development Core Team, 2011, R LANG ENV STAT COMP; Reddy CS, 2008, LIFE SCI J, V5, P84; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Robin V, 2011, ANIMAL BEHAV; Robin VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013321; Sekar S, 2012, J ANIM ECOL, V81, P174, DOI 10.1111/j.1365-2656.2011.01909.x; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; Takami Y, 2004, MOL ECOL, V13, P245, DOI 10.1046/j.1365-294X.2003.02040.x; Timm AE, 2006, J ECON ENTOMOL, V99, P341, DOI 10.1603/0022-0493-99.2.341; Vandewoestijne S, 2004, BASIC APPL ECOL, V5, P581, DOI 10.1016/j.baae.2004.07.004; Varas-Nelson A.C., 2010, CONSERVATION GENETIC; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vila M, 2011, J ZOOL SYST EVOL RES, V49, P119, DOI 10.1111/j.1439-0469.2010.00587.x; Warshall P., 1994, BIODIVERSITY MANAGEM, P6; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; WIKLUND C, 1977, OIKOS, V28, P56, DOI 10.2307/3543323; WIKRAMANAYAKE E, 2001, TERRESTRIAL ECOREGIO; Wynter-Blyth M. A., 1957, BUTTERFLIES INDIAN R; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	56	17	17	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71573	10.1371/journal.pone.0071573	http://dx.doi.org/10.1371/journal.pone.0071573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936518	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324518400114
J	Vogel, A; Fester, T; Eisenhauer, N; Scherer-Lorenzen, M; Schmid, B; Weisser, WW; Weigelt, A				Vogel, Anja; Fester, Thomas; Eisenhauer, Nico; Scherer-Lorenzen, Michael; Schmid, Bernhard; Weisser, Wolfgang W.; Weigelt, Alexandra			Separating Drought Effects from Roof Artifacts on Ecosystem Processes in a Grassland Drought Experiment	PLOS ONE			English	Article							PRECIPITATION MANIPULATION EXPERIMENTS; CLIMATE-CHANGE EXPERIMENTS; LITTER DECOMPOSITION; TEMPERATE GRASSLANDS; GAS-CHROMATOGRAPHY; BIODIVERSITY LOSS; SUMMER DROUGHT; PLANT LITTER; ELEVATED CO2; DIVERSITY	1: Given the predictions of increased drought probabilities under various climate change scenarios, there have been numerous experimental field studies simulating drought using transparent roofs in different ecosystems and regions. Such roofs may, however, have unknown side effects, called artifacts, on the measured variables potentially confounding the experimental results. A roofed control allows the quantification of potential artifacts, which is lacking in most experiments. 2: We conducted a drought experiment in experimental grasslands to study artifacts of transparent roofs and the resulting effects of artifacts on ecosystems relative to drought on three response variables (aboveground biomass, litter decomposition and plant metabolite profiles). We established three drought treatments, using (1) transparent roofs to exclude rainfall, (2) an unroofed control treatment receiving natural rainfall and (3) a roofed control, nested in the drought treatment but with rain water reapplied according to ambient conditions. 3: Roofs had a slight impact on air (+0.14 degrees C during night) and soil temperatures (-0.45 degrees C on warm days, +0.25 degrees C on cold nights), while photosynthetically active radiation was decreased significantly (-16%). Aboveground plant community biomass was reduced in the drought treatment (-41%), but there was no significant difference between the roofed and unroofed control, i.e., there were no measurable roof artifact effects. 4: Compared to the unroofed control, litter decomposition was decreased significantly both in the drought treatment (-26%) and in the roofed control treatment (-18%), suggesting artifact effects of the transparent roofs. Moreover, aboveground metabolite profiles in the model plant species Medicago x varia were different from the unroofed control in both the drought and roofed control treatments, and roof artifact effects were of comparable magnitude as drought effects. 5: Our results stress the need for roofed control treatments when using transparent roofs for studying drought effects, because roofs can cause significant side effects.	[Vogel, Anja; Eisenhauer, Nico; Weigelt, Alexandra] Univ Jena, Inst Ecol, Jena, Germany; [Fester, Thomas] Helmholtz Zentrum Umweltforsch UFZ, Dept Umweltmikrobiol, Leipzig, Germany; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Weisser, Wolfgang W.] Tech Univ Munich, Ctr Food & Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Weigelt, Alexandra] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany	Friedrich Schiller University of Jena; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Freiburg; University of Zurich; Technical University of Munich; Leipzig University	Vogel, A (corresponding author), Univ Jena, Inst Ecol, Jena, Germany.	anja.vogel@uni-jena.de	Eisenhauer, Nico/I-5932-2012; Schmid, Bernhard/C-8625-2009; Weisser, Wolfgang W/B-9718-2014; Scherer-Lorenzen, Michael/AGB-4140-2022; Eisenhauer, Nico/I-3191-2019	Eisenhauer, Nico/0000-0002-0371-6720; Schmid, Bernhard/0000-0002-8430-3214; Weisser, Wolfgang W/0000-0002-2757-8959; Scherer-Lorenzen, Michael/0000-0001-9566-590X; Eisenhauer, Nico/0000-0002-0371-6720	University of Jena; Deutsche Forschungsgemeinschaft (DFG) [FOR 456, Ei 862/2]	University of Jena; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The drought experiment was funded by the University of Jena (grant to Alexandra Weigelt) with additional support of the Universities of Zurich, Gottingen and Freiburg. The Jena Experiment was funded by the Deutsche Forschungsgemeinschaft (DFG; FOR 456). Nico Eisenhauer gratefully acknowledges funding by the DFG (Ei 862/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Ballare C L, 2011, Photochem Photobiol Sci, V10, P226, DOI 10.1039/c0pp90035d; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bontti EE, 2009, GLOBAL CHANGE BIOL, V15, P1356, DOI 10.1111/j.1365-2486.2008.01815.x; Brandt LA, 2010, ECOSYSTEMS, V13, P765, DOI 10.1007/s10021-010-9353-2; Butof A, 2012, GLOBAL CHANGE BIOL, V18, P127, DOI 10.1111/j.1365-2486.2011.02539.x; Butenschoen O, 2011, SOIL BIOL BIOCHEM, V43, P1902, DOI 10.1016/j.soilbio.2011.05.011; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carlyle CN, 2011, ECOSYSTEMS, V14, P489, DOI 10.1007/s10021-011-9425-y; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Desbrosses GG, 2005, PLANT PHYSIOL, V137, P1302, DOI 10.1104/pp.104.054957; Eisenhauer N, 2012, GLOBAL CHANGE BIOL, V18, P435, DOI 10.1111/j.1365-2486.2011.02555.x; Emmett BA, 2004, ECOSYSTEMS, V7, P625, DOI 10.1007/s10021-004-0220-x; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; Fester T, 2011, OECOLOGIA, V167, P913, DOI 10.1007/s00442-011-2037-6; Foereid B, 2011, SOIL BIOL BIOCHEM, V43, P1383, DOI 10.1016/j.soilbio.2011.03.004; Fraser LH, 2013, FRONT ECOL ENVIRON, V11, P147, DOI 10.1890/110279; Fry EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057027; Gilgen AK, 2009, BIOGEOSCIENCES, V6, P2525, DOI 10.5194/bg-6-2525-2009; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; Haywood JM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016000; Hollander M., 1973, NONPARAMETRIC STAT M; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Jansen JJ, 2010, PHYTOCHEM ANALYSIS, V21, P48, DOI 10.1002/pca.1181; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kuhn M, 2012, CARET CLASSIFICATION; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Merchant A, 2011, FUNCT PLANT BIOL, V38, P934, DOI 10.1071/FP11105; Mikkelsen TN, 2008, FUNCT ECOL, V22, P185, DOI 10.1111/j.1365-2435.2007.01362.x; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pearcy RW, 1999, HDB FUNCTIONAL PLANT; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rustad LE, 2008, SCI TOTAL ENVIRON, V404, P222, DOI 10.1016/j.scitotenv.2008.04.050; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Sanaullah M, 2012, PLANT SOIL, V352, P277, DOI 10.1007/s11104-011-0995-4; Sanaullah M, 2011, APPL SOIL ECOL, V48, P38, DOI 10.1016/j.apsoil.2011.02.004; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; Shinoda M, 2010, J ARID ENVIRON, V74, P63, DOI 10.1016/j.jaridenv.2009.07.004; Solomon S., 2007, PHYS SCI BASIS WORKI; Svejcar T, 1999, J ARID ENVIRON, V42, P187, DOI 10.1006/jare.1999.0514; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Vicca S, 2012, NEW PHYTOL, V195, P518, DOI 10.1111/j.1469-8137.2012.04224.x; Vogel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036992; Wang YF, 2007, ECOL LETT, V10, P401, DOI 10.1111/j.1461-0248.2007.01031.x; White SR, 2012, BIOL LETTERS, V8, P484, DOI 10.1098/rsbl.2011.0956; Yahdjian L, 2006, ECOSYSTEMS, V9, P128, DOI 10.1007/s10021-004-0118-7; Yahdjian L, 2002, OECOLOGIA, V133, P95, DOI 10.1007/s00442-002-1024-3	54	32	32	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70997	10.1371/journal.pone.0070997	http://dx.doi.org/10.1371/journal.pone.0070997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936480	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400086
J	Valcour, VG; Ananworanich, J; Agsalda, M; Sailasuta, N; Chalermchai, T; Schuetz, A; Shikuma, C; Liang, CY; Jirajariyavej, S; Sithinamsuwan, P; Tipsuk, S; Clifford, DB; Paul, R; Fletcher, JLK; Marovich, MA; Slike, BM; DeGruttola, V; Shiramizu, B				Valcour, Victor G.; Ananworanich, Jintanat; Agsalda, Melissa; Sailasuta, Napapon; Chalermchai, Thep; Schuetz, Alexandra; Shikuma, Cecilia; Liang, Chin-Yuan; Jirajariyavej, Supunee; Sithinamsuwan, Pasiri; Tipsuk, Somporn; Clifford, David B.; Paul, Robert; Fletcher, James L. K.; Marovich, Mary A.; Slike, Bonnie M.; DeGruttola, Victor; Shiramizu, Bruce		SEARCH 011 Protocol Team	HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naive Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CIRCULATING MONOCYTES; DISEASE PROGRESSION; DEMENTIA; IMPAIRMENT; INFECTION; HAART; CELLS; AIDS	Objectives: Cognitive impairment remains frequent in HIV, despite combination antiretroviral therapy (cART). Leading theories implicate peripheral monocyte HIV DNA reservoirs as a mechanism for spread of the virus to the brain. These reservoirs remain present despite cART. The objective of this study was to determine if the level of HIV DNA in CD14(+) enriched monocytes predicted cognitive impairment and brain injury. Methods: We enrolled 61 cART-naive HIV-infected Thais in a prospective study and measured HIV DNA in CD14+ enriched monocyte samples in a blinded fashion. We determined HAND diagnoses by consensus panel and all participants underwent magnetic resonance spectroscopy (MRS) to measure markers of brain injury. Immune activation was measured via cytokines in cerebrospinal fluid (CSF). Results: The mean (SD) age was 35 (6.9) years, CD4 T-lymphocyte count was 236 (139) and log(10) plasma HIV RNA was 4.8 (0.73). Twenty-eight of 61 met HAND criteria. The log(10) CD14(+) HIV DNA was associated with HAND in unadjusted and adjusted models (p=0.001). There was a 14.5 increased odds ratio for HAND per 1 log-value of HIV DNA (10-fold increase in copy number). Plasma CD14(+) HIV DNA was associated with plasma and CSF neopterin (p = 0.023) and with MRS markers of neuronal injury (lower N-acetyl aspartate) and glial dysfunction (higher myoinositol) in multiple brain regions. Interpretation: Reservoir burden of HIV DNA in monocyte-enriched (CD14(+)) peripheral blood cells increases risk for HAND in treatment-naive HIV+ subjects and is directly associated with CSF immune activation and both brain injury and glial dysfunction by MRS.	[Valcour, Victor G.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Valcour, Victor G.] Univ Calif San Francisco, Dept Med, Div Geriatr Med, San Francisco, CA USA; [Ananworanich, Jintanat; Chalermchai, Thep; Tipsuk, Somporn; Fletcher, James L. K.] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand; [Ananworanich, Jintanat] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand; [Ananworanich, Jintanat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Ananworanich, Jintanat; Agsalda, Melissa; Shikuma, Cecilia; Liang, Chin-Yuan; Shiramizu, Bruce] Univ Hawaii, Hawaii Ctr AIDS, Honolulu, HI 96822 USA; [Sailasuta, Napapon] Huntington Med Res Inst, Pasadena, CA USA; [Schuetz, Alexandra] Armed Forces Res Inst Med Sci, Dept Retrovirol, Bangkok 10400, Thailand; [Jirajariyavej, Supunee] Taksin Hosp, Bangkok, Thailand; [Sithinamsuwan, Pasiri] Phramongkutklao Hosp, Dept Med, Div Neurol, Bangkok, Thailand; [Clifford, David B.] Washington Univ, Dept Neurol, St Louis, MO USA; [Paul, Robert] Univ Missouri, Dept Psychol, St Louis, MO 63121 USA; [Marovich, Mary A.] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Marovich, Mary A.; Slike, Bonnie M.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Slike, Bonnie M.] Queen Savang Vadhana Mem Hosp, Si Racha, Thailand; [DeGruttola, Victor] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Thai Red Cross Society; Thai Red Cross Society; Chulalongkorn University; University of Hawaii System; Huntington Medical Research Institutes; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Phramongkutklao Hospital; Washington University (WUSTL); University of Missouri System; University of Missouri Saint Louis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Harvard T.H. Chan School of Public Health; Thai Red Cross Society	Valcour, VG (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA.	vvalcour@memory.ucsf.edu	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Chalermchai, Thep/0000-0001-7839-7835	NINDS/NIH [R01-NS053359, R01-NS061696, R01-NS053345]; NIMH/NIH [R21-MH072388]; NIMHD/NIH [MD007584]; National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through UCSF-CTSI [UL1 TR000004]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc [W81XWH-11-2-0174]; U.S. Department of Defense [W81XWH-11-2-0174]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI081450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH072388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061696, R01NS053359, R01NS053345] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through UCSF-CTSI; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; U.S. Department of Defense(United States Department of Defense); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by R01-NS053359 (NINDS/NIH - SRK), R01-NS061696 (NINDS/NIH - VV), R21-MH072388 (NIMH/NIH - VV), R01-NS053345 (NINDS/NIH - BS), and MD007584 (NIMHD/NIH - BS, CS). Added statistical assistance was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through UCSF-CTSI Grant Number UL1 TR000004. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. This work was supported in part by a cooperative agreement (W81XWH-11-2-0174) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, and the U.S. Department of Defense. The views expressed are those of the authors and should not be construed to represent the positions of the US Army or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Avettand-Fenoel V, 2008, J CLIN VIROL, V42, P399, DOI 10.1016/j.jcv.2008.03.013; Bell JE, 1998, BRAIN, V121, P2043, DOI 10.1093/brain/121.11.2043; Cantres-Rosario Y, 2013, AIDS, V27, P347, DOI 10.1097/QAD.0b013e32835b3e47; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Heaps JM, 2012, J CLIN EXPT IN PRESS; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Le Douce V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-32; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P51; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rouzioux C, 2005, J INFECT DIS, V192, P46, DOI 10.1086/430610; Ryan LA, 2001, J INFECT DIS, V184, P699, DOI 10.1086/323036; Schirmer T, 2000, NMR BIOMED, V13, P28, DOI 10.1002/(SICI)1099-1492(200002)13:1<28::AID-NBM606>3.0.CO;2-L; Shikuma CM, 2012, ANTIVIR THER, V17, P1233, DOI 10.3851/IMP2411; Shiramizu B, 2005, AIDS, V19, P45, DOI 10.1097/00002030-200501030-00005; Shiramizu B, 2012, J NEUROVIROL, V18, P69, DOI 10.1007/s13365-011-0068-8; Shiramizu B, 2007, J NEUROPSYCH CLIN N, V19, P157, DOI 10.1176/appi.neuropsych.19.2.157; Sungkanuparph S, 2010, ASIAN BIOMED, V4, P515, DOI 10.2478/abm-2010-0066; Valcour VG, 2007, NEUROLOGY, V68, P525, DOI 10.1212/01.wnl.0000253196.78193.c7; Valcour VG, 2009, NEUROLOGY, V72, P992, DOI 10.1212/01.wnl.0000344404.12759.83; Valcour VG, 2010, J LEUKOCYTE BIOL, V87, P621, DOI 10.1189/jlb.0809571; Wirachsilp Piyanot, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P814; Wright SM, 1997, NMR BIOMED, V10, P394, DOI 10.1002/(SICI)1099-1492(199712)10:8<394::AID-NBM494>3.0.CO;2-0; Yuan L, 2013, J NEUROVIROL	29	62	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70164	10.1371/journal.pone.0070164	http://dx.doi.org/10.1371/journal.pone.0070164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936155	Green Published, gold			2022-12-27	WOS:000322633700058
J	Ebbing, C; Kiserud, T; Johnsen, SL; Albrechtsen, S; Rasmussen, S				Ebbing, Cathrine; Kiserud, Torvid; Johnsen, Synnove Lian; Albrechtsen, Susanne; Rasmussen, Svein			Prevalence, Risk Factors and Outcomes of Velamentous and Marginal Cord Insertions: A Population-Based Study of 634,741 Pregnancies	PLOS ONE			English	Article							MEDICAL BIRTH REGISTRY; UMBILICAL-CORD; VASA-PREVIA; CLINICAL-SIGNIFICANCE; PLACENTAL ABRUPTION; WEIGHT; VALIDATION; DIAGNOSIS; TWINS; COMPRESSION	Objectives: To determine the prevalence of, and risk factors for anomalous insertions of the umbilical cord, and the risk for adverse outcomes of these pregnancies. Design: Population-based registry study. Setting: Medical Birth Registry of Norway 1999-2009. Population: All births (gestational age >16 weeks to <45 weeks) in Norway (623,478 singletons and 11,263 pairs of twins). Methods: Descriptive statistics and odds ratios (ORs) for risk factors and adverse outcomes based on logistic regressions adjusted for confounders. Main outcome measures: Velamentous or marginal cord insertion. Abruption of the placenta, placenta praevia, preeclampsia, preterm birth, operative delivery, low Apgar score, transferral to neonatal intensive care unit (NICU), malformations, birthweight, and perinatal death. Results: The prevalence of abnormal cord insertion was 7.8% (1.5% velamentous, 6.3% marginal) in singleton pregnancies and 16.9% (6% velamentous, 10.9% marginal) in twins. The two conditions shared risk factors; twin gestation and pregnancies conceived with the aid of assisted reproductive technology were the most important, while bleeding in pregnancy, advanced maternal age, maternal chronic disease, female foetus and previous pregnancy with anomalous cord insertion were other risk factors. Velamentous and marginal insertion was associated with an increased risk of adverse outcomes such as placenta praevia (OR = 3.7, (95% CI = 3.1-4.6)), and placental abruption (OR = 2.6, (95% CI = 2.1-3.2)). The risk of pre-eclampsia, preterm birth and delivery by acute caesarean was doubled, as was the risk of low Apgar score, transferral to NICU, low birthweight and malformations. For velamentous insertion the risk of perinatal death at term was tripled, OR = 3.3 (95% CI = 2.5-4.3). Conclusion: The prevalence of velamentous and marginal insertions of the umbilical cord was 7.8% in singletons and 16.9% in twin gestations, with marginal insertion being more common than velamentous. The conditions were associated with common risk factors and an increased risk of adverse perinatal outcomes; these risks were greater for velamentous than for marginal insertion.	[Ebbing, Cathrine; Johnsen, Synnove Lian; Albrechtsen, Susanne; Rasmussen, Svein] Haukeland Hosp, Dept Obstet & Gynaecol, N-5021 Bergen, Norway; [Ebbing, Cathrine; Kiserud, Torvid; Rasmussen, Svein] Univ Bergen, Clin Foetal Physiol Res Grp, Dept Clin Sci, N-5020 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen	Ebbing, C (corresponding author), Haukeland Hosp, Dept Obstet & Gynaecol, N-5021 Bergen, Norway.	cathrine.ebbing@molmed.uib.no	Albrechtsen, Susanne/H-4680-2019; Ebbing, Cathrine/ABC-9123-2020	Ebbing, Cathrine/0000-0002-4331-1250; Kiserud, Torvid/0000-0003-1825-1660	Western Norway Regional Health Authority [911581]	Western Norway Regional Health Authority	Cathrine Ebbing was supported financially by the Western Norway Regional Health Authority (Post doctoral grant no 911581).	Antoniou EE, 2011, BIOL REPROD, V85, P137, DOI 10.1095/biolreprod.110.088807; Baghestan E, 2007, ACTA OBSTET GYN SCAN, V86, P205, DOI 10.1080/00016340601111364; Benirschke K., 1990, PATHOLOGY HUMAN PLAC, P319; Cipriano LE, 2010, BJOG-INT J OBSTET GY, V117, P1108, DOI 10.1111/j.1471-0528.2010.02621.x; Collins JH, 2002, SEMIN PERINATOL, V26, P79, DOI 10.1053/sper.2002.29860; De Paepe ME, 2010, PLACENTA, V31, P380, DOI 10.1016/j.placenta.2010.02.018; Delbaere I, 2007, HUM REPROD, V22, P2763, DOI 10.1093/humrep/dem191; EDDLEMAN KA, 1992, AM J PERINAT, V9, P123, DOI 10.1055/s-2007-994684; Engeland A, 2009, ACTA OBSTET GYN SCAN, V88, P1083, DOI 10.1080/00016340903128454; Hanley ML, 2002, OBSTET GYNECOL, V99, P477, DOI 10.1016/S0029-7844(01)01734-3; Heinonen S, 1996, AM J PERINAT, V13, P437, DOI 10.1055/s-2007-994384; Heinonen S, 1996, BRIT J OBSTET GYNAEC, V103, P209, DOI 10.1111/j.1471-0528.1996.tb09707.x; Hutcheon JA, 2012, OBSTET GYNECOL, V119, P1251, DOI 10.1097/AOG.0b013e318253d3df; ITSKOVITZ J, 1987, AM J PHYSIOL, V252, pH100, DOI 10.1152/ajpheart.1987.252.1.H100; Kent EM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.077; Khong TY, 1998, PLACENTA, V19, P577, DOI 10.1016/S0143-4004(98)90017-0; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P126, DOI 10.1002/uog.2832; Loos RJF, 2001, BRIT J OBSTET GYNAEC, V108, P943, DOI 10.1111/j.1471-0528.2001.00220.x; Machin GA, 1997, J REPROD MED, V42, P785; Misra DP, 2009, PLACENTA, V30, P1052, DOI 10.1016/j.placenta.2009.09.008; MONIE IW, 1965, AM J OBSTET GYNECOL, V93, P276, DOI 10.1016/0002-9378(65)90670-8; Nilsen RM, 2008, AM J EPIDEMIOL, V167, P867, DOI 10.1093/aje/kwm373; Oyelese Y, 2004, OBSTET GYNECOL, V103, P937, DOI 10.1097/01.AOG.0000123245.48645.98; Papathanasiou D, 2010, FETAL DIAGN THER, V28, P48, DOI 10.1159/000315493; Raisanen S, 2012, EUR J OBSTE IN PRESS; Rasmussen S, 2000, ACTA OBSTET GYN SCAN, V79, P502, DOI 10.1034/j.1600-0412.2000.079006502.x; Rasmussen S, 2003, ACTA OBSTET GYN SCAN, V82, P109, DOI 10.1034/j.1600-0412.2003.00009.x; Redline R. W., 2011, PLACENTA DEV DIS, P114; ROBINSON LK, 1983, AM J OBSTET GYNECOL, V146, P191, DOI 10.1016/0002-9378(83)91052-9; Salafia CM, 2007, BIRTH DEFECTS RES A, V79, P281, DOI 10.1002/bdra.20345; Sato Y, 2006, PEDIATRICS, V117, pE113, DOI 10.1542/peds.2005-1501; Sepulveda W, 2003, ULTRASOUND OBST GYN, V21, P564, DOI 10.1002/uog.132; Skulstad SM, 2005, EARLY HUM DEV, V81, P325, DOI 10.1016/j.earlhumdev.2004.07.006; SOIFER SJ, 1987, J DEV PHYSIOL, V9, P239; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; Thureen PJ, 1997, AM J OBSTET GYNECOL, V176, P967, DOI 10.1016/S0002-9378(97)70387-9; UYANWAHAKPOM P, 1977, BRIT J OBSTET GYNAEC, V84, P941, DOI 10.1111/j.1471-0528.1977.tb12525.x; Yang QY, 2009, AM J PERINAT, V26, P279, DOI 10.1055/s-0028-1103156	38	106	106	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70380	10.1371/journal.pone.0070380	http://dx.doi.org/10.1371/journal.pone.0070380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936197	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200079
J	Fu, SL; Yang, MY; Fei, YY; Tan, FQ; Ren, ZL; Yan, BJ; Zhang, HY; Tang, ZX				Fu, Shulan; Yang, Manyu; Fei, Yunyan; Tan, Feiquan; Ren, Zhenglong; Yan, Benju; Zhang, Huaiyu; Tang, Zongxiang			Alterations and Abnormal Mitosis of Wheat Chromosomes Induced by Wheat-Rye Monosomic Addition Lines	PLOS ONE			English	Article							MICRONUCLEUS FORMATION; CYTOSINE METHYLATION; GENOME VARIATION; BREAD WHEAT; ELIMINATION; AEGILOPS; POLYPLOIDIZATION; HETEROCHROMATIN; INSTABILITY; INTERPHASE	Background: Wheat-rye addition lines are an old topic. However, the alterations and abnormal mitotic behaviours of wheat chromosomes caused by wheat-rye monosomic addition lines are seldom reported. Methodology/Principal Findings: Octoploid triticale was derived from common wheat T. aestivum L. 'Mianyang11'xrye S. cereale L. 'Kustro' and some progeny were obtained by the controlled backcrossing of triticale with 'Mianyang11' followed by self-fertilization. Genomic in situ hybridization (GISH) using rye genomic DNA and fluorescence in situ hybridization (FISH) using repetitive sequences pAs1 and pSc119.2 as probes were used to analyze the mitotic chromosomes of these progeny. Strong pSc119.2 FISH signals could be observed at the telomeric regions of 3DS arms in 'Mianyang11'. However, the pSc119.2 FISH signals were disappeared from the selfed progeny of 4R monosomic addition line and the changed 3D chromosomes could be transmitted to next generation stably. In one of the selfed progeny of 7R monosomic addition line, one 2D chromosome was broken and three 4A chromosomes were observed. In the selfed progeny of 6R monosomic addition line, structural variation and abnormal mitotic behaviour of 3D chromosome were detected. Additionally, 1A and 4B chromosomes were eliminated from some of the progeny of 6R monosomic addition line. Conclusions/Significance: These results indicated that single rye chromosome added to wheat might cause alterations and abnormal mitotic behaviours of wheat chromosomes and it is possible that the stress caused by single alien chromosome might be one of the factors that induced karyotype alteration of wheat.	[Fu, Shulan; Yang, Manyu; Fei, Yunyan; Tan, Feiquan; Ren, Zhenglong; Yan, Benju; Zhang, Huaiyu; Tang, Zongxiang] Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Fu, SL (corresponding author), Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China.	fushulan@sicau.edu.cn; zxtang@sicau.edu.cn			National Natural Science Foundation of China [31000713, 31171557]; National High Technology Research and Development Program ("863'' Program) of China [2011AA100101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ("863'' Program) of China(National High Technology Research and Development Program of China)	This study was supported by National Natural Science Foundation of China (No. 31000713 and 31171557) and by the National High Technology Research and Development Program ("863'' Program) of China (No. 2011AA100101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; APPELS R, 1982, THEOR APPL GENET, V63, P235, DOI 10.1007/BF00304002; BENNETT MD, 1976, CHROMOSOMA, V54, P175, DOI 10.1007/BF00292839; Bento M, 2010, THEOR APPL GENET, V121, P489, DOI 10.1007/s00122-010-1325-6; Bento M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001402; Brasileiro-Vidal AC, 2005, PLANT CELL REP, V24, P172, DOI 10.1007/s00299-005-0913-4; de las Heras JI, 2001, HEREDITY, V87, P474, DOI 10.1046/j.1365-2540.2001.00931.x; Friebe B, 2001, CHROMOSOME RES, V9, P137, DOI 10.1023/A:1009283003903; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054057; Gernand D, 2006, CYTOGENET GENOME RES, V114, P169, DOI 10.1159/000093334; Gernand D, 2005, PLANT CELL, V17, P2431, DOI 10.1105/tpc.105.034249; GUSTAFSON JP, 1983, CHROMOSOMA, V88, P293, DOI 10.1007/BF00292906; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Hua YW, 2006, ANN BOT-LONDON, V97, P993, DOI 10.1093/aob/mcl073; Kynast RG, 2000, CHROMOSOME RES, V8, P133, DOI 10.1023/A:1009294519798; LAPITAN NLV, 1984, THEOR APPL GENET, V68, P547, DOI 10.1007/BF00285012; Liu B, 1998, GENOME, V41, P272, DOI 10.1139/gen-41-2-272; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Ma XF, 2004, GENOME, V47, P839, DOI [10.1139/g04-051, 10.1139/G04-051]; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; MARTINEZ I, 1994, THEOR APPL GENET, V89, P982, DOI 10.1007/BF00224528; MCCLINTOCK B, 1978, STADLER GENET S, V10, P25; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; REN ZL, 1990, PLANT BREEDING, V105, P257, DOI 10.1111/j.1439-0523.1990.tb01283.x; SACHS L, 1952, HEREDITY, V6, P157, DOI 10.1038/hdy.1952.17; Sepsi A, 2008, THEOR APPL GENET, V116, P825, DOI 10.1007/s00122-008-0716-4; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; SNOAD BRIAN, 1955, HEREDITY, V9, P129, DOI 10.1038/hdy.1955.7; Szakacs E, 2010, J APPL GENET, V51, P149, DOI 10.1007/BF03195723; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Tang ZX, 2012, J PLANT RES, V125, P283, DOI 10.1007/s10265-011-0432-z; Tang ZX, 2012, INT J PLANT SCI, V173, P1, DOI 10.1086/662655; Tu YQ, 2009, ANN BOT-LONDON, V103, P1039, DOI 10.1093/aob/mcp045; Vega JM, 1998, GENETICS, V148, P1285	36	34	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70483	10.1371/journal.pone.0070483	http://dx.doi.org/10.1371/journal.pone.0070483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936213	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200089
J	Ferrini, ME; Simons, BJ; Bassett, DJP; Bradley, MO; Roberts, K; Jaffar, Z				Ferrini, Maria E.; Simons, Bryan J.; Bassett, David J. P.; Bradley, Matthews O.; Roberts, Kevan; Jaffar, Zeina			S-Nitrosoglutathione Reductase Inhibition Regulates Allergen-Induced Lung Inflammation and Airway Hyperreactivity	PLOS ONE			English	Article							NF-KAPPA-B; T-CELLS; EXPERIMENTAL ASTHMA; PROSTAGLANDIN I-2; NITROGEN-OXIDES; SMOOTH-MUSCLE; NITRIC-OXIDE; GUINEA-PIG; BRONCHODILATOR; NITROSOTHIOLS	Allergic asthma is characterized by Th2 type inflammation, leading to airway hyperresponsivenes, mucus hypersecretion and tissue remodeling. S-Nitrosoglutathione reductase (GSNOR) is an alcohol dehydrogenase involved in the regulation of intracellular levels of S-nitrosothiols. GSNOR activity has been shown to be elevated in human asthmatic lungs, resulting in diminished S-nitrosothiols and thus contributing to increased airway hyperreactivity. Using a mouse model of allergic airway inflammation, we report that intranasal administration of a new selective inhibitor of GSNOR, SPL-334, caused a marked reduction in airway hyperreactivity, allergen-specific T cells and eosinophil accumulation, and mucus production in the lungs in response to allergen inhalation. Moreover, SPL-334 treatment resulted in a significant decrease in the production of the Th2 cytokines IL-5 and IL-13 and the level of the chemokine CCL11 (eotaxin-1) in the airways. Collectively, these observations reveal that GSNOR inhibitors are effective not only in reducing airway hyperresponsiveness but also in limiting lung inflammatory responses mediated by CD4(+) Th2 cells. These findings suggest that the inhibition of GSNOR may provide a novel therapeutic approach for the treatment of allergic airway inflammation.	[Ferrini, Maria E.; Simons, Bryan J.; Roberts, Kevan; Jaffar, Zeina] Univ Montana, Ctr Environm Hlth Sci Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Bassett, David J. P.] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Bradley, Matthews O.] SAJE Pharma, Kalispell, MT USA	University of Montana System; University of Montana; Wayne State University	Jaffar, Z (corresponding author), Univ Montana, Ctr Environm Hlth Sci Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.	Zeina.jaffar@umontana.edu			Centers of Biomedical Research Excellence (COBRE, NIH) [P20RR017670]; SAJE Pharma grants; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103338] Funding Source: NIH RePORTER	Centers of Biomedical Research Excellence (COBRE, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); SAJE Pharma grants; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Centers of Biomedical Research Excellence (COBRE, NIH, P20RR017670) and SAJE Pharma grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNENBERG G, 1995, J PHARMACOL EXP THER, V272, P1238; Fang KH, 2000, AM J PHYSIOL-LUNG C, V279, pL716, DOI 10.1152/ajplung.2000.279.4.L716; Foster MW, 2011, AM J PHYSIOL-LUNG C, V301, pL739, DOI 10.1152/ajplung.00134.2011; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; GASTON B, 1994, J PHARMACOL EXP THER, V268, P978; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Henderson EM, 2005, TRENDS MOL MED, V11, P481, DOI 10.1016/j.molmed.2005.09.009; Jaffar Z, 2002, J IMMUNOL, V169, P5997, DOI 10.4049/jimmunol.169.10.5997; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Jaffar Z, 2011, J IMMUNOL, V187, P5380, DOI 10.4049/jimmunol.1101261; Kacmarek RM, 1996, AM J RESP CRIT CARE, V153, P128, DOI 10.1164/ajrccm.153.1.8542105; Kasaian MT, 2008, BIOCHEM PHARMACOL, V76, P147, DOI 10.1016/j.bcp.2008.04.002; KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Matsukura S, 1999, J IMMUNOL, V163, P6876; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Que LG, 2009, AM J RESP CRIT CARE, V180, P226, DOI 10.1164/rccm.200901-0158OC; Sanghani PC, 2009, J BIOL CHEM, V284, P24354, DOI 10.1074/jbc.M109.019919; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Sun XC, 2012, BIOORG MED CHEM LETT, V22, P2338, DOI 10.1016/j.bmcl.2012.01.047; WEVER AMJ, 1994, RESP MED, V88, P613, DOI 10.1016/S0954-6111(05)80010-1; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wu H, 2007, J ALLERGY CLIN IMMUN, V120, P322, DOI 10.1016/j.jaci.2007.04.022	30	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70351	10.1371/journal.pone.0070351	http://dx.doi.org/10.1371/journal.pone.0070351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936192	Green Submitted, gold, Green Published			2022-12-27	WOS:000322433300100
J	Novokhatska, O; Dergai, M; Tsyba, L; Skrypkina, I; Filonenko, V; Moreau, J; Rynditch, A				Novokhatska, Olga; Dergai, Mykola; Tsyba, Liudmyla; Skrypkina, Inessa; Filonenko, Valeriy; Moreau, Jacques; Rynditch, Alla			Adaptor Proteins Intersectin 1 and 2 Bind Similar Proline-Rich Ligands but Are Differentially Recognized by SH2 Domain-Containing Proteins	PLOS ONE			English	Article							DENDRITIC SPINE DEVELOPMENT; CDC42 GEF INTERSECTIN; ALZHEIMERS-DISEASE; FORMS; IDENTIFICATION; ABNORMALITIES; ORIENTATION; REVEALS; COMPLEX; NUMB	Background: Scaffolding proteins of the intersectin (ITSN) family, ITSN1 and ITSN2, are crucial for the initiation stage of clathrin-mediated endocytosis. These proteins are closely related but have implications in distinct pathologies. To determine how these proteins could be separated in certain cell pathways we performed a comparative study of ITSNs. Methodology/Principal Findings: We have shown that endogenous ITSN1 and ITSN2 colocalize and form a complex in cells. A structural comparison of five SH3 domains, which mediated most ITSNs protein-protein interactions, demonstrated a similarity of their ligand-binding sites. We showed that the SH3 domains of ITSN2 bound well-established interactors of ITSN1 as well as newly identified ITSNs protein partners. A search for a novel interacting interface revealed multiple tyrosines that could be phosphorylated in ITSN2. Phosphorylation of ITSN2 isoforms but not ITSN1 short isoform was observed in various cell lines. EGF stimulation of HeLa cells enhanced tyrosine phosphorylation of ITSN2 isoforms and enabled their recognition by the SH2 domains of the Fyn, Fgr and Abl1 kinases, the regulatory subunit of PI3K, the adaptor proteins Grb2 and Crk, and phospholipase C gamma. The SH2 domains mentioned were unable to bind ITSN1 short isoform. Conclusions/Significance: Our results indicate that during evolution of vertebrates ITSN2 acquired a novel protein-interaction interface that allows its specific recognition by the SH2 domains of signaling proteins. We propose that these data could be important to understand the functional diversity of paralogous ITSN proteins.	[Novokhatska, Olga; Dergai, Mykola; Tsyba, Liudmyla; Skrypkina, Inessa; Rynditch, Alla] Ukrainian Acad Sci, Inst Mol Biol & Genet, Dept Funct Genom, UA-252627 Kiev, Ukraine; [Novokhatska, Olga; Dergai, Mykola; Tsyba, Liudmyla; Skrypkina, Inessa; Filonenko, Valeriy; Rynditch, Alla] Ukrainian Acad Sci, Inst Mol Biol & Genet, State Key Lab Mol & Cellular Biol, UA-252627 Kiev, Ukraine; [Filonenko, Valeriy] Ukrainian Acad Sci, Inst Mol Biol & Genet, Dept Cell Signal Syst, UA-252627 Kiev, Ukraine; [Moreau, Jacques] Inst Jacques Monod, Dept Mol Mech Dev, F-75251 Paris, France	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; UDICE-French Research Universities; Universite Paris Cite	Rynditch, A (corresponding author), Ukrainian Acad Sci, Inst Mol Biol & Genet, Dept Funct Genom, UA-252627 Kiev, Ukraine.	rynditch@imbg.org.ua	Filonenko, Valeriy V/D-5447-2015; Skrypkina, Inessa/AAD-4837-2019	Filonenko, Valeriy V/0000-0003-1839-3335; Skrypkina, Inessa/0000-0003-0529-6069; Rynditch, Alla/0000-0003-1590-7839	target complex interdisciplinary programme of scientific researches of NAS of Ukraine "Fundamentals of molecular and cell biotechnologies'', NAS of Ukraine and Russian Foundation for Basic Research; FEBS Collaborative Experimental Scholarship; President of Ukraine	target complex interdisciplinary programme of scientific researches of NAS of Ukraine "Fundamentals of molecular and cell biotechnologies'', NAS of Ukraine and Russian Foundation for Basic Research; FEBS Collaborative Experimental Scholarship; President of Ukraine	This work was funded partially by target complex interdisciplinary programme of scientific researches of NAS of Ukraine "Fundamentals of molecular and cell biotechnologies'', joint project of NAS of Ukraine and Russian Foundation for Basic Research. ON was supported by FEBS Collaborative Experimental Scholarship and President of Ukraine "Grant for gifted youth''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011291; Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Asbach B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038540; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Dergai M, 2011, GENE, V485, P120, DOI 10.1016/j.gene.2011.06.021; Dergai M, 2010, BIOCHEM BIOPH RES CO, V399, P307, DOI 10.1016/j.bbrc.2010.07.080; Dergai O, 2013, CELL SIGNAL, V25, P33, DOI 10.1016/j.cellsig.2012.09.011; Dergai O, 2010, BIOCHEM BIOPH RES CO, V402, P408, DOI 10.1016/j.bbrc.2010.10.045; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fuentes JJ, 1999, J NEURAL TRANSM-SUPP, P337; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Hunter MP, 2011, NEUROREPORT, V22, P767, DOI 10.1097/WNR.0b013e32834ae348; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; Lim CS, 2007, BIOCHEMISTRY-US, V46, P9874, DOI 10.1021/bi700357s; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Morderer D, 2012, GENE, V505, P360, DOI 10.1016/j.gene.2012.06.061; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Nikolaienko O, 2009, CELL SIGNAL, V21, P753, DOI 10.1016/j.cellsig.2009.01.013; Nishida M, 2001, EMBO J, V20, P2995, DOI 10.1093/emboj/20.12.2995; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Novokhatska O, 2011, BIOCHEM BIOPH RES CO, V408, P663, DOI 10.1016/j.bbrc.2011.04.081; O'Bryan JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3152re10; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pechstein A, 2010, BIOCHEM SOC T, V38, P181, DOI 10.1042/BST0380181; Primeau M, 2011, FEBS LETT, V585, P847, DOI 10.1016/j.febslet.2011.02.022; Pucharcos C, 1999, EUR J HUM GENET, V7, P704, DOI 10.1038/sj.ejhg.5200356; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Pucharcos C, 2001, BBA-GENE STRUCT EXPR, V1521, P1, DOI 10.1016/S0167-4781(01)00276-7; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santonico Elena, 2007, BMC Biochemistry, V8, P29, DOI 10.1186/1471-2091-8-29; Scappini E, 2007, HUM MOL GENET, V16, P1862, DOI 10.1093/hmg/ddm134; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Specht K, 2009, BREAST CANCER RES TR, V118, P45, DOI 10.1007/s10549-008-0207-y; Tsyba L, 2008, BIOCHEM BIOPH RES CO, V372, P929, DOI 10.1016/j.bbrc.2008.05.156; Tsyba L, 2011, GENE, V473, P67, DOI 10.1016/j.gene.2010.11.016; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wilmot B, 2008, NEUROBIOL AGING, V29, P524, DOI 10.1016/j.neurobiolaging.2006.11.008; Wong KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036023	50	10	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70546	10.1371/journal.pone.0070546	http://dx.doi.org/10.1371/journal.pone.0070546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936226	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300107
J	Atanasova, R; Angoulvant, A; Tefit, M; Gay, F; Guitard, J; Mazier, D; Fairhead, C; Hennequin, C				Atanasova, Ralitsa; Angoulvant, Adela; Tefit, Maurel; Gay, Frederick; Guitard, Juliette; Mazier, Dominique; Fairhead, Cecile; Hennequin, Christophe			A Mouse Model for Candida glabrata Hematogenous Disseminated Infection Starting from the Gut: Evaluation of Strains with Different Adhesion Properties	PLOS ONE			English	Article							PROTEIN-CALORIE MALNUTRITION; BLOOD-STREAM; ALBICANS; EPIDEMIOLOGY; VIRULENCE; TRANSLOCATION; CONSEQUENCES; PATHOGENESIS; CASPOFUNGIN; RESISTANCE	Adhesion to digestive mucosa is considered a crucial first step in the pathogenicity of invasive Candida infections. Candida glabrata disseminated infections predominantly start from the gut. A mouse model of disseminated infection starting from the gut was set up. Hematogenous dissemination was obtained after a low-protein diet followed by a regimen of cyclophosphamide-methotrexate and an oral inoculation of the yeasts via the drinking water. The liver was the first organ infected (day 7 post-infection), and lethality was 100% at day 21 post-infection. This new mouse model was used to compare the mortality rate and fungal burden in deep organs induced by 5 strains exhibiting different levels of adhesion to enterocyte Caco-2 cells, as determined in a test on 36 C. glabrata strains. In this model, no statistical difference of lethality was demonstrated between the strains, and fungal burden varied in kidneys and lungs but without correlation with the level of adhesion to enterocytes. Further studies using the model developed here allow analysis of the crossing of the digestive mucosa by yeasts, and help relate this to yet-poorly understood adhesion phenotypes.	[Atanasova, Ralitsa; Tefit, Maurel; Gay, Frederick; Guitard, Juliette; Mazier, Dominique; Hennequin, Christophe] Univ Paris 06, UMR S945, Paris, France; [Angoulvant, Adela] Hop Bicetre, AP HP, Unite Parasitol Mycol, Le Kremlin Bicetre, France; [Angoulvant, Adela; Fairhead, Cecile] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [Angoulvant, Adela; Fairhead, Cecile] CNRS, UMR 8621, F-91405 Orsay, France; [Gay, Frederick] Grp Hosp Pitie Salpetriere, APHP, Serv Parasitol Mycol, F-75634 Paris, France; [Guitard, Juliette; Mazier, Dominique; Hennequin, Christophe] INSERM, U945, Paris, France; [Guitard, Juliette; Mazier, Dominique; Hennequin, Christophe] Hop St Antoine, AP HP, Serv Parasitol Mycol, F-75571 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Hennequin, C (corresponding author), Univ Paris 06, UMR S945, Paris, France.	christophe.hennequin@upmc.fr	Hennequin, Christophe/AAF-2755-2021; Fairhead, Cecile/D-9011-2014; Guitard, Juliette/AAE-6344-2019	Hennequin, Christophe/0000-0002-4528-927X; Guitard, Juliette/0000-0002-9782-3577; Fairhead, Cecile/0000-0002-0456-0377	DIM Maladies Infectieuses, Ile de France	DIM Maladies Infectieuses, Ile de France	Ralitsa Atanasova was the recipient of a PhD grant from the DIM Maladies Infectieuses, Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Brisse S, 2009, EUKARYOT CELL, V8, P287, DOI 10.1128/EC.00215-08; Brun S, 2005, J ANTIMICROB CHEMOTH, V56, P307, DOI 10.1093/jac/dki200; Castano I, 2005, MOL MICROBIOL, V55, P1246, DOI 10.1111/j.1365-2958.2004.04465.x; Chapeland-Leclerc F, 2010, ANTIMICROB AGENTS CH, V54, P1360, DOI 10.1128/AAC.01138-09; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Enache-Angoulvant A, 2010, J CLIN MICROBIOL, V48, P4028, DOI 10.1128/JCM.02140-09; Ferrari S, 2011, ANTIMICROB AGENTS CH, V55, P1852, DOI 10.1128/AAC.01271-10; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Grenouillet F, 2007, J CLIN MICROBIOL, V45, P3781, DOI 10.1128/JCM.01603-07; Halliwell SC, 2012, EUKARYOT CELL, V11, P141, DOI 10.1128/EC.05232-11; Hedderwick SA, 2000, EUR J CLIN MICROBIOL, V19, P663, DOI 10.1007/s100960000348; Jawhara S, 2012, J BIOL CHEM, V287, P11313, DOI 10.1074/jbc.M111.329300; Klevay MJ, 2008, DIAGN MICR INFEC DIS, V60, P273, DOI 10.1016/j.diagmicrobio.2007.10.001; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; Kuhn DM, 2012, FEMS YEAST RES, V12, P398, DOI 10.1111/j.1567-1364.2011.00785.x; Kurioka T, 1998, INFECT IMMUN, V66, P1726, DOI 10.1128/IAI.66.4.1726-1734.1998; L'Ollivier C, 2012, INFECT GENET EVOL, V12, P1949, DOI 10.1016/j.meegid.2012.07.025; Maestre-Reyna M, 2012, P NATL ACAD SCI USA, V109, P16864, DOI 10.1073/pnas.1207653109; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; Olson JA, 2005, ANTIMICROB AGENTS CH, V49, P4895, DOI 10.1128/AAC.49.12.4895-4902.2005; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; PINTO M, 1983, BIOL CELL, V47, P323; Rangel-Frausto MS, 1999, CLIN INFECT DIS, V29, P253, DOI 10.1086/520194; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Takahashi K, 2003, MICROB PATHOGENESIS, V35, P179, DOI 10.1016/j.micpath.2003.06.001; Yan L, 2013, MICROBIOL RES, V168, P389, DOI 10.1016/j.micres.2013.02.008; Zupancic ML, 2008, MOL MICROBIOL, V68, P547, DOI 10.1111/j.1365-2958.2008.06184.x	36	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69664	10.1371/journal.pone.0069664	http://dx.doi.org/10.1371/journal.pone.0069664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936069	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000142
J	Wu, LN; Wei, XW; Fan, Y; Miao, JN; Wang, LL; Zhang, Y; Wu, D; Yuan, ZW				Wu, Li-na; Wei, Xiao-wei; Fan, Yang; Miao, Jia-ning; Wang, Li-li; Zhang, Yi; Wu, Di; Yuan, Zheng-wei			Altered Expression of 14-3-3 zeta Protein in Spinal Cords of Rat Fetuses with Spina Bifida Aperta	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; DIFFERENTIAL EXPRESSION; CELL-PROLIFERATION; DOWN-REGULATION; OXIDANT STRESS; BIRTH-DEFECTS; FETAL RATS; P53; SURVIVAL; APOPTOSIS	Background: A large number of studies have confirmed that excessive apoptosis is one of the reasons for deficient neuronal function in neural tube defects (NTDs). A previous study from our laboratory used 2-D gel electrophoresis to demonstrate that 14-3-3 zeta expression was low in the spinal cords of rat fetuses with spina bifida aperta at embryonic day (E) 17. As a member of the 14-3-3 protein family, 14-3-3 zeta plays a crucial role in the determination of cell fate and anti-apoptotic activity. However, neither the expression of 14-3-3 zeta in defective spinal cords, nor the correlation between 14-3-3 zeta and excessive apoptosis in NTDs has been fully confirmed. Methodology/Principal Findings: We used immunoblotting and quantitative real-time PCR (qRT-PCR) to quantify the expression of 14-3-3 zeta and double immunofluorescence to visualize 14-3-3 zeta and apoptosis. We found that, compared with controls, 14-3-3 zeta was down-regulated in spina bifida between E12 and E15. Excessive apoptotic cells and low expression of 14-3-3 zeta were observed in the dorsal region of spinal cords with spina bifida during the same time period. To initially explore the molecular mechanisms of apoptosis in NTDs, we investigated the expression of microRNA-7 (miR-7), microRNA-375 (miR-375) and microRNA-451 (miR-451), which are known to down-regulate 14-3-3 zeta in several different cell types. We also investigated the expression of p53, a molecule that is downstream of 14-3-3 zeta and can be down-regulated by it. We discovered that, in contrast to the reduction of 14-3-3 zeta expression, the expression of miR-451, miR-375 and p53 increased in spina bifida rat fetuses. Conclusions/Significance: These data suggest that the reduced expression of 14-3-3 zeta plays a role in the excessive apoptosis that occurs in spina bifida and may be partly regulated by the over-expression of miR-451 and miR-375, and the consequent up-regulation of p53 might further promote apoptosis in spina bifida.	[Wu, Li-na] China Med Univ, Shengjing Hosp, Dept Lab Med, Shenyang, Peoples R China; [Wei, Xiao-wei; Fan, Yang; Miao, Jia-ning; Wang, Li-li; Zhang, Yi; Wu, Di; Yuan, Zheng-wei] China Med Univ, Shengjing Hosp, Key Lab, Hlth Minist Congenital Malformat, Shenyang, Peoples R China	China Medical University; China Medical University	Yuan, ZW (corresponding author), China Med Univ, Shengjing Hosp, Key Lab, Hlth Minist Congenital Malformat, Shenyang, Peoples R China.	yuanzw@hotmail.com	wang, lili/HDL-7210-2022		National Natural Foundation of China [81070538, 81171072, 81270755, 81200481]; research Fund for the Doctoral Program of Higher Education of China [20122104110010]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the National Natural Foundation of China (nos. 81070538, 81171072, 81270755, 81200481) and the research Fund for the Doctoral Program of Higher Education of China (no. 20122104110010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cao WD, 2010, APOPTOSIS, V15, P230, DOI 10.1007/s10495-009-0437-4; Correia-Pinto J, 2002, J PEDIATR SURG, V37, P488, DOI 10.1053/jpsu.2002.30872; Danes CG, 2008, CANCER RES, V68, P1760, DOI 10.1158/0008-5472.CAN-07-3177; DATE I, 1993, SURG NEUROL, V40, P471, DOI 10.1016/0090-3019(93)90049-7; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; DIEZPARDO JA, 1995, EUR J PEDIATR SURG, V5, P198, DOI 10.1055/s-2008-1066204; Dobson M, 2011, BBA-MOL CELL RES, V1813, P1453, DOI 10.1016/j.bbamcr.2011.05.001; Dong SZ, 2007, BLOOD, V110, P360, DOI 10.1182/blood-2006-12-065615; Drewek MJ, 1997, PEDIATR NEUROSURG, V27, P190, DOI 10.1159/000121250; Fan Y, 2011, J PROTEOMICS, V75, P668, DOI 10.1016/j.jprot.2011.09.006; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Guan KP, 2009, BIRTH DEFECTS RES A, V85, P583, DOI 10.1002/bdra.20576; Harris MN, 2004, BLOOD, V104, P1314, DOI 10.1182/blood-2004-01-0046; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Heyninck K., 2004, METH MOL B, V282, P223; Kawamoto S, 2000, CYTOTECHNOLOGY, V33, P253, DOI 10.1023/A:1008129020728; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kitao Y, 2002, J NEUROCYTOL, V31, P765, DOI 10.1023/A:1025760116189; Kleppe R, 2011, SEMIN CELL DEV BIOL, V22, P713, DOI 10.1016/j.semcdb.2011.08.008; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee JA, 2008, ONCOGENE, V27, P1297, DOI 10.1038/sj.onc.1210740; Li H, 2012, J CELL MOL MED, V16, P1606, DOI 10.1111/j.1582-4934.2011.01470.x; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Liang S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/516469; Liang SH, 2001, EUR J BIOCHEM, V268, P2779, DOI 10.1046/j.1432-1327.2001.02227.x; Liu Y, 2010, BRAIN RES, V1336, P98, DOI 10.1016/j.brainres.2010.04.009; Lu ZJ, 2011, ELECTROPHORESIS, V32, P3612, DOI 10.1002/elps.201100230; MacKay RK, 2011, ALCOHOL CLIN EXP RES, V35, P1041, DOI 10.1111/j.1530-0277.2011.01436.x; Matta A, 2010, MOL CANCER THER, V9, P2676, DOI 10.1158/1535-7163.MCT-10-0312; MIRNICS K, 1995, J COMP NEUROL, V355, P589, DOI 10.1002/cne.903550408; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Sari Y, 2010, ELECTROPHORESIS, V31, P483, DOI 10.1002/elps.200900385; Shirakashi Y, 2006, ACTA NEUROPATHOL, V112, P681, DOI 10.1007/s00401-006-0132-2; Silhan J, 2009, J BIOL CHEM, V284, P19349, DOI 10.1074/jbc.M109.002725; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wei XW, 2012, INT J DEV NEUROSCI, V30, P375, DOI 10.1016/j.ijdevneu.2012.03.340; XIAO KZ, 1990, INT J EPIDEMIOL, V19, P978; Yang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037205; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Yuan ZW, 2003, J PEDIATR SURG, V38, P1383, DOI 10.1016/S0022-3468(03)00401-9; Zhang Z, 2012, FEBS LETT, V586, P20, DOI 10.1016/j.febslet.2011.07.042; Zhao JJ, 2008, CHILD NERV SYST, V24, P485, DOI 10.1007/s00381-007-0520-5; Zhou JB, 2009, MOL CELL BIOL, V29, P4167, DOI 10.1128/MCB.01067-08	62	16	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70457	10.1371/journal.pone.0070457	http://dx.doi.org/10.1371/journal.pone.0070457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936434	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500037
J	D'Emic, MD; Mannion, PD; Upchurch, P; Benson, RBJ; Pang, QQ; Cheng, ZW				D'Emic, Michael D.; Mannion, Philip D.; Upchurch, Paul; Benson, Roger B. J.; Pang, Qiqing; Cheng Zhengwu			Osteology of Huabeisaurus allocotus (Sauropoda: Titanosauriformes) from the Upper Cretaceous of China	PLOS ONE			English	Article							RAPETOSAURUS-KRAUSEI SAUROPODA; PHYLOGENETIC AFFINITIES; NEUQUENSAURUS-AUSTRALIS; DINOSAURIA SAUROPODA; EVOLUTIONARY HISTORY; SP-NOV; SAURISCHIA; PATAGONIA; REDESCRIPTION; SPECIMEN	Background: The Late Cretaceous titanosauriform sauropod Huabeisaurus allocotus Pang and Cheng is known from teeth and much of the postcranial skeleton. Its completeness makes it an important taxon for integrating and interpreting anatomical observations from more fragmentary Cretaceous East Asian sauropods and for understanding titanosauriform evolution in general. Methodology/Principal Findings: We present a detailed redescription of Huabeisaurus allocotus and a suite of anatomical comparisons with other titanosauriforms that demonstrate its validity via autapomorphies (e.g., division of some presacral vertebral laminae, reduced development of caudal ribs, the development of fossae relative to one another in caudal vertebral neural arches, high tibia-to-femur ratio). Huabeisaurus shares many features with other Cretaceous East Asian sauropods (e.g., pendant cervical ribs, anterior-middle caudal vertebrae with a nearly flat anterior centrum face and a concave posterior centrum face) that are absent in sauropods from other landmasses and strata, suggesting a close relationship among many of these forms within the clade Somphospondyli. Conclusions/Significance: Restudy of Huabeisaurus provides further evidence for the existence of a clade of somphospondylans - Euhelopodidae - mainly found in the Cretaceous of East Asia. Euhelopodidae represents a fourth example of the evolution of narrow crowns within Sauropoda, along with diplodocoids, brachiosaurids, and advanced titanosaurs (lithostrotians). Despite being known from fewer species than Diplodocoidea, Brachiosauridae, or Lithostrotia, euhelopodids possessed a broader range of tooth shapes than any of these clades, suggesting that euhelopodids exemplified a comparably broad range of feeding strategies and perhaps diets.	[D'Emic, Michael D.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Mannion, Philip D.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England; [Upchurch, Paul] UCL, Dept Earth Sci, London, England; [Benson, Roger B. J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Pang, Qiqing] Shijiazhuang Univ Econ, Shijiazhuang, Peoples R China; [Cheng Zhengwu] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Imperial College London; University of London; University College London; University of Oxford; Hebei GEO University; Chinese Academy of Geological Sciences	D'Emic, MD (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	michael.demic@stonybrook.edu	Upchurch, Paul/C-1654-2008	Mannion, Philip/0000-0002-9361-6941; Benson, Roger/0000-0001-8244-6177	Geological Society of America; Alexander von Humboldt Research Fellowship (Museum fur Naturkunde, Berlin); Junior Research Fellowship (Imperial College London); Leverhulme Trust Research Grant [RPG-129]	Geological Society of America; Alexander von Humboldt Research Fellowship (Museum fur Naturkunde, Berlin); Junior Research Fellowship (Imperial College London); Leverhulme Trust Research Grant(Leverhulme Trust)	Funding was provided by the Geological Society of America to MDD, an Alexander von Humboldt Research Fellowship (Museum fur Naturkunde, Berlin) and a Junior Research Fellowship (Imperial College London) to PDM, and Leverhulme Trust Research Grant RPG-129 to PU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett PM, 2002, PALAEONTOLOGY, V45, P1197, DOI 10.1111/1475-4983.00282; Berman D. S., 1978, B CARNEGIE MUS NAT H, V8, P1; Bonaparte J. F., 2000, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V256, P25; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Buffetaut E, 2002, S GEOL THAIL, V1, P95; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; Campos DA, 2005, ARQUIVOS MUSEU NACL, V63, P656; Canudo JI, 2008, J VERTEBR PALEONTOL, V28, P712, DOI 10.1671/0272-4634(2008)28[712:ANSTSG]2.0.CO;2; Carballido JL, 2011, J VERTEBR PALEONTOL, V31, P93, DOI 10.1080/02724634.2011.539651; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Cheng Zhengwu, 1996, Acta Geoscientia Sinica, V17, P135; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; D'Emic MD, 2013, J SYST PALAEONTOL, V11, P707, DOI 10.1080/14772019.2012.667446; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; D'Emic MD, 2011, ACTA PALAEONTOL POL, V56, P61, DOI 10.4202/app.2009.0149; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Gilmore CW., 1946, US DEP INTERGEOL SUR, V210-C, P29, DOI DOI 10.3133/PP210C; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Kellner Alexander W., 2006, Boletim do Museu Nacional Nova Serie Geologia, V74, P1; Ksepka DT, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3508[1:EEALSF]2.0.CO;2; Ksepka DT, 2010, AM MUS NOVITATES, V3700; Lu Junchang, 2009, [Journal of the paleontological Society of Korea, 고생물학회지], V25, P43; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2012, J SYST PALAEONTOL, V10, P521, DOI 10.1080/14772019.2011.595432; Mannion PD, 2011, J SYST PALAEONTOL, V9, P355, DOI 10.1080/14772019.2010.527379; Mannion PD, 2011, ZOOL J LINN SOC-LOND, V163, P155, DOI 10.1111/j.1096-3642.2011.00699.x; Mannion PD, 2009, CRETACEOUS RES, V30, P521, DOI 10.1016/j.cretres.2008.09.005; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Martin Valerie, 1999, Oryctos, V2, P39; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; McIntosh J.S., 1990, P345; Mo JY, 2006, ACTA GEOL SIN-ENGL, V80, P486; Osborn H. F., 1921, Memoirs from the American Museum of Natural History New York NS, V3, P247; Ostrom J.H., 1966, MARSHS DINOSAURS; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pang Q, 1995, J HEBEI COLL GEOLO S, V18, P1; Pang Q, 2001, LATE CRETACEOUS DINO, P75; Pang Q, 2001, NEW DINOSAUR FAUNA L, P19; Pang Qiqing, 1996, Journal of Hebei College of Geology, V19, P227; Pang QQ, 1998, PROG NAT SCI, V8, P326; Pang QQ, 2000, ACTA GEOL SIN-ENGL, V74, P117; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Core Team, R LANG ENV STAT COMP; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Romer A, 1956, OSTEOLOGY REPTILES; Rose PJ, 2007, PALAEONTOL ELECTRON, V10; Saegusa H, 2011, AN ACAD BRAS CIENC, V83, P247, DOI 10.1590/S0001-37652011000100014; Salgado L, 2005, J VERTEBR PALEONTOL, V25, P623, DOI 10.1671/0272-4634(2005)025[0623:ANSONA]2.0.CO;2; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Sarkar D., 2019, NLME LINEAR NONLINEA; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Suteethorn S, 2010, NEUES JAHRB GEOL P-A, V256, P109, DOI 10.1127/0077-7749/2010/0036; Tanimoto M., 2006, CHIGAKUKENKYU, V54, P223; Tieshang K, 1996, NUCL TECHNIQUES, V19, P625; Upchurch P, 2003, J VERTEBR PALEONTOL, V23, P208, DOI 10.1671/0272-4634(2003)23[208:TAATOC]2.0.CO;2; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch Paul, 2011, Palaeontological Association Field Guides to Fossils, V14, P476; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Whitlock JA, 2011, ZOOL J LINN SOC-LOND, V161, P872, DOI 10.1111/j.1096-3642.2010.00665.x; Whitlock JA, 2011, PALAEONTOLOGY, V54, P351, DOI 10.1111/j.1475-4983.2010.01029.x; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2003, J SYST PALAEONTOL, V1, P125, DOI 10.1017/S1477201903001044; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P591, DOI 10.1080/02724634.1999.10011168; Wilson Jeffrey A., 2012, Contributions from the Museum of Paleontology University of Michigan, V32, P1; Wilson Jeffrey A., 2011, Contributions from the Museum of Paleontology University of Michigan, V32, P59; Wilson JA, 2011, PALAEONTOLOGY, V54, P981, DOI 10.1111/j.1475-4983.2011.01087.x; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Yao K, 1997, VERTEBRAT PALASIATIC, V35, P170; You HL, 2009, P ROY SOC B-BIOL SCI, V276, P4077, DOI 10.1098/rspb.2009.1278; You HL, 2004, ACTA GEOL SIN-ENGL, V78, P907; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663; Zhang YH., 1988, MIDDLE JURASSIC DINO	85	44	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69375	10.1371/journal.pone.0069375	http://dx.doi.org/10.1371/journal.pone.0069375			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936326	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800016
J	Lin, Y; Zeng, Y; Zhang, F; Xue, L; Huang, Z; Li, WX; Guo, MX				Lin, Yi; Zeng, Yan; Zhang, Fan; Xue, Lu; Huang, Zan; Li, Wenxin; Guo, Mingxiong			Characterization of MicroRNA Expression Profiles and the Discovery of Novel MicroRNAs Involved in Cancer during Human Embryonic Development	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ANIMAL DEVELOPMENT; NONCODING RNAS; CELL-SURVIVAL; IN-VIVO; PROLIFERATION; MIR-122; FAMILY; DIFFERENTIATION; IDENTIFICATION	MicroRNAs (miRNAs), approximately 22-nucleotide non-coding RNA molecules, regulate a variety of pivotal physiological or pathological processes, including embryonic development and tumorigenesis. To obtain comprehensive expression profiles of miRNAs in human embryos, we characterized miRNA expression in weeks 4-6 of human embryonic development using miRNA microarrays and identified 50 human-embryo-specific miRNAs (HES-miRNAs). Furthermore, we selected three non-conserved or primate-specific miRNAs, hsa-miR-638, -720, and -1280, and examined their expression levels in various normal and tumor tissues. The results show that expression of most miRNAs is extremely low during early human embryonic development. In addition, the expression of some non-conserved or primate-specific miRNAs is significantly different between tumor and the corresponding normal tissue samples, suggesting that the miRNAs are closely related to the pathological processes of various tumors. This study presents the first comprehensive overview of miRNA expression during human embryonic development and offers immediate evidence of the relationship between human early embryonic development and tumorigenesis.	[Lin, Yi; Zeng, Yan; Zhang, Fan; Xue, Lu; Li, Wenxin; Guo, Mingxiong] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [Lin, Yi; Zeng, Yan; Zhang, Fan; Xue, Lu; Li, Wenxin; Guo, Mingxiong] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Huang, Zan] Wuhan Univ, Coll Life Sci, Dept Biochem & Mol Biol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Li, WX (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	liwxlab@whu.edu.cn; guomx@whu.edu.cn	LIN, YI/AAC-3335-2020	LIN, YI/0000-0001-8209-1185; Huang, Zan/0000-0001-5623-6950	National High Technology Research and Development Program of China (863 Program) [2006AA02A306]; National Natural Science Foundation of China [30871245, 31271511]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High Technology Research and Development Program of China (863 Program) Grant 2006AA02A306, National Natural Science Foundation of China Grant 30871245 and 31271511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nakhle H, 2010, CANCER RES, V70, P4778, DOI 10.1158/0008-5472.CAN-09-4104; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bignold LP, 2006, CELL BIOL INT, V30, P640, DOI 10.1016/j.cellbi.2006.04.002; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Castro FO, 2010, THERIOGENOLOGY, V73, P71, DOI 10.1016/j.theriogenology.2009.08.003; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cheng TC, 2004, BIOL REPROD, V70, P1270, DOI 10.1095/biolreprod.103.023283; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Durr M, 2003, ONCOGENE, V22, P9185, DOI 10.1038/sj.onc.1207134; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Furnari F, 2010, NATURE, V465, P1016, DOI 10.1038/4651016a; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hill MA, 2007, CLIN OBSTET GYNECOL, V50, P2, DOI 10.1097/GRF.0b013e31802f119d; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jian P, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-20; Jones CI, 2012, BRIT J CANCER, V107, P1987, DOI 10.1038/bjc.2012.525; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Katsushima K, 2012, J BIOL CHEM, V287, P27396, DOI 10.1074/jbc.M112.359109; Kiezun Adam, 2012, BMC Res Notes, V5, P92, DOI 10.1186/1756-0500-5-92; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kosik KS, 2010, CELL, V143, P21, DOI 10.1016/j.cell.2010.09.008; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Li DC, 2012, TOXICOL SCI, V125, P382, DOI 10.1093/toxsci/kfr299; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao JM, 2012, CELL CYCLE, V11, P2624, DOI 10.4161/cc.20809; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Ma YL, 2010, J CELL MOL MED, V14, P2697, DOI 10.1111/j.1582-4934.2010.01191.x; Majid S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046743; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; PAPAIOANNOU VE, 1984, CELL DIFFER DEV, V15, P175, DOI 10.1016/0045-6039(84)90071-X; PAPAIOANNOU VE, 1993, INT J DEV BIOL, V37, P33; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Piepoli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033663; PIERCE GB, 1983, AM J PATHOL, V113, P115; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ropponen KM, 1999, J CLIN PATHOL, V52, P10, DOI 10.1136/jcp.52.1.10; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; Shinozuka E, 2013, BIOCHEM BIOPH RES CO, V430, P101, DOI 10.1016/j.bbrc.2012.11.005; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Theiler K, 1972, HOUSE MOUSE ATLAS EM; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Tzukerman M, 2006, CANCER RES, V66, P3792, DOI 10.1158/0008-5472.CAN-05-3467; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yi C, 2012, ONCOGENE, V31, P4421, DOI 10.1038/onc.2011.629; Yi H, 2010, FASEB J, V24, P3341, DOI 10.1096/fj.10-158782; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	90	24	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69230	10.1371/journal.pone.0069230	http://dx.doi.org/10.1371/journal.pone.0069230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936320	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800013
J	Pavliha, D; Music, MM; Sersa, G; Miklavcic, D				Pavliha, Denis; Music, Maja M.; Sersa, Gregor; Miklavcic, Damijan			Electroporation-Based Treatment Planning for Deep-Seated Tumors Based on Automatic Liver Segmentation of MRI Images	PLOS ONE			English	Article							STANDARD OPERATING PROCEDURES; IRREVERSIBLE ELECTROPORATION; ELECTROCHEMOTHERAPY; CT; TISSUE; METASTASES; ABLATION; MODELS; SNAKES	Electroporation is the phenomenon that occurs when a cell is exposed to a high electric field, which causes transient cell membrane permeabilization. A paramount electroporation-based application is electrochemotherapy, which is performed by delivering high-voltage electric pulses that enable the chemotherapeutic drug to more effectively destroy the tumor cells. Electrochemotherapy can be used for treating deep-seated metastases (e.g. in the liver, bone, brain, soft tissue) using variable-geometry long-needle electrodes. To treat deep-seated tumors, patient-specific treatment planning of the electroporation-based treatment is required. Treatment planning is based on generating a 3D model of the organ and target tissue subject to electroporation (i.e. tumor nodules). The generation of the 3D model is done by segmentation algorithms. We implemented and evaluated three automatic liver segmentation algorithms: region growing, adaptive threshold, and active contours (snakes). The algorithms were optimized using a seven-case dataset manually segmented by the radiologist as a training set, and finally validated using an additional four-case dataset that was previously not included in the optimization dataset. The presented results demonstrate that patient's medical images that were not included in the training set can be successfully segmented using our three algorithms. Besides electroporation-based treatments, these algorithms can be used in applications where automatic liver segmentation is required.	[Pavliha, Denis; Miklavcic, Damijan] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia; [Music, Maja M.; Sersa, Gregor] Inst Oncol Ljubljana, Ljubljana, Slovenia	University of Ljubljana; Institute of Oncology - Slovenia	Miklavcic, D (corresponding author), Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia.	damijan.miklavcic@fe.uni-lj.si	Miklavčič, Damijan/A-9497-2008	Miklavčič, Damijan/0000-0003-3506-9449	Slovenian Research Agency (ARRS)	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (ARRS). Research was conducted in the scope of the Electroporation in Biology and Medicine (EBAM) European Associated Laboratory (LEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2011, CANCER RES, V71, P3753, DOI 10.1158/0008-5472.CAN-11-0451; Casciaro S, 2012, IEEE SENS J, V12, P464, DOI 10.1109/JSEN.2011.2108281; Chi YL, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2010.2093523; Crocetti L, 2008, INVEST RADIOL, V43, P33, DOI 10.1097/RLI.0b013e31815597dc; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Edhemovic I, 2011, TECHNOL CANCER RES T, V10, P475, DOI 10.7785/tcrt.2012.500224; Fini M, 2011, CLINICAL ASPECTS OF ELECTROPORATION, P115, DOI 10.1007/978-1-4419-8363-3_10; HEIMANN T, 2004, INT ARCH PHOTOGRAMME, V35, P317; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kotnik T, 2010, J MEMBRANE BIOL, V236, P3, DOI 10.1007/s00232-010-9279-9; Lecchi M, 2008, EUR J NUCL MED MOL I, V35, P821, DOI 10.1007/s00259-007-0631-y; Linguraru MG, 2012, MED IMAGE ANAL, V16, P904, DOI 10.1016/j.media.2012.02.001; Linnert M, 2012, RADIOL ONCOL, V46, P271, DOI 10.2478/v10019-012-0042-y; Mahmood F, 2011, BIOELECTROCHEMISTRY, V81, P10, DOI 10.1016/j.bioelechem.2010.12.002; Mali B, 2013, EJSO-EUR J SURG ONC, V39, P4, DOI 10.1016/j.ejso.2012.08.016; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Massoptier L, 2008, EUR RADIOL, V18, P1658, DOI 10.1007/s00330-008-0924-y; Miklavcic D, 2012, MED BIOL ENG COMPUT, V50, P1213, DOI 10.1007/s11517-012-0991-8; Miklavcic D, 2010, BIOMEDICAL ENG ONLIN, V9; Miklavcic D, 2012, J MEMBRANE BIOL, V245, P591, DOI 10.1007/s00232-012-9493-8; Mir LM, 2006, EJC SUPPL, V4, P14, DOI 10.1016/j.ejcsup.2006.08.003; National Electrical Manufacturers Association, 2009, CP 467 ADD DICOM; National Electrical Manufacturers Association. and American College of Radiology, 2009, DIG IM COMM MED DICO; Neal RE, 2011, J CLIN ONCOL, V29, pE372, DOI 10.1200/JCO.2010.33.0902; Pahr DH, 2009, COMPUT METHOD BIOMEC, V12, P45, DOI [10.1080/10255840802144105, 10.1080/10255840903065399]; Pavliha D, 2012, BIOELECTROCHEMISTRY, V87, P265, DOI 10.1016/j.bioelechem.2012.01.007; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2008, J VISUALIZED EXPT, V22; Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Zheng YJ, 2009, LECT NOTES COMPUT SC, V5762, P852, DOI 10.1007/978-3-642-04271-3_103; Zupanic A, 2009, OPTIMIZATION NUMERIC, P203; Zupanic A, 2008, RADIOL ONCOL, V42, P93, DOI 10.2478/v10019-008-0005-5; Zupanic A, 2012, PHYS MED BIOL, V57, P5425, DOI 10.1088/0031-9155/57/17/5425	34	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69068	10.1371/journal.pone.0069068	http://dx.doi.org/10.1371/journal.pone.0069068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936315	gold, Green Published			2022-12-27	WOS:000324545800009
J	Burdan, F; Mocarska, A; Janczarek, M; Klepacz, R; Losicki, M; Patyra, K; Brodzik, A; Kiszka, J; Chruscicka, A; Zelzowska-Cieslinska, I; Staroslawska, E				Burdan, Franciszek; Mocarska, Agnieszka; Janczarek, Marzena; Klepacz, Robert; Losicki, Marek; Patyra, Krzysztof; Brodzik, Agnieszka; Kiszka, Joanna; Chruscicka, Aneta; Zelzowska-Cieslinska, Iwonna; Staroslawska, Elzbieta			Incidence of Spinal Perineurial (Tarlov) Cysts among East-European Patients	PLOS ONE			English	Article							MENINGEAL CYSTS	The spinal perineurial cyst (Tarlov) is a dilatation between the perineurium and endoneurium of spinal nerve roots, located at level of the spinal ganglion and filled with cerebrospinal fluid but without communication with the perineurial subarachnoid space. The aim of the study was to evaluate it incidence among East-European patients. The retrospective data collected during various magnetic resonance spinal examinations and stored on the picture archiving and communication system was analyzed for an incidence of perineurial cysts. From among 842 patients that underwent examination, 75 cases perineurial cysts were revealed. In 22 cases single anomalies were found. In remaining 53 cases, multiple uni- or less frequently bilateral changes were noted. The most common position was the sacral canal, particularly the level of S2 and S3. Occasionally, cysts were also visible on the cervical, thoracic and lumbar level. Incidence of sacral perineurial cysts was significantly higher in females than in males. Similar data was found for single and multiple changes despite of their localization. Insignificant changes were seen for patient age and cyst size. Perineurial spinal cysts were the most frequently observed on the sacral level and such changes were more common in females.	[Burdan, Franciszek; Mocarska, Agnieszka; Losicki, Marek; Brodzik, Agnieszka; Zelzowska-Cieslinska, Iwonna] St Johns Canc Ctr, Dept Radiol, Lublin, Poland; [Burdan, Franciszek] Med Univ Lublin, Dept Human Anat, Lublin, Poland; [Janczarek, Marzena] Med Univ Lublin, Dept Neuroradiol & Intervent Radiol, Lublin, Poland; [Klepacz, Robert] Med Univ Lublin, Dept Clin Pathol, Lublin, Poland; [Patyra, Krzysztof; Chruscicka, Aneta] St Johns Canc Ctr, Dept Radiotherapy, Lublin, Poland; [Kiszka, Joanna; Staroslawska, Elzbieta] St Johns Canc Ctr, Dept Clin Oncol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Burdan, F (corresponding author), St Johns Canc Ctr, Dept Radiol, Lublin, Poland.	fb3@wp.pl		Klepacz, Robert/0000-0001-5040-8846; Burdan, Franciszek/0000-0001-5305-8829	Medical University of Lublin; St. John's Hospital	Medical University of Lublin; St. John's Hospital	The study was supported by Medical University of Lublin and St. John's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT KH, 1957, J NEUROSURG, V14, P5, DOI 10.3171/jns.1957.14.1.0005; DAVIS SW, 1993, RADIOLOGY, V187, P445, DOI 10.1148/radiology.187.2.8475288; Erkoc MF, 2012, FOLIA MORPHOL, V71, P217; Jung KT, 2012, KOREAN J PAIN, V25, P191, DOI 10.3344/kjp.2012.25.3.191; Kosar MI, 2012, FOLIA MORPHOL, V71, P65; Langdown AJ, 2005, J SPINAL DISORD TECH, V18, P29, DOI 10.1097/01.bsd.0000133495.78245.71; Lucantoni C, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11221; Murphy KJ, 2011, SEMIN MUSCULOSKEL R, V15, P163, DOI 10.1055/s-0031-1275599; NABORS MW, 1988, J NEUROSURG, V68, P366, DOI 10.3171/jns.1988.68.3.0366; Oaklander AL, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11374; Park HJ, 2011, AM J ROENTGENOL, V196, P1151, DOI 10.2214/AJR.10.5457; PAULSEN RD, 1994, AM J NEURORADIOL, V15, P293; TARLOV IM, 1970, J NEUROL NEUROSUR PS, V33, P833, DOI 10.1136/jnnp.33.6.833; Voyadzis JM, 2001, J NEUROSURG, V95, P25, DOI 10.3171/spi.2001.95.1.0025; Younes M, 2009, REV NEUROL-FRANCE, V165, P282, DOI 10.1016/j.neurol.2008.07.019	15	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71514	10.1371/journal.pone.0071514	http://dx.doi.org/10.1371/journal.pone.0071514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936511	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400110
J	Ha, GH; Kim, JL; Breuer, EKY				Ha, Geun-Hyoung; Kim, Jung-Lye; Breuer, Eun-Kyoung Yim			TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; ACIDIC COILED-COIL; GENE-EXPRESSION PROFILES; T(4/14)(P16.3,Q32) CHROMOSOMAL TRANSLOCATION; BREAST-CANCER; MULTIPLE-MYELOMA; E-CADHERIN; CELL-LINES; HUMAN GLIOBLASTOMA	The third member of transforming acidic coiled-coil protein (TACC) family, TACC3, has been shown to be an important player in the regulation of centrosome/microtubule dynamics during mitosis and found to be deregulated in a variety of human malignancies. Our previous studies have suggested that TACC3 may be involved in cervical cancer progression and chemoresistance, and its overexpression can induce epithelial-mesenchymal transition (EMT) by activating the phosphatidylinositol 3-kinase (PI3K)/Akt and extracellular signal-regulated protein kinases (ERKs) signal transduction pathways. However, the upstream mechanisms of TACC3-mediated EMT and its functional/clinical importance in human cervical cancer remain elusive. Epidermal growth factor (EGF) has been shown to be a potent inducer of EMT in cervical cancer and associated with tumor invasion and metastasis. In this study, we found that TACC3 is overexpressed in cervical cancer and can be induced upon EGF stimulation. The induction of TACC3 by EGF is dependent on the tyrosine kinase activity of the EGF receptor (EGFR). Intriguingly, depletion of TACC3 abolishes EGF-mediated EMT, suggesting that TACC3 is required for EGF/EGFR-driven EMT process. Moreover, Snail, a key player in EGF-mediated EMT, is found to be correlated with the expression of TACC3 in cervical cancer. Collectively, our study highlights a novel function for TACC3 in EGF-mediated EMT process and suggests that targeting of TACC3 may be an attractive strategy to treat cervical cancers driven by EGF/EGFR signaling pathways.	[Ha, Geun-Hyoung; Kim, Jung-Lye; Breuer, Eun-Kyoung Yim] Loyola Univ Chicago, Stritch Sch Med, Dept Radiat Oncol, Maywood, IL USA	Loyola University Chicago	Breuer, EKY (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Radiat Oncol, Maywood, IL USA.	eubreuer@lumc.edu		Ha, Geun-Hyoung/0000-0002-9125-1934				Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Albee AJ, 2008, MOL BIOL CELL, V19, P3347, DOI 10.1091/mbc.E07-11-1204; Ali SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011059; Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; Bargo S, 2010, BIOCHEM BIOPH RES CO, V400, P606, DOI 10.1016/j.bbrc.2010.08.111; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Chakraborty J, 2008, VIROLOGY, V377, P100, DOI 10.1016/j.virol.2008.04.008; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034071; Chiang YH, 2008, J CELL PHYSIOL, V214, P810, DOI 10.1002/jcp.21277; Conte N, 2002, ONCOGENE, V21, P5619, DOI 10.1038/sj.onc.1205658; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Duncan CD, 2010, ADVANCED CRIME SCENE PHOTOGRAPHY, P1; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Finelli P, 1999, BLOOD, V94, P724, DOI 10.1182/blood.V94.2.724.414k05_724_732; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Gomez-Baldo L, 2010, CELL CYCLE, V9, P1143, DOI 10.4161/cc.9.6.11018; Goncalves A, 2008, GYNECOL ONCOL, V108, P42, DOI 10.1016/j.ygyno.2007.07.057; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Guyot R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-3; Ha GH, 2013, CANCER LETT, V336, P24, DOI 10.1016/j.canlet.2013.04.022; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Hajra KM, 2002, CANCER RES, V62, P1613; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; Hertlein L, 2011, ARCH GYNECOL OBSTET, V283, P109, DOI 10.1007/s00404-010-1389-1; Hougardy BMT, 2005, GYNECOL ONCOL, V97, P353, DOI 10.1016/j.ygyno.2005.01.036; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Ittmann M, 2009, NEOPLASIA, V11, P305, DOI 10.1593/neo.81530; Jeng JC, 2009, CELL CYCLE, V8, P3537, DOI 10.4161/cc.8.21.9935; Johns TG, 2003, P NATL ACAD SCI USA, V100, P15871, DOI 10.1073/pnas.2036503100; Jung CK, 2006, PATHOL INT, V56, P503, DOI 10.1111/j.1440-1827.2006.01998.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kang HN, 2012, BLOOD, V119, P1872, DOI 10.1182/blood-2011-10-382861; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kersemaekers AMF, 1999, CLIN CANCER RES, V5, P577; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; L'Esperance S, 2006, INT J ONCOL, V29, P5; Lauffart B, 2003, GENOMICS, V81, P192, DOI 10.1016/S0888-7543(02)00039-3; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; Lee HJ, 2010, CELL CYCLE, V9, P2389, DOI 10.4161/cc.9.12.11904; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Lee MY, 2012, AM J TRANSL RES, V4, P1; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; Line A, 2002, CANCER GENET CYTOGEN, V139, P78, DOI 10.1016/S0165-4608(02)00607-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Malgeri U, 2000, CANCER RES, V60, P4058; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Myong NH, 2012, KOREAN J PATHOL, V46, P341, DOI 10.4132/KoreanJPathol.2012.46.4.341; O'Brien LL, 2005, MOL BIOL CELL, V16, P2836, DOI 10.1091/mbc.e04-10-0926; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Peters DG, 2005, CANCER EPIDEM BIOMAR, V14, P1717, DOI 10.1158/1055-9965.EPI-04-0704; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Raff JW, 2002, TRENDS CELL BIOL, V12, P222, DOI 10.1016/S0962-8924(02)02268-7; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Robertson ED, 2012, J CELL SCI, V125, P3320, DOI 10.1242/jcs.095125; Sadek CM, 2000, MECH DEVELOP, V97, P13, DOI 10.1016/S0925-4773(00)00415-9; Sadek CM, 2003, GENE EXPR PATTERNS, V3, P203, DOI 10.1016/S1567-133X(02)00066-2; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Schonrath K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033116; Schrevel M, 2011, MODERN PATHOL, V24, P720, DOI 10.1038/modpathol.2010.239; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Serrano ML, 2008, HORM METAB RES, V40, P661, DOI 10.1055/s-0028-1082080; Shen L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-232; Shivapurkar N, 1999, CANCER RES, V59, P3576; Shivapurkar N, 2001, HUM PATHOL, V32, P169, DOI 10.1053/hupa.2001.21560; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Soonthornthum T, 2011, ANN ONCOL, V22, P2166, DOI 10.1093/annonc/mdq723; Stewart JP, 2004, BRIT J HAEMATOL, V126, P72, DOI 10.1111/j.1365-2141.2004.04996.x; Still IH, 1999, ONCOGENE, V18, P4032, DOI 10.1038/sj.onc.1202801; Still IH, 1999, GENOMICS, V58, P165, DOI 10.1006/geno.1999.5829; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Ulisse S, 2007, ENDOCR-RELAT CANCER, V14, P827, DOI 10.1677/ERC-07-0053; Wang ML, 2011, CARCINOGENESIS, V32, P872, DOI 10.1093/carcin/bgr060; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yao R, 2007, CANCER SCI, V98, P555, DOI 10.1111/j.1349-7006.2007.00433.x; Yim EK, 2009, ONCOL REP, V21, P549, DOI 10.3892/or_00000256; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056	95	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70353	10.1371/journal.pone.0070353	http://dx.doi.org/10.1371/journal.pone.0070353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936413	Green Published, gold			2022-12-27	WOS:000324518400058
J	Li, XB; Tang, YL; Wang, CY				Li, Xianbin; Tang, Yilang; Wang, Chuanyue			Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							RISPERIDONE-INDUCED HYPERPROLACTINEMIA; PSYCHOTIC-INDUCED HYPERPROLACTINEMIA; SHAKUYAKU-KANZO-TO; DOUBLE-BLIND; HERBAL MEDICINE; PARTIAL AGONIST; SCHIZOPHRENIA; CLOZAPINE; OLANZAPINE; AMISULPRIDE	Objective: To compare the safety and efficacy of adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia. Methods: Population: adult patients presenting with antipsychotic-induced hyperprolactinemia diagnosed by prolactin level with or without prolactin-related symptoms. Interventions: adjunctive aripiprazole vs. adjunctive placebo. Outcome measures: adverse events and efficacy of treatment. Studies: randomized controlled trials. Results: Five randomized controlled trials with a total of 639 patients (326 adjunctive aripiprazole, 313 adjunctive placebo) met the inclusion criteria. Adjunctive aripiprazole was associated with a 79.11% (125/158) prolactin level normalization rate. Meta-analysis of insomnia, headache, sedation, psychiatric disorder, extrapyramidal symptom, dry mouth, and fatigue showed no significant differences in the adjunctive aripiprazole treatment group compared with the placebo group (risk difference (Mantel-Haenszel, random or fixed) -0.05 to 0.04 (95% confidence interval -0.13 to 0.16); I-2 = 0% to 68%, P = 0.20 to 0.70). However, sedation, insomnia, and headache were more frequent when the adjunctive aripiprazole dose was higher than 15 mg/day. Meta-analysis of the prolactin level normalization indicated adjunctive aripiprazole was superior to placebo (risk difference (Mantel-Haenszel, random) 0.76 (95% confidence interval 0.67 to 0.85); I-2 = 43%, P<0.00001). The subgroup analysis confirmed that the subjects who received adjunctive aripiprazole 5 mg/day showed a degree of prolactin normalization similar to that of all participants. No significant differences between groups in discontinuation and improvements of psychiatric symptoms. Conclusion: Adjunctive aripiprazole is both safe and effective as a reasonable choice treatment for patients with antipsychotic-induced hyperprolactinemia. The appropriate dose of adjunctive aripiprazole may be 5 mg/day.	[Li, Xianbin; Wang, Chuanyue] Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing, Peoples R China; [Tang, Yilang] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA	Capital Medical University; Emory University	Wang, CY (corresponding author), Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing, Peoples R China.	wcymanu@163.com	Wang, Chuan-Yue/C-9369-2015; Tang, Yilang/AAH-7164-2020	Wang, Chuan-Yue/0000-0001-6549-3713; 	National Natural Science Foundation of China [81071083]; Beijing Science and Technology Commission [D101107047810001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Commission	The study was supported by the National Natural Science Foundation of China (81071083). This study was also funded by the Beijing Science and Technology Commission (D101107047810001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assion HJ, 2008, PHARMACOPSYCHIATRY, V41, P24, DOI 10.1055/s-2007-993209; BHATTACHARJEE J, 2008, COCHRANE DATABASE SY; Biller BMK, 1999, J REPROD MED, V44, P1075; Bonanno DG, 2001, ANN PHARMACOTHER, V35, P563; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Byerly M, 2007, J CLIN PSYCHOPHARM, V27, P639, DOI 10.1097/jcp.0b013e31815ac4e5; Chen HZ, 2009, CHIN J PSYCHIAT, V42, P4; Chen JX, 2009, J CLIN PSYCHIAT, V70, P1058, DOI 10.4088/JCP.08l04671; Chen LJ., 2010, J CLIN PSYCHIAT, V20, P304; Correll CU, 2009, SCHIZOPHRENIA BULL, V35, P443, DOI 10.1093/schbul/sbn018; DeLeon A, 2004, CLIN THER, V26, P649, DOI 10.1016/S0149-2918(04)90066-5; Gianfrancesco FD, 2002, J CLIN PSYCHIAT, V63, P920, DOI 10.4088/JCP.v63n1010; Grunder G, 2003, ARCH GEN PSYCHIAT, V60, P974, DOI 10.1001/archpsyc.60.10.974; Haddad PM, 2004, DRUGS, V64, P2291, DOI 10.2165/00003495-200464200-00003; HALBREICH U, 1995, PSYCHOSOM MED, V57, P485, DOI 10.1097/00006842-199509000-00011; Halbreich Uriel, 2003, J Psychiatr Pract, V9, P344, DOI 10.1097/00131746-200309000-00003; Hoffer ZS, 2009, PSYCHOSOMATICS, V50, P317, DOI 10.1176/appi.psy.50.4.317; Honer WG, 2006, NEW ENGL J MED, V354, P472, DOI 10.1056/NEJMoa053222; [纪菊英 JI Juying], 2008, [中华精神科杂志, Chinese Journal of Psychiatry], V41, P169; Josiassen RC, 2005, AM J PSYCHIAT, V162, P130, DOI 10.1176/appi.ajp.162.1.130; Kane JM, 2009, J CLIN PSYCHIAT, V70, P1348, DOI 10.4088/JCP.09m05154yel; Keck PE, 2000, J AFFECT DISORDERS, V59, pS31, DOI 10.1016/S0165-0327(00)00177-4; Keck PE, 2003, AM J PSYCHIAT, V160, P1651, DOI 10.1176/appi.ajp.160.9.1651; Lehman AF, 2004, AM J PSYCHIAT, V161, P1; MARDER SR, 1994, AM J PSYCHIAT, V151, P825; Marder SR, 2003, SCHIZOPHR RES, V61, P123, DOI 10.1016/S0920-9964(03)00050-1; MARKEN PA, 1992, CLIN PHARMACY, V11, P851; McQuade RD, 2004, J CLIN PSYCHIAT, V65, P47; Rainka MM, 2009, J CLIN PHARM THER, V34, P595, DOI 10.1111/j.1365-2710.2008.01009.x; Raskin S, 2000, ACTA PSYCHIAT SCAND, V101, P334, DOI 10.1034/j.1600-0447.2000.101004334.x; Ried Karin, 2006, Aust Fam Physician, V35, P635; Rocha FL, 2010, PROG NEURO-PSYCHOPH, V34, P1153, DOI 10.1016/j.pnpbp.2010.06.003; Saitis M, 2008, PSYCHIAT CLIN NEUROS, V62, P624, DOI 10.1111/j.1440-1819.2008.01859.x; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Shim JC, 2007, AM J PSYCHIAT, V164, P1404, DOI 10.1176/appi.ajp.2007.06071075; Szarfman A, 2006, PHARMACOTHERAPY, V26, P748, DOI 10.1592/phco.26.6.748; Wang CY, 2010, AM J PSYCHIAT, V167, P676, DOI 10.1176/appi.ajp.2009.09030358; Wang PS, 2002, ARCH GEN PSYCHIAT, V59, P1147, DOI 10.1001/archpsyc.59.12.1147; Xu L, 2006, ZHONGGUO XING WEI YI, V15, P718, DOI [10.3760/Cma.j.I ssn.1674-6554.2006.08.019, DOI 10.3760/CMA.J.ISSN.1674-6554.2006.08.019]; Yagcioglu AEA, 2005, J CLIN PSYCHIAT, V66, P63, DOI 10.4088/JCP.v66n0109; Yamada K, 1997, J CLIN PSYCHOPHARM, V17, P234, DOI 10.1097/00004714-199706000-00025; Yamada K, 1999, J CLIN PSYCHOPHARM, V19, P380, DOI 10.1097/00004714-199908000-00018; Yokoi F, 2002, NEUROPSYCHOPHARMACOL, V27, P248, DOI 10.1016/S0893-133X(02)00304-4; Yuan HN, 2008, J CLIN PSYCHOPHARM, V28, P264, DOI 10.1097/JCP.0b013e318172473c	44	42	50	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70179	10.1371/journal.pone.0070179	http://dx.doi.org/10.1371/journal.pone.0070179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936389	gold, Green Published, Green Submitted			2022-12-27	WOS:000324518400042
J	Oliveira, MRC; Correa, AS; de Souza, GA; Guedes, RNC; de Oliveira, LO				Carvalho Oliveira, Marcia Rodrigues; Correa, Alberto Soares; de Souza, Giselle Anselmo; Carvalho Guedes, Raul Narciso; de Oliveira, Luiz Orlando			Mesoamerican Origin and Pre- and Post-Columbian Expansions of the Ranges of Acanthoscelides obtectus Say, a Cosmopolitan Insect Pest of the Common Bean	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; POPULATION-GENETICS; MITOCHONDRIAL-DNA; DIVERSITY; COLEOPTERA; LANDRACES; SOFTWARE; HISTORY; GROWTH; SITES	An unprecedented global transfer of agricultural resources followed the discovery of the New World; one consequence of this process was that staple food plants of Neotropical origin, such as the common bean (Phaseolus vulgaris), soon expanded their ranges overseas. Yet many pests and diseases were also transported. Acanthoscelides obtectus is a cosmopolitan seed predator associated with P. vulgaris. Codispersal within the host seed seems to be an important determinant of the ability of A. obtectus to expand its range over long distances. We examined the phylogeographic structure of A. obtectus by (a) sampling three mitochondrial gene sequences (12s rRNA, 16s rRNA, and the gene that encodes cytochrome c oxidase subunit I (COI)) throughout most of the species' range and (b) exploring its late evolutionary history. Our findings indicate a Mesoamerican origin for the current genealogical lineages of A. obtectus. Each of the two major centers of genetic diversity of P. vulgaris (the Andes and Mesoamerica) contains a highly differentiated lineage of the bean beetle. Brazil has two additional, closely related lineages, both of which predate the Andean lineage and have the Mesoamerican lineage as their ancestor. The cosmopolitan distribution of A. obtectus has resulted from recent expansions of the two Brazilian lineages. We present additional evidence for both pre-Columbian and post-Columbian range expansions as likely events that shaped the current distribution of A. obtectus worldwide.	[Carvalho Oliveira, Marcia Rodrigues; de Souza, Giselle Anselmo; de Oliveira, Luiz Orlando] Univ Fed Vicosa, Inst Biotecnol Aplicada Agr, Lab Biol Mol & Filogeog, Vicosa, MG, Brazil; [Correa, Alberto Soares; Carvalho Guedes, Raul Narciso] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	de Oliveira, LO (corresponding author), Univ Fed Vicosa, Inst Biotecnol Aplicada Agr, Lab Biol Mol & Filogeog, Vicosa, MG, Brazil.	luiz.ufv@hotmail.com	Correa, Alberto S/C-4683-2014; Guedes, Raul Narciso Carvalho/L-3924-2013; Oliveira, Luiz/D-6435-2013	Correa, Alberto S/0000-0002-3788-7480; Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Oliveira, Luiz/0000-0002-5578-2260	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [PQ 305710/2009-5]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [PPM-00211-11]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)- grant number PQ 305710/2009-5; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) - grant number PPM-00211-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarez N, 2005, MOL ECOL, V14, P1015, DOI 10.1111/j.1365-294X.2005.02470.x; Alvarez N, 2005, J ZOOL SYST EVOL RES, V43, P29, DOI 10.1111/j.1439-0469.2004.00286.x; Alvarez N, 2007, EVOLUTION, V61, P2986, DOI 10.1111/j.1558-5646.2007.00235.x; BAIER AH, 1992, J STORED PROD RES, V28, P289, DOI 10.1016/0022-474X(92)90011-E; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beebe S, 2001, CROP SCI, V41, P854, DOI 10.2135/cropsci2001.413854x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Burle ML, 2010, THEOR APPL GENET, V121, P801, DOI 10.1007/s00122-010-1350-5; Clark TL, 2001, INSECT MOL BIOL, V10, P303, DOI 10.1046/j.0962-1075.2001.00269.x; Correa AS, 2011, CROP PROT, V30, P1655, DOI 10.1016/j.cropro.2011.08.022; Cross H, 2006, DARWINS HARVEST NEW, P121, DOI DOI 10.7312/MOTL13316-007; Dixon EJ, 2001, QUATERNARY SCI REV, V20, P277; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Freitas FDO, 2006, PESQUI AGROPECU BRAS, V41, P1199, DOI 10.1590/S0100-204X2006000700018; Fu YX, 1997, GENETICS, V147, P915; GEPTS P, 1988, ECON BOT, V42, P86, DOI 10.1007/BF02859038; Gepts P., 1988, Genetic resources of Phaseolus beans., P215; Gepts P, 1998, HORTSCIENCE, V33, P1124, DOI 10.21273/HORTSCI.33.7.1124; Guedes RNC, 1997, ENTOMOL EXP APPL, V84, P49, DOI 10.1023/A:1003018305244; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; KAMI J, 1995, P NATL ACAD SCI USA, V92, P1101, DOI 10.1073/pnas.92.4.1101; KAPLAN L, 1973, SCIENCE, V179, P76, DOI 10.1126/science.179.4068.76; KIMURA M, 1969, GENETICS, V61, P893; Labeyrie V., 1990, BIOL INVASIONS EUROP, P229, DOI [10.1007/s10340-014-0602-6, DOI 10.1007/S10340-014-0602-6]; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohman DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-301; LOPEZ JV, 1994, J MOL EVOL, V39, P174; McNeill Alfred, 2003, COLUMBIAN EXCHANGE B, P13; Nunn N, 2010, J ECON PERSPECT, V24, P163, DOI 10.1257/jep.24.2.163; Nylander JAA., 2004, BIOINFORMATICS; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Prous A, 1984, REV ARQUEOLOGIA MUSE, V2, P59, DOI [10.24885/ sab.v2i1.36, DOI 10.24885/SAB.V2I1.36]; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rees David P., 1996, P1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schneider S, 1999, GENETICS, V152, P1079; Smith R.H., 1985, P423; Southgate B.J., 1978, P219; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; Thakur DR, 2012, PAK J ZOOL, V44, P189; Toro O, 1990, WILD BEAN PHASEOLUS	47	31	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70039	10.1371/journal.pone.0070039	http://dx.doi.org/10.1371/journal.pone.0070039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936139	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700052
J	Ramdani, F; Hino, M				Ramdani, Fatwa; Hino, Masateru			Land Use Changes and GHG Emissions from Tropical Forest Conversion by Oil Palm Plantations in Riau Province, Indonesia	PLOS ONE			English	Article								Increasing prices and demand for biofuel and cooking oil from importer countries have caused a remarkable expansion of oil palm plantations in Indonesia. In this paper, we attempt to monitor the expansion of oil palm plantations on peat land and in tropical forests. We measure the GHG emissions from the land conversion activities at provincial scale. Using Landsat images from three different periods (1990s, 2000s and 2012), we classified LULC of the Riau Province, which is the largest oil palm producing region in Indonesia. A hybrid method of integration, generated by combining automatic processing and manual analysis, yields the best results. We found that the tropical rainforest cover decreased from similar to 63% in the 1990s to similar to 37% in the 2000s. By 2012, the remaining tropical rainforest cover was only similar to 22%. From the 1990s to the 2000s, conversion of forests and peat lands was the primary source of emissions, total CO2 emitted to the atmosphere was estimated at similar to 26.6 million tCO(2)center dot y(-1), with 40.62% and 59.38% of the emissions from conversion of peat lands and forests, respectively. Between 2000 and 2012, the total CO2 emitted to the atmosphere was estimated at similar to 5.2 million tCO(2).y(-1), with 69.94% and 27.62% of the emissions from converted peat lands and converted forests, respectively. The results show that in the Riau Province, the oil palm industry boomed in the period from 1990 to 2000, with transformation of tropical forest and peat land as the primary source of emissions. The decrease of CO2 emissions in the period from 2000 to 2012 is possibly due to the enforcement of a moratorium on deforestation.	[Ramdani, Fatwa; Hino, Masateru] Tohoku Univ, Grad Sch Sci, Inst Geog, Dept Earth Sci, Sendai, Miyagi 980, Japan	Tohoku University	Ramdani, F (corresponding author), Tohoku Univ, Grad Sch Sci, Inst Geog, Dept Earth Sci, Sendai, Miyagi 980, Japan.	fatwa@s.tohoku.ac.jp	Ramdani, Fatwa/O-8596-2019; Ramdani, Fatwa/GQZ-0457-2022; Ramdani, Fatwa/AAI-6767-2020	Ramdani, Fatwa/0000-0001-7331-8034; Ramdani, Fatwa/0000-0002-8645-354X; Ramdani, Fatwa/0000-0002-8645-354X	Ministry of Education, Culture, Sports, Science and Technology - Japan (MEXT)	Ministry of Education, Culture, Sports, Science and Technology - Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank the Ministry of Education, Culture, Sports, Science and Technology - Japan (MEXT) for a MEXT Scholarship.	API (Agro Products India), 2011, OIL PALM; BPS, 2011, IND OIL PALM STAT; BPS (National Statistical Beaureu), 2011, DIR OIL PALM PLANT C; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; FAOSTAT, 2012, ONL STAT SERV; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Hairiah K, 2005, RAPID CARBON STOCK A; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hooijer A, 2006, Q39432006 DELFT HYDR; IPCC (Intergovernmental Panel on Climate change), 2000, LAND USE LAND USE CH; Jupesta J, 2012, APPL ENERG, V90, P211, DOI 10.1016/j.apenergy.2011.02.020; Koh LP, 2011, P NATL ACAD SCI USA, V108, P5127, DOI 10.1073/pnas.1018776108; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Langner A, 2009, GLOBAL CHANGE BIOL, V15, P48, DOI 10.1111/j.1365-2486.2008.01828.x; LOPES A, 1990, IEEE T GEOSCI REMOTE, V28, P992, DOI 10.1109/36.62623; Minister of Forestry, 2011, KEP MENT KEH REP IND; Oil World, 2010, OIL WORLD ANN; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Ramdani F., 2013, SCI REPORT TOHOKU U, V59, P31; United States Department of Agriculture Indonesia, 2010, RIS GLOB DEM FUELS O; *WETL INT, 2004, MAPS PEATL DISTR CAR; *WETL INT, 2003, MAPS PEATL DISTR CAR; WRM (World Rainforest Movement), 2008, AN EX LEG REL OIL PA	25	46	46	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70323	10.1371/journal.pone.0070323	http://dx.doi.org/10.1371/journal.pone.0070323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936186	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200074
J	Sharp, GC; Ma, HW; Saunders, PTK; Norman, JE				Sharp, Gemma C.; Ma, Hongwu; Saunders, Philippa T. K.; Norman, Jane E.			A Computational Model of Lipopolysaccharide-Induced Nuclear Factor Kappa B Activation: A Key Signalling Pathway in Infection-Induced Preterm Labour	PLOS ONE			English	Article							GENE-EXPRESSION; BIRTH; TOLL-LIKE-RECEPTOR-4; PROGESTERONE; MYOMETRIUM	Preterm birth is the single biggest cause of significant neonatal morbidity and mortality, and the incidence is rising. Development of new therapies to treat and prevent preterm labour is seriously hampered by incomplete understanding of the molecular mechanisms that initiate labour at term and preterm. Computational modelling provides a new opportunity to improve this understanding. It is a useful tool in (i) identifying gaps in knowledge and informing future research, and (ii) providing the basis for an in silico model of parturition in which novel drugs to prevent or treat preterm labour can be "tested". Despite their merits, computational models are rarely used to study the molecular events initiating labour. Here, we present the first attempt to generate a dynamic kinetic model that has relevance to the molecular mechanisms of preterm labour. Using published data, we model an important candidate signalling pathway in infection-induced preterm labour: that of lipopolysaccharide (LPS) -induced activation of Nuclear Factor kappa B. This is the first model of this pathway to explicitly include molecular interactions upstream of Nuclear Factor kappa B activation. We produced a formalised graphical depiction of the pathway and built a kinetic model based on ordinary differential equations. The kinetic model accurately reproduced published in vitro time course plots of Lipopolysaccharide-induced Nuclear Factor kappa B activation in mouse embryo fibroblasts. In this preliminary work we have provided proof of concept that it is possible to build computational models of signalling pathways that are relevant to the regulation of labour, and suggest that models that are validated with wet-lab experiments have the potential to greatly benefit the field.	[Sharp, Gemma C.; Saunders, Philippa T. K.; Norman, Jane E.] Univ Edinburgh, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland; [Ma, Hongwu] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland; [Ma, Hongwu] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Norman, Jane E.] Univ Edinburgh, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; University of Edinburgh	Sharp, GC (corresponding author), Univ Edinburgh, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland.	Gemma.sharp@ed.ac.uk	Sharp, Gemma/U-1294-2019; Saunders, Philippa TK/C-7489-2013; Ma, Hongwu/I-5263-2013	Sharp, Gemma/0000-0003-2906-4035; Saunders, Philippa TK/0000-0001-9051-9380; Ma, Hongwu/0000-0001-5325-2314	University of Edinburgh Principal's Research Fund; Albert McKern Bequest; Tommy's Baby Charity; National Key Basic Research Program of China [2012CB725203, 2011CBA00804]; MRC [G1100356, G1002033] Funding Source: UKRI; Medical Research Council [G1100356, G1002033] Funding Source: researchfish	University of Edinburgh Principal's Research Fund; Albert McKern Bequest; Tommy's Baby Charity; National Key Basic Research Program of China(National Basic Research Program of China); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful for funding from the University of Edinburgh Principal's Research Fund (for a PhD studentship to GCS), the Albert McKern Bequest and Tommy's Baby Charity. HM is grateful for support from the National Key Basic Research Program of China (2012CB725203, 2011CBA00804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Breitling R, 2008, BRIEF BIOINFORM, V9, P404, DOI 10.1093/bib/bbn026; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Chapman NR, 2004, J CLIN ENDOCR METAB, V89, P5683, DOI 10.1210/jc.2004-0873; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; CROSTON GE, 1995, J BIOL CHEM, V270, P16514, DOI 10.1074/jbc.270.28.16514; DOKTER WHA, 1995, LEUKEMIA, V9, P425; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Equils O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008502; FIDEL PL, 1994, AM J REPROD IMMUNOL, V32, P1; Freeman TC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-65; Golightly E, 2011, MOL CELL ENDOCRINOL, V335, P52, DOI 10.1016/j.mce.2010.08.005; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Li LP, 2010, MOL HUM REPROD, V16, P267, DOI 10.1093/molehr/gap106; Li R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020560; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Newton R, 1997, BIOCHEM BIOPH RES CO, V237, P28, DOI 10.1006/bbrc.1997.7064; Norman JE, 2013, LANCET, V381, P184, DOI 10.1016/S0140-6736(12)61956-4; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sehringer B, 2000, J CLIN ENDOCR METAB, V85, P4859, DOI 10.1210/jc.85.12.4859; Selvarajoo K, 2006, FEBS LETT, V580, P1457, DOI 10.1016/j.febslet.2006.01.046; Smolen P.D., 2004, MOL NETW INTROD CELL, P391; Wang H, 2003, BIOL REPROD, V69, P1957, DOI 10.1095/biolreprod.103.019620; Wu GD, 1997, J BIOL CHEM, V272, P2396; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	28	19	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70180	10.1371/journal.pone.0070180	http://dx.doi.org/10.1371/journal.pone.0070180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936158	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200061
J	Balan, S; Yamada, K; Hattori, E; Iwayama, Y; Toyota, T; Ohnishi, T; Maekawa, M; Toyoshima, M; Iwata, Y; Suzuki, K; Kikuchi, M; Yoshikawa, T				Balan, Shabeesh; Yamada, Kazuo; Hattori, Eiji; Iwayama, Yoshimi; Toyota, Tomoko; Ohnishi, Tetsuo; Maekawa, Motoko; Toyoshima, Manabu; Iwata, Yasuhide; Suzuki, Katsuaki; Kikuchi, Mitsuru; Yoshikawa, Takeo			Population-Specific Haplotype Association of the Postsynaptic Density Gene DLG4 with Schizophrenia, in Family-Based Association Studies	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; RECEPTOR TRAFFICKING; JAPANESE POPULATION; PREFRONTAL CORTEX; PSD-95; POLYMORPHISMS; UBIQUITINATION; DYSCONNECTION; INVOLVEMENT	The post-synaptic density (PSD) of glutamatergic synapses harbors a multitude of proteins critical for maintaining synaptic dynamics. Alteration of protein expression levels in this matrix is a marked phenomenon of neuropsychiatric disorders including schizophrenia, where cognitive functions are impaired. To investigate the genetic relationship of genes expressed in the PSD with schizophrenia, a family-based association analysis of genetic variants in PSD genes such as DLG4, DLG1, PICK1 and MDM2, was performed, using Japanese samples (124 pedigrees, n = 376 subjects). Results showed a significant association of the rs17203281 variant from the DLG4 gene, with preferential transmission of the C allele (p = 0.02), although significance disappeared after correction for multiple testing. Replication analysis of this variant, found no association in a Chinese schizophrenia cohort (293 pedigrees, n = 1163 subjects) or in a Japanese case-control sample (n = 4182 subjects). The DLG4 expression levels between postmortem brain samples from schizophrenia patients showed no significant changes from controls. Interestingly, a five marker haplotype in DLG4, involving rs2242449, rs17203281, rs390200, rs222853 and rs222837, was enriched in a population specific manner, where the sequences A-C-C-C-A and G-C-C-C-A accumulated in Japanese (p = 0.0009) and Chinese (p = 0.0007) schizophrenia pedigree samples, respectively. However, this could not be replicated in case-control samples. None of the variants in other examined candidate genes showed any significant association in these samples. The current study highlights a putative role for DLG4 in schizophrenia pathogenesis, evidenced by haplotype association, and warrants further dense screening for variants within these haplotypes.	[Balan, Shabeesh; Yamada, Kazuo; Hattori, Eiji; Iwayama, Yoshimi; Toyota, Tomoko; Ohnishi, Tetsuo; Maekawa, Motoko; Toyoshima, Manabu; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Saitama, Japan; [Iwata, Yasuhide; Suzuki, Katsuaki] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Shizuoka, Japan; [Kikuchi, Mitsuru] Kanazawa Univ, Grad Sch Med, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan	RIKEN; Hamamatsu University School of Medicine; Kanazawa University	Yoshikawa, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Psychiat, Saitama, Japan.	takeo@brain.riken.jp	Ohnishi, Tetsuo/AAC-2767-2022; Ohnishi, Tetsuo/D-3791-2018; Balan, Shabeesh/K-5753-2014; Ohnishi, Tetsuo/AAC-5694-2019; Yoshikawa, Takeo/F-9599-2019	Ohnishi, Tetsuo/0000-0002-6696-9725; Balan, Shabeesh/0000-0002-1098-1290; Ohnishi, Tetsuo/0000-0002-6696-9725; Suzuki, Katsuaki/0000-0003-0446-3355	RIKEN Brain Science Institute Funds; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059571, R01MH060879, U01MH046318, R01MH060870, R01MH059586, R01MH059566, U01MH046289, R01MH059588, U01MH046276, R01MH059565, R01MH059587, R01MH061675] Funding Source: NIH RePORTER	RIKEN Brain Science Institute Funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by RIKEN Brain Science Institute Funds. In addition, a part of this study is the result of the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGGONO V, 2012, REGULATION AMPA RECE; Balu DT, 2011, NEUROSCI BIOBEHAV R, V35, P848, DOI 10.1016/j.neubiorev.2010.10.005; Beneyto M, 2006, SYNAPSE, V60, P585, DOI 10.1002/syn.20329; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Boeckers TM, 2006, CELL TISSUE RES, V326, P409, DOI 10.1007/s00441-006-0274-5; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carroll LS, 2011, AM J MED GENET B, V156B, P844, DOI 10.1002/ajmg.b.31231; Catts VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035511; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cheng MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015107; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dev KK, 2006, TRENDS PHARMACOL SCI, V27, P574, DOI 10.1016/j.tips.2006.09.007; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Egerton A, 2012, CURR PHARM BIOTECHNO, V13, P1500, DOI 10.2174/138920112800784961; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Hattori E, 2009, AM J MED GENET B, V150B, P1110, DOI 10.1002/ajmg.b.30941; Hong CJ, 2004, NEUROREPORT, V15, P1965, DOI 10.1097/00001756-200408260-00026; IASEVOLI F, 2012, NEUROCHEM RES, P1; Ishiguro H, 2007, NEUROSCI RES, V58, P145, DOI 10.1016/j.neures.2007.02.008; Itokawa M, 2003, PHARMACOGENETICS, V13, P271, DOI 10.1097/00008571-200305000-00006; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kawashima R, 2006, NEUROSCI LETT, V400, P168, DOI 10.1016/j.neulet.2006.02.036; Klei L, 2005, HUM GENET, V117, P349, DOI 10.1007/s00439-005-1320-1; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; Liu NJ, 2008, ADV GENET, V60, P335, DOI 10.1016/S0065-2660(07)00414-2; Lussier MP, 2011, J NEUROSCI, V31, P3077, DOI 10.1523/JNEUROSCI.5944-10.2011; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Pritchard JK, 2000, GENETICS, V155, P945; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Tsai SJ, 2007, J NEURAL TRANSM, V114, P423, DOI 10.1007/s00702-006-0587-2; Uezato A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-2; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Yamada K, 2004, BIOL PSYCHIAT, V56, P683, DOI 10.1016/j.biopsych.2004.08.015; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008; Yamada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020468; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026	51	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70302	10.1371/journal.pone.0070302	http://dx.doi.org/10.1371/journal.pone.0070302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936182	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300098
J	Oldfield, NJ; Matar, S; Bidmos, FA; Alamro, M; Neal, KR; Turner, DPJ; Bayliss, CD; Ala'Aldeen, DAA				Oldfield, Neil J.; Matar, Suzan; Bidmos, Fadil A.; Alamro, Mohammed; Neal, Keith R.; Turner, David P. J.; Bayliss, Christopher D.; Ala'Aldeen, Dlawer A. A.			Prevalence and Phase Variable Expression Status of Two Autotransporters, NalP and MspA, in Carriage and Disease Isolates of Neisseria meningitidis	PLOS ONE			English	Article							HEPARIN-BINDING PROTEIN; MULTICOMPONENT VACCINE; SEROGROUP-B; SERINE-PROTEASE; SEQUENCE; DELETION; 4CMENB; CELL	Neisseria meningitidis is a human nasopharyngeal commensal capable of causing life-threatening septicemia and meningitis. Many meningococcal surface structures, including the autotransporter proteins NalP and MspA, are subject to phase variation (PV) due to the presence of homopolymeric tracts within their coding sequences. The functions of MspA are unknown. NalP proteolytically cleaves several surface-located virulence factors including the 4CMenB antigen NhbA. Therefore, NalP is a phase-variable regulator of the meningococcal outer membrane and secretome whose expression may reduce isolate susceptibility to 4CMenB-induced immune responses. To improve our understanding of the contributions of MspA and NalP to meningococcal-host interactions, their distribution and phase-variable expression status was studied in epidemiologically relevant samples, including 127 carriage and 514 invasive isolates representative of multiple clonal complexes and serogroups. Prevalence estimates of >98% and >88% were obtained for mspA and nalP, respectively, with no significant differences in their frequencies in disease versus carriage isolates. 16% of serogroup B (MenB) invasive isolates, predominately from clonal complexes ST-269 and ST-461, lacked nalP. Deletion of nalP often resulted from recombination events between flanking repetitive elements. PolyC tract lengths ranged from 6-15 bp in nalP and 6-14 bp in mspA. In an examination of PV status, 58.8% of carriage, and 40.1% of invasive nalP-positive MenB isolates were nalP phase ON. The frequency of this phenotype was not significantly different in serogroup Y (MenY) carriage strains, but was significantly higher in invasive MenY strains (86.3%; p<0.0001). Approximately 90% of MenB carriage and invasive isolates were mspA phase ON; significantly more than MenY carriage (32.7%) or invasive (13.7%) isolates. This differential expression resulted from different mode mspA tract lengths between the serogroups. Our data indicates a differential requirement for NalP and MspA expression in MenB and MenY strains and is a step towards understanding the contributions of phase-variable loci to meningococcal biology.	[Oldfield, Neil J.; Matar, Suzan; Turner, David P. J.; Ala'Aldeen, Dlawer A. A.] Univ Nottingham, Sch Mol Med Sci, Mol Bacteriol & Immunol Grp, Nottingham NG7 2RD, England; [Matar, Suzan] Univ Jordan, Dept Biol Sci & Med Anal, Amman, Jordan; [Bidmos, Fadil A.; Alamro, Mohammed] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Neal, Keith R.; Bayliss, Christopher D.] Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Jordan; University of Leicester; University of Nottingham	Ala'Aldeen, DAA (corresponding author), Univ Nottingham, Sch Mol Med Sci, Mol Bacteriol & Immunol Grp, Nottingham NG7 2RD, England.	daa@nottingham.ac.uk	Bidmos, Fadil/AAD-8401-2020; Matar, Suzan/N-1987-2015; Oldfield, Neil J/C-2599-2009	Bidmos, Fadil/0000-0003-2843-409X; Oldfield, Neil J/0000-0001-7423-8378; Bayliss, Christopher/0000-0002-5564-2145; Turner, David/0000-0001-7432-3505; Matar, Suzan/0000-0001-6490-1690	Meningitis Research Foundation [1002.0]	Meningitis Research Foundation(Meningitis Research Foundation (MRF))	FAB was supported by Meningitis Research Foundation grant number 1002.0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Tahar K, 2000, MOL MICROBIOL, V37, P1094, DOI 10.1046/j.1365-2958.2000.02061.x; Arenas J, 2013, MOL MICROBIOL, V87, P254, DOI 10.1111/mmi.12097; Bayliss CD, 2008, INFECT IMMUN, V76, P5038, DOI 10.1128/IAI.00395-08; Bayliss CD, 2012, ANN NY ACAD SCI, V1267, P39, DOI 10.1111/j.1749-6632.2012.06584.x; Benz I, 2011, INT J MED MICROBIOL, V301, P461, DOI 10.1016/j.ijmm.2011.03.003; Bidmos FA, 2011, J CLIN MICROBIOL, V49, P506, DOI 10.1128/JCM.01322-10; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Claus H, 2007, J CLIN MICROBIOL, V45, P2960, DOI 10.1128/JCM.00696-07; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Gorringe AR, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18500; Grijpstra J, 2013, RES MICROBIOL, V164, P562, DOI 10.1016/j.resmic.2013.03.010; Hadi HA, 2001, MOL MICROBIOL, V41, P611, DOI 10.1046/j.1365-2958.2001.02516.x; Harrison OB, 2009, J INFECT DIS, V200, P94, DOI 10.1086/599377; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Marsh JW, 2007, J CLIN MICROBIOL, V45, P1333, DOI 10.1128/JCM.02422-06; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Roussel-Jazede V, 2010, INFECT IMMUN, V78, P3083, DOI 10.1128/IAI.01193-09; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Turner David P., 2009, P347; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; Turner DPJ, 2002, INFECT IMMUN, V70, P4447, DOI 10.1128/IAI.70.8.4447-4461.2002; Van der Ende A, 1999, INFECT IMMUN, V67, P2928, DOI 10.1128/IAI.67.6.2928-2934.1999; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; van Ulsen P, 2006, MICROBES INFECT, V8, P2088, DOI 10.1016/j.micinf.2006.03.007; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Yogev R, 2011, HUM VACCINES, V7, P828, DOI 10.4161/hv.7.8.16270	33	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69746	10.1371/journal.pone.0069746	http://dx.doi.org/10.1371/journal.pone.0069746			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936091	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300061
J	Higginson, DS; Sahgal, A; Lawrence, MV; Moyer, S; Stefanescu, M; Willson, AK; Qaqish, B; Zanation, A; Marks, LB; Garg, S; Chera, BS				Higginson, Daniel S.; Sahgal, Alok; Lawrence, Michael V.; Moyer, Sarah; Stefanescu, Mihaela; Willson, Adam K.; Qaqish, Bahjat; Zanation, Adam; Marks, Lawrence B.; Garg, Seema; Chera, Bhishamjit S.			External Beam Radiotherapy for Head and Neck Cancers Is Associated with Increased Variability in Retinal Vascular Oxygenation	PLOS ONE			English	Article							RADIATION RETINOPATHY; SATURATION; IRRADIATION; OXIMETRY; OCCLUSION; VESSELS	Background: Radiation retinopathy is a possible post-treatment complication of radiation therapy. The pathophysiologic mechanism is hypothesized to be microvascular in origin, but evidence is limited. In an effort to study retinal oxygenation in these patients, we herein evaluate the repeatability and variability of retinal oximetry measurements in subjects who had previously received radiation and make comparisons to a cohort of unirradiated subjects. Methods: Using retinal oximetry, a non-invasive imaging modality, we performed in vivo measurements of arteriole (SaO(2)) and venule SO2 (SvO(2)) in subjects (n = 9, 18 retinas) who had received incidental radiation to their retinas (>= 45 Gy to one retina) and in healthy subjects (n = 20, 40 retinas). A total of 1367 SO2 observations on 593 vessels in 29 persons were analyzed to assess three sources of variance in vessel SO2: 1) variance in repeated measurements of the same vessel ("repeatability"), 2) variance in different vessels within the same subject ("within-subject variability"), and 3) variance between subjects ("between-subject variability"). Results: Retinal oximetry measurements were highly repeatable in both irradiated patients and unirradiated subjects. The within-subject variability of SvO(2) and SaO(2) measurements constituted the highest component of variance in both groups and was significantly higher in venules vs. arterioles (relative effect size 1.8, p<0.001) and in irradiated subjects vs. unirradiated subjects (relative effect size 1.6, p<0.001). Conclusions: Retinal oximetry is a highly repeatable technology and can be reliably used to study vascular oxygenation in irradiated subjects. Different vessels within the same subject exhibit a high degree of variability, suggesting that pooled analyses of multiple vessels are most likely to be informative of regional retinal oxygenation. Finally, irradiated subjects exhibited significantly higher within-subject variability in SO2 measurements, suggesting that radiation may cause regional alterations in retinal oxygen delivery and/or metabolism.	[Higginson, Daniel S.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Sahgal, Alok; Moyer, Sarah; Garg, Seema] Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC USA; [Lawrence, Michael V.; Stefanescu, Mihaela; Willson, Adam K.; Marks, Lawrence B.; Chera, Bhishamjit S.] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Qaqish, Bahjat] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Zanation, Adam] Univ N Carolina, Dept Otolaryngol, Chapel Hill, NC USA	Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chera, BS (corresponding author), Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA.	bchera@med.unc.edu	Higginson, Daniel/AAW-4021-2020; Higginson, Daniel/X-8619-2018	Higginson, Daniel/0000-0002-6686-7454; Higginson, Daniel/0000-0002-6686-7454	National Center for Research Resources [UL1RR025747]; RSNA Research Resident Grant; Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); RSNA Research Resident Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Center for Research Resources (UL1RR025747 to BSC); RSNA Research Resident Grant (to DSH); and an unrestricted (ophthalmology) departmental grant from Research to Prevent Blindness. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOAKU WMK, 1990, EYE, V4, P657, DOI 10.1038/eye.1990.93; ARCHER D B, 1991, Eye (London), V5, P239; Beach JM, 1999, J APPL PHYSIOL, V86, P748, DOI 10.1152/jappl.1999.86.2.748; CHAN RC, 1976, RADIOLOGY, V120, P673, DOI 10.1148/120.3.673; Emami B, 1991, J NUCL MED, V15, P109, DOI DOI 10.1016/0360-3016(91)90171-Y; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; GASS JDM, 1968, ARCH OPHTHALMOL-CHIC, V80, P606, DOI 10.1001/archopht.1968.00980050608006; Hammer M, 2009, GRAEF ARCH CLIN EXP, V247, P1025, DOI 10.1007/s00417-009-1078-6; Hammer M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976032; Hardarson SH, 2006, INVEST OPHTH VIS SCI, V47, P5011, DOI 10.1167/iovs.06-0039; Hardarson SH, 2012, BRIT J OPHTHALMOL, V96, P560, DOI 10.1136/bjophthalmol-2011-300640; Hardarson SH, 2010, AM J OPHTHALMOL, V150, P871, DOI 10.1016/j.ajo.2010.06.020; HAYREH SS, 1970, BRIT J OPHTHALMOL, V54, P705, DOI 10.1136/bjo.54.11.705; IRVINE AR, 1987, AM J OPHTHALMOL, V103, P790, DOI 10.1016/S0002-9394(14)74395-8; JIANG GL, 1994, RADIOTHER ONCOL, V30, P17, DOI 10.1016/0167-8140(94)90005-1; Monroe AT, 2005, INT J RADIAT ONCOL, V61, P856, DOI 10.1016/j.ijrobp.2004.07.664; Palsson O, 2012, INVEST OPHTH VIS SCI, V53, P1729, DOI 10.1167/iovs.11-8621; PARSONS JT, 1994, INT J RADIAT ONCOL, V30, P765, DOI 10.1016/0360-3016(94)90347-6; Schweitzer D, 1999, IEEE T BIO-MED ENG, V46, P1454, DOI 10.1109/10.804573; Traustason S, 2009, BRIT J OPHTHALMOL, V93, P1064, DOI 10.1136/bjo.2008.148460; Traustason S, 2011, INVEST OPHTH VIS SCI, V52, P5064, DOI 10.1167/iovs.11-7275; World Health Organization, 1980, INT CLASS IMP DIS HA	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69657	10.1371/journal.pone.0069657	http://dx.doi.org/10.1371/journal.pone.0069657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936342	gold, Green Published, Green Submitted			2022-12-27	WOS:000324401500015
J	Hotta, CT; Nishiyama, MY; Souza, GM				Hotta, Carlos Takeshi; Nishiyama, Milton Yutaka, Jr.; Souza, Glaucia Mendes			Circadian Rhythms of Sense and Antisense Transcription in Sugarcane, a Highly Polyploid Crop	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENE-EXPRESSION; KEY PATHWAYS; PERIOD LENGTH; GROWTH VIGOR; CLOCK; GENOME; RESPONSES; RNA; PROTEIN	Commercial sugarcane (Saccharum hybrid) is a highly polyploid and aneuploid grass that stores large amounts of sucrose in its stem. We have measured circadian rhythms of sense and antisense transcription in a commercial cultivar (RB855453) using a custom oligoarray with 14,521 probes that hybridize to sense transcripts (SS) and 7,380 probes that hybridize to antisense transcripts (AS). We estimated that 32% of SS probes and 22% AS probes were rhythmic. This is a higher proportion of rhythmic probes than the usually found in similar experiments in other plant species. Orthologs and inparalogs of Arabidopsis thaliana, sugarcane, rice, maize and sorghum were grouped in ortholog clusters. When ortholog clusters were used to compare probes among different datasets, sugarcane also showed a higher proportion of rhythmic elements than the other species. Thus, it is possible that a higher proportion of transcripts are regulated by the sugarcane circadian clock. Thirty-six percent of the identified AS/SS pairs had significant correlated time courses and 64% had uncorrelated expression patterns. The clustering of transcripts with similar function, the anticipation of daily environmental changes and the temporal compartmentation of metabolic processes were some properties identified in the circadian sugarcane transcriptome. During the day, there was a dominance of transcripts associated with photosynthesis and carbohydrate metabolism, including sucrose and starch synthesis. During the night, there was dominance of transcripts associated with genetic processing, such as histone regulation and RNA polymerase, ribosome and protein synthesis. Finally, the circadian clock also regulated hormone signalling pathways: a large proportion of auxin and ABA signalling components were regulated by the circadian clock in an unusual biphasic distribution.	[Hotta, Carlos Takeshi; Nishiyama, Milton Yutaka, Jr.; Souza, Glaucia Mendes] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil	Universidade de Sao Paulo	Souza, GM (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.	glmsouza@iq.usp.br	Nishiyama, Milton Y/H-4002-2013; Hotta, Carlos Takeshi/G-9760-2012; Nishiyama, Milton/AAE-5736-2021; Souza, Glaucia/E-6780-2012	Nishiyama, Milton Y/0000-0002-2410-0562; Hotta, Carlos Takeshi/0000-0003-3349-6121; Nishiyama, Milton/0000-0002-2410-0562; Souza, Glaucia/0000-0001-6903-9913	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). GMS is recipient of a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Productivity Fellowship. CTH was supported by a post-doctorate fellowship from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Carrieri C, 2012, NATURE; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378; D'Hont A, 2001, INTERNATIONAL SOCIETY OF SUGAR CANE TECHNOLOGISTS, VOL II, PROCEEDINGS, P556; Dal-Bianco M, 2012, CURR OPIN BIOTECH, V23, P265, DOI 10.1016/j.copbio.2011.09.002; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Filichkin SA, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-20; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Gibon Y, 2009, PLANT CELL ENVIRON, V32, P859, DOI 10.1111/j.1365-3040.2009.01965.x; Grivet L, 2002, CURR OPIN PLANT BIOL, V5, P122, DOI 10.1016/S1369-5266(02)00234-0; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Helliwell CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021513; Herrero E, 2012, PLANT CELL, V24, P428, DOI 10.1105/tpc.111.093807; Higgins J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-247; Hong SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011461; Hotta C. T., 2010, Tropical Plant Biology, V3, P75, DOI 10.1007/s12042-010-9050-5; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Khanna R, 2003, PLANT PHYSIOL, V133, P1530, DOI 10.1104/pp.103.030007; Kim J, 2008, PLANT CELL, V20, P307, DOI 10.1105/tpc.107.055715; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kolmos E, 2009, HFSP J, V3, P350, DOI 10.2976/1.3218766; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Lembke CG, 2012, PLANT MOL BIOL, V79, P461, DOI 10.1007/s11103-012-9922-1; Lidder P, 2005, PLANT PHYSIOL, V138, P2374, DOI 10.1104/pp.105.060368; Lu SX, 2011, PLANT PHYSIOL, V155, P906, DOI 10.1104/pp.110.167015; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Luo C, 2012, PLANT J; McClung CR, 2011, ADV GENET, V74, P105, DOI 10.1016/B978-0-12-387690-4.00004-0; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Miller M, 2012, G3-GENES GENOM GENET, V2, P505, DOI 10.1534/g3.112.002162; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Robertson F, 2009, PLANT MOL BIOL, V69, P419, DOI 10.1007/s11103-008-9407-4; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Rohwer JM, 2001, BIOCHEM J, V358, P437, DOI 10.1042/0264-6021:3580437; Roulin A, 2012, PLANT J; Sanchez SE, 2010, NATURE; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Staiger D, 2011, TRENDS PLANT SCI, V16, P517, DOI 10.1016/j.tplants.2011.06.002; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Wang XX, 2012, PLANT CELL, V24, P3278, DOI 10.1105/tpc.112.100081; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Yilmaz A, 2009, PLANT PHYSIOL, V149, P171, DOI 10.1104/pp.108.128579	75	22	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71847	10.1371/journal.pone.0071847	http://dx.doi.org/10.1371/journal.pone.0071847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936527	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500082
J	Sergi, PN; Roccasalvo, IM; Tonazzini, I; Cecchini, M; Micera, S				Sergi, Pier Nicola; Roccasalvo, Iolanda Morana; Tonazzini, Ilaria; Cecchini, Marco; Micera, Silvestro			Cell Guidance on Nanogratings: A Computational Model of the Interplay between PC12 Growth Cones and Nanostructures	PLOS ONE			English	Article							AXONAL ELONGATION; NEURONAL POLARITY; POINT CONTACTS; ADHESION; SIGNALS; HAND; DIRECTIONALITY; REGENERATION; CYTOSKELETON; INFORMATION	Background: Recently, the effects of nanogratings have been investigated on PC12 with respect to cell polarity, neuronal differentiation, migration, maturation of focal adhesions and alignment of neurites. Methodology/Principal Findings: A synergistic procedure was used to study the mechanism of alignment of PC12 neurites with respect to the main direction of nanogratings. Finite Element simulations were used to qualitatively assess the distribution of stresses at the interface between non-spread growth cones and filopodia, and to study their dependence on filopodial length and orientation. After modelling all adhesions under non-spread growth cone and filopodial protrusions, the values of local stress maxima resulted from the length of filopodia. Since the stress was assumed to be the main triggering cause leading to the increase and stabilization of filopodia, the position of the local maxima was directly related to the orientation of neurites. An analytic closed form equation was then written to quantitatively assess the average ridge width needed to achieve a given neuritic alignment (R-2 = 0.96), and the alignment course, when the ridge depth varied (R-2 = 0.97). A computational framework was implemented within an improved free Java environment (CX3D) and in silico simulations were carried out to reproduce and predict biological experiments. No significant differences were found between biological experiments and in silico simulations (alignment, p = 0.3571; tortuosity, p = 0.2236) with a standard level of confidence (95%). Conclusions/Significance: A mechanism involved in filopodial sensing of nanogratings is proposed and modelled through a synergistic use of FE models, theoretical equations and in silico simulations. This approach shows the importance of the neuritic terminal geometry, and the key role of the distribution of the adhesion constraints for the cell/substrate coupling process. Finally, the effects of the geometry of nanogratings were explicitly considered in cell/surface interactions thanks to the analytic framework presented in this work.	[Sergi, Pier Nicola; Roccasalvo, Iolanda Morana; Micera, Silvestro] Scuola Super Sant Anna, Neural Engn Area, BioRobot Inst, Pisa, Italy; [Tonazzini, Ilaria; Cecchini, Marco] Ist Nanosci Natl Council Res CNR, Natl Enterprise NanoSci & NanoTechnol NEST, Pisa, Italy; [Tonazzini, Ilaria; Cecchini, Marco] Scuola Normale Super Pisa, Pisa, Italy; [Micera, Silvestro] Ecole Polytech Fed Lausanne, Translat Neural Engn Lab, Ctr Neuroprosthet, Lausanne, Switzerland; [Micera, Silvestro] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Engn, Lausanne, Switzerland	Scuola Superiore Sant'Anna; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Sergi, PN (corresponding author), Scuola Super Sant Anna, Neural Engn Area, BioRobot Inst, Pisa, Italy.	p.sergi@sssup.it	Sergi, Pier Nicola/F-5857-2010; Micera, Silvestro/AAD-6630-2021; Tonazzini, Ilaria/AAP-7941-2020	Cecchini, Marco/0000-0002-9688-2356; Tonazzini, Ilaria/0000-0002-7323-2174; sergi, pier nicola/0000-0002-7872-1591	European Union [NMP-280778, NMP4-LA-2009-229289 NanoII, NMP3-SL-2009-229294 NanoCARD]	European Union(European Commission)	This work was partly funded by the European Union Seventh Framework Programme (FP7/2007-2013) under MERIDIAN project (NMP-280778, Micro and Nano Engineered Bi-Directional Carbon Interfaces for Advanced Peripheral Nervous System Prosthetics and Hybrid Bionics) and under grant agreement no. NMP4-LA-2009-229289 NanoII and grant agreement no. NMP3-SL-2009-229294 NanoCARD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALETTA JM, 1988, J NEUROSCI, V8, P1425; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; ARREGUI CO, 1994, J NEUROSCI, V14, P6967; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Borisyuk R, 2008, BIOSYSTEMS, V93, P101, DOI 10.1016/j.biosystems.2008.03.012; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; BURMEISTER DW, 1988, J NEUROSCI, V8, P3151; Carrozza MC, 2006, BIOL CYBERN, V95, P629, DOI 10.1007/s00422-006-0124-2; Cecchini M, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/50/505103; Ciofani G, 2011, MED BIOL ENG COMPUT, V49, P163, DOI 10.1007/s11517-010-0687-x; Ciofani G, 2009, BIOMED MICRODEVICES, V11, P517, DOI 10.1007/s10544-008-9258-4; Cipriani C, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-29; CLARK P, 1990, DEVELOPMENT, V108, P635; CONNOLLY JL, 1987, NEUROCHEM RES, V12, P861, DOI 10.1007/BF00966307; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Dario P, 1998, IEEE Trans Rehabil Eng, V6, P353, DOI 10.1109/86.736149; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; Ferrari A, 2011, NANO LETT, V11, P505, DOI 10.1021/nl103349s; Ferrari A, 2010, BIOMATERIALS, V31, P4682, DOI 10.1016/j.biomaterials.2010.02.032; Ferrari A, 2010, BIOMATERIALS, V31, P2565, DOI 10.1016/j.biomaterials.2009.12.010; Ferrari A, 2009, IEEE T BIO-MED ENG, V56, P2692, DOI 10.1109/TBME.2009.2027424; Foley JD, 2005, BIOMATERIALS, V26, P3639, DOI 10.1016/j.biomaterials.2004.09.048; Francisco H, 2007, BIOMATERIALS, V28, P3398, DOI 10.1016/j.biomaterials.2007.04.015; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Goodhill GJ, 2004, NEURAL COMPUT, V16, P2221, DOI 10.1162/0899766041941934; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Jang KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015966; LAMOUREUX P, 1989, NATURE, V340, P156, DOI 10.1038/340159a0; Maskery S, 2005, ANNU REV BIOMED ENG, V7, P187, DOI 10.1146/annurev.bioeng.7.060804.100446; Meucci S, 2012, SOFT MATTER, V8, P1109, DOI 10.1039/c1sm06256e; Meur AML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004334; Micera S, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-53; Micera S, 2010, P IEEE, V98, P407, DOI 10.1109/JPROC.2009.2038726; Navarro X, 2005, J PERIPHER NERV SYST, V10, P229, DOI 10.1111/j.1085-9489.2005.10303.x; Renaudin A, 1999, J NEUROSCI RES, V55, P458, DOI 10.1002/(SICI)1097-4547(19990215)55:4<458::AID-JNR6>3.0.CO;2-D; Rossini PM, 2010, CLIN NEUROPHYSIOL, V121, P777, DOI 10.1016/j.clinph.2010.01.001; Steketee MB, 2002, J NEUROSCI, V22, P8071; Stieglitz T, 2002, BIOSENS BIOELECTRON, V17, P685, DOI 10.1016/S0956-5663(02)00019-2; Wieringa P, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/27/275102; ZHENG J, 1991, J NEUROSCI, V11, P1117; Zubler F, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.025.2009	44	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70304	10.1371/journal.pone.0070304	http://dx.doi.org/10.1371/journal.pone.0070304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936404	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500026
J	Zhang, Y; Babaian, A; Gagnier, L; Mager, DL				Zhang, Ying; Babaian, Artem; Gagnier, Liane; Mager, Dixie L.			Visualized Computational Predictions of Transcriptional Effects by Intronic Endogenous Retroviruses	PLOS ONE			English	Article							SOMATIC RETROTRANSPOSITION; TRANSPOSABLE ELEMENTS; INTERSPERSED REPEATS; HUMAN GENOMES; HUMAN BRAIN; MOUSE; GENES; MUTAGENESIS; LANDSCAPE; PATTERNS	When endogenous retroviruses (ERVs) or other transposable elements (TEs) insert into an intron, the consequence on gene transcription can range from negligible to a complete ablation of normal transcripts. With the advance of sequencing technology, more and more insertionally polymorphic or private TE insertions are being identified in humans and mice, of which some could have a significant impact on host gene expression. Nevertheless, an efficient and low cost approach to prioritize their potential effect on gene transcription has been lacking. By building a computational model based on artificial neural networks (ANN), we demonstrate the feasibility of using machine-learning approaches to predict the likelihood that intronic ERV insertions will have major effects on gene transcription, focusing on the two ERV families, namely Intracisternal A-type Particle (IAP) and Early Transposon (ETn)/MusD elements, which are responsible for the majority of ERV-induced mutations in mice. We trained the ANN model using properties associated with these ERVs known to cause germ-line mutations (positive cases) and properties associated with likely neutral ERVs of the same families (negative cases), and derived a set of prediction plots that can visualize the likelihood of affecting gene transcription by ERV insertions. Our results show a highly reliable prediction power of our model, and offer a potential approach to computationally screen for other types of TE insertions that may affect gene transcription or even cause disease.	[Zhang, Ying; Babaian, Artem; Gagnier, Liane; Mager, Dixie L.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Zhang, Ying; Babaian, Artem; Gagnier, Liane; Mager, Dixie L.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia	Mager, DL (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	dmager@bccrc.ca		Mager, Dixie/0000-0002-5955-2550; Babaian, Artem/0000-0002-4315-6262	Canadian Institutes of Health Research [MOP-10825]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant MOP-10825 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bishop C.M., 1995, NEURAL NETWORKS PATT; Cutter AD, 2005, J MOL EVOL, V61, P733, DOI 10.1007/s00239-004-0243-0; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Grover D, 2003, MOL BIOL EVOL, V20, P1420, DOI 10.1093/molbev/msg153; Gunther F, 2010, R J; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kaer K, 2013, GENE, V518, P231, DOI 10.1016/j.gene.2013.01.008; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Li JF, 2012, GENOME RES, V22, P870, DOI 10.1101/gr.130740.111; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Mortada H, 2010, J MOL EVOL, V71, P180, DOI 10.1007/s00239-010-9376-5; Nellaker C, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r45; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Sironi M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r120; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; van de Lagemaat LN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r86; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030158; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002046	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71971	10.1371/journal.pone.0071971	http://dx.doi.org/10.1371/journal.pone.0071971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936536	Green Submitted, gold, Green Published			2022-12-27	WOS:000324401500086
J	Lecointre, G; Ameziane, N; Boisselier, MC; Bonillo, C; Busson, F; Causse, R; Chenuil, A; Couloux, A; Coutanceau, JP; Cruaud, C; d'Acoz, CD; De Ridder, C; Denys, G; Dettai, A; Duhamel, G; Eleaume, M; Feral, JP; Gallut, C; Havermans, C; Held, C; Hemery, L; Lautredou, AC; Martin, P; Ozouf-Costaz, C; Pierrat, B; Pruvost, P; Puillandre, N; Samadi, S; Saucede, T; Schubart, C; David, B				Lecointre, Guillaume; Ameziane, Nadia; Boisselier, Marie-Catherine; Bonillo, Celine; Busson, Frederic; Causse, Romain; Chenuil, Anne; Couloux, Arnaud; Coutanceau, Jean-Pierre; Cruaud, Corinne; d'Acoz, Cedric d'Udekem; De Ridder, Chantal; Denys, Gael; Dettai, Agnes; Duhamel, Guy; Eleaume, Marc; Feral, Jean-Pierre; Gallut, Cyril; Havermans, Charlotte; Held, Christoph; Hemery, Lenaig; Lautredou, Anne-Claire; Martin, Patrick; Ozouf-Costaz, Catherine; Pierrat, Benjamin; Pruvost, Patrice; Puillandre, Nicolas; Samadi, Sarah; Saucede, Thomas; Schubart, Christoph; David, Bruno			Is the Species Flock Concept Operational? The Antarctic Shelf Case	PLOS ONE			English	Article							SOUTHERN-OCEAN; MITOCHONDRIAL LINEAGES; PROMACHOCRINUS-KERGUELENSIS; FISHES PERCIFORMES; CLIMATE-CHANGE; NOTOTHENIOIDEI; DIVERSITY; TELEOSTEI; CRUSTACEA; AMPHIPODA	There has been a significant body of literature on species flock definition but not so much about practical means to appraise them. We here apply the five criteria of Eastman and McCune for detecting species flocks in four taxonomic components of the benthic fauna of the Antarctic shelf: teleost fishes, crinoids (feather stars), echinoids (sea urchins) and crustacean arthropods. Practical limitations led us to prioritize the three historical criteria (endemicity, monophyly, species richness) over the two ecological ones (ecological diversity and habitat dominance). We propose a new protocol which includes an iterative fine-tuning of the monophyly and endemicity criteria in order to discover unsuspected flocks. As a result nine "full" species flocks (fulfilling the five criteria) are briefly described. Eight other flocks fit the three historical criteria but need to be further investigated from the ecological point of view (here called "core flocks"). The approach also shows that some candidate taxonomic components are no species flocks at all. The present study contradicts the paradigm that marine species flocks are rare. The hypothesis according to which the Antarctic shelf acts as a species flocks generator is supported, and the approach indicates paths for further ecological studies and may serve as a starting point to investigate the processes leading to flock-like patterning of biodiversity.	[Lecointre, Guillaume; Boisselier, Marie-Catherine; Coutanceau, Jean-Pierre; Dettai, Agnes; Gallut, Cyril; Lautredou, Anne-Claire; Ozouf-Costaz, Catherine; Puillandre, Nicolas; Samadi, Sarah] Museum Natl Hist Nat, UMR UPMC MNHN CNRS IRD Systemat Adaptat Evolut 71, Dept Systemat & Evolut, F-75231 Paris, France; [Ameziane, Nadia; Busson, Frederic; Causse, Romain; Denys, Gael; Duhamel, Guy; Eleaume, Marc; Hemery, Lenaig; Pruvost, Patrice] Museum Natl Hist Nat, UMR UPMC MNHN CNRS IRD BOREA 7208, Dept Milieux & Peuplements Aquat, F-75231 Paris, France; [Bonillo, Celine] Museum Natl Hist Nat, UMS MNHN CNRS Outils & Methodes Systemat Integrat, F-75231 Paris, France; [Chenuil, Anne; Feral, Jean-Pierre] Univ Aix Marseille 2, UMR CNRS DIMAR Diversite Evolut & Ecol Fonct Mari, F-13284 Marseille 07, France; [Couloux, Arnaud; Cruaud, Corinne] Genoscope, Ctr Natl Sequencage, Evry, France; [d'Acoz, Cedric d'Udekem; Havermans, Charlotte; Martin, Patrick] Royal Belgian Inst Nat Sci, Brussels, Belgium; [De Ridder, Chantal] Univ Libre Bruxelles, Biol Marine Lab, Brussels, Belgium; [Held, Christoph] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Pierrat, Benjamin; Saucede, Thomas; David, Bruno] Univ Bourgogne, UMR BIOGEOSCI 6282, CNRS, Dijon, France; [Schubart, Christoph] Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Royal Belgian Institute of Natural Sciences; Universite Libre de Bruxelles; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; University of Regensburg	Lecointre, G (corresponding author), Museum Natl Hist Nat, UMR UPMC MNHN CNRS IRD Systemat Adaptat Evolut 71, Dept Systemat & Evolut, CP 39, F-75231 Paris, France.	lecointr@mnhn.fr	Hemery, Lenaïg/AAA-5799-2021; DAVID, Bruno/N-8798-2013; FERAL, Jean-Pierre/A-8199-2008; Dettai, Agnes/Q-6743-2019; Pruvost, Patrice/E-5690-2011; samadi, sarah/G-5011-2010; Villsen, Kurt/C-7965-2015; FERAL, Jean-Pierre/M-9608-2019; FERAL, Jean-Pierre/N-1895-2018; CHENUIL, Anne/E-3902-2012; Martin, Patrick/V-9708-2019	Hemery, Lenaïg/0000-0001-5337-4514; FERAL, Jean-Pierre/0000-0001-7627-0160; samadi, sarah/0000-0003-0725-9368; FERAL, Jean-Pierre/0000-0001-7627-0160; FERAL, Jean-Pierre/0000-0001-7627-0160; CHENUIL, Anne/0000-0001-8141-7147; Martin, Patrick/0000-0002-6033-8412; Havermans, Charlotte/0000-0002-1126-4074; Gallut, Cyril/0000-0002-6486-0179; Couloux, Arnaud/0000-0003-2356-0062; Cruaud, Corinne/0000-0002-4752-7278; Ameziane, Nadia/0000-0002-8546-9961	Centre national pour la Recherche scientifique (CNRS); Museum national d'Histoire naturelle (MNHN); Agence nationale pour la Recherche (ANR) [USAR 07-BLAN-0213-01]; "Service de Systematique Moleculaire'' of the Museum national d'Histoire naturelle [UMS 2700 CNRS]; Genoscope [2005/67]; Museum national d'Histoire naturelle [2005/67]; DFG [SCHU-1460-8]; Belgian Science Policy [MO/36/022, WI/36/H04, SD/BA/02B]	Centre national pour la Recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Museum national d'Histoire naturelle (MNHN); Agence nationale pour la Recherche (ANR)(French National Research Agency (ANR)); "Service de Systematique Moleculaire'' of the Museum national d'Histoire naturelle(Centre National de la Recherche Scientifique (CNRS)); Genoscope; Museum national d'Histoire naturelle; DFG(German Research Foundation (DFG)); Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Centre national pour la Recherche scientifique (CNRS), the Museum national d'Histoire naturelle (MNHN) and the Agence nationale pour la Recherche (ANR, grant number "ANTFLOCKS'', USAR 07-BLAN-0213-01 to G. L.), the "Service de Systematique Moleculaire'' of the Museum national d'Histoire naturelle (UMS 2700 CNRS), the "Consortium national de Recherche en Genomique'': it is part of the agreement number 2005/67 between the Genoscope and the Museum national d'Histoire naturelle on the project 'Macrophylogeny of life' directed by G. L. This work was further supported by DFG project SCHU-1460-8 to C. S. and C. He., the Belgian Science Policy ("Action I'' grant number MO/36/022 to C. U. A., "Action II'' grant number WI/36/H04 to C. Ha., "PADDII'' grant number SD/BA/02B to C. D. R.). This project is a contribution to the EBA-SCAR program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.B., 1999, ANTARCTIC MARINE GEO; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Bargelloni L, 2000, SYST BIOL, V49, P114, DOI 10.1080/10635150050207429; Barnard JL, 1991, RECORDS AUSTR MUSE 1, P41; Brandt A, 2012, SO OCEAN DEEP BENTHI, P291; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Castelin M, 2011, DEEP-SEA RES PT I, V58, P637, DOI 10.1016/j.dsr.2011.03.008; Causse R, 2011, POLAR SCI, V5, P272, DOI 10.1016/j.polar.2011.03.004; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chen Wei-Jen, 1998, P287; CLARK AH, 1967, B US NATL MUSEUM, V82, P1, DOI DOI 10.5479/SI.03629236.82.3; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; Clarke A, 1997, MARINE BIODIVERSITY-BOOK, P122, DOI 10.1017/CBO9780511752360.007; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; CLARKE A, 1989, GEOLOGICAL SOC SPECI, V47, P253; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; D'Acoz CD, 2012, ZOOTAXA, P1; d'Acoz Cedric d'Udekem, 2010, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V80, P127; d'Acoz Cedric d'Udekem, 2009, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V79, P243; d'Acoz CD, 2009, J NAT HIST, V43, P2087, DOI 10.1080/00222930903094647; d'Acoz Cedric d'Udekem, 2008, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V78, P45; Dauby P, 2001, POLAR BIOL, V24, P657; Dauby P, 2001, HYDROBIOLOGIA, V443, P69, DOI 10.1023/A:1017596120422; David B, 2005, SCI MAR, V69, P201, DOI 10.3989/scimar.2005.69s2201; David B., 2005, ANTARCTIC ECHINOIDEA, V10; De Broyer C, 2001, POLAR BIOL, V24, P744, DOI 10.1007/s003000100276; De Broyer Claude, 2007, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V77, P1; De Broyer Claude, 2004, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V74, P61; De Broyer C, 2011, DEEP-SEA RES PT II, V58, P5, DOI 10.1016/j.dsr2.2010.10.007; Derome N, 2002, MOL PHYLOGENET EVOL, V24, P139, DOI 10.1016/S1055-7903(02)00223-3; Dettai A, 2012, MAR GENOM, V8, P49, DOI 10.1016/j.margen.2012.02.003; Diaz A, 2011, DEEP-SEA RES PT II, V58, P205, DOI 10.1016/j.dsr2.2010.10.012; Duhamel G, 2010, CYBIUM, V34, P319; Eastman J. T, 1993, ANTARCTIC FISH BIOL; Eastman JT, 2005, POLAR BIOL, V28, P93, DOI 10.1007/s00300-004-0667-4; Eastman JT, 2000, J FISH BIOL, V57, P84, DOI 10.1111/j.1095-8649.2000.tb02246.x; Ekau W., 1991, P NIPR S POLAR BIOL, V4, P36; Eleaume M, 2006, THESIS MUSEUM NATL H; Froese R., 2012, FISHBASE; Ghigliotti L, 2010, ANTARCT SCI, V22, P805, DOI 10.1017/S0954102010000660; Grant RA, 2011, POLAR BIOL, V34, P775, DOI 10.1007/s00300-010-0932-7; Greenwood PH, 1984, WHAT IS SPECIES FLOC, P13; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Hardy C, 2011, DEEP-SEA RES PT II, V58, P84, DOI 10.1016/j.dsr2.2010.05.025; Havermans C, 2011, DEEP-SEA RES PT II, V58, P230, DOI 10.1016/j.dsr2.2010.09.028; Havermans C, 2010, MOL PHYLOGENET EVOL, V55, P202, DOI 10.1016/j.ympev.2009.10.025; Held C, 2000, MOL PHYLOGENET EVOL, V15, P165, DOI 10.1006/mpev.1999.0739; Hemery LG, 2012, MOL ECOL, V21, P2502, DOI 10.1111/j.1365-294X.2012.05512.x; Hemery L.G., 2011, THESIS MUSEUM NATL H; Heterier V, 2008, MAR ECOL PROG SER, V364, P67, DOI 10.3354/meps07487; Janko K, 2011, MOL PHYLOGENET EVOL, V60, P305, DOI 10.1016/j.ympev.2011.03.008; Jones CD, 2008, POLAR BIOL, V31, P1481, DOI 10.1007/s00300-008-0489-x; Kennett J., 1982, MARINE GEOLOGY; KLAGES M, 1990, POLAR BIOL, V10, P359; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Krabbe K, 2010, POLAR BIOL, V33, P281, DOI 10.1007/s00300-009-0703-5; Krapp RH, 2008, DEEP-SEA RES PT II, V55, P1015, DOI 10.1016/j.dsr2.2007.12.018; Krug AZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015362; La Mesa M, 2004, POLAR BIOL, V27, P321, DOI 10.1007/s00300-004-0599-z; Lautredou AC, 2010, POLAR SCI, V4, P333, DOI 10.1016/j.polar.2010.04.006; Lautredou AC, 2012, MOL PHYLOGENET EVOL, V65, P87, DOI 10.1016/j.ympev.2012.05.032; Lautredou AC, 2009, THESIS MUSEUM NATL H; Lecointre G, 2012, PHYLOGENY SYSTEMATIC, P97; Lecointre G, 2011, POLAR BIOL, V34, P1135, DOI 10.1007/s00300-011-0974-5; Ledoux JB, 2012, POLAR BIOL, V35, P611, DOI 10.1007/s00300-011-1106-y; Leese F, 2008, CONSERV GENET, V9, P1369, DOI 10.1007/s10592-007-9491-z; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Lockhart SJ, 2006, THESIS U SANTA CRUZ; Lorz AN, 2009, ZOOKEYS, P91, DOI 10.3897/zookeys.18.103; Logsdon JM, 1997, P NATL ACAD SCI USA, V94, P3485, DOI 10.1073/pnas.94.8.3485; Lombarte A, 2003, ANTARCT SCI, V15, P211, DOI 10.1017/S0954102003001196; Macnaughton MO, 2007, POLAR BIOL, V30, P1013, DOI 10.1007/s00300-007-0260-8; MADDISON W, 1989, CLADISTICS, V5, P365, DOI 10.1111/j.1096-0031.1989.tb00569.x; Matschiner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018911; Morescalchi A, 1996, POLAR BIOL, V16, P559; Near TJ, 2008, MOL PHYLOGENET EVOL, V47, P832, DOI 10.1016/j.ympev.2007.11.027; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Near TJ, 2003, MOL PHYLOGENET EVOL, V28, P87, DOI 10.1016/S1055-7903(03)00029-0; Near TJ, 2004, MOL PHYLOGENET EVOL, V32, P881, DOI 10.1016/j.ympev.2004.01.002; Ozouf-Costaz C, 1999, PROCEEDINGS OF THE 5TH INDO-PACIFIC FISH CONFERENCE, P427; Ozouf-Costaz C, 1991, CYBIUM, V15, P275; Patarnello T, 2011, BIOESSAYS, V33, P260, DOI 10.1002/bies.201000124; Pierrat B, 2012, MAR ECOL PROG SER, V463, P215, DOI 10.3354/meps09842; Pisano E., 2002, FISH ADAPTATION, P311; POULIN E, 1995, MAR ECOL PROG SER, V118, P179, DOI 10.3354/meps118179; Poulin E, 1996, EVOLUTION, V50, P820, DOI 10.1111/j.1558-5646.1996.tb03891.x; Ragua-Gil JM, 2004, MAR BIOL, V144, P829, DOI 10.1007/s00227-003-1269-3; Raupach MJ, 2010, MAR BIOL, V157, P1783, DOI 10.1007/s00227-010-1451-3; Ribbink AJ, 1984, IS SPECIES FLOCK CON, P21; Sanchez S, 2007, POLAR BIOL, V30, P155, DOI 10.1007/s00300-006-0170-1; Speel J.A., 1983, Antarctic Research Series, V38, P1; Starmans A, 2002, MAR ECOL PROG SER, V225, P45, DOI 10.3354/meps225045; Stein David L., 2012, Zootaxa, V3285, P1; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Verheye M, 2011, MEMOIRE U CATHOLIQUE, P127; Wilson NG, 2007, MAR BIOL, V152, P895, DOI 10.1007/s00227-007-0742-9; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Zeidler Wolfgang, 2009, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V79, P1	99	44	44	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e68787	10.1371/journal.pone.0068787	http://dx.doi.org/10.1371/journal.pone.0068787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936311	Green Published, gold			2022-12-27	WOS:000324545800006
J	Liu, WM; Huang, P; Kar, N; Burgett, M; Muller-Greven, G; Nowacki, AS; Distelhorst, CW; Lathia, JD; Rich, JN; Kappes, JC; Gladson, CL				Liu, Wei Michael; Huang, Ping; Kar, Niladri; Burgett, Monica; Muller-Greven, Gaelle; Nowacki, Amy S.; Distelhorst, Clark W.; Lathia, Justin D.; Rich, Jeremy N.; Kappes, John C.; Gladson, Candece L.			Lyn Facilitates Glioblastoma Cell Survival under Conditions of Nutrient Deprivation by Promoting Autophagy	PLOS ONE			English	Article							SRC FAMILY KINASES; CHRONIC LYMPHOCYTIC-LEUKEMIA; COLON-CARCINOMA CELLS; MYELOGENOUS LEUKEMIA; TYROSINE KINASE; MONITORING AUTOPHAGY; PROSTATE-CANCER; RESISTANT CELLS; TUMOR-GROWTH; DNA-DAMAGE	Members of the Src family kinases (SFK) can modulate diverse cellular processes, including division, death and survival, but their role in autophagy has been minimally explored. Here, we investigated the roles of Lyn, a SFK, in promoting the survival of human glioblastoma tumor (GBM) cells in vitro and in vivo using lentiviral vector-mediated expression of constitutively-active Lyn (CA-Lyn) or dominant-negative Lyn (DN-Lyn). Expression of either CA-Lyn or DN-Lyn had no effect on the survival of U87 GBM cells grown under nutrient-rich conditions. In contrast, under nutrient-deprived conditions (absence of supplementation with L-glutamine, which is essential for growth of GBM cells, and FBS) CA-Lyn expression enhanced survival and promoted autophagy as well as inhibiting cell death and promoting proliferation. Expression of DN-Lyn promoted cell death. In the nutrient-deprived GBM cells, CA-Lyn expression enhanced AMPK activity and reduced the levels of pS6 kinase whereas DN-Lyn enhanced the levels of pS6 kinase. Similar results were obtained in vitro using another cultured GBM cell line and primary glioma stem cells. On propagation of the transduced GBM cells in the brains of nude mice, the CA-Lyn xenografts formed larger tumors than control cells and autophagosomes were detectable in the tumor cells. The DN-Lyn xenografts formed smaller tumors and contained more apoptotic cells. Our findings suggest that on nutrient deprivation in vitro Lyn acts to enhance the survival of GBM cells by promoting autophagy and proliferation as well as inhibiting cell death, and Lyn promotes the same effects in vivo in xenograft tumors. As the levels of Lyn protein or its activity are elevated in several cancers these findings may be of broad relevance to cancer biology.	[Liu, Wei Michael; Huang, Ping; Kar, Niladri; Burgett, Monica; Muller-Greven, Gaelle; Gladson, Candece L.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Nowacki, Amy S.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Lathia, Justin D.; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Burgett, Monica; Muller-Greven, Gaelle] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Distelhorst, Clark W.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; University of Alabama System; University of Alabama Birmingham	Gladson, CL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA.	gladsoc@ccf.org	Lathia, Justin/AHB-8296-2022; Rich, Jeremy/AAM-1445-2021	Nowacki, Amy/0000-0002-1216-1448	NIH NCI [CA043703, CA109748, CA127620, CA152883]; University of Alabama at Birmingham (UAB) Center for AIDS Research Virology and Sequencing Cores [P30-AI-27767]; Genetically Defined Microbe and Expression Core of the UAB Mucosal HIV and Immunobiology Center [R24 DK-64400]; NATIONAL CANCER INSTITUTE [R01CA175120, P30CA043703, R01CA109748, R01CA085804, R01CA127620, R01CA152883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Alabama at Birmingham (UAB) Center for AIDS Research Virology and Sequencing Cores; Genetically Defined Microbe and Expression Core of the UAB Mucosal HIV and Immunobiology Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH NCI grants CA043703 (CWD), CA109748, CA127620 and CA152883(CLG), the University of Alabama at Birmingham (UAB) Center for AIDS Research Virology and Sequencing Cores (P30-AI-27767) and the Genetically Defined Microbe and Expression Core of the UAB Mucosal HIV and Immunobiology Center (R24 DK-64400) (JCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia MS, 2010, CANCER LETT, V298, P139, DOI 10.1016/j.canlet.2010.08.014; Ahn JH, 2011, CANCER LETT, V310, P188, DOI 10.1016/j.canlet.2011.06.034; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Anastasiou D, 2012, CELL RES, V22, P443, DOI 10.1038/cr.2012.5; Bates RC, 2001, CANCER RES, V61, P5275; Cai HJ, 2011, P NATL ACAD SCI USA, V108, P6579, DOI 10.1073/pnas.1103904108; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Goldenberg-Furmanov M, 2004, CANCER RES, V64, P1058, DOI 10.1158/0008-5472.CAN-03-2420; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Guan H, 2008, MOL CANCER THER, V7, P1807, DOI 10.1158/1535-7163.MCT-08-0058; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Iida M, 2013, ONCOGENE, V32, P759, DOI 10.1038/onc.2012.90; Kharas Michael G, 2010, Genes Cancer, V1, P1164, DOI 10.1177/1947601911407327; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Lathia JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024807; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Lu-Emerson C, 2011, J NEURO-ONCOL, V104, P287, DOI 10.1007/s11060-010-0489-x; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Marquez RT, 2012, AM J CANCER RES, V2, P214; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; Milano V, 2009, MOL CANCER THER, V8, P394, DOI 10.1158/1535-7163.MCT-08-0669; Mulky A, 2005, J MOL BIOL, V349, P673, DOI 10.1016/j.jmb.2005.03.057; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Sandilands E, 2012, NAT CELL BIOL, V14, P51, DOI 10.1038/ncb2386; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Stettner AR, 2005, CANCER RES, V65, P5535, DOI 10.1158/0008-5472.CAN-04-3688; Summy JM, 2003, J CELL SCI, V116, P2585, DOI 10.1242/jcs.00466; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tibaldi E, 2011, LEUKEMIA, V25, P1768, DOI 10.1038/leu.2011.152; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; Trentin L, 2008, BLOOD, V112, P4665, DOI 10.1182/blood-2008-02-139139; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang DY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019629, 10.1371/journal.pone.0019835]; Weissenberger J, 1997, ONCOGENE, V14, P2005, DOI 10.1038/sj.onc.1201168; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Xu JY, 2010, BLOOD, V115, P2709, DOI 10.1182/blood-2009-05-223776; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Zimmerman EI, 2010, MOL PHARMACOL, V78, P811, DOI 10.1124/mol.110.066258	53	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70804	10.1371/journal.pone.0070804	http://dx.doi.org/10.1371/journal.pone.0070804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936469	Green Submitted, gold, Green Published			2022-12-27	WOS:000324545800050
J	Chamberlain, CS; Leiferman, EM; Frisch, KE; Brickson, SL; Murphy, WL; Baer, GS; Vanderby, R				Chamberlain, Connie S.; Leiferman, Ellen M.; Frisch, Kayt E.; Brickson, Stacey L.; Murphy, William L.; Baer, Geoffrey S.; Vanderby, Ray			Interleukin Expression after Injury and the Effects of Interleukin-1 Receptor Antagonist	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; INFLAMMATION; JOINT; LIGAMENT; MICE; CYTOKINES; PARADIGM; FIBROSIS; DISEASE; REPAIR	Ligament healing follows a series of complex coordinated events involving various cell types, cytokines, as well as other factors, producing a mechanically inferior tissue more scar-like than native tissue. Macrophages provide an ongoing source of cytokines to modulate inflammatory cell adhesion and migration as well as fibroblast proliferation. Studying interleukins inherent to ligament healing during peak macrophage activation and angiogenesis may elucidate inflammatory mediators involved in subsequent scar formation. Herein, we used a rat healing model assayed after surgical transection of their medial collateral ligaments (MCLs). On days 3 and 7 post-injury, ligaments were collected and used for microarray analysis. Of the 12 significantly modified interleukins, components of the interleukin-1 family were significantly up-regulated. We therefore examined the influence of interleukin-1 receptor antagonist (IL-1Ra) on MCL healing. Transected rat MCLs received PBS or IL-1Ra at the time of surgery. Inhibition of IL-1 activation decreased pro-inflammatory cytokines (IL-1 alpha, IL-1 beta, IL-12, IL-2, and IFN-gamma), myofibroblasts, and proliferating cells, as well as increased anti-inflammatory cytokines (IL-10), endothelial cells/blood vessel lumen, M2 macrophages, and granulation tissue size without compromising the mechanical properties. These results support the concept that IL-1Ra modulates MCL-localized granulation tissue components and cytokine production to create a transient environment that is less inflammatory. Overall, IL-1Ra may have therapeutic potential early in the healing cascade by stimulating the M2 macrophages and altering the granulation tissue components. However, the single dose of IL-1Ra used in this study was insufficient to maintain the more regenerative early response. Due to the transient influence on most of the healing components tested, IL-1Ra may have greater therapeutic potential with sustained delivery.	[Chamberlain, Connie S.; Leiferman, Ellen M.; Brickson, Stacey L.; Murphy, William L.; Baer, Geoffrey S.; Vanderby, Ray] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA; [Frisch, Kayt E.; Murphy, William L.; Vanderby, Ray] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vanderby, R (corresponding author), Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA.	vanderby@ortho.wisc.edu			National Institutes of Health (NIH) [AR049266, AR059916]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049266, R01AR059916] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Financial support was provided by the National Institutes of Health (NIH), Grant Nos. AR049266 and AR059916. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREND W P, 1990, Progress in Growth Factor Research, V2, P193, DOI 10.1016/0955-2235(90)90018-F; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bosschaerts T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001045; Chamberlain CS, 2011, MICROSC MICROANAL, V17, P779, DOI 10.1017/S1431927611011925; Chamberlain CS, 2011, J APPL PHYSIOL, V111, P552, DOI 10.1152/japplphysiol.00073.2011; Chamberlain CS, 2011, CONNECT TISSUE RES, V52, P203, DOI 10.3109/03008207.2010.511355; Chamberlain CS, 2009, WOUND REPAIR REGEN, V17, P206, DOI 10.1111/j.1524-475X.2009.00465.x; Chaudhuri V, 2007, J CUTAN PATHOL, V34, P146, DOI 10.1111/j.1600-0560.2006.00584.x; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; FONTANA A, 1982, RHEUMATOL INT, V2, P49, DOI 10.1007/BF00541245; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Hanke ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042476; Ikonomidis I, 2008, CIRCULATION, V117, P2662, DOI 10.1161/CIRCULATIONAHA.107.731877; Kim DH, 2010, SPINE, V35, P1527, DOI 10.1097/BRS.0b013e3181e4efb6; Ko JY, 2008, J ORTHOP RES, V26, P1090, DOI 10.1002/jor.20631; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kuek A, 2007, POSTGRAD MED J, V83, P251, DOI 10.1136/pgmj.2006.052688; Liss C, 2001, INT J CANCER, V93, P781, DOI 10.1002/ijc.1407; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Naldini Antonella, 2005, Current Drug Targets - Inflammation and Allergy, V4, P3, DOI 10.2174/1568010053622830; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nigrovic PA, 2011, ARTHRITIS RHEUM-US, V63, P545, DOI 10.1002/art.30128; Nixon R, 2007, RHEUMATOLOGY, V46, P1140, DOI 10.1093/rheumatology/kem072; PETTIPHER ER, 1986, P NATL ACAD SCI USA, V83, P8749, DOI 10.1073/pnas.83.22.8749; Puehler W, 2006, NEUROSCIENCE, V141, P989, DOI 10.1016/j.neuroscience.2006.03.078; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; VANDELOO AAJ, 1990, ANN RHEUM DIS, V49, P238, DOI 10.1136/ard.49.4.238; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WOOD DD, 1983, ARTHRITIS RHEUM, V26, P975, DOI 10.1002/art.1780260806; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Xiao WB, 2008, J CLIN INVEST, V118, P924, DOI 10.1172/JCI34013; Zhang B, 2011, J CRANIOFAC SURG, V22, P711, DOI 10.1097/SCS.0b013e31820873c6	34	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71631	10.1371/journal.pone.0071631	http://dx.doi.org/10.1371/journal.pone.0071631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936523	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400115
J	Das, SK; Chisti, MJ; Huq, S; Malek, MA; Vanderlee, L; Kaur, G; Salam, MA; Ahmed, T; Faruque, ASG; Al Mamun, A				Das, Sumon Kumar; Chisti, Mohammod Jobayer; Huq, Sayeeda; Malek, Mohammad Abdul; Vanderlee, Lana; Kaur, Guddu; Salam, Mohammed Abdus; Ahmed, Tahmeed; Faruque, Abu Syed Golam; Al Mamun, Abdullah			Clinical Characteristics, Etiology and Antimicrobial Susceptibility among Overweight and Obese Individuals with Diarrhea: Observed at a Large Diarrheal Disease Hospital, Bangladesh	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SYSTEMATIC ANALYSIS; CHILD-MORTALITY; NATIONAL CAUSES; WEIGHT; HEALTH; MALNUTRITION; ASSOCIATION; PREVALENCE; ROTAVIRUS	Background: The present study aimed to determine the clinical characteristics and etiology of overweight and obese (OO) individuals with diarrhea attending an urban Dhaka Hospital, International Centre for Diarrheal Disease Research (icddr, b), Bangladesh. Methods: Total of 508 under-5 children, 96 individuals of 5-19 years and 1331 of > 19 years were identified as OO from the Diarrheal Disease Surveillance System (DDSS) between 1993-2011. Two comparison groups such as well-nourished and malnourished individuals from respective age stratums were selected. Results: Isolation rate of rotavirus was higher among OO under-5 children compared to malnourished group (46% vs. 28%). Rotavirus infection among OO individuals aged 5-19 years (9% vs. 3%) (9% vs. 3%) and.19 years (6% vs. 4%) (6% vs. 3%) was higher compared to well-nourished and malnourished children. Conversely, Vibrio cholerae was lower among all OO age groups compared to well-nourished and malnourished ones. Shigella (4% vs. 6%) (4% vs. 8%), and Campylobacter (3% vs. 5%) (3% vs. 5%) were lower only among OO in > 19 years individuals compared to their counterparts of the same age stratum. Salmonella was similarly isolated in all age strata and nutritional groups. In multinomial logistic regression among under-5 children, significant association was observed only with use of antimicrobials at home [OR-1.97] and duration of hospital stay [OR-0.68]. For individuals aged 5-19 years, use of antimicrobials at home (OR-1.83), some or severe dehydration (OR-3.12), having received intravenous saline (OR-0.46) and rotavirus diarrhea (OR-2.96) were found to be associated with OO respectively. Moreover, significant associations were also found for duration of diarrhea before coming to hospital (> 24 hours) (OR-1.24), Shigella (OR-0.46), and Campylobacter (OR-0.58) among.19 years OO individuals along with other associated co-variates in 5-19 years group (all p < 0.05). Conclusion and significance: Higher proportion of OO were infected with rotavirus and a greater proportion of them used antimicrobials before coming to the hospital.	[Das, Sumon Kumar; Chisti, Mohammod Jobayer; Huq, Sayeeda; Malek, Mohammad Abdul; Salam, Mohammed Abdus; Ahmed, Tahmeed; Faruque, Abu Syed Golam] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Vanderlee, Lana] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Kaur, Guddu] Univ Sydney, Sydney, NSW 2006, Australia; [Al Mamun, Abdullah] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of Waterloo; University of Sydney; University of Queensland	Faruque, ASG (corresponding author), Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh.	gfaruque@icddrb.org	Chisti, Mohammod J/A-7216-2018; Das, Sumon Kumar/AAD-1551-2019; Das, Sumon Kumar/T-6384-2019; Mamun, Abdullah A/A-4673-2011; Mamun, Abdullah/HHM-9898-2022	Mamun, Abdullah A/0000-0002-1535-8086; Vanderlee, Lana/0000-0001-5384-1821	International Centre for Diarrheal Disease Research (icddr,b); Government of the People's Republic of Bangladesh through IHP-HNPRP	International Centre for Diarrheal Disease Research (icddr,b); Government of the People's Republic of Bangladesh through IHP-HNPRP	Hospital surveillance was funded by the International Centre for Diarrheal Disease Research (icddr,b) and the Government of the People's Republic of Bangladesh through IHP-HNPRP. icddr,b acknowledges with gratitude the commitment of the Government of the People's Republic of Bangladesh to the icddr,b's research efforts. icddr, b also gratefully acknowledges the following donors who provide unrestricted support to the Centre's research efforts: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Embassy of the Kingdom of the Netherlands, Swedish International Development Cooperation Agency, Swiss Agency for Development and Cooperation, and Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, M100S20 CLIN LAB STA; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chisti MJ, 2007, ACTA PAEDIATR, V96, P693, DOI 10.1111/j.1651-2227.2007.00192.x; Das SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062029; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; Denno DM, 2012, CLIN INFECT DIS; Dewan N, 1998, ACTA PAEDIATR, V87, P627, DOI 10.1080/080352598750014012; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Harris AM, 2008, AM J TROP MED HYG, V79, P708, DOI 10.4269/ajtmh.2008.79.708; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Koneman E. W., 1997, COLOUR ATLAS TXB DIA, P785; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lean MEJ, 1999, ARCH INTERN MED, V159, P837, DOI 10.1001/archinte.159.8.837; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; National Obesity Observatory (Public Health England), 2011, SIMPL GUID CLASS BOD; Opintan JA, 2010, AM J TROP MED HYG, V83, P936, DOI 10.4269/ajtmh.2010.09-0792; Pol M, 2007, J DAIRY SCI, V90, P262, DOI 10.3168/jds.S0022-0302(07)72627-9; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Qadri F, 2005, EMERG INFECT DIS, V11, P1104, DOI 10.3201/eid1107.041266; Rahman M, 2003, J CLIN MICROBIOL, V41, P2088, DOI 10.1128/JCM.41.5.2088-2095.2003; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; Sansonetti PJ, 2006, PLOS MED, V3, P1465, DOI 10.1371/journal.pmed.0030354; Schlaudecker EP, 2011, CURR OPIN INFECT DIS, V24, P496, DOI 10.1097/QCO.0b013e328349287d; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; STOLL BJ, 1982, BRIT MED J, V285, P1185, DOI 10.1136/bmj.285.6349.1185; Thapar N, 2004, LANCET, V363, P641, DOI 10.1016/S0140-6736(04)15599-2; World Health Organization, 1987, MAN LAB INV AC ENT I; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhang ZY, 2012, ACTA PHARMACOL SIN, V33, P145, DOI 10.1038/aps.2011.185	37	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70402	10.1371/journal.pone.0070402	http://dx.doi.org/10.1371/journal.pone.0070402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936424	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400064
J	Jiang, MH; Yang, SM; Yan, KK; Liu, J; Zhao, J; Fang, Y				Jiang, Minghuan; Yang, Shimin; Yan, Kangkang; Liu, Jun; Zhao, Jun; Fang, Yu			Measuring Access to Medicines: A Survey of Prices, Availability and Affordability in Shaanxi Province of China	PLOS ONE			English	Article							POLICY	Objective: To measure the prices and availability of selected medicines in Shaanxi Province after the implementation of new healthcare reform in 2009. Methods: Data on the prices and availability of 47 medicines were collected from 50 public and 36 private sector medicine outlets in six regions of Shaanxi Province, Western China using a standardized methodology developed by the World Health Organization and Health Action International from September to October 2010. Medicine prices were compared with international reference prices to obtain a median price ratio. Affordability was measured as the number of days' wages required for the lowest-paid unskilled government worker to purchase standard treatments for common conditions. Findings: The mean availabilities of originator brands and lowest-priced generics were 8.9% and 26.5% in the public sector, and 18.1% and 43.6% in the private sector, respectively. The public sector procured generics and originator brands at median price ratios of 0.75 and 8.49, respectively, while patients paid 0.97 and 10.16. Final patient prices for lowest-priced generics and originator brands in the private sector were about 1.53 and 8.36 times their international retail prices, respectively. Public sector vendors applied high markups of 30.4% to generics, and 19.6% to originator brands. In the private sector, originator brands cost 390.7% more, on average, than their generic equivalents. Generic medicines were priced 17.3% higher in the private sector than the public sector. The lowest-paid government worker would need 0.1 day's wages to purchase captopril for lowest-priced generics from private sector, while 6.6 days' wages for losartan. For originator brands, the costs rise to 1.2 days' wages for salbutamol inhaler and 15.6 days' wages for omeprazole. Conclusions: The prices, availability and affordability of medicines in China should be improved to ensure equitable access to basic medical treatments, especially for the poor. This requires multi-faceted interventions, as well as the review and refocusing of policies, regulations and educational interventions.	[Jiang, Minghuan; Yang, Shimin; Yan, Kangkang; Liu, Jun; Zhao, Jun; Fang, Yu] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian 710049, Peoples R China; [Fang, Yu] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Fang, Yu] Harvard Univ, Pilgrim Hlth Care Inst, Boston, MA 02115 USA	Xi'an Jiaotong University; Harvard University; Harvard Medical School; Harvard University	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian 710049, Peoples R China.	yufang@mail.xjtu.edu.cn			National Natural Science Fund [71103141/G0308]; Fundamental Research Funds for the Central Universities [2011jdhz62]; Shaanxi Provincial Social Science Fund [10E066]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shaanxi Provincial Social Science Fund	This medicine price survey was conducted with financial support from the National Natural Science Fund (No: 71103141/G0308), the Fundamental Research Funds for the Central Universities (No: 2011jdhz62) and the Shaanxi Provincial Social Science Fund (No: 10E066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn T, 2011, LANCET, V377, P1557, DOI 10.1016/S0140-6736(11)60625-9; Archana P, 2005, MED PRICING AVAILABI; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Department of Human Resources and Social Security of Shaanxi Province, 2010, LOW WAG STAND SHAANX; Gelders S., 2006, PRICE AVAILABILITY A; Guan XD, 2011, J PUBLIC HEALTH POL, V32, P305, DOI 10.1057/jphp.2011.34; Guo Y, 2010, LANCET, V375, P1056, DOI 10.1016/S0140-6736(10)60397-2; Kotwani A, 2011, MED PRICES AVAILABIL; Kotwani A, 2003, MED PRICES STATE RAJ; Lakshmi Suresh PK, 2004, MED PRICES AVAILABIL; Ministry of Health, 2011, CHIN HLTH STAT DIG 2; MSH, 2009, INT DRUG PRIC IND GU; OECD Library, 2010, HLTH GLANC EUR 2010; Shoba I, 2004, MED PRICES AVAILABIL; Singal GL, 2004, MED PRICES AVAILABIL; Sun Q., 2004, SURVEY MED PRICES AV; Sun Q, 2008, HEALTH AFFAIR, V27, P1042, DOI 10.1377/hlthaff.27.4.1042; The Ministry of Health, 2009, CHIN NAT EML; The State Council, 2009, CHIN COMM PART CENTR; Tian X, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-401; Tripathi SK, 2005, MED PRICES AVAILABIL; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; World Health Organization, 2011, WORLD MED SIT 2011 A; World Health Organization Health Action International, 2003, MEAS MED PRIC AV AFF; Xiao Y, 2013, SOC SCI MED, V93, P220, DOI 10.1016/j.socscimed.2012.09.034; Yang H, 2010, HEALTH POLICY PLANN, V25, P219, DOI 10.1093/heapol/czp056; Yang LP, 2012, HLTH POLICY PLANNING, P1, DOI DOI 10.1093/HEAPOL/CZS116; Yang S., 2010, MED PRICES AVAILABIL; Ye L., 2006, SURVEY MED PRICES AV; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	31	30	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70836	10.1371/journal.pone.0070836	http://dx.doi.org/10.1371/journal.pone.0070836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936471	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400084
J	Scholte, FEM; Tas, A; Martina, BEE; Cordioli, P; Narayanan, K; Makino, S; Snijder, EJ; van Hemert, MJ				Scholte, Florine E. M.; Tas, Ali; Martina, Byron E. E.; Cordioli, Paolo; Narayanan, Krishna; Makino, Shinji; Snijder, Eric J.; van Hemert, Martijn J.			Characterization of Synthetic Chikungunya Viruses Based on the Consensus Sequence of Recent E1-226V Isolates	PLOS ONE			English	Article							AEDES-ALBOPICTUS; GENE-EXPRESSION; RNA; REPLICATION; INFECTION; RIBAVIRIN; CHLOROQUINE; OUTBREAK; CLONE; FITNESS	Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that re-emerged in 2004 and has caused massive outbreaks in recent years. The lack of a licensed vaccine or treatment options emphasize the need to obtain more insight into the viral life cycle and CHIKV-host interactions. Infectious cDNA clones are important tools for such studies, and for mechanism of action studies on antiviral compounds. Existing CHIKV cDNA clones are based on a single genome from an individual clinical isolate, which is expected to have evolved specific characteristics in response to the host environment, and possibly also during subsequent cell culture passaging. To obtain a virus expected to have the general characteristics of the recent E1-226V CHIKV isolates, we have constructed a new CHIKV full-length cDNA clone, CHIKV LS3, based on the consensus sequence of their aligned genomes. Here we report the characterization of this synthetic virus and a green fluorescent protein-expressing variant (CHIKV LS3-GFP). Their characteristics were compared to those of natural strain ITA07-RA1, which was isolated during the 2007 outbreak in Italy. In cell culture the synthetic viruses displayed phenotypes comparable to the natural isolate, and in a mouse model they caused lethal infections that were indistinguishable from infections with a natural strain. Compared to ITA07-RA1 and clinical isolate NL10/152, the synthetic viruses displayed similar sensitivities to several antiviral compounds. 3-deaza-adenosine was identified as a new inhibitor of CHIKV replication. Cyclosporin A had no effect on CHIKV replication, suggesting that cyclophilins - opposite to what was found for other +RNA viruses- do not play an essential role in CHIKV replication. The characterization of the consensus sequence-based synthetic viruses and their comparison to natural isolates demonstrated that CHIKV LS3 and LS3-GFP are suitable and representative tools to study CHIKV-host interactions, screen for antiviral compounds and unravel their mode of action.	[Scholte, Florine E. M.; Tas, Ali; Snijder, Eric J.; van Hemert, Martijn J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Mol Virol Lab, Leiden, Netherlands; [Martina, Byron E. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Cordioli, Paolo] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Narayanan, Krishna; Makino, Shinji] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; IZS Lombardia e Emilia; University of Texas System; University of Texas Medical Branch Galveston	van Hemert, MJ (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Mol Virol Lab, Leiden, Netherlands.	m.j.van_hemert@lumc.nl	Makino, Shinji/E-8014-2015; Snijder, Eric J./E-6073-2018; Scholte, Florine/J-5213-2019	Makino, Shinji/0000-0002-7831-1576; Snijder, Eric J./0000-0003-3297-2309; Scholte, Florine/0000-0003-2110-3087; Martina, Byron/0000-0003-4980-4619; van Hemert, Martijn/0000-0002-2617-9243	European Union [260644]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under SILVER grant agreement nr. 260644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briolant S, 2004, ANTIVIR RES, V61, P111, DOI 10.1016/j.antiviral.2003.09.005; Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; De Clercq E, 1998, NUCLEOS NUCLEOT NUCL, V17, P625, DOI 10.1080/07328319808005205; De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; de Wilde AH, 2011, J GEN VIROL, V92, P2542, DOI 10.1099/vir.0.034983-0; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; Delogu I, 2011, J MED VIROL, V83, P1058, DOI 10.1002/jmv.22019; DEVRIES AAF, 1990, NUCLEIC ACIDS RES, V18, P3241, DOI 10.1093/nar/18.11.3241; Frank C, 2011, VECTOR-BORNE ZOONOT, V11, P631, DOI 10.1089/vbz.2010.0269; Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214; Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0; Hong Zhi, 2002, Prog Drug Res, V59, P41; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009; Khan M, 2010, J MED VIROL, V82, P817, DOI 10.1002/jmv.21663; Kummerer BM, 2012, J GEN VIROL, V93, P1991, DOI 10.1099/vir.0.043752-0; Kujala P, 2001, J VIROL, V75, P3873, DOI 10.1128/JVI.75.8.3873-3884.2001; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Lelli D, 2009, CHIKUNGUNYA MONOCLON; Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2; Liu WJ, 2011, J VIROL, V85, P5674, DOI 10.1128/JVI.02622-10; MCCAMMON JR, 1979, ANTIMICROB AGENTS CH, V15, P356, DOI 10.1128/AAC.15.3.356; McTighe SP, 2012, VECTOR-BORNE ZOONOT, V12, P867, DOI 10.1089/vbz.2012.0978; Metz SW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-353; Moreno H, 2011, J VIROL, V85, P7246, DOI 10.1128/JVI.00614-11; Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151; Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Shah NR, 2010, BIOL CHEM, V5; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Vanlandingham DL, 2005, INSECT BIOCHEM MOLEC, V35, P1162, DOI 10.1016/j.ibmb.2005.05.008; VANMARLE G, 1995, J VIROL, V69, P7851, DOI 10.1128/JVI.69.12.7851-7856.1995; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Warrier R, 2008, J VIROL, V82, P4461, DOI 10.1128/JVI.01936-07; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Werneke SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002322; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	54	55	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71047	10.1371/journal.pone.0071047	http://dx.doi.org/10.1371/journal.pone.0071047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936484	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400090
J	Shin, YJ; Kim, EH; Roy, A; Kim, JH				Shin, Yong Jae; Kim, Eun Hye; Roy, Adhiraj; Kim, Jeong-Ho			Evidence for a Novel Mechanism of the PAK1 Interaction with the Rho-GTPases Cdc42 and Rac	PLOS ONE			English	Article							P21-ACTIVATED KINASE PAK1; PROTEIN-KINASE; CANCER-CELLS; ADAPTER PROTEIN; IN-VIVO; ACTIVATION; PHOSPHORYLATION; DOMAIN; SWITCH; AUTOINHIBITION	P21-activated kinase 1 (PAK1) is activated by binding to GTP-bound Rho GTPases Cdc42 and Rac via its CRIB domain. Here, we provide evidence that S79 in the CRIB domain of PAK1 is not directly involved in this binding but is crucial for PAK1 activation. S79A mutation reduces the binding affinity of PAK1 for the GTPases and inhibits autophosphorylation and kinase activity of PAK1. Thus, this mutation abrogates the ability of PAK1 to induce changes in cell morphology and motility and to promote malignant transformation of prostate epithelial cells. We also show that growth of the prostate cancer cell line PC3 is inhibited by the treatment of a PAK1-inhibiting peptide comprising 19 amino acids centered on S79, but not by the PAK1 peptide containing the S79A mutation, and that this growth inhibition is correlated with reduced autophosphorylation activity of PAK1. Together, these findings demonstrate a significant role of S79 in PAK1 activation and provide evidence for a novel mechanism of the CRIB-mediated interaction of PAK1 with Cdc42 and Rac.	[Shin, Yong Jae; Kim, Eun Hye; Roy, Adhiraj; Kim, Jeong-Ho] George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA	George Washington University	Kim, JH (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA.	jh_kim@gwu.edu	Roy, Adhiraj/AAR-7311-2021	Roy, Adhiraj/0000-0001-7584-8872	NIH from the National Institute of General Medical Science [GM087470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087470] Funding Source: NIH RePORTER	NIH from the National Institute of General Medical Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grant GM087470 (JK) from the National Institute of General Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Bellmann-Sickert K, 2010, TRENDS PHARMACOL SCI, V31, P434, DOI 10.1016/j.tips.2010.06.003; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; Chong BH, 2001, THROMB HAEMOSTASIS, V86, P1170, DOI 10.1055/s-0037-1616046; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Chongtham D S, 2001, J Postgrad Med, V47, P282; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Dadke D, 2003, CANCER RES, V63, P8837; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Deshiere A, 2012, ONCOGENE; Grannell MS, 2001, IRISH J MED SCI, V170, P244, DOI 10.1007/BF03167788; Hegde MR, 2001, INDIAN J MED RES, V114, P141; Ho A, 2001, CANCER RES, V61, P474; Hoffman GR, 2000, CELL, V102, P403, DOI 10.1016/S0092-8674(00)00045-3; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; King CC, 2000, METHOD ENZYMOL, V325, P315; Kiosses WB, 2002, CIRC RES, V90, P697, DOI 10.1161/01.RES.0000014227.76102.5D; Lee F Y, 2001, HPB (Oxford), V3, P231, DOI 10.1080/136518201753242271; Leesmidt Vinai, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P674; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lin MH, 2001, CLIN BIOCHEM, V34, P661, DOI 10.1016/S0009-9120(01)00281-8; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; SAHYOUN N, 1991, P NATL ACAD SCI USA, V88, P2643, DOI 10.1073/pnas.88.7.2643; Sanchez-Solana B, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404061; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Shin YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030393; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Thullberg M, 2007, ONCOGENE, V26, P1820, DOI 10.1038/sj.onc.1209983; Tu H, 1999, MOL CELL BIOL, V19, P602; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Yang Ming, 2005, Current Drug Targets - Infectious Disorders, V5, P433, DOI 10.2174/156800505774912901; Yeo SN, 2001, ANN ACAD MED SINGAP, V30, P632; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	43	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71495	10.1371/journal.pone.0071495	http://dx.doi.org/10.1371/journal.pone.0071495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936510	gold, Green Published			2022-12-27	WOS:000324518400109
J	Swartjes, M; Niesters, M; Heij, L; Dunne, A; Aarts, L; Hand, CC; Kim, HS; Brines, M; Cerami, A; Dahan, A				Swartjes, Maarten; Niesters, Marieke; Heij, Lara; Dunne, Ann; Aarts, Leon; Hand, Carla Cerami; Kim, Hyung-Suk; Brines, Michael; Cerami, Anthony; Dahan, Albert			Ketamine Does Not Produce Relief of Neuropathic Pain in Mice Lacking the beta-Common Receptor (CD131)	PLOS ONE			English	Article							LONG-TERM RELIEF; TERTIARY STRUCTURE; SPINAL-CORD; ERYTHROPOIETIN; ANTAGONISTS; EXPRESSION; SUBUNIT; SYSTEM; PROTECTION; ALLODYNIA	Neuropathic pain (NP) is a debilitating condition associated with traumatic, metabolic, autoimmune and neurological etiologies. Although the triggers for NP are diverse, there are common underlying pathways, including activation of immune cells in the spinal cord and up-regulation of the N-methyl-D-aspartate receptor (NMDAR). Ketamine, a well-known NDMAR antagonist, reduces neuropathic pain in a sustained manner. Recent study has shown that the novel 11-amino acid peptide erythropoietin derivative ARA290 produces a similar, long-lasting relief of NP. Here, we show that both drugs also have similar effects on the expression of mRNA of the NMDAR, as well as that of microglia, astrocytes and chemokine (C-C motif) ligand 2, all-important contributors to the development of NP. Although the effects of ketamine and ARA 290 on NP and its molecular mediators suggest a common mechanism of action, ARA 290 has no affinity for the NMDAR and acts specifically via the innate repair receptor (IRR) involved in tissue protection. We speculated therefore, that the IRR might be critically involved in the action of ketamine on neuropathic pain. To evaluate this, we studied the effects of ketamine and ARA 290 on acute pain, side effects, and allodynia following a spared nerve injury model in mice lacking the beta-common receptor (beta cR), a structural component of the IRR. Ketamine (50 mg/kg) and ARA 290 (30 mu g/kg) produced divergent effects on acute pain: ketamine produced profound antinociception accompanied with psychomotor side effects, but ARA290 did not, in both normal and knock out mice. In contrast, while both drugs were antiallodynic in WT mice, they had no effect on NP in mice lacking the beta cR. Together, these results show that an intact IRR is required for the effective treatment of NP with either ketamine or ARA 290, but is not involved in ketamine's analgesic and side effects.	[Swartjes, Maarten; Niesters, Marieke; Heij, Lara; Aarts, Leon; Cerami, Anthony; Dahan, Albert] Leiden Univ, Med Ctr, Dept Anesthesiol, Leiden, Netherlands; [Dunne, Ann; Brines, Michael; Cerami, Anthony] Araim Pharmaceut, Ossining, NY USA; [Hand, Carla Cerami; Kim, Hyung-Suk] Univ N Carolina, Chapel Hill, NC USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of North Carolina; University of North Carolina Chapel Hill	Dahan, A (corresponding author), Leiden Univ, Med Ctr, Dept Anesthesiol, Leiden, Netherlands.	a.dahan@lumc.nl	Brinesd, Michael/AAE-6072-2020; Dahan, Albert/B-8845-2008; Heij, Lara/AAU-2792-2020	Dahan, Albert/0000-0003-3161-3945; Heij, Lara/0000-0002-0602-3356; Cerami, Carla/0000-0002-7634-0955; Brines, Michael/0000-0003-4151-4449	United States Department of Defense Medical Research and Development Program, Washington, D.C. [101498960]	United States Department of Defense Medical Research and Development Program, Washington, D.C.	This work was supported by grant 101498960 from the United States Department of Defense Medical Research and Development Program, Washington, D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault A, 2009, PAIN, V146, P308, DOI 10.1016/j.pain.2009.08.003; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines M, 2012, MOL MED, V18, P486, DOI 10.2119/molmed.2011.00414; Broughton SE, 2012, IMMUNOL REV, V250, P277, DOI 10.1111/j.1600-065X.2012.01164.x; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Christoph T, 2006, NEUROPHARMACOLOGY, V51, P12, DOI 10.1016/j.neuropharm.2006.02.007; COHEN ML, 1973, ANESTHESIOLOGY, V39, P370, DOI 10.1097/00000542-197310000-00003; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dansereau MA, 2008, J NEUROCHEM, V106, P757, DOI 10.1111/j.1471-4159.2008.05429.x; Erichsen HK, 2002, PAIN, V98, P151, DOI 10.1016/S0304-3959(02)00039-8; Hayashi Y, 2011, J NEUROSCI, V31, P17370, DOI 10.1523/JNEUROSCI.4152-11.2011; Heij L, 2012, MOL MED, V18, P1430, DOI 10.2119/molmed.2012.00332; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Labombarda F, 2008, NEUROSCI LETT, V447, P115, DOI 10.1016/j.neulet.2008.09.062; Lipton SA, 2004, NEW ENGL J MED, V350, P2516, DOI 10.1056/NEJMcibr041121; Loix S, 2011, ACTA ANAESTH BELG, V62, P47; Mei XP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-6; Niesters M, 2013, EXPERT OPIN ORPHAN D, V1, P77, DOI 10.1517/21678707.2013.719289; Niesters M, 2012, EXPERT OPIN DRUG MET, V8, P1409, DOI 10.1517/17425255.2012.712686; Noppers I, 2010, EXPERT OPIN PHARMACO, V11, P2417, DOI 10.1517/14656566.2010.515978; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Sacca R, 2010, METHODS MOL BIOL, V602, P37, DOI 10.1007/978-1-60761-058-8_3; Sekiguchi Y, 2003, SPINE, V28, P2577, DOI 10.1097/01.BRS.0000096674.12519.12; Sigtermans MJ, 2009, PAIN, V145, P304, DOI 10.1016/j.pain.2009.06.023; Swartjes M, 2011, ANESTHESIOLOGY, V115, P1084, DOI 10.1097/ALN.0b013e31822fcefd; Swartjes M, 2011, ANESTHESIOLOGY, V115, P165, DOI 10.1097/ALN.0b013e31821bdb9b; Takahashi T, 2010, ANESTH ANALG, V111, P1051, DOI 10.1213/ANE.0b013e3181ed12fc; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; Wilson JA, 2005, PAIN, V117, P421, DOI 10.1016/j.pain.2005.07.005; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	35	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71326	10.1371/journal.pone.0071326	http://dx.doi.org/10.1371/journal.pone.0071326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936499	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400102
J	Takamochi, K; Takeuchi, K; Hayashi, T; Oh, S; Suzuki, K				Takamochi, Kazuya; Takeuchi, Kengo; Hayashi, Takuo; Oh, Shiaki; Suzuki, Kenji			A Rational Diagnostic Algorithm for the Identification of ALK Rearrangement in Lung Cancer: A Comprehensive Study of Surgically Treated Japanese Patients	PLOS ONE			English	Article							EML4-ALK FUSION GENE; GROWTH-FACTOR RECEPTOR; SENSITIVE DETECTION; MUTATIONS; IMMUNOHISTOCHEMISTRY; KIF5B-ALK; FEATURES; SYSTEM; EGFR; RARE	Background: EML4-ALK fusion gene is found in only a small subset (2-6%) of non-small cell lung cancer. There is an urgent need to establish a rational diagnostic algorithm to identify this rare but important fusion in lung cancer. Methods: We performed a comprehensive analysis of EGFR/KRAS mutation and ALK rearrangement in a total of 360 surgically resected lung cancers. ALK rearrangement was examined by 3 analyses: multiplex reverse transcription-PCR, fluorescent in situ hybridization (FISH), and immunohistochemistry (IHC) with the intercalated antibody-enhanced polymer method. A scoring system was used for IHC (iScore). A test set (202 patients with unselected lung cancer) was used for proposing a diagnostic algorithm. This diagnostic algorithm was validated in 158 patients with EGFR and KRAS mutation-negative adenocarcinoma. Results: ALK rearrangement was identified in 2 patients (1.0%) from the test set and both adenocarcinomas were negative for EGFR and KRAS mutations. The results of FISH and RT-PCR were completely matched. The highest iScore 3 was found only in the 2 positive cases. A diagnostic algorithm was proposed: IHC screening for ALK rearrangement followed by confirmatory FISH. In the validation set, 8 cases (5.1%) had iScore 3 and were positive for FISH, while the other cases had iScore 0 and were negative for FISH. Conclusions: Screening for ALK rearrangement by IHC followed by confirmatory FISH is a rational diagnostic algorithm. If needed, patients may be selected for screening ALK rearrangement by their EGFR and KRAS mutation status.	[Takamochi, Kazuya; Oh, Shiaki; Suzuki, Kenji] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 113, Japan; [Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan; [Hayashi, Takuo] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 113, Japan	Juntendo University; Japanese Foundation for Cancer Research; Juntendo University	Suzuki, K (corresponding author), Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 113, Japan.	kjsuzuki@juntendo.ac.jp	; Takeuchi, Kengo/C-3614-2008	HAYASHI, TAKUO/0000-0002-8544-9370; Takeuchi, Kengo/0000-0002-1599-5800	Ministry of Health, Labor and Welfare of Japan [10103778]; Smoking Research Foundation	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Smoking Research Foundation	This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan (10103778, and by the Smoking Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Boland JM, 2009, HUM PATHOL, V40, P1152, DOI 10.1016/j.humpath.2009.01.012; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik JH, 2012, LUNG CANCER, V76, P403, DOI 10.1016/j.lungcan.2011.11.008; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sakairi Y, 2010, CLIN CANCER RES, V16, P4938, DOI 10.1158/1078-0432.CCR-10-0099; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shinmura K, 2008, LUNG CANCER, V61, P163, DOI 10.1016/j.lungcan.2007.12.013; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2012, CLIN CANCER RES, V18, P5682, DOI 10.1158/1078-0432.CCR-11-2947; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2013, J THORAC ONCOL, V8, pE67, DOI 10.1097/JTO.0b013e318293e1ff; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Togashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031323; Wallander ML, 2012, ARCH PATHOL LAB MED, V136, P796, DOI 10.5858/arpa.2011-0321-OA; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Wong DWS, 2011, CANCER-AM CANCER SOC, V117, P2709, DOI 10.1002/cncr.25843; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181	28	37	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69794	10.1371/journal.pone.0069794	http://dx.doi.org/10.1371/journal.pone.0069794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936355	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400024
J	Lian, IA; Langaas, M; Moses, E; Johansson, A				Lian, Ingrid A.; Langaas, Mette; Moses, Eric; Johansson, Asa			Differential Gene Expression at the Maternal-Fetal Interface in Preeclampsia Is Influenced by Gestational Age	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; BINDING-PROTEIN; HYPERTENSION; DISCOVERY; PREGNANCY; PATTERNS	Genome-wide transcription data of utero-placental tissue has been used to identify altered gene expression associated with preeclampsia (PE). As many women with PE deliver preterm, there is often a difference in gestational age between PE women and healthy pregnant controls. This may pose a potential bias since gestational age has been shown to dramatically influence gene expression in utero-placental tissue. By pooling data from three genome-wide transcription studies of the maternal-fetal interface, we have evaluated the relative effect of gestational age and PE on gene expression. A total of 18,180 transcripts were evaluated in 49 PE cases and 105 controls, with gestational age ranging from week 14 to 42. A total of 22 transcripts were associated with PE, whereas 92 transcripts with gestational age (nominal P value <1.51*10(-6), Bonferroni adjusted P value <0.05). Our results indicate that gestational age has a great influence on gene expression both in normal and PE-complicated pregnancies. This effect might introduce serious bias in data analyses and needs to be carefully assessed in future genome-wide transcription studies.	[Lian, Ingrid A.] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Langaas, Mette] NTNU, Dept Math Sci, Trondheim, Norway; [Moses, Eric] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Perth, WA 6009, Australia; [Johansson, Asa] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Johansson, Asa] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Western Australia; Uppsala University; Uppsala University	Johansson, A (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	asa.johansson@igp.uu.se	Johansson, Åsa/AAG-6799-2021; Langaas, Mette/G-7423-2012; Johansson, Åsa/G-5270-2011; Langaas, Mette/AAD-5948-2020	Johansson, Åsa/0000-0002-2915-4498; Johansson, Åsa/0000-0002-2915-4498; Langaas, Mette/0000-0002-5714-0288; Moses, Eric/0000-0001-7781-4465	Functional genomics (FUGE) in Norway within the Research Council of Norway; Norwegian University of Science and Technology (NTNU); Sven och Dagmar Salens stiftelse; Swedish Society for Medical Research	Functional genomics (FUGE) in Norway within the Research Council of Norway; Norwegian University of Science and Technology (NTNU); Sven och Dagmar Salens stiftelse; Swedish Society for Medical Research	This work was supported by grants from Functional genomics (FUGE) in Norway within the Research Council of Norway (A.J.), motility grant from the Norwegian University of Science and Technology (NTNU) (A.J.), Sven och Dagmar Salens stiftelse (A.J.) and the Swedish Society for Medical Research (A.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-294; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Benjamini Y, 2001, ANN STAT, V29, P1165; Bozaoglu K, 2010, J CLIN ENDOCR METAB, V95, P2476, DOI 10.1210/jc.2010-0042; Carr DB, 2009, HYPERTENS PREGNANCY, V28, P435, DOI 10.3109/10641950802629675; CLIFTON VL, 1995, J CLIN ENDOCR METAB, V80, P2888, DOI 10.1210/jc.80.10.2888; Egbor M, 2006, PLACENTA, V27, P727, DOI 10.1016/j.placenta.2005.06.002; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Kolundzic N, 2011, PLACENTA, V32, P909, DOI 10.1016/j.placenta.2011.07.087; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Langaas M, 2005, J ROY STAT SOC B, V67, P555, DOI 10.1111/j.1467-9868.2005.00515.x; Lian IA, 2010, PLACENTA, V31, P615, DOI 10.1016/j.placenta.2010.04.003; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; PERKINS AV, 1995, BRIT J OBSTET GYNAEC, V102, P118, DOI 10.1111/j.1471-0528.1995.tb09063.x; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Rockett JC, 2004, GENOMICS, V83, P541, DOI 10.1016/j.ygeno.2003.09.017; Schroeder BM, 2002, AM FAM PHYSICIAN, V66, P330; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smyth G, 2005, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Than NG, 2011, TRENDS ENDOCRINOL ME; VANDENBRULE FA, 1994, BIOCHEM BIOPH RES CO, V201, P388, DOI 10.1006/bbrc.1994.1713; Wetzka B, 2003, EXP CLIN ENDOCR DIAB, V111, P154, DOI 10.1055/s-2003-39778; Williams D, 2003, CURR OPIN OBSTET GYN, V15, P465, DOI 10.1097/00001703-200312000-00002; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Witlin AG, 1997, ANNU REV MED, V48, P115; Zhang Z, 2010, MOL GENET METAB, V99, P309, DOI 10.1016/j.ymgme.2009.10.179	39	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69848	10.1371/journal.pone.0069848	http://dx.doi.org/10.1371/journal.pone.0069848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936112	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700047
J	Derbenev, AV; Smith, BN				Derbenev, Andrei V.; Smith, Bret N.			Dexamethasone Rapidly Increases GABA Release in the Dorsal Motor Nucleus of the Vagus via Retrograde Messenger-Mediated Enhancement of TRPV1 Activity	PLOS ONE			English	Article							ENDOGENOUS CANNABINOIDS; BRAIN-STEM; ENDOCANNABINOID RELEASE; SYNAPTIC-TRANSMISSION; EXCITATORY SYNAPSES; VAGAL COMPLEX; NEURONS; INHIBITION; RECEPTORS; GLUTAMATE	Glucocorticoids influence vagal parasympathetic output to the viscera via mechanisms that include modulation of neural circuitry in the dorsal vagal complex, a principal autonomic regulatory center. Glucocorticoids can modulate synaptic neurotransmitter release elsewhere in the brain by inducing release of retrograde signalling molecules. We tested the hypothesis that the glucocorticoid agonist dexamethasone (DEX) modulates GABA release in the rat dorsal motor nucleus of the vagus (DMV). Whole-cell patch-clamp recordings revealed that DEX (1-10 mu M) rapidly (i.e. within three minutes) increased the frequency of tetrodotoxin-resistant, miniature IPSCs (mIPSCs) in 67% of DMV neurons recorded in acutely prepared slices. Glutamate-mediated mEPSCs were also enhanced by DEX (10 mu M), and blockade of ionotropic glutamate receptors reduced the DEX effect on mIPSC frequency. Antagonists of type I or II corticosteroid receptors blocked the effect of DEX on mIPSCs. The effect was mimicked by application of the membrane-impermeant BSA-conjugated DEX, and intracellular blockade of G protein function with GDP S-beta in the recorded cell prevented the effect of DEX. The enhancement of GABA release was blocked by the TRPV1 antagonists, 5'-iodoresiniferatoxin or capsazepine, but was not altered by the cannabinoid type 1 receptor antagonist AM251. The DEX effect was prevented by blocking fatty acid amide hydrolysis or by inhibiting anandamide transport, implicating involvement of the endocannabinoid system in the response. These findings indicate that DEX induces an enhancement of GABA release in the DMV, which is mediated by activation of TRPV1 receptors on afferent terminals. The effect is likely induced by anandamide or other 'endovanilloid', suggesting activation of a local retrograde signal originating from DMV neurons to enhance synaptic inhibition locally in response to glucocorticoids.	[Derbenev, Andrei V.; Smith, Bret N.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA; [Derbenev, Andrei V.; Smith, Bret N.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Derbenev, Andrei V.] Tulane Univ, Sch Med, Dept Physiol, New Orleans, LA 70112 USA	University of Kentucky; Tulane University; Tulane University	Smith, BN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA.	bret.smith@uky.edu			NIH [R01 DK080901, R01 DK056132]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056132, R01DK080901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01 DK080901 and R01 DK056132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHIMA RS, 1990, NEUROSCIENCE, V39, P579, DOI 10.1016/0306-4522(90)90244-X; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Beierlein M, 2006, J NEUROSCI, V26, P9935, DOI 10.1523/JNEUROSCI.0958-06.2006; Browning KN, 2011, AUTON NEUROSCI-BASIC, V161, P6, DOI 10.1016/j.autneu.2010.11.001; Browning KN, 1999, J PHYSIOL-LONDON, V517, P521, DOI 10.1111/j.1469-7793.1999.0521t.x; Chen J, 2009, CHROMATOGRAPHIA, V69, P1, DOI 10.1365/s10337-008-0841-x; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chiu CYQ, 2008, NEUROPHARMACOLOGY, V54, P68, DOI 10.1016/j.neuropharm.2007.06.026; Cusin I, 2001, OBES RES, V9, P401, DOI 10.1038/oby.2001.52; DALLMAN MF, 1987, ANN NY ACAD SCI, V512, P402, DOI 10.1111/j.1749-6632.1987.tb24976.x; Davis SF, 2004, BRAIN RES, V1017, P208, DOI 10.1016/j.brainres.2004.05.049; Davis SF, 2003, J NEUROSCI, V23, P3844; Derbenev AV, 2006, J NEUROSCI, V26, P9666, DOI 10.1523/JNEUROSCI.1591-06.2006; Derbenev AV, 2004, J PHYSIOL-LONDON, V559, P923, DOI 10.1113/jphysiol.2004.067470; Di S, 2005, J PHYSIOL-LONDON, V569, P751, DOI 10.1113/jphysiol.2005.097477; Di S, 2005, ENDOCRINOLOGY, V146, P4292, DOI 10.1210/en.2005-0610; Di S, 2003, J NEUROSCI, V23, P4850; Di S, 2008, PROG BRAIN RES, V170, P379, DOI 10.1016/S0079-6123(08)00431-7; Di S, 2009, J NEUROSCI, V29, P393, DOI 10.1523/JNEUROSCI.4546-08.2009; Doyle MW, 2002, J NEUROSCI, V22, P8222; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gao H, 2010, J NEUROPHYSIOL, V103, P904, DOI 10.1152/jn.00511.2009; Glatzer NR, 2007, J NEUROPHYSIOL, V98, P1591, DOI 10.1152/jn.00336.2007; Ho CM, 2004, ANESTH ANALG, V99, P734, DOI 10.1213/01.ANE.0000130003.68288.C7; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Ji B, 2013, PEPTIDES, V40, P188, DOI 10.1016/j.peptides.2012.10.009; Johnson LR, 2005, NEUROSCIENCE, V136, P289, DOI 10.1016/j.neuroscience.2005.06.050; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; LAUGHTON WB, 1987, AM J PHYSIOL, V252, pR13, DOI 10.1152/ajpregu.1987.252.1.R13; Michael GJ, 1999, J NEUROSCI, V19, P1844; Ming OY, 2000, BRIT J PHARMACOL, V129, P865, DOI 10.1038/sj.bjp.0703122; Minowa S, 2005, BRAIN RES, V1039, P75, DOI 10.1016/j.brainres.2005.01.048; Papanek PE, 1997, AM J PHYSIOL-REG I, V272, pR158, DOI 10.1152/ajpregu.1997.272.1.R158; Peters JH, 2010, NEURON, V65, P657, DOI 10.1016/j.neuron.2010.02.017; RINAMAN L, 1989, J NEUROSCI, V9, P1985; Roux J, 2009, NEUROPHARMACOLOGY, V56, P1106, DOI 10.1016/j.neuropharm.2009.03.009; SAPHIER D, 1988, BRAIN RES, V453, P183, DOI 10.1016/0006-8993(88)90157-6; SAPOLSKY RM, 1990, NEUROENDOCRINOLOGY, V51, P328, DOI 10.1159/000125357; Scheuer DA, 2004, AM J PHYSIOL-HEART C, V286, pH458, DOI 10.1152/ajpheart.00824.2003; Shank SS, 2003, AM J PHYSIOL-HEART C, V284, pH1751, DOI 10.1152/ajpheart.01033.2002; Sharkey KA, 2007, EUR J NEUROSCI, V25, P2773, DOI 10.1111/j.1460-9568.2007.05521.x; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; TRAVAGLI RA, 1991, AM J PHYSIOL, V260, pG531, DOI 10.1152/ajpgi.1991.260.3.G531; Wang LL, 2005, MOL PHARMACOL, V67, P489, DOI 10.1124/mol.104.005595; Williams KW, 2007, ENDOCRINOLOGY, V148, P1868, DOI 10.1210/en.2006-1098; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zsombok A, 2011, J NEUROSCI, V31, P14024, DOI 10.1523/JNEUROSCI.2081-11.2011	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70505	10.1371/journal.pone.0070505	http://dx.doi.org/10.1371/journal.pone.0070505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936221	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200092
J	Touloumi, G; Pantazis, N; Chaix, ML; Bucher, HC; Zangerle, R; Kran, AMB; Thiebaut, R; Masquelier, B; Kucherer, C; Monforte, AD; Meyer, L; Porter, K				Touloumi, Giota; Pantazis, Nikos; Chaix, Marie-Laure; Bucher, Heiner C.; Zangerle, Robert; Kran, Anne-Marte Bakken; Thiebaut, Rodolphe; Masquelier, Bernard; Kucherer, Claudia; Monforte, Antonella d'Arminio; Meyer, Laurence; Porter, Kholoud		CASCADE Collaboration EuroCoord	Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration	PLOS ONE			English	Article							NON-B SUBTYPES; ACTIVE ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; DRUG-RESISTANCE; TYPE-1 SUBTYPE; IMPACT; INDIVIDUALS; DIVERSITY; EPIDEMIOLOGY; INFECTION	Background: We aimed to compare rates of virologic response and CD4 changes after combination antiretroviral (cART) initiation in individuals infected with B and specific non-B HIV subtypes. Methods: Using CASCADE data we analyzed HIV-RNA and CD4 counts for persons infected >= 1996, >= 15 years of age. We used survival and longitudinal modeling to estimate probabilities of virologic response (confirmed HIV-RNA <500 c/ml), and failure (HIV-RNA>500 c/ml at 6 months or >= 1000 c/ml following response) and CD4 increase after cART initiation. Results: 2003 (1706 B, 142 CRF02_AG, 55 A, 53 C, 47 CRF01_AE) seroconverters were included in analysis. There was no evidence of subtype effect overall for response or failure (p = 0.075 and 0.317, respectively) although there was a suggestion that those infected with subtypes CRF01_AE and A responded sooner than those with subtype B infection [HR (95% CI): 1.37 (1.01-1.86) and 1.29 (0.96-1.72), respectively]. Rates of CD4 increase were similar in all subtypes except subtype A, which tended to have lower initial, but faster long-term, increases. Conclusions: Virologic and immunologic response to cART was similar across all studied subtypes but statistical power was limited by the rarity of some non-B subtypes. Current antiretroviral agents seem to have similar efficacy in subtype B and most widely encountered non-B infections in high-income countries.	[Touloumi, Giota; Pantazis, Nikos] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Chaix, Marie-Laure] Univ Paris 05, CHU Necker Enfants Malad, AP HP, Lab Virol,EA 3620, Paris, France; [Bucher, Heiner C.] Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland; [Zangerle, Robert] Univ Innsbruck Hosp, A-6020 Innsbruck, Austria; [Kran, Anne-Marte Bakken] Oslo Univ Hosp Ulleval, Dept Microbiol, Oslo, Norway; [Thiebaut, Rodolphe] Univ Bordeaux, INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Masquelier, Bernard] Hosp Pellegrin, Bordeaux, France; [Kucherer, Claudia] Robert Koch Inst, Berlin, Germany; [Monforte, Antonella d'Arminio] Univ Milan, Inst Infect Dis, San Paolo Hosp, Milan, Italy; [Meyer, Laurence] Univ Paris 11, INSERM, AP HP, U1018, Paris, France; [Porter, Kholoud] MRC Clin Trials Unit, London, England	Athens Medical School; National & Kapodistrian University of Athens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Medical University of Innsbruck; University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Robert Koch Institute; San Paolo-Polo Universitaria Hospital; University of Milan; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Medical Research Council Clinical Trials Unit	Touloumi, G (corresponding author), Univ Athens, Sch Med, GR-11527 Athens, Greece.	gtouloum@med.uoa.gr	Thiebaut, Rodolphe/T-6803-2019	Thiebaut, Rodolphe/0000-0002-5235-3962; d'Arminio Monforte, Antonella/0000-0003-0073-1789; Porter, Kholoud/0000-0002-9226-6206; Pantazis, Nikos/0000-0002-4196-5066	European Union [260694]; MRC [MC_U122886351] Funding Source: UKRI; Medical Research Council [MC_U122886351] Funding Source: researchfish	European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1978, SCAND J STAT, V5, P141; Alexander CS, 2002, ANTIVIR THER, V7, P31; Atlas A, 2005, AIDS RES HUM RETROV, V21, P221, DOI 10.1089/aid.2005.21.221; Bannister WP, 2006, ANTIVIR THER, V11, P707; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bocket L, 2005, ANTIVIR THER, V10, P247; Boyd AE, 2005, HIV MED, V6, P59, DOI 10.1111/j.1468-1293.2005.00267.x; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; De Wit S, 2004, AIDS, V18, P2330, DOI 10.1097/00002030-200411190-00016; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Fox J, 2007, 13 ANN C BRIT HIV AS; Frater AJ, 2002, AIDS, V16, P1139, DOI 10.1097/00002030-200205240-00007; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Geretti AM, 2009, CLIN INFECT DIS, V48, P1296, DOI 10.1086/598502; Giuliani M, 2009, AIDS RES HUM RETROV, V25, P157, DOI 10.1089/aid.2008.0175; Gonzalez-Alba JM, 2011, J VIROL, V85, P10755, DOI 10.1128/JVI.00454-11; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2006, AIDS REV, V8, P98; Jensen-Fangel S, 2002, CLIN INFECT DIS, V35, P1541, DOI 10.1086/344769; Kalbfleish J. D., 2002, STAT ANAL FAILURE TI; Kantor R, 2006, CURR OPIN INFECT DIS, V19, P594, DOI 10.1097/QCO.0b013e3280109122; Lacerda HR, 2007, MEM I OSWALDO CRUZ, V102, P693, DOI [10.1590/S0074-02762007005000103, 10.1590/S0074-02762007000600006]; Lal RB, 2005, INDIAN J MED RES, V121, P287; Perrin L, 2003, LANCET INFECT DIS, V3, P22, DOI 10.1016/S1473-3099(03)00484-5; De Arellano ER, 2007, AIDS RES HUM RETROV, V23, P891, DOI 10.1089/aid.2006.0288; Scherrer AU, 2011, CLIN INFECT DIS, V53, P1143, DOI 10.1093/cid/cir669; Sharp PM, 2010, PHILOS T R SOC B, V365, P2487, DOI 10.1098/rstb.2010.0031; Staehelin C, 2012, JAIDS-J ACQ IMM DEF, V59, P79, DOI 10.1097/QAI.0b013e318236be70; Tebit DM, 2007, AIDS REV, V9, P75; Tesoriero J, 2003, JAIDS-J ACQ IMM DEF, V33, P484, DOI 10.1097/00126334-200308010-00009; Trevino A, 2011, AIDS RES HUM RETROV, V27, P633, DOI [10.1089/aid.2010.0247, 10.1089/AID.2010.0247]	32	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e71174	10.1371/journal.pone.0071174	http://dx.doi.org/10.1371/journal.pone.0071174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936260	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200113
J	Tukaj, S; Kleszczynski, K; Vafia, K; Groth, S; Meyersburg, D; Trzonkowski, P; Ludwig, RJ; Zillikens, D; Schmidt, E; Fischer, TW; Kasperkiewicz, M				Tukaj, Stefan; Kleszczynski, Konrad; Vafia, Katerina; Groth, Stephanie; Meyersburg, Damian; Trzonkowski, Piotr; Ludwig, Ralf J.; Zillikens, Detlef; Schmidt, Enno; Fischer, Tobias W.; Kasperkiewicz, Michael			Aberrant Expression and Secretion of Heat Shock Protein 90 in Patients with Bullous Pemphigoid	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE; HSP90; INHIBITION; GP96; SKIN; ENCEPHALOMYELITIS; AUTOANTIBODIES; PSORIASIS; RESPONSES	The cell stress chaperone heat shock protein 90 (Hsp90) has been implicated in inflammatory responses and its inhibition has proven successful in different mouse models of autoimmune diseases, including epidermolysis bullosa acquisita. Here, we investigated expression levels and secretory responses of Hsp90 in patients with bullous pemphigoid (BP), the most common subepidermal autoimmune blistering skin disease. In comparison to healthy controls, the following observations were made: (i) Hsp90 was highly expressed in the skin of BP patients, whereas its serum levels were decreased and inversely associated with IgG autoantibody levels against the NC16A immunodominant region of the BP180 autoantigen, (ii) in contrast, neither aberrant levels of circulating Hsp90 nor any correlation of this protein with serum autoantibodies was found in a control cohort of autoimmune bullous disease patients with pemphigus vulgaris, (iii) Hsp90 was highly expressed in and restrictedly released from peripheral blood mononuclear cells of BP patients, and (iv) Hsp90 was potently induced in and restrictedly secreted from human keratinocyte (HaCaT) cells by BP serum and isolated anti-BP180 NC16A IgG autoantibodies, respectively. Our results reveal an upregulated Hsp90 expression at the site of inflammation and an autoantibody-mediated dysregulation of the intracellular and extracellular distribution of this chaperone in BP patients. These findings suggest that Hsp90 may play a pathophysiological role and represent a novel potential treatment target in BP.	[Tukaj, Stefan; Kleszczynski, Konrad; Vafia, Katerina; Groth, Stephanie; Meyersburg, Damian; Ludwig, Ralf J.; Zillikens, Detlef; Schmidt, Enno; Fischer, Tobias W.; Kasperkiewicz, Michael] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Trzonkowski, Piotr] Med Univ Gdansk, Dept Clin Immunol & Transplantol, Gdansk, Poland	University of Lubeck; Fahrenheit Universities; Medical University Gdansk	Kasperkiewicz, M (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	Michael.Kasperkiewicz@uk-sh.de	Trzonkowski, Piotr/U-1137-2018; Zillikens, Detlef/C-8572-2011; Tukaj, Stefan/G-6746-2014; Ludwig, Ralf J/A-2629-2008; Schmidt, Enno/C-4008-2009; Kasperkiewicz, Michael/G-4829-2014; Ludwig, Ralf/F-3996-2018; Goletz, Stephanie/K-1358-2014	Trzonkowski, Piotr/0000-0001-5287-5210; Ludwig, Ralf J/0000-0002-1394-1737; Schmidt, Enno/0000-0002-1206-8913; Ludwig, Ralf/0000-0002-1394-1737; Kleszczynski, Konrad/0000-0002-1311-263X; Tukaj, Stefan/0000-0003-1288-0511	Deutsche Forschungsgemeinschaft [EXC 301-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft EXC 301-2 Inflammation at Interfaces (M.K., R.L., E.S., D.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayramgurler D, 2004, J CUTAN PATHOL, V31, P586, DOI 10.1111/j.0303-6987.2004.00234.x; BERRA A, 1994, INVEST OPHTH VIS SCI, V35, P352; Businaro R, 2009, ATHEROSCLEROSIS, V207, P74, DOI 10.1016/j.atherosclerosis.2009.04.026; Chandawarkar RY, 2004, INT IMMUNOL, V16, P615, DOI 10.1093/intimm/dxh063; Cheng C. Yan, 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P1, DOI 10.2174/187152208783790778; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Dello Russo C, 2006, J NEUROCHEM, V99, P1351, DOI 10.1111/j.1471-4159.2006.04221.x; DHILLON V, 1993, BRIT J RHEUMATOL, V32, P883; Ergun T, 2001, J AM ACAD DERMATOL, V45, P904, DOI 10.1067/mjd.2001.117728; ERKELLERYUKSEL FM, 1992, J AUTOIMMUN, V5, P803, DOI 10.1016/0896-8411(92)90194-U; Ghoreishi M, 2000, J Dermatol, V27, P370; Ghoreishi Mehran, 1993, Journal of Dermatology (Tokyo), V20, P400; Han JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009792; Jarvis M, 2003, TRANSPLANTATION, V76, P849, DOI 10.1097/01.TP.0000083556.73555.78; Jonak C, 2009, FRONT BIOSCI-LANDMRK, V14, P4758, DOI 10.2741/3565; Kasperkiewicz M, 2007, CLIN REV ALLERG IMMU, V33, P67, DOI 10.1007/s12016-007-0030-y; Kasperkiewicz M, 2011, BLOOD, V117, P6135, DOI 10.1182/blood-2010-10-314609; Liu Z, 2009, EUR J IMMUNOL, V39, P3110, DOI 10.1002/eji.200939593; Ludwig RJ, 2009, GIORN ITAL DERMAT V, V144, P339; Magalhaesi WV, 2012, EUR J DERMATOL, V22, P8, DOI 10.1684/ejd.2011.1530; Nordlind K, 2002, IMMUNOPHARM IMMUNOT, V24, P83; Rice JW, 2008, ARTHRITIS RHEUM-US, V58, P3765, DOI 10.1002/art.24047; Ripley BJM, 2001, J AUTOIMMUN, V17, P341, DOI 10.1006/jaut.2001.0549; Schmidt E, 2000, J INVEST DERMATOL, V115, P842, DOI 10.1046/j.1523-1747.2000.00141.x; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Seung NR, 2007, J CUTAN PATHOL, V34, P903, DOI 10.1111/j.1600-0560.2007.00756.x; Shimp SK, 2012, CELL MOL IMMUNOL, V9, P255, DOI 10.1038/cmi.2012.5; Shimp SK, 2012, INFLAMM RES, V61, P521, DOI 10.1007/s00011-012-0442-x; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tukaj S, 2010, CELL STRESS CHAPERON, V15, P555, DOI 10.1007/s12192-010-0168-z; Van den Bergh F, 2012, EXP DERMATOL, V21, P605, DOI 10.1111/j.1600-0625.2012.01529.x; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Wilson N, 2000, J CUTAN PATHOL, V27, P176, DOI 10.1034/j.1600-0560.2000.027004176.x; Yeo M, 2004, BIOCHEM BIOPH RES CO, V320, P816, DOI 10.1016/j.bbrc.2004.05.214; Yun TJ, 2011, J IMMUNOL, V186, P563, DOI 10.4049/jimmunol.1000222	37	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70496	10.1371/journal.pone.0070496	http://dx.doi.org/10.1371/journal.pone.0070496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936217	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200090
J	Vingerhoets, G; Nys, J; Honore, P; Vandekerckhove, E; Vandemaele, P				Vingerhoets, Guy; Nys, Jo; Honore, Pieterjan; Vandekerckhove, Elisabeth; Vandemaele, Pieter			Human Left Ventral Premotor Cortex Mediates Matching of Hand Posture to Object Use	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; PARIETAL CORTEX; BRAIN; ACTIVATION; IMITATION; REGIONS; DORSAL; MIRROR; MONKEY; MOTOR	Visuomotor transformations for grasping have been associated with a fronto-parietal network in the monkey brain. The human homologue of the parietal monkey region (AIP) has been identified as the anterior part of the intraparietal sulcus (aIPS), whereas the putative human equivalent of the monkey frontal region (F5) is located in the ventral part of the premotor cortex (vPMC). Results from animal studies suggest that monkey F5 is involved in the selection of appropriate hand postures relative to the constraints of the task. In humans, the functional roles of aIPS and vPMC appear to be more complex and the relative contribution of each region to grasp selection remains uncertain. The present study aimed to identify modulation in brain areas sensitive to the difficulty level of tool object - hand posture matching. Seventeen healthy right handed participants underwent fMRI while observing pictures of familiar tool objects followed by pictures of hand postures. The task was to decide whether the hand posture matched the functional use of the previously shown object. Conditions were manipulated for level of difficulty. Compared to a picture matching control task, the tool object - hand posture matching conditions conjointly showed increased modulation in several left hemispheric regions of the superior and inferior parietal lobules (including aIPS), the middle occipital gyrus, and the inferior temporal gyrus. Comparison of hard versus easy conditions selectively modulated the left inferior frontal gyrus with peak activity located in its opercular part (Brodmann area (BA) 44). We suggest that in the human brain, vPMC/BA44 is involved in the matching of hand posture configurations in accordance with visual and functional demands.	[Vingerhoets, Guy; Nys, Jo] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Vingerhoets, Guy; Nys, Jo; Honore, Pieterjan; Vandekerckhove, Elisabeth; Vandemaele, Pieter] Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Vandemaele, Pieter] Univ Ghent, Dept Radiol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Vingerhoets, G (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	guy.vingerhoets@ugent.be			Fund for Scientific Research Flanders [G.0345.04, G.0555.11]	Fund for Scientific Research Flanders(FWO)	This study was supported by grants number G.0345.04 and G.0555.11 attributed to the first author by the Fund for Scientific Research Flanders (www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgaertner A, 2007, EUR J NEUROSCI, V25, P881, DOI 10.1111/j.1460-9568.2007.05346.x; Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Buxbaum LJ, 2006, BRAIN RES, V1117, P175, DOI 10.1016/j.brainres.2006.08.010; Buxbaum LJ, 2005, COGNITIVE BRAIN RES, V25, P226, DOI 10.1016/j.cogbrainres.2005.05.014; Buxbaum LJ, 2005, NEUROPSYCHOLOGIA, V43, P917, DOI 10.1016/j.neuropsychologia.2004.09.006; Buxbaum LJ, 2003, NEUROPSYCHOLOGIA, V41, P1091, DOI 10.1016/S0028-3932(02)00314-7; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Daprati E, 2006, TRENDS COGN SCI, V10, P265, DOI 10.1016/j.tics.2006.04.005; Davare M, 2010, CURR BIOL, V20, P176, DOI 10.1016/j.cub.2009.11.063; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Gallivan JP, 2011, J NEUROSCI, V31, P17149, DOI 10.1523/JNEUROSCI.1058-11.2011; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Goldenberg G, 2009, BRAIN, V132, P1645, DOI 10.1093/brain/awp080; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Haaland KY, 2000, BRAIN, V123, P2306, DOI 10.1093/brain/123.11.2306; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hesse MD, 2009, J COGNITIVE NEUROSCI, V21, P776, DOI 10.1162/jocn.2009.21058; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; KLATZKY RL, 1987, J MOTOR BEHAV, V19, P187; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Liu TT, 2004, NEUROIMAGE, V21, P401, DOI 10.1016/j.neuroimage.2003.09.031; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Makuuchi M, 2012, HUM BRAIN MAPP, V33, P1821, DOI 10.1002/hbm.21323; Molenberghs P, 2007, CEREB CORTEX, V17, P2703, DOI 10.1093/cercor/bhl179; Molnar-Szakacs I, 2005, CEREB CORTEX, V15, P986, DOI 10.1093/cercor/bhh199; Molnar-Szakacs I, 2006, NEUROIMAGE, V33, P923, DOI 10.1016/j.neuroimage.2006.07.035; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ortigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006962; Pelgrims B, 2005, J COGNITIVE NEUROSCI, P84; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Shmuelof L, 2005, NEURON, V47, P457, DOI 10.1016/j.neuron.2005.06.034; Talairach J, 1988, COPLANAR SEREOTAXIC; Tunik E, 2007, NEUROIMAGE, V36, pT77, DOI 10.1016/j.neuroimage.2007.03.026; Tunik E, 2005, NAT NEUROSCI, V8, P505, DOI 10.1038/nn1430; Tunik E, 2008, J NEUROSCI, V28, P14422, DOI 10.1523/JNEUROSCI.4734-08.2008; Vaesen K, 2012, BEHAV BRAIN SCI, V35, P203, DOI 10.1017/S0140525X11001452; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Vesia M, 2010, J NEUROSCI, V30, P13053, DOI 10.1523/JNEUROSCI.1644-10.2010; Vingerhoets G, 2010, NEUROSCIENCE, V169, P1158, DOI 10.1016/j.neuroscience.2010.05.080; Vingerhoets G, 2009, BRAIN COGNITION, V69, P481, DOI 10.1016/j.bandc.2008.10.003; Vingerhoets G, 2008, NEUROIMAGE, V40, P1380, DOI 10.1016/j.neuroimage.2007.12.058; Vingerhoets G, 2012, NEUROPSYCHOL REHABIL, V22, P752, DOI 10.1080/09602011.2012.686885; Vingerhoets G, 2012, HUM BRAIN MAPP, V33, P763, DOI 10.1002/hbm.21247; Vingerhoets G, 2009, NEUROIMAGE, V47, P1832, DOI 10.1016/j.neuroimage.2009.05.100; Whatmough C, 2002, NEUROPSYCHOLOGIA, V40, P174, DOI 10.1016/S0028-3932(01)00083-5	65	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70480	10.1371/journal.pone.0070480	http://dx.doi.org/10.1371/journal.pone.0070480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936212	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200088
J	Gavrilov, S; Harvey, RP; Papaioannou, VE				Gavrilov, Svetlana; Harvey, Richard P.; Papaioannou, Virginia E.			Lack of Genetic Interaction between Tbx20 and Tbx3 in Early Mouse Heart Development	PLOS ONE			English	Article							ULNAR-MAMMARY SYNDROME; T-BOX GENES; TRANSCRIPTION FACTOR; CONDUCTION SYSTEM; EXPRESSION; MUTATIONS; PROLIFERATION; SPECIFICATION; REPRESSOR; NETWORKS	Members of the T-box family of transcription factors are important regulators orchestrating the complex regionalization of the developing mammalian heart. Individual mutations in Tbx20 and Tbx3 cause distinct congenital heart abnormalities in the mouse: Tbx20 mutations result in failure of heart looping, developmental arrest and lack of chamber differentiation, while hearts of Tbx3 mutants progress further, loop normally but show atrioventricular convergence and outflow tract defects. The two genes have overlapping areas of expression in the atrioventricular canal and outflow tract of the heart but their potential genetic interaction has not been previously investigated. In this study we produced compound mutants to investigate potential genetic interactions at the earliest stages of heart development. We find that Tbx20; Tbx3 double heterozygous mice are viable and fertile with no apparent abnormalities, while double homozygous mutants are embryonic lethal by midgestation. Double homozygous mutant embryos display abnormal cardiac morphogenesis, lack of heart looping, expression patterns of cardiac genes and time of death that are indistinguishable from Tbx20 homozygous mutants. Prior to death, the double homozygotes show an overall developmental delay similar to Tbx3 homozygous mutants. Thus the effects of Tbx20 are epistatic to Tbx3 in the heart but Tbx3 is epistatic to Tbx20 with respect to developmental delay.	[Gavrilov, Svetlana; Papaioannou, Virginia E.] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA; [Harvey, Richard P.] Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Lab, Darlinghurst, NSW, Australia; [Harvey, Richard P.] Univ New S Wales, St Vincents Hosp Clin Sch, Kensington, NSW 2033, Australia	Columbia University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Papaioannou, VE (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA.	vep1@columbia.edu		Harvey, Richard/0000-0002-9950-9792; Gavrilov, Svetlana/0000-0002-6639-1855; Papaioannou, Virginia/0000-0001-7558-8601	National Health and Medical Research Council (NHMRC) Australia Fellowship [573705]; NHMRC [573732]; National Heart Foundation of Australia; National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) [4R37HD033082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD033082] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Richard P. Harvey holds a National Health and Medical Research Council (NHMRC) Australia Fellowship (573705). This work was funded by grants from the NHMRC (573732) and National Heart Foundation of Australia (Richard P. Harvey) and the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD), Grant Number 4R37HD033082 (Virginia E. Papaioannou). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Cai XQ, 2011, DEV BIOL, V360, P381, DOI 10.1016/j.ydbio.2011.09.023; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Frank DU, 2012, P NATL ACAD SCI USA, V109, pE154, DOI 10.1073/pnas.1115165109; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hammer S, 2008, J CELL BIOCHEM, V104, P1022, DOI 10.1002/jcb.21686; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; KRAUS F, 2001, MECH DEVELOP, V100, P89; Linden H, 2009, AM J MED GENET A, V149A, P2809, DOI 10.1002/ajmg.a.33096; Liu CX, 2008, EUR J MED GENET, V51, P580, DOI 10.1016/j.ejmg.2008.09.001; Meneghini V, 2006, EUR J MED GENET, V49, P151, DOI 10.1016/j.ejmg.2005.04.021; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Mesbah K, 2012, HUM MOL GENET, V21, P1217, DOI 10.1093/hmg/ddr553; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Qian L, 2008, P NATL ACAD SCI USA, V105, P19833, DOI 10.1073/pnas.0808705105; Ribeiro I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000398; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Washkowitz AJ, 2012, WIRES SYST BIOL MED, V4, P273, DOI 10.1002/wsbm.1162; WILKINSON DG, 1992, WHOLE MOUNT IN SITU	29	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70149	10.1371/journal.pone.0070149	http://dx.doi.org/10.1371/journal.pone.0070149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936153	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300091
J	Ma, N; Xing, C; Xiao, H; Wang, Y; Wang, K; Hou, CM; Han, GC; Chen, GJ; Marrero, B; Wang, YJ; Shen, BF; Li, Y; Wang, RX				Ma, Ning; Xing, Chen; Xiao, He; Wang, Yi; Wang, Ke; Hou, Chunmei; Han, Gencheng; Chen, Guojiang; Marrero, Bernadette; Wang, Yujuan; Shen, Beifen; Li, Yan; Wang, Renxi			C5a Regulates IL-12(+)DC Migration to Induce Pathogenic Th1 and Th17 Cells in Sepsis	PLOS ONE			English	Article							RECEPTOR; MODEL; DEFINITIONS; NEUTROPHILS; EXPRESSION; APOPTOSIS; CYTOKINE; ANTI-C5A; SHOCK; RAT	Objective: It is well known that complement system C5a is excessively activated during the onset of sepsis. However, it is unclear whether C5a can regulate dentritic cells (DCs) to stimulate adaptive immune cells such as Th1 and Th17 in sepsis. Methods: Sepsis was induced by cecal ligation and puncture (CLP). CLP-induced sepsis was treated with anti-C5a or IL-12. IL-12(+)DC, IFN gamma(+)Th1, and IL-17(+)Th17 cells were analyzed by flow cytometry. IL-12 was measured by ELISA. Results: Our studies here showed that C5a induced IL-12(+)DC cell migration from the peritoneal cavity to peripheral blood and lymph nodes. Furthermore, IL-12(+)DC cells induced the expansion of pathogenic IFN gamma(+)Th1 and IL-17(+)Th17 cells in peripheral blood and lymph nodes. Moreover, IL-12, secreted by DC cells in the peritoneal cavity, is an important factor that prevents the development of sepsis. Conclusion: Our data suggests that C5a regulates IL-12(+)DC cell migration to induce pathogenic Th1 and Th17 cells in sepsis.	[Ma, Ning; Xing, Chen; Xiao, He; Wang, Yi; Wang, Ke; Hou, Chunmei; Han, Gencheng; Chen, Guojiang; Shen, Beifen; Li, Yan; Wang, Renxi] Chinese Acad Med Sci, Inst Basic Med Sci, Immunol Lab, Beijing 100730, Peoples R China; [Ma, Ning] Jilin Univ, Dept Rheumatol, Hosp 1, Changchun 130023, Peoples R China; [Marrero, Bernadette] NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Wang, Yujuan] NEI, Immunopathol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Jilin University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Li, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Immunol Lab, Beijing 100730, Peoples R China.	liyan62033@yahoo.com.cn; wang_renxi@yahoo.com	wang, yujuan/C-8428-2016; Wang, Renxi/AAM-1326-2020; Wang, Ke/GXM-9831-2022; Ke, Wang/AAI-4120-2020	Wang, Renxi/0000-0003-4130-3334	National Basic Research Program 973 Grants [2013CB530506]; Beijing Natural Science Foundation [7132139]	National Basic Research Program 973 Grants(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by National Basic Research Program 973 Grants (2013CB530506) and Beijing Natural Science Foundation (7132139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Czermak BJ, 2013, J IMMUNOL, V162, P5437; GOLDSTEI.IM, 1974, J IMMUNOL, V113, P1583; Guo RF, 2000, J CLIN INVEST, V106, P1271, DOI 10.1172/JCI10793; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Guo RF, 2002, J IMMUNOL, V169, P307, DOI 10.4049/jimmunol.169.1.307; Hopken U, 1996, EUR J IMMUNOL, V26, P1103, DOI 10.1002/eji.1830260522; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; Lee KP, 1999, ROLE COSTIMULATION H, P191; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mollnes TE, 2002, BLOOD, V100, P1869; Moss M, 2004, INTENS CARE MED, V30, P527, DOI 10.1007/s00134-004-2182-z; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; Riedemann NC, 2002, FASEB J, V16, P887, DOI 10.1096/fj.02-0033fje; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; SACKS T, 1978, J CLIN INVEST, V61, P1161, DOI 10.1172/JCI109031; SMEDEGARD G, 1989, AM J PATHOL, V135, P489; Sousa CRE, 2001, IMMUNITY, V14, P495; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; STRIETER RM, 1992, AM J PATHOL, V141, P397; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269	29	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69779	10.1371/journal.pone.0069779	http://dx.doi.org/10.1371/journal.pone.0069779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936099	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000154
J	Laffita-Mesa, JM; Pupo, JMR; Sera, RM; Mojena, YV; Kouri, V; Laguna-Salvia, L; Martinez-Godales, M; Figueira, JAV; Bauer, PO; Rodriguez-Labrada, R; Zaldivar, YG; Paucar, M; Svenningsson, P; Perez, LV				Miguel Laffita-Mesa, Jose; Rodriguez Pupo, Jorge Michel; Moreno Sera, Raciel; Vazquez Mojena, Yaimee; Kouri, Vivian; Laguna-Salvia, Leonides; Martinez-Godales, Michael; Valdevila Figueira, Jose A.; Bauer, Peter O.; Rodriguez-Labrada, Roberto; Gonzalez Zaldivar, Yanetza; Paucar, Martin; Svenningsson, Per; Velazquez Perez, Luis			De Novo Mutations in Ataxin-2 Gene and ALS Risk	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LENGTH POLYGLUTAMINE EXPANSIONS; SPINOCEREBELLAR ATAXIA; REPEAT EXPANSIONS; CAG-REPEATS; SCA2 LOCUS; HEXANUCLEOTIDE REPEAT; TRINUCLEOTIDE REPEAT; ATXN2; C9ORF72	Pathogenic CAG repeat expansion in the ataxin-2 gene (ATXN2) is the genetic cause of spinocerebellar ataxia type 2 (SCA2). Recently, it has been associated with Parkinsonism and increased genetic risk for amyotrophic lateral sclerosis (ALS). Here we report the association of de novo mutations in ATXN2 with autosomal dominant ALS. These findings support our previous conjectures based on population studies on the role of large normal ATXN2 alleles as the source for new mutations being involved in neurodegenerative pathologies associated with CAG expansions. The de novo mutations expanded from ALS/SCA2 non-risk alleles as proven by meta-analysis method. The ALS risk was associated with SCA2 alleles as well as with intermediate CAG lengths in the ATXN2. Higher risk for ALS was associated with pathogenic CAG repeat as revealed by meta-analysis.	[Miguel Laffita-Mesa, Jose; Vazquez Mojena, Yaimee; Rodriguez-Labrada, Roberto; Gonzalez Zaldivar, Yanetza; Velazquez Perez, Luis] Ctr Res & Rehabil Hereditary Ataxias, Holguin, Cuba; [Miguel Laffita-Mesa, Jose; Rodriguez-Labrada, Roberto; Velazquez Perez, Luis] Cuban Acad Sci ACC, Branch Biomed, Havana, Cuba; [Rodriguez Pupo, Jorge Michel; Laguna-Salvia, Leonides; Valdevila Figueira, Jose A.] Clin & Surg Hosp Lucia Iniquez Landin, Holguin, Cuba; [Kouri, Vivian; Martinez-Godales, Michael] Inst Trop Med Pedro Kouri, Virol Lab, Dept ITS, Havana, Cuba; [Paucar, Martin; Svenningsson, Per] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, S-10401 Stockholm, Sweden; [Bauer, Peter O.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Moreno Sera, Raciel] Policlin & Med Fac, Baguanos, Holguin, Cuba	Academia de Ciencias de Cuba; Karolinska Institutet; Mayo Clinic	Laffita-Mesa, JM (corresponding author), Ctr Res & Rehabil Hereditary Ataxias, Holguin, Cuba.	laffita@ataxia.hlg.sld.cu; cirahsca2@cristal.hlg.sld.cu	Laffita-Mesa, Jose Miguel/AAH-4020-2021; Velázquez-Pérez, Luis/AAM-4460-2020; RodrÃguez-Labrada, Roberto/AAM-1692-2020; Svenningsson, Per JL/K-5210-2014; Bauer, Peter O./AAD-6502-2022	Bauer, Peter O./0000-0003-2811-1354; Rodriguez-Labrada, Roberto/0000-0003-3193-7683; Paucar, Martin/0000-0003-3735-1480	Third World Academy of Sciences (TWAS) [06-329 RG/BIO/LA UNESCO FR: 3240157855]; BIOLABS Research Award; Cuban Ministry of Health; Science and Technology Ministry	Third World Academy of Sciences (TWAS); BIOLABS Research Award; Cuban Ministry of Health; Science and Technology Ministry	This work was supported in part by Third World Academy of Sciences (TWAS) in the framework of the Research Grant Project 06-329 RG/BIO/LA UNESCO FR: 3240157855 and BIOLABS Research Award all to JMLM and a grant of the Cuban Ministry of Health and the Science and Technology Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2004, EUR J BIOCHEM, V271, P3155, DOI 10.1111/j.1432-1033.2004.04245.x; Almqvist EW, 2001, CLIN GENET, V60, P198, DOI 10.1034/j.1399-0004.2001.600305.x; Alonso E, 2007, MOVEMENT DISORD, V22, P1050, DOI 10.1002/mds.21470; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Bauer P, 2004, J NEUROL, V251, P1023, DOI 10.1007/s00415-004-0482-4; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chen YP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.015; Choudhry S, 2001, HUM MOL GENET, V10, P2437, DOI 10.1093/hmg/10.21.2437; Conforti FL, 2012, NEUROLOGY, V79, P2315, DOI 10.1212/WNL.0b013e318278b618; Corrado L, 2011, HUM GENET, V130, P575, DOI 10.1007/s00439-011-1000-2; Costanzi-Porrini S, 2000, NEUROLOGY, V54, P491, DOI 10.1212/WNL.54.2.491; Daoud H, 2011, ARCH NEUROL-CHICAGO, V68, P739, DOI 10.1001/archneurol.2011.111; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fernandez M, 2000, NEUROLOGY, V55, P569, DOI 10.1212/WNL.55.4.569; Fischbeck KH, 2011, NEUROLOGY, V76, P2050, DOI 10.1212/WNL.0b013e31821f4498; Futamura N, 1998, ACTA NEUROL SCAND, V98, P55, DOI 10.1111/j.1600-0404.1998.tb07378.x; Gellera C, 2012, NEUROBIOL AGING, DOI [10.1016/j.neurobiolaging.2012.02.004, DOI 10.1016/J.NEUR0BI0LAGING.2012.02.004]; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Gispert S, 2012, NEUROBIOL DIS, V45, P356, DOI 10.1016/j.nbd.2011.08.021; Hart M, 2012, ALS ASS ATAXIN 2 POL, DOI [10.1523/JNEUROSCI.0996-12.2012, DOI 10.1523/JNEUR0SCI.0996-12.2012]; Hart MP, 2012, ACTA NEUROPATHOL, V124, P221, DOI 10.1007/s00401-012-0985-5; HERNANDEZ A, 1995, GENOMICS, V25, P433, DOI 10.1016/0888-7543(95)80043-L; Lahut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042956; Lattante S, 2012, NEUROLOGY, V79, P66, DOI 10.1212/WNL.0b013e31825dceca; Lee T, 2011, NEUROLOGY, V76, P2062, DOI 10.1212/WNL.0b013e31821f4447; Lee T, 2011, HUM MOL GENET, V20, P1697, DOI 10.1093/hmg/ddr045; Liu D, 2013, NEUROBIOL AGING, V34, pE3, DOI 10.1016/j.neurobiolaging.2013.03.017; Mao R, 2002, AM J MED GENET, V110, P338, DOI 10.1002/ajmg.10467; Laffita-Mesa JM, 2012, HUM GENET, V131, P625, DOI 10.1007/s00439-011-1101-y; Laffita-Mesa JM, 2012, EUR J HUM GENET, V20, P41, DOI 10.1038/ejhg.2011.154; Mittal U, 2005, J HUM GENET, V50, P155, DOI 10.1007/s10038-005-0233-0; Mizushima K, 1999, J MED GENET, V36, P112; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Paciorkowski AR, 2011, NEUROLOGY, V77, P1055, DOI 10.1212/WNL.0b013e31822e5627; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ramos EM, 2010, AM J MED GENET B, V153B, P524, DOI 10.1002/ajmg.b.31013; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ross OA, 2011, HUM MOL GENET, V20, P3207, DOI 10.1093/hmg/ddr227; Santos Nieves, 1999, Biotecnologia Aplicada, V16, P219; Schols L, 2000, HUM GENET, V107, P132, DOI 10.1007/s004390000346; Shizuka M, 1998, J NEUROL SCI, V161, P85, DOI 10.1016/S0022-510X(98)00270-6; Soraru G, 2011, NEUROLOGY, V76, P2030, DOI 10.1212/WNL.0b013e31821e557a; Stevanin G, 1998, HUM MOL GENET, V7, P1809, DOI 10.1093/hmg/7.11.1809; Van Damme P, 2011, NEUROLOGY, V76, P2066, DOI 10.1212/WNL.0b013e31821f445b; Van Langenhove T, 2011, NEUROBIOL AGING, DOI [10.1016/j.neurobiolaging.2011.09.025, DOI 10.1016/J.NEUR0BI0LAGING.2011.09.025]; Velazquez-Perez L, 2011, CEREBELLUM, V10, P184, DOI 10.1007/s12311-011-0265-2; Yu ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017951; Zaldivar T, 2009, NEUROLOGY, V72, P1640, DOI 10.1212/WNL.0b013e3181a55f7b	49	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70560	10.1371/journal.pone.0070560	http://dx.doi.org/10.1371/journal.pone.0070560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936447	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500043
J	Sasaya, K; Sudo, H; Maeda, G; Kawashiri, S; Imai, K				Sasaya, Kazunobu; Sudo, Haruka; Maeda, Genta; Kawashiri, Shuichi; Imai, Kazushi			Concomitant Loss of p120-Catenin and beta-Catenin Membrane Expression and Oral Carcinoma Progression with E-Cadherin Reduction	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GROWTH-FACTOR RECEPTOR; P120 CATENIN; ALPHA-CATENIN; CANCER; BREAST; TRANSITION; ADHESION; BINDING; DOMAIN	The binding of p120-catenin and beta-catenin to the cytoplasmic domain of E-cadherin establishes epithelial cell-cell adhesion. Reduction and loss of catenin expression degrades E-cadherin-mediated carcinoma cell-cell adhesion and causes carcinomas to progress into aggressive states. Since both catenins are differentially regulated and play distinct roles when they dissociate from E-cadherin, evaluation of their expression, subcellular localization and the correlation with E-cadherin expression are important subjects. However, the same analyses are not readily performed on squamous cell carcinomas in which E-cadherin expression determines the disease progression. In the present study, we examined expression and subcellular localization of p120-catenin and beta-catenin in oral carcinomas (n = 67) and its implications in the carcinoma progression and E-cadherin expression using immunohitochemistry. At the invasive front, catenin-membrane-positive carcinoma cells were decreased in the dedifferentiated (p120-catenin, P < 0.05; beta-catenin, P < 0.05) and invasive carcinomas (p120-catenin, P < 0.01; beta-catenin, P < 0.05) and with the E-cadherin staining (p120-catenin, P < 0.01; beta-catenin, P < 0.01). Carcinoma cells with beta-catenin cytoplasmic and/or nuclear staining were increased at the invasive front compared to the center of tumors (P < 0.01). Although the p120-catenin isoform shift from three to one associates with carcinoma progression, it was not observed after TGF-beta, EGF or TNF-alpha treatments. The total amount of p120-catenin expression was decreased upon co-treatment of TGF-beta with EGF or TNF-alpha. The above data indicate that catenin membrane staining is a primary determinant for E-cadherin-mediated cell-cell adhesion and progression of oral carcinomas. Furthermore, it suggests that loss of p120-catenin expression and cytoplasmic localization of beta-catenin fine-tune the carcinoma progression.	[Sasaya, Kazunobu; Sudo, Haruka; Maeda, Genta; Imai, Kazushi] Nippon Dent Univ Tokyo, Dept Biochem, Sch Life Dent Tokyo, Tokyo, Japan; [Kawashiri, Shuichi] Kanazawa Univ, Sch Med, Dept Oral Surg, Kanazawa, Ishikawa 920, Japan	Nippon Dental University; Kanazawa University	Imai, K (corresponding author), Nippon Dent Univ Tokyo, Dept Biochem, Sch Life Dent Tokyo, Tokyo, Japan.	kimai@tky.ndu.ac.jp	Imai, Kazushi/E-7206-2012		JSPS KAKENHI [22592103]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from JSPS KAKENHI 22592103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt R, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/616023; Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anbalagan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033017; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Chung Y, 2007, ANN SURG ONCOL, V14, P3260, DOI 10.1245/s10434-007-9511-8; Daley WP, 2012, DEVELOPMENT, V139, P411, DOI 10.1242/dev.075366; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Esposito NN, 2007, MODERN PATHOL, V20, P130, DOI 10.1038/modpathol.3800721; Fujii M, 2011, J MOL HISTOL, V42, P499, DOI 10.1007/s10735-011-9357-z; Gu BN, 2010, J CELL BIOCHEM, V110, P1279, DOI 10.1002/jcb.22650; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hamada S, 2013, J CELL PHYSIOL, V228, P1255, DOI 10.1002/jcp.24280; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047899; Howe LR, 2003, CANCER RES, V63, P1906; Imai K, 2012, SQUAMOUS CELL CARCIN, P121; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jin HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040355; Langner C, 2004, J CLIN PATHOL, V57, P773, DOI 10.1136/jcp.2003.015743; Liu H, 2007, CELL STRUCT FUNCT, V32, P127, DOI 10.1247/csf.07023; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; Maeda G, 2005, INT J ONCOL, V27, P1535; Maeda G, 2007, ODONTOLOGY, V95, P24, DOI 10.1007/s10266-007-0068-6; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Miyashita Y, 2007, J CELL SCI, V120, P4395, DOI 10.1242/jcs.03489; Mizunuma H, 2003, BRIT J CANCER, V88, P1543, DOI 10.1038/sj.bjc.6600952; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Ohsugi M, 1997, DEV BIOL, V185, P261, DOI 10.1006/dbio.1997.8560; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P760, DOI 10.2741/3956; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Srinivasan R, 2000, CANCER RES, V60, P1483; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Uraguchi M, 2004, J DENT RES, V83, P327, DOI 10.1177/154405910408300411; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Wang EH, 2006, HISTOL HISTOPATHOL, V21, P841, DOI 10.14670/HH-21.841; Westfall MD, 2004, CARCINOGENESIS, V25, P857, DOI 10.1093/carcin/bgh148; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yang ZB, 2004, CLIN CANCER RES, V10, P658, DOI 10.1158/1078-0432.CCR-0382-03; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang JY, 2010, J PATHOL, V222, P76, DOI 10.1002/path.2742	55	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69777	10.1371/journal.pone.0069777	http://dx.doi.org/10.1371/journal.pone.0069777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936352	gold, Green Published, Green Submitted			2022-12-27	WOS:000324401500018
J	Schartum-Hansen, H; Ueland, PM; Pedersen, ER; Meyer, K; Ebbing, M; Bleie, O; Svingen, GFT; Seifert, R; Vikse, BE; Nygard, O				Schartum-Hansen, Hall; Ueland, Per M.; Pedersen, Eva R.; Meyer, Klaus; Ebbing, Marta; Bleie, Oyvind; Svingen, Gard F. T.; Seifert, Reinhard; Vikse, Bjorn E.; Nygard, Ottar			Assessment of Urinary Betaine as a Marker of Diabetes Mellitus in Cardiovascular Patients	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; GLYCINE BETAINE; MASS-SPECTROMETRY; HOMOCYSTEINE METABOLISM; PROLINE BETAINE; PLASMA; EXCRETION; CHOLINE; DIMETHYLGLYCINE; DIAGNOSIS	Abnormal urinary excretion of betaine has been demonstrated in patients with diabetes or metabolic syndrome. We aimed to identify the main predictors of excretion in cardiovascular patients and to make initial assessment of its feasibility as a risk marker of future diabetes development. We used data from 2396 patients participating in the Western Norway B-vitamin Intervention Trial, who delivered urine and blood samples at baseline, and in the majority at two visits during follow-up of median 39 months. Betaine in urine and plasma were measured by liquid-chromatography-tandem mass spectrometry. The strongest determinants of urinary betaine excretion by multiple regression were diabetes mellitus, age and estimated glomerular filtration rate; all p < 0.001. Patients with diabetes mellitus (n = 264) had a median excretion more than three times higher than those without. We found a distinct non-linear association between urinary betaine excretion and glycated hemoglobin, with a break-point at 6.5%, and glycated hemoglobin was the strongest determinant of betaine excretion in patients with diabetes mellitus. The discriminatory power for diabetes mellitus corresponded to an area under the curve by receiver-operating characteristics of 0.82, and betaine excretion had a coefficient of reliability of 0.73. We also found a significant, independent log-linear relation between baseline betaine excretion and the risk of developing new diabetes during follow-up. The good discriminatory power for diabetes, high test-retest stability and independent association with future risk of new diabetes should motivate further investigation on the role of betaine excretion in risk assessment and long-term follow-up of diabetes mellitus.	[Schartum-Hansen, Hall; Pedersen, Eva R.; Svingen, Gard F. T.; Nygard, Ottar] Univ Bergen, Dept Clin Sci, Cardiol Sect, Bergen, Norway; [Schartum-Hansen, Hall] Univ Bergen, Nordic Ctr Excellence Human Nutr MitoHlth, Bergen, Norway; [Schartum-Hansen, Hall; Ebbing, Marta; Bleie, Oyvind; Seifert, Reinhard; Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Ueland, Per M.] Univ Bergen, Dept Clin Sci, Pharmacol Sect, Bergen, Norway; [Ueland, Per M.] Haukeland Hosp, Lab Clin Biochem, N-5021 Bergen, Norway; [Meyer, Klaus] Bevital AS, Bergen, Norway; [Vikse, Bjorn E.] Univ Bergen, Dept Clin Sci, Renal Res Grp, Bergen, Norway; [Vikse, Bjorn E.] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Schartum-Hansen, H (corresponding author), Univ Bergen, Dept Clin Sci, Cardiol Sect, Bergen, Norway.	hlsc@helse-bergen.no	Ueland, Per M/C-7340-2013	Pedersen, Eva Ringdal/0000-0002-2545-1866; Ueland, Per Magne/0000-0002-1903-0571	University of Bergen, Bergen, Norway; Nordic Centre of Excellence Programme on Food, Nutrition and Health - MitoHealth, Bergen, Norway; Foundation to Promote Research into Functional Vitamin B12-Deficiency, Bergen, Norway	University of Bergen, Bergen, Norway; Nordic Centre of Excellence Programme on Food, Nutrition and Health - MitoHealth, Bergen, Norway; Foundation to Promote Research into Functional Vitamin B12-Deficiency, Bergen, Norway	This work was funded by the University of Bergen, Bergen, Norway, the Nordic Centre of Excellence Programme on Food, Nutrition and Health - MitoHealth, Bergen, Norway and the Foundation to Promote Research into Functional Vitamin B12-Deficiency, Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson W, 2007, EUR J NUTR, V46, P446, DOI 10.1007/s00394-007-0684-5; Biroccio A, 2005, ANAL BIOCHEM, V336, P279, DOI 10.1016/j.ab.2004.10.002; Conti M, 2009, CLIN CHEM LAB MED, V47, P1553, DOI 10.1515/CCLM.2009.341; Dellow WJ, 1999, DIABETES RES CLIN PR, V43, P91, DOI 10.1016/S0168-8227(98)00115-6; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Gloyn AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040962; Holm PI, 2003, CLIN CHEM, V49, P286, DOI 10.1373/49.2.286; Inzucchi SE, 2012, NEW ENGL J MED, V367, P542, DOI 10.1056/NEJMcp1103643; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; LEVER M, 1994, CLIN CHIM ACTA, V230, P69, DOI 10.1016/0009-8981(94)90090-6; Lever M, 2005, METABOLISM, V54, P1, DOI 10.1016/j.metabol.2004.07.007; Lever M, 2004, CLIN BIOCHEM, V37, P184, DOI 10.1016/j.clinbiochem.2003.11.004; LEVER M, 1994, BBA-GEN SUBJECTS, V1200, P259, DOI 10.1016/0304-4165(94)90165-1; Lever M, 2007, CLIN BIOCHEM, V40, P798, DOI 10.1016/j.clinbiochem.2007.03.009; Lever M, 2007, CLIN BIOCHEM, V40, P447, DOI 10.1016/j.clinbiochem.2006.10.029; Lever M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-34; Lever M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037883; Lever M, 2009, CARDIOVASC DRUG THER, V23, P395, DOI 10.1007/s10557-009-6188-1; Lever M, 2009, CLIN BIOCHEM, V42, P706, DOI 10.1016/j.clinbiochem.2009.02.001; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LIN CS, 1986, J PROTEIN CHEM, V5, P193, DOI 10.1007/BF01025488; Matheson A, 2010, DIABETES-METAB RES, V26, P150, DOI 10.1002/dmrr.1068; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Neuhofer W, 2005, ANNU REV PHYSIOL, V67, P531, DOI 10.1146/annurev.physiol.67.031103.154456; Padilla Maria Cristina Armas, 2007, Am J Ther, V14, P154, DOI 10.1097/01.pap.0000249938.05382.d0; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Pummer S, 2000, AM J PHYSIOL-RENAL, V278, pF434, DOI 10.1152/ajprenal.2000.278.3.F434; QuinonesGalvan A, 1997, J NEPHROL, V10, P188; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Thomas MC, 2005, ADV CHRONIC KIDNEY D, V12, P177, DOI 10.1053/j.ackd.2005.01.008; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Wijekoon EP, 2005, DIABETES, V54, P3245, DOI 10.2337/diabetes.54.11.3245; Windelberg A, 2005, CLIN CHEM, V51, P2103, DOI 10.1373/clinchem.2005.053835; WUNZ TM, 1993, AM J PHYSIOL, V264, pF948, DOI 10.1152/ajprenal.1993.264.6.F948	37	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69454	10.1371/journal.pone.0069454	http://dx.doi.org/10.1371/journal.pone.0069454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936331	Green Submitted, Green Published, gold			2022-12-27	WOS:000324401500010
J	Avila-Poveda, OH; Abadia-Chanona, QY				Avila-Poveda, Omar Hernando; Abadia-Chanona, Quetzalli Yasu			Emergence, Development, and Maturity of the Gonad of Two Species of Chitons "Sea Cockroach" (Mollusca: Polyplacophora) through the Early Life Stages	PLOS ONE			English	Article							LEPIDOCHITONA-CINEREUS MOLLUSCA; SEXUAL-DIFFERENTIATION; POPULATION-STRUCTURE; TONICELLA-MARMOREA; MAZATLAN BAY; OOGENESIS; MORPHOLOGY; ULTRASTRUCTURE; FERTILIZATION; OOCYTES	This study describes and recognises, using histological and microscopical examinations on a morphometrical basis, several gonad traits through the early life stages of Chiton articulatus and C. albolineatus. Gonadal ontogenesis, gonad development stages, sexual differentiation, onset of the first sexual maturity, and growth sequences or "early life stages" were determined. In addition, allometry between lengths and body weight pooled for both sexes per each chiton were calculated using equation Y=aX(b). A total of 125 chitons (4 <= TL <= 40 mm, in total length "TL") were used. All allometric relations showed a strong positive correlation (r), close to 1, with b-values above three, indicating an isometric growth. Gonadal ontogenesis and gonad development stages were categorised into three periods ("Pw" without gonad, "Pe" gonad emergence, and "Pf" gonadal sac formed) and four stages ("S0" gametocytogenesis, "S1" gametogenesis, "S2" mature, and "S3" spawning), respectively. Compound digital images were attained for each process. Periods and stages are overlapped among them and between species, with the following overall confidence intervals in TL: Pw 6.13-14.32 mm, Pe 10.32-16.93 mm, Pf 12.99-25.01 mm, S0 16.08-24.34 mm (females) and 19.51-26.60 mm (males), S1 27.15-35.63 mm (females) and 23.45-32.27 mm (males), S2 24.48-40.24 mm (females) and 25.45-32.87 mm (males). Sexual differentiation (in S0) of both chitons occurs first as a female then as a male; although, males reach the onset of the first sexual maturity earlier than females, thus for C. articulatus males at 17 mm and females at 32 mm, and for C. albolineatus males at 23.5 mm and females at 28 mm, all in TL. Four early life stages (i.e., subjuvenile, juvenile, subadult, and adult) are described and proposed to distinguish growth sequences. Our results may be useful to diverse disciplines, from developmental biology to fisheries management.	[Avila-Poveda, Omar Hernando] Univ Mar, Div Estudios Posgrad, UMAR, Puerto Angel, Oaxaca, Mexico; [Abadia-Chanona, Quetzalli Yasu] Univ Mar UMAR, Lab Histol, Puerto Angel, Oaxaca, Mexico		Avila-Poveda, OH (corresponding author), Univ Mar, Div Estudios Posgrad, UMAR, Puerto Angel, Oaxaca, Mexico.	oavila@colombia.com	Avila-Poveda, Omar Hernando/B-7533-2012	Avila-Poveda, Omar Hernando/0000-0002-4411-0602	SNI-CONACYT [44175]; UMAR [2II1108]; SAGARPA-CONACyT [2003-C01-125]; SERVITORNO-AVILA	SNI-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UMAR; SAGARPA-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SERVITORNO-AVILA	Funding for this research was supported in multiple ways: securing the samplings was personally done by O. H. Avila-Poveda with the SNI-CONACYT stimulus (number 44175, from January to July 2012). Facilities for the use of histology equipment were supported by UMAR project number 2II1108 to O. H. Avila-Poveda, and by SAGARPA-CONACyT project number 2003-C01-125 acquired by S. J. Serrano-Guzman. All of the histological materials were generously donated by S. J. Serrano-Guzman (UMAR Professor-Researcher; SAGARPA-CONACyT Project No. 2003-C01-125). The stay in the locality during all collections, the histological processing and writing of this research was sponsored by a grant familial (SERVITORNO-AVILA) to O. H. Avila-Poveda. Except for O. H. Avila-Poveda, the other funders had no role in study design, collections and data analysis, decision to publish, or preparation of the manuscript.	Adiyodi KG, 1983, OOGENESIS OVIPOSITIO, V1; ANDERSON E, 1969, J MORPHOL, V129, P89, DOI 10.1002/jmor.1051290107; Aquinas-Nimitz M, 1964, Q J MICROSC SCI, V105, P481; Avila-Poveda OH, 2013, AM MALACOL BULL, V31, P65, DOI 10.4003/006.031.0118; Avila-Poveda OH, 2009, INVERTEBR REPROD DEV, V53, P1, DOI 10.1080/07924259.2009.9652284; Avila-Poveda OH, 2009, BIOL BULL-US, V216, P94, DOI 10.1086/BBLv216n1p94; Ball JJ, 1999, THESIS SAN DIEGO STA; BAXTER JM, 1978, MAR BIOL, V46, P305, DOI 10.1007/BF00391401; BAXTER JM, 1986, ZOOL J LINN SOC-LOND, V88, P167, DOI 10.1111/j.1096-3642.1986.tb01185.x; BAXTER JM, 1982, J MOLLUS STUD, V48, P275, DOI 10.1093/oxfordjournals.mollus.a065649; Benitez-Villalobos F, 2012, AQUAT BIOL, V17, P119, DOI 10.3354/ab00467; Boletzky SV, 2003, ADV MAR BIOL, V44, P143, DOI 10.1016/S0065-2881(03)44003-0; Buckland-Nicks J, 2000, BIOL BULL, V199, P59, DOI 10.2307/1542707; Buckland-Nicks J, 2008, AM MALACOL BULL, V25, P97, DOI 10.4003/0740-2783-25.1.97; Buckland-Nicks J, 2008, BIOL BULL-US, V214, P182; Buckland-Nicks J, 2010, INVERTEBR BIOL, V129, P319, DOI 10.1111/j.1744-7410.2010.00208.x; Buckland-Nicks J, 2009, INVERTEBR REPROD DEV, V53, P165, DOI 10.1080/07924259.2009.9652302; BUCKLANDNICKS J, 1993, BIOL BULL-US, V184, P269, DOI 10.2307/1542445; BUCKLANDNICKS J, 1990, ZOOMORPHOLOGY, V109, P179, DOI 10.1007/BF00312469; BUCKLANDNICKS JA, 1993, J EXP ZOOL, V265, P567, DOI 10.1002/jez.1402650513; Coe WR, 1944, Q REV BIOL, V19, P85, DOI 10.1086/394688; Coe WR, 1943, Q REV BIOL, V18, P154, DOI 10.1086/394673; Connors MJ, 2012, J STRUCT BIOL, V177, P314, DOI 10.1016/j.jsb.2011.12.019; COWDEN RR, 1974, DIFFERENTIATION, V2, P249, DOI 10.1111/j.1432-0436.1974.tb00358.x; COWDEN RR, 1961, BIOL BULL, V120, P313, DOI 10.2307/1539533; Crossmon G, 1937, ANAT REC, V69, P33, DOI 10.1002/ar.1090690105; DAVENPORT R, 1965, EXP CELL RES, V39, P74, DOI 10.1016/0014-4827(65)90009-1; Deshpande U.D., 1983, Proceedings of the Indian National Science Academy Part B Biological Sciences, V49, P613; DESHPANDE UD, 1983, MAR BIOL, V72, P227, DOI 10.1007/BF00396827; DURFORT M, 1982, MALACOLOGIA, V22, P211; EERNISSE DJ, 1988, BIOL BULL, V174, P287, DOI 10.2307/1541955; Fioroni P., 1983, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V109, P153; Flores-Campanal LM, 2007, REV MEX BIODIVERS, V78, p23S; Flores-Garza R., 2012, NATURAL RESOURCES, V3, P11, DOI [10.4236, DOI 10.4236/NR.2012.31003]; Garnault P, 1888, ARCH ZOOLOGIE EXPT G, V6, P83; Gaymer CF, 2004, VELIGER, V47, P141; GRASSO M, 1971, Monitore Zoologico Italiano, V5, P133; Gray P, 1954, BLAKISTON, V43, P403; GUTIERREZ M, 1967, INVEST PESQ, V31, P265; Haller B xEla, 1906, Jenaische Zeitschrift fuer Naturwissenschaft, V41, P159; Heath H, 1908, ZOOL ANZ, V32, P10; Higley RM, 1912, BIOL BULL-US, V22, P95, DOI 10.2307/1536171; Holguin-Quinones O.E., 2006, RECURSOS PESQUEROS A; Hu Bing, 2008, Zoological Research, V29, P145; HUNTER WR, 1965, BIOL BULL, V128, P508, DOI 10.2307/1539910; Ituarte C, 2010, MALACOLOGIA, V53, P167, DOI 10.4002/040.053.0110; Leon-Herrera R, 2009, DISTRIBUCION TALLAS; Lincoln R.J., 1979, INVERTEBRATE ANIMALS, P150, DOI [10.5962/bhl.title.138449, DOI 10.5962/BHL.TITLE.138449]; LUBET P, 1981, ARCH ANAT MICROSC MO, V70, P47; Martinez R, 2011, AQUAT BIOL, V11, P249, DOI 10.3354/ab00305; Flores-Campana LM, 2012, REV BIOL MAR OCEANOG, V47, P203, DOI 10.4067/S0718-19572012000200004; Montalenti Giuseppe, 1946, PUBBL STAZ ZOOL NAPOLI, V20, P1; Olea-de-la-Cruz FG, 2011, 44 W SOC MAL ANN M 1; OTWAY NM, 1994, MAR BIOL, V121, P105, DOI 10.1007/BF00349479; Pashchenko SV, 1998, INVERTEBR REPROD DEV, V33, P47, DOI 10.1080/07924259.1998.9652341; Plate L.H., 1898, ZOOLOGISCHE JAHRBU S, V4, P1; Plate LH, 1902, ZOOL JAHRB         S, V5, P281; Plate LH, 1902, ZOOLOGISCHE JB S, V5, P15; Quinones OEH, 2002, J SHELLFISH RES, V21, P239; Ramirez-Alvarez C, 2014, INVERTEBR REPROD DEV, V58, P49, DOI 10.1080/07924259.2013.808709; RICHTER HP, 1976, HELGOLAND WISS MEER, V28, P250, DOI 10.1007/BF01610585; RICHTER HP, 1986, DEV GROWTH DIFFER, V28, P7; RICHTER HP, 1974, HELGOLAND WISS MEER, V26, P42, DOI 10.1007/BF01613304; RUSSELLPINTO F, 1983, GAMETE RES, V8, P345, DOI 10.1002/mrd.1120080405; SAKKER ER, 1984, ZOOMORPHOLOGY, V104, P111, DOI 10.1007/BF00312025; Scarano A, 2009, J MOLLUS STUD, V75, P91, DOI 10.1093/mollus/eyn039; SCHELTEMA AH, 1973, Z MORPHOL TIERE, V76, P97, DOI 10.1007/BF00452060; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schwabe E, 2010, SPIXIANA, V33, P171; Schweikart A., 1904, Zoologischer Anzeiger, Vxxvii, P636; SELWOOD L, 1968, J MORPHOL, V125, P71, DOI 10.1002/jmor.1051250105; SELWOOD L, 1970, Z ZELLFORSCH MIK ANA, V104, P178, DOI 10.1007/BF00309729; Villegas-Maldonado S, 2007, ESTUDIOS MALACOLOGIA, P57; Von Boletzky S., 1989, GEOBIOS-LYON, V22, P67; Zar JH., 2010, BIOSTAT ANAL, V5th; [No title captured]	76	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69785	10.1371/journal.pone.0069785	http://dx.doi.org/10.1371/journal.pone.0069785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936353	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800025
J	Kressner, C; Nollau, P; Grosse, R; Brandt, DT				Kressner, Camilla; Nollau, Peter; Grosse, Robert; Brandt, Dominique T.			Functional Interaction of SCAI with the SWI/SNF Complex for Transcription and Tumor Cell Invasion	PLOS ONE			English	Article							SWI-SNF COMPLEX; CYCLE ARREST; CANCER; BRG1; EXPRESSION; SUPPRESSOR; SUBUNIT	We have recently characterized SCAI (Suppressor of Cancer Cell Invasion), a transcriptional modulator regulating cancer cell motility through suppression of MAL/SRF dependent gene transcription. We show here that SCAI is expressed in a wide range of normal human tissues and its expression is diminished in a large array of primary human breast cancer samples indicating that SCAI expression might be linked to the etiology of human cancer. To establish a functional link between SCAI and tumorigenesis we performed affinity columns to identify SCAI-interacting proteins. Our data show that SCAI interacts with the tumor suppressing SWI/SNF chromatin remodeling complex to promote changes in gene expression and the invasive capacities of human tumor cells. Moreover our data implicate a functional hierarchy between SCAI and BRM, since SCAI function is abrogated in the absence of BRM expression.	[Kressner, Camilla; Grosse, Robert; Brandt, Dominique T.] Univ Marburg, Inst Pharmacol, Marburg, Germany; [Nollau, Peter] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, Hamburg, Germany	Philipps University Marburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Brandt, DT (corresponding author), Univ Marburg, Inst Pharmacol, Marburg, Germany.	dominique.brandt@staff.uni-marburg.de		Grosse, Robert/0000-0002-3380-5273	Wilhelm-Sander Stiftung [2010.038.1]; Deutsche Forschungs Gemeinschaft [GR 2111/2-1]	Wilhelm-Sander Stiftung; Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Wilhelm-Sander Stiftung to DTB (Nr. 2010.038.1) and by a grant to RG by the Deutsche Forschungs Gemeinschaft (GR 2111/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Dierck Kevin, 2009, V527, P131, DOI 10.1007/978-1-60327-834-8_11; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Farrants AKO, 2008, FEBS LETT, V582, P2041, DOI 10.1016/j.febslet.2008.04.032; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Kleer CG, 2002, AM J PATHOL, V160, P579, DOI 10.1016/S0002-9440(10)64877-8; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69947	10.1371/journal.pone.0069947	http://dx.doi.org/10.1371/journal.pone.0069947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936361	Green Submitted, gold, Green Published			2022-12-27	WOS:000324545800026
J	Okemoto, K; Wagner, B; Meisen, H; Haseley, A; Kaur, B; Chiocca, EA				Okemoto, Kazuo; Wagner, Benjamin; Meisen, Hans; Haseley, Amy; Kaur, Balveen; Chiocca, Ennio Antonio			STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; GENE-EXPRESSION; SMALL-MOLECULE; BRAIN-TUMORS; VIRUS; INHIBITION	Recent studies report that STAT3 signaling is a master regulator of mesenchymal transformation of gliomas and that STAT3 modulated genes are highly expressed in the mesenchymal transcriptome of gliomas. A currently studied experimental treatment for gliomas consists of intratumoral injection of oncolytic viruses (OV), such as oncolytic herpes simplex virus type 1 (oHSV). We have described one particular oHSV (rQNestin34.5) that exhibits potent anti-glioma activity in animal models. Here, we hypothesized that alterations in STAT3 signaling in glioma cells may affect the replicative ability of rQNestin34.5. In fact, human U251 glioma cells engineered to either over-express STAT3 or with genetic down-regulation of STAT3 supported oHSV replication to a significantly higher or lesser degree, respectively, when compared to controls. Administration of pharmacologic agents that increase STAT3 phosphorylation/activation (Valproic Acid) or increase STAT3 levels (Interleukin 6) also significantly enhanced oHSV replication. Instead, administration of inhibitors of STAT3 phosphorylation/activation (LLL12) significantly reduced oHSV replication. STAT3 led to a reduction in interferon signaling in oHSV infected cells and inhibition of interferon signaling abolished the effect of STAT3 on oHSV replication. These data thus indicate that STAT3 signaling in malignant gliomas enhances oHSV replication, likely by inhibiting the interferon response in infected glioma cells, thus suggesting avenues for possible potentiation of oncolytic virotherapy.	[Okemoto, Kazuo; Wagner, Benjamin; Meisen, Hans; Haseley, Amy; Kaur, Balveen; Chiocca, Ennio Antonio] Ohio State Univ, James Canc Hosp, Ctr Comprehens Canc,Dept Neurol Surg, Dardinger Ctr Neurooncol & Neurosci,Solove Res In, Columbus, OH 43210 USA; [Okemoto, Kazuo; Wagner, Benjamin; Meisen, Hans; Haseley, Amy; Kaur, Balveen; Chiocca, Ennio Antonio] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Chiocca, Ennio Antonio] Brigham & Womens Faulkner Hosp, Inst Neurosci Brigham, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA USA; [Chiocca, Ennio Antonio] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute	Chiocca, EA (corresponding author), Ohio State Univ, James Canc Hosp, Ctr Comprehens Canc,Dept Neurol Surg, Dardinger Ctr Neurooncol & Neurosci,Solove Res In, Columbus, OH 43210 USA.	Eachiocca@partners.org	kaur, Balveen/E-3355-2011		NIH [1P01CA163205-01A1]; NATIONAL CANCER INSTITUTE [R01CA150153, P01CA163205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064607] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant 1P01CA163205-01A1 to EAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwalla PK, 2012, METHODS MOL BIOL, V797, P1, DOI 10.1007/978-1-61779-340-0_1; Ahmed AU, 2012, METHODS MOL BIOL, V797, P97, DOI 10.1007/978-1-61779-340-0_8; Alvarez-Breckenridge CA, 2012, J VIROL, V86, P4566, DOI 10.1128/JVI.05545-11; Ball S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018820; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; Dempsey MF, 2006, NUCL MED COMMUN, V27, P611, DOI 10.1097/00006231-200608000-00003; Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016; Hernandez-Alcoceba R, 2011, CLIN TRANSL ONCOL, V13, P229, DOI 10.1007/s12094-011-0647-4; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; Kohsaka S, 2012, MOL CANCER THER, V11, P1289, DOI 10.1158/1535-7163.MCT-11-0801; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Liu Y, 2010, ANTI-CANCER AGENT ME, V10, P512, DOI 10.2174/187152010793498636; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Wei J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016195, 10.1371/journal.pone.0017868]; Wollmann G, 2012, CANCER J, V18, P69, DOI 10.1097/PPO.0b013e31824671c9	19	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71932	10.1371/journal.pone.0071932	http://dx.doi.org/10.1371/journal.pone.0071932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936533	Green Submitted, gold, Green Published			2022-12-27	WOS:000324545800072
J	Buchanan, CM; Dickson, JMJ; Lee, WJ; Guthridge, MA; Kendall, JD; Shepherd, PR				Buchanan, Christina M.; Dickson, James M. J.; Lee, Woo-Jeong; Guthridge, Mark A.; Kendall, Jackie D.; Shepherd, Peter R.			Oncogenic Mutations of p110 alpha Isoform of PI 3-Kinase Upregulate Its Protein Kinase Activity	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; SERINE KINASE; LIPID KINASE; CATALYTIC SUBUNIT; PIK3CA GENE; IN-VITRO; INSULIN; AUTOPHOSPHORYLATION; P110-DELTA; P85	In addition to lipid kinase activity, the class-I PI 3-kinases also function as protein kinases targeting regulatory autophosphorylation sites and exogenous substrates. The latter include a recently identified regulatory phosphorylation of the GM-CSF/IL-3 beta c receptor contributing to survival of acute myeloid leukaemia cells. Previous studies suggested differences in the protein kinase activity of the 4 isoforms of class-I PI 3-kinase so we compared the ability of all class-I PI 3-kinases and 2 common oncogenic mutants to autophosphorylate, and to phosphorylate an intracellular fragment of the GM-CSF/IL-3 beta c receptor (beta ic). We find p110 alpha, p110 beta and p110 gamma all phosphorylate beta ic but p110 beta is much less effective. The two most common oncogenic mutants of p110 alpha, H1047R and E545K have stronger protein kinase activity than wildtype p110 delta, both in terms of autophosphorylation and towards beta ic. Importantly, the lipid kinase activity of the oncogenic mutants is still inhibited by autophosphorylation to a similar extent as wildtype p110 alpha. Previous evidence indicates the protein kinase activity of p110 alpha is Mn2+ dependent, casting doubt over its role in vivo. However, we show that the oncogenic mutants of p110 alpha plus p110b beta and p110 gamma all display significant activity in the presence of Mg2+. Furthermore we demonstrate that some small molecule inhibitors of p110 alpha lipid kinase activity (PIK-75 and A66) are equally effective against the protein kinase activity, but other inhibitors (e.g. wortmannin and TGX221) show different patterns of inhibition against the lipid and protein kinases activities. These findings have implications for the function of PI 3-kinase, especially in tumours carrying p110 alpha mutations.	[Buchanan, Christina M.; Lee, Woo-Jeong; Shepherd, Peter R.] Univ Auckland, Dept Mol Med, Auckland, New Zealand; [Buchanan, Christina M.; Dickson, James M. J.; Kendall, Jackie D.; Shepherd, Peter R.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Dickson, James M. J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Guthridge, Mark A.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Kendall, Jackie D.] Univ Auckland, Auckland Canc Soc, Res Ctr, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland; Monash University; University of Auckland	Shepherd, PR (corresponding author), Univ Auckland, Dept Mol Med, Auckland, New Zealand.	peter.shepherd@auckland.ac.nz	guthridge, mark a/I-1889-2014	guthridge, mark a/0000-0002-0536-3471	Maurice Wilkins Centre for Molecular Biodiscovery; Ministry of Business, Innovation and Employment	Maurice Wilkins Centre for Molecular Biodiscovery; Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was funded by The Maurice Wilkins Centre for Molecular Biodiscovery; http://cmb1.auckland.ac.nz/. Dr Buchanan's salary is funded by the Maurice Wilkins Centre for Molecular Biodiscovery, and the salaries of Dr Dickson and Ms Lee are fully funded by a grant from the Ministry of Business, Innovation and Employment; http://www.msi.govt.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Beeton CA, 2000, BIOCHEM J, V350, P353, DOI 10.1042/0264-6021:3500353; Bondev A, 1999, BIOL CHEM, V380, P1337, DOI 10.1515/BC.1999.171; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; Chaussade C, 2009, BIOCHEM BIOPH RES CO, V381, P577, DOI 10.1016/j.bbrc.2009.02.081; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Czupalla C, 2003, J BIOL CHEM, V278, P11536, DOI 10.1074/jbc.M210351200; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Foukas LC, 2004, MOL CELL BIOL, V24, P966, DOI 10.1128/MCB.24.3.966-975.2004; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Geltz NR, 1998, BLOOD, V91, P930, DOI 10.1182/blood.V91.3.930.930_930_939; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Jamieson SM, 2011, BIOCHEM J, V438, P10; Juss JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045933; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; LAM K, 1994, J BIOL CHEM, V269, P20648; Layton MJ, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-30; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Phillips WA, 1998, CANCER, V83, P41, DOI 10.1002/(SICI)1097-0142(19980701)83:1<41::AID-CNCR6>3.0.CO;2-H; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Powell JA, 2009, BLOOD, V114, P4859, DOI 10.1182/blood-2009-02-204818; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Sun MH, 2011, CELL CYCLE, V10, P3731, DOI 10.4161/cc.10.21.17920; TANTI JF, 1994, BIOCHEM J, V304, P17, DOI 10.1042/bj3040017; Uddin S, 1997, J IMMUNOL, V158, P2390; Vanhaesebroeck B, 1999, EMBO J, V18, P1292, DOI 10.1093/emboj/18.5.1292; Vogt PK, 2011, CURR TOP MICROBIOL, V347, P79, DOI 10.1007/82_2010_80; Vogt PK, 2009, CURR OPIN GENET DEV, V19, P12, DOI 10.1016/j.gde.2008.11.011; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; WEDLER FC, 1989, NEUROCHEM RES, V14, P1129, DOI 10.1007/BF00965619; WOSCHOLSKI R, 1994, J BIOL CHEM, V269, P25067; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	44	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71337	10.1371/journal.pone.0071337	http://dx.doi.org/10.1371/journal.pone.0071337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936502	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400105
J	Wang, QY; Kan, BA; Wang, RB				Wang, Qiuya; Kan, Biao; Wang, Ruibai			Isolation and Characterization of the New Mosaic Filamentous Phage VFJ Phi of Vibrio cholerae	PLOS ONE			English	Article							VGJ-PHI; CTX-PHI; BACTERIOPHAGE; TOXIN; VIRULENCE; DNA	Filamentous phages have distinguished roles in conferring many pathogenicity and survival related features to Gram-negative bacteria including the medically important Vibrio cholerae, which carries factors such as cholera toxin on phages. A novel filamentous phage, designated VFJ Phi, was isolated in this study from an ampicillin and kanamycin-resistant O139 serogroup V. cholerae strain ICDC-4470. The genome of VFJ Phi is 8555 nucleotides long, including 12 predicted open reading frames (ORFs), which are organized in a modular structure. VFJW was found to be a mosaic of two groups of V. cholerae phages. A large part of the genome is highly similar to that of the fs2 phage, and the remaining 700 bp is homologous to VEJ and VCY Phi. This 700 bp region gave VFJ Phi several characteristics that are not found in fs2 and other filamentous phages. In its native host ICDC-4470 and newly-infected strain N16961, VFJ Phi was found to exist as a plasmid but did not integrate into the host chromosome. It showed a relatively wide host range but did not infect the classical biotype O1 V. cholerae strains. After infection, the host strains exhibited obvious inhibition of both growth and flagellum formation and had acquired a low level of ampicillin resistance and a high level of kanamycin resistance. The antibiotic resistances were not directly conferred to the hosts by phage-encoded genes and were not related to penicillinase. The discovery of VFJ Phi updates our understanding of filamentous phages as well as the evolution and classification of V. cholerae filamentous phage, and the study provides new information on the interaction between phages and their host bacteria.	[Wang, Qiuya; Kan, Biao; Wang, Ruibai] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Wang, RB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	wangruibai@icdc.cn			National Natural Science Foundation of China [30870099]; National Science and Technology Major Project [2012ZX10004215]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project	This work was supported by grants from the National Natural Science Foundation of China (30870099) and the National Science and Technology Major Project (2012ZX10004215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari W, 2012, J MICROBIOL, V50, P631, DOI 10.1007/s12275-012-2116-3; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Campos J, 2003, J BACTERIOL, V185, P7231, DOI 10.1128/JB.185.24.7231-7240.2003; Campos J, 2003, J BACTERIOL, V185, P5685, DOI 10.1128/JB.185.19.5685-5696.2003; Campos J, 2010, MICROBIOL-SGM, V156, P108, DOI 10.1099/mic.0.032235-0; Das B, 2011, INDIAN J MED RES, V133, P195; Davis BM, 2003, CURR OPIN MICROBIOL, V6, P35, DOI 10.1016/S1369-5274(02)00005-X; Nguyen DT, 2008, FEMS MICROBIOL LETT, V284, P225, DOI 10.1111/j.1574-6968.2008.01200.x; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Faruque SM, 2005, J BACTERIOL, V187, P4095, DOI 10.1128/JB.187.12.4095-4103.2005; HAIGHT TH, 1952, AM J CLIN PATHOL, V22, P806, DOI 10.1093/ajcp/22.8_ts.806; Honma Y, 1997, BBA-MOL BASIS DIS, V1362, P109, DOI 10.1016/S0925-4439(97)00055-0; Ikema M, 1998, MICROBIOL-SGM, V144, P1901, DOI 10.1099/00221287-144-7-1901; Iyer LM, 2006, BIOINFORMATICS, V22, P257, DOI 10.1093/bioinformatics/bti767; Jouravleva EA, 1998, MICROBIOL-UK, V144, P315, DOI 10.1099/00221287-144-2-315; Kar S, 1996, FEMS MICROBIOL LETT, V145, P17, DOI 10.1016/0378-1097(96)00369-2; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; McLeod SM, 2005, MOL MICROBIOL, V57, P347, DOI 10.1111/j.1365-2958.2005.04676.x; Nakasone N, 1998, MICROBIOL IMMUNOL, V42, P237, DOI 10.1111/j.1348-0421.1998.tb02277.x; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; RISHOVD S, 1994, VIROLOGY, V200, P744, DOI 10.1006/viro.1994.1238; Sambrook J., 2001, MOL CLONING LAB MANU; Tsou Amy M, 2008, Commun Integr Biol, V1, P42; Waldor MK, 2005, CURR OPIN MICROBIOL, V8, P459, DOI 10.1016/j.mib.2005.06.001; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Xue H, 2012, APPL ENVIRON MICROB, V78, P28, DOI 10.1128/AEM.06297-11	28	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70934	10.1371/journal.pone.0070934	http://dx.doi.org/10.1371/journal.pone.0070934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936475	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400085
J	Hartung, FM; Renner, B				Hartung, Freda-Marie; Renner, Britta			Social Curiosity and Gossip: Related but Different Drives of Social Functioning	PLOS ONE			English	Article							EPISTEMIC CURIOSITY; OPPORTUNITIES; PSYCHOLOGY; KNOWLEDGE; BEHAVIOR; BELONG; NEED	The present online-questionnaire study examined two fundamental social behaviors, social curiosity and gossip, and their interrelations in an English (n = 218) and a German sample (n = 152). Analyses showed that both samples believed that they are less gossipy but more curious than their peers. Multidimensional SEM of self and trait conceptions indicated that social curiosity and gossip are related constructs but with different patterns of social functions. Gossip appears to serve predominantly entertainment purposes whereas social curiosity appears to be more driven by a general interest in gathering information about how other people feel, think, and behave and the need to belong. Relationships to other personality traits (N, E, O) provided additional evidence for divergent validity. The needs for gathering and disseminating social information might represent two interlinked but different drives of cultural learning.	[Hartung, Freda-Marie; Renner, Britta] Univ Konstanz, Dept Psychol Psychol Assessment & Hlth Psychol, Constance, Germany	University of Konstanz	Hartung, FM (corresponding author), Univ Konstanz, Dept Psychol Psychol Assessment & Hlth Psychol, Constance, Germany.	freda-marie.hartung@uni-konstanz.de; britta.renner@uni-konstanz.de	Renner, Britta/AAW-1895-2020	Renner, Britta/0000-0001-8385-2839				[Anonymous], 2006, EXPLORING PSYCHOL IN; Arbuckle J., 2008, AMOS 17 0 USERS GUID; Bandura Albert, 1977, SOCIAL LEARNING THEO; Baumeister R. F., 2005, CULTURAL ANIMAL HUMA; Baumeister RF, 2004, REV GEN PSYCHOL, V8, P111, DOI 10.1037/1089-2680.8.2.111; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Beersma B, 2011, SOC PSYCHOL PERS SCI, V2, P642, DOI 10.1177/1948550611405073; Ben-Ze'ev A., 1994, GOOD GOSSIP, P11; BERG CA, 1985, ADV CHILD DEV BEHAV, V19, P1, DOI 10.1016/S0065-2407(08)60387-0; Berlyne DE, 1954, BRIT J PSYCHOL, V45, P180, DOI 10.1111/j.2044-8295.1954.tb01243.x; Costa P. T., 1989, NEO PI NEO FFI MAN S; Derech-Zehavi A., 1994, GOOD GOSSIP PP, P180; Dunbar RIM, 1997, HUM NATURE-INT BIOS, V8, P231, DOI 10.1007/BF02912493; Dunbar RIM, 2004, REV GEN PSYCHOL, V8, P100, DOI 10.1037/1089-2680.8.2.100; Feinberg M, 2012, J PERS SOC PSYCHOL, V102, P1015, DOI 10.1037/a0026650; Foster EK, 2004, REV GEN PSYCHOL, V8, P78, DOI 10.1037/1089-2680.8.2.78; Gallagher M., 2007, J POSIT PSYCHOL, V2, P236, DOI [DOI 10.1080/17439760701552345, 10.1080/17439760701552345]; GIAMBRA LM, 1992, PSYCHOL AGING, V7, P150, DOI 10.1037/0882-7974.7.1.150; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; Guerin B, 2006, PSYCHOL REC, V56, P23, DOI 10.1007/BF03395535; Hartung FM, 2011, PERS SOC PSYCHOL B, V37, P796, DOI 10.1177/0146167211400618; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huebner GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037575; KAGAN J, 1972, J PERS SOC PSYCHOL, V22, P51, DOI 10.1037/h0032356; Kang MJ, 2009, PSYCHOL SCI, V20, P963, DOI 10.1111/j.1467-9280.2009.02402.x; Kashdan T.B., 2009, OXFORD HDB POSITIVE, P367, DOI 10.1093/oxfordhb/9780195187243.001.0001/oxfordhb-9780195187243-e-034; Kashdan TB, 2004, J PERS ASSESS, V82, P291, DOI 10.1207/s15327752jpa8203_05; Kashdan TB, 2011, J PERS, V79, P1067, DOI 10.1111/j.1467-6494.2010.00697.x; Kline RB, 2005, PRINCIPLES PRACTICE; Law K. S., 2000, TRANSLATING QUESTION, DOI 10.4135/9781412986373; LEVIN J, 1985, SEX ROLES, V12, P281, DOI 10.1007/BF00287594; Litman JA, 2003, J PERS ASSESS, V80, P75, DOI 10.1207/S15327752JPA8001_16; Litman JA, 2005, PERS INDIV DIFFER, V38, P963, DOI 10.1016/j.paid.2004.09.003; Litman JA, 2008, PERS INDIV DIFFER, V44, P1585, DOI 10.1016/j.paid.2008.01.014; Litman JA, 2007, PERS INDIV DIFFER, V43, P1448, DOI 10.1016/j.paid.2007.04.021; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; LOEWENSTEIN G, 1994, PSYCHOL BULL, V116, P75, DOI 10.1037/0033-2909.116.1.75; Lovden M, 2005, PSYCHOL AGING, V20, P423, DOI 10.1037/0882-7974.20.3.423; McAndrew FT, 2002, J APPL SOC PSYCHOL, V32, P1064, DOI 10.1111/j.1559-1816.2002.tb00256.x; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; Mesoudi A, 2006, BRIT J PSYCHOL, V97, P405, DOI 10.1348/000712605X85871; Piazza J, 2008, EVOL HUM BEHAV, V29, P172, DOI 10.1016/j.evolhumbehav.2007.12.002; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; Renner B, 2006, J PERS ASSESS, V87, P305, DOI 10.1207/s15327752jpa8703_11; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schumacker, 2001, NEW DEV TECHNIQUES S, P269, DOI DOI 10.4324/9781410601858; Sharpsteen DJ, 1987, 95 M AM PSYCH ASS NE; SWANN WB, 1981, J PERS SOC PSYCHOL, V40, P635, DOI 10.1037/0022-3514.40.4.635; Taylor EM, 2005, THESIS W VIRGINIA U; Thompson B, 2004, EXPLORATORY CONFIRMA; Trudewind C., 2000, MOTIVATIONAL PSYCHOL, P15; von Stumm S, 2013, PSYCHOL BULL, V139, P841, DOI 10.1037/a0030746; Watson DC, 2012, SEX ROLES, V67, P494, DOI 10.1007/s11199-012-0160-4; WILSON DS, 2000, EVOLUTION COGNITION, P347	54	18	18	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69996	10.1371/journal.pone.0069996	http://dx.doi.org/10.1371/journal.pone.0069996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936130	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700049
J	Ambatipudi, S; Bhosale, PG; Heath, E; Pandey, M; Kumar, G; Kane, S; Patil, A; Maru, GB; Desai, RS; Watt, FM; Mahimkar, MB				Ambatipudi, Srikant; Bhosale, Priyanka G.; Heath, Emma; Pandey, Manishkumar; Kumar, Gaurav; Kane, Shubhada; Patil, Asawari; Maru, Girish B.; Desai, Rajiv S.; Watt, Fiona M.; Mahimkar, Manoj B.			Downregulation of Keratin 76 Expression during Oral Carcinogenesis of Human, Hamster and Mouse	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DIFFERENTIATION-SPECIFIC KERATINS; GENE-EXPRESSION; CYTOKERATIN EXPRESSION; EPITHELIAL DYSPLASIA; HUMAN HEAD; CANCER; TUMOR; PROTEINS; MODELS	Background: Keratins are structural marker proteins with tissue specific expression; however, recent reports indicate their involvement in cancer progression. Previous study from our lab revealed deregulation of many genes related to structural molecular integrity including KRT76. Here we evaluate the role of KRT76 downregulation in oral precancer and cancer development. Methods: We evaluated KRT76 expression by qRT-PCR in normal and tumor tissues of the oral cavity. We also analyzed K76 expression by immunohistochemistry in normal, oral precancerous lesion (OPL), oral squamous cell carcinoma (OSCC) and in hamster model of oral carcinogenesis. Further, functional implication of KRT76 loss was confirmed using KRT76-knockout (KO) mice. Results: We observed a strong association of reduced K76 expression with increased risk of OPL and OSCC development. The buccal epithelium of DMBA treated hamsters showed a similar trend. Oral cavity of KRT76-KO mice showed preneoplastic changes in the gingivobuccal epithelium while no pathological changes were observed in KRT76 negative tissues such as tongue. Conclusion: The present study demonstrates loss of KRT76 in oral carcinogenesis. The KRT76-KO mice data underlines the potential of KRT76 being an early event although this loss is not sufficient to drive the development of oral cancers. Thus, future studies to investigate the contributing role of KRT76 in light of other tumor driving events are warranted.	[Ambatipudi, Srikant; Bhosale, Priyanka G.; Pandey, Manishkumar; Kumar, Gaurav; Maru, Girish B.; Mahimkar, Manoj B.] Tata Mem Hosp, Canc Res Inst, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India; [Heath, Emma; Watt, Fiona M.] Kings Coll London, Ctr Stem Cells & Regenerat Med, London, England; [Kane, Shubhada; Patil, Asawari] Tata Mem Hosp, Dept Pathol, Tata Mem Ctr, Bombay 400012, Maharashtra, India; [Desai, Rajiv S.] Nair Hosp, Dept Oral Pathol & Microbiol, Coll Dent, Bombay, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; University of London; King's College London; Tata Memorial Centre (TMC); Tata Memorial Hospital	Mahimkar, MB (corresponding author), Tata Mem Hosp, Canc Res Inst, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India.	mmahimkar@actrec.gov.in	Watt, Fiona/AHB-0226-2022; Patil, Asawari/AAW-1878-2020; Kumar, Gaurav/AAU-2967-2021; Ambatipudi, Srikant/GLV-6259-2022	Watt, Fiona/0000-0001-9151-5154; Patil, Asawari/0000-0002-8203-986X; Kumar, Gaurav/0000-0003-2406-1249; MARU, GIRISH/0000-0003-2833-3061; Ambatipudi, Srikant/0000-0003-3102-3603; Bhosale, Priyanka/0000-0003-2832-654X	Lady Tata Memorial Trust, Mumbai; Advanced Centre for Treatment Research and Education in Cancer (ACTREC); UK Medical Research Council; Wellcome Trust	Lady Tata Memorial Trust, Mumbai; Advanced Centre for Treatment Research and Education in Cancer (ACTREC); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thankfully acknowledge Lady Tata Memorial Trust, Mumbai for generously funding MBM for the gene expression profiling study; Advanced Centre for Treatment Research and Education in Cancer (ACTREC) for core funds to MBM and GBM; and the UK Medical Research Council and the Wellcome Trust for the financial support to FMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambatipudi S, 2012, GENE CHROMOSOME CANC, V51, P161, DOI 10.1002/gcc.20940; Biesheuvel CJ, 2008, J CLIN EPIDEMIOL, V61, P125, DOI 10.1016/j.jclinepi.2007.03.002; Bloor BK, 2001, ORAL ONCOL, V37, P251, DOI 10.1016/S1368-8375(00)00094-4; Bloor BK, 2000, J ORAL PATHOL MED, V29, P376, DOI 10.1034/j.1600-0714.2000.290803.x; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; BOYD NM, 1991, CARCINOGENESIS, V12, P1767, DOI 10.1093/carcin/12.10.1767; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; CLAUSEN H, 1986, J INVEST DERMATOL, V86, P249, DOI 10.1111/1523-1747.ep12285369; COLLIN C, 1992, DIFFERENTIATION, V51, P137, DOI 10.1111/j.1432-0436.1992.tb00690.x; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Crowel DL, 1999, J DENT RES, V78, P1256, DOI 10.1177/00220345990780061001; DALE B A, 1990, Critical Reviews in Oral Biology and Medicine, V1, P167; Fillies T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-10; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; GIMENEZCONTI IB, 1990, CANCER RES, V50, P4441; GIMENEZCONTI IB, 1993, J CELL BIOCHEM, P83; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Gires O, 2006, BIOCHEM BIOPH RES CO, V343, P252, DOI 10.1016/j.bbrc.2006.02.139; Kanojia D, 2006, ORAL ONCOL, V42, P655, DOI 10.1016/j.oraloncology.2005.10.013; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Khanom R, 2012, HISTOL HISTOPATHOL, V27, P949, DOI 10.14670/HH-27.949; Konig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057996; Kroger C, 2011, AM J PATHOL, V178, P1578, DOI 10.1016/j.ajpath.2010.12.055; Kumar G, 2012, J ENVIRON PATHOL TOX, V31, P295, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i4.10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SL, 2006, HEAD NECK-J SCI SPEC, V28, P945, DOI 10.1002/hed.20397; Matthias C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-267; Mignogna MD, 2004, ORAL ONCOL, V40, P120, DOI 10.1016/j.oraloncology.2003.08.001; Mikami T, 2011, ORAL ONCOL, V47, P497, DOI 10.1016/j.oraloncology.2011.03.015; Mognetti B, 2006, ORAL ONCOL, V42, P448, DOI 10.1016/j.oraloncology.2005.07.014; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Ohkura S, 2005, ORAL ONCOL, V41, P607, DOI 10.1016/j.oraloncology.2005.01.011; Pan X, 2012, CURRENT OPINION CELL; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Relchelt J, 2002, J CELL SCI, V115, P2639; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sakamoto K, 2011, HISTOPATHOLOGY, V58, P531, DOI 10.1111/j.1365-2559.2011.03759.x; SALLEY JJ, 1954, J DENT RES, V33, P253, DOI 10.1177/00220345540330021201; SANTIS HELEN, 1964, ORAL SURG ORAL MED AND ORAL PATHOL, V17, P207, DOI 10.1016/0030-4220(64)90144-6; Schaaij-Visser TBM, 2010, ORAL ONCOL, V46, P123, DOI 10.1016/j.oraloncology.2009.11.012; SCHWARTZ JL, 1989, TUMOR BIOL, V10, P297, DOI 10.1159/000217629; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; Su L, 1996, J ORAL PATHOL MED, V25, P293, DOI 10.1111/j.1600-0714.1996.tb00265.x; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Takikita M, 2011, ANTICANCER RES, V31, P945; Tanaka T., 2011, J ONCOL, V2011; Taneja P, 2011, CLIN MED INSIGHTS-ON, V5, P235, DOI 10.4137/CMO.S7516; Toruner GA, 2004, CANCER GENET CYTOGEN, V154, P27, DOI 10.1016/j.cancergencyto.2004.01.026; Toyoshima T, 2008, J CANCER RES CLIN, V134, P515, DOI 10.1007/s00432-007-0308-8; Vaidya MM, 1996, ORAL ONCOL, V32B, P333, DOI 10.1016/0964-1955(96)00012-7; Vaidya MM, 1998, ORAL ONCOL, V34, P261, DOI 10.1016/S1368-8375(97)00095-X; Valraktaris E, 2008, ORAL ONCOL, V44, P315, DOI 10.1016/j.oraloncology.2007.08.015; Wei KJ, 2009, ORAL DIS, V15, P111, DOI 10.1111/j.1601-0825.2008.01501.x; XU XC, 1995, CANCER EPIDEM BIOMAR, V4, P871; Yanagawa T, 2007, J EXP CLIN CANC RES, V26, P215	59	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70688	10.1371/journal.pone.0070688	http://dx.doi.org/10.1371/journal.pone.0070688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936238	Green Submitted, gold, Green Published			2022-12-27	WOS:000323114200099
J	Spisak, S; Solymosi, N; Ittzes, P; Bodor, A; Kondor, D; Vattay, G; Bartak, BK; Sipos, F; Galamb, O; Tulassay, Z; Szallasi, Z; Rasmussen, S; Sicheritz-Ponten, T; Brunak, S; Molnar, B; Csabai, I				Spisak, Sandor; Solymosi, Norbert; Ittzes, Peter; Bodor, Andras; Kondor, Daniel; Vattay, Gabor; Bartak, Barbara K.; Sipos, Ferenc; Galamb, Orsolya; Tulassay, Zsolt; Szallasi, Zoltan; Rasmussen, Simon; Sicheritz-Ponten, Thomas; Brunak, Soren; Molnar, Bela; Csabai, Istvan			Complete Genes May Pass from Food to Human Blood	PLOS ONE			English	Article							CELL-FREE DNA; INGESTED FOREIGN DNA; BARR-VIRUS DNA; CIRCULATING DNA; CANCER-PATIENTS; MATERNAL PLASMA; BACTERIAL-DNA; FETAL DNA; SERUM; QUANTITATION	Our bloodstream is considered to be an environment well separated from the outside world and the digestive tract. According to the standard paradigm large macromolecules consumed with food cannot pass directly to the circulatory system. During digestion proteins and DNA are thought to be degraded into small constituents, amino acids and nucleic acids, respectively, and then absorbed by a complex active process and distributed to various parts of the body through the circulation system. Here, based on the analysis of over 1000 human samples from four independent studies, we report evidence that meal-derived DNA fragments which are large enough to carry complete genes can avoid degradation and through an unknown mechanism enter the human circulation system. In one of the blood samples the relative concentration of plant DNA is higher than the human DNA. The plant DNA concentration shows a surprisingly precise log-normal distribution in the plasma samples while non-plasma (cord blood) control sample was found to be free of plant DNA.	[Spisak, Sandor; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary; [Spisak, Sandor; Szallasi, Zoltan] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Solymosi, Norbert; Ittzes, Peter; Bodor, Andras; Kondor, Daniel; Vattay, Gabor; Csabai, Istvan] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Solymosi, Norbert] Szent Istvan Univ, Dept Anim Hyg Herd Hlth & Vet Ethol, Budapest, Hungary; [Bartak, Barbara K.; Sipos, Ferenc; Galamb, Orsolya; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Rasmussen, Simon; Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Csabai, Istvan] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Hungarian Academy of Sciences; Harvard University; Boston Children's Hospital; Harvard Medical School; Eotvos Lorand University; Hungarian University of Agriculture & Life Sciences; Semmelweis University; Technical University of Denmark; Johns Hopkins University	Spisak, S (corresponding author), Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary.	Sandor.Spisak@childrens.harvard.edu	Rasmussen, Simon/AAA-2308-2020; Csabai, Istvan/F-6045-2011; Sipos, Ferenc/GYV-6182-2022; Rasmussen, Simon/G-6258-2016; Vattay, Gabor/Q-4266-2019; Kondor, Daniel/AAD-9871-2019; Solymosi, Norbert/B-5428-2012; Vattay, Gabor/G-9638-2017; Brunak, Soren/O-6621-2016; Sicheritz-Ponten, Thomas/A-4325-2017	Rasmussen, Simon/0000-0001-6323-9041; Csabai, Istvan/0000-0001-9232-9898; Rasmussen, Simon/0000-0001-6323-9041; Kondor, Daniel/0000-0003-3720-7462; Vattay, Gabor/0000-0002-0919-9429; Solymosi, Norbert/0000-0003-1783-2041; Szallasi, Zoltan/0000-0001-5395-7509; Brunak, Soren/0000-0003-0316-5866; Sicheritz-Ponten, Thomas/0000-0001-6615-1141	 [OTKA-80177];  [OTKA-77779]	; 	We thank grants OTKA-80177 and OTKA-77779, TECH08:3dhist08 for the Hungarian Natioanal Technology Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDICH A, 1965, SCIENCE, V148, P374, DOI 10.1126/science.148.3668.374; Capone RB, 2000, CLIN CANCER RES, V6, P4171; Chainark P, 2008, FISHERIES SCI, V74, P380, DOI 10.1111/j.1444-2906.2008.01535.x; Chen SP, 2013, GENOME MED, V5, DOI 10.1186/gm422; Cherepanova AV, 2008, ANN NY ACAD SCI, V1137, P218, DOI 10.1196/annals.1448.016; Dong SM, 2002, CANCER EPIDEM BIOMAR, V11, P3; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Garcia-Olmo DC, 2010, CANCER RES, V70, P560, DOI 10.1158/0008-5472.CAN-09-3513; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hoegh AM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/787545; Holdenrieder S, 2005, CLIN CHEM, V51, P1544, DOI 10.1373/clinchem.2005.049320; Jahr S, 2001, CANCER RES, V61, P1659; Jiang FM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-57; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; Katano H, 2012, INT J CLIN EXP PATHO, V5, P814; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TH, 2001, TRANSFUSION, V41, P276, DOI 10.1046/j.1537-2995.2001.41020276.x; LEON SA, 1977, CANCER RES, V37, P646; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 2001, CLIN CANCER RES, V7, P1856; Lui YNYN, 2002, CLIN CHEM, V48, P421; Mandel P., 1948, CR SOC BIOL, V142, P241; Mazza R, 2005, TRANSGENIC RES, V14, P775, DOI 10.1007/s11248-005-0009-5; Minchin RF, 2001, J PHARMACOL EXP THER, V296, P1006; Ngan RKC, 2002, CLIN CANCER RES, V8, P986; Patutina O, 2011, BIOCHIMIE, V93, P689, DOI 10.1016/j.biochi.2010.12.011; Ponomaryova AA, 2011, EUR J CANCER PREV, V20, P453, DOI 10.1097/CEJ.0b013e3283498eb4; Rhoades RA., 2003, MED PHYSL; Rizzi A, 2012, CRIT REV FOOD SCI, V52, P142, DOI 10.1080/10408398.2010.499480; ROGERS JC, 1972, P NATL ACAD SCI USA, V69, P1685, DOI 10.1073/pnas.69.7.1685; SANDERSON IR, 1994, J NUTR, V124, pS131, DOI 10.1093/jn/124.suppl_1.131S; Schubbert R, 1998, MOL GEN GENET, V259, P569, DOI 10.1007/s004380050850; Sharma R, 2006, J AGR FOOD CHEM, V54, P1699, DOI 10.1021/jf052459o; Skvortsova TE, 2006, BRIT J CANCER, V94, P1492, DOI 10.1038/sj.bjc.6603117; STROUN M, 1987, EUR J CANCER CLIN ON, V23, P707, DOI 10.1016/0277-5379(87)90266-5; Stroun M, 2001, ANN NY ACAD SCI, V945, P258; Tudisco R, 2010, ANIMAL, V4, P1662, DOI 10.1017/S1751731110000728; VANBUREN CT, 1994, J NUTR, V124, pS160, DOI 10.1093/jn/124.suppl_1.160S; Wang BG, 2003, CANCER RES, V63, P3966; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Ziegler A, 2002, CANCER TREAT REV, V28, P255, DOI 10.1016/S0305-7372(02)00077-4	48	43	47	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69805	10.1371/journal.pone.0069805	http://dx.doi.org/10.1371/journal.pone.0069805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936105	gold, Green Published			2022-12-27	WOS:000323114200046
J	David, SP; Ware, JJ; Chu, IM; Loftus, PD; Fusar-Poli, P; Radua, J; Munafo, MR; Ioannidis, JPA				David, Sean P.; Ware, Jennifer J.; Chu, Isabella M.; Loftus, Pooja D.; Fusar-Poli, Paolo; Radua, Joaquim; Munafo, Marcus R.; Ioannidis, John P. A.			Potential Reporting Bias in fMRI Studies of the Brain	PLOS ONE			English	Article							ALE METAANALYSIS; SAMPLE-SIZE; EXCESS; RELIABILITY; ACTIVATION	Background: Functional magnetic resonance imaging (fMRI) studies have reported multiple activation foci associated with a variety of conditions, stimuli or tasks. However, most of these studies used fewer than 40 participants. Methodology: After extracting data (number of subjects, condition studied, number of foci identified and threshold) from 94 brain fMRI meta-analyses (k = 1,788 unique datasets) published through December of 2011, we analyzed the correlation between individual study sample sizes and number of significant foci reported. We also performed an analysis where we evaluated each meta-analysis to test whether there was a correlation between the sample size of the meta-analysis and the number of foci that it had identified. Correlation coefficients were then combined across all meta-analyses to obtain a summary correlation coefficient with a fixed effects model and we combine correlation coefficients, using a Fisher's z transformation. Principal Findings: There was no correlation between sample size and the number of foci reported in single studies (r = 0.0050) but there was a strong correlation between sample size and number of foci in meta-analyses (r = 0.62, p<0.001). Only studies with sample sizes <45 identified larger (>40) numbers of foci and claimed as many discovered foci as studies with sample sizes >= 45, whereas meta-analyses yielded a limited number of foci relative to the yield that would be anticipated from smaller single studies. Conclusions: These results are consistent with possible reporting biases affecting small fMRI studies and suggest the need to promote standardized large-scale evidence in this field. It may also be that small studies may be analyzed and reported in ways that may generate a larger number of claimed foci or that small fMRI studies with inconclusive, null, or not very promising results may not be published at all.	[David, Sean P.; Chu, Isabella M.; Loftus, Pooja D.] Stanford Univ, Dept Med, Sch Med, Div Gen Med Disciplines, Stanford, CA 94305 USA; [David, Sean P.] SRI Int, Ctr Hlth Sci, Policy Div, Menlo Pk, CA 94025 USA; [David, Sean P.; Ware, Jennifer J.; Munafo, Marcus R.] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England; [Ware, Jennifer J.] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Fusar-Poli, Paolo; Radua, Joaquim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England; [Fusar-Poli, Paolo; Radua, Joaquim] South London & Maudsley NHS Fdn Trust, OASIS Team, London, England; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	Stanford University; SRI International; University of Bristol; Cardiff University; University of London; King's College London; South London & Maudsley NHS Trust; Stanford University; Stanford University; Stanford University	David, SP (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Gen Med Disciplines, Stanford, CA 94305 USA.	spdavid@stanford.edu	Ioannidis, John P. A./G-9836-2011; Radua, Joaquim/H-6424-2019; Munafo, Marcus/AAE-2306-2020; Fusar-Poli, Paolo/D-8605-2011	Radua, Joaquim/0000-0003-1240-5438; Munafo, Marcus/0000-0002-4049-993X; Fusar-Poli, Paolo/0000-0003-3582-6788; David, Sean/0000-0002-4922-2603	National Institute on Drug Abuse US Public Health Service [DA027331, DA017441]; Institute of Medicine (IOM) (Puffer/American Board of Family Medicine/IOM Anniversary Fellowship); British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research under the auspices of the UK Clinical Research Collaboration; EU-GEI; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027331, R01DA017441] Funding Source: NIH RePORTER	National Institute on Drug Abuse US Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)United States Public Health Service); Institute of Medicine (IOM) (Puffer/American Board of Family Medicine/IOM Anniversary Fellowship); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research under the auspices of the UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); EU-GEI; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. David acknowledges funding from the National Institute on Drug Abuse US Public Health Service grants DA027331 and DA017441 and a stipend supporting curation and statistical assistance from the Institute of Medicine (IOM) (Puffer/American Board of Family Medicine/IOM Anniversary Fellowship). Dr. Munafo acknowledges support for his time from the UK Centre for Tobacco Control Studies (a UKCRC Public Health Research Centre of Excellence) and funding from British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Medical Research Council, and the National Institute for Health Research under the auspices of the UK Clinical Research Collaboration. Dr. Fusar-Poli acknowledges funding from the EU-GEI study (project of the European network of national schizophrenia networks studying Gene-Environment Interactions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2010, BRAIN RES REV, V62, P183, DOI 10.1016/j.brainresrev.2009.11.001; Amanzio M, 2011, HUMAN BRAIN MAPPING; Arsalidou M, 2011, BRAIN TOPOGR, V24, P149, DOI 10.1007/s10548-011-0171-4; Brooks SJ, 2012, NEUROIMAGE, V59, P2962, DOI 10.1016/j.neuroimage.2011.09.077; Brown GG, 2011, NEUROIMAGE, V54, P2163, DOI 10.1016/j.neuroimage.2010.09.076; Brown S, 2011, NEUROIMAGE, V58, P250, DOI 10.1016/j.neuroimage.2011.06.012; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Bzdok D, 2011, BRAIN STRUCT FUNCT, V215, P209, DOI 10.1007/s00429-010-0287-4; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Faro SH, 2010, FUNCTIONAL MRI BASIC; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Fusar-Poli P, 2011, NEUROSCI BIOBEHAV R, V35, P1175, DOI 10.1016/j.neubiorev.2010.12.005; Fusar-Poli P, 2012, SCHIZOPHRENIA BULL, V38, P1297, DOI 10.1093/schbul/sbr134; Gountouna VE, 2010, NEUROIMAGE, V49, P552, DOI 10.1016/j.neuroimage.2009.07.026; Ingre M, 2013, NEUROIMAGE; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Kavvoura FK, 2008, AM J EPIDEMIOL, V168, P855, DOI 10.1093/aje/kwn206; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lindquist MA, 2013, NEUROIMAGE; Madre M, 2013, PSYCHOL MED, V43, P143, DOI 10.1017/S0033291712000943; McGuire P, 2008, TRENDS PHARMACOL SCI, V29, P91, DOI 10.1016/j.tips.2007.11.005; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Poldrack RA, 2011, HDB FUNCTIONAL MRI D; Radua J, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-6; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Surguladze S, 2011, EUR PSYCHIAT, V26; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Ziermans TB, 2009, SCHIZOPHR RES, V112, P1, DOI 10.1016/j.schres.2009.04.013	36	72	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70104	10.1371/journal.pone.0070104	http://dx.doi.org/10.1371/journal.pone.0070104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936149	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300089
J	Gabriel, K; Ingram, A; Austin, R; Kapoor, A; Tang, D; Majeed, F; Qureshi, T; Al-Nedawi, K				Gabriel, Kathleen; Ingram, Alistair; Austin, Richard; Kapoor, Anil; Tang, Damu; Majeed, Fadwa; Qureshi, Talha; Al-Nedawi, Khalid			Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer	PLOS ONE			English	Article							PHOSPHATASE-ACTIVITY; EXPRESSION; MICROVESICLES; PHOSPHORYLATION; PTEN/MMAC1; PATHWAY; CELLS; P27; ASSOCIATION; PROGRESSION	PTEN is a potent tumor-suppressor protein. Aggressive and metastatic prostate cancer (PC) is associated with a reduction or loss of PTEN expression. PTEN reduction often occurs without gene mutations, and its downregulation is not fully understood. Herein, we show that PTEN is incorporated in the cargo of exosomes derived from cancer cells. PTEN is not detected in exosomes derived from normal, noncancerous cells. We found that PTEN can be transferred to other cells through exosomes. In cells that have a reduction or complete loss of PTEN expression, the transferred PTEN is competent to confer tumor-suppression activity to acceptor cells. In PC patients, we show that PTEN is incorporated in the cargo of exosomes that circulate in their blood. Interestingly, normal subjects have no PTEN expression in their blood exosomes. Further, we found that the prostate-specific antigen (PSA) is incorporated in PC patients' and normal subjects' blood exosomes. These data suggest that exosomal PTEN can compensate for PTEN loss in PTEN deficient cells, and may have diagnostic value for prostate cancer.	[Gabriel, Kathleen; Ingram, Alistair; Austin, Richard; Tang, Damu; Majeed, Fadwa; Qureshi, Talha; Al-Nedawi, Khalid] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [Gabriel, Kathleen; Ingram, Alistair; Austin, Richard; Tang, Damu; Majeed, Fadwa; Qureshi, Talha; Al-Nedawi, Khalid] St Josephs Hosp, Hamilton Ctr Kidney Res, Hamilton, ON, Canada; [Kapoor, Anil] McMaster Univ, Dept Surg, Div Urol, Hamilton, ON L8S 4L8, Canada	McMaster University; McGill University; McMaster University; McMaster University	Al-Nedawi, K (corresponding author), McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada.	alnedaw@mcmaster.ca	Tang, Damu/AAQ-1786-2021; Kapoor, Anil/AAQ-7184-2021	Tang, Damu/0000-0002-3282-9521; Kapoor, Anil/0000-0001-9180-8029; , Khalid/0000-0001-5140-3799	Movember Foundation [D2013-2]; Prostate Cancer Canada	Movember Foundation; Prostate Cancer Canada	This work was awarded by Prostate Cancer Canada and is proudly funded by the Movember Foundation, Grant # D2013-2 for K.Al. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2005, ARTERIOSCL THROM VAS, V25, P1744, DOI 10.1161/01.ATV.0000172007.86541.76; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Crawford ED, 2010, UROLOGY, V75, P502, DOI 10.1016/j.urology.2009.05.099; De Visschere P, 2010, JBR-BTR, V93, P62, DOI 10.5334/jbr-btr.121; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; Halvorsen OJ, 2003, CLIN CANCER RES, V9, P1474; Harvey Philip, 2009, BMC Urol, V9, P14, DOI 10.1186/1471-2490-9-14; He LZ, 2010, J CLIN INVEST, V120, P2094, DOI 10.1172/JCI40778; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Khan S, 2004, INT J CANCER, V112, P407, DOI 10.1002/ijc.20447; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McDavid K, 2004, PUBLIC HEALTH REP, V119, P174, DOI 10.1177/003335490411900211; McMenamin ME, 1999, CANCER RES, V59, P4291; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nagy JA, 2012, CLIN EXPT METASTASIS; Nieuwland R, 2010, THROMB RES, V125, pS49, DOI 10.1016/j.thromres.2010.01.037; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Ross AH, 2009, P NATL ACAD SCI USA, V106, P1297, DOI 10.1073/pnas.0812473106; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Salvesen HB, 2004, INT J ONCOL, V25, P1615; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Suzuki H, 1998, CANCER RES, V58, P204; Tosoian J, 2010, THESCIENTIFICWORLDJO, V10, P1919, DOI 10.1100/tsw.2010.182; Uzoh CC, 2009, BJU INT, V104, P556, DOI 10.1111/j.1464-410X.2009.08411.x; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943	44	90	96	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70047	10.1371/journal.pone.0070047	http://dx.doi.org/10.1371/journal.pone.0070047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936141	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300086
J	Schwab, SA; Brand, M; Schlude, IK; Wuest, W; Meier-Meitinger, M; Distel, L; Schulz-Wendtland, R; Uder, M; Kuefner, MA				Schwab, Siegfried A.; Brand, Michael; Schlude, Ina-Kristin; Wuest, Wolfgang; Meier-Meitinger, Martina; Distel, Luitpold; Schulz-Wendtland, Ruediger; Uder, Michael; Kuefner, Michael A.			X-Ray Induced Formation of gamma-H2AX Foci after Full-Field Digital Mammography and Digital Breast-Tomosynthesis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; CORONARY CT ANGIOGRAPHY; PRIMARY HUMAN FIBROBLASTS; BLOOD-LYMPHOCYTES; DATA-ACQUISITION; DNA-DAMAGE; REPAIR; CELLS; RADIOSENSITIVITY; IRRADIATION	Purpose: To determine in-vivo formation of x-ray induced gamma-H2AX foci in systemic blood lymphocytes of patients undergoing full-field digital mammography (FFDM) and to estimate foci after FFDM and digital breast-tomosynthesis (DBT) using a biological phantom model. Materials and Methods: The study complies with the Declaration of Helsinki and was performed following approval by the ethic committee of the University of Erlangen-Nuremberg. Written informed consent was obtained from every patient. For in-vivo tests, systemic blood lymphocytes were obtained from 20 patients before and after FFDM. In order to compare in-vivo post-exposure with pre-exposure foci levels, the Wilcoxon matched pairs test was used. For in-vitro experiments, isolated blood lymphocytes from healthy volunteers were irradiated at skin and glandular level of a porcine breast using FFDM and DBT. Cells were stained against the phosphorylated histone variant gamma-H2AX, and foci representing distinct DNA damages were quantified. Results: Median in-vivo foci level/cell was 0.086 (range 0.067-0.116) before and 0.094 (0.076-0.126) after FFDM (p = 0.0004). In the in-vitro model, the median x-ray induced foci level/cell after FFDM was 0.120 (range 0.086-0.140) at skin level and 0.035 (range 0.030-0.050) at glandular level. After DBT, the median x-ray induced foci level/cell was 0.061 (range 0.040-0.081) at skin level and 0.015 (range 0.006-0.020) at glandular level. Conclusion: In patients, mammography induces a slight but significant increase of gamma-H2AX foci in systemic blood lymphocytes. The introduced biological phantom model is suitable for the estimation of x-ray induced DNA damages in breast tissue in different breast imaging techniques.	[Schwab, Siegfried A.; Brand, Michael; Schlude, Ina-Kristin; Wuest, Wolfgang; Meier-Meitinger, Martina; Schulz-Wendtland, Ruediger; Uder, Michael; Kuefner, Michael A.] Univ Erlangen Nurnberg, Inst Radiol, D-91054 Erlangen, Bavaria, Germany; [Distel, Luitpold] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Bavaria, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schwab, SA (corresponding author), Univ Erlangen Nurnberg, Inst Radiol, D-91054 Erlangen, Bavaria, Germany.	dr.siegfried.schwab@gmx.net	Distel, Luitpold/ABD-9880-2020	Distel, Luitpold/0000-0002-8040-3226				Adliene D, RAD PROT DOSIMETRY, V139, P298; Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Belyaev IY, 2010, MUTAT RES-REV MUTAT, V704, P132, DOI 10.1016/j.mrrev.2010.01.011; Brand M, 2012, EUR J RADIOL, V81, pE357, DOI 10.1016/j.ejrad.2011.11.027; Colin C, 2012, BREAST, V21, P409, DOI 10.1016/j.breast.2011.12.003; Colin C, 2011, INT J RADIAT BIOL, V87, P1103, DOI 10.3109/09553002.2011.608410; Frankenberg D, 2002, RADIAT RES, V157, P99, DOI 10.1667/0033-7587(2002)157[0099:ENTBMX]2.0.CO;2; Frankenberg-Schwager M, 2002, INT J RADIAT BIOL, V78, P781, DOI 10.1080/09553000210149777; Frankenberg-Schwager M, 2012, INT J RADIAT BIOL, V88, P846, DOI 10.3109/09553002.2012.711500; Geisel D, 2008, RADIOLOGY, V248, P852, DOI 10.1148/radiol.2483071686; Goodarzi AA, 2012, MUTAT RES-FUND MOL M, V736, P39, DOI 10.1016/j.mrfmmm.2011.05.017; Hendrick RE, 2010, RADIOLOGY, V257, P246, DOI 10.1148/radiol.10100570; Kegel P, 2007, DNA REPAIR, V6, P1692, DOI 10.1016/j.dnarep.2007.05.013; Keyrilainen J, 2010, ACTA RADIOL, V51, P866, DOI 10.3109/02841851.2010.504742; Kuefner MA, 2010, EUR RADIOL, V20, P2917, DOI 10.1007/s00330-010-1873-9; Kuefner MA, 2010, INVEST RADIOL, V45, P182, DOI 10.1097/RLI.0b013e3181d3eddf; Kuefner MA, 2009, INVEST RADIOL, V44, P440, DOI 10.1097/RLI.0b013e3181a654a5; Kuhne M, 2005, RADIAT RES, V164, P669, DOI 10.1667/RR3461.1; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; May MS, 2012, EUR J NUCL MED MOL I, V39, P1712, DOI 10.1007/s00259-012-2201-1; Nazarov OB, 2003, RADIAT RES, V160, P309, DOI 10.1667/RR3043; Niklason LT, 1997, RADIOLOGY, V205, P399, DOI 10.1148/radiology.205.2.9356620; Prionas ND, 2010, RADIOLOGY, V256, P714, DOI 10.1148/radiol.10092311; Rafferty EA, 2013, RADIOLOGY, V266, P104, DOI 10.1148/radiol.12120674; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Schmid E, 2003, RADIAT RES, V160, P499, DOI 10.1667/RR3070	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70660	10.1371/journal.pone.0070660	http://dx.doi.org/10.1371/journal.pone.0070660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936236	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300111
J	Yamamoto, S; Bayat, V; Bellen, HJ; Tan, CG				Yamamoto, Shinya; Bayat, Vafa; Bellen, Hugo J.; Tan, Change			Protein Phosphatase 1 beta Limits Ring Canal Constriction during Drosophila Germline Cyst Formation	PLOS ONE			English	Article							MYOSIN PHOSPHATASE; INTERCELLULAR BRIDGES; CONTRACTILE RING; ANILLIN; CYTOKINESIS; SUBUNIT; FUSOME; ROLES; ULTRASTRUCTURE; SPECTRIN	Germline cyst formation is essential for the propagation of many organisms including humans and flies. The cytoplasm of germline cyst cells communicate with each other directly via large intercellular bridges called ring canals. Ring canals are often derived from arrested contractile rings during incomplete cytokinesis. However how ring canal formation, maintenance and growth are regulated remains unclear. To better understand this process, we carried out an unbiased genetic screen in Drosophila melanogaster germ cells and identified multiple alleles of flapwing (flw), a conserved serine/threonine-specific protein phosphatase. Flw had previously been reported to be unnecessary for early D. melanogaster oogenesis using a hypomorphic allele. We found that loss of Flw leads to over-constricted nascent ring canals and subsequently tiny mature ring canals, through which cytoplasmic transfer from nurse cells to the oocyte is impaired, resulting in small, non-functional eggs. Flw is expressed in germ cells undergoing incomplete cytokinesis, completely colocalized with the Drosophila myosin binding subunit of myosin phosphatase (DMYPT). This colocalization, together with genetic interaction studies, suggests that Flw functions together with DMYPT to negatively regulate myosin activity during ring canal formation. The identification of two subunits of the tripartite myosin phosphatase as the first two main players required for ring canal constriction indicates that tight regulation of myosin activity is essential for germline cyst formation and reproduction in D. melanogaster and probably other species as well.	[Yamamoto, Shinya; Bayat, Vafa; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Yamamoto, Shinya; Bellen, Hugo J.] Texas Childrens Hosp, Houston, TX 77030 USA; [Bayat, Vafa] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Tan, Change] Univ Missouri, Div Biol Sci, Bond Life Sci Ctr, Columbia, MO 65211 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Missouri System; University of Missouri Columbia	Tan, CG (corresponding author), Univ Missouri, Div Biol Sci, Bond Life Sci Ctr, Columbia, MO 65211 USA.	tanc@missouri.edu	Bayat, Vafa/ABG-2774-2021; Yamamoto, Shinya/ABB-2837-2021	Yamamoto, Shinya/0000-0003-2172-8036; Tan, Change/0000-0001-8291-3337; Bayat, Vafa/0000-0002-1524-0520; Bellen, Hugo/0000-0001-5992-5989	National Institutes of Health (NIH) [1RC4GM096355-01]; Nakajima Foundation; DB Program [T32 HD055200]; Edward and Josephine Hudson Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC4GM096355] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nakajima Foundation; DB Program; Edward and Josephine Hudson Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was in part supported by the National Institutes of Health (NIH) (1RC4GM096355-01 to H.J.B.). S.Y. was supported by a fellowship from the Nakajima Foundation. V.B. received support from the DB Program training grant T32 HD055200 and the Edward and Josephine Hudson Scholarship Fund. H.J.B. is an HHMI investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews J, 1998, DEV GENES EVOL, V207, P482, DOI 10.1007/s004270050139; Bennett D, 2006, J MOL BIOL, V364, P196, DOI 10.1016/j.jmb.2006.08.094; BRAND AH, 1993, DEVELOPMENT, V118, P401; BYERS TJ, 1987, J CELL BIOL, V105, P2103, DOI 10.1083/jcb.105.5.2103; Chou TB, 1996, GENETICS, V144, P1673; D'Avino PP, 2009, J CELL SCI, V122, P1071, DOI 10.1242/jcs.034785; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; deCuevas M, 1996, DEVELOPMENT, V122, P3959; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Goldbach P, 2010, MOL BIOL CELL, V21, P1482, DOI 10.1091/mbc.E09-08-0714; GONDOS B, 1987, INT J GYNECOL PATHOL, V6, P124, DOI 10.1097/00004347-198706000-00004; GONDOS B, 1993, EUR UROL, V23, P68; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Guo GQ, 2004, J THEOR BIOL, V229, P139, DOI 10.1016/j.jtbi.2004.03.010; Haglund Kaisa, 2011, Communicative & Integrative Biology, V4, P1, DOI 10.4161/cib.4.1.13550; Haglund K, 2010, CURR BIOL, V20, P944, DOI 10.1016/j.cub.2010.03.068; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kirchner J, 2007, GENETICS, V176, P273, DOI 10.1534/genetics.106.069914; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; LIN HF, 1994, DEVELOPMENT, V120, P947; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Majumder P, 2012, CURR BIOL, V22, P363, DOI 10.1016/j.cub.2012.01.037; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mizuno T, 2002, DEVELOPMENT, V129, P1215; Ong S, 2010, DEV BIOL, V346, P161, DOI 10.1016/j.ydbio.2010.06.008; Ong SK, 2010, DEV BIOL, V337, P84, DOI 10.1016/j.ydbio.2009.10.018; PERRIMON N, 1989, GENETICS, V121, P333; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Raghavan S, 2000, CURR BIOL, V10, P269, DOI 10.1016/S0960-9822(00)00364-X; Rees JS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002386; Robinson DN, 1996, TRENDS CELL BIOL, V6, P474, DOI 10.1016/0962-8924(96)84945-2; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Sun Y, 2011, DEVELOPMENT, V138, P1991, DOI 10.1242/dev.062190; Swiatek P, 2009, CELL TISSUE RES, V337, P137, DOI 10.1007/s00441-009-0788-8; Tan CG, 2003, DEVELOPMENT, V130, P671, DOI 10.1242/dev.00298; THAKER HM, 1992, GENETICS, V131, P883; Venken KJT, 2010, GENETICS, V186, P1111, DOI 10.1534/genetics.110.121285; Vereshchagina N, 2004, MOL BIOL CELL, V15, P4395, DOI 10.1091/mbc.E04-02-0139; Vlachos S, 2011, GENETICS, V187, P501, DOI 10.1534/genetics.110.120998; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Xiong B, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001438; Yamamoto S, 2012, SCIENCE; Zhang K, 2013, J CELL BIOL, V200, P807, DOI 10.1083/jcb.201208033; Zhang LA, 2011, GENE EXPR PATTERNS, V11, P93, DOI 10.1016/j.gep.2010.09.008	50	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e70502	10.1371/journal.pone.0070502	http://dx.doi.org/10.1371/journal.pone.0070502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936219	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300104
J	Regus-Leidig, H; Ott, C; Lohner, M; Atorf, J; Fuchs, M; Sedmak, T; Kremers, J; Fejtova, A; Gundelfinger, ED; Brandstatter, JH				Regus-Leidig, Hanna; Ott, Corinna; Loehner, Martina; Atorf, Jenny; Fuchs, Michaela; Sedmak, Tina; Kremers, Jan; Fejtova, Anna; Gundelfinger, Eckart D.; Brandstaetter, Johann H.			Identification and Immunocytochemical Characterization of Piccolino, a Novel Piccolo Splice Variant Selectively Expressed at Sensory Ribbon Synapses of the Eye and Ear	PLOS ONE			English	Article							NEUROTRANSMITTER RELEASE SITE; CYTOMATRIX PROTEIN PICCOLO; PRESYNAPTIC ACTIVE ZONES; SYNAPTIC RIBBONS; CA2+ SENSOR; BASSOON; RETINA; CELLS; EXOCYTOSIS; COMPONENT	Piccolo is one of the largest cytomatrix proteins present at active zones of chemical synapses, where it is suggested to play a role in recruiting and integrating molecules relevant for both synaptic vesicle exo- and endocytosis. Here we examined the retina of a Piccolo-mutant mouse with a targeted deletion of exon 14 in the Pclo gene. Piccolo deficiency resulted in its profound loss at conventional chemical amacrine cell synapses but retinal ribbon synapses were structurally and functionally unaffected. This led to the identification of a shorter, ribbon-specific Piccolo variant, Piccolino, present in retinal photoreceptor cells, bipolar cells, as well as in inner hair cells of the inner ear. By RT-PCR analysis and the generation of a Piccolino-specific antibody we show that non-splicing of intron 5/6 leads to premature translation termination and generation of the C-terminally truncated protein specifically expressed at active zones of ribbon synapse containing cell types. With in situ proximity ligation assays we provide evidence that this truncation leads to the absence of interaction sites for Bassoon, Munc13, and presumably also ELKS/CAST, RIM2, and the L-type Ca2+ channel which exist in the full-length Piccolo at active zones of conventional chemical synapses. The putative lack of interactions with proteins of the active zone suggests a function of Piccolino at ribbon synapses of sensory neurons different from Piccolo's function at conventional chemical synapses.	[Regus-Leidig, Hanna; Ott, Corinna; Loehner, Martina; Fuchs, Michaela; Sedmak, Tina; Brandstaetter, Johann H.] Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany; [Atorf, Jenny; Kremers, Jan] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Fejtova, Anna; Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Fejtova, Anna; Gundelfinger, Eckart D.] Ctr Behav Brain Sci, Magdeburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Leibniz Institut fur Neurobiologie (LIN)	Brandstatter, JH (corresponding author), Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany.	jbrandst@biologie.uni-erlangen.de	Kremers, Jan/X-3125-2019; Fejtova, Anna/AAZ-1024-2020; Fejtova, Anna/E-6343-2015	Kremers, Jan/0000-0002-9293-7380; Fuchs, Michaela/0000-0001-7778-6708; Atorf, Jenny/0000-0003-0935-1897; Fejtova, Anna/0000-0002-1815-4409	Deutsche Forschungsgemeinschaft [BR 1643/4-2]; Joint Initiative for Research and Innovation of the Leibniz Association	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Joint Initiative for Research and Innovation of the Leibniz Association	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (BR 1643/4-2) to JHB and HRL and the Joint Initiative for Research and Innovation of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; Bush RA, 1996, J OPT SOC AM A, V13, P557, DOI 10.1364/JOSAA.13.000557; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; CERVETTO L, 1974, SCIENCE, V183, P417, DOI 10.1126/science.183.4123.417; Cooper B, 2012, J NEUROSCI, V32, P8040, DOI 10.1523/JNEUROSCI.4240-11.2012; Deguchi-Tawarada M, 2006, J COMP NEUROL, V495, P480, DOI 10.1002/cne.20893; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Dieck ST, 2012, J NEUROSCI, V32, P12192, DOI 10.1523/JNEUROSCI.0752-12.2012; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Dong CJ, 2000, VISION RES, V40, P579, DOI 10.1016/S0042-6989(99)00203-5; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Gundelfinger ED, 2012, CURR OPIN NEUROBIOL, V22, P423, DOI 10.1016/j.conb.2011.10.005; Gustafsdottir SM, 2005, ANAL BIOCHEM, V345, P2, DOI 10.1016/j.ab.2005.01.018; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Lauer AM, 2012, NEUROBIOL AGING, V33, P2892, DOI 10.1016/j.neurobiolaging.2012.02.007; Limbach C, 2011, P NATL ACAD SCI USA, V108, pE392, DOI 10.1073/pnas.1101707108; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Muresan V, 1999, J NEUROSCI, V19, P1027; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Sedmak T, 2009, METHOD CELL BIOL, V94, P259, DOI 10.1016/S0091-679X(08)94013-9; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Snellman J, 2011, NAT NEUROSCI, V14, P1135, DOI 10.1038/nn.2870; Spiwoks-Becker I, 2008, CELL TISSUE RES, V333, P185, DOI 10.1007/s00441-008-0627-3; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Venkatesan JK, 2010, J NEUROSCI, V30, P6559, DOI 10.1523/JNEUROSCI.3701-09.2010; Viswanathan Suresh, 2002, Documenta Ophthalmologica, V105, P223, DOI 10.1023/A:1020505104334; Wang XW, 2009, J NEUROSCI, V29, P12584, DOI 10.1523/JNEUROSCI.1255-09.2009; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004	39	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70373	10.1371/journal.pone.0070373	http://dx.doi.org/10.1371/journal.pone.0070373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936420	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500030
J	Russo, R; Cavaliere, F; Varano, GP; Milanese, M; Adornetto, A; Nucci, C; Bonanno, G; Morrone, LA; Corasaniti, MT; Bagetta, G				Russo, Rossella; Cavaliere, Federica; Varano, Giuseppe Pasquale; Milanese, Marco; Adornetto, Annagrazia; Nucci, Carlo; Bonanno, Giambattista; Morrone, Luigi Antonio; Corasaniti, Maria Tiziana; Bagetta, Giacinto			Impairment of Neuronal Glutamate Uptake and Modulation of the Glutamate Transporter GLT-1 Induced by Retinal Ischemia	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GANGLION-CELL DEATH; AMINO-ACIDS; DIFFERENTIAL EXPRESSION; EXPERIMENTAL GLAUCOMA; INTRAOCULAR-PRESSURE; ELEVATED GLUTAMATE; MAMMALIAN RETINA; SPLICE VARIANT; NMDA RECEPTOR	Excitotoxicity has been implicated in the retinal neuronal loss in several ocular pathologies including glaucoma. Dysfunction of Excitatory Amino Acid Transporters is often a key component of the cascade leading to excitotoxic cell death. In the retina, glutamate transport is mainly operated by the glial glutamate transporter GLAST and the neuronal transporter GLT-1. In this study we evaluated the expression of GLAST and GLT-1 in a rat model of acute glaucoma based on the transient increase of intraocular pressure (IOP) and characterized by high glutamate levels during the reperfusion that follows the ischemic event associated with raised IOP. No changes were reported in GLAST expression while, at neuronal level, a reduction of glutamate uptake and of transporter reversal-mediated glutamate release was observed in isolated retinal synaptosomes. This was accompanied by modulation of GLT-1 expression leading to the reduction of the canonical 65 kDa form and upregulation of a GLT-1-related 38 kDa protein. These results support a role for neuronal transporters in glutamate accumulation observed in the retina following an ischemic event and suggest the presence of a GLT-1 neuronal new alternative splice variant, induced in response to the detrimental stimulus.	[Russo, Rossella; Cavaliere, Federica; Varano, Giuseppe Pasquale; Adornetto, Annagrazia; Morrone, Luigi Antonio; Bagetta, Giacinto] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy; [Morrone, Luigi Antonio; Bagetta, Giacinto] Univ Calabria, Sect Neuropharmacol Normal & Pathol Neuronal Plas, Univ Consortium Adapt Disorders & Head Pain UCHAD, Arcavacata Di Rende, Italy; [Milanese, Marco; Bonanno, Giambattista] Univ Genoa, Dept Pharm, Unit Pharmacol & Toxicol, Genoa, Italy; [Milanese, Marco; Bonanno, Giambattista] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Nucci, Carlo] Univ Roma Tor Vergata, Dept Expt Med & Surg, Ophthalmol Unit, Rome, Italy; [Corasaniti, Maria Tiziana] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	University of Calabria; University of Calabria; University of Genoa; University of Genoa; University of Rome Tor Vergata; Magna Graecia University of Catanzaro	Russo, R (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy.	rossella.russo@unical.it	Milanese, Marco/C-4444-2013; Milanese, Marco/AAB-2238-2021; Bonanno, Giambattista/C-5856-2008; Corasaniti, Maria Tiziana/N-1332-2015; Bagetta, Giacinto/N-9716-2018; Bagetta, Giacinto/E-8402-2012; Adornetto, Annagrazia/AAG-5467-2020	Milanese, Marco/0000-0003-3384-0666; Milanese, Marco/0000-0003-3384-0666; Corasaniti, Maria Tiziana/0000-0001-6472-0697; Bagetta, Giacinto/0000-0001-8540-6218; Bagetta, Giacinto/0000-0001-8540-6218; Adornetto, Annagrazia/0000-0003-1869-2642; Bonanno, Giambattista/0000-0003-3744-5786; Russo, Rossella/0000-0001-8758-6523	University of Calabria	University of Calabria	This research was funded by the University of Calabria (http://www.unical.it/portale/ricerca/finanziamenti/), ex quota 60%. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 1998, GRAEF ARCH CLIN EXP, V236, P766, DOI 10.1007/s004170050156; Barnett NL, 2000, INVEST OPHTH VIS SCI, V41, P585; Barnett NL, 2001, NEUROCHEM INT, V39, P291, DOI 10.1016/S0197-0186(01)00033-X; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Chidlow G, 2003, BRAIN RES, V963, P298, DOI 10.1016/S0006-8993(02)04052-0; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299, DOI 10.1001/archopht.1996.01100130295012; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; Fernandez DC, 2009, INVEST OPHTH VIS SCI, V50, P3922, DOI 10.1167/iovs.08-3344; Furuya T, 2012, CURR EYE RES, V37, P170, DOI 10.3109/02713683.2011.645105; Gillessen T, 2002, ADV EXP MED BIOL, V513, P3; Hare WA, 2004, INVEST OPHTH VIS SCI, V45, P2640, DOI 10.1167/iovs.03-0567; Honig LS, 2000, NEUROLOGY, V55, P1082, DOI 10.1212/WNL.55.8.1082; Iuvone PM, 2002, INVEST OPHTH VIS SCI, V43, P564; Kowluru RA, 2011, INVEST OPHTH VIS SCI, V52, P8665, DOI 10.1167/iovs.10-6768; Lam DMK, 1997, INVEST OPHTH VIS SCI, V38, P553; Lee A, 2011, NEUROSCI LETT, V504, P228, DOI 10.1016/j.neulet.2011.09.029; Li SY, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/426769; Liu CH, 2013, BASIC CLIN PHARMACOL, V112, P19, DOI 10.1111/bcpt.12011; LOUZADAJUNIOR P, 1992, J NEUROCHEM, V59, P358, DOI 10.1111/j.1471-4159.1992.tb08912.x; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Martin KRG, 2002, INVEST OPHTH VIS SCI, V43, P2236; Meyer T, 1998, NEUROSCI LETT, V241, P68, DOI 10.1016/S0304-3940(97)00973-7; Milanese M, 2011, J NEUROCHEM, V116, P1028, DOI 10.1111/j.1471-4159.2010.07155.x; Munch C, 2002, J NEUROCHEM, V82, P594, DOI 10.1046/j.1471-4159.2002.01012.x; Napper GA, 1999, VISUAL NEUROSCI, V16, P149, DOI 10.1017/S0952523899161108; Naskar R, 2000, INVEST OPHTH VIS SCI, V41, P1940; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Park CK, 2009, EXP BRAIN RES, V197, P101, DOI 10.1007/s00221-009-1896-0; Pow DV, 2004, DEV BRAIN RES, V153, P1, DOI 10.1016/j.devbrainres.2004.06.019; Pow DV, 1999, CELL TISSUE RES, V297, P57, DOI 10.1007/s004410051333; Pow DV, 2001, NEUROCHEM INT, V38, P463, DOI 10.1016/S0197-0186(00)00114-5; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; RAITERI M, 1984, J PHARMACOL EXP THER, V231, P671; Rao VLR, 2001, NEUROCHEM RES, V26, P497; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; RAUEN T, 1994, NEUROSCI LETT, V169, P137, DOI 10.1016/0304-3940(94)90375-1; Rauen T, 2000, NEUROCHEM INT, V37, P179, DOI 10.1016/S0197-0186(00)00021-8; Rauen T, 2000, AMINO ACIDS, V19, P53, DOI 10.1007/s007260070033; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Russo R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.29; Russo R, 2008, J NEUROCHEM, V107, P1347, DOI 10.1111/j.1471-4159.2008.05694.x; Russo R, 2008, PROG BRAIN RES, V173, P583, DOI 10.1016/S0079-6123(08)01144-8; Russo R, 2009, INT REV NEUROBIOL, V85, P407, DOI 10.1016/S0074-7742(09)85028-9; Schmitt A, 2002, NEUROSCIENCE, V109, P45, DOI 10.1016/S0306-4522(01)00451-1; Schuettauf F, 2007, GRAEF ARCH CLIN EXP, V245, P1157, DOI 10.1007/s00417-006-0531-z; Scott HA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.008; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Sullivan RKP, 2006, INVEST OPHTH VIS SCI, V47, P3853, DOI 10.1167/iovs.06-0231; UtsunomiyaTate N, 1997, FEBS LETT, V416, P312, DOI 10.1016/S0014-5793(97)01232-5; Vorwerk CK, 2000, INVEST OPHTH VIS SCI, V41, P3615; Walton HS, 2005, J NEUROCHEM, P371; WoldeMussie E, 2002, J GLAUCOMA, V11, P474, DOI 10.1097/00061198-200212000-00003; Yeh TH, 2005, NEUROBIOL DIS, V18, P476, DOI 10.1016/j.nbd.2004.12.011	62	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69250	10.1371/journal.pone.0069250	http://dx.doi.org/10.1371/journal.pone.0069250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936321	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500008
J	Sun, LN; Yang, HS; Chen, MY; Ma, DY; Lin, CG				Sun, Lina; Yang, Hongsheng; Chen, Muyan; Ma, Deyou; Lin, Chenggang			RNA-Seq Reveals Dynamic Changes of Gene Expression in Key Stages of Intestine Regeneration in the Sea Cucumber Apostichopus japonicas	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; SKELETAL-MUSCLE; RAT-LIVER; SIGNALING PATHWAY; MOLECULAR-CLONING; SATELLITE CELLS; MESSENGER-RNA; ACTIVATION; PROTEIN; INDUCTION	Background: Sea cucumbers (Holothuroidea; Echinodermata) have the capacity to regenerate lost tissues and organs. Although the histological and cytological aspects of intestine regeneration have been extensively studied, little is known of the genetic mechanisms involved. There has, however, been a renewed effort to develop a database of Expressed Sequence Tags (ESTs) in Apostichopus japonicus, an economically-important species that occurs in China. This is important for studies on genetic breeding, molecular markers and special physiological phenomena. We have also constructed a library of ESTs obtained from the regenerative body wall and intestine of A. japonicus. The database has increased to similar to 30000 ESTs. Results: We used RNA-Seq to determine gene expression profiles associated with intestinal regeneration in A. japonicus at 3, 7, 14 and 21 days post evisceration (dpe). This was compared to profiles obtained from a normally-functioning intestine. Approximately 5 million (M) reads were sequenced in every library. Over 2400 up-regulated genes (>10%) and over 1000 down-regulated genes (similar to 5%) were observed at 3 and 7dpe (log(2)Ratio >= 1, FDR <= 0.001). Specific "Go terms" revealed that the DEGs (Differentially Expressed Genes) performed an important function at every regeneration stage. Besides some expected pathways (for example, Ribosome and Spliceosome pathway term), the "Notch signaling pathway," the "ECM-receptor interaction" and the "Cytokine-cytokine receptor interaction" were significantly enriched. We also investigated the expression profiles of developmental genes, ECM-associated genes and Cytoskeletal genes. Twenty of the most important differentially expressed genes (DEGs) were verified by Real-time PCR, which resulted in a trend concordance of almost 100% between the two techniques. Conclusion: Our studies demonstrated dynamic changes in global gene expression during intestine regeneration and presented a series of candidate genes and enriched pathways that contribute to intestine regeneration in sea cucumbers. This provides a foundation for future studies on the genetics/molecular mechanisms associated with intestine regeneration.	[Sun, Lina; Yang, Hongsheng; Ma, Deyou; Lin, Chenggang] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Ma, Deyou; Lin, Chenggang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Muyan] Ocean Univ China, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ocean University of China	Yang, HS (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	hshyang@ms.qdio.ac.cn; chenmuyan@gmail.com		Lin, Chenggang/0000-0002-0748-4322	National Natural Science Foundation of China [41076103]; National Key Technology R&D Program in the 12th Five Year Plan of China [2011BAD13B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program in the 12th Five Year Plan of China(National Key Technology R&D Program)	This study was supported by the National Natural Science Foundation of China (No. 41076103) and National Key Technology R&D Program in the 12th Five Year Plan of China (No. 2011BAD13B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Akkila WM, 1997, BIOCHEM J, V325, P87, DOI 10.1042/bj3250087; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai S, 2005, MATRIX BIOL, V24, P247, DOI 10.1016/j.matbio.2005.03.007; Bayascas JR, 1997, DEVELOPMENT, V124, P141; Beek CW, 2006, MECH DEVELOP, V123, P674, DOI 10.1016/j.mod.2006.07.001; Bely AE, 2001, DEVELOPMENT, V128, P2781; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BISBY MA, 1992, MOL NEUROBIOL, V6, P107, DOI 10.1007/BF02780547; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Boer JM, 2002, NEUROMUSCULAR DISORD, V12, pS118, DOI 10.1016/S0960-8966(02)00092-5; Burastero G, 2010, BONE, V47, P117, DOI 10.1016/j.bone.2010.03.023; Carlson MRJ, 2001, DEV BIOL, V229, P396, DOI 10.1006/dbio.2000.0104; Carnevali MDC, 2006, ISJ-INVERT SURVIV J, V3, P64; Christen B, 2003, DEV DYNAM, V226, P349, DOI 10.1002/dvdy.10231; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Croce J, 2011, DEVELOPMENT, V138, P3297, DOI 10.1242/dev.058792; de Coupade C, 2000, HEPATOLOGY, V31, P371, DOI 10.1002/hep.510310217; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Duke-Cohan JS, 1998, P NATL ACAD SCI USA, V95, P11336, DOI 10.1073/pnas.95.19.11336; Ferreira L, 2011, KIDNEY INT, V79, P518, DOI 10.1038/ki.2010.439; GABBIANI G, 1984, J CELL SCI, V66, P39; Garcia-Arraras JE, 1998, J EXP ZOOL, V281, P288, DOI 10.1002/(SICI)1097-010X(19980701)281:4<288::AID-JEZ5>3.0.CO;2-K; Garcia-Arraras JE, 2001, MICROSC RES TECHNIQ, V55, P438, DOI 10.1002/jemt.1189; Garcia-Arraras JE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-61; Garcia-Arraras JE, 2010, CURR PHARM DESIGN, V16, P942, DOI 10.2174/138161210790883426; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Geetha-Loganathan P, 2005, DEV BIOL, V288, P221, DOI 10.1016/j.ydbio.2005.09.035; Geetha-Loganathan P, 2006, ANAT EMBRYOL, V211, P183, DOI 10.1007/s00429-005-0069-6; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Grogg MW, 2005, NATURE, V438, P858, DOI 10.1038/nature04175; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Harashima M, 2008, J BIOCHEM, V143, P537, DOI 10.1093/jb/mvm248; Hayes S, 2007, DEV BIOL, V312, P300, DOI 10.1016/j.ydbio.2007.09.046; HOFFMAN PN, 1988, P NATL ACAD SCI USA, V85, P4530, DOI 10.1073/pnas.85.12.4530; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Kim T, 2003, HEPATOLOGY, V26, P896; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Kuramoto T, 2001, P NATL ACAD SCI USA, V98, P559, DOI 10.1073/pnas.98.2.559; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Li TT, 2010, MOL GENET GENOMICS, V283, P485, DOI 10.1007/s00438-010-0530-y; Liu ZW, 2001, BBA-GENE STRUCT EXPR, V1518, P183, DOI 10.1016/S0167-4781(01)00170-1; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mashanov VS, 2001, INVERTEBR REPROD DEV, V39, P143, DOI 10.1080/07924259.2001.9652477; Mashanov VS, 2005, BIOL BULL-US, V209, P184, DOI 10.2307/3593108; Mashanov VS, 2011, GENE EXPRESSION PATT; Miguel-Ruiz JES, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-3; Miguel-Ruiz JES, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-115; MIKUCKI SA, 1991, J NEUROSCI RES, V30, P213, DOI 10.1002/jnr.490300122; MILLER FD, 1989, J NEUROSCI, V9, P1452; Mohan R, 2002, J BIOL CHEM, V277, P2065, DOI 10.1074/jbc.M107611200; Moore DL, 2011, MOL CELL NEUROSCI, V47, P233, DOI 10.1016/j.mcn.2011.05.005; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murray G, 2004, CELL TISSUE RES, V318, P515, DOI 10.1007/s00441-004-0978-3; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamura K, 2007, BRAIN RES, V1136, P28, DOI 10.1016/j.brainres.2006.12.032; Neels JG, 2000, BLOOD, V96, P3459, DOI 10.1182/blood.V96.10.3459.h8003459_3459_3465; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; ONDA H, 1990, DEVELOPMENT, V108, P657; ONG DE, 1987, J BIOL CHEM, V262, P2729; Ortiz-Pineda PA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-262; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Pfeifer K, 2012, DEV GENES EVOL, P1; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Ramirez-Gomez F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006178; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rojas-Cartagena C, 2007, PHYSIOL GENOMICS, V31, P203, DOI 10.1152/physiolgenomics.00228.2006; Rychel AL, 2009, STEM CELLS IN MARINE ORGANISMS, P245, DOI 10.1007/978-90-481-2767-2_10; Santiago P, 2000, J EXP ZOOL, V288, P335, DOI 10.1002/1097-010X(20001215)288:4<335::AID-JEZ6>3.0.CO;2-1; Schubert FR, 2002, MECH DEVELOP, V114, P143, DOI 10.1016/S0925-4773(02)00039-4; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Suarez-Castillo EC, 2004, GENE, V334, P133, DOI 10.1016/j.gene.2004.03.023; Sun L, 2011, COMP BIOCHEM PHYS D, V6, P195, DOI 10.1016/j.cbd.2011.03.002; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Thompson JS, 2000, MICROSC RES TECHNIQ, V51, P129, DOI 10.1002/1097-0029(20001015)51:2<129::AID-JEMT4>3.0.CO;2-Y; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; Wang KC, 2009, TRENDS CELL BIOL, V19, P268, DOI 10.1016/j.tcb.2009.03.007; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WHALEN RG, 1990, DEV BIOL, V141, P24, DOI 10.1016/0012-1606(90)90099-5; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xia W, 2007, J DALIAN FISHERIES U, V05; Xiao YT, 2007, BIOCHEM BIOPH RES CO, V362, P550, DOI 10.1016/j.bbrc.2007.08.045; Xu CS, 2008, AMINO ACIDS, V34, P91, DOI 10.1007/s00726-007-0576-2; YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933; Zang YQ, 2012, AQUACULTURE, V358, P50, DOI 10.1016/j.aquaculture.2012.06.007; Zheng FX, 2006, HYDROBIOLOGIA, V571, P109, DOI 10.1007/s10750-006-0231-z	100	57	61	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69441	10.1371/journal.pone.0069441	http://dx.doi.org/10.1371/journal.pone.0069441			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936330	gold, Green Published, Green Submitted			2022-12-27	WOS:000324401500009
J	Evans, BD; Stringer, SM				Evans, Benjamin D.; Stringer, Simon M.			How Lateral Connections and Spiking Dynamics May Separate Multiple Objects Moving Together	PLOS ONE			English	Article							CAT VISUAL-CORTEX; SINGLE NEURONS; SCENE SEGMENTATION; TEMPORAL CORTEX; STIMULI PRESENT; RECOGNITION; RESPONSES; REPRESENTATION; BINDING; SYSTEM	Over successive stages, the ventral visual system of the primate brain develops neurons that respond selectively to particular objects or faces with translation, size and view invariance. The powerful neural representations found in Inferotemporal cortex form a remarkably rapid and robust basis for object recognition which belies the difficulties faced by the system when learning in natural visual environments. A central issue in understanding the process of biological object recognition is how these neurons learn to form separate representations of objects from complex visual scenes composed of multiple objects. We show how a one-layer competitive network comprised of 'spiking' neurons is able to learn separate transformation-invariant representations (exemplified by one-dimensional translations) of visual objects that are always seen together moving in lock-step, but separated in space. This is achieved by combining 'Mexican hat' functional lateral connectivity with cell firing-rate adaptation to temporally segment input representations of competing stimuli through anti-phase oscillations (perceptual cycles). These spiking dynamics are quickly and reliably generated, enabling selective modification of the feed-forward connections to neurons in the next layer through Spike-Time-Dependent Plasticity (STDP), resulting in separate translation-invariant representations of each stimulus. Variations in key properties of the model are investigated with respect to the network's ability to develop appropriate input representations and subsequently output representations through STDP. Contrary to earlier rate-coded models of this learning process, this work shows how spiking neural networks may learn about more than one stimulus together without suffering from the 'superposition catastrophe'. We take these results to suggest that spiking dynamics are key to understanding biological visual object recognition.	[Evans, Benjamin D.; Stringer, Simon M.] Univ Oxford, Dept Expt Psychol, Oxford Ctr Theoret Neurosci & Artificial Intellig, Oxford OX1 3UD, England	University of Oxford	Evans, BD (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford Ctr Theoret Neurosci & Artificial Intellig, S Parks Rd, Oxford OX1 3UD, England.	benjamin.evans@psy.ox.ac.uk		Evans, Benjamin/0000-0002-1734-6070	Economic and Social Research Council	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by the Economic and Social Research Council (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 1998, CEREB CORTEX, V8, P462, DOI 10.1093/cercor/8.5.462; [Anonymous], 1998, NEURAL NETWORKS BRAI; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BISHOP CM, 1997, NEURAL NETWORKS PATT; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Choe Y, 2003, NEUROCOMPUTING, V52-4, P707, DOI 10.1016/S0925-2312(02)00747-6; Choe Y, 1998, NEUROCOMPUTING, V21, P139, DOI 10.1016/S0925-2312(98)00040-X; Cox DD, 2005, NAT NEUROSCI, V8, P1145, DOI 10.1038/nn1519; de Almeida L, 2009, J NEUROSCI, V29, P7497, DOI 10.1523/JNEUROSCI.6044-08.2009; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Elliffe MCM, 2002, BIOL CYBERN, V86, P59, DOI 10.1007/s004220100284; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Evans BD, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00046; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Gerstner W., 2006, SPIKING NEURON MODEL; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gutig R, 2003, J NEUROSCI, V23, P3697; Hennequin G, 2010, FRONTIERS COMPUTATIO, V4, P1; Hess RF, 2003, J PHYSIOL-PARIS, V97, P105, DOI 10.1016/j.jphysparis.2003.09.013; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Isik L, 2012, FRONTIERS COMPUTATIO, V6, P1; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Koch Christof, 1999, P1; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Li N, 2008, SCIENCE, V321, P1502, DOI 10.1126/science.1160028; Li N, 2012, J NEUROSCI, V32, P6611, DOI 10.1523/JNEUROSCI.3786-11.2012; Liu YH, 2001, J COMPUT NEUROSCI, V10, P25, DOI 10.1023/A:1008916026143; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MacKay D. J. C., 2003, INFORM THEORY INFERE; MALACH R, 1994, CEREB CORTEX, V4, P151, DOI 10.1093/cercor/4.2.151; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miconi T, 2010, FRONT HUM NEUROSCI, V4, P1; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; Mukkulamen R, 2005, COMPUTATIONAL MAPS V; NISCHWITZ A, 1995, BIOL CYBERN, V73, P389, DOI 10.1007/BF00201473; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Perrinet L, 2001, NEUROCOMPUTING, V38, P817, DOI 10.1016/S0925-2312(01)00460-X; Perry G, 2006, VISION RES, V46, P3994, DOI 10.1016/j.visres.2006.07.025; REITBOECK HJ, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P638, DOI 10.1109/ICNN.1993.298629; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Rolls ET, 2000, NEURAL COMPUT, V12, P2547, DOI 10.1162/089976600300014845; Singer W, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P43, DOI 10.1016/B978-0-12-374168-4.00004-6; Spratling MW, 2005, IEEE T PATTERN ANAL, V27, P753, DOI 10.1109/TPAMI.2005.105; Stoecker M, 1996, NEUROCOMPUTING, V11, P123, DOI 10.1016/0925-2312(94)00054-9; Stringer SM, 2008, NEURAL NETWORKS, V21, P888, DOI 10.1016/j.neunet.2007.11.004; Stringer SM, 2007, NETWORK-COMP NEURAL, V18, P161, DOI 10.1080/09548980701556055; Stringer SM, 2006, BIOL CYBERN, V94, P128, DOI 10.1007/s00422-005-0030-z; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tanabe M, 1998, J NEUROPHYSIOL, V80, P2268, DOI 10.1152/jn.1998.80.5.2268; Tanaka K, 1996, NEURAL NETWORKS, V9, P1459, DOI 10.1016/S0893-6080(96)00045-7; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; TOVEE MJ, 1994, J NEUROPHYSIOL, V72, P1049, DOI 10.1152/jn.1994.72.3.1049; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Tromans JM, 2012, NETWORK-COMP NEURAL, V23, P1, DOI 10.3109/0954898X.2011.651520; Troyer TW, 1998, J NEUROSCI, V18, P5908; TSO DY, 1986, J NEUROSCI, V6, P1160; Usher M, 1998, NATURE, V394, P179, DOI 10.1038/28166; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5; von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8	68	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69952	10.1371/journal.pone.0069952	http://dx.doi.org/10.1371/journal.pone.0069952			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936362	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800027
J	Li, Y; Tian, CF; Chen, WF; Wang, L; Sui, XH; Chen, WX				Li, Yan; Tian, Chang Fu; Chen, Wen Feng; Wang, Lei; Sui, Xin Hua; Chen, Wen Xin			High-Resolution Transcriptomic Analyses of Sinorhizobium sp NGR234 Bacteroids in Determinate Nodules of Vigna unguiculata and Indeterminate Nodules of Leucaena leucocephala	PLOS ONE			English	Article							SP STRAIN NGR234; SYMBIOTIC NITROGEN-FIXATION; BRADYRHIZOBIUM-JAPONICUM; NITRIC-OXIDE; PROTEIN SECRETION; GENE-EXPRESSION; ROOT-NODULE; MELILOTI; LEGUME; DIFFERENTIATION	The rhizobium-legume symbiosis is a model system for studying mutualistic interactions between bacteria and eukaryotes. Sinorhizobium sp. NGR234 is distinguished by its ability to form either indeterminate nodules or determinate nodules with diverse legumes. Here, we presented a high-resolution RNA-seq transcriptomic analysis of NGR234 bacteroids in indeterminate nodules of Leucaena leucocephala and determinate nodules of Vigna unguiculata. In contrast to exponentially growing free-living bacteria, non-growing bacteroids from both legumes recruited several common cellular functions such as cbb3 oxidase, thiamine biosynthesis, nitrate reduction pathway (NO-producing), succinate metabolism, PHB (poly-3-hydroxybutyrate) biosynthesis and phosphate/phosphonate transporters. However, different transcription profiles between bacteroids from two legumes were also uncovered for genes involved in the biosynthesis of exopolysaccharides, lipopolysaccharides, T3SS (type three secretion system) and effector proteins, cytochrome bd ubiquinol oxidase, PQQ (pyrroloquinoline quinone), cytochrome c550, pseudoazurin, biotin, phasins and glycolate oxidase, and in the metabolism of glutamate and phenylalanine. Noteworthy were the distinct expression patterns of genes encoding phasins, which are thought to be involved in regulating the surface/volume ratio of PHB granules. These patterns are in good agreement with the observed granule size difference between bacteroids from L. leucocephala and V. unguiculata.	[Li, Yan; Tian, Chang Fu; Chen, Wen Feng; Wang, Lei; Sui, Xin Hua; Chen, Wen Xin] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Li, Yan; Tian, Chang Fu; Chen, Wen Feng; Wang, Lei; Sui, Xin Hua; Chen, Wen Xin] China Agr Univ, Minist Agr, Key Lab Soil Microbiol, Beijing 100094, Peoples R China; [Li, Yan; Tian, Chang Fu; Chen, Wen Feng; Sui, Xin Hua; Chen, Wen Xin] China Agr Univ, Rhizobium Res Ctr, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Tian, CF (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	changfutian@gmail.com	Tian, Chang Fu/C-2507-2012; Tian, Chang Fu/O-4482-2019	Tian, Chang Fu/0000-0002-0479-363X; Tian, Chang Fu/0000-0002-0479-363X	National Natural Science Foundation of China [31200002, 31170002]; Innovative Project of State Key Laboratory of Agrobiotechnology (SKLAB) Grant [2012SKLAB01-9]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Project of State Key Laboratory of Agrobiotechnology (SKLAB) Grant	This study was funded by National Natural Science Foundation of China (31200002), National Natural Science Foundation of China (31170002), and Innovative Project of State Key Laboratory of Agrobiotechnology (SKLAB) Grant (2012SKLAB01-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES P, 1981, J BACTERIOL, V148, P728, DOI 10.1128/JB.148.2.728-729.1981; Ampe F, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r15; Ardissone S, 2011, MOL PLANT MICROBE IN, V24, P1513, DOI 10.1094/MPMI-05-11-0143; Ardissone S, 2011, J BACTERIOL, V193, P2218, DOI 10.1128/JB.01260-10; Bardin S, 1996, J BACTERIOL, V178, P4540, DOI 10.1128/jb.178.15.4540-4547.1996; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Baudouin E, 2006, MOL PLANT MICROBE IN, V19, P970, DOI 10.1094/MPMI-19-0970; Becker A, 2004, MOL PLANT MICROBE IN, V17, P292, DOI 10.1094/MPMI.2004.17.3.292; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bernardelli CE, 2001, CURR MICROBIOL, V42, P310, DOI 10.1007/s002840010222; Bernardelli CE, 2008, PLANT SOIL, V313, P217, DOI 10.1007/s11104-008-9694-1; Borziak K, 2007, BIOINFORMATICS, V23, P2518, DOI 10.1093/bioinformatics/btm384; BOTT M, 1995, J BACTERIOL, V177, P2214, DOI 10.1128/jb.177.8.2214-2217.1995; Broughton WJ, 2006, J BACTERIOL, V188, P3654, DOI 10.1128/JB.188.10.3654-3663.2006; Bueno Emilio, 2008, FEMS Microbiol Lett, V279, P188, DOI 10.1111/j.1574-6968.2007.01034.x; Cam Y, 2012, NEW PHYTOL, V196, P548, DOI 10.1111/j.1469-8137.2012.04282.x; Capela D, 2006, MOL PLANT MICROBE IN, V19, P363, DOI 10.1094/MPMI-19-0363; Batista JSD, 2012, J PROTEOMICS, V75, P1211, DOI 10.1016/j.jprot.2011.10.032; DAY DA, 1989, AUST J PLANT PHYSIOL, V16, P69, DOI 10.1071/PP9890069; Deakin WJ, 2009, NAT REV MICROBIOL, V7, P312, DOI 10.1038/nrmicro2091; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Djordjevic MA, 2004, PROTEOMICS, V4, P1859, DOI 10.1002/pmic.200300802; ENCARNACION S, 1995, J BACTERIOL, V177, P3058, DOI 10.1128/jb.177.11.3058-3066.1995; FINAN TM, 1995, GENE, V152, P65, DOI 10.1016/0378-1119(94)00643-7; Finnie C, 1997, MOL MICROBIOL, V25, P135, DOI 10.1046/j.1365-2958.1997.4471803.x; Franck WL, 2008, J BACTERIOL, V190, P6697, DOI 10.1128/JB.00543-08; Fraysse N, 2002, GLYCOBIOLOGY, V12, P741, DOI 10.1093/glycob/cwf078; Fujihara S, 2009, MICROBES ENVIRON, V24, P1, DOI 10.1264/jsme2.ME08557; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Geiger O, 1999, MOL MICROBIOL, V32, P63, DOI 10.1046/j.1365-2958.1999.01325.x; Haag AF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001169; Hofmann K, 2000, FEMS MICROBIOL LETT, V182, P41, DOI 10.1111/j.1574-6968.2000.tb08870.x; Horchani F, 2011, PLANT PHYSIOL, V155, P1023, DOI 10.1104/pp.110.166140; Jamet A, 2003, MOL PLANT MICROBE IN, V16, P217, DOI 10.1094/MPMI.2003.16.3.217; Jamet A, 2007, J BACTERIOL, V189, P8741, DOI 10.1128/JB.01130-07; JOHNSON GV, 1966, PLANT PHYSIOL, V41, P1330, DOI 10.1104/pp.41.8.1330; Kaminski PA, 1996, J BACTERIOL, V178, P5989, DOI 10.1128/jb.178.20.5989-5994.1996; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; Kereszt A, 2011, MOL PLANT MICROBE IN, V24, P1300, DOI 10.1094/MPMI-06-11-0152; Kobayashi H, 2004, MOL MICROBIOL, V51, P335, DOI 10.1046/j.1365-2958.2003.03841.x; Koch M, 2010, MOL PLANT MICROBE IN, V23, P784, DOI 10.1094/MPMI-23-6-0784; KUKIMOTO M, 1995, PROTEIN ENG, V8, P153, DOI 10.1093/protein/8.2.153; Lang K, 2008, MOL GENET GENOMICS, V279, P203, DOI 10.1007/s00438-007-0280-7; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Lopez-Guerrero MG, 2012, PLASMID, V68, P149, DOI 10.1016/j.plasmid.2012.07.002; Lopez-Lara IM, 2005, MOL PLANT MICROBE IN, V18, P973, DOI 10.1094/MPMI-18-0973; Marie C, 2004, MOL PLANT MICROBE IN, V17, P958, DOI 10.1094/MPMI.2004.17.9.958; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Meakin GE, 2007, MICROBIOL-SGM, V153, P411, DOI 10.1099/mic.0.2006/000059-0; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; MirandaRios J, 1997, J BACTERIOL, V179, P6887, DOI 10.1128/jb.179.22.6887-6893.1997; Misra HS, 2012, J BIOSCIENCES, V37, P313, DOI 10.1007/s12038-012-9195-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulley G, 2011, MOL MICROBIOL, V80, P149, DOI 10.1111/j.1365-2958.2011.07565.x; Nagata M, 2008, MOL PLANT MICROBE IN, V21, P1175, DOI 10.1094/MPMI-21-9-1175; Nomura M, 2010, SOIL SCI PLANT NUTR, V56, P579, DOI 10.1111/j.1747-0765.2010.00500.x; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Oono R, 2010, NEW PHYTOL, V187, P508, DOI 10.1111/j.1469-8137.2010.03261.x; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Perret X, 1999, MOL MICROBIOL, V32, P415, DOI 10.1046/j.1365-2958.1999.01361.x; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Pii Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-21; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; Ramirez-Trujillo JA, 2007, J BACTERIOL, V189, P5875, DOI 10.1128/JB.00385-07; Reuhs BL, 2005, J BACTERIOL, V187, P6479, DOI 10.1128/JB.187.18.6479-6487.2005; Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; SOBERON M, 1990, J BACTERIOL, V172, P1676, DOI 10.1128/jb.172.3.1676-1680.1990; Staehelin C, 2006, J BACTERIOL, V188, P6168, DOI 10.1128/JB.00365-06; Suzuki S, 2007, APPL ENVIRON MICROB, V73, P6650, DOI 10.1128/AEM.01514-07; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tian CF, 2012, P NATL ACAD SCI USA, V109, P8629, DOI 10.1073/pnas.1120436109; Tsukada S, 2009, APPL ENVIRON MICROB, V75, P5037, DOI 10.1128/AEM.00398-09; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711, DOI 10.1104/pp.106.078691; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Vercruysse M, 2011, MOL PLANT MICROBE IN, V24, P1553, DOI 10.1094/MPMI-05-11-0140; VINCENT J. M., 1970, A manual for the practical study of the root-nodule bacteria.; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x; Wang CX, 2007, J BACTERIOL, V189, P9050, DOI 10.1128/JB.01190-07; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; York GM, 2001, J BACTERIOL, V183, P2394, DOI 10.1128/JB.183.7.2394-2397.2001	92	21	23	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70531	10.1371/journal.pone.0070531	http://dx.doi.org/10.1371/journal.pone.0070531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936444	Green Submitted, gold, Green Published			2022-12-27	WOS:000324545800043
J	Ge, YY; Wu, B; Qi, X; Zhao, KC; Guo, XL; Zhu, YF; Qi, YH; Shi, ZY; Zhou, MH; Wang, H; Cui, LB				Ge, Yiyue; Wu, Bin; Qi, Xian; Zhao, Kangchen; Guo, Xiling; Zhu, Yefei; Qi, Yuhua; Shi, Zhiyang; Zhou, Minghao; Wang, Hua; Cui, Lunbiao			Rapid and Sensitive Detection of Novel Avian-Origin Influenza A (H7N9) Virus by Reverse Transcription Loop-Mediated Isothermal Amplification Combined with a Lateral-Flow Device	PLOS ONE			English	Article							CROSS-PRIMING AMPLIFICATION; RT-LAMP; MYCOBACTERIUM-TUBERCULOSIS; DISEASE VIRUS; FEVER VIRUS; DIPSTICK; INFECTION; SYSTEM; CHINA; DNA	A severe disease in humans caused by a novel avian-origin influenza A (H7N9) virus emerged in China recently, which has caused at least 128 cases and 26 deaths. Rapid detection of the novel H7N9 virus is urgently needed to differentiate the disease from other infections, and to facilitate infection control as well as epidemiologic investigations. In this study, a reverse transcription loop-mediated isothermal amplification combined with a lateral flow device (RT-LAMP-LFD) assay to rapidly detect H7N9 virus was developed and evaluated. The RT-LAMP primers were designed to target the haemagglutinin (HA) and neuraminidase (NA) genes of H7N9 virus. Results of 10-fold dilution series assays showed that analysis of RT-LAMP products by the LFD method was as sensitive as real-time turbidity detection, and that the analytic sensitivities of the HA and NA RT-LAMP assays were both 10 copies of synthetic RNA. Furthermore, both the assays showed 100% clinical specificity for identification of H7N9 virus. The performance characteristics of the RT-LAMP-LFD assay were evaluated with 80 clinical specimens collected from suspected H7N9 patients. The NA RT-LAMP-LFD assay was more sensitive than real time RT-PCR assay. Compared with a combination of virus culture and real-time RT-PCR, the sensitivity, specificity, positive predictive value, and negative predictive value of the RT-LAMP-LFD assay were all 100%. Overall, The RT-LAMP-LFD assay established in this study can be used as a reliable method for early diagnosis of the avian-origin influenza A (H7N9) virus infection.	[Ge, Yiyue; Zhao, Kangchen; Guo, Xiling; Qi, Yuhua; Shi, Zhiyang; Zhou, Minghao; Wang, Hua; Cui, Lunbiao] Minist Hlth, Key Labs Enter Pathogen Microbiol, Jiangsu Prov Ctr Dis Control & Prevent, Inst Pathogen Microbiol, Nanjing, Jiangsu, Peoples R China; [Wu, Bin; Qi, Xian; Zhu, Yefei] Jiangsu Prov Ctr Dis Prevent & Control, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Cui, LB (corresponding author), Minist Hlth, Key Labs Enter Pathogen Microbiol, Jiangsu Prov Ctr Dis Control & Prevent, Inst Pathogen Microbiol, Nanjing, Jiangsu, Peoples R China.	lbcui@njmu.edu.cn	zhou, minghao/GZA-7244-2022; ge, yiyue/AAW-9914-2021; cui, lunbiao/AAP-7931-2021	Zhu, Yefei/0000-0002-2625-2199	National Major Science & Technology Projects for Infectious Disease Control and Prevention [2013ZX10004103-006]; Jiangsu Province Health Development Project with Science and Education [ZX201109]; Jiangsu Province Key Medical Talent Foundation [RC2011191, RC2011084, JKRC2011001]; Science and Technology Pillar program of Jiangsu Province [BE2011796]	National Major Science & Technology Projects for Infectious Disease Control and Prevention; Jiangsu Province Health Development Project with Science and Education; Jiangsu Province Key Medical Talent Foundation; Science and Technology Pillar program of Jiangsu Province	This study was supported in part by the National Major Science & Technology Projects for Infectious Disease Control and Prevention (2013ZX10004103-006), the Jiangsu Province Health Development Project with Science and Education (ZX201109), the Jiangsu Province Key Medical Talent Foundation (RC2011191, RC2011084, JKRC2011001), and the Science and Technology Pillar program of Jiangsu Province (BE2011796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HUM INF INFL A H7N9; Chow WHA, 2008, J MOL DIAGN, V10, P452, DOI 10.2353/jmoldx.2008.080008; Corman VM, 2013, EUROSURVEILLANCE, V18, P10; Cui LB, 2012, J CLIN MICROBIOL, V50, P3881, DOI 10.1128/JCM.01931-12; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Dukes JP, 2006, ARCH VIROL, V151, P1093, DOI 10.1007/s00705-005-0708-5; Fang RD, 2009, J CLIN MICROBIOL, V47, P845, DOI 10.1128/JCM.01528-08; Foord AJ, 2012, J VIROL METHODS, V181, P93, DOI 10.1016/j.jviromet.2012.01.020; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Imai M, 2006, VACCINE, V24, P6679, DOI 10.1016/j.vaccine.2006.05.046; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; James HE, 2010, J VIROL METHODS, V164, P68, DOI 10.1016/j.jviromet.2009.11.034; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Njiru ZK, 2011, DIAGN MICR INFEC DIS, V69, P205, DOI 10.1016/j.diagmicrobio.2010.08.026; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Osman HAM, 2013, J VIROL METHODS, V190, P4, DOI 10.1016/j.jviromet.2013.03.004; Prompamorn P, 2011, LETT APPL MICROBIOL, V52, P344, DOI 10.1111/j.1472-765X.2011.03007.x; Taubenberger JK, 2007, JAMA-J AM MED ASSOC, V297, P2025, DOI 10.1001/jama.297.18.2025; Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004; Tomlinson JA, 2010, PHYTOPATHOLOGY, V100, P143, DOI 10.1094/PHYTO-100-2-0143; Tsai SM, 2012, J VIROL METHODS, V181, P117, DOI 10.1016/j.jviromet.2011.09.002; Tsai SM, 2009, J VIROL METHODS, V157, P200, DOI 10.1016/j.jviromet.2009.01.003; Wang C, 2013, LETT APPL MICROBIOL, V56, P229, DOI 10.1111/lam.12039; Wang X, 2012, J VIROL METHODS, V179, P330, DOI 10.1016/j.jviromet.2011.11.019; Whiting SH, 1998, J MOL BIOL, V278, P559, DOI 10.1006/jmbi.1998.1720; WHO, 2013, REAL TIM RT PCR PROT	31	69	73	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69941	10.1371/journal.pone.0069941	http://dx.doi.org/10.1371/journal.pone.0069941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936359	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400027
J	Halasiddappa, LM; Koefeler, H; Futerman, AH; Hermetter, A				Halasiddappa, Lingaraju M.; Koefeler, Harald; Futerman, Anthony H.; Hermetter, Albin			Oxidized Phospholipids Induce Ceramide Accumulation in RAW 264.7 Macrophages: Role of Ceramide Synthases	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; RADIATION-INDUCED APOPTOSIS; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; ACTIVATION; SPHINGOMYELINASE; INHIBITION; SUBSTRATE; OXIDATION; GROWTH	Oxidized phospholipids (OxPLs), including 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine (PGPC) and 1-palmitoyl-2-oxovaleroyl-sn-glycero-3-phosphocholine (POVPC) are among several biologically active derivatives that are generated during oxidation of low-density lipoproteins (LDLs). These OxPLs are factors contributing to proatherogenic effects of oxidized LDLs (OxLDLs), including inflammation, proliferation and death of vascular cells. OxLDL also elicits formation of the lipid messenger ceramide (Cer) which plays a pivotal role in apoptotic signaling pathways. Here we report that both PGPC and POVPC are cytotoxic to cultured macrophages and induce apoptosis in these cells which is associated with increased cellular ceramide levels after several hours. In addition, exposure of RAW 264.7 cells to POVPC and PGPC under the same conditions resulted in a significant increase in ceramide synthase activity, whereas, acid or neutral sphingomyelinase activities were not affected. PGPC is not only more toxic than POVPC, but also a more potent inducer of ceramide formation by activating a limited subset of CerS isoforms. The stimulated CerS activities are in line with the C-16-, C-22-, and C-24.0-Cer species that are generated under the influence of the OxPL. Fumonisin B1, a specific inhibitor of CerS, suppressed OxPL-induced ceramide generation, demonstrating that OxPL-induced CerS activity in macrophages is responsible for the accumulation of ceramide. OxLDL elicits the same cellular ceramide and CerS effects. Thus, it is concluded that PGPC and POVPC are active components that contribute to the capacity of this lipoprotein to elevate ceramide levels in macrophages.	[Halasiddappa, Lingaraju M.; Hermetter, Albin] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Koefeler, Harald] Med Univ Graz, Core Facil Mass Spectrometry, Graz, Austria; [Halasiddappa, Lingaraju M.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Graz University of Technology; Medical University of Graz; Weizmann Institute of Science	Hermetter, A (corresponding author), Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria.	albin.hermetter@tugraz.at		Kofeler, Harald/0000-0002-2725-9616; Futerman, Anthony/0000-0003-0013-0115	Austrian Science Fund (FWF) [I308-B12, W901-B05]; Austrian Science Fund (FWF) [F 3006, W 901, I 308] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF), grant numbers I308-B12 (ESF EuroMEMBRANE CRP OXPL) and W901-B05 (DK Molecular Enzymology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge N, 1996, J BIOL CHEM, V271, P19251, DOI 10.1074/jbc.271.32.19251; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHUNG BH, 1980, J LIPID RES, V21, P284; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Escargueil-Blanc I, 1998, J BIOL CHEM, V273, P27389, DOI 10.1074/jbc.273.42.27389; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Kashiwakura Y, 2004, CIRCULATION, V110, P3329, DOI 10.1161/01.CIR.0000147828.86593.85; Kinscherf R, 1997, FEBS LETT, V405, P55, DOI 10.1016/S0014-5793(97)00157-9; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liao WC, 1999, J BIOL CHEM, V274, P17908, DOI 10.1074/jbc.274.25.17908; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; Loidl A, 2003, J BIOL CHEM, V278, P32921, DOI 10.1074/jbc.M306088200; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Moumtzi A, 2007, J LIPID RES, V48, P565, DOI 10.1194/jlr.M600394-JLR200; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Napoli C, 2003, ANN NY ACAD SCI, V1010, P698, DOI 10.1196/annals.1299.127; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Qin JD, 2009, J NEUROCHEM, V110, P1388, DOI 10.1111/j.1471-4159.2009.06231.x; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Rhode S, 2009, J BIOL CHEM, V284, P2258, DOI 10.1074/jbc.M807591200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Salvayre R, 2002, BBA-MOL CELL BIOL L, V1585, P213, DOI 10.1016/S1388-1981(02)00343-8; Schiffmann S, 2010, BIOCHEM PHARMACOL, V80, P1632, DOI 10.1016/j.bcp.2010.08.012; SERGEI AN, 2010, J CARDIOVASC PHARM, V53, P198, DOI DOI 10.1097/FJC.0B013E31819B52D5.CERAMIDE; Stemmer U, 2012, BBA-MOL CELL BIOL L, V1821, P706, DOI 10.1016/j.bbalip.2012.01.014; Stemmer U, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-110; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Tabas I, 2004, CELL DEATH DIFFER, V11, pS12, DOI 10.1038/sj.cdd.4401444; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Walton KA, 2006, J LIPID RES, V47, P1967, DOI 10.1194/jlr.M600060-JLR200; Wang HT, 2001, CANCER RES, V61, P5102; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zettler ME, 2004, ARTERIOSCL THROM VAS, V24, P727, DOI 10.1161/01.ATV.0000120373.95552.aa	42	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70002	10.1371/journal.pone.0070002	http://dx.doi.org/10.1371/journal.pone.0070002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936132	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700050
J	Li, YR; Geary, DC				Li, Yaoran; Geary, David C.			Developmental Gains in Visuospatial Memory Predict Gains in Mathematics Achievement	PLOS ONE			English	Article							ELEMENTARY-SCHOOL-CHILDREN; ENTRANCE TEST-SCORES; SHORT-TERM-MEMORY; WORKING-MEMORY; LEARNING-DISABILITIES; SEX-DIFFERENCES; GENDER-DIFFERENCES; PRECOCIOUS YOUTH; SPATIAL ABILITY; NUMBER LINE	Visuospatial competencies are related to performance in mathematical domains in adulthood, but are not consistently related to mathematics achievement in children. We confirmed the latter for first graders and demonstrated that children who show above average first-to-fifth grade gains in visuospatial memory have an advantage over other children in mathematics. The study involved the assessment of the mathematics and reading achievement of 177 children in kindergarten to fifth grade, inclusive, and their working memory capacity and processing speed in first and fifth grade. Intelligence was assessed in first grade and their second to fourth grade teachers reported on their in-class attentive behavior. Developmental gains in visuospatial memory span (d = 2.4) were larger than gains in the capacity of the central executive (d = 1.6) that in turn were larger than gains in phonological memory span (d = 1.1). First to fifth grade gains in visuospatial memory and in speed of numeral processing predicted end of fifth grade mathematics achievement, as did first grade central executive scores, intelligence, and in-class attentive behavior. The results suggest there are important individual differences in the rate of growth of visuospatial memory during childhood and that these differences become increasingly important for mathematics learning.	[Li, Yaoran] Univ Missouri, Dept Educ Sch & Counseling Psychol, Columbia, MO USA; [Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; [Geary, David C.] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Geary, DC (corresponding author), Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA.	GearyD@missouri.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [R37 HD045914]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045914] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research was funded by grant R37 HD045914 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan NP, 2011, DEV PSYCHOL, V47, P905, DOI 10.1037/a0023748; Andersson U, 2010, J EDUC PSYCHOL, V102, P115, DOI 10.1037/a0016838; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bull R, 1997, J EXP CHILD PSYCHOL, V65, P1, DOI 10.1006/jecp.1996.2358; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; CASEY MB, 1995, DEV PSYCHOL, V31, P697, DOI 10.1037/0012-1649.31.4.697; Casey MB, 1997, DEV PSYCHOL, V33, P669, DOI 10.1037/0012-1649.33.4.669; Clark CA, 2013, CHILD DEV IN PRESS; Clark CAC, 2010, DEV PSYCHOL, V46, P1176, DOI 10.1037/a0019672; Cowan N, 2013, HDB DEV CHI IN PRESS; Cowan N., 1997, DEV MEMORY CHILDHOOD, P163; Cowan N, 2011, DEVELOPMENTAL SCI, V14, P1066, DOI 10.1111/j.1467-7687.2011.01060.x; DARK VJ, 1991, J EDUC PSYCHOL, V83, P48, DOI 10.1037/0022-0663.83.1.48; de Abreu PMJE, 2010, INTELLIGENCE, V38, P552, DOI 10.1016/j.intell.2010.07.003; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Fuchs LS, 2006, J EDUC PSYCHOL, V98, P29, DOI 10.1037/0022-0663.98.1.29; Fuchs LS, 2010, DEV PSYCHOL, V46, P1731, DOI 10.1037/a0020662; Fuchs LS, 2010, CHILD DEV, V81, P1520, DOI 10.1111/j.1467-8624.2010.01489.x; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; Geary DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054651; Geary DC, 2012, J EXP CHILD PSYCHOL, V113, P49, DOI 10.1016/j.jecp.2012.03.003; Geary DC, 2011, DEV PSYCHOL, V47, P1539, DOI 10.1037/a0025510; Geary DC, 2000, J EXP CHILD PSYCHOL, V77, P337, DOI 10.1006/jecp.2000.2594; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Geary DC, 2004, J EXP CHILD PSYCHOL, V88, P121, DOI 10.1016/j.jecp.2004.03.002; GEARY DC, 1989, J EXP CHILD PSYCHOL, V47, P175, DOI 10.1016/0022-0965(89)90028-3; Geary DC, 2012, MALE FEMALE EVOLUTIO; Gunderson EA, 2012, DEV PSYCHOL, V48, P1229, DOI 10.1037/a0027433; Hamilton CJ, 2003, EUR J COGN PSYCHOL, V15, P43, DOI 10.1080/09541440303597; Holmes J., 2006, ED PSYCHOL, V26, P339, DOI [10.1080/01443410500341056, DOI 10.1080/01443410500341056]; Imbo I, 2007, J EXP CHILD PSYCHOL, V96, P284, DOI 10.1016/j.jecp.2006.09.001; JOHNSON ES, 1984, J EDUC PSYCHOL, V76, P1359, DOI 10.1037/0022-0663.76.6.1359; Krajewski K, 2009, J EXP CHILD PSYCHOL, V103, P516, DOI 10.1016/j.jecp.2009.03.009; Kyttala M, 2008, EUR J PSYCHOL EDUC, V23, P77, DOI 10.1007/BF03173141; Lachance JA, 2006, LEARN INDIVID DIFFER, V16, P195, DOI 10.1016/j.lindif.2005.12.001; Logie RH, 1997, EUR J COGN PSYCHOL, V9, P241, DOI 10.1080/713752559; LOGIE RH, 1987, J EXP PSYCHOL LEARN, V13, P310, DOI 10.1037/0278-7393.13.2.310; Lubinski D, 2006, PERSPECT PSYCHOL SCI, V1, P316, DOI 10.1111/j.1745-6916.2006.00019.x; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; Mazzocco MMM, 2003, ANN DYSLEXIA, V53, P218, DOI 10.1007/s11881-003-0011-7; Meyer ML, 2010, LEARN INDIVID DIFFER, V20, P101, DOI 10.1016/j.lindif.2009.08.004; Mix KS, 2012, ADV CHILD DEV BEHAV, V42, P197; Passolunghi MC, 2007, COGNITIVE DEV, V22, P165, DOI 10.1016/j.cogdev.2006.09.001; Pickering S., 2001, WORKING MEMORY TEST; Pickering SJ, 2001, MEMORY, V9, P423, DOI 10.1080/09658210143000182; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Rasmussen C, 2005, J EXP CHILD PSYCHOL, V91, P137, DOI 10.1016/j.jecp.2005.01.004; SAS Institute, 2004, STAT AN SYST 7 5; Swanson HL, 2008, J EDUC PSYCHOL, V100, P343, DOI 10.1037/0022-0663.100.2.343; Swanson HL, 2011, J EDUC PSYCHOL, V103, P821, DOI 10.1037/a0025114; Swanson HL, 2001, J EXP CHILD PSYCHOL, V79, P294, DOI 10.1006/jecp.2000.2587; Swanson J. M., 2008, CATEGORICAL DIMENSIO; Toll SWM, 2011, J LEARN DISABIL-US, V44, P521, DOI 10.1177/0022219410387302; Van der Ven SHG, 2012, BRIT J EDUC PSYCHOL, V82, P100, DOI 10.1111/j.2044-8279.2011.02035.x; Webb RM, 2007, J EDUC PSYCHOL, V99, P397, DOI 10.1037/0022-0663.99.2.397; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D, 2001, WECHSLER INDIVIDUAL, Vsecond; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	62	40	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70160	10.1371/journal.pone.0070160	http://dx.doi.org/10.1371/journal.pone.0070160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936154	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700057
J	Li, ZY; Guo, YL; Lu, Y; Li, JZ; Jin, ZG; Li, HB; Lu, YP; Dai, P; Han, DY; Cheng, J; Yuan, HJ				Li, Zhengyue; Guo, Yilian; Lu, Yu; Li, Jianzhong; Jin, Zhanguo; Li, Hongbo; Lu, Yanping; Dai, Pu; Han, Dongyi; Cheng, Jing; Yuan, Huijun			Identification of a Novel TECTA Mutation in a Chinese DFNA8/12 Family with Prelingual Progressive Sensorineural Hearing Impairment	PLOS ONE			English	Article							TECTORIAL MEMBRANE; DEAFNESS	Tectorial membrane, an extracellular matrix of the cochlea, plays a crucial role in the transmission of sound to the sensory hair cells. Alpha-tectorin is the most important noncollagenous component of the tectorial membrane and the otolith membrane in the maculae of the vestibular system. Defects in TECTA, the gene encodes alpha-tectorin, are cause of both dominant (DFNA8/12) and recessive (DFNB21) forms of deafness. Here, we report a three-generation Chinese family characterized by prelingual progressive sensorineural hearing impairment. We mapped the disease locus to chromosome 11q23-24 region, overlapping with the DFNA8/12 locus. Sequencing of candidate gene TECTA revealed a heterozygous c.5945C>A substitution in exon 19, causing amino acid substitution of Ala to Asp at a conservative position 1982. The A1982D substitution is consistent with hearing loss in this Chinese family and has not been found in 200 random control chromosomes. To our knowledge, this is the first TECTA mutation identified in Chinese population. Our data provides additional molecular and clinical information for establishing a better genotype-phenotype understanding of DFNA8/12.	[Li, Zhengyue; Lu, Yu; Jin, Zhanguo; Li, Hongbo; Dai, Pu; Han, Dongyi; Cheng, Jing; Yuan, Huijun] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing, Peoples R China; [Guo, Yilian] Zhongshan Tradit Chinese Med Hosp Guangdong Prov, Dept Otolaryngol, Zhongshan, Guangdong, Peoples R China; [Li, Jianzhong] NanJing Command PLA, FuZhou Gen Hosp, Dept Otolaryngol, Fuzhou, Fujian Province, Peoples R China; [Lu, Yanping] Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Guangzhou University of Chinese Medicine; Chinese People's Liberation Army General Hospital	Cheng, J (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing, Peoples R China.	chj.grace@gmail.com; yuanhj301@163.com			National Natural Science Foundation of China [81030017]; National Science Fund for Distinguished Young Scholars [81125008]; National Basic Research Program [2013CB945402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program(National Basic Research Program of China)	These investigations were supported by Key Project of National Natural Science Foundation of China (81030017), National Science Fund for Distinguished Young Scholars (81125008) to HJ Yuan and The National Basic Research Program (2013CB945402) to DY Han and HJ Yuan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasti F, 2008, INT J PEDIATR OTORHI, V72, P249, DOI 10.1016/j.ijporl.2007.09.023; Balciuniene J, 1999, HUM GENET, V105, P211, DOI 10.1007/s004390051091; Hughes DC, 1998, GENOMICS, V48, P46, DOI 10.1006/geno.1997.5159; Iwasaki S, 2002, ARCH OTOLARYNGOL, V128, P913, DOI 10.1001/archotol.128.8.913; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; RICHARDSON GP, 1987, HEARING RES, V25, P45, DOI 10.1016/0378-5955(87)90078-5; Richardson GP, 2008, CURR OPIN OTOLARYNGO, V16, P458, DOI 10.1097/MOO.0b013e32830e20c4; THALMANN I, 1987, LARYNGOSCOPE, V97, P357; THALMANN I, 1993, CONNECT TISSUE RES, V29, P191, DOI 10.3109/03008209309016826; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60	12	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70134	10.1371/journal.pone.0070134	http://dx.doi.org/10.1371/journal.pone.0070134			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936151	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700056
J	Liang, BL; Qi, L; Yang, JR; Cao, ZZ; Zu, XB; Liu, LF; Wang, L				Liang, Boluo; Qi, Lin; Yang, Jinrui; Cao, Zhenzhen; Zu, Xiongbing; Liu, Longfei; Wang, Long			Ergonomic Status of Laparoscopic Urologic Surgery: Survey Results from 241 Urologic Surgeons in China	PLOS ONE			English	Article							MINIMALLY INVASIVE SURGERY; OPERATING TABLE HEIGHT; INSTRUMENTS; IMPROVEMENT; PRINCIPLES; EXPERIENCE	Background: The prolonged and frequent use of laparoscopic equipment raises ergonomic risks that may cause physical distress for surgeons. We aimed to assess the prevalence of urologic surgeons' physical distress associated with ergonomic problems in the operating room (OR) and their awareness of the ergonomic guidelines in China. Methods: A sample of 300 laparoscopic urologists in China was assessed using a questionnaire on demographic information, ergonomic issues in the OR, musculoskeletal symptoms, and awareness of the ergonomic guidelines for the OR. Results: There were 241 survey respondents (86.7%) with valid questionnaires. Among the respondents, only 43.6% placed the operating table at pubic height during the actual operation. The majority of the respondents (63.5%) used only one monitor during the procedure. Only 29.9% placed the monitor below the eye level. More than half of the respondents (50.6%) preferred to use manual control instead of the foot pedal. Most of the respondents (95.0%) never used the body support. The respondents experienced discomfort in the following regions, in ascending order: leg (21.6%), hand (30.3%), wrist (32.8%), shoulder (33.6%), back (53.1%), and neck (58.1%). The respondents with over 250 total operations experienced less discomfort than those with less than 250 total operations. Most of the respondents (84.6%) were unaware of the ergonomic guidelines. However, almost all of the respondents (98.3%) regarded the ergonomic guidelines to be important in the OR. Conclusions: Most of the laparoscopic urologists were not aware of the ergonomic guidelines for the OR; hence, they have been suffering from varying degrees of physical discomfort caused by ergonomic issues. There is an urgent need for education regarding ergonomic guidelines in the OR for laparoscopic urologists in China.	[Liang, Boluo] Cent South Univ, Xiangya Hosp 2, Dept Reprod Ctr, Changsha, Hunan, Peoples R China; [Qi, Lin; Zu, Xiongbing; Liu, Longfei; Wang, Long] Cent South Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Yang, Jinrui] Cent South Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China; [Cao, Zhenzhen] Cent South Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Dept Gynecol Oncol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Wang, L (corresponding author), Cent South Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China.	wanglong_csu@163.com						Albayrak A, 2007, SURG ENDOSC, V21, P1835, DOI 10.1007/s00464-007-9249-1; Bagrodia A, 2009, J ENDOUROL, V23, P627, DOI 10.1089/end.2008.0556; Berguer R, 1998, SURG ENDOSC-ULTRAS, V12, P458, DOI 10.1007/s004649900705; Berguer R, 1999, SURG ENDOSC-ULTRAS, V13, P466, DOI 10.1007/PL00009635; Berguer R, 2006, J SURG RES, V134, P87, DOI 10.1016/j.jss.2005.10.003; Berquer R, 2002, SURG ENDOSC, V16, P416, DOI 10.1007/s00464-001-8190-y; Campero JM, 2012, UROL ANNALS, V4, P162, DOI 10.4103/0974-7796.102664; Franasiak J, 2012, GYNECOL ONCOL, V126, P437, DOI 10.1016/j.ygyno.2012.05.016; Gofrit ON, 2008, UROLOGY, V71, P404, DOI 10.1016/j.urology.2007.07.077; Hemal AK, 2001, J ENDOUROL, V15, P499, DOI 10.1089/089277901750299294; MAJEED AW, 1993, ARCH SURG-CHICAGO, V128, P357; Manasnayakorn S, 2009, SURG ENDOSC, V23, P783, DOI 10.1007/s00464-008-0068-9; Matern U, 1999, SURG ENDOSC-ULTRAS, V13, P174, DOI 10.1007/s004649900934; Miller K, 2012, HUM FACTORS, V54, P1087, DOI 10.1177/0018720812451046; Sari V, 2010, MINIM INVASIV THER, V19, P105, DOI 10.3109/13645701003643972; Uhrich ML, 2002, SURG ENDOSC, V16, P635, DOI 10.1007/s00464-001-8151-5; van Det MJ, 2009, SURG ENDOSC, V23, P1279, DOI 10.1007/s00464-008-0148-x; van Veelen MA, 2004, MINIM INVASIV THER, V13, P161, DOI 10.1080/13645700410033193; van Veelen MA, 2003, SURG ENDOSC, V17, P1086, DOI 10.1007/s00464-002-9185-z; van Veelen MA, 2003, SURG ENDOSC, V17, P699, DOI 10.1007/s00464-002-9186-y; van Veelen MA, 2002, J LAPAROENDOSC ADV A, V12, P47, DOI 10.1089/109264202753486920; Van Veelen MA, 1999, J LAPAROENDOSC ADV A, V9, P481, DOI 10.1089/lap.1999.9.481; van Veelen MA, 2001, J LAPAROENDOSC ADV A, V11, P17, DOI 10.1089/10926420150502896; Wauben LSGL, 2006, SURG ENDOSC, V20, P1268, DOI 10.1007/s00464-005-0647-y; Welcker K, 2012, INTERACT CARDIOV TH, V15, P197, DOI 10.1093/icvts/ivs173; Xiao DJ, 2012, APPL ERGON, V43, P548, DOI 10.1016/j.apergo.2011.08.010	26	26	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e70423	10.1371/journal.pone.0070423	http://dx.doi.org/10.1371/journal.pone.0070423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936202	Green Submitted, gold, Green Published			2022-12-27	WOS:000322633700072
J	Sweet, MJ; Bythell, JC; Nugues, MM				Sweet, Michael J.; Bythell, John C.; Nugues, Maggy M.			Algae as Reservoirs for Coral Pathogens	PLOS ONE			English	Article							YELLOW BAND DISEASE; WHITE SYNDROME; CAUSATIVE AGENT; SP-NOV.; BACTERIAL COMMUNITIES; NUTRIENT ENRICHMENT; LOCAL VARIABILITY; REEF; ECOLOGY; COMPETITION	Benthic algae are associated with coral death in the form of stress and disease. It's been proposed that they release exudates, which facilitate invasion of potentially pathogenic microbes at the coral-algal interface, resulting in coral disease. However, the original source of these pathogens remains unknown. This study examined the ability of benthic algae to act as reservoirs of coral pathogens by characterizing surface associated microbes associated with major Caribbean and Indo-Pacific algal species/types and by comparing them to potential pathogens of two dominant coral diseases: White Syndrome (WS) in the Indo-Pacific and Yellow Band Disease (YBD) in the Caribbean. Coral and algal sampling was conducted simultaneously at the same sites to avoid spatial effects. Potential pathogens were defined as those absent or rare in healthy corals, increasing in abundance in healthy tissues adjacent to a disease lesion, and dominant in disease lesions. Potentially pathogenic bacteria were detected in both WS and YBD and were also present within the majority of algal species/types (54 and 100% for WS and YBD respectively). Pathogenic ciliates were associated only with WS and not YBD lesions and these were also present in 36% of the Indo-Pacific algal species. Although potential pathogens were associated with many algal species, their presence was inconsistent among replicate algal samples and detection rates were relatively low, suggestive of low density and occurrence. At the community level, coral-associated microbes irrespective of the health of their host differed from algal-associated microbes, supporting that algae and corals have distinctive microbial communities associated with their tissue. We conclude that benthic algae are common reservoirs for a variety of different potential coral pathogens. However, algal-associated microbes alone are unlikely to cause coral death. Initial damage or stress to the coral via other competitive mechanisms is most likely a prerequisite to potential transmission of these pathogens.	[Sweet, Michael J.; Bythell, John C.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nugues, Maggy M.] Univ Perpignan, CBETM, Lab Excellence CORAIL, F-66025 Perpignan, France; [Nugues, Maggy M.] Univ Perpignan, CBETM, USR CRIOBE EPHE CNRS 3278, F-66025 Perpignan, France	Newcastle University - UK; Universite Perpignan Via Domitia; Universite Perpignan Via Domitia	Sweet, MJ (corresponding author), Newcastle Univ, Sch Biol, Ridley Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.j.sweet@ncl.ac.uk	Nugues, Maggy M/O-4314-2015; Bythell, John/ABE-6138-2021; Bythell, John C/E-7962-2010	Nugues, Maggy M/0000-0002-1399-9787; Bythell, John/0000-0003-2416-9786; Bythell, John C/0000-0003-2416-9786	Natural Environmental Research Council, UK [NE/E006949]; Natural Environment Research Council [NE/H020616/1] Funding Source: researchfish; NERC [NE/H020616/1] Funding Source: UKRI	Natural Environmental Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environmental Research Council, UK (NE/E006949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aronson RB, 1998, CORAL REEFS, V17, P223, DOI 10.1007/s003380050122; Barott KL, 2012, TRENDS MICROBIOL, V20, P621, DOI 10.1016/j.tim.2012.08.004; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Bender D, 2012, J EXP MAR BIOL ECOL, V429, P15, DOI 10.1016/j.jembe.2012.06.014; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; BYTHELL J, 1993, MAR POLLUT BULL, V26, P296; Bythell JC, 2000, MAR ECOL PROG SER, V204, P93, DOI 10.3354/meps204093; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Croquer A, 2013, ENV MICROBIOL REP, V5, P90, DOI 10.1111/j.1758-2229.2012.00397.x; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; DONE TJ, 1991, CORAL REEFS, V9, P183, DOI 10.1007/BF00290420; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Guppy R, 2006, MAR ECOL PROG SER, V328, P133, DOI 10.3354/meps328133; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hayes RL, 1998, REV BIOL TROP, V46, P173; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; McClanahan T, 2002, CONSERV ECOL, V6; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Morrow KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044859; MOUCHKA ME, 2010, INTEGR COMP BIOL, P1, DOI DOI 10.1093/ICB/ICQ061:P1-13; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Muyzer G, 1999, CURR OPIN MICROBIOL, V2, P317, DOI 10.1016/S1369-5274(99)80055-1; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Paul VJ, 2008, NAT PROD REP, V25, P662, DOI 10.1039/b702742g; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Sanchez O, 2007, APPL ENVIRON MICROB, V73, P5962, DOI 10.1128/AEM.00817-07; Sevak HP, 2012, BOT MAR, V55, P311, DOI 10.1515/bot-2012-0111; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; Thurber RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044246; Vermeij M.J.A., 2010, PLOS ONE, V5; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Vu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004514; Wolf AT, 2013, ECOLOGY, V94, P1667, DOI 10.1890/12-0680.1; Work TM, 2011, J INVERTEBR PATHOL, V107, P127, DOI 10.1016/j.jip.2011.03.009; Xu DH, 2012, J FISH DIS, V35, P887, DOI 10.1111/j.1365-2761.2012.01436.x	64	59	62	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69717	10.1371/journal.pone.0069717	http://dx.doi.org/10.1371/journal.pone.0069717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936086	gold, Green Submitted, Green Published			2022-12-27	WOS:000322633700042
J	Thomas, L; Bielemeier, A; Lambert, PA; Darveau, RP; Marshall, LJ; Devitt, A				Thomas, Leanne; Bielemeier, Anne; Lambert, Peter A.; Darveau, Richard P.; Marshall, Lindsay J.; Devitt, Andrew			The N-Terminus of CD14 Acts to Bind Apoptotic Cells and Confers Rapid-Tethering Capabilities on Non-Myeloid Cells	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING; CD14-DEPENDENT CLEARANCE; AUTOIMMUNE-DISEASE; HUMAN MACROPHAGES; EPITHELIAL-CELLS; RECOGNITION; PHAGOCYTOSIS; IDENTIFICATION; MEMBRANE; RECEPTOR	Cell death and removal of cell corpses in a timely manner is a key event in both physiological and pathological situations including tissue homeostasis and the resolution of inflammation. Phagocytic clearance of cells dying by apoptosis is a complex sequential process comprising attraction, recognition, tethering, signalling and ultimately phagocytosis and degradation of cell corpses. A wide range of molecules acting as apoptotic cell-associated ligands, phagocyte-associated receptors or soluble bridging molecules have been implicated within this process. The role of myeloid cell CD14 in mediating apoptotic cell interactions with macrophages has long been known though key molecules and residues involved have not been defined. Here we sought to further dissect the function of CD14 in apoptotic cell clearance. A novel panel of THP-1 cell-derived phagocytes was employed to demonstrate that CD14 mediates effective apoptotic cell interactions with macrophages in the absence of detectable TLR4 whilst binding and responsiveness to LPS requires TLR4. Using a targeted series of CD14 point mutants expressed in non-myeloid cells we reveal CD14 residue 11 as key in the binding of apoptotic cells whilst other residues are reported as key for LPS binding. Importantly we note that expression of CD14 in non-myeloid cells confers the ability to bind rapidly to apoptotic cells. Analysis of a panel of epithelial cells reveals that a number naturally express CD14 and that this is competent to mediate apoptotic cell clearance. Taken together these data suggest that CD14 relies on residue 11 for apoptotic cell tethering and it may be an important tethering molecule on so called 'non-professional' phagocytes thus contributing to apoptotic cell clearance in a non-myeloid setting. Furthermore these data establish CD14 as a rapid-acting tethering molecule, expressed in monocytes, which may thus confer responsiveness of circulating monocytes to apoptotic cell derived material.	[Thomas, Leanne; Bielemeier, Anne; Lambert, Peter A.; Marshall, Lindsay J.; Devitt, Andrew] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Thomas, Leanne; Bielemeier, Anne; Lambert, Peter A.; Marshall, Lindsay J.; Devitt, Andrew] Aston Univ, Aston Res Ctr Healthy Ageing, Birmingham B4 7ET, W Midlands, England; [Darveau, Richard P.] Univ Washington, Dept Periodont, Seattle, WA 98195 USA	Aston University; Aston University; University of Washington; University of Washington Seattle	Devitt, A (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	a.devitt1@aston.ac.uk	Marshall, Lindsay/AGG-6207-2022	Marshall, Lindsay/0000-0001-7281-7974; Lambert, Peter/0000-0002-8243-2741; Devitt, Andrew/0000-0002-4651-6761	Aston Annual Fund; Humane Research Trust; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E002080/1]; BBSRC [BB/E002080/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002080/1] Funding Source: researchfish	Aston Annual Fund; Humane Research Trust; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to the Aston Annual Fund for funding to support LT and the Humane Research Trust for funding to support AB (http://www.humaneresearch.org.uk). AD was in receipt of a Biotechnology and Biological Sciences Research Council (BBSRC) new Investigator Award (BB/E002080/1; www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown S, 2002, NATURE, V418, P200, DOI 10.1038/nature00811; Cao WM, 2004, J MOL ENDOCRINOL, V32, P497, DOI 10.1677/jme.0.0320497; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; Devitt A, 2003, CELL DEATH DIFFER, V10, P371, DOI 10.1038/sj.cdd.4401168; Devitt A, 2004, J CELL BIOL, V167, P1161, DOI 10.1083/jcb.200410057; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Devitt A, 2011, J LEUKOCYTE BIOL, V90, P447, DOI 10.1189/jlb.0211095; DINI L, 1995, J CELL SCI, V108, P967; DINI L, 1992, FEBS LETT, V296, P174, DOI 10.1016/0014-5793(92)80373-O; Dini L, 1998, BIOCHEM SOC T, V26, P635, DOI 10.1042/bst0260635; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; FLORA PK, 1994, EUR J IMMUNOL, V24, P2625, DOI 10.1002/eji.1830241109; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gregory CD, 2004, IMMUNOLOGY, V113, P1, DOI 10.1111/j.1365-2567.2004.01959.x; Gregory CD, 2000, CURR OPIN IMMUNOL, V12, P27, DOI 10.1016/S0952-7915(99)00047-3; Gregory CD, 2003, APOPTOSIS AUTOIMMUNI, P111; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Gregory CD, 2010, APOPTOSIS, V15, P1029, DOI 10.1007/s10495-010-0485-9; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HAZIOT A, 1988, J IMMUNOL, V141, P547; Henriksen PA, 2004, FEBS LETT, V574, P80, DOI 10.1016/j.febslet.2004.08.008; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P713, DOI 10.1513/pats.200605-104SF; Huyton T, 2007, IMMUNOL CELL BIOL, V85, P406, DOI 10.1038/sj.icb.7100089; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Iwaki D, 2005, BIOCHEM BIOPH RES CO, V328, P173, DOI 10.1016/j.bbrc.2004.12.162; Jersmann HPA, 2005, IMMUNOL CELL BIOL, V83, P462, DOI 10.1111/j.1440-1711.2005.01370.x; JUAN TSC, 1995, J BIOL CHEM, V270, P17237, DOI 10.1074/jbc.270.29.17237; JUAN TSC, 1995, J BIOL CHEM, V270, P5219, DOI 10.1074/jbc.270.10.5219; Julius P, 2010, SCAND J IMMUNOL, V71, P304, DOI 10.1111/j.1365-3083.2010.02375.x; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Moffatt O, 1996, IMMUNOLOGY, V89, pR176; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; PRIME SS, 1990, J PATHOL, V160, P259, DOI 10.1002/path.1711600313; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; Shapiro RA, 1997, INFECT IMMUN, V65, P293, DOI 10.1128/IAI.65.1.293-297.1997; Shiratsuchi A, 2004, J IMMUNOL, V172, P2039, DOI 10.4049/jimmunol.172.4.2039; SIMMONS DL, 1989, BLOOD, V73, P284; Stelter F, 1997, EUR J BIOCHEM, V243, P100, DOI 10.1111/j.1432-1033.1997.00100.x; Stelter F, 1999, J IMMUNOL, V163, P6035; Tennant I, 2012, CELL DEATH IN PRESS; Torr EE, 2012, CELL DEATH DIFFER, V19, P671, DOI 10.1038/cdd.2011.167; Triantafilou M, 2002, J CELL SCI, V115, P2603; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Viriyakosol S, 2000, J BIOL CHEM, V275, P3144, DOI 10.1074/jbc.275.5.3144; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; Viriyakosol S, 1996, INFECT IMMUN, V64, P653, DOI 10.1128/IAI.64.2.653-656.1996; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	61	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70691	10.1371/journal.pone.0070691	http://dx.doi.org/10.1371/journal.pone.0070691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936239	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200100
J	Yin, L; Zhao, Q; Li, L; Zhang, SL; Chen, XQ; Ma, C; Kang, L; Liu, M; Zhang, CL; Yan, P; Wang, RF				Yin, Lei; Zhao, Qian; Li, Ling; Zhang, Su Lei; Chen, Xue Qi; Ma, Chao; Kang, Lei; Liu, Meng; Zhang, Chun Li; Yan, Ping; Wang, Rong Fu			An Experimental Study on I-131-CHIBA-1001: A Radioligand for alpha 7 Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							COGNITIVE DEFICITS; PHARMACOLOGICAL CHARACTERIZATION; BINDING-SITES; BRAIN; AGONIST; RAT; ACTIVATION; BUNGAROTOXIN; DISCOVERY; ATTENTION	Objective: The alpha 7 nicotinic acetylcholine receptors (nAChRs) play a vital role in the pathophysiology of neuropsychiatric diseases such as Alzheimer's disease and depression. However, there is currently no suitable positron emission tomography (PET) or Single-Photon Emission Computed Tomography (SPECT) radioligands for imaging alpha 7 nAChRs in brain. Here our aim is to radiosynthesize a novel SPECT radioligand I-131-CHIBA-1001 for whole body biodistribution study and in vivo imaging of alpha 7 nAChRs in brain. Method: I-131-CHIBA-1001 was radiosynthesized by chloramine-T method. Different conditions of reaction time and temperature were tested to get a better radiolabeling yield. Radiolabeling yield and radiochemical purities of I-131-CHIBA1001 were analyzed by thin layer chromatography (TLC) and high-performance liquid chromatography (HPLC) system. Whole body biodistribution study was performed at different time points post injection of I-131-CHIBA-1001 in KM mice. Monkey subject was used for in vivo SPECT imaging in brain. Result: The radiolabeling yield of I-131-CHIBA-1001 reached 96% within 1.5 similar to 2.0 h at 90 similar to 95 degrees C. The radiochemical purity reached more than 99% after HPLC purification. I-131-CHIBA-1001 was highly stable in saline and fresh human serum in room temperature and 37 degrees C separately. The biodistribution data of brain at 15, 30, and 60 min were 11.05 +/- 1.04%ID/g, 8.8 +/- 0.04%ID/g and 6.28 +/- 1.13%ID/g, respectively. In experimental SPECT imaging, the distribution of radioactivity in the brain regions was paralleled with the distribution of alpha 7 nAChRs in the monkey brain. Moreover, in the blocking SPECT imaging study, the selective alpha 7 nAChR agonist SSR180711 blocked the radioactive uptake in the brain successfully. Conclusion: The CHIBA-1001 can be successfully radiolabeled with I-131 using the chloramine-T method. I-131-CHIBA-1001 can successfully accumulate in the monkey brain and image the alpha 7 acetylcholine receptors. I-131-CHIBA-1001 can be a candidate for imaging alpha 7 acetylcholine receptors, which will be of great value for the diagnosis and treatment of mental diseases.	[Yin, Lei; Zhao, Qian; Li, Ling; Zhang, Su Lei; Chen, Xue Qi; Ma, Chao; Kang, Lei; Liu, Meng; Zhang, Chun Li; Yan, Ping; Wang, Rong Fu] Peking Univ, Hosp 1, Dept Nucl Med, Beijing 100871, Peoples R China; [Zhao, Qian] Ningxia Med Univ, Gen Hosp, Dept Nucl Med, Ningxia, Peoples R China	Peking University; Ningxia Medical University	Yan, P (corresponding author), Peking Univ, Hosp 1, Dept Nucl Med, Beijing 100871, Peoples R China.	pingyanzheng@126.com; rongfu_wang2003@yahoo.com.cn		Kang, Lei/0000-0001-8729-4547	National Natural Science Foundation of China [NSFC 30870729, 81071183]; Ministry of Science and Technology of People's Republic of China [2011YQ030114, 2011YQ03011409]; Research Fund of the Key Laboratory of Radiopharmaceuticals, Beijing Normal University, China; Ministry of Education, Department of Chemistry, Beijing Normal University [110202, 110204, 120201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); Research Fund of the Key Laboratory of Radiopharmaceuticals, Beijing Normal University, China; Ministry of Education, Department of Chemistry, Beijing Normal University	The National Natural Science Foundation of China (NSFC 30870729 and 81071183) http://www.nsfc.gov.cn/Portal0/default166.htm; the Ministry of Science and Technology of People's Republic of China (Projects 2011YQ030114 and 2011YQ03011409) http://www.most.gov.cn/eng/; the Research Fund of the Key Laboratory of Radiopharmaceuticals, Beijing Normal University, China; the Ministry of Education, Department of Chemistry, Beijing Normal University (110202,110204 and 120201) http://www.chem.bnu.edu.cn/ENG/content.aspx?cId = 56. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak S, 2009, NEUROPSYCHOPHARMACOL, V34, P1753, DOI 10.1038/npp.2008.232; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Bodnar AL, 2005, J MED CHEM, V48, P905, DOI 10.1021/jm049363q; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Freedman R, 2008, AM J PSYCHIAT, V165, P1040, DOI 10.1176/appi.ajp.2008.07071135; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Han ZY, 2003, J COMP NEUROL, V461, P49, DOI 10.1002/cne.10659; HASHIMOTO K, 1990, EUR J PHARMACOL, V180, P273, DOI 10.1016/0014-2999(90)90310-3; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Hashimoto K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003231; Kulak JM, 2006, EUR J NEUROSCI, V23, P2604, DOI 10.1111/j.1460-9568.2006.04804.x; Kulak JM, 2004, BRAIN RES, V999, P193, DOI 10.1016/j.brainres.2003.10.062; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Li Zhuo, 2007, Zhonghua Yi Xue Za Zhi, V87, P2105; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACALLAN DRE, 1988, FEBS LETT, V226, P357, DOI 10.1016/0014-5793(88)81454-6; MARKS MJ, 1982, MOL PHARMACOL, V22, P554; Navarro HA, 2002, SYNAPSE, V44, P117, DOI 10.1002/syn.10062; Navarro HA, 2000, J MED CHEM, V43, P142, DOI 10.1021/jm990544f; Ogawa M, 2006, NUCL MED BIOL, V33, P311, DOI 10.1016/j.nucmedbio.2005.12.016; Pichat P, 2007, NEUROPSYCHOPHARMACOL, V32, P17, DOI 10.1038/sj.npp.1301188; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; SEGAL M, 1978, BRAIN RES, V148, P105, DOI 10.1016/0006-8993(78)90381-5; Tanibuchi Y, 2010, BRAIN RES, V1348, P200, DOI 10.1016/j.brainres.2010.06.008; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Thomsen MS, 2009, NEUROPHARMACOLOGY, V56, P1001, DOI 10.1016/j.neuropharm.2009.02.003; Toyohara J, 2010, CURR TOP MED CHEM, V10, P1544, DOI 10.2174/156802610793176828; Toyohara Jun, 2010, Open Med Chem J, V4, P37, DOI 10.2174/1874104501004010037; Wang DW, 2009, CHIN J TRAUMATOL, V12, P355, DOI 10.3760/cma.j.issn.1008-1275.2009.06.007; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; Wu J, 2010, BRAIN RES, V1360, P130, DOI 10.1016/j.brainres.2010.08.095; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008; Young JW, 2004, NEUROPSYCHOPHARMACOL, V29, P891, DOI 10.1038/sj.npp.1300393	37	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70188	10.1371/journal.pone.0070188	http://dx.doi.org/10.1371/journal.pone.0070188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936161	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200062
J	Zhang, LJ; Cui, JJ; Leonard, M; Nephew, K; Li, YQ; Zhang, XT				Zhang, Lijiang; Cui, Jiajun; Leonard, Marissa; Nephew, Kenneth; Li, Yongquan; Zhang, Xiaoting			Silencing MED1 Sensitizes Breast Cancer Cells to Pure Anti-Estrogen Fulvestrant In Vitro and In Vivo	PLOS ONE			English	Article							ESTROGEN-RECEPTOR MODULATORS; FACTOR-KAPPA-B; ENDOCRINE RESISTANCE; TAMOXIFEN RESISTANCE; COACTIVATOR COMPLEX; ACQUIRED-RESISTANCE; GENE-TRANSCRIPTION; ER-ALPHA; GROWTH; MECHANISMS	Pure anti-estrogen fulvestrant has been shown to be a promising ER antagonist for locally advanced and metastatic breast cancer. Unfortunately, a significant proportion of patients developed resistance to this type of endocrine therapy but the molecular mechanisms governing cellular responsiveness to this agent remain poorly understood. Here, we've reported that knockdown of estrogen receptor coactivator MED1 sensitized fulvestrant resistance breast cancer cells to fulvestrant treatment. We found that MED1 knockdown further promoted cell cycle arrest induced by fulvestrant. Using an orthotopic xenograft mouse model, we found that knockdown of MED1 significantly reduced tumor growth in mice. Importantly, knockdown of MED1 further potentiated tumor growth inhibition by fulvestrant. Mechanistic studies indicated that combination of fulvestrant treatment and MED1 knockdown is able to cooperatively inhibit the expression of ER target genes. Chromatin immunoprecipitation experiments further supported a role for MED1 in regulating the recruitment of RNA polymerase II and transcriptional corepressor HDAC1 on endogenous ER target gene promoter in the presence of fulvestrant. These results demonstrate a role for MED1 in mediating resistance to the pure anti-estrogen fulvestrant both in vitro and in vivo.	[Zhang, Lijiang; Cui, Jiajun; Leonard, Marissa; Zhang, Xiaoting] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH USA; [Zhang, Lijiang; Li, Yongquan] Zhejiang Univ, Inst Biochem, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Lijiang] Zhejiang Acad Med Sci, Ctr Safety Evaluat, Hangzhou, Zhejiang, Peoples R China; [Nephew, Kenneth] Indiana Univ Sch Med, Dept Med Sci, Bloomington, IN USA	University System of Ohio; University of Cincinnati; Zhejiang University; Zhejiang Academy of Medical Sciences; Indiana University System; Indiana University Bloomington	Li, YQ (corresponding author), Zhejiang Univ, Inst Biochem, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	lyq@zju.edu.cn; zhangxt@ucmail.uc.edu			University of Cincinnati Cancer Center Startup Grant; University of Cincinnati Cancer Center Pilot Grant; Ride Cincinnati Award; Susan G. Komen for the Cure Foundation Career Catalyst Grant; Department of Defense Idea Award; American Cancer Society Research Scholar Grant; NIH [U54 CA113001]; Institutional Clinical and Translational Science Award, NIH/NCRR [UL1RR026314]; NATIONAL CANCER INSTITUTE [U54CA113001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER	University of Cincinnati Cancer Center Startup Grant; University of Cincinnati Cancer Center Pilot Grant; Ride Cincinnati Award; Susan G. Komen for the Cure Foundation Career Catalyst Grant; Department of Defense Idea Award(United States Department of Defense); American Cancer Society Research Scholar Grant(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Clinical and Translational Science Award, NIH/NCRR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by University of Cincinnati Cancer Center Startup and Pilot Grants, Ride Cincinnati Award, Susan G. Komen for the Cure Foundation Career Catalyst Grant, Department of Defense Idea Award and American Cancer Society Research Scholar Grant (to XZ), and NIH U54 CA113001 (to KN). This project was also supported by Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number UL1RR026314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Burakov D, 2000, J BIOL CHEM, V275, P20928, DOI 10.1074/jbc.M002013200; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cook KL, 2011, EXPERT REV ANTICANC, V11, P1283, DOI [10.1586/ERA.11.111, 10.1586/era.11.111]; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; Demirpence E, 2002, CANCER RES, V62, P6519; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Flemming J, 2009, BREAST CANCER RES TR, V115, P255, DOI 10.1007/s10549-008-0137-8; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Frogne T, 2009, BREAST CANCER RES TR, V114, P263, DOI 10.1007/s10549-008-0011-8; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Gu ZP, 2002, CANCER RES, V62, P3428; Howell A, 2006, CRIT REV ONCOL HEMAT, V57, P265, DOI 10.1016/j.critrevonc.2005.08.001; Howell A, 2005, CANCER TREAT REV, V31, pS3, DOI 10.1016/j.ctrv.2005.08.010; Howell A, 2006, ENDOCR-RELAT CANCER, V13, P689, DOI 10.1677/erc.1.00846; Ishii Y, 2011, CLIN CANCER RES, V17, P2292, DOI 10.1158/1078-0432.CCR-10-1745; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Johnston SRD, 2005, J STEROID BIOCHEM, V95, P173, DOI 10.1016/j.jsbmb.2005.04.004; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Lamy PJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2824; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; Luoh SW, 2002, CANCER GENET CYTOGEN, V136, P43, DOI 10.1016/S0165-4608(01)00657-4; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nagalingam A, 2012, CARCINOGENESIS, V33, P918, DOI 10.1093/carcin/bgs105; Nicholson RI, 2005, ENDOCR-RELAT CANCER, V12, pS29, DOI 10.1677/erc.1.00991; Nicholson RI, 2005, BREAST CANCER RES TR, V93, pS3, DOI 10.1007/s10549-005-9036-4; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Riggins RB, 2005, MOL CANCER THER, V4, P33; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Varshochi R, 2005, J BIOL CHEM, V280, P3185, DOI 10.1074/jbc.M408063200; Warnmark A, 2001, J BIOL CHEM, V276, P23397, DOI 10.1074/jbc.M011651200; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yde CW, 2012, BREAST CANCER RES TR, V135, P67, DOI 10.1007/s10549-012-2053-1; Zhang DX, 2011, J BIOL CHEM, V286, P17746, DOI 10.1074/jbc.M110.206029; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhao HJ, 2011, MOL CARCINOGEN, V50, P383, DOI 10.1002/mc.20721; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	51	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70641	10.1371/journal.pone.0070641	http://dx.doi.org/10.1371/journal.pone.0070641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936234	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200097
J	McCaughey, G; Diamond, P; Elborn, JS; McKevitt, M; Tunney, MM				McCaughey, Gerard; Diamond, Paul; Elborn, J. Stuart; McKevitt, Matt; Tunney, Michael M.			Resistance Development of Cystic Fibrosis Respiratory Pathogens When Exposed to Fosfomycin and Tobramycin Alone and in Combination under Aerobic and Anaerobic Conditions	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; OXYGEN LIMITATION; ESCHERICHIA-COLI; SPUTUM; FOSFOMYCIN/TOBRAMYCIN; EMERGENCE; INFECTION; FREQUENCY; ADULTS	Although antibiotics from different classes are frequently prescribed in combination to prevent the development of resistance amongst Cystic Fibrosis (CF) respiratory pathogens, there is a lack of data as to the efficacy of this approach. We have previously shown that a 4:1 (w/w) combination of fosfomycin and tobramycin (F:T) has excellent activity against CF pathogens with increased activity under physiologically relevant anaerobic conditions. Therefore, the aim of this study was to determine whether F:T could delay or prevent the onset of resistance compared to either fosfomycin or tobramycin alone under aerobic and anaerobic conditions. The frequency of spontaneous mutants arising following exposure to fosfomycin, tobramycin and F:T was determined for clinical Pseudomonas aeruginosa and MRSA isolates under aerobic and anaerobic conditions. The effect of sub-inhibitory concentrations of fosfomycin, tobramycin and F:T on the induction of resistance was also investigated, with the stability of resistance and fitness cost associated with resistance assessed if it developed. P. aeruginosa and MRSA isolates had a lower frequency of spontaneous mutants to F:T compared to fosfomycin and tobramycin under both aerobic and anaerobic conditions. There was a maximum two-fold increase in F:T MICs when P. aeruginosa and MRSA isolates were passaged in sub-inhibitory F:T for 12 days. In contrast, sequential resistance to fosfomycin and tobramycin developed quickly (n = 3 days for both) after passage in sub-inhibitory concentrations. Once developed, both fosfomycin and tobramycin resistance was stable and not associated with a biological fitness cost to either P. aeruginosa or MRSA isolates. The results of this study suggest that F:T may prevent the development of resistance compared to fosfomycin or tobramycin alone under aerobic and physiologically relevant anaerobic conditions. F:T may be a potential treatment option in CF patients chronically colonised by MRSA and/or P. aeruginosa.	[McCaughey, Gerard; Elborn, J. Stuart; Tunney, Michael M.] Queens Univ Belfast, CF & Airways Microbiol Res Grp, Belfast, Antrim, North Ireland; [McCaughey, Gerard; Diamond, Paul; Tunney, Michael M.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Elborn, J. Stuart] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [McKevitt, Matt] Gilead Sci Inc, Seattle, WA USA	Queens University Belfast; Queens University Belfast; Queens University Belfast; Gilead Sciences	Tunney, MM (corresponding author), Queens Univ Belfast, CF & Airways Microbiol Res Grp, Belfast, Antrim, North Ireland.	m.tunney@qub.ac.uk		elborn, joseph/0000-0002-2323-442X; TUNNEY, MICHAEL/0000-0002-7433-7074	Gilead Sciences Inc.; Health and Social Care Research and Development, Public Health Agency, Northern Ireland; UK National Institute for Health Research Career Scientist Award; Public Health Agency [STL/3713/07, CDV/3650/07] Funding Source: researchfish	Gilead Sciences Inc.(Gilead Sciences); Health and Social Care Research and Development, Public Health Agency, Northern Ireland; UK National Institute for Health Research Career Scientist Award; Public Health Agency	This work was supported by Gilead Sciences Inc. MMT was supported by a Health and Social Care Research and Development, Public Health Agency, Northern Ireland, funded UK National Institute for Health Research Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlana D, 2011, PHARMACOTHERAPY, V31, P146, DOI 10.1592/phco.31.2.146; Burkhardt O, 2006, J ANTIMICROB CHEMOTH, V58, P822, DOI 10.1093/jac/dkl328; CLSI, 2018, METHODS DILUTION ANT; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Ellington MJ, 2006, J ANTIMICROB CHEMOTH, V58, P848, DOI 10.1093/jac/dkl315; Emerson J, 2010, PEDIATR PULM, V45, P363, DOI 10.1002/ppul.21198; Field TR, 2005, EUR J CLIN MICROBIOL, V24, P677, DOI 10.1007/s10096-005-0031-9; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; Karageorgopoulos DE, 2012, J ANTIMICROB CHEMOTH, V67, P255, DOI 10.1093/jac/dkr466; King P, 2010, DIAGN MICR INFEC DIS, V66, P181, DOI 10.1016/j.diagmicrobio.2009.09.009; Lechtzin N, 2006, RESPIRATION, V73, P27, DOI 10.1159/000087686; MacLeod DL, 2012, ANTIMICROB AGENTS CH, V56, P1529, DOI 10.1128/AAC.05958-11; MacLeod DL, 2009, J ANTIMICROB CHEMOTH, V64, P829, DOI 10.1093/jac/dkp282; McCaughey G, 2012, J CYST FIBROS, V11, P163, DOI 10.1016/j.jcf.2011.11.003; Merlo CA, 2007, CHEST, V132, P562, DOI 10.1378/chest.06-2888; Moriarty TF, 2007, PEDIATR PULM, V42, P1008, DOI 10.1002/ppul.20671; Nair CG, 2013, LETT APPL MICROBIOL, V56, P149, DOI 10.1111/lam.12032; Nilsson AI, 2003, ANTIMICROB AGENTS CH, V47, P2850, DOI 10.1128/AAC.47.9.2850-2858.2003; Oliver A, 2010, INT J MED MICROBIOL, V300, P563, DOI 10.1016/j.ijmm.2010.08.009; Olofsson SK, 2007, CLIN INFECT DIS, V45, pS129, DOI 10.1086/519256; Perron GG, 2012, APPL ENVIRON MICROB, V78, P6137, DOI 10.1128/AEM.01078-12; Rodriguez-Rojas A, 2010, ANTIMICROB AGENTS CH, V54, P4948, DOI 10.1128/AAC.00415-10; Rodriguez-Rojas A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010193; Sahuquillo Arce J M, 2006, Rev Esp Quimioter, V19, P252; Saiman L, 2007, PAEDIATR RESPIR REV, V8, P249, DOI 10.1016/j.prrv.2007.04.006; THAUVIN C, 1988, ANTIMICROB AGENTS CH, V32, P919, DOI 10.1128/AAC.32.6.919; Trapnell BC, 2012, AM J RESP CRIT CARE, V185, P171, DOI 10.1164/rccm.201105-0924OC; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; UK CF Trust Infection Control Working Group, 2009, ANT TREATM CYST FIBR; Valenza G, 2010, SCAND J INFECT DIS, V42, P885, DOI 10.3109/00365548.2010.509333; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wu YL, 1999, J ANTIMICROB CHEMOTH, V44, P389, DOI 10.1093/jac/44.3.389	34	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69763	10.1371/journal.pone.0069763	http://dx.doi.org/10.1371/journal.pone.0069763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936095	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300065
J	Shelton, EL; Galindo, CL; Williams, CH; Pfaltzgraff, E; Hong, CC; Bader, DM				Shelton, Elaine L.; Galindo, Cristi L.; Williams, Charles H.; Pfaltzgraff, Elise; Hong, Charles C.; Bader, David M.			Autotaxin Signaling Governs Phenotypic Heterogeneity in Visceral and Parietal Mesothelia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SEROSAL MESOTHELIUM; EXPRESSION; LUNG; IDENTIFICATION; VASCULATURE; FIBROBLASTS; MOTILITY; ORIGIN; ALPHA	Mesothelia, which cover all coelomic organs and body cavities in vertebrates, perform diverse functions in embryonic and adult life. Yet, mesothelia are traditionally viewed as simple, uniform epithelia. Here we demonstrate distinct differences between visceral and parietal mesothelia, the most basic subdivision of this tissue type, in terms of gene expression, adhesion, migration, and invasion. Gene profiling determined that autotaxin, a secreted lysophospholipase D originally discovered as a tumor cell-motility-stimulating factor, was expressed exclusively in the more motile and invasive visceral mesothelia and at abnormally high levels in mesotheliomas. Gain and loss of function studies demonstrate that autotaxin signaling is indeed a critical factor responsible for phenotypic differences within mesothelia. Furthermore, we demonstrate that known and novel small molecule inhibitors of the autotaxin signaling pathway dramatically blunt migratory and invasive behaviors of aggressive mesotheliomas. Taken together, this study reveals distinct phenotypes within the mesothelial cell lineage, demonstrates that differential autotaxin expression is the molecular underpinning for these differences, and provides a novel target and lead compounds to intervene in invasive mesotheliomas.	[Shelton, Elaine L.; Galindo, Cristi L.; Hong, Charles C.; Bader, David M.] Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA; [Williams, Charles H.; Pfaltzgraff, Elise; Hong, Charles C.; Bader, David M.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Hong, Charles C.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Hong, Charles C.] Vet Affairs, Res Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Bader, DM (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA.	david.bader@vanderbilt.edu	Williams, Charles/H-2351-2015	Williams, Charles/0000-0002-0331-5652; Shelton, Elaine/0000-0003-0929-2882	NIH [1R01DK070741-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grant 1R01DK070741-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BartonDavis ER, 1996, AM J PHYSIOL-CELL PH, V271, pC1409, DOI 10.1152/ajpcell.1996.271.4.C1409; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Bourgoin SG, 2010, CURR OPIN INVEST DR, V11, P515; Boutin JA, 2009, CELL MOL LIFE SCI, V66, P3009, DOI 10.1007/s00018-009-0056-9; Brunetti O, 1997, MUSCLE NERVE, V20, P1404, DOI 10.1002/(SICI)1097-4598(199711)20:11<1404::AID-MUS8>3.0.CO;2-E; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Ferguson CG, 2006, ORG LETT, V8, P2023, DOI 10.1021/ol060414i; Ferry G, 2008, J PHARMACOL EXP THER, V327, P809, DOI 10.1124/jpet.108.141911; Gulyas M, 2003, J PATHOL, V199, P479, DOI 10.1002/path.1312; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Herrick SE, 2000, J PATHOL, V192, P67; Huang da W., 2009, CURR PROTOC BIOINFOR; Ilagan RM, 2010, BIOTECHNIQUES, V48, P153, DOI 10.2144/000113349; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kawaguchi M, 2007, DEV DYNAM, V236, P2973, DOI 10.1002/dvdy.21334; Li Q, 2004, ANTICANCER RES, V24, P1327; Litbarg NO, 2007, CELL TISSUE RES, V328, P487, DOI 10.1007/s00441-006-0356-4; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moore AJ, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-34; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Perez-Pomares JM, 2002, INT J DEV BIOL, V46, P1005; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Shelton E. L., 2012, J TISSUE ENG REGEN M; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Visser CE, 1998, CLIN EXP IMMUNOL, V112, P270; WHITAKER D, 1982, CRC CR REV TOXICOL, V10, P81, DOI 10.3109/10408448209041321; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Yung S, 2007, PERITON DIALYSIS INT, V27, pS110	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69712	10.1371/journal.pone.0069712	http://dx.doi.org/10.1371/journal.pone.0069712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936085	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300060
J	Dorff, KC; Chambwe, N; Zeno, Z; Simi, M; Shaknovich, R; Campagne, F				Dorff, Kevin C.; Chambwe, Nyasha; Zeno, Zachary; Simi, Manuele; Shaknovich, Rita; Campagne, Fabien			GobyWeb: Simplified Management and Analysis of Gene Expression and DNA Methylation Sequencing Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; CLOUD; PACKAGE; VIRUS	We present GobyWeb, a web-based system that facilitates the management and analysis of high-throughput sequencing (HTS) projects. The software provides integrated support for a broad set of HTS analyses and offers a simple plugin extension mechanism. Analyses currently supported include quantification of gene expression for messenger and small RNA sequencing, estimation of DNA methylation (i.e., reduced bisulfite sequencing and whole genome methyl-seq), or the detection of pathogens in sequenced data. In contrast to previous analysis pipelines developed for analysis of HTS data, GobyWeb requires significantly less storage space, runs analyses efficiently on a parallel grid, scales gracefully to process tens or hundreds of multi-gigabyte samples, yet can be used effectively by researchers who are comfortable using a web browser. We conducted performance evaluations of the software and found it to either outperform or have similar performance to analysis programs developed for specialized analyses of HTS data. We found that most biologists who took a one-hour GobyWeb training session were readily able to analyze RNA-Seq data with state of the art analysis tools. GobyWeb can be obtained at http://gobyweb.campagnelab.org and is freely available for non-commercial use. GobyWeb plugins are distributed in source code and licensed under the open source LGPL3 license to facilitate code inspection, reuse and independent extensions http://github.com/CampagneLaboratory/gobyweb2-plugins.	[Dorff, Kevin C.; Zeno, Zachary; Simi, Manuele; Campagne, Fabien] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Chambwe, Nyasha; Campagne, Fabien] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Chambwe, Nyasha] Weill Cornell Med Coll, Triinst Training Program Computat Biol & Med, New York, NY USA; [Shaknovich, Rita] Weill Cornell Med Coll, Dept Pathol, New York, NY USA; [Shaknovich, Rita] Weill Cornell Med Coll, Dept Med, New York, NY USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Campagne, F (corresponding author), Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA.	fac2003@campagnelab.org	Chambwe, Nyasha/M-7796-2013	Chambwe, Nyasha/0000-0002-2812-0122; Simi, Manuele/0000-0001-6898-6249; Campagne, Fabien/0000-0001-6237-3564	(NIH/NCRR) of Clinical and Translation Science Center at Weill Cornell Medical College [UL1 RR024996]; Lymphoma and Leukemia Society Translational Research Program [LLS 6304-11]; NIH/NIMH [R01 MH086883]; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086883] Funding Source: NIH RePORTER	(NIH/NCRR) of Clinical and Translation Science Center at Weill Cornell Medical College; Lymphoma and Leukemia Society Translational Research Program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant UL1 RR024996 (NIH/NCRR) of the Clinical and Translation Science Center at Weill Cornell Medical College, by grant LLS 6304-11 from the Lymphoma and Leukemia Society Translational Research Program, and by R01 MH086883 (NIH/NIMH). Support was also provided by the Tri-Institutional Training Program in Computational Biology and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Anders S., 2010, MOL BIOL+, V43, P1, DOI DOI 10.1186/GB-2010-11-10-R106; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Campagne F, 2012, COMPRESSION STRUCTUR; Chikhi R, 2012, SPACE EFFICIENT EXAC; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dean J., 2004, MAPREDUCE SIMPLIFIED; Dobin A, 2012, BIOINFORMATICS; Dorff KC, 2000, GOBYWEB SOFTWARE; Dudley JT, 2010, GENOME MED, V2, DOI 10.1186/gm172; Fischer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041948; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hull D, 2006, NUCLEIC ACIDS RES, V34, pW729, DOI 10.1093/nar/gkl320; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Lin Z, 2012, J VIROL, V86, P2970, DOI 10.1128/JVI.06717-11; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson M, 2009, BIOCONDUCTOR, P1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485	33	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69666	10.1371/journal.pone.0069666	http://dx.doi.org/10.1371/journal.pone.0069666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936070	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000143
J	Saunier, R; Esposito, M; Dassa, EP; Delahodde, A				Saunier, Remy; Esposito, Michela; Dassa, Emmanuel P.; Delahodde, Agnes			Integrity of the Saccharomyces cerevisiae Rpn11 Protein Is Critical for Formation of Proteasome Storage Granules (PSG) and Survival in Stationary Phase	PLOS ONE			English	Article							REGULATORY PARTICLE; MITOCHONDRIAL MORPHOLOGY; TERMINAL DOMAIN; 26S PROTEASOME; SUBUNIT RPN11; LIFE-SPAN; YEAST; TRANSCRIPTION; DEGRADATION; GENE	Decline of proteasome activity has been reported in mammals, flies and yeasts during aging. In the yeast Saccharomyces cerevisiae, the reduction of proteolysis in stationary phase is correlated with disassembly of the 26S proteasomes into their 20S and 19S subcomplexes. However a recent report showed that upon entry into the stationary phase, proteasome subunits massively re-localize from the nucleus into mobile cytoplasmic structures called proteasome storage granules (PSGs). Whether proteasome subunits in PSG are assembled into active complexes remains an open question that we addressed in the present study. We showed that a particular mutant of the RPN11 gene (rpn11-m1), encoding a proteasome lid subunit already known to exhibit proteasome assembly/stability defect in vitro, is unable to form PSGs and displays a reduced viability in stationary phase. Full restoration of long-term survival and PSG formation in rpn11-m1 cells can be achieved by the expression in trans of the last 45 amino acids of the C-terminal domain of Rpn11, which was moreover found to co-localize with PSGs. In addition, another rpn11 mutant leading to seven amino acids change in the Rpn11 C-terminal domain, which exhibits assembled-26S proteasomes, is able to form PSGs but with a delay compared to the wild type situation. Altogether, our findings indicate that PSGs are formed of fully assembled 26S proteasomes and suggest a critical role for the Rpn11 protein in this process.	[Saunier, Remy; Esposito, Michela; Dassa, Emmanuel P.; Delahodde, Agnes] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Delahodde, A (corresponding author), Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France.	agnes.delahodde@igmors.u-psud.fr			French government (MESR) fellowship; Italian Instituto Pasteur Fondazione Cenci Bolognetti	French government (MESR) fellowship; Italian Instituto Pasteur Fondazione Cenci Bolognetti	RS was supported by a French government (MESR) fellowship and ME by the Italian Instituto Pasteur Fondazione Cenci Bolognetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Chandra A, 2010, CURR GENET, V56, P543, DOI 10.1007/s00294-010-0321-3; Chandra A, 2010, J BIOL CHEM, V285, P8330, DOI 10.1074/jbc.M109.076786; Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048; Chen QH, 2004, FREE RADICAL BIO MED, V37, P859, DOI 10.1016/j.freeradbiomed.2004.05.025; CHODER M, 1991, GENE DEV, V5, P2315, DOI 10.1101/gad.5.12a.2315; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Daignan-Fornier B, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-20; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; FUGE EK, 1994, J BACTERIOL, V176, P5802, DOI 10.1128/JB.176.18.5802-5813.1994; Gaczynska M, 2001, MECH AGEING DEV, V122, P235, DOI 10.1016/S0047-6374(00)00246-3; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Hanna J, 2012, J BIOL CHEM, V287, P34400, DOI 10.1074/jbc.M112.390294; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann L, 2009, J CELL SCI, V122, P3673, DOI 10.1242/jcs.050229; Jona G, 2000, BBA-GENE STRUCT EXPR, V1491, P37, DOI 10.1016/S0167-4781(00)00016-6; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Reed SH, 2007, DNA REPAIR, V6, P149, DOI 10.1016/j.dnarep.2006.10.026; Rinaldi T, 1998, MOL BIOL CELL, V9, P2917, DOI 10.1091/mbc.9.10.2917; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rinaldi T, 2002, GENE, V286, P43, DOI 10.1016/S0378-1119(01)00799-5; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Sagot I, 2006, MOL BIOL CELL, V17, P4645, DOI 10.1091/mbc.E06-04-0282; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	41	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70357	10.1371/journal.pone.0070357	http://dx.doi.org/10.1371/journal.pone.0070357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936414	gold, Green Submitted, Green Published			2022-12-27	WOS:000324401500028
J	Wang, HY; Zhu, YC; Zhao, MC; Wu, CL; Zhang, P; Tang, L; Zhang, HJ; Chen, XF; Yang, YQ; Liu, GT				Wang, Heyong; Zhu, Yingchao; Zhao, Mingchuan; Wu, Chunlian; Zhang, Peng; Tang, Liang; Zhang, Huijun; Chen, Xiaofeng; Yang, Yaoqin; Liu, Gentao			miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin beta 1 and Matrix Metalloproteinase2 (MMP2)	PLOS ONE			English	Article							EXPRESSION; MICRORNAS; PROLIFERATION; CARCINOMA; INVOLVEMENT; APOPTOSIS; CLEAVAGE; NETWORK; GROWTH	Our pilot study using miRNA arrays found that miRNA-29c (miR-29c) is differentially expressed in the paired low-metastatic lung cancer cell line 95C compared to the high-metastatic lung cancer cell line 95D. Bioinformatics analysis shows that integrin beta 1 and matrix metalloproteinase 2 (MMP2) could be important target genes of miR-29c. Therefore, we hypothesized that miR-29c suppresses lung cancer cell adhesion to extracellular matrix (ECM) and metastasis by targeting integrin beta 1 and MMP2. The gain-of-function studies that raised miR-29c expression in 95D cells by using its mimics showed reductions in cell proliferation, adhesion to ECM, invasion and migration. In contrasts, loss-of-function studies that reduced miR-29c by using its inhibitor in 95C cells promoted proliferation, adhesion to ECM, invasion and migration. Furthermore, the dual-luciferase reporter assay demonstrated that miR-29c inhibited the expression of the luciferase gene containing the 3'-UTRs of integrin beta 1 and MMP2 mRNA. Western blotting indicated that miR-29c downregulated the expression of integrin beta 1 and MMP2 at the protein level. Gelatin zymography analysis further confirmed that miR-29c decreased MMP2 enzyme activity. Nude mice with xenograft models of lung cancer cells confirmed that miR-29c inhibited lung cancer metastasis in vivo, including bone and liver metastasis. Taken together, our results demonstrate that miR-29c serves as a tumor metastasis suppressor, which suppresses lung cancer cell adhesion to ECM and metastasis by directly inhibiting integrin beta 1 and MMP2 expression and by further reducing MMP2 enzyme activity. The results show that miR-29c may be a novel therapeutic candidate target to slow lung cancer metastasis.	[Wang, Heyong; Zhao, Mingchuan; Zhang, Peng; Tang, Liang; Zhang, Huijun; Chen, Xiaofeng] Tongji Univ, Cent Lab, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China; [Zhu, Yingchao; Yang, Yaoqin] Tongji Univ, Inst Oncol, Sch Med, Shanghai 200092, Peoples R China; [Wu, Chunlian; Liu, Gentao] Tongji Univ, Ctr Translat Med, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China; [Wu, Chunlian] China West Normal Univ, Sch Life Sci, Nanchong, Sichuan Provinc, Peoples R China	Tongji University; Tongji University; Tongji University; China West Normal University	Yang, YQ (corresponding author), Tongji Univ, Inst Oncol, Sch Med, Shanghai 200092, Peoples R China.	Yaoqiny@163.com; liugt@tongji.edu.cn	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		National Natural Science Foundation of China [30800631, 30872553, 81272433]; Shanghai Science and Technology Committee [09411964800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by in part by grants from the National Natural Science Foundation of China (No. 30800631, No. 30872553 and No. 81272433) and a grant from the Shanghai Science and Technology Committee (No. 09411964800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Corcoran ML, 1996, ENZYME PROTEIN, V49, P7, DOI 10.1159/000468613; Ding DP, 2011, CARCINOGENESIS, V32, P1025, DOI 10.1093/carcin/bgr078; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Feng SP, 2011, NUCLEIC ACIDS RES, V39, P6669, DOI 10.1093/nar/gkr232; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Haara O, 2009, DIFFERENTIATION, V77, P298, DOI 10.1016/j.diff.2008.10.006; He C, 2001, J CANCER RES CLIN, V127, P180, DOI 10.1007/s004320000192; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ju LX, 2010, J CELL BIOCHEM, V111, P1565, DOI 10.1002/jcb.22888; Kato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046576; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Kryczka J, 2012, J BIOL CHEM, V287, P36556, DOI 10.1074/jbc.M112.384909; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu N, 2013, CANCER LETT, V329, P181, DOI 10.1016/j.canlet.2012.10.032; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Reddy SDN, 2010, CANCER BIOL THER, V9, P479, DOI 10.4161/cbt.9.7.11402; Rojiani MV, 2010, INT J CLIN EXP PATHO, V3, P775; Rothschild SI, 2012, ONCOGENE, V31, P4221, DOI 10.1038/onc.2011.578; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Su LP, 2005, CLIN CANCER RES, V11, P8273, DOI 10.1158/1078-0432.CCR-05-0537; Taki M, 2006, INT J ONCOL, V28, P487; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Wang CM, 2011, BIOCHEM BIOPH RES CO, V411, P586, DOI 10.1016/j.bbrc.2011.06.191; Wang DS, 2012, CLIN CANCER RES, V18, P4589, DOI 10.1158/1078-0432.CCR-11-3127; Xiong SD, 2011, INT J BIOL SCI, V7, P805, DOI 10.7150/ijbs.7.805; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406	39	70	75	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70192	10.1371/journal.pone.0070192	http://dx.doi.org/10.1371/journal.pone.0070192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936390	Green Published, gold, Green Submitted			2022-12-27	WOS:000324401500023
J	Zheng, HF; Yang, YP; Hu, LF; Wang, MX; Wang, F; Cao, LD; Li, D; Mao, CJ; Xiong, KP; Wang, JD; Liu, CF				Zheng, Hui-Fen; Yang, Ya-Ping; Hu, Li-Fang; Wang, Mei-Xia; Wang, Fen; Cao, Li-Dan; Li, Da; Mao, Cheng-Jie; Xiong, Kang-Ping; Wang, Jian-Da; Liu, Chun-Feng			Autophagic Impairment Contributes to Systemic Inflammation-Induced Dopaminergic Neuron Loss in the Midbrain	PLOS ONE			English	Article							PARKINSONS-DISEASE; INNATE IMMUNITY; MICROGLIA; LIPOPOLYSACCHARIDE; NEURODEGENERATION; ACTIVATION; BRAIN; ALPHA; P62; NEUROTOXICITY	Background: Neuroinflammation plays an important role in the pathogenesis of Parkinson's disease (PD), inducing and accelerating dopaminergic (DA) neuron loss. Autophagy, a critical mechanism for clearing misfolded or aggregated proteins such as alpha-synuclein (alpha-SYN), may affect DA neuron survival in the midbrain. However, whether autophagy contributes to neuroinflammation-induced toxicity in DA neurons remains unknown. Results: Intraperitoneal injection of lipopolysaccharide (LPS, 5 mg/kg) into young (3-month-old) and aged (16-month-old) male C57BL/6J mice was observed to cause persistent neuroinflammation that was associated with a delayed and progressive loss of DA neurons and accumulation of alpha-SYN in the midbrain. The autophagic substrate-p62 (SQSTM1) persistently increased, whereas LC3-II and HDAC6 exhibited early increases followed by a decline. In vitro studies further demonstrated that TNF-alpha induced cell death in PC12 cells. Moreover, a sublethal dose of TNF-alpha (50 ng/ml) increased the expression of LC3-II, p62, and alpha-SYN, implying that TNF-alpha triggered autophagic impairment in cells. Conclusion: Neuroinflammation may cause autophagic impairment, which could in turn result in DA neuron degeneration in midbrain.	[Zheng, Hui-Fen; Yang, Ya-Ping; Hu, Li-Fang; Wang, Mei-Xia; Wang, Fen; Cao, Li-Dan; Li, Da; Mao, Cheng-Jie; Xiong, Kang-Ping; Wang, Jian-Da; Liu, Chun-Feng] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China; [Zheng, Hui-Fen; Yang, Ya-Ping; Hu, Li-Fang; Wang, Mei-Xia; Wang, Fen; Cao, Li-Dan; Li, Da; Mao, Cheng-Jie; Xiong, Kang-Ping; Wang, Jian-Da; Liu, Chun-Feng] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Zheng, Hui-Fen] Yixing Peoples Hosp, Dept Neurol, Yixing, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Liu, CF (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China.	liucf@suda.edu.cn	Hu, Li-Fang/S-3153-2019; Hu, Li-Fang/ABD-9621-2021	Hu, Li-Fang/0000-0001-8326-7779; Hu, Li-Fang/0000-0001-8326-7779; Liu, Chunfeng/0000-0001-9318-925X	National Natural Science Foundation of China [81171213, 81171212]; Natural Science Foundation of Jiangsu Province of China [BK2010228]; National Basic Science Key Project (973 project) [2011CB510003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); National Basic Science Key Project (973 project)(National Basic Research Program of China)	This work was supported by grants from National Natural Science Foundation of China (81171213 to LCF and 81171212 to HLF), Natural Science Foundation of Jiangsu Province of China (BK2010228to LCF). This work was also partially supported by the National Basic Science Key Project (973 project, 2011CB510003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Cheung ZH, 2011, J NEUROCHEM, V118, P317, DOI 10.1111/j.1471-4159.2011.07314.x; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Gabryel B, 2012, PHARMACOL REP, V64, P1; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Hakansson A, 2005, MOVEMENT DISORD, V20, P569, DOI 10.1002/mds.20378; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hoshino K, 1999, J IMMUNOL, V162, P3749; Inamdar A, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/938528, DOI 10.1155/2012/938528]; Infante J, 2008, EUR J NEUROL, V15, P431, DOI 10.1111/j.1468-1331.2008.02092.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McGuire SO, 2001, EXP NEUROL, V169, P219, DOI 10.1006/exnr.2001.7688; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tomas-Camardiel M, 2004, NEUROBIOL DIS, V16, P190, DOI 10.1016/j.nbd.2004.01.010; Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318; Xu XA, 2011, BRAIN RES, V1381, P90, DOI 10.1016/j.brainres.2011.01.025; Yu WH, 2009, AM J PATHOL, V175, P736, DOI 10.2353/ajpath.2009.080928	40	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70472	10.1371/journal.pone.0070472	http://dx.doi.org/10.1371/journal.pone.0070472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936437	Green Published, Green Submitted, gold			2022-12-27	WOS:000324401500039
J	Rose, P; Frobel, J; Graumann, PL; Muller, M				Rose, Patrick; Froebel, Julia; Graumann, Peter L.; Mueller, Matthias			Substrate-Dependent Assembly of the Tat Translocase as Observed in Live Escherichia coli Cells	PLOS ONE			English	Article							TWIN-ARGININE-TRANSLOCATION; PROTEIN-TRANSPORT SYSTEM; SEC-INDEPENDENT PROTEIN; BACILLUS-SUBTILIS; SIGNAL PEPTIDE; PRECURSOR PROTEINS; FOLDED PROTEINS; BINDING-SITE; EXPORT PATHWAY; IN TOPOLOGY	The twin-arginine translocation (Tat) pathway guides fully folded proteins across membranes of bacteria, archaea and plant chloroplasts. In Escherichia coli, Tat-specific transport is executed in a still largely unknown manner by three functionally diverse membrane proteins, termed TatA, TatB, and TatC. In order to follow the intracellular distribution of the TatABC proteins in live E. coli cells, we have individually expressed fluorophore-tagged versions of each Tat protein in addition to a set of chromosomally encoded TatABC proteins. In this way, a Tat translocase could form from the native TatABC proteins and be visualized via the association of a fluorescent Tat variant. A functionally active TatA-green fluorescent protein fusion was found to re-locate from a uniform distribution in the membrane into a few clusters preferentially located at the cell poles. Clustering was absolutely dependent on the co-expression of functional Tat substrates, the proton-motive force, and the cognate TatBC subunits. Likewise, polar cluster formation of a functional TatB-mCherry fusion required TatA and TatC and that of a functional TatC-mCherry fusion a functional Tat substrate. Furthermore we directly demonstrate the co-localization of TatA and TatB in the same fluorescent clusters. Our collective results are consistent with distinct Tat translocation sites dynamically forming in vivo in response to newly synthesized Tat substrates.	[Rose, Patrick; Froebel, Julia; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79106 Freiburg, Germany; [Rose, Patrick] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Graumann, Peter L.] Univ Marburg, LOEWE Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany; [Graumann, Peter L.] Univ Marburg, Dept Chem, Marburg, Germany	University of Freiburg; University of Freiburg; Philipps University Marburg; Philipps University Marburg	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, Hugstetter Str 55, D-79106 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de		Graumann, Peter/0000-0002-8033-5171	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746, Forschergruppe 929]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by the Sonderforschungsbereich 746 and Forschergruppe 929 of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Aldridge C, 2012, J BIOL CHEM, V287, P34752, DOI 10.1074/jbc.M112.385666; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355; Barrett CML, 2007, J BIOL CHEM, V282, P36206, DOI 10.1074/jbc.M704127200; Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bo H, 2011, BIOMOL CONCEPTS, V2, P507; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; Celedon JM, 2012, J CELL BIOL, V197, P523, DOI 10.1083/jcb.201201096; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hicks MG, 2003, FEBS LETT, V539, P61, DOI 10.1016/S0014-5793(03)00198-4; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Huang KC, 2010, MOL MICROBIOL, V76, P822, DOI 10.1111/j.1365-2958.2010.07168.x; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x; Kneuper H, 2012, MOL MICROBIOL, V85, P945, DOI 10.1111/j.1365-2958.2012.08151.x; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Lo SM, 2012, PLANT J, V71, P656, DOI 10.1111/j.1365-313X.2012.05020.x; Ma XY, 2013, PLANT CELL, V25, P999, DOI 10.1105/tpc.112.107409; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Mehner D, 2012, J BIOL CHEM, V287, P27834, DOI 10.1074/jbc.M112.374983; Mikhaleva NI, 1999, FEBS LETT, V463, P331, DOI 10.1016/S0014-5793(99)01661-0; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Ray N, 2005, J BIOL CHEM, V280, P17961, DOI 10.1074/jbc.M413521200; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Ridder ANJA, 2009, J BACTERIOL, V191, P4410, DOI 10.1128/JB.00215-09; Rodriguez F, 2013, P NATL ACAD SCI USA; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Vrancken K, 2007, APPL MICROBIOL BIOT, V73, P1150, DOI 10.1007/s00253-006-0571-7; Walther TH, 2013, CELL, V152, P316, DOI 10.1016/j.cell.2012.12.017; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; White GF, 2010, J BIOL CHEM, V285, P2294, DOI 10.1074/jbc.M109.065458; Yamaguchi S, 2013, MOL MICROBIOL, V87, P656, DOI 10.1111/mmi.12122; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	68	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e69488	10.1371/journal.pone.0069488	http://dx.doi.org/10.1371/journal.pone.0069488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936332	Green Submitted, Green Published, gold			2022-12-27	WOS:000324545800019
J	Adamik, J; Wang, KZQ; Unlu, S; Su, AJA; Tannahill, GM; Galson, DL; O'Neill, LA; Auron, PE				Adamik, Juraj; Wang, Kent Z. Q.; Unlu, Sebnem; Su, An-Jey A.; Tannahill, Gillian M.; Galson, Deborah L.; O'Neill, Luke A.; Auron, Philip E.			Distinct Mechanisms for Induction and Tolerance Regulate the Immediate Early Genes Encoding Interleukin 1 beta and Tumor Necrosis Factor alpha	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR SPI-1/PU.1; PROINTERLEUKIN 1-BETA GENE; TOLL-LIKE RECEPTORS; C/EBP-BETA; CHROMOSOME CONFORMATION; INDUCED APOPTOSIS; SWI/SNF COMPLEX; BINDING-PROTEIN; DNA-BINDING	Interleukin-1 beta and Tumor Necrosis Factor a play related, but distinct, roles in immunity and disease. Our study revealed major mechanistic distinctions in the Toll-like receptor (TLR) signaling-dependent induction for the rapidly expressed genes (IL1B and TNF) coding for these two cytokines. Prior to induction, TNF exhibited pre-bound TATA Binding Protein (TBP) and paused RNA Polymerase II (Pol II), hallmarks of poised immediate-early (IE) genes. In contrast, unstimulated IL1B displayed very low levels of both TBP and paused Pol II, requiring the lineage-specific Spi-1/PU.1 (Spi1) transcription factor as an anchor for induction-dependent interaction with two TLR-activated transcription factors, C/EBP beta and NF-kappa B. Activation and DNA binding of these two pre-expressed factors resulted in de novo recruitment of TBP and Pol II to IL1B in concert with a permissive state for elongation mediated by the recruitment of elongation factor P-TEFb. This Spi1-dependent mechanism for IL1B transcription, which is unique for a rapidly-induced/poised IE gene, was more dependent upon P-TEFb than was the case for the TNF gene. Furthermore, the dependence on phosphoinositide 3-kinase for P-TEFb recruitment to IL1B paralleled a greater sensitivity to the metabolic state of the cell and a lower sensitivity to the phenomenon of endotoxin tolerance than was evident for TNF. Such differences in induction mechanisms argue against the prevailing paradigm that all IE genes possess paused Pol II and may further delineate the specific roles played by each of these rapidly expressed immune modulators.	[Adamik, Juraj; Wang, Kent Z. Q.; Su, An-Jey A.; Auron, Philip E.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA; [Unlu, Sebnem; Auron, Philip E.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA USA; [Tannahill, Gillian M.; O'Neill, Luke A.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Galson, Deborah L.] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol,Canc Inst, Pittsburgh, PA 15213 USA	Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Trinity College Dublin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Auron, PE (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA.	auronp@duq.edu	Galson, Deborah L./E-9370-2010	Galson, Deborah L./0000-0002-2045-8807; O'Neill, Luke/0000-0002-4333-2748; Adamik, Juraj/0000-0002-3604-158X	Duquesne University Hunkele Dreaded Disease Award; Interleukin Foundation; Science Foundation Ireland; National Institutes of Health [AR057310]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057310] Funding Source: NIH RePORTER	Duquesne University Hunkele Dreaded Disease Award; Interleukin Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by The Duquesne University Hunkele Dreaded Disease Award and The Interleukin Foundation (http://interleukinfoundation.org/) to P.E.A.; Science Foundation Ireland (http://www.sfi.ie/) to L.A.J.O.; and the National Institutes of Health (AR057310) to D.L.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Argiles JM, 2011, EUR J PHARMACOL, V668, pS81, DOI 10.1016/j.ejphar.2011.07.007; AURON PE, 1994, EUR CYTOKINE NETW, V5, P573; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; CHEN CYA, 1994, MOL CELL BIOL, V14, P416, DOI 10.1128/MCB.14.1.416; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Core LJ, 2009, GENE DEV, V23, P1606, DOI 10.1101/gad.1827709; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; FENTON MJ, 1988, J IMMUNOL, V140, P2267; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; GALSON DL, 1993, MOL CELL BIOL, V13, P2929, DOI 10.1128/MCB.13.5.2929; Gilchrist D. A., 2012, BIOCH BIOPHYS ACTA; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; GODAMBE SA, 1995, MOL CELL BIOL, V15, P112, DOI 10.1128/MCB.15.1.112; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kang HT, 2006, LIFE SCI, V78, P1392, DOI 10.1016/j.lfs.2005.07.001; Kenneth NS, 2009, J BIOL CHEM, V284, P4123, DOI 10.1074/jbc.M808491200; KOMINATO Y, 1995, MOL CELL BIOL, V15, P58; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KRONKE M, 1988, CANCER RES, V48, P5417; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Listman JA, 2005, J BIOL CHEM, V280, P41421, DOI 10.1074/jbc.M509143200; Marecki S, 2004, MOL IMMUNOL, V40, P723, DOI 10.1016/j.molimm.2003.08.007; Marmiroli S, 1998, FEBS LETT, V438, P49, DOI 10.1016/S0014-5793(98)01270-8; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Morotti A, 2006, AM J HEMATOL, V81, P938, DOI 10.1002/ajh.20732; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; Sandor F, 2005, FOLIA BIOL-PRAGUE, V51, P188; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; SHIRAKAWA F, 1993, MOL CELL BIOL, V13, P1332, DOI 10.1128/MCB.13.3.1332; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang KZQ, 2006, J CELL SCI, V119, P1579, DOI 10.1242/jcs.02889; Wara-Aswapati N, 1999, MOL CELL BIOL, V19, P6803; Wu JQ, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-1189-1185-1220, DOI 10.1186/GB-2008-1189-1185-1220]; Xie J, 2008, CANCER INFORM, V6, P138; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; ZUCKERMAN SH, 1991, INFECT IMMUN, V59, P2774, DOI 10.1128/IAI.59.8.2774-2780.1991	73	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70622	10.1371/journal.pone.0070622	http://dx.doi.org/10.1371/journal.pone.0070622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936458	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000324518400078
J	Chang, JC; Kuo, HC; Hsu, TY; Ou, CY; Liu, CA; Chuang, H; Liang, HM; Huang, HW; Yang, KD				Chang, Jen-Chieh; Kuo, Ho-Chang; Hsu, Te-Yao; Ou, Chia-Yu; Liu, Chieh-An; Chuang, Hau; Liang, Hsiu-Mei; Huang, Hurng-Wern; Yang, Kuender D.			Different Genetic Associations of the IgE Production among Fetus, Infancy and Childhood	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; S-TRANSFERASE GSTP1; SKIN PRICK TEST; CORD BLOOD; IMMUNOGLOBULIN-E; POLYMORPHISM ASSOCIATION; ALLERGIC SENSITIZATION; QUANTITATIVE TRAITS; IN-UTERO; ASTHMA	Elevation of serum IgE levels has long been associated with allergic diseases. Many genes have been linked to IgE production, but few have been linked to the developmental aspects of genetic association with IgE production. To clarify developmental genetic association, we investigated what genes and gene-gene interactions affect IgE levels among fetus, infancy and childhood in Taiwan individuals. A birth cohort of 571 children with completion of IgE measurements from newborn to 1.5, 3, and 6 years of age was subject to genetic association analysis on the 384-customized SNPs of 159 allergy candidate genes. Fifty-three SNPs in 37 genes on innate and adaptive immunity, and stress and response were associated with IgE production. Polymorphisms of the IL13, and the HLA-DPA1 and HLA-DQA1 were, respectively, the most significantly associated with the IgE production at newborn and 6 years of age. Analyses of gene-gene interactions indentified that the combination of NPSR1, rs324981 TT with FGF1, rs2282797 CC had the highest risk (85.7%) of IgE elevation at 1.5 years of age (P = 1.46x10(-4)). The combination of IL13, CYFIP2 and PDE2A was significantly associated with IgE elevation at 3 years of age (P = 5.98x10(-7)), and the combination of CLEC2D, COLEC11 and CCL2 was significantly associated with IgE elevation at 6 years of age (P = 6.65x10(-7)). Our study showed that the genetic association profiles of the IgE production among fetus, infancy and childhood are different. Genetic markers for early prediction and prevention of allergic sensitization may rely on age-based genetic association profiles.	[Chang, Jen-Chieh; Huang, Hurng-Wern] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Chang, Jen-Chieh; Chuang, Hau] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan; [Chang, Jen-Chieh; Kuo, Ho-Chang; Hsu, Te-Yao; Ou, Chia-Yu; Chuang, Hau; Liang, Hsiu-Mei] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Hsu, Te-Yao; Ou, Chia-Yu; Liang, Hsiu-Mei] Kaohsiung Chang Gung Mem Hosp, Dept Obstet, Kaohsiung, Taiwan; [Liu, Chieh-An] Po Jen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Yang, Kuender D.] Show Chwan Mem Hosp Chang Bing, Dept Med Res & Dev, Changhua, Taiwan; [Yang, Kuender D.] Natl Yang Ming Univ, Inst Clin Med Sci, Taipei 112, Taiwan	National Sun Yat Sen University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University	Huang, HW (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan.	sting@mail.nsysu.edu.tw; yangkd.yeh@hotmail.com	Kuo, Ho-Chang/AAQ-6644-2020	Kuo, Ho-Chang/0000-0002-3295-2984	National Science Council [98-3112-B-182-004, 99-3112-B-182-004]; Chang Gung Memorial Hospital grant [CZRPG880253]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital grant(Chang Gung Memorial Hospital)	This work was supported by funding from the National Science Council grants: 98-3112-B-182-004 and 99-3112-B-182-004 to KDY; and Chang Gung Memorial Hospital grant: CZRPG880253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2005, J ALLERGY CLIN IMMUN, V116, P961, DOI 10.1016/j.jaci.2005.09.004; Altin J, 2010, BLOOD REV, V24, P163, DOI 10.1016/j.blre.2010.06.002; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bottema RWB, 2010, EUR RESPIR J, V35, P54, DOI 10.1183/09031936.00018909; Bottema RWB, 2010, J ALLERGY CLIN IMMUN, V126, P338, DOI 10.1016/j.jaci.2010.04.024; Cardaba B, 2001, INT ARCH ALLERGY IMM, V125, P297, DOI 10.1159/000053830; Chang JC, 2004, PEDIAT ALLERG IMM-UK, V15, P506, DOI 10.1111/j.1399-3038.2004.00161.x; Chen CW, 2009, IEEE T CIRC SYST VID, V19, P1, DOI 10.1109/TCSVT.2009.2012413; Ciprandi G, 2011, CLIN LAB, V57, P83; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Dehlink E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012204; Dijk FN, 2013, CURR OPIN ALLERGY CL, V13, P193, DOI 10.1097/ACI.0b013e32835eb707; Ferguson A, 2009, PEDIAT ALLERG IMM-UK, V20, P710, DOI 10.1111/j.1399-3038.2009.00869.x; Fryer AA, 2000, AM J RESP CRIT CARE, V161, P1437, DOI 10.1164/ajrccm.161.5.9903006; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Gui JA, 2011, HUM GENET, V129, P101, DOI 10.1007/s00439-010-0905-5; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Hoffjan S, 2004, J ALLERGY CLIN IMMUN, V113, P511, DOI 10.1016/j.jaci.2003.10.044; Hon KLE, 2010, PEDIAT ALLERG IMM-UK, V21, P831, DOI 10.1111/j.1399-3038.2010.01022.x; Hong XM, 2010, J ALLERGY CLIN IMMUN, V126, P1059, DOI 10.1016/j.jaci.2010.08.029; Immervoll T, 2001, HUM MUTAT, V18, P327, DOI 10.1002/humu.1194; Jacobsen HP, 2001, J ALLERGY CLIN IMMUN, V107, P659; Karmaus W, 2001, AM J EPIDEMIOL, V154, P909, DOI 10.1093/aje/154.10.909; Kere J, 2005, PHILOS T R SOC B, V360, P1551, DOI 10.1098/rstb.2005.1684; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Liu CA, 2003, J ALLERGY CLIN IMMUN, V112, P899, DOI 10.1016/j.jaci.2003.08.030; Malerba Giovanni, 2005, Journal of Applied Genetics, V46, P93; Mansur AH, 2000, CLIN EXP ALLERGY, V30, P1371, DOI 10.1046/j.1365-2222.2000.00944.x; Mapp CE, 2002, J ALLERGY CLIN IMMUN, V109, P867, DOI 10.1067/mai.2002.123234; Moffatt MF, 2003, HUM MOL GENET, V12, P625, DOI 10.1093/hmg/ddg059; Moffatt MF, 2001, EUR J HUM GENET, V9, P341, DOI 10.1038/sj.ejhg.5200636; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Palmer LJ, 2000, AM J RESP CRIT CARE, V161, P1836, DOI 10.1164/ajrccm.161.6.9805104; Palmer LJ, 2000, EUR J HUM GENET, V8, P853, DOI 10.1038/sj.ejhg.5200551; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Ricci G, 2003, ALLERGY, V58, P38, DOI 10.1034/j.1398-9995.2003.23761.x; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sadeghnejad A, 2004, THORAX, V59, P936, DOI 10.1136/thx.2004.024224; Sadeghnejad A, 2007, PEDIAT ALLERG IMM-UK, V18, P288, DOI 10.1111/j.1399-3038.2006.00524.x; Sandberg M, 2009, PEDIAT ALLERG IMM-UK, V20, P519, DOI 10.1111/j.1399-3038.2008.00794.x; Scirica CV, 2007, CHEST, V132, p770S, DOI 10.1378/chest.07-1905; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Simpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC; VANASPEREN PP, 1984, J ALLERGY CLIN IMMUN, V73, P381, DOI 10.1016/0091-6749(84)90412-3; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wang JY, 2005, J HUM GENET, V50, P249, DOI 10.1007/s10038-005-0248-6; Warrier MR, 2008, J ASTHMA, V45, P257, DOI 10.1080/02770900801966180; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wjst M, 2013, CURR OPIN ALLERGY CL, V13, P112, DOI 10.1097/ACI.0b013e32835c1674; Woszczek G, 2002, EUR RESPIR J, V20, P79, DOI 10.1183/09031936.02.01002001; Yang KD, 2010, ALLERGY, V65, P731, DOI 10.1111/j.1398-9995.2009.02260.x; Yang KD, 2007, J ALLERGY CLIN IMMUN, V120, P842, DOI 10.1016/j.jaci.2007.07.009; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	56	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70362	10.1371/journal.pone.0070362	http://dx.doi.org/10.1371/journal.pone.0070362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936416	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400060
J	Gnanapavan, S; Grant, D; Morant, S; Furby, J; Hayton, T; Teunissen, CE; Leoni, V; Marta, M; Brenner, R; Palace, J; Miller, DH; Kapoor, R; Giovannoni, G				Gnanapavan, Sharmilee; Grant, Donna; Morant, Steve; Furby, Julian; Hayton, Tom; Teunissen, Charlotte E.; Leoni, Valerio; Marta, Monica; Brenner, Robert; Palace, Jacqueline; Miller, David H.; Kapoor, Raj; Giovannoni, Gavin			Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS - Neurofilament as a Surrogate of Disease Progression	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; AXONAL DAMAGE; INFLAMMATION; IMPACT; SERUM; MRI	Objective: Lamotrigine trial in SPMS was a randomised control trial to assess whether partial blockade of sodium channels has a neuroprotective effect. The current study was an additional study to investigate the value of neurofilament (NfH) and other biomarkers in predicting prognosis and/or response to treatment. Methods: SPMS patients who attended the NHNN or the Royal Free Hospital, UK, eligible for inclusion were invited to participate in the biomarker study. Primary outcome was whether lamotrigine would significantly reduce detectable serum NfH at 0-12, 12-24 and 0-24 months compared to placebo. Other serum/plasma and CSF biomarkers were also explored. Results: Treatment effect by comparing absolute changes in NfH between the lamotrigine and placebo group showed no difference, however based on serum lamotrigine adherence there was significant decline in NfH (NfH 12-24 months p = 0.043, Nfh 0-24 months p = 0.023). Serum NfH correlated with disability: walking times, 9-HPT (non-dominant hand), PASAT, z-score, MSIS-29 (psychological) and EDSS and MRI cerebral atrophy and MTR. Other biomarkers explored in this study were not found to be significantly associated, aside from that of plasma osteopontin. Conclusions: The relations between NfH and clinical scores of disability and MRI measures of atrophy and disease burden support NfH being a potential surrogate endpoint complementing MRI in neuroprotective trials and sample sizes for such trials are presented here. We did not observe a reduction in NfH levels between the Lamotrigine and placebo arms, however, the reduction in serum NfH levels based on lamotrigine adherence points to a possible neuroprotective effect of lamotrigine on axonal degeneration.	[Gnanapavan, Sharmilee; Grant, Donna; Furby, Julian; Hayton, Tom; Miller, David H.; Kapoor, Raj] UCL Inst Neurol, Dept Neuroinflammat, London, England; [Morant, Steve] Independent Statistician, Haddenham, Bucks, England; [Teunissen, Charlotte E.] VU Univ Med Ctr Amsterdam, Dept Clin Chem, Amsterdam, Netherlands; [Leoni, Valerio] Fdn IRCCS Neurol Inst Carlo Besta, Lab Clin Pathol & Med Genet, Milan, Italy; [Marta, Monica; Giovannoni, Gavin] Queen Mary Univ London, Blizzard Inst, London, England; [Brenner, Robert] Royal Free Hosp, Dept Clin Neurosci, London NW3 2QG, England; [Palace, Jacqueline] Radcliffe Infirm, Univ Dept Clin Neurol, Oxford OX2 6HE, England	University of London; University College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; IRCCS Istituto Neurologico Besta; University of London; Queen Mary University London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Radcliffe Infirmary; University of Oxford	Gnanapavan, S (corresponding author), UCL Inst Neurol, Dept Neuroinflammat, London, England.	s.gnanapavan@ucl.ac.uk	Marta, Monica/H-3376-2019; Leoni, Valerio/AAC-1652-2019	Marta, Monica/0000-0002-5464-9070; LEONI, VALERIO/0000-0002-8954-0366; Morant, Steven/0000-0001-5674-3784	National MS Society (USA) under the Promise initiative; MS Society of Great Britain and Northern Ireland; Italian Minister of Health; National Institute for Health Research [NF-SI-0508-10058] Funding Source: researchfish	National MS Society (USA) under the Promise initiative; MS Society of Great Britain and Northern Ireland; Italian Minister of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by National MS Society (USA) under the Promise 2010 initiative and the MS Society of Great Britain and Northern Ireland as part of exploratory analysis for the UK MS Clinical Trial Network. VL is supported by Italian Minister of Health grant for young researcher 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers E, 2002, NEUROLOGY, V59, P1766, DOI 10.1212/01.WNL.0000036566.00866.26; Cheriyan J, 2012, ARCH NEUROL-CHICAGO, V69, P82, DOI 10.1001/archneurol.2011.674; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Jasperse B, 2007, J NEUROL, V254, P631, DOI 10.1007/s00415-006-0415-5; Jia Yan, 2012, Clin Proteomics, V9, P9, DOI 10.1186/1559-0275-9-9; Kapoor R, 2010, LANCET NEUROL, V9, P681, DOI 10.1016/S1474-4422(10)70131-9; Kester MI, 2012, NEUROBIOL AGING, V33, P1591, DOI 10.1016/j.neurobiolaging.2011.05.013; Koyama T, 2011, PM&R, V3, P40, DOI 10.1016/j.pmrj.2010.09.004; Kuhle J, 2011, NEUROLOGY, V76, P1206, DOI 10.1212/WNL.0b013e31821432ff; Leoni V, 2008, BRAIN, V131, P2851, DOI 10.1093/brain/awn212; McGuigan C, 2004, J NEUROL NEUROSUR PS, V75, P266; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Pasol J, 2010, MULT SCLER INT, V2010, DOI 10.1155/2010/542691; Petzold A, 2005, J NEUROL NEUROSUR PS, V76, P206, DOI 10.1136/jnnp.2004.043315; Petzold A, 2004, J IMMUNOL METHODS, V287, P169, DOI 10.1016/j.jim.2004.01.015; Petzold A, 2004, MULT SCLER J, V10, P281, DOI 10.1191/1352458504ms1021sr; Petzold A, 2011, MULT SCLER INT, V2012; Rejdak K, 2003, J NEUROL SCI, V208, P1, DOI 10.1016/S0022-510X(02)00412-4; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Teunissen CE, 2009, NEUROLOGY, V72, P1322, DOI 10.1212/WNL.0b013e3181a0fe3f; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a	21	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70019	10.1371/journal.pone.0070019	http://dx.doi.org/10.1371/journal.pone.0070019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936370	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400031
J	Rajaraman, R; Sun, ZF; Sundaram, R; Vullikanti, AKS				Rajaraman, Rajmohan; Sun, Zhifeng; Sundaram, Ravi; Vullikanti, Anil Kumar S.			Network Effects of Risk Behavior Change Following Prophylactic Interventions	PLOS ONE			English	Article							HIV VACCINES; PANDEMIC INFLUENZA; SOCIAL-BEHAVIOR; EPIDEMIC; VACCINATION; EFFICACY; IMPACT; SEX; MEN; ERA	We formulated a network-based model to understand how risk behavior change in conjunction with failure of prophylactic interventions can lead to unintended outcomes where "less (intervention) is more (effective).'' Our model captures the distinction between one- and two-sided risk behavior change. In one-sided situations (e.g. influenza/H1N1) it is sufficient for either individual in an interaction to exhibit risk behavior change whereas in two-sided situations (e.g. AIDS/HIV) it is necessary for both individuals in the interaction to exhibit risk behavior change, for a potential transmission of the disease. A central discovery is that this phenomenon occurs at differing levels of intervention coverage depending upon the "sidedness'' of the interaction. We find that for one-sided interactions, sufficiently high vaccination coverage is necessary for mitigating the effects of risk behavior; for two-sided interactions, it is essential to combine prophylactic treatments with programs aimed at reducing risky behavior. Furthermore, again dependent on the "sidedness,'' targeting highly connected nodes can be strictly worse than uniformly random interventions at the same level of coverage.	[Rajaraman, Rajmohan; Sun, Zhifeng; Sundaram, Ravi] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA; [Vullikanti, Anil Kumar S.] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA; [Vullikanti, Anil Kumar S.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	Northeastern University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Vullikanti, AKS (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	vsakumar@vt.edu			NSF NETS [CNS-0915985]; NSF [CCF-1216038]; DTRA CNIMS [HDTRA1-11-D-0016-0001]; NIH MIDAS [2U01GM070694-09]; NSF CAREER [CNS-0845700]; NSF NETSE [CNS-1011769]; NSF ICES [CCF-1216000]; DOE [DE-SC0003957]; Division Of Computer and Network Systems [1011769] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1216000] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER	NSF NETS(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NSF(National Science Foundation (NSF)); DTRA CNIMS; NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF NETSE(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NSF ICES; DOE(United States Department of Energy (DOE)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work of Rajmohan Rajaraman and Zhifeng Sun has been partially supported by NSF NETS CNS-0915985. Rajmohan Rajaraman and Ravi Sundaram have also been partially supported by NSF CCF-1216038. The work of Anil Vullikanti has been partially supported by DTRA CNIMS Grant HDTRA1-11-D-0016-0001, NIH MIDAS Grant 2U01GM070694-09, NSF CAREER Grant CNS-0845700, NSF NETSE Grant CNS-1011769, NSF ICES CCF-1216000 and DOE DE-SC0003957. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KM, 2007, JAIDS-J ACQ IMM DEF, V46, P78; [Anonymous], 2013, PERTUSSIS WHOOPING C; [Anonymous], 2011, CDC FLU VACC EFF; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrett CL, 2009, WINT SIMUL C PROC, P948; Berger N, 2005, PROCEEDINGS OF THE SIXTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P301; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Blower S, 2002, QUANTITATIVE EVALUAT; BLOWER SM, 1994, SCIENCE, V265, P1451, DOI 10.1126/science.8073289; Bollobas B., 2006, PERCOLATION; Brewer NT, 2007, ANN BEHAV MED, V34, P95, DOI 10.1007/BF02879925; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; ERDOS P, 1960, B INT STATIST INST, V38, P343; Forster A, 2010, J HEALTH COMMUN, V15, P205, DOI 10.1080/10810730903528066; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ganesh A, 2005, P INFOCOM; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; HALLORAN ME, 1994, STAT MED, V13, P357, DOI 10.1002/sim.4780130404; Jackson M, 2010, HDB SOCIAL EC; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Klein SL, 2003, PHYSIOL BEHAV, V79, P441, DOI 10.1016/S0031-9384(03)00163-X; Klimt B., 2004, CEAS; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Manski C, 2010, PNAS, V107, P18753; MCLEAN AR, 1993, P ROY SOC B-BIOL SCI, V253, P9, DOI 10.1098/rspb.1993.0075; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Mei S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-118; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Meyers LA, 2007, B AM MATH SOC, V44, P63; Mirrlees JA, 1999, REV ECON STUD, V66, P321; Moore J., 2002, PARASITES BEHAV ANIM; Newman M.E.J., 2002, PHYS REV E, V66; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Rajaraman R, 2012, TECHNICAL REPORT; Reiber C, 2010, ANN EPIDEMIOL, V20, P729, DOI 10.1016/j.annepidem.2010.06.014; Ripeanu M, 2002, IEEE INTERNET COMPUT, V6, P50, DOI 10.1109/4236.978369; Smith RJ, 2004, LANCET INFECT DIS, V4, P636, DOI 10.1016/S1473-3099(04)01148-X; Soderberg B, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066121; van der Straten A, 2000, AIDS, V14, pF47, DOI 10.1097/00002030-200003100-00003; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Volz E, 2008, J ROYAL SOC INTERFAC; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Wang YB, 2009, PHYSICA A, V388, P2535, DOI 10.1016/j.physa.2009.02.036; Wilson DP, 2008, P NATL ACAD SCI USA, V105, P9835, DOI 10.1073/pnas.0711813105; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	50	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e64653	10.1371/journal.pone.0064653	http://dx.doi.org/10.1371/journal.pone.0064653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936290	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400001
J	Schuman, B; Evans, SV; Fyles, TM				Schuman, Brock; Evans, Stephen V.; Fyles, Thomas M.			Geometric Attributes of Retaining Glycosyltransferase Enzymes Favor an Orthogonal Mechanism	PLOS ONE			English	Article							BLOOD-GROUP-A; CRYSTAL-STRUCTURE; NEISSERIA-MENINGITIDIS; STRUCTURAL BASIS; SUBSTRATE; GLUCOSYLTRANSFERASE; INSIGHTS; COMPLEX; MUTANT; TUMOR	Retaining glycosyltransferase enzymes retain the stereochemistry of the donor glycosidic linkage after transfer to an acceptor molecule. The mechanism these enzymes utilize to achieve retention of the anomeric stereochemistry has been a matter of much debate. Re-analysis of previously released structural data from retaining and inverting glycosyltransferases allows competing mechanistic proposals to be evaluated. The binding of metal-nucleotide-sugars between inverting and retaining enzymes is conformationally unique and requires the donor substrate to occupy two different orientations in the two types of glycosyltransferases. The available structures of retaining glycosyltransferases lack appropriately positioned enzymatic dipolar residues to initiate or stabilize the intermediates of a dissociative mechanism. Further, available structures show that the acceptor nucleophile and anomeric carbon of the donor sugar are in close proximity. Structural features support orthogonal (front-side) attack from a position lying <= 90 degrees from the C1-O phosphate bond for retaining enzymes. These structural conclusions are consistent with the geometric conclusions of recent kinetic and computational studies.	[Schuman, Brock; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Fyles, Thomas M.] Univ Victoria, Dept Chem, Victoria, BC, Canada	University of Victoria; University of Victoria	Fyles, TM (corresponding author), Univ Victoria, Dept Chem, Victoria, BC, Canada.	tmf@uvic.ca		Evans, Stephen/0000-0002-0366-4027; Schuman, Brock/0000-0002-8613-6245	Canadian Institutes of Health Research [MOP-77655]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from the Canadian Institutes of Health Research (www.cihr.gc.ca) MOP-77655 to SVE, who is a Michael Smith Foundation for Health Research (msfhr.org) Senior Scholar. Ongoing support to TMF was from the Natural Science and Engineering Research Council of Canada (www.nserc-csnrg.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz D, 2012, CHEMBIOCHEM, V13, P1673, DOI 10.1002/cbic.201200155; Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Andre I, 2003, CARBOHYD RES, V338, P865, DOI 10.1016/S0008-6215(03)00050-8; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; BUZZI S, 1974, CANCER RES, V34, P3481; Byrne GW, 2011, TRANSPLANTATION, V91, P287, DOI 10.1097/TP.0b013e318203c27d; Chan J, 2012, J AM CHEM SOC, V134, P1212, DOI 10.1021/ja209339j; CHELSKY D, 1975, J BIOL CHEM, V250, P5669; Cheng JS, 2010, GLYCOBIOLOGY, V20, P260, DOI 10.1093/glycob/cwp172; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Di Marco VB, 2006, MASS SPECTROM REV, V25, P347, DOI 10.1002/mas.20070; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; GERTNER BJ, 1988, FARADAY DISCUSS, V85, P297, DOI 10.1039/dc9888500297; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gomez H, 2012, J AM CHEM SOC, V134, P4743, DOI 10.1021/ja210490f; GROTE RF, 1980, J CHEM PHYS, V73, P2715, DOI 10.1063/1.440485; GSCHAIDMEIER H, 1995, BIOCHEM PHARMACOL, V49, P1601, DOI 10.1016/0006-2952(95)00095-H; Hakomori S, 1996, CANCER RES, V56, P5309; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Howard S, 1998, J BIOL CHEM, V273, P2067, DOI 10.1074/jbc.273.4.2067; Kakuda S, 2004, J BIOL CHEM, V279, P22693, DOI 10.1074/jbc.M400622200; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; KATRITZKY AR, 1990, CHEM SOC REV, V19, P83, DOI 10.1039/cs9901900083; KIM HJ, 1990, J PHYS CHEM-US, V94, P2736, DOI 10.1021/j100370a004; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lobsanov YD, 2004, J BIOL CHEM, V279, P17921, DOI 10.1074/jbc.M312720200; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Marionneau S, 2002, GLYCOBIOLOGY, V12, P851, DOI 10.1093/glycob/cwf103; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mas E, 1998, GLYCOBIOLOGY, V8, P605, DOI 10.1093/glycob/8.6.605; Mathieu S, 2007, INT J CANCER, V121, P1680, DOI 10.1002/ijc.22797; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Nagano N, 2007, PROTEINS, V66, P147, DOI 10.1002/prot.21193; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Pastores GM, 2007, CLIN THER, V29, P1645, DOI 10.1016/j.clinthera.2007.08.006; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; RAVINDRANATH MH, 1991, CANCER, V67, P3029, DOI 10.1002/1097-0142(19910615)67:12<3029::AID-CNCR2820671217>3.0.CO;2-8; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Schramm VL, 2001, CURR OPIN STRUC BIOL, V11, P657, DOI 10.1016/S0959-440X(01)00269-X; Schuman B, 2011, ACTA CRYSTALLOGR F, V67, P258, DOI 10.1107/S1744309110051298; Schuman B, 2010, J MOL BIOL, V402, P399, DOI 10.1016/j.jmb.2010.07.036; Sindhuwinata N, 2010, GLYCOBIOLOGY, V20, P718, DOI 10.1093/glycob/cwq019; SINNOTT ML, 1980, J AM CHEM SOC, V102, P2026, DOI 10.1021/ja00526a043; Sommer N, 2004, BIOCHEM BIOPH RES CO, V323, P809, DOI 10.1016/j.bbrc.2004.08.170; Soya N, 2011, GLYCOBIOLOGY, V21, P547, DOI 10.1093/glycob/cwq190; Tumbale P, 2009, J BIOL CHEM, V284, P25126, DOI 10.1074/jbc.M109.033878; Umesiri FE, 2010, MED RES REV, V30, P290, DOI 10.1002/med.20190; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Weil R 3rd, 1973, Surg Forum, V24, P194; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; WERTHER JL, 1994, BRIT J CANCER, V69, P613, DOI 10.1038/bjc.1994.114; Wong SMS, 2011, INFECT IMMUN, V79, P1971, DOI 10.1128/IAI.01269-10; Yamamoto H, 1997, J NEUROCHEM, V68, P2566; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	64	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71077	10.1371/journal.pone.0071077	http://dx.doi.org/10.1371/journal.pone.0071077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936487	Green Published, gold, Green Submitted			2022-12-27	WOS:000324518400093
J	Yentrapalli, R; Azimzadeh, O; Sriharshan, A; Malinowsky, K; Merl, J; Wojcik, A; Harms-Ringdahl, M; Atkinson, MJ; Becker, KF; Haghdoost, S; Tapio, S				Yentrapalli, Ramesh; Azimzadeh, Omid; Sriharshan, Arundhathi; Malinowsky, Katharina; Merl, Juliane; Wojcik, Andrzej; Harms-Ringdahl, Mats; Atkinson, Michael J.; Becker, Karl-Friedrich; Haghdoost, Siamak; Tapio, Soile			The PI3K/Akt/mTOR Pathway Is Implicated in the Premature Senescence of Primary Human Endothelial Cells Exposed to Chronic Radiation	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PROTEIN-KINASE B; PROGENITOR CELLS; IONIZING-RADIATION; REPLICATIVE SENESCENCE; PROTEOMIC ANALYSIS; TELOMERASE INACTIVATION; ACCELERATES SENESCENCE; MORTALITY EXPERIENCE; LABEL-FREE	The etiology of radiation-induced cardiovascular disease (CVD) after chronic exposure to low doses of ionizing radiation is only marginally understood. We have previously shown that a chronic low-dose rate exposure (4.1 mGy/h) causes human umbilical vein endothelial cells (HUVECs) to prematurely senesce. We now show that a dose rate of 2.4 mGy/h is also able to trigger premature senescence in HUVECs, primarily indicated by a loss of growth potential and the appearance of the senescence-associated markers beta-galactosidase (SA-beta-gal) and p21. In contrast, a lower dose rate of 1.4 mGy/h was not sufficient to inhibit cellular growth or increase SA-beta-gal-staining despite an increased expression of p21. We used reverse phase protein arrays and triplex Isotope Coded Protein Labeling with LC-ESI-MS/MS to study the proteomic changes associated with chronic radiation-induced senescence. Both technologies identified inactivation of the PI3K/Akt/mTOR pathway accompanying premature senescence. In addition, expression of proteins involved in cytoskeletal structure and EIF2 signaling was reduced. Age-related diseases such as CVD have been previously associated with increased endothelial cell senescence. We postulate that a similar endothelial aging may contribute to the increased rate of CVD seen in populations chronically exposed to low-dose-rate radiation.	[Yentrapalli, Ramesh; Azimzadeh, Omid; Sriharshan, Arundhathi; Atkinson, Michael J.; Tapio, Soile] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Radiat Biol, Neuherberg, Germany; [Yentrapalli, Ramesh; Wojcik, Andrzej; Harms-Ringdahl, Mats; Haghdoost, Siamak] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Ctr Radiat Protect Res, S-10691 Stockholm, Sweden; [Malinowsky, Katharina; Becker, Karl-Friedrich] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany; [Merl, Juliane] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Muenchen, Res Unit Prot Sci, Neuherberg, Germany; [Atkinson, Michael J.] Tech Univ Munich, Dept Radiat Oncol, Klinikum Rechts Isar, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stockholm University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Tapio, S (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Radiat Biol, Neuherberg, Germany.	soile.tapio@helmholtz-muenchen.de	Yentrapalli, Ramesh/P-2488-2014; Merl-Pham, Juliane/N-7258-2014; Tapio, Soile/M-7358-2014; Atkinson, Michael/AAU-5127-2020; Tapio, Soile/CAJ-5871-2022; Yentrapalli, Ramesh/N-3509-2019; Atkinson, Michael J/E-5537-2011; Becker, Karl-Friedrich/D-3636-2015	Yentrapalli, Ramesh/0000-0001-6292-4792; Merl-Pham, Juliane/0000-0002-3422-4083; Tapio, Soile/0000-0001-9860-3683; Atkinson, Michael/0000-0003-3358-2089; Yentrapalli, Ramesh/0000-0001-6292-4792; Atkinson, Michael J/0000-0003-3358-2089; Azimzadeh, Omid/0000-0001-8984-0388; Becker, Karl-Friedrich/0000-0002-6801-4498	European Community's Seventh Framework Program (EURATOM) [249689]; Swedish Radiation Safety Authority	European Community's Seventh Framework Program (EURATOM); Swedish Radiation Safety Authority	This work was supported by grants from the European Community's Seventh Framework Program (EURATOM) contract number 249689 (DoReMi) and Swedish Radiation Safety Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Ashmore JP, 1998, AM J EPIDEMIOL, V148, P564, DOI 10.1093/oxfordjournals.aje.a009682; Azimzadeh O, 2012, J PROTEOMICS, V75, P2384, DOI 10.1016/j.jprot.2012.02.019; Azimzadeh O, 2011, PROTEOMICS, V11, P3299, DOI 10.1002/pmic.201100178; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Barjaktarovic Z, 2013, RADIOTHER ONCOL, V106, P404, DOI 10.1016/j.radonc.2013.01.017; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Berg D, 2012, J CELL PHYSIOL, V227, P204, DOI 10.1002/jcp.22718; Bernier MO, 2012, BRIT J RADIOL, V85, P53, DOI 10.1259/bjr/90758403; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Breitschopf K, 2001, FEBS LETT, V493, P21, DOI 10.1016/S0014-5793(01)02272-4; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Budoff M, 2011, J CARDIOVASC COMPUT, V5, P275, DOI 10.1016/j.jcct.2011.05.004; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Cannon B, 2013, NATURE, V493, pS2, DOI 10.1038/493S2a; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; Chaerkady R, 2011, PROTEOMICS, V11, P4007, DOI 10.1002/pmic.201100107; Chen YX, 2010, J LEUKOCYTE BIOL, V87, P137, DOI 10.1189/jlb.0809562; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Demirci S, 2009, INT J RADIAT ONCOL, V73, P980, DOI 10.1016/j.ijrobp.2008.11.016; Dormond O, 2007, J BIOL CHEM, V282, P23679, DOI 10.1074/jbc.M700563200; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Igrashi K, 2007, EXP CELL RES, V313, P3326, DOI 10.1016/j.yexcr.2007.06.001; Imanishi T, 2006, ATHEROSCLEROSIS, V189, P288, DOI 10.1016/j.atherosclerosis.2005.12.031; Ivanov VK, 2006, HEALTH PHYS, V90, P199, DOI 10.1097/01.HP.0000175835.31663.ea; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kaczmarek A, 2004, STRUCT CHEM, V15, P517, DOI 10.1023/B:STUC.0000037910.26456.59; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laufs U, 1999, J BIOL CHEM, V274, P21926, DOI 10.1074/jbc.274.31.21926; Lee JH, 2006, PROTEOMICS, V6, P1351, DOI 10.1002/pmic.200500287; Li J, 2013, MOL MED REP, V7, P598, DOI 10.3892/mmr.2012.1180; Liu W, 2012, INT J ENV RES PUB HE, V9, P4688, DOI 10.3390/ijerph9124688; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; MCCHESNEY SL, 1988, INT J RADIAT ONCOL, V14, P1169, DOI 10.1016/0360-3016(88)90395-1; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Menendez JC, 1998, INT J RADIAT ONCOL, V41, P905, DOI 10.1016/S0360-3016(98)00112-6; Merl J, 2012, PROTEOMICS, V12, P1902, DOI 10.1002/pmic.201100549; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Oh CW, 2001, RADIAT RES, V156, P232, DOI 10.1667/0033-7587(2001)156[0232:IOASLP]2.0.CO;2; Pammer J, 2006, LAB INVEST, V86, P997, DOI 10.1038/labinvest.3700461; Pluder F, 2011, RADIAT ENVIRON BIOPH, V50, P155, DOI 10.1007/s00411-010-0342-9; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sarioglu H, 2006, PROTEOMICS, V6, P2407, DOI 10.1002/pmic.200500680; Seol MA, 2012, J VET SCI, V13, P331, DOI 10.4142/jvs.2012.13.4.331; Shao HJ, 2011, J PROTEOMICS, V74, P1895, DOI 10.1016/j.jprot.2011.04.032; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Sriharshan A, 2012, J PROTEOMICS, V75, P2319, DOI 10.1016/j.jprot.2012.02.009; Suzuki M, 2008, J RADIAT RES, V49, P105, DOI 10.1269/jrr.07081; Thill M, 2011, MOL VIS, V17, P85; Wagner M, 2001, EXP GERONTOL, V36, P1327, DOI 10.1016/S0531-5565(01)00105-X; Wiest PW, 2002, SEMIN ULTRASOUND CT, V23, P402, DOI 10.1016/S0887-2171(02)90011-9; Xia L, 2008, BRIT J PHARMACOL, V155, P387, DOI 10.1038/bjp.2008.272; Xiao-Hong D, 2013, PHARM BIOL; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Young EF, 2011, RADIAT RES, V176, P415, DOI 10.1667/RR2665.1; Zhu JH, 2006, J MOL CELL CARDIOL, V40, P648, DOI 10.1016/j.yjmcc.2006.01.011	73	68	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e70024	10.1371/journal.pone.0070024	http://dx.doi.org/10.1371/journal.pone.0070024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936371	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400032
J	Yuan, TT; Li, JJ; Zhang, MY				Yuan, Tingting; Li, Jingjing; Zhang, Mei-Yun			HIV-1 Envelope Glycoprotein Variable Loops Are Indispensable for Envelope Structural Integrity and Virus Entry	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; POTENT NEUTRALIZATION; CYTOPLASMIC TAIL; C INFECTION; V3 LOOP; TYPE-1; DOMAINS; GP120; REGION; BROAD	HIV-1 envelope (Env) glycoprotein is a trimer of heterodimer of gp120 and gp41, and derives from a trimeric glycoprotein precursor, gp160. Gp120 contains five conserved regions that are interspersed with 5 variable loop regions (V1-V5). Env variations in variable loop length and amino acid composition may associate with virus pathogenesis, virus sensitivity to neutralizing antibodies (nAbs) and disease progression. To investigate the role of each variable loop in Env function, we generated a panel of JRFL gp160 loop deletion mutants and examined the effects of each loop deletion on Env expression, Env cell surface display and Env-mediated virus entry into permissive cells. We found that deletion of V1 and V2 (Delta V1V2), or loop D (Delta lpD) abolished virus entry, the same effect as deletion of V3 (Delta V3), while deletion of V3 crown (Delta V3C) significantly enhanced virus assembly and entry. We further found that deletion of V4 (Delta V4) or V5 (Delta V5), or replacement of V4 or V5 with flexible linkers of the same lengths knocked out the receptor and coreceptor binding sites in gp120, but significantly enhanced the exposure of the N-trimer structure and the membrane proximal external region (MPER) in gp41. Although deletion of V4 or V5 did not affect Env expression, they negatively affected Env cell surface display, leading to the failure in virus assembly and subsequent entry. Taken together, we found that Env variable loops were indispensable for Env structural integrity and virus entry. Our findings may have implications for development of HIV-1 vaccine immunogens and therapeutics.	[Yuan, Tingting; Li, Jingjing; Zhang, Mei-Yun] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, AIDS Inst, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, MY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, AIDS Inst, Hong Kong, Hong Kong, Peoples R China.	zhangmy@hku.hk			Hong Kong Research Grants Consuls (RGC) General Research Fund (GRF) [785210, 785112]; China 12th 5-year Mega project for HIV/AIDS [2012ZX10001006]	Hong Kong Research Grants Consuls (RGC) General Research Fund (GRF); China 12th 5-year Mega project for HIV/AIDS	This work was supported by Hong Kong Research Grants Consuls (RGC) General Research Fund (GRF) (#785210 and #785112) and China 12th 5-year Mega project for HIV/AIDS (#2012ZX10001006) to MYZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Castro E, 2008, AIDS RES HUM RETROV, V24, P106, DOI 10.1089/aid.2007.0139; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Gazarian KG, 2013, MOL IMMUNOL, V54, P148, DOI 10.1016/j.molimm.2012.11.016; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Monno L, 2011, ANTIMICROB AGENTS CH, V55, P5078, DOI 10.1128/AAC.00743-11; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Piller SC, 2000, J VIROL, V74, P11717, DOI 10.1128/JVI.74.24.11717-11723.2000; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	25	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e69789	10.1371/journal.pone.0069789	http://dx.doi.org/10.1371/journal.pone.0069789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936354	Green Submitted, Green Published, gold			2022-12-27	WOS:000324518400023
J	Bichler, Z; Lim, HC; Zeng, L; Tan, EK				Bichler, Zoe; Lim, Han Chi; Zeng, Li; Tan, Eng King			Non-Motor and Motor Features in LRRK2 Transgenic Mice	PLOS ONE			English	Article							PARKINSONS-DISEASE; OLFACTORY DEFICITS; RISK-FACTORS; MUTATION; PATHOGENESIS; STRAINS; MODELS; OVEREXPRESSION; NEUROPATHOLOGY; NOCICEPTION	Background: Non-motor symptoms are increasingly recognized as important features of Parkinson's disease (PD). LRRK2 mutations are common causes of familial and sporadic PD. Non-motor features have not been yet comprehensively evaluated in LRRK2 transgenic mouse models. Objective: Using a transgenic mouse model overexpressing the R1441G mutation of the human LRRK2 gene, we have investigated the longitudinal correlation between motor and non-motor symptoms and determined if specific non-motor phenotypes precede motor symptoms. Methodology: We investigated the onset of motor and non-motor phenotypes on the LRRK2(R1441G) BAC transgenic mice and their littermate controls from 4 to 21 month-old using a battery of behavioral tests. The transgenic mutant mice displayed mild hypokinesia in the open field from 16 months old, with gastrointestinal dysfunctions beginning at 6 months old. Non-motor features such as depression and anxiety-like behaviors, sensorial functions (pain sensitivity and olfaction), and learning and memory abilities in the passive avoidance test were similar in the transgenic animals compared to littermate controls. Conclusions: LRRK2(R1441G) BAC transgenic mice displayed gastrointestinal dysfunction at an early stage but did not have abnormalities in fine behaviors, olfaction, pain sensitivity, mood disorders and learning and memory compared to non-transgenic littermate controls. The observations on olfaction and gastrointestinal dysfunction in this model validate findings in human carriers. These mice did recapitulate mild Parkinsonian motor features at late stages but compensatory mechanisms modulating the progression of PD in these models should be further evaluated.	[Bichler, Zoe; Tan, Eng King] Natl Inst Neurosci, Behav Neurosci Lab, Singapore, Singapore; [Bichler, Zoe; Zeng, Li; Tan, Eng King] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorders, Singapore, Singapore; [Lim, Han Chi; Zeng, Li] Natl Inst Neurosci, Neural Stem Cell Lab, Singapore, Singapore; [Tan, Eng King] Natl Inst Neurosci, Dept Neurol, Singapore, Singapore	National Neuroscience Institute (NNI); National University of Singapore; National Neuroscience Institute (NNI); National Neuroscience Institute (NNI)	Bichler, Z (corresponding author), Natl Inst Neurosci, Behav Neurosci Lab, Singapore, Singapore.	zoe.bichler@gmail.com; tan.eng.king@sgh.com.sg		Bichler, Zoe/0000-0003-1942-480X	Singapore Millennium Foundation; National Medical Research Council; Duke NUS Graduate Medical School	Singapore Millennium Foundation(Singapore Millennium Foundation); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Duke NUS Graduate Medical School(National University of Singapore)	The authors thank Singapore Millennium Foundation, National Medical Research Council and Duke NUS Graduate Medical School for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardayfio P, 2008, NEUROBIOL DIS, V31, P406, DOI 10.1016/j.nbd.2008.05.017; Beal MF, 2010, NATURE, V466, pS8, DOI 10.1038/466S8a; Bjorklund A, 2010, PROG BRAIN RES, V184, P325, DOI 10.1016/S0079-6123(10)84017-8; Blonder LX, 2011, BEHAV NEUROL, V24, P201, DOI [10.1155/2011/143857, 10.3233/BEN-2011-0329]; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Brown RE, 2007, LEARN MEMORY, V14, P134, DOI 10.1101/lm.473907; Burbulla LF, 2011, J NEUROL SCI, V306, P1, DOI 10.1016/j.jns.2011.04.005; Chaudhuri KR, 2011, PARKINSONISM RELAT D, V17, P717, DOI 10.1016/j.parkreldis.2011.02.018; Crabtree DM, 2012, BRAIN RES BULL, V88, P13, DOI 10.1016/j.brainresbull.2011.07.019; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Desplats P, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-49; Devine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022489; Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Gandhi PN, 2009, J NEUROSCI RES, V87, P1283, DOI 10.1002/jnr.21949; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Gillardon F, 2012, NEUROSCIENCE, V208, P41, DOI 10.1016/j.neuroscience.2012.02.001; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Herzig MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036581; Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25; Johansen KK, 2011, PARKINSONISM RELAT D, V17, P528, DOI 10.1016/j.parkreldis.2011.04.014; Khedr EM, 2013, CLIN NEUROL NEUROSUR, V115, P673, DOI 10.1016/j.clineuro.2012.07.032; Kumari U, 2009, FEBS J, V276, P6455, DOI 10.1111/j.1742-4658.2009.07344.x; Lad HV, 2010, PHYSIOL BEHAV, V99, P301, DOI 10.1016/j.physbeh.2009.11.007; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Li TX, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/942412; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Maekawa T, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-15; Marsala SZ, 2011, J NEUROL, V258, P627, DOI 10.1007/s00415-010-5812-0; Marti-Masso JF, 2009, MOVEMENT DISORD, V24, P1998, DOI 10.1002/mds.22677; Martinez-Martin P, 2010, NAT REV NEUROL, V6, P243, DOI 10.1038/nrneurol.2010.49; Meissner WG, 2011, NAT REV DRUG DISCOV, V10, P377, DOI 10.1038/nrd3430; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Mogil JS, 1998, PAIN, V76, P115, DOI 10.1016/S0304-3959(98)00032-3; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Peng J, 2010, J NEUROCHEM, V115, P1363, DOI 10.1111/j.1471-4159.2010.07036.x; Petrovitch H, 2009, MOVEMENT DISORD, V24, P371, DOI 10.1002/mds.22360; Potter MC, 2010, PLOS CURR, V2, DOI [DOI 10.1371/CURRENTS.RRN1201, 10.1371/currents.RRN1201]; Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962; QUOCK RM, 1993, BRAIN RES, V614, P52, DOI 10.1016/0006-8993(93)91017-M; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Ren GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020630; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Ruiz-Martinez J, 2011, MOVEMENT DISORD, V26, P2026, DOI 10.1002/mds.23773; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schapira A, 2011, PARKINSONS DIS; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Sherer TB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002488; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Tan EK, 2007, HUM GENET, V120, P857, DOI 10.1007/s00439-006-0268-0; Tan EK, 2010, PARKINSONS DIS, V5, P15; Tan EK, 2010, HUM MUTAT, V31, P561, DOI 10.1002/humu.21225; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Tillerson JL, 2006, BEHAV BRAIN RES, V172, P97, DOI 10.1016/j.bbr.2006.04.025; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Vlajinac H, 2013, STRESS HEALTH, V29, P50, DOI 10.1002/smi.2424; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Wey MCY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031522; Wu YC, 2011, ARCH NEUROL-CHICAGO, V68, P22, DOI 10.1001/archneurol.2010.321	64	38	38	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e70249	10.1371/journal.pone.0070249	http://dx.doi.org/10.1371/journal.pone.0070249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936174	gold, Green Submitted, Green Published			2022-12-27	WOS:000323114200069
J	Fareed, M; Pathak, MK; Bihari, V; Kamal, R; Srivastava, AK; Kesavachandran, CN				Fareed, Mohd; Pathak, Manoj Kumar; Bihari, Vipin; Kamal, Ritul; Srivastava, Anup Kumar; Kesavachandran, Chandrasekharan Nair			Adverse Respiratory Health and Hematological Alterations among Agricultural Workers Occupationally Exposed to Organophosphate Pesticides: A Cross-Sectional Study in North India	PLOS ONE			English	Article							ERYTHROCYTE CHOLINESTERASE ACTIVITY; FARM-WORKERS; RISK-FACTORS; SYMPTOMS; ASSOCIATION; APPLICATORS; SPRAYERS; LEVEL; SERUM; IOWA	Background: Non-protective work practices followed by farm workers during spraying of pesticides lead to occupational exposure among them. Objective: This study is designed to explore the respiratory health and hematological profile of agricultural workers occupationally exposed to OP pesticides. Materials and Methods: A cross sectional study was undertaken among 166 pesticide sprayers working in mango orchards of Lucknow district in North India compared with 77 controls to assess the respiratory illness, lung functions, cholinesterase levels and hematological profile. A questionnaire based survey and clinical examination for respiratory health were conducted among study subjects. Lung function test was conducted among study subjects by using spirometer. Cholinesterase level as biomarker of OP pesticides and hematological profile of study subjects were investigated in the laboratory by following the standard protocols. Results: Overall respiratory morbidity observed among exposed subjects was 36.75%. Symptoms for respiratory illness like dry cough, productive cough, wheezing, irritation of throat and blood stained sputum were found to be significantly more (p<0.05) among pesticide sprayers than controls. Lung function parameters viz. PEFR, FEV1, %PEFR predicted, %FEV1 predicted and FEV1/FVC were found to be significantly decreased (p<0.05) among pesticide sprayers as compared to controls. Exposure wise distribution of respiratory illness and lung functions among pesticide sprayers show that the exposure duration significantly elevates (p<0.05) the respiratory problems and significantly decreases (p<0.001) lung functions among pesticide sprayers. Activities of acetylcholinesterase and butyrylcholinesterase were found to be significantly depleted (p<0.001) among pesticide sprayers as compared to controls which show the exposure of OP pesticides among them. The hematological profile viz. RBC, WBC, monocytes, neutrophils, MCV, MCH, MCHC and platelet count were significantly altered (p<0.001) in pesticide sprayers than controls. Conclusion: This study shows that the unsafe occupational exposure of OP pesticides causes respiratory illness, decreased lung functions and hematological alterations among pesticide sprayers.	[Fareed, Mohd; Pathak, Manoj Kumar; Bihari, Vipin; Kamal, Ritul; Srivastava, Anup Kumar; Kesavachandran, Chandrasekharan Nair] CSIR Indian Inst Toxicol Res CSIR IITR, Div Epidemiol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Kesavachandran, CN (corresponding author), CSIR Indian Inst Toxicol Res CSIR IITR, Div Epidemiol, Lucknow, Uttar Pradesh, India.	ckchandran@iitr.res.in		Kamal, Ritul/0000-0001-9741-1698; Srivastava, Anup Kumar/0000-0002-0211-7814	Uttar Pradesh Council of Science & Technology (UP-CST), Lucknow, India [CST/SERPD/D-860]; Council of Scientific and Industrial Research (CSIR), New Delhi, India;  [BSC- 011]	Uttar Pradesh Council of Science & Technology (UP-CST), Lucknow, India; Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); 	This study is a part of a project (CST/SERPD/D-860) financially supported by Uttar Pradesh Council of Science & Technology (UP-CST), Lucknow, India. The publication charges have been funded by institutional project BSC- 011. Additionally, one of the authors (MF) received Senior Research Fellowship and contingency grant for this study from Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bener A, 1999, Allerg Immunol (Paris), V31, P52; BLAIR A, 1992, SCAND J WORK ENV HEA, V18, P209, DOI 10.5271/sjweh.1578; BROWN LM, 1990, CANCER RES, V50, P6585; CHAMBERS HW, 1989, PESTIC BIOCHEM PHYS, V33, P125, DOI 10.1016/0048-3575(89)90003-5; DEMERS PA, 1993, AM J IND MED, V23, P629, DOI 10.1002/ajim.4700230410; Dinsdale D, 1992, CLIN EXPT TOXICOLOGY, P156; Do PG, 1992, OCCUPATIONAL LUNG DI, V13, P311; Eason C, 2002, TOXICOLOGY, V64, P1739; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fareed Mohammad, 2010, Toxicological and Environmental Chemistry, V92, P1919, DOI 10.1080/02772248.2010.484252; Gomes J, 1997, OCCUP MED-OXFORD, V47, P90, DOI 10.1093/occmed/47.2.90; He FS, 1999, TOXICOL LETT, V108, P277, DOI 10.1016/S0378-4274(99)00099-5; Hernandez AF, 2008, INHAL TOXICOL, V20, P839, DOI [10.1080/08958370801905524, 10.1080/08958370801905524 ]; Hoppin JA, 2002, J EXPO ANAL ENV EPID, V12, P313, DOI 10.1038/sj.jea.7500232; Hoppin JA, 2006, ANN NY ACAD SCI, V1076, P343, DOI 10.1196/annals.1371.044; Issaragrisil S, 1997, AM J PUBLIC HEALTH, V87, P1551, DOI 10.2105/AJPH.87.9.1551; Joshaghani Hamid Reza, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P381, DOI 10.2478/v10001-007-0039-8; Kesavachandran C, 2006, REDOX REP, V11, P159, DOI 10.1179/135100006X116673; Khristeva V, 1993, Probl Khig, V18, P97; Kimbell-Dunn MR, 2001, AM J IND MED, V39, P292, DOI 10.1002/1097-0274(200103)39:3&lt;292::AID-AJIM1017&gt;3.0.CO;2-F; Kossmann S, 1997, Przegl Lek, V54, P702; Leilanie J, 2007, J OCC MED TOX, P2; LOPEZCARILLO L, 1993, ARCH ENVIRON HEALTH, V48, P359, DOI 10.1080/00039896.1993.9936726; MCCONNELL R, 1994, AM J PUBLIC HEALTH, V84, P479, DOI 10.2105/AJPH.84.3.479; Mekonnen Y, 2005, OCCUP MED-OXFORD, V55, P504, DOI 10.1093/occmed/kqi088; PARENTMASSIN D, 1993, J PHARMACOL TOXICOL, V30, P203, DOI 10.1016/1056-8719(93)90018-A; Pathak MK, 2011, OCCUP MED-OXFORD, V61, P512, DOI 10.1093/occmed/kqr064; Pathak MK, 2013, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-013-1743-5, DOI 10.1007/S11356-013-1743-5)]; Radon K, 2001, EUR RESPIR J, V17, P747, DOI 10.1183/09031936.01.17407470; RAMA DBK, 1992, SCI TOTAL ENVIRON, V122, P315, DOI 10.1016/0048-9697(92)90049-X; Rama DBK, 1995, OCCUP HLTH SAFETY, V5, P17; Rastogi S K, 1983, Indian J Chest Dis Allied Sci, V25, P186; Rastogi S K, 2008, Indian J Occup Environ Med, V12, P29, DOI 10.4103/0019-5278.40813; Remor AP, 2009, ENVIRON INT, V35, P273, DOI 10.1016/j.envint.2008.06.011; ROBINSON DG, 1993, ERGONOMICS, V36, P951, DOI 10.1080/00140139308967959; Roldan-Tapia L, 2006, NEUROTOXICOL TERATOL, V28, P694, DOI 10.1016/j.ntt.2006.07.004; Schenker MB, 1998, AM J RESP CRIT CARE, V158, pS1; SENTHILSELVAN A, 1992, AM REV RESPIR DIS, V146, P884, DOI 10.1164/ajrccm/146.4.884; Spiegiel RW, 1981, CLIN TOXICOL CONSULT, V3, P45; Sprince NL, 2000, AM J IND MED, V38, P455, DOI 10.1002/1097-0274(200010)38:4&lt;455::AID-AJIM12&gt;3.0.CO;2-L; Sungur M, 2001, CRIT CARE, V5, P211, DOI 10.1186/cc1025; SWAEN GMH, 1992, SCAND J WORK ENV HEA, V18, P201, DOI 10.5271/sjweh.1587; Wesseling C, 1997, INT J HEALTH SERV, V27, P273, DOI 10.2190/E259-N3AH-TA1Y-H591; Wilkins JR, 1999, AM J IND MED, V35, P150, DOI 10.1002/(SICI)1097-0274(199902)35:2&lt;150::AID-AJIM7&gt;3.0.CO;2-5; Worthing CR, 1987, PESTICIDE MANUAL WOR; Yamanaka S, 1993, Nihon Eiseigaku Zasshi, V48, P955; Zhang LX, 2002, EUR RESPIR J, V20, P1525, DOI 10.1183/09031936.02.00028602	47	69	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69755	10.1371/journal.pone.0069755	http://dx.doi.org/10.1371/journal.pone.0069755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191SQ	23936093	Green Submitted, gold, Green Published			2022-12-27	WOS:000322433300063
J	Shen, Z; Fahey, JV; Bodwell, JE; Rodriguez-Garcia, M; Rossoll, RM; Crist, SG; Patel, MV; Wira, CR				Shen, Zheng; Fahey, John V.; Bodwell, Jack E.; Rodriguez-Garcia, Marta; Rossoll, Richard M.; Crist, Sarah G.; Patel, Mickey V.; Wira, Charles R.			Estradiol Regulation of Nucleotidases in Female Reproductive Tract Epithelial Cells and Fibroblasts	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; ESTROGEN-RECEPTOR MODULATORS; HEPATOCYTE GROWTH-FACTOR; ENDOCRINE REGULATION; STROMAL FIBROBLASTS; ADAPTIVE IMMUNITY; GENE-EXPRESSION; INNATE IMMUNITY; HIV PREVENTION; GENITAL-TRACT	The use of topical and oral adenosine derivatives in HIV prevention that need to be maintained in tissues and cells at effective levels to prevent transmission prompted us to ask whether estradiol could influence the regulation of catabolic nucleotidase enzymes in epithelial cells and fibroblasts from the upper and lower female reproductive tract (FRT) as these might affect cellular TFV-DP levels. Epithelial cells and fibroblasts were isolated from endometrium (EM), endocervix (CX) and ectocervix (ECX) tissues from hysterectomy patients, grown to confluence and treated with or without estradiol prior to RNA isolation. The expression of nucleotidase (NT) genes was measurable by RT-PCR in epithelial cells and fibroblasts from all FRT tissues. To determine if sex hormones have the potential to regulate NT, we evaluated NT gene expression and NT biological activity in FRT cells following hormone treatment. Estradiol increased expression of Cytosolic 5'-nucleotidase after 2 or 4 h in endometrial epithelial cells but not epithelial cells or fibroblasts from other sites. In studies using a modified 5'-Nucleotidase biological assay for nucleotidases, estradiol increased NT activity in epithelial cells and fibroblasts from the EM, CX and ECX at 24 and 48 h. In related studies, HUVEC primary cells and a HUVEC cell line were unresponsive to estradiol in terms of nucleotidase expression or biological activity. Our findings of an increase in nucleotidase expression and biological activity induced by estradiol do not directly assess changes in microbicide metabolism. However, they do suggest that when estradiol levels are elevated during the menstrual cycle, FRT epithelial cells and fibroblasts from the EM, CX and ECX have the potential to influence microbicide levels that could enhance protection of HIV-target cells (CD4+T cells, macrophages and dendritic cells) throughout the FRT.	[Shen, Zheng; Fahey, John V.; Bodwell, Jack E.; Rodriguez-Garcia, Marta; Rossoll, Richard M.; Crist, Sarah G.; Patel, Mickey V.; Wira, Charles R.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA	Dartmouth College	Wira, CR (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA.	Charles.R.Wira@Dartmouth.edu			Advanced BioScience Laboratories, Inc. [HHSN272201000001C]; NIH [AI07176, AI102838]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102838] Funding Source: NIH RePORTER	Advanced BioScience Laboratories, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Advanced BioScience Laboratories, Inc. (Contract #HHSN272201000001C) and NIH grants AI07176 and AI102838. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliagas E, 2010, ACTA PHYSIOL, V199, P191, DOI 10.1111/j.1748-1716.2010.02095.x; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balzarini J, 2000, PHARMACOL THERAPEUT, V87, P175, DOI 10.1016/S0163-7258(00)00050-4; Borowiec A, 2006, ACTA BIOCHIM POL, V53, P269; Bucci M, 2001, CELL BIOL INT, V25, P859, DOI 10.1006/cbir.2001.0771; CAC, 2003, HIV AIDS SURVEILLANC; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Christensen LD, 1996, APMIS, V104, P126, DOI 10.1111/j.1699-0463.1996.tb00697.x; Coleman J, 2012, 19 INT AIDS C AIDS 2; Coleman KD, 2012, AM J REPROD IMMUNOL, V67, P44, DOI 10.1111/j.1600-0897.2011.01063.x; Coleman KD, 2009, FERTIL STERIL, V92, P1107, DOI 10.1016/j.fertnstert.2008.10.047; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fahey JV, 2002, J INFECT DIS, V185, P1606, DOI 10.1086/340512; Farnell YZ, 2003, J STEROID BIOCHEM, V84, P453, DOI 10.1016/S0960-0760(03)00066-9; Galmarini CM, 2005, HAEMATOLOGICA, V90, P1699; Gengiah TN, 2012, EXPERT OPIN INV DRUG, V21, P695, DOI 10.1517/13543784.2012.667072; Ghosh M, 2012, AM J REPROD IMMUNOL; Ghosh M, 2013, AM J REPROD IMMUNOL, V69, P51, DOI 10.1111/aji.12027; Ghosh M, 2013, AM J REPROD IMMUNOL, V69, P41, DOI 10.1111/aji.12019; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; Heneine W, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007419; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; JENSEN EV, 1967, ARCH ANAT MICROSC MO, V56, P547; Kalsi K, 2002, MOL CELL BIOCHEM, V232, P113, DOI 10.1023/A:1014806916844; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kashuba AD, 2011, MEMBR BIOCHEM; Kearney BR, 2005, J CLIN PHARMACOL, V45, P935, DOI 10.1177/0091270005278949; Kohler JJ, 2011, LAB INVEST, V91, P852, DOI 10.1038/labinvest.2011.48; Koumas L, 2001, AM J PATHOL, V159, P925, DOI 10.1016/S0002-9440(10)61768-3; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Lennon PF, 1998, J EXP MED, V188, P1433, DOI 10.1084/jem.188.8.1433; Li RWS, 2008, AM J PHYSIOL-HEART C, V295, pH1177, DOI 10.1152/ajpheart.91513.2007; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Marrazzo J, 2013, PREEXPOSURE PROPHYLA; Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205; MCNATTY KP, 1976, J ENDOCRINOL, V71, P77, DOI 10.1677/joe.0.0710077; Meter RA, 2005, FERTIL STERIL, V84, P191, DOI 10.1016/j.fertnstert.2005.01.104; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Ochiel DO, 2008, CURR WOMENS HEALTH R, V4, P102, DOI 10.2174/157340408784246395; Ohtsuki S, 2005, J CELL PHYSIOL, V204, P896, DOI 10.1002/jcp.20352; Patel MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035654; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Sabolic I, 2007, PFLUG ARCH EUR J PHY, V455, P397, DOI 10.1007/s00424-007-0308-1; Seve P, 2005, LUNG CANCER, V49, P363, DOI 10.1016/j.lungcan.2005.04.008; Spychala J, 2004, CLIN CANCER RES, V10, P708, DOI 10.1158/1078-0432.CCR-0811-03; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; Toth B, 2008, HISTOCHEM CELL BIOL, V130, P399, DOI 10.1007/s00418-008-0426-7; van der Straten A, 2012, AIDS; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Wira CR, 2011, MUCOSAL IMMUNOL, V4, P335, DOI 10.1038/mi.2010.72; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2011, AM J REPROD IMMUNOL, V65, P196, DOI 10.1111/j.1600-0897.2011.00970.x; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Yegutkin GG, 2001, FASEB J, V15, P251, DOI 10.1096/fj.00-0268com; Zanin RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031205	64	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69854	10.1371/journal.pone.0069854	http://dx.doi.org/10.1371/journal.pone.0069854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936114	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300071
J	Song, Y; Park, HJ; Kang, SN; Jang, SH; Lee, SJ; Ko, YG; Kim, GS; Cho, JH				Song, Yuno; Park, Hyoung Joon; Kang, Suk Nam; Jang, Sun-Hee; Lee, Soo-Jung; Ko, Yeoung-Gyu; Kim, Gon-Sup; Cho, Jae-Hyeon			Blueberry Peel Extracts Inhibit Adipogenesis in 3T3-L1 Cells and Reduce High-Fat Diet-Induced Obesity	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE; ACTIVATED PROTEIN-KINASE; ADIPOCYTE DIFFERENTIATION; C/EBP-ALPHA; INSULIN-RESISTANCE; GENE PROMOTER; CANCER CELLS; GLUCOSE; BINDING; GROWTH	This study examined the anti-obesity effect and mechanism of action of blueberry peel extracts (BPE) in 3T3-L1 cells and high-fat diet (HFD)-induced obese rats. The levels of lipid accumulation were measured, along with the changes in the expression of genes and proteins associated with adipocyte differentiation in 3T3-L1 cells. Evidenced by Oil-red O staining and triglyceride assay, BPE dose-dependently inhibited lipid accumulation at concentrations of 0, 50, and 200 mg/ml. BPE decreased the expression of the key adipocyte differentiation regulator C/EBP beta, as well as the C/EBP alpha and PPAR gamma genes, during the differentiation of preadipocytes into adipocytes. Moreover, BPE down-regulated adipocyte-specific genes such as aP2 and FAS compared with control adipocytes. The specific mechanism mediating the effects of BP revealed that insulin-stimulated phosphorylation of Akt was strongly decreased, and its downstream substrate, phospho-GSK3 beta, was downregulated by BPE treatment in 3T3-L1 cells. Together, these data indicated that BP exerted anti-adipogenic activity by inhibiting the expression of PPAR gamma and C/EBP beta and the Akt signaling pathway in 3T3-L1 adipocytes. Next, we investigated whether BP extracts attenuated HFD-induced obesity in rats. Oral administration of BPE reduced HFD-induced body weight gain significantly without affecting food intake. The epididymal or perirenal adipose tissue weights were lower in rats on an HFD plus BPE compared with the tissue weights of HFD-induced obese rats. Total cholesterol and triglyceride levels in the rats fed BPE were modestly reduced, and the HDL-cholesterol level was significantly increased in HFD plus BP-fed rats compared with those of HFD-fed rats. Taken together, these results demonstrated an inhibitory effect of BP on adipogenesis through the down-regulation of C/EBP beta, C/EBP alpha, and PPAR gamma and the reduction of the phospho-Akt adipogenic factor in 3T3-L1 cells. Moreover, BPE reduced body weight gain and inhibited fat accumulation in an HFD-induced animal model of obesity.	[Song, Yuno; Park, Hyoung Joon; Jang, Sun-Hee; Kim, Gon-Sup; Cho, Jae-Hyeon] Gyeongsang Natl Univ, Coll Vet Med, Inst Life Sci, Jinju, South Korea; [Lee, Soo-Jung] Gyeongsang Natl Univ, Deptment Foods & Nutr, Jinju, South Korea; [Kang, Suk Nam] Gyeongnam Natl Univ Sci & Technol, Dept Anim Sci & Biotechnol, Jinju, South Korea; [Ko, Yeoung-Gyu] RDA, Natl Inst Anim Sci, Anim Genet Resources Stn, Namwon, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongnam National University of Science and Technology; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Cho, JH (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Inst Life Sci, Jinju, South Korea.	jaehcho@gnu.ac.kr			Ministry of Education, Basic Science Research Program, National Research Foundation, Korea [20120008419]	Ministry of Education, Basic Science Research Program, National Research Foundation, Korea	This work was supported by the Ministry of Education, Basic Science Research Program, National Research Foundation, Korea (no. 20120008419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi M, 2003, MIDDLE E PHARM, V11, P6; Adams LS, 2010, CANCER RES, V70, P3594, DOI 10.1158/0008-5472.CAN-09-3565; Ahmet I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005954; Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Black MH, 2013, J NUTR, V143, P479, DOI 10.3945/jn.112.170449; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; DeFuria J, 2009, J NUTR, V139, P1510, DOI 10.3945/jn.109.105155; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Heber D, 2003, PRIMARY CARE, V30, P441, DOI 10.1016/S0095-4543(03)00015-0; Jeon T, 2004, LIFE SCI, V75, P3195, DOI 10.1016/j.lfs.2004.06.012; Joseph JA, 2005, AM J CLIN NUTR, V81, p313S, DOI 10.1093/ajcn/81.1.313S; Jou PC, 2010, J AGR FOOD CHEM, V58, P12703, DOI 10.1021/jf103121c; Kalt W, 2008, BRIT J NUTR, V100, P70, DOI 10.1017/S0007114507877658; Khanal RC, 2012, J MED FOOD, V15, P802, DOI 10.1089/jmf.2011.0212; Li YC, 2011, EUR FOOD RES TECHNOL, V233, P897, DOI 10.1007/s00217-011-1572-z; Liu F, 1997, LIFE SCI, V60, P763, DOI 10.1016/S0024-3205(97)00004-0; Lopes GKB, 1999, BBA-GEN SUBJECTS, V1472, P142, DOI 10.1016/S0304-4165(99)00117-8; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matchett MD, 2006, J NUTR BIOCHEM, V17, P117, DOI 10.1016/j.jnutbio.2005.05.014; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Park HJ, 2012, FOOD CHEM, V134, P227, DOI 10.1016/j.foodchem.2012.02.101; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; Prior RL, 1999, P SOC EXP BIOL MED, V220, P255, DOI 10.1046/j.1525-1373.1999.d01-44.x; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Shim M, 2003, J BIOL CHEM, V278, P19674, DOI 10.1074/jbc.M301356200; Silva Alfredo Rodrigues Leite da, 2012, BAR, Braz. Adm. Rev., V9, P1; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Vuong T, 2009, INT J OBESITY, V33, P1166, DOI 10.1038/ijo.2009.149; Vuong T, 2007, CAN J PHYSIOL PHARM, V85, P956, DOI 10.1139/Y07-090; WISE LS, 1979, J BIOL CHEM, V254, P273; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002	45	47	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69925	10.1371/journal.pone.0069925	http://dx.doi.org/10.1371/journal.pone.0069925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936120	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300076
J	Zhou, CQ; Li, SS; Chen, ZM; Li, FQ; Lei, P; Peng, GG				Zhou, Chang-Qing; Li, Shan-Shan; Chen, Zhong-Mei; Li, Feng-Qun; Lei, Peng; Peng, Guo-Guang			Rotigotine Transdermal Patch in Parkinson's Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; DOPAMINE AGONISTS; LEVODOPA; TOLERABILITY; ROPINIROLE; PRAMIPEXOLE; PLACEBO; SAFETY	Background and Methods: The efficacy and safety of rotigotine transdermal patch in Parkinson's disease (PD) were studied in some clinical trials. We performed a systematic review and meta-analysis of randomized controlled trials to evaluate the efficacy, tolerability, and safety of rotigotine transdermal patch versus placebo in PD. Results: Six randomized controlled trials (1789 patients) were included in this meta-analysis. As compared with placebo, the use of rotigotine resulted in greater improvements in Unified Parkinson's Disease Rating Scale activities of daily living score (weighted mean difference [WMD] -1.69, 95% confidence interval [CI] -2.18 to -1.19), motor score (WMD -3.86, 95% CI -4.86 to -2.86), and the activities of daily living and motor subtotal score (WMD -4.52, 95% CI -5.86 to -3.17). Rotigotine was associated with a significantly higher rate of withdrawals due to adverse events (relative risk [RR] 1.82, 95% CI 1.29-2.59), and higher rates of application site reactions (RR 2.92, 95% CI 2.29-3.72), vomiting (RR 5.18, 95% CI 2.25-11.93), and dyskinesia (RR 2.52, 95% CI 1.47-4.32) compared with placebo. No differences were found in the relative risks of headache, constipation, back pain, diarrhea, or serious adverse events. Conclusions: Our meta-analysis showed that the use of rotigotine can reduce the symptoms of PD. However, rotigotine was also associated with a higher incidence of adverse events, especially application site reactions, compared with placebo.	[Zhou, Chang-Qing; Li, Shan-Shan; Chen, Zhong-Mei; Li, Feng-Qun; Lei, Peng; Peng, Guo-Guang] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University	Peng, GG (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	penwan233@sina.com						Baker WL, 2009, PARKINSONISM RELAT D, V15, P287, DOI 10.1016/j.parkreldis.2008.07.004; Blindauer K, 2003, ARCH NEUROL-CHICAGO, V60, P1721; Braun M, 2005, EUR J NEUROL, V12, P96; Cummings JL, 2010, CLIN DRUG INVEST, V30, P41, DOI 10.2165/11531270-000000000-00000; Elshoff JP, 2012, CLIN THER, V34, P966, DOI 10.1016/j.clinthera.2012.02.008; Ferrer I, 2011, J NEURAL TRANSM, V118, P821, DOI 10.1007/s00702-010-0482-8; Giladi N, 2007, MOVEMENT DISORD, V22, P2398, DOI 10.1002/mds.21741; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; Hauser RA, 2011, MOVEMENT DISORD, V26, P813, DOI 10.1002/mds.23638; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jankovic J, 2007, ARCH NEUROL-CHICAGO, V64, P676, DOI 10.1001/archneur.64.5.676; Jenner P, 2005, NEUROLOGY, V65, pS3, DOI 10.1212/WNL.65.2_suppl_1.S3; Kulisevsky J, 2010, DRUG SAFETY, V33, P147, DOI 10.2165/11319860-000000000-00000; Lees AJ, 2001, NEUROLOGY, V57, P1687, DOI 10.1212/WNL.57.9.1687; LeWitt PA, 2007, NEUROLOGY, V68, P1262, DOI 10.1212/01.wnl.0000259516.61938.bb; Metman LV, 2001, CLIN NEUROPHARMACOL, V24, P163, DOI 10.1097/00002826-200105000-00008; Oertel W, 2013, PARKINSONISM RELAT D, V19, P37, DOI 10.1016/j.parkreldis.2012.06.009; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; POEWE W, 2002, PARKINSONS DIS MOVEM, P104; Poewe WH, 2007, LANCET NEUROL, V6, P513, DOI 10.1016/S1474-4422(07)70108-4; QUINN N, 2001, PARKINSONISM RELAT D, V7, pS66; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Sanford M, 2011, CNS DRUGS, V25, P699, DOI 10.2165/11206750-000000000-00000; Schnitzler A, 2010, PARKINSONISM RELAT D, V16, P513, DOI 10.1016/j.parkreldis.2010.06.009; Schrag A, 2000, BRAIN, V123, P2297, DOI 10.1093/brain/123.11.2297; Talati R, 2009, INT J CLIN PRACT, V63, P613, DOI 10.1111/j.1742-1241.2009.02027.x; Talati R, 2009, PARKINSONISM RELAT D, V15, P500, DOI 10.1016/j.parkreldis.2008.12.007; Trenkwalder C, 2011, MOVEMENT DISORD, V26, P90, DOI 10.1002/mds.23441; UCB, 2012, NEUPR APPR US FDA PA; Wullner U, 2010, J NEURAL TRANSM, V117, P855, DOI 10.1007/s00702-010-0425-4; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1	32	24	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69738	10.1371/journal.pone.0069738	http://dx.doi.org/10.1371/journal.pone.0069738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936090	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000152
J	Adams, RI; Miletto, M; Taylor, JW; Bruns, TD				Adams, Rachel I.; Miletto, Marzia; Taylor, John W.; Bruns, Thomas D.			The Diversity and Distribution of Fungi on Residential Surfaces	PLOS ONE			English	Article							QUANTITATIVE PCR; BACTERIAL; AIRBORNE; COMMUNITY; WORLD; DUST	The predominant hypothesis regarding the composition of microbial assemblages in indoor environments is that fungal assemblages are structured by outdoor air with a moderate contribution by surface growth, whereas indoor bacterial assemblages represent a mixture of bacteria entered from outdoor air, shed by building inhabitants, and grown on surfaces. To test the fungal aspect of this hypothesis, we sampled fungi from three surface types likely to support growth and therefore possible contributors of fungi to indoor air: drains in kitchens and bathrooms, sills beneath condensation-prone windows, and skin of human inhabitants. Sampling was done in replicated units of a university-housing complex without reported mold problems, and sequences were analyzed using both QIIME and the new UPARSE approach to OTU-binning, to the same result. Surfaces demonstrated a mycological profile similar to that of outdoor air from the same locality, and assemblages clustered by surface type. "Weedy" genera typical of indoor air, such as Cladosporium and Cryptococcus, were abundant on sills, as were a diverse set of fungi of likely outdoor origin. Drains supported more depauperate assemblages than the other surfaces and contained thermotolerant genera such as Exophiala, Candida, and Fusarium. Most surprising was the composition detected on residents' foreheads. In addition to harboring Malassezia, a known human commensal, skin also possessed a surprising richness of non-resident fungi, including plant pathogens such as ergot (Claviceps purperea). Overall, fungal richness across indoor surfaces was high, but based on known autecologies, most of these fungi were unlikely to be growing on surfaces. We conclude that while some endogenous fungal growth on typical household surfaces does occur, particularly on drains and skin, all residential surfaces appear - to varying degrees - to be passive collectors of airborne fungi of putative outdoor origin, a view of the origins of the indoor microbiome quite different from bacteria.	[Adams, Rachel I.; Miletto, Marzia; Taylor, John W.; Bruns, Thomas D.] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Adams, RI (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	adamsri@berkeley.edu		Adams, Rachel/0000-0003-4499-5743	Alfred P. Sloan Foundation [2010-10-03]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was funded with a grant from the Alfred P. Sloan Foundation (http://www.sloan.org), grant number 2010-10-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Abe N, 2011, BIOCONTROL SCI, V16, P139, DOI 10.4265/bio.16.139; Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Akbari H, 2009, CLIMATIC CHANGE, V94, P275, DOI 10.1007/s10584-008-9515-9; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Ara Katsutoshi, 2004, Allergology International, V53, P369, DOI 10.1111/j.1440-1592.2004.00356.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang DC, 2006, JAMA-J AM MED ASSOC, V296, P953, DOI 10.1001/jama.296.8.953; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Edgar RC, 2013, NAT METHODS ADV; Edgar RC, 2013, UPARSE PIPELINE; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fisher AJ, 2007, PLANT DIS, V91, P380, DOI 10.1094/PDIS-91-4-0380; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Hamada N, 2010, BIOCONTROL SCI, V15, P51, DOI 10.4265/bio.15.51; Hamada N, 2009, MYCOSCIENCE, V50, P421, DOI 10.1007/s10267-009-0500-6; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Horner WE, 2004, APPL ENVIRON MICROB, V70, P6394, DOI 10.1128/AEM.70.11.6394-6400.2004; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Karvala K, 2010, INT ARCH OCC ENV HEA, V83, P855, DOI 10.1007/s00420-010-0507-5; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kuhn DM, 2003, CLIN MICROBIOL REV, V16, P144, DOI 10.1128/CMR.16.1.144-172.2003; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Nonnenmann MW, 2012, J ENVIRON MONITOR, V14, P2038, DOI 10.1039/c2em30229b; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; R Development Core Team, 2012, R LANG ENV STAT COMP; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; SAMSON RA, 2001, MICROORGANISMS HOME, P287, DOI DOI 10.1201/9780203302934; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zalar P, 2011, FUNGAL BIOL-UK, V115, P997, DOI 10.1016/j.funbio.2011.04.007; Zhang ES, 2011, MICROBIOL IMMUNOL, V55, P625, DOI 10.1111/j.1348-0421.2011.00364.x; Zhou G, 2000, MOL CELL PROBE, V14, P339, DOI 10.1006/mcpr.2000.0324	52	107	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78866	10.1371/journal.pone.0078866	http://dx.doi.org/10.1371/journal.pone.0078866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	23936296	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300039
J	Xu, CB; Li, XM; Zhang, LH				Xu, Chengbin; Li, Xuemei; Zhang, Lihong			The Effect of Calcium Chloride on Growth, Photosynthesis, and Antioxidant Responses of Zoysia japonica under Drought Conditions	PLOS ONE			English	Article							WHEAT TRITICUM-AESTIVUM; PROLINE METABOLISM; OXIDATIVE STRESS; WATER-DEFICIT; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; TOLERANCE; ACID; L.; INVOLVEMENT	Few attempts have been made to study the alleviating effects of signal molecules on zoysiagrass (Zoysia japonica) under drought stress. Calcium chloride has been shown to ameliorate the adverse effects of drought stress on many plants. It is necessary to investigate how to enhance drought tolerance of zoysiagrass using calcium chloride. The study elucidated the effects of calcium chloride on zoysiagrass under drought conditions by investigating the following parameters: biomass, chlorophyll (Chl) content, net photosynthetic rate (Pn), chlorophyll fluorescence, antioxidant enzymes, proline content, and malondialdehyde (MDA) content. Experimental conditions consisted of an aqueous CaCl2 solution at 5, 10, and 20 mM sprayed on zoysiagrass leaves for 3 d, following by an inducement of drought conditions by withholding water for 16 d. Under drought conditions, all CaCl2 pretreatments were found to increase the above-ground fresh biomass, as well as below-ground fresh and dry biomass. The resulting Chl (a, b, a +b) contents of the 5 and 10 mM CaCl2 pretreatment groups were higher than those of the control. In the later stages of drought conditions, the chlorophyll fluorescence parameter Fv/Fm was higher in leaves treated with 10 mM CaCl2 than in the leaves of the other two treatment groups. Zoysiagrass pretreated with 10 mM CaCl2 possessed both the maximum observed Pn and antioxidant enzyme activities. Meanwhile, lower MDA and proline contents were recorded in the plants pretreated with 5 and 10 mM CaCl2 under drought conditions. As a whole, the drought tolerance of zoysiagrass was improved to some extent by the application of a moderate calcium concentration.	[Xu, Chengbin; Zhang, Lihong] Liaoning Univ, Sch Environm Sci, Shenyang 110036, Peoples R China; [Li, Xuemei] Shenyang Normal Univ, Coll Chem & Life Sci, Shenyang, Peoples R China	Liaoning University; Shenyang Normal University	Zhang, LH (corresponding author), Liaoning Univ, Sch Environm Sci, Shenyang 110036, Peoples R China.	lihongzhang132@163.com		Roe, Oluf Dimitri/0000-0002-4870-5822	National Nature Science Foundation of China [31070285, 31270369]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Nature Science Foundation of China (31070285, 31270369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SB, 2007, ENVIRON EXP BOT, V59, P21, DOI 10.1016/j.envexpbot.2005.09.009; Ahmed M, 2011, AGR WATER MANAGE, V98, P1808, DOI 10.1016/j.agwat.2011.07.003; Antosiewicz DM, 2004, ENVIRON POLLUT, V129, P237, DOI 10.1016/j.envpol.2003.10.025; Arshi A, 2006, ACTA PHYSIOL PLANT, V28, P137, DOI 10.1007/s11738-006-0040-z; Guimaraes FVA, 2011, PLANT GROWTH REGUL, V65, P55, DOI 10.1007/s10725-011-9574-1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Ben Amor N, 2010, ACTA PHYSIOL PLANT, V32, P453, DOI 10.1007/s11738-009-0420-2; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Cousson A, 2009, BIOL PLANTARUM, V53, P53, DOI 10.1007/s10535-009-0008-0; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Diaz-Espejo A, 2007, PLANT CELL ENVIRON, V30, P922, DOI 10.1111/j.1365-3040.2007.001686.x; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Du HM, 2008, ACTA HORTIC, P207; Fu JM, 2001, ENVIRON EXP BOT, V45, P105, DOI 10.1016/S0098-8472(00)00084-8; Hojati M, 2011, J PLANT PHYSIOL, V168, P782, DOI 10.1016/j.jplph.2010.11.009; Huang B, 1999, PLANT SOIL, V208, P179, DOI 10.1023/A:1004472314631; Ishibashi Y, 2011, J PLANT PHYSIOL, V168, P1562, DOI 10.1016/j.jplph.2011.02.003; Israr M, 2011, J HAZARD MATER, V186, P1520, DOI 10.1016/j.jhazmat.2010.12.021; Issam N, 2012, PLANT GROWTH REGUL, V68, P37, DOI 10.1007/s10725-012-9691-5; Jaleel CA, 2007, COLLOID SURFACE B, V60, P110, DOI 10.1016/j.colsurfb.2007.06.006; Ku HM, 2012, BIOL PLANTARUM, V56, P337, DOI 10.1007/s10535-012-0095-1; Levitt J, 1980, CHILLING FREEZING HI; Liang X, 2009, J HYDROL, V376, P243, DOI 10.1016/j.jhydrol.2009.07.035; Ma QQ, 2006, J PLANT PHYSIOL, V163, P165, DOI 10.1016/j.jplph.2005.04.023; Ma R, 2005, J ARID ENVIRON, V63, P177, DOI 10.1016/j.jaridenv.2005.01.021; Mafakheri A, 2010, AUST J CROP SCI, V4, P580; Maggio A, 2002, PLANT J, V31, P699, DOI 10.1046/j.1365-313X.2002.01389.x; Mao Pei Sheng, 2009, Grassland Science, V55, P1, DOI 10.1111/j.1744-697X.2009.00129.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Monclus R, 2006, NEW PHYTOL, V169, P765, DOI 10.1111/j.1469-8137.2005.01630.x; Nayyar H, 2002, BIOL PLANTARUM, V45, P65, DOI 10.1023/A:1015132019686; Shan CJ, 2010, PLANT SCI, V178, P130, DOI 10.1016/j.plantsci.2009.11.002; Shao HB, 2008, CR BIOL, V331, P587, DOI 10.1016/j.crvi.2008.03.012; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Shoresh M, 2011, FREE RADICAL BIO MED, V51, P1221, DOI 10.1016/j.freeradbiomed.2011.03.036; Siddiqui MH, 2011, PROTOPLASMA, V248, P503, DOI 10.1007/s00709-010-0197-6; Soares-Cordeiro AS, 2009, PHOTOSYNTHETICA, V47, P304, DOI 10.1007/s11099-009-0047-y; Tan W, 2011, J PLANT PHYSIOL, V168, P2063, DOI 10.1016/j.jplph.2011.06.009; Tattini M, 2009, ENVIRON EXP BOT, V65, P72, DOI 10.1016/j.envexpbot.2008.01.005; Upadhyaya H, 2011, PLANT CELL REP, V30, P495, DOI 10.1007/s00299-010-0958-x; Wang KH, 2012, J PLANT PHYSIOL, V169, P492, DOI 10.1016/j.jplph.2011.12.007; Wang Y, 2009, BIOL PLANTARUM, V53, P179, DOI 10.1007/s10535-009-0030-2; Wang Y, 2009, PROG NAT SCI-MATER, V19, P435, DOI 10.1016/j.pnsc.2008.07.016; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xu X, 2008, TREE PHYSIOL, V28, P1751, DOI 10.1093/treephys/28.11.1751; Zehra A, 2012, S AFR J BOT, V78, P122, DOI 10.1016/j.sajb.2011.05.016; Zhao HJ, 2007, PLANT GROWTH REGUL, V51, P255, DOI 10.1007/s10725-007-9167-1; Zhou B, 2009, BIOL PLANTARUM, V53, P63, DOI 10.1007/s10535-009-0009-z	49	104	116	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68214	10.1371/journal.pone.0068214	http://dx.doi.org/10.1371/journal.pone.0068214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23936312	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000145
J	Xu, JY; Xue, CC; Xue, D; Zhao, JM; Gai, JY; Guo, N; Xing, H				Xu, Jinyan; Xue, Chenchen; Xue, Dong; Zhao, Jinming; Gai, Junyi; Guo, Na; Xing, Han			Overexpression of GmHsp90s, a Heat Shock Protein 90 (Hsp90) Gene Family Cloning from Soybean, Decrease Damage of Abiotic Stresses in Arabidopsis thaliana	PLOS ONE			English	Article							PROLINE ACCUMULATION; MOLECULAR CHAPERONES; LIPID-PEROXIDATION; EXPRESSION; SEQUENCE; PLANTS; HOMEOSTASIS; PROTECTION; GENOMICS; ENCODES	Hsp90 is one of the most conserved and abundant molecular chaperones and is an essential component of the protective stress response; however, its roles in abiotic stress responses in soybean (Glycine max) remain obscure. Here, 12 GmHsp90 genes from soybean were identified and found to be expressed and to function differentially under abiotic stresses. The 12 GmHsp90 genes were isolated and named GmHsp90A1-GmHsp90A6, GmHsp90B1, GmHsp90B2, GmHsp90C1.1, GmHsp90C1.2, GmHsp90C2.1 and GmHsp90C2.2 based on their characteristics and high homology to other Hsp90s according to a new nomenclature system. Quantitative real-time PCR expression data revealed that all the genes exhibited higher transcript levels in leaves and could be strongly induced under heat, osmotic and salt stress but not cold stress. Overexpression of five typical genes (GmHsp90A2, GmHsp90A4, GmHsp90B1, GmHsp90C1.1 and GmHsp90C2.1) in Arabidopsis thaliana provided useful evidences that GmHsp90 genes can decrease damage of abiotic stresses. In addition, an abnormal accumulation of proline was detected in some transgenic Arabidopsis plants suggested overexpressing GmHsp90s may affect the synthesis and response system of proline. Our work represents a systematic determination of soybean genes encoding Hsp90s, and provides useful evidence that GmHsp90 genes function differently in response to abiotic stresses and may affect the synthesis and response system of proline.	[Xu, Jinyan; Xue, Chenchen; Xue, Dong; Zhao, Jinming; Gai, Junyi; Guo, Na; Xing, Han] Nanjing Agr Univ, Minist Agr,Natl Ctr Soybean Improvement, Key Lab Biol & Genet & Breeding Soybean, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Guo, N (corresponding author), Nanjing Agr Univ, Minist Agr,Natl Ctr Soybean Improvement, Key Lab Biol & Genet & Breeding Soybean, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	guona@njau.edu.cn; hanx@njau.edu.cn		Xue, Chenchen/0000-0002-9703-2986	National Basic Research Program of China (973 program) [2009CB118400]; Modern Agro-industry Technology Research System of China [CARS-004-PS10]; National Core Soybean Genetic Engineering Project [2011ZX08004-002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 program)(National Basic Research Program of China); Modern Agro-industry Technology Research System of China; National Core Soybean Genetic Engineering Project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The work was supported by the National Basic Research Program of China (973 program: 2009CB118400), Modern Agro-industry Technology Research System of China (CARS-004-PS10), National Core Soybean Genetic Engineering Project (2011ZX08004-002) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIGUE R, 1994, EMBO J, V13, P6099, DOI 10.1002/j.1460-2075.1994.tb06956.x; Banilas G, 2012, AUST J GRAPE WINE R, V18, P29, DOI 10.1111/j.1755-0238.2011.00166.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Cao DS, 2003, PLANT J, V33, P107, DOI 10.1046/j.1365-313X.2003.016011.x; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FELSHEIM RF, 1992, PLANT PHYSIOL, V100, P1764, DOI 10.1104/pp.100.4.1764; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Fu DQ, 2009, MOL PLANT MICROBE IN, V22, P86, DOI 10.1094/MPMI-22-1-0086; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hossain M, 2003, CURR MICROBIOL, V46, P70, DOI 10.1007/s00284-002-3831-5; Hossain Z, 2012, J PROTEOME RES, V11, P37, DOI 10.1021/pr200863r; Kornbrot D, 2000, BRIT J MATH STAT PSY, V53, P335; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu DL, 2009, CURR MICROBIOL, V58, P129, DOI 10.1007/s00284-008-9288-4; Liu DL, 2006, PLANT PHYSIOL BIOCH, V44, P380, DOI 10.1016/j.plaphy.2006.06.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARRS KA, 1993, DEV GENET, V14, P27, DOI 10.1002/dvg.1020140105; Michaels G S, 1998, Pac Symp Biocomput, P42; Milioni D, 1997, PLANT MOL BIOL, V35, P955, DOI 10.1023/A:1005874521528; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neckers L, 2007, CHEM BIOL, V14, P1204, DOI 10.1016/j.chembiol.2007.11.002; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; NORUSIS MJ, 1990, SPSS ADV STAT USERS; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Parvanova D, 2004, PLANT PHYSIOL BIOCH, V42, P57, DOI 10.1016/j.plaphy.2003.10.007; Picard D, 1990, REDUCED LEVELS HSP90; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prassinos C, 2008, PLANT MOL BIOL, V67, P323, DOI 10.1007/s11103-008-9322-8; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Priti K, 1995, PLANT PHYSIOL, V107, P9; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Reddy RK, 1998, PLANT SCI, V131, P131, DOI 10.1016/S0168-9452(97)00254-9; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHMEDES A, 1989, J AM OIL CHEM SOC, V66, P813, DOI 10.1007/BF02653674; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz G, 1996, PLANT MOL BIOL, V30, P479, DOI 10.1007/BF00049326; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Song HM, 2012, BIOL PLANTARUM, V56, P197, DOI 10.1007/s10535-012-0042-1; Song HM, 2010, J PLANT PHYSIOL, V167, P1172, DOI 10.1016/j.jplph.2010.03.016; Song HM, 2009, PLANTA, V229, P955, DOI 10.1007/s00425-008-0886-y; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; WALTHERLARSEN H, 1993, PLANT MOL BIOL, V21, P1097, DOI 10.1007/BF00023606; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wilkins MR, 1999, METH MOL B, V112, P531; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Ye SF, 2012, CHINESE SCI BULL, V57, P336, DOI 10.1007/s11434-011-4863-7; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	65	52	66	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69810	10.1371/journal.pone.0069810	http://dx.doi.org/10.1371/journal.pone.0069810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936107	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300068
J	Zhou, XY; Barsky, LW; Adams, GB				Zhou, Xiaoying; Barsky, Lora W.; Adams, Gregor B.			Placental Growth Factor Expression Is Required for Bone Marrow Endothelial Cell Support of Primitive Murine Hematopoietic Cells	PLOS ONE			English	Article							STEM-CELL; PROGENITOR CELLS; VASCULAR NICHE; IN-VIVO; THERAPEUTIC NEOVASCULARIZATION; SELF-RENEWAL; TRANSPLANTATION; RECONSTITUTION; TISSUE; MOUSE	Two distinct microenvironmental niches that regulate hematopoietic stem/progenitor cell physiology in the adult bone marrow have been proposed; the endosteal and the vascular niche. While extensive studies have been performed relating to molecular interactions in the endosteal niche, the mechanisms that regulate hematopoietic stem/progenitor cell interaction with bone marrow endothelial cells are less well defined. Here we demonstrate that endothelial cells derived from the bone marrow supported hematopoietic stem/progenitor cells to a higher degree than other endothelial or stromal cell populations. This support was dependant upon placental growth factor expression, as genetic knockdown of mRNA levels reduced the ability of endothelial cells to support hematopoietic stem/progenitor cells in vitro. Furthermore, using an in vivo model of recovery from radiation induced myelosuppression, we demonstrate that bone marrow endothelial cells were able to augment the recovery of the hematopoietic stem/progenitor cells. However, this effect was diminished when the same cells with reduced placental growth factor expression were administered, possibly owing to a reduced homing of the cells to the bone marrow vasculature. Our data suggest that placental growth factor elaborated from bone marrow endothelial cells mediates the regulatory effects of the vascular niche on hematopoietic stem/progenitor cell physiology.	[Zhou, Xiaoying; Barsky, Lora W.; Adams, Gregor B.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California	Adams, GB (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	gregorad@med.usc.edu		Adams, Rachel/0000-0003-4499-5743	California Institute for Regenerative Medicine	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by the California Institute for Regenerative Medicine (XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Ewing P, 2003, J IMMUNOL METHODS, V283, P307, DOI 10.1016/j.jim.2003.08.004; Feng YM, 2009, BLOOD, V113, P755, DOI 10.1182/blood-2008-06-161794; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Gerber HP, 2003, J MOL MED, V81, P20, DOI 10.1007/s00109-002-0397-4; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grassinger J, 2012, CYTOKINE, V58, P218, DOI 10.1016/j.cyto.2012.01.014; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kwon KR, 2010, STEM CELLS, V28, P268, DOI 10.1002/stem.285; LAMBERTSEN RH, 1984, BLOOD, V63, P287; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Larrivee B, 2006, EXP HEMATOL, V34, P1741, DOI 10.1016/j.exphem.2006.08.006; Li WM, 2004, EXP HEMATOL, V32, P1226, DOI 10.1016/j.exphem.2004.09.001; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Miyamoto Y, 2007, J MOL CELL CARDIOL, V43, P627, DOI 10.1016/j.yjmcc.2007.08.001; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; PLOEMACHER RE, 1991, BLOOD, V78, P2527; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Taichman RS, 1998, STEM CELLS, V16, P7, DOI 10.1002/stem.160007; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yan Z, 2013, TRANSPL P, V45, P427, DOI 10.1016/j.transproceed.2012.03.064; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	53	107	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e67861	10.1371/journal.pone.0067861	http://dx.doi.org/10.1371/journal.pone.0067861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936296	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800001
J	Morozov, A; Pasternak, AF; Arashkevich, EG				Morozov, Andrew; Pasternak, Anna F.; Arashkevich, Elena G.			Revisiting the Role of Individual Variability in Population Persistence and Stability	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; VISUAL PREDATION RISK; FUNCTIONAL-RESPONSE; ZOOPLANKTON; BEHAVIOR; PREY; PERSONALITIES; SELECTION; PARADOX; GROWTH	Populations often exhibit a pronounced degree of individual variability and this can be important when constructing ecological models. In this paper, we revisit the role of inter-individual variability in population persistence and stability under predation pressure. As a case study, we consider interactions between a structured population of zooplankton grazers and their predators. Unlike previous structured population models, which only consider variability of individuals according to the age or body size, we focus on physiological and behavioural structuring. We first experimentally demonstrate a high degree of variation of individual consumption rates in three dominant species of herbivorous copepods (Calanus finmarchicus, Calanus glacialis, Calanus euxinus) and show that this disparity implies a pronounced variation in the consumption capacities of individuals. Then we construct a parsimonious predator-prey model which takes into account the intra-population variability of prey individuals according to behavioural traits: effectively, each organism has a 'personality' of its own. Our modelling results show that structuring of prey according to their growth rate and vulnerability to predation can dampen predator-prey cycles and enhance persistence of a species, even if the resource stock for prey is unlimited. The main mechanism of efficient top-down regulation is shown to work by letting the prey population become dominated by less vulnerable individuals when predator densities are high, while the trait distribution recovers when the predator densities are low.	[Morozov, Andrew] Univ Leicester, Dept Math, Leicester, Leics, England; [Morozov, Andrew; Pasternak, Anna F.; Arashkevich, Elena G.] PP Shirshov Oceanol Inst, Lab Plankton Ecol, Moscow, Russia	University of Leicester; Russian Academy of Sciences; Shirshov Institute of Oceanology	Morozov, A (corresponding author), Univ Leicester, Dept Math, Leicester, Leics, England.	am379@leicester.ac.uk	Ashhab, Ashraf AL/AAF-4989-2019; Arashkevich, Elena/E-8175-2014; Pasternak, Anna F/E-6121-2014; Morozov, Andrew/AAI-6528-2020	Ashhab, Ashraf AL/0000-0002-3716-2279; Arashkevich, Elena/0000-0003-0374-3064; Pasternak, Anna F/0000-0003-0317-5861; Minz, Dror/0000-0001-6746-9151; Gillor, Osnat/0000-0003-0849-2241	EU [FP7-226248]; RFBR (Russian Federation) [10-04-00386]	EU(European Commission); RFBR (Russian Federation)(Russian Foundation for Basic Research (RFBR)Russian Federation)	The study was partially supported by EU grant Arctic Tipping Points (FP7-226248) and RFBR grant 10-04-00386 (Russian Federation) to AP. The funding was used to cover the expenses of zooplankton feeding experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, ECOLOGY, V77, P1125, DOI 10.2307/2265581; Allen L. J. S., 2007, INTRO MATH BIOL; ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; BAMSTEDT U, 1988, HYDROBIOLOGIA, V167, P43, DOI 10.1007/BF00026293; BOLLENS SM, 1989, J PLANKTON RES, V11, P1047, DOI 10.1093/plankt/11.5.1047; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; CHARLESWORTH B, 1972, THEOR POPUL BIOL, V3, P377, DOI 10.1016/0040-5809(72)90011-1; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; CULLEN JJ, 1992, J GEOPHYS RES-OCEANS, V97, P639, DOI 10.1029/91JC01320; Cushing J., 1998, J SOC IND APPL MATH; Dagg MJ, 1997, LIMNOL OCEANOGR, V42, P974, DOI 10.4319/lo.1997.42.5.0974; De Robertis A, 2002, LIMNOL OCEANOGR, V47, P925, DOI 10.4319/lo.2002.47.4.0925; De Robertis A, 2000, LIMNOL OCEANOGR, V45, P1838, DOI 10.4319/lo.2000.45.8.1838; Diekmann O, 2010, J MATH BIOL, V61, P277, DOI 10.1007/s00285-009-0299-y; DRITS AV, 1994, HYDROBIOLOGIA, V293, P201, DOI 10.1007/BF00229942; Edwards CA, 2000, J MAR RES, V58, P37, DOI 10.1357/002224000321511197; EHLINGER TJ, 1990, ECOLOGY, V71, P886, DOI 10.2307/1937360; FERNO A, 1995, AQUACULTURE, V132, P285, DOI 10.1016/0044-8486(94)00384-Z; Genkai-Kato M, 1999, P ROY SOC B-BIOL SCI, V266, P1215, DOI 10.1098/rspb.1999.0765; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gurney WSC, 2001, J ANIM ECOL, V70, P881, DOI 10.1046/j.0021-8790.2001.00549.x; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; Kooi BW, 2000, COMMENT THEOR BIOL, V8, P125; Lehtiniemi M, 2006, MAR BIOL, V149, P845, DOI 10.1007/s00227-006-0243-2; Leising AW, 2005, J PLANKTON RES, V27, P987, DOI 10.1093/plankt/fbi084; Magal P., 2008, LECT NOTES MATH, V1936; MATHER JA, 1993, J COMP PSYCHOL, V107, P336, DOI 10.1037/0735-7036.107.3.336; Metz J., 1986, LECT NOTES BIOMATHEM, DOI DOI 10.1007/978-3-662-13159-6; Morozov AY, 2010, J THEOR BIOL, V262, P346, DOI 10.1016/j.jtbi.2009.09.023; Morozov A, 2008, DEEP-SEA RES PT II, V55, P2285, DOI 10.1016/j.dsr2.2008.05.008; Nisbet R.M., 1997, STRUCTURED POPULATIO, V18, P89; OATEN A, 1975, AM NAT, V109, P289, DOI 10.1086/282998; OHMAN MD, 1990, ECOL MONOGR, V60, P257, DOI 10.2307/1943058; Paffenhofer GA, 1996, J PLANKTON RES, V18, P1699, DOI 10.1093/plankt/18.9.1699; PAFFENHOFER GA, 1994, J PLANKTON RES, V16, P617, DOI 10.1093/plankt/16.6.617; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; Petrovskii SV, 2003, ECOL LETT, V6, P455, DOI 10.1046/j.1461-0248.2003.00451.x; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Saiz E, 2007, LIMNOL OCEANOGR, V52, P668, DOI 10.4319/lo.2007.52.2.0668; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Sekino T, 1999, EVOL ECOL, V13, P267, DOI 10.1023/A:1006797101565; Seuront L, 2004, MAR ECOL PROG SER, V283, P199, DOI 10.3354/meps283199; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Torgersen T, 2003, J PLANKTON RES, V25, P565, DOI 10.1093/plankt/25.5.565; Tuljapurkar S., 1997, STRUCTURED POPULATIO; Utne ACW, 1997, CAN J ZOOL, V75, P2027, DOI 10.1139/z97-836; van Oers K, 2005, BEHAV ECOL, V16, P716, DOI 10.1093/beheco/ari045; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	49	90	97	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70576	10.1371/journal.pone.0070576	http://dx.doi.org/10.1371/journal.pone.0070576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936450	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800045
J	Gong, YY; Li, JZ; Schnitzer, MJ				Gong, Yiyang; Li, Jin Zhong; Schnitzer, Mark J.			Enhanced Archaerhodopsin Fluorescent Protein Voltage Indicators	PLOS ONE			English	Article							BACTERIORHODOPSIN MUTANTS; ACTION-POTENTIALS; IN-VIVO; FRET; OPTIMIZATION; DYNAMICS; NEURONS; PROBE	A longstanding goal in neuroscience has been to develop techniques for imaging the voltage dynamics of genetically defined subsets of neurons. Optical sensors of transmembrane voltage would enhance studies of neural activity in contexts ranging from individual neurons cultured in vitro to neuronal populations in awake-behaving animals. Recent progress has identified Archaerhodopsin (Arch) based sensors as a promising, genetically encoded class of fluorescent voltage indicators that can report single action potentials. Wild-type Arch exhibits sub-millisecond fluorescence responses to trans-membrane voltage, but its light-activated proton pump also responds to the imaging illumination. An Arch mutant (Arch-D95N) exhibits no photocurrent, but has a slower, similar to 40 ms response to voltage transients. Here we present Arch-derived voltage sensors with trafficking signals that enhance their localization to the neural membrane. We also describe Arch mutant sensors (Arch-EEN and -EEQ) that exhibit faster kinetics and greater fluorescence dynamic range than Arch-D95N, and no photocurrent at the illumination intensities normally used for imaging. We benchmarked these voltage sensors regarding their spike detection fidelity by using a signal detection theoretic framework that takes into account the experimentally measured photon shot noise and optical waveforms for single action potentials. This analysis revealed that by combining the sequence mutations and enhanced trafficking sequences, the new sensors improved the fidelity of spike detection by nearly three-fold in comparison to Arch-D95N.	[Gong, Yiyang; Li, Jin Zhong; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Gong, Yiyang; Li, Jin Zhong; Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Gong, YY (corresponding author), Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA.	yiyangg@stanford.edu		Gong, Yiyang/0000-0002-1855-930X	Stanford CNC program; Stanford BioX Interdisciplinary Initiatives Program (IIP) grant; National Academies Keck Futures Initiative (NAKFI) research grant	Stanford CNC program; Stanford BioX Interdisciplinary Initiatives Program (IIP) grant; National Academies Keck Futures Initiative (NAKFI) research grant	This work was supported by the Stanford CNC program, the Stanford BioX Interdisciplinary Initiatives Program (IIP) grant, and a National Academies Keck Futures Initiative (NAKFI) research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; Chemla S, 2010, J PHYSIOL-PARIS, V104, P40, DOI 10.1016/j.jphysparis.2009.11.009; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kalaidzidis IV, 1997, FEBS LETT, V418, P239, DOI 10.1016/S0014-5793(97)01390-2; Kolodner P, 1996, P NATL ACAD SCI USA, V93, P11618, DOI 10.1073/pnas.93.21.11618; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; LANYI JK, 1992, J BIOENERG BIOMEMBR, V24, P169, DOI 10.1007/BF00762675; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lundby A, 2010, EUR BIOPHYS J BIOPHY, V39, P1625, DOI 10.1007/s00249-010-0620-0; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; MARINETTI T, 1989, P NATL ACAD SCI USA, V86, P529, DOI 10.1073/pnas.86.2.529; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mishina Y, 2012, BIOPHYS J, V103, P669, DOI 10.1016/j.bpj.2012.07.031; Moltke S, 1995, BIOPHYS J, V69, P2074, DOI 10.1016/S0006-3495(95)80078-0; Mutoh H, 2012, ACS CHEM NEUROSCI, V3, P585, DOI 10.1021/cn300041b; Mutoh H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004555; Perron A, 2009, CHEM BIOL, V16, P1268, DOI 10.1016/j.chembiol.2009.11.014; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Saeedi P, 2012, BIOTECHNOL LETT, V34, P455, DOI 10.1007/s10529-011-0731-4; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; SALZBERG BM, 1993, JPN J PHYSIOL, V43, pS37; SALZBERG BM, 1977, J NEUROPHYSIOL, V40, P1281, DOI 10.1152/jn.1977.40.6.1281; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Sjulson L, 2008, J NEUROSCI, V28, P5582, DOI 10.1523/JNEUROSCI.0055-08.2008; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Wilt BA, 2013, BIOPHYS J, V104, P51, DOI 10.1016/j.bpj.2012.07.058	41	71	89	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66959	10.1371/journal.pone.0066959	http://dx.doi.org/10.1371/journal.pone.0066959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840563	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200112
J	Pasternak, Z; Al-Ashhab, A; Gatica, J; Gafny, R; Avraham, S; Minz, D; Gillor, O; Jurkevitch, E				Pasternak, Zohar; Al-Ashhab, Ashraf; Gatica, Joao; Gafny, Ron; Avraham, Shlomit; Minz, Dror; Gillor, Osnat; Jurkevitch, Edouard			Spatial and Temporal Biogeography of Soil Microbial Communities in Arid and Semiarid Regions	PLOS ONE			English	Article							DISTANCE-DECAY; DIVERSITY; 16S	Microbial communities in soils may change in accordance with distance, season, climate, soil texture and other environmental parameters. Microbial diversity patterns have been extensively surveyed in temperate regions, but few such studies attempted to address them with respect to spatial and temporal scales and their correlations to environmental factors, especially in arid ecosystems. In order to fill this gap on a regional scale, the molecular fingerprints and abundance of three taxonomic groups - Bacteria, alpha-Proteobacteria and Actinobacteria - were sampled from soils 0.5-100 km apart in arid, semi-arid, dry Mediterranean and shoreline Mediterranean regions in Israel. Additionally, on a local scale, the molecular fingerprints of three taxonomic groups - Bacteria, Archaea and Fungi - were sampled from soils 1 cm-500 m apart in the semi-arid region, in both summer and winter. Fingerprints of the Bacteria differentiated between all regions (P<0.02), while those of the a-Proteobacteria differentiated between some of the regions (0.01<P<0.09), and actinobacterial fingerprints were similar among all regions (P>0.05). Locally, fingerprints of archaea and fungi did not display distance-decay relationships (P>0.13), that is, the dissimilarity between communities did not increase with geographic distance. Neither was this phenomenon evident in bacterial samples in summer (P>0.24); in winter, however, differences between bacterial communities significantly increased as the geographic distances between them grew (P<0.01). Microbial community structures, as well as microbial abundance, were both significantly correlated to precipitation and soil characteristics: texture, organic matter and water content (R-2>0.60, P<0.01). We conclude that on the whole, microbial biogeography in arid and semi-arid soils in Israel is determined more by specific environmental factors than geographic distances and spatial distribution patterns.	[Pasternak, Zohar; Gatica, Joao; Jurkevitch, Edouard] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Microbiol & Plant Dis, IL-76100 Rehovot, Israel; [Al-Ashhab, Ashraf; Gillor, Osnat] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Zuckerberg Inst Water Res, IL-84993 Sede Boqer, Israel; [Gafny, Ron; Avraham, Shlomit] Israel Police Natl Headquarters, DIFS, Forens Biol Lab, Jerusalem, Israel; [Minz, Dror] Agr Res Org, Volcani Ctr, Inst Soil Water & Environm Sci, IL-50250 Bet Dagan, Israel	Hebrew University of Jerusalem; Ben Gurion University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Pasternak, Z (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Microbiol & Plant Dis, IL-76100 Rehovot, Israel.	zpast@yahoo.com	Ashhab, Ashraf AL/AAF-4989-2019; Arashkevich, Elena/E-8175-2014; Pasternak, Anna F/E-6121-2014; Morozov, Andrew/AAI-6528-2020	Ashhab, Ashraf AL/0000-0002-3716-2279; Arashkevich, Elena/0000-0003-0374-3064; Pasternak, Anna F/0000-0003-0317-5861; Minz, Dror/0000-0001-6746-9151; Gillor, Osnat/0000-0003-0849-2241	Technical Support Working Group of the U.S. CTTSO (Combating Terrorism Technical Support Office)	Technical Support Working Group of the U.S. CTTSO (Combating Terrorism Technical Support Office)	Funding for this project was provided by the Technical Support Working Group of the U.S. CTTSO (Combating Terrorism Technical Support Office). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Bachar A, 2012, MICROB ECOL, V63, P694, DOI 10.1007/s00248-011-9957-x; Bachar A, 2010, MICROB ECOL, V60, P453, DOI 10.1007/s00248-010-9727-1; Bell CW, 2009, MICROB ECOL, V58, P827, DOI 10.1007/s00248-009-9529-5; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Clark J, 2009, MICROB ECOL, V57, P248, DOI 10.1007/s00248-008-9475-7; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Egert M, 2003, APPL ENVIRON MICROB, V69, P2555, DOI 10.1128/AEM.69.5.2555-2562.2003; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Franklin RB, 2003, FEMS MICROBIOL ECOL, V44, P335, DOI 10.1016/S0168-6496(03)00074-6; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LeBlanc JC, 2008, APPL ENVIRON MICROB, V74, P2627, DOI 10.1128/AEM.02711-07; Mangan SA, 2004, OECOLOGIA, V141, P687, DOI 10.1007/s00442-004-1684-2; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mather P. M., 1976, COMPUTATIONAL METHOD; Mielke P., 1984, METEOROLOGICAL APPL, P813; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; MOYER CL, 1994, APPL ENVIRON MICROB, V60, P871, DOI 10.1128/AEM.60.3.871-879.1994; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Pasternak Z, 2012, INT RES J MICROBIOL, V3, P363; Sensabaugh GF, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P49, DOI 10.1007/978-1-4020-9204-6_4; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184; WILLIAMS S T, 1972, Soil Biology and Biochemistry, V4, P215, DOI 10.1016/0038-0717(72)90014-4	36	90	97	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69705	10.1371/journal.pone.0069705	http://dx.doi.org/10.1371/journal.pone.0069705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23936450	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900071
J	Martin, RM; Patel, R; Oken, E; Thompson, J; Zinovik, A; Kramer, MS; Vilchuck, K; Bogdanovich, N; Sergeichick, N; Foo, Y; Gusina, N				Martin, Richard M.; Patel, Rita; Oken, Emily; Thompson, Jennifer; Zinovik, Alexander; Kramer, Michael S.; Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Foo, Ying; Gusina, Nina			Filter Paper Blood Spot Enzyme Linked Immunoassay for Adiponectin and Application in the Evaluation of Determinants of Child Insulin Sensitivity	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLASMA ADIPONECTIN; MYOCARDIAL-INFARCTION; RESISTANCE; OBESITY; SAMPLES; FAT; SEX; OVERWEIGHT; ADIPOSITY	Background: Adiponectin is an adipocyte-derived hormone that acts as a marker of insulin sensitivity. Bloodspot sampling by fingerstick onto filter paper may increase the feasibility of large-scale studies of the determinants of insulin sensitivity. We first describe the validation of an enzyme-linked immunoassay (ELISA) for quantifying adiponectin from dried blood spots and then demonstrate its application in a large trial (PROBIT). Methods: We quantified adiponectin from 3-mm diameter discs (approximate to 3 mu L of blood) punched from dried blood spots obtained from: i) whole blood standards (validation); and ii) PROBIT trial samples (application) in which paediatricians collected blood spots from 13,879 children aged 11.5 years from 31 sites across Belarus. We examined the distribution of bloodspot adiponectin by demographic and anthropometric factors, fasting insulin and glucose. Results: In the validation study, mean intra-assay coefficients of variation (n = 162) were 15%, 13% and 10% for 'low' (6.78 mg/ml), 'medium' (18.18 mg/ml) and 'high' (33.13 mg/ml) internal quality control (IQC) samples, respectively; the respective inter-assay values (n = 40) were 23%, 21% and 14%. The correlation coefficient between 50 paired whole bloodspot versus plasma samples, collected simultaneously, was 0.87 (95% CI: 0.78 to 0.93). Recovery of known quantities of adiponectin (between 4.5 to 36 mu g/ml) was 100.3-133%. Bloodspot adiponectin was stable for at least 30 months at -80 degrees C. In PROBIT, we successfully quantified fasting adiponectin from dried blood spots in 13,329 of 13,879 (96%) children. Mean adiponectin (standard deviation) concentrations were 17.34 mu g/ml (7.54) in boys and 18.41 mu g/ml (7.92) in girls and were inversely associated with body mass index, fat mass, triceps and subscapular skin-fold thickness, waist circumference, height and fasting glucose. Conclusions: Bloodspot ELISA is suitable for measuring adiponectin in very small volumes of blood collected on filter paper and can be applied to large-scale studies.	[Martin, Richard M.; Patel, Rita; Foo, Ying] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Martin, Richard M.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Martin, Richard M.] Univ Bristol, Univ Hosp Bristol NHS Fdn Trust, Natl Inst Hlth Res Bristol, Nutr Biomed Res Unit, Bristol, Avon, England; [Oken, Emily; Thompson, Jennifer] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Oken, Emily; Thompson, Jennifer] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Zinovik, Alexander; Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Gusina, Nina] Natl Res & Appl Med Mother & Child Ctr, Minsk, BELARUS; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada	University of Bristol; University of Bristol; University of Bristol; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; McGill University; McGill University	Martin, RM (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	richard.martin@bristol.ac.uk		Poynter, Matthew/0000-0002-7578-4570; Lundblad, Lennart/0000-0002-1749-8242; Ather, Jennifer/0000-0003-0484-5599; Hoyt, Laura/0000-0002-0350-4154	European Union [FOOD-DT-2005-007036]; Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research [MOP - 53155]; USA National Institutes of Health [R01 HD 050758]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050758] Funding Source: NIH RePORTER	European Union(European Commission); Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by European Union, grant no. FOOD-DT-2005-007036; Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research (MOP - 53155); and the USA National Institutes of Health (reference: R01 HD 050758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asayama K, 2003, OBES RES, V11, P1072, DOI 10.1038/oby.2003.147; Bacha F, 2004, DIABETES CARE, V27, P547, DOI 10.2337/diacare.27.2.547; Barker DJP, 1998, MOTHERS BABIES HLTH; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Cho E, 2002, J AM COLL CARDIOL, V40, P954, DOI 10.1016/S0735-1097(02)02044-2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cruz M, 2004, DIABETES CARE, V27, P1451, DOI 10.2337/diacare.27.6.1451; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Klamer A, 2007, EUR J ENDOCRINOL, V157, P189, DOI 10.1530/EJE-06-0710; Kuh D, 1997, LIFE COURSE APPROACH; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lynch JF, 1998, MED J AUSTRALIA, V168, P61, DOI 10.5694/j.1326-5377.1998.tb126712.x; Martin RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046752; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; McDowell MA, 2010, ANTHROPOMETRIC REFER; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; National Committee for Clinical Laboratory Standards (NCCLS), 1997, A4A3 NCCLS; Okada T, 2006, ATHEROSCLEROSIS, V188, P179, DOI 10.1016/j.atherosclerosis.2005.10.030; Ong KK, 2006, DIABETES, V55, P1337, DOI 10.2337/db05-1272; Parker SP, 1999, J CLIN PATHOL, V52, P633, DOI 10.1136/jcp.52.9.633; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Punthakee Z, 2006, J CLIN ENDOCR METAB, V91, P2119, DOI 10.1210/jc.2005-2346; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Shand BI, 2003, DIABETES OBES METAB, V5, P349, DOI 10.1046/j.1463-1326.2003.00279.x; Singhal A, 2005, J CLIN ENDOCR METAB, V90, P4615, DOI 10.1210/jc.2005-0131; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Smith GD, 1997, LANCET, V349, P284, DOI 10.1016/S0140-6736(05)64894-5; Stefan N, 2002, J CLIN ENDOCR METAB, V87, P4652, DOI 10.1210/jc.2002-020694; Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9; Tsou PL, 2004, DIABETES CARE, V27, P308, DOI 10.2337/diacare.27.2.308; WARNICK GR, 1994, ARCH PATHOL LAB MED, V118, P1110; Weiss R, 2003, J CLIN ENDOCR METAB, V88, P2014, DOI 10.1210/jc.2002-021711; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Williams SR, 2009, J GERONTOL B; Worthman CM, 1997, AM J PHYS ANTHROPOL, V104, P1	45	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71315	10.1371/journal.pone.0071315	http://dx.doi.org/10.1371/journal.pone.0071315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936498	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400101
J	Morgan, MAJ; Muller, PSS; Mould, A; Newland, SA; Nichols, J; Robertson, EJ; Cooke, A; Bikoff, EK				Morgan, Marc A. J.; Muller, Pari S. S.; Mould, Arne; Newland, Stephen A.; Nichols, Jennifer; Robertson, Elizabeth J.; Cooke, Anne; Bikoff, Elizabeth K.			The Nonconventional MHC Class II Molecule DM Governs Diabetes Susceptibility in NOD Mice	PLOS ONE			English	Article							INVARIANT CHAIN; ANTIGEN PRESENTATION; PEPTIDE BINDING; CELL MATURATION; MUTANT MICE; H2-M; COMPLEXES; MOUSE; REQUIREMENTS; REPERTOIRE	The spontaneous destruction of insulin producing pancreatic beta cells in non-obese diabetic (NOD) mice provides a valuable model of type 1 diabetes. As in humans, disease susceptibility is controlled by the classical MHC class II genes that guide CD4(+) T cell responses to self and foreign antigens. It has long been suspected that the dedicated class II chaperone designated HLA-DM in humans or H-2M in mice also makes an important contribution, but due to tight linkage within the MHC, a possible role played by DM peptide editing has not been previously tested by conventional genetic approaches. Here we exploited newly established germ-line competent NOD ES cells to engineer a loss of function allele. DM deficient NOD mice display defective class II peptide occupancy and surface expression, and are completely protected against type 1 diabetes. Interestingly the mutation results in increased proportional representation of CD4(+)Foxp3(+) regulatory T cells and the absence of pathogenic CD4(+) T effectors. Overall, this striking phenotype establishes that DM-mediated peptide selection plays an essential role in the development of autoimmune diabetes in NOD mice.	[Morgan, Marc A. J.; Muller, Pari S. S.; Mould, Arne; Robertson, Elizabeth J.; Bikoff, Elizabeth K.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Newland, Stephen A.; Cooke, Anne] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Nichols, Jennifer] Univ Cambridge, MRC, Cambridge Stem Cell Inst, Wellcome Trust, Cambridge, England	University of Oxford; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Bikoff, EK (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	elizabeth.bikoff@path.ox.ac.uk	Cooke, Anne/S-4763-2019; Mallat, Ziad/D-4041-2012; Hardy, Christopher/A-8794-2008; Chariton, Anthony/F-2373-2011; Court, Leon/J-7138-2013	Cooke, Anne/0000-0003-3327-6081; Mallat, Ziad/0000-0003-0443-7878; Hardy, Christopher/0000-0002-7419-566X; Chariton, Anthony/0000-0002-5809-3372; , Bin/0000-0001-9190-968X; Nichols, Jennifer/0000-0002-8650-1388; Court, Leon/0000-0003-3673-9504; Mould, Arne/0000-0002-2004-4348	Wellcome Trust; MRC [G0801841] Funding Source: UKRI; Medical Research Council [G0801841] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Bikoff EK, 2001, J IMMUNOL, V166, P5087, DOI 10.4049/jimmunol.166.8.5087; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Denzin LK, 2005, IMMUNOL REV, V207, P279, DOI 10.1111/j.0105-2896.2005.00302.x; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Guerder S, 2012, CURR OPIN IMMUNOL, V24, P99, DOI 10.1016/j.coi.2012.01.008; Hanna J, 2009, CELL STEM CELL, V5, P124, DOI 10.1016/j.stem.2009.06.007; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Karlsson L, 2005, CURR OPIN IMMUNOL, V17, P65, DOI 10.1016/j.coi.2004.11.003; Kenty G, 1998, J IMMUNOL, V160, P606; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Koonce CH, 2004, J IMMUNOL, V173, P3271, DOI 10.4049/jimmunol.173.5.3271; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; Kovats S, 1998, J EXP MED, V187, P245, DOI 10.1084/jem.187.2.245; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mellanby RJ, 2008, AUTOIMMUNITY, V41, P383, DOI 10.1080/08916930801991021; Mellanby RJ, 2006, J IMMUNOL, V177, P7588, DOI 10.4049/jimmunol.177.11.7588; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Peleraux A, 1996, IMMUNOGENETICS, V43, P204, DOI 10.1007/BF00587301; Rich JD, 2003, J IMMUNOL, V171, P853, DOI 10.4049/jimmunol.171.2.853; Schulze MSED, 2012, CURR OPIN IMMUNOL, V24, P105, DOI 10.1016/j.coi.2011.11.004; Serreze DV, 2001, CURR DIRECT AUTOIMMU, V4, P31; Stadinski B, 2010, IMMUNITY, V32, P446, DOI 10.1016/j.immuni.2010.04.008; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Tourne S, 1997, P NATL ACAD SCI USA, V94, P9255, DOI 10.1073/pnas.94.17.9255; Yi W, 2010, J CLIN INVEST, V120, P1324, DOI 10.1172/JCI40220	45	84	89	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56738	10.1371/journal.pone.0056738	http://dx.doi.org/10.1371/journal.pone.0056738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23991013	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300189
J	Ai, HS; Huang, LS; Ren, J				Ai, Huashui; Huang, Lusheng; Ren, Jun			Genetic Diversity, Linkage Disequilibrium and Selection Signatures in Chinese and Western Pigs Revealed by Genome-Wide SNP Markers	PLOS ONE			English	Article							B RECEPTOR GENE; DOMESTIC PIG; ADAPTATION; DELETION; TRAITS; ORIGIN; BREEDS; EXTENT	To investigate population structure, linkage disequilibrium (LD) pattern and selection signature at the genome level in Chinese and Western pigs, we genotyped 304 unrelated animals from 18 diverse populations using porcine 60 K SNP chips. We confirmed the divergent evolution between Chinese and Western pigs and showed distinct topological structures of the tested populations. We acquired the evidence for the introgression of Western pigs into two Chinese pig breeds. Analysis of runs of homozygosity revealed that historical inbreeding reduced genetic variability in several Chinese breeds. We found that intrapopulation LD extents are roughly comparable between Chinese and Western pigs. However, interpopulation LD is much longer in Western pigs compared with Chinese pigs with average r(0.3)(2) values of 125 kb for Western pigs and only 10.5 kb for Chinese pigs. The finding indicates that higher-density markers are required to capture LD with causal variants in genome-wide association studies and genomic selection on Chinese pigs. Further, we looked across the genome to identify candidate loci under selection using F-ST outlier tests on two contrast samples: Tibetan pigs versus lowland pigs and belted pigs against non-belted pigs. Interestingly, we highlighted several genes including ADAMTS12, SIM1 and NOS1 that show signatures of natural selection in Tibetan pigs and are likely important for genetic adaptation to high altitude. Comparison of our findings with previous reports indicates that the underlying genetic basis for high-altitude adaptation in Tibetan pigs, Tibetan peoples and yaks is likely distinct from one another. Moreover, we identified the strongest signal of directional selection at the EDNRB loci in Chinese belted pigs, supporting EDNRB as a promising candidate gene for the white belt coat color in Chinese pigs. Altogether, our findings advance the understanding of the genome biology of Chinese and Western pigs.	[Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	lushenghuang@hotmail.com; renjunjxau@hotmail.com	Ren, Jun/H-9793-2019; Cheng, Alfred/C-3327-2014; Wu, William K.K./A-3277-2009; Chan, Franky/M-1043-2018; Chan, Francis K.L./F-4851-2010; SUNG, Joseph J Y/R-3203-2018	Yu, Fei-Hai/0000-0001-5007-1745; Cheng, Alfred/0000-0003-2345-6951; Dong, Bi-Cheng/0000-0002-9658-9969; Wu, William K.K./0000-0002-5662-5240; Chan, Franky/0000-0003-0567-2052; Zhang, Lin/0000-0003-1634-3780; Chan, Francis K.L./0000-0001-7388-2436; SUNG, Joseph J Y/0000-0003-3125-5199	Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]; National Natural Science Foundation of China [31160450]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT1136) and National Natural Science Foundation of China (31160450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; CECCHERINI I, 1995, HUM MOL GENET, V4, P2089, DOI 10.1093/hmg/4.11.2089; Fan B, 2002, ANIM GENET, V33, P422, DOI 10.1046/j.1365-2052.2002.00898.x; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Giuffra E, 2000, GENETICS, V154, P1785; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kline DD, 1998, J PHYSIOL-LONDON, V511, P273, DOI 10.1111/j.1469-7793.1998.273bi.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; McLaren D. G., 1990, Animal Breeding Abstracts, V58, P347; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ren J, 2011, HEREDITY, V106, P862, DOI 10.1038/hdy.2010.129; Ren Jun, 2002, Acta Genetica Sinica, V29, P774; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; SVED J A, 1971, Theoretical Population Biology, V2, P125; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang SL, 2003, GENET SEL EVOL, V35, P657, DOI 10.1051/gse:2003045	42	212	229	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56001	10.1371/journal.pone.0056001	http://dx.doi.org/10.1371/journal.pone.0056001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409110	Green Submitted, gold, Green Published			2022-12-27	WOS:000315157200102
J	Lin, CW; Chen, PN; Chen, MK; Yang, WE; Tang, CH; Yang, SF; Hsieh, YS				Lin, Chiao-Wen; Chen, Pei-Ni; Chen, Mu-Kuan; Yang, Wei-En; Tang, Chih-Hsin; Yang, Shun-Fa; Hsieh, Yih-Shou			Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; TISSUE INHIBITOR; INVASION; FLAVONOIDS; CARCINOMA; MIGRATION; INACTIVATION; INFLAMMATION	Background: Kaempferol has been proposed as a potential drug for cancer chemoprevention and treatment because it is a natural polyphenol contained in plant-based foods. Recent studies have demonstrated that kaempferol protects against cardiovascular disease and cancer. Based on this finding, we investigated the mechanisms by which kaempferol produces the anti-metastatic effect in human tongue squamous cell carcinoma SCC4 cells. Methodology/Principal Findings: In this study, we provided molecular evidence associated with the anti-metastatic effect of kaempferol by demonstrating a substantial suppression of SCC4 cell migration and invasion. This effect was associated with reduced expressions of MMP-2 and TIMP-2 mRNA and protein levels. Analysis of the transcriptional regulation indicated that kaempferol inhibited MMP-2 transcription by suppressing c-Jun activity. Kaempferol also produced an inhibitory effect on the phosphorylation of ERK1/2. Conclusions: These findings provide new insights into the molecular mechanisms involved in the anti-metastatic effect of kaempferol, and are valuable in the prevention of oral cancer metastasis.	[Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Yang, Wei-En; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; csmcysh@csmu.edu.tw	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	National Science Council, Taiwan [NSC-100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from National Science Council, Taiwan (NSC-100-2632-B-040-001-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Bestwick CS, 2005, BBA-MOL BASIS DIS, V1740, P340, DOI 10.1016/j.bbadis.2004.10.005; Bosetti C, 2005, CANCER EPIDEM BIOMAR, V14, P805, DOI 10.1158/1055-9965.EPI-04-0838; Bosetti C, 2006, NUTR CANCER, V56, P123, DOI 10.1207/s15327914nc5602_1; Bourboulia D, 2013, ONCOTARGET, V4, P166; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen HJ, 2013, ONCOL REP, V30, P925, DOI 10.3892/or.2013.2490; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Vicente JC, 2005, ORAL ONCOL, V41, P568, DOI 10.1016/j.oraloncology.2004.12.008; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Douglas DA, 1997, J PROTEIN CHEM, V16, P237, DOI 10.1023/A:1026348808069; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008; Gohji K, 1996, CANCER RES, V56, P3196; Hong IK, 2005, EXP MOL MED, V37, P230, DOI 10.1038/emm.2005.31; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; Huang YB, 2013, INT J UROL; Iype E M, 2001, J Postgrad Med, V47, P171; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kang JW, 2010, PHYTOTHER RES, V24, pS77, DOI 10.1002/ptr.2913; Kawabata K, 2005, BIOSCI BIOTECH BIOCH, V69, P307, DOI 10.1271/bbb.69.307; Labbe D, 2009, J NUTR, V139, P646, DOI 10.3945/jn.108.102616; Leifler KS, 2013, J IMMUNOL, V190, P4420, DOI 10.4049/jimmunol.1202610; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Luo HT, 2009, NUTR CANCER, V61, P554, DOI 10.1080/01635580802666281; Ma CY, 2011, J AGR FOOD CHEM, V59, P9032, DOI 10.1021/jf202027n; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Peng CY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/732578; Rossi M, 2006, CANCER EPIDEM BIOMAR, V15, P1555, DOI 10.1158/1055-9965.EPI-06-0017; Shan B, 2013, ASIAN PAC J TROP MED, V6, P826, DOI 10.1016/S1995-7645(13)60146-7; Sun CY, 2006, ACTA PHARMACOL SIN, V27, P1447, DOI 10.1111/j.1745-7254.2006.00343.x; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; Wang XX, 2013, TUMOUR BIOL; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xiao HB, 2009, EUR J PHARMACOL, V616, P213, DOI 10.1016/j.ejphar.2009.06.022; Yang JS, 2013, FOOD CHEM TOXICOL, V59, P801, DOI 10.1016/j.fct.2013.06.028; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Zhao MJ, 2013, INT J MED SCI, V10, P995, DOI 10.7150/ijms.5963	50	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80883	10.1371/journal.pone.0080883	http://dx.doi.org/10.1371/journal.pone.0080883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278338	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100123
J	Lin, C; Zou, Y; Qin, J; Liu, XR; Jiang, Y; Ke, CH; Zou, Q				Lin, Chen; Zou, Ying; Qin, Ji; Liu, Xiangrong; Jiang, Yi; Ke, Caihuan; Zou, Quan			Hierarchical Classification of Protein Folds Using a Novel Ensemble Classifier	PLOS ONE			English	Article							REPRESENTATIVE SET; SCOP; RECOGNITION; SELECTION; DATABASE; IMPACT	The analysis of biological information from protein sequences is important for the study of cellular functions and interactions, and protein fold recognition plays a key role in the prediction of protein structures. Unfortunately, the prediction of protein fold patterns is challenging due to the existence of compound protein structures. Here, we processed the latest release of the Structural Classification of Proteins (SCOP, version 1.75) database and exploited novel techniques to impressively increase the accuracy of protein fold classification. The techniques proposed in this paper include ensemble classifying and a hierarchical framework, in the first layer of which similar or redundant sequences were deleted in two manners; a set of base classifiers, fused by various selection strategies, divides the input into seven classes; in the second layer of which, an analogous ensemble method is adopted to predict all protein folds. To our knowledge, it is the first time all protein folds can be intelligently detected hierarchically. Compared with prior studies, our experimental results demonstrated the efficiency and effectiveness of our proposed method, which achieved a success rate of 74.21%, which is much higher than results obtained with previous methods (ranging from 45.6% to 70.5%). When applied to the second layer of classification, the prediction accuracy was in the range between 23.13% and 46.05%. This value, which may not be remarkably high, is scientifically admirable and encouraging as compared to the relatively low counts of proteins from most fold recognition programs. The web server Hierarchical Protein Fold Prediction (HPFP) is available at http://datamining.xmu.edu.cn/software/hpfp.	[Lin, Chen; Zou, Ying; Liu, Xiangrong; Jiang, Yi; Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China; [Qin, Ji; Ke, Caihuan] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Peoples R China; [Lin, Chen; Liu, Xiangrong] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Lin, C (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China.	chenlin@xmu.edu.cn; zouquan@xmu.edu.cn	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	Natural Science Foundation of China [61001013, 61102136]; Natural Science Foundation of Fujian Province of China [2011J05158, 2010J01350]; National Basic Research Program of China [2010CB1264000]; Base Research Project of Shenzhen Bureau of Science, Technology and Information [JC201006030858A, JCYJ20120618155655087]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National Basic Research Program of China(National Basic Research Program of China); Base Research Project of Shenzhen Bureau of Science, Technology and Information	The work was supported by the Natural Science Foundation of China (No. 61001013, No. 61102136), Natural Science Foundation of Fujian Province of China (No. 2011J05158, No. 2010J01350), The National Basic Research Program of China (No. 2010CB1264000) and the Base Research Project of Shenzhen Bureau of Science, Technology and Information(JC201006030858A, JCYJ20120618155655087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BOBERG J, 1992, PROTEINS, V14, P265, DOI 10.1002/prot.340140212; Boisvert S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-110; Bologna G, 2003, ARTIF INTELL MED, V28, P141, DOI 10.1016/S0933-3657(03)00055-1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2003, ANAL BIOCHEM, V268, P407; Cai YD, 2010, MOL CELLS, V30, P99, DOI 10.1007/s10059-010-0093-0; Chen K, 2007, BIOINFORMATICS, V23, P2843, DOI 10.1093/bioinformatics/btm475; Chen W, 2012, GENET MOL RES, V11, P174, DOI 10.4238/2012.January.27.4; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Feng JH, 2012, VLDB J, V21, P437, DOI 10.1007/s00778-011-0252-8; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOBOHM U, 1994, PROTEIN SCI, V3, P522; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Honda M, 2005, J AUTOIMMUN, V25, P133, DOI 10.1016/j.jaut.2005.03.009; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nanni L, 2006, NEUROCOMPUTING, V69, P2434, DOI 10.1016/j.neucom.2006.01.026; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Vendruscolo M, 2005, P NATL ACAD SCI USA, V102, P5641, DOI 10.1073/pnas.0500274102; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X; Zou Q, 2013, J COMPUT THEOR NANOS, V10, P1038, DOI 10.1166/jctn.2013.2804	31	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56499	10.1371/journal.pone.0056499	http://dx.doi.org/10.1371/journal.pone.0056499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24278338	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200085
J	Wang, JB; Zhu, TC; Ni, HW; Zhong, HX; Fu, XL; Wang, JF				Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng			Effects of Elevated CO2 and Nitrogen Deposition on Ecosystem Carbon Fluxes on the Sanjiang Plain Wetland in Northeast China	PLOS ONE			English	Article							NET ECOSYSTEM; SOIL RESPIRATION; EXCHANGE; FOREST; SEQUESTRATION; LIMITATION; GRASSLAND; RESPONSES; DIOXIDE; ENRICHMENT	Background: Increasing atmospheric CO2 and nitrogen (N) deposition across the globe may affect ecosystem CO2 exchanges and ecosystem carbon cycles. Additionally, it remains unknown how increased N deposition and N addition will alter the effects of elevated CO2 on wetland ecosystem carbon fluxes. Methodology/Principal Findings: Beginning in 2010, a paired, nested manipulative experimental design was used in a temperate wetland of northeastern China. The primary factor was elevated CO2, accomplished using Open Top Chambers, and N supplied as NH4NO3 was the secondary factor. Gross primary productivity (GPP) was higher than ecosystem respiration (ER), leading to net carbon uptake (measured by net ecosystem CO2 exchange, or NEE) in all four treatments over the growing season. However, their magnitude had interannual variations, which coincided with air temperature in the early growing season, with the soil temperature and with the vegetation cover. Elevated CO2 significantly enhanced GPP and ER but overall reduced NEE because the stimulation caused by the elevated CO2 had a greater impact on ER than on GPP. The addition of N stimulated ecosystem C fluxes in both years and ameliorated the negative impact of elevated CO2 on NEE. Conclusion/Significance: In this ecosystem, future elevated CO2 may favor carbon sequestration when coupled with increasing nitrogen deposition.	[Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Wang, Jianbo; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng] Heilongjiang Acad Sci, Inst Nat Resources & Ecol, Harbin, Heilongjiang Pr, Peoples R China	Northeast Normal University - China	Ni, HW (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	nihongwei2000@163.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30970452]; Heilongjiang Province Funds for Distinguished Young Scientists [JC03-09]; Fundamental Research Funds for the Finance Department of Heilongjiang Province [2012EFA-02]; Natural Science Foundation of Heilongjiang Province [C201032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Funds for Distinguished Young Scientists; Fundamental Research Funds for the Finance Department of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This research was supported by the National Natural Science Foundation of China (30970452), the Heilongjiang Province Funds for Distinguished Young Scientists (JC03-09), Fundamental Research Funds for the Finance Department of Heilongjiang Province (2012EFA-02), and the Natural Science Foundation of Heilongjiang Province (C201032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2011, GLOBAL CHANGE BIOL, V17, P3546, DOI 10.1111/j.1365-2486.2011.02484.x; Aeschlimann U, 2005, PLANT CELL ENVIRON, V28, P823, DOI 10.1111/j.1365-3040.2005.01331.x; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Bachman S, 2010, OECOLOGIA, V162, P791, DOI 10.1007/s00442-009-1511-x; Bonneville MC, 2008, AGR FOREST METEOROL, V148, P69, DOI 10.1016/j.agrformet.2007.09.004; Bradford MA, 2008, GLOBAL CHANGE BIOL, V14, P1113, DOI 10.1111/j.1365-2486.2008.01564.x; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Hymus GJ, 2003, GLOBAL CHANGE BIOL, V9, P1802, DOI 10.1111/j.1365-2486.2003.00675.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Jasoni RL, 2005, GLOBAL CHANGE BIOL, V11, P749, DOI 10.1111/j.1365-2486.2005.00948.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Kivimaki SK, 2013, ENVIRON EXP BOT, V90, P53, DOI 10.1016/j.envexpbot.2012.09.003; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu De-yan, 2008, Ying Yong Sheng Tai Xue Bao, V19, P2599; [刘德燕 LIU Deyan], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P305; Lovell RD, 1997, BIOL FERT SOILS, V26, P28, DOI 10.1007/s003740050338; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Milchunas DG, 2005, PLANT SOIL, V268, P111, DOI 10.1007/s11104-004-0230-7; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pendall E, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001821; Randerson JT, 2002, ECOL APPL, V12, P937, DOI 10.1890/1051-0761(2002)012[0937:NEPACM]2.0.CO;2; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Saarnio S, 2003, ECOSYSTEMS, V6, P46, DOI 10.1007/s10021-002-0208-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2011, AGR FOREST METEOROL, V151, P1131, DOI 10.1016/j.agrformet.2011.04.001; Sowerby A, 2000, SOIL BIOL BIOCHEM, V32, P1359, DOI 10.1016/S0038-0717(00)00045-6; Steduto P, 2002, AGR FOREST METEOROL, V111, P171, DOI 10.1016/S0168-1923(02)00023-0; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; [孙志高 SUN Zhigao], 2007, [水科学进展, Advances in Water Science], V18, P182; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao GuangYing, 2008, Research of Environmental Sciences, V21, P134; Zhou XP, 2012, J ENVIRON SCI, V24, P2104, DOI 10.1016/S1001-0742(11)61057-7	46	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66563	10.1371/journal.pone.0066563	http://dx.doi.org/10.1371/journal.pone.0066563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	24244307	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800079
J	Wang, JH; Sharma, A; Ghamande, SA; Bush, S; Ferris, D; Zhi, WB; He, MF; Wang, MY; Wang, XX; Miller, E; Hopkins, D; Macfee, M; Guan, RL; Tang, JH; She, JX				Wang, Jinhua; Sharma, Ashok; Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Macfee, Michael; Guan, Ruili; Tang, Jinhai; She, Jin-Xiong			Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer	PLOS ONE			English	Article							BIOMARKER PANELS; DIAGNOSIS; PROGRESSION; MARKERS; INFLAMMATION; VALIDATION; CA-125; CA125; ASSAY	Background: Biomarkers play critical roles in early detection, diagnosis and monitoring of therapeutic outcome and recurrence of cancer. Previous biomarker research on ovarian cancer (OC) has mostly focused on the discovery and validation of diagnostic biomarkers. The primary purpose of this study is to identify serum biomarkers for prognosis and therapeutic outcomes of ovarian cancer. Experimental Design: Forty serum proteins were analyzed in 70 serum samples from healthy controls (HC) and 101 serum samples from serous OC patients at three different disease phases: post diagnosis (PD), remission (RM) and recurrence (RC). The utility of serum proteins as OC biomarkers was evaluated using a variety of statistical methods including survival analysis. Results: Ten serum proteins (PDGF-AB/BB, PDGF-AA, CRP, sFas, CA125, SAA, sTNFRII, sIL-6R, IGFBP6 and MDC) have individually good area-under-the-curve (AUC) values (AUC = 0.69-0.86) and more than 10 three-marker combinations have excellent AUC values (0.91-0.93) in distinguishing active cancer samples (PD & RC) from HC. The mean serum protein levels for RM samples are usually intermediate between HC and OC patients with active cancer (PD & RC). Most importantly, five proteins (sICAM1, RANTES, sgp130, sTNFR-II and sVCAM1) measured at remission can classify, individually and in combination, serous OC patients into two subsets with significantly different overall survival (best HR = 17, p <10(-3)). Conclusion: We identified five serum proteins which, when measured at remission, can accurately predict the overall survival of serous OC patients, suggesting that they may be useful for monitoring the therapeutic outcomes for ovarian cancer.	[Wang, Jinhua; Sharma, Ashok; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Guan, Ruili; She, Jin-Xiong] Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Wang, Jinhua; He, Mingfang; Tang, Jinhai; She, Jin-Xiong] Nanjing Univ Technol, Sino Amer Canc Res Inst, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Wang, Meiyao; Tang, Jinhai; She, Jin-Xiong] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Tang, Jinhai] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; He, Mingfang; She, Jin-Xiong] Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Macfee, Michael] Georgia Hlth Sci Univ, Dept Obstet & Gynecol, Augusta, GA USA; [Guan, Ruili] Beijing Univ, Inst Urol Surg, Hosp 1, Beijing 100871, Peoples R China	University System of Georgia; Augusta University; Nanjing Tech University; Nanjing Medical University; Nanjing Medical University; Nanjing Tech University; University System of Georgia; Augusta University; Peking University	She, JX (corresponding author), Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@gru.edu	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure [RC2011091]; Jiangsu Government Scholarship; "333" Plan	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure; Jiangsu Government Scholarship; "333" Plan	This work was partly supported by a grant from the Georgia Cancer Coalition to DF and JXS. JXS was supported by the Georgia Research Alliance as an eminent scholar. JW was supported by Jiangsu Medical key Figure (RC2011091) and Jiangsu Government Scholarship and "333" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amonkar SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004599; Antovska S V, 2011, Klin Onkol, V24, P435; Autelitano DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-45; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Ben-Hamo R, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-3; Burger RA, 2004, CANCER-AM CANCER SOC, V101, P106, DOI 10.1002/cncr.20314; Burger RA, 2011, GYNECOL ONCOL, V121, P230, DOI 10.1016/j.ygyno.2010.11.035; Clarke CH, 2011, GYNECOL ONCOL, V122, P548, DOI 10.1016/j.ygyno.2011.06.002; Das PM, 2008, BIOMARK MED, V2, P291, DOI 10.2217/17520363.2.3.291; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Havrilesky LJ, 2008, GYNECOL ONCOL, V110, P374, DOI 10.1016/j.ygyno.2008.04.041; Hefler-Frischmuth K, 2009, EUR J OBSTET GYN R B, V147, P65, DOI 10.1016/j.ejogrb.2009.06.010; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hogdall C, 2011, GYNECOL ONCOL, V123, P308, DOI 10.1016/j.ygyno.2011.07.018; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim K, 2009, CLIN LAB MED, V29, P47, DOI 10.1016/j.cll.2009.02.001; Langmar Z, 2011, EUR J GYNAECOL ONCOL, V32, P605; Lee CK, 2011, J NATL CANCER I, V103, P1338, DOI 10.1093/jnci/djr282; Lu D, 2011, GYNECOL ONCOL, V122, P560, DOI 10.1016/j.ygyno.2011.05.039; Lundin E, 2009, CANCER CAUSE CONTROL, V20, P1151, DOI 10.1007/s10552-009-9330-2; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mury D, 2011, J CANCER RES CLIN, V137, P1131, DOI 10.1007/s00432-011-0977-1; Nolen B, 2010, GYNECOL ONCOL, V117, P440, DOI 10.1016/j.ygyno.2010.02.005; Rahbari NN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-286; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skaznik-Wikiel ME, 2011, INT J GYNECOL CANCER, V21, P1013, DOI 10.1097/IGC.0b013e31821ce903; Steffensen KD, 2011, INT J GYNECOL CANCER, V21, P1040, DOI 10.1097/IGC.0b013e31821e052e; Tang A, 2012, GYNECOL ONCOL; Toriola AT, 2011, ANN ONCOL, V22, P1916, DOI 10.1093/annonc/mdq694; van Altena AM, 2010, GYNECOL ONCOL, V119, P265, DOI 10.1016/j.ygyno.2010.07.025; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Yip P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029533; Yurkovetsky Z, 2007, GYNECOL ONCOL, V107, P58, DOI 10.1016/j.ygyno.2007.05.041; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zheng YY, 2007, CLIN CANCER RES, V13, P6984, DOI 10.1158/1078-0432.CCR-07-1409; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	42	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78393	10.1371/journal.pone.0078393	http://dx.doi.org/10.1371/journal.pone.0078393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244307	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600026
J	Wang, JL; Hu, Y; Kong, X; Wang, ZH; Chen, HY; Xu, J; Fang, JY				Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan			Candidate microRNA Biomarkers in Human Gastric Cancer: A Systematic Review and Validation Study	PLOS ONE			English	Review							CELL-PROLIFERATION; POTENTIAL BIOMARKERS; SERUM MIR-21; EXPRESSION; INVASION; PROGRESSION; MIR-17-5P; MIGRATION; MIR-18A; DYSREGULATION	Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide and there is therefore a clear need to search for more sensitive early diagnostic biomarkers. We performed a systematic review of eight published miRNA profiling studies that compared GC tissues with adjacent noncancerous tissues. A miRNA ranking system was used that took the frequency of comparisons, direction of differential expression and total sample size into consideration. We identified five miRNAs that were most consistently reported to be upregulated (miR-21, miR-106b, miR-17, miR-18a and miR-20a) and two miRNAs that were downregulated (miR-378 and miR-638). Six of these were further validated in 32 paired sets of GC and adjacent noncancerous tissue samples using real-time PCR. MiR-21, miR-106b, miR-17, miR-18a and miR-20a were confirmed to be upregulatedin GC tissues, while the expression of miR-378 was decreased. Moreover, we found a significant association between expression levels of miR-21, miR-106b, miR-17, miR-18a and miR-20a and clinicopathological features of GC. These miRNAs may be used for diagnostic and/or prognostic biomarkers for GC and therefore warrant further investigation.	[Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China; [Fang, Jing-Yuan] Minist Hlth, Key Lab Gastroenterol & Hepatol, Shanghai, Peoples R China; [Fang, Jing-Yuan] State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China.	xujieletter@gmail.com; jingyuanfang@yahoo.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of Key Program [30830055]; Ministry of Public Health, China [200802094]; Ministry of Education [20090073110077]; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine [BXJ201219]	National Natural Science Foundation of Key Program; Ministry of Public Health, China; Ministry of Education; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine	This work was supported by grants from the National Natural Science Foundation of Key Program (No. 30830055), the Ministry of Public Health, China (No. 200802094), the Ministry of Education (No. 20090073110077) to Fang JY, and the Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine (No. BXJ201219) to Wang JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Ang TL, 2010, SINGAP MED J, V51, P93; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Cao Z, 2012, J CANCER RES CLIN, V138, P611, DOI 10.1007/s00432-011-1140-8; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen LT, 2012, MED ONCOL, V29, P1673, DOI 10.1007/s12032-011-0083-x; Cui L, 2013, CANCER, DOI [10.1002/cncr.27903, DOI 10.1002/CNCR.27903.PMID:23335180]; Deng H, 2013, GENE; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Faltejskova P, 2012, CANCER BIOMARK, V12, P199, DOI 10.3233/CBM-130308; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Guo L, 2012, MOL BIOL REP; Han ML, 2012, CANCER SCI, V103, P1058, DOI 10.1111/j.1349-7006.2012.02281.x; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li LH, 2012, DIGEST DIS SCI, V57, P2910, DOI 10.1007/s10620-012-2317-y; Li X, 2012, CANCER BIOL THER, V13, P890, DOI 10.4161/cbt.20841; Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ma YL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2276; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang J, 2012, EUR J CANCER, V48, P1904, DOI 10.1016/j.ejca.2011.11.026; Wang M, 2013, EUR J CANC; Wang M, 2012, MOL MED REP, V5, P1514, DOI 10.3892/mmr.2012.828; Wohrer SS, 2004, ANN ONCOL, V15, P1585, DOI 10.1093/annonc/mdh422; Wu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044579; Wu W, 2013, BRIT J CANCER, V108, P653, DOI 10.1038/bjc.2012.587; Xu YJ, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/640168; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yu J, 2010, CANCER BIOL THER, V10, P748, DOI 10.4161/cbt.10.8.13083; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645	56	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73683	10.1371/journal.pone.0073683	http://dx.doi.org/10.1371/journal.pone.0073683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24244307	Green Published, Green Submitted, gold			2022-12-27	WOS:000326405300110
J	Wang, JG; Han, J; Jia, YX; Zeng, W; Hou, XT; Meng, X				Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu			Outcome of Veno-Arterial Extracorporeal Membrane Oxygenation for Patients Undergoing Valvular Surgery	PLOS ONE			English	Article							POSTCARDIOTOMY CARDIOGENIC-SHOCK; ADULT PATIENTS; LIFE-SUPPORT; SURVIVAL; EXPERIENCE; FAILURE; RESCUE; RISK	Background: We evaluated retrospectively the early and midterm results of using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support in patients undergoing valvular surgery. Methods: A total of 87 patients undergoing valvular surgery received VA-ECMO due to refractory postcardiotomy cardiogenic shock (PCS), who were eligible for inclusion were enrolled in this study. Preoperative, perioperative, and postoperative variables were assessed and analyzed for possible associations with mortality in hospital and after discharge. Results: The mean age, additive EuroSCORE, and left ventricular ejection fraction (LVEF) for all patients was 65 +/- 7 years, 6.1 +/- 1.9 points, and 46% +/- 12%, respectively. The mean duration of VA-ECMO support was 61 +/- 37 hours. Intra-aortic balloon pumps (IABP) were implanted in 47.1% of patients. Weaning from VA-ECMO was successful in 59% of patients, and 49% were discharged. Multivariate analysis revealed that being >65 years old (odds ratio [OR], 2.75), receiving postoperative renal replacement treatment (OR, 2.47), having a peak lactate level >= 12 mmol L-1 (OR, 2.18), and receiving VA-ECMO for >60 hours (OR, 3.2) were independent predictors of in-hospital mortality. IABP support (OR, 0.46) was protective. In addition, persistent heart failure with an LVEF <40% was an independent predictor of mortality after discharge. Conclusions: VA-ECMO is an acceptable technique for the treatment of PCS in patients undergoing valvular surgery, who would otherwise die. It is justified by the good long-term outcomes of hospital survivors, but the use of VA-ECMO must be decided on an individual risk profile basis because of high morbidity and mortality rates.	[Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China	Capital Medical University	Wang, JG (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	wangjiangang7545@126.com; mxu@263.net	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30900629]; Beijing Novo Program [2010B047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Novo Program	This work was supported by the National Natural Science Foundation of China [Grant No. 30900629] and the Beijing Novo Program [Grant No. 2010B047]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt M, EUR J CARDIOTHORAC S, V40, P689; Aubron C, 2013, INFECT CONT HOSP EP, V34, P24, DOI 10.1086/668439; Aziz TA, 2010, J HEART LUNG TRANSPL, V29, P66, DOI 10.1016/j.healun.2009.08.025; Bakhtiary F, 2008, J THORAC CARDIOV SUR, V135, P382, DOI 10.1016/j.jtcvs.2007.08.007; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Doll N, 2004, ANN THORAC SURG, V77, P151, DOI 10.1016/S0003-4975(03)01329-8; GOLDING LAR, 1992, ANN THORAC SURG, V54, P1059, DOI 10.1016/0003-4975(92)90070-K; Gupta P, 2012, ANN THORAC SURG, V93, P1584, DOI 10.1016/j.athoracsur.2012.01.008; Hsu PS, 2010, EUR J CARDIO-THORAC, V37, P328, DOI 10.1016/j.ejcts.2009.07.033; Ko WJ, 2002, ANN THORAC SURG, V73, P538, DOI 10.1016/S0003-4975(01)03330-6; Lin JW, 2010, RESUSCITATION, V81, P796, DOI 10.1016/j.resuscitation.2010.03.002; Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009; MUEHRCKE DD, 1995, J THORAC CARDIOV SUR, V110, P843, DOI 10.1016/S0022-5223(95)70119-2; RASTAN AJ, 2010, J THORAC CARDIOVASC, V139; Rastan AJ, 2010, J THORAC CARDIOV SUR, V139, P302, DOI 10.1016/j.jtcvs.2009.10.043; Smedira NG, 2001, J THORAC CARDIOV SUR, V122, P92, DOI 10.1067/mtc.2001.114351; Wang JG, 2009, ANN THORAC SURG, V88, P1897, DOI 10.1016/j.athoracsur.2009.08.009; Wu MY, 2010, RESUSCITATION, V81, P1111, DOI 10.1016/j.resuscitation.2010.04.031	18	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63924	10.1371/journal.pone.0063924	http://dx.doi.org/10.1371/journal.pone.0063924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	24244307	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600036
J	Zhu, X; Silva, LCR; Doane, TA; Horwath, WR				Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.			Iron: The Forgotten Driver of Nitrous Oxide Production in Agricultural Soil	PLOS ONE			English	Article							SPECTROPHOTOMETRIC DETERMINATION; WETLAND SOILS; NO EMISSIONS; FERROUS IRON; OXIDATION; REDUCTION; N2O; NITRATE; MICROORGANISMS; HYDROXYLAMINE	In response to rising interest over the years, many experiments and several models have been devised to understand emission of nitrous oxide (N2O) from agricultural soils. Notably absent from almost all of this discussion is iron, even though its role in both chemical and biochemical reactions that generate N2O was recognized well before research on N2O emission began to accelerate. We revisited iron by exploring its importance alongside other soil properties commonly believed to control N2O production in agricultural systems. A set of soils from California's main agricultural regions was used to observe N2O emission under conditions representative of typical field scenarios. Results of multivariate analysis showed that in five of the twelve different conditions studied, iron ranked higher than any other intrinsic soil property in explaining observed emissions across soils. Upcoming studies stand to gain valuable information by considering iron among the drivers of N2O emission, expanding the current framework to include coupling between biotic and abiotic reactions.	[Zhu, Xia] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zhu, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Doane, TA (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	tadoane@ucdavis.edu	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	California Department of Resources Recycling and Recovery [IWM09027]; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station	California Department of Resources Recycling and Recovery; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station(University of California System)	Support was provided by the California Department of Resources Recycling and Recovery (www.calrecycle.ca.gov), Agreement IWM09027; the J. G. Boswell Endowed Chair in Soil Science; and the University of California Agricultural Experiment Station (http://caes.ucdavis.edu/research/agexpstn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson G, 2002, J CHEM SOC DALTON, P2548, DOI 10.1039/b201602h; BOUWMAN AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P557, DOI 10.1029/93GB01186; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; BREMNER JM, 1946, NATURE, V158, P790, DOI 10.1038/158790b0; Bremner JM, 1997, NUTR CYCL AGROECOSYS, V49, P7, DOI 10.1023/A:1009798022569; BREMNER JM, 1980, SOIL BIOL BIOCHEM, V12, P263, DOI 10.1016/0038-0717(80)90072-3; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Burger M, 2011, ACS SYM SER, V1072, P179; Burt R, 1992, 42 USDA; CASSEL DK, 1986, AGRONOMY, V9, P901; Chalamet A, 1976, SOIL BIOL BIOCHEM, V9, P281; CHAO TT, 1966, SOIL SCI SOC AM PRO, V30, P193, DOI 10.2136/sssaj1966.03615995003000020016x; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Dobbie KE, 1999, J GEOPHYS RES-ATMOS, V104, P26891, DOI 10.1029/1999JD900378; Dominik P, 2000, TALANTA, V51, P701, DOI 10.1016/S0039-9140(99)00324-0; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272, DOI 10.2134/jeq1990.00472425001900020013x; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P74, DOI 10.1890/100137; Freibauer A, 2003, BIOGEOCHEMISTRY, V63, P93, DOI 10.1023/A:1023398108860; Freney JR, 1997, NUTR CYCL AGROECOSYS, V49, P1, DOI 10.1023/A:1009702832489; Glass JB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00061; Goetz O., 2010, HDB PARTIAL LEAST SQ, P411, DOI [10.1007/978-3-540-32827-8_33, DOI 10.1007/978-3-540-32827-8]; HANSEN HCB, 1994, GEOCHIM COSMOCHIM AC, V58, P2599, DOI 10.1016/0016-7037(94)90131-7; HENDRICKSON AH, 1945, PLANT PHYSIOL, V20, P517, DOI 10.1104/pp.20.4.517; Li CS, 2000, J GEOPHYS RES-ATMOS, V105, P4369, DOI 10.1029/1999JD900949; LOVELAND PJ, 1984, J SOIL SCI, V35, P243, DOI 10.1111/j.1365-2389.1984.tb00280.x; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Marcoulides GA, 2009, MIS QUART, V33, P171; MEIKLEJOHN J, 1953, J GEN MICROBIOL, V8, P58, DOI 10.1099/00221287-8-1-58; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; ROBERTSON K, 1994, J ENVIRON QUAL, V23, P805, DOI 10.2134/jeq1994.00472425002300040027x; Sahrawat K. L., 1986, Advances in Soil Science, USA, V4, P103; SCHUPPLI PA, 1983, SOIL SCI SOC AM J, V47, P1026, DOI 10.2136/sssaj1983.03615995004700050037x; Shrestha J, 2009, SOIL SCI, V174, P156, DOI 10.1097/SS.0b013e3181988fbf; Silver WL, 2011, IRON REDOX ENGINE DR; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Straub KL, 1996, APPL ENVIRON MICROB, V62, P1458, DOI 10.1128/AEM.62.4.1458-1460.1996; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Thomson AJ, 2012, PHILOS T R SOC B, V367, P1157, DOI 10.1098/rstb.2011.0415; Veihmeyer FJ, 1931, SOIL SCI, V32, P181, DOI 10.1097/00010694-193109000-00003; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124	46	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60146	10.1371/journal.pone.0060146	http://dx.doi.org/10.1371/journal.pone.0060146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555906	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900060
J	Zhu, XY; Li, P; Yang, YB; Liu, ML				Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin			Xuezhikang, Extract of Red Yeast Rice, Improved Abnormal Hemorheology, Suppressed Caveolin-1 and Increased eNOS Expression in Atherosclerotic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BLOOD-CELLS; HEART-DISEASE; ERYTHROCYTES; VISCOSITY; AORTA; DEFORMABILITY; PATHOGENESIS; ACTIVATION; PATHWAY	Background: Xuezhikang is the extract of red yeast rice, which has been widely used for the management of atherosclerotic disease, but the molecular basis of its antiatherosclerotic effects has not yet been fully identified. Here we investigated the changes of eNOS in vascular endothelia and RBCs, eNOS regulatory factor Caveolin-1 in endothelia, and hemorheological parameters in atherosclerotic rats to explore the protective effects of Xuezhikang. Methodology/Principal Findings: Wistar rats were divided into 4 groups (n = 12/group) group C, controls; group M, high-cholesterol diet (HCD) induced atherosclerotic models; group X, HCD+Xuezhikang; and group L, HCD+Lovastatin. In group X, Xuezhikang inhibited oxidative stress, down-regulated caveolin-1 in aorta wall (P<0.05), up-regulated eNOS expression in vascular endothelia and erythrocytes (P<0.05), increased NOx (nitrite and nitrate) in plasma and cGMP in erythrocyte plasma and aorta wall (P<0.05), increased erythrocyte deformation index (EDI), and decreased whole blood viscosity and plasma viscosity (P<0.05), with the improvement of arterial pathology. Conclusions/Significance: Xuezhikang up-regulated eNOS expression in vascular endothelia and RBCs, increased plasma NOx and improved abnormal hemorheology in high cholesterol diet induced atherosclerotic rats. The elevated eNOS/NO and improved hemorheology may be beneficial to atherosclerotic disease.	[Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin] Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China	Peking University	Liu, ML (corresponding author), Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China.	meilinliu@yahoo.com	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	China Health & Medical Development Foundation	China Health & Medical Development Foundation	This work was supported by China Health & Medical Development Foundation (http://www.chmdf.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti MR, 2006, CLIN EXP PHARMACOL P, V33, P305, DOI 10.1111/j.1440-1681.2006.04366.x; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Chen LY, 1998, J CARDIOVASC PHARM, V32, P57, DOI 10.1097/00005344-199807000-00009; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gori T, 2011, CLIN HEMORHEOL MICRO, V49, P37, DOI 10.3233/CH-2011-1455; HAHN R, 1989, ANGIOLOGY, V40, P914, DOI 10.1177/000331978904001010; Herold S, 2004, INORG CHEM, V43, P3783, DOI 10.1021/ic035340a; Heyman SN, 1999, MICROCIRCULATION, V6, P199; Horn P, 2011, FREE RADICAL RES, V45, P653, DOI 10.3109/10715762.2011.574288; Huang ZY, 2004, LIFE SCI, V75, P3103, DOI 10.1016/j.lfs.2004.04.054; JORIS I, 1983, AM J PATHOL, V113, P341; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Koenig W, 1998, ARTERIOSCL THROM VAS, V18, P768, DOI 10.1161/01.ATV.18.5.768; Korbut RA, 2002, J PHYSIOL PHARMACOL, V53, P655; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Kuwai T, 2006, J ATHEROSCLER THROMB, V13, P286, DOI 10.5551/jat.13.286; Lam TY, 2006, EUR J PHARMACOL, V546, P134, DOI 10.1016/j.ejphar.2006.07.003; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee AJ, 1998, CIRCULATION, V97, P1467; Lee BK, 2008, CLIN HEMORHEOL MICRO, V39, P43, DOI 10.3233/CH-2008-1066; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Li JJ, 2005, CLIN CHIM ACTA, V352, P217, DOI 10.1016/j.cccn.2004.09.026; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; Ma JY, 2000, J AGR FOOD CHEM, V48, P5220, DOI 10.1021/jf000338c; MONCADA S, 1991, PHARMACOL REV, V43, P109; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rassaf T, 2003, NAT MED, V9, P481, DOI 10.1038/nm0503-481; Recchia FA, 2000, AM J PHYSIOL-HEART C, V279, pH852, DOI 10.1152/ajpheart.2000.279.2.H852; Toda N, 2011, INT J ANGIOL, V20, P121, DOI 10.1055/s-0031-1283220; Tsuda K, 2000, BIOCHEM BIOPH RES CO, V275, P946, DOI 10.1006/bbrc.2000.3408; Xue ZH, 2007, CLIN EXP PHARMACOL P, V34, P27, DOI 10.1111/j.1440-1681.2007.04547.x; Zorio E, 2008, CLIN HEMORHEOL MICRO, V39, P33, DOI 10.3233/CH-2008-1065	40	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62731	10.1371/journal.pone.0062731	http://dx.doi.org/10.1371/journal.pone.0062731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23555906	Green Submitted, gold, Green Published			2022-12-27	WOS:000318852400008
